Entry,Entry_Name,Gene_Names,Protein_names,Gene_Names_synonym,gene_id,HGNC_name,HGNC_prev_name,HGNC_alias_name,HGNC_alias_symbol,NCBI_nomenclaturename,NCBI_otheraliases,Gene_name(primary)
A1KXE4,F168B_HUMAN,FAM168B; KIAA0280L; MANI,Myelin-associated neurite-outgrowth inhibitor; Mani; p20,KIAA0280L; MANI,130074,family with sequence similarity 168 member B,family with sequence similarity 168; member B,myelin associated neurite outgrowth inhibitor,KIAA0280L; MANI,family with sequence similarity 168 member B,MANI,FAM168B
A1X283,SPD2B_HUMAN,SH3PXD2B; FAD49; KIAA1295; TKS4,SH3 and PX domain-containing protein 2B; Adapter protein HOFI; Factor for adipocyte differentiation 49; Tyrosine kinase substrate with four SH3 domains,FAD49; KIAA1295; TKS4,285590,SH3 and PX domains 2B,KIAA1295,,FLJ20831,SH3 and PX domains 2B,FAD49; FTHS; HOFI; KIAA1295; TKS4; TSK4,SH3PXD2B
A8K4G0,CLM7_HUMAN,CD300LB; CD300B; CLM7; CMRF35A2; IREM3; LMIR5; TREM5; UNQ2530/PRO6029,CMRF35-like molecule 7; CLM-7; CD300 antigen-like family member B; CMRF35-A2; Immune receptor expressed on myeloid cells 3; IREM-3; Leukocyte mono-Ig-like receptor 5; Triggering receptor expressed on myeloid cells 5; TREM-5; CD antigen CD300b,CD300B; CLM7; CMRF35A2; IREM3; LMIR5; TREM5,124599,CD300 molecule like family member b,CD300 antigen like family member B; CD300 molecule-like family member b,triggering receptor expressed on myeloid cells 5,TREM5; CLM7,CD300 molecule like family member b,CD300b; CLM-7; CLM7; CMRF35-A2; IREM-3; IREM3; TREM-5; TREM5,CD300LB
A8MW95,BECN2_HUMAN,BECN2; BECN1L1; BECN1P1,Beclin-2; Beclin-1 autophagy-related pseudogene 1; Beclin-1-like protein 1,BECN1L1; BECN1P1,441925,beclin 2,beclin 1; autophagy related; pseudogene 1,,,beclin 2,BECN1L1; BECN1P1,BECN2
A8MYU2,KCNU1_HUMAN,KCNU1; KCNMA3; KCNMC1; SLO3,Potassium channel subfamily U member 1; Calcium-activated potassium channel subunit alpha-3; Calcium-activated potassium channel; subfamily M subunit alpha-3; KCa5; Slowpoke homolog 3,KCNMA3; KCNMC1; SLO3,157855,potassium calcium-activated channel subfamily U member 1,potassium channel; subfamily U; member 1,,KCa5.1; Slo3; KCNMC1; Kcnma3,potassium calcium-activated channel subfamily U member 1,KCNMC1; KCa5; KCa5.1; Kcnma3; SPGF79; Slo3,KCNU1
C9JLW8,MCRI1_HUMAN,MCRIP1; FAM195B; GRAN2,Mapk-regulated corepressor-interacting protein 1; Granulin-2; Protein FAM195B,FAM195B; GRAN2,348262,MAPK regulated corepressor interacting protein 1,family with sequence similarity 195; member B; family with sequence similarity 195 member B,granulin-2,GRAN2; MCRIP,MAPK regulated corepressor interacting protein 1,FAM195B; GRAN2; MCRIP,MCRIP1
O00139,KIF2A_HUMAN,KIF2A; KIF2; KNS2,Kinesin-like protein KIF2A; Kinesin-2; hK2,KIF2; KNS2,3796,kinesin family member 2A,kinesin heavy chain member 2,,HK2,kinesin family member 2A,CDCBM3; HK2; KIF2,KIF2A
O00141,SGK1_HUMAN,SGK1; SGK,Serine/threonine-protein kinase Sgk1; EC 2.7.11.1; Serum/glucocorticoid-regulated kinase 1,SGK,6446,serum/glucocorticoid regulated kinase 1,serum/glucocorticoid regulated kinase,,,serum/glucocorticoid regulated kinase 1,SGK,SGK1
O00144,FZD9_HUMAN,FZD9; FZD3,Frizzled-9; Fz-9; hFz9; FzE6; CD antigen CD349,FZD3,8326,frizzled class receptor 9,frizzled (Drosophila) homolog 9; frizzled homolog 9 (Drosophila); frizzled 9; seven transmembrane spanning receptor; frizzled family receptor 9,Frizzled-9,FZD3; CD349,frizzled class receptor 9,CD349; FZD3,FZD9
O00161,SNP23_HUMAN,SNAP23,Synaptosomal-associated protein 23; SNAP-23; Vesicle-membrane fusion protein SNAP-23,,8773,synaptosome associated protein 23,synaptosomal-associated protein; 23kDa,,SNAP23A; SNAP23B; HsT17016,synaptosome associated protein 23,HsT17016; SNAP-23; SNAP23A; SNAP23B,SNAP23
O00168,PLM_HUMAN,FXYD1; PLM,Phospholemman; FXYD domain-containing ion transport regulator 1; Sodium/potassium-transporting ATPase subunit FXYD1,PLM,5348,FXYD domain containing ion transport regulator 1,phospholemman,,,FXYD domain containing ion transport regulator 1,PLM,FXYD1
O00170,AIP_HUMAN,AIP; XAP2,AH receptor-interacting protein; AIP; Aryl-hydrocarbon receptor-interacting protein; HBV X-associated protein 2; XAP-2; Immunophilin homolog ARA9,XAP2,9049,AHR interacting HSP90 co-chaperone,aryl hydrocarbon receptor interacting protein; aryl hydrocarbon receptor-interacting protein,hepatitis B virus X-associated cellular protein 2; aryl hydrocarbon receptor-associated protein 9; FKBP prolyl isomerase 16; X-associated protein-2; FK506-binding protein 37; Ah receptor activated 9,XAP2; ARA9; FKBP16; FKBP37,AHR interacting HSP90 co-chaperone,ARA9; FKBP16; FKBP37; PITA1; SMTPHN; XAP-2; XAP2,AIP
O00206,TLR4_HUMAN,TLR4,Toll-like receptor 4; hToll; CD antigen CD284,,7099,toll like receptor 4,toll-like receptor 4,,hToll; CD284; TLR-4; ARMD10,toll like receptor 4,ARMD10; CD284; TLR-4; TOLL,TLR4
O00213,APBB1_HUMAN,APBB1; FE65; RIR,Amyloid beta precursor protein binding family B member 1; Amyloid-beta A4 precursor protein-binding family B member 1; Protein Fe65,FE65; RIR,322,amyloid beta precursor protein binding family B member 1,amyloid beta (A4) precursor protein-binding; family B; member 1 (Fe65),,Fe65,amyloid beta precursor protein binding family B member 1,FE65; MGC:9072; RIR,APBB1
O00221,IKBE_HUMAN,NFKBIE; IKBE,NF-kappa-B inhibitor epsilon; NF-kappa-BIE; I-kappa-B-epsilon; IkB-E; IkB-epsilon; IkappaBepsilon,IKBE,4794,NFKB inhibitor epsilon,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; epsilon,NF-kappa-B inhibitor epsilon,IKBE,NFKB inhibitor epsilon,IKBE,NFKBIE
O00231,PSD11_HUMAN,PSMD11,26S proteasome non-ATPase regulatory subunit 11; 26S proteasome regulatory subunit RPN6; 26S proteasome regulatory subunit S9; 26S proteasome regulatory subunit p44.5,,5717,proteasome 26S subunit; non-ATPase 11,proteasome (prosome; macropain) 26S subunit; non-ATPase; 11,,S9; p44.5; MGC3844; Rpn6,proteasome 26S subunit; non-ATPase 11,Rpn6; S9; p44.5,PSMD11
O00238,BMR1B_HUMAN,BMPR1B,Bone morphogenetic protein receptor type-1B; BMP type-1B receptor; BMPR-1B; EC 2.7.11.30; CD antigen CDw293,,658,bone morphogenetic protein receptor type 1B,bone morphogenetic protein receptor; type IB,,ALK6; CDw293,bone morphogenetic protein receptor type 1B,ALK-6; ALK6; AMD3; AMDD; BDA1D; BDA2; CDw293,BMPR1B
O00255,MEN1_HUMAN,MEN1; SCG2,Menin,SCG2,4221,menin 1,multiple endocrine neoplasia I,menin,,menin 1,MEAI; SCG2,MEN1
O00257,CBX4_HUMAN,CBX4,E3 SUMO-protein ligase CBX4; EC 2.3.2.-; Chromobox protein homolog 4; Polycomb 2 homolog; Pc2; hPc2,,8535,chromobox 4,chromobox homolog 4 (Drosophila Pc class); chromobox homolog 4,NS5ATP1-binding protein 16; Pc class 2 homolog (Drosophila); E3 SUMO-protein ligase CBX4,hPC2; PC2; NBP16,chromobox 4,NBP16; PC2,CBX4
O00267,SPT5H_HUMAN,SUPT5H; SPT5; SPT5H,Transcription elongation factor SPT5; hSPT5; DRB sensitivity-inducing factor 160 kDa subunit; DSIF p160; DRB sensitivity-inducing factor large subunit; DSIF large subunit; Tat-cotransactivator 1 protein; Tat-CT1 protein,SPT5; SPT5H,6829,SPT5 homolog; DSIF elongation factor subunit,suppressor of Ty (S.cerevisiae) 5 homolog; suppressor of Ty 5 homolog (S. cerevisiae),,SPT5H; SPT5; FLJ34157,SPT5 homolog; DSIF elongation factor subunit,SPT5; SPT5H; Tat-CT1,SUPT5H
O00303,EIF3F_HUMAN,EIF3F; EIF3S5,Eukaryotic translation initiation factor 3 subunit F; eIF3f; Deubiquitinating enzyme eIF3f; EC 3.4.19.12; Eukaryotic translation initiation factor 3 subunit 5; eIF-3-epsilon; eIF3 p47,EIF3S5,8665,eukaryotic translation initiation factor 3 subunit F,eukaryotic translation initiation factor 3; subunit 5 epsilon; 47kDa; eukaryotic translation initiation factor 3; subunit F,,eIF3-epsilon; eIF3-p47,eukaryotic translation initiation factor 3 subunit F,EIF3S5; MRT67; eIF3-p47,EIF3F
O00305,CACB4_HUMAN,CACNB4; CACNLB4,Voltage-dependent L-type calcium channel subunit beta-4; CAB4; Calcium channel voltage-dependent subunit beta 4,CACNLB4,785,calcium voltage-gated channel auxiliary subunit beta 4,calcium channel; voltage-dependent; beta 4 subunit,,EJM4,calcium voltage-gated channel auxiliary subunit beta 4,CAB4; CACNLB4; EA5; EIG9; EJM; EJM4; EJM6,CACNB4
O00311,CDC7_HUMAN,CDC7; CDC7L1,Cell division cycle 7-related protein kinase; CDC7-related kinase; HsCdc7; huCdc7; EC 2.7.11.1,CDC7L1,8317,cell division cycle 7,CDC7 (cell division cycle 7; S. cerevisiae; homolog)-like 1; CDC7 cell division cycle 7 (S. cerevisiae); cell division cycle 7 (S. cerevisiae); cell division cycle 7 homolog (S. cerevisiae),,Hsk1; huCdc7; HsCdc7,cell division cycle 7,CDC7L1; HsCDC7; Hsk1; huCDC7,CDC7
O00327,BMAL1_HUMAN,BMAL1; ARNTL; BHLHE5; MOP3; PASD3,Basic helix-loop-helix ARNT-like protein 1; Aryl hydrocarbon receptor nuclear translocator-like protein 1; Basic-helix-loop-helix-PAS protein MOP3; Brain and muscle ARNT-like 1; Class E basic helix-loop-helix protein 5; bHLHe5; Member of PAS protein 3; PAS domain-containing protein 3; bHLH-PAS protein JAP3,ARNTL; BHLHE5; MOP3; PASD3,406,basic helix-loop-helix ARNT like 1,aryl hydrocarbon receptor nuclear translocator like,brain and muscle ARNT-like 1; basic helix-loop-helix family member e5; PAS domain containing 3; member of PAS superfamily 3,MOP3; JAP3; PASD3; bHLHe5; ARNTL1,basic helix-loop-helix ARNT like 1,ARNTL; ARNTL1; BMAL1c; JAP3; MOP3; PASD3; TIC; bHLHe5,BMAL1
O00329,PK3CD_HUMAN,PIK3CD,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3-kinase subunit delta; PI3K-delta; PI3Kdelta; PtdIns-3-kinase subunit delta; EC 2.7.1.137; EC 2.7.1.153; Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PtdIns-3-kinase subunit p110-delta; p110delta,,5293,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit delta,phosphoinositide-3-kinase; catalytic; delta polypeptide; phosphatidylinositol-4;5-bisphosphate 3-kinase; catalytic subunit delta,phosphatidylinositol 3-kinase; catalytic; delta polypeptide; phosphoinositide-3-kinase C,p110D,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit delta,APDS; IMD14; IMD14A; IMD14B; P110DELTA; PI3K; ROCHIS; p110D,PIK3CD
O00399,DCTN6_HUMAN,DCTN6; WS3,Dynactin subunit 6; Dynactin subunit p27; Protein WS-3,WS3,10671,dynactin subunit 6,dynactin 6,Dynactin subunit p27,WS-3; p27,dynactin subunit 6,WS-3; WS3; p27,DCTN6
O00401,WASL_HUMAN,WASL,Actin nucleation-promoting factor WASL; Neural Wiskott-Aldrich syndrome protein; N-WASP,,8976,WASP like actin nucleation promoting factor,Wiskott-Aldrich syndrome-like; Wiskott-Aldrich syndrome like,,N-WASP; NWASP; WASPB,WASP like actin nucleation promoting factor,N-WASP; NWASP; WASPB,WASL
O00418,EF2K_HUMAN,EEF2K,Eukaryotic elongation factor 2 kinase; eEF-2 kinase; eEF-2K; EC 2.7.11.20; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase,,29904,eukaryotic elongation factor 2 kinase,,,eEF-2K; CaMKIII,eukaryotic elongation factor 2 kinase,CaMKIII; HSU93850; eEF-2K,EEF2K
O00429,DNM1L_HUMAN,DNM1L; DLP1; DRP1,Dynamin-1-like protein; EC 3.6.5.5; Dnm1p/Vps1p-like protein; DVLP; Dynamin family member proline-rich carboxyl-terminal domain less; Dymple; Dynamin-like protein; Dynamin-like protein 4; Dynamin-like protein IV; HdynIV; Dynamin-related protein 1,DLP1; DRP1,10059,dynamin 1 like,,,DRP1; DVLP; HDYNIV; DYMPLE; VPS1,dynamin 1 like,DLP1; DRP1; DVLP; DYMPLE; EMPF; EMPF1; HDYNIV; OPA5,DNM1L
O00443,P3C2A_HUMAN,PIK3C2A,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha; PI3K-C2-alpha; PtdIns-3-kinase C2 subunit alpha; EC 2.7.1.137; EC 2.7.1.153; EC 2.7.1.154; Phosphoinositide 3-kinase-C2-alpha,,5286,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,phosphoinositide-3-kinase; class 2; alpha polypeptide; phosphatidylinositol-4-phosphate 3-kinase; catalytic subunit type 2 alpha,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,PI3K-C2alpha,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,CPK; OCSKD; PI3-K-C2(ALPHA); PI3-K-C2A; PI3K-C2-alpha; PI3K-C2alpha,PIK3C2A
O00444,PLK4_HUMAN,PLK4; SAK; STK18,Serine/threonine-protein kinase PLK4; EC 2.7.11.21; Polo-like kinase 4; PLK-4; Serine/threonine-protein kinase 18; Serine/threonine-protein kinase Sak,SAK; STK18,10733,polo like kinase 4,serine/threonine kinase 18; polo-like kinase 4 (Drosophila); polo-like kinase 4,,Sak,polo like kinase 4,MCCRP2; SAK; STK18,PLK4
O00459,P85B_HUMAN,PIK3R2,Phosphatidylinositol 3-kinase regulatory subunit beta; PI3-kinase regulatory subunit beta; PI3K regulatory subunit beta; PtdIns-3-kinase regulatory subunit beta; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta; PI3-kinase subunit p85-beta; PtdIns-3-kinase regulatory subunit p85-beta,,5296,phosphoinositide-3-kinase regulatory subunit 2,phosphoinositide-3-kinase; regulatory subunit 2 (beta),phosphoinositide-3-kinase regulatory subunit beta,P85B; p85; p85beta; p85-BETA,phosphoinositide-3-kinase regulatory subunit 2,MPPH; MPPH1; P85B; p85; p85-BETA; p85beta,PIK3R2
O00463,TRAF5_HUMAN,TRAF5; RNF84,TNF receptor-associated factor 5; RING finger protein 84,RNF84,7188,TNF receptor associated factor 5,,,RNF84,TNF receptor associated factor 5,MGC:39780; RNF84,TRAF5
O00482,NR5A2_HUMAN,NR5A2; B1F; CPF; FTF,Nuclear receptor subfamily 5 group A member 2; Alpha-1-fetoprotein transcription factor; B1-binding factor; hB1F; CYP7A promoter-binding factor; Hepatocytic transcription factor; Liver receptor homolog 1; LRH-1,B1F; CPF; FTF,2494,nuclear receptor subfamily 5 group A member 2,nuclear receptor subfamily 5; group A; member 2,liver receptor homolog-1,FTZ-F1beta; hB1F; LRH-1; FTZ-F1; hB1F-2; B1F2; LRH1,nuclear receptor subfamily 5 group A member 2,B1F; B1F2; CPF; FTF; FTZ-F1; FTZ-F1beta; LRH-1; LRH1; hB1F-2,NR5A2
O00506,STK25_HUMAN,STK25; SOK1; YSK1,Serine/threonine-protein kinase 25; EC 2.7.11.1; Ste20-like kinase; Sterile 20/oxidant stress-response kinase 1; SOK-1; Ste20/oxidant stress response kinase 1,SOK1; YSK1,10494,serine/threonine kinase 25,serine/threonine kinase 25 (Ste20; yeast homolog),,SOK1; YSK1,serine/threonine kinase 25,SOK1; YSK1,STK25
O00560,SDCB1_HUMAN,SDCBP; MDA9; SYCL,Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1,MDA9; SYCL,6386,syndecan binding protein,,syntenin; syntenin-1,SYCL; MDA-9; SDCBP1,syndecan binding protein,MDA-9; MDA9; SDCBP1; ST1; SYCL; TACIP18,SDCBP
O00562,PITM1_HUMAN,PITPNM1; DRES9; NIR2; PITPNM,Membrane-associated phosphatidylinositol transfer protein 1; Drosophila retinal degeneration B homolog; Phosphatidylinositol transfer protein; membrane-associated 1; PITPnm 1; Pyk2 N-terminal domain-interacting receptor 2; NIR-2,DRES9; NIR2; PITPNM,9600,phosphatidylinositol transfer protein membrane associated 1,phosphatidylinositol transfer protein; membrane associated 1,PYK2 N-terminal domain-interacting receptor 2; retinal degeneration B alpha 1,DRES9; NIR2; RDGB1; RDGBA1; Rd9; RDGB,phosphatidylinositol transfer protein membrane associated 1,DRES9; NIR2; PITPNM; RDGB; RDGB1; RDGBA; RDGBA1; Rd9,PITPNM1
O00566,MPP10_HUMAN,MPHOSPH10; MPP10,U3 small nucleolar ribonucleoprotein protein MPP10; M phase phosphoprotein 10,MPP10,10199,M-phase phosphoprotein 10,M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein),protein phosphatase 1; regulatory subunit 106; U3 small nucleolar ribonucleoprotein,MPP10; MPP10P; CT90; PPP1R106,M-phase phosphoprotein 10,CT90; MPP10; MPP10P; PPP1R106,MPHOSPH10
O00571,DDX3X_HUMAN,DDX3X; DBX; DDX3,ATP-dependent RNA helicase DDX3X; EC 3.6.4.13; CAP-Rf; DEAD box protein 3; X-chromosomal; DEAD box; X isoform; DBX; Helicase-like protein 2; HLP2,DBX; DDX3,1654,DEAD-box helicase 3 X-linked,DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3; DEAD (Asp-Glu-Ala-Asp) box polypeptide 3; X-linked; DEAD (Asp-Glu-Ala-Asp) box helicase 3; X-linked,Helicase-like protein 2,DBX; HLP2; DDX14; CAP-Rf,DEAD-box helicase 3 X-linked,CAP-Rf; DBX; DDX14; DDX3; HLP2; MRX102; MRXSSB,DDX3X
O00574,CXCR6_HUMAN,CXCR6; BONZO; STRL33; TYMSTR,C-X-C chemokine receptor type 6; CXC-R6; CXCR-6; CDw186; G-protein coupled receptor STRL33; G-protein coupled receptor bonzo; CD antigen CD186,BONZO; STRL33; TYMSTR,10663,C-X-C motif chemokine receptor 6,chemokine (C-X-C motif) receptor 6,,TYMSTR; STRL33; BONZO; CD186,C-X-C motif chemokine receptor 6,BONZO; CD186; CDw186; STRL33; TYMSTR,CXCR6
O00631,SARCO_HUMAN,SLN,Sarcolipin,,6588,sarcolipin,,,MGC12301; MGC125854; MGC125855,sarcolipin,,SLN
O00716,E2F3_HUMAN,E2F3; KIAA0075,Transcription factor E2F3; E2F-3,KIAA0075,1871,E2F transcription factor 3,,,,E2F transcription factor 3,E2F-3,E2F3
O00743,PPP6_HUMAN,PPP6C; PPP6,Serine/threonine-protein phosphatase 6 catalytic subunit; PP6C; EC 3.1.3.16,PPP6,5537,protein phosphatase 6 catalytic subunit,protein phosphatase 6; catalytic subunit,,PP6,protein phosphatase 6 catalytic subunit,PP6; PP6C,PPP6C
O00744,WN10B_HUMAN,WNT10B; WNT12,Protein Wnt-10b; Protein Wnt-12,WNT12,7480,Wnt family member 10B,wingless-type MMTV integration site family; member 10B,,WNT-12; SHFM6,Wnt family member 10B,SHFM6; STHAG8; WNT-12,WNT10B
O00755,WNT7A_HUMAN,WNT7A,Protein Wnt-7a,,7476,Wnt family member 7A,wingless-type MMTV integration site family; member 7A,proto-oncogene Wnt7a protein,Wnt-7a,Wnt family member 7A,SANTOS; Wnt-7a,WNT7A
O00763,ACACB_HUMAN,ACACB; ACC2; ACCB,Acetyl-CoA carboxylase 2; EC 6.4.1.2; ACC-beta,ACC2; ACCB,32,acetyl-CoA carboxylase beta,acetyl-Coenzyme A carboxylase beta,acetyl-CoA carboxylase 2,HACC275; ACC2; ACCB; ACC-beta; ACCbeta; ACACbeta,acetyl-CoA carboxylase beta,ACACbeta; ACC-beta; ACC2; ACCB; ACCbeta; HACC275,ACACB
O00767,SCD_HUMAN,SCD; FADS5; SCD1; SCDOS,Stearoyl-CoA desaturase; hSCD1; EC 1.14.19.1; Acyl-CoA desaturase; Delta(9; Delta-9 desaturase; Fatty acid desaturase,FADS5; SCD1; SCDOS,6319,stearoyl-CoA desaturase,stearoyl-CoA desaturase opposite strand; stearoyl-CoA desaturase (delta-9-desaturase),acyl-CoA desaturase; fatty acid desaturase; delta-9-desaturase,FADS5; SCD1,stearoyl-CoA desaturase,FADS5; MSTP008; SCD1; SCDOS; hSCD1,SCD
O14490,DLGP1_HUMAN,DLGAP1; DAP1; GKAP,Disks large-associated protein 1; DAP-1; Guanylate kinase-associated protein; hGKAP; PSD-95/SAP90-binding protein 1; SAP90/PSD-95-associated protein 1; SAPAP1,DAP1; GKAP,9229,DLG associated protein 1,discs; large (Drosophila) homolog-associated protein 1; discs large homolog associated protein 1,,GKAP; SAPAP1; DAP-1,DLG associated protein 1,DAP-1; DAP-1-ALPHA; DAP-1-BETA; DAP1; DLGAP1A; DLGAP1B; GKAP; SAPAP1,DLGAP1
O14493,CLD4_HUMAN,CLDN4; CPER; CPETR1; WBSCR8,Claudin-4; Clostridium perfringens enterotoxin receptor; CPE-R; CPE-receptor; Williams-Beuren syndrome chromosomal region 8 protein,CPER; CPETR1; WBSCR8,1364,claudin 4,,Clostridium perfringens enterotoxin receptor 1; Williams-Beuren syndrome chromosomal region 8 protein,CPE-R; WBSCR8; hCPE-R,claudin 4,CPE-R; CPER; CPETR; CPETR1; WBSCR8; hCPE-R,CLDN4
O14497,ARI1A_HUMAN,ARID1A; BAF250; BAF250A; C1orf4; OSA1; SMARCF1,AT-rich interactive domain-containing protein 1A; ARID domain-containing protein 1A; B120; BRG1-associated factor 250; BAF250; BRG1-associated factor 250a; BAF250A; Osa homolog 1; hOSA1; SWI-like protein; SWI/SNF complex protein p270; SWI/SNF-related; matrix-associated; actin-dependent regulator of chromatin subfamily F member 1; hELD,BAF250; BAF250A; C1orf4; OSA1; SMARCF1,8289,AT-rich interaction domain 1A,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily f; member 1; AT rich interactive domain 1A (SWI- like); AT rich interactive domain 1A (SWI-like),,B120; P270; C10rf4; BAF250; BAF250a,AT-rich interaction domain 1A,B120; BAF250; BAF250a; BM029; C1orf4; CSS2; ELD; MRD14; OSA1; P270; SMARCF1; hELD; hOSA1,ARID1A
O14508,SOCS2_HUMAN,SOCS2; CIS2; SSI2; STATI2,Suppressor of cytokine signaling 2; SOCS-2; Cytokine-inducible SH2 protein 2; CIS-2; STAT-induced STAT inhibitor 2; SSI-2,CIS2; SSI2; STATI2,8835,suppressor of cytokine signaling 2,,STAT-induced STAT inhibitor-2,STATI2; SSI2; SOCS-2; SSI-2; CIS2; Cish2,suppressor of cytokine signaling 2,CIS2; Cish2; SOCS-2; SSI-2; SSI2; STATI2,SOCS2
O14519,CDKA1_HUMAN,CDK2AP1; CDKAP1; DOC1,Cyclin-dependent kinase 2-associated protein 1; CDK2-associated protein 1; Deleted in oral cancer 1; DOC-1; Putative oral cancer suppressor,CDKAP1; DOC1,8099,cyclin dependent kinase 2 associated protein 1,CDK2-associated protein 1,,DORC1; doc-1; DOC1; ST19; p12DOC-1,cyclin dependent kinase 2 associated protein 1,DOC1; DORC1; ST19; doc-1; p12DOC-1,CDK2AP1
O14522,PTPRT_HUMAN,PTPRT; KIAA0283,Receptor-type tyrosine-protein phosphatase T; R-PTP-T; EC 3.1.3.48; Receptor-type tyrosine-protein phosphatase rho; RPTP-rho,KIAA0283,11122,protein tyrosine phosphatase receptor type T,,,RPTPrho; KIAA0283,protein tyrosine phosphatase receptor type T,R-PTP-T; RPTP-rho; RPTPrho,PTPRT
O14543,SOCS3_HUMAN,SOCS3; CIS3; SSI3,Suppressor of cytokine signaling 3; SOCS-3; Cytokine-inducible SH2 protein 3; CIS-3; STAT-induced STAT inhibitor 3; SSI-3,CIS3; SSI3,9021,suppressor of cytokine signaling 3,,,SSI-3; CIS3; SOCS-3; Cish3,suppressor of cytokine signaling 3,ATOD4; CIS3; Cish3; SOCS-3; SSI-3; SSI3,SOCS3
O14558,HSPB6_HUMAN,HSPB6,Heat shock protein beta-6; HspB6; Heat shock 20 kDa-like protein p20; Heat shock protein family B member 6,,126393,heat shock protein family B (small) member 6,heat shock protein; alpha-crystallin-related; B6,protein phosphatase 1; regulatory subunit 91,FLJ32389; Hsp20; PPP1R91,heat shock protein family B (small) member 6,HEL55; Hsp20; PPP1R91,HSPB6
O14559,RHG33_HUMAN,ARHGAP33; SNX26; TCGAP,Rho GTPase-activating protein 33; Rho-type GTPase-activating protein 33; Sorting nexin-26; Tc10/CDC42 GTPase-activating protein,SNX26; TCGAP,115703,Rho GTPase activating protein 33,sorting nexin 26,,FLJ39019; TCGAP,Rho GTPase activating protein 33,NOMA-GAP; SNX26; TCGAP,ARHGAP33
O14578,CTRO_HUMAN,CIT; CRIK; KIAA0949; STK21,Citron Rho-interacting kinase; CRIK; EC 2.7.11.1; Serine/threonine-protein kinase 21,CRIK; KIAA0949; STK21,11113,citron rho-interacting serine/threonine kinase,citron (rho-interacting; serine/threonine kinase 21),serine/threonine kinase 21,KIAA0949; STK21; CRIK; CITK,citron rho-interacting serine/threonine kinase,CITK; CRIK; MCPH17; STK21,CIT
O14595,CTDS2_HUMAN,CTDSP2; NIF2; OS4; SCP2,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2; EC 3.1.3.16; Nuclear LIM interactor-interacting factor 2; NLI-interacting factor 2; Protein OS-4; Small C-terminal domain phosphatase 2; Small CTD phosphatase 2; SCP2,NIF2; OS4; SCP2,10106,CTD small phosphatase 2,CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) small phosphatase 2,conserved gene amplified in osteosarcoma; nuclear LIM interactor-interacting factor 2; NLI-interacting factor 2; small CTD phosphatase 2,OS4; SCP2; PSR2,CTD small phosphatase 2,OS4; PSR2; SCP2,CTDSP2
O14610,GBGT2_HUMAN,GNGT2; GNG8; GNG9; GNGT8,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2; I; S; O; G gamma-C; G-gamma-8; G-gamma-9; Guanine nucleotide binding protein gamma transducing activity polypeptide 2,GNG8; GNG9; GNGT8,2793,G protein subunit gamma transducin 2,guanine nucleotide binding protein (G protein); gamma transducing activity polypeptide 2,,GNG9,G protein subunit gamma transducin 2,G-GAMMA-8; G-GAMMA-C; GNG9; GNGT8; HG3I,GNGT2
O14640,DVL1_HUMAN,DVL1,Segment polarity protein dishevelled homolog DVL-1; Dishevelled-1; DSH homolog 1,,1855,dishevelled segment polarity protein 1,dishevelled 1 (homologous to Drosophila dsh); dishevelled; dsh homolog 1 (Drosophila),,,dishevelled segment polarity protein 1,DRS2; DVL; DVL1L1; DVL1P1,DVL1
O14641,DVL2_HUMAN,DVL2,Segment polarity protein dishevelled homolog DVL-2; Dishevelled-2; DSH homolog 2,,1856,dishevelled segment polarity protein 2,dishevelled 2 (homologous to Drosophila dsh); dishevelled; dsh homolog 2 (Drosophila),,,dishevelled segment polarity protein 2,,DVL2
O14649,KCNK3_HUMAN,KCNK3; TASK; TASK1,Potassium channel subfamily K member 3; Acid-sensitive potassium channel protein TASK-1; TWIK-related acid-sensitive K(+; Two pore potassium channel KT3.1; Two pore K(+,TASK; TASK1,3777,potassium two pore domain channel subfamily K member 3,potassium channel; subfamily K; member 3; potassium channel; two pore domain subfamily K; member 3,TWIK-related acid-sensitive K+ 1,K2p3.1; TASK; TASK-1; TASK1,potassium two pore domain channel subfamily K member 3,K2p3.1; OAT1; PPH4; TASK; TASK-1; TASK1; TBAK1,KCNK3
O14654,IRS4_HUMAN,IRS4,Insulin receptor substrate 4; IRS-4; 160 kDa phosphotyrosine protein; py160; Phosphoprotein of 160 kDa; pp160,,8471,insulin receptor substrate 4,,,PY160; IRS-4,insulin receptor substrate 4,CHNG9; IRS-4; PY160,IRS4
O14686,KMT2D_HUMAN,KMT2D; ALR; MLL2; MLL4,Histone-lysine N-methyltransferase 2D; Lysine N-methyltransferase 2D; EC 2.1.1.364; ALL1-related protein; Myeloid/lymphoid or mixed-lineage leukemia protein 2,ALR; MLL2; MLL4,8085,lysine methyltransferase 2D,trinucleotide repeat containing 21; myeloid/lymphoid or mixed-lineage leukemia 2; lysine (K)-specific methyltransferase 2D,histone-lysine N-methyltransferase 2D; ALL1-related,ALR; MLL4; CAGL114,lysine methyltransferase 2D,AAD10; ALR; BCAHH; CAGL114; KABUK1; KMS; MLL2; MLL4; TNRC21,KMT2D
O14713,ITBP1_HUMAN,ITGB1BP1; ICAP1,Integrin beta-1-binding protein 1; Integrin cytoplasmic domain-associated protein 1; ICAP-1,ICAP1,9270,integrin subunit beta 1 binding protein 1,integrin beta 1 binding protein 1,integrin cytoplasmic domain-associated protein 1; integrin cytoplasmic domain-associated protein 1-beta; integrin cytoplasmic domain-associated protein 1-alpha; bodenin,ICAP-1A; ICAP-1B; ICAP1; ICAP1A; ICAP1B; ICAP-1alpha,integrin subunit beta 1 binding protein 1,ICAP-1A; ICAP-1B; ICAP-1alpha; ICAP1; ICAP1A; ICAP1B,ITGB1BP1
O14727,APAF_HUMAN,APAF1; KIAA0413,Apoptotic protease-activating factor 1; APAF-1,KIAA0413,317,apoptotic peptidase activating factor 1,apoptotic protease activating factor; apoptotic peptidase activating factor,,CED4; APAF-1,apoptotic peptidase activating factor 1,APAF-1; CED4,APAF1
O14730,RIOK3_HUMAN,RIOK3; SUDD,Serine/threonine-protein kinase RIO3; EC 2.7.11.1; RIO kinase 3; sudD homolog,SUDD,8780,RIO kinase 3,sudD (suppressor of bimD6; Aspergillus nidulans) homolog; RIO kinase 3 (yeast),,,RIO kinase 3,SUDD,RIOK3
O14733,MP2K7_HUMAN,MAP2K7; JNKK2; MEK7; MKK7; PRKMK7; SKK4,Dual specificity mitogen-activated protein kinase kinase 7; MAP kinase kinase 7; MAPKK 7; EC 2.7.12.2; JNK-activating kinase 2; MAPK/ERK kinase 7; MEK 7; Stress-activated protein kinase kinase 4; SAPK kinase 4; SAPKK-4; SAPKK4; c-Jun N-terminal kinase kinase 2; JNK kinase 2; JNKK 2,JNKK2; MEK7; MKK7; PRKMK7; SKK4,5609,mitogen-activated protein kinase kinase 7,,Dual specificity mitogen-activated protein kinase kinase 7; stress-activated protein kinase kinase 4,MKK7; Jnkk2; SAPKK4,mitogen-activated protein kinase kinase 7,JNKK2; MAPKK7; MEK; MEK 7; MKK7; PRKMK7; SAPKK-4; SAPKK4,MAP2K7
O14737,PDCD5_HUMAN,PDCD5; TFAR19,Programmed cell death protein 5; TF-1 cell apoptosis-related protein 19; Protein TFAR19,TFAR19,9141,programmed cell death 5,,TFAR19 novel apoptosis-related; TF1 cell apoptosis-related gene 19,TFAR19; MGC9294,programmed cell death 5,TFAR19,PDCD5
O14744,ANM5_HUMAN,PRMT5; HRMT1L5; IBP72; JBP1; SKB1,Protein arginine N-methyltransferase 5; PRMT5; EC 2.1.1.320; 72 kDa ICln-binding protein; Histone-arginine N-methyltransferase PRMT5; Jak-binding protein 1; Shk1 kinase-binding protein 1 homolog; SKB1 homolog; SKB1Hs,HRMT1L5; IBP72; JBP1; SKB1,10419,protein arginine methyltransferase 5,skb1 (S. pombe) homolog; SKB1 homolog (S. pombe),,SKB1Hs,protein arginine methyltransferase 5,HRMT1L5; HSL7; IBP72; JBP1; SKB1; SKB1Hs,PRMT5
O14745,NHRF1_HUMAN,NHERF1; NHERF; SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1; +; +; NHERF-1; Ezrin-radixin-moesin-binding phosphoprotein 50; EBP50; Regulatory cofactor of Na(+; +; Sodium-hydrogen exchanger regulatory factor 1; Solute carrier family 9 isoform A3 regulatory factor 1,NHERF; SLC9A3R1,9368,NHERF family PDZ scaffold protein 1,solute carrier family 9 (sodium/hydrogen exchanger); isoform 3 regulatory factor 1; solute carrier family 9 (sodium/hydrogen exchanger); isoform 3 regulator 1; solute carrier family 9 (sodium/hydrogen exchanger); member 3 regulator 1; solute carrier family 9; subfamily A (NHE3; cation proton antiporter 3); member 3 regulator 1; SLC9A3 regulator 1,ezrin-radixin-moesin-binding phosphoprotein 50; Na(+)/H(+) exchange regulatory cofactor 1,NHERF; EBP50; NHERF-1; NHE-RF,NHERF family PDZ scaffold protein 1,EBP50; NHE-RF; NHERF; NHERF-1; NPHLOP2; SLC9A3R1,NHERF1
O14746,TERT_HUMAN,TERT; EST2; TCS1; TRT,Telomerase reverse transcriptase; EC 2.7.7.49; HEST2; Telomerase catalytic subunit; Telomerase-associated protein 2; TP2,EST2; TCS1; TRT,7015,telomerase reverse transcriptase,,,TRT; TP2; TCS1; hEST2; EST2,telomerase reverse transcriptase,CMM9; DKCA2; DKCB4; EST2; PFBMFT1; TCS1; TP2; TRT; hEST2; hTRT,TERT
O14757,CHK1_HUMAN,CHEK1; CHK1,Serine/threonine-protein kinase Chk1; EC 2.7.11.1; CHK1 checkpoint homolog; Cell cycle checkpoint kinase; Checkpoint kinase-1,CHK1,1111,checkpoint kinase 1,CHK1 (checkpoint; S.pombe) homolog; CHK1 checkpoint homolog (S. pombe),,CHK1,checkpoint kinase 1,CHK1; OZEMA21,CHEK1
O14773,TPP1_HUMAN,TPP1; CLN2; GIG1; UNQ267/PRO304,Tripeptidyl-peptidase 1; TPP-1; EC 3.4.14.9; Cell growth-inhibiting gene 1 protein; Lysosomal pepstatin-insensitive protease; LPIC; Tripeptidyl aminopeptidase; Tripeptidyl-peptidase I; TPP-I,CLN2,1200,tripeptidyl peptidase 1,ceroid-lipofuscinosis; neuronal 2; late infantile (Jansky-Bielschowsky disease); spinocerebellar ataxia; autosomal recessive 7; tripeptidyl peptidase I,TPP I; lysosomal pepstatin-insensitive carboxypeptidase,LPIC; TPP-1,tripeptidyl peptidase 1,CLN2; GIG1; LPIC; SCAR7; TPP-1,TPP1
O14775,GNB5_HUMAN,GNB5,Guanine nucleotide-binding protein subunit beta-5; Gbeta5; Transducin beta chain 5,,10681,G protein subunit beta 5,guanine nucleotide binding protein (G protein); beta 5,Guanine nucleotide-binding protein subunit beta-5; Transducin beta chain 5,GB5,G protein subunit beta 5,GB5; HG2E; IDDCA; LADCI; LDMLS1; LDMLS2; gbeta5,GNB5
O14777,NDC80_HUMAN,NDC80; HEC; HEC1; KNTC2,Kinetochore protein NDC80 homolog; Highly expressed in cancer protein; Kinetochore protein Hec1; HsHec1; Kinetochore-associated protein 2; Retinoblastoma-associated protein HEC,HEC; HEC1; KNTC2,10403,NDC80 kinetochore complex component,highly expressed in cancer; rich in leucine heptad repeats (yeast); kinetochore associated 2; NDC80 kinetochore complex component homolog (S. cerevisiae),,HEC; HEC1; hsNDC80; TID3,NDC80 kinetochore complex component,HEC; HEC1; HsHec1; KNTC2; TID3; hsNDC80,NDC80
O14807,RASM_HUMAN,MRAS; RRAS3,Ras-related protein M-Ras; EC 3.6.5.2; Ras-related protein R-Ras3,RRAS3,22808,muscle RAS oncogene homolog,,,M-RAs; R-RAS3; RRAS3,muscle RAS oncogene homolog,M-RAs; NS11; R-RAS3; RRAS3,MRAS
O14813,PHX2A_HUMAN,PHOX2A; ARIX; PMX2A,Paired mesoderm homeobox protein 2A; ARIX1 homeodomain protein; Aristaless homeobox protein homolog; Paired-like homeobox 2A,ARIX; PMX2A,401,paired like homeobox 2A,aristaless (Drosophila) homeobox; aristaless homeobox (Drosophila); fibrosis of extraocular muscles; congenital; 2; autosomal recessive; paired-like (aristaless) homeobox 2a; paired like homeobox 2a,,PMX2A; CFEOM2,paired like homeobox 2A,ARIX; CFEOM2; FEOM2; NCAM2; PMX2A,PHOX2A
O14818,PSA7_HUMAN,PSMA7; HSPC,Proteasome subunit alpha type-7; Proteasome subunit RC6-1; Proteasome subunit XAPC7; Proteasome subunit alpha-4; alpha-4,HSPC,5688,proteasome 20S subunit alpha 7,proteasome (prosome; macropain) subunit; alpha type; 7; proteasome subunit alpha 7,proteasome subunit XAPC7; proteasome subunit RC6-1; proteasome subunit ??4,XAPC7; C6; HSPC; RC6-1,proteasome 20S subunit alpha 7,C6; HEL-S-276; HSPC; RC6-1; XAPC7,PSMA7
O14827,RGRF2_HUMAN,RASGRF2; GRF2,Ras-specific guanine nucleotide-releasing factor 2; Ras-GRF2; Ras guanine nucleotide exchange factor 2,GRF2,5924,Ras protein specific guanine nucleotide releasing factor 2,,,GRF2; Ras-GRF2,Ras protein specific guanine nucleotide releasing factor 2,GRF2; RAS-GRF2,RASGRF2
O14904,WNT9A_HUMAN,WNT9A; WNT14,Protein Wnt-9a; Protein Wnt-14,WNT14,7483,Wnt family member 9A,wingless-type MMTV integration site family; member 14; wingless-type MMTV integration site family; member 9A,,,Wnt family member 9A,WNT14,WNT9A
O14905,WNT9B_HUMAN,WNT9B; WNT14B; WNT15; UNQ6973/PRO21956,Protein Wnt-9b; Protein Wnt-14b; Protein Wnt-15,WNT14B; WNT15,7484,Wnt family member 9B,wingless-type MMTV integration site family; member 15; wingless-type MMTV integration site family; member 9B,,WNT14B,Wnt family member 9B,WNT14B; WNT15,WNT9B
O14920,IKKB_HUMAN,IKBKB; IKKB,Inhibitor of nuclear factor kappa-B kinase subunit beta; I-kappa-B-kinase beta; IKK-B; IKK-beta; IkBKB; EC 2.7.11.10; I-kappa-B kinase 2; IKK-2; IKK2; Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Serine/threonine protein kinase IKBKB; EC 2.7.11.1,IKKB,3551,inhibitor of nuclear factor kappa B kinase subunit beta,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase beta,,IKK2; NFKBIKB; IKK-beta; IKKB,inhibitor of nuclear factor kappa B kinase subunit beta,IKK-2; IKK-beta; IKK2; IKKB; IMD15; IMD15A; IMD15B; NFKBIKB,IKBKB
O14936,CSKP_HUMAN,CASK; LIN2,Peripheral plasma membrane protein CASK; hCASK; EC 2.7.11.1; Calcium/calmodulin-dependent serine protein kinase; Protein lin-2 homolog,LIN2,8573,calcium/calmodulin dependent serine protein kinase,trinucleotide repeat containing 8; calcium/calmodulin-dependent serine protein kinase (MAGUK family),,LIN2; CAGH39; FGS4,calcium/calmodulin dependent serine protein kinase,CAGH39; CAMGUK; CMG; FGS4; LIN2; MICPCH; MRXSNA; TNRC8; hCASK,CASK
O14939,PLD2_HUMAN,PLD2,Phospholipase D2; PLD 2; hPLD2; EC 3.1.4.4; Choline phosphatase 2; PLD1C; Phosphatidylcholine-hydrolyzing phospholipase D2,,5338,phospholipase D2,,choline phosphatase 2,,phospholipase D2,PLD1C,PLD2
O14950,ML12B_HUMAN,MYL12B; MRLC2; MYLC2B,Myosin regulatory light chain 12B; MLC-2A; MLC-2; Myosin regulatory light chain 2-B; smooth muscle isoform; Myosin regulatory light chain 20 kDa; MLC20; Myosin regulatory light chain MRLC2; SHUJUN-1,MRLC2; MYLC2B,103910,myosin light chain 12B,myosin; light chain 12B; regulatory,myosin regulatory light chain 2,MRLC2,myosin light chain 12B,MLC-B; MRLC2,MYL12B
O14958,CASQ2_HUMAN,CASQ2,Calsequestrin-2; Calsequestrin; cardiac muscle isoform,,845,calsequestrin 2,calsequestrin 2 (cardiac muscle),,PDIB2,calsequestrin 2,PDIB2,CASQ2
O14964,HGS_HUMAN,HGS; HRS,Hepatocyte growth factor-regulated tyrosine kinase substrate; Hrs; Protein pp110,HRS,9146,hepatocyte growth factor-regulated tyrosine kinase substrate,,,Hrs; ZFYVE8; Vps27,hepatocyte growth factor-regulated tyrosine kinase substrate,HRS,HGS
O14965,AURKA_HUMAN,AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6,Aurora kinase A; EC 2.7.11.1; Aurora 2; Aurora/IPL1-related kinase 1; ARK-1; Aurora-related kinase 1; Breast tumor-amplified kinase; Ipl1- and aurora-related kinase 1; Serine/threonine-protein kinase 15; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase Ayk1; Serine/threonine-protein kinase aurora-A,AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6,6790,aurora kinase A,serine/threonine kinase 15; serine/threonine kinase 6,protein phosphatase 1; regulatory subunit 47; Aurora-A kinase,BTAK; AurA; STK7; ARK1; PPP1R47; AIK,aurora kinase A,AIK; ARK1; AURA; BTAK; PPP1R47; STK15; STK6; STK7,AURKA
O14974,MYPT1_HUMAN,PPP1R12A; MBS; MYPT1,Protein phosphatase 1 regulatory subunit 12A; Myosin phosphatase-targeting subunit 1; Myosin phosphatase target subunit 1; Protein phosphatase myosin-binding subunit,MBS; MYPT1,4659,protein phosphatase 1 regulatory subunit 12A,protein phosphatase 1; regulatory (inhibitor) subunit 12A; protein phosphatase 1; regulatory subunit 12A,myosin phosphatase-targeting subunit 1; myosin binding subunit,MBS; M130,protein phosphatase 1 regulatory subunit 12A,GUBS; M130; MBS; MYPT1,PPP1R12A
O14976,GAK_HUMAN,GAK; DNAJC26,Cyclin-G-associated kinase; EC 2.7.11.1; DnaJ homolog subfamily C member 26,DNAJC26,2580,cyclin G associated kinase,,auxilin-2,DNAJC26,cyclin G associated kinase,DNAJ26; DNAJC26,GAK
O14980,XPO1_HUMAN,XPO1; CRM1,Exportin-1; Exp1; Chromosome region maintenance 1 protein homolog,CRM1,7514,exportin 1,exportin 1 (CRM1; yeast; homolog); exportin 1 (CRM1 homolog; yeast),chromosome region maintenance 1 homolog (yeast),CRM1; CRM-1; emb,exportin 1,CRM-1; CRM1; emb; exp1,XPO1
O14986,PI51B_HUMAN,PIP5K1B; STM7,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta; PIP5K1-beta; PtdIns(4; EC 2.7.1.68; Phosphatidylinositol 4-phosphate 5-kinase type I beta; PIP5KIbeta; Protein STM-7; Type I phosphatidylinositol 4-phosphate 5-kinase beta,STM7,8395,phosphatidylinositol-4-phosphate 5-kinase type 1 beta,phosphatidylinositol-4-phosphate 5-kinase; type I; beta,,STM7; MSS4,phosphatidylinositol-4-phosphate 5-kinase type 1 beta,MSS4; STM7,PIP5K1B
O15014,ZN609_HUMAN,ZNF609; KIAA0295,Zinc finger protein 609,KIAA0295,23060,zinc finger protein 609,,,KIAA0295,zinc finger protein 609,,ZNF609
O15020,SPTN2_HUMAN,SPTBN2; KIAA0302; SCA5,Spectrin beta chain; non-erythrocytic 2; Beta-III spectrin; Spinocerebellar ataxia 5 protein,KIAA0302; SCA5,6712,spectrin beta; non-erythrocytic 2,spinocerebellar ataxia 5,,,spectrin beta; non-erythrocytic 2,GTRAP41; SCA5; SCAR14,SPTBN2
O15027,SC16A_HUMAN,SEC16A; KIAA0310; SEC16; SEC16L,Protein transport protein Sec16A; SEC16 homolog A; p250,KIAA0310; SEC16; SEC16L,9919,SEC16 homolog A; endoplasmic reticulum export factor,KIAA0310; SEC16 homolog A (S. cerevisiae),,p250; Sec16L,SEC16 homolog A; endoplasmic reticulum export factor,KIAA0310; SEC16L; p250,SEC16A
O15033,AREL1_HUMAN,AREL1; KIAA0317,Apoptosis-resistant E3 ubiquitin protein ligase 1; EC 2.3.2.26; Apoptosis-resistant HECT-type E3 ubiquitin transferase 1,KIAA0317,9870,apoptosis resistant E3 ubiquitin protein ligase 1,KIAA0317,fibrosis-inducing E3 ligase 1,FIEL1,apoptosis resistant E3 ubiquitin protein ligase 1,FIEL1; KIAA0317,AREL1
O15055,PER2_HUMAN,PER2; KIAA0347,Period circadian protein homolog 2; hPER2; Circadian clock protein PERIOD 2,KIAA0347,8864,period circadian regulator 2,period (Drosophila) homolog 2; period homolog 2 (Drosophila); period circadian clock 2,,KIAA0347,period circadian regulator 2,FASPS; FASPS1,PER2
O15056,SYNJ2_HUMAN,SYNJ2; KIAA0348,Synaptojanin-2; EC 3.1.3.36; Synaptic inositol 1;4;5-trisphosphate 5-phosphatase 2,KIAA0348,8871,synaptojanin 2,,synaptic inositol 1;4;5-trisphosphate 5-phosphatase 2; phosphoinositide 5-phosphatase; inositol polyphosphate-5-phosphatase H,INPP5H,synaptojanin 2,INPP5H,SYNJ2
O15084,ANR28_HUMAN,ANKRD28; KIAA0379,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A; PP6-ARS-A; Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A; Ankyrin repeat domain-containing protein 28; Phosphatase interactor targeting protein hnRNP K; PITK,KIAA0379,23243,ankyrin repeat domain 28,,phosphatase interactor targeting K protein; protein phosphatase 6 ankyrin repeat subunit A; protein phosphatase 1; regulatory subunit 65,KIAA0379; PITK; PP6-ARS-A; PPP1R65; FAP79; CFAP79,ankyrin repeat domain 28,CFAP79; FAP79; PITK; PPP1R65,ANKRD28
O15111,IKKA_HUMAN,CHUK; IKKA; TCF16,Inhibitor of nuclear factor kappa-B kinase subunit alpha; I-kappa-B kinase alpha; IKK-A; IKK-alpha; IkBKA; IkappaB kinase; EC 2.7.11.10; Conserved helix-loop-helix ubiquitous kinase; I-kappa-B kinase 1; IKK-1; IKK1; Nuclear factor NF-kappa-B inhibitor kinase alpha; NFKBIKA; Transcription factor 16; TCF-16,IKKA; TCF16,1147,component of inhibitor of nuclear factor kappa B kinase complex,conserved helix-loop-helix ubiquitous kinase,inhibitor of nuclear factor kappa-B kinase subunit alpha; I-kappa-B kinase,IKK1; IKK-alpha; IkBKA; NFKBIKA; IKKA,component of inhibitor of nuclear factor kappa B kinase complex,BPS2; IKBKA; IKK-1; IKK-alpha; IKK1; IKKA; NFKBIKA; TCF16,CHUK
O15117,FYB1_HUMAN,FYB1; FYB; SLAP130,FYN-binding protein 1; Adhesion and degranulation promoting adaptor protein; ADAP; FYB-120/130; p120/p130; FYN-T-binding protein; SLAP-130; SLP-76-associated phosphoprotein,FYB; SLAP130,2533,FYN binding protein 1,FYN-binding protein (FYB-120/130); FYN binding protein,adhesion and degranulation promoting adaptor protein,SLAP-130; FYB-120/130; ADAP,FYN binding protein 1,ADAP; FYB; PRO0823; SLAP-130; SLAP130; THC3,FYB1
O15119,TBX3_HUMAN,TBX3,T-box transcription factor TBX3; T-box protein 3,,6926,T-box transcription factor 3,ulnar mammary syndrome; T-box 3,,TBX3-ISO; XHL,T-box transcription factor 3,TBX3-ISO; UMS; XHL,TBX3
O15143,ARC1B_HUMAN,ARPC1B; ARC41,Actin-related protein 2/3 complex subunit 1B; Arp2/3 complex 41 kDa subunit; p41-ARC,ARC41,10095,actin related protein 2/3 complex subunit 1B,actin related protein 2/3 complex; subunit 1B (41 kD); actin related protein 2/3 complex subunit 1B; 41kDa,ARP2/3 protein complex subunit p41; actin related protein 2/3 complex; subunit 1A (41 kD),ARC41; p40-ARC; p41-ARC,actin related protein 2/3 complex subunit 1B,ARC41; IMD71; PLTEID; p40-ARC; p41-ARC,ARPC1B
O15151,MDM4_HUMAN,MDM4; MDMX,Protein Mdm4; Double minute 4 protein; Mdm2-like p53-binding protein; Protein Mdmx; p53-binding protein Mdm4,MDMX,4194,MDM4 regulator of p53,mouse double minute 4; human homolog of; p53-binding protein; Mdm4; transformed 3T3 cell double minute 4; p53 binding protein (mouse); Mdm4 p53 binding protein homolog (mouse); MDM4; p53 regulator,,MDMX; HDMX,MDM4 regulator of p53,BMFS6; HDMX; MDMX; MRP1,MDM4
O15162,PLS1_HUMAN,PLSCR1,Phospholipid scramblase 1; PL scramblase 1; Ca(2+; Erythrocyte phospholipid scramblase; Mg(2+; EC 3.1.-.-; MmTRA1b,,5359,phospholipid scramblase 1,,,MMTRA1B,phospholipid scramblase 1,MMTRA1B,PLSCR1
O15169,AXIN1_HUMAN,AXIN1; AXIN,Axin-1; Axis inhibition protein 1; hAxin,AXIN,8312,axin 1,,protein phosphatase 1; regulatory subunit 49,PPP1R49,axin 1,AXIN; CMDOH; PPP1R49,AXIN1
O15194,CTDSL_HUMAN,CTDSPL; C3orf8; NIF1; NIFL; SCP3; YA22,CTD small phosphatase-like protein; CTDSP-like; EC 3.1.3.16; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3; NIF-like protein; Nuclear LIM interactor-interacting factor 1; NLI-interacting factor 1; Protein YA22; hYA22; RBSP3; Small C-terminal domain phosphatase 3; SCP3; Small CTD phosphatase 3,C3orf8; NIF1; NIFL; SCP3; YA22,10217,CTD small phosphatase like,chromosome 3 open reading frame 8; CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) small phosphatase-like,small CTD phosphatase 3; HYA22 protein; RB protein serine phosphatase from chromosome 3,HYA22; SCP3; PSR1; RBSP3,CTD small phosphatase like,C3orf8; HYA22; PSR1; RBSP3; SCP3,CTDSPL
O15198,SMAD9_HUMAN,SMAD9; MADH6; MADH9; SMAD8,Mothers against decapentaplegic homolog 9; MAD homolog 9; Mothers against DPP homolog 9; Madh6; SMAD family member 9; SMAD 9; Smad9,MADH6; MADH9; SMAD8,4093,SMAD family member 9,MAD; mothers against decapentaplegic homolog 9 (Drosophila); SMAD; mothers against DPP homolog 9 (Drosophila),,SMAD8; SMAD8/9,SMAD family member 9,MADH6; MADH9; PPH2; SMAD8; SMAD8/9; SMAD8A; SMAD8B,SMAD9
O15217,GSTA4_HUMAN,GSTA4,Glutathione S-transferase A4; EC 2.5.1.18; GST class-alpha member 4; Glutathione S-transferase A4-4,,2941,glutathione S-transferase alpha 4,glutathione S-transferase A4,,,glutathione S-transferase alpha 4,GSTA4-4; GTA4,GSTA4
O15259,NPHP1_HUMAN,NPHP1; NPH1,Nephrocystin-1; Juvenile nephronophthisis 1 protein,NPH1,4867,nephrocystin 1,nephronophthisis 1 (juvenile),,JBTS4; SLSN1,nephrocystin 1,JBTS4; NPH1; SLSN1,NPHP1
O15264,MK13_HUMAN,MAPK13; PRKM13; SAPK4,Mitogen-activated protein kinase 13; MAP kinase 13; MAPK 13; EC 2.7.11.24; Mitogen-activated protein kinase p38 delta; MAP kinase p38 delta; Stress-activated protein kinase 4,PRKM13; SAPK4,5603,mitogen-activated protein kinase 13,,,SAPK4; p38delta,mitogen-activated protein kinase 13,MAPK 13; MAPK-13; PRKM13; SAPK4; p38delta,MAPK13
O15266,SHOX_HUMAN,SHOX; PHOG,Short stature homeobox protein; Pseudoautosomal homeobox-containing osteogenic protein; Short stature homeobox-containing protein,PHOG,6473,SHOX homeobox,short stature homeobox,pseudoautosomal homeobox-containing osteogenic gene,PHOG; GCFX; SS; SHOXY; SHOX1,SHOX homeobox,GCFX; PHOG; SHOX1; SHOXY; SS,SHOX
O15269,SPTC1_HUMAN,SPTLC1; LCB1,Serine palmitoyltransferase 1; EC 2.3.1.50; Long chain base biosynthesis protein 1; LCB 1; Serine-palmitoyl-CoA transferase 1; SPT 1; SPT1,LCB1,10558,serine palmitoyltransferase long chain base subunit 1,hereditary sensory neuropathy; type 1,,LCB1; SPTI; HSAN1; hLCB1,serine palmitoyltransferase long chain base subunit 1,ALS27; HSAN1; HSN1; LBC1; LCB1; SPT1; SPTI,SPTLC1
O15273,TELT_HUMAN,TCAP,Telethonin; Titin cap protein,,8557,titin-cap,limb girdle muscular dystrophy 2G (autosomal recessive); titin-cap (telethonin),19 kDa sarcomeric protein; teneurin C-terminal associated peptide,T-cap; TELE; telethonin; CMD1N,titin-cap,CMD1N; CMH25; LGMD2G; LGMDR7; T-cap; TELE; telethonin,TCAP
O15287,FANCG_HUMAN,FANCG; XRCC9,Fanconi anemia group G protein; Protein FACG; DNA repair protein XRCC9,XRCC9,2189,FA complementation group G,Fanconi anemia complementation group G,DNA repair protein XRCC9; X-ray repair; complementing defective; in Chinese hamster; 9; X-ray repair complementing defective repair in Chinese hamster cells 9,FAG,FA complementation group G,FAG; XRCC9,FANCG
O15294,OGT1_HUMAN,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit; EC 2.4.1.255; O-GlcNAc transferase subunit p110; O-linked N-acetylglucosamine transferase 110 kDa subunit; OGT,,8473,O-linked N-acetylglucosamine (GlcNAc) transferase,O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase),UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase,O-GLCNAC; HRNT1; MGC22921; FLJ23071; OGT1,O-linked N-acetylglucosamine (GlcNAc) transferase,HINCUT-1; HRNT1; MRX106; O-GLCNAC; OGT1; XLID106,OGT
O15297,PPM1D_HUMAN,PPM1D; WIP1,Protein phosphatase 1D; EC 3.1.3.16; Protein phosphatase 2C isoform delta; PP2C-delta; Protein phosphatase magnesium-dependent 1 delta; p53-induced protein phosphatase 1,WIP1,8493,protein phosphatase; Mg2+/Mn2+ dependent 1D,protein phosphatase 1D magnesium-dependent; delta isoform; protein phosphatase; Mg2+/Mn2+ dependent; 1D,wild-type p53-induced phosphatase 1; protein phosphatase 2C; delta isoform,Wip1; PP2C-DELTA,protein phosphatase; Mg2+/Mn2+ dependent 1D,IDDGIP; JDVS; PP2C-DELTA; WIP1,PPM1D
O15304,SIVA_HUMAN,SIVA1; SIVA,Apoptosis regulatory protein Siva; CD27-binding protein; CD27BP,SIVA,10572,SIVA1 apoptosis inducing factor,,,SIVA; Siva-1; Siva-2; CD27BP,SIVA1 apoptosis inducing factor,CD27BP; SIVA; Siva-1; Siva-2,SIVA1
O15350,P73_HUMAN,TP73; P73,Tumor protein p73; p53-like transcription factor; p53-related protein,P73,7161,tumor protein p73,,,P73,tumor protein p73,CILD47; P73,TP73
O15355,PPM1G_HUMAN,PPM1G; PPM1C,Protein phosphatase 1G; EC 3.1.3.16; Protein phosphatase 1C; Protein phosphatase 2C isoform gamma; PP2C-gamma; Protein phosphatase magnesium-dependent 1 gamma,PPM1C,5496,protein phosphatase; Mg2+/Mn2+ dependent 1G,protein phosphatase 1G (formerly 2C); magnesium-dependent; gamma isoform; protein phosphatase; Mg2+/Mn2+ dependent; 1G,PP2C; gamma; protein phosphatase 2C; gamma isoform,PP2CG; PP2Cgamma,protein phosphatase; Mg2+/Mn2+ dependent 1G,PP2CG; PP2CGAMMA; PPP2CG,PPM1G
O15357,SHIP2_HUMAN,INPPL1; SHIP2,Phosphatidylinositol 3;4;5-trisphosphate 5-phosphatase 2; EC 3.1.3.86; Inositol polyphosphate phosphatase-like protein 1; INPPL-1; Protein 51C; SH2 domain-containing inositol 5'-phosphatase 2; SH2 domain-containing inositol phosphatase 2; SHIP-2,SHIP2,3636,inositol polyphosphate phosphatase like 1,,51C protein; SH2 domain-containing inositol 5'-phosphatase 2; phosphatidylinositol 3;4;5-trisphosphate 5-phosphatase 2,SHIP2,inositol polyphosphate phosphatase like 1,OPSMD; SHIP2,INPPL1
O15360,FANCA_HUMAN,FANCA; FAA; FACA; FANCH,Fanconi anemia group A protein; Protein FACA,FAA; FACA; FANCH,2175,FA complementation group A,Fanconi anemia complementation group A,,FAA; FA-H; FAH,FA complementation group A,FA; FA-H; FA1; FAA; FACA; FAH; FANCH,FANCA
O15379,HDAC3_HUMAN,HDAC3,Histone deacetylase 3; HD3; EC 3.5.1.98; Protein deacetylase HDAC3; EC 3.5.1.-; Protein deacylase HDAC3; EC 3.5.1.-; RPD3-2; SMAP45,,8841,histone deacetylase 3,,,RPD3; HD3; RPD3-2; KDAC3,histone deacetylase 3,HD3; KDAC3; RPD3; RPD3-2,HDAC3
O15392,BIRC5_HUMAN,BIRC5; API4; IAP4,Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor 4; Apoptosis inhibitor survivin,API4; IAP4,332,baculoviral IAP repeat containing 5,apoptosis inhibitor 4; baculoviral IAP repeat-containing 5,,EPR-1; survivin,baculoviral IAP repeat containing 5,API4; EPR-1,BIRC5
O15399,NMDE4_HUMAN,GRIN2D; GluN2D; NMDAR2D,Glutamate receptor ionotropic; NMDA 2D; GluN2D; EB11; Glutamate NMDA receptor subunit epsilon-4; N-methyl D-aspartate receptor subtype 2D; NMDAR2D; NR2D,GluN2D; NMDAR2D,2906,glutamate ionotropic receptor NMDA type subunit 2D,glutamate receptor; ionotropic; N-methyl D-aspartate 2D,N-methyl-d-aspartate receptor subunit 2D,GluN2D; EB11; NR2D,glutamate ionotropic receptor NMDA type subunit 2D,DEE46; EB11; EIEE46; GluN2D; NMDAR2D; NR2D,GRIN2D
O15446,RPA34_HUMAN,POLR1G; ASE1; CAST; CD3EAP; PAF49,DNA-directed RNA polymerase I subunit RPA34; A34.5; Antisense to ERCC-1 protein; ASE-1; CD3-epsilon-associated protein; CD3E-associated protein; DNA-directed RNA polymerase I subunit G; RNA polymerase I-associated factor PAF49,ASE1; CAST; CD3EAP; PAF49,10849,RNA polymerase I subunit G,CD3e antigen; epsilon polypeptide associated protein; CD3e molecule associated protein,CD3 epsilon associated protein; antisense to ERCC 1,ASE-1; CAST; PAF49; RPA34; A34.5,RNA polymerase I subunit G,ASE-1; ASE1; CAST; CD3EAP; PAF49; RPA34,POLR1G
O15455,TLR3_HUMAN,TLR3,Toll-like receptor 3; CD antigen CD283,,7098,toll like receptor 3,toll-like receptor 3,,CD283,toll like receptor 3,CD283; IIAE2; IMD83,TLR3
O15492,RGS16_HUMAN,RGS16; RGSR,Regulator of G-protein signaling 16; RGS16; A28-RGS14P; Retinal-specific RGS; RGS-r; hRGS-r; Retinally abundant regulator of G-protein signaling,RGSR,6004,regulator of G protein signaling 16,regulator of G-protein signalling 16; regulator of G-protein signaling 16,,A28-RGS14; RGS-r,regulator of G protein signaling 16,A28-RGS14; A28-RGS14P; RGS-R,RGS16
O15511,ARPC5_HUMAN,ARPC5; ARC16,Actin-related protein 2/3 complex subunit 5; Arp2/3 complex 16 kDa subunit; p16-ARC,ARC16,10092,actin related protein 2/3 complex subunit 5,actin related protein 2/3 complex; subunit 5 (16 kD); actin related protein 2/3 complex subunit 5; 16kDa,Arp2/3 protein complex subunit p16,p16-Arc; ARC16; dJ127C7.3,actin related protein 2/3 complex subunit 5,ARC16; IMD113; dJ127C7.3; p16-Arc,ARPC5
O15516,CLOCK_HUMAN,CLOCK; BHLHE8; KIAA0334,Circadian locomoter output cycles protein kaput; hCLOCK; EC 2.3.1.48; Class E basic helix-loop-helix protein 8; bHLHe8,BHLHE8; KIAA0334,9575,clock circadian regulator,clock (mouse) homolog; clock homolog (mouse),Circadian locomoter output cycles protein kaput,KIAA0334; KAT13D; bHLHe8,clock circadian regulator,KAT13D; bHLHe8,CLOCK
O15519,CFLAR_HUMAN,CFLAR; CASH; CASP8AP1; CLARP; MRIT,CASP8 and FADD-like apoptosis regulator; Caspase homolog; CASH; Caspase-eight-related protein; Casper; Caspase-like apoptosis regulatory protein; CLARP; Cellular FLICE-like inhibitory protein; c-FLIP; FADD-like antiapoptotic molecule 1; FLAME-1; Inhibitor of FLICE; I-FLICE; MACH-related inducer of toxicity; MRIT; Usurpin,CASH; CASP8AP1; CLARP; MRIT,8837,CASP8 and FADD like apoptosis regulator,CASP8 and FADD-like apoptosis regulator,,CASH; Casper; CLARP; FLAME; FLIP; I-FLICE; MRIT; c-FLIP; cFLIP,CASP8 and FADD like apoptosis regulator,CASH; CASP8AP1; CLARP; Casper; FLAME; FLAME-1; FLAME1; FLIP; I-FLICE; MRIT; c-FLIP; c-FLIPL; c-FLIPR; c-FLIPS; cFLIP,CFLAR
O15523,DDX3Y_HUMAN,DDX3Y; DBY,ATP-dependent RNA helicase DDX3Y; EC 3.6.4.13; DEAD box protein 3; Y-chromosomal,DBY,8653,DEAD-box helicase 3 Y-linked,DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide; Y chromosome; DEAD (Asp-Glu-Ala-Asp) box polypeptide 3; Y-linked; DEAD (Asp-Glu-Ala-Asp) box helicase 3; Y-linked,,,DEAD-box helicase 3 Y-linked,DBY,DDX3Y
O15524,SOCS1_HUMAN,SOCS1; SSI1; TIP3,Suppressor of cytokine signaling 1; SOCS-1; JAK-binding protein; JAB; STAT-induced STAT inhibitor 1; SSI-1; Tec-interacting protein 3; TIP-3,SSI1; TIP3,8651,suppressor of cytokine signaling 1,,,SOCS-1; SSI-1; JAB; TIP3; Cish1,suppressor of cytokine signaling 1,AISIMD; CIS1; CISH1; JAB; SOCS-1; SSI-1; SSI1; TIP-3; TIP3,SOCS1
O15530,PDPK1_HUMAN,PDPK1; PDK1,3-phosphoinositide-dependent protein kinase 1; hPDK1; EC 2.7.11.1,PDK1,5170,3-phosphoinositide dependent protein kinase 1,,PkB kinase,PDK1,3-phosphoinositide dependent protein kinase 1,PDK1; PDPK2; PDPK2P; PRO0461,PDPK1
O15551,CLD3_HUMAN,CLDN3; C7orf1; CPETR2,Claudin-3; Clostridium perfringens enterotoxin receptor 2; CPE-R 2; CPE-receptor 2; Rat ventral prostate.1 protein homolog; hRVP1,C7orf1; CPETR2,1365,claudin 3,,Clostridium perfringens enterotoxin receptor 2; ventral prostate.1-like protein; claudin-3; CPE-receptor 2,RVP1; CPE-R2; HRVP1,claudin 3,C7orf1; CPE-R2; CPETR2; HRVP1; RVP1,CLDN3
O15553,MEFV_HUMAN,MEFV; MEF; TRIM20,Pyrin; Marenostrin,MEF; TRIM20,4210,MEFV innate immunity regulator; pyrin,Mediterranean fever; MEFV; pyrin innate immunity regulator,marenostrin,FMF; TRIM20,MEFV innate immunity regulator; pyrin,FMF; MEF; PAAND; TRIM20,MEFV
O15554,KCNN4_HUMAN,KCNN4; IK1; IKCA1; KCA4; SK4,Intermediate conductance calcium-activated potassium channel protein 4; SKCa 4; SKCa4; hSK4; Gardos channel; IKCa1; hIK1; KCa3.1; Putative Gardos channel; hKCa4,IK1; IKCA1; KCA4; SK4,3783,potassium calcium-activated channel subfamily N member 4,potassium intermediate/small conductance calcium-activated channel; subfamily N; member 4; potassium channel; calcium activated intermediate/small conductance subfamily N alpha; member 4,small conductance calcium-activated potassium channel 4; intermediate conductance calcium-activated potassium channel,KCa3.1; hSK4; hKCa4; hIKCa1; IK,potassium calcium-activated channel subfamily N member 4,DHS2; IK; IK1; IKCA1; KCA4; KCa3.1; SK4; hIK1; hIKCa1; hKCa4; hSK4,KCNN4
O43148,MCES_HUMAN,RNMT; KIAA0398,mRNA cap guanine-N(7) methyltransferase; 7; EC 2.1.1.56; RG7MT1; mRNA (guanine-N(7; mRNA cap methyltransferase; hCMT1; hMet; hcm1p,KIAA0398,8731,RNA guanine-7 methyltransferase,RNA (guanine-7-) methyltransferase,mRNA cap guanine-N7 methyltransferase,RG7MT1; N7-MTase,RNA guanine-7 methyltransferase,CMT1; CMT1c; MET; Met; N7-MTase; RG7MT1; cm1p; hCMT1; hMet,RNMT
O43156,TTI1_HUMAN,TTI1; KIAA0406; SMG10,TELO2-interacting protein 1 homolog; Protein SMG10,KIAA0406; SMG10,9675,TELO2 interacting protein 1,KIAA0406; Tel2 interacting protein 1 homolog (S. pombe),smg-10 homolog; nonsense mediated mRNA decay factor (C. elegans),smg-10,TELO2 interacting protein 1,KIAA0406; NEDMIM; smg-10,TTI1
O43157,PLXB1_HUMAN,PLXNB1; KIAA0407; PLXN5; SEP,Plexin-B1; Semaphorin receptor SEP,KIAA0407; PLXN5; SEP,5364,plexin B1,,,SEP; KIAA0407,plexin B1,PLEXIN-B1; PLXN5; SEP,PLXNB1
O43164,PJA2_HUMAN,PJA2; KIAA0438; RNF131,E3 ubiquitin-protein ligase Praja-2; Praja2; EC 2.3.2.27; RING finger protein 131; RING-type E3 ubiquitin transferase Praja-2,KIAA0438; RNF131,9867,praja ring finger ubiquitin ligase 2,ring finger protein 131; praja ring finger 2; praja ring finger 2; E3 ubiquitin protein ligase,,KIAA0438; Neurodap1; PRAJA2,praja ring finger ubiquitin ligase 2,Neurodap1; RNF131,PJA2
O43175,SERA_HUMAN,PHGDH; PGDH3,D-3-phosphoglycerate dehydrogenase; 3-PGDH; EC 1.1.1.95; 2-oxoglutarate reductase; EC 1.1.1.399; Malate dehydrogenase; EC 1.1.1.37,PGDH3,26227,phosphoglycerate dehydrogenase,,D-3-phosphoglycerate dehydrogenase,SERA; PGDH; PDG,phosphoglycerate dehydrogenase,3-PGDH; 3PGDH; HEL-S-113; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA,PHGDH
O43181,NDUS4_HUMAN,NDUFS4,NADH dehydrogenase ubiquinone iron-sulfur protein 4; mitochondrial; Complex I-18 kDa; CI-18 kDa; Complex I-AQDQ; CI-AQDQ; NADH-ubiquinone oxidoreductase 18 kDa subunit,,4724,NADH:ubiquinone oxidoreductase subunit S4,NADH dehydrogenase (ubiquinone) Fe-S protein 4 (18kD) (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 4; 18kDa (NADH-coenzyme Q reductase),complex I 18kDa subunit,AQDQ; CI-18,NADH:ubiquinone oxidoreductase subunit S4,AQDQ; CI-18; CI-18 kDa; CI-AQDQ; MC1DN1,NDUFS4
O43255,SIAH2_HUMAN,SIAH2,E3 ubiquitin-protein ligase SIAH2; EC 2.3.2.27; RING-type E3 ubiquitin transferase SIAH2; Seven in absentia homolog 2; Siah-2; hSiah2,,6478,siah E3 ubiquitin protein ligase 2,seven in absentia (Drosophila) homolog 2; seven in absentia homolog 2 (Drosophila),,,siah E3 ubiquitin protein ligase 2,hSiah2,SIAH2
O43257,ZNHI1_HUMAN,ZNHIT1; CGBP1; ZNFN4A1,Zinc finger HIT domain-containing protein 1; Cyclin-G1-binding protein 1; Zinc finger protein subfamily 4A member 1; p18 Hamlet,CGBP1; ZNFN4A1,10467,zinc finger HIT-type containing 1,zinc finger protein; subfamily 4A (HIT domain containing); member 1; zinc finger; HIT domain containing 1,putative cyclin G1 interacting protein,CG1I; H_DJ0747G18.14; p18(Hamlet),zinc finger HIT-type containing 1,CG1I; ZNFN4A1; p18(Hamlet),ZNHIT1
O43283,M3K13_HUMAN,MAP3K13; LZK,Mitogen-activated protein kinase kinase kinase 13; EC 2.7.11.25; Leucine zipper-bearing kinase; Mixed lineage kinase; MLK,LZK,9175,mitogen-activated protein kinase kinase kinase 13,,leucine zipper-bearing kinase,LZK; MEKK13,mitogen-activated protein kinase kinase kinase 13,LZK; MEKK13; MLK,MAP3K13
O43293,DAPK3_HUMAN,DAPK3; ZIPK,Death-associated protein kinase 3; DAP kinase 3; EC 2.7.11.1; DAP-like kinase; Dlk; MYPT1 kinase; Zipper-interacting protein kinase; ZIP-kinase,ZIPK,1613,death associated protein kinase 3,,,ZIP; ZIPK,death associated protein kinase 3,DLK; ZIP; ZIPK,DAPK3
O43294,TGFI1_HUMAN,TGFB1I1; ARA55,Transforming growth factor beta-1-induced transcript 1 protein; Androgen receptor coactivator 55 kDa protein; Androgen receptor-associated protein of 55 kDa; Hydrogen peroxide-inducible clone 5 protein; Hic-5,ARA55,7041,transforming growth factor beta 1 induced transcript 1,,hydrogen peroxide-inducible clone-5,Hic-5; TSC-5; ARA55; HIC-5,transforming growth factor beta 1 induced transcript 1,ARA55; HIC-5; HIC5; TSC-5,TGFB1I1
O43303,CP110_HUMAN,CCP110; CEP110; CP110; KIAA0419,Centriolar coiled-coil protein of 110 kDa; Centrosomal protein of 110 kDa; CP110; Cep110,CEP110; CP110; KIAA0419,9738,centriolar coiled-coil protein 110,centriolar coiled coil protein 110kDa,,KIAA0419; CP110,centriolar coiled-coil protein 110,CP110; Cep110,CCP110
O43312,MTSS1_HUMAN,MTSS1; KIAA0429; MIM,Protein MTSS 1; Metastasis suppressor YGL-1; Metastasis suppressor protein 1; Missing in metastasis protein,KIAA0429; MIM,9788,MTSS I-BAR domain containing 1,metastasis suppressor 1; MTSS1; I-BAR domain containing,missing in metastasis,KIAA0429; MIMA; MIMB; MIM,MTSS I-BAR domain containing 1,MIM; MIMA; MIMB,MTSS1
O43315,AQP9_HUMAN,AQP9; SSC1,Aquaporin-9; AQP-9; Aquaglyceroporin-9; Small solute channel 1,SSC1,366,aquaporin 9,,,SSC1; HsT17287,aquaporin 9,AQP-9; HsT17287; SSC1; T17287,AQP9
O43318,M3K7_HUMAN,MAP3K7; TAK1,Mitogen-activated protein kinase kinase kinase 7; EC 2.7.11.25; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1,TAK1,6885,mitogen-activated protein kinase kinase kinase 7,,TGF-beta activated kinase 1,MEKK7,mitogen-activated protein kinase kinase kinase 7,CSCF; FMD2; MEKK7; TAK1; TGF1a,MAP3K7
O43353,RIPK2_HUMAN,RIPK2; CARDIAK; RICK; RIP2; UNQ277/PRO314/PRO34092,Receptor-interacting serine/threonine-protein kinase 2; EC 2.7.11.1; CARD-containing interleukin-1 beta-converting enzyme-associated kinase; CARD-containing IL-1 beta ICE-kinase; RIP-like-interacting CLARP kinase; Receptor-interacting protein 2; RIP-2; Tyrosine-protein kinase RIPK2; EC 2.7.10.2,CARDIAK; RICK; RIP2,8767,receptor interacting serine/threonine kinase 2,receptor-interacting serine-threonine kinase 2,,RICK; RIP2; CARDIAK; CARD3,receptor interacting serine/threonine kinase 2,CARD3; CARDIAK; CCK; GIG30; RICK; RIP2,RIPK2
O43379,WDR62_HUMAN,WDR62; C19orf14,WD repeat-containing protein 62,C19orf14,284403,WD repeat domain 62,chromosome 19 open reading frame 14; microcephaly; primary autosomal recessive 2,,DKFZP434J046; FLJ33298,WD repeat domain 62,C19orf14; MCPH2,WDR62
O43395,PRPF3_HUMAN,PRPF3; HPRP3; PRP3,U4/U6 small nuclear ribonucleoprotein Prp3; Pre-mRNA-splicing factor 3; hPrp3; U4/U6 snRNP 90 kDa protein,HPRP3; PRP3,9129,pre-mRNA processing factor 3,retinitis pigmentosa 18 (autosomal dominant); PRP3 pre-mRNA processing factor 3 homolog (yeast); PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),U4/U6 small nuclear ribonucleoprotein Prp3,Prp3; hPrp3; SNRNP90,pre-mRNA processing factor 3,HPRP3; HPRP3P; PRP3; Prp3p; RP18; SNRNP90,PRPF3
O43432,IF4G3_HUMAN,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3; eIF-4-gamma 3; eIF-4G 3; eIF4G 3; eIF-4-gamma II; eIF4GII,,8672,eukaryotic translation initiation factor 4 gamma 3,eukaryotic translation initiation factor 4 gamma; 3,,eIF4GII,eukaryotic translation initiation factor 4 gamma 3,eIF-4G 3; eIF4G 3; eIF4GII,EIF4G3
O43464,HTRA2_HUMAN,HTRA2; OMI; PRSS25,Serine protease HTRA2; mitochondrial; EC 3.4.21.108; High temperature requirement protein A2; HtrA2; Omi stress-regulated endoprotease; Serine protease 25; Serine proteinase OMI,OMI; PRSS25,27429,HtrA serine peptidase 2,protease; serine; 25,,OMI; PARK13,HtrA serine peptidase 2,MGCA8; OMI; PARK13; PRSS25,HTRA2
O43490,PROM1_HUMAN,PROM1; PROML1; MSTP061,Prominin-1; Antigen AC133; Prominin-like protein 1; CD antigen CD133,PROML1,8842,prominin 1,prominin (mouse)-like 1; macular dystrophy; retinal 2; Stargardt disease 4 (autosomal dominant),AC133 antigen; Retinitis pigmentosa 41; Cone-rod dystrophy 12,AC133; CD133; RP41; CORD12,prominin 1,AC133; CD133; CORD12; MCDR2; MSTP061; PROML1; RP41; STGD4,PROM1
O43504,LTOR5_HUMAN,LAMTOR5; HBXIP; XIP,Ragulator complex protein LAMTOR5; Hepatitis B virus X-interacting protein; HBV X-interacting protein; HBX-interacting protein; Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5,HBXIP; XIP,10542,late endosomal/lysosomal adaptor; MAPK and MTOR activator 5,hepatitis B virus x interacting protein,HBx-interacting protein; hepatitis B virus x-interacting protein (9.6kD),XIP; MGC71071,late endosomal/lysosomal adaptor; MAPK and MTOR activator 5,HBXIP; XIP,LAMTOR5
O43516,WIPF1_HUMAN,WIPF1; WASPIP; WIP,WAS/WASL-interacting protein family member 1; Protein PRPL-2; Wiskott-Aldrich syndrome protein-interacting protein; WASP-interacting protein,WASPIP; WIP,7456,WAS/WASL interacting protein family member 1,Wiskott-Aldrich syndrome protein interacting protein; WAS/WASL interacting protein family; member 1,,WIP,WAS/WASL interacting protein family member 1,PRPL-2; WAS2; WASPIP; WIP,WIPF1
O43521,B2L11_HUMAN,BCL2L11; BIM,Bcl-2-like protein 11; Bcl2-L-11; Bcl2-interacting mediator of cell death,BIM,10018,BCL2 like 11,BCL2-like 11 (apoptosis facilitator),,BOD; BimL; BimEL; BimS; BIM,BCL2 like 11,BAM; BIM; BOD,BCL2L11
O43524,FOXO3_HUMAN,FOXO3; FKHRL1; FOXO3A,Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1,FKHRL1; FOXO3A,2309,forkhead box O3,,,AF6q21; FOXO2,forkhead box O3,AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A,FOXO3
O43526,KCNQ2_HUMAN,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2; KQT-like 2; Neuroblastoma-specific potassium channel subunit alpha KvLQT2; Voltage-gated potassium channel subunit Kv7.2,,3785,potassium voltage-gated channel subfamily Q member 2,potassium voltage-gated channel; KQT-like subfamily; member 2; potassium channel; voltage gated KQT-like subfamily Q; member 2,,Kv7.2; ENB1; BFNC; KCNA11; HNSPC,potassium voltage-gated channel subfamily Q member 2,BFNC; DEE7; EBN; EBN1; ENB1; HNSPC; KCNA11; KV7.2,KCNQ2
O43541,SMAD6_HUMAN,SMAD6; MADH6,Mothers against decapentaplegic homolog 6; MAD homolog 6; Mothers against DPP homolog 6; SMAD family member 6; SMAD 6; Smad6; hSMAD6,MADH6,4091,SMAD family member 6,MAD; mothers against decapentaplegic homolog 6 (Drosophila); SMAD; mothers against DPP homolog 6 (Drosophila),,HsT17432,SMAD family member 6,AOVD2; HsT17432; MADH6; MADH7,SMAD6
O43542,XRCC3_HUMAN,XRCC3,DNA repair protein XRCC3; X-ray repair cross-complementing protein 3,,7517,X-ray repair cross complementing 3,X-ray repair complementing defective repair in Chinese hamster cells 3,RAD51-like; DNA repair protein XRCC3,,X-ray repair cross complementing 3,CMM6,XRCC3
O43561,LAT_HUMAN,LAT,Linker for activation of T-cells family member 1; 36 kDa phosphotyrosine adapter protein; pp36; p36-38,,27040,linker for activation of T cells,,linker for activation of T cells; transmembrane adaptor,LAT1,linker for activation of T cells,IMD52; LAT1; pp36,LAT
O43586,PPIP1_HUMAN,PSTPIP1; CD2BP1,Proline-serine-threonine phosphatase-interacting protein 1; PEST phosphatase-interacting protein 1; CD2-binding protein 1; H-PIP,CD2BP1,9051,proline-serine-threonine phosphatase interacting protein 1,,CD2 cytoplasmic tail-binding protein; CD2 antigen-binding protein 1; PEST phosphatase-interacting protein 1,PSTPIP; CD2BP1L; CD2BP1; CD2BP1S; H-PIP; PAPAS,proline-serine-threonine phosphatase interacting protein 1,AICZC; CD2BP1; CD2BP1L; CD2BP1S; H-PIP; PAPA; PAPAS; PSTPIP,PSTPIP1
O43597,SPY2_HUMAN,SPRY2,Protein sprouty homolog 2; Spry-2,,10253,sprouty RTK signaling antagonist 2,sprouty (Drosophila) homolog 2; sprouty homolog 2 (Drosophila),,hSPRY2,sprouty RTK signaling antagonist 2,IGAN3; hSPRY2,SPRY2
O43602,DCX_HUMAN,DCX; DBCN; LISX,Neuronal migration protein doublecortin; Doublin; Lissencephalin-X; Lis-X,DBCN; LISX,1641,doublecortin,doublecortex; lissencephaly; X-linked (doublecortin),doublecortex,SCLH; DC; LISX; DBCN; XLIS,doublecortin,DBCN; DC; LISX; SCLH; XLIS,DCX
O43609,SPY1_HUMAN,SPRY1,Protein sprouty homolog 1; Spry-1,,10252,sprouty RTK signaling antagonist 1,sprouty (Drosophila) homolog 1 (antagonist of FGF signaling); sprouty homolog 1; antagonist of FGF signaling (Drosophila),,hSPRY1,sprouty RTK signaling antagonist 1,hSPRY1,SPRY1
O43613,OX1R_HUMAN,HCRTR1,Orexin/Hypocretin receptor type 1; Hypocretin receptor type 1; Orexin receptor type 1; Ox-1-R; Ox1-R; Ox1R,,3061,hypocretin receptor 1,hypocretin (orexin) receptor 1,orexin receptor 1,OX1R; OXR1; ORXR1,hypocretin receptor 1,ORXR1; OX1R; OXR1,HCRTR1
O43623,SNAI2_HUMAN,SNAI2; SLUG; SLUGH,Zinc finger protein SNAI2; Neural crest transcription factor Slug; Protein snail homolog 2,SLUG; SLUGH,6591,snail family transcriptional repressor 2,slug homolog; zinc finger protein (chicken); snail homolog 2 (Drosophila); snail family zinc finger 2,,SLUGH1; SNAIL2; SLUGH,snail family transcriptional repressor 2,SLUG; SLUGH; SLUGH1; SNAIL2; WS2D,SNAI2
O43639,NCK2_HUMAN,NCK2; GRB4,Cytoplasmic protein NCK2; Growth factor receptor-bound protein 4; NCK adaptor protein 2; Nck-2; SH2/SH3 adaptor protein NCK-beta,GRB4,8440,NCK adaptor protein 2,,,NCKbeta,NCK adaptor protein 2,GRB4; NCKbeta,NCK2
O43660,PLRG1_HUMAN,PLRG1,Pleiotropic regulator 1,,5356,pleiotropic regulator 1,pleiotropic regulator 1 (PRL1; Arabidopsis homolog); pleiotropic regulator 1 (PRL1 homolog; Arabidopsis),transport and golgi organization 4 homolog (Drosophila),PRL1; Prp46; PRPF46; Cwc1; TANGO4,pleiotropic regulator 1,Cwc1; PRL1; PRP46; PRPF46; TANGO4,PLRG1
O43663,PRC1_HUMAN,PRC1,Protein regulator of cytokinesis 1,,9055,protein regulator of cytokinesis 1,,anaphase spindle elongation 1 homolog (S. cerevisiae),ASE1; MAP65,protein regulator of cytokinesis 1,ASE1; MAP65,PRC1
O43665,RGS10_HUMAN,RGS10,Regulator of G-protein signaling 10; RGS10,,6001,regulator of G protein signaling 10,regulator of G-protein signalling 10; regulator of G-protein signaling 10,,,regulator of G protein signaling 10,,RGS10
O43683,BUB1_HUMAN,BUB1; BUB1L,Mitotic checkpoint serine/threonine-protein kinase BUB1; hBUB1; EC 2.7.11.1; BUB1A,BUB1L,699,BUB1 mitotic checkpoint serine/threonine kinase,budding uninhibited by benzimidazoles 1 (yeast homolog); budding uninhibited by benzimidazoles 1 homolog (yeast),,hBUB1; BUB1A,BUB1 mitotic checkpoint serine/threonine kinase,BUB1A; BUB1L; MCPH30; hBUB1,BUB1
O43684,BUB3_HUMAN,BUB3,Mitotic checkpoint protein BUB3,,9184,BUB3 mitotic checkpoint protein,BUB3 (budding uninhibited by benzimidazoles 3; yeast) homolog; budding uninhibited by benzimidazoles 3 homolog (yeast),,BUB3L,BUB3 mitotic checkpoint protein,BUB3L; hBUB3,BUB3
O43734,CIKS_HUMAN,TRAF3IP2; C6orf2; C6orf4; C6orf5; C6orf6,E3 ubiquitin ligase TRAF3IP2; EC 2.3.2.27; Adapter protein CIKS; Connection to IKK and SAPK/JNK; E3 ubiquitin-protein ligase CIKS; Nuclear factor NF-kappa-B activator 1; ACT1; TRAF3-interacting protein 2,C6orf2; C6orf4; C6orf5; C6orf6,10758,TRAF3 interacting protein 2,chromosome 6 open reading frame 5; chromosome 6 open reading frame 2,,DKFZP586G0522; ACT1; CIKS,TRAF3 interacting protein 2,ACT1; C6orf2; C6orf4; C6orf5; C6orf6; CANDF8; CIKS; PSORS13,TRAF3IP2
O43741,AAKB2_HUMAN,PRKAB2,5'-AMP-activated protein kinase subunit beta-2; AMPK subunit beta-2,,5565,protein kinase AMP-activated non-catalytic subunit beta 2,protein kinase; AMP-activated; beta 2 non-catalytic subunit,AMPK beta 2,,protein kinase AMP-activated non-catalytic subunit beta 2,,PRKAB2
O43749,OR1F1_HUMAN,OR1F1; OLFMF; OR1F10; OR1F4; OR1F5; OR1F6; OR1F7; OR1F8; OR1F9,Olfactory receptor 1F1; Olfactory receptor 16-35; OR16-35; Olfactory receptor 1F10; Olfactory receptor 1F4; Olfactory receptor 1F5; Olfactory receptor 1F6; Olfactory receptor 1F7; Olfactory receptor 1F8; Olfactory receptor 1F9; Olfactory receptor OR16-4,OLFMF; OR1F10; OR1F4; OR1F5; OR1F6; OR1F7; OR1F8; OR1F9,4992,olfactory receptor family 1 subfamily F member 1,olfactory receptor; family 1; subfamily F; member 1; olfactory receptor family 1 subfamily F member 1 (gene/pseudogene),,Olfmf; OR16-36; OR16-37; OR16-88; OR16-89; OR16-90; OLFMF; OR3-145,olfactory receptor family 1 subfamily F member 1,OLFMF; OR16-36; OR16-37; OR16-88; OR16-89; OR16-90; OR1F10; OR1F13P; OR1F4; OR1F5; OR1F6; OR1F7; OR1F8; OR1F9; OR3-145; ORL1023,OR1F1
O43768,ENSA_HUMAN,ENSA,Alpha-endosulfine; ARPP-19e,,2029,endosulfine alpha,,,MGC4319; MGC8394; MGC78563; ARPP-19e,endosulfine alpha,ARPP-19e,ENSA
O43781,DYRK3_HUMAN,DYRK3,Dual specificity tyrosine-phosphorylation-regulated kinase 3; EC 2.7.12.1; Regulatory erythroid kinase; REDK,,8444,dual specificity tyrosine phosphorylation regulated kinase 3,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3; dual specificity tyrosine-(Y)-phosphorylation regulated kinase 3,regulatory erythroid kinase; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 5; protein kinase Dyrk3,RED; REDK; hYAK3-2,dual specificity tyrosine phosphorylation regulated kinase 3,DYRK5; RED; REDK; hYAK3-2,DYRK3
O43791,SPOP_HUMAN,SPOP,Speckle-type POZ protein; HIB homolog 1; Roadkill homolog 1,,8405,speckle type BTB/POZ protein,speckle-type POZ protein,,TEF2; BTBD32,speckle type BTB/POZ protein,BTBD32; NEDMACE; NEDMIDF; NSDVS1; NSDVS2; TEF2,SPOP
O43823,AKAP8_HUMAN,AKAP8; AKAP95,A-kinase anchor protein 8; AKAP-8; A-kinase anchor protein 95 kDa; AKAP 95,AKAP95,10270,A-kinase anchoring protein 8,A kinase (PRKA) anchor protein 8,A-kinase anchor protein; 95kDa,AKAP95; DKFZp586B1222,A-kinase anchoring protein 8,AKAP 95; AKAP-8; AKAP-95; AKAP95,AKAP8
O43852,CALU_HUMAN,CALU,Calumenin; Crocalbin; IEF SSP 9302,,813,calumenin,,,,calumenin,,CALU
O43865,SAHH2_HUMAN,AHCYL1; DCAL; IRBIT; XPVKONA,S-adenosylhomocysteine hydrolase-like protein 1; DC-expressed AHCY-like molecule; IP(3; 3; IRBIT; Putative adenosylhomocysteinase 2; S-adenosyl-L-homocysteine hydrolase 2; AdoHcyase 2,DCAL; IRBIT; XPVKONA,10768,adenosylhomocysteinase like 1,S-adenosylhomocysteine hydrolase-like 1; adenosylhomocysteinase-like 1,inositol 1;4;5-trisphosphate receptor-binding protein; protein phosphatase 1; regulatory subunit 78,XPVKONA; IRBIT; PPP1R78,adenosylhomocysteinase like 1,DCAL; IRBIT; PPP1R78; PRO0233; XPVKONA,AHCYL1
O43889,CREB3_HUMAN,CREB3; LZIP,Cyclic AMP-responsive element-binding protein 3; CREB-3; cAMP-responsive element-binding protein 3; Leucine zipper protein; Luman; Transcription factor LZIP-alpha; N-terminal Luman; Transcriptionally active form,LZIP,10488,cAMP responsive element binding protein 3,cAMP responsive element binding protein 3 (luman),small leucine zipper protein,LZIP; Luman; sLZIP,cAMP responsive element binding protein 3,LUMAN; LZIP; sLZIP,CREB3
O43914,TYOBP_HUMAN,TYROBP; DAP12; KARAP,TYRO protein tyrosine kinase-binding protein; DNAX-activation protein 12; Killer-activating receptor-associated protein; KAR-associated protein,DAP12; KARAP,7305,transmembrane immune signaling adaptor TYROBP,polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; TYRO protein tyrosine kinase binding protein,killer activating receptor associated protein; DNAX-activation protein 12; DNAX adaptor protein 12,DAP12; PLO-SL; KARAP,transmembrane immune signaling adaptor TYROBP,DAP12; KARAP; PLOSL; PLOSL1,TYROBP
O43918,AIRE_HUMAN,AIRE; APECED,Autoimmune regulator; Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein; APECED protein,APECED,326,autoimmune regulator,autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy),autoimmune polyendocrinopathy candidiasis ectodermal dystrophy,PGA1; APS1,autoimmune regulator,AIRE1; APECED; APS1; APSI; PGA1,AIRE
O60229,KALRN_HUMAN,KALRN; DUET; DUO; HAPIP; TRAD,Kalirin; EC 2.7.11.1; Huntingtin-associated protein-interacting protein; Protein Duo; Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain,DUET; DUO; HAPIP; TRAD,8997,kalirin RhoGEF kinase,huntingtin-associated protein interacting protein (duo),serine/threonine kinase with Dbl and pleckstrin homology domains,duo; Hs.8004; TRAD; DUET; Kalirin; ARHGEF24; KALNC2,kalirin RhoGEF kinase,ARHGEF24; CHD5; CHDS5; DUET; DUO; HAPIP; KALNC2; TRAD,KALRN
O60237,MYPT2_HUMAN,PPP1R12B; MYPT2,Protein phosphatase 1 regulatory subunit 12B; Myosin phosphatase-targeting subunit 2; Myosin phosphatase target subunit 2,MYPT2,4660,protein phosphatase 1 regulatory subunit 12B,protein phosphatase 1; regulatory (inhibitor) subunit 12B; protein phosphatase 1; regulatory subunit 12B,myosin phosphatase regulatory subunit; myosin phosphatase; target subunit 2,MGC87886; MGC131980; PP1bp55,protein phosphatase 1 regulatory subunit 12B,MYPT2; PP1bp55,PPP1R12B
O60238,BNI3L_HUMAN,BNIP3L; BNIP3A; BNIP3H; NIX,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like; Adenovirus E1B19K-binding protein B5; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A; NIP3-like protein X; NIP3L,BNIP3A; BNIP3H; NIX,665,BCL2 interacting protein 3 like,BCL2/adenovirus E1B 19kDa interacting protein 3 like,NIP-3-like protein X,Nix; BNIP3a,BCL2 interacting protein 3 like,BNIP3a; NIP3L; NIX,BNIP3L
O60240,PLIN1_HUMAN,PLIN1; PERI; PLIN,Perilipin-1; Lipid droplet-associated protein,PERI; PLIN,5346,perilipin 1,perilipin,,,perilipin 1,FPLD4; PERI; PLIN,PLIN1
O60244,MED14_HUMAN,MED14; ARC150; CRSP2; CXorf4; DRIP150; EXLM1; RGR1; TRAP170,Mediator of RNA polymerase II transcription subunit 14; Activator-recruited cofactor 150 kDa component; ARC150; Cofactor required for Sp1 transcriptional activation subunit 2; CRSP complex subunit 2; Mediator complex subunit 14; RGR1 homolog; hRGR1; Thyroid hormone receptor-associated protein complex 170 kDa component; Trap170; Transcriptional coactivator CRSP150; Vitamin D3 receptor-interacting protein complex 150 kDa component; DRIP150,ARC150; CRSP2; CXorf4; DRIP150; EXLM1; RGR1; TRAP170,9282,mediator complex subunit 14,cofactor required for Sp1 transcriptional activation; subunit 2; 150kDa,,EXLM1; CRSP150; TRAP170; RGR1; CSRP,mediator complex subunit 14,CRSP150; CRSP2; CSRP; CXorf4; DRIP150; EXLM1; RGR1; TRAP170,MED14
O60260,PRKN_HUMAN,PRKN; PARK2,E3 ubiquitin-protein ligase parkin; Parkin; EC 2.3.2.31; Parkin RBR E3 ubiquitin-protein ligase; Parkinson juvenile disease protein 2; Parkinson disease protein 2,PARK2,5071,parkin RBR E3 ubiquitin protein ligase,Parkinson disease (autosomal recessive; juvenile) 2; parkin; parkinson protein 2; E3 ubiquitin protein ligase (parkin),E3 ubiquitin ligase,PDJ; AR-JP; parkin,parkin RBR E3 ubiquitin protein ligase,AR-JP; LPRS2; PARK2; PDJ,PRKN
O60266,ADCY3_HUMAN,ADCY3; KIAA0511,Adenylate cyclase type 3; EC 4.6.1.1; ATP pyrophosphate-lyase 3; Adenylate cyclase type III; AC-III; Adenylate cyclase; olfactive type; Adenylyl cyclase 3; AC3,KIAA0511,109,adenylate cyclase 3,,,AC3,adenylate cyclase 3,AC-III; AC3; BMIQ19,ADCY3
O60271,JIP4_HUMAN,SPAG9; HSS; KIAA0516; MAPK8IP4; SYD1; HLC6,C-Jun-amino-terminal kinase-interacting protein 4; JIP-4; JNK-interacting protein 4; Cancer/testis antigen 89; CT89; Human lung cancer oncogene 6 protein; HLC-6; JNK-associated leucine-zipper protein; JLP; Mitogen-activated protein kinase 8-interacting protein 4; Proliferation-inducing protein 6; Protein highly expressed in testis; PHET; Sperm surface protein; Sperm-associated antigen 9; Sperm-specific protein; Sunday driver 1,HSS; KIAA0516; MAPK8IP4; SYD1,9043,sperm associated antigen 9,,sperm surface protein; JNK/SAPK-associated protein; JNK interacting protein; sperm specific protein; c-Jun NH2-terminal kinase-associated leucine zipper protein; Max-binding protein; JNK-associated leucine-zipper protein; HLC-4 protein; lung cancer oncogene 4; proliferation-inducing gene 6; cancer/testis antigen 89,HSS; SYD1; KIAA0516; MGC14967; MGC74461; MGC117291; JLP; PHET; HLC4; FLJ13450; FLJ14006; FLJ26141; FLJ34602; CT89; JIP4; JIP-4; PIG6,sperm associated antigen 9,CT89; HLC-6; HLC4; HLC6; JIP-4; JIP4; JLP; PHET; PIG6,SPAG9
O60282,KIF5C_HUMAN,KIF5C; KIAA0531; NKHC2,Kinesin heavy chain isoform 5C; EC 3.6.4.-; Kinesin heavy chain neuron-specific 2; Kinesin-1,KIAA0531; NKHC2,3800,kinesin family member 5C,,neuron-specific kinesin heavy chain 2,NKHC2,kinesin family member 5C,CDCBM2; KINN; NKHC; NKHC-2; NKHC2,KIF5C
O60285,NUAK1_HUMAN,NUAK1; ARK5; KIAA0537; OMPHK1,NUAK family SNF1-like kinase 1; EC 2.7.11.1; AMPK-related protein kinase 5; ARK5; Omphalocele kinase 1,ARK5; KIAA0537; OMPHK1,9891,NUAK family kinase 1,NUAK family; SNF1-like kinase; 1,AMP-activated protein kinase family member 5,ARK5; KIAA0537,NUAK family kinase 1,ARK5,NUAK1
O60331,PI51C_HUMAN,PIP5K1C; KIAA0589,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma; PIP5K1gamma; PtdIns(4; EC 2.7.1.68; Type I phosphatidylinositol 4-phosphate 5-kinase gamma,KIAA0589,23396,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma,phosphatidylinositol-4-phosphate 5-kinase; type I; gamma,,PIP5Kgamma; KIAA0589; LCCS3,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma,LCCS3; PIP5K-GAMMA; PIP5K1-gamma; PIP5Kgamma,PIP5K1C
O60341,KDM1A_HUMAN,KDM1A; AOF2; KDM1; KIAA0601; LSD1,Lysine-specific histone demethylase 1A; EC 1.14.99.66; BRAF35-HDAC complex protein BHC110; Flavin-containing amine oxidase domain-containing protein 2; histone H3-dimethyl-L-lysine(4,AOF2; KDM1; KIAA0601; LSD1,23028,lysine demethylase 1A,amine oxidase (flavin containing) domain 2; lysine (K)-specific demethylase 1,Lysine-specific histone demethylase 1A,KIAA0601; BHC110; LSD1,lysine demethylase 1A,AIMAH3; AOF2; BHC110; CPRF; KDM1; LSD1,KDM1A
O60343,TBCD4_HUMAN,TBC1D4; AS160; KIAA0603,TBC1 domain family member 4; Akt substrate of 160 kDa; AS160,AS160; KIAA0603,9882,TBC1 domain family member 4,TBC1 domain family; member 4,Akt substrate of 160 kDa,KIAA0603; AS160; DKFZp779C0666,TBC1 domain family member 4,AS160; NIDDM5,TBC1D4
O60346,PHLP1_HUMAN,PHLPP1; KIAA0606; PHLPP; PLEKHE1; SCOP,PH domain leucine-rich repeat-containing protein phosphatase 1; EC 3.1.3.16; Pleckstrin homology domain-containing family E member 1; PH domain-containing family E member 1; Suprachiasmatic nucleus circadian oscillatory protein; hSCOP,KIAA0606; PHLPP; PLEKHE1; SCOP,23239,PH domain and leucine rich repeat protein phosphatase 1,pleckstrin homology domain containing; family E (with leucine rich repeats) member 1; PH domain and leucine rich repeat protein phosphatase,protein phosphatase; Mg2+/Mn2+ dependent 3A,KIAA0606; SCOP; PPM3A,PH domain and leucine rich repeat protein phosphatase 1,PHLPP; PLEKHE1; PPM3A; SCOP,PHLPP1
O60353,FZD6_HUMAN,FZD6,Frizzled-6; Fz-6; hFz6,,8323,frizzled class receptor 6,frizzled (Drosophila) homolog 6; frizzled homolog 6 (Drosophila); frizzled 6; seven transmembrane spanning receptor; frizzled family receptor 6,,Hfz6,frizzled class receptor 6,FZ-6; FZ6; HFZ6; NDNC1; NDNC10,FZD6
O60359,CCG3_HUMAN,CACNG3,Voltage-dependent calcium channel gamma-3 subunit; Neuronal voltage-gated calcium channel gamma-3 subunit; Transmembrane AMPAR regulatory protein gamma-3; TARP gamma-3,,10368,calcium voltage-gated channel auxiliary subunit gamma 3,calcium channel; voltage-dependent; gamma subunit 3,,,calcium voltage-gated channel auxiliary subunit gamma 3,,CACNG3
O60381,HBP1_HUMAN,HBP1,HMG box-containing protein 1; HMG box transcription factor 1; High mobility group box transcription factor 1,,26959,HMG-box transcription factor 1,,,,HMG-box transcription factor 1,,HBP1
O60391,NMD3B_HUMAN,GRIN3B,Glutamate receptor ionotropic; NMDA 3B; GluN3B; N-methyl-D-aspartate receptor subtype 3B; NMDAR3B; NR3B,,116444,glutamate ionotropic receptor NMDA type subunit 3B,glutamate receptor; ionotropic; N-methyl-D-aspartate 3B,,GluN3B,glutamate ionotropic receptor NMDA type subunit 3B,GluN3B; NR3B,GRIN3B
O60479,DLX3_HUMAN,DLX3,Homeobox protein DLX-3,,1747,distal-less homeobox 3,distal-less homeo box 3,,,distal-less homeobox 3,AI4; TDO,DLX3
O60500,NPHN_HUMAN,NPHS1; NPHN,Nephrin; Renal glomerulus-specific cell adhesion receptor,NPHN,4868,NPHS1 adhesion molecule; nephrin,nephrosis 1; congenital; Finnish type (nephrin); NPHS1; nephrin,,CNF; NPHN,NPHS1 adhesion molecule; nephrin,CNF; NPHN; nephrin,NPHS1
O60503,ADCY9_HUMAN,ADCY9; KIAA0520,Adenylate cyclase type 9; EC 4.6.1.1; ATP pyrophosphate-lyase 9; Adenylate cyclase type IX; ACIX; Adenylyl cyclase 9; AC9,KIAA0520,115,adenylate cyclase 9,,,AC9,adenylate cyclase 9,AC9; ACIX,ADCY9
O60504,VINEX_HUMAN,SORBS3; SCAM1,Vinexin; SH3-containing adapter molecule 1; SCAM-1; Sorbin and SH3 domain-containing protein 3,SCAM1,10174,sorbin and SH3 domain containing 3,,,SCAM-1; SH3D4; vinexin,sorbin and SH3 domain containing 3,SCAM-1; SCAM1; SH3D4,SORBS3
O60506,HNRPQ_HUMAN,SYNCRIP; HNRPQ; NSAP1,Heterogeneous nuclear ribonucleoprotein Q; hnRNP Q; Glycine- and tyrosine-rich RNA-binding protein; GRY-RBP; NS1-associated protein 1; Synaptotagmin-binding; cytoplasmic RNA-interacting protein,HNRPQ; NSAP1,10492,synaptotagmin binding cytoplasmic RNA interacting protein,,heterogeneous nuclear ribonucleoprotein Q,NSAP1; GRY-RBP; dJ3J17.2; HNRPQ1; hnRNP-Q; HNRNPQ,synaptotagmin binding cytoplasmic RNA interacting protein,GRY-RBP; GRYRBP; HNRNPQ; HNRPQ1; NSAP1; PP68; hnRNP-Q,SYNCRIP
O60563,CCNT1_HUMAN,CCNT1,Cyclin-T1; CycT1; Cyclin-T,,904,cyclin T1,human immunodeficiency virus type 1 (HIV-1) expression (elevated) 1,,CCNT; CYCT1,cyclin T1,CCNT; CYCT1; HIVE1,CCNT1
O60566,BUB1B_HUMAN,BUB1B; BUBR1; MAD3L; SSK1,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta; EC 2.7.11.1; MAD3/BUB1-related protein kinase; hBUBR1; Mitotic checkpoint kinase MAD3L; Protein SSK1,BUBR1; MAD3L; SSK1,701,BUB1 mitotic checkpoint serine/threonine kinase B,budding uninhibited by benzimidazoles 1 (yeast homolog); beta; budding uninhibited by benzimidazoles 1 homolog beta (yeast),,BUBR1; MAD3L; Bub1A; SSK1,BUB1 mitotic checkpoint serine/threonine kinase B,BUB1beta; BUBR1; Bub1A; MAD3L; MVA1; SSK1; hBUBR1,BUB1B
O60573,IF4E2_HUMAN,EIF4E2; EIF4EL3,Eukaryotic translation initiation factor 4E type 2; eIF-4E type 2; eIF4E type 2; Eukaryotic translation initiation factor 4E homologous protein; Eukaryotic translation initiation factor 4E-like 3; eIF4E-like protein 4E-LP; mRNA cap-binding protein 4EHP; h4EHP; mRNA cap-binding protein type 3,EIF4EL3,9470,eukaryotic translation initiation factor 4E family member 2,eukaryotic translation initiation factor 4E-like 3,,IF4e; 4EHP,eukaryotic translation initiation factor 4E family member 2,4E-LP; 4EHP; EIF4EL3; IF4e; h4EHP,EIF4E2
O60602,TLR5_HUMAN,TLR5; TIL3,Toll-like receptor 5; Toll/interleukin-1 receptor-like protein 3,TIL3,7100,toll like receptor 5,systemic lupus erythematosus susceptibility 1; toll-like receptor 5,Toll/interleukin-1 receptor-like protein 3,TIL3; FLJ10052; MGC126430; MGC126431,toll like receptor 5,MELIOS; SLE1; SLEB1; TIL3,TLR5
O60610,DIAP1_HUMAN,DIAPH1; DIAP1,Protein diaphanous homolog 1; Diaphanous-related formin-1; DRF1,DIAP1,1729,diaphanous related formin 1,diaphanous (Drosophila; homolog) 1; diaphanous homolog 1 (Drosophila),mammalian diaphanous related formin 1,hDIA1; LFHL1; mDia1,diaphanous related formin 1,DFNA1; DIA1; DRF1; LFHL1; SCBMS; hDIA1; mDia1,DIAPH1
O60671,RAD1_HUMAN,RAD1; REC1,Cell cycle checkpoint protein RAD1; hRAD1; Rad1-like DNA damage checkpoint protein,REC1,5810,RAD1 checkpoint DNA exonuclease,RAD1 (S. pombe) homolog; RAD1 homolog (S. pombe),exonuclease homolog RAD1; checkpoint control protein HRAD1; cell cycle checkpoint protein Hrad1; Rad1-like DNA damage checkpoint; DNA repair exonuclease REC1; RAD1 checkpoint clamp component,HRAD1; REC1,RAD1 checkpoint DNA exonuclease,HRAD1; REC1,RAD1
O60673,REV3L_HUMAN,REV3L; POLZ; REV3,DNA polymerase zeta catalytic subunit; EC 2.7.7.7; Protein reversionless 3-like; REV3-like; hREV3,POLZ; REV3,5980,REV3 like; DNA directed polymerase zeta catalytic subunit,REV3 (yeast homolog)-like; catalytic subunit of DNA polymerase zeta; REV3-like; catalytic subunit of DNA polymerase zeta (yeast); REV3-like; polymerase (DNA directed); zeta; catalytic subunit,polymerase; DNA; zeta,POLZ; REV3,REV3 like; DNA directed polymerase zeta catalytic subunit,POLZ; REV3,REV3L
O60674,JAK2_HUMAN,JAK2,Tyrosine-protein kinase JAK2; EC 2.7.10.2; Janus kinase 2; JAK-2,,3717,Janus kinase 2,,,JTK10,Janus kinase 2,JTK10,JAK2
O60701,UGDH_HUMAN,UGDH,UDP-glucose 6-dehydrogenase; UDP-Glc dehydrogenase; UDP-GlcDH; UDPGDH; EC 1.1.1.22,,7358,UDP-glucose 6-dehydrogenase,UDP-glucose dehydrogenase,uridine-diphospho glucose dehydrogenase,GDH; UDPGDH; UDP-GlcDH; UGD,UDP-glucose 6-dehydrogenase,DEE84; EIEE84; GDH; UDP-GlcDH; UDPGDH; UGD,UGDH
O60711,LPXN_HUMAN,LPXN; LDLP,Leupaxin,LDLP,9404,leupaxin,,,LDPL,leupaxin,LDPL,LPXN
O60716,CTND1_HUMAN,CTNND1; KIAA0384,Catenin delta-1; Cadherin-associated Src substrate; CAS; p120 catenin; p120(ctn; p120(cas,KIAA0384,1500,catenin delta 1,catenin (cadherin-associated protein); delta 1,,KIAA0384; p120; p120cas; p120ctn,catenin delta 1,BCDS2; CAS; CTNND; P120CAS; P120CTN; p120; p120(CAS); p120(CTN),CTNND1
O60729,CC14B_HUMAN,CDC14B,Dual specificity protein phosphatase CDC14B; EC 3.1.3.16; EC 3.1.3.48; CDC14 cell division cycle 14 homolog B,,8555,cell division cycle 14B,CDC14 (cell division cycle 14; S. cerevisiae) homolog B; CDC14 cell division cycle 14 homolog B (S. cerevisiae),,Cdc14B1; Cdc14B2; CDC14B3; hCDC14B,cell division cycle 14B,CDC14B3; Cdc14B1; Cdc14B2; hCDC14B,CDC14B
O60814,H2B1K_HUMAN,H2BC12; H2BFT; HIRIP1; HIST1H2BK,Histone H2B type 1-K; H2B K; HIRA-interacting protein 1,H2BFT; HIRIP1; HIST1H2BK,85236,H2B clustered histone 12,H2B histone family; member T; histone 1; H2bk; histone cluster 1; H2bk; histone cluster 1 H2B family member k,,H2BFAiii,H2B clustered histone 12,H2B/S; H2BFAiii; H2BFT; H2BK; HIST1H2BK,H2BC12
O60825,F262_HUMAN,PFKFB2,6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 2; 6PF-2-K/Fru-2;6-P2ase 2; PFK/FBPase 2; 6PF-2-K/Fru-2;6-P2ase heart-type isozyme; EC 2.7.1.105; EC 3.1.3.46,,5208,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 2,,,,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 2,PFK-2/FBPase-2,PFKFB2
O60829,PAGE4_HUMAN,PAGE4; GAGEC1; JM27,P antigen family member 4; PAGE-4; G antigen family C member 1; PAGE-1,GAGEC1,9506,PAGE family member 4,G antigen; family C; 1; P antigen family; member 4 (prostate associated),,PAGE-4; CT16.7,PAGE family member 4,CT16.7; GAGE-9; GAGEC1; JM-27; JM27; PAGE-1; PAGE-4,PAGE4
O60840,CAC1F_HUMAN,CACNA1F; CACNAF1,Voltage-dependent L-type calcium channel subunit alpha-1F; Voltage-gated calcium channel subunit alpha Cav1.4,CACNAF1,778,calcium voltage-gated channel subunit alpha1 F,Aland island eye disease (Forsius-Eriksson ocular albinism; ocular albinism type 2); calcium channel; voltage-dependent; L type; alpha 1F subunit,,Cav1.4; JM8; JMC8; CSNBX2; CORDX3; CSNB2A; OA2,calcium voltage-gated channel subunit alpha1 F,AIED; COD3; COD4; CORDX; CORDX3; CSNB2; CSNB2A; CSNBX2; Cav1.4; Cav1.4alpha1; JM8; JMC8; OA2,CACNA1F
O60885,BRD4_HUMAN,BRD4; HUNK1,Bromodomain-containing protein 4; Protein HUNK1,HUNK1,23476,bromodomain containing 4,bromodomain-containing 4,mitotic chromosome-associated protein; chromosome-associated protein; female sterile homeotic related gene 4,HUNKI; MCAP; CAP; HUNK1; FSHRG4,bromodomain containing 4,CAP; CDLS6; FSHRG4; HUNK1; HUNKI; MCAP,BRD4
O60928,KCJ13_HUMAN,KCNJ13,Inward rectifier potassium channel 13; Inward rectifier K(+; Potassium channel; inwardly rectifying subfamily J member 13,,3769,potassium inwardly rectifying channel subfamily J member 13,potassium inwardly-rectifying channel; subfamily J; member 13,,Kir7.1; Kir1.4; LCA16,potassium inwardly rectifying channel subfamily J member 13,KIR1.4; KIR7.1; LCA16; SVD,KCNJ13
O60934,NBN_HUMAN,NBN; NBS; NBS1; P95,Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1; hNbs1,NBS; NBS1; P95,4683,nibrin,Nijmegen breakage syndrome 1 (nibrin),,ATV; AT-V2; AT-V1,nibrin,AT-V1; AT-V2; ATV; NBS; NBS1; P95; hNbs1,NBN
O60936,NOL3_HUMAN,NOL3; ARC; NOP,Nucleolar protein 3; Apoptosis repressor with CARD; Muscle-enriched cytoplasmic protein; Myp; Nucleolar protein of 30 kDa; Nop30,ARC; NOP,8996,nucleolar protein 3,nucleolar protein 3 (apoptosis repressor with CARD domain),,ARC; NOP30; MYP; CARD2,nucleolar protein 3,ARC; FCM; MYOCL1; MYP; NOP; NOP30,NOL3
O60941,DTNB_HUMAN,DTNB,Dystrobrevin beta; DTN-B; Beta-dystrobrevin,,1838,dystrobrevin beta,dystrobrevin; beta,,,dystrobrevin beta,,DTNB
O75015,FCG3B_HUMAN,FCGR3B; CD16B; FCG3; FCGR3; IGFR3,Low affinity immunoglobulin gamma Fc region receptor III-B; Fc-gamma RIII-beta; CD16-I; Fc-gamma RIII; Fc-gamma RIIIb; FcRIII; FcRIIIb; FcR-10; IgG Fc receptor III-1; CD antigen CD16b,CD16B; FCG3; FCGR3; IGFR3,2215,Fc gamma receptor IIIb,Fc fragment of IgG; low affinity IIIb; receptor for (CD16); Fc fragment of IgG; low affinity IIIb; receptor (CD16b); Fc fragment of IgG receptor IIIb,,CD16; CD16b; FcgammaRIIIb; FcRIIIb,Fc gamma receptor IIIb,CD16; CD16-I; CD16A; CD16b; FCG3; FCGR3; FCGR3A; FCR-10; FCRIII; FCRIIIb,FCGR3B
O75030,MITF_HUMAN,MITF; BHLHE32,Microphthalmia-associated transcription factor; Class E basic helix-loop-helix protein 32; bHLHe32,BHLHE32,4286,melanocyte inducing transcription factor,Waardenburg syndrome; type 2A; microphthalmia-associated transcription factor; melanogenesis associated transcription factor,homolog of mouse microphthalmia,MI; bHLHe32,melanocyte inducing transcription factor,CMM8; COMMAD; MI; MITF-A; WS2; WS2A; bHLHe32,MITF
O75051,PLXA2_HUMAN,PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235,Plexin-A2; Semaphorin receptor OCT,KIAA0463; OCT; PLXN2,5362,plexin A2,,plexin 2; plexin-A2; semaphorin receptor OCT; transmembrane protein OCT,OCT; FLJ11751; FLJ30634; KIAA0463,plexin A2,OCT; PLXN2,PLXNA2
O75061,AUXI_HUMAN,DNAJC6; KIAA0473,Auxilin; EC 3.1.3.-; DnaJ homolog subfamily C member 6,KIAA0473,9829,DnaJ heat shock protein family (Hsp40) member C6,DnaJ (Hsp40) homolog; subfamily C; member 6,auxilin,KIAA0473; PARK19,DnaJ heat shock protein family (Hsp40) member C6,DJC6; PARK19,DNAJC6
O75084,FZD7_HUMAN,FZD7,Frizzled-7; Fz-7; hFz7; FzE3,,8324,frizzled class receptor 7,frizzled (Drosophila) homolog 7; frizzled homolog 7 (Drosophila); frizzled 7; seven transmembrane spanning receptor; frizzled family receptor 7,Frizzled-7,FzE3,frizzled class receptor 7,FzE3,FZD7
O75116,ROCK2_HUMAN,ROCK2; KIAA0619,Rho-associated protein kinase 2; EC 2.7.11.1; Rho kinase 2; Rho-associated; coiled-coil-containing protein kinase 2; Rho-associated; coiled-coil-containing protein kinase II; ROCK-II; p164 ROCK-2,KIAA0619,9475,Rho associated coiled-coil containing protein kinase 2,,,,Rho associated coiled-coil containing protein kinase 2,ROCK-II,ROCK2
O75122,CLAP2_HUMAN,CLASP2; KIAA0627,CLIP-associating protein 2; Cytoplasmic linker-associated protein 2; Protein Orbit homolog 2; hOrbit2,KIAA0627,23122,cytoplasmic linker associated protein 2,,,KIAA0627,cytoplasmic linker associated protein 2,,CLASP2
O75143,ATG13_HUMAN,ATG13; KIAA0652,Autophagy-related protein 13,KIAA0652,9776,autophagy related 13,KIAA0652; ATG13 autophagy related 13 homolog (S. cerevisiae),,,autophagy related 13,KIAA0652; PARATARG8,ATG13
O75150,BRE1B_HUMAN,RNF40; BRE1B; KIAA0661,E3 ubiquitin-protein ligase BRE1B; BRE1-B; EC 2.3.2.27; 95 kDa retinoblastoma-associated protein; RBP95; RING finger protein 40; RING-type E3 ubiquitin transferase BRE1B,BRE1B; KIAA0661,9810,ring finger protein 40,,BRE1 E3 ubiquitin ligase homolog B (S. cerevisiae),KIAA0661; RBP95; BRE1B; STARING,ring finger protein 40,BRE1B; RBP95; STARING,RNF40
O75151,PHF2_HUMAN,PHF2; CENP-35; KIAA0662,Lysine-specific demethylase PHF2; EC 1.14.11.-; GRC5; PHD finger protein 2,CENP-35; KIAA0662,5253,PHD finger protein 2,,jumonji C domain-containing histone demethylase 1E; centromere protein 35,KIAA0662; JHDM1E; CENP-35; KDM7C,PHD finger protein 2,CENP-35; GRC5; JHDM1E; KDM7C,PHF2
O75152,ZC11A_HUMAN,ZC3H11A; KIAA0663; ZC3HDC11A,Zinc finger CCCH domain-containing protein 11A,KIAA0663; ZC3HDC11A,9877,zinc finger CCCH-type containing 11A,zinc finger CCCH-type domain containing 11A,,KIAA0663,zinc finger CCCH-type containing 11A,ZC3HDC11A,ZC3H11A
O75154,RFIP3_HUMAN,RAB11FIP3; ARFO1; KIAA0665,Rab11 family-interacting protein 3; FIP3; FIP3-Rab11; Rab11-FIP3; Arfophilin-1; EF hands-containing Rab-interacting protein; Eferin; MU-MB-17.148,ARFO1; KIAA0665,9727,RAB11 family interacting protein 3,RAB11 family interacting protein 3 (class II),arfophilin-1,KIAA0665; Rab11-FIP3; eferin,RAB11 family interacting protein 3,CART1; FIP3; FIP3-Rab11; Rab11-FIP3,RAB11FIP3
O75170,PP6R2_HUMAN,PPP6R2; KIAA0685; PP6R2; SAPS2,Serine/threonine-protein phosphatase 6 regulatory subunit 2; SAPS domain family member 2,KIAA0685; PP6R2; SAPS2,9701,protein phosphatase 6 regulatory subunit 2,KIAA0685; SAPS domain family; member 2; protein phosphatase 6; regulatory subunit 2,,dJ579N16.1; SAP190,protein phosphatase 6 regulatory subunit 2,KIAA0685; PP6R2; SAP190; SAPS2,PPP6R2
O75179,ANR17_HUMAN,ANKRD17; GTAR; KIAA0697,Ankyrin repeat domain-containing protein 17; Gene trap ankyrin repeat protein; Serologically defined breast cancer antigen NY-BR-16,GTAR; KIAA0697,26057,ankyrin repeat domain 17,,,GTAR; KIAA0697; FLJ22206; NY-BR-16; MASK2,ankyrin repeat domain 17,CAGS; GTAR; MASK2; NY-BR-16,ANKRD17
O75319,DUS11_HUMAN,DUSP11; PIR1,RNA/RNP complex-1-interacting phosphatase; EC 3.1.3.-; Dual specificity protein phosphatase 11; Phosphatase that interacts with RNA/RNP complex 1,PIR1,8446,dual specificity phosphatase 11,dual specificity phosphatase 11 (RNA/RNP complex 1-interacting),RNA/RNP complex 1-interacting,PIR1,dual specificity phosphatase 11,PIR1,DUSP11
O75365,TP4A3_HUMAN,PTP4A3; PRL3,Protein tyrosine phosphatase type IVA 3; EC 3.1.3.48; PRL-R; Protein-tyrosine phosphatase 4a3; Protein-tyrosine phosphatase of regenerating liver 3; PRL-3,PRL3,11156,protein tyrosine phosphatase 4A3,protein tyrosine phosphatase type IVA; member 3,phosphatase of regenerating liver 3,PRL-3; PRL-R; PRL3,protein tyrosine phosphatase 4A3,PRL-3; PRL-R; PRL3,PTP4A3
O75369,FLNB_HUMAN,FLNB; FLN1L; FLN3; TABP; TAP,Filamin-B; FLN-B; ABP-278; ABP-280 homolog; Actin-binding-like protein; Beta-filamin; Filamin homolog 1; Fh1; Filamin-3; Thyroid autoantigen; Truncated actin-binding protein; Truncated ABP,FLN1L; FLN3; TABP; TAP,2317,filamin B,filamin B; beta (actin binding protein 278); Larsen syndrome 1 (autosomal dominant); filamin B; beta,actin binding protein 278; beta filamin,TAP; TABP; ABP-278; FH1,filamin B,ABP-278; ABP-280; AOI; FH1; FLN-B; FLN1L; LRS1; SCT; TABP; TAP,FLNB
O75376,NCOR1_HUMAN,NCOR1; KIAA1047,Nuclear receptor corepressor 1; N-CoR; N-CoR1,KIAA1047,9611,nuclear receptor corepressor 1,nuclear receptor co-repressor 1,thyroid hormone- and retinoic acid receptor-associated corepressor 1; protein phosphatase 1; regulatory subunit 109,N-CoR; hCIT529I10; TRAC1; hN-CoR; KIAA1047; MGC104216; PPP1R109,nuclear receptor corepressor 1,N-CoR; N-CoR1; PPP1R109; TRAC1; hN-CoR,NCOR1
O75385,ULK1_HUMAN,ULK1; KIAA0722,Serine/threonine-protein kinase ULK1; EC 2.7.11.1; Autophagy-related protein 1 homolog; ATG1; hATG1; Unc-51-like kinase 1,KIAA0722,8408,unc-51 like autophagy activating kinase 1,unc-51 (C. elegans)-like kinase 1; unc-51-like kinase 1 (C. elegans),ATG1 autophagy related 1 homolog (S. cerevisiae),ATG1; ATG1A,unc-51 like autophagy activating kinase 1,ATG1; ATG1A; UNC51; Unc51.1; hATG1,ULK1
O75410,TACC1_HUMAN,TACC1; KIAA1103,Transforming acidic coiled-coil-containing protein 1; Gastric cancer antigen Ga55; Taxin-1,KIAA1103,6867,transforming acidic coiled-coil containing protein 1,transforming; acidic coiled-coil containing protein 1,,,transforming acidic coiled-coil containing protein 1,Ga55,TACC1
O75449,KTNA1_HUMAN,KATNA1,Katanin p60 ATPase-containing subunit A1; Katanin p60 subunit A1; EC 5.6.1.1; p60 katanin,,11104,katanin catalytic subunit A1,katanin p60 (ATPase-containing) subunit A 1; katanin p60 (ATPase containing) subunit A 1,,,katanin catalytic subunit A1,,KATNA1
O75460,ERN1_HUMAN,ERN1; IRE1,Serine/threonine-protein kinase/endoribonuclease IRE1; Endoplasmic reticulum-to-nucleus signaling 1; Inositol-requiring protein 1; hIRE1p; Ire1-alpha; IRE1a; EC 2.7.11.1; EC 3.1.26.-,IRE1,2081,endoplasmic reticulum to nucleus signaling 1,ER to nucleus signalling 1,inositol-requiring enzyme 1; Serine/threonine-protein kinase/endoribonuclease IRE1,IRE1; IRE1P,endoplasmic reticulum to nucleus signaling 1,IRE1; IRE1P; IRE1a; hIRE1p,ERN1
O75461,E2F6_HUMAN,E2F6,Transcription factor E2F6; E2F-6,,1876,E2F transcription factor 6,,,E2F-6,E2F transcription factor 6,E2F-6,E2F6
O75469,NR1I2_HUMAN,NR1I2; PXR,Nuclear receptor subfamily 1 group I member 2; Orphan nuclear receptor PAR1; Orphan nuclear receptor PXR; Pregnane X receptor; Steroid and xenobiotic receptor; SXR,PXR,8856,nuclear receptor subfamily 1 group I member 2,nuclear receptor subfamily 1; group I; member 2,pregnane X receptor; orphan nuclear receptor PXR,ONR1; PXR; BXR; SXR; PAR2,nuclear receptor subfamily 1 group I member 2,BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR,NR1I2
O75475,PSIP1_HUMAN,PSIP1; DFS70; LEDGF; PSIP2,PC4 and SFRS1-interacting protein; CLL-associated antigen KW-7; Dense fine speckles 70 kDa protein; DFS 70; Lens epithelium-derived growth factor; Transcriptional coactivator p75/p52,DFS70; LEDGF; PSIP2,11168,PC4 and SRSF1 interacting protein 1,PC4 and SFRS1 interacting protein 2; PC4 and SFRS1 interacting protein 1,lens epithelium-derived growth factor,p52; LEDGF; p75; DFS70,PC4 and SRSF1 interacting protein 1,DFS70; LEDGF; PAIP; PSIP2; p52; p75,PSIP1
O75494,SRS10_HUMAN,SRSF10; FUSIP1; FUSIP2; SFRS13A; TASR,Serine/arginine-rich splicing factor 10; 40 kDa SR-repressor protein; SRrp40; FUS-interacting serine-arginine-rich protein 1; Splicing factor SRp38; Splicing factor; arginine/serine-rich 13A; TLS-associated protein with Ser-Arg repeats; TASR; TLS-associated protein with SR repeats; TLS-associated serine-arginine protein; TLS-associated SR protein,FUSIP1; FUSIP2; SFRS13A; TASR,10772,serine and arginine rich splicing factor 10,FUS-interacting protein (serine-arginine rich) 2; FUS interacting protein (serine/arginine-rich) 1; splicing factor; arginine/serine-rich 13A; neural-salient SR protein; serine/arginine-rich splicing factor 10,splicing factor; arginine/serine-rich 13; SR splicing factor 10; protein phosphatase 1; regulatory subunit 149,TASR1; TASR2; SRp38; SRrp40; SFRS13; PPP1R149,serine and arginine rich splicing factor 10,FUSIP1; FUSIP2; NSSR; PPP1R149; SFRS13; SFRS13A; SRp38; SRrp40; TASR; TASR1; TASR2,SRSF10
O75496,GEMI_HUMAN,GMNN,Geminin,,51053,geminin DNA replication inhibitor,,,Gem,geminin DNA replication inhibitor,Gem; MGORS6,GMNN
O75531,BAF_HUMAN,BANF1; BAF; BCRG1,Barrier-to-autointegration factor; Breakpoint cluster region protein 1,BAF; BCRG1,8815,barrier to autointegration nuclear assembly factor 1,BAF nuclear assembly factor 1; barrier to autointegration factor 1,,BAF,barrier to autointegration nuclear assembly factor 1,BAF; BCRP1; D14S1460; NGPS,BANF1
O75533,SF3B1_HUMAN,SF3B1; SAP155,Splicing factor 3B subunit 1; Pre-mRNA-splicing factor SF3b 155 kDa subunit; SF3b155; Spliceosome-associated protein 155; SAP 155,SAP155,23451,splicing factor 3b subunit 1,splicing factor 3b; subunit 1; 155kD; splicing factor 3b; subunit 1; 155kDa,,SAP155; SF3b155; PRPF10; Prp10; Hsh155,splicing factor 3b subunit 1,Hsh155; MDS; PRP10; PRPF10; SAP155; SF3b155,SF3B1
O75563,SKAP2_HUMAN,SKAP2; PRAP; RA70; SAPS; SCAP2; SKAP55R,Src kinase-associated phosphoprotein 2; Pyk2/RAFTK-associated protein; Retinoic acid-induced protein 70; SKAP55 homolog; SKAP-55HOM; SKAP-HOM; Src family-associated phosphoprotein 2; Src kinase-associated phosphoprotein 55-related protein; Src-associated adapter protein with PH and SH3 domains,PRAP; RA70; SAPS; SCAP2; SKAP55R,8935,src kinase associated phosphoprotein 2,src family associated phosphoprotein 2,,RA70; SKAP-HOM; SKAP55R; SAPS,src kinase associated phosphoprotein 2,PRAP; RA70; SAPS; SCAP2; SKAP-HOM; SKAP55R,SKAP2
O75581,LRP6_HUMAN,LRP6,Low-density lipoprotein receptor-related protein 6; LRP-6,,4040,LDL receptor related protein 6,low density lipoprotein receptor-related protein 6,,ADCAD2,LDL receptor related protein 6,ADCAD2; STHAG7,LRP6
O75582,KS6A5_HUMAN,RPS6KA5; MSK1,Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL,MSK1,9252,ribosomal protein S6 kinase A5,ribosomal protein S6 kinase; 90kD; polypeptide 5,,MSK1; RLPK,ribosomal protein S6 kinase A5,MSK1; MSPK1; RLPK,RPS6KA5
O75592,MYCB2_HUMAN,MYCBP2; KIAA0916; PAM,E3 ubiquitin-protein ligase MYCBP2; EC 2.3.2.33; Myc-binding protein 2; Protein associated with Myc,KIAA0916; PAM,23077,MYC binding protein 2,MYC binding protein 2; E3 ubiquitin protein ligase,PAM/Highwire/RPM-1 protein 1,PAM; KIAA0916; FLJ10106; PHR1,MYC binding protein 2,Myc-bp2; PAM; PHR1; Phr,MYCBP2
O75604,UBP2_HUMAN,USP2; UBP41,Ubiquitin carboxyl-terminal hydrolase 2; EC 3.4.19.12; 41 kDa ubiquitin-specific protease; Deubiquitinating enzyme 2; Ubiquitin thioesterase 2; Ubiquitin-specific-processing protease 2,UBP41,9099,ubiquitin specific peptidase 2,ubiquitin specific protease 2,,UBP41,ubiquitin specific peptidase 2,UBP41; USP9,USP2
O75616,ERAL1_HUMAN,ERAL1; HERA,GTPase Era; mitochondrial; H-ERA; hERA; Conserved ERA-like GTPase; CEGA; ERA-W; ERA-like protein 1,HERA,26284,Era like 12S mitochondrial rRNA chaperone 1,Era (E. coli G-protein homolog)-like 1; Era G-protein-like 1 (E. coli); Era-like 12S mitochondrial rRNA chaperone 1,,HERA-B,Era like 12S mitochondrial rRNA chaperone 1,CEGA; ERA; ERA-W; ERAL1A; ERAL1B; H-ERA; HERA-A; HERA-B; PRLTS6,ERAL1
O75628,REM1_HUMAN,REM1; GES; REM,GTP-binding protein REM 1; GTPase-regulating endothelial cell sprouting; Rad and Gem-like GTP-binding protein 1,GES; REM,28954,RRAD and GEM like GTPase 1,RAS (RAD and GEM)-like GTP-binding,GTPase GES,GES,RRAD and GEM like GTPase 1,GD:REM; GES,REM1
O75676,KS6A4_HUMAN,RPS6KA4; MSK2,Ribosomal protein S6 kinase alpha-4; S6K-alpha-4; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 4; Nuclear mitogen- and stress-activated protein kinase 2; Ribosomal protein kinase B; RSKB,MSK2,8986,ribosomal protein S6 kinase A4,ribosomal protein S6 kinase; 90kD; polypeptide 4,,RSK-B; MSK2,ribosomal protein S6 kinase A4,MSK2; RSK-B; S6K-alpha-4,RPS6KA4
O75688,PPM1B_HUMAN,PPM1B; PP2CB,Protein phosphatase 1B; EC 3.1.3.16; Protein phosphatase 2C isoform beta; PP2C-beta,PP2CB,5495,protein phosphatase; Mg2+/Mn2+ dependent 1B,protein phosphatase 1B (formerly 2C); magnesium-dependent; beta isoform; protein phosphatase; Mg2+/Mn2+ dependent; 1B,protein phosphatase 2C; beta isoform,PPC2BETAX; PP2CB; PP2CBETA,protein phosphatase; Mg2+/Mn2+ dependent 1B,PP2C-beta; PP2C-beta-X; PP2CB; PP2CBETA; PPC2BETAX,PPM1B
O75689,ADAP1_HUMAN,ADAP1; CENTA1,Arf-GAP with dual PH domain-containing protein 1; Centaurin-alpha-1; Cnt-a1; Putative MAPK-activating protein PM25,CENTA1,11033,ArfGAP with dual PH domains 1,centaurin; alpha 1,,GCS1L,ArfGAP with dual PH domains 1,CENTA1; GCS1L; p42IP4,ADAP1
O75716,STK16_HUMAN,STK16; MPSK1; PKL12; TSF1,Serine/threonine-protein kinase 16; EC 2.7.11.1; Myristoylated and palmitoylated serine/threonine-protein kinase; MPSK; Protein kinase PKL12; TGF-beta-stimulated factor 1; TSF-1; Tyrosine-protein kinase STK16; EC 2.7.10.2; hPSK,MPSK1; PKL12; TSF1,8576,serine/threonine kinase 16,,,PKL12; MPSK,serine/threonine kinase 16,KRCT; MPSK; PKL12; PSK; TSF1; hPSK,STK16
O75762,TRPA1_HUMAN,TRPA1; ANKTM1,Transient receptor potential cation channel subfamily A member 1; Ankyrin-like with transmembrane domains protein 1; Transformation-sensitive protein p120; p120; Wasabi receptor,ANKTM1,8989,transient receptor potential cation channel subfamily A member 1,ankyrin-like with transmembrane domains 1; transient receptor potential cation channel; subfamily A; member 1,,,transient receptor potential cation channel subfamily A member 1,ANKTM1; FEPS; FEPS1; p120,TRPA1
O75807,PR15A_HUMAN,PPP1R15A; GADD34,Protein phosphatase 1 regulatory subunit 15A; Growth arrest and DNA damage-inducible protein GADD34; Myeloid differentiation primary response protein MyD116 homolog,GADD34,23645,protein phosphatase 1 regulatory subunit 15A,protein phosphatase 1; regulatory (inhibitor) subunit 15A; protein phosphatase 1; regulatory subunit 15A,growth arrest and DNA-damage-inducible 34,GADD34,protein phosphatase 1 regulatory subunit 15A,GADD34,PPP1R15A
O75822,EIF3J_HUMAN,EIF3J; EIF3S1; PRO0391,Eukaryotic translation initiation factor 3 subunit J; eIF3j; Eukaryotic translation initiation factor 3 subunit 1; eIF-3-alpha; eIF3 p35,EIF3S1,8669,eukaryotic translation initiation factor 3 subunit J,eukaryotic translation initiation factor 3; subunit 1 alpha; 35kDa; eukaryotic translation initiation factor 3; subunit J,,eIF3-p35; eIF3-alpha,eukaryotic translation initiation factor 3 subunit J,EIF3S1; eIF3-alpha; eIF3-p35,EIF3J
O75886,STAM2_HUMAN,STAM2; HBP,Signal transducing adapter molecule 2; STAM-2; Hrs-binding protein,HBP,10254,signal transducing adaptor molecule 2,signal transducing adaptor molecule (SH3 domain and ITAM motif) 2,HSE1 homolog (S. cerevisiae),Hbp,signal transducing adaptor molecule 2,Hbp; STAM2A; STAM2B,STAM2
O75914,PAK3_HUMAN,PAK3; OPHN3,Serine/threonine-protein kinase PAK 3; EC 2.7.11.1; Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3,OPHN3,5063,p21 (RAC1) activated kinase 3,mental retardation; X-linked 47; p21 (CDKN1A)-activated kinase 3; p21 protein (Cdc42/Rac)-activated kinase 3,,hPAK3; bPAK,p21 (RAC1) activated kinase 3,ARA; MRX30; MRX47; OPHN3; PAK-3; PAK3beta; XLID30; bPAK; beta-PAK,PAK3
O75925,PIAS1_HUMAN,PIAS1; DDXBP1,E3 SUMO-protein ligase PIAS1; EC 2.3.2.-; DEAD/H box-binding protein 1; E3 SUMO-protein transferase PIAS1; Gu-binding protein; GBP; Protein inhibitor of activated STAT protein 1; RNA helicase II-binding protein,DDXBP1,8554,protein inhibitor of activated STAT 1,DEAD/H (Asp-Glu-Ala-Asp/His) box binding protein 1,zinc finger; MIZ-type containing 3,GBP; GU/RH-II; ZMIZ3,protein inhibitor of activated STAT 1,DDXBP1; GBP; GU/RH-II; ZMIZ3,PIAS1
O75943,RAD17_HUMAN,RAD17; R24L,Cell cycle checkpoint protein RAD17; hRad17; RF-C/activator 1 homolog,R24L,5884,RAD17 checkpoint clamp loader component,RAD1 (S. pombe) homolog; RAD17 homolog (S. pombe),,Rad24; RAD17Sp; CCYC,RAD17 checkpoint clamp loader component,CCYC; HRAD17; R24L; RAD17SP; RAD24,RAD17
O75952,CABYR_HUMAN,CABYR; CBP86; FSP2,Calcium-binding tyrosine phosphorylation-regulated protein; Calcium-binding protein 86; Cancer/testis antigen 88; CT88; Fibrousheathin II; Fibrousheathin-2; FSP-2; Testis-specific calcium-binding protein CBP86,CBP86; FSP2,26256,calcium binding tyrosine phosphorylation regulated,calcium binding tyrosine-(Y)-phosphorylation regulated,fibrousheathin 2; cancer/testis antigen 88,FSP-2; CBP86; CT88,calcium binding tyrosine phosphorylation regulated,CABYRa; CABYRc; CABYRc/d; CABYRe; CBP86; CT88; FSP-2; FSP2,CABYR
O75955,FLOT1_HUMAN,FLOT1,Flotillin-1,,10211,flotillin 1,,,,flotillin 1,,FLOT1
O75962,TRIO_HUMAN,TRIO,Triple functional domain protein; EC 2.7.11.1; PTPRF-interacting protein,,7204,trio Rho guanine nucleotide exchange factor,triple functional domain (PTPRF interacting),,ARHGEF23,trio Rho guanine nucleotide exchange factor,ARHGEF23; MEBAS; MRD44; MRD63; tgat,TRIO
O76021,RL1D1_HUMAN,RSL1D1; CATX11; CSIG; PBK1; L12,Ribosomal L1 domain-containing protein 1; CATX-11; Cellular senescence-inhibited gene protein; Protein PBK1,CATX11; CSIG; PBK1,26156,ribosomal L1 domain containing 1,,,PBK1; L12; DKFZP564M182; CSIG; UTP30,ribosomal L1 domain containing 1,CSIG; L12; PBK1; UTP30,RSL1D1
O76039,CDKL5_HUMAN,CDKL5; STK9,Cyclin-dependent kinase-like 5; EC 2.7.11.22; Serine/threonine-protein kinase 9,STK9,6792,cyclin dependent kinase like 5,serine/threonine kinase 9; cyclin-dependent kinase-like 5,,EIEE2; CFAP247,cyclin dependent kinase like 5,CFAP247; DEE2; EIEE2; ISSX; STK9,CDKL5
O76054,S14L2_HUMAN,SEC14L2; C22orf6; KIAA1186; KIAA1658,SEC14-like protein 2; Alpha-tocopherol-associated protein; TAP; hTAP; Squalene transfer protein; Supernatant protein factor; SPF,C22orf6; KIAA1186; KIAA1658,23541,SEC14 like lipid binding 2,SEC14 (S. cerevisiae)-like 2; SEC14-like 2 (S. cerevisiae); SEC14-like lipid binding 2,supernatant protein factor; tocopherol-associated protein 1,TAP; SPF; KIAA1186; KIAA1658; TAP1,SEC14 like lipid binding 2,C22orf6; SPF; TAP; TAP1,SEC14L2
O76061,STC2_HUMAN,STC2,Stanniocalcin-2; STC-2; Stanniocalcin-related protein; STC-related protein; STCRP,,8614,stanniocalcin 2,,,STC-2,stanniocalcin 2,STC-2; STCRP,STC2
O76070,SYUG_HUMAN,SNCG; BCSG1; PERSYN; PRSN,Gamma-synuclein; Breast cancer-specific gene 1 protein; Persyn; Synoretin; SR,BCSG1; PERSYN; PRSN,6623,synuclein gamma,,synoretin; breast cancer-specific gene 1; ?-synuclein,BCSG1; SR; persyn,synuclein gamma,BCSG1; SR,SNCG
O76090,BEST1_HUMAN,BEST1; VMD2,Bestrophin-1; TU15B; Vitelliform macular dystrophy protein 2,VMD2,7439,bestrophin 1,vitelliform macular dystrophy 2,Best disease,BMD; BEST; RP50,bestrophin 1,ARB; BEST; BMD; Best1V1Delta2; RP50; TU15B; VMD2,BEST1
O94759,TRPM2_HUMAN,TRPM2; EREG1; KNP3; LTRPC2; TRPC7,Transient receptor potential cation channel subfamily M member 2; Estrogen-responsive element-associated gene 1 protein; Long transient receptor potential channel 2; LTrpC-2; LTrpC2; Transient receptor potential channel 7; TrpC7; Transient receptor potential melastatin 2,EREG1; KNP3; LTRPC2; TRPC7,7226,transient receptor potential cation channel subfamily M member 2,transient receptor potential cation channel; subfamily M; member 2,,KNP3; LTRPC2; NUDT9L1; NUDT9H; EREG1,transient receptor potential cation channel subfamily M member 2,EREG1; KNP3; LTRPC2; LTrpC-2; NUDT9H; NUDT9L1; TRPC7,TRPM2
O94761,RECQ4_HUMAN,RECQL4; RECQ4,ATP-dependent DNA helicase Q4; EC 5.6.2.4; DNA 3'-5' helicase RecQ4; DNA helicase; RecQ-like type 4; RecQ4; RTS; RecQ protein-like 4,RECQ4,9401,RecQ like helicase 4,RecQ helicase-like 4,,RecQ4,RecQ like helicase 4,RECQ4,RECQL4
O94762,RECQ5_HUMAN,RECQL5; RECQ5,ATP-dependent DNA helicase Q5; EC 5.6.2.4; DNA 3'-5' helicase RecQ5; DNA helicase; RecQ-like type 5; RecQ5; RecQ protein-like 5,RECQ5,9400,RecQ like helicase 5,,RecQ protein 5,RecQ5; FLJ90603,RecQ like helicase 5,RECQ5,RECQL5
O94763,RMP_HUMAN,URI1; C19orf2; NNX3; PPP1R19; RMP; URI,Unconventional prefoldin RPB5 interactor 1; Protein NNX3; Protein phosphatase 1 regulatory subunit 19; RNA polymerase II subunit 5-mediating protein; RPB5-mediating protein,C19orf2; NNX3; PPP1R19; RMP; URI,8725,URI1 prefoldin like chaperone,chromosome 19 open reading frame 2,unconventional prefoldin RPB5 interactor; RPB5-mediating protein; protein phosphatase 1; regulatory subunit 19,RMP; NNX3; FLJ10575; URI; PPP1R19,URI1 prefoldin like chaperone,C19orf2; NNX3; PPP1R19; RMP; URI,URI1
O94782,UBP1_HUMAN,USP1,Ubiquitin carboxyl-terminal hydrolase 1; EC 3.4.19.12; Deubiquitinating enzyme 1; hUBP; Ubiquitin thioesterase 1; Ubiquitin-specific-processing protease 1,,7398,ubiquitin specific peptidase 1,ubiquitin specific protease 1,Ubiquitinyl hydrolase 1; Ubiquitin carboxyl-terminal hydrolase 1; ubiquitin thiolesterase 1,,ubiquitin specific peptidase 1,UBP,USP1
O94804,STK10_HUMAN,STK10; LOK,Serine/threonine-protein kinase 10; EC 2.7.11.1; Lymphocyte-oriented kinase,LOK,6793,serine/threonine kinase 10,,lymphocyte-oriented kinase,LOK; PRO2729,serine/threonine kinase 10,LOK; PRO2729,STK10
O94806,KPCD3_HUMAN,PRKD3; EPK2; PRKCN,Serine/threonine-protein kinase D3; EC 2.7.11.13; Protein kinase C nu type; Protein kinase EPK2; nPKC-nu,EPK2; PRKCN,23683,protein kinase D3,protein kinase C; nu,,EPK2,protein kinase D3,EPK2; PKC-NU; PKD3; PRKCN; nPKC-NU,PRKD3
O94811,TPPP_HUMAN,TPPP; TPPP1,Tubulin polymerization-promoting protein; TPPP; EC 3.6.5.-; 25 kDa brain-specific protein; TPPP/p25; p24; p25-alpha,TPPP1,11076,tubulin polymerization promoting protein,,brain specific protein p25 alpha,p25alpha; TPPP1; p25; TPPP/p25,tubulin polymerization promoting protein,TPPP/p25; TPPP1; p24; p25; p25alpha,TPPP
O94880,PHF14_HUMAN,PHF14; KIAA0783,PHD finger protein 14,KIAA0783,9678,PHD finger protein 14,,,KIAA0783,PHD finger protein 14,,PHF14
O94887,FARP2_HUMAN,FARP2; KIAA0793; PLEKHC3,FERM; ARHGEF and pleckstrin domain-containing protein 2; FERM domain-including RhoGEF; FIR; FERM; RhoGEF and pleckstrin domain-containing protein 2; Pleckstrin homology domain-containing family C member 3; PH domain-containing family C member 3,KIAA0793; PLEKHC3,9855,FERM; ARH/RhoGEF and pleckstrin domain protein 2,FERM; RhoGEF and pleckstrin domain protein 2,,KIAA0793; FIR; PLEKHC3; FRG,FERM; ARH/RhoGEF and pleckstrin domain protein 2,FIR; FRG; PLEKHC3,FARP2
O94901,SUN1_HUMAN,SUN1; KIAA0810; UNC84A,SUN domain-containing protein 1; Protein unc-84 homolog A; Sad1/unc-84 protein-like 1,KIAA0810; UNC84A,23353,Sad1 and UNC84 domain containing 1,unc-84 homolog A (C. elegans),Sad1 unc-84 domain protein 1,KIAA0810; FLJ12407,Sad1 and UNC84 domain containing 1,UNC84A,SUN1
O94913,PCF11_HUMAN,PCF11; KIAA0824,Pre-mRNA cleavage complex 2 protein Pcf11; Pre-mRNA cleavage complex II protein Pcf11,KIAA0824,51585,PCF11 cleavage and polyadenylation factor subunit,PCF11; cleavage and polyadenylation factor II subunit; homolog (S. cerevisiae); PCF11; cleavage and polyadenylation factor subunit; homolog (S. cerevisiae),,KIAA0824,PCF11 cleavage and polyadenylation factor subunit,,PCF11
O94916,NFAT5_HUMAN,NFAT5; KIAA0827; TONEBP,Nuclear factor of activated T-cells 5; NF-AT5; T-cell transcription factor NFAT5; Tonicity-responsive enhancer-binding protein; TonE-binding protein; TonEBP,KIAA0827; TONEBP,10725,nuclear factor of activated T cells 5,nuclear factor of activated T-cells 5; tonicity-responsive; nuclear factor of activated T-cells 5,tonicity-responsive enhancer binding protein,TONEBP; KIAA0827; NFATL1; OREBP; NFATZ; NF-AT5,nuclear factor of activated T cells 5,NF-AT5; NFATL1; NFATZ; OREBP; TONEBP,NFAT5
O94921,CDK14_HUMAN,CDK14; KIAA0834; PFTK1,Cyclin-dependent kinase 14; EC 2.7.11.22; Cell division protein kinase 14; Serine/threonine-protein kinase PFTAIRE-1; hPFTAIRE1,KIAA0834; PFTK1,5218,cyclin dependent kinase 14,PFTAIRE protein kinase 1,,PFTAIRE1,cyclin dependent kinase 14,PFTAIRE1; PFTK1,CDK14
O94925,GLSK_HUMAN,GLS; GLS1; KIAA0838,Glutaminase kidney isoform; mitochondrial; GLS; EC 3.5.1.2; K-glutaminase; L-glutamine amidohydrolase,GLS1; KIAA0838,2744,glutaminase,,glutaminase C; K-glutaminase,KIAA0838; GLS1; GAC; GAM; KGA,glutaminase,AAD20; CASGID; DEE71; EIEE71; GAC; GAM; GDPAG; GLS1; KGA,GLS
O94953,KDM4B_HUMAN,KDM4B; JHDM3B; JMJD2B; KIAA0876,Lysine-specific demethylase 4B; EC 1.14.11.66; JmjC domain-containing histone demethylation protein 3B; Jumonji domain-containing protein 2B; histone H3-trimethyl-L-lysine(9,JHDM3B; JMJD2B; KIAA0876,23030,lysine demethylase 4B,jumonji domain containing 2B; lysine (K)-specific demethylase 4B,tudor domain containing 14B,KIAA0876; TDRD14B,lysine demethylase 4B,JMJD2B; MRD65; TDRD14B,KDM4B
O94992,HEXI1_HUMAN,HEXIM1; CLP1; EDG1; HIS1; MAQ1,Protein HEXIM1; Cardiac lineage protein 1; Estrogen down-regulated gene 1 protein; Hexamethylene bis-acetamide-inducible protein 1; Menage a quatre protein 1,CLP1; EDG1; HIS1; MAQ1,10614,HEXIM P-TEFb complex subunit 1,hexamethylene bisacetamide inducible 1,,CLP-1; HIS1; MAQ1; EDG1,HEXIM P-TEFb complex subunit 1,CLP1; EDG1; HIS1; MAQ1,HEXIM1
O95047,OR2A4_HUMAN,OR2A4; OR2A10,Olfactory receptor 2A4; Olfactory receptor 2A10; Olfactory receptor OR6-37,OR2A10,79541,olfactory receptor family 2 subfamily A member 4,olfactory receptor; family 2; subfamily A; member 10; olfactory receptor; family 2; subfamily A; member 4,,,olfactory receptor family 2 subfamily A member 4,OR2A10; OR2A7,OR2A4
O95071,UBR5_HUMAN,UBR5; EDD; EDD1; HYD; KIAA0896,E3 ubiquitin-protein ligase UBR5; EC 2.3.2.26; E3 ubiquitin-protein ligase; HECT domain-containing 1; Hyperplastic discs protein homolog; hHYD; Progestin-induced protein,EDD; EDD1; HYD; KIAA0896,51366,ubiquitin protein ligase E3 component n-recognin 5,E3 ubiquitin protein ligase; HECT domain containing; 1,,DD5; HYD; EDD; KIAA0896,ubiquitin protein ligase E3 component n-recognin 5,DD5; EDD; EDD1; HYD,UBR5
O95140,MFN2_HUMAN,MFN2; CPRP1; KIAA0214,Mitofusin-2; EC 3.6.5.-; Transmembrane GTPase MFN2,CPRP1; KIAA0214,9927,mitofusin 2,,,CPRP1; KIAA0214; MARF; CMT2A2,mitofusin 2,CMT2A; CMT2A2; CMT2A2A; CMT2A2B; CPRP1; HMSN6A; HSG; MARF; MSL,MFN2
O95147,DUS14_HUMAN,DUSP14; MKP6,Dual specificity protein phosphatase 14; EC 3.1.3.16; EC 3.1.3.48; MKP-1-like protein tyrosine phosphatase; MKP-L; Mitogen-activated protein kinase phosphatase 6; MAP kinase phosphatase 6; MKP-6,MKP6,11072,dual specificity phosphatase 14,,MKP-1 like protein tyrosine phosphatase,MKP-L; MKP6,dual specificity phosphatase 14,MKP-L; MKP6,DUSP14
O95166,GBRAP_HUMAN,GABARAP; FLC3B; HT004,Gamma-aminobutyric acid receptor-associated protein; GABA(A; MM46,FLC3B,11337,GABA type A receptor-associated protein,GABA(A) receptor-associated protein,,MM46; ATG8A,GABA type A receptor-associated protein,ATG8A; GABARAP-a; MM46,GABARAP
O95180,CAC1H_HUMAN,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H; Low-voltage-activated calcium channel alpha1 3.2 subunit; Voltage-gated calcium channel subunit alpha Cav3.2,,8912,calcium voltage-gated channel subunit alpha1 H,calcium channel; voltage-dependent; T type; alpha 1H subunit,,Cav3.2,calcium voltage-gated channel subunit alpha1 H,CACNA1HB; Cav3.2; ECA6; EIG6; HALD4,CACNA1H
O95185,UNC5C_HUMAN,UNC5C; UNC5H3,Netrin receptor UNC5C; Protein unc-5 homolog 3; Protein unc-5 homolog C,UNC5H3,8633,unc-5 netrin receptor C,unc5 (C.elegans homolog) c; unc-5 homolog C (C. elegans),,,unc-5 netrin receptor C,UNC5H3,UNC5C
O95235,KI20A_HUMAN,KIF20A; MKLP2; RAB6KIFL,Kinesin-like protein KIF20A; GG10_2; Mitotic kinesin-like protein 2; MKlp2; Rab6-interacting kinesin-like protein; Rabkinesin-6,MKLP2; RAB6KIFL,10112,kinesin family member 20A,RAB6 interacting; kinesin-like (rabkinesin6),mitotic kinesin-like protein 2,MKLP2,kinesin family member 20A,MKLP2; RAB6KIFL; RCM6,KIF20A
O95239,KIF4A_HUMAN,KIF4A; KIF4,Chromosome-associated kinesin KIF4A; Chromokinesin-A,KIF4,24137,kinesin family member 4A,,chromokinesin KIF4A,KIF4-G1; KIF4; HSA271784; FLJ12530; FLJ12655; FLJ14204; FLJ20631; MRX100,kinesin family member 4A,KIF4; KIF4G1; MRX100; TMDI; XLID100,KIF4A
O95243,MBD4_HUMAN,MBD4; MED1,Methyl-CpG-binding domain protein 4; EC 3.2.2.-; Methyl-CpG-binding endonuclease 1; Methyl-CpG-binding protein MBD4; Mismatch-specific DNA N-glycosylase,MED1,8930,methyl-CpG binding domain 4; DNA glycosylase,methyl-CpG binding domain protein 4,,MED1,methyl-CpG binding domain 4; DNA glycosylase,MED1; TPDS2; UVM1,MBD4
O95251,KAT7_HUMAN,KAT7; HBO1; HBOa; MYST2,Histone acetyltransferase KAT7; EC 2.3.1.48; Histone acetyltransferase binding to ORC1; Lysine acetyltransferase 7; MOZ; YBF2/SAS3; SAS2 and TIP60 protein 2; MYST-2,HBO1; HBOa; MYST2,11143,lysine acetyltransferase 7,MYST histone acetyltransferase 2; K(lysine) acetyltransferase 7,histone acetyltransferase binding to ORC1,HBOA; HBO1; ZC2HC7,lysine acetyltransferase 7,HBO1; HBOA; MYST2; ZC2HC7,KAT7
O95267,GRP1_HUMAN,RASGRP1; RASGRP,RAS guanyl-releasing protein 1; Calcium and DAG-regulated guanine nucleotide exchange factor II; CalDAG-GEFII; Ras guanyl-releasing protein,RASGRP,10125,RAS guanyl releasing protein 1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II,CalDAG-GEFII; RASGRP,RAS guanyl releasing protein 1,CALDAG-GEFI; CALDAG-GEFII; IMD64; RASGRP,RASGRP1
O95271,TNKS1_HUMAN,TNKS; PARP5A; PARPL; TIN1; TINF1; TNKS1,Poly ADP-ribose polymerase tankyrase-1; EC 2.4.2.30; ADP-ribosyltransferase diphtheria toxin-like 5; ARTD5; Poly ADP-ribose polymerase 5A; Protein poly-ADP-ribosyltransferase tankyrase-1; EC 2.4.2.-; TNKS-1; TRF1-interacting ankyrin-related ADP-ribose polymerase; Tankyrase I; Tankyrase-1; TANK1,PARP5A; PARPL; TIN1; TINF1; TNKS1,8658,tankyrase,tankyrase; TRF1-interacting ankyrin-related ADP-ribose polymerase,TRF1-interacting ankyrin-related ADP-ribose polymerase 1,TIN1; TINF1; TNKS1; PARP-5a; PARP5A; pART5; ARTD5,tankyrase,ARTD5; PARP-5a; PARP5A; PARPL; TIN1; TINF1; TNKS1; pART5,TNKS
O95278,EPM2A_HUMAN,EPM2A,Laforin; EC 3.1.3.-; EC 3.1.3.16; EC 3.1.3.48; Glucan phosphatase; Glycogen phosphatase; Lafora PTPase; LAFPTPase,,7957,EPM2A glucan phosphatase; laforin,epilepsy; progressive myoclonus type 2; Lafora disease (laforin); epilepsy; progressive myoclonus type 2A; Lafora disease (laforin); EPM2A; laforin glucan phosphatase,,LDE; LD,EPM2A glucan phosphatase; laforin,EPM2; MELF; MELF2,EPM2A
O95292,VAPB_HUMAN,VAPB; UNQ484/PRO983,Vesicle-associated membrane protein-associated protein B/C; VAMP-B/VAMP-C; VAMP-associated protein B/C; VAP-B/VAP-C,,9217,VAMP associated protein B and C,VAMP (vesicle-associated membrane protein)-associated protein B and C,,VAP-B; VAP-C; ALS8,VAMP associated protein B and C,ALS8; VAMP-B; VAP-B,VAPB
O95295,SNAPN_HUMAN,SNAPIN; BLOC1S7; SNAP25BP; SNAPAP,SNARE-associated protein Snapin; Biogenesis of lysosome-related organelles complex 1 subunit 7; BLOC-1 subunit 7; Synaptosomal-associated protein 25-binding protein; SNAP-associated protein,BLOC1S7; SNAP25BP; SNAPAP,23557,SNAP associated protein,SNAP-associated protein,snapin; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1; subunit 7; BLOC-1 related complex subunit 3,BLOC1S7; BORCS3,SNAP associated protein,BLOC1S7; BLOS7; BORCS3; SNAPAP,SNAPIN
O95297,MPZL1_HUMAN,MPZL1; PZR; UNQ849/PRO1787,Myelin protein zero-like protein 1; Protein zero-related,PZR,9019,myelin protein zero like 1,,,PZR; FLJ21047,myelin protein zero like 1,MPZL1b; PZR; PZR1b; PZRa; PZRb,MPZL1
O95382,M3K6_HUMAN,MAP3K6; ASK2; MAPKKK6; MEKK6,Mitogen-activated protein kinase kinase kinase 6; EC 2.7.11.25; Apoptosis signal-regulating kinase 2,ASK2; MAPKKK6; MEKK6,9064,mitogen-activated protein kinase kinase kinase 6,,apoptosis signal regulating kinase 2,MAPKKK6; ASK2; MEKK6,mitogen-activated protein kinase kinase kinase 6,ASK2; MAPKKK6; MEKK6,MAP3K6
O95398,RPGF3_HUMAN,RAPGEF3; CGEF1; EPAC; EPAC1,Rap guanine nucleotide exchange factor 3; Exchange factor directly activated by cAMP 1; Exchange protein directly activated by cAMP 1; EPAC 1; Rap1 guanine-nucleotide-exchange factor directly activated by cAMP; cAMP-regulated guanine nucleotide exchange factor I; cAMP-GEFI,CGEF1; EPAC; EPAC1,10411,Rap guanine nucleotide exchange factor 3,RAP guanine-nucleotide-exchange factor (GEF) 3; Rap guanine nucleotide exchange factor (GEF) 3,exchange protein directly activated by cAMP 1,cAMP-GEFI; EPAC; bcm910,Rap guanine nucleotide exchange factor 3,CAMP-GEFI; EPAC; EPAC1; HSU79275; bcm910,RAPGEF3
O95425,SVIL_HUMAN,SVIL,Supervillin; Archvillin; p205/p250,,6840,supervillin,,archvillin,,supervillin,MFM10,SVIL
O95433,AHSA1_HUMAN,AHSA1; C14orf3; HSPC322,Activator of 90 kDa heat shock protein ATPase homolog 1; AHA1; p38,C14orf3,10598,activator of HSP90 ATPase activity 1,chromosome 14 open reading frame 3; AHA1; activator of heat shock 90kDa protein ATPase homolog 1 (yeast),,p38; Aha1; hAha1,activator of HSP90 ATPase activity 1,AHA1; C14orf3; hAha1; p38,AHSA1
O95453,PARN_HUMAN,PARN; DAN,Poly(A)-specific ribonuclease PARN; A; EC 3.1.13.4; Deadenylating nuclease; Deadenylation nuclease; Polyadenylate-specific ribonuclease,DAN,5073,poly(A)-specific ribonuclease,poly(A)-specific ribonuclease (deadenylation nuclease),deadenylation nuclease,DAN,poly(A)-specific ribonuclease,DAN; DKCB6; PFBMFT4,PARN
O95471,CLD7_HUMAN,CLDN7; CEPTRL2; CPETRL2,Claudin-7; CLDN-7,CEPTRL2; CPETRL2,1366,claudin 7,,,Hs.84359,claudin 7,CEPTRL2; CLDN-7; CPETRL2; Hs.84359; claudin-1,CLDN7
O95476,CNEP1_HUMAN,CTDNEP1; DULLARD,CTD nuclear envelope phosphatase 1; EC 3.1.3.16; Serine/threonine-protein phosphatase dullard,DULLARD,23399,CTD nuclear envelope phosphatase 1,dullard homolog (Xenopus laevis),C-terminal domain nuclear envelope phosphatase 1,HSA011916; NET56,CTD nuclear envelope phosphatase 1,DULLARD; HSA011916; NET56,CTDNEP1
O95477,ABCA1_HUMAN,ABCA1; ABC1; CERP,Phospholipid-transporting ATPase ABCA1; EC 7.6.2.1; ATP-binding cassette sub-family A member 1; ATP-binding cassette transporter 1; ABC-1; ATP-binding cassette 1; Cholesterol efflux regulatory protein,ABC1; CERP,19,ATP binding cassette subfamily A member 1,ATP-binding cassette; sub-family A (ABC1); member 1,Tangier disease,TGD,ATP binding cassette subfamily A member 1,ABC-1; ABC1; CERP; HDLCQTL13; HDLDT1; HPALP1; TGD,ABCA1
O95551,TYDP2_HUMAN,TDP2; EAP2; TTRAP; AD-022,Tyrosyl-DNA phosphodiesterase 2; Tyr-DNA phosphodiesterase 2; hTDP2; EC 3.1.4.-; 5'-tyrosyl-DNA phosphodiesterase; 5'-Tyr-DNA phosphodiesterase; ETS1-associated protein 2; ETS1-associated protein II; EAPII; TRAF and TNF receptor-associated protein; Tyrosyl-RNA phosphodiesterase; VPg unlinkase,EAP2; TTRAP,51567,tyrosyl-DNA phosphodiesterase 2,TRAF and TNF receptor associated protein,,,tyrosyl-DNA phosphodiesterase 2,AD022; EAP2; EAPII; TTRAP; dJ30M3.3; hTDP2,TDP2
O95600,KLF8_HUMAN,KLF8; BKLF3; ZNF741,Krueppel-like factor 8; Basic krueppel-like factor 3; Zinc finger protein 741,BKLF3; ZNF741,11279,KLF transcription factor 8,Kruppel like factor 8,,BKLF3; ZNF741; DXS741,KLF transcription factor 8,BKLF3; ZNF741,KLF8
O95613,PCNT_HUMAN,PCNT; KIAA0402; PCNT2,Pericentrin; Kendrin; Pericentrin-B,KIAA0402; PCNT2,5116,pericentrin,pericentrin 2 (kendrin),kendrin; Seckel syndrome 4,KEN; KIAA0402; PCN; PCNTB; SCKL4,pericentrin,KEN; MOPD2; PCN; PCNT2; PCNTB; PCTN2; SCKL4,PCNT
O95644,NFAC1_HUMAN,NFATC1; NFAT2; NFATC,Nuclear factor of activated T-cells; cytoplasmic 1; NF-ATc1; NFATc1; NFAT transcription complex cytosolic component; NF-ATc; NFATc,NFAT2; NFATC,4772,nuclear factor of activated T cells 1,nuclear factor of activated T-cells; cytoplasmic; calcineurin-dependent 1; nuclear factor of activated T-cells 1,,NF-ATC; NFATc; NFAT2,nuclear factor of activated T cells 1,NF-ATC; NF-ATc1.2; NFAT2; NFATc,NFATC1
O95707,RPP29_HUMAN,POP4; RPP29,Ribonuclease P protein subunit p29; hPOP4,RPP29,10775,POP4 homolog; ribonuclease P/MRP subunit,processing of precursor 4; ribonuclease P/MRP subunit (S. cerevisiae),,RPP29,POP4 homolog; ribonuclease P/MRP subunit,RPP29,POP4
O95721,SNP29_HUMAN,SNAP29,Synaptosomal-associated protein 29; SNAP-29; Soluble 29 kDa NSF attachment protein; Vesicle-membrane fusion protein SNAP-29,,9342,synaptosome associated protein 29,synaptosomal-associated protein; 29kDa,soluble 29 kDa NSF attachment protein; cerebral dysgenesis; neuropathy; ichthyosis and keratoderma syndrome,SNAP-29; CEDNIK,synaptosome associated protein 29,CEDNIK; SNAP-29,SNAP29
O95747,OXSR1_HUMAN,OXSR1; KIAA1101; OSR1,Serine/threonine-protein kinase OSR1; EC 2.7.11.1; Oxidative stress-responsive 1 protein,KIAA1101; OSR1,9943,oxidative stress responsive kinase 1,oxidative-stress responsive 1,,KIAA1101,oxidative stress responsive kinase 1,OSR1,OXSR1
O95785,WIZ_HUMAN,WIZ; ZNF803,Protein Wiz; Widely-interspaced zinc finger-containing protein; Zinc finger protein 803,ZNF803,58525,WIZ zinc finger,widely interspaced zinc finger motifs,,ZNF803,WIZ zinc finger,ZNF803,WIZ
O95786,RIGI_HUMAN,RIGI; DDX58,Antiviral innate immune response receptor RIG-I; ATP-dependent RNA helicase DDX58; EC 3.6.4.13; DEAD box protein 58; RIG-I-like receptor 1; RLR-1; RNA sensor RIG-I; Retinoic acid-inducible gene 1 protein; RIG-1; Retinoic acid-inducible gene I protein; RIG-I,DDX58,23586,RNA sensor RIG-I,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58; DExD/H-box helicase 58,RNA helicase RIG-I; retinoic acid inducible gene I; Antiviral innate immune response receptor RIG-I,RIG-I; FLJ13599; DKFZp434J1111; RIG-1; RIG1,RNA sensor RIG-I,DDX58; RIG-I; RIG1; RLR-1; SGMRT2,RIGI
O95816,BAG2_HUMAN,BAG2,BAG family molecular chaperone regulator 2; BAG-2; Bcl-2-associated athanogene 2,,9532,BAG cochaperone 2,BCL2 associated athanogene 2,,,BAG cochaperone 2,BAG-2; dJ417I1.2,BAG2
O95817,BAG3_HUMAN,BAG3; BIS,BAG family molecular chaperone regulator 3; BAG-3; Bcl-2-associated athanogene 3; Bcl-2-binding protein Bis; Docking protein CAIR-1,BIS,9531,BAG cochaperone 3,BCL2 associated athanogene 3,BAG family molecular chaperone regulator 3,,BAG cochaperone 3,BAG-3; BIS; CAIR-1; CMD1HH; CMT2JJ; HMND15; MFM6,BAG3
O95819,M4K4_HUMAN,MAP4K4; HGK; KIAA0687; NIK,Mitogen-activated protein kinase kinase kinase kinase 4; EC 2.7.11.1; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4; MEK kinase kinase 4; MEKKK 4; Nck-interacting kinase,HGK; KIAA0687; NIK,9448,mitogen-activated protein kinase kinase kinase kinase 4,,HPK/GCK-like kinase; hepatocyte progenitor kinase-like/germinal center kinase-like kinase,HGK; NIK; FLH21957,mitogen-activated protein kinase kinase kinase kinase 4,FLH21957; HEL-S-31; HGK; MEKKK4; NIK,MAP4K4
O95822,DCMC_HUMAN,MLYCD,Malonyl-CoA decarboxylase; mitochondrial; MCD; EC 4.1.1.9,,23417,malonyl-CoA decarboxylase,,,MCD; hMCD,malonyl-CoA decarboxylase,MCD,MLYCD
O95835,LATS1_HUMAN,LATS1; WARTS,Serine/threonine-protein kinase LATS1; EC 2.7.11.1; Large tumor suppressor homolog 1; WARTS protein kinase; h-warts,WARTS,9113,large tumor suppressor kinase 1,LATS (large tumor suppressor; Drosophila) homolog 1; LATS; large tumor suppressor; homolog 1 (Drosophila),,WARTS,large tumor suppressor kinase 1,WARTS; wts,LATS1
O95863,SNAI1_HUMAN,SNAI1; SNAH,Zinc finger protein SNAI1; Protein snail homolog 1; Protein sna,SNAH,6615,snail family transcriptional repressor 1,snail 1 (drosophila homolog); zinc finger protein; snail homolog 1 (Drosophila); snail family zinc finger 1,,SNA; SLUGH2; SNAH; SNAIL1; SNAIL,snail family transcriptional repressor 1,SLUGH2; SNA; SNAH; SNAIL; SNAIL1; dJ710H13.1,SNAI1
O95905,ECD_HUMAN,ECD,Protein ecdysoneless homolog; Human suppressor of GCR two; hSGT1,,11319,ecdysoneless cell cycle regulator,ecdysoneless homolog (Drosophila),,hSGT1; GCR2,ecdysoneless cell cycle regulator,GCR2; HSGT1; SGT1,ECD
O95983,MBD3_HUMAN,MBD3,Methyl-CpG-binding domain protein 3; Methyl-CpG-binding protein MBD3,,53615,methyl-CpG binding domain protein 3,,,,methyl-CpG binding domain protein 3,,MBD3
O95997,PTTG1_HUMAN,PTTG1; EAP1; PTTG; TUTR1,Securin; Esp1-associated protein; Pituitary tumor-transforming gene 1 protein; Tumor-transforming protein 1; hPTTG,EAP1; PTTG; TUTR1,9232,PTTG1 regulator of sister chromatid separation; securin,pituitary tumor-transforming 1,ESP1-associated protein 1; tumor-transforming protein 1; endogenous cardiac regeneration-associated regulator,PTTG; HPTTG; EAP1; securin; ECRAR,PTTG1 regulator of sister chromatid separation; securin,EAP1; ECRAR; HPTTG; PTTG; TUTR1,PTTG1
O95999,BCL10_HUMAN,BCL10; CIPER; CLAP,B-cell lymphoma/leukemia 10; B-cell CLL/lymphoma 10; Bcl-10; CARD-containing molecule enhancing NF-kappa-B; CARD-like apoptotic protein; hCLAP; CED-3/ICH-1 prodomain homologous E10-like regulator; CIPER; Cellular homolog of vCARMEN; cCARMEN; Cellular-E10; c-E10; Mammalian CARD-containing adapter molecule E10; mE10,CIPER; CLAP,8915,BCL10 immune signaling adaptor,B cell CLL/lymphoma 10; BCL10; immune signaling adaptor,CARD-like apoptotic protein; CARD-containing apoptotic signaling protein; CARD containing molecule enhancing NF-kB; caspase-recruiting domain-containing protein; CARD-containing proapoptotic protein,CARMEN; CIPER; mE10; c-E10; CLAP,BCL10 immune signaling adaptor,CARMEN; CIPER; CLAP; IMD37; c-E10; mE10,BCL10
O96013,PAK4_HUMAN,PAK4; KIAA1142,Serine/threonine-protein kinase PAK 4; EC 2.7.11.1; p21-activated kinase 4; PAK-4,KIAA1142,10298,p21 (RAC1) activated kinase 4,p21(CDKN1A)-activated kinase 4; p21 protein (Cdc42/Rac)-activated kinase 4,,,p21 (RAC1) activated kinase 4,,PAK4
O96014,WNT11_HUMAN,WNT11,Protein Wnt-11,,7481,Wnt family member 11,wingless-type MMTV integration site family; member 11,,,Wnt family member 11,HWNT11,WNT11
O96017,CHK2_HUMAN,CHEK2; CDS1; CHK2; RAD53,Serine/threonine-protein kinase Chk2; EC 2.7.11.1; CHK2 checkpoint homolog; Cds1 homolog; Hucds1; hCds1; Checkpoint kinase 2,CDS1; CHK2; RAD53,11200,checkpoint kinase 2,CHK2 (checkpoint; S.pombe) homolog; CHK2 checkpoint homolog (S. pombe),,CDS1; CHK2; HuCds1; PP1425; bA444G7,checkpoint kinase 2,CDS1; CHK2; HuCds1; LFS2; PP1425; RAD53; TPDS4; hCds1,CHEK2
O96018,APBA3_HUMAN,APBA3; MINT3; X11L2,Amyloid-beta A4 precursor protein-binding family A member 3; Adapter protein X11gamma; Neuron-specific X11L2 protein; Neuronal Munc18-1-interacting protein 3; Mint-3,MINT3; X11L2,9546,amyloid beta precursor protein binding family A member 3,amyloid beta (A4) precursor protein-binding; family A; member 3,X11-like 2,X11L2; mint3,amyloid beta precursor protein binding family A member 3,MGC:15815; X11L2; mint3,APBA3
O96028,NSD2_HUMAN,NSD2; KIAA1090; MMSET; TRX5; WHSC1,Histone-lysine N-methyltransferase NSD2; EC 2.1.1.357; Multiple myeloma SET domain-containing protein; MMSET; Nuclear SET domain-containing protein 2; Protein trithorax-5; Wolf-Hirschhorn syndrome candidate 1 protein,KIAA1090; MMSET; TRX5; WHSC1,7468,nuclear receptor binding SET domain protein 2,Wolf-Hirschhorn syndrome candidate 1,multiple myeloma SET domain containing protein,MMSET; KMT3G,nuclear receptor binding SET domain protein 2,KMT3F; KMT3G; MMSET; RAUST; REIIBP; TRX5; WHS; WHSC1,NSD2
P00338,LDHA_HUMAN,LDHA; PIG19,L-lactate dehydrogenase A chain; LDH-A; EC 1.1.1.27; Cell proliferation-inducing gene 19 protein; LDH muscle subunit; LDH-M; Renal carcinoma antigen NY-REN-59,,3939,lactate dehydrogenase A,,,,lactate dehydrogenase A,GSD11; HEL-S-133P; LDHM; PIG19,LDHA
P00367,DHE3_HUMAN,GLUD1; GLUD,Glutamate dehydrogenase 1; mitochondrial; GDH 1; EC 1.4.1.3,GLUD,2746,glutamate dehydrogenase 1,,,GDH; GDH1; hGDH1,glutamate dehydrogenase 1,GDH; GDH1; GLUD; hGDH1,GLUD1
P00439,PH4H_HUMAN,PAH,Phenylalanine-4-hydroxylase; PAH; EC 1.14.16.1; Phe-4-monooxygenase,,5053,phenylalanine hydroxylase,,phenylalanine 4-monooxygenase,PH,phenylalanine hydroxylase,PH; PKU; PKU1,PAH
P00441,SODC_HUMAN,SOD1,Superoxide dismutase Cu-Zn; EC 1.15.1.1; Superoxide dismutase 1; hSod1,,6647,superoxide dismutase 1,amyotrophic lateral sclerosis 1 (adult); superoxide dismutase 1; soluble,,IPOA,superoxide dismutase 1,ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer,SOD1
P00519,ABL1_HUMAN,ABL1; ABL; JTK7,Tyrosine-protein kinase ABL1; EC 2.7.10.2; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150,ABL; JTK7,25,ABL proto-oncogene 1; non-receptor tyrosine kinase,v-abl Abelson murine leukemia viral oncogene homolog 1; c-abl oncogene 1; receptor tyrosine kinase; c-abl oncogene 1; non-receptor tyrosine kinase,,JTK7; c-ABL; p150,ABL proto-oncogene 1; non-receptor tyrosine kinase,ABL; BCR-ABL; CHDSKM; JTK7; bcr/abl; c-ABL; c-ABL1; p150; v-abl,ABL1
P00533,EGFR_HUMAN,EGFR; ERBB; ERBB1; HER1,Epidermal growth factor receptor; EC 2.7.10.1; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1,ERBB; ERBB1; HER1,1956,epidermal growth factor receptor,epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog),erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian); erb-b2 receptor tyrosine kinase 1,ERBB1; ERRP,epidermal growth factor receptor,ERBB; ERBB1; ERRP; HER1; NISBD2; NNCIS; PIG61; mENA,EGFR
P00540,MOS_HUMAN,MOS,Proto-oncogene serine/threonine-protein kinase mos; EC 2.7.11.1; Oocyte maturation factor mos; Proto-oncogene c-Mos,,4342,MOS proto-oncogene; serine/threonine kinase,v-mos Moloney murine sarcoma viral oncogene homolog,,,MOS proto-oncogene; serine/threonine kinase,MSV; OZEMA20,MOS
P00558,PGK1_HUMAN,PGK1; PGKA; MIG10; OK/SW-cl.110,Phosphoglycerate kinase 1; EC 2.7.11.1; EC 2.7.2.3; Cell migration-inducing gene 10 protein; Primer recognition protein 2; PRP 2,PGKA,5230,phosphoglycerate kinase 1,,,,phosphoglycerate kinase 1,HEL-S-68p; MIG10; PGKA,PGK1
P00736,C1R_HUMAN,C1R,Complement C1r subcomponent; EC 3.4.21.41; Complement component 1 subcomponent r,,715,complement C1r,complement component 1; r subcomponent,,,complement C1r,EDS8; EDSPD1,C1R
P00749,UROK_HUMAN,PLAU,Urokinase-type plasminogen activator; U-plasminogen activator; uPA; EC 3.4.21.73,,5328,plasminogen activator; urokinase,,,URK; UPA,plasminogen activator; urokinase,ATF; BDPLT5; QPD; UPA; URK; u-PA,PLAU
P01100,FOS_HUMAN,FOS; G0S7,Protein c-Fos; Cellular oncogene fos; Fos proto-oncogene; AP-1 transcription factor subunit; G0/G1 switch regulatory protein 7; Proto-oncogene c-Fos; Transcription factor AP-1 subunit c-Fos,G0S7,2353,Fos proto-oncogene; AP-1 transcription factor subunit,v-fos FBJ murine osteosarcoma viral oncogene homolog; FBJ murine osteosarcoma viral oncogene homolog,,c-fos; AP-1,Fos proto-oncogene; AP-1 transcription factor subunit,AP-1; C-FOS; p55,FOS
P01106,MYC_HUMAN,MYC; BHLHE39,Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64,BHLHE39,4609,MYC proto-oncogene; bHLH transcription factor,v-myc avian myelocytomatosis viral oncogene homolog,,c-Myc; bHLHe39; MYCC,MYC proto-oncogene; bHLH transcription factor,MRTL; MYCC; bHLHe39; c-Myc,MYC
P01111,RASN_HUMAN,NRAS; HRAS1,GTPase NRas; EC 3.6.5.2; Transforming protein N-Ras,HRAS1,4893,NRAS proto-oncogene; GTPase,neuroblastoma RAS viral (v-ras) oncogene homolog; neuroblastoma RAS viral oncogene homolog,,N-ras,NRAS proto-oncogene; GTPase,ALPS4; CMNS; KRAS; N-ras; NCMS; NRAS1; NS6,NRAS
P01112,RASH_HUMAN,HRAS; HRAS1,GTPase HRas; EC 3.6.5.2; H-Ras-1; Ha-Ras; Transforming protein p21; c-H-ras; p21ras,HRAS1,3265,HRas proto-oncogene; GTPase,v-Ha-ras Harvey rat sarcoma viral oncogene homolog; Harvey rat sarcoma viral oncogene homolog,,,HRas proto-oncogene; GTPase,C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras,HRAS
P01116,RASK_HUMAN,KRAS; KRAS2; RASK2,GTPase KRas; EC 3.6.5.2; K-Ras 2; Ki-Ras; c-K-ras; c-Ki-ras,KRAS2; RASK2,3845,KRAS proto-oncogene; GTPase,v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; Kirsten rat sarcoma viral oncogene homolog,,KRAS1; K-Ras4B,KRAS proto-oncogene; GTPase,'C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2,KRAS
P01350,GAST_HUMAN,GAST; GAS,Gastrin Cleaved into: Gastrin-71; Gastrin component I; G52; Gastrin component II; Gastrin-34; G34; Gastrin component III; Gastrin-17; G17; G14; G6,GAS,2520,gastrin,,preprogastrin,,gastrin,GAS,GAST
P01589,IL2RA_HUMAN,IL2RA,Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; TAC antigen; p55; CD antigen CD25,,3559,interleukin 2 receptor subunit alpha,insulin-dependent diabetes mellitus 10; interleukin 2 receptor; alpha,,CD25,interleukin 2 receptor subunit alpha,CD25; IDDM10; IL2R; IMD41; TCGFR; p55,IL2RA
P01730,CD4_HUMAN,CD4,T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3; CD antigen CD4,,920,CD4 molecule,CD4 antigen (p55); T-cell surface glycoprotein CD4,,T4; Leu-3,CD4 molecule,CD4mut; IMD79; Leu-3; OKT4D; T4,CD4
P01889,HLAB_HUMAN,HLA-B; HLAB,HLA class I histocompatibility antigen; B alpha chain; Human leukocyte antigen B; HLA-B,HLAB,3106,major histocompatibility complex; class I; B,ankylosing spondylitis,,,major histocompatibility complex; class I; B,AS; B-4901; HLAB,HLA-B
P02489,CRYAA_HUMAN,CRYAA; CRYA1; HSPB4,Alpha-crystallin A chain; Heat shock protein beta-4; HspB4; Heat shock protein family B member 4; 1-172; 1-168; 1-162,CRYA1; HSPB4,102724652,crystallin alpha A,crystallin; alpha A,,HSPB4,,CRYAA; CRYAA2,CRYAA
P02511,CRYAB_HUMAN,CRYAB; CRYA2; HSPB5,Alpha-crystallin B chain; Alpha(B; Heat shock protein beta-5; HspB5; Heat shock protein family B member 5; Renal carcinoma antigen NY-REN-27; Rosenthal fiber component,CRYA2; HSPB5,1410,crystallin alpha B,crystallin; alpha B,,HSPB5,crystallin alpha B,CMD1II; CRYA2; CTPP2; CTRCT16; HEL-S-101; HSPB5; MFM2,CRYAB
P02545,LMNA_HUMAN,LMNA; LMN1,Prelamin-A/C Cleaved into: Lamin-A/C; 70 kDa lamin; Renal carcinoma antigen NY-REN-32,LMN1,4000,lamin A/C,cardiomyopathy; dilated 1A (autosomal dominant); limb girdle muscular dystrophy 1B (autosomal dominant); progeria 1 (Hutchinson-Gilford type); lamin A/C-like 1,mandibuloacral dysplasia type A; progerin,HGPS; MADA,lamin A/C,CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1,LMNA
P02649,APOE_HUMAN,APOE,Apolipoprotein E; Apo-E,,348,apolipoprotein E,Alzheimer disease 2 (APOE*E4-associated; late onset),,,apolipoprotein E,AD2; APO-E; ApoE4; LDLCQ5; LPG,APOE
P02671,FIBA_HUMAN,FGA,Fibrinogen alpha chain Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain,,2243,fibrinogen alpha chain,fibrinogen; A alpha polypeptide,,,fibrinogen alpha chain,AMYLD2; Fib2,FGA
P02686,MBP_HUMAN,MBP,Myelin basic protein; MBP; Myelin A1 protein; Myelin membrane encephalitogenic protein,,4155,myelin basic protein,,,,myelin basic protein,,MBP
P02730,B3AT_HUMAN,SLC4A1; AE1; DI; EPB3,Band 3 anion transport protein; Anion exchange protein 1; AE 1; Anion exchanger 1; Solute carrier family 4 member 1; CD antigen CD233,AE1; DI; EPB3,6521,solute carrier family 4 member 1 (Diego blood group),Waldner blood group; erythrocyte membrane protein band 3; Diego blood group; solute carrier family 4; anion exchanger; member 1 (erythrocyte membrane protein band 3; Diego blood group); solute carrier family 4 (anion exchanger); member 1; solute carrier family 4 (anion exchanger); member 1 (Diego blood group),Froese blood group; Swann blood group; Wright blood group; Band 3 anion transport protein,RTA1A; CD233; FR; SW; WR; EMPB3,solute carrier family 4 member 1 (Diego blood group),AE1; BND3; CD233; CHC; DI; EMPB3; EPB3; FR; RTA1A; SAO; SPH4; SW; WD; WD1; WR,SLC4A1
P02786,TFR1_HUMAN,TFRC,Transferrin receptor protein 1; TR; TfR; TfR1; Trfr; T9; p90; CD antigen CD71; sTfR,,7037,transferrin receptor,transferrin receptor (p90; CD71),,CD71; TFR1; p90,transferrin receptor,CD71; IMD46; T9; TFR; TFR1; TR; TRFR; p90,TFRC
P02810,PRPC_HUMAN,PRH1; PRH2,Salivary acidic proline-rich phosphoprotein 1/2; Db-s; PRP-1/PRP-2; Parotid acidic protein; Pa; Parotid double-band protein; Parotid isoelectric focusing variant protein; PIF-S; Parotid proline-rich protein 1/2; Pr1/Pr2; Protein C; Db-F; PIF-F; PRP-3/PRP-4; Protein A,;,5554,proline rich protein HaeIII subfamily 1,,,Pa,proline rich protein HaeIII subfamily 1,Db-s; PA; PIF-S; PRH2; PRP-1/PRP-2; Pr1/Pr2,PRH1; PRH2
P03372,ESR1_HUMAN,ESR1; ESR; NR3A1,Estrogen receptor; ER; ER-alpha; Estradiol receptor; Nuclear receptor subfamily 3 group A member 1,ESR; NR3A1,2099,estrogen receptor 1,,nuclear receptor subfamily 3 group A member 1; estrogen receptor alpha; oestrogen receptor alpha; E2 receptor alpha; estradiol receptor,ER; NR3A1; Era; ER-alpha,estrogen receptor 1,ER; ESR; ESRA; ESTRR; Era; NR3A1,ESR1
P04004,VTNC_HUMAN,VTN,Vitronectin; VN; S-protein; Serum-spreading factor; V75,,7448,vitronectin,vitronectin (serum spreading factor; somatomedin B; complement S-protein),serum spreading factor; somatomedin B; complement S-protein,VN,vitronectin,V75; VN; VNT,VTN
P04035,HMDH_HUMAN,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase; HMG-CoA reductase; EC 1.1.1.34,,3156,3-hydroxy-3-methylglutaryl-CoA reductase,3-hydroxy-3-methylglutaryl-Coenzyme A reductase,hydroxymethylglutaryl-CoA reductase; 3-hydroxy-3-methylglutaryl CoA reductase (NADPH),,3-hydroxy-3-methylglutaryl-CoA reductase,LDLCQ3; LGMDR28; MYPLG,HMGCR
P04040,CATA_HUMAN,CAT,Catalase; EC 1.11.1.6,,847,catalase,,,,catalase,,CAT
P04049,RAF1_HUMAN,RAF1; RAF,RAF proto-oncogene serine/threonine-protein kinase; EC 2.7.11.1; Proto-oncogene c-RAF; cRaf; Raf-1,RAF,5894,Raf-1 proto-oncogene; serine/threonine kinase,v-raf-1 murine leukemia viral oncogene homolog 1,C-Raf proto-oncogene; serine/threonine kinase,Raf-1; c-Raf; CRAF,Raf-1 proto-oncogene; serine/threonine kinase,CMD1NN; CRAF; NS5; Raf-1; c-Raf,RAF1
P04083,ANXA1_HUMAN,ANXA1; ANX1; LPC1,Annexin A1; Annexin I; Annexin-1; Calpactin II; Calpactin-2; Chromobindin-9; Lipocortin I; Phospholipase A2 inhibitory protein; p35,ANX1; LPC1,301,annexin A1,,,,annexin A1,ANX1; LPC1,ANXA1
P04150,GCR_HUMAN,NR3C1; GRL,Glucocorticoid receptor; GR; Nuclear receptor subfamily 3 group C member 1,GRL,2908,nuclear receptor subfamily 3 group C member 1,glucocorticoid receptor; nuclear receptor subfamily 3; group C; member 1; nuclear receptor subfamily 3; group C; member 1 (glucocorticoid receptor),,GR,nuclear receptor subfamily 3 group C member 1,GCCR; GCR; GCRST; GR; GRL,NR3C1
P04156,PRIO_HUMAN,PRNP; ALTPRP; PRIP; PRP,Major prion protein; PrP; ASCR; PrP27-30; PrP33-35C; CD antigen CD230,ALTPRP; PRIP; PRP,5621,prion protein (Kanno blood group),prion protein (p27-30); prion protein,Creutzfeldt-Jakob disease; Gerstmann-Strausler-Scheinker syndrome; fatal familial insomnia; p27-30,CD230; PRP; AltPrP,prion protein (Kanno blood group),ASCR; AltPrP; CD230; CJD; GSS; KURU; PRIP; PrP; PrP27-30; PrP33-35C; PrPc; p27-30,PRNP
P04179,SODM_HUMAN,SOD2,Superoxide dismutase Mn; mitochondrial; EC 1.15.1.1,,6648,superoxide dismutase 2,superoxide dismutase 2; mitochondrial,gastric cancer?associated lncRNA 1; manganese superoxide dismutase,GC1; IPOB; MnSOD; GClnc1; lncRNA-GC1,superoxide dismutase 2,GC1; GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD; lncRNA-GC1,SOD2
P04183,KITH_HUMAN,TK1,Thymidine kinase; cytosolic; EC 2.7.1.21,,7083,thymidine kinase 1,thymidine kinase 1; soluble,cytosolic thymidine kinase,,thymidine kinase 1,TK2,TK1
P04198,MYCN_HUMAN,MYCN; BHLHE37; NMYC,N-myc proto-oncogene protein; Class E basic helix-loop-helix protein 37; bHLHe37,BHLHE37; NMYC,4613,MYCN proto-oncogene; bHLH transcription factor,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,,bHLHe37; N-myc; MYCNOT,MYCN proto-oncogene; bHLH transcription factor,FGLDS1; MODED; MPAPA; MYCNsORF; MYCNsPEP; N-myc; NMYC; ODED; bHLHe37,MYCN
P04406,G3P_HUMAN,GAPDH; GAPD; CDABP0047; OK/SW-cl.12,Glyceraldehyde-3-phosphate dehydrogenase; GAPDH; EC 1.2.1.12; Peptidyl-cysteine S-nitrosylase GAPDH; EC 2.6.99.-,GAPD,2597,glyceraldehyde-3-phosphate dehydrogenase,,,,glyceraldehyde-3-phosphate dehydrogenase,G3PD; GAPD; HEL-S-162eP,GAPDH
P04626,ERBB2_HUMAN,ERBB2; HER2; MLN19; NEU; NGL,Receptor tyrosine-protein kinase erbB-2; EC 2.7.10.1; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD antigen CD340,HER2; MLN19; NEU; NGL,2064,erb-b2 receptor tyrosine kinase 2,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog); v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2,neuro/glioblastoma derived oncogene homolog; human epidermal growth factor receptor 2; metastatic lymph node gene 19,NEU; HER-2; CD340; HER2; c-ERB2; c-ERB-2; MLN-19; p185(erbB2),erb-b2 receptor tyrosine kinase 2,CD340; HER-2; HER-2/neu; HER2; MLN 19; MLN-19; NEU; NGL; TKR1; VSCN2; c-ERB-2; c-ERB2; p185(erbB2),ERBB2
P04628,WNT1_HUMAN,WNT1; INT1,Proto-oncogene Wnt-1; Proto-oncogene Int-1 homolog,INT1,7471,Wnt family member 1,wingless-type MMTV integration site family; member 1,,,Wnt family member 1,BMND16; INT1; OI15,WNT1
P04629,NTRK1_HUMAN,NTRK1; MTC; TRK; TRKA,High affinity nerve growth factor receptor; EC 2.7.10.1; Neurotrophic tyrosine kinase receptor type 1; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor; Tyrosine kinase receptor A; Trk-A; gp140trk; p140-TrkA,MTC; TRK; TRKA,4914,neurotrophic receptor tyrosine kinase 1,neurotrophic tyrosine kinase; receptor; type 1,high affinity nerve growth factor receptor; tropomyosin receptor kinase A,TRK; TRKA; MTC,neurotrophic receptor tyrosine kinase 1,MTC; TRK; TRK1; TRKA; Trk-A; p140-TrkA,NTRK1
P04637,P53_HUMAN,TP53; P53,Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53,P53,7157,tumor protein p53,,Li-Fraumeni syndrome,p53; LFS1,tumor protein p53,BCC7; BMFS5; LFS1; P53; TRP53,TP53
P04792,HSPB1_HUMAN,HSPB1; HSP27; HSP28,Heat shock protein beta-1; HspB1; 28 kDa heat shock protein; Estrogen-regulated 24 kDa protein; Heat shock 27 kDa protein; HSP 27; Heat shock protein family B member 1; Stress-responsive protein 27; SRP27,HSP27; HSP28,3315,heat shock protein family B (small) member 1,heat shock 27kD protein 1; heat shock 27kDa protein 1,,HSP27; HSP28; Hs.76067; Hsp25; CMT2F,heat shock protein family B (small) member 1,CMT2F; HEL-S-102; HMN2B; HMND3; HS.76067; HSP27; HSP28; Hsp25; SRP27,HSPB1
P04818,TYSY_HUMAN,TYMS; TS; OK/SW-cl.29,Thymidylate synthase; TS; TSase; EC 2.1.1.45,TS,7298,thymidylate synthetase,,,Tsase; TMS; HsT422,thymidylate synthetase,DKCD; HST422; TMS; TS,TYMS
P04899,GNAI2_HUMAN,GNAI2; GNAI2B,Guanine nucleotide-binding protein G(i) subunit alpha-2; i; Adenylate cyclase-inhibiting G alpha protein,GNAI2B,2771,G protein subunit alpha i2,guanine nucleotide binding protein (G protein); alpha inhibiting activity polypeptide 2,GTP-binding regulatory protein Gi alpha-2 chain; Guanine nucleotide-binding protein G(i) subunit alpha-2,GIP,G protein subunit alpha i2,GIP; GNAI2B; HG1C; H_LUCA15.1; H_LUCA16.1,GNAI2
P05023,AT1A1_HUMAN,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1; Na(+; +; EC 7.2.2.13; Sodium pump subunit alpha-1,,476,ATPase Na+/K+ transporting subunit alpha 1,ATPase; Na+/K+ transporting; alpha 1 polypeptide,sodium/potassium-transporting ATPase subunit alpha-1; sodium pump subunit alpha-1; sodium-potassium ATPase catalytic subunit alpha-1,,ATPase Na+/K+ transporting subunit alpha 1,CMT2DD; HOMGSMR2,ATP1A1
P05026,AT1B1_HUMAN,ATP1B1; ATP1B,Sodium/potassium-transporting ATPase subunit beta-1; Sodium/potassium-dependent ATPase subunit beta-1,ATP1B,481,ATPase Na+/K+ transporting subunit beta 1,ATPase; Na+/K+ transporting; beta 1 polypeptide,sodium/potassium-transporting ATPase subunit beta-1; sodium pump subunit beta-1; sodium-potassium ATPase subunit beta 1 (non-catalytic),,ATPase Na+/K+ transporting subunit beta 1,ATP1B,ATP1B1
P05067,A4_HUMAN,APP; A4; AD1,Amyloid-beta precursor protein; APP; ABPP; APPI; Alzheimer disease amyloid A4 protein homolog; Alzheimer disease amyloid protein; Amyloid precursor protein; Amyloid-beta (A4; Amyloid-beta A4 protein; Cerebral vascular amyloid peptide; CVAP; PreA4; Protease nexin-II; PN-II; S-APP-alpha; S-APP-beta; Beta-secretase C-terminal fragment; Beta-CTF; Abeta42; Beta-APP42; Abeta40; Beta-APP40; Alpha-secretase C-terminal fragment; Alpha-CTF; 42; 40; Amyloid intracellular domain 59; AICD-59; AID(59; Gamma-CTF(59; Amyloid intracellular domain 57; AICD-57; AID(57; Gamma-CTF(57; Amyloid intracellular domain 50; AICD-50; AID(50; Gamma-CTF(50,A4; AD1,351,amyloid beta precursor protein,Alzheimer disease; amyloid beta (A4) precursor protein,peptidase nexin-II,alpha-sAPP,amyloid beta precursor protein,AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; alpha-sAPP; preA4,APP
P05091,ALDH2_HUMAN,ALDH2; ALDM,Aldehyde dehydrogenase; mitochondrial; EC 1.2.1.3; ALDH class 2; ALDH-E2; ALDHI,ALDM,217,aldehyde dehydrogenase 2 family member,aldehyde dehydrogenase 2 family (mitochondrial),,,aldehyde dehydrogenase 2 family member,ALDH-E2; ALDHI; ALDM,ALDH2
P05093,CP17A_HUMAN,CYP17A1; CYP17; S17AH,Steroid 17-alpha-hydroxylase/17;20 lyase; EC 1.14.14.19; 17-alpha-hydroxyprogesterone aldolase; EC 1.14.14.32; CYPXVII; Cytochrome P450 17A1; Cytochrome P450-C17; Cytochrome P450c17; Steroid 17-alpha-monooxygenase,CYP17; S17AH,1586,cytochrome P450 family 17 subfamily A member 1,cytochrome P450; subfamily XVII (steroid 17-alpha-hydroxylase); adrenal hyperplasia; cytochrome P450; family 17; subfamily A; polypeptide 1,Steroid 17-alpha-monooxygenase,P450C17; CPT7; S17AH,cytochrome P450 family 17 subfamily A member 1,CPT7; CYP17; P450C17; S17AH,CYP17A1
P05106,ITB3_HUMAN,ITGB3; GP3A,Integrin beta-3; Platelet membrane glycoprotein IIIa; GPIIIa; CD antigen CD61,GP3A,3690,integrin subunit beta 3,integrin; beta 3 (platelet glycoprotein IIIa; antigen CD61),platelet glycoprotein IIIa; antigen CD61,CD61; GPIIIa,integrin subunit beta 3,BDPLT16; BDPLT2; BDPLT24; CD61; GP3A; GPIIIa; GT; GT2,ITGB3
P05107,ITB2_HUMAN,ITGB2; CD18; MFI7,Integrin beta-2; Cell surface adhesion glycoproteins LFA-1/CR3/p150;95 subunit beta; Complement receptor C3 subunit beta; CD antigen CD18,CD18; MFI7,3689,integrin subunit beta 2,integrin; beta 2 (antigen CD18 (p95); lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit); integrin; beta 2 (complement component 3 receptor 3 and 4 subunit),complement component 3 receptor 3 and 4 subunit,LFA-1; MAC-1,integrin subunit beta 2,CD18; LAD; LCAMB; LFA-1; MAC-1; MF17; MFI7,ITGB2
P05114,HMGN1_HUMAN,HMGN1; HMG14,Non-histone chromosomal protein HMG-14; High mobility group nucleosome-binding domain-containing protein 1,HMG14,3150,high mobility group nucleosome binding domain 1,high-mobility group (nonhistone chromosomal) protein 14; high-mobility group nucleosome binding domain 1,high-mobility group nucleosome binding 1; nonhistone chromosomal protein HMG-14,FLJ27265; FLJ31471; MGC104230; MGC117425,high mobility group nucleosome binding domain 1,HMG14,HMGN1
P05129,KPCG_HUMAN,PRKCG; PKCG,Protein kinase C gamma type; PKC-gamma; EC 2.7.11.13,PKCG,5582,protein kinase C gamma,protein kinase C; gamma,PKC-gamma,PKCC; MGC57564; PKC??,protein kinase C gamma,PKC-gamma; PKCC; PKCG; PKCI(3); PKCgamma; SCA14,PRKCG
P05186,PPBT_HUMAN,ALPL,Alkaline phosphatase; tissue-nonspecific isozyme; AP-TNAP; TNS-ALP; TNSALP; EC 3.1.3.1; Alkaline phosphatase liver/bone/kidney isozyme; Phosphoamidase; Phosphocreatine phosphatase; EC 3.9.1.1,,249,alkaline phosphatase; biomineralization associated,alkaline phosphatase; liver/bone/kidney,tissue non-specific alkaline phosphatase,TNSALP; TNALP; TNAP,alkaline phosphatase; biomineralization associated,AP-TNAP; APTNAP; HOPS; HPPA; HPPC; HPPI; HPPO; TNALP; TNAP; TNS-ALP; TNSALP,ALPL
P05187,PPB1_HUMAN,ALPP; PLAP,Alkaline phosphatase; placental type; EC 3.1.3.1; Alkaline phosphatase Regan isozyme; Placental alkaline phosphatase 1; PLAP-1,PLAP,250,alkaline phosphatase; placental,alkaline phosphatase; placental (Regan isozyme),Regan isozyme; placental alkaline phosphatase,PALP; PLAP,alkaline phosphatase; placental,ALP; ALPI; IAP; PALP; PLAP; PLAP-1,ALPP
P05198,IF2A_HUMAN,EIF2S1; EIF2A,Eukaryotic translation initiation factor 2 subunit 1; Eukaryotic translation initiation factor 2 subunit alpha; eIF-2-alpha; eIF-2A; eIF-2alpha; eIF2-alpha,EIF2A,1965,eukaryotic translation initiation factor 2 subunit alpha,eukaryotic translation initiation factor 2; subunit 1 (alpha; 35kD ); eukaryotic translation initiation factor 2; subunit 1 alpha; 35kDa,,EIF-2alpha; EIF2A,eukaryotic translation initiation factor 2 subunit alpha,EIF-2; EIF-2A; EIF-2alpha; EIF2; EIF2A,EIF2S1
P05204,HMGN2_HUMAN,HMGN2; HMG17,Non-histone chromosomal protein HMG-17; High mobility group nucleosome-binding domain-containing protein 2,HMG17,3151,high mobility group nucleosomal binding domain 2,high-mobility group (nonhistone chromosomal) protein 17; high-mobility group nucleosomal binding domain 2,,,high mobility group nucleosomal binding domain 2,HMG17,HMGN2
P05387,RLA2_HUMAN,RPLP2; D11S2243E; RPP2,Large ribosomal subunit protein P2; 60S acidic ribosomal protein P2; Renal carcinoma antigen NY-REN-44,D11S2243E; RPP2,6181,ribosomal protein lateral stalk subunit P2,ribosomal protein; large; P2,60S acidic ribosomal protein P2; acidic ribosomal phosphoprotein P2,P2; RPP2; MGC71408; LP2,ribosomal protein lateral stalk subunit P2,D11S2243E; LP2; P2; RPP2,RPLP2
P05412,JUN_HUMAN,JUN,Transcription factor Jun; Activator protein 1; AP1; Proto-oncogene c-Jun; Transcription factor AP-1 subunit Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39,,3725,Jun proto-oncogene; AP-1 transcription factor subunit,v-jun avian sarcoma virus 17 oncogene homolog; jun oncogene,,c-Jun; AP-1,Jun proto-oncogene; AP-1 transcription factor subunit,AP-1; AP1; c-Jun; cJUN; p39,JUN
P05549,AP2A_HUMAN,TFAP2A; AP2TF; TFAP2,Transcription factor AP-2-alpha; AP2-alpha; AP-2 transcription factor; Activating enhancer-binding protein 2-alpha; Activator protein 2; AP-2,AP2TF; TFAP2,7020,transcription factor AP-2 alpha,transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha); transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),,AP-2; AP-2alpha,transcription factor AP-2 alpha,AP-2; AP-2alpha; AP2TF; BOFS; TFAP2,TFAP2A
P05556,ITB1_HUMAN,ITGB1; FNRB; MDF2; MSK12,Integrin beta-1; Fibronectin receptor subunit beta; Glycoprotein IIa; GPIIA; VLA-4 subunit beta; CD antigen CD29,FNRB; MDF2; MSK12,3688,integrin subunit beta 1,integrin; beta 1 (fibronectin receptor; beta polypeptide; antigen CD29 includes MDF2; MSK12),,CD29; GPIIA,integrin subunit beta 1,CD29; FNRB; GPIIA; MDF2; MSK12; VLA-BETA; VLAB,ITGB1
P05771,KPCB_HUMAN,PRKCB; PKCB; PRKCB1,Protein kinase C beta type; PKC-B; PKC-beta; EC 2.7.11.13,PKCB; PRKCB1,5579,protein kinase C beta,protein kinase C; beta 1; protein kinase C; beta,,PKC??,protein kinase C beta,PKC-beta; PKCB; PKCI(2); PKCbeta; PRKCB1; PRKCB2,PRKCB
P05783,K1C18_HUMAN,KRT18; CYK18; PIG46,Keratin; type I cytoskeletal 18; Cell proliferation-inducing gene 46 protein; Cytokeratin-18; CK-18; Keratin-18; K18,CYK18,3875,keratin 18,keratin 18; type I,,,keratin 18,CK-18; CYK18; K18,KRT18
P05787,K2C8_HUMAN,KRT8; CYK8,Keratin; type II cytoskeletal 8; Cytokeratin-8; CK-8; Keratin-8; K8; Type-II keratin Kb8,CYK8,3856,keratin 8,keratin 8; type II,,CARD2; K8; CK8; CK-8; CYK8; K2C8; KO,keratin 8,CARD2; CK-8; CK8; CYK8; K2C8; K8; KO,KRT8
P05814,CASB_HUMAN,CSN2; CASB,Beta-casein,CASB,1447,casein beta,,,,casein beta,CASB; PDC213,CSN2
P06127,CD5_HUMAN,CD5; LEU1,T-cell surface glycoprotein CD5; Lymphocyte antigen T1/Leu-1; CD antigen CD5,LEU1,921,CD5 molecule,CD5 antigen (p56-62),,T1,CD5 molecule,LEU1; T1,CD5
P06213,INSR_HUMAN,INSR,Insulin receptor; IR; EC 2.7.10.1; CD antigen CD220,,3643,insulin receptor,,,CD220,insulin receptor,CD220; HHF5,INSR
P06239,LCK_HUMAN,LCK,Tyrosine-protein kinase Lck; EC 2.7.10.2; Leukocyte C-terminal Src kinase; LSK; Lymphocyte cell-specific protein-tyrosine kinase; Protein YT16; Proto-oncogene Lck; T cell-specific protein-tyrosine kinase; p56-LCK,,3932,LCK proto-oncogene; Src family tyrosine kinase,lymphocyte-specific protein tyrosine kinase,,,LCK proto-oncogene; Src family tyrosine kinase,IMD22; LSK; YT16; p56lck; pp58lck,LCK
P06241,FYN_HUMAN,FYN,Tyrosine-protein kinase Fyn; EC 2.7.10.2; Proto-oncogene Syn; Proto-oncogene c-Fyn; Src-like kinase; SLK; p59-Fyn,,2534,FYN proto-oncogene; Src family tyrosine kinase,FYN oncogene related to SRC; FGR; YES,,SYN; SLK; MGC45350,FYN proto-oncogene; Src family tyrosine kinase,SLK; SYN; p59-FYN,FYN
P06396,GELS_HUMAN,GSN,Gelsolin; AGEL; Actin-depolymerizing factor; ADF; Brevin,,2934,gelsolin,gelsolin (amyloidosis; Finnish type),amyloidosis; Finnish type,DKFZp313L0718,gelsolin,ADF; AGEL; AMYLD4,GSN
P06400,RB_HUMAN,RB1,Retinoblastoma-associated protein; p105-Rb; p110-RB1; pRb; Rb; pp110,,5925,RB transcriptional corepressor 1,osteosarcoma; retinoblastoma 1,prepro-retinoblastoma-associated protein; protein phosphatase 1; regulatory subunit 130,RB; PPP1R130,RB transcriptional corepressor 1,OSRC; PPP1R130; RB; p105-Rb; p110-RB1; pRb; pp110,RB1
P06401,PRGR_HUMAN,PGR; NR3C3,Progesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3,NR3C3,5241,progesterone receptor,,,PR; NR3C3,progesterone receptor,NR3C3; PR,PGR
P06493,CDK1_HUMAN,CDK1; CDC2; CDC28A; CDKN1; P34CDC2,Cyclin-dependent kinase 1; CDK1; EC 2.7.11.22; EC 2.7.11.23; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase,CDC2; CDC28A; CDKN1; P34CDC2,983,cyclin dependent kinase 1,cell division cycle 2; G1 to S and G2 to M,,CDC28A,cyclin dependent kinase 1,CDC2; CDC28A; P34CDC2,CDK1
P06702,S10A9_HUMAN,S100A9; CAGB; CFAG; MRP14,Protein S100-A9; Calgranulin-B; Calprotectin L1H subunit; Leukocyte L1 complex heavy chain; Migration inhibitory factor-related protein 14; MRP-14; p14; S100 calcium-binding protein A9,CAGB; CFAG; MRP14,6280,S100 calcium binding protein A9,calgranulin B; S100 calcium-binding protein A9 (calgranulin B),Calprotectin L1H subunit; Leukocyte L1 complex heavy chain; Migration inhibitory factor-related protein 14,P14; MIF; NIF; LIAG; MRP14; MAC387; 60B8AG; CGLB; MRP-14; S100-A9,S100 calcium binding protein A9,60B8AG; CAGB; CFAG; CGLB; L1AG; LIAG; MAC387; MIF; MRP14; NIF; P14; S100-A9,S100A9
P06730,IF4E_HUMAN,EIF4E; EIF4EL1; EIF4F,Eukaryotic translation initiation factor 4E; eIF-4E; eIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein,EIF4EL1; EIF4F,1977,eukaryotic translation initiation factor 4E,,,EIF4E1,eukaryotic translation initiation factor 4E,AUTS19; CBP; EIF4E1; EIF4EL1; EIF4F; eIF-4E,EIF4E
P06733,ENOA_HUMAN,ENO1; ENO1L1; MBPB1; MPB1,Alpha-enolase; EC 4.2.1.11; 2-phospho-D-glycerate hydro-lyase; C-myc promoter-binding protein; Enolase 1; MBP-1; MPB-1; Non-neural enolase; NNE; Phosphopyruvate hydratase; Plasminogen-binding protein,ENO1L1; MBPB1; MPB1,2023,enolase 1,enolase 1; (alpha); ENO1 intronic transcript 1; ENO1 intronic transcript 1 (non-protein coding),alpha-enolase,PPH; MBP-1,enolase 1,ENO1-IT1; ENO1L1; HEL-S-17; MPB1; NNE; PPH,ENO1
P06737,PYGL_HUMAN,PYGL,Glycogen phosphorylase; liver form; EC 2.4.1.1,,5836,glycogen phosphorylase L,phosphorylase; glycogen; liver,Hers disease; glycogen storage disease type VI; glycogen phosphorylase; liver form,GSD6,glycogen phosphorylase L,GSD6,PYGL
P06744,G6PI_HUMAN,GPI,Glucose-6-phosphate isomerase; GPI; EC 5.3.1.9; Autocrine motility factor; AMF; Neuroleukin; NLK; Phosphoglucose isomerase; PGI; Phosphohexose isomerase; PHI; Sperm antigen 36; SA-36,,2821,glucose-6-phosphate isomerase,glucose phosphate isomerase,,AMF; NLK,glucose-6-phosphate isomerase,AMF; CNSHA4; GNPI; NLK; PGI; PHI; SA-36; SA36,GPI
P06748,NPM_HUMAN,NPM1; NPM,Nucleophosmin; NPM; Nucleolar phosphoprotein B23; Nucleolar protein NO38; Numatrin,NPM,4869,nucleophosmin 1,nucleophosmin (nucleolar phosphoprotein B23; numatrin); nucleophosmin,nucleolar phosphoprotein B23; numatrin; nucleophosmin/nucleoplasmin family; member 1,B23; NPM,nucleophosmin 1,B23; NPM,NPM1
P06899,H2B1J_HUMAN,H2BC11; H2BFR; HIST1H2BJ,Histone H2B type 1-J; Histone H2B.1; Histone H2B.r; H2B/r,H2BFR; HIST1H2BJ,8970,H2B clustered histone 11,H2B histone family; member R; histone 1; H2bj; histone cluster 1; H2bj; histone cluster 1 H2B family member j,,H2B/r,H2B clustered histone 11,H2B/r; H2BFR; H2BJ; HIST1H2BJ,H2BC11
P07101,TY3H_HUMAN,TH; TYH,Tyrosine 3-monooxygenase; EC 1.14.16.2; Tyrosine 3-hydroxylase; TH,TYH,7054,tyrosine hydroxylase,,tyrosine 3-monooxygenase,DYT5b,tyrosine hydroxylase,DYT14; DYT5b; TYH,TH
P07196,NFL_HUMAN,NEFL; NF68; NFL,Neurofilament light polypeptide; NF-L; 68 kDa neurofilament protein; Neurofilament triplet L protein,NF68; NFL,4747,neurofilament light chain,neurofilament; light polypeptide 68kDa; neurofilament; light polypeptide; neurofilament light,protein phosphatase 1; regulatory subunit 110,NFL; CMT1F; CMT2E; NF68; PPP1R110,neurofilament light chain,CMT1F; CMT2E; CMTDIG; NF-L; NF68; NFL; PPP1R110,NEFL
P07197,NFM_HUMAN,NEFM; NEF3; NFM,Neurofilament medium polypeptide; NF-M; 160 kDa neurofilament protein; Neurofilament 3; Neurofilament triplet M protein,NEF3; NFM,4741,neurofilament medium chain,neurofilament; medium polypeptide 150kDa; neurofilament; medium polypeptide; neurofilament medium,,NFM; NF-M,neurofilament medium chain,NEF3; NF-M; NFM,NEFM
P07203,GPX1_HUMAN,GPX1,Glutathione peroxidase 1; GPx-1; GSHPx-1; EC 1.11.1.9; Cellular glutathione peroxidase; Phospholipid-hydroperoxide glutathione peroxidase GPX1; EC 1.11.1.12,,2876,glutathione peroxidase 1,,selenoprotein GPX1,,glutathione peroxidase 1,GPXD; GSHPX1,GPX1
P07332,FES_HUMAN,FES; FPS,Tyrosine-protein kinase Fes/Fps; EC 2.7.10.2; Feline sarcoma/Fujinami avian sarcoma oncogene homolog; Proto-oncogene c-Fes; Proto-oncogene c-Fps; p93c-fes,FPS,2242,FES proto-oncogene; tyrosine kinase,feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog; feline sarcoma oncogene,Oncogene FES; feline sarcoma virus; c-fes/fps protein,FPS,FES proto-oncogene; tyrosine kinase,FPS,FES
P07333,CSF1R_HUMAN,CSF1R; FMS,Macrophage colony-stimulating factor 1 receptor; CSF-1 receptor; CSF-1-R; CSF-1R; M-CSF-R; EC 2.7.10.1; Proto-oncogene c-Fms; CD antigen CD115,FMS,1436,colony stimulating factor 1 receptor,McDonough feline sarcoma viral (v-fms) oncogene homolog,,C-FMS; CSFR; CD115,colony stimulating factor 1 receptor,BANDDOS; C-FMS; CD115; CSF-1R; CSFR; FIM2; FMS; GPSC; HDLS; HDLS1; M-CSF-R,CSF1R
P07355,ANXA2_HUMAN,ANXA2; ANX2; ANX2L4; CAL1H; LPC2D,Annexin A2; Annexin II; Annexin-2; Calpactin I heavy chain; Calpactin-1 heavy chain; Chromobindin-8; Lipocortin II; Placental anticoagulant protein IV; PAP-IV; Protein I; p36,ANX2; ANX2L4; CAL1H; LPC2D,302,annexin A2,,annexin II,LIP2,annexin A2,ANX2; ANX2L4; CAL1H; HEL-S-270; LIP2; LPC2; LPC2D; P36; PAP-IV,ANXA2
P07384,CAN1_HUMAN,CAPN1; CANPL1; PIG30,Calpain-1 catalytic subunit; EC 3.4.22.52; Calcium-activated neutral proteinase 1; CANP 1; Calpain mu-type; Calpain-1 large subunit; Cell proliferation-inducing gene 30 protein; Micromolar-calpain; muCANP,CANPL1,823,calpain 1,calpain 1; (mu/I) large subunit,,muCANP; muCL; CANP; CANPL1,calpain 1,CANP; CANP1; CANPL1; SPG76; muCANP; muCL,CAPN1
P07437,TBB5_HUMAN,TUBB; TUBB5; OK/SW-cl.56,Tubulin beta chain; Tubulin beta-5 chain,TUBB5,203068,tubulin beta class I,tubulin; beta polypeptide; tubulin; beta; tubulin; beta class I,class I beta-tubulin; beta1-tubulin,OK/SW-cl.56; MGC16435; M40; Tubb5,tubulin beta class I,CDCBM6; CSCSC1; M40; OK/SW-cl.56; TUBB1; TUBB5,TUBB
P07550,ADRB2_HUMAN,ADRB2; ADRB2R; B2AR,Beta-2 adrenergic receptor; Beta-2 adrenoreceptor; Beta-2 adrenoceptor,ADRB2R; B2AR,154,adrenoceptor beta 2,adrenergic; beta-2-; receptor; surface; adrenoceptor beta 2; surface,,ADRBR; BAR; B2AR; ARB2,adrenoceptor beta 2,ADRB2R; ADRBR; ARB2; B2AR; BAR; BETA2AR,ADRB2
P07737,PROF1_HUMAN,PFN1,Profilin-1; Epididymis tissue protein Li 184a; Profilin I,,5216,profilin 1,,,,profilin 1,ALS18,PFN1
P07766,CD3E_HUMAN,CD3E; T3E,T-cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; CD antigen CD3e,T3E,916,CD3 epsilon subunit of T-cell receptor complex,CD3e antigen; epsilon polypeptide (TiT3 complex); CD3e molecule; epsilon (CD3-TCR complex); CD3e molecule,T-cell surface glycoprotein CD3 epsilon chain,CD3epsilon; CD3-epsilon,CD3 epsilon subunit of T-cell receptor complex,CD3epsilon; IMD18; T3E; TCRE,CD3E
P07814,SYEP_HUMAN,EPRS1; EPRS; GLNS; PARS; QARS; QPRS; PIG32,Bifunctional glutamate/proline--tRNA ligase; Bifunctional aminoacyl-tRNA synthetase; Cell proliferation-inducing gene 32 protein; Glutamatyl-prolyl-tRNA synthetase; EC 6.1.1.17; Glutamyl-tRNA synthetase; GluRS; EC 6.1.1.15; Prolyl-tRNA synthetase,EPRS; GLNS; PARS; QARS; QPRS,2058,glutamyl-prolyl-tRNA synthetase 1,glutamyl-prolyl-tRNA synthetase,glutamate tRNA ligase; proline tRNA ligase,EARS; PARS; GLUPRORS,glutamyl-prolyl-tRNA synthetase 1,EARS; EPRS; GLUPRORS; HLD15; PARS; PIG32; QARS; QPRS,EPRS1
P07900,HS90A_HUMAN,HSP90AA1; HSP90A; HSPC1; HSPCA,Heat shock protein HSP 90-alpha; EC 3.6.4.10; Heat shock 86 kDa; HSP 86; HSP86; Heat shock protein family C member 1; Lipopolysaccharide-associated protein 2; LAP-2; LPS-associated protein 2; Renal carcinoma antigen NY-REN-38,HSP90A; HSPC1; HSPCA,3320,heat shock protein 90 alpha family class A member 1,heat shock 90kD protein 1; alpha; heat shock 90kDa protein 1; alpha; heat shock protein 90kDa alpha (cytosolic); class A member 1,,Hsp89; Hsp90; FLJ31884; HSP90N,heat shock protein 90 alpha family class A member 1,EL52; HEL-S-65p; HSP86; HSP89A; HSP90A; HSP90N; HSPC1; HSPCA; HSPCAL1; HSPCAL4; HSPN; Hsp103; Hsp89; Hsp90; LAP-2; LAP2,HSP90AA1
P07910,HNRPC_HUMAN,HNRNPC; HNRPC,Heterogeneous nuclear ribonucleoproteins C1/C2; hnRNP C1/C2,HNRPC,3183,heterogeneous nuclear ribonucleoprotein C,heterogeneous nuclear ribonucleoprotein C (C1/C2),,,heterogeneous nuclear ribonucleoprotein C,C1; C2; HNRNP; HNRPC; MRD74; SNRPC,HNRNPC
P07947,YES_HUMAN,YES1; YES,Tyrosine-protein kinase Yes; EC 2.7.10.2; Proto-oncogene c-Yes; p61-Yes,YES,7525,YES proto-oncogene 1; Src family tyrosine kinase,v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1,,Yes; c-yes; HsT441,YES proto-oncogene 1; Src family tyrosine kinase,HsT441; P61-YES; Yes; c-yes,YES1
P07948,LYN_HUMAN,LYN; JTK8,Tyrosine-protein kinase Lyn; EC 2.7.10.2; Lck/Yes-related novel protein tyrosine kinase; V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; p53Lyn; p56Lyn,JTK8,4067,LYN proto-oncogene; Src family tyrosine kinase,v-yes-1 Yamaguchi sarcoma viral related oncogene homolog,,JTK8,LYN proto-oncogene; Src family tyrosine kinase,JTK8; SAIDV; p53Lyn; p56Lyn,LYN
P07949,RET_HUMAN,RET; CDHF12; CDHR16; PTC,Proto-oncogene tyrosine-protein kinase receptor Ret; EC 2.7.10.1; Cadherin family member 12; Proto-oncogene c-Ret,CDHF12; CDHR16; PTC,5979,ret proto-oncogene,multiple endocrine neoplasia and medullary thyroid carcinoma 1; Hirschsprung disease 1,cadherin-related family member 16; RET receptor tyrosine kinase; rearranged during transfection,PTC; CDHF12; RET51; CDHR16,ret proto-oncogene,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1,RET
P07954,FUMH_HUMAN,FH,Fumarate hydratase; mitochondrial; Fumarase; HsFH; EC 4.2.1.2,,2271,fumarate hydratase,,fumarase,,fumarate hydratase,FMRD; HLRCC; HsFH; LRCC; MCL; MCUL1,FH
P08047,SP1_HUMAN,SP1; TSFP1,Transcription factor Sp1,TSFP1,6667,Sp1 transcription factor,,specificity protein 1,,Sp1 transcription factor,,SP1
P08069,IGF1R_HUMAN,IGF1R,Insulin-like growth factor 1 receptor; EC 2.7.10.1; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221,,3480,insulin like growth factor 1 receptor,insulin-like growth factor 1 receptor,,JTK13; CD221; IGFIR; MGC18216; IGFR,insulin like growth factor 1 receptor,CD221; IGFIR; IGFR; JTK13,IGF1R
P08100,OPSD_HUMAN,RHO; OPN2,Rhodopsin; Opsin-2,OPN2,6010,rhodopsin,retinitis pigmentosa 4; autosomal dominant,opsin 2; rod pigment,OPN2; CSNBAD1,rhodopsin,CSNBAD1; OPN2; RP4,RHO
P08138,TNR16_HUMAN,NGFR; TNFRSF16,Tumor necrosis factor receptor superfamily member 16; Gp80-LNGFR; Low affinity neurotrophin receptor p75NTR; Low-affinity nerve growth factor receptor; NGF receptor; Low-affinity nerve growth factor receptor p75NGFR; Low-affinity nerve growth factor receptor p75NGR; p75 ICD; CD antigen CD271,TNFRSF16,4804,nerve growth factor receptor,nerve growth factor receptor (TNFR superfamily; member 16),low affinity nerve growth factor receptor; TNFR superfamily; member 16,TNFRSF16; CD271; p75NTR,nerve growth factor receptor,CD271; Gp80-LNGFR; TNFRSF16; p75(NTR); p75NTR,NGFR
P08151,GLI1_HUMAN,GLI1; GLI,Zinc finger protein GLI1; Glioma-associated oncogene; Oncogene GLI,GLI,2735,GLI family zinc finger 1,glioma-associated oncogene homolog 1 (zinc finger protein); glioma-associated oncogene family zinc finger 1,,,GLI family zinc finger 1,GLI; PAPA8; PPD1,GLI1
P08172,ACM2_HUMAN,CHRM2,Muscarinic acetylcholine receptor M2,,1129,cholinergic receptor muscarinic 2,,acetylcholine receptor; muscarinic 2,,cholinergic receptor muscarinic 2,HM2,CHRM2
P08183,MDR1_HUMAN,ABCB1; MDR1; PGY1,ATP-dependent translocase ABCB1; ATP-binding cassette sub-family B member 1; Multidrug resistance protein 1; EC 7.6.2.2; P-glycoprotein 1; Phospholipid transporter ABCB1; EC 7.6.2.1; CD antigen CD243,MDR1; PGY1,5243,ATP binding cassette subfamily B member 1,colchicin sensitivity; ATP-binding cassette; sub-family B (MDR/TAP); member 1,multidrug resistance protein 1; P-glycoprotein,P-gp; CD243; GP170; ABC20; p-170; PGY1,ATP binding cassette subfamily B member 1,ABC20; CD243; CLCS; ENPAT; GP170; MDR1; P-GP; PGY1; p-170,ABCB1
P08195,4F2_HUMAN,SLC3A2; MDU1,Amino acid transporter heavy chain SLC3A2; 4F2 cell-surface antigen heavy chain; 4F2hc; 4F2 heavy chain antigen; Lymphocyte activation antigen 4F2 large subunit; Solute carrier family 3 member 2; CD antigen CD98,MDU1,6520,solute carrier family 3 member 2,solute carrier family 3 (activators of dibasic and neutral amino acid transport); member 2; solute carrier family 3 (amino acid transporter heavy chain); member 2,antigen identified by monoclonal antibodies 4F2; TRA1.10; TROP4; and T43; antigen defined by monoclonal antibody 4F2; heavy chain; 4F2 heavy chain; CD98 heavy chain; monoclonal antibody 44D7; 4F2 cell-surface antigen heavy chain; lymphocyte activation antigen 4F2 large subunit,4T2HC; 4F2; NACAE; CD98; CD98HC; 4F2HC,solute carrier family 3 member 2,4F2; 4F2HC; 4T2HC; CD98; CD98HC; MDU1; NACAE,SLC3A2
P08235,MCR_HUMAN,NR3C2; MCR; MLR,Mineralocorticoid receptor; MR; Nuclear receptor subfamily 3 group C member 2,MCR; MLR,4306,nuclear receptor subfamily 3 group C member 2,mineralocorticoid receptor; nuclear receptor subfamily 3; group C; member 2,,MR,nuclear receptor subfamily 3 group C member 2,MCR; MLR; MR; NR3C2VIT,NR3C2
P08237,PFKAM_HUMAN,PFKM; PFKX,ATP-dependent 6-phosphofructokinase; muscle type; ATP-PFK; PFK-M; EC 2.7.1.11; 6-phosphofructokinase type A; Phosphofructo-1-kinase isozyme A; PFK-A; Phosphohexokinase,PFKX,5213,phosphofructokinase; muscle,phosphofructokinase; polypeptide X,protein phosphatase 1; regulatory subunit 122,PFK-1; PPP1R122,phosphofructokinase; muscle,ATP-PFK; GSD7; PFK-1; PFK-A; PFK1; PFKA; PFKX; PPP1R122,PFKM
P08238,HS90B_HUMAN,HSP90AB1; HSP90B; HSPC2; HSPC3; HSPCB,Heat shock protein HSP 90-beta; HSP 90; Heat shock 84 kDa; HSP 84; HSP84; Heat shock protein family C member 3,HSP90B; HSPC2; HSPC3; HSPCB,3326,heat shock protein 90 alpha family class B member 1,heat shock 90kD protein 1; beta; heat shock 90kDa protein 1; beta; heat shock protein 90kDa alpha (cytosolic); class B member 1,,,heat shock protein 90 alpha family class B member 1,D6S182; HSP84; HSP90B; HSPC2; HSPCB,HSP90AB1
P08253,MMP2_HUMAN,MMP2; CLG4A,72 kDa type IV collagenase; EC 3.4.24.24; 72 kDa gelatinase; Gelatinase A; Matrix metalloproteinase-2; MMP-2; TBE-1,CLG4A,4313,matrix metallopeptidase 2,matrix metalloproteinase 2 (gelatinase A; 72kDa gelatinase; 72kDa type IV collagenase),,TBE-1,matrix metallopeptidase 2,CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1,MMP2
P08473,NEP_HUMAN,MME; EPN,Neprilysin; EC 3.4.24.11; Atriopeptidase; Common acute lymphocytic leukemia antigen; CALLA; Enkephalinase; Neutral endopeptidase 24.11; NEP; Neutral endopeptidase; Skin fibroblast elastase; SFE; CD antigen CD10,EPN,4311,membrane metalloendopeptidase,,neutral endopeptidase; enkephalinase; neprilysin,CALLA; CD10; NEP,membrane metalloendopeptidase,CALLA; CD10; CMT2T; NEP; SCA43; SFE,MME
P08559,ODPA_HUMAN,PDHA1; PHE1A,Pyruvate dehydrogenase E1 component subunit alpha; somatic form; mitochondrial; EC 1.2.4.1; PDHE1-A type I,PHE1A,5160,pyruvate dehydrogenase E1 subunit alpha 1,pyruvate dehydrogenase (lipoamide) alpha 1; pyruvate dehydrogenase alpha 1,pyruvate dehydrogenase E1 component subunit alpha; somatic form; mitochondrial,E1alpha,pyruvate dehydrogenase E1 subunit alpha 1,E1alpha; PDHA; PDHAD; PDHCE1A; PHE1A,PDHA1
P08567,PLEK_HUMAN,PLEK; P47,Pleckstrin; Platelet 47 kDa protein; p47,P47,5341,pleckstrin,,,P47; PLEK1,pleckstrin,P47; PLEK1,PLEK
P08575,PTPRC_HUMAN,PTPRC; CD45,Receptor-type tyrosine-protein phosphatase C; EC 3.1.3.48; Leukocyte common antigen; L-CA; T200; CD antigen CD45,CD45,5788,protein tyrosine phosphatase receptor type C,,leukocyte-common antigen; glycoprotein 180,LCA; T200; GP180; LY5; B220; CD45R,protein tyrosine phosphatase receptor type C,B220; CD45; CD45R; GP180; IMD105; L-CA; LCA; LY5; T200,PTPRC
P08581,MET_HUMAN,MET,Hepatocyte growth factor receptor; HGF receptor; EC 2.7.10.1; HGF/SF receptor; Proto-oncogene c-Met; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met,,4233,MET proto-oncogene; receptor tyrosine kinase,met proto-oncogene,hepatocyte growth factor receptor,HGFR; RCCP2; DFNB97,MET proto-oncogene; receptor tyrosine kinase,AUTS9; DA11; DFNB97; HGFR; RCCP2; c-Met,MET
P08588,ADRB1_HUMAN,ADRB1; ADRB1R; B1AR,Beta-1 adrenergic receptor; Beta-1 adrenoreceptor; Beta-1 adrenoceptor,ADRB1R; B1AR,153,adrenoceptor beta 1,adrenergic; beta-1-; receptor,,,adrenoceptor beta 1,ADRB1R; B1AR; BETA1AR; FNSS2; RHR,ADRB1
P08590,MYL3_HUMAN,MYL3,Myosin light chain 3; Cardiac myosin light chain 1; CMLC1; Myosin light chain 1; slow-twitch muscle B/ventricular isoform; MLC1SB; Ventricular myosin alkali light chain; Ventricular myosin light chain 1; VLCl; Ventricular/slow twitch myosin alkali light chain; MLC-lV/sb,,4634,myosin light chain 3,myosin; light polypeptide 3; alkali; ventricular; skeletal; slow; myosin; light chain 3; alkali; ventricular; skeletal; slow,,CMH8; VLC1; MLC1V; MLC1SB,myosin light chain 3,CMH8; MLC-lV/sb; MLC1SB; MLC1V; VLC1; VLCl,MYL3
P08621,RU17_HUMAN,SNRNP70; RNPU1Z; RPU1; SNRP70; U1AP1,U1 small nuclear ribonucleoprotein 70 kDa; U1 snRNP 70 kDa; U1-70K; snRNP70,RNPU1Z; RPU1; SNRP70; U1AP1,6625,small nuclear ribonucleoprotein U1 subunit 70,small nuclear ribonucleoprotein 70kDa (RNP antigen); small nuclear ribonucleoprotein 70kDa (U1); small nuclear ribonucleoprotein; U1 70kDa subunit,,U1-70K; Snp1,small nuclear ribonucleoprotein U1 subunit 70,RNPU1Z; RPU1; SNRP70; Snp1; U1-70K; U170K; U1AP; U1RNP,SNRNP70
P08631,HCK_HUMAN,HCK,Tyrosine-protein kinase HCK; EC 2.7.10.2; Hematopoietic cell kinase; Hemopoietic cell kinase; p59-HCK/p60-HCK; p59Hck; p61Hck,,3055,HCK proto-oncogene; Src family tyrosine kinase,hemopoietic cell kinase,,JTK9,HCK proto-oncogene; Src family tyrosine kinase,AIPCV; JTK9; p59Hck; p61Hck,HCK
P08637,FCG3A_HUMAN,FCGR3A; CD16A; FCG3; FCGR3; IGFR3,Low affinity immunoglobulin gamma Fc region receptor III-A; IgG Fc receptor III-A; CD16-II; CD16a antigen; Fc-gamma RIII-alpha; Fc-gamma RIII; Fc-gamma RIIIa; FcRIII; FcRIIIa; FcgammaRIIIA; FcR-10; IgG Fc receptor III-2; CD antigen CD16a,CD16A; FCG3; FCGR3; IGFR3,2214,Fc gamma receptor IIIa,Fc fragment of IgG; low affinity IIIa; receptor for (CD16); Fc fragment of IgG; low affinity IIIa; receptor (CD16a); Fc fragment of IgG receptor IIIa,,CD16; CD16a; FcgammaRIIIa; FcGRIIIA,Fc gamma receptor IIIa,CD16; CD16-II; CD16A; FCG3; FCGR3; FCGRIII; FCR-10; FCRIII; FCRIIIA; FcGRIIIA; IGFR3; IMD20,FCGR3A
P08670,VIME_HUMAN,VIM,Vimentin,,7431,vimentin,,,,vimentin,,VIM
P08684,CP3A4_HUMAN,CYP3A4; CYP3A3,Cytochrome P450 3A4; EC 1.14.14.1; 1;4-cineole 2-exo-monooxygenase; 1;8-cineole 2-exo-monooxygenase; EC 1.14.14.56; Albendazole monooxygenase (sulfoxide-forming; EC 1.14.14.73; Albendazole sulfoxidase; CYPIIIA3; CYPIIIA4; Cholesterol 25-hydroxylase; Cytochrome P450 3A3; Cytochrome P450 HLp; Cytochrome P450 NF-25; Cytochrome P450-PCN1; Nifedipine oxidase; Quinine 3-monooxygenase; EC 1.14.14.55,CYP3A3,1576,cytochrome P450 family 3 subfamily A member 4,cytochrome P450; subfamily IIIA (niphedipine oxidase); polypeptide 4; cytochrome P450; family 3; subfamily A; polypeptide 4,,,cytochrome P450 family 3 subfamily A member 4,CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1; VDDR3,CYP3A4
P08727,K1C19_HUMAN,KRT19,Keratin; type I cytoskeletal 19; Cytokeratin-19; CK-19; Keratin-19; K19,,3880,keratin 19,keratin 19; type I,keratin; type I cytoskeletal 19; keratin; type I; 40-kd; cytokeratin 19; 40-kDa keratin intermediate filament,K19; CK19; K1CS; MGC15366,keratin 19,CK19; K19; K1CS,KRT19
P08754,GNAI3_HUMAN,GNAI3,Guanine nucleotide-binding protein G(i) subunit alpha-3; i; G(i,,2773,G protein subunit alpha i3,guanine nucleotide binding protein (G protein); alpha inhibiting activity polypeptide 3,Guanine nucleotide-binding protein G(k) subunit alpha,87U6,G protein subunit alpha i3,87U6; ARCND1; ARCODS; HG1A,GNAI3
P08833,IBP1_HUMAN,IGFBP1; IBP1,Insulin-like growth factor-binding protein 1; IBP-1; IGF-binding protein 1; IGFBP-1; Placental protein 12; PP12,IBP1,3484,insulin like growth factor binding protein 1,insulin-like growth factor binding protein 1,placental protein 12; amniotic fluid binding protein; alpha-pregnancy-associated endometrial globulin; growth hormone independent-binding protein; binding protein-28; binding protein-26; binding protein-25; IGF-binding protein 1,IGF-BP25; AFBP; hIGFBP-1; PP12,insulin like growth factor binding protein 1,AFBP; IBP1; IGF-BP25; PP12; hIGFBP-1,IGFBP1
P08922,ROS1_HUMAN,ROS1; MCF3; ROS,Proto-oncogene tyrosine-protein kinase ROS; EC 2.7.10.1; Proto-oncogene c-Ros; Proto-oncogene c-Ros-1; Receptor tyrosine kinase c-ros oncogene 1; c-Ros receptor tyrosine kinase,MCF3; ROS,6098,ROS proto-oncogene 1; receptor tyrosine kinase,v-ros avian UR2 sarcoma virus oncogene homolog 1; v-ros UR2 sarcoma virus oncogene homolog 1 (avian); c-ros oncogene 1 ; receptor tyrosine kinase,,MCF3; ROS; c-ros-1,ROS proto-oncogene 1; receptor tyrosine kinase,MCF3; ROS; c-ros-1,ROS1
P09038,FGF2_HUMAN,FGF2; FGFB,Fibroblast growth factor 2; FGF-2; Basic fibroblast growth factor; bFGF; Heparin-binding growth factor 2; HBGF-2,FGFB,2247,fibroblast growth factor 2,fibroblast growth factor 2 (basic),,,fibroblast growth factor 2,BFGF; FGF-2; FGFB; HBGF-2,FGF2
P09211,GSTP1_HUMAN,GSTP1; FAEES3; GST3,Glutathione S-transferase P; EC 2.5.1.18; GST class-pi; GSTP1-1,FAEES3; GST3,2950,glutathione S-transferase pi 1,,,GSTP,glutathione S-transferase pi 1,DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI,GSTP1
P09327,VILI_HUMAN,VIL1; VIL,Villin-1,VIL,7429,villin 1,,,D2S1471,villin 1,D2S1471; VIL,VIL1
P09467,F16P1_HUMAN,FBP1; FBP,Fructose-1;6-bisphosphatase 1; FBPase 1; EC 3.1.3.11; D-fructose-1;6-bisphosphate 1-phosphohydrolase 1; Liver FBPase,FBP,2203,fructose-bisphosphatase 1,fructose-1;6-bisphosphatase 1,,,fructose-bisphosphatase 1,FBP,FBP1
P09471,GNAO_HUMAN,GNAO1,Guanine nucleotide-binding protein G(o) subunit alpha; o; EC 3.6.5.-,,2775,G protein subunit alpha o1,guanine nucleotide binding protein (G protein); alpha activating activity polypeptide O,,G-ALPHA-o,G protein subunit alpha o1,DEE17; EIEE17; G-ALPHA-o; GNAO; HG1G; HLA-DQB1; NEDIM,GNAO1
P09493,TPM1_HUMAN,TPM1; C15orf13; TMSA,Tropomyosin alpha-1 chain; Alpha-tropomyosin; Tropomyosin-1,C15orf13; TMSA,7168,tropomyosin 1,chromosome 15 open reading frame 13; cardiomyopathy; hypertrophic 3; tropomyosin 1 (alpha),,,tropomyosin 1,C15orf13; CMD1Y; CMH3; HEL-S-265; HTM-alpha; LVNC9; TMSA,TPM1
P09497,CLCB_HUMAN,CLTB,Clathrin light chain B; Lcb,,1212,clathrin light chain B,clathrin; light polypeptide (Lcb); clathrin; light chain B,,Lcb,clathrin light chain B,LCB,CLTB
P09544,WNT2_HUMAN,WNT2; INT1L1; IRP,Protein Wnt-2; Int-1-like protein 1; Int-1-related protein; IRP,INT1L1; IRP,7472,Wnt family member 2,wingless-type MMTV integration site family member 2,secreted growth factor,IRP,Wnt family member 2,INT1L1; IRP,WNT2
P09601,HMOX1_HUMAN,HMOX1; HO; HO1,Heme oxygenase 1; HO-1; EC 1.14.14.18,HO; HO1,3162,heme oxygenase 1,heme oxygenase (decycling) 1,,bK286B10; HO-1,heme oxygenase 1,HMOX1D; HO-1; HSP32; bK286B10,HMOX1
P09619,PGFRB_HUMAN,PDGFRB; PDGFR; PDGFR1,Platelet-derived growth factor receptor beta; PDGF-R-beta; PDGFR-beta; EC 2.7.10.1; Beta platelet-derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; Platelet-derived growth factor receptor 1; PDGFR-1; CD antigen CD140b,PDGFR; PDGFR1,5159,platelet derived growth factor receptor beta,platelet-derived growth factor receptor; beta polypeptide,,JTK12; CD140b; PDGFR1,platelet derived growth factor receptor beta,CD140B; IBGC4; IMF1; JTK12; KOGS; OPDKD; PDGFR; PDGFR-1; PDGFR1; PENTT,PDGFRB
P09622,DLDH_HUMAN,DLD; GCSL; LAD; PHE3,Dihydrolipoyl dehydrogenase; mitochondrial; EC 1.8.1.4; Dihydrolipoamide dehydrogenase; Glycine cleavage system L protein,GCSL; LAD; PHE3,1738,dihydrolipoamide dehydrogenase,dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex; 2-oxo-glutarate complex; branched chain keto acid dehydrogenase complex),pyruvate dehydrogenase complex subunit E3; 2-oxo-glutarate complex; branched chain keto acid dehydrogenase complex; glycine cleavage system protein L,DLDH; E3; OGDC-E3,dihydrolipoamide dehydrogenase,DLDD; DLDH; E3; GCSL; LAD; OGDC-E3; PHE3,DLD
P09629,HXB7_HUMAN,HOXB7; HOX2C,Homeobox protein Hox-B7; Homeobox protein HHO.C1; Homeobox protein Hox-2C,HOX2C,3217,homeobox B7,homeo box B7,,,homeobox B7,HHO.C1; HOX2; HOX2C; Hox-2.3,HOXB7
P09651,ROA1_HUMAN,HNRNPA1; HNRPA1,Heterogeneous nuclear ribonucleoprotein A1; hnRNP A1; Helix-destabilizing protein; Single-strand RNA-binding protein; hnRNP core protein A1,HNRPA1,3178,heterogeneous nuclear ribonucleoprotein A1,,,hnRNP-A1; ALS20,heterogeneous nuclear ribonucleoprotein A1,ALS19; ALS20; HNRPA1; HNRPA1L3; IBMPFD3; MPD3; UP 1; hnRNP A1; hnRNP-A1,HNRNPA1
P09693,CD3G_HUMAN,CD3G; T3G,T-cell surface glycoprotein CD3 gamma chain; T-cell receptor T3 gamma chain; CD antigen CD3g,T3G,917,CD3 gamma subunit of T-cell receptor complex,CD3g antigen; gamma polypeptide (TiT3 complex); CD3g molecule; gamma (CD3-TCR complex); CD3g molecule,T-cell surface glycoprotein CD3 gamma chain,CD3-GAMMA; CD3GAMMA,CD3 gamma subunit of T-cell receptor complex,CD3-GAMMA; CD3GAMMA; IMD17; T3G,CD3G
P09758,TACD2_HUMAN,TACSTD2; GA733-1; M1S1; TROP2,Tumor-associated calcium signal transducer 2; Cell surface glycoprotein Trop-2; Membrane component chromosome 1 surface marker 1; Pancreatic carcinoma marker protein GA733-1,GA733-1; M1S1; TROP2,4070,tumor associated calcium signal transducer 2,membrane component chromosome 1 surface marker 1,epithelial glycoprotein-1; trophoblast cell surface antigen 2,TROP2; GA733-1; EGP-1,tumor associated calcium signal transducer 2,EGP-1; EGP1; GA733-1; GA7331; GP50; M1S1; TROP2,TACSTD2
P09769,FGR_HUMAN,FGR; SRC2,Tyrosine-protein kinase Fgr; EC 2.7.10.2; Gardner-Rasheed feline sarcoma viral (v-fgr; Proto-oncogene c-Fgr; p55-Fgr; p58-Fgr; p58c-Fgr,SRC2,2268,FGR proto-oncogene; Src family tyrosine kinase,Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog; v-fgr feline Gardner-Rasheed sarcoma viral oncogene homolog; feline Gardner-Rasheed sarcoma viral oncogene homolog,,c-fgr; p55c-fgr,FGR proto-oncogene; Src family tyrosine kinase,SRC2; c-fgr; c-src2; p55-Fgr; p55c-fgr; p58-Fgr; p58c-fgr,FGR
P09874,PARP1_HUMAN,PARP1; ADPRT; PPOL,Poly ADP-ribose polymerase 1; PARP-1; EC 2.4.2.30; ADP-ribosyltransferase diphtheria toxin-like 1; ARTD1; DNA ADP-ribosyltransferase PARP1; EC 2.4.2.-; NAD(+; ADPRT 1; PolyADP-ribose synthase 1; Protein poly-ADP-ribosyltransferase PARP1; EC 2.4.2.-; Poly ADP-ribose polymerase 1; 89-kDa form; NT-PARP-1; Poly ADP-ribose polymerase 1; 24-kDa form; Poly ADP-ribose polymerase 1; 28-kDa form,ADPRT; PPOL,142,poly(ADP-ribose) polymerase 1,ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase); poly (ADP-ribose) polymerase family; member 1,,PARP; ARTD1; Poly-PARP; PARS,poly(ADP-ribose) polymerase 1,ADPRT; ADPRT 1; ADPRT1; ARTD1; PARP; PARP-1; PARS; PPOL; Poly-PARP; pADPRT-1,PARP1
P09917,LOX5_HUMAN,ALOX5; LOG5,Polyunsaturated fatty acid 5-lipoxygenase; EC 1.13.11.-; Arachidonate 5-lipoxygenase; 5-LO; 5-lipoxygenase; EC 1.13.11.34,LOG5,240,arachidonate 5-lipoxygenase,,,5-LOX,arachidonate 5-lipoxygenase,5-LO; 5-LOX; 5LPG; LOG5,ALOX5
P09923,PPBI_HUMAN,ALPI,Intestinal-type alkaline phosphatase; IAP; Intestinal alkaline phosphatase; EC 3.1.3.1,,248,alkaline phosphatase; intestinal,,intestinal alkaline phosphatase,IAP,alkaline phosphatase; intestinal,IAP,ALPI
P09958,FURIN_HUMAN,FURIN; FUR; PACE; PCSK3,Furin; EC 3.4.21.75; Dibasic-processing enzyme; Paired basic amino acid residue-cleaving enzyme; PACE,FUR; PACE; PCSK3,5045,furin; paired basic amino acid cleaving enzyme,paired basic amino acid cleaving enzyme (furin; membrane associated receptor protein); furin (paired basic amino acid cleaving enzyme),proprotein convertase subtilisin/kexin 3; subtilisin-like proprotein convertase 1,SPC1,furin; paired basic amino acid cleaving enzyme,FUR; PACE; PCSK3; SPC1,FURIN
P0C0S8,H2A1_HUMAN,H2AC11; H2AFP; HIST1H2AG;; H2AC13; H2AFC; HIST1H2AI;; H2AC15; H2AFD; HIST1H2AK;; H2AC16; H2AFI; HIST1H2AL;; H2AC17; H2AFN; HIST1H2AM,Histone H2A type 1; H2A.1; Histone H2A/ptl,H2AFP; HIST1H2AG;; H2AFC; HIST1H2AI;; H2AFD; HIST1H2AK;; H2AFI; HIST1H2AL;; H2AFN; HIST1H2AM,8329,H2A clustered histone 11,H2A histone family; member P; histone 1; H2ag; histone cluster 1; H2ag; histone cluster 1 H2A family member g,,pH2A/f; H2A/p; H2A.1b,H2A clustered histone 13,H2A/c; H2AC11; H2AC15; H2AC16; H2AC17; H2AFC; HIST1H2AI,H2AC11; H2AC13; H2AC15; H2AC16; H2AC17
P0C1S8,WEE2_HUMAN,WEE2; WEE1B,Wee1-like protein kinase 2; EC 2.7.10.2; Wee1-like protein kinase 1B; Wee1B kinase,WEE1B,494551,WEE2 oocyte meiosis inhibiting kinase,WEE1 homolog 2 (S. pombe); WEE1 homolog 2,,FLJ16107; WEE1B,WEE2 oocyte meiosis inhibiting kinase,OOMD5; OZEMA5; WEE1B,WEE2
P0C1Z6,TFPT_HUMAN,TFPT; INO80F,TCF3 fusion partner; INO80 complex subunit F; Protein FB1,INO80F,29844,TCF3 fusion partner,TCF3 (E2A) fusion partner (in childhood Leukemia),amida; partner of the E2A; INO80 complex subunit F,FB1; amida; INO80F,TCF3 fusion partner,FB1; INO80F; amida,TFPT
P0C869,PA24B_HUMAN,PLA2G4B,Cytosolic phospholipase A2 beta; cPLA2-beta; EC 3.1.1.4; Lysophospholipase A1 group IVB; EC 3.1.1.5; Phospholipase A2 group IVB,,100137049,phospholipase A2 group IVB,phospholipase A2; group IVB (cytosolic),,cPLA2-beta; HsT16992,phospholipase A2 group IVB,HsT16992; cPLA2-beta,PLA2G4B
P0DMV8,HS71A_HUMAN,HSPA1A; HSP72; HSPA1; HSX70,Heat shock 70 kDa protein 1A; Heat shock 70 kDa protein 1; HSP70-1; HSP70.1; Heat shock protein family A member 1A,HSP72; HSPA1; HSX70,3303,heat shock protein family A (Hsp70) member 1A,heat shock 70kD protein 1A; heat shock 70kDa protein 1A,,HSP70-1,heat shock protein family A (Hsp70) member 1A,HEL-S-103; HSP70; HSP70-1; HSP70-1A; HSP70-2; HSP70.1; HSP70.2; HSP70I; HSP72; HSPA1,HSPA1A
P0DP23,CALM1_HUMAN,CALM1; CALM; CAM; CAM1,Calmodulin-1,CALM; CAM; CAM1,801,calmodulin 1,calmodulin 1 (phosphorylase kinase; delta),prepro-calmodulin 1; phosphorylase kinase subunit delta; phosphorylase kinase subunit delta 1,CAMI; PHKD; DD132; PHKD1,calmodulin 1,CALML2; CAM2; CAM3; CAMB; CAMC; CAMI; CAMIII; CPVT4; DD132; LQT14; PHKD; PHKD1; caM,CALM1
P0DP24,CALM2_HUMAN,CALM2; CAM2; CAMB,Calmodulin-2,CAM2; CAMB,801,calmodulin 2,calmodulin 2 (phosphorylase kinase; delta),prepro-calmodulin 2; phosphorylase kinase subunit delta; phosphorylase kinase subunit delta 2,PHKD; PHKD2; CAMII,calmodulin 1,CALML2; CAM2; CAM3; CAMB; CAMC; CAMI; CAMIII; CPVT4; DD132; LQT14; PHKD; PHKD1; caM,CALM2
P0DP25,CALM3_HUMAN,CALM3; CALML2; CAM3; CAMC; CAMIII,Calmodulin-3,CALML2; CAM3; CAMC; CAMIII,801,calmodulin 3,calmodulin 3 (phosphorylase kinase; delta),prepro-calmodulin 3; phosphorylase kinase subunit delta; phosphorylase kinase subunit delta 3,PHKD; PHKD3,calmodulin 1,CALML2; CAM2; CAM3; CAMB; CAMC; CAMI; CAMIII; CPVT4; DD132; LQT14; PHKD; PHKD1; caM,CALM3
P10070,GLI2_HUMAN,GLI2; THP,Zinc finger protein GLI2; GLI family zinc finger protein 2; Tax helper protein,THP,2736,GLI family zinc finger 2,GLI-Kruppel family member GLI2; glioma-associated oncogene family zinc finger 2,tax-responsive element-2 holding protein; tax helper protein 1; tax helper protein 2,THP2; HPE9; THP1,GLI family zinc finger 2,CJS; HPE9; PHS2; THP1; THP2,GLI2
P10071,GLI3_HUMAN,GLI3,Transcriptional activator GLI3; GLI3 form of 190 kDa; GLI3-190; GLI3 full-length protein; GLI3FL; GLI3 C-terminally truncated form; GLI3 form of 83 kDa; GLI3-83,,2737,GLI family zinc finger 3,Greig cephalopolysyndactyly syndrome; GLI-Kruppel family member GLI3; glioma-associated oncogene family zinc finger 3,zinc finger protein GLI3; oncogene GLI3; DNA-binding protein,PAP-A; PAPA; PAPA1; PAPB; ACLS; PPDIV,GLI family zinc finger 3,ACLS; GCPS; GLI3-190; GLI3FL; PAP-A; PAPA; PAPA1; PAPB; PHS; PPDIV,GLI3
P10242,MYB_HUMAN,MYB,Transcriptional activator Myb; Proto-oncogene c-Myb,,4602,MYB proto-oncogene; transcription factor,v-myb avian myeloblastosis viral oncogene homolog,,c-myb,MYB proto-oncogene; transcription factor,Cmyb; c-myb; c-myb_CDS; efg,MYB
P10243,MYBA_HUMAN,MYBL1; AMYB,Myb-related protein A; A-Myb; Myb-like protein 1,AMYB,4603,MYB proto-oncogene like 1,v-myb avian myeloblastosis viral oncogene homolog-like 1,,AMYB; A-myb,MYB proto-oncogene like 1,A-MYB; AMYB,MYBL1
P10244,MYBB_HUMAN,MYBL2; BMYB,Myb-related protein B; B-Myb; Myb-like protein 2,BMYB,4605,MYB proto-oncogene like 2,v-myb avian myeloblastosis viral oncogene homolog-like 2,,BMYB; B-MYB,MYB proto-oncogene like 2,B-MYB; BMYB,MYBL2
P10275,ANDR_HUMAN,AR; DHTR; NR3C4,Androgen receptor; Dihydrotestosterone receptor; Nuclear receptor subfamily 3 group C member 4,DHTR; NR3C4,367,androgen receptor,dihydrotestosterone receptor; spinal and bulbar muscular atrophy,testicular feminization; Kennedy disease,AIS; NR3C4; SMAX1; HUMARA,androgen receptor,AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM,AR
P10276,RARA_HUMAN,RARA; NR1B1,Retinoic acid receptor alpha; RAR-alpha; Nuclear receptor subfamily 1 group B member 1,NR1B1,5914,retinoic acid receptor alpha,retinoic acid receptor; alpha,,RAR; NR1B1; RARalpha; RAR-alpha,retinoic acid receptor alpha,NR1B1; RAR; RARalpha,RARA
P10301,RRAS_HUMAN,RRAS,Ras-related protein R-Ras; EC 3.6.5.-; p23,,6237,RAS related,related RAS viral (r-ras) oncogene homolog,Oncogene RRAS,R-Ras; RRAS1,RAS related,R-Ras; RRAS1,RRAS
P10398,ARAF_HUMAN,ARAF; ARAF1; PKS; PKS2,Serine/threonine-protein kinase A-Raf; EC 2.7.11.1; Proto-oncogene A-Raf; Proto-oncogene A-Raf-1; Proto-oncogene Pks,ARAF1; PKS; PKS2,369,A-Raf proto-oncogene; serine/threonine kinase,v-raf murine sarcoma 3611 viral oncogene homolog 1,,A-Raf,A-Raf proto-oncogene; serine/threonine kinase,A-RAF; ARAF1; PKS2; RAFA1,ARAF
P10412,H14_HUMAN,H1-4; H1F4; HIST1H1E,Histone H1.4; Histone H1b; Histone H1s-4,H1F4; HIST1H1E,3008,H1.4 linker histone; cluster member,H1 histone family; member 4; histone 1; H1e; histone cluster 1; H1e; histone cluster 1 H1 family member e,,H1.4; H1e; H1s-4,H1.4 linker histone; cluster member,H1.4; H1E; H1F4; H1s-4; HIST1H1E; RMNS; dJ221C16.5,H1-4
P10415,BCL2_HUMAN,BCL2,Apoptosis regulator Bcl-2,,596,BCL2 apoptosis regulator,B-cell CLL/lymphoma 2; BCL2; apoptosis regulator,protein phosphatase 1; regulatory subunit 50,Bcl-2; PPP1R50,BCL2 apoptosis regulator,Bcl-2; PPP1R50,BCL2
P10586,PTPRF_HUMAN,PTPRF; LAR,Receptor-type tyrosine-protein phosphatase F; EC 3.1.3.48; Leukocyte common antigen related; LAR,LAR,5792,protein tyrosine phosphatase receptor type F,,leukocyte antigen-related tyrosine phosphatase; leukocyte common antigen related,,protein tyrosine phosphatase receptor type F,BNAH2; LAR,PTPRF
P10588,NR2F6_HUMAN,NR2F6; EAR2; ERBAL2,Nuclear receptor subfamily 2 group F member 6; V-erbA-related protein 2; EAR-2,EAR2; ERBAL2,2063,nuclear receptor subfamily 2 group F member 6,nuclear receptor subfamily 2; group F; member 6,,EAR-2; EAR2,nuclear receptor subfamily 2 group F member 6,EAR-2; EAR2; ERBAL2,NR2F6
P10599,THIO_HUMAN,TXN; TRDX; TRX; TRX1,Thioredoxin; Trx; ATL-derived factor; ADF; Surface-associated sulphydryl protein; SASP; allergen Hom s Trx,TRDX; TRX; TRX1,7295,thioredoxin,,,TRX; Trx80; TXN1,thioredoxin,TRDX; TRX; TRX1; TXN1; Trx80,TXN
P10636,TAU_HUMAN,MAPT; MAPTL; MTBT1; TAU,Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau,MAPTL; MTBT1; TAU,4137,microtubule associated protein tau,,G protein beta1/gamma2 subunit-interacting factor 1; microtubule-associated protein tau; isoform 4; protein phosphatase 1; regulatory subunit 103; Tau-derived paired helical filament hexapeptide,MTBT1; tau; PPND; FTDP-17; TAU; MSTD; MTBT2; FLJ31424; MGC138549; PPP1R103; tau-40; Tau-PHF6,microtubule associated protein tau,DDPAC; FTD1; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU; Tau-PHF6; tau-40,MAPT
P10644,KAP0_HUMAN,PRKAR1A; PKR1; PRKAR1; TSE1,cAMP-dependent protein kinase type I-alpha regulatory subunit; Tissue-specific extinguisher 1; TSE1,PKR1; PRKAR1; TSE1,5573,protein kinase cAMP-dependent type I regulatory subunit alpha,tissue specific extinguisher 1; protein kinase; cAMP-dependent; regulatory; type I; alpha; protein kinase; cAMP-dependent; regulatory subunit type I alpha,Carney complex type 1,CNC1,protein kinase cAMP-dependent type I regulatory subunit alpha,ACRDYS1; ADOHR; CAR; CNC; CNC1; PKR1; PPNAD1; PRKAR1; Prkar1alpha; TSE1,PRKAR1A
P10646,TFPI1_HUMAN,TFPI; LACI; TFPI1,Tissue factor pathway inhibitor; TFPI; Extrinsic pathway inhibitor; EPI; Lipoprotein-associated coagulation inhibitor; LACI,LACI; TFPI1,7035,tissue factor pathway inhibitor,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),extrinsic pathway inhibitor,EPI; TFI; TFPI1,tissue factor pathway inhibitor,EPI; LACI; TFI; TFPI1,TFPI
P10721,KIT_HUMAN,KIT; SCFR,Mast/stem cell growth factor receptor Kit; SCFR; EC 2.7.10.1; Piebald trait protein; PBT; Proto-oncogene c-Kit; Tyrosine-protein kinase Kit; p145 c-kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD antigen CD117,SCFR,3815,KIT proto-oncogene; receptor tyrosine kinase,piebald trait; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,mast/stem cell growth factor receptor Kit,CD117; SCFR; C-Kit,KIT proto-oncogene; receptor tyrosine kinase,C-Kit; CD117; MASTC; PBT; SCFR,KIT
P10747,CD28_HUMAN,CD28,T-cell-specific surface glycoprotein CD28; TP44; CD antigen CD28,,940,CD28 molecule,CD28 antigen (Tp44),T-cell-specific surface glycoprotein,,CD28 molecule,IMD123; Tp44,CD28
P10828,THB_HUMAN,THRB; ERBA2; NR1A2; THR1,Thyroid hormone receptor beta; Nuclear receptor subfamily 1 group A member 2; c-erbA-2; c-erbA-beta,ERBA2; NR1A2; THR1,7068,thyroid hormone receptor beta,thyroid hormone receptor; beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog 2); pituitary resistance to thyroid hormone; thyroid hormone receptor; beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2; avian); thyroid hormone receptor; beta,avian erythroblastic leukemia viral (v-erb-a) oncogene homolog 2; oncogene ERBA2; generalized resistance to thyroid hormone; thyroid hormone receptor beta 1; nuclear receptor subfamily 1 group A member 2,THRB1; THRB2; NR1A2; THR1; ERBA-BETA; GRTH; TRbeta; TRb; c-erbA-beta; c-erbA-2; THRbeta; TRbeta1; THRbeta1; Thrbeta2,thyroid hormone receptor beta,C-ERBA-2; C-ERBA-BETA; ERBA2; GRTH; NR1A2; PRTH; THR1; THRB1; THRB2; THRbeta; THRbeta1; TRb; TRbeta; TRbeta1; Thrbeta2,THRB
P10912,GHR_HUMAN,GHR,Growth hormone receptor; GH receptor; Somatotropin receptor; GH-binding protein; GHBP; Serum-binding protein,,2690,growth hormone receptor,,growth hormone binding protein,GHBP,growth hormone receptor,GHBP; GHIP,GHR
P10914,IRF1_HUMAN,IRF1,Interferon regulatory factor 1; IRF-1,,3659,interferon regulatory factor 1,,interferon regulatory factor-1,MAR,interferon regulatory factor 1,IMD117; IRF-1; MAR,IRF1
P10916,MLRV_HUMAN,MYL2; MLC2,Myosin regulatory light chain 2; ventricular/cardiac muscle isoform; MLC-2; MLC-2v; Cardiac myosin light chain 2; Myosin light chain 2; slow skeletal/ventricular muscle isoform; MLC-2s/v; Ventricular myosin light chain 2,MLC2,4633,myosin light chain 2,myosin; light polypeptide 2; regulatory; cardiac; slow; myosin; light chain 2; regulatory; cardiac; slow,cardiac ventricular myosin light chain 2,CMH10,myosin light chain 2,CMH10; MFM12; MLC-2; MLC-2s/v; MLC-2v; MLC2,MYL2
P11021,BIP_HUMAN,HSPA5; GRP78,Endoplasmic reticulum chaperone BiP; EC 3.6.4.10; 78 kDa glucose-regulated protein; GRP-78; Binding-immunoglobulin protein; BiP; Heat shock protein 70 family protein 5; HSP70 family protein 5; Heat shock protein family A member 5; Immunoglobulin heavy chain-binding protein,GRP78,3309,heat shock protein family A (Hsp70) member 5,heat shock 70kD protein 5 (glucose-regulated protein; 78kD); heat shock 70kDa protein 5 (glucose-regulated protein; 78kDa),glucose-regulated protein; 78kDa,BiP,heat shock protein family A (Hsp70) member 5,BIP; GRP78; HEL-S-89n,HSPA5
P11047,LAMC1_HUMAN,LAMC1; LAMB2,Laminin subunit gamma-1; Laminin B2 chain; Laminin-1 subunit gamma; Laminin-10 subunit gamma; Laminin-11 subunit gamma; Laminin-2 subunit gamma; Laminin-3 subunit gamma; Laminin-4 subunit gamma; Laminin-6 subunit gamma; Laminin-7 subunit gamma; Laminin-8 subunit gamma; Laminin-9 subunit gamma; S-laminin subunit gamma; S-LAM gamma,LAMB2,3915,laminin subunit gamma 1,laminin; gamma 1 (formerly LAMB2),Laminin B2 chain,,laminin subunit gamma 1,LAMB2,LAMC1
P11137,MTAP2_HUMAN,MAP2,Microtubule-associated protein 2; MAP-2,,4133,microtubule associated protein 2,,,MAP2A; MAP2B; MAP2C,microtubule associated protein 2,MAP-2; MAP2A; MAP2B; MAP2C,MAP2
P11171,EPB41_HUMAN,EPB41; E41P,Protein 4.1; P4.1; 4.1R; Band 4.1; EPB4.1; Erythrocyte membrane protein band 4.1,E41P,2035,erythrocyte membrane protein band 4.1,elliptocytosis 1; RH-linked,,4.1R,erythrocyte membrane protein band 4.1,4.1R; EL1; HE,EPB41
P11177,ODPB_HUMAN,PDHB; PHE1B,Pyruvate dehydrogenase E1 component subunit beta; mitochondrial; PDHE1-B; EC 1.2.4.1,PHE1B,5162,pyruvate dehydrogenase E1 subunit beta,pyruvate dehydrogenase (lipoamide) beta,,PDHE1B; E1beta,pyruvate dehydrogenase E1 subunit beta,E1beta; PDHBD; PDHE1-B; PDHE1B; PHE1B,PDHB
P11216,PYGB_HUMAN,PYGB,Glycogen phosphorylase; brain form; EC 2.4.1.1,,5834,glycogen phosphorylase B,phosphorylase; glycogen; brain,glycogen phosphorylase; brain form,,glycogen phosphorylase B,GPBB,PYGB
P11217,PYGM_HUMAN,PYGM,Glycogen phosphorylase; muscle form; EC 2.4.1.1; Myophosphorylase,,5837,glycogen phosphorylase; muscle associated,phosphorylase; glycogen; muscle,McArdle syndrome; glycogen storage disease type V; glycogen phosphorylase; muscle form; myophosphorylase,GSD5,glycogen phosphorylase; muscle associated,GSD5,PYGM
P11233,RALA_HUMAN,RALA; RAL,Ras-related protein Ral-A; EC 3.6.5.2,RAL,5898,RAS like proto-oncogene A,v-ral simian leukemia viral oncogene homolog A (ras related),RAS-like protein A; Ras-related protein Ral-A; Ras family small GTP binding protein RALA; ras related GTP binding protein A,,RAS like proto-oncogene A,HINCONS; RAL,RALA
P11234,RALB_HUMAN,RALB,Ras-related protein Ral-B; EC 3.6.5.2,,5899,RAS like proto-oncogene B,v-ral simian leukemia viral oncogene homolog B,ras related GTP binding protein B,,RAS like proto-oncogene B,,RALB
P11274,BCR_HUMAN,BCR; BCR1; D22S11,Breakpoint cluster region protein; EC 2.7.11.1; Renal carcinoma antigen NY-REN-26,BCR1; D22S11,613,BCR activator of RhoGEF and GTPase,breakpoint cluster region; BCR; RhoGEF and GTPase activating protein,,D22S662; CML; PHL; ALL,BCR activator of RhoGEF and GTPase,ALL; BCR1; CML; D22S11; D22S662; PHL,BCR
P11308,ERG_HUMAN,ERG,Transcriptional regulator ERG; Transforming protein ERG,,2078,ETS transcription factor ERG,v-ets avian erythroblastosis virus E26 oncogene related; v-ets avian erythroblastosis virus E26 oncogene homolog,transcriptional regulator ERG (transforming protein ERG); v-ets erythroblastosis virus E26 oncogene like; TMPRSS2-ERG prostate cancer specific; ETS-related gene,erg-3; p55,ETS transcription factor ERG,LMPHM14; erg-3; p55,ERG
P11309,PIM1_HUMAN,PIM1,Serine/threonine-protein kinase pim-1; EC 2.7.11.1,,5292,Pim-1 proto-oncogene; serine/threonine kinase,pim-1 oncogene,,,Pim-1 proto-oncogene; serine/threonine kinase,PIM,PIM1
P11362,FGFR1_HUMAN,FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR,Fibroblast growth factor receptor 1; FGFR-1; EC 2.7.10.1; Basic fibroblast growth factor receptor 1; BFGFR; bFGF-R-1; Fms-like tyrosine kinase 2; FLT-2; N-sam; Proto-oncogene c-Fgr; CD antigen CD331,BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR,2260,fibroblast growth factor receptor 1,fms-related tyrosine kinase 2,Pfeiffer syndrome,H2; H3; H4; H5; CEK; FLG; BFGFR; N-SAM; CD331,fibroblast growth factor receptor 1,BFGFR; CD331; CEK; ECCL; FGFBR; FGFR-1; FLG; FLT-2; FLT2; HBGFR; HH2; HRTFDS; KAL2; N-SAM; OGD; bFGF-R-1,FGFR1
P11387,TOP1_HUMAN,TOP1,DNA topoisomerase 1; EC 5.6.2.1; DNA topoisomerase I,,7150,DNA topoisomerase I,topoisomerase (DNA) I,Scl-70 antigen,,DNA topoisomerase I,TOPI,TOP1
P11388,TOP2A_HUMAN,TOP2A; TOP2,DNA topoisomerase 2-alpha; EC 5.6.2.2; DNA topoisomerase II; alpha isozyme,TOP2,7153,DNA topoisomerase II alpha,topoisomerase (DNA) II alpha 170kDa,,TOP2alpha; TOPIIA,DNA topoisomerase II alpha,TOP2; TOP2alpha; TOPIIA; TP2A,TOP2A
P11413,G6PD_HUMAN,G6PD,Glucose-6-phosphate 1-dehydrogenase; G6PD; EC 1.1.1.49,,2539,glucose-6-phosphate dehydrogenase,,,G6PD1,glucose-6-phosphate dehydrogenase,CNSHA1; G6PD1,G6PD
P11473,VDR_HUMAN,VDR; NR1I1,Vitamin D3 receptor; VDR; 1;25-dihydroxyvitamin D3 receptor; Nuclear receptor subfamily 1 group I member 1,NR1I1,7421,vitamin D receptor,vitamin D (1;25- dihydroxyvitamin D3) receptor,protein phosphatase 1; regulatory subunit 163; 1;25- dihydroxyvitamin D3 receptor,NR1I1; PPP1R163,vitamin D receptor,NR1I1; PPP1R163,VDR
P11488,GNAT1_HUMAN,GNAT1; GNATR,Guanine nucleotide-binding protein G(t) subunit alpha-1; t; Transducin alpha-1 chain,GNATR,2779,G protein subunit alpha transducin 1,guanine nucleotide binding protein (G protein); alpha transducing activity polypeptide 1,,CSNBAD3,G protein subunit alpha transducin 1,CSNB1G; CSNBAD3; GBT1; GNATR; HG1F,GNAT1
P11511,CP19A_HUMAN,CYP19A1; ARO1; CYAR; CYP19,Aromatase; EC 1.14.14.14; CYPXIX; Cytochrome P-450AROM; Cytochrome P450 19A1; Estrogen synthase,ARO1; CYAR; CYP19,1588,cytochrome P450 family 19 subfamily A member 1,cytochrome P450; subfamily XIX (aromatization of androgens); cytochrome P450; family 19; subfamily A; polypeptide 1,,ARO; P-450AROM; CPV1; ARO1; CYAR; aromatase,cytochrome P450 family 19 subfamily A member 1,ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM,CYP19A1
P11717,MPRI_HUMAN,IGF2R; MPRI,Cation-independent mannose-6-phosphate receptor; CI Man-6-P receptor; CI-MPR; M6PR; 300 kDa mannose 6-phosphate receptor; MPR 300; Insulin-like growth factor 2 receptor; Insulin-like growth factor II receptor; IGF-II receptor; M6P/IGF2 receptor; M6P/IGF2R; CD antigen CD222,MPRI,3482,insulin like growth factor 2 receptor,insulin-like growth factor 2 receptor,cation-independent mannose-6 phosphate receptor,CD222; MPRI; MPR1; CIMPR; M6P-R; CI-M6PR; CI-MPR; MPR300,insulin like growth factor 2 receptor,CD222; CI-M6PR; CIMPR; M6P-R; M6P/IGF2R; MPR 300; MPR1; MPR300; MPRI,IGF2R
P11802,CDK4_HUMAN,CDK4,Cyclin-dependent kinase 4; EC 2.7.11.22; Cell division protein kinase 4; PSK-J3,,1019,cyclin dependent kinase 4,,,PSK-J3,cyclin dependent kinase 4,CMM3; PSK-J3,CDK4
P11831,SRF_HUMAN,SRF,Serum response factor; SRF,,6722,serum response factor,,minichromosome maintenance 1 homolog (S. cerevisiae); c-fos serum response element-binding transcription factor,MCM1,serum response factor,MCM1,SRF
P11908,PRPS2_HUMAN,PRPS2,Ribose-phosphate pyrophosphokinase 2; EC 2.7.6.1; PPRibP; Phosphoribosyl pyrophosphate synthase II; PRS-II,,5634,phosphoribosyl pyrophosphate synthetase 2,,PRS II; ribose-phosphate diphosphokinase 2,,phosphoribosyl pyrophosphate synthetase 2,PRSII,PRPS2
P11912,CD79A_HUMAN,CD79A; IGA; MB1,B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein; CD antigen CD79a,IGA; MB1,973,CD79a molecule,CD79A antigen (immunoglobulin-associated alpha); CD79a molecule; immunoglobulin-associated alpha,B-cell antigen receptor complex-associated protein alpha chain,MB-1; Ig-alpha; MB1; IGAlpha,CD79a molecule,IGA; IGAlpha; MB-1; MB1,CD79A
P12004,PCNA_HUMAN,PCNA,Proliferating cell nuclear antigen; PCNA; Cyclin,,5111,proliferating cell nuclear antigen,,,,proliferating cell nuclear antigen,ATLD2,PCNA
P12036,NFH_HUMAN,NEFH; KIAA0845; NFH,Neurofilament heavy polypeptide; NF-H; 200 kDa neurofilament protein; Neurofilament triplet H protein,KIAA0845; NFH,4744,neurofilament heavy chain,neurofilament; heavy polypeptide 200kDa; neurofilament heavy polypeptide; neurofilament heavy,,NF-H; NFH,neurofilament heavy chain,CMT2CC; NFH,NEFH
P12235,ADT1_HUMAN,SLC25A4; AAC1; ANT1,ADP/ATP translocase 1; ADP;ATP carrier protein 1; ADP;ATP carrier protein; heart/skeletal muscle isoform T1; Adenine nucleotide translocator 1; ANT 1; Solute carrier family 25 member 4,AAC1; ANT1,291,solute carrier family 25 member 4,solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator); member 4; Adenine nucleotide translocator 1; progressive external ophthalmoplegia 3; progressive external ophthalmoplegia 2,ADP/ATP translocase 1; ADP/ATP carrier 1,T1; AAC1,solute carrier family 25 member 4,AAC1; ANT; ANT 1; ANT1; MTDPS12; MTDPS12A; PEO2; PEO3; PEOA2; T1,SLC25A4
P12259,FA5_HUMAN,F5,Coagulation factor V; Activated protein C cofactor; Proaccelerin; labile factor,,2153,coagulation factor V,coagulation factor V (proaccelerin; labile factor),,,coagulation factor V,FVL; PCCF; RPRGL1; THPH2,F5
P12268,IMDH2_HUMAN,IMPDH2; IMPD2,Inosine-5'-monophosphate dehydrogenase 2; IMP dehydrogenase 2; IMPD 2; IMPDH 2; EC 1.1.1.205; Inosine-5'-monophosphate dehydrogenase type II; IMP dehydrogenase II; IMPDH-II,IMPD2,3615,inosine monophosphate dehydrogenase 2,IMP (inosine 5'-monophosphate) dehydrogenase 2,,,inosine monophosphate dehydrogenase 2,IMPD2; IMPDH-II,IMPDH2
P12270,TPR_HUMAN,TPR,Nucleoprotein TPR; Megator; NPC-associated intranuclear protein; Translocated promoter region protein,,7175,translocated promoter region; nuclear basket protein,translocated promoter region (to activated MET oncogene),,,translocated promoter region; nuclear basket protein,MRT79,TPR
P12272,PTHR_HUMAN,PTHLH; PTHRP,Parathyroid hormone-related protein; PTH-rP; PTHrP; Parathyroid hormone-like protein; PLP; PTHrP107-139,PTHRP,5744,parathyroid hormone like hormone,,osteostatin; parathyroid hormone-like hormone preproprotein; parathyroid hormone-related protein preproprotein,PTHRP; HHM; PLP; PTHR,parathyroid hormone like hormone,BDE2; HHM; PLP; PTHR; PTHRP,PTHLH
P12314,FCGR1_HUMAN,FCGR1A; FCG1; FCGR1; IGFR1,High affinity immunoglobulin gamma Fc receptor I; IgG Fc receptor I; Fc-gamma RI; FcRI; Fc-gamma RIA; FcgammaRIa; CD antigen CD64,FCG1; FCGR1; IGFR1,2209,Fc gamma receptor Ia,Fc fragment of IgG; high affinity Ia; receptor for (CD64); Fc fragment of IgG; high affinity Ia; receptor (CD64); Fc fragment of IgG receptor Ia,Fc gamma RI,CD64; CD64A; FcgammaRI; FcgammaRIa; FCG1; FCGR1,Fc gamma receptor Ia,CD64; CD64A; FCG1; FCGR1; FCRI; FcgammaRI; IGFR1,FCGR1A
P12318,FCG2A_HUMAN,FCGR2A; CD32; FCG2; FCGR2A1; IGFR2,Low affinity immunoglobulin gamma Fc region receptor II-a; IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIa; FcRII-a; CD antigen CD32,CD32; FCG2; FCGR2A1; IGFR2,2212,Fc gamma receptor IIa,Fc fragment of IgG; low affinity IIa; receptor for (CD32); Fc fragment of IgG; low affinity IIa; receptor (CD32); Fc fragment of IgG receptor IIa,Immunoglobulin G Fc receptor II,CD32; CD32A; IGFR2; CDw32; Fc-gamma-RIIa; FcgammaRIIa,Fc gamma receptor IIa,CD32; CD32A; CDw32; FCG2; FCGR2; FCGR2A1; FcGR; FcgammaRIIa; IGFR2,FCGR2A
P12524,MYCL_HUMAN,MYCL; BHLHE38; LMYC; MYCL1,Protein L-Myc; Class E basic helix-loop-helix protein 38; bHLHe38; Protein L-Myc-1; V-myc myelocytomatosis viral oncogene homolog,BHLHE38; LMYC; MYCL1,4610,MYCL proto-oncogene; bHLH transcription factor,v-myc avian myelocytomatosis viral oncogene homolog 1; lung carcinoma derived,l-myc protein; myc-related gene from lung cancer; oncogene lmyc,LMYC; bHLHe38,MYCL proto-oncogene; bHLH transcription factor,L-Myc; LMYC; MYCL1; bHLHe38,MYCL
P12694,ODBA_HUMAN,BCKDHA,2-oxoisovalerate dehydrogenase subunit alpha; mitochondrial; EC 1.2.4.4; Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain; BCKDE1A; BCKDH E1-alpha,,593,branched chain keto acid dehydrogenase E1 subunit alpha,branched chain keto acid dehydrogenase E1; alpha polypeptide (maple syrup urine disease); 2-oxoisovalerate dehydrogenase (lipoamide); branched chain keto acid dehydrogenase E1; alpha polypeptide,maple syrup urine disease; 2-oxoisovalerate dehydrogenase subunit alpha; mitochondrial,MSU,branched chain keto acid dehydrogenase E1 subunit alpha,BCKDE1A; MSU; MSUD1; MSUD1A; OVD1A,BCKDHA
P12755,SKI_HUMAN,SKI,Ski oncogene; Proto-oncogene c-Ski,,6497,SKI proto-oncogene,v-ski avian sarcoma viral oncogene homolog,Sloan-Kettering Institute proto-oncogene,,SKI proto-oncogene,SGS; SKV,SKI
P12814,ACTN1_HUMAN,ACTN1,Alpha-actinin-1; Alpha-actinin cytoskeletal isoform; F-actin cross-linking protein; Non-muscle alpha-actinin-1,,87,actinin alpha 1,,,,actinin alpha 1,BDPLT15,ACTN1
P12821,ACE_HUMAN,ACE; DCP; DCP1,Angiotensin-converting enzyme; ACE; EC 3.4.15.1; Dipeptidyl carboxypeptidase I; Kininase II; CD antigen CD143,DCP; DCP1,1636,angiotensin I converting enzyme,angiotensin I converting enzyme (peptidyl-dipeptidase A) 1,peptidyl-dipeptidase A,ACE1; CD143,angiotensin I converting enzyme,ACE1; CD143; DCP; DCP1,ACE
P12829,MYL4_HUMAN,MYL4; MLC1; PRO1957,Myosin light chain 4; Myosin light chain 1; embryonic muscle/atrial isoform; Myosin light chain alkali GT-1 isoform,MLC1,4635,myosin light chain 4,myosin; light polypeptide 4; alkali; atrial; embryonic; myosin; light chain 4; alkali; atrial; embryonic,myosin; atrial/fetal muscle; light chain; atrial myosin light chain 1,ALC1; AMLC; GT1; PRO1957,myosin light chain 4,ALC1; AMLC; GT1; PRO1957,MYL4
P12830,CADH1_HUMAN,CDH1; CDHE; UVO,Cadherin-1; CAM 120/80; Epithelial cadherin; E-cadherin; Uvomorulin; CD antigen CD324,CDHE; UVO,999,cadherin 1,cadherin 1; type 1; E-cadherin (epithelial),E-Cadherin,uvomorulin; CD324,cadherin 1,Arc-1; BCDS1; CD324; CDHE; ECAD; LCAM; UVO,CDH1
P12931,SRC_HUMAN,SRC; SRC1,Proto-oncogene tyrosine-protein kinase Src; EC 2.7.10.2; Proto-oncogene c-Src; pp60c-src; p60-Src,SRC1,6714,SRC proto-oncogene; non-receptor tyrosine kinase,v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog,,ASV; c-src,SRC proto-oncogene; non-receptor tyrosine kinase,ASV; SRC1; THC6; c-SRC; p60-Src,SRC
P12956,XRCC6_HUMAN,XRCC6; G22P1,X-ray repair cross-complementing protein 6; EC 3.6.4.-; EC 4.2.99.-; 5'-deoxyribose-5-phosphate lyase Ku70; 5'-dRP lyase Ku70; 70 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 1; ATP-dependent DNA helicase II 70 kDa subunit; CTC box-binding factor 75 kDa subunit; CTC75; CTCBF; DNA repair protein XRCC6; Lupus Ku autoantigen protein p70; Ku70; Thyroid-lupus autoantigen; TLAA; X-ray repair complementing defective repair in Chinese hamster cells 6,G22P1,2547,X-ray repair cross complementing 6,thyroid autoantigen 70kD (Ku antigen); thyroid autoantigen 70kDa (Ku antigen); X-ray repair complementing defective repair in Chinese hamster cells 6,Ku autoantigen; 70kDa,D22S731; D22S671; KU70; ML8,X-ray repair cross complementing 6,CTC75; CTCBF; G22P1; KU70; ML8; TLAA,XRCC6
P12980,LYL1_HUMAN,LYL1; BHLHA18,Protein lyl-1; Class A basic helix-loop-helix protein 18; bHLHa18; Lymphoblastic leukemia-derived sequence 1,BHLHA18,4066,LYL1 basic helix-loop-helix family member,lymphoblastic leukemia derived sequence 1; lymphoblastic leukemia associated hematopoiesis regulator 1,,bHLHa18,LYL1 basic helix-loop-helix family member,bHLHa18,LYL1
P13010,XRCC5_HUMAN,XRCC5; G22P2,X-ray repair cross-complementing protein 5; EC 3.6.4.-; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair protein XRCC5; Ku80; Ku86; Lupus Ku autoantigen protein p86; Nuclear factor IV; Thyroid-lupus autoantigen; TLAA; X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining,G22P2,7520,X-ray repair cross complementing 5,X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen; 80kD),Ku autoantigen; 80kDa,KU80; KARP-1; Ku86; KUB2,X-ray repair cross complementing 5,KARP-1; KARP1; KU80; KUB2; Ku86; NFIV,XRCC5
P13051,UNG_HUMAN,UNG; DGU; UNG1; UNG15,Uracil-DNA glycosylase; UDG; EC 3.2.2.27,DGU; UNG1; UNG15,7374,uracil DNA glycosylase,,uracil-DNA glycosylase 1; uracil-DNA glycosylase 2,UDG; UNG1; UNG2; HIGM4,uracil DNA glycosylase,DGU; HIGM4; HIGM5; UDG; UNG1; UNG15; UNG2,UNG
P13349,MYF5_HUMAN,MYF5; BHLHC2,Myogenic factor 5; Myf-5; Class C basic helix-loop-helix protein 2; bHLHc2,BHLHC2,4617,myogenic factor 5,,,bHLHc2,myogenic factor 5,EORVA; bHLHc2,MYF5
P13473,LAMP2_HUMAN,LAMP2,Lysosome-associated membrane glycoprotein 2; LAMP-2; Lysosome-associated membrane protein 2; CD107 antigen-like family member B; LGP-96; CD antigen CD107b,,3920,lysosomal associated membrane protein 2,lysosomal-associated membrane protein 2,,CD107b,lysosomal associated membrane protein 2,CD107b; DND; LAMP-2; LAMPB; LGP-96; LGP110,LAMP2
P13498,CY24A_HUMAN,CYBA,Cytochrome b-245 light chain; Cytochrome b(558; Cytochrome b558 subunit alpha; Neutrophil cytochrome b 22 kDa polypeptide; Superoxide-generating NADPH oxidase light chain subunit; p22 phagocyte B-cytochrome; p22-phox; p22phox,,1535,cytochrome b-245 alpha chain,cytochrome b-245; alpha polypeptide,flavocytochrome b-558 alpha polypeptide; Cytochrome b-245 light chain,p22-PHOX; p22phox,cytochrome b-245 alpha chain,CGD4; p22-PHOX,CYBA
P13569,CFTR_HUMAN,CFTR; ABCC7,Cystic fibrosis transmembrane conductance regulator; CFTR; ATP-binding cassette sub-family C member 7; Channel conductance-controlling ATPase; EC 5.6.1.6; cAMP-dependent chloride channel,ABCC7,1080,CF transmembrane conductance regulator,cystic fibrosis transmembrane conductance regulator; ATP-binding cassette (sub-family C; member 7),ATP-binding cassette sub-family C; member 7,MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP,CF transmembrane conductance regulator,ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1,CFTR
P13612,ITA4_HUMAN,ITGA4; CD49D,Integrin alpha-4; CD49 antigen-like family member D; Integrin alpha-IV; VLA-4 subunit alpha; CD antigen CD49d,CD49D,3676,integrin subunit alpha 4,integrin; alpha 4 (antigen CD49D; alpha 4 subunit of VLA-4 receptor),antigen CD49D; alpha 4 subunit of VLA-4 receptor,CD49d,integrin subunit alpha 4,CD49D; IA4,ITGA4
P13631,RARG_HUMAN,RARG; NR1B3,Retinoic acid receptor gamma; RAR-gamma; Nuclear receptor subfamily 1 group B member 3,NR1B3,5916,retinoic acid receptor gamma,retinoic acid receptor; gamma,,RARC; NR1B3; RARgamma; RAR-gamma,retinoic acid receptor gamma,NR1B3; RARC; RARgamma,RARG
P13637,AT1A3_HUMAN,ATP1A3,Sodium/potassium-transporting ATPase subunit alpha-3; Na(+; +; EC 7.2.2.13; Na(+; +; III; Sodium pump subunit alpha-3,,478,ATPase Na+/K+ transporting subunit alpha 3,dystonia 12; ATPase; Na+/K+ transporting; alpha 3 polypeptide,sodium/potassium-transporting ATPase subunit alpha-3; sodium pump subunit alpha-3; sodium-potassium ATPase catalytic subunit alpha-3,,ATPase Na+/K+ transporting subunit alpha 3,AHC2; ATP1A1; CAPOS; DEE99; DYT12; RDP,ATP1A3
P13639,EF2_HUMAN,EEF2; EF2,Elongation factor 2; EF-2; EC 3.6.5.-,EF2,1938,eukaryotic translation elongation factor 2,,polypeptidyl-tRNA translocase,EEF-2,eukaryotic translation elongation factor 2,EEF-2; EF-2; EF2; SCA26,EEF2
P13686,PPA5_HUMAN,ACP5,Tartrate-resistant acid phosphatase type 5; TR-AP; EC 3.1.3.2; Tartrate-resistant acid ATPase; TrATPase; Type 5 acid phosphatase,,54,acid phosphatase 5; tartrate resistant,,tartrate-resistant acid phosphatase; human purple acid phosphatase,TRAP; HPAP; TRAcP,acid phosphatase 5; tartrate resistant,HPAP; TRACP5a; TRACP5b; TRAP; TRAcP; TrATPase,ACP5
P13688,CEAM1_HUMAN,CEACAM1; BGP; BGP1,Cell adhesion molecule CEACAM1; Biliary glycoprotein 1; BGP-1; Carcinoembryonic antigen-related cell adhesion molecule 1; CEA cell adhesion molecule 1; CD antigen CD66a,BGP; BGP1,634,CEA cell adhesion molecule 1,carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); carcinoembryonic antigen related cell adhesion molecule 1,,BGP1; CD66a,CEA cell adhesion molecule 1,BGP; BGP1; BGPI,CEACAM1
P13693,TCTP_HUMAN,TPT1,Translationally-controlled tumor protein; TCTP; Fortilin; Histamine-releasing factor; HRF; p23,,7178,tumor protein; translationally-controlled 1,,,TCTP; fortilin,tumor protein; translationally-controlled 1,HRF; TCTP; p02; p23,TPT1
P13726,TF_HUMAN,F3,Tissue factor; TF; Coagulation factor III; Thromboplastin; CD antigen CD142,,2152,coagulation factor III; tissue factor,coagulation factor III (thromboplastin; tissue factor),tissue factor,CD142; TF,coagulation factor III; tissue factor,CD142; TF; TFA,F3
P13796,PLSL_HUMAN,LCP1; PLS2,Plastin-2; L-plastin; LC64P; Lymphocyte cytosolic protein 1; LCP-1,PLS2,3936,lymphocyte cytosolic protein 1,lymphocyte cytosolic protein 1 (L-plastin),plastin 2,PLS2; CP64; L-PLASTIN; LC64P,lymphocyte cytosolic protein 1,CP64; HEL-S-37; L-PLASTIN; LC64P; LPL; PLS2,LCP1
P13807,GYS1_HUMAN,GYS1; GYS,Glycogen starch synthase; muscle; EC 2.4.1.11; Glycogen synthase 1,GYS,2997,glycogen synthase 1,glycogen synthase 1 (muscle),,GSY,glycogen synthase 1,GSY; GYS,GYS1
P13861,KAP2_HUMAN,PRKAR2A; PKR2; PRKAR2,cAMP-dependent protein kinase type II-alpha regulatory subunit,PKR2; PRKAR2,5576,protein kinase cAMP-dependent type II regulatory subunit alpha,protein kinase; cAMP-dependent; regulatory; type II; alpha; protein kinase; cAMP-dependent; regulatory subunit type II alpha,,,protein kinase cAMP-dependent type II regulatory subunit alpha,PKR2; PRKAR2,PRKAR2A
P14136,GFAP_HUMAN,GFAP,Glial fibrillary acidic protein; GFAP,,2670,glial fibrillary acidic protein,,intermediate filament protein,FLJ45472,glial fibrillary acidic protein,ALXDRD,GFAP
P14317,HCLS1_HUMAN,HCLS1; HS1,Hematopoietic lineage cell-specific protein; Hematopoietic cell-specific LYN substrate 1; LckBP1; p75,HS1,3059,hematopoietic cell-specific Lyn substrate 1,,cortactin-like,HS1; CTTNL,hematopoietic cell-specific Lyn substrate 1,CTTNL; HS1; lckBP1; p75,HCLS1
P14415,AT1B2_HUMAN,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2; Adhesion molecule in glia; AMOG; Sodium/potassium-dependent ATPase subunit beta-2,,482,ATPase Na+/K+ transporting subunit beta 2,ATPase; Na+/K+ transporting; beta 2 polypeptide,sodium/potassium-transporting ATPase subunit beta-2; sodium pump subunit beta-2; sodium-potassium ATPase subunit beta 2 (non-catalytic),AMOG,ATPase Na+/K+ transporting subunit beta 2,AMOG,ATP1B2
P14598,NCF1_HUMAN,NCF1; NOXO2; SH3PXD1A,Neutrophil cytosol factor 1; NCF-1; 47 kDa autosomal chronic granulomatous disease protein; 47 kDa neutrophil oxidase factor; NCF-47K; Neutrophil NADPH oxidase factor 1; Nox organizer 2; Nox-organizing protein 2; SH3 and PX domain-containing protein 1A; p47-phox,NOXO2; SH3PXD1A,653361,neutrophil cytosolic factor 1,neutrophil cytosolic factor 1 (47kD; chronic granulomatous disease; autosomal 1),NADPH oxidase organizer 2; chronic granulomatous disease; autosomal 1,p47phox; NOXO2; NCF1A; SH3PXD1A,neutrophil cytosolic factor 1,CGD1; NCF-1; NCF-47K; NCF1A; NOXO2; SH3PXD1A; p47-phox; p47phox,NCF1
P14618,KPYM_HUMAN,PKM; OIP3; PK2; PK3; PKM2,Pyruvate kinase PKM; EC 2.7.1.40; Cytosolic thyroid hormone-binding protein; CTHBP; Opa-interacting protein 3; OIP-3; Pyruvate kinase 2/3; Pyruvate kinase muscle isozyme; Threonine-protein kinase PKM2; EC 2.7.11.1; Thyroid hormone-binding protein 1; THBP1; Tumor M2-PK; Tyrosine-protein kinase PKM2; EC 2.7.10.2; p58,OIP3; PK2; PK3; PKM2,5315,pyruvate kinase M1/2,pyruvate kinase; muscle,,THBP1; OIP3; PK3,pyruvate kinase M1/2,CTHBP; HEL-S-30; OIP3; PK3; PKM2; TCB; THBP1; p58,PKM
P14625,ENPL_HUMAN,HSP90B1; GRP94; HSPC4; TRA1,Endoplasmin; 94 kDa glucose-regulated protein; GRP-94; Heat shock protein 90 kDa beta member 1; Heat shock protein family C member 4; Tumor rejection antigen 1; gp96 homolog,GRP94; HSPC4; TRA1,7184,heat shock protein 90 beta family member 1,tumor rejection antigen (gp96) 1; heat shock protein 90kDa beta (Grp94); member 1,endoplasmin,GP96; GRP94,heat shock protein 90 beta family member 1,ECGP; GP96; GRP94; HEL-S-125m; HEL35; TRA1,HSP90B1
P14635,CCNB1_HUMAN,CCNB1; CCNB,G2/mitotic-specific cyclin-B1,CCNB,891,cyclin B1,,G2/mitotic-specific cyclin B1,,cyclin B1,CCNB,CCNB1
P14649,MYL6B_HUMAN,MYL6B; MLC1SA,Myosin light chain 6B; Myosin light chain 1 slow-twitch muscle A isoform; MLC1sa; Smooth muscle and nonmuscle myosin light chain alkali 6B,MLC1SA,140465,myosin light chain 6B,myosin; light polypeptide 6B; alkali; smooth muscle and non-muscle; myosin; light chain 6B; alkali; smooth muscle and non-muscle,myosin light chain 1 slow a,MLC1SA,myosin light chain 6B,MLC1SA,MYL6B
P14672,GLUT4_HUMAN,SLC2A4; GLUT4,Solute carrier family 2; facilitated glucose transporter member 4; Glucose transporter type 4; insulin-responsive; GLUT-4,GLUT4,6517,solute carrier family 2 member 4,solute carrier family 2 (facilitated glucose transporter); member 4,,,solute carrier family 2 member 4,GLUT4,SLC2A4
P14679,TYRO_HUMAN,TYR,Tyrosinase; EC 1.14.18.1; LB24-AB; Monophenol monooxygenase; SK29-AB; Tumor rejection antigen AB,,7299,tyrosinase,,oculocutaneous albinism IA,OCAIA; OCA1A; OCA1,tyrosinase,ATN; CMM8; OCA1; OCA1A; OCAIA; SHEP3,TYR
P14784,IL2RB_HUMAN,IL2RB; IL15RB,Interleukin-2 receptor subunit beta; IL-2 receptor subunit beta; IL-2R subunit beta; IL-2RB; High affinity IL-2 receptor subunit beta; Interleukin-15 receptor subunit beta; p70-75; p75; CD antigen CD122,IL15RB,3560,interleukin 2 receptor subunit beta,interleukin 15 receptor; beta; interleukin 2 receptor; beta,,CD122,interleukin 2 receptor subunit beta,CD122; IL15RB; IMD63; P70-75,IL2RB
P14859,PO2F1_HUMAN,POU2F1; OCT1; OTF1,POU domain; class 2; transcription factor 1; NF-A1; Octamer-binding protein 1; Oct-1; Octamer-binding transcription factor 1; OTF-1,OCT1; OTF1,5451,POU class 2 homeobox 1,POU domain class 2; transcription factor 1,,OCT1,POU class 2 homeobox 1,OCT1; OTF1; Oct1Z; oct-1B,POU2F1
P14866,HNRPL_HUMAN,HNRNPL; HNRPL; P/OKcl.14,Heterogeneous nuclear ribonucleoprotein L; hnRNP L,HNRPL,3191,heterogeneous nuclear ribonucleoprotein L,,,,heterogeneous nuclear ribonucleoprotein L,HNRPL; P/OKcl.14; hnRNP-L,HNRNPL
P14921,ETS1_HUMAN,ETS1; EWSR2,Protein C-ets-1; p54,EWSR2,2113,ETS proto-oncogene 1; transcription factor,v-ets avian erythroblastosis virus E26 oncogene homolog 1,Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1; ets protein,FLJ10768; ETS-1,ETS proto-oncogene 1; transcription factor,ETS-1; EWSR2; c-ets-1; p54,ETS1
P14923,PLAK_HUMAN,JUP; CTNNG; DP3,Junction plakoglobin; Catenin gamma; Desmoplakin III; Desmoplakin-3,CTNNG; DP3,3728,junction plakoglobin,catenin (cadherin-associated protein); gamma 80kDa,desmosomal protein 3,DP3; PDGB; PKGB; DPIII; PG,junction plakoglobin,CTNNG; DP3; DPIII; PDGB; PG; PKGB,JUP
P15036,ETS2_HUMAN,ETS2,Protein C-ets-2,,2114,ETS proto-oncogene 2; transcription factor,v-ets erythroblastosis virus E26 oncogene homolog 2 (avian); v-ets avian erythroblastosis virus E26 oncogene homolog 2,,,ETS proto-oncogene 2; transcription factor,ETS2IT1,ETS2
P15056,BRAF_HUMAN,BRAF; BRAF1; RAFB1,Serine/threonine-protein kinase B-raf; EC 2.7.11.1; Proto-oncogene B-Raf; p94; v-Raf murine sarcoma viral oncogene homolog B1,BRAF1; RAFB1,673,B-Raf proto-oncogene; serine/threonine kinase,v-raf murine sarcoma viral oncogene homolog B,,BRAF1; BRAF-1,B-Raf proto-oncogene; serine/threonine kinase,B-RAF1; B-raf; BRAF-1; BRAF1; NS7; RAFB1,BRAF
P15090,FABP4_HUMAN,FABP4,Fatty acid-binding protein; adipocyte; Adipocyte lipid-binding protein; ALBP; Adipocyte-type fatty acid-binding protein; A-FABP; AFABP; Fatty acid-binding protein 4,,2167,fatty acid binding protein 4,,adipocyte fatty acid binding protein,A-FABP; aP2,fatty acid binding protein 4,A-FABP; AFABP; ALBP; HEL-S-104; aP2,FABP4
P15104,GLNA_HUMAN,GLUL; GLNS,Glutamine synthetase; GS; EC 6.3.1.2; Glutamate--ammonia ligase; Palmitoyltransferase GLUL; EC 2.3.1.225,GLNS,2752,glutamate-ammonia ligase,glutamate-ammonia ligase (glutamine synthase),glutamine synthetase,,glutamate-ammonia ligase,DEE116; GLNS; GS; PIG43; PIG59,GLUL
P15153,RAC2_HUMAN,RAC2,Ras-related C3 botulinum toxin substrate 2; EC 3.6.5.2; GX; Small G protein; p21-Rac2,,5880,Rac family small GTPase 2,ras-related C3 botulinum toxin substrate 2 (rho family; small GTP binding protein Rac2),,EN-7,Rac family small GTPase 2,EN-7; Gx; HSPC022; IMD73A; IMD73B; IMD73C; p21-Rac2,RAC2
P15172,MYOD1_HUMAN,MYOD1; BHLHC1; MYF3; MYOD,Myoblast determination protein 1; Class C basic helix-loop-helix protein 1; bHLHc1; Myogenic factor 3; Myf-3,BHLHC1; MYF3; MYOD,4654,myogenic differentiation 1,myogenic factor 3,myoblast determination protein 1,PUM; MYOD; bHLHc1,myogenic differentiation 1,CMYO17; CMYP17; MYF3; MYOD; MYODRIF; PUM; bHLHc1,MYOD1
P15260,INGR1_HUMAN,IFNGR1,Interferon gamma receptor 1; IFN-gamma receptor 1; IFN-gamma-R1; CDw119; Interferon gamma receptor alpha-chain; IFN-gamma-R-alpha; CD antigen CD119,,3459,interferon gamma receptor 1,,,CD119,interferon gamma receptor 1,CD119; IFNGR; IMD27A; IMD27B,IFNGR1
P15289,ARSA_HUMAN,ARSA,Arylsulfatase A; ASA; EC 3.1.6.8; Cerebroside-sulfatase,,410,arylsulfatase A,,metachromatic leucodystrophy,ASA,arylsulfatase A,ASA; MLD,ARSA
P15309,PPAP_HUMAN,ACP3; ACPP,Prostatic acid phosphatase; PAP; EC 3.1.3.2; 5'-nucleotidase; 5'-NT; EC 3.1.3.5; Acid phosphatase 3; Ecto-5'-nucleotidase; Protein tyrosine phosphatase ACP3; EC 3.1.3.48; Thiamine monophosphatase; TMPase,ACPP,55,acid phosphatase 3,acid phosphatase; prostate,prostatic acid phosphatase,ACP-3; PAP; TM-PAP,acid phosphatase 3,5'-NT; ACP-3; ACPP; TM-PAP,ACP3
P15311,EZRI_HUMAN,EZR; VIL2,Ezrin; Cytovillin; Villin-2; p81,VIL2,7430,ezrin,villin 2 (ezrin),cytovillin 2,,ezrin,CVIL; CVL; HEL-S-105; VIL2,EZR
P15336,ATF2_HUMAN,ATF2; CREB2; CREBP1,Cyclic AMP-dependent transcription factor ATF-2; cAMP-dependent transcription factor ATF-2; Activating transcription factor 2; Cyclic AMP-responsive element-binding protein 2; CREB-2; cAMP-responsive element-binding protein 2; HB16; cAMP response element-binding protein CRE-BP1,CREB2; CREBP1,1386,activating transcription factor 2,cAMP responsive element binding protein 2,,TREB7; CRE-BP1; HB16,activating transcription factor 2,CRE-BP1; CREB-2; CREB2; HB16; TREB7,ATF2
P15374,UCHL3_HUMAN,UCHL3,Ubiquitin carboxyl-terminal hydrolase isozyme L3; UCH-L3; EC 3.4.19.12; Ubiquitin thioesterase L3,,7347,ubiquitin C-terminal hydrolase L3,ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase),ubiquitin thiolesterase,,ubiquitin C-terminal hydrolase L3,UCH-L3,UCHL3
P15382,KCNE1_HUMAN,KCNE1,Potassium voltage-gated channel subfamily E member 1; Delayed rectifier potassium channel subunit IsK; IKs producing slow voltage-gated potassium channel subunit beta Mink; Minimal potassium channel; MinK,,3753,potassium voltage-gated channel subfamily E regulatory subunit 1,potassium voltage-gated channel; Isk-related family; member 1; potassium channel; voltage gated subfamily E regulatory beta subunit 1,Jervell and Lange-Nielsen syndrome 2; Long QT syndrome 5,minK; IsK; JLNS2; LQT5,potassium voltage-gated channel subfamily E regulatory subunit 1,ISK; JLNS; JLNS2; LQT2/5; LQT5; MinK,KCNE1
P15391,CD19_HUMAN,CD19,B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD antigen CD19,,930,CD19 molecule,CD19 antigen,,,CD19 molecule,B4; CVID3,CD19
P15407,FOSL1_HUMAN,FOSL1; FRA1,Fos-related antigen 1; FRA-1,FRA1,8061,FOS like 1; AP-1 transcription factor subunit,FOS like antigen 1,,fra-1,FOS like 1; AP-1 transcription factor subunit,FRA; FRA1; fra-1,FOSL1
P15408,FOSL2_HUMAN,FOSL2; FRA2,Fos-related antigen 2; FRA-2,FRA2,2355,FOS like 2; AP-1 transcription factor subunit,FOS like antigen 2,,FRA2; FLJ23306,FOS like 2; AP-1 transcription factor subunit,ACED; FRA2,FOSL2
P15498,VAV_HUMAN,VAV1; VAV,Proto-oncogene vav,VAV,7409,vav guanine nucleotide exchange factor 1,vav 1 oncogene; vav 1 guanine nucleotide exchange factor,,,vav guanine nucleotide exchange factor 1,VAV,VAV1
P15529,MCP_HUMAN,CD46; MCP; MIC10,Membrane cofactor protein; TLX; Trophoblast leukocyte common antigen; CD antigen CD46,MCP; MIC10,4179,CD46 molecule,antigen identified by monoclonal antibody TRA-2-10; membrane cofactor protein (CD46; trophoblast-lymphocyte cross-reactive antigen); CD46 antigen; complement regulatory protein; CD46 molecule; complement regulatory protein,trophoblast-lymphocyte cross-reactive antigen,TRA2.10; MGC26544; TLX,CD46 molecule,AHUS2; MCP; MIC10; TLX; TRA2.10,CD46
P15531,NDKA_HUMAN,NME1; NDPKA; NM23,Nucleoside diphosphate kinase A; NDK A; NDP kinase A; EC 2.7.4.6; Granzyme A-activated DNase; GAAD; Metastasis inhibition factor nm23; NM23-H1; Tumor metastatic process-associated protein,NDPKA; NM23,4830,NME/NM23 nucleoside diphosphate kinase 1,non-metastatic cells 1; protein (NM23A) expressed in,,NM23; NM23-H1; NDPKA,NME/NM23 nucleoside diphosphate kinase 1,AWD; GAAD; NB; NBS; NDKA; NDPK-A; NDPKA; NM23; NM23-H1,NME1
P15735,PHKG2_HUMAN,PHKG2,Phosphorylase b kinase gamma catalytic chain; liver/testis isoform; PHK-gamma-LT; PHK-gamma-T; EC 2.7.11.19; PSK-C3; Phosphorylase kinase subunit gamma-2,,5261,phosphorylase kinase catalytic subunit gamma 2,phosphorylase kinase; gamma 2 (testis),,,phosphorylase kinase catalytic subunit gamma 2,GSD9C,PHKG2
P15822,ZEP1_HUMAN,HIVEP1; ZNF40,Zinc finger protein 40; Cirhin interaction protein; CIRIP; Gate keeper of apoptosis-activating protein; GAAP; Human immunodeficiency virus type I enhancer-binding protein 1; HIV-EP1; Major histocompatibility complex-binding protein 1; MBP-1; Positive regulatory domain II-binding factor 1; PRDII-BF1,ZNF40,3096,HIVEP zinc finger 1,human immunodeficiency virus type I enhancer-binding protein 1; zinc finger protein 40; human immunodeficiency virus type I enhancer binding protein 1,,CIRIP; MBP-1; CRYBP1; PRDII-BF1; ZAS1; Schnurri-1; ZNF40A,HIVEP zinc finger 1,CIRIP; CRYBP1; GAAP; MBP-1; PRDII-BF1; Schnurri-1; ZAS1; ZNF40; ZNF40A,HIVEP1
P15923,TFE2_HUMAN,TCF3; BHLHB21; E2A; ITF1,Transcription factor E2-alpha; Class B basic helix-loop-helix protein 21; bHLHb21; Immunoglobulin enhancer-binding factor E12/E47; Immunoglobulin transcription factor 1; Kappa-E2-binding factor; Transcription factor 3; TCF-3; Transcription factor ITF-1,BHLHB21; E2A; ITF1,6929,transcription factor 3,,transcription factor E2-alpha; immunoglobulin transcription factor 1; kappa-E2-binding factor; E2A immunoglobulin enhancer-binding factor E12/E47; VDR interacting repressor,E2A; ITF1; MGC129647; MGC129648; bHLHb21; VDIR; E47; p75,transcription factor 3,AGM8; AGM8A; AGM8B; E2A; E47; ITF1; TCF-3; VDIR; bHLHb21; p75,TCF3
P15924,DESP_HUMAN,DSP,Desmoplakin; DP; 250/210 kDa paraneoplastic pemphigus antigen,,1832,desmoplakin,desmoplakin (DPI; DPII),,KPPS2; PPKS2; DPI; DPII,desmoplakin,DCWHKTA; DP,DSP
P15927,RFA2_HUMAN,RPA2; REPA2; RPA32; RPA34,Replication protein A 32 kDa subunit; RP-A p32; Replication factor A protein 2; RF-A protein 2; Replication protein A 34 kDa subunit; RP-A p34,REPA2; RPA32; RPA34,6118,replication protein A2,replication protein A2 (32kD); replication protein A2; 32kDa,,,replication protein A2,REPA2; RP-A p32; RP-A p34; RPA32,RPA2
P15941,MUC1_HUMAN,MUC1; PUM,Mucin-1; MUC-1; Breast carcinoma-associated antigen DF3; Cancer antigen 15-3; CA 15-3; Carcinoma-associated mucin; Episialin; H23AG; Krebs von den Lungen-6; KL-6; PEMT; Peanut-reactive urinary mucin; PUM; Polymorphic epithelial mucin; PEM; Tumor-associated epithelial membrane antigen; EMA; Tumor-associated mucin; CD antigen CD227; MUC1-NT; MUC1-alpha; MUC1-beta; MUC1-CT,PUM,4582,mucin 1; cell surface associated,mucin 1; transmembrane; medullary cystic kidney disease 1 (autosomal dominant),epithelial membrane antigen,CD227; PEM; ADMCKD; ADMCKD1; MCKD; MCD; KL-6; EMA; Ca15-3,mucin 1; cell surface associated,ADMCKD; ADMCKD1; ADTKD2; CA 15-3; CD227; Ca15-3; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM,MUC1
P15976,GATA1_HUMAN,GATA1; ERYF1; GF1,Erythroid transcription factor; Eryf1; GATA-binding factor 1; GATA-1; GF-1; NF-E1 DNA-binding protein,ERYF1; GF1,2623,GATA binding protein 1,GATA-binding protein 1 (globin transcription factor 1); globin transcription factor 1,nuclear factor; erythroid 1,ERYF1; NFE1; GATA-1; NF-E1,GATA binding protein 1,CNSHA9; ERYF1; GATA-1; GF-1; GF1; HAEADA; NF-E1; NFE1; XLANP; XLTDA; XLTT,GATA1
P16066,ANPRA_HUMAN,NPR1; ANPRA,Atrial natriuretic peptide receptor 1; EC 4.6.1.2; Atrial natriuretic peptide receptor type A; ANP-A; ANPR-A; NPR-A; Guanylate cyclase A; GC-A,ANPRA,4881,natriuretic peptide receptor 1,atrionatriuretic peptide receptor A; natriuretic peptide receptor A,guanylate cyclase A,GUCY2A; ANPa,natriuretic peptide receptor 1,ANPRA; ANPa; GUC2A; GUCY2A; NPRA,NPR1
P16070,CD44_HUMAN,CD44; LHR; MDU2; MDU3; MIC4,CD44 antigen; CDw44; Epican; Extracellular matrix receptor III; ECMR-III; GP90 lymphocyte homing/adhesion receptor; HUTCH-I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycoprotein 1; PGP-1; Phagocytic glycoprotein I; PGP-I; CD antigen CD44,LHR; MDU2; MDU3; MIC4,960,CD44 molecule (IN blood group),CD44 antigen (homing function and Indian blood group system),hematopoietic cell E- and L-selectin ligand; chondroitin sulfate proteoglycan 8; phagocyte glycoprotein 1; In(Lu) related-p80; extracellular matrix receptor-III; homing cell adhesion molecule,IN; MC56; Pgp1; PGP-1; CD44R; HCELL; CSPG8; Hermes-1; CDw44; HUTCH-1; HUTCH-I; ECM-III; H-CAM,CD44 molecule (IN blood group),CDW44; CSPG8; ECM-III; ECMR-III; H-CAM; HCELL; HUTCH-1; HUTCH-I; Hermes-1; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1,CD44
P16104,H2AX_HUMAN,H2AX; H2AFX,Histone H2AX; H2a/x; Histone H2A.X,H2AFX,3014,H2A.X variant histone,H2A histone family; member X; H2A histone family member X,,,H2A.X variant histone,H2A.X; H2A/X; H2AFX,H2AX
P16118,F261_HUMAN,PFKFB1; F6PK; PFRX,6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 1; 6PF-2-K/Fru-2;6-P2ase 1; PFK/FBPase 1; 6PF-2-K/Fru-2;6-P2ase liver isozyme; EC 2.7.1.105; EC 3.1.3.46,F6PK; PFRX,5207,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 1,,,,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 1,F6PK; HL2K; PFRX,PFKFB1
P16144,ITB4_HUMAN,ITGB4,Integrin beta-4; GP150; CD antigen CD104,,3691,integrin subunit beta 4,integrin; beta 4,,CD104,integrin subunit beta 4,CD104; GP150; JEB5A; JEB5B,ITGB4
P16150,LEUK_HUMAN,SPN; CD43,Leukosialin; GPL115; Galactoglycoprotein; GALGP; Leukocyte sialoglycoprotein; Sialophorin; CD antigen CD43; CD43-ct; CD43ct,CD43,6693,sialophorin,sialophorin (gpL115; leukosialin; CD43),leukosialin,LSN; CD43; GPL115; LEU-22,sialophorin,CD43; GALGP; GPL115; LEU-22; LSN,SPN
P16220,CREB1_HUMAN,CREB1,Cyclic AMP-responsive element-binding protein 1; CREB-1; cAMP-responsive element-binding protein 1,,1385,cAMP responsive element binding protein 1,,,,cAMP responsive element binding protein 1,CREB; CREB-1,CREB1
P16234,PGFRA_HUMAN,PDGFRA; PDGFR2; RHEPDGFRA,Platelet-derived growth factor receptor alpha; PDGF-R-alpha; PDGFR-alpha; EC 2.7.10.1; Alpha platelet-derived growth factor receptor; Alpha-type platelet-derived growth factor receptor; CD140 antigen-like family member A; CD140a antigen; Platelet-derived growth factor alpha receptor; Platelet-derived growth factor receptor 2; PDGFR-2; CD antigen CD140a,PDGFR2; RHEPDGFRA,5156,platelet derived growth factor receptor alpha,platelet-derived growth factor receptor; alpha polypeptide,,CD140a; PDGFR2; GAS9,platelet derived growth factor receptor alpha,CD140A; PDGFR-2; PDGFR2,PDGFRA
P16284,PECA1_HUMAN,PECAM1,Platelet endothelial cell adhesion molecule; PECAM-1; EndoCAM; GPIIA'; PECA1; CD antigen CD31,,5175,platelet and endothelial cell adhesion molecule 1,platelet/endothelial cell adhesion molecule 1,CD31 antigen,CD31,platelet and endothelial cell adhesion molecule 1,CD31; CD31/EndoCAM; GPIIA'; PECA1; PECAM-1; endoCAM,PECAM1
P16298,PP2BB_HUMAN,PPP3CB; CALNA2; CALNB; CNA2,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform; EC 3.1.3.16; CAM-PRP catalytic subunit; Calmodulin-dependent calcineurin A subunit beta isoform; CNA beta,CALNA2; CALNB; CNA2,5532,protein phosphatase 3 catalytic subunit beta,protein phosphatase 3 (formerly 2B); catalytic subunit; beta isoform (calcineurin A beta); protein phosphatase 3 (formerly 2B); catalytic subunit; beta isoform; protein phosphatase 3; catalytic subunit; beta isozyme,calcineurin A beta; protein phosphatase 2B; catalytic subunit; beta isoform,CALNA2; CNA2; PP2Bbeta,protein phosphatase 3 catalytic subunit beta,CALNA2; CALNB; CNA2; PP2Bbeta,PPP3CB
P16333,NCK1_HUMAN,NCK1; NCK,SH2/SH3 adapter protein NCK1; Cytoplasmic protein NCK1; NCK adapter protein 1; Nck-1; SH2/SH3 adapter protein NCK-alpha,NCK,4690,NCK adaptor protein 1,,,NCKalpha,NCK adaptor protein 1,NCK; NCKalpha; nck-1,NCK1
P16401,H15_HUMAN,H1-5; H1F5; HIST1H1B,Histone H1.5; Histone H1a; Histone H1b; Histone H1s-3,H1F5; HIST1H1B,3009,H1.5 linker histone; cluster member,H1 histone family; member 5; histone 1; H1b; histone cluster 1; H1b; histone cluster 1 H1 family member b,,H1b; H1s-3,H1.5 linker histone; cluster member,H1; H1.5; H1B; H1F5; H1s-3; HIST1H1B,H1-5
P16403,H12_HUMAN,H1-2; H1F2; HIST1H1C,Histone H1.2; Histone H1c; Histone H1d; Histone H1s-1,H1F2; HIST1H1C,3006,H1.2 linker histone; cluster member,H1 histone family; member 2; histone 1; H1c; histone cluster 1; H1c; histone cluster 1 H1 family member c,,H1.2; H1s-1; H1c,H1.2 linker histone; cluster member,H1.2; H1C; H1F2; H1s-1; HIST1H1C,H1-2
P16410,CTLA4_HUMAN,CTLA4; CD152,Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD antigen CD152,CD152,1493,cytotoxic T-lymphocyte associated protein 4,celiac disease 3; insulin-dependent diabetes mellitus 12,gluten-sensitive enteropathy; celiac disease,CD152; CD; GSE; CTLA-4,cytotoxic T-lymphocyte associated protein 4,ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12,CTLA4
P16520,GBB3_HUMAN,GNB3,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3; I; S; T; Transducin beta chain 3,,2784,G protein subunit beta 3,guanine nucleotide binding protein (G protein); beta polypeptide 3,transducin beta chain 3; Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,,G protein subunit beta 3,CSNB1H; HG2D,GNB3
P16581,LYAM2_HUMAN,SELE; ELAM1,E-selectin; CD62 antigen-like family member E; Endothelial leukocyte adhesion molecule 1; ELAM-1; Leukocyte-endothelial cell adhesion molecule 2; LECAM2; CD antigen CD62E,ELAM1,6401,selectin E,endothelial adhesion molecule 1,,ESEL; CD62E,selectin E,CD62E; ELAM; ELAM1; ESEL; LECAM2; selectin-e,SELE
P16591,FER_HUMAN,FER; TYK3,Tyrosine-protein kinase Fer; EC 2.7.10.2; Feline encephalitis virus-related kinase FER; Fujinami poultry sarcoma/Feline sarcoma-related protein Fer; Proto-oncogene c-Fer; Tyrosine kinase 3; p94-Fer,TYK3,2241,FER tyrosine kinase,fer (fps/fes related) tyrosine kinase,phosphoprotein NCP94; protein phosphatase 1; regulatory subunit 74,TYK3; PPP1R74,FER tyrosine kinase,PPP1R74; TYK3; p94-Fer,FER
P16662,UD2B7_HUMAN,UGT2B7; UGTB2B9,UDP-glucuronosyltransferase 2B7; UDPGT 2B7; UGT2B7; EC 2.4.1.17; 3;4-catechol estrogen-specific UDPGT; UDP-glucuronosyltransferase 2B9; UDPGT 2B9; UDPGTh-2,UGTB2B9,7364,UDP glucuronosyltransferase family 2 member B7,UDP glycosyltransferase 2 family; polypeptide B7,,UGT2B9,UDP glucuronosyltransferase family 2 member B7,UDPGT 2B7; UDPGT 2B9; UDPGT2B7; UDPGTH2; UDPGTh-2; UGT2B9,UGT2B7
P16671,CD36_HUMAN,CD36; GP3B; GP4,Platelet glycoprotein 4; Fatty acid translocase; FAT; Glycoprotein IIIb; GPIIIB; Leukocyte differentiation antigen CD36; PAS IV; PAS-4; Platelet collagen receptor; Platelet glycoprotein IV; GPIV; Thrombospondin receptor; CD antigen CD36,GP3B; GP4,948,CD36 molecule (CD36 blood group),CD36 antigen (collagen type I receptor; thrombospondin receptor); CD36 molecule (thrombospondin receptor),scavenger receptor class B member 3; Platelet glycoprotein 4; fatty acid translocase,SCARB3; GPIV; FAT; GP4; GP3B; GPIIIB,CD36 molecule (CD36 blood group),BDPLT10; CHDS7; FAT; GP3B; GP4; GPIV; PASIV; SCARB3,CD36
P16885,PLCG2_HUMAN,PLCG2,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-2; EC 3.1.4.11; Phosphoinositide phospholipase C-gamma-2; Phospholipase C-IV; PLC-IV; Phospholipase C-gamma-2; PLC-gamma-2,,5336,phospholipase C gamma 2,phospholipase C; gamma 2 (phosphatidylinositol-specific),,,phospholipase C gamma 2,APLAID; FCAS3; PLC-IV; PLC-gamma-2,PLCG2
P16949,STMN1_HUMAN,STMN1; C1orf215; LAP18; OP18,Stathmin; Leukemia-associated phosphoprotein p18; Metablastin; Oncoprotein 18; Op18; Phosphoprotein p19; pp19; Prosolin; Protein Pr22; pp17,C1orf215; LAP18; OP18,3925,stathmin 1,chromosome 1 open reading frame 215; stathmin 1/oncoprotein 18,oncoprotein 18,SMN; OP18; PR22; PP19; PP17; Lag; FLJ32206,stathmin 1,C1orf215; LAP18; Lag; OP18; PP17; PP19; PR22; SMN,STMN1
P16989,YBOX3_HUMAN,YBX3; CSDA; DBPA,Y-box-binding protein 3; Cold shock domain-containing protein A; DNA-binding protein A; Single-strand DNA-binding protein NF-GMB,CSDA; DBPA,8531,Y-box binding protein 3,cold shock domain protein A,cold-shock domain containing A1,dbpA; ZONAB; CSDA1,Y-box binding protein 3,CSDA; CSDA1; DBPA; ZONAB,YBX3
P17096,HMGA1_HUMAN,HMGA1; HMGIY,High mobility group protein HMG-I/HMG-Y; HMG-I(Y; High mobility group AT-hook protein 1; High mobility group protein A1; High mobility group protein R,HMGIY,3159,high mobility group AT-hook 1,high-mobility group (nonhistone chromosomal) protein isoforms I and Y,,,high mobility group AT-hook 1,HMG-R; HMGA1A; HMGIY,HMGA1
P17181,INAR1_HUMAN,IFNAR1; IFNAR,Interferon alpha/beta receptor 1; IFN-R-1; IFN-alpha/beta receptor 1; Cytokine receptor class-II member 1; Cytokine receptor family 2 member 1; CRF2-1; Type I interferon receptor 1,IFNAR,3454,interferon alpha and beta receptor subunit 1,interferon (alpha; beta and omega) receptor 1,IFNalpha/beta receptor 1; type I interferon receptor 1; interferon alpha/beta receptor 1,IFRC,interferon alpha and beta receptor subunit 1,AVP; IFN-alpha-REC; IFNAR; IFNBR; IFRC; IMD106,IFNAR1
P17252,KPCA_HUMAN,PRKCA; PKCA; PRKACA,Protein kinase C alpha type; PKC-A; PKC-alpha; EC 2.7.11.13,PKCA; PRKACA,5578,protein kinase C alpha,protein kinase C; alpha,,PKC??,protein kinase C alpha,AAG6; PKC-alpha; PKCA; PKCI+/-; PKCalpha; PRKACA,PRKCA
P17275,JUNB_HUMAN,JUNB,Transcription factor JunB; Transcription factor AP-1 subunit JunB,,3726,JunB proto-oncogene; AP-1 transcription factor subunit,,,,JunB proto-oncogene; AP-1 transcription factor subunit,AP-1,JUNB
P17301,ITA2_HUMAN,ITGA2; CD49B,Integrin alpha-2; CD49 antigen-like family member B; Collagen receptor; Platelet membrane glycoprotein Ia; GPIa; VLA-2 subunit alpha; CD antigen CD49b,CD49B,3673,integrin subunit alpha 2,integrin; alpha 2 (CD49B; alpha 2 subunit of VLA-2 receptor),alpha 2 subunit of VLA-2 receptor; alpha 2 integrin; glycoprotein Ia; very late activation receptor subunit alpha-2; human platelet alloantigen 5,GPIa; VLAA2; HPA-5,integrin subunit alpha 2,BR; CD49B; GPIa; HPA-5; VLA-2; VLAA2,ITGA2
P17302,CXA1_HUMAN,GJA1; GJAL,Gap junction alpha-1 protein; Connexin-43; Cx43; Gap junction 43 kDa heart protein,GJAL,2697,gap junction protein alpha 1,gap junction protein; alpha-like; gap junction protein; alpha 1; 43kDa (connexin 43); gap junction protein; alpha 1; 43kDa,oculodentodigital dysplasia (syndactyly type III); connexin 43,CX43; ODD; ODOD; SDTY3,gap junction protein alpha 1,AVSD3; CMDR; CX43; EKVP; EKVP3; GJAL; HLHS1; HSS; ODDD; PPKCA,GJA1
P17405,ASM_HUMAN,SMPD1; ASM,Sphingomyelin phosphodiesterase; EC 3.1.4.12; EC 3.1.4.3; Acid sphingomyelinase; aSMase,ASM,6609,sphingomyelin phosphodiesterase 1,sphingomyelin phosphodiesterase 1; acid lysosomal,acid sphingomyelinase; Niemann-Pick type A/B,ASM,sphingomyelin phosphodiesterase 1,ASM; ASMASE; NPD,SMPD1
P17480,UBF1_HUMAN,UBTF; UBF; UBF1,Nucleolar transcription factor 1; Autoantigen NOR-90; Upstream-binding factor 1; UBF-1,UBF; UBF1,7343,upstream binding transcription factor,upstream binding transcription factor; RNA polymerase I,,UBF; NOR-90; UBF1; UBF2,upstream binding transcription factor,CONDBA; NOR-90; UBF; UBF-1; UBF1; UBF2,UBTF
P17535,JUND_HUMAN,JUND,Transcription factor JunD; Transcription factor AP-1 subunit JunD,,3727,JunD proto-oncogene; AP-1 transcription factor subunit,,transcription factor jun-D; JunD-FL isoform; activator protein 1,AP-1,JunD proto-oncogene; AP-1 transcription factor subunit,AP-1,JUND
P17542,TAL1_HUMAN,TAL1; BHLHA17; SCL; TCL5,T-cell acute lymphocytic leukemia protein 1; TAL-1; Class A basic helix-loop-helix protein 17; bHLHa17; Stem cell protein; T-cell leukemia/lymphoma protein 5,BHLHA17; SCL; TCL5,6886,TAL bHLH transcription factor 1; erythroid differentiation factor,T-cell acute lymphocytic leukemia 1,,SCL; bHLHa17,TAL bHLH transcription factor 1; erythroid differentiation factor,SCL; TCL5; bHLHa17; tal-1,TAL1
P17544,ATF7_HUMAN,ATF7; ATFA,Cyclic AMP-dependent transcription factor ATF-7; cAMP-dependent transcription factor ATF-7; Activating transcription factor 7; Transcription factor ATF-A,ATFA,11016,activating transcription factor 7,,,ATFA,activating transcription factor 7,ATFA,ATF7
P17600,SYN1_HUMAN,SYN1,Synapsin-1; Brain protein 4.1; Synapsin I,,6853,synapsin I,mental retardation; X-linked 50,Synapsin-1,,synapsin I,EPILX; EPILX1; MRX50; SYN1a; SYN1b; SYNI,SYN1
P17612,KAPCA_HUMAN,PRKACA; PKACA,cAMP-dependent protein kinase catalytic subunit alpha; PKA C-alpha; EC 2.7.11.11,PKACA,5566,protein kinase cAMP-activated catalytic subunit alpha,protein kinase; cAMP-dependent; catalytic; alpha; protein kinase; cAMP-dependent; alpha catalytic subunit,cAMP-dependent protein kinase catalytic subunit alpha; PKA C-alpha,PKACa,protein kinase cAMP-activated catalytic subunit alpha,CAFD1; PKACA; PPNAD4,PRKACA
P17655,CAN2_HUMAN,CAPN2; CANPL2,Calpain-2 catalytic subunit; EC 3.4.22.53; Calcium-activated neutral proteinase 2; CANP 2; Calpain M-type; Calpain large polypeptide L2; Calpain-2 large subunit; Millimolar-calpain; M-calpain,CANPL2,824,calpain 2,calpain 2; (m/II) large subunit,,mCANP; CANPml; CANPL2,calpain 2,CANP2; CANPL2; CANPml; mCANP,CAPN2
P17661,DESM_HUMAN,DES,Desmin,,1674,desmin,,intermediate filament protein; cardiomyopathy; dilated 1I,CMD1I; CSM1; CSM2; LGMD2R,desmin,CDCD3; CSM1; CSM2; LGMD1D; LGMD1E; LGMD2R,DES
P17676,CEBPB_HUMAN,CEBPB; TCF5; PP9092,CCAAT/enhancer-binding protein beta; C/EBP beta; Liver activator protein; LAP; Liver-enriched inhibitory protein; LIP; Nuclear factor NF-IL6; Transcription factor 5; TCF-5,TCF5,1051,CCAAT enhancer binding protein beta,CCAAT/enhancer binding protein (C/EBP); beta; CCAAT/enhancer binding protein beta,liver-enriched transcriptional activator protein; nuclear factor of interleukin 6; interleukin 6-dependent DNA-binding protein,LAP; CRP2; NFIL6; IL6DBP; C/EBP-beta,CCAAT enhancer binding protein beta,C/EBP-beta; IL6DBP; NF-IL6; TCF5,CEBPB
P17706,PTN2_HUMAN,PTPN2; PTPT,Tyrosine-protein phosphatase non-receptor type 2; EC 3.1.3.48; T-cell protein-tyrosine phosphatase; TCPTP,PTPT,5771,protein tyrosine phosphatase non-receptor type 2,,,TCELLPTP; TC-PTP; TCPTP; TC45; TC48,protein tyrosine phosphatase non-receptor type 2,PTN2; PTPT; TC-PTP; TC45; TC48; TCELLPTP; TCPTP,PTPN2
P17812,PYRG1_HUMAN,CTPS1; CTPS,CTP synthase 1; EC 6.3.4.2; CTP synthetase 1; UTP--ammonia ligase 1,CTPS,1503,CTP synthase 1,CTP synthase,,GATD5A,CTP synthase 1,CTPS; GATD5; GATD5A; IMD24,CTPS1
P17813,EGLN_HUMAN,ENG; END,Endoglin; CD antigen CD105,END,2022,endoglin,Osler-Rendu-Weber syndrome 1,,END; HHT1; CD105,endoglin,END; HHT1; ORW1,ENG
P17844,DDX5_HUMAN,DDX5; G17P1; HELR; HLR1,Probable ATP-dependent RNA helicase DDX5; EC 3.6.4.13; DEAD box protein 5; RNA helicase p68,G17P1; HELR; HLR1,1655,DEAD-box helicase 5,DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 (RNA helicase; 68kD); DEAD (Asp-Glu-Ala-Asp) box polypeptide 5; DEAD (Asp-Glu-Ala-Asp) box helicase 5,,p68,DEAD-box helicase 5,G17P1; HLR1; HUMP68; p68,DDX5
P17861,XBP1_HUMAN,XBP1; TREB5; XBP2,X-box-binding protein 1; XBP-1; Tax-responsive element-binding protein 5; TREB-5,TREB5; XBP2,7494,X-box binding protein 1,,,,X-box binding protein 1,TREB-5; TREB5; XBP-1; XBP2,XBP1
P17931,LEG3_HUMAN,LGALS3; MAC2,Galectin-3; Gal-3; 35 kDa lectin; Carbohydrate-binding protein 35; CBP 35; Galactose-specific lectin 3; Galactoside-binding protein; GALBP; IgE-binding protein; L-31; Laminin-binding protein; Lectin L-29; Mac-2 antigen,MAC2,3958,galectin 3,lectin; galactoside-binding; soluble; 3,advanced glycation end-product receptor 3,MAC-2; GALIG,galectin 3,CBP35; GAL3; GALBP; GALIG; L31; LGALS2; MAC2,LGALS3
P17936,IBP3_HUMAN,IGFBP3; IBP3,Insulin-like growth factor-binding protein 3; IBP-3; IGF-binding protein 3; IGFBP-3,IBP3,3486,insulin like growth factor binding protein 3,insulin-like growth factor binding protein 3,growth hormone-dependent binding protein; acid stable subunit of the 140 K IGF complex; binding protein 53; binding protein 29; IGF-binding protein 3,IBP3; BP-53,insulin like growth factor binding protein 3,BP-53; IBP-3; IBP3; IGFBP-3,IGFBP3
P17948,VGFR1_HUMAN,FLT1; FLT; FRT; VEGFR1,Vascular endothelial growth factor receptor 1; VEGFR-1; EC 2.7.10.1; Fms-like tyrosine kinase 1; FLT-1; Tyrosine-protein kinase FRT; Tyrosine-protein kinase receptor FLT; FLT; Vascular permeability factor receptor,FLT; FRT; VEGFR1,2321,fms related receptor tyrosine kinase 1,fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor); fms-related tyrosine kinase 1; fms related tyrosine kinase 1,vascular endothelial growth factor receptor 1; vascular permeability factor receptor,VEGFR1,fms related receptor tyrosine kinase 1,FLT; FLT-1; VEGFR-1; VEGFR1,FLT1
P18031,PTN1_HUMAN,PTPN1; PTP1B,Tyrosine-protein phosphatase non-receptor type 1; EC 3.1.3.48; Protein-tyrosine phosphatase 1B; PTP-1B,PTP1B,5770,protein tyrosine phosphatase non-receptor type 1,,,,protein tyrosine phosphatase non-receptor type 1,PTP1B,PTPN1
P18084,ITB5_HUMAN,ITGB5,Integrin beta-5,,3693,integrin subunit beta 5,integrin; beta 5,,,integrin subunit beta 5,,ITGB5
P18146,EGR1_HUMAN,EGR1; KROX24; ZNF225,Early growth response protein 1; EGR-1; AT225; Nerve growth factor-induced protein A; NGFI-A; Transcription factor ETR103; Transcription factor Zif268; Zinc finger protein 225; Zinc finger protein Krox-24,KROX24; ZNF225,1958,early growth response 1,,nerve growth factor-induced protein A; transcription factor ETR103; zinc finger gene 225; early growth response protein 1,225; TIS8; AT225; G0S30; NGFI-A; ZIF268; KROX-24; ZIF-268,early growth response 1,AT225; G0S30; KROX-24; NGFI-A; TIS8; ZIF-268; ZIF268; ZNF225,EGR1
P18206,VINC_HUMAN,VCL,Vinculin; Metavinculin; MV,,7414,vinculin,,metavinculin,VINC,vinculin,CMD1W; CMH15; HEL114; MV; MVCL; VINC,VCL
P18433,PTPRA_HUMAN,PTPRA; PTPA; PTPRL2,Receptor-type tyrosine-protein phosphatase alpha; Protein-tyrosine phosphatase alpha; R-PTP-alpha; EC 3.1.3.48,PTPA; PTPRL2,5786,protein tyrosine phosphatase receptor type A,,,LRP; HLPR; HPTPA; RPTPA,protein tyrosine phosphatase receptor type A,HEPTP; HLPR; HPTPA; HPTPalpha; LRP; PTPA; PTPRL2; R-PTP-alpha; RPTPA,PTPRA
P18507,GBRG2_HUMAN,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2; GABA(A; GABAAR subunit gamma-2,,2566,gamma-aminobutyric acid type A receptor subunit gamma2,gamma-aminobutyric acid (GABA) A receptor; gamma 2,GABA(A) receptor; gamma 2,,gamma-aminobutyric acid type A receptor subunit gamma2,CAE2; DEE74; ECA2; EIEE74; FEB8; GEFSP3,GABRG2
P18545,CNRG_HUMAN,PDE6G; PDEG,Retinal rod rhodopsin-sensitive cGMP 3';5'-cyclic phosphodiesterase subunit gamma; GMP-PDE gamma; EC 3.1.4.35,PDEG,5148,phosphodiesterase 6G,phosphodiesterase 6G; cGMP-specific; rod; gamma,,RP57,phosphodiesterase 6G,PDEG; RP57,PDE6G
P18615,NELFE_HUMAN,NELFE; RD; RDBP,Negative elongation factor E; NELF-E; RNA-binding protein RD,RD; RDBP,7936,negative elongation factor complex member E,RD RNA-binding protein; RD RNA binding protein,,RD; D6S45; NELF-E; RDP,negative elongation factor complex member E,D6S45; NELF-E; RD; RDBP; RDP,NELFE
P18669,PGAM1_HUMAN,PGAM1; PGAMA; CDABP0006,Phosphoglycerate mutase 1; EC 5.4.2.11; EC 5.4.2.4; BPG-dependent PGAM 1; Phosphoglycerate mutase isozyme B; PGAM-B,PGAMA,5223,phosphoglycerate mutase 1,phosphoglycerate mutase 1 (brain),Phosphoglycerate mutase A; nonmuscle form,PGAM-B,phosphoglycerate mutase 1,HEL-S-35; PGAM-B; PGAMA,PGAM1
P18754,RCC1_HUMAN,RCC1; CHC1,Regulator of chromosome condensation; Cell cycle regulatory protein; Chromosome condensation protein 1,CHC1,1104,regulator of chromosome condensation 1,chromosome condensation 1,,,regulator of chromosome condensation 1,CHC1; RCC1-I,RCC1
P18827,SDC1_HUMAN,SDC1; SDC,Syndecan-1; SYND1; CD antigen CD138,SDC,6382,syndecan 1,,syndecan proteoglycan 1,CD138; syndecan; SYND1,syndecan 1,CD138; SDC; SYND1; syndecan,SDC1
P18846,ATF1_HUMAN,ATF1,Cyclic AMP-dependent transcription factor ATF-1; cAMP-dependent transcription factor ATF-1; Activating transcription factor 1; Protein TREB36,,466,activating transcription factor 1,,,TREB36,activating transcription factor 1,EWS-ATF1; FUS/ATF-1; TREB36,ATF1
P18848,ATF4_HUMAN,ATF4; CREB2; TXREB,Cyclic AMP-dependent transcription factor ATF-4; cAMP-dependent transcription factor ATF-4; Activating transcription factor 4; Cyclic AMP-responsive element-binding protein 2; CREB-2; cAMP-responsive element-binding protein 2; Tax-responsive enhancer element-binding protein 67; TaxREB67,CREB2; TXREB,468,activating transcription factor 4,activating transcription factor 4 (tax-responsive enhancer element B67),tax-responsive enhancer element B67,TAXREB67; CREB-2,activating transcription factor 4,CREB-2; CREB2; TAXREB67; TXREB,ATF4
P18850,ATF6A_HUMAN,ATF6,Cyclic AMP-dependent transcription factor ATF-6 alpha; cAMP-dependent transcription factor ATF-6 alpha; Activating transcription factor 6 alpha; ATF6-alpha,,22926,activating transcription factor 6,,activating transcription factor 6 alpha,ATF6A; ATP6alpha,activating transcription factor 6,ACHM7; ATF6A; ATP6alpha,ATF6
P18858,DNLI1_HUMAN,LIG1,DNA ligase 1; EC 6.5.1.1; DNA ligase I; Polydeoxyribonucleotide synthase ATP 1,,3978,DNA ligase 1,ligase I; DNA; ATP-dependent,DNA ligase I,LIGI; hLig1,DNA ligase 1,IMD96; LIGI; hLig1,LIG1
P18887,XRCC1_HUMAN,XRCC1,DNA repair protein XRCC1; X-ray repair cross-complementing protein 1,,7515,X-ray repair cross complementing 1,X-ray repair complementing defective repair in Chinese hamster cells 1,DNA repair protein XRCC1,,X-ray repair cross complementing 1,RCC; SCAR26,XRCC1
P19022,CADH2_HUMAN,CDH2; CDHN; NCAD,Cadherin-2; CDw325; Neural cadherin; N-cadherin; CD antigen CD325,CDHN; NCAD,1000,cadherin 2,cadherin 2; type 1; N-cadherin (neuronal),N-cadherin,CDHN; CD325,cadherin 2,ACOGS; ADHD8; ARVD14; CD325; CDHN; CDw325; NCAD,CDH2
P19086,GNAZ_HUMAN,GNAZ,Guanine nucleotide-binding protein G(z) subunit alpha; z; G(x; Gz-alpha,,2781,G protein subunit alpha z,guanine nucleotide binding protein (G protein); alpha z polypeptide,,,G protein subunit alpha z,HG1H; gz-alpha,GNAZ
P19105,ML12A_HUMAN,MYL12A; MLCB; MRLC3; RLC,Myosin regulatory light chain 12A; Epididymis secretory protein Li 24; HEL-S-24; MLC-2B; Myosin RLC; Myosin regulatory light chain 2; nonsarcomeric; Myosin regulatory light chain MRLC3,MLCB; MRLC3; RLC,10627,myosin light chain 12A,myosin; light polypeptide; regulatory; non-sarcomeric (20kD); myosin; light chain 12A; regulatory; non-sarcomeric,myosin regulatory light chain 3,MLCB; MYL2B; MRLC3; MRCL3,myosin light chain 12A,HEL-S-24; MLC-2B; MLCB; MRCL3; MRLC3; MYL2B,MYL12A
P19174,PLCG1_HUMAN,PLCG1; PLC1,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-1; EC 3.1.4.11; PLC-148; Phosphoinositide phospholipase C-gamma-1; Phospholipase C-II; PLC-II; Phospholipase C-gamma-1; PLC-gamma-1,PLC1,5335,phospholipase C gamma 1,phospholipase C; gamma 1 (formerly subtype 148); phospholipase C; gamma 1,,PLC148; PLC-II; PLCgamma1; NCKAP3,phospholipase C gamma 1,IDAA; NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1,PLCG1
P19235,EPOR_HUMAN,EPOR,Erythropoietin receptor; EPO-R,,2057,erythropoietin receptor,,,EPO-R,erythropoietin receptor,EPO-R,EPOR
P19338,NUCL_HUMAN,NCL,Nucleolin; Protein C23,,4691,nucleolin,,,C23; Nsr1,nucleolin,C23; Nsr1,NCL
P19367,HXK1_HUMAN,HK1,Hexokinase-1; EC 2.7.1.1; Brain form hexokinase; Hexokinase type I; HK I; Hexokinase-A,,3098,hexokinase 1,,,,hexokinase 1,CNSHA5; HK; HK1-ta; HK1-tb; HK1-tc; HKD; HKI; HMSNR; HXK1; NEDVIBA; NMSR; RP79; hexokinase,HK1
P19404,NDUV2_HUMAN,NDUFV2,NADH dehydrogenase ubiquinone flavoprotein 2; mitochondrial; NDUFV2; EC 7.1.1.2; NADH-ubiquinone oxidoreductase 24 kDa subunit,,4729,NADH:ubiquinone oxidoreductase core subunit V2,NADH dehydrogenase (ubiquinone) flavoprotein 2 (24kD); NADH dehydrogenase (ubiquinone) flavoprotein 2; 24kDa,complex I 24kDa subunit; NADH dehydrogenase ubiquinone flavoprotein 2; mitochondrial,CI-24k,NADH:ubiquinone oxidoreductase core subunit V2,CI-24k; MC1DN7,NDUFV2
P19419,ELK1_HUMAN,ELK1,ETS domain-containing protein Elk-1,,2002,ETS transcription factor ELK1,ELK1; member of ETS oncogene family,,,ETS transcription factor ELK1,,ELK1
P19429,TNNI3_HUMAN,TNNI3; TNNC1,Troponin I; cardiac muscle; Cardiac troponin I,TNNC1,7137,troponin I3; cardiac type,cardiomyopathy; dilated 2A (autosomal recessive); troponin I type 3 (cardiac); troponin I type 3,,TNNC1; CMH7; cTNI,troponin I3; cardiac type,CMD1FF; CMD2A; CMH7; RCM1; TNNC1; cTnI,TNNI3
P19438,TNR1A_HUMAN,TNFRSF1A; TNFAR; TNFR1,Tumor necrosis factor receptor superfamily member 1A; Tumor necrosis factor receptor 1; TNF-R1; Tumor necrosis factor receptor type I; TNF-RI; TNFR-I; p55; p60; CD antigen CD120a; TBPI,TNFAR; TNFR1,7132,TNF receptor superfamily member 1A,tumor necrosis factor receptor superfamily; member 1A,,TNF-R; TNFAR; TNFR60; TNF-R-I; CD120a; TNF-R55,TNF receptor superfamily member 1A,CD120a; FPF; TBP1; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR1; TNFR55; TNFR60; p55; p55-R; p60,TNFRSF1A
P19447,ERCC3_HUMAN,ERCC3; XPB; XPBC,General transcription and DNA repair factor IIH helicase/translocase subunit XPB; TFIIH subunit XPB; EC 5.6.2.4; Basic transcription factor 2 89 kDa subunit; BTF2 p89; DNA 3'-5' helicase/translocase XPB; DNA excision repair protein ERCC-3; DNA repair protein complementing XP-B cells; TFIIH basal transcription factor complex 89 kDa subunit; TFIIH 89 kDa subunit; TFIIH p89; Xeroderma pigmentosum group B-complementing protein,XPB; XPBC,2071,ERCC excision repair 3; TFIIH core complex helicase subunit,excision repair cross-complementing rodent repair deficiency; complementation group 3; excision repair cross-complementation group 3,xeroderma pigmentosum group B complementing,XPB; BTF2; RAD25; Ssl2,ERCC excision repair 3; TFIIH core complex helicase subunit,BTF2; GTF2H; RAD25; Ssl2; TFIIH; TTD2; XPB,ERCC3
P19484,TFEB_HUMAN,TFEB; BHLHE35,Transcription factor EB; Class E basic helix-loop-helix protein 35; bHLHe35,BHLHE35,7942,transcription factor EB,,,TCFEB; bHLHe35,transcription factor EB,ALPHATFEB; BHLHE35; TCFEB,TFEB
P19525,E2AK2_HUMAN,EIF2AK2; PKR; PRKR,Interferon-induced; double-stranded RNA-activated protein kinase; EC 2.7.11.1; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein kinase; Protein kinase RNA-activated; PKR; Protein kinase R; Tyrosine-protein kinase EIF2AK2; EC 2.7.10.2; p68 kinase,PKR; PRKR,5610,eukaryotic translation initiation factor 2 alpha kinase 2,protein kinase; interferon-inducible double stranded RNA dependent,protein phosphatase 1; regulatory subunit 83; Protein Kinase RNA-activated; protein kinase RNA-regulated; Protein Kinase R,PKR; PPP1R83,eukaryotic translation initiation factor 2 alpha kinase 2,DYT33; EIF2AK1; LEUDEN; PKR; PPP1R83; PRKR,EIF2AK2
P19544,WT1_HUMAN,WT1,Wilms tumor protein; WT33,,7490,WT1 transcription factor,Wilms tumor 1,,WAGR; WIT-2; AWT1; NPHS4; WT-1,WT1 transcription factor,AWT1; GUD; NPHS4; WAGR; WIT-2; WT-1; WT33,WT1
P19634,SL9A1_HUMAN,SLC9A1; APNH1; NHE1,Sodium/hydrogen exchanger 1; APNH; Na(+; +; Na(+; +; NHE-1; Solute carrier family 9 member 1,APNH1; NHE1,6548,solute carrier family 9 member A1,solute carrier family 9 (sodium/hydrogen exchanger); isoform 1 (antiporter; Na+/H+; amiloride sensitive); solute carrier family 9 (sodium/hydrogen exchanger); member 1; solute carrier family 9; subfamily A (NHE1; cation proton antiporter 1); member 1,protein phosphatase 1; regulatory subunit 143; Sodium/hydrogen exchanger 1,PPP1R143,solute carrier family 9 member A1,APNH; LIKNS; NHE-1; NHE1; PPP1R143,SLC9A1
P19784,CSK22_HUMAN,CSNK2A2; CK2A2,Casein kinase II subunit alpha'; CK II alpha'; EC 2.7.11.1,CK2A2,1459,casein kinase 2 alpha 2,casein kinase 2; alpha prime polypeptide,casein kinase 2 alpha',CSNK2A1; CK2alpha',casein kinase 2 alpha 2,CK2A2; CK2alpha'; CSNK2A1,CSNK2A2
P19793,RXRA_HUMAN,RXRA; NR2B1,Retinoic acid receptor RXR-alpha; Nuclear receptor subfamily 2 group B member 1; Retinoid X receptor alpha,NR2B1,6256,retinoid X receptor alpha,retinoid X receptor; alpha,nuclear receptor subfamily 2 group B member 1,NR2B1; RXRalpha; RXR-alpha,retinoid X receptor alpha,NR2B1; RXR-alpha; RXRalpha,RXRA
P19838,NFKB1_HUMAN,NFKB1,Nuclear factor NF-kappa-B p105 subunit; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,,4790,nuclear factor kappa B subunit 1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,Nuclear factor NF-kappa-B p105 subunit,KBF1; p105; NFKB-p50; p50; NF-kappaB; NFkappaB; NF-kB1,nuclear factor kappa B subunit 1,CVID12; EBP-1; KBF1; NF-kB; NF-kB1; NF-kappa-B1; NF-kappaB; NF-kappabeta; NFKB-p105; NFKB-p50; NFkappaB,NFKB1
P19878,NCF2_HUMAN,NCF2; NOXA2; P67PHOX,Neutrophil cytosol factor 2; NCF-2; 67 kDa neutrophil oxidase factor; NADPH oxidase activator 2; Neutrophil NADPH oxidase factor 2; p67-phox,NOXA2; P67PHOX,4688,neutrophil cytosolic factor 2,neutrophil cytosolic factor 2 (65kD; chronic granulomatous disease; autosomal 2),NADPH oxidase activator 2; chronic granulomatous disease; autosomal 2,p67phox; NOXA2,neutrophil cytosolic factor 2,NCF-2; NOXA2; P67-PHOX; P67PHOX,NCF2
P20020,AT2B1_HUMAN,ATP2B1; PMCA1,Plasma membrane calcium-transporting ATPase 1; EC 7.2.2.10; Plasma membrane calcium ATPase isoform 1; PMCA1; Plasma membrane calcium pump isoform 1,PMCA1,490,ATPase plasma membrane Ca2+ transporting 1,ATPase; Ca++ transporting; plasma membrane 1,plasma membrane calcium-transporting ATPase 1,PMCA1,ATPase plasma membrane Ca2+ transporting 1,MRD66; PMCA1; PMCA1kb,ATP2B1
P20042,IF2B_HUMAN,EIF2S2; EIF2B,Eukaryotic translation initiation factor 2 subunit 2; Eukaryotic translation initiation factor 2 subunit beta; eIF2-beta,EIF2B,8894,eukaryotic translation initiation factor 2 subunit beta,eukaryotic translation initiation factor 2; subunit 2 (beta; 38kD ); eukaryotic translation initiation factor 2; subunit 2 beta; 38kDa,protein phosphatase 1; regulatory subunit 67,EIF2beta; PPP1R67,eukaryotic translation initiation factor 2 subunit beta,EIF2; EIF2B; EIF2beta; PPP1R67; eIF-2-beta,EIF2S2
P20138,CD33_HUMAN,CD33; SIGLEC3,Myeloid cell surface antigen CD33; Sialic acid-binding Ig-like lectin 3; Siglec-3; gp67; CD antigen CD33,SIGLEC3,945,CD33 molecule,CD33 antigen (gp67),sialic acid binding Ig-like lectin 3,SIGLEC3; SIGLEC-3; p67; FLJ00391; CD33rSiglec,CD33 molecule,CD33rSiglec; SIGLEC-3; SIGLEC3; p67,CD33
P20248,CCNA2_HUMAN,CCNA2; CCN1; CCNA,Cyclin-A2; Cyclin-A; Cyclin A,CCN1; CCNA,890,cyclin A2,,,,cyclin A2,CCN1; CCNA,CCNA2
P20273,CD22_HUMAN,CD22; SIGLEC2,B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD antigen CD22,SIGLEC2,933,CD22 molecule,CD22 antigen,sialic acid binding Ig-like lectin 2,SIGLEC-2; SIGLEC2,CD22 molecule,SIGLEC-2; SIGLEC2,CD22
P20338,RAB4A_HUMAN,RAB4A; RAB4,Ras-related protein Rab-4A; EC 3.6.5.2,RAB4,5867,RAB4A; member RAS oncogene family,,,HRES-1/RAB4,RAB4A; member RAS oncogene family,HRES-1; HRES-1/RAB4; HRES1; RAB4,RAB4A
P20339,RAB5A_HUMAN,RAB5A; RAB5,Ras-related protein Rab-5A; EC 3.6.5.2,RAB5,5868,RAB5A; member RAS oncogene family,,RAS-associated protein RAB5A,,RAB5A; member RAS oncogene family,RAB5,RAB5A
P20393,NR1D1_HUMAN,NR1D1; EAR1; HREV; THRAL,Nuclear receptor subfamily 1 group D member 1; Rev-erbA-alpha; V-erbA-related protein 1; EAR-1,EAR1; HREV; THRAL,9572,nuclear receptor subfamily 1 group D member 1,nuclear receptor subfamily 1; group D; member 1,,ear-1; hRev; Rev-ErbAalpha; THRA1; REVERBA; REVERBalpha,nuclear receptor subfamily 1 group D member 1,EAR1; REVERBA; REVERBalpha; THRA1; THRAL; ear-1; hRev,NR1D1
P20700,LMNB1_HUMAN,LMNB1; LMN2; LMNB,Lamin-B1,LMN2; LMNB,4001,lamin B1,,,,lamin B1,ADLD; ADLDAT; LMN; LMN2; LMNB; MCPH26,LMNB1
P20749,BCL3_HUMAN,BCL3; BCL4; D19S37,B-cell lymphoma 3 protein; BCL-3; Proto-oncogene BCL3,BCL4; D19S37,602,BCL3 transcription coactivator,B cell CLL/lymphoma 3; BCL3; transcription coactivator,B-cell lymphoma 3-encoded protein; B-cell leukemia/lymphoma 3; chronic lymphatic leukemia protein,,BCL3 transcription coactivator,BCL4; D19S37,BCL3
P20810,ICAL_HUMAN,CAST,Calpastatin; Calpain inhibitor; Sperm BS-17 component,,831,calpastatin,MIR583 host gene,,,calpastatin,BS-17; MIR583HG; PLACK,CAST
P20823,HNF1A_HUMAN,HNF1A; TCF1,Hepatocyte nuclear factor 1-alpha; HNF-1-alpha; HNF-1A; Liver-specific transcription factor LF-B1; LFB1; Transcription factor 1; TCF-1,TCF1,6927,HNF1 homeobox A,transcription factor 1; hepatic; LF-B1; hepatic nuclear factor (HNF1); albumin proximal factor,,HNF1; LFB1; HNF1??,HNF1 homeobox A,HNF-1-alpha; HNF-1A; HNF1; HNF1alpha; HNF4A; IDDM20; LFB1; MODY3; TCF-1; TCF1,HNF1A
P20936,RASA1_HUMAN,RASA1; GAP; RASA,Ras GTPase-activating protein 1; GAP; GTPase-activating protein; RasGAP; Ras p21 protein activator; p120GAP,GAP; RASA,5921,RAS p21 protein activator 1,RAS p21 protein activator (GTPase activating protein) 1,capillary malformation-arteriovenous malformation; p120 RAS GTPase activating protein; Ras GTPase-activating protein 1,GAP; CM-AVM; p120GAP; p120RASGAP; p120,RAS p21 protein activator 1,CM-AVM; CMAVM; CMAVM1; GAP; PKWS; RASA; RASGAP; p120; p120GAP; p120RASGAP,RASA1
P20963,CD3Z_HUMAN,CD247; CD3Z; T3Z; TCRZ,T-cell surface glycoprotein CD3 zeta chain; T-cell receptor T3 zeta chain; CD antigen CD247,CD3Z; T3Z; TCRZ,919,CD247 molecule,CD3z antigen; zeta polypeptide (TiT3 complex); CD247 antigen,T-cell surface glycoprotein CD3 zeta chain,CD3H; CD3Q; TCRZ; CD3-ZETA; CD3ZETA,CD247 molecule,CD3-ZETA; CD3H; CD3Q; CD3Z; CD3ZETA; IMD25; T3Z; TCRZ,CD247
P21127,CD11B_HUMAN,CDK11B; CDC2L1; CDK11; PITSLREA; PK58,Cyclin-dependent kinase 11B; EC 2.7.11.22; Cell division cycle 2-like protein kinase 1; CLK-1; Cell division protein kinase 11B; Galactosyltransferase-associated protein kinase p58/GTA; PITSLRE serine/threonine-protein kinase CDC2L1; p58 CLK-1,CDC2L1; CDK11; PITSLREA; PK58,984,cyclin dependent kinase 11B,cell division cycle 2-like 1 (PITSLRE proteins),,CDK11-p110; CDK11-p58; CDK11-p46,cyclin dependent kinase 11B,CDC2L1; CDK11; CDK11-p110; CDK11-p46; CDK11-p58; CLK-1; PITSLREA; PK58; p58; p58CDC2L1; p58CLK-1,CDK11B
P21333,FLNA_HUMAN,FLNA; FLN; FLN1,Filamin-A; FLN-A; Actin-binding protein 280; ABP-280; Alpha-filamin; Endothelial actin-binding protein; Filamin-1; Non-muscle filamin,FLN; FLN1,2316,filamin A,filamin A; alpha (actin binding protein 280); filamin A; alpha,actin binding protein 280; alpha filamin,ABP-280,filamin A,ABP-280; ABPX; CSBS; CVD1; FGS2; FLN; FLN-A; FLN1; FMD; MNS; NHBP; OPD; OPD1; OPD2; XLVD; XMVD,FLNA
P21359,NF1_HUMAN,NF1,Neurofibromin; Neurofibromatosis-related protein NF-1,,4763,neurofibromin 1,,neurofibromatosis; von Recklinghausen disease; Watson disease,,neurofibromin 1,NFNS; VRNF; WSS,NF1
P21397,AOFA_HUMAN,MAOA,Amine oxidase flavin-containing A; EC 1.4.3.21; EC 1.4.3.4; Monoamine oxidase type A; MAO-A,,4128,monoamine oxidase A,,,,monoamine oxidase A,BRNRS; MAO-A,MAOA
P21399,ACOHC_HUMAN,ACO1; IREB1,Cytoplasmic aconitate hydratase; Aconitase; EC 4.2.1.3; Citrate hydro-lyase; Ferritin repressor protein; Iron regulatory protein 1; IRP1; Iron-responsive element-binding protein 1; IRE-BP 1,IREB1,48,aconitase 1,aconitase 1; soluble,aconitate hydratase; cytoplasmic; soluble aconitase; cytosplasmic aconitase,IRP1; IREBP,aconitase 1,ACONS; HEL60; IREB1; IREBP; IREBP1; IRP1,ACO1
P21453,S1PR1_HUMAN,S1PR1; CHEDG1; EDG1,Sphingosine 1-phosphate receptor 1; S1P receptor 1; S1P1; Endothelial differentiation G-protein coupled receptor 1; Sphingosine 1-phosphate receptor Edg-1; S1P receptor Edg-1; CD antigen CD363,CHEDG1; EDG1,1901,sphingosine-1-phosphate receptor 1,endothelial differentiation; sphingolipid G-protein-coupled receptor; 1,,edg-1; D1S3362; CD363,sphingosine-1-phosphate receptor 1,CD363; CHEDG1; D1S3362; ECGF1; EDG-1; EDG1; S1P1,S1PR1
P21462,FPR1_HUMAN,FPR1,fMet-Leu-Phe receptor; fMLP receptor; N-formyl peptide receptor; FPR; N-formylpeptide chemoattractant receptor,,2357,formyl peptide receptor 1,,fMet-Leu-Phe receptor; N-formylpeptide receptor,FPR; FMLP,formyl peptide receptor 1,FMLP; FPR,FPR1
P21673,SAT1_HUMAN,SAT1; SAT,Diamine acetyltransferase 1; EC 2.3.1.57; Polyamine N-acetyltransferase 1; Putrescine acetyltransferase; Spermidine/spermine N(1; SSAT; SSAT-1,SAT,6303,spermidine/spermine N1-acetyltransferase 1,spermidine/spermine N1-acetyltransferase,diamine N-acetyltransferase 1,SSAT,spermidine/spermine N1-acetyltransferase 1,DC21; KFSD; KFSDX; SAT; SSAT; SSAT-1,SAT1
P21675,TAF1_HUMAN,TAF1; BA2R; CCG1; CCGS; TAF2A,Transcription initiation factor TFIID subunit 1; EC 2.3.1.48; EC 2.7.11.1; Cell cycle gene 1 protein; TBP-associated factor 250 kDa; p250; Transcription initiation factor TFIID 250 kDa subunit; TAF(II; TAFII-250; TAFII250,BA2R; CCG1; CCGS; TAF2A,6872,TATA-box binding protein associated factor 1,TATA box binding protein (TBP)-associated factor; RNA polymerase II; A; 250kD; dystonia 3 (with Parkinsonism); TAF1 RNA polymerase II; TATA box binding protein (TBP)-associated factor; 250kDa,,NSCL2; TAFII250; KAT4; DYT3/TAF1,TATA-box binding protein associated factor 1,BA2R; CCG1; CCGS; DYT3; DYT3/TAF1; KAT4; MRXS33; N-TAF1; NSCL2; OF; P250; TAF(II)250; TAF2A; TAFII-250; TAFII250; XDP,TAF1
P21730,C5AR1_HUMAN,C5AR1; C5AR; C5R1,C5a anaphylatoxin chemotactic receptor 1; C5a anaphylatoxin chemotactic receptor; C5a-R; C5aR; CD antigen CD88,C5AR; C5R1,728,complement C5a receptor 1,complement component 5 receptor 1 (C5a ligand); complement component 5a receptor 1,,C5A; C5AR; CD88,complement C5a receptor 1,C5A; C5AR; C5R1; CD88,C5AR1
P21731,TA2R_HUMAN,TBXA2R,Thromboxane A2 receptor; TXA2-R; Prostanoid TP receptor,,6915,thromboxane A2 receptor,,,,thromboxane A2 receptor,BDPLT13; TXA2-R,TBXA2R
P21796,VDAC1_HUMAN,VDAC1; VDAC,Non-selective voltage-gated ion channel VDAC1; Outer mitochondrial membrane protein porin 1; Plasmalemmal porin; Porin 31HL; Porin 31HM; Voltage-dependent anion-selective channel protein 1; VDAC-1; hVDAC1,VDAC,7416,voltage dependent anion channel 1,,,MGC111064; PORIN,voltage dependent anion channel 1,PORIN; VDAC-1,VDAC1
P21802,FGFR2_HUMAN,FGFR2; BEK; KGFR; KSAM,Fibroblast growth factor receptor 2; FGFR-2; EC 2.7.10.1; K-sam; KGFR; Keratinocyte growth factor receptor; CD antigen CD332,BEK; KGFR; KSAM,2263,fibroblast growth factor receptor 2,bacteria-expressed kinase; keratinocyte growth factor receptor; craniofacial dysostosis 1; Jackson-Weiss syndrome,Crouzon syndrome; Pfeiffer syndrome,CEK3; TK14; TK25; ECT1; K-SAM; CD332,fibroblast growth factor receptor 2,BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25,FGFR2
P21817,RYR1_HUMAN,RYR1; RYDR,Ryanodine receptor 1; RYR-1; RyR1; Skeletal muscle calcium release channel; Skeletal muscle ryanodine receptor; Skeletal muscle-type ryanodine receptor; Type 1 ryanodine receptor,RYDR,6261,ryanodine receptor 1,central core disease of muscle; ryanodine receptor 1 (skeletal),protein phosphatase 1; regulatory subunit 137,RYR; PPP1R137,ryanodine receptor 1,CCO; CMYO1A; CMYO1B; CMYP1A; CMYP1B; KDS; MHS; MHS1; PPP1R137; RYDR; RYR; RYR-1; SKRR,RYR1
P21860,ERBB3_HUMAN,ERBB3; HER3,Receptor tyrosine-protein kinase erbB-3; EC 2.7.10.1; Proto-oncogene-like protein c-ErbB-3; Tyrosine kinase-type cell surface receptor HER3,HER3,2065,erb-b2 receptor tyrosine kinase 3,lethal congenital contracture syndrome 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3,human epidermal growth factor receptor 3,HER3,erb-b2 receptor tyrosine kinase 3,ErbB-3; FERLK; HER3; LCCS2; MDA-BF-1; VSCN1; c-erbB-3; c-erbB3; erbB3-S; p180-ErbB3; p45-sErbB3; p85-sErbB3,ERBB3
P21980,TGM2_HUMAN,TGM2,Protein-glutamine gamma-glutamyltransferase 2; EC 2.3.2.13; Erythrocyte transglutaminase; Heart G alpha(h; hhG alpha(h; Isopeptidase TGM2; EC 3.4.-.-; Protein G alpha(h; G(h; Protein-glutamine deamidase TGM2; EC 3.5.1.44; Protein-glutamine dopaminyltransferase TGM2; EC 2.3.1.-; Protein-glutamine histaminyltransferase TGM2; EC 2.3.1.-; Protein-glutamine noradrenalinyltransferase TGM2; EC 2.3.1.-; Protein-glutamine serotonyltransferase TGM2; EC 2.3.1.-; Tissue transglutaminase; tTG; tTgase; Transglutaminase C; TG(C; TGC; TGase C; Transglutaminase H; TGase H; Transglutaminase II; TGase II; Transglutaminase-2; TG2; TGase-2; hTG2,,7052,transglutaminase 2,transglutaminase 2 (C polypeptide; protein-glutamine-gamma-glutamyltransferase),C polypeptide; protein-glutamine-gamma-glutamyltransferase,TGC; TG2,transglutaminase 2,G(h); TG(C); TGC; hTG2; tTG,TGM2
P22001,KCNA3_HUMAN,KCNA3; HGK5,Potassium voltage-gated channel subfamily A member 3; HGK5; HLK3; HPCN3; Voltage-gated K(+; Voltage-gated potassium channel subunit Kv1.3,HGK5,3738,potassium voltage-gated channel subfamily A member 3,potassium voltage-gated channel; shaker-related subfamily; member 3; potassium channel,,Kv1.3; MK3; HLK3; HPCN3; RP11-284N8.3,potassium voltage-gated channel subfamily A member 3,HGK5; HLK3; HPCN3; HUKIII; KV1.3; MK3; PCN3,KCNA3
P22059,OSBP1_HUMAN,OSBP; OSBP1,Oxysterol-binding protein 1,OSBP1,5007,oxysterol binding protein,,,OSBP1,oxysterol binding protein,OSBP1,OSBP
P22234,PUR6_HUMAN,PAICS; ADE2; AIRC; PAIS,Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase; PAICS; EC 4.1.1.21; AIR carboxylase; AIRC; EC 6.3.2.6; SAICAR synthetase,ADE2; AIRC; PAIS,10606,phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase,phosphoribosylaminoimidazole carboxylase; phosphoribosylaminoimidazole succinocarboxamide synthetase,,ADE2H1; AIRC,phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase,ADE2; ADE2H1; AIRC; PAICSD; PAIS,PAICS
P22314,UBA1_HUMAN,UBA1; A1S9T; UBE1,Ubiquitin-like modifier-activating enzyme 1; EC 6.2.1.45; Protein A1S9; Ubiquitin-activating enzyme E1,A1S9T; UBE1,7317,ubiquitin like modifier activating enzyme 1,ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing); ubiquitin-activating enzyme E1; ubiquitin-like modifier activating enzyme 1,UBA1; ubiquitin-activating enzyme E1 homolog (yeast); POC20 centriolar protein homolog (Chlamydomonas),UBE1X; POC20; CFAP124,ubiquitin like modifier activating enzyme 1,A1S9; A1S9T; A1ST; AMCX1; CFAP124; GXP1; POC20; SMAX2; UBA1A; UBE1; UBE1X; VEXAS,UBA1
P22392,NDKB_HUMAN,NME2; NM23B,Nucleoside diphosphate kinase B; NDK B; NDP kinase B; EC 2.7.4.6; C-myc purine-binding transcription factor PUF; Histidine protein kinase NDKB; EC 2.7.13.3; nm23-H2,NM23B,4831,NME/NM23 nucleoside diphosphate kinase 2,non-metastatic cells 2; protein (NM23B) expressed in,,NM23-H2; NDPKB,NME/NM23 nucleoside diphosphate kinase 2,NDKB; NDPK-B; NDPKB; NM23-H2; NM23B; PUF,NME2
P22415,USF1_HUMAN,USF1; BHLHB11; USF,Upstream stimulatory factor 1; Class B basic helix-loop-helix protein 11; bHLHb11; Major late transcription factor 1,BHLHB11; USF,7391,upstream transcription factor 1,,,UEF; MLTFI; bHLHb11,upstream transcription factor 1,FCHL; FCHL1; HYPLIP1; MLTF; MLTFI; UEF; bHLHb11,USF1
P22455,FGFR4_HUMAN,FGFR4; JTK2; TKF,Fibroblast growth factor receptor 4; FGFR-4; EC 2.7.10.1; CD antigen CD334,JTK2; TKF,2264,fibroblast growth factor receptor 4,,tyrosine kinase related to fibroblast growth factor receptor,JTK2; CD334; TKF,fibroblast growth factor receptor 4,CD334; JTK2; TKF,FGFR4
P22459,KCNA4_HUMAN,KCNA4; KCNA4L,Potassium voltage-gated channel subfamily A member 4; HPCN2; Voltage-gated K(+; Voltage-gated potassium channel HBK4; Voltage-gated potassium channel HK1; Voltage-gated potassium channel subunit Kv1.4,KCNA4L,3739,potassium voltage-gated channel subfamily A member 4,potassium voltage-gated channel; shaker-related subfamily; member 4-like; potassium voltage-gated channel; shaker-related subfamily; member 4,,Kv1.4; HK1; HPCN2; PCN2,potassium voltage-gated channel subfamily A member 4,HBK4; HK1; HPCN2; HUKII; KCNA4L; KCNA8; KV1.4; MCIDDS; PCN2,KCNA4
P22460,KCNA5_HUMAN,KCNA5,Potassium voltage-gated channel subfamily A member 5; HPCN1; Voltage-gated potassium channel HK2; Voltage-gated potassium channel subunit Kv1.5,,3741,potassium voltage-gated channel subfamily A member 5,potassium voltage-gated channel; shaker-related subfamily; member 5,,Kv1.5; HK2; HPCN1,potassium voltage-gated channel subfamily A member 5,ATFB7; HCK1; HK2; HPCN1; KV1.5; PCN1,KCNA5
P22607,FGFR3_HUMAN,FGFR3; JTK4,Fibroblast growth factor receptor 3; FGFR-3; EC 2.7.10.1; CD antigen CD333,JTK4,2261,fibroblast growth factor receptor 3,achondroplasia; thanatophoric dwarfism,,CEK2; JTK4; CD333,fibroblast growth factor receptor 3,ACH; CD333; CEK2; HSFGFR3EX; JTK4,FGFR3
P22612,KAPCG_HUMAN,PRKACG,cAMP-dependent protein kinase catalytic subunit gamma; PKA C-gamma; EC 2.7.11.11,,5568,protein kinase cAMP-activated catalytic subunit gamma,protein kinase; cAMP-dependent; catalytic; gamma; protein kinase; cAMP-dependent; gamma catalytic subunit,,PKACg,protein kinase cAMP-activated catalytic subunit gamma,BDPLT19; KAPG; PKACg,PRKACG
P22626,ROA2_HUMAN,HNRNPA2B1; HNRPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1; hnRNP A2/B1,HNRPA2B1,3181,heterogeneous nuclear ribonucleoprotein A2/B1,,,HNRNPA2; HNRNPB1,heterogeneous nuclear ribonucleoprotein A2/B1,HNRNPA2; HNRNPB1; HNRPA2; HNRPA2B1; HNRPB1; IBMPFD2; OPMD2; RNPA2; SNRPB1,HNRNPA2B1
P22670,RFX1_HUMAN,RFX1,MHC class II regulatory factor RFX1; Enhancer factor C; EF-C; Regulatory factor X 1; RFX; Transcription factor RFX1,,5989,regulatory factor X1,regulatory factor X; 1 (influences HLA class II expression),trans-acting regulatory factor 1; enhancer factor C; MHC class II regulatory factor RFX,EF-C,regulatory factor X1,EFC; RFX,RFX1
P22674,CCNO_HUMAN,CCNO,Cyclin-O,,10309,cyclin O,cyclin U,,UDG2; FLJ22422; UNG2,cyclin O,CCNU; CILD29; UDG2,CCNO
P22681,CBL_HUMAN,CBL; CBL2; RNF55,E3 ubiquitin-protein ligase CBL; EC 2.3.2.27; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; RING-type E3 ubiquitin transferase CBL; Signal transduction protein CBL,CBL2; RNF55,867,Cbl proto-oncogene,Cas-Br-M (murine) ecotropic retroviral transforming sequence; Cbl proto-oncogene; E3 ubiquitin protein ligase,oncogene CBL2,RNF55; c-Cbl,Cbl proto-oncogene,C-CBL; CBL2; FRA11B; NSLL; RNF55,CBL
P22694,KAPCB_HUMAN,PRKACB,cAMP-dependent protein kinase catalytic subunit beta; PKA C-beta; EC 2.7.11.11,,5567,protein kinase cAMP-activated catalytic subunit beta,protein kinase; cAMP-dependent; catalytic; beta; protein kinase; cAMP-dependent; beta catalytic subunit,cAMP-dependent protein kinase catalytic subunit beta; PKA C-beta,PKACb,protein kinase cAMP-activated catalytic subunit beta,CAFD2; PKA C-beta; PKACB,PRKACB
P22736,NR4A1_HUMAN,NR4A1; GFRP1; HMR; NAK1,Nuclear receptor subfamily 4immunitygroup A member 1; Early response protein NAK1; Nuclear hormone receptor NUR/77; Nur77; Orphan nuclear receptor HMR; Orphan nuclear receptor TR3; ST-59; Testicular receptor 3,GFRP1; HMR; NAK1,3164,nuclear receptor subfamily 4 group A member 1,nuclear receptor subfamily 4; group A; member 1,,TR3; N10; NAK-1; NGFIB; NUR77,nuclear receptor subfamily 4 group A member 1,GFRP1; HMR; N10; NAK-1; NGFIB; NP10; NUR77; TR3,NR4A1
P23025,XPA_HUMAN,XPA; XPAC,DNA repair protein complementing XP-A cells; Xeroderma pigmentosum group A-complementing protein,XPAC,7507,XPA; DNA damage recognition and repair factor,xeroderma pigmentosum; complementation group A,,XPAC; XP1,XPA; DNA damage recognition and repair factor,XP1; XPAC,XPA
P23246,SFPQ_HUMAN,SFPQ; PSF,Splicing factor; proline- and glutamine-rich; 100 kDa DNA-pairing protein; hPOMp100; DNA-binding p52/p100 complex; 100 kDa subunit; Polypyrimidine tract-binding protein-associated-splicing factor; PSF; PTB-associated-splicing factor,PSF,6421,splicing factor proline and glutamine rich,splicing factor proline/glutamine rich (polypyrimidine tract-binding protein-associated); splicing factor proline/glutamine-rich,polypyrimidine tract binding protein associated; protein phosphatase 1; regulatory subunit 140,PSF; PPP1R140,splicing factor proline and glutamine rich,POMP100; PPP1R140; PSF,SFPQ
P23258,TBG1_HUMAN,TUBG1; TUBG,Tubulin gamma-1 chain; Gamma-1-tubulin; Gamma-tubulin complex component 1; GCP-1,TUBG,7283,tubulin gamma 1,tubulin; gamma polypeptide; tubulin; gamma 1,,TUBGCP1,tubulin gamma 1,CDCBM4; GCP-1; TUBG; TUBGCP1,TUBG1
P23327,SRCH_HUMAN,HRC; HCP,Sarcoplasmic reticulum histidine-rich calcium-binding protein,HCP,3270,histidine rich calcium binding protein,histidine-rich calcium-binding protein,,MGC133236,histidine rich calcium binding protein,,HRC
P23396,RS3_HUMAN,RPS3; OK/SW-cl.26,Small ribosomal subunit protein uS3; 40S ribosomal protein S3; EC 4.2.99.18,,6188,ribosomal protein S3,,IMR-90 ribosomal protein S3; 40S ribosomal protein S3,FLJ26283; FLJ27450; MGC87870; S3; uS3,ribosomal protein S3,S3; uS3,RPS3
P23443,KS6B1_HUMAN,RPS6KB1; STK14A,Ribosomal protein S6 kinase beta-1; S6K-beta-1; S6K1; EC 2.7.11.1; 70 kDa ribosomal protein S6 kinase 1; P70S6K1; p70-S6K 1; Ribosomal protein S6 kinase I; Serine/threonine-protein kinase 14A; p70 ribosomal S6 kinase alpha; p70 S6 kinase alpha; p70 S6K-alpha; p70 S6KA,STK14A,6198,ribosomal protein S6 kinase B1,ribosomal protein S6 kinase; 70kD; polypeptide 1,,S6K1; p70(S6K)-alpha; PS6K; S6K,ribosomal protein S6 kinase B1,PS6K; S6K; S6K-beta-1; S6K1; STK14A; p70 S6KA; p70(S6K)-alpha; p70-S6K; p70-alpha,RPS6KB1
P23458,JAK1_HUMAN,JAK1; JAK1A; JAK1B,Tyrosine-protein kinase JAK1; EC 2.7.10.2; Janus kinase 1; JAK-1,JAK1A; JAK1B,3716,Janus kinase 1,,,JAK1A; JTK3,Janus kinase 1,AIIDE; JAK1A; JAK1B; JTK3,JAK1
P23467,PTPRB_HUMAN,PTPRB; PTPB,Receptor-type tyrosine-protein phosphatase beta; Protein-tyrosine phosphatase beta; R-PTP-beta; EC 3.1.3.48; Vascular endothelial protein tyrosine phosphatase; VE-PTP,PTPB,5787,protein tyrosine phosphatase receptor type B,,,,protein tyrosine phosphatase receptor type B,HPTP-BETA; HPTPB; PTPB; R-PTP-BETA; VEPTP,PTPRB
P23468,PTPRD_HUMAN,PTPRD,Receptor-type tyrosine-protein phosphatase delta; Protein-tyrosine phosphatase delta; R-PTP-delta; EC 3.1.3.48,,5789,protein tyrosine phosphatase receptor type D,,,PTPD; HPTP,protein tyrosine phosphatase receptor type D,HPTP; HPTPD; HPTPDELTA; PTPD; R-PTP-delta; RPTPDELTA,PTPRD
P23469,PTPRE_HUMAN,PTPRE,Receptor-type tyrosine-protein phosphatase epsilon; Protein-tyrosine phosphatase epsilon; R-PTP-epsilon; EC 3.1.3.48,,5791,protein tyrosine phosphatase receptor type E,,,PTPE,protein tyrosine phosphatase receptor type E,HPTPE; PTPE; R-PTP-EPSILON,PTPRE
P23471,PTPRZ_HUMAN,PTPRZ1; HTPZP2; PTPRZ; PTPRZ2; PTPZ,Receptor-type tyrosine-protein phosphatase zeta; R-PTP-zeta; EC 3.1.3.48; Protein-tyrosine phosphatase receptor type Z polypeptide 1; Protein-tyrosine phosphatase receptor type Z polypeptide 2; R-PTP-zeta-2,HTPZP2; PTPRZ; PTPRZ2; PTPZ,5803,protein tyrosine phosphatase receptor type Z1,protein tyrosine phosphatase; receptor-type; Z polypeptide 1,,PTP18; RPTPB; phosphacan,protein tyrosine phosphatase receptor type Z1,HPTPZ; HPTPzeta; PTP-ZETA; PTP18; PTPRZ; PTPZ; R-PTP-zeta-2; RPTPB; RPTPbeta; phosphacan,PTPRZ1
P23527,H2B1O_HUMAN,H2BC17; H2BFH; H2BFN; HIST1H2BO,Histone H2B type 1-O; H2B-clustered histone 17; Histone H2B.2; Histone H2B.n; H2B/n,H2BFH; H2BFN; HIST1H2BO,8348,H2B clustered histone 17,H2B histone family; member N; histone 1; H2bo; histone cluster 1; H2bo; histone cluster 1 H2B family member o,,H2B/n; H2B.2,H2B clustered histone 17,H2B.2; H2B/n; H2BFN; HIST1H2BO; dJ193B12.2,H2BC17
P23528,COF1_HUMAN,CFL1; CFL,Cofilin-1; 18 kDa phosphoprotein; p18; Cofilin; non-muscle isoform,CFL,1072,cofilin 1,cofilin 1 (non-muscle),,,cofilin 1,CFL; HEL-S-15; cofilin,CFL1
P23560,BDNF_HUMAN,BDNF,Neurotrophic factor BDNF precursor form; proBDNF; Abrineurin; Brain-derived neurotrophic factor,,627,brain derived neurotrophic factor,,neurotrophin,,brain derived neurotrophic factor,ANON2; BULN2,BDNF
P23588,IF4B_HUMAN,EIF4B,Eukaryotic translation initiation factor 4B; eIF-4B,,1975,eukaryotic translation initiation factor 4B,,,,eukaryotic translation initiation factor 4B,EIF-4B; PRO1843,EIF4B
P23634,AT2B4_HUMAN,ATP2B4; ATP2B2; MXRA1,Plasma membrane calcium-transporting ATPase 4; PMCA4; EC 7.2.2.10; Matrix-remodeling-associated protein 1; Plasma membrane calcium ATPase isoform 4; Plasma membrane calcium pump isoform 4,ATP2B2; MXRA1,493,ATPase plasma membrane Ca2+ transporting 4,matrix-remodelling associated 1; ATPase; Ca++ transporting; plasma membrane 4,plasma membrane calcium-transporting ATPase 4,PMCA4,ATPase plasma membrane Ca2+ transporting 4,ATP2B2; MXRA1; PMCA4; PMCA4b; PMCA4x,ATP2B4
P23677,IP3KA_HUMAN,ITPKA,Inositol-trisphosphate 3-kinase A; EC 2.7.1.127; Inositol 1;4;5-trisphosphate 3-kinase A; IP3 3-kinase A; IP3K A; InsP 3-kinase A,,3706,inositol-trisphosphate 3-kinase A,inositol 1;4;5-trisphosphate 3-kinase A,,IP3KA; IP3-3KA,inositol-trisphosphate 3-kinase A,IP3-3KA; IP3KA,ITPKA
P23743,DGKA_HUMAN,DGKA; DAGK; DAGK1,Diacylglycerol kinase alpha; DAG kinase alpha; EC 2.7.1.107; EC 2.7.1.93; 80 kDa diacylglycerol kinase; Diglyceride kinase alpha; DGK-alpha,DAGK; DAGK1,1606,diacylglycerol kinase alpha,diacylglycerol kinase; alpha (80kD); diacylglycerol kinase; alpha 80kDa,,DGK-alpha,diacylglycerol kinase alpha,DAGK; DAGK1; DGK-alpha,DGKA
P23760,PAX3_HUMAN,PAX3; HUP2,Paired box protein Pax-3; HuP2,HUP2,5077,paired box 3,Waardenburg syndrome 1; paired box gene 3 (Waardenburg syndrome 1),,HUP2; PAX-3,paired box 3,CDHS; HUP2; PAX-3; WS1; WS3,PAX3
P23769,GATA2_HUMAN,GATA2,Endothelial transcription factor GATA-2; GATA-binding protein 2,,2624,GATA binding protein 2,GATA-binding protein 2,,NFE1B,GATA binding protein 2,DCML; IMD21; MONOMAC; NFE1B,GATA2
P23771,GATA3_HUMAN,GATA3,Trans-acting T-cell-specific transcription factor GATA-3; GATA-binding factor 3,,2625,GATA binding protein 3,GATA-binding protein 3,,HDR,GATA binding protein 3,HDR; HDRS,GATA3
P23975,SC6A2_HUMAN,SLC6A2; NAT1; NET1; SLC6A5,Sodium-dependent noradrenaline transporter; Norepinephrine transporter; NET; Solute carrier family 6 member 2,NAT1; NET1; SLC6A5,6530,solute carrier family 6 member 2,solute carrier family 6 (neurotransmitter transporter; noradrenalin); member 2; solute carrier family 6 (neurotransmitter transporter); member 2,norepinephrine transporter,NET,solute carrier family 6 member 2,NAT1; NET; NET1; SLC6A5,SLC6A2
P24385,CCND1_HUMAN,CCND1; BCL1; PRAD1,G1/S-specific cyclin-D1; B-cell lymphoma 1 protein; BCL-1; BCL-1 oncogene; PRAD1 oncogene,BCL1; PRAD1,595,cyclin D1,cyclin D1 (PRAD1: parathyroid adenomatosis 1),parathyroid adenomatosis 1; B-cell CLL/lymphoma 1; G1/S-specific cyclin D1,U21B31,cyclin D1,BCL1; D11S287E; PRAD1; U21B31,CCND1
P24390,ERD21_HUMAN,KDELR1; ERD2.1,ER lumen protein-retaining receptor 1; KDEL endoplasmic reticulum protein retention receptor 1; KDEL receptor 1; Putative MAPK-activating protein PM23,ERD2.1,10945,KDEL endoplasmic reticulum protein retention receptor 1,KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,,ERD2.1; ERD2; HDEL,KDEL endoplasmic reticulum protein retention receptor 1,ERD2; ERD2.1; HDEL; PM23,KDELR1
P24588,AKAP5_HUMAN,AKAP5; AKAP79,A-kinase anchor protein 5; AKAP-5; A-kinase anchor protein 79 kDa; AKAP 79; H21; cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein,AKAP79,9495,A-kinase anchoring protein 5,A kinase (PRKA) anchor protein 5,,AKAP75; AKAP79,A-kinase anchoring protein 5,AKAP75; AKAP79; H21,AKAP5
P24666,PPAC_HUMAN,ACP1,Low molecular weight phosphotyrosine protein phosphatase; LMW-PTP; LMW-PTPase; EC 3.1.3.48; Adipocyte acid phosphatase; Low molecular weight cytosolic acid phosphatase; EC 3.1.3.2; Red cell acid phosphatase 1,,52,acid phosphatase 1,acid phosphatase 1; soluble,acid phosphatase of erythrocyte; low molecular weight phosphotyrosine protein phosphatase; red cell acid phosphatase,HAAP; LMW-PTP; LMWPTP,acid phosphatase 1,HAAP; LMW-PTP; LMWPTP,ACP1
P24723,KPCL_HUMAN,PRKCH; PKCL; PRKCL,Protein kinase C eta type; EC 2.7.11.13; PKC-L; nPKC-eta,PKCL; PRKCL,5583,protein kinase C eta,protein kinase C; eta,,PKC-L; PKCL,protein kinase C eta,PKC-L; PKCL; PRKCL; nPKC-eta; uORF2,PRKCH
P24752,THIL_HUMAN,ACAT1; ACAT; MAT,Acetyl-CoA acetyltransferase; mitochondrial; EC 2.3.1.9; Acetoacetyl-CoA thiolase; T2,ACAT; MAT,38,acetyl-CoA acetyltransferase 1,acetyl-Coenzyme A acetyltransferase 1,acetoacetyl Coenzyme A thiolase,THIL,acetyl-CoA acetyltransferase 1,ACAT; MAT; T2; THIL,ACAT1
P24844,MYL9_HUMAN,MYL9; MLC2; MRLC1; MYRL2,Myosin regulatory light polypeptide 9; 20 kDa myosin light chain; LC20; MLC-2C; Myosin RLC; Myosin regulatory light chain 2; smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRLC1,MLC2; MRLC1; MYRL2,10398,myosin light chain 9,myosin; light polypeptide 9; regulatory; myosin; light chain 9; regulatory,myosin regulatory light chain 2; smooth muscle isoform; myosin regulatory light chain 1,MYRL2; MLC2; LC20; MRLC1,myosin light chain 9,LC20; MLC-2C; MLC2; MMIHS4; MRLC1; MYRL2,MYL9
P24864,CCNE1_HUMAN,CCNE1; CCNE,G1/S-specific cyclin-E1,CCNE,898,cyclin E1,,cyclin Es; cyclin Et,,cyclin E1,CCNE; pCCNE1,CCNE1
P24928,RPB1_HUMAN,POLR2A; POLR2,DNA-directed RNA polymerase II subunit RPB1; RNA polymerase II subunit B1; EC 2.7.7.6; 3'-5' exoribonuclease; EC 3.1.13.-; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase III largest subunit; RNA-directed RNA polymerase II subunit RPB1; EC 2.7.7.48,POLR2,5430,RNA polymerase II subunit A,polymerase (RNA) II (DNA directed) polypeptide A; 220kDa,DNA-directed RNA polymerase II largest subunit; RNA polymerase II 220 kd subunit; RNA polymerase II subunit B1,POLRA; RPB1,RNA polymerase II subunit A,NEDHIB; POLR2; POLRA; RPB1; RPBh1; RPO2; RPOL2; RpIILS; hRPB220; hsRPB1,POLR2A
P24941,CDK2_HUMAN,CDK2; CDKN2,Cyclin-dependent kinase 2; EC 2.7.11.22; Cell division protein kinase 2; p33 protein kinase,CDKN2,1017,cyclin dependent kinase 2,,,,cyclin dependent kinase 2,CDKN2; p33(CDK2),CDK2
P25024,CXCR1_HUMAN,CXCR1; CMKAR1; IL8RA,C-X-C chemokine receptor type 1; CXC-R1; CXCR-1; CDw128a; High affinity interleukin-8 receptor A; IL-8R A; IL-8 receptor type 1; CD antigen CD181,CMKAR1; IL8RA,3577,C-X-C motif chemokine receptor 1,interleukin 8 receptor; alpha; chemokine (C-X-C motif) receptor 1,,CKR-1; CDw128a; CD181,C-X-C motif chemokine receptor 1,C-C; C-C-CKR-1; CD128; CD181; CDw128a; CKR-1; CMKAR1; IL8R1; IL8RA; IL8RBA,CXCR1
P25025,CXCR2_HUMAN,CXCR2; IL8RB,C-X-C chemokine receptor type 2; CXC-R2; CXCR-2; CDw128b; GRO/MGSA receptor; High affinity interleukin-8 receptor B; IL-8R B; IL-8 receptor type 2; CD antigen CD182,IL8RB,3579,C-X-C motif chemokine receptor 2,interleukin 8 receptor; beta; chemokine (C-X-C motif) receptor 2,,CMKAR2; CD182,C-X-C motif chemokine receptor 2,CD182; CDw128b; CMKAR2; IL8R2; IL8RA; IL8RB; WHIMS2,CXCR2
P25054,APC_HUMAN,APC; DP2.5,Adenomatous polyposis coli protein; Protein APC; Deleted in polyposis 2.5,DP2.5,324,APC regulator of WNT signaling pathway,adenomatosis polyposis coli; adenomatous polyposis coli; APC; WNT signaling pathway regulator,protein phosphatase 1; regulatory subunit 46,DP2; DP3; DP2.5; PPP1R46,APC regulator of WNT signaling pathway,BTPS2; DESMD; DP2; DP2.5; DP3; GS; PPP1R46,APC
P25098,ARBK1_HUMAN,GRK2; ADRBK1; BARK; BARK1,Beta-adrenergic receptor kinase 1; Beta-ARK-1; EC 2.7.11.15; G-protein coupled receptor kinase 2,ADRBK1; BARK; BARK1,156,G protein-coupled receptor kinase 2,adrenergic; beta; receptor kinase 1,,BARK1,G protein-coupled receptor kinase 2,ADRBK1; BARK1; BETA-ARK1,GRK2
P25205,MCM3_HUMAN,MCM3,DNA replication licensing factor MCM3; EC 3.6.4.12; DNA polymerase alpha holoenzyme-associated protein P1; P1-MCM3; RLF subunit beta; p102,,4172,minichromosome maintenance complex component 3,minichromosome maintenance deficient (S. cerevisiae) 3; MCM3 minichromosome maintenance deficient 3 (S. cerevisiae),,,minichromosome maintenance complex component 3,HCC5; P1-MCM3; P1.h; RLFB,MCM3
P25490,TYY1_HUMAN,YY1; INO80S,Transcriptional repressor protein YY1; Delta transcription factor; INO80 complex subunit S; NF-E1; Yin and yang 1; YY-1,INO80S,7528,YY1 transcription factor,,INO80 complex subunit S; Yin and Yang 1 protein,NF-E1; DELTA; UCRBP; YIN-YANG-1; INO80S,YY1 transcription factor,DELTA; GADEVS; INO80S; NF-E1; UCRBP; YIN-YANG-1,YY1
P25685,DNJB1_HUMAN,DNAJB1; DNAJ1; HDJ1; HSPF1,DnaJ homolog subfamily B member 1; DnaJ protein homolog 1; Heat shock 40 kDa protein 1; HSP40; Heat shock protein 40; Human DnaJ protein 1; hDj-1,DNAJ1; HDJ1; HSPF1,3337,DnaJ heat shock protein family (Hsp40) member B1,DnaJ (Hsp40) homolog; subfamily B; member 1,radial spoke 16 homolog B (Chlamydomonas),Hsp40; Sis1; RSPH16B,DnaJ heat shock protein family (Hsp40) member B1,HSPF1; Hdj1; Hsp40; RSPH16B; Sis1,DNAJB1
P25686,DNJB2_HUMAN,DNAJB2; HSJ1; HSPF3,DnaJ homolog subfamily B member 2; Heat shock 40 kDa protein 3; Heat shock protein J1; HSJ-1,HSJ1; HSPF3,3300,DnaJ heat shock protein family (Hsp40) member B2,DnaJ (Hsp40) homolog; subfamily B; member 2,,HSPF3; CMT2T,DnaJ heat shock protein family (Hsp40) member B2,CMT2T; DSMA5; HMNR5; HSJ-1; HSJ1; HSPF3,DNAJB2
P25963,IKBA_HUMAN,NFKBIA; IKBA; MAD3; NFKBI,NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3,IKBA; MAD3; NFKBI,4792,NFKB inhibitor alpha,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; alpha,NF-kappa-B inhibitor alpha,IKBA; MAD-3; IkappaBalpha,NFKB inhibitor alpha,EDAID2; IKBA; MAD-3; NFKBI,NFKBIA
P26010,ITB7_HUMAN,ITGB7,Integrin beta-7; Gut homing receptor beta subunit,,3695,integrin subunit beta 7,integrin; beta 7,,,integrin subunit beta 7,,ITGB7
P26038,MOES_HUMAN,MSN,Moesin; Membrane-organizing extension spike protein,,4478,moesin,,,,moesin,HEL70; IMD50,MSN
P26045,PTN3_HUMAN,PTPN3; PTPH1,Tyrosine-protein phosphatase non-receptor type 3; EC 3.1.3.48; Protein-tyrosine phosphatase H1; PTP-H1,PTPH1,5774,protein tyrosine phosphatase non-receptor type 3,,,PTPH1,protein tyrosine phosphatase non-receptor type 3,PTP-H1; PTPH1,PTPN3
P26358,DNMT1_HUMAN,DNMT1; AIM; CXXC9; DNMT,DNA; cytosine-5; Dnmt1; EC 2.1.1.37; CXXC-type zinc finger protein 9; DNA methyltransferase HsaI; DNA MTase HsaI; M.HsaI; MCMT,AIM; CXXC9; DNMT,1786,DNA methyltransferase 1,DNA (cytosine-5-)-methyltransferase 1,,MCMT; CXXC9,DNA methyltransferase 1,ADCADN; AIM; CXXC9; DNMT; HSN1E; MCMT; m.HsaI,DNMT1
P26368,U2AF2_HUMAN,U2AF2; U2AF65,Splicing factor U2AF 65 kDa subunit; U2 auxiliary factor 65 kDa subunit; hU2AF(65; hU2AF65; U2 snRNP auxiliary factor large subunit,U2AF65,11338,U2 small nuclear RNA auxiliary factor 2,U2 (RNU2) small nuclear RNA auxiliary factor 2,U2 small nuclear ribonucleoprotein auxiliary factor (65kD); splicing factor U2AF 65 kD subunit; U2 snRNP auxiliary factor large subunit,U2AF65,U2 small nuclear RNA auxiliary factor 2,DEVDFB; U2AF65,U2AF2
P26373,RL13_HUMAN,RPL13; BBC1; OK/SW-cl.46,Large ribosomal subunit protein eL13; 60S ribosomal protein L13; Breast basic conserved protein 1,BBC1,6137,ribosomal protein L13,,breast basic conserved 1,D16S444E; BBC1; L13; eL13,ribosomal protein L13,BBC1; D16S444E; D16S44E; L13; SEMDIST; eL13,RPL13
P26599,PTBP1_HUMAN,PTBP1; PTB,Polypyrimidine tract-binding protein 1; PTB; 57 kDa RNA-binding protein PPTB-1; Heterogeneous nuclear ribonucleoprotein I; hnRNP I,PTB,5725,polypyrimidine tract binding protein 1,polypyrimidine tract binding protein (heterogeneous nuclear ribonucleoprotein I),heterogeneous nuclear ribonucleoprotein I,HNRPI; HNRNP-I; PTB2; PTB3; PTB-1; PTB4; pPTB,polypyrimidine tract binding protein 1,HNRNP-I; HNRNPI; HNRPI; PTB; PTB-1; PTB-T; PTB2; PTB3; PTB4; pPTB,PTBP1
P26651,TTP_HUMAN,ZFP36; G0S24; NUP475; RNF162A; TIS11A; TTP,mRNA decay activator protein ZFP36; G0/G1 switch regulatory protein 24; Growth factor-inducible nuclear protein NUP475; Tristetraprolin; Zinc finger protein 36; Zfp-36,G0S24; NUP475; RNF162A; TIS11A; TTP,7538,ZFP36 ring finger protein,zinc finger protein 36; C3H type; homolog (mouse),tristetraprolin,RNF162A; TIS11; G0S24; TTP; NUP475,ZFP36 ring finger protein,G0S24; GOS24; NUP475; RNF162A; TIS11; TTP; zfp-36,ZFP36
P26678,PPLA_HUMAN,PLN; PLB,Phospholamban; PLB,PLB,5350,phospholamban,,,CMD1P,phospholamban,CMD1P; CMH18; PLB,PLN
P27348,1433T_HUMAN,YWHAQ,14-3-3 protein theta; 14-3-3 protein T-cell; 14-3-3 protein tau; Protein HS1,,10971,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; theta polypeptide; protein; theta,protein tau; 14-3-3 theta,HS1; 14-3-3,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta,14-3-3; 1C5; HS1,YWHAQ
P27361,MK03_HUMAN,MAPK3; ERK1; PRKM3,Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; EC 2.7.11.24; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1,ERK1; PRKM3,5595,mitogen-activated protein kinase 3,,,ERK1; p44mapk; p44erk1; ERK-1,mitogen-activated protein kinase 3,ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK,MAPK3
P27448,MARK3_HUMAN,MARK3; CTAK1; EMK2,MAP/microtubule affinity-regulating kinase 3; EC 2.7.11.1; C-TAK1; cTAK1; Cdc25C-associated protein kinase 1; ELKL motif kinase 2; EMK-2; Protein kinase STK10; Ser/Thr protein kinase PAR-1; Par-1a; Serine/threonine-protein kinase p78,CTAK1; EMK2,4140,microtubule affinity regulating kinase 3,MAP/microtubule affinity-regulating kinase 3,,CTAK1; KP78; PAR-1A,microtubule affinity regulating kinase 3,CTAK1; KP78; PAR1A; Par-1a; VIPB,MARK3
P27482,CALL3_HUMAN,CALML3,Calmodulin-like protein 3; CaM-like protein; CLP; Calmodulin-related protein NB-1,,810,calmodulin like 3,calmodulin-like 3,,CLP,calmodulin like 3,CLP,CALML3
P27540,ARNT_HUMAN,ARNT; BHLHE2,Aryl hydrocarbon receptor nuclear translocator; ARNT protein; Class E basic helix-loop-helix protein 2; bHLHe2; Dioxin receptor; nuclear translocator; Hypoxia-inducible factor 1-beta; HIF-1-beta; HIF1-beta,BHLHE2,405,aryl hydrocarbon receptor nuclear translocator,,hypoxia inducible factor 1 subunit beta,HIF-1beta; bHLHe2; ARNT1,aryl hydrocarbon receptor nuclear translocator,ARNT1; HIF-1-beta; HIF-1beta; HIF1-beta; HIF1B; HIF1BETA; TANGO; bHLHe2,ARNT
P27707,DCK_HUMAN,DCK,Deoxycytidine kinase; dCK; EC 2.7.1.74; Deoxyadenosine kinase; EC 2.7.1.76; Deoxyguanosine kinase; EC 2.7.1.113,,1633,deoxycytidine kinase,,,,deoxycytidine kinase,,DCK
P27708,PYR1_HUMAN,CAD,Multifunctional protein CAD; Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase; EC 6.3.5.5; GATase; GLNase; EC 3.5.1.2; CPS; CPSase; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3,,790,carbamoyl-phosphate synthetase 2; aspartate transcarbamylase; and dihydroorotase,,,GATD4,carbamoyl-phosphate synthetase 2; aspartate transcarbamylase; and dihydroorotase,CDG1Z; DEE50; EIEE50; GATD4,CAD
P27815,PDE4A_HUMAN,PDE4A; DPDE2,3';5'-cyclic-AMP phosphodiesterase 4A; EC 3.1.4.53; DPDE2; PDE46; cAMP-specific phosphodiesterase 4A,DPDE2,5141,phosphodiesterase 4A,phosphodiesterase 4A; cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E2); phosphodiesterase 4A; cAMP-specific,phosphodiesterase E2 dunce homolog (Drosophila),,phosphodiesterase 4A,DPDE2; PDE4; PDE46,PDE4A
P27816,MAP4_HUMAN,MAP4,Microtubule-associated protein 4; MAP-4,,4134,microtubule associated protein 4,,,,microtubule associated protein 4,,MAP4
P27824,CALX_HUMAN,CANX,Calnexin; IP90; Major histocompatibility complex class I antigen-binding protein p88; p90,,821,calnexin,,major histocompatibility complex class I antigen-binding protein p88,CNX; IP90; P90,calnexin,CNX; IP90; P90,CANX
P27986,P85A_HUMAN,PIK3R1; GRB1,Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase subunit p85-alpha; PtdIns-3-kinase regulatory subunit p85-alpha,GRB1,5295,phosphoinositide-3-kinase regulatory subunit 1,phosphoinositide-3-kinase; regulatory subunit 1 (alpha),phosphoinositide-3-kinase regulatory subunit alpha; growth factor receptor bound 1; PI3 kinase-associated p85,GRB1; p85-ALPHA; p85; p85alpha,phosphoinositide-3-kinase regulatory subunit 1,AGM7; GRB1; IMD36; p85; p85-ALPHA; p85alpha,PIK3R1
P28289,TMOD1_HUMAN,TMOD1; D9S57E; TMOD,Tropomodulin-1; Erythrocyte tropomodulin; E-Tmod,D9S57E; TMOD,7111,tropomodulin 1,,,ETMOD,tropomodulin 1,D9S57E; ETMOD; TMOD,TMOD1
P28324,ELK4_HUMAN,ELK4; SAP1,ETS domain-containing protein Elk-4; Serum response factor accessory protein 1; SAP-1; SRF accessory protein 1,SAP1,2005,ETS transcription factor ELK4,ELK4; ETS-domain protein (SRF accessory protein 1),SRF accessory protein 1,SAP1,ETS transcription factor ELK4,SAP1,ELK4
P28329,CLAT_HUMAN,CHAT,Choline O-acetyltransferase; CHOACTase; ChAT; Choline acetylase; EC 2.3.1.6,,1103,choline O-acetyltransferase,choline acetyltransferase,,CHOACTase,choline O-acetyltransferase,CHOACTASE; CMS1A; CMS1A2; CMS6,CHAT
P28482,MK01_HUMAN,MAPK1; ERK2; PRKM1; PRKM2,Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; EC 2.7.11.24; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2,ERK2; PRKM1; PRKM2,5594,mitogen-activated protein kinase 1,,Extracellular signal-regulated kinase 2,ERK; ERK2; p41mapk; MAPK2,mitogen-activated protein kinase 1,ERK; ERK-2; ERK2; ERT1; MAPK2; NS13; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK,MAPK1
P28562,DUS1_HUMAN,DUSP1; CL100; MKP1; PTPN10; VH1,Dual specificity protein phosphatase 1; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase hVH1; Mitogen-activated protein kinase phosphatase 1; MAP kinase phosphatase 1; MKP-1; Protein-tyrosine phosphatase CL100,CL100; MKP1; PTPN10; VH1,1843,dual specificity phosphatase 1,,,HVH1; CL100; MKP-1,dual specificity phosphatase 1,CL100; HVH1; MKP-1; MKP1; PTPN10,DUSP1
P28749,RBL1_HUMAN,RBL1,Retinoblastoma-like protein 1; 107 kDa retinoblastoma-associated protein; p107; pRb1,,5933,RB transcriptional corepressor like 1,retinoblastoma-like 1,,p107; cp107; PRB1,RB transcriptional corepressor like 1,CP107; PRB1; p107,RBL1
P28799,GRN_HUMAN,GRN,Progranulin; PGRN; Acrogranin; Epithelin precursor; Glycoprotein of 88 Kda; GP88; Glycoprotein 88; Granulin precursor; PC cell-derived growth factor; PCDGF; Proepithelin; PEPI; Granulin G; Granulin F; Epithelin-2; Granulin B; Epithelin-1; Granulin A; Granulin C; Granulin D; Granulin E,,2896,granulin precursor,,progranulin,PCDGF; PGRN; CLN11,granulin precursor,CLN11; FTD2; GEP; GP88; PCDGF; PEPI; PGRN,GRN
P28827,PTPRM_HUMAN,PTPRM; PTPRL1,Receptor-type tyrosine-protein phosphatase mu; Protein-tyrosine phosphatase mu; R-PTP-mu; EC 3.1.3.48,PTPRL1,5797,protein tyrosine phosphatase receptor type M,,,RPTPU; hR-PTPu,protein tyrosine phosphatase receptor type M,PTPRL1; R-PTP-MU; RPTPM; RPTPU; hR-PTPu,PTPRM
P29074,PTN4_HUMAN,PTPN4,Tyrosine-protein phosphatase non-receptor type 4; EC 3.1.3.48; Protein-tyrosine phosphatase MEG1; MEG; PTPase-MEG1,,5775,protein tyrosine phosphatase non-receptor type 4,protein tyrosine phosphatase; non-receptor type 4 (megakaryocyte),,PTPMEG,protein tyrosine phosphatase non-receptor type 4,MEG; PTPMEG; PTPMEG1,PTPN4
P29317,EPHA2_HUMAN,EPHA2; ECK,Ephrin type-A receptor 2; EC 2.7.10.1; Epithelial cell kinase; Tyrosine-protein kinase receptor ECK,ECK,1969,EPH receptor A2,EphA2,,,EPH receptor A2,ARCC2; CTPA; CTPP1; CTRCT6; ECK,EPHA2
P29320,EPHA3_HUMAN,EPHA3; ETK; ETK1; HEK; TYRO4,Ephrin type-A receptor 3; EC 2.7.10.1; EPH-like kinase 4; EK4; hEK4; HEK; Human embryo kinase; Tyrosine-protein kinase TYRO4; Tyrosine-protein kinase receptor ETK1; Eph-like tyrosine kinase 1,ETK; ETK1; HEK; TYRO4,2042,EPH receptor A3,EphA3,,HEK; HEK4,EPH receptor A3,EK4; ETK; ETK1; HEK; HEK4; TYRO4,EPHA3
P29322,EPHA8_HUMAN,EPHA8; EEK; HEK3; KIAA1459,Ephrin type-A receptor 8; EC 2.7.10.1; EPH- and ELK-related kinase; EPH-like kinase 3; EK3; hEK3; Tyrosine-protein kinase receptor EEK,EEK; HEK3; KIAA1459,2046,EPH receptor A8,EphA8,,Hek3,EPH receptor A8,EEK; EK3; HEK3,EPHA8
P29323,EPHB2_HUMAN,EPHB2; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5,Ephrin type-B receptor 2; EC 2.7.10.1; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH tyrosine kinase 3; EPH-like kinase 5; EK5; hEK5; Renal carcinoma antigen NY-REN-47; Tyrosine-protein kinase TYRO5; Tyrosine-protein kinase receptor EPH-3,DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5,2048,EPH receptor B2,EphB2,,Hek5; Tyro5,EPH receptor B2,BDPLT22; CAPB; DRT; EK5; EPHT3; ERK; Hek5; PCBC; Tyro5,EPHB2
P29350,PTN6_HUMAN,PTPN6; HCP; PTP1C,Tyrosine-protein phosphatase non-receptor type 6; EC 3.1.3.48; Hematopoietic cell protein-tyrosine phosphatase; Protein-tyrosine phosphatase 1C; PTP-1C; Protein-tyrosine phosphatase SHP-1; SH-PTP1,HCP; PTP1C,5777,protein tyrosine phosphatase non-receptor type 6,,,HCP; HCPH; PTP-1C; SHP-1; SHP1,protein tyrosine phosphatase non-receptor type 6,HCP; HCPH; HPTP1C; PTP-1C; SH-PTP1; SHP-1; SHP-1L; SHP1,PTPN6
P29353,SHC1_HUMAN,SHC1; SHC; SHCA,SHC-transforming protein 1; SHC-transforming protein 3; SHC-transforming protein A; Src homology 2 domain-containing-transforming protein C1; SH2 domain protein C1,SHC; SHCA,6464,SHC adaptor protein 1,SHC (Src homology 2 domain-containing) transforming protein 1,,p66; ShcA,SHC adaptor protein 1,SHC; SHCA,SHC1
P29374,ARI4A_HUMAN,ARID4A; RBBP1; RBP1,AT-rich interactive domain-containing protein 4A; ARID domain-containing protein 4A; Retinoblastoma-binding protein 1; RBBP-1,RBBP1; RBP1,5926,AT-rich interaction domain 4A,retinoblastoma-binding protein 1; AT rich interactive domain 4A (RBP1-like),,RBP1; RBP-1,AT-rich interaction domain 4A,RBBP-1; RBBP1; RBP-1; RBP1,ARID4A
P29375,KDM5A_HUMAN,KDM5A; JARID1A; RBBP2; RBP2,Lysine-specific demethylase 5A; EC 1.14.11.67; Histone demethylase JARID1A; Jumonji/ARID domain-containing protein 1A; Retinoblastoma-binding protein 2; RBBP-2; histone H3-trimethyl-L-lysine(4,JARID1A; RBBP2; RBP2,5927,lysine demethylase 5A,retinoblastoma-binding protein 2; Jumonji; AT rich interactive domain 1A (RBBP2-like); jumonji; AT rich interactive domain 1A; lysine (K)-specific demethylase 5A,,,lysine demethylase 5A,NEDEHC; RBBP-2; RBBP2; RBP2,KDM5A
P29401,TKT_HUMAN,TKT,Transketolase; TK; EC 2.2.1.1,,7086,transketolase,,Wernicke-Korsakoff syndrome,,transketolase,HEL-S-48; HEL107; SDDHD; TK; TKT1,TKT
P29474,NOS3_HUMAN,NOS3,Nitric oxide synthase 3; EC 1.14.13.39; Constitutive NOS; cNOS; EC-NOS; NOS type III; NOSIII; Nitric oxide synthase; endothelial; Endothelial NOS; eNOS,,4846,nitric oxide synthase 3,nitric oxide synthase 3 (endothelial cell),endothelial nitric oxide synthase,ECNOS; eNOS,nitric oxide synthase 3,ECNOS; eNOS,NOS3
P29475,NOS1_HUMAN,NOS1,Nitric oxide synthase 1; EC 1.14.13.39; Constitutive NOS; NC-NOS; NOS type I; Neuronal NOS; N-NOS; nNOS; Nitric oxide synthase; brain; bNOS; Peptidyl-cysteine S-nitrosylase NOS1,,4842,nitric oxide synthase 1,nitric oxide synthase 1 (neuronal),,nNOS,nitric oxide synthase 1,IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS,NOS1
P29590,PML_HUMAN,PML; MYL; PP8675; RNF71; TRIM19,Protein PML; E3 SUMO-protein ligase PML; EC 2.3.2.-; Promyelocytic leukemia protein; RING finger protein 71; RING-type E3 SUMO transferase PML; Tripartite motif-containing protein 19; TRIM19,MYL; PP8675; RNF71; TRIM19,5371,PML nuclear body scaffold,promyelocytic leukemia,,MYL; TRIM19; RNF71,PML nuclear body scaffold,MYL; PP8675; RNF71; TRIM19,PML
P29597,TYK2_HUMAN,TYK2,Non-receptor tyrosine-protein kinase TYK2; EC 2.7.10.2,,7297,tyrosine kinase 2,,,JTK1,tyrosine kinase 2,IMD35; JTK1,TYK2
P29692,EF1D_HUMAN,EEF1D; EF1D,Elongation factor 1-delta; EF-1-delta; Antigen NY-CO-4,EF1D,1936,eukaryotic translation elongation factor 1 delta,eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein),,EF-1D; FLJ20897,eukaryotic translation elongation factor 1 delta,EF-1D; EF1D; FP1047,EEF1D
P29803,ODPAT_HUMAN,PDHA2; PDHAL,Pyruvate dehydrogenase E1 component subunit alpha; testis-specific form; mitochondrial; EC 1.2.4.1; PDHE1-A type II,PDHAL,5161,pyruvate dehydrogenase E1 subunit alpha 2,pyruvate dehydrogenase (lipoamide) alpha 2; pyruvate dehydrogenase alpha 2,,,pyruvate dehydrogenase E1 subunit alpha 2,PDHAL; SPGF70,PDHA2
P29966,MARCS_HUMAN,MARCKS; MACS; PRKCSL,Myristoylated alanine-rich C-kinase substrate; MARCKS; Protein kinase C substrate; 80 kDa protein; light chain; 80K-L protein; PKCSL,MACS; PRKCSL,4082,myristoylated alanine rich protein kinase C substrate,myristoylated alanine-rich protein kinase C substrate (MARCKS; 80K-L),,PKCSL; 80K-L,myristoylated alanine rich protein kinase C substrate,80K-L; MACS; PKCSL; PRKCSL,MARCKS
P29972,AQP1_HUMAN,AQP1; CHIP28,Aquaporin-1; AQP-1; Aquaporin-CHIP; Channel-like integral membrane protein of 28 kDa; Urine water channel,CHIP28,358,aquaporin 1 (Colton blood group),Colton blood group; aquaporin 1 (channel-forming integral protein; 28kDa); aquaporin 1 (channel-forming integral protein; 28kDa; CO blood group); aquaporin 1,,CHIP28,aquaporin 1 (Colton blood group),AQP-CHIP; CHIP28; CO,AQP1
P30041,PRDX6_HUMAN,PRDX6; AOP2; KIAA0106,Peroxiredoxin-6; EC 1.11.1.27; 1-Cys peroxiredoxin; 1-Cys PRX; 24 kDa protein; Acidic calcium-independent phospholipase A2; aiPLA2; EC 3.1.1.4; Antioxidant protein 2; Glutathione-dependent peroxiredoxin; Liver 2D page spot 40; Lysophosphatidylcholine acyltransferase 5; LPC acyltransferase 5; LPCAT-5; Lyso-PC acyltransferase 5; EC 2.3.1.23; Non-selenium glutathione peroxidase; NSGPx; Red blood cells page spot 12,AOP2; KIAA0106,9588,peroxiredoxin 6,,,AOP2; KIAA0106; 1-Cys; NSGPx; PRX; aiPLA2; MGC46173; p29,peroxiredoxin 6,1-Cys; AOP2; HEL-S-128m; LPCAT-5; NSGPx; PRX; aiPLA2; p29,PRDX6
P30050,RL12_HUMAN,RPL12,Large ribosomal subunit protein uL11; 60S ribosomal protein L12,,6136,ribosomal protein L12,,,L12; uL11,ribosomal protein L12,L12; uL11,RPL12
P30086,PEBP1_HUMAN,PEBP1; PBP; PEBP,Phosphatidylethanolamine-binding protein 1; PEBP-1; HCNPpp; Neuropolypeptide h3; Prostatic-binding protein; Raf kinase inhibitor protein; RKIP; HCNP,PBP; PEBP,5037,phosphatidylethanolamine binding protein 1,prostatic binding protein,Raf kinase inhibitory protein; hippocampal cholinergic neurostimulating peptide,RKIP; HCNP; PEBP,phosphatidylethanolamine binding protein 1,HCNP; HCNPpp; HEL-210; HEL-S-34; HEL-S-96; PBP; PEBP; PEBP-1; RKIP,PEBP1
P30101,PDIA3_HUMAN,PDIA3; ERP57; ERP60; GRP58,Protein disulfide-isomerase A3; EC 5.3.4.1; 58 kDa glucose-regulated protein; 58 kDa microsomal protein; p58; Disulfide isomerase ER-60; Endoplasmic reticulum resident protein 57; ER protein 57; ERp57; Endoplasmic reticulum resident protein 60; ER protein 60; ERp60,ERP57; ERP60; GRP58,2923,protein disulfide isomerase family A member 3,glucose regulated protein; 58kDa; protein disulfide isomerase-associated 3; protein disulfide isomerase family A; member 3,,P58; ERp61; ERp57; ERp60; GRP57; PI-PLC; HsT17083,protein disulfide isomerase family A member 3,ER60; ERp57; ERp60; ERp61; GRP57; GRP58; HEL-S-269; HEL-S-93n; HsT17083; P58; PI-PLC,PDIA3
P30153,2AAA_HUMAN,PPP2R1A,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform; PP2Aa; Medium tumor antigen-associated 61 kDa protein; PP2A subunit A isoform PR65-alpha; PP2A subunit A isoform R1-alpha,,5518,protein phosphatase 2 scaffold subunit Aalpha,protein phosphatase 2 (formerly 2A); regulatory subunit A (PR 65); alpha isoform,protein phosphatase 2A; regulatory subunit A; alpha isoform; protein phosphatase 2; 65kDa regulatory subunit A; protein phosphatase 2A structural subunit A; alpha isoform; Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PR65A; PP2A-Aalpha; PP2AA,protein phosphatase 2 scaffold subunit Aalpha,HJS2; MRD36; PP2A-Aalpha; PP2AA; PP2AAALPHA; PR65A,PPP2R1A
P30154,2AAB_HUMAN,PPP2R1B,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform; PP2A subunit A isoform PR65-beta; PP2A subunit A isoform R1-beta,,5519,protein phosphatase 2 scaffold subunit Abeta,protein phosphatase 2 (formerly 2A); regulatory subunit A (PR 65); beta isoform; protein phosphatase 2 regulatory subunit A; beta,PP2A-A-beta; protein phosphatase 2A; regulatory subunit A; beta isoform,PR65B; PP2A-Abeta,protein phosphatase 2 scaffold subunit Abeta,PP2A-Abeta; PR65B,PPP2R1B
P30203,CD6_HUMAN,CD6,T-cell differentiation antigen CD6; T12; TP120; CD antigen CD6,,923,CD6 molecule,CD6 antigen,,Tp120,CD6 molecule,TP120,CD6
P30260,CDC27_HUMAN,CDC27; ANAPC3; D0S1430E; D17S978E,Cell division cycle protein 27 homolog; Anaphase-promoting complex subunit 3; APC3; CDC27 homolog; CDC27Hs; H-NUC,ANAPC3; D0S1430E; D17S978E,996,cell division cycle 27,D0S1430E; D17S978E,anaphase promoting complex subunit 3,APC3; ANAPC3; NUC2,cell division cycle 27,ANAPC3; APC3; CDC27Hs; D0S1430E; D17S978E; H-NUC; HNUC; NUC2,CDC27
P30273,FCERG_HUMAN,FCER1G,High affinity immunoglobulin epsilon receptor subunit gamma; Fc receptor gamma-chain; FcRgamma; Fc-epsilon RI-gamma; IgE Fc receptor subunit gamma; FceRI gamma,,2207,Fc epsilon receptor Ig,Fc fragment of IgE; high affinity I; receptor for; gamma polypeptide; Fc fragment of IgE receptor Ig,FcepsilonRI gamma chain,FcepsilonRIgamma,Fc epsilon receptor Ig,FCRG,FCER1G
P30279,CCND2_HUMAN,CCND2,G1/S-specific cyclin-D2,,894,cyclin D2,,G1/S-specific cyclin D2,,cyclin D2,KIAK0002; MPPH3,CCND2
P30281,CCND3_HUMAN,CCND3,G1/S-specific cyclin-D3,,896,cyclin D3,,,,cyclin D3,,CCND3
P30291,WEE1_HUMAN,WEE1,Wee1-like protein kinase; WEE1hu; EC 2.7.10.2; Wee1A kinase,,7465,WEE1 G2 checkpoint kinase,wee1+ (S. pombe) homolog; WEE1 homolog (S. pombe),,WEE1A,WEE1 G2 checkpoint kinase,WEE1A; WEE1hu,WEE1
P30304,MPIP1_HUMAN,CDC25A,M-phase inducer phosphatase 1; EC 3.1.3.48; Dual specificity phosphatase Cdc25A,,993,cell division cycle 25A,,CDC25 homolog A (S. pombe); M-phase inducer phosphatase 1,,cell division cycle 25A,CDC25A2,CDC25A
P30305,MPIP2_HUMAN,CDC25B; CDC25HU2,M-phase inducer phosphatase 2; EC 3.1.3.48; Dual specificity phosphatase Cdc25B,CDC25HU2,994,cell division cycle 25B,,CDC25 homolog B (S. pombe); M-phase inducer phosphatase 2,MPIP2,cell division cycle 25B,,CDC25B
P30307,MPIP3_HUMAN,CDC25C,M-phase inducer phosphatase 3; EC 3.1.3.48; Dual specificity phosphatase Cdc25C,,995,cell division cycle 25C,,protein phosphatase 1; regulatory subunit 60; CDC25 homolog C (S. pombe); M-phase inducer phosphatase 3,PPP1R60,cell division cycle 25C,CDC25; PPP1R60,CDC25C
P30405,PPIF_HUMAN,PPIF; CYP3,Peptidyl-prolyl cis-trans isomerase F; mitochondrial; PPIase F; EC 5.2.1.8; Cyclophilin D; CyP-D; CypD; Cyclophilin F; Mitochondrial cyclophilin; CyP-M; Rotamase F,CYP3,10105,peptidylprolyl isomerase F,peptidylprolyl isomerase F (cyclophilin F),cyclophilin D,hCyP3; Cyp-D; CypD,peptidylprolyl isomerase F,CYP3; CyP-M; Cyp-D; CypD,PPIF
P30411,BKRB2_HUMAN,BDKRB2; BKR2,B2 bradykinin receptor; B2R; BK-2 receptor,BKR2,624,bradykinin receptor B2,,,BK-2,bradykinin receptor B2,B2R; BK-2; BK2; BKR2; BRB2,BDKRB2
P30419,NMT1_HUMAN,NMT1; NMT,Glycylpeptide N-tetradecanoyltransferase 1; EC 2.3.1.97; Myristoyl-CoA:protein N-myristoyltransferase 1; HsNMT1; NMT 1; Type I N-myristoyltransferase; Peptide N-myristoyltransferase 1; Protein-lysine myristoyltransferase NMT1; EC 2.3.1.-,NMT,4836,N-myristoyltransferase 1,,alternative; short form NMT-S; myristoyl-CoA:protein N-myristoyltransferase; long form; NMT-L,NMT,N-myristoyltransferase 1,HsNMT1; NMT,NMT1
P30518,V2R_HUMAN,AVPR2; ADHR; DIR; DIR3; V2R,Vasopressin V2 receptor; V2R; AVPR V2; Antidiuretic hormone receptor; Renal-type arginine vasopressin receptor,ADHR; DIR; DIR3; V2R,554,arginine vasopressin receptor 2,,nephrogenic diabetes insipidus,V2R,arginine vasopressin receptor 2,ADHR; DI1; DIR; DIR3; NDI; NDI1; V2R,AVPR2
P30530,UFO_HUMAN,AXL; UFO,Tyrosine-protein kinase receptor UFO; EC 2.7.10.1; AXL oncogene,UFO,558,AXL receptor tyrosine kinase,,,UFO; JTK11; Tyro7; ARK,AXL receptor tyrosine kinase,ARK; AXL3; JTK11; Tyro7; UFO,AXL
P30556,AGTR1_HUMAN,AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B,Type-1 angiotensin II receptor; AT1AR; AT1BR; Angiotensin II type-1 receptor; AT1 receptor,AGTR1A; AGTR1B; AT2R1; AT2R1B,185,angiotensin II receptor type 1,angiotensin receptor 1B,angiotensin II type 1 receptor,AT1; AT2R1; AGTR1A; AT2R1A; HAT1R; AG2S; AT2R1B; AT1B; ATR1,angiotensin II receptor type 1,AG2S; AGTR1B; AT1; AT1AR; AT1B; AT1BR; AT1R; AT2R1; ATR1; HAT1R,AGTR1
P30622,CLIP1_HUMAN,CLIP1; CYLN1; RSN,CAP-Gly domain-containing linker protein 1; Cytoplasmic linker protein 1; Cytoplasmic linker protein 170 alpha-2; CLIP-170; Reed-Sternberg intermediate filament-associated protein; Restin,CYLN1; RSN,6249,CAP-Gly domain containing linker protein 1,restin (Reed-Steinberg cell-expressed intermediate filament-associated protein); CAP-GLY domain containing linker protein 1,restin,CYLN1; CLIP170; CLIP; CLIP-170,CAP-Gly domain containing linker protein 1,CLIP; CLIP-170; CLIP170; CYLN1; RSN,CLIP1
P30626,SORCN_HUMAN,SRI,Sorcin; 22 kDa protein; CP-22; CP22; V19,,6717,sorcin,,,,sorcin,CP-22; CP22; SCN; V19,SRI
P30874,SSR2_HUMAN,SSTR2,Somatostatin receptor type 2; SS-2-R; SS2-R; SS2R; SST2; SRIF-1,,6752,somatostatin receptor 2,,,,somatostatin receptor 2,SST2,SSTR2
P31040,SDHA_HUMAN,SDHA; SDH2; SDHF,Succinate dehydrogenase ubiquinone flavoprotein subunit; mitochondrial; EC 1.3.5.1; Flavoprotein subunit of complex II; Fp; Malate dehydrogenase quinone flavoprotein subunit; EC 1.1.5.-,SDH2; SDHF,6389,succinate dehydrogenase complex flavoprotein subunit A,succinate dehydrogenase complex; subunit A; flavoprotein (Fp); succinate dehydrogenase complex subunit A; flavoprotein (Fp),succinate dehydrogenase ubiquinone flavoprotein subunit; flavoprotein subunit of complex II,FP; SDHF,succinate dehydrogenase complex flavoprotein subunit A,CMD1GG; FP; MC2DN1; NDAXOA; PGL5; PPGL5; SDH1; SDH2; SDHF,SDHA
P31152,MK04_HUMAN,MAPK4; ERK4; PRKM4,Mitogen-activated protein kinase 4; MAP kinase 4; MAPK 4; EC 2.7.11.24; Extracellular signal-regulated kinase 4; ERK-4; MAP kinase isoform p63; p63-MAPK,ERK4; PRKM4,5596,mitogen-activated protein kinase 4,,,Erk3-related; Erk4,mitogen-activated protein kinase 4,ERK-4; ERK4; PRKM4; p63-MAPK; p63MAPK,MAPK4
P31260,HXA10_HUMAN,HOXA10; HOX1H,Homeobox protein Hox-A10; Homeobox protein Hox-1.8; Homeobox protein Hox-1H; PL,HOX1H,3206,homeobox A10,homeo box A10,,,homeobox A10,HOX1; HOX1.8; HOX1H; PL,HOXA10
P31270,HXA11_HUMAN,HOXA11; HOX1I,Homeobox protein Hox-A11; Homeobox protein Hox-1I,HOX1I,3207,homeobox A11,homeo box A11,,,homeobox A11,HOX1; HOX1I; RUSAT1,HOXA11
P31321,KAP1_HUMAN,PRKAR1B,cAMP-dependent protein kinase type I-beta regulatory subunit,,5575,protein kinase cAMP-dependent type I regulatory subunit beta,protein kinase; cAMP-dependent; regulatory; type I; beta; protein kinase; cAMP-dependent; regulatory subunit type I beta,,,protein kinase cAMP-dependent type I regulatory subunit beta,MASNS; PRKAR1,PRKAR1B
P31323,KAP3_HUMAN,PRKAR2B,cAMP-dependent protein kinase type II-beta regulatory subunit,,5577,protein kinase cAMP-dependent type II regulatory subunit beta,protein kinase; cAMP-dependent; regulatory; type II; beta; protein kinase; cAMP-dependent; regulatory subunit type II beta,,,protein kinase cAMP-dependent type II regulatory subunit beta,PRKAR2; RII-BETA,PRKAR2B
P31350,RIR2_HUMAN,RRM2; RR2,Ribonucleoside-diphosphate reductase subunit M2; EC 1.17.4.1; Ribonucleotide reductase small chain; Ribonucleotide reductase small subunit,RR2,6241,ribonucleotide reductase regulatory subunit M2,ribonucleotide reductase M2 polypeptide; chromosome 2 open reading frame 48,,FLJ25102,ribonucleotide reductase regulatory subunit M2,C2orf48; R2; RR2; RR2M,RRM2
P31431,SDC4_HUMAN,SDC4,Syndecan-4; SYND4; Amphiglycan; Ryudocan core protein,,6385,syndecan 4,syndecan 4 (amphiglycan; ryudocan),syndecan proteoglycan 4,SYND4; amphiglycan; ryudocan,syndecan 4,SYND4,SDC4
P31645,SC6A4_HUMAN,SLC6A4; HTT; SERT,Sodium-dependent serotonin transporter; SERT; 5HT transporter; 5HTT; Solute carrier family 6 member 4,HTT; SERT,6532,solute carrier family 6 member 4,solute carrier family 6 (neurotransmitter transporter; serotonin); member 4; 5-hydroxytryptamine (serotonin) transporter; obsessive-compulsive disorder 1; solute carrier family 6 (neurotransmitter transporter); member 4,serotonin transporter 1,5-HTT; SERT1,solute carrier family 6 member 4,5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT,SLC6A4
P31749,AKT1_HUMAN,AKT1; PKB; RAC,RAC-alpha serine/threonine-protein kinase; EC 2.7.11.1; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha,PKB; RAC,207,AKT serine/threonine kinase 1,v-akt murine thymoma viral oncogene homolog 1,protein kinase B,RAC; PKB; PRKBA; AKT; RAC-alpha,AKT serine/threonine kinase 1,AKT; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA,AKT1
P31751,AKT2_HUMAN,AKT2,RAC-beta serine/threonine-protein kinase; EC 2.7.11.1; Protein kinase Akt-2; Protein kinase B beta; PKB beta; RAC protein kinase beta; RAC-PK-beta,,208,AKT serine/threonine kinase 2,v-akt murine thymoma viral oncogene homolog 2,,PKB??,AKT serine/threonine kinase 2,HIHGHH; PKBB; PKBBETA; PRKBB; RAC-BETA,AKT2
P31939,PUR9_HUMAN,ATIC; PURH; OK/SW-cl.86,Bifunctional purine biosynthesis protein ATIC; AICAR transformylase/inosine monophosphate cyclohydrolase; ATIC; EC 2.1.2.3; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; AICAR formyltransferase; AICAR transformylase; IMP cyclohydrolase; EC 3.5.4.10; IMP synthase; Inosinicase,PURH,471,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,,phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase,PURH; AICARFT; IMPCHASE,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,AICAR; AICARFT; HEL-S-70p; IMPCHASE; PURH,ATIC
P31943,HNRH1_HUMAN,HNRNPH1; HNRPH; HNRPH1,Heterogeneous nuclear ribonucleoprotein H; hnRNP H,HNRPH; HNRPH1,3187,heterogeneous nuclear ribonucleoprotein H1,heterogeneous nuclear ribonucleoprotein H1 (H),Heterogeneous nuclear ribonucleoprotein H,hnRNPH,heterogeneous nuclear ribonucleoprotein H1,HNRPH; HNRPH1; NEDCDS; hnRNPH,HNRNPH1
P31946,1433B_HUMAN,YWHAB,14-3-3 protein beta/alpha; Protein 1054; Protein kinase C inhibitor protein 1; KCIP-1,,7529,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; alpha polypeptide; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; beta polypeptide,14-3-3 beta; 14-3-3 alpha,,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,GW128; HEL-S-1; HS1; KCIP-1; YWHAA,YWHAB
P31947,1433S_HUMAN,SFN; HME1,14-3-3 protein sigma; Epithelial cell marker protein 1; Stratifin,HME1,2810,stratifin,,14-3-3 sigma,YWHAS,stratifin,YWHAS,SFN
P31994,FCG2B_HUMAN,FCGR2B; CD32; FCG2; IGFR2,Low affinity immunoglobulin gamma Fc region receptor II-b; IgG Fc receptor II-b; CDw32; Fc-gamma RII-b; Fc-gamma-RIIb; FcRII-b; CD antigen CD32,CD32; FCG2; IGFR2,2213,Fc gamma receptor IIb,Fc fragment of IgG; low affinity IIb; receptor for (CD32); Fc fragment of IgG; low affinity IIb; receptor (CD32); Fc fragment of IgG receptor IIb,,CD32; CD32B; FcgammaRIIb; FcGRIIB,Fc gamma receptor IIb,CD32; CD32B; FCG2; FCGR2; FCGR2C; FcGRIIB; FcRII-c; FcgammaRIIb; IGFR2,FCGR2B
P31995,FCG2C_HUMAN,FCGR2C; CD32; FCG2; IGFR2,Low affinity immunoglobulin gamma Fc region receptor II-c; IgG Fc receptor II-c; CDw32; Fc-gamma RII-c; Fc-gamma-RIIc; FcRII-c; CD antigen CD32,CD32; FCG2; IGFR2,9103,Fc gamma receptor IIc (gene/pseudogene),Fc fragment of IgG; low affinity IIc; receptor for (CD32); Fc fragment of IgG; low affinity IIc; receptor for (CD32) (gene/pseudogene); Fc fragment of IgG receptor IIc (gene/pseudogene),,hFcRII-C; CD32C; Fc-gamma-RIIc; FcgammaRIIc,Fc gamma receptor IIc (gene/pseudogene),CD32; CD32C; CDW32; FCG2; FCRIIC; FcgammaRIIc; IGFR2,FCGR2C
P32004,L1CAM_HUMAN,L1CAM; CAML1; MIC5,Neural cell adhesion molecule L1; N-CAM-L1; NCAM-L1; CD antigen CD171,CAML1; MIC5,3897,L1 cell adhesion molecule,antigen identified by monoclonal antibody R1,neural cell adhesion molecule L1,CD171; NCAM-L1; CAML1,L1 cell adhesion molecule,CAML1; CD171; HSAS; HSAS1; HYCX; MASA; MIC5; N-CAM-L1; N-CAML1; NCAM-L1; S10; SPG1,L1CAM
P32121,ARRB2_HUMAN,ARRB2; ARB2; ARR2,Beta-arrestin-2; Arrestin beta-2; Non-visual arrestin-3,ARB2; ARR2,409,arrestin beta 2,arrestin; beta 2,arrestin 3,BARR2; DKFZp686L0365,arrestin beta 2,ARB2; ARR2; BARR2,ARRB2
P32245,MC4R_HUMAN,MC4R,Melanocortin receptor 4; MC4-R,,4160,melanocortin 4 receptor,,,,melanocortin 4 receptor,BMIQ20,MC4R
P32246,CCR1_HUMAN,CCR1; CMKBR1; CMKR1; SCYAR1,C-C chemokine receptor type 1; C-C CKR-1; CC-CKR-1; CCR-1; CCR1; HM145; LD78 receptor; Macrophage inflammatory protein 1-alpha receptor; MIP-1alpha-R; RANTES-R; CD antigen CD191,CMKBR1; CMKR1; SCYAR1,1230,C-C motif chemokine receptor 1,chemokine (C-C motif) receptor 1,,CKR-1; MIP1aR; CD191,C-C motif chemokine receptor 1,CD191; CKR-1; CKR1; CMKBR1; HM145; MIP1aR; SCYAR1,CCR1
P32248,CCR7_HUMAN,CCR7; CMKBR7; EBI1; EVI1,C-C chemokine receptor type 7; C-C CKR-7; CC-CKR-7; CCR-7; BLR2; CDw197; Epstein-Barr virus-induced G-protein coupled receptor 1; EBI1; EBV-induced G-protein coupled receptor 1; MIP-3 beta receptor; CD antigen CD197,CMKBR7; EBI1; EVI1,1236,C-C motif chemokine receptor 7,chemokine (C-C motif) receptor 7,,BLR2; CDw197; CD197,C-C motif chemokine receptor 7,BLR2; CC-CKR-7; CCR-7; CD197; CDw197; CMKBR7; EBI1,CCR7
P32298,GRK4_HUMAN,GRK4; GPRK2L; GPRK4,G protein-coupled receptor kinase 4; EC 2.7.11.16; G protein-coupled receptor kinase GRK4; ITI1,GPRK2L; GPRK4,2868,G protein-coupled receptor kinase 4,G protein-coupled receptor kinase 2-like (Drosophila),,GPRK4,G protein-coupled receptor kinase 4,GPRK2L; GPRK4; GRK4a; IT11,GRK4
P32302,CXCR5_HUMAN,CXCR5; BLR1; MDR15,C-X-C chemokine receptor type 5; CXC-R5; CXCR-5; Burkitt lymphoma receptor 1; Monocyte-derived receptor 15; MDR-15; CD antigen CD185,BLR1; MDR15,643,C-X-C motif chemokine receptor 5,Burkitt lymphoma receptor 1; GTP-binding protein; Burkitt lymphoma receptor 1; GTP binding protein (chemokine (C-X-C motif) receptor 5); chemokine (C-X-C motif) receptor 5,,MDR15; CD185,C-X-C motif chemokine receptor 5,BLR1; CD185; MDR15,CXCR5
P32418,NAC1_HUMAN,SLC8A1; CNC; NCX1,Sodium/calcium exchanger 1; Na(+; 2+; Solute carrier family 8 member 1,CNC; NCX1,6546,solute carrier family 8 member A1,solute carrier family 8 (sodium/calcium exchanger); member 1,Na+/Ca++ exchanger,,solute carrier family 8 member A1,NCX1,SLC8A1
P32519,ELF1_HUMAN,ELF1,ETS-related transcription factor Elf-1; E74-like factor 1,,1997,E74 like ETS transcription factor 1,E74-like factor 1 (ets domain transcription factor),,,E74 like ETS transcription factor 1,EFTUD1; RIA1,ELF1
P32927,IL3RB_HUMAN,CSF2RB; IL3RB; IL5RB,Cytokine receptor common subunit beta; CDw131; GM-CSF/IL-3/IL-5 receptor common beta subunit; CD antigen CD131,IL3RB; IL5RB,1439,colony stimulating factor 2 receptor subunit beta,colony stimulating factor 2 receptor; beta; low-affinity (granulocyte-macrophage); colony stimulating factor 2 receptor beta common subunit,beta common cytokine receptor; beta-GM-CSF receptor,IL5RB; CD131; betaGMR,colony stimulating factor 2 receptor subunit beta,CD131; CDw131; IL3RB; IL5RB; SMDP5; betaGMR,CSF2RB
P32929,CGL_HUMAN,CTH,Cystathionine gamma-lyase; CGL; CSE; EC 4.4.1.1; Cysteine desulfhydrase; Cysteine-protein sulfhydrase; Gamma-cystathionase; Homocysteine desulfhydrase; EC 4.4.1.2,,1491,cystathionine gamma-lyase,cystathionase (cystathionine gamma-lyase),,CSE,cystathionine gamma-lyase,CGL; CSE,CTH
P32942,ICAM3_HUMAN,ICAM3,Intercellular adhesion molecule 3; ICAM-3; CDw50; ICAM-R; CD antigen CD50,,3385,intercellular adhesion molecule 3,,,CDW50; ICAM-R; CD50,intercellular adhesion molecule 3,CD50; CDW50; ICAM-R,ICAM3
P33076,C2TA_HUMAN,CIITA; MHC2TA,MHC class II transactivator; CIITA; EC 2.3.1.-; EC 2.7.11.1,MHC2TA,4261,class II major histocompatibility complex transactivator,MHC class II transactivator; class II; major histocompatibility complex; transactivator,NLR family; acid domain containing; nucleotide-binding oligomerization domain; leucine rich repeat and acid domain containing,C2TA; NLRA,class II major histocompatibility complex transactivator,C2TA; CIITAIV; MHC2D1; MHC2TA; NLRA,CIITA
P33151,CADH5_HUMAN,CDH5,Cadherin-5; 7B4 antigen; Vascular endothelial cadherin; VE-cadherin; CD antigen CD144,,1003,cadherin 5,cadherin 5; type 2; VE-cadherin (vascular epithelium); cadherin 5; type 2 (vascular endothelium),VE-cadherin,7B4; CD144,cadherin 5,7B4; CD144,CDH5
P33176,KINH_HUMAN,KIF5B; KNS; KNS1,Kinesin-1 heavy chain; Conventional kinesin heavy chain; Ubiquitous kinesin heavy chain; UKHC,KNS; KNS1,3799,kinesin family member 5B,,ubiquitous kinesin heavy chain,KNS; uKHC,kinesin family member 5B,HEL-S-61; KINH; KNS; KNS1; UKHC,KIF5B
P33241,LSP1_HUMAN,LSP1; WP34,Lymphocyte-specific protein 1; 47 kDa actin-binding protein; 52 kDa phosphoprotein; pp52; Lymphocyte-specific antigen WP34,WP34,4046,lymphocyte specific protein 1,,,WP34,lymphocyte specific protein 1,WP34; pp52,LSP1
P33316,DUT_HUMAN,DUT,Deoxyuridine 5'-triphosphate nucleotidohydrolase; mitochondrial; dUTPase; EC 3.6.1.23; dUTP pyrophosphatase,,1854,deoxyuridine triphosphatase,dUTP pyrophosphatase,dUTP diphosphatase,dUTPase,deoxyuridine triphosphatase,BMFDMS; dUTPase,DUT
P33527,MRP1_HUMAN,ABCC1; MRP; MRP1,Multidrug resistance-associated protein 1; EC 7.6.2.2; ATP-binding cassette sub-family C member 1; Glutathione-S-conjugate-translocating ATPase ABCC1; EC 7.6.2.3; Leukotriene C(4; LTC4 transporter,MRP; MRP1,4363,ATP binding cassette subfamily C member 1 (ABCC1 blood group),multidrug resistance associated protein 1; ATP-binding cassette; sub-family C (CFTR/MRP); member 1; ATP binding cassette subfamily C member 1,glutathione S-conjugate export pump,GS-X,ATP binding cassette subfamily C member 1 (ABCC1 blood group),ABC29; ABCC; DFNA77; GS-X; MRP; MRP1,ABCC1
P33778,H2B1B_HUMAN,H2BC3; H2BFF; HIST1H2BB,Histone H2B type 1-B; H2B-clustered histone 3; Histone H2B.1; Histone H2B.f; H2B/f,H2BFF; HIST1H2BB,3018,H2B clustered histone 3,H2B histone family; member F; histone 1; H2bb; histone cluster 1; H2bb; histone cluster 1 H2B family member b,,H2B/f,H2B clustered histone 3,H2B.1; H2B/f; H2BFF; HIST1H2BB,H2BC3
P33981,TTK_HUMAN,TTK; MPS1; MPS1L1,Dual specificity protein kinase TTK; EC 2.7.12.1; Phosphotyrosine picked threonine-protein kinase; PYT,MPS1; MPS1L1,7272,TTK protein kinase,,cancer/testis antigen 96; monopolar spindle 1 kinase,MPS1; MPS1L1; CT96; MPH1,TTK protein kinase,CT96; ESK; MPH1; MPS1; MPS1L1; PYT,TTK
P33991,MCM4_HUMAN,MCM4; CDC21,DNA replication licensing factor MCM4; EC 3.6.4.12; CDC21 homolog; P1-CDC21,CDC21,4173,minichromosome maintenance complex component 4,MCM4 minichromosome maintenance deficient 4 (S. cerevisiae),DNA replication licensing factor MCM4,CDC54; hCdc21; P1-Cdc21; MGC33310,minichromosome maintenance complex component 4,CDC21; CDC54; IMD54; NKCD; NKGCD; P1-CDC21; hCdc21,MCM4
P33992,MCM5_HUMAN,MCM5; CDC46,DNA replication licensing factor MCM5; EC 3.6.4.12; CDC46 homolog; P1-CDC46,CDC46,4174,minichromosome maintenance complex component 5,minichromosome maintenance deficient (S. cerevisiae) 5 (cell division cycle 46); MCM5 minichromosome maintenance deficient 5; cell division cycle 46 (S. cerevisiae),,,minichromosome maintenance complex component 5,CDC46; MGORS8; P1-CDC46,MCM5
P33993,MCM7_HUMAN,MCM7; CDC47; MCM2,DNA replication licensing factor MCM7; EC 3.6.4.12; CDC47 homolog; P1.1-MCM3,CDC47; MCM2,4176,minichromosome maintenance complex component 7,minichromosome maintenance deficient (S. cerevisiae) 7; MCM7 minichromosome maintenance deficient 7 (S. cerevisiae),protein phosphatase 1; regulatory subunit 104,CDC47; PPP1R104,minichromosome maintenance complex component 7,CDC47; MCM2; P1.1-MCM3; P1CDC47; P85MCM; PNAS146; PPP1R104,MCM7
P34741,SDC2_HUMAN,SDC2; HSPG1,Syndecan-2; SYND2; Fibroglycan; Heparan sulfate proteoglycan core protein; HSPG; CD antigen CD362,HSPG1,6383,syndecan 2,heparan sulfate proteoglycan 1; cell surface-associated,syndecan proteoglycan 2,fibroglycan; SYND2; CD362,syndecan 2,CD362; HSPG; HSPG1; SYND2,SDC2
P34947,GRK5_HUMAN,GRK5; GPRK5,G protein-coupled receptor kinase 5; EC 2.7.11.16; G protein-coupled receptor kinase GRK5,GPRK5,2869,G protein-coupled receptor kinase 5,,,,G protein-coupled receptor kinase 5,FP2025; GPRK5,GRK5
P34982,OR1D2_HUMAN,OR1D2; OLFR1,Olfactory receptor 1D2; Olfactory receptor 17-4; OR17-4; Olfactory receptor OR17-6; Olfactory receptor-like protein HGMP07E,OLFR1,4991,olfactory receptor family 1 subfamily D member 2,olfactory receptor; family 1; subfamily D; member 2,,OR17-4,olfactory receptor family 1 subfamily D member 2,OLFR1; OR17-4,OR1D2
P34998,CRFR1_HUMAN,CRHR1; CRFR; CRFR1; CRHR,Corticotropin-releasing factor receptor 1; CRF-R-1; CRF-R1; CRFR-1; Corticotropin-releasing hormone receptor 1; CRH-R-1; CRH-R1,CRFR; CRFR1; CRHR,104909134,corticotropin releasing hormone receptor 1,,corticotropin-releasing factor receptor,CRF-R; CRF1,LINC02210-CRHR1 readthrough,CRHR1-IT1-CRHR1; MGC57346-CRHR1,CRHR1
P35221,CTNA1_HUMAN,CTNNA1,Catenin alpha-1; Alpha E-catenin; Cadherin-associated protein; Renal carcinoma antigen NY-REN-13,,1495,catenin alpha 1,catenin (cadherin-associated protein); alpha 1 (102kD),alpha-E-catenin,CAP102,catenin alpha 1,CAP102; MDBS2; MDPT2,CTNNA1
P35222,CTNB1_HUMAN,CTNNB1; CTNNB; OK/SW-cl.35; PRO2286,Catenin beta-1; Beta-catenin,CTNNB,1499,catenin beta 1,catenin (cadherin-associated protein); beta 1 (88kD); catenin (cadherin-associated protein); beta 1; 88kDa; catenin (cadherin-associated protein); beta 1,,beta-catenin; armadillo,catenin beta 1,CTNNB; EVR7; MRD19; NEDSDV; armadillo,CTNNB1
P35226,BMI1_HUMAN,BMI1; PCGF4; RNF51,Polycomb complex protein BMI-1; Polycomb group RING finger protein 4; RING finger protein 51,PCGF4; RNF51,100532731,BMI1 proto-oncogene; polycomb ring finger,polycomb group ring finger 4; B lymphoma Mo-MLV insertion region 1 homolog (mouse),,RNF51,COMMD3-BMI1 readthrough,BMI1; PCGF4; RNF51,BMI1
P35228,NOS2_HUMAN,NOS2; NOS2A,Nitric oxide synthase; inducible; EC 1.14.13.39; Hepatocyte NOS; HEP-NOS; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2,NOS2A,4843,nitric oxide synthase 2,nitric oxide synthase 2A (inducible; hepatocytes); nitric oxide synthase 2; inducible,,iNOS; NOS; HEP-NOS,nitric oxide synthase 2,HEP-NOS; INOS; NOS; NOS2A,NOS2
P35232,PHB1_HUMAN,PHB1; PHB,Prohibitin 1,PHB,5245,prohibitin 1,prohibitin,,BAP32,prohibitin 1,BAP32; HEL-215; HEL-S-54e; PHB,PHB1
P35236,PTN7_HUMAN,PTPN7,Tyrosine-protein phosphatase non-receptor type 7; EC 3.1.3.48; Hematopoietic protein-tyrosine phosphatase; HEPTP; Protein-tyrosine phosphatase LC-PTP,,5778,protein tyrosine phosphatase non-receptor type 7,,,HEPTP; LC-PTP,protein tyrosine phosphatase non-receptor type 7,BPTP-4; HEPTP; LC-PTP; LPTP; PTPNI,PTPN7
P35240,MERL_HUMAN,NF2; SCH,Merlin; Moesin-ezrin-radixin-like protein; Neurofibromin-2; Schwannomerlin; Schwannomin,SCH,4771,NF2; moesin-ezrin-radixin like (MERLIN) tumor suppressor,neurofibromin 2 (bilateral acoustic neuroma); neurofibromin 2 (merlin),moesin-ezrin-radixin like; schwannomin; bilateral acoustic neurofibromatosis,merlin; ACN; SCH; BANF; merlin-1,NF2; moesin-ezrin-radixin like (MERLIN) tumor suppressor,ACN; BANF; SCH; SWNV; merlin-1,NF2
P35241,RADI_HUMAN,RDX,Radixin,,5962,radixin,deafness; autosomal recessive 24,,,radixin,DFNB24,RDX
P35251,RFC1_HUMAN,RFC1; RFC140,Replication factor C subunit 1; Activator 1 140 kDa subunit; A1 140 kDa subunit; Activator 1 large subunit; Activator 1 subunit 1; DNA-binding protein PO-GA; Replication factor C 140 kDa subunit; RF-C 140 kDa subunit; RFC140; Replication factor C large subunit,RFC140,5981,replication factor C subunit 1,replication factor C (activator 1) 1 (145kD); replication factor C (activator 1) 1; 145kDa,,A1; PO-GA; RFC140; MHCBFB,replication factor C subunit 1,A1; CANVAS; MHCBFB; PO-GA; RECC1; RFC; RFC140,RFC1
P35269,T2FA_HUMAN,GTF2F1; RAP74,General transcription factor IIF subunit 1; General transcription factor IIF 74 kDa subunit; Transcription initiation factor IIF subunit alpha; TFIIF-alpha; Transcription initiation factor RAP74,RAP74,2962,general transcription factor IIF subunit 1,general transcription factor IIF; polypeptide 1 (74kD subunit); general transcription factor IIF; polypeptide 1; 74kDa,,TFIIF; BTF4; RAP74; TF2F1,general transcription factor IIF subunit 1,BTF4; RAP74; TF2F1; TFIIF,GTF2F1
P35270,SPRE_HUMAN,SPR,Sepiapterin reductase; SPR; EC 1.1.1.153,,6697,sepiapterin reductase,sepiapterin reductase (7;8-dihydrobiopterin:NADP+ oxidoreductase),short chain dehydrogenase/reductase family 38C; member 1; Sepiapterin reductase (L-erythro-7;8-dihydrobiopterin forming),SDR38C1,sepiapterin reductase,SDR38C1,SPR
P35354,PGH2_HUMAN,PTGS2; COX2,Prostaglandin G/H synthase 2; EC 1.14.99.1; Cyclooxygenase-2; COX-2; PHS II; Prostaglandin H2 synthase 2; PGH synthase 2; PGHS-2; Prostaglandin-endoperoxide synthase 2,COX2,5743,prostaglandin-endoperoxide synthase 2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),prostaglandin G/H synthase 2; cyclooxygenase 2,COX2,prostaglandin-endoperoxide synthase 2,COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2,PTGS2
P35367,HRH1_HUMAN,HRH1,Histamine H1 receptor; H1-R; H1R; HH1R,,3269,histamine receptor H1,,,,histamine receptor H1,H1-R; H1R; HH1R; hisH1,HRH1
P35372,OPRM_HUMAN,OPRM1; MOR1,Mu-type opioid receptor; M-OR-1; MOR-1; Mu opiate receptor; Mu opioid receptor; MOP; hMOP,MOR1,4988,opioid receptor mu 1,opioid receptor; mu 1,Mu opiate receptor; Mu opioid receptor,MOR1; MOP,opioid receptor mu 1,LMOR; M-OR-1; MOP; MOR; MOR1; OPRM,OPRM1
P35398,RORA_HUMAN,RORA; NR1F1; RZRA,Nuclear receptor ROR-alpha; Nuclear receptor RZR-alpha; Nuclear receptor subfamily 1 group F member 1; RAR-related orphan receptor A; Retinoid-related orphan receptor-alpha,NR1F1; RZRA,6095,RAR related orphan receptor A,RAR-related orphan receptor A,nuclear receptor subfamily 1 group F member 1; Nuclear receptor ROR-alpha; RAR-related orphan nuclear receptor alpha,RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1; ROR??,RAR related orphan receptor A,IDDECA; NR1F1; ROR1; ROR2; ROR3; RORa1; RORalpha; RZR-ALPHA; RZRA,RORA
P35498,SCN1A_HUMAN,SCN1A; NAC1; SCN1,Sodium channel protein type 1 subunit alpha; Sodium channel protein brain I subunit alpha; Sodium channel protein type I subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.1,NAC1; SCN1,6323,sodium voltage-gated channel alpha subunit 1,febrile convulsions 3; sodium channel; voltage-gated; type I; alpha subunit; sodium channel; voltage gated; type I alpha subunit,,Nav1.1; GEFSP2; HBSCI; NAC1; SMEI,sodium voltage-gated channel alpha subunit 1,DEE6; DEE6A; DEE6B; DRVT; EIEE6; FEB3; FEB3A; FHM3; GEFSP2; HBSCI; NAC1; Nav1.1; SCN1; SMEI,SCN1A
P35520,CBS_HUMAN,CBS,Cystathionine beta-synthase; EC 4.2.1.22; Beta-thionase; Serine sulfhydrase,,102724560,cystathionine beta-synthase,cystathionine-beta-synthase,,HIP4,,CBS; CBSL,CBS
P35548,MSX2_HUMAN,MSX2; HOX8,Homeobox protein MSX-2; Homeobox protein Hox-8,HOX8,4488,msh homeobox 2,msh (Drosophila) homeo box homolog 2; parietal foramina 1; msh homeobox homolog 2 (Drosophila),craniosynostosis; type 2,CRS2; FPP; HOX8; MSH; PFM,msh homeobox 2,CRS2; FPP; HOX8; MSH; PFM; PFM1,MSX2
P35557,HXK4_HUMAN,GCK,Hexokinase-4; HK4; EC 2.7.1.1; Glucokinase; Hexokinase type IV; HK IV; Hexokinase-D,,2645,glucokinase,maturity onset diabetes of the young 2; glucokinase (hexokinase 4),hexokinase 4,HK4,glucokinase,FGQTL3; GK; GLK; HHF3; HK4; HKIV; HXKP; LGLK; MODY2; PNDM1,GCK
P35568,IRS1_HUMAN,IRS1,Insulin receptor substrate 1; IRS-1,,3667,insulin receptor substrate 1,,,HIRS-1,insulin receptor substrate 1,HIRS-1,IRS1
P35579,MYH9_HUMAN,MYH9,Myosin-9; Cellular myosin heavy chain; type A; Myosin heavy chain 9; Myosin heavy chain; non-muscle IIa; Non-muscle myosin heavy chain A; NMMHC-A; Non-muscle myosin heavy chain IIa; NMMHC II-a; NMMHC-IIA,,4627,myosin heavy chain 9,myosin; heavy polypeptide 9; non-muscle,nonmuscle myosin heavy chain II-A,NMMHCA; NMHC-II-A; MHA; FTNS; EPSTS,myosin heavy chain 9,BDPLT6; DFNA17; EPSTS; FTNS; MATINS; MHA; NMHC-II-A; NMMHC-IIA; NMMHCA,MYH9
P35580,MYH10_HUMAN,MYH10,Myosin-10; Cellular myosin heavy chain; type B; Myosin heavy chain 10; Myosin heavy chain; non-muscle IIb; Non-muscle myosin heavy chain B; NMMHC-B; Non-muscle myosin heavy chain IIb; NMMHC II-b; NMMHC-IIB,,4628,myosin heavy chain 10,myosin; heavy polypeptide 10; non-muscle,,NMMHCB,myosin heavy chain 10,NMMHC-IIB; NMMHCB,MYH10
P35611,ADDA_HUMAN,ADD1; ADDA,Alpha-adducin; Erythrocyte adducin subunit alpha,ADDA,118,adducin 1,adducin 1 (alpha),alpha-adducin,,adducin 1,ADDA,ADD1
P35612,ADDB_HUMAN,ADD2; ADDB,Beta-adducin; Erythrocyte adducin subunit beta,ADDB,119,adducin 2,adducin 2 (beta),beta-adducin,ADDB,adducin 2,ADDB,ADD2
P35626,ARBK2_HUMAN,GRK3; ADRBK2; BARK2,G protein-coupled receptor kinase 3; EC 2.7.11.15; Beta-adrenergic receptor kinase 2; Beta-ARK-2,ADRBK2; BARK2,157,G protein-coupled receptor kinase 3,adrenergic; beta; receptor kinase 2,,BARK2,G protein-coupled receptor kinase 3,ADRBK2; BARK2,GRK3
P35637,FUS_HUMAN,FUS; TLS,RNA-binding protein FUS; 75 kDa DNA-pairing protein; Oncogene FUS; Oncogene TLS; POMp75; Translocated in liposarcoma protein,TLS,2521,FUS RNA binding protein,fusion; derived from t(12;16) malignant liposarcoma; amyotrophic lateral sclerosis 6; fusion (involved in t(12;16) in malignant liposarcoma); fused in sarcoma,heterogeneous nuclear ribonucleoprotein P2; translocated in liposarcoma,TLS; FUS1; hnRNP-P2; HNRNPP2,FUS RNA binding protein,ALS6; ETM4; FUS1; HNRNPP2; POMP75; TLS; altFUS,FUS
P35638,DDIT3_HUMAN,DDIT3; CHOP; CHOP10; GADD153,DNA damage-inducible transcript 3 protein; DDIT-3; C/EBP zeta; C/EBP-homologous protein; CHOP; C/EBP-homologous protein 10; CHOP-10; CCAAT/enhancer-binding protein homologous protein; Growth arrest and DNA damage-inducible protein GADD153,CHOP; CHOP10; GADD153,1649,DNA damage inducible transcript 3,DNA-damage-inducible transcript 3,C/EBP zeta; C/EBP homologous protein; growth arrest and DNA-damage-inducible gene,CHOP10; GADD153; CHOP,DNA damage inducible transcript 3,AltDDIT3; C/EBPzeta; CEBPZ; CHOP; CHOP-10; CHOP10; GADD153,DDIT3
P35658,NU214_HUMAN,NUP214; CAIN; CAN; KIAA0023,Nuclear pore complex protein Nup214; 214 kDa nucleoporin; Nucleoporin Nup214; Protein CAN,CAIN; CAN; KIAA0023,8021,nucleoporin 214,nucleoporin 214kD (CAIN); nucleoporin 214kDa,nuclear pore complex protein Nup214; CAN protein; putative oncogene,CAIN; CAN; D9S46E; N214,nucleoporin 214,CAIN; CAN; IIAE9,NUP214
P35659,DEK_HUMAN,DEK,Protein DEK,,7913,DEK proto-oncogene,DEK oncogene (DNA binding); DEK oncogene,,D6S231E,DEK proto-oncogene,D6S231E,DEK
P35790,CHKA_HUMAN,CHKA; CHK; CKI,Choline kinase alpha; CK; EC 2.7.1.32; CHETK-alpha; Ethanolamine kinase; EK; EC 2.7.1.82,CHK; CKI,1119,choline kinase alpha,choline kinase,,CKI,choline kinase alpha,CHK; CK; CKI; EK; NEDMIMS,CHKA
P35813,PPM1A_HUMAN,PPM1A; PPPM1A,Protein phosphatase 1A; EC 3.1.3.16; Protein phosphatase 2C isoform alpha; PP2C-alpha; Protein phosphatase IA,PPPM1A,5494,protein phosphatase; Mg2+/Mn2+ dependent 1A,protein phosphatase 1A (formerly 2C); magnesium-dependent; alpha isoform; protein phosphatase; Mg2+/Mn2+ dependent; 1A,phosphatase 2C alpha; protein phosphatase 2C; alpha isoform,MGC9201; PP2Calpha; PP2CA,protein phosphatase; Mg2+/Mn2+ dependent 1A,PP2C-ALPHA; PP2CA; PP2Calpha,PPM1A
P35869,AHR_HUMAN,AHR; BHLHE76,Aryl hydrocarbon receptor; Ah receptor; AhR; Class E basic helix-loop-helix protein 76; bHLHe76,BHLHE76,196,aryl hydrocarbon receptor,,,bHLHe76,aryl hydrocarbon receptor,FVH3; RP85; bHLHe76,AHR
P35900,K1C20_HUMAN,KRT20,Keratin; type I cytoskeletal 20; Cytokeratin-20; CK-20; Keratin-20; K20; Protein IT,,54474,keratin 20,keratin 20; type I,,CK20; K20; MGC35423,keratin 20,CD20; CK-20; CK20; K20; KRT21,KRT20
P35916,VGFR3_HUMAN,FLT4; VEGFR3,Vascular endothelial growth factor receptor 3; VEGFR-3; EC 2.7.10.1; Fms-like tyrosine kinase 4; FLT-4; Tyrosine-protein kinase receptor FLT4,VEGFR3,2324,fms related receptor tyrosine kinase 4,fms-related tyrosine kinase 4; fms related tyrosine kinase 4,vascular endothelial growth factor receptor 3; VEGF receptor-3; Feline McDonough Sarcoma (FMS)-like tyrosine kinase 4; primary congenital lymphedema,VEGFR3; PCL; VEGFR-3,fms related receptor tyrosine kinase 4,CHTD7; FLT-4; FLT41; LMPH1A; LMPHM1; PCL; VEGFR-3; VEGFR3,FLT4
P35968,VGFR2_HUMAN,KDR; FLK1; VEGFR2,Vascular endothelial growth factor receptor 2; VEGFR-2; EC 2.7.10.1; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309,FLK1; VEGFR2,3791,kinase insert domain receptor,kinase insert domain receptor (a type III receptor tyrosine kinase),vascular endothelial growth factor receptor 2; fetal liver kinase 1,FLK1; VEGFR; VEGFR2; CD309,kinase insert domain receptor,CD309; FLK1; VEGFR; VEGFR2,KDR
P36402,TCF7_HUMAN,TCF7; TCF1,Transcription factor 7; TCF-7; T-cell-specific transcription factor 1; T-cell factor 1; TCF-1,TCF1,6932,transcription factor 7,transcription factor 7 (T-cell specific; HMG-box),T-cell-factor-7,TCF-1,transcription factor 7,TCF-1,TCF7
P36507,MP2K2_HUMAN,MAP2K2; MEK2; MKK2; PRKMK2,Dual specificity mitogen-activated protein kinase kinase 2; MAP kinase kinase 2; MAPKK 2; EC 2.7.12.2; ERK activator kinase 2; MAPK/ERK kinase 2; MEK 2,MEK2; MKK2; PRKMK2,5605,mitogen-activated protein kinase kinase 2,,MAP kinase kinase 2,MEK2; MKK2,mitogen-activated protein kinase kinase 2,CFC4; MAPKK2; MEK2; MKK2; PRKMK2,MAP2K2
P36542,ATPG_HUMAN,ATP5F1C; ATP5C; ATP5C1; ATP5CL1,ATP synthase subunit gamma; mitochondrial; ATP synthase F1 subunit gamma; F-ATPase gamma subunit,ATP5C; ATP5C1; ATP5CL1,509,ATP synthase F1 subunit gamma,ATP synthase; H+ transporting; mitochondrial F1 complex; gamma polypeptide 1,,,ATP synthase F1 subunit gamma,ATP5C; ATP5C1; ATP5CL1,ATP5F1C
P36544,ACHA7_HUMAN,CHRNA7; NACHRA7,Neuronal acetylcholine receptor subunit alpha-7,NACHRA7,1139,cholinergic receptor nicotinic alpha 7 subunit,cholinergic receptor; nicotinic; alpha polypeptide 7; cholinergic receptor; nicotinic; alpha 7 (neuronal); cholinergic receptor; nicotinic alpha 7,acetylcholine receptor; nicotinic; alpha 7 (neuronal),,cholinergic receptor nicotinic alpha 7 subunit,CHRNA7-2; NACHRA7,CHRNA7
P36871,PGM1_HUMAN,PGM1,Phosphoglucomutase-1; PGM 1; EC 5.4.2.2; Glucose phosphomutase 1,,5236,phosphoglucomutase 1,,,,phosphoglucomutase 1,CDG1T; GSD14,PGM1
P36873,PP1G_HUMAN,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit; PP-1G; EC 3.1.3.16; Protein phosphatase 1C catalytic subunit,,5501,protein phosphatase 1 catalytic subunit gamma,protein phosphatase 1; catalytic subunit; gamma isoform; protein phosphatase 1; catalytic subunit; gamma isozyme,,PP1C; PP1gamma,protein phosphatase 1 catalytic subunit gamma,PP-1G; PP1C; PPP1G,PPP1CC
P36888,FLT3_HUMAN,FLT3; CD135; FLK2; STK1,Receptor-type tyrosine-protein kinase FLT3; EC 2.7.10.1; FL cytokine receptor; Fetal liver kinase-2; FLK-2; Fms-like tyrosine kinase 3; FLT-3; Stem cell tyrosine kinase 1; STK-1; CD antigen CD135,CD135; FLK2; STK1,2322,fms related receptor tyrosine kinase 3,fms-related tyrosine kinase 3; fms related tyrosine kinase 3,,STK1; FLK2; CD135,fms related receptor tyrosine kinase 3,CD135; FLK-2; FLK2; STK1,FLT3
P36894,BMR1A_HUMAN,BMPR1A; ACVRLK3; ALK3,Bone morphogenetic protein receptor type-1A; BMP type-1A receptor; BMPR-1A; EC 2.7.11.30; Activin receptor-like kinase 3; ALK-3; Serine/threonine-protein kinase receptor R5; SKR5; CD antigen CD292,ACVRLK3; ALK3,657,bone morphogenetic protein receptor type 1A,bone morphogenetic protein receptor; type IA,,ALK3; CD292,bone morphogenetic protein receptor type 1A,10q23del; ACVRLK3; ALK-3; ALK3; BMPR-1A; CD292; SKR5,BMPR1A
P36896,ACV1B_HUMAN,ACVR1B; ACVRLK4; ALK4,Activin receptor type-1B; EC 2.7.11.30; Activin receptor type IB; ACTR-IB; Activin receptor-like kinase 4; ALK-4; Serine/threonine-protein kinase receptor R2; SKR2,ACVRLK4; ALK4,91,activin A receptor type 1B,activin A receptor; type IB,,ALK4; SKR2; ActRIB,activin A receptor type 1B,ACTRIB; ACVRLK4; ALK4; SKR2,ACVR1B
P36897,TGFR1_HUMAN,TGFBR1; ALK5; SKR4,TGF-beta receptor type-1; TGFR-1; EC 2.7.11.30; Activin A receptor type II-like protein kinase of 53kD; Activin receptor-like kinase 5; ALK-5; ALK5; Serine/threonine-protein kinase receptor R4; SKR4; TGF-beta type I receptor; Transforming growth factor-beta receptor type I; TGF-beta receptor type I; TbetaR-I,ALK5; SKR4,7046,transforming growth factor beta receptor 1,multiple self-healing squamous epithelioma; transforming growth factor beta receptor I,activin A receptor type II-like kinase; 53kDa,ALK-5; ACVRLK4; ALK5; TBRI; TBR-i,transforming growth factor beta receptor 1,AAT5; ACVRLK4; ALK-5; ALK5; ESS1; LDS1; LDS1A; LDS2A; MSSE; SKR4; TBR-i; TBRI; TGFR-1; tbetaR-I,TGFBR1
P36955,PEDF_HUMAN,SERPINF1; PEDF; PIG35,Pigment epithelium-derived factor; PEDF; Cell proliferation-inducing gene 35 protein; EPC-1; Serpin F1,PEDF,5176,serpin family F member 1,serine (or cysteine) proteinase inhibitor; clade F (alpha-2 antiplasmin; pigment epithelium derived factor); member 1; pigment epithelium-derived factor,alpha-2 antiplasmin; proliferation-inducing protein 35,EPC-1; PIG35,serpin family F member 1,EPC-1; OI12; OI6; PEDF; PIG35,SERPINF1
P36956,SRBP1_HUMAN,SREBF1; BHLHD1; SREBP1,Sterol regulatory element-binding protein 1; SREBP-1; Class D basic helix-loop-helix protein 1; bHLHd1; Sterol regulatory element-binding transcription factor 1; Transcription factor SREBF1,BHLHD1; SREBP1,6720,sterol regulatory element binding transcription factor 1,,Sterol regulatory element-binding protein 1,SREBP1; bHLHd1; SREBP-1c; SREBP1a,sterol regulatory element binding transcription factor 1,HMD; IFAP2; SREBP1; bHLHd1,SREBF1
P37023,ACVL1_HUMAN,ACVRL1; ACVRLK1; ALK1,Activin receptor type-1-like; EC 2.7.11.30; Activin receptor-like kinase 1; ALK-1; Serine/threonine-protein kinase receptor R3; SKR3; TGF-B superfamily receptor type I; TSR-I,ACVRLK1; ALK1,94,activin A receptor like type 1,activin A receptor type II-like 1; activin A receptor type IL,activin receptor-like kinase 1,HHT2; ALK1; HHT,activin A receptor like type 1,ACVRLK1; ALK-1; ALK1; HHT; HHT2; ORW2; SKR3; TSR-I,ACVRL1
P37173,TGFR2_HUMAN,TGFBR2,TGF-beta receptor type-2; TGFR-2; EC 2.7.11.30; TGF-beta type II receptor; Transforming growth factor-beta receptor type II; TGF-beta receptor type II; TbetaR-II,,7048,transforming growth factor beta receptor 2,transforming growth factor; beta receptor II (70/80kDa); transforming growth factor beta receptor II,,TBRII; TBR-ii,transforming growth factor beta receptor 2,AAT3; FAA3; LDS1B; LDS2; LDS2B; MFS2; RIIC; TAAD2; TBR-ii; TBRII; TGFR-2; TGFbeta-RII; tbetaR-II,TGFBR2
P37231,PPARG_HUMAN,PPARG; NR1C3,Peroxisome proliferator-activated receptor gamma; PPAR-gamma; Nuclear receptor subfamily 1 group C member 3,NR1C3,5468,peroxisome proliferator activated receptor gamma,peroxisome proliferative activated receptor; gamma; peroxisome proliferator-activated receptor gamma,,PPARG1; PPARG2; NR1C3; PPARgamma,peroxisome proliferator activated receptor gamma,CIMT1; FPLD3; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma,PPARG
P37802,TAGL2_HUMAN,TAGLN2; KIAA0120; CDABP0035,Transgelin-2; Epididymis tissue protein Li 7e; SM22-alpha homolog,KIAA0120,8407,transgelin 2,,SM22-alpha homolog,KIAA0120; HA1756,transgelin 2,HA1756,TAGLN2
P37840,SYUA_HUMAN,SNCA; NACP; PARK1,Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP,NACP; PARK1,6622,synuclein alpha,Parkinson disease (autosomal dominant; Lewy body) 4; synuclein; alpha (non A4 component of amyloid precursor),non A4 component of amyloid precursor; alpha-synuclein; ??-synuclein,NACP; PD1,synuclein alpha,NACP; PARK1; PARK4; PD1,SNCA
P38159,RBMX_HUMAN,RBMX; HNRPG; RBMXP1,RNA-binding motif protein; X chromosome; Glycoprotein p43; Heterogeneous nuclear ribonucleoprotein G; hnRNP G,HNRPG; RBMXP1,27316,RNA binding motif protein X-linked,RNA binding motif protein; X chromosome,heterogeneous nuclear ribonucleoprotein G,RNMX; hnRNP-G; HNRNPG,RNA binding motif protein X-linked,HNRNPG; HNRPG; MRXS11; MRXSG; MRXSH; RBMXP1; RBMXRT; RNMX; hnRNP-G,RBMX
P38398,BRCA1_HUMAN,BRCA1; RNF53,Breast cancer type 1 susceptibility protein; EC 2.3.2.27; RING finger protein 53; RING-type E3 ubiquitin transferase BRCA1,RNF53,672,BRCA1 DNA repair associated,breast cancer 1; early onset; breast cancer 1,BRCA1/BRCA2-containing complex; subunit 1; protein phosphatase 1; regulatory subunit 53; Fanconi anemia; complementation group S,RNF53; BRCC1; PPP1R53; FANCS,BRCA1 DNA repair associated,BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53,BRCA1
P38432,COIL_HUMAN,COIL; CLN80,Coilin; p80-coilin,CLN80,8161,coilin,,,CLN80; p80-coilin,coilin,CLN80; p80-coilin,COIL
P38646,GRP75_HUMAN,HSPA9; GRP75; HSPA9B; mt-HSP70,Stress-70 protein; mitochondrial; 75 kDa glucose-regulated protein; GRP-75; Heat shock 70 kDa protein 9; Heat shock protein family A member 9; Mortalin; MOT; Peptide-binding protein 74; PBP74,GRP75; HSPA9B; mt-HSP70,3313,heat shock protein family A (Hsp70) member 9,heat shock 70kDa protein 9B (mortalin-2); heat shock 70kDa protein 9 (mortalin),mortalin2; mortalin; 75 kDa glucose-regulated protein; Stress-70 protein; mitochondrial,GRP75; PBP74; mot-2; mthsp75,heat shock protein family A (Hsp70) member 9,CRP40; CSA; EVPLS; GRP-75; GRP75; HEL-S-124m; HSPA9B; MOT; MOT2; MTHSP75; PBP74; SAAN; SIDBA4,HSPA9
P38919,IF4A3_HUMAN,EIF4A3; DDX48; KIAA0111,Eukaryotic initiation factor 4A-III; eIF-4A-III; eIF4A-III; EC 3.6.4.13; ATP-dependent RNA helicase DDX48; ATP-dependent RNA helicase eIF4A-3; DEAD box protein 48; Eukaryotic initiation factor 4A-like NUK-34; Eukaryotic translation initiation factor 4A isoform 3; Nuclear matrix protein 265; NMP 265; hNMP 265,DDX48; KIAA0111,9775,eukaryotic translation initiation factor 4A3,DEAD (Asp-Glu-Ala-Asp) box polypeptide 48; eukaryotic translation initiation factor 4A; isoform 3,,KIAA0111; EIF4AIII; Fal1,eukaryotic translation initiation factor 4A3,DDX48; Fal1; MUK34; NMP265; NUK34; RCPS; eIF-4A-III; eIF4A-III; eIF4AIII,EIF4A3
P38936,CDN1A_HUMAN,CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1,Cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21,CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1,1026,cyclin dependent kinase inhibitor 1A,cyclin-dependent kinase inhibitor 1A (p21; Cip1),Cdk-interacting protein 1,P21; CIP1; WAF1; SDI1; CAP20; p21CIP1; p21Cip1/Waf1; p21,cyclin dependent kinase inhibitor 1A,CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1,CDKN1A
P39019,RS19_HUMAN,RPS19,Small ribosomal subunit protein eS19; 40S ribosomal protein S19,,6223,ribosomal protein S19,loss of heterozygosity on chromosome 19; region 1; loss of heterozygosity; 19; chromosomal region 1,Diamond-Blackfan anemia,S19; eS19; DBA,ribosomal protein S19,DBA; DBA1; LOH19CR1; S19; eS19,RPS19
P39687,AN32A_HUMAN,ANP32A; C15orf1; LANP; MAPM; PHAP1,Acidic leucine-rich nuclear phosphoprotein 32 family member A; Acidic nuclear phosphoprotein pp32; pp32; Leucine-rich acidic nuclear protein; LANP; Mapmodulin; Potent heat-stable protein phosphatase 2A inhibitor I1PP2A; Putative HLA-DR-associated protein I; PHAPI,C15orf1; LANP; MAPM; PHAP1,8125,acidic nuclear phosphoprotein 32 family member A,acidic (leucine-rich) nuclear phosphoprotein 32 family; member A,,LANP; PP32; I1PP2A; PHAPI; MAPM; mapmodulin,acidic nuclear phosphoprotein 32 family member A,C15orf1; HPPCn; I1PP2A; LANP; MAPM; PHAP1; PHAPI; PP32,ANP32A
P39748,FEN1_HUMAN,FEN1; RAD2,Flap endonuclease 1; FEN-1; EC 3.1.-.-; DNase IV; Flap structure-specific endonuclease 1; Maturation factor 1; MF1; hFEN-1,RAD2,2237,flap structure-specific endonuclease 1,,maturation factor-1; DNase IV,FEN-1; MF1,flap structure-specific endonuclease 1,FEN-1; MF1; RAD2,FEN1
P39880,CUX1_HUMAN,CUX1; CUTL1,Homeobox protein cut-like 1; CCAAT displacement protein; CDP; CDP/Cux p200; Homeobox protein cux-1,CUTL1,1523,cut like homeobox 1,cut (Drosophila)-like 1 (CCAAT displacement protein); cut-like 1; CCAAT displacement protein (Drosophila); cut-like homeobox 1,golgi integral membrane protein 6; CUX1 gene Alternatively Spliced Product,CDP; CDP1; CUX; CUT; Clox; CDP/Cut; CDP/Cux; Cux/CDP; CASP; GOLIM6,cut like homeobox 1,CASP; CDP; CDP/Cut; CDP1; COY1; CUTL1; CUX; Clox; Cux/CDP; GDDI; GOLIM6; Nbla10317; p100; p110; p200; p75,CUX1
P40189,IL6RB_HUMAN,IL6ST,Interleukin-6 receptor subunit beta; IL-6 receptor subunit beta; IL-6R subunit beta; IL-6R-beta; IL-6RB; CDw130; Interleukin-6 signal transducer; Membrane glycoprotein 130; gp130; Oncostatin-M receptor subunit alpha; CD antigen CD130,,3572,interleukin 6 cytokine family signal transducer,interleukin 6 signal transducer (gp130; oncostatin M receptor); interleukin 6 signal transducer,gp130; oncostatin M receptor; Interleukin-6 receptor subunit beta; membrane glycoprotein 130,GP130; CD130; sGP130; IL-6RB,interleukin 6 cytokine family signal transducer,CD130; CDW130; GP130; HIES4; HIES4A; HIES4B; IL-6RB; IMD94; STWS2; sGP130,IL6ST
P40259,CD79B_HUMAN,CD79B; B29; IGB,B-cell antigen receptor complex-associated protein beta chain; B-cell-specific glycoprotein B29; Ig-beta; Immunoglobulin-associated B29 protein; CD antigen CD79b,B29; IGB,974,CD79b molecule,CD79B antigen (immunoglobulin-associated beta); CD79b molecule; immunoglobulin-associated beta,B-cell antigen receptor complex-associated protein beta chain,B29; Ig-beta; Igbeta,CD79b molecule,AGM6; B29; IGB; Igbeta,CD79B
P40337,VHL_HUMAN,VHL,von Hippel-Lindau disease tumor suppressor; Protein G7; pVHL,,7428,von Hippel-Lindau tumor suppressor,von Hippel-Lindau syndrome; von Hippel-Lindau tumor suppressor; E3 ubiquitin protein ligase,,VHL1,von Hippel-Lindau tumor suppressor,HRCA1; RCA1; VHL1; pVHL,VHL
P40429,RL13A_HUMAN,RPL13A,Large ribosomal subunit protein uL13; 23 kDa highly basic protein; 60S ribosomal protein L13a,,23521,ribosomal protein L13a,tissue specific transplantation antigen 1,,L13A; uL13,ribosomal protein L13a,L13A; TSTA1; uL13,RPL13A
P40692,MLH1_HUMAN,MLH1; COCA2,DNA mismatch repair protein Mlh1; MutL protein homolog 1,COCA2,4292,mutL homolog 1,mutL (E. coli) homolog 1 (colon cancer; nonpolyposis type 2); mutL homolog 1; colon cancer; nonpolyposis type 2 (E. coli),,HNPCC; FCC2; HNPCC2; MLH-1,mutL homolog 1,COCA2; FCC2; HNPCC; HNPCC2; LYNCH2; MLH-1; MMRCS1; hMLH1,MLH1
P40763,STAT3_HUMAN,STAT3; APRF,Signal transducer and activator of transcription 3; Acute-phase response factor,APRF,6774,signal transducer and activator of transcription 3,signal transducer and activator of transcription 3 (acute-phase response factor),,APRF,signal transducer and activator of transcription 3,ADMIO; ADMIO1; APRF; HIES,STAT3
P40818,UBP8_HUMAN,USP8; KIAA0055; UBPY,Ubiquitin carboxyl-terminal hydrolase 8; EC 3.4.19.12; Deubiquitinating enzyme 8; Ubiquitin isopeptidase Y; hUBPy; Ubiquitin thioesterase 8; Ubiquitin-specific-processing protease 8,KIAA0055; UBPY,9101,ubiquitin specific peptidase 8,ubiquitin specific protease 8,Ubiquitin carboxyl-terminal hydrolase 8; Ubiquitin isopeptidase Y,HumORF8; KIAA0055; UBPY; SPG59,ubiquitin specific peptidase 8,HumORF8; PITA4; SPG59; UBPY,USP8
P41002,CCNF_HUMAN,CCNF; FBX1; FBXO1,Cyclin-F; F-box only protein 1,FBX1; FBXO1,899,cyclin F,,,FBX1; FBXO1,cyclin F,FBX1; FBXO1; FTDALS5,CCNF
P41091,IF2G_HUMAN,EIF2S3; EIF2G,Eukaryotic translation initiation factor 2 subunit 3; EC 3.6.5.3; Eukaryotic translation initiation factor 2 subunit gamma X; eIF2-gamma X; eIF2gX,EIF2G,1968,eukaryotic translation initiation factor 2 subunit gamma,eukaryotic translation initiation factor 2; subunit 3 (gamma; 52kD); eukaryotic translation initiation factor 2; subunit 3 gamma; 52kDa,eukaryotic translation initiation factor 2G,EIF2gamma; EIF2,eukaryotic translation initiation factor 2 subunit gamma,EIF2; EIF2G; EIF2gamma; MEHMO; MRXSBRK; eIF-2gA; eIF2gX,EIF2S3
P41134,ID1_HUMAN,ID1; BHLHB24; ID,DNA-binding protein inhibitor ID-1; Class B basic helix-loop-helix protein 24; bHLHb24; Inhibitor of DNA binding 1; Inhibitor of differentiation 1,BHLHB24; ID,3397,inhibitor of DNA binding 1,inhibitor of DNA binding 1; dominant negative helix-loop-helix protein,DNA-binding protein inhibitor ID-1; inhibitor of differentiation 1,dJ857M17.1.2; bHLHb24,inhibitor of DNA binding 1,ID; bHLHb24,ID1
P41143,OPRD_HUMAN,OPRD1; OPRD,Delta-type opioid receptor; D-OR-1; DOR-1,OPRD,4985,opioid receptor delta 1,opioid receptor; delta 1,,,opioid receptor delta 1,DOP; DOR; DOR1; OPRD,OPRD1
P41145,OPRK_HUMAN,OPRK1; OPRK,Kappa-type opioid receptor; K-OR-1; KOR-1,OPRK,4986,opioid receptor kappa 1,opioid receptor; kappa 1,,KOR; OPRK,opioid receptor kappa 1,K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK,OPRK1
P41146,OPRX_HUMAN,OPRL1; OOR; ORL1,Nociceptin receptor; Kappa-type 3 opioid receptor; KOR-3; Orphanin FQ receptor,OOR; ORL1,4987,opioid related nociceptin receptor 1,opiate receptor-like 1,LC132 receptor-like; orphanin FQ receptor; kappa3-related opioid receptor; nociceptin/orphanin FQ receptor,NOCIR; ORL1; OOR; KOR-3; NOPr; PNOCR,opioid related nociceptin receptor 1,KOR-3; KOR3; NOCIR; NOP; NOPr; OOR; OPRL; ORL1; PNOCR,OPRL1
P41161,ETV5_HUMAN,ETV5; ERM,ETS translocation variant 5; Ets-related protein ERM,ERM,2119,ETS variant transcription factor 5,ets variant gene 5 (ets-related molecule); ETS variant 5,ets-related molecule,ERM,ETS variant transcription factor 5,ERM,ETV5
P41180,CASR_HUMAN,CASR; GPRC2A; PCAR1,Extracellular calcium-sensing receptor; CaR; CaSR; hCasR; Parathyroid cell calcium-sensing receptor 1; PCaR1,GPRC2A; PCAR1,846,calcium sensing receptor,hypocalciuric hypercalcemia 1; calcium-sensing receptor,severe neonatal hyperparathyroidism,FHH; NSHPT; GPRC2A,calcium sensing receptor,CAR; EIG8; FHH; FIH; GPRC2A; HHC; HHC1; HYPOC1; NSHPT; PCAR1; hCasR,CASR
P41181,AQP2_HUMAN,AQP2,Aquaporin-2; AQP-2; ADH water channel; Aquaporin-CD; AQP-CD; Collecting duct water channel protein; WCH-CD; Water channel protein for renal collecting duct,,359,aquaporin 2,aquaporin 2 (collecting duct),,,aquaporin 2,AQP-CD; NDI2; WCH-CD,AQP2
P41182,BCL6_HUMAN,BCL6; BCL5; LAZ3; ZBTB27; ZNF51,B-cell lymphoma 6 protein; BCL-6; B-cell lymphoma 5 protein; BCL-5; Protein LAZ-3; Zinc finger and BTB domain-containing protein 27; Zinc finger protein 51,BCL5; LAZ3; ZBTB27; ZNF51,604,BCL6 transcription repressor,zinc finger protein 51; B cell CLL/lymphoma 6; BCL6; transcription repressor,,ZBTB27; LAZ3; BCL5; BCL6A,BCL6 transcription repressor,BCL5; BCL6A; LAZ3; ZBTB27; ZNF51,BCL6
P41208,CETN2_HUMAN,CETN2; CALT; CEN2,Centrin-2; Caltractin isoform 1,CALT; CEN2,1069,centrin 2,centrin; EF-hand protein; 2,,CEN2,centrin 2,CALT; CEN2,CETN2
P41212,ETV6_HUMAN,ETV6; TEL; TEL1,Transcription factor ETV6; ETS translocation variant 6; ETS-related protein Tel1; Tel,TEL; TEL1,2120,ETS variant transcription factor 6,ets variant gene 6 (TEL oncogene); ETS variant 6,TEL oncogene,TEL,ETS variant transcription factor 6,TEL; TEL/ABL; THC5,ETV6
P41220,RGS2_HUMAN,RGS2; G0S8; GIG31,Regulator of G-protein signaling 2; RGS2; Cell growth-inhibiting gene 31 protein; G0/G1 switch regulatory protein 8,G0S8,5997,regulator of G protein signaling 2,regulator of G-protein signalling 2; 24kD; regulator of G-protein signalling 2; 24kDa; regulator of G-protein signaling 2; 24kDa; regulator of G-protein signaling 2,,,regulator of G protein signaling 2,G0S8,RGS2
P41221,WNT5A_HUMAN,WNT5A,Protein Wnt-5a,,7474,Wnt family member 5A,wingless-type MMTV integration site family; member 5A,WNT-5A protein,hWNT5A,Wnt family member 5A,hWNT5A,WNT5A
P41235,HNF4A_HUMAN,HNF4A; HNF4; NR2A1; TCF14,Hepatocyte nuclear factor 4-alpha; HNF-4-alpha; Nuclear receptor subfamily 2 group A member 1; Transcription factor 14; TCF-14; Transcription factor HNF-4,HNF4; NR2A1; TCF14,3172,hepatocyte nuclear factor 4 alpha,,,NR2A1; HNF4,hepatocyte nuclear factor 4 alpha,FRTS4; HNF4; HNF4a7; HNF4a8; HNF4a9; HNF4alpha; MODY; MODY1; NR2A1; NR2A21; TCF; TCF-14; TCF14,HNF4A
P41236,IPP2_HUMAN,PPP1R2; IPP2,Protein phosphatase inhibitor 2; IPP-2,IPP2,5504,protein phosphatase 1 regulatory inhibitor subunit 2,protein phosphatase 1; regulatory (inhibitor) subunit 2,,IPP2; PPP1R2A,protein phosphatase 1 regulatory inhibitor subunit 2,IPP-2; IPP2; PPP1R2A,PPP1R2
P41240,CSK_HUMAN,CSK,Tyrosine-protein kinase CSK; EC 2.7.10.2; C-Src kinase; Protein-tyrosine kinase CYL,,1445,C-terminal Src kinase,c-src tyrosine kinase; CSK; non-receptor tyrosine kinase,,,C-terminal Src kinase,,CSK
P41279,M3K8_HUMAN,MAP3K8; COT; ESTF,Mitogen-activated protein kinase kinase kinase 8; EC 2.7.11.25; Cancer Osaka thyroid oncogene; Proto-oncogene c-Cot; Serine/threonine-protein kinase cot; Tumor progression locus 2; TPL-2,COT; ESTF,1326,mitogen-activated protein kinase kinase kinase 8,,,Tpl-2; EST; c-COT; MEKK8,mitogen-activated protein kinase kinase kinase 8,AURA2; COT; EST; ESTF; MEKK8; TPL2; Tpl-2; c-COT,MAP3K8
P41597,CCR2_HUMAN,CCR2; CMKBR2,C-C chemokine receptor type 2; C-C CKR-2; CC-CKR-2; CCR-2; CCR2; Monocyte chemoattractant protein 1 receptor; MCP-1-R; CD antigen CD192,CMKBR2,729230,C-C motif chemokine receptor 2,chemokine (C-C motif) receptor 2,,CC-CKR-2; CKR2; MCP-1-R; CD192; FLJ78302,C-C motif chemokine receptor 2,CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R; PCLUD,CCR2
P41743,KPCI_HUMAN,PRKCI; DXS1179E,Protein kinase C iota type; EC 2.7.11.13; Atypical protein kinase C-lambda/iota; PRKC-lambda/iota; aPKC-lambda/iota; nPKC-iota,DXS1179E,5584,protein kinase C iota,protein kinase C; iota,,PKCI,protein kinase C iota,DXS1179E; PKCI; nPKC-iota,PRKCI
P42166,LAP2A_HUMAN,TMPO; LAP2,Lamina-associated polypeptide 2; isoform alpha; Thymopoietin isoform alpha; TP alpha; Thymopoietin-related peptide isoform alpha; TPRP isoform alpha; TP; Splenin; TP5,LAP2,7112,thymopoietin,,LEM domain containing 4,TP; LAP2; LEMD4,thymopoietin,CMD1T; LAP2; LEMD4; PRO0868; TP,TMPO
P42224,STAT1_HUMAN,STAT1,Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84,,6772,signal transducer and activator of transcription 1,signal transducer and activator of transcription 1; 91kD; signal transducer and activator of transcription 1; 91kDa,transcription factor ISGF-3 components p91/p84,STAT91; ISGF-3,signal transducer and activator of transcription 1,CANDF7; IMD31A; IMD31B; IMD31C; ISGF-3; STAT91,STAT1
P42226,STAT6_HUMAN,STAT6,Signal transducer and activator of transcription 6; IL-4 Stat,,6778,signal transducer and activator of transcription 6,signal transducer and activator of transcription 6; interleukin-4 induced,,D12S1644; IL-4-STAT,signal transducer and activator of transcription 6,D12S1644; HIES6; IL-4-STAT; STAT6B; STAT6C,STAT6
P42229,STA5A_HUMAN,STAT5A; STAT5,Signal transducer and activator of transcription 5A,STAT5,6776,signal transducer and activator of transcription 5A,,,MGF,signal transducer and activator of transcription 5A,MGF; STAT5,STAT5A
P42261,GRIA1_HUMAN,GRIA1; GLUA1; GLUH1; GLUR1,Glutamate receptor 1; GluR-1; AMPA-selective glutamate receptor 1; GluR-A; GluR-K1; Glutamate receptor ionotropic; AMPA 1,GLUA1; GLUH1; GLUR1,2890,glutamate ionotropic receptor AMPA type subunit 1,glutamate receptor; ionotropic; AMPA 1,Glutamate receptor 1; AMPA receptor subunit GluA1,GluA1; GLURA,glutamate ionotropic receptor AMPA type subunit 1,GLUH1; GLUR1; GLURA; GluA1; HBGR1; MRD67; MRT76,GRIA1
P42262,GRIA2_HUMAN,GRIA2; GluA2; GLUR2,Glutamate receptor 2; GluR-2; AMPA-selective glutamate receptor 2; GluR-B; GluR-K2; Glutamate receptor ionotropic; AMPA 2,GluA2; GLUR2,2891,glutamate ionotropic receptor AMPA type subunit 2,glutamate receptor; ionotropic; AMPA 2,Glutamate receptor 2; AMPA receptor subunit GluA2,GluA2; GLURB; GluR-K2; GluR-B; GluR-2,glutamate ionotropic receptor AMPA type subunit 2,GLUR2; GLURB; GluA2; GluR-K2; HBGR2; NEDLIB; gluR-2; gluR-B,GRIA2
P42263,GRIA3_HUMAN,GRIA3; GluA3; GLUR3; GLURC,Glutamate receptor 3; GluR-3; AMPA-selective glutamate receptor 3; GluR-C; GluR-K3; Glutamate receptor ionotropic; AMPA 3,GluA3; GLUR3; GLURC,2892,glutamate ionotropic receptor AMPA type subunit 3,glutamate receptor; ionotrophic; AMPA 3,Glutamate receptor 3; AMPA receptor subunit GluA3,GluA3; GLURC; MRX94; GluR-3; GluR-C; GluR-K3; iGluR3,glutamate ionotropic receptor AMPA type subunit 3,GLUR-C; GLUR-K3; GLUR3; GLURC; GluA3; MRX94; MRXSW; iGluR3,GRIA3
P42336,PK3CA_HUMAN,PIK3CA,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3-kinase subunit alpha; PI3K-alpha; PI3Kalpha; PtdIns-3-kinase subunit alpha; EC 2.7.1.137; EC 2.7.1.153; Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha; PtdIns-3-kinase subunit p110-alpha; p110alpha; Phosphoinositide 3-kinase alpha; Phosphoinositide-3-kinase catalytic alpha polypeptide; Serine/threonine protein kinase PIK3CA; EC 2.7.11.1,,5290,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit alpha,phosphoinositide-3-kinase; catalytic; alpha polypeptide; phosphatidylinositol-4;5-bisphosphate 3-kinase; catalytic subunit alpha,,PI3K,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit alpha,CCM4; CLAPO; CLOVE; CWS5; HMH; MCAP; MCM; MCMTC; PI3K; PI3K-alpha; p110-alpha,PIK3CA
P42338,PK3CB_HUMAN,PIK3CB; PIK3C1,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit beta isoform; PI3-kinase subunit beta; PI3K-beta; PI3Kbeta; PtdIns-3-kinase subunit beta; EC 2.7.1.153; Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; PtdIns-3-kinase subunit p110-beta; p110beta; Serine/threonine protein kinase PIK3CB; EC 2.7.11.1,PIK3C1,5291,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit beta,phosphoinositide-3-kinase; catalytic; beta polypeptide; phosphatidylinositol-4;5-bisphosphate 3-kinase; catalytic subunit beta,,,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit beta,P110BETA; PI3K; PI3KBETA; PIK3C1,PIK3CB
P42345,MTOR_HUMAN,MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1,Serine/threonine-protein kinase mTOR; EC 2.7.11.1; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic target of rapamycin; Rapamycin and FKBP12 target 1; Rapamycin target protein 1; Tyrosine-protein kinase mTOR; EC 2.7.10.2,FRAP; FRAP1; FRAP2; RAFT1; RAPT1,2475,mechanistic target of rapamycin kinase,FK506 binding protein 12-rapamycin associated protein 1; mechanistic target of rapamycin (serine/threonine kinase); mechanistic target of rapamycin,FK506 binding protein 12-rapamycin associated protein 2; rapamycin target protein; FKBP12-rapamycin complex-associated protein 1; FKBP-rapamycin associated protein; rapamycin associated protein FRAP2; dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1); rapamycin and FKBP12 target 1; mammalian target of rapamycin,RAFT1; RAPT1; FLJ44809,mechanistic target of rapamycin kinase,FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS,MTOR
P42566,EPS15_HUMAN,EPS15; AF1P,Epidermal growth factor receptor substrate 15; Protein Eps15; Protein AF-1p,AF1P,2060,epidermal growth factor receptor pathway substrate 15,,,AF-1P; MLLT5,epidermal growth factor receptor pathway substrate 15,AF-1P; AF1P; MLLT5,EPS15
P42574,CASP3_HUMAN,CASP3; CPP32,Caspase-3; CASP-3; EC 3.4.22.56; Apopain; Cysteine protease CPP32; CPP-32; Protein Yama; SREBP cleavage activity 1; SCA-1,CPP32,836,caspase 3,caspase 3; apoptosis-related cysteine protease; caspase 3; apoptosis-related cysteine peptidase,,CPP32; CPP32B; Yama; apopain,caspase 3,CPP32; CPP32B; SCA-1,CASP3
P42575,CASP2_HUMAN,CASP2; ICH1; NEDD2,Caspase-2; CASP-2; EC 3.4.22.55; Neural precursor cell expressed developmentally down-regulated protein 2; NEDD-2; Protease ICH-1,ICH1; NEDD2,835,caspase 2,neural precursor cell expressed; developmentally down-regulated 2; caspase 2; apoptosis-related cysteine peptidase,protein phosphatase 1; regulatory subunit 57,ICH1; PPP1R57; MGC2181,caspase 2,CASP-2; ICH1; MRT80; NEDD-2; NEDD2; PPP1R57,CASP2
P42677,RS27_HUMAN,RPS27; MPS1,Small ribosomal subunit protein eS27; 40S ribosomal protein S27; Metallopan-stimulin 1; MPS-1,MPS1,6232,ribosomal protein S27,ribosomal protein S27 (metallopanstimulin 1),metallopanstimulin 1,MPS-1; MPS1; S27; eS27,ribosomal protein S27,DBA17; MPS-1; MPS1; S27; eS27,RPS27
P42679,MATK_HUMAN,MATK; CTK; HYL,Megakaryocyte-associated tyrosine-protein kinase; EC 2.7.10.2; CSK homologous kinase; CHK; Hematopoietic consensus tyrosine-lacking kinase; Protein kinase HYL; Tyrosine-protein kinase CTK,CTK; HYL,4145,megakaryocyte-associated tyrosine kinase,,Csk-homologous kinase; tyrosine-protein kinase CTK; protein kinase HYL; hematopoietic consensus tyrosine-lacking kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase; Csk-type protein tyrosine kinase; HYL tyrosine kinase; tyrosine kinase MATK; leukocyte carboxyl-terminal src kinase related,HYLTK; CTK; HYL; Lsk; CHK; HHYLTK; DKFZp434N1212; MGC1708; MGC2101,megakaryocyte-associated tyrosine kinase,CHK; CTK; HHYLTK; HYL; HYLTK; Lsk,MATK
P42680,TEC_HUMAN,TEC; PSCTK4,Tyrosine-protein kinase Tec; EC 2.7.10.2,PSCTK4,7006,tec protein tyrosine kinase,,,PSCTK4,tec protein tyrosine kinase,PSCTK4,TEC
P42681,TXK_HUMAN,TXK; PTK4; RLK,Tyrosine-protein kinase TXK; EC 2.7.10.2; Protein-tyrosine kinase 4; Resting lymphocyte kinase,PTK4; RLK,7294,TXK tyrosine kinase,PTK4 protein tyrosine kinase 4,,TKL; PSCTK5; BTKL; RLK,TXK tyrosine kinase,BTKL; PSCTK5; PTK4; RLK; TKL,TXK
P42684,ABL2_HUMAN,ABL2; ABLL; ARG,Tyrosine-protein kinase ABL2; EC 2.7.10.2; Abelson murine leukemia viral oncogene homolog 2; Abelson tyrosine-protein kinase 2; Abelson-related gene protein; Tyrosine-protein kinase ARG,ABLL; ARG,27,ABL proto-oncogene 2; non-receptor tyrosine kinase,v-abl Abelson murine leukemia viral oncogene homolog 2 (arg; Abelson-related gene); v-abl Abelson murine leukemia viral oncogene homolog 2; c-abl oncogene 2; non-receptor tyrosine kinase,Abelson-related gene,ARG,ABL proto-oncogene 2; non-receptor tyrosine kinase,ABLL; ARG,ABL2
P42685,FRK_HUMAN,FRK; PTK5; RAK,Tyrosine-protein kinase FRK; EC 2.7.10.2; FYN-related kinase; Nuclear tyrosine protein kinase RAK; Protein-tyrosine kinase 5,PTK5; RAK,2444,fyn related Src family tyrosine kinase,PTK5 protein tyrosine kinase 5; fyn-related kinase; fyn-related Src family tyrosine kinase,,RAK; GTK,fyn related Src family tyrosine kinase,GTK; PTK5; RAK,FRK
P42768,WASP_HUMAN,WAS; IMD2,Actin nucleation-promoting factor WAS; Wiskott-Aldrich syndrome protein; WASp,IMD2,7454,WASP actin nucleation promoting factor,thrombocytopenia 1 (X-linked); Wiskott-Aldrich syndrome (eczema-thrombocytopenia); Wiskott-Aldrich syndrome,eczema-thrombocytopenia,WASP; WASPA,WASP actin nucleation promoting factor,IMD2; SCNX; THC; THC1; WASP; WASPA,WAS
P42771,CDN2A_HUMAN,CDKN2A; CDKN2; MTS1,Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A,CDKN2; MTS1,1029,cyclin dependent kinase inhibitor 2A,cyclin-dependent kinase inhibitor 2A (melanoma; p16; inhibits CDK4),CDKN2A/ARF Intron 2 lncRNA; multiple tumour suppressor 1; cyclin-dependent kinase 4 inhibitor A; p19 alternate open reading frame; p14 alternate open reading frame; inhibitor of cdk4 A,CDK4I; p16; INK4a; MTS1; CMM2; ARF; p19; p14; INK4; p16INK4a; p19Arf; p14ARF; P16-INK4A; CAI2,cyclin dependent kinase inhibitor 2A,ARF; CAI2; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16,CDKN2A
P42858,HD_HUMAN,HTT; HD; IT15,Huntingtin; Huntington disease protein; HD protein,HD; IT15,3064,huntingtin,huntingtin (Huntington disease),,IT15,huntingtin,HD; IT15; LOMARS,HTT
P42892,ECE1_HUMAN,ECE1,Endothelin-converting enzyme 1; ECE-1; EC 3.4.24.71,,1889,endothelin converting enzyme 1,,,,endothelin converting enzyme 1,ECE,ECE1
P42898,MTHR_HUMAN,MTHFR,Methylenetetrahydrofolate reductase; NADPH; EC 1.5.1.53,,4524,methylenetetrahydrofolate reductase,5;10-methylenetetrahydrofolate reductase (NADPH); methylenetetrahydrofolate reductase (NAD(P)H),,,methylenetetrahydrofolate reductase,,MTHFR
P43003,EAA1_HUMAN,SLC1A3; EAAT1; GLAST; GLAST1,Excitatory amino acid transporter 1; Sodium-dependent glutamate/aspartate transporter 1; GLAST-1; Solute carrier family 1 member 3,EAAT1; GLAST; GLAST1,6507,solute carrier family 1 member 3,solute carrier family 1 (glial high affinity glutamate transporter); member 3,excitatory amino acid transporter 1; glutamate/aspartate transporter 1,EAAT1; GLAST; EA6; GLAST1; GLAST-1,solute carrier family 1 member 3,EA6; EAAT1; GLAST; GLAST1,SLC1A3
P43119,PI2R_HUMAN,PTGIR; PRIPR,Prostacyclin receptor; Prostaglandin I2 receptor; PGI receptor; PGI2 receptor; Prostanoid IP receptor,PRIPR,5739,prostaglandin I2 receptor,prostaglandin I2 (prostacyclin) receptor (IP),prostacyclin receptor,IP,prostaglandin I2 receptor,IP; PRIPR,PTGIR
P43146,DCC_HUMAN,DCC; IGDCC1,Netrin receptor DCC; Colorectal cancer suppressor; Immunoglobulin superfamily DCC subclass member 1; Tumor suppressor protein DCC,IGDCC1,1630,DCC netrin 1 receptor,deleted in colorectal carcinoma,immunoglobulin superfamily; DCC subclass; member 1,IGDCC1; NTN1R1,DCC netrin 1 receptor,CRC18; CRCR1; HGPPS2; IGDCC1; MRMV1; NTN1R1,DCC
P43243,MATR3_HUMAN,MATR3; KIAA0723,Matrin-3,KIAA0723,9782,matrin 3,myopathy; distal 2,,KIAA0723; MGC9105; VCPDM,matrin 3,ALS21; MPD2; VCPDM,MATR3
P43250,GRK6_HUMAN,GRK6; GPRK6,G protein-coupled receptor kinase 6; EC 2.7.11.16; G protein-coupled receptor kinase GRK6,GPRK6,2870,G protein-coupled receptor kinase 6,,,,G protein-coupled receptor kinase 6,GPRK6,GRK6
P43307,SSRA_HUMAN,SSR1; TRAPA; PSEC0262,Translocon-associated protein subunit alpha; TRAP-alpha; Signal sequence receptor subunit alpha; SSR-alpha,TRAPA,6745,signal sequence receptor subunit 1,signal sequence receptor; alpha,translocon-associated protein alpha,TRAPA,signal sequence receptor subunit 1,TRAPA,SSR1
P43351,RAD52_HUMAN,RAD52,DNA repair protein RAD52 homolog,,5893,RAD52 homolog; DNA repair protein,RAD52 (S. cerevisiae) homolog; RAD52 homolog (S. cerevisiae),,,RAD52 homolog; DNA repair protein,,RAD52
P43364,MAGAB_HUMAN,MAGEA11; MAGE11,Melanoma-associated antigen 11; Cancer/testis antigen 1.11; CT1.11; MAGE-11 antigen,MAGE11,4110,MAGE family member A11,melanoma antigen family A11,MAGE-11 antigen; melanoma-associated antigen 11; cancer/testis antigen family 1; member 11,MAGE-11; MAGEA-11; MGC10511; CT1.11,MAGE family member A11,CT1.11; MAGE-11; MAGE11; MAGEA-11,MAGEA11
P43378,PTN9_HUMAN,PTPN9,Tyrosine-protein phosphatase non-receptor type 9; EC 3.1.3.48; Protein-tyrosine phosphatase MEG2; PTPase MEG2,,5780,protein tyrosine phosphatase non-receptor type 9,,,MEG2,protein tyrosine phosphatase non-receptor type 9,MEG2; PTPMEG2,PTPN9
P43403,ZAP70_HUMAN,ZAP70; SRK,Tyrosine-protein kinase ZAP-70; EC 2.7.10.2; 70 kDa zeta-chain associated protein; Syk-related tyrosine kinase,SRK,7535,zeta chain of T cell receptor associated protein kinase 70,SRK,tyrosine-protein kinase ZAP-70,ZAP-70; STD,zeta chain of T cell receptor associated protein kinase 70,ADMIO2; IMD48; SRK; STCD; STD; TZK; ZAP-70,ZAP70
P43405,KSYK_HUMAN,SYK,Tyrosine-protein kinase SYK; EC 2.7.10.2; Spleen tyrosine kinase; p72-Syk,,6850,spleen associated tyrosine kinase,spleen tyrosine kinase,,,spleen associated tyrosine kinase,IMD82; p72-Syk,SYK
P43629,KI3L1_HUMAN,KIR3DL1; CD158E; NKAT3; NKB1,Killer cell immunoglobulin-like receptor 3DL1; CD158 antigen-like family member E; HLA-BW4-specific inhibitory NK cell receptor; Natural killer-associated transcript 3; NKAT-3; p70 natural killer cell receptor clones CL-2/CL-11; p70 NK receptor CL-2/CL-11; CD antigen CD158e,CD158E; NKAT3; NKB1,3811,killer cell immunoglobulin like receptor; three Ig domains and long cytoplasmic tail 1,killer cell immunoglobulin-like receptor; three domains; long cytoplasmic tail; 1,,cl-2; NKB1; cl-11; nkat3; NKB1B; AMB11; CD158e1/2; CD158E1; CD158e2,killer cell immunoglobulin like receptor; three Ig domains and long cytoplasmic tail 1,CD158E1; KIR; KIR2DL5B; KIR3DL1/S1; NKAT-3; NKAT3; NKB1; NKB1B,KIR3DL1
P43686,PRS6B_HUMAN,PSMC4; MIP224; TBP7,26S proteasome regulatory subunit 6B; 26S proteasome AAA-ATPase subunit RPT3; MB67-interacting protein; MIP224; Proteasome 26S subunit ATPase 4; Tat-binding protein 7; TBP-7,MIP224; TBP7,5704,proteasome 26S subunit; ATPase 4,proteasome (prosome; macropain) 26S subunit; ATPase; 4,protease 26S subunit 6; Tat-binding protein 7; MB67 interacting protein,TBP7; S6; MGC8570; MGC13687; MGC23214; TBP-7; RPT3,proteasome 26S subunit; ATPase 4,MIP224; RPT3; S6; TBP-7; TBP7,PSMC4
P43694,GATA4_HUMAN,GATA4,Transcription factor GATA-4; GATA-binding factor 4,,2626,GATA binding protein 4,GATA-binding protein 4,,,GATA binding protein 4,ASD2; TACHD; TOF; VSD1,GATA4
P45379,TNNT2_HUMAN,TNNT2,Troponin T; cardiac muscle; TnTc; Cardiac muscle troponin T; cTnT,,7139,troponin T2; cardiac type,cardiomyopathy; hypertrophic 2; cardiomyopathy; dilated 1D (autosomal dominant); troponin T type 2 (cardiac),,CMPD2,troponin T2; cardiac type,CMD1D; CMH2; CMPD2; LVNC6; RCM3; TnTC; cTnT,TNNT2
P45973,CBX5_HUMAN,CBX5; HP1A,Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha,HP1A,23468,chromobox 5,chromobox homolog 5 (Drosophila HP1 alpha); chromobox homolog 5 (HP1 alpha homolog; Drosophila); chromobox homolog 5,HP1 alpha homolog (Drosophila),HP1Hs-alpha; HP1; HP1-ALPHA; HP1alpha,chromobox 5,HEL25; HP1; HP1A; HP1alpha,CBX5
P45983,MK08_HUMAN,MAPK8; JNK1; PRKM8; SAPK1; SAPK1C,Mitogen-activated protein kinase 8; MAP kinase 8; MAPK 8; EC 2.7.11.24; JNK-46; Stress-activated protein kinase 1c; SAPK1c; Stress-activated protein kinase JNK1; c-Jun N-terminal kinase 1,JNK1; PRKM8; SAPK1; SAPK1C,5599,mitogen-activated protein kinase 8,,JUN N-terminal kinase,JNK; JNK1; SAPK1,mitogen-activated protein kinase 8,JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c,MAPK8
P45984,MK09_HUMAN,MAPK9; JNK2; PRKM9; SAPK1A,Mitogen-activated protein kinase 9; MAP kinase 9; MAPK 9; EC 2.7.11.24; JNK-55; Stress-activated protein kinase 1a; SAPK1a; Stress-activated protein kinase JNK2; c-Jun N-terminal kinase 2,JNK2; PRKM9; SAPK1A,5601,mitogen-activated protein kinase 9,,Jun kinase,JNK2; p54a; SAPK,mitogen-activated protein kinase 9,JNK-55; JNK2; JNK2A; JNK2ALPHA; JNK2B; JNK2BETA; PRKM9; SAPK; SAPK1a; p54a; p54aSAPK,MAPK9
P45985,MP2K4_HUMAN,MAP2K4; JNKK1; MEK4; MKK4; PRKMK4; SEK1; SERK1; SKK1,Dual specificity mitogen-activated protein kinase kinase 4; MAP kinase kinase 4; MAPKK 4; EC 2.7.12.2; JNK-activating kinase 1; MAPK/ERK kinase 4; MEK 4; SAPK/ERK kinase 1; SEK1; Stress-activated protein kinase kinase 1; SAPK kinase 1; SAPKK-1; SAPKK1; c-Jun N-terminal kinase kinase 1; JNKK,JNKK1; MEK4; MKK4; PRKMK4; SEK1; SERK1; SKK1,6416,mitogen-activated protein kinase kinase 4,SAPK/ERK kinase 1,stress-activated protein kinase kinase 1; c-Jun NH2-terminal kinase kinase 1,MEK4; JNKK1; PRKMK4; MKK4; MAPKK4; SAPKK1; SKK1; JNKK; SEK1,mitogen-activated protein kinase kinase 4,JNKK; JNKK1; MAPKK4; MEK4; MKK4; PRKMK4; SAPKK-1; SAPKK1; SEK1; SERK1; SKK1,MAP2K4
P46013,KI67_HUMAN,MKI67,Proliferation marker protein Ki-67; Antigen identified by monoclonal antibody Ki-67; Antigen KI-67; Antigen Ki67,,4288,marker of proliferation Ki-67,antigen identified by monoclonal antibody Ki-67,protein phosphatase 1; regulatory subunit 105; Molecular Immunology Borstel antibody 1,MIB-1; PPP1R105; Ki-67,marker of proliferation Ki-67,KIA; MIB-; MIB-1; PPP1R105,MKI67
P46019,KPB2_HUMAN,PHKA2; PHKLA; PYK,Phosphorylase b kinase regulatory subunit alpha; liver isoform; Phosphorylase kinase alpha L subunit,PHKLA; PYK,5256,phosphorylase kinase regulatory subunit alpha 2,,,,phosphorylase kinase regulatory subunit alpha 2,GSD9A; PHK; PYK; PYKL; XLG; XLG2,PHKA2
P46020,KPB1_HUMAN,PHKA1; PHKA,Phosphorylase b kinase regulatory subunit alpha; skeletal muscle isoform; Phosphorylase kinase alpha M subunit,PHKA,5255,phosphorylase kinase regulatory subunit alpha 1,phosphorylase kinase; alpha 1 (muscle),,,phosphorylase kinase regulatory subunit alpha 1,PHKA,PHKA1
P46060,RAGP1_HUMAN,RANGAP1; KIAA1835; SD,Ran GTPase-activating protein 1; RanGAP1,KIAA1835; SD,5905,Ran GTPase activating protein 1,segregation distorter homolog (Drosophila),,Fug1; KIAA1835,Ran GTPase activating protein 1,Fug1; RANGAP; SD,RANGAP1
P46092,CCR10_HUMAN,CCR10; GPR2,C-C chemokine receptor type 10; C-C CKR-10; CC-CKR-10; CCR-10; G-protein coupled receptor 2,GPR2,2826,C-C motif chemokine receptor 10,G protein-coupled receptor 2; chemokine (C-C motif) receptor 10,,,C-C motif chemokine receptor 10,GPR2,CCR10
P46094,XCR1_HUMAN,XCR1; CCXCR1; GPR5,Chemokine XC receptor 1; G-protein coupled receptor 5; Lymphotactin receptor; XC chemokine receptor 1,CCXCR1; GPR5,2829,X-C motif chemokine receptor 1,chemokine (C motif) XC receptor 1; chemokine (C motif) receptor 1,,,X-C motif chemokine receptor 1,CCXCR1; GPR5,XCR1
P46108,CRK_HUMAN,CRK,Adapter molecule crk; Proto-oncogene c-Crk; p38,,1398,CRK proto-oncogene; adaptor protein,v-crk avian sarcoma virus CT10 oncogene homolog,,,CRK proto-oncogene; adaptor protein,CRKII; p38,CRK
P46109,CRKL_HUMAN,CRKL,Crk-like protein,,1399,CRK like proto-oncogene; adaptor protein,v-crk avian sarcoma virus CT10 oncogene homolog-like,,,CRK like proto-oncogene; adaptor protein,,CRKL
P46379,BAG6_HUMAN,BAG6; BAT3; G3,Large proline-rich protein BAG6; BAG family molecular chaperone regulator 6; BCL2-associated athanogene 6; BAG-6; HLA-B-associated transcript 3; Protein G3; Protein Scythe,BAT3; G3,7917,BAG cochaperone 6,HLA-B associated transcript 3; BCL2 associated athanogene 6,,G3; D6S52E; Scythe,BAG cochaperone 6,BAG-6; BAT3; D6S52E; G3,BAG6
P46459,NSF_HUMAN,NSF,Vesicle-fusing ATPase; EC 3.6.4.6; N-ethylmaleimide-sensitive fusion protein; NEM-sensitive fusion protein; Vesicular-fusion protein NSF,,4905,N-ethylmaleimide sensitive factor; vesicle fusing ATPase,N-ethylmaleimide-sensitive factor; N-ethylmaleimide sensitive factor,N-ethylmaleimide-sensitive factor-like protein,SKD2; SEC18,N-ethylmaleimide sensitive factor; vesicle fusing ATPase,DEE96; SEC18; SKD2,NSF
P46527,CDN1B_HUMAN,CDKN1B; KIP1; p27,Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; p27Kip1,KIP1; p27,1027,cyclin dependent kinase inhibitor 1B,cyclin-dependent kinase inhibitor 1B (p27; Kip1),,KIP1; P27KIP1,cyclin dependent kinase inhibitor 1B,CDKN4; KIP1; MEN1B; MEN4; P27KIP1,CDKN1B
P46531,NOTC1_HUMAN,NOTCH1; TAN1,Neurogenic locus notch homolog protein 1; Notch 1; hN1; Translocation-associated notch protein TAN-1; NEXT; NICD,TAN1,4851,notch receptor 1,Notch (Drosophila) homolog 1 (translocation-associated); Notch homolog 1; translocation-associated (Drosophila); notch 1,,,notch receptor 1,AOS5; AOVD1; TAN1; hN1,NOTCH1
P46695,IEX1_HUMAN,IER3; DIF2; IEX1; PRG1,Radiation-inducible immediate-early gene IEX-1; Differentiation-dependent gene 2 protein; Protein DIF-2; Immediate early protein GLY96; Immediate early response 3 protein; PACAP-responsive gene 1 protein; Protein PRG1,DIF2; IEX1; PRG1,8870,immediate early response 3,,,IEX-1; DIF-2; PRG1; IEX-1L,immediate early response 3,DIF-2; DIF2; GLY96; IEX-1; IEX-1L; IEX1; PRG1,IER3
P46734,MP2K3_HUMAN,MAP2K3; MEK3; MKK3; PRKMK3; SKK2,Dual specificity mitogen-activated protein kinase kinase 3; MAP kinase kinase 3; MAPKK 3; EC 2.7.12.2; MAPK/ERK kinase 3; MEK 3; Stress-activated protein kinase kinase 2; SAPK kinase 2; SAPKK-2; SAPKK2,MEK3; MKK3; PRKMK3; SKK2,5606,mitogen-activated protein kinase kinase 3,,MAPK/ERK kinase 3; MAP kinase kinase 3; dual specificity mitogen activated protein kinase kinase 3; stress-activated protein kinase kinase 2,MEK3; MKK3; MAPKK3; SAPKK2,mitogen-activated protein kinase kinase 3,MAPKK3; MEK3; MKK3; PRKMK3; SAPKK-2; SAPKK2,MAP2K3
P46778,RL21_HUMAN,RPL21,Large ribosomal subunit protein eL21; 60S ribosomal protein L21,,6144,ribosomal protein L21,,60S ribosomal protein L21,L21; FLJ27458; MGC71252; MGC104274; MGC104275; DKFZp686C06101; eL21,ribosomal protein L21,HYPT12; L21; eL21,RPL21
P46783,RS10_HUMAN,RPS10,Small ribosomal subunit protein eS10; 40S ribosomal protein S10,,6204,ribosomal protein S10,,,MGC88819; S10; eS10,ribosomal protein S10,DBA9; S10; eS10,RPS10
P46937,YAP1_HUMAN,YAP1; YAP65,Transcriptional coactivator YAP1; Yes-associated protein 1; Protein yorkie homolog; Yes-associated protein YAP65 homolog,YAP65,10413,Yes1 associated transcriptional regulator,Yes-associated protein 1; 65kDa; Yes associated protein 1,,YAP65; YAP-1,Yes1 associated transcriptional regulator,COB1; YAP; YAP-1; YAP2; YAP65; YKI,YAP1
P46939,UTRN_HUMAN,UTRN; DMDL; DRP1,Utrophin; Dystrophin-related protein 1; DRP-1,DMDL; DRP1,7402,utrophin,utrophin (homologous to dystrophin),,DRP; DRP1,utrophin,DMDL; DRP; DRP1,UTRN
P46940,IQGA1_HUMAN,IQGAP1; KIAA0051,Ras GTPase-activating-like protein IQGAP1; p195,KIAA0051,8826,IQ motif containing GTPase activating protein 1,,RasGAP-like with IQ motifs,p195; KIAA0051; SAR1; HUMORFA01,IQ motif containing GTPase activating protein 1,HUMORFA01; SAR1; p195,IQGAP1
P47710,CASA1_HUMAN,CSN1S1; CASA; CSN1,Alpha-S1-casein Cleaved into: Casoxin-D,CASA; CSN1,1446,casein alpha s1,casein; alpha,,,casein alpha s1,CASA; CSN1,CSN1S1
P47712,PA24A_HUMAN,PLA2G4A; CPLA2; PLA2G4,Cytosolic phospholipase A2; cPLA2; Phospholipase A2 group IVA; EC 3.1.1.4; Phosphatidylcholine 2-acylhydrolase; EC 3.1.1.5,CPLA2; PLA2G4,5321,phospholipase A2 group IVA,phospholipase A2; group IVA (cytosolic; calcium-dependent),,cPLA2-alpha,phospholipase A2 group IVA,GURDP; PLA2G4; cPLA2; cPLA2-alpha,PLA2G4A
P47736,RPGP1_HUMAN,RAP1GAP; KIAA0474; RAP1GA1,Rap1 GTPase-activating protein 1; Rap1GAP; Rap1GAP1,KIAA0474; RAP1GA1,5909,RAP1 GTPase activating protein,RAP1; GTPase activating protein 1,,KIAA0474; RAP1GAP1; RAP1GAPII,RAP1 GTPase activating protein,RAP1GA1; RAP1GAP1; RAP1GAPII; RAPGAP,RAP1GAP
P47974,TISD_HUMAN,ZFP36L2; ERF2; RNF162C; TIS11D,mRNA decay activator protein ZFP36L2; Butyrate response factor 2; EGF-response factor 2; ERF-2; TPA-induced sequence 11d; Zinc finger protein 36; C3H1 type-like 2; ZFP36-like 2,ERF2; RNF162C; TIS11D,678,ZFP36 ring finger protein like 2,butyrate response factor 2 (EGF-response factor 2); zinc finger protein 36; C3H type-like 2,,ERF2; RNF162C; TIS11D,ZFP36 ring finger protein like 2,BRF2; ERF-2; ERF2; OOMD13; OZEMA13; RNF162C; TIS11D,ZFP36L2
P47989,XDH_HUMAN,XDH; XDHA,Xanthine dehydrogenase/oxidase Includes: Xanthine dehydrogenase; XD; EC 1.17.1.4; XO; EC 1.17.3.2; Xanthine oxidoreductase; XOR,XDHA,7498,xanthine dehydrogenase,xanthene dehydrogenase,,XOR; XO,xanthine dehydrogenase,XAN1; XO; XOR,XDH
P48048,KCNJ1_HUMAN,KCNJ1; ROMK1,ATP-sensitive inward rectifier potassium channel 1; ATP-regulated potassium channel ROM-K; Inward rectifier K(+; Potassium channel; inwardly rectifying subfamily J member 1,ROMK1,3758,potassium inwardly rectifying channel subfamily J member 1,potassium inwardly-rectifying channel; subfamily J; member 1,ATP-sensitive inward rectifier potassium channel 1,Kir1.1; ROMK1,potassium inwardly rectifying channel subfamily J member 1,KIR1.1; ROMK; ROMK1,KCNJ1
P48050,KCNJ4_HUMAN,KCNJ4; IRK3,Inward rectifier potassium channel 4; HIRK2; HRK1; Hippocampal inward rectifier; HIR; Inward rectifier K(+; IRK-3; Potassium channel; inwardly rectifying subfamily J member 4,IRK3,3761,potassium inwardly rectifying channel subfamily J member 4,potassium inwardly-rectifying channel; subfamily J; member 4,,Kir2.3; HIR; HRK1; hIRK2; IRK3,potassium inwardly rectifying channel subfamily J member 4,HIR; HIRK2; HRK1; IRK-3; IRK3; Kir2.3,KCNJ4
P48058,GRIA4_HUMAN,GRIA4; GluA4; GLUR4,Glutamate receptor 4; GluR-4; GluR4; AMPA-selective glutamate receptor 4; GluR-D; Glutamate receptor ionotropic; AMPA 4,GluA4; GLUR4,2893,glutamate ionotropic receptor AMPA type subunit 4,glutamate receptor; ionotrophic; AMPA 4,Glutamate receptor 4,GluA4; GLURD; GluR-4; GluR-D; GLUR4C,glutamate ionotropic receptor AMPA type subunit 4,GLUR4; GLUR4C; GLURD; GluA4; GluA4-ATD; NEDSGA,GRIA4
P48167,GLRB_HUMAN,GLRB,Glycine receptor subunit beta; Glycine receptor 58 kDa subunit,,2743,glycine receptor beta,,,,glycine receptor beta,HKPX2,GLRB
P48200,IREB2_HUMAN,IREB2,Iron-responsive element-binding protein 2; IRE-BP 2; Iron regulatory protein 2; IRP2,,3658,iron responsive element binding protein 2,,,IRP2,iron responsive element binding protein 2,ACO3; IRE-BP 2; IRE-BP2; IRP2; IRP2AD; NDCAMA,IREB2
P48426,PI42A_HUMAN,PIP4K2A; PI5P4KA; PIP5K2; PIP5K2A,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha; EC 2.7.1.149; 1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha; Diphosphoinositide kinase 2-alpha; PIP5KIII; Phosphatidylinositol 5-Phosphate 4-Kinase; PI5P4Kalpha; Phosphatidylinositol 5-phosphate 4-kinase type II alpha; PI(5; PIP4KII-alpha; PtdIns(4; PtdIns(4; PtdIns(5,PI5P4KA; PIP5K2; PIP5K2A,5305,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,phosphatidylinositol-4-phosphate 5-kinase; type II; alpha; phosphatidylinositol-5-phosphate 4-kinase; type II; alpha,,PIP5KIIA; PIP5KIIalpha,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,PI5P4KA; PIP5K2A; PIP5KII-alpha; PIP5KIIA; PIPK,PIP4K2A
P48436,SOX9_HUMAN,SOX9,Transcription factor SOX-9,,6662,SRY-box transcription factor 9,campomelic dysplasia; autosomal sex-reversal; SRY (sex determining region Y)-box 9; SRY-box 9,,SRA1,SRY-box transcription factor 9,CMD1; CMPD1; ENH13; SRA1; SRXX2; SRXY10; TES; TESCO,SOX9
P48454,PP2BC_HUMAN,PPP3CC; CALNA3; CNA3,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform; EC 3.1.3.16; CAM-PRP catalytic subunit; Calcineurin; testis-specific catalytic subunit; Calmodulin-dependent calcineurin A subunit gamma isoform,CALNA3; CNA3,5533,protein phosphatase 3 catalytic subunit gamma,protein phosphatase 3 (formerly 2B); catalytic subunit; gamma isoform (calcineurin A gamma); protein phosphatase 3 (formerly 2B); catalytic subunit; gamma isoform; protein phosphatase 3; catalytic subunit; gamma isozyme,calcineurin A gamma; protein phosphatase 2B; catalytic subunit; gamma isoform,CALNA3; PP2Bgamma,protein phosphatase 3 catalytic subunit gamma,CALNA3; CNA3; PP2Bgamma,PPP3CC
P48544,KCNJ5_HUMAN,KCNJ5; GIRK4,G protein-activated inward rectifier potassium channel 4; GIRK-4; Cardiac inward rectifier; CIR; Heart KATP channel; Inward rectifier K(+; IRK-4; KATP-1; Potassium channel; inwardly rectifying subfamily J member 5,GIRK4,3762,potassium inwardly rectifying channel subfamily J member 5,potassium inwardly-rectifying channel; subfamily J; member 5,G protein-activated inward rectifier potassium channel 4,Kir3.4; CIR; KATP1; GIRK4; LQT13,potassium inwardly rectifying channel subfamily J member 5,CIR; GIRK4; KATP1; KIR3.4; LQT13,KCNJ5
P48549,KCNJ3_HUMAN,KCNJ3; GIRK1,G protein-activated inward rectifier potassium channel 1; GIRK-1; Inward rectifier K(+; Potassium channel; inwardly rectifying subfamily J member 3,GIRK1,3760,potassium inwardly rectifying channel subfamily J member 3,potassium inwardly-rectifying channel; subfamily J; member 3,G protein-activated inward rectifier potassium channel 1,Kir3.1; GIRK1; KGA,potassium inwardly rectifying channel subfamily J member 3,GIRK1; KGA; KIR3.1,KCNJ3
P48634,PRC2A_HUMAN,PRRC2A; BAT2; G2,Protein PRRC2A; HLA-B-associated transcript 2; Large proline-rich protein BAT2; Proline-rich and coiled-coil-containing protein 2A; Protein G2,BAT2; G2,7916,proline rich coiled-coil 2A,HLA-B associated transcript 2; proline-rich coiled-coil 2A,,G2; D6S51E,proline rich coiled-coil 2A,BAT2; D6S51; D6S51E; G2,PRRC2A
P48729,KC1A_HUMAN,CSNK1A1,Casein kinase I isoform alpha; CKI-alpha; EC 2.7.11.1; CK1,,1452,casein kinase 1 alpha 1,casein kinase 1; alpha 1,clock regulator kinase,CK1; CK1a; CK1alpha; CKIa; CKIalpha,casein kinase 1 alpha 1,CK1; CK1a; CKIa; HEL-S-77p; HLCDGP1; PRO2975,CSNK1A1
P48730,KC1D_HUMAN,CSNK1D; HCKID,Casein kinase I isoform delta; CKI-delta; CKId; EC 2.7.11.1; Tau-protein kinase CSNK1D; EC 2.7.11.26,HCKID,1453,casein kinase 1 delta,casein kinase 1; delta,,HCKID; CKID; CKIdelta,casein kinase 1 delta,ASPS; CKI-delta; CKId; CKIdelta; FASPS2; HCKID,CSNK1D
P48736,PK3CG_HUMAN,PIK3CG,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit gamma isoform; PI3-kinase subunit gamma; PI3K-gamma; PI3Kgamma; PtdIns-3-kinase subunit gamma; EC 2.7.1.137; EC 2.7.1.153; EC 2.7.1.154; Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma; PtdIns-3-kinase subunit p110-gamma; p110gamma; Phosphoinositide-3-kinase catalytic gamma polypeptide; Serine/threonine protein kinase PIK3CG; EC 2.7.11.1; p120-PI3K,,5294,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit gamma,phosphoinositide-3-kinase; catalytic; gamma polypeptide; phosphatidylinositol-4;5-bisphosphate 3-kinase; catalytic subunit gamma,,,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit gamma,IMD97; PI3CG; PI3K; PI3Kgamma; PIK3; p110gamma; p120-PI3K,PIK3CG
P48751,B3A3_HUMAN,SLC4A3; AE3,Anion exchange protein 3; AE 3; Anion exchanger 3; CAE3/BAE3; Cardiac/brain band 3-like protein; Neuronal band 3-like protein; Solute carrier family 4 member 3,AE3,6508,solute carrier family 4 member 3,solute carrier family 4; anion exchanger; member 3; solute carrier family 4 (anion exchanger); member 3,Anion exchanger 3; neuronal,AE3; SLC2C,solute carrier family 4 member 3,AE3; CAE3/BAE3; SLC2C; SQT7,SLC4A3
P48764,SL9A3_HUMAN,SLC9A3; NHE3,Sodium/hydrogen exchanger 3; Na(+; +; NHE-3; Solute carrier family 9 member 3,NHE3,6550,solute carrier family 9 member A3,solute carrier family 9 (sodium/hydrogen exchanger); isoform 3; solute carrier family 9 (sodium/hydrogen exchanger); member 3; solute carrier family 9; subfamily A (NHE3; cation proton antiporter 3); member 3,Sodium/hydrogen exchanger 3,NHE-3,solute carrier family 9 member A3,DIAR8; NHE-3; NHE3,SLC9A3
P49005,DPOD2_HUMAN,POLD2,DNA polymerase delta subunit 2; DNA polymerase delta subunit p50,,5425,DNA polymerase delta 2; accessory subunit,polymerase (DNA directed); delta 2; regulatory subunit (50kD); polymerase (DNA directed); delta 2; regulatory subunit 50kDa; polymerase (DNA) delta 2; accessory subunit,Pol delta B subunit (p50); DNA polymerase delta subunit p50,,DNA polymerase delta 2; accessory subunit,,POLD2
P49006,MRP_HUMAN,MARCKSL1; MLP; MRP,MARCKS-related protein; MARCKS-like protein 1; Macrophage myristoylated alanine-rich C kinase substrate; Mac-MARCKS; MacMARCKS,MLP; MRP,65108,MARCKS like 1,MARCKS-like protein,,F52; MacMARCKS; MLP1,MARCKS like 1,F52; MACMARCKS; MLP; MLP1; MRP,MARCKSL1
P49023,PAXI_HUMAN,PXN,Paxillin,,5829,paxillin,,,,paxillin,,PXN
P49137,MAPK2_HUMAN,MAPKAPK2,MAP kinase-activated protein kinase 2; MAPK-activated protein kinase 2; MAPKAP kinase 2; MAPKAP-K2; MAPKAPK-2; MK-2; MK2; EC 2.7.11.1,,9261,MAPK activated protein kinase 2,mitogen-activated protein kinase-activated protein kinase 2,,MK2,MAPK activated protein kinase 2,MAPKAP-K2; MK-2; MK2,MAPKAPK2
P49238,CX3C1_HUMAN,CX3CR1; CMKBRL1; GPR13,CX3C chemokine receptor 1; C-X3-C CKR-1; CX3CR1; Beta chemokine receptor-like 1; CMK-BRL-1; CMK-BRL1; Fractalkine receptor; G-protein coupled receptor 13; V28,CMKBRL1; GPR13,1524,C-X3-C motif chemokine receptor 1,chemokine (C-X3-C) receptor 1; chemokine (C-X3-C motif) receptor 1,,CMKDR1; V28; CCRL1,C-X3-C motif chemokine receptor 1,CCRL1; CMKBRL1; CMKDR1; GPR13; GPRV28; V28,CX3CR1
P49279,NRAM1_HUMAN,SLC11A1; LSH; NRAMP; NRAMP1,Natural resistance-associated macrophage protein 1; NRAMP 1; Solute carrier family 11 member 1,LSH; NRAMP; NRAMP1,6556,solute carrier family 11 member 1,solute carrier family 11 (proton-coupled divalent metal ion transporter); member 1; Leishmaniasis resistance; natural resistance-associated macrophage protein 1,,,solute carrier family 11 member 1,LSH; NRAMP; NRAMP1,SLC11A1
P49321,NASP_HUMAN,NASP,Nuclear autoantigenic sperm protein; NASP,,4678,nuclear autoantigenic sperm protein,nuclear autoantigenic sperm protein (histone-binding),NASP histone chaperone,FLB7527; FLJ31599; FLJ35510; MGC19722; MGC20372; MGC2297; DKFZp547F162; PRO1999,nuclear autoantigenic sperm protein,FLB7527; HMDRA1; PRO1999,NASP
P49336,CDK8_HUMAN,CDK8,Cyclin-dependent kinase 8; EC 2.7.11.22; EC 2.7.11.23; Cell division protein kinase 8; Mediator complex subunit CDK8; Mediator of RNA polymerase II transcription subunit CDK8; Protein kinase K35,,1024,cyclin dependent kinase 8,cyclin-dependent kinase 8,,K35,cyclin dependent kinase 8,IDDHBA; K35,CDK8
P49407,ARRB1_HUMAN,ARRB1; ARR1,Beta-arrestin-1; Arrestin beta-1; Non-visual arrestin-2,ARR1,408,arrestin beta 1,arrestin; beta 1,arrestin 2,,arrestin beta 1,ARB1; ARR1,ARRB1
P49418,AMPH_HUMAN,AMPH; AMPH1,Amphiphysin,AMPH1,273,amphiphysin,amphiphysin (Stiff-Mann syndrome with breast cancer 128kD autoantigen); amphiphysin (Stiff-Man syndrome with breast cancer 128kDa autoantigen),,,amphiphysin,AMPH1,AMPH
P49427,UB2R1_HUMAN,CDC34; UBCH3; UBE2R1,Ubiquitin-conjugating enzyme E2 R1; EC 2.3.2.23; (E3-independent; EC 2.3.2.24; E2 ubiquitin-conjugating enzyme R1; Ubiquitin-conjugating enzyme E2-32 kDa complementing; Ubiquitin-conjugating enzyme E2-CDC34; Ubiquitin-protein ligase R1,UBCH3; UBE2R1,997,cell division cycle 34; ubiquitin conjugating enzyme,,ubiquitin conjugating enzyme E2 R1,E2-CDC34; UBE2R1; UBC3,cell division cycle 34; ubiquitin conjugating enzyme,E2-CDC34; UBC3; UBCH3; UBE2R1,CDC34
P49448,DHE4_HUMAN,GLUD2; GLUDP1,Glutamate dehydrogenase 2; mitochondrial; GDH 2; EC 1.4.1.3,GLUDP1,2747,glutamate dehydrogenase 2,glutamate dehydrogenase pseudogene 1,,,glutamate dehydrogenase 2,GDH2; GLUDP1,GLUD2
P49450,CENPA_HUMAN,CENPA,Histone H3-like centromeric protein A; Centromere autoantigen A; Centromere protein A; CENP-A,,1058,centromere protein A,centromere protein A (17kD); centromere protein A; 17kDa,centromere-specific histone; histone H3-like centromeric protein A,CENP-A; CenH3,centromere protein A,CENP-A; CenH3,CENPA
P49459,UBE2A_HUMAN,UBE2A; RAD6A,Ubiquitin-conjugating enzyme E2 A; EC 2.3.2.23; E2 ubiquitin-conjugating enzyme A; RAD6 homolog A; HR6A; hHR6A; Ubiquitin carrier protein A; Ubiquitin-protein ligase A,RAD6A,7319,ubiquitin conjugating enzyme E2 A,ubiquitin-conjugating enzyme E2A (RAD6 homolog); ubiquitin-conjugating enzyme E2A,,UBC2; HHR6A; RAD6A; HR6A,ubiquitin conjugating enzyme E2 A,HHR6A; MRXS30; MRXSN; RAD6A; UBC2,UBE2A
P49585,PCY1A_HUMAN,PCYT1A; CTPCT; PCYT1,Choline-phosphate cytidylyltransferase A; EC 2.7.7.15; CCT-alpha; CTP:phosphocholine cytidylyltransferase A; CCT A; CT A; Phosphorylcholine transferase A,CTPCT; PCYT1,5130,phosphate cytidylyltransferase 1A; choline,phosphate cytidylyltransferase 1; choline; alpha isoform; phosphate cytidylyltransferase 1; choline; alpha,phosphate cytidylyltransferase 1; choline; alpha isoform; CTP:phosphocholine cytidylyltransferase-alpha; choline-phosphate cytidylyltransferase alpha; phosphorylcholine transferase alpha,CT; CTPCT; CCTalpha,phosphate cytidylyltransferase 1A; choline,CCTA; CCTalpha; CGL5; CT; CTA; CTPCT; PCYT1; SMDCRD,PCYT1A
P49593,PPM1F_HUMAN,PPM1F; KIAA0015; POPX2,Protein phosphatase 1F; EC 3.1.3.16; Ca(2+; CaM-kinase phosphatase; CaMKPase; Partner of PIX 2; Protein fem-2 homolog; hFem-2,KIAA0015; POPX2,9647,protein phosphatase; Mg2+/Mn2+ dependent 1F,protein phosphatase 1F (PP2C domain containing); protein phosphatase; Mg2+/Mn2+ dependent; 1F,partner of PIX 2; Ca(2+)/calmodulin-dependent protein kinase phosphatase,FEM-2; KIAA0015; POPX2; CaMKPase; CAMKP,protein phosphatase; Mg2+/Mn2+ dependent 1F,CAMKP; CaMKPase; FEM-2; POPX2; hFEM-2,PPM1F
P49674,KC1E_HUMAN,CSNK1E,Casein kinase I isoform epsilon; CKI-epsilon; CKIe; EC 2.7.11.1,,102800317,casein kinase 1 epsilon,casein kinase 1; epsilon,,HCKIE; CKIE; CKIepsilon,TPTEP2-CSNK1E readthrough,LOC400927-CSNK1E,CSNK1E
P49682,CXCR3_HUMAN,CXCR3; GPR9,C-X-C chemokine receptor type 3; CXC-R3; CXCR-3; CKR-L2; G protein-coupled receptor 9; Interferon-inducible protein 10 receptor; IP-10 receptor; CD antigen CD183,GPR9,2833,C-X-C motif chemokine receptor 3,G protein-coupled receptor 9; chemokine (C-X-C motif) receptor 3,,CKR-L2; CMKAR3; IP10-R; MigR; CD183,C-X-C motif chemokine receptor 3,CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR,CXCR3
P49685,GPR15_HUMAN,GPR15,G-protein coupled receptor 15; Brother of Bonzo; BoB,,2838,G protein-coupled receptor 15,,,,G protein-coupled receptor 15,BOB,GPR15
P49715,CEBPA_HUMAN,CEBPA; CEBP,CCAAT/enhancer-binding protein alpha; C/EBP alpha,CEBP,1050,CCAAT enhancer binding protein alpha,CCAAT/enhancer binding protein (C/EBP); alpha; CCAAT/enhancer binding protein alpha,,C/EBP-alpha,CCAAT enhancer binding protein alpha,C/EBP-alpha; CEBP,CEBPA
P49716,CEBPD_HUMAN,CEBPD,CCAAT/enhancer-binding protein delta; C/EBP delta; Nuclear factor NF-IL6-beta; NF-IL6-beta,,1052,CCAAT enhancer binding protein delta,CCAAT/enhancer binding protein (C/EBP); delta; CCAAT/enhancer binding protein delta,,CRP3; CELF; C/EBP-delta; NF-IL6-beta,CCAAT enhancer binding protein delta,C/EBP-delta; CELF; CRP3; NF-IL6-beta,CEBPD
P49736,MCM2_HUMAN,MCM2; BM28; CCNL1; CDCL1; KIAA0030,DNA replication licensing factor MCM2; EC 3.6.4.12; Minichromosome maintenance protein 2 homolog; Nuclear protein BM28,BM28; CCNL1; CDCL1; KIAA0030,4171,minichromosome maintenance complex component 2,minichromosome maintenance deficient (S. cerevisiae) 2 (mitotin); MCM2 minichromosome maintenance deficient 2; mitotin (S. cerevisiae),mitotin,D3S3194; KIAA0030; BM28; cdc19; DFNA70,minichromosome maintenance complex component 2,BM28; CCNL1; CDCL1; D3S3194; DFNA70; MITOTIN; cdc19,MCM2
P49757,NUMB_HUMAN,NUMB; C14orf41,Protein numb homolog; h-Numb; Protein S171,C14orf41,8650,NUMB endocytic adaptor protein,numb (Drosophila) homolog; chromosome 14 open reading frame 41; numb homolog (Drosophila),,,NUMB endocytic adaptor protein,C14orf41; S171; c14_5527,NUMB
P49759,CLK1_HUMAN,CLK1; CLK,Dual specificity protein kinase CLK1; EC 2.7.12.1; CDC-like kinase 1,CLK,1195,CDC like kinase 1,CDC-like kinase 1,,,CDC like kinase 1,CLK; CLK/STY; STY,CLK1
P49760,CLK2_HUMAN,CLK2,Dual specificity protein kinase CLK2; EC 2.7.12.1; CDC-like kinase 2,,1196,CDC like kinase 2,CDC-like kinase 2,,,CDC like kinase 2,,CLK2
P49761,CLK3_HUMAN,CLK3,Dual specificity protein kinase CLK3; EC 2.7.12.1; CDC-like kinase 3,,1198,CDC like kinase 3,CDC-like kinase 3,,,CDC like kinase 3,PHCLK3; PHCLK3/152,CLK3
P49768,PSN1_HUMAN,PSEN1; AD3; PS1; PSNL1,Presenilin-1; PS-1; EC 3.4.23.-; Protein S182; PS1-CTF12,AD3; PS1; PSNL1,5663,presenilin 1,Alzheimer disease 3,familial Alzheimer Disease,FAD; S182; PS1; PS-1; PSNL1,presenilin 1,ACNINV3; AD3; CMD1U; FAD; PS-1; PS1; PSNL1; S182,PSEN1
P49789,FHIT_HUMAN,FHIT,Bis(5'-adenosyl)-triphosphatase; 5'-adenosyl; EC 3.6.1.29; AP3A hydrolase; AP3Aase; Adenosine 5'-monophosphoramidase FHIT; EC 3.9.1.-; Adenylylsulfatase; EC 3.6.2.1; Adenylylsulfate-ammonia adenylyltransferase; EC 2.7.7.51; Diadenosine 5';5'''-P1;P3-triphosphate hydrolase; Dinucleosidetriphosphatase; Fragile histidine triad protein,,2272,fragile histidine triad diadenosine triphosphatase,fragile histidine triad gene; fragile histidine triad,bis(5'-adenosyl)-triphosphatase,FRA3B; AP3Aase,fragile histidine triad diadenosine triphosphatase,AP3Aase; FRA3B,FHIT
P49790,NU153_HUMAN,NUP153,Nuclear pore complex protein Nup153; 153 kDa nucleoporin; Nucleoporin Nup153,,9972,nucleoporin 153,nucleoporin 153kDa,,HNUP153,nucleoporin 153,HNUP153; N153,NUP153
P49792,RBP2_HUMAN,RANBP2; NUP358,E3 SUMO-protein ligase RanBP2; EC 2.3.2.-; 358 kDa nucleoporin; Nuclear pore complex protein Nup358; Nucleoporin Nup358; Ran-binding protein 2; RanBP2; p270,NUP358,5903,RAN binding protein 2,acute necrotizing encephalopathy 1 (autosomal dominant),nucleoporin 358,NUP358; ADANE,RAN binding protein 2,ADANE; ANE1; IIAE3; NUP358; TRP1; TRP2,RANBP2
P49795,RGS19_HUMAN,RGS19; GAIP; GNAI3IP,Regulator of G-protein signaling 19; RGS19; G-alpha-interacting protein; GAIP,GAIP; GNAI3IP,10287,regulator of G protein signaling 19,regulator of G-protein signalling 19; regulator of G-protein signaling 19,,GAIP; RGSGAIP,regulator of G protein signaling 19,GAIP; RGSGAIP,RGS19
P49802,RGS7_HUMAN,RGS7,Regulator of G-protein signaling 7; RGS7,,6000,regulator of G protein signaling 7,regulator of G-protein signalling 7; regulator of G-protein signaling 7,,,regulator of G protein signaling 7,,RGS7
P49810,PSN2_HUMAN,PSEN2; AD4; PS2; PSNL2; STM2,Presenilin-2; PS-2; EC 3.4.23.-; AD3LP; AD5; E5-1; STM-2,AD4; PS2; PSNL2; STM2,5664,presenilin 2,Alzheimer disease 4,Alzheimer disease 3-like,AD3L; STM2; PS2; PS-2; E5-1,presenilin 2,AD3L; AD4; CMD1V; PS2; STM2,PSEN2
P49815,TSC2_HUMAN,TSC2; TSC4,Tuberin; Tuberous sclerosis 2 protein,TSC4,7249,TSC complex subunit 2,tuberous sclerosis 2,protein phosphatase 1; regulatory subunit 160,tuberin; LAM; PPP1R160,TSC complex subunit 2,LAM; PPP1R160; TSC4,TSC2
P49840,GSK3A_HUMAN,GSK3A,Glycogen synthase kinase-3 alpha; GSK-3 alpha; EC 2.7.11.26; Serine/threonine-protein kinase GSK3A; EC 2.7.11.1,,2931,glycogen synthase kinase 3 alpha,,,,glycogen synthase kinase 3 alpha,,GSK3A
P49841,GSK3B_HUMAN,GSK3B,Glycogen synthase kinase-3 beta; GSK-3 beta; EC 2.7.11.26; Serine/threonine-protein kinase GSK3B; EC 2.7.11.1,,2932,glycogen synthase kinase 3 beta,,,,glycogen synthase kinase 3 beta,,GSK3B
P49915,GUAA_HUMAN,GMPS,GMP synthase glutamine-hydrolyzing; EC 6.3.5.2; GMP synthetase; Glutamine amidotransferase,,8833,guanine monophosphate synthase,guanine monophosphate synthetase,GMP synthase,GATD7,guanine monophosphate synthase,GATD7,GMPS
P49916,DNLI3_HUMAN,LIG3,DNA ligase 3; EC 6.5.1.1; DNA ligase III; Polydeoxyribonucleotide synthase ATP 3,,3980,DNA ligase 3,ligase II; DNA; ATP-dependent; ligase III; DNA; ATP-dependent,DNA ligase III,LIG3alpha,DNA ligase 3,LIG2; LIG3alpha; MTDPS20,LIG3
P49917,DNLI4_HUMAN,LIG4,DNA ligase 4; EC 6.5.1.1; DNA ligase IV; Polydeoxyribonucleotide synthase ATP 4,,3981,DNA ligase 4,ligase IV; DNA; ATP-dependent,polydeoxyribonucleotide synthase ATP 4; polynucleotide ligase; sealase; DNA repair enzyme; DNA joinase; DNA ligase IV,,DNA ligase 4,LIG4S,LIG4
P49918,CDN1C_HUMAN,CDKN1C; KIP2,Cyclin-dependent kinase inhibitor 1C; Cyclin-dependent kinase inhibitor p57; p57Kip2,KIP2,1028,cyclin dependent kinase inhibitor 1C,Beckwith-Wiedemann syndrome; cyclin-dependent kinase inhibitor 1C (p57; Kip2),,P57; KIP2,cyclin dependent kinase inhibitor 1C,BWCR; BWS; KIP2; WBS; p57; p57Kip2,CDKN1C
P49959,MRE11_HUMAN,MRE11; HNGS1; MRE11A,Double-strand break repair protein MRE11; EC 3.1.-.-; Meiotic recombination 11 homolog 1; MRE11 homolog 1; Meiotic recombination 11 homolog A; MRE11 homolog A,HNGS1; MRE11A,4361,MRE11 homolog; double strand break repair nuclease,MRE11 meiotic recombination 11 homolog A (S. cerevisiae); MRE11 homolog A; double strand break repair nuclease,AT-like disease,ATLD,MRE11 homolog; double strand break repair nuclease,ATLD; HNGS1; MRE11A; MRE11B,MRE11
P50148,GNAQ_HUMAN,GNAQ; GAQ,Guanine nucleotide-binding protein G(q) subunit alpha; q; EC 3.6.5.-; Guanine nucleotide-binding protein alpha-q,GAQ,2776,G protein subunit alpha q,guanine nucleotide binding protein (G protein); q polypeptide,,G-ALPHA-q; GAQ,G protein subunit alpha q,CMAL; CMC1; G-ALPHA-q; GAQ; SWS,GNAQ
P50150,GBG4_HUMAN,GNG4; GNGT4,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4; I; S; O,GNGT4,2786,G protein subunit gamma 4,guanine nucleotide binding protein (G protein); gamma 4,,,G protein subunit gamma 4,HG3C,GNG4
P50151,GBG10_HUMAN,GNG10; GNGT10,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10; I; S; O,GNGT10,2790,G protein subunit gamma 10,guanine nucleotide binding protein (G protein); gamma 10,,,G protein subunit gamma 10,,GNG10
P50281,MMP14_HUMAN,MMP14,Matrix metalloproteinase-14; MMP-14; EC 3.4.24.80; MMP-X1; Membrane-type matrix metalloproteinase 1; MT-MMP 1; MTMMP1; Membrane-type-1 matrix metalloproteinase; MT1-MMP; MT1MMP,,4323,matrix metallopeptidase 14,matrix metalloproteinase 14 (membrane-inserted); matrix metallopeptidase 14 (membrane-inserted),membrane type 1 metalloprotease; membrane type 1-matrix metalloproteinase,MT1-MMP,matrix metallopeptidase 14,MMP-14; MMP-X1; MT-MMP; MT-MMP 1; MT1-MMP; MT1MMP; MTMMP1; WNCHRS,MMP14
P50402,EMD_HUMAN,EMD; EDMD; STA,Emerin,EDMD; STA,2010,emerin,Emery-Dreifuss muscular dystrophy,LEM domain containing 5,STA; LEMD5,emerin,EDMD; LEMD5; STA,EMD
P50502,F10A1_HUMAN,ST13; AAG2; FAM10A1; HIP; SNC6,Hsc70-interacting protein; Hip; Aging-associated protein 2; Progesterone receptor-associated p48 protein; Protein FAM10A1; Putative tumor suppressor ST13; Renal carcinoma antigen NY-REN-33; Suppression of tumorigenicity 13 protein,AAG2; FAM10A1; HIP; SNC6,6767,ST13 Hsp70 interacting protein,suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein); ST13; Hsp70 interacting protein,progesterone receptor-associated p48 protein,SNC6; HSPABP1; HIP; P48; FAM10A1,ST13 Hsp70 interacting protein,AAG2; FAM10A1; FAM10A4; HIP; HOP; HSPABP; HSPABP1; P48; PRO0786; SNC6,ST13
P50542,PEX5_HUMAN,PEX5; PXR1,Peroxisomal targeting signal 1 receptor; PTS1 receptor; PTS1R; PTS1-BP; Peroxin-5; Peroxisomal C-terminal targeting signal import receptor; Peroxisome receptor 1,PXR1,5830,peroxisomal biogenesis factor 5,peroxisome receptor 1,peroxisomal targeting signal 1 receptor; peroxisomal import receptor 5,PTS1R,peroxisomal biogenesis factor 5,PBD2A; PBD2B; PTS1-BP; PTS1R; PXR1; RCDP5,PEX5
P50548,ERF_HUMAN,ERF,ETS domain-containing transcription factor ERF; Ets2 repressor factor; PE-2,,2077,ETS2 repressor factor,Ets2 repressor factor,,PE-2; PE2,ETS2 repressor factor,CHYTS; CRS4; PE-2; PE2,ERF
P50549,ETV1_HUMAN,ETV1; ER81,ETS translocation variant 1; Ets-related protein 81,ER81,2115,ETS variant transcription factor 1,ets variant gene 1; ETS variant 1,,ER81,ETS variant transcription factor 1,ER81,ETV1
P50552,VASP_HUMAN,VASP,Vasodilator-stimulated phosphoprotein; VASP,,7408,vasodilator stimulated phosphoprotein,vasodilator-stimulated phosphoprotein,,,vasodilator stimulated phosphoprotein,,VASP
P50570,DYN2_HUMAN,DNM2; DYN2,Dynamin-2; EC 3.6.5.5; Dynamin 2; Dynamin II,DYN2,1785,dynamin 2,,dynamin II; cytoskeletal protein,DYNII; DYN2; CMTDIB; CMTDI1; DI-CMTB; CMT2M,dynamin 2,CMT2M; CMTDI1; CMTDIB; DI-CMTB; DYN2; DYNII; LCCS5,DNM2
P50613,CDK7_HUMAN,CDK7; CAK; CAK1; CDKN7; MO15; STK1,Cyclin-dependent kinase 7; EC 2.7.11.22; EC 2.7.11.23; 39 kDa protein kinase; p39 Mo15; CDK-activating kinase 1; Cell division protein kinase 7; Serine/threonine-protein kinase 1; TFIIH basal transcription factor complex kinase subunit,CAK; CAK1; CDKN7; MO15; STK1,1022,cyclin dependent kinase 7,cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase); cyclin-dependent kinase 7 (MO15 homolog; Xenopus laevis; cdk-activating kinase),,CAK1; CDKN7; MO15; STK1; CAK,cyclin dependent kinase 7,CAK; CAK1; CDKN7; HCAK; MO15; STK1; p39MO15,CDK7
P50616,TOB1_HUMAN,TOB1; TOB; TROB1,Protein Tob1; Transducer of erbB-2 1,TOB; TROB1,10140,transducer of ERBB2; 1,,,TOB; TROB; APRO5,transducer of ERBB2; 1,APRO5; APRO6; PIG49; TOB; TROB; TROB1,TOB1
P50750,CDK9_HUMAN,CDK9; CDC2L4; TAK,Cyclin-dependent kinase 9; EC 2.7.11.22; EC 2.7.11.23; C-2K; Cell division cycle 2-like protein kinase 4; Cell division protein kinase 9; Serine/threonine-protein kinase PITALRE; Tat-associated kinase complex catalytic subunit,CDC2L4; TAK,1025,cyclin dependent kinase 9,cyclin-dependent kinase 9 (CDC2-related kinase),,PITALRE; C-2k; TAK,cyclin dependent kinase 9,C-2k; CDC2L4; CTK1; PITALRE; TAK,CDK9
P50895,BCAM_HUMAN,BCAM; LU; MSK19,Basal cell adhesion molecule; Auberger B antigen; B-CAM cell surface glycoprotein; F8/G253 antigen; Lutheran antigen; Lutheran blood group glycoprotein; CD antigen CD239,LU; MSK19,4059,basal cell adhesion molecule (Lutheran blood group),Lutheran blood group (Auberger b antigen included); basal cell adhesion molecule (Lu and Au blood groups),,CD239; B-CAM; F8/G253,basal cell adhesion molecule (Lutheran blood group),AU; B-CAM; CD239; F8/G253; LU; MSK19,BCAM
P50993,AT1A2_HUMAN,ATP1A2; KIAA0778,Sodium/potassium-transporting ATPase subunit alpha-2; Na(+; +; EC 7.2.2.13; Sodium pump subunit alpha-2,KIAA0778,477,ATPase Na+/K+ transporting subunit alpha 2,migraine; hemiplegic 2; ATPase; Na+/K+ transporting; alpha 2 (+) polypeptide; ATPase; Na+/K+ transporting; alpha 2 polypeptide,sodium/potassium-transporting ATPase subunit alpha-2; sodium pump subunit alpha-2; sodium-potassium ATPase catalytic subunit alpha-2,FHM2,ATPase Na+/K+ transporting subunit alpha 2,DEE98; FARIMPD; FHM2; MHP2,ATP1A2
P51114,FXR1_HUMAN,FXR1,RNA-binding protein FXR1; FMR1 autosomal homolog 1; hFXR1p,,8087,FMR1 autosomal homolog 1,fragile X mental retardation; autosomal homolog 1,,,FMR1 autosomal homolog 1,CMYO9A; CMYO9B; CMYP9A; CMYP9B; FXR1P; MYOPMIL; MYORIBF,FXR1
P51397,DAP1_HUMAN,DAP; DAP1,Death-associated protein 1; DAP-1,DAP1,1611,death associated protein,,death associated protein 1,DAP1,death associated protein,DAP1,DAP
P51398,RT29_HUMAN,DAP3; MRPS29,Small ribosomal subunit protein mS29; 28S ribosomal protein S29; mitochondrial; MRP-S29; S29mt; Death-associated protein 3; DAP-3; Ionizing radiation resistance conferring protein,MRPS29,7818,death associated protein 3,,mitochondrial 28S ribosomal protein S29,MRPS29; DAP-3; MRP-S29; bMRP-10; MGC126058; MGC126059; DKFZp686G12159; mS29,death associated protein 3,DAP-3; MRP-S29; MRPS29; PRLTS7; S29mt; bMRP-10; mS29,DAP3
P51451,BLK_HUMAN,BLK,Tyrosine-protein kinase Blk; EC 2.7.10.2; B lymphocyte kinase; p55-Blk,,640,BLK proto-oncogene; Src family tyrosine kinase,B lymphoid tyrosine kinase,,MGC10442,BLK proto-oncogene; Src family tyrosine kinase,MODY11,BLK
P51452,DUS3_HUMAN,DUSP3; VHR,Dual specificity protein phosphatase 3; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase VHR; Vaccinia H1-related phosphatase; VHR,VHR,1845,dual specificity phosphatase 3,vaccinia virus phosphatase VH1-related,,,dual specificity phosphatase 3,VHR,DUSP3
P51532,SMCA4_HUMAN,SMARCA4; BAF190A; BRG1; SNF2B; SNF2L4,Transcription activator BRG1; EC 3.6.4.-; ATP-dependent helicase SMARCA4; BRG1-associated factor 190A; BAF190A; Mitotic growth and transcription activator; Protein BRG-1; Protein brahma homolog 1; SNF2-beta; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4,BAF190A; BRG1; SNF2B; SNF2L4,6597,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a; member 4,SNF2-like 4; global transcription activator homologous sequence; sucrose nonfermenting-like 4; mitotic growth and transcription activator; BRM/SWI2-related gene 1; homeotic gene regulator; nuclear protein GRB1; brahma protein-like 1; ATP-dependent helicase SMARCA4,hSNF2b; BRG1; BAF190; SNF2; SWI2; SNF2-BETA; SNF2LB; FLJ39786,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,BAF190; BAF190A; BRG1; CSS4; MRD16; OTSC12; RTPS2; SNF2; SNF2-beta; SNF2L4; SNF2LB; SWI2; hSNF2b,SMARCA4
P51587,BRCA2_HUMAN,BRCA2; FACD; FANCD1,Breast cancer type 2 susceptibility protein; Fanconi anemia group D1 protein,FACD; FANCD1,675,BRCA2 DNA repair associated,Fanconi anemia; complementation group D1; breast cancer 2; early onset; breast cancer 2,BRCA1/BRCA2-containing complex; subunit 2,FAD; FAD1; BRCC2; XRCC11,BRCA2 DNA repair associated,BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; GLM3; PNCA2; XRCC11,BRCA2
P51608,MECP2_HUMAN,MECP2,Methyl-CpG-binding protein 2; MeCp-2 protein; MeCp2,,4204,methyl-CpG binding protein 2,mental retardation; X-linked 16; mental retardation; X-linked 79; Rett syndrome; methyl CpG binding protein 2 (Rett syndrome); methyl CpG binding protein 2,,,methyl-CpG binding protein 2,AUTSX3; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT,MECP2
P51617,IRAK1_HUMAN,IRAK1; IRAK,Interleukin-1 receptor-associated kinase 1; IRAK-1; EC 2.7.11.1,IRAK,3654,interleukin 1 receptor associated kinase 1,,,IRAK; pelle,interleukin 1 receptor associated kinase 1,IRAK; pelle,IRAK1
P51636,CAV2_HUMAN,CAV2,Caveolin-2,,858,caveolin 2,,,CAV,caveolin 2,CAV,CAV2
P51649,SSDH_HUMAN,ALDH5A1; SSADH,Succinate-semialdehyde dehydrogenase; mitochondrial; EC 1.2.1.24; Aldehyde dehydrogenase family 5 member A1; NAD(+,SSADH,7915,aldehyde dehydrogenase 5 family member A1,aldehyde dehydrogenase 5 family; member A1,succinate-semialdehyde dehydrogenase,SSADH; SSDH,aldehyde dehydrogenase 5 family member A1,SSADH; SSDH,ALDH5A1
P51674,GPM6A_HUMAN,GPM6A; M6A,Neuronal membrane glycoprotein M6-a; M6a,M6A,2823,glycoprotein M6A,,,,glycoprotein M6A,GPM6; M6A,GPM6A
P51677,CCR3_HUMAN,CCR3; CMKBR3,C-C chemokine receptor type 3; C C CKR3; C-C CKR-3; CC-CKR-3; CCR-3; CCR3; CKR 3; CKR3; Eosinophil eotaxin receptor; CD antigen CD193,CMKBR3,1232,C-C motif chemokine receptor 3,chemokine (C-C motif) receptor 3,,CC-CKR-3; CKR3; CD193,C-C motif chemokine receptor 3,C C CKR3; CC-CKR-3; CD193; CKR 3; CKR3; CMKBR3,CCR3
P51679,CCR4_HUMAN,CCR4; CMKBR4,C-C chemokine receptor type 4; C-C CKR-4; CC-CKR-4; CCR-4; CCR4; K5-5; CD antigen CD194,CMKBR4,1233,C-C motif chemokine receptor 4,chemokine (C-C motif) receptor 4,,CC-CKR-4; CMKBR4; CKR4; k5-5; ChemR13; CD194,C-C motif chemokine receptor 4,CC-CKR-4; CD194; CKR4; CMKBR4; ChemR13; HGCN:14099; K5-5,CCR4
P51681,CCR5_HUMAN,CCR5; CMKBR5,C-C chemokine receptor type 5; C-C CKR-5; CC-CKR-5; CCR-5; CCR5; CHEMR13; HIV-1 fusion coreceptor; CD antigen CD195,CMKBR5,1234,C-C motif chemokine receptor 5,chemokine (C-C motif) receptor 5; chemokine (C-C motif) receptor 5 (gene/pseudogene); C-C motif chemokine receptor 5 (gene/pseudogene),,CKR-5; CC-CKR-5; CKR5; CD195; IDDM22,C-C motif chemokine receptor 5,CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22,CCR5
P51684,CCR6_HUMAN,CCR6; CKRL3; CMKBR6; GPR29; STRL22,C-C chemokine receptor type 6; C-C CKR-6; CC-CKR-6; CCR-6; Chemokine receptor-like 3; CKR-L3; DRY6; G-protein coupled receptor 29; GPR-CY4; GPRCY4; LARC receptor; CD antigen CD196,CKRL3; CMKBR6; GPR29; STRL22,1235,C-C motif chemokine receptor 6,chemokine (C-C motif) receptor 6,,CKR-L3; GPR-CY4; CMKBR6; GPR29; DRY-6; DCR2; BN-1; CD196,C-C motif chemokine receptor 6,BN-1; C-C CKR-6; CC-CKR-6; CCR-6; CD196; CKR-L3; CKRL3; CMKBR6; DCR2; DRY6; GPR29; GPRCY4; STRL22,CCR6
P51685,CCR8_HUMAN,CCR8; CKRL1; CMKBR8; CMKBRL2,C-C chemokine receptor type 8; C-C CKR-8; CC-CKR-8; CCR-8; CC chemokine receptor CHEMR1; CMKBRL2; Chemokine receptor-like 1; CKR-L1; GPR-CY6; GPRCY6; TER1; CD antigen CDw198,CKRL1; CMKBR8; CMKBRL2,1237,C-C motif chemokine receptor 8,chemokine (C-C motif) receptor 8,,CY6; TER1; CKR-L1; GPR-CY6; CDw198,C-C motif chemokine receptor 8,CC-CKR-8; CCR-8; CDw198; CKRL1; CMKBR8; CMKBRL2; CY6; GPRCY6; TER1,CCR8
P51686,CCR9_HUMAN,CCR9; GPR28,C-C chemokine receptor type 9; C-C CKR-9; CC-CKR-9; CCR-9; G-protein coupled receptor 28; GPR-9-6; CD antigen CDw199,GPR28,10803,C-C motif chemokine receptor 9,chemokine (C-C motif) receptor 9,,GPR-9-6; CDw199,C-C motif chemokine receptor 9,CC-CKR-9; CDw199; GPR-9-6; GPR28,CCR9
P51692,STA5B_HUMAN,STAT5B,Signal transducer and activator of transcription 5B,,6777,signal transducer and activator of transcription 5B,,,,signal transducer and activator of transcription 5B,GHISID2; STAT5,STAT5B
P51787,KCNQ1_HUMAN,KCNQ1; KCNA8; KCNA9; KVLQT1,Potassium voltage-gated channel subfamily KQT member 1; IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1; KQT-like 1; Voltage-gated potassium channel subunit Kv7.1,KCNA8; KCNA9; KVLQT1,3784,potassium voltage-gated channel subfamily Q member 1,potassium voltage-gated channel; KQT-like subfamily; member 1; potassium channel; voltage gated KQT-like subfamily Q; member 1,Jervell and Lange-Nielsen syndrome 1,Kv7.1; KCNA8; KVLQT1; JLNS1; LQT1,potassium voltage-gated channel subfamily Q member 1,ATFB1; ATFB3; JLNS1; KCNA8; KCNA9; KVLQT1; Kv1.9; Kv7.1; LQT; LQT1; RWS; SQT2; WRS,KCNQ1
P51790,CLCN3_HUMAN,CLCN3,H(+)/Cl(-) exchange transporter 3; +; -; Chloride channel protein 3; ClC-3; Chloride transporter ClC-3,,1182,chloride voltage-gated channel 3,chloride channel 3; chloride channel; voltage-sensitive 3,,CLC3; ClC-3,chloride voltage-gated channel 3,CLC3; ClC-3; NEDHYBA; NEDSBA,CLCN3
P51805,PLXA3_HUMAN,PLXNA3; PLXN4; SEX,Plexin-A3; Plexin-4; Semaphorin receptor SEX,PLXN4; SEX,55558,plexin A3,,,SEX; XAP-6; 6.3; Plxn3,plexin A3,6.3; HSSEXGENE; PLXN3; PLXN4; XAP-6,PLXNA3
P51809,VAMP7_HUMAN,VAMP7; SYBL1,Vesicle-associated membrane protein 7; VAMP-7; Synaptobrevin-like protein 1; Tetanus-insensitive VAMP; Ti-VAMP,SYBL1,6845,vesicle associated membrane protein 7,synaptobrevin-like 1,,VAMP-7; TI-VAMP,vesicle associated membrane protein 7,SYBL1; TI-VAMP; TIVAMP; VAMP-7,VAMP7
P51812,KS6A3_HUMAN,RPS6KA3; ISPK1; MAPKAPK1B; RSK2,Ribosomal protein S6 kinase alpha-3; S6K-alpha-3; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 3; p90-RSK 3; p90RSK3; Insulin-stimulated protein kinase 1; ISPK-1; MAP kinase-activated protein kinase 1b; MAPK-activated protein kinase 1b; MAPKAP kinase 1b; MAPKAPK-1b; Ribosomal S6 kinase 2; RSK-2; pp90RSK2,ISPK1; MAPKAPK1B; RSK2,6197,ribosomal protein S6 kinase A3,ribosomal protein S6 kinase; 90kD; polypeptide 3,,RSK2; HU-3,ribosomal protein S6 kinase A3,CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; RSK; RSK2; S6K-alpha3; XLID19; p90-RSK2; pp90RSK2,RPS6KA3
P51813,BMX_HUMAN,BMX,Cytoplasmic tyrosine-protein kinase BMX; EC 2.7.10.2; Bone marrow tyrosine kinase gene in chromosome X protein; Epithelial and endothelial tyrosine kinase; ETK; NTK38,,660,BMX non-receptor tyrosine kinase,,BTK-like on X chromosome,ETK; PSCTK3,BMX non-receptor tyrosine kinase,ETK; PSCTK2; PSCTK3,BMX
P51817,PRKX_HUMAN,PRKX; PKX1,cAMP-dependent protein kinase catalytic subunit PRKX; PrKX; Protein kinase X; Protein kinase X-linked; Serine/threonine-protein kinase PRKX; EC 2.7.11.1; Protein kinase PKX1,PKX1,5613,protein kinase cAMP-dependent X-linked catalytic subunit,protein kinase X-linked,,PKX1,protein kinase cAMP-dependent X-linked catalytic subunit,PKX1,PRKX
P51946,CCNH_HUMAN,CCNH,Cyclin-H; MO15-associated protein; p34; p37,,902,cyclin H,,CDK-activating kinase complex subunit; cyclin-dependent kinase-activating kinase complex subunit; MO15-associated protein; CAK complex subunit,p34; p37; CycH,cyclin H,CAK; CycH; p34; p37,CCNH
P51955,NEK2_HUMAN,NEK2; NEK2A; NLK1,Serine/threonine-protein kinase Nek2; EC 2.7.11.1; HSPK 21; Never in mitosis A-related kinase 2; NimA-related protein kinase 2; NimA-like protein kinase 1,NEK2A; NLK1,4751,NIMA related kinase 2,NIMA (never in mitosis gene a)-related kinase 2,HsPK 21; protein phosphatase 1; regulatory subunit 111,NLK1; NEK2A; RP67; PPP1R111,NIMA related kinase 2,HsPK21; NEK2A; NLK1; PPP1R111; RP67,NEK2
P51956,NEK3_HUMAN,NEK3,Serine/threonine-protein kinase Nek3; EC 2.7.11.1; HSPK 36; Never in mitosis A-related kinase 3; NimA-related protein kinase 3,,4752,NIMA related kinase 3,NIMA (never in mitosis gene a)-related kinase 3,serine/threonine-protein kinase NEK3; phosphorylase B kinase kinase; glycogen synthase A kinase; hydroxyalkyl-protein kinase,HSPK36; MGC29949,NIMA related kinase 3,HSPK36,NEK3
P52272,HNRPM_HUMAN,HNRNPM; HNRPM; NAGR1,Heterogeneous nuclear ribonucleoprotein M; hnRNP M,HNRPM; NAGR1,4670,heterogeneous nuclear ribonucleoprotein M,,CEA receptor,HTGR1; HNRNPM4; HNRPM4; CEAR,heterogeneous nuclear ribonucleoprotein M,CEAR; HNRNPM4; HNRPM; HNRPM4; HTGR1; NAGR1; hnRNP M,HNRNPM
P52292,IMA1_HUMAN,KPNA2; RCH1; SRP1,Importin subunit alpha-1; Karyopherin subunit alpha-2; RAG cohort protein 1; SRP1-alpha,RCH1; SRP1,3838,karyopherin subunit alpha 2,karyopherin alpha 2 (RAG cohort 1; importin alpha 1); karyopherin alpha 2,RAG cohort 1; importin alpha 1; nuclear pore-targeting complex 58kD component,SRP1alpha; IPOA1; QIP2; PTAC58,karyopherin subunit alpha 2,IPOA1; PTAC58; QIP2; RCH1; SRP1-alpha; SRP1alpha,KPNA2
P52294,IMA5_HUMAN,KPNA1; RCH2,Importin subunit alpha-5; Karyopherin subunit alpha-1; Nucleoprotein interactor 1; NPI-1; RAG cohort protein 2; SRP1-beta,RCH2,3836,karyopherin subunit alpha 1,karyopherin alpha 1 (importin alpha 5); karyopherin alpha 1,importin alpha 5,SRP1; RCH2; NPI-1; IPOA5,karyopherin subunit alpha 1,IPOA5; NPI-1; RCH2; SRP1,KPNA1
P52333,JAK3_HUMAN,JAK3,Tyrosine-protein kinase JAK3; EC 2.7.10.2; Janus kinase 3; JAK-3; Leukocyte janus kinase; L-JAK,,3718,Janus kinase 3,,tyrosine-protein kinase JAK3; leukocyte Janus kinase,L-JAK; JAKL; LJAK; JAK3_HUMAN; JAK-3,Janus kinase 3,JAK-3; JAK3_HUMAN; JAKL; L-JAK; LJAK,JAK3
P52564,MP2K6_HUMAN,MAP2K6; MEK6; MKK6; PRKMK6; SKK3,Dual specificity mitogen-activated protein kinase kinase 6; MAP kinase kinase 6; MAPKK 6; EC 2.7.12.2; MAPK/ERK kinase 6; MEK 6; Stress-activated protein kinase kinase 3; SAPK kinase 3; SAPKK-3; SAPKK3,MEK6; MKK6; PRKMK6; SKK3,5608,mitogen-activated protein kinase kinase 6,,protein kinase; mitogen-activated; kinase 6 (MAP kinase kinase 6),MEK6; MKK6; SAPKK3; MAPKK6,mitogen-activated protein kinase kinase 6,MAPKK6; MEK6; MKK6; PRKMK6; SAPKK-3; SAPKK3,MAP2K6
P52565,GDIR1_HUMAN,ARHGDIA; GDIA1,Rho GDP-dissociation inhibitor 1; Rho GDI 1; Rho-GDI alpha,GDIA1,396,Rho GDP dissociation inhibitor alpha,Rho GDP dissociation inhibitor (GDI) alpha,,RHOGDI,Rho GDP dissociation inhibitor alpha,GDIA1; HEL-S-47e; NPHS8; RHOGDI; RHOGDI-1,ARHGDIA
P52566,GDIR2_HUMAN,ARHGDIB; GDIA2; GDID4; RAP1GN1,Rho GDP-dissociation inhibitor 2; Rho GDI 2; Ly-GDI; Rho-GDI beta,GDIA2; GDID4; RAP1GN1,397,Rho GDP dissociation inhibitor beta,Rho GDP dissociation inhibitor (GDI) beta,,Ly-GDI; RhoGDI2,Rho GDP dissociation inhibitor beta,D4; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1; RhoGDI2,ARHGDIB
P52630,STAT2_HUMAN,STAT2,Signal transducer and activator of transcription 2; p113,,6773,signal transducer and activator of transcription 2,signal transducer and activator of transcription 2; 113kD; signal transducer and activator of transcription 2; 113kDa,,STAT113,signal transducer and activator of transcription 2,IMD44; ISGF-3; P113; PTORCH3; STAT113,STAT2
P52655,TF2AA_HUMAN,GTF2A1; TF2A1,Transcription initiation factor IIA subunit 1; General transcription factor IIA subunit 1; TFIIAL; Transcription initiation factor TFIIA 42 kDa subunit; TFIIA-42; TFIIA p35 subunit; TFIIA p19 subunit,TF2A1,2957,general transcription factor IIA subunit 1,glucose regulated protein; 58kD pseudogene; general transcription factor IIA; 1; 19/37kDa; general transcription factor IIA 1,TFIIA alpha/beta subunits,TFIIA,general transcription factor IIA subunit 1,TF2A1; TFIIA; TFIIA-42; TFIIAL,GTF2A1
P52732,KIF11_HUMAN,KIF11; EG5; KNSL1; TRIP5,Kinesin-like protein KIF11; Kinesin-like protein 1; Kinesin-like spindle protein HKSP; Kinesin-related motor protein Eg5; Thyroid receptor-interacting protein 5; TR-interacting protein 5; TRIP-5,EG5; KNSL1; TRIP5,3832,kinesin family member 11,kinesin-like 1,,Eg5; HKSP; TRIP5,kinesin family member 11,EG5; HKSP; KNSL1; MCLMR; TRIP5,KIF11
P52735,VAV2_HUMAN,VAV2,Guanine nucleotide exchange factor VAV2; VAV-2,,7410,vav guanine nucleotide exchange factor 2,vav 2 oncogene; vav 2 guanine nucleotide exchange factor,,,vav guanine nucleotide exchange factor 2,VAV-2,VAV2
P52757,CHIO_HUMAN,CHN2; ARHGAP3; BCH,Beta-chimaerin; Beta-chimerin; Rho GTPase-activating protein 3,ARHGAP3; BCH,1124,chimerin 2,chimerin (chimaerin) 2,beta chimerin; chimaerin 2,ARHGAP3; RhoGAP3,chimerin 2,ARHGAP3; BCH; CHN2-3; RHOGAP3,CHN2
P52789,HXK2_HUMAN,HK2,Hexokinase-2; EC 2.7.1.1; Hexokinase type II; HK II; Hexokinase-B; Muscle form hexokinase,,3099,hexokinase 2,,,,hexokinase 2,HKII; HXK2,HK2
P52799,EFNB2_HUMAN,EFNB2; EPLG5; HTKL; LERK5,Ephrin-B2; EPH-related receptor tyrosine kinase ligand 5; LERK-5; HTK ligand; HTK-L,EPLG5; HTKL; LERK5,1948,ephrin B2,ephrin-B2,HTK ligand; ligand of eph-related kinase 5; eph-related receptor tyrosine kinase ligand 5,LERK5; Htk-L; HTKL; MGC126226; MGC126227; MGC126228,ephrin B2,EPLG5; HTKL; Htk-L; LERK5; ephrin-B2,EFNB2
P52907,CAZA1_HUMAN,CAPZA1,F-actin-capping protein subunit alpha-1; CapZ alpha-1,,829,capping actin protein of muscle Z-line subunit alpha 1,capping protein (actin filament) muscle Z-line; alpha 1; capping actin protein of muscle Z-line alpha subunit 1,,CAPPA1,capping actin protein of muscle Z-line subunit alpha 1,CAPPA1; CAPZ; CAZ1,CAPZA1
P52926,HMGA2_HUMAN,HMGA2; HMGIC,High mobility group protein HMGI-C; High mobility group AT-hook protein 2,HMGIC,8091,high mobility group AT-hook 2,high-mobility group (nonhistone chromosomal) protein isoform I-C,,BABL; LIPO,high mobility group AT-hook 2,BABL; HMGI-C; HMGIC; LIPO; SRS5; STQTL9,HMGA2
P52945,PDX1_HUMAN,PDX1; IPF1; STF1,Pancreas/duodenum homeobox protein 1; PDX-1; Glucose-sensitive factor; GSF; Insulin promoter factor 1; IPF-1; Insulin upstream factor 1; IUF-1; Islet/duodenum homeobox-1; IDX-1; Somatostatin-transactivating factor 1; STF-1,IPF1; STF1,3651,pancreatic and duodenal homeobox 1,insulin promoter factor 1; homeodomain transcription factor,Islet/duodenum homeobox-1; somatostatin transcription factor 1; Glucose-sensitive factor; insulin upstream factor 1,IDX-1; STF-1; PDX-1; MODY4; GSF; IUF-1,pancreatic and duodenal homeobox 1,GSF; IDX-1; IPF1; IUF1; MODY4; PAGEN1; PDX-1; STF-1,PDX1
P52948,NUP98_HUMAN,NUP98; ADAR2,Nuclear pore complex protein Nup98-Nup96; EC 3.4.21.-; 98 kDa nucleoporin; Nucleoporin Nup98; Nup98; 96 kDa nucleoporin; Nucleoporin Nup96; Nup96,ADAR2,4928,nucleoporin 98 and 96 precursor,nucleoporin 98kDa; nucleoporin 98,Nuclear pore complex protein Nup98-Nup96; nucleoporin 96,NUP96; Nup98-Nup96; Nup98-96; NUP196,nucleoporin 98 and 96 precursor,ADIR2; NUP196; NUP96; Nup98-96,NUP98
P53004,BIEA_HUMAN,BLVRA; BLVR; BVR,Biliverdin reductase A; BVR A; EC 1.3.1.24; Biliverdin-IX alpha-reductase,BLVR; BVR,644,biliverdin reductase A,,biliverdin reductase IXalpha,BVRA; BVRalpha,biliverdin reductase A,BLVR; BVR; BVRA; BVRalpha,BLVRA
P53041,PPP5_HUMAN,PPP5C; PPP5,Serine/threonine-protein phosphatase 5; PP5; EC 3.1.3.16; Protein phosphatase T; PP-T; PPT,PPP5,5536,protein phosphatase 5 catalytic subunit,protein phosphatase 5; catalytic subunit,,PP5,protein phosphatase 5 catalytic subunit,PP5; PPP5; PPT,PPP5C
P53350,PLK1_HUMAN,PLK1; PLK,Serine/threonine-protein kinase PLK1; EC 2.7.11.21; Polo-like kinase 1; PLK-1; Serine/threonine-protein kinase 13; STPK13,PLK,5347,polo like kinase 1,polo-like kinase (Drosophila); polo-like kinase 1,,,polo like kinase 1,PLK; STPK13,PLK1
P53355,DAPK1_HUMAN,DAPK1; DAPK,Death-associated protein kinase 1; DAP kinase 1; EC 2.7.11.1,DAPK,1612,death associated protein kinase 1,death-associated protein kinase 1,,DAPK,death associated protein kinase 1,DAPK; ROCO3,DAPK1
P53365,ARFP2_HUMAN,ARFIP2; POR1,Arfaptin-2; ADP-ribosylation factor-interacting protein 2; Partner of RAC1; POR1,POR1,23647,ARF interacting protein 2,ADP ribosylation factor interacting protein 2,arfaptin 2,POR1,ARF interacting protein 2,POR1,ARFIP2
P53367,ARFP1_HUMAN,ARFIP1,Arfaptin-1; ADP-ribosylation factor-interacting protein 1,,27236,ARF interacting protein 1,ADP ribosylation factor interacting protein 1,arfaptin 1,HSU52521,ARF interacting protein 1,HSU52521,ARFIP1
P53396,ACLY_HUMAN,ACLY,ATP-citrate synthase; EC 2.3.3.8; ATP-citrate (pro-S-; ACL; Citrate cleavage enzyme,,47,ATP citrate lyase,,ATP citrate synthase,ATPCL; CLATP; ACL,ATP citrate lyase,ACL; ATPCL; CLATP,ACLY
P53539,FOSB_HUMAN,FOSB; G0S3,Protein FosB; FosB proto-oncogene; AP-1 transcription factor subunit; G0/G1 switch regulatory protein 3; Transcription factor AP-1 subunit FosB,G0S3,2354,FosB proto-oncogene; AP-1 transcription factor subunit,FBJ murine osteosarcoma viral oncogene homolog B,oncogene FOS-B; activator protein 1,G0S3; GOSB; GOS3; AP-1; MGC42291; DKFZp686C0818,FosB proto-oncogene; AP-1 transcription factor subunit,AP-1; G0S3; GOS3; GOSB,FOSB
P53667,LIMK1_HUMAN,LIMK1; LIMK,LIM domain kinase 1; LIMK-1; EC 2.7.11.1,LIMK,3984,LIM domain kinase 1,,,LIMK,LIM domain kinase 1,LIMK; LIMK-1,LIMK1
P53671,LIMK2_HUMAN,LIMK2,LIM domain kinase 2; LIMK-2; EC 2.7.11.1,,3985,LIM domain kinase 2,,,,LIM domain kinase 2,,LIMK2
P53778,MK12_HUMAN,MAPK12; ERK6; SAPK3,Mitogen-activated protein kinase 12; MAP kinase 12; MAPK 12; EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 gamma; Stress-activated protein kinase 3,ERK6; SAPK3,6300,mitogen-activated protein kinase 12,,,ERK6; PRKM12; p38gamma; SAPK-3,mitogen-activated protein kinase 12,ERK-6; ERK3; ERK6; MAPK 12; P38GAMMA; PRKM12; SAPK-3; SAPK3,MAPK12
P53779,MK10_HUMAN,MAPK10; JNK3; JNK3A; PRKM10; SAPK1B,Mitogen-activated protein kinase 10; MAP kinase 10; MAPK 10; EC 2.7.11.24; MAP kinase p49 3F12; Stress-activated protein kinase 1b; SAPK1b; Stress-activated protein kinase JNK3; c-Jun N-terminal kinase 3,JNK3; JNK3A; PRKM10; SAPK1B,5602,mitogen-activated protein kinase 10,,,JNK3; p493F12; p54bSAPK,mitogen-activated protein kinase 10,JNK3; JNK3A; PRKM10; SAPK1b; p493F12; p54bSAPK,MAPK10
P53801,PTTG_HUMAN,PTTG1IP; C21orf1; C21orf3,Pituitary tumor-transforming gene 1 protein-interacting protein; Pituitary tumor-transforming gene protein-binding factor; PBF; PTTG-binding factor,C21orf1; C21orf3,754,PTTG1 interacting protein,pituitary tumor-transforming 1 interacting protein,,PBF; PTTG1IP1,PTTG1 interacting protein,C21orf1; C21orf3; PBF; PTTG1IP1,PTTG1IP
P53804,TTC3_HUMAN,TTC3; DCRR1; RNF105; TPRD,E3 ubiquitin-protein ligase TTC3; EC 2.3.2.27; Protein DCRR1; RING finger protein 105; RING-type E3 ubiquitin transferase TTC3; TPR repeat protein D; Tetratricopeptide repeat protein 3; TPR repeat protein 3,DCRR1; RNF105; TPRD,7267,tetratricopeptide repeat domain 3,,,TPRD; TPRDI; DCRR1; TPRDII; TPRDIII; RNF105,tetratricopeptide repeat domain 3,DCRR1; RNF105; TPRDIII,TTC3
P53805,RCAN1_HUMAN,RCAN1; ADAPT78; CSP1; DSC1; DSCR1,Calcipressin-1; Adapt78; Down syndrome critical region protein 1; Myocyte-enriched calcineurin-interacting protein 1; MCIP1; Regulator of calcineurin 1,ADAPT78; CSP1; DSC1; DSCR1,1827,regulator of calcineurin 1,Down syndrome critical region gene 1,,,regulator of calcineurin 1,ADAPT78; CSP1; DSC1; DSCR1; MCIP1; RCN1,RCAN1
P54132,BLM_HUMAN,BLM; RECQ2; RECQL3,RecQ-like DNA helicase BLM; EC 5.6.2.4; Bloom syndrome protein; DNA 3'-5' helicase BLM; DNA helicase; RecQ-like type 2; RecQ2; RecQ protein-like 3,RECQ2; RECQL3,641,BLM RecQ like helicase,Bloom syndrome; Bloom syndrome RecQ like helicase,,BS; RECQL3; RECQ2,BLM RecQ like helicase,BS; MGRISCE1; RECQ2; RECQL2; RECQL3,BLM
P54198,HIRA_HUMAN,HIRA; DGCR1; HIR; TUPLE1,Protein HIRA; TUP1-like enhancer of split protein 1,DGCR1; HIR; TUPLE1,7290,histone cell cycle regulator,HIR (histone cell cycle regulation defective) homolog A (S. cerevisiae),DiGeorge critical region gene 1; histone regulator A,DGCR1; TUP1,histone cell cycle regulator,DGCR1; TUP1; TUPLE1,HIRA
P54252,ATX3_HUMAN,ATXN3; ATX3; MJD; MJD1; SCA3,Ataxin-3; EC 3.4.19.12; Machado-Joseph disease protein 1; Spinocerebellar ataxia type 3 protein,ATX3; MJD; MJD1; SCA3,4287,ataxin 3,Machado-Joseph disease (spinocerebellar ataxia 3; olivopontocerebellar ataxia 3; autosomal dominant; ataxin 3),,ATX3; JOS,ataxin 3,AT3; ATX3; JOS; MJD; MJD1; SCA3,ATXN3
P54253,ATX1_HUMAN,ATXN1; ATX1; SCA1,Ataxin-1; Spinocerebellar ataxia type 1 protein,ATX1; SCA1,6310,ataxin 1,spinocerebellar ataxia 1 (olivopontocerebellar ataxia 1; autosomal dominant; ataxin 1),,D6S504E; ATX1,ataxin 1,ATX1; D6S504E; SCA1,ATXN1
P54259,ATN1_HUMAN,ATN1; D12S755E; DRPLA,Atrophin-1; Dentatorubral-pallidoluysian atrophy protein,D12S755E; DRPLA,1822,atrophin 1,dentatorubral-pallidoluysian atrophy (atrophin-1),,B37,atrophin 1,B37; CHEDDA; D12S755E; DRPLA; HRS; NOD,ATN1
P54274,TERF1_HUMAN,TERF1; PIN2; TRBF1; TRF; TRF1,Telomeric repeat-binding factor 1; NIMA-interacting protein 2; TTAGGG repeat-binding factor 1; Telomeric protein Pin2/TRF1,PIN2; TRBF1; TRF; TRF1,7013,telomeric repeat binding factor 1,telomeric repeat binding factor (NIMA-interacting) 1,,PIN2; TRF1; TRF,telomeric repeat binding factor 1,PIN2; TRBF1; TRF; TRF1; hTRF1-AS; t-TRF1,TERF1
P54284,CACB3_HUMAN,CACNB3; CACNLB3,Voltage-dependent L-type calcium channel subunit beta-3; CAB3; Calcium channel voltage-dependent subunit beta 3,CACNLB3,784,calcium voltage-gated channel auxiliary subunit beta 3,calcium channel; voltage-dependent; beta 3 subunit,,,calcium voltage-gated channel auxiliary subunit beta 3,CAB3; CACNLB3,CACNB3
P54289,CA2D1_HUMAN,CACNA2D1; CACNL2A; CCHL2A; MHS3,Voltage-dependent calcium channel subunit alpha-2/delta-1; Voltage-gated calcium channel subunit alpha-2/delta-1,CACNL2A; CCHL2A; MHS3,781,calcium voltage-gated channel auxiliary subunit alpha2delta 1,long intergenic non-protein coding RNA 1112; calcium channel; voltage-dependent; alpha 2/delta subunit 1,,lncRNA-N3; alpha2delta-1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,CACNA2; CACNL2A; CCHL2A; DEE110; LINC01112; lncRNA-N3,CACNA2D1
P54296,MYOM2_HUMAN,MYOM2,Myomesin-2; 165 kDa connectin-associated protein; 165 kDa titin-associated protein; M-protein; Myomesin family member 2,,9172,myomesin 2,myomesin (M-protein) 2 (165kD); myomesin (M-protein) 2; 165kDa,,,myomesin 2,TTNAP,MYOM2
P54578,UBP14_HUMAN,USP14; TGT,Ubiquitin carboxyl-terminal hydrolase 14; EC 3.4.19.12; Deubiquitinating enzyme 14; Ubiquitin thioesterase 14; Ubiquitin-specific-processing protease 14,TGT,9097,ubiquitin specific peptidase 14,ubiquitin specific protease 14 (tRNA-guanine transglycosylase); ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),,TGT; Ubp6,ubiquitin specific peptidase 14,TGT; Ubp6,USP14
P54619,AAKG1_HUMAN,PRKAG1,5'-AMP-activated protein kinase subunit gamma-1; AMPK gamma1; AMPK subunit gamma-1; AMPKg,,5571,protein kinase AMP-activated non-catalytic subunit gamma 1,protein kinase; AMP-activated; gamma 1 non-catalytic subunit,,,protein kinase AMP-activated non-catalytic subunit gamma 1,AMPKG,PRKAG1
P54646,AAPK2_HUMAN,PRKAA2; AMPK; AMPK2,5'-AMP-activated protein kinase catalytic subunit alpha-2; AMPK subunit alpha-2; EC 2.7.11.1; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase; EC 2.7.11.31,AMPK; AMPK2,5563,protein kinase AMP-activated catalytic subunit alpha 2,protein kinase; AMP-activated; alpha 2 catalytic subunit,,AMPK; AMPKa2,protein kinase AMP-activated catalytic subunit alpha 2,AMPK; AMPK2; AMPKa2; PRKAA,PRKAA2
P54709,AT1B3_HUMAN,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3; Sodium/potassium-dependent ATPase subunit beta-3; ATPB-3; CD antigen CD298,,483,ATPase Na+/K+ transporting subunit beta 3,ATPase; Na+/K+ transporting; beta 3 polypeptide,sodium/potassium-transporting ATPase subunit beta-3; sodium pump subunit beta-3; sodium-potassium ATPase subunit beta 3 (non-catalytic),FLJ29027; CD298,ATPase Na+/K+ transporting subunit beta 3,ATPB-3; CD298,ATP1B3
P54710,ATNG_HUMAN,FXYD2; ATP1C; ATP1G1,Sodium/potassium-transporting ATPase subunit gamma; Na(+; +; FXYD domain-containing ion transport regulator 2; Sodium pump gamma chain,ATP1C; ATP1G1,486,FXYD domain containing ion transport regulator 2,hypomagnesemia 2; renal,,MGC12372,FXYD domain containing ion transport regulator 2,ATP1G1; HOMG2,FXYD2
P54753,EPHB3_HUMAN,EPHB3; ETK2; HEK2; TYRO6,Ephrin type-B receptor 3; EC 2.7.10.1; EPH-like tyrosine kinase 2; EPH-like kinase 2; Embryonic kinase 2; EK2; hEK2; Tyrosine-protein kinase TYRO6,ETK2; HEK2; TYRO6,2049,EPH receptor B3,EphB3,,Hek2; Tyro6,EPH receptor B3,EK2; ETK2; HEK2; TYRO6,EPHB3
P54762,EPHB1_HUMAN,EPHB1; ELK; EPHT2; HEK6; NET,Ephrin type-B receptor 1; EC 2.7.10.1; ELK; EPH tyrosine kinase 2; EPH-like kinase 6; EK6; hEK6; Neuronally-expressed EPH-related tyrosine kinase; NET; Tyrosine-protein kinase receptor EPH-2,ELK; EPHT2; HEK6; NET,2047,EPH receptor B1,EphB1,,Hek6,EPH receptor B1,ELK; EPHT2; Hek6; NET,EPHB1
P54764,EPHA4_HUMAN,EPHA4; HEK8; SEK; TYRO1,Ephrin type-A receptor 4; EC 2.7.10.1; EPH-like kinase 8; EK8; hEK8; Tyrosine-protein kinase TYRO1; Tyrosine-protein kinase receptor SEK,HEK8; SEK; TYRO1,2043,EPH receptor A4,EphA4,,Hek8,EPH receptor A4,EK8; HEK8; SEK; TYRO1,EPHA4
P54829,PTN5_HUMAN,PTPN5,Tyrosine-protein phosphatase non-receptor type 5; EC 3.1.3.48; Neural-specific protein-tyrosine phosphatase; Striatum-enriched protein-tyrosine phosphatase; STEP,,84867,protein tyrosine phosphatase non-receptor type 5,protein tyrosine phosphatase; non-receptor type 5 (striatum-enriched),striatal-enriched protein tyrosine phosphatase,STEP; PTPSTEP; STEP61,protein tyrosine phosphatase non-receptor type 5,PTPSTEP; STEP; STEP61,PTPN5
P54840,GYS2_HUMAN,GYS2,Glycogen starch synthase; liver; EC 2.4.1.11; Glycogen synthase 2,,2998,glycogen synthase 2,glycogen synthase 2 (liver),,,glycogen synthase 2,,GYS2
P55010,IF5_HUMAN,EIF5,Eukaryotic translation initiation factor 5; eIF-5,,1983,eukaryotic translation initiation factor 5,,,,eukaryotic translation initiation factor 5,EIF-5; EIF-5A,EIF5
P55011,S12A2_HUMAN,SLC12A2; NKCC1,Solute carrier family 12 member 2; Basolateral Na-K-Cl symporter; Bumetanide-sensitive sodium-(potassium; BSC2; Na-K-2Cl cotransporter 1; hNKCC1,NKCC1,6558,solute carrier family 12 member 2,solute carrier family 12 (sodium/potassium/chloride transporter); member 2,basolateral Na-K-Cl symporter; protein phosphatase 1; regulatory subunit 141; bumetanide-sensitive cotransporter type 2,NKCC1; BSC2; BSC-2; PPP1R141; CCC1,solute carrier family 12 member 2,BSC; BSC-2; BSC2; CCC1; KILQS; NKCC1; PPP1R141; hNKCC1,SLC12A2
P55017,S12A3_HUMAN,SLC12A3; NCC; TSC,Solute carrier family 12 member 3; Na-Cl cotransporter; NCC; Na-Cl symporter; Thiazide-sensitive sodium-chloride cotransporter,NCC; TSC,6559,solute carrier family 12 member 3,solute carrier family 12 (sodium/chloride transporter); member 3,Na-Cl symporter; sodium-chloride co-transporter; Thiazide-sensitive sodium-chloride cotransporter,NCCT; NCC; TSC,solute carrier family 12 member 3,NCC; NCCT; TSC,SLC12A3
P55039,DRG2_HUMAN,DRG2,Developmentally-regulated GTP-binding protein 2; DRG-2; Translation factor GTPase DRG2; TRAFAC GTPase DRG2; EC 3.6.5.-,,1819,developmentally regulated GTP binding protein 2,developmentally regulated GTP-binding protein 2,,,developmentally regulated GTP binding protein 2,,DRG2
P55040,GEM_HUMAN,GEM; KIR,GTP-binding protein GEM; GTP-binding mitogen-induced T-cell protein; RAS-like protein KIR,KIR,2669,GTP binding protein overexpressed in skeletal muscle,GTP-binding protein overexpressed in skeletal muscle,kinase-inducible Ras-like protein,KIR,GTP binding protein overexpressed in skeletal muscle,KIR,GEM
P55042,RAD_HUMAN,RRAD; RAD,GTP-binding protein RAD; RAD1; Ras associated with diabetes,RAD,6236,RRAD; Ras related glycolysis inhibitor and calcium channel regulator,Ras-related associated with diabetes; RRAD; Ras related glycolysis inihibitor and calcium channel regulator,,REM3; RAD,RRAD; Ras related glycolysis inhibitor and calcium channel regulator,RAD; RAD1; REM3,RRAD
P55055,NR1H2_HUMAN,NR1H2; LXRB; NER; UNR,Oxysterols receptor LXR-beta; Liver X receptor beta; Nuclear receptor NER; Nuclear receptor subfamily 1 group H member 2; Ubiquitously-expressed nuclear receptor,LXRB; NER; UNR,7376,nuclear receptor subfamily 1 group H member 2,ubiquitously-expressed nuclear receptor; nuclear receptor subfamily 1; group H; member 2,liver X receptor-beta,NER; NER-I; RIP15; LXR-b; LXRb,nuclear receptor subfamily 1 group H member 2,LXR-b; LXRB; NER; NER-I; RIP15; UNR,NR1H2
P55060,XPO2_HUMAN,CSE1L; CAS; XPO2,Exportin-2; Exp2; Cellular apoptosis susceptibility protein; Chromosome segregation 1-like protein; Importin-alpha re-exporter,CAS; XPO2,1434,chromosome segregation 1 like,chromosome segregation 1 (yeast homolog)-like; CSE1 chromosome segregation 1-like (yeast); CSE1 chromosome segregation 1 like,cellular apoptosis susceptibility,CAS; XPO2; CSE1,chromosome segregation 1 like,CAS; CSE1; XPO2,CSE1L
P55064,AQP5_HUMAN,AQP5,Aquaporin-5; AQP-5,,362,aquaporin 5,,,,aquaporin 5,AQP-5; PPKB,AQP5
P55072,TERA_HUMAN,VCP; HEL-220; HEL-S-70,Transitional endoplasmic reticulum ATPase; TER ATPase; EC 3.6.4.6; 15S Mg(2+; Valosin-containing protein; VCP,HEL-220; HEL-S-70,7415,valosin containing protein,valosin-containing protein,transitional endoplasmic reticulum ATPase,IBMPFD; p97; CDC48; TERA,valosin containing protein,CDC48; FTDALS6; TERA; p97,VCP
P55081,MFAP1_HUMAN,MFAP1,Microfibrillar-associated protein 1; Spliceosome B complex protein MFAP1,,4236,microfibril associated protein 1,microfibrillar associated protein 1,,AMP,microfibril associated protein 1,AMP,MFAP1
P55087,AQP4_HUMAN,AQP4,Aquaporin-4; AQP-4; Mercurial-insensitive water channel; MIWC; WCH4,,361,aquaporin 4,,Mercurial-insensitive water channel,MIWC; AQP-4; hAQP4,aquaporin 4,MIWC; MLC4; WCH4; hAQP4,AQP4
P55196,AFAD_HUMAN,AFDN; AF6; MLLT4,Afadin; ALL1-fused gene from chromosome 6 protein; Protein AF-6; Afadin adherens junction formation factor,AF6; MLLT4,4301,afadin; adherens junction formation factor,myeloid/lymphoid or mixed-lineage leukemia; translocated to; 4,,AF-6; AF6,afadin; adherens junction formation factor,AF6; MLL-AF6; MLLT4; l-afadin,AFDN
P55199,ELL_HUMAN,ELL; C19orf17,RNA polymerase II elongation factor ELL; Eleven-nineteen lysine-rich leukemia protein,C19orf17,8178,elongation factor for RNA polymerase II,chromosome 19 open reading frame 17; elongation factor RNA polymerase II,protein phosphatase 1; regulatory subunit 68; eleven-nineteen lysine-rich leukemia gene,Men; ELL1; PPP1R68,elongation factor for RNA polymerase II,C19orf17; ELL1; MEN; PPP1R68,ELL
P55210,CASP7_HUMAN,CASP7; MCH3,Caspase-7; CASP-7; EC 3.4.22.60; Apoptotic protease Mch-3; CMH-1; ICE-like apoptotic protease 3; ICE-LAP3,MCH3,840,caspase 7,caspase 7; apoptosis-related cysteine protease; caspase 7; apoptosis-related cysteine peptidase,,MCH3; CMH-1; ICE-LAP3,caspase 7,CASP-7; CMH-1; ICE-LAP3; LICE2; MCH3,CASP7
P55211,CASP9_HUMAN,CASP9; MCH6,Caspase-9; CASP-9; EC 3.4.22.62; Apoptotic protease Mch-6; Apoptotic protease-activating factor 3; APAF-3; ICE-like apoptotic protease 6; ICE-LAP6,MCH6,842,caspase 9,caspase 9; apoptosis-related cysteine protease; caspase 9; apoptosis-related cysteine peptidase,protein phosphatase 1; regulatory subunit 56,MCH6; ICE-LAP6; APAF-3; PPP1R56,caspase 9,APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56,CASP9
P55212,CASP6_HUMAN,CASP6; MCH2,Caspase-6; CASP-6; CSP-6; EC 3.4.22.59; Apoptotic protease Mch-2; Caspase-6 subunit p20; Caspase-6 subunit p10,MCH2,839,caspase 6,caspase 6; apoptosis-related cysteine protease; caspase 6; apoptosis-related cysteine peptidase,mammalian Ced-3 homologue 2,MCH2; caspase-6; CSP-6,caspase 6,CSP-6; MCH2; caspase-6,CASP6
P55273,CDN2D_HUMAN,CDKN2D,Cyclin-dependent kinase 4 inhibitor D; p19-INK4d,,1032,cyclin dependent kinase inhibitor 2D,cyclin-dependent kinase inhibitor 2D (p19; inhibits CDK4),,INK4D; p19,cyclin dependent kinase inhibitor 2D,INK4D; p19; p19-INK4D,CDKN2D
P55316,FOXG1_HUMAN,FOXG1; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C,Forkhead box protein G1; Brain factor 1; BF-1; BF1; Brain factor 2; BF-2; BF2; hBF-2; Forkhead box protein G1A; Forkhead box protein G1B; Forkhead box protein G1C; Forkhead-related protein FKHL1; HFK1; Forkhead-related protein FKHL2; HFK2; Forkhead-related protein FKHL3; HFK3,FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C,2290,forkhead box G1,forkhead box G1B; forkhead box G1C; forkhead box G1A,brain factor 1,HFK2; QIN; BF1; HFK1; HFK3; HBF-3,forkhead box G1,BF1; BF2; FHKL3; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C; HBF-1; HBF-2; HBF-3; HBF-G2; HBF2; HFK1; HFK2; HFK3; KHL2; QIN,FOXG1
P55317,FOXA1_HUMAN,FOXA1; HNF3A; TCF3A,Hepatocyte nuclear factor 3-alpha; HNF-3-alpha; HNF-3A; Forkhead box protein A1; Transcription factor 3A; TCF-3A,HNF3A; TCF3A,3169,forkhead box A1,hepatocyte nuclear factor 3; alpha,,,forkhead box A1,HNF3A; TCF3A,FOXA1
P55327,TPD52_HUMAN,TPD52,Tumor protein D52; Protein N8,,7163,tumor protein D52,,,D52; hD52; N8L,tumor protein D52,D52; N8L; PC-1; PrLZ; hD52,TPD52
P55795,HNRH2_HUMAN,HNRNPH2; FTP3; HNRPH2,Heterogeneous nuclear ribonucleoprotein H2; hnRNP H2; FTP-3; Heterogeneous nuclear ribonucleoprotein H'; hnRNP H',FTP3; HNRPH2,3188,heterogeneous nuclear ribonucleoprotein H2,heterogeneous nuclear ribonucleoprotein H2 (H'),,hnRNPH'; FTP3; HNRPH',heterogeneous nuclear ribonucleoprotein H2,FTP3; HNRPH'; HNRPH2; MRXSB; NRPH2; hnRNPH',HNRNPH2
P55895,RAG2_HUMAN,RAG2,V(D)J recombination-activating protein 2; D; RAG-2,,5897,recombination activating 2,recombination activating gene 2,,,recombination activating 2,RAG-2,RAG2
P55957,BID_HUMAN,BID,BH3-interacting domain death agonist; p22 BID; BID; p15 BID; p13 BID; p11 BID,,637,BH3 interacting domain death agonist,,,,BH3 interacting domain death agonist,FP497,BID
P56192,SYMC_HUMAN,MARS1; MARS,Methionine--tRNA ligase; cytoplasmic; EC 6.1.1.10; Methionyl-tRNA synthetase; MetRS,MARS,4141,methionyl-tRNA synthetase 1,methionyl-tRNA synthetase,methionine tRNA ligase 1; cytoplasmic; Methionine--tRNA ligase; cytoplasmic,MetRS; SPG70; CMT2U,methionyl-tRNA synthetase 1,CMT2U; ILFS2; ILLD; MARS; METRS; MRS; MTRNS; SPG70; TTD9,MARS1
P56270,MAZ_HUMAN,MAZ; ZNF801,Myc-associated zinc finger protein; MAZI; Pur-1; Purine-binding transcription factor; Serum amyloid A-activating factor-1; SAF-1; Transcription factor Zif87; ZF87; Zinc finger protein 801,ZNF801,4150,MYC associated zinc finger protein,MYC-associated zinc finger protein (purine-binding transcription factor),purine-binding transcription factor,ZF87; Pur-1; Zif87; ZNF801,MYC associated zinc finger protein,PUR1; Pur-1; SAF-1; SAF-2; SAF-3; ZF87; ZNF801; Zif87,MAZ
P56524,HDAC4_HUMAN,HDAC4; KIAA0288,Histone deacetylase 4; HD4; EC 3.5.1.98,KIAA0288,9759,histone deacetylase 4,brachydactyly-mental retardation syndrome,,KIAA0288; HDAC-A; HDACA; HD4; HA6116; HDAC-4,histone deacetylase 4,AHO3; BDMR; HA6116; HD4; HDAC-4; HDAC-A; HDACA; NEDCHF; NEDCHID,HDAC4
P56537,IF6_HUMAN,EIF6; EIF3A; ITGB4BP; OK/SW-cl.27,Eukaryotic translation initiation factor 6; eIF-6; B(2; B4 integrin interactor; CAB; p27(BBP,EIF3A; ITGB4BP,3692,eukaryotic translation initiation factor 6,integrin beta 4 binding protein,,p27BBP; b(2)gcn,eukaryotic translation initiation factor 6,CAB; EIF3A; ITGB4BP; b(2)gcn; eIF-6; p27(BBP); p27BBP,EIF6
P56539,CAV3_HUMAN,CAV3,Caveolin-3; M-caveolin,,859,caveolin 3,,M-caveolin,VIP-21; LGMD1C; VIP21; LQT9,caveolin 3,LGMD1C; LQT9; MPDT; RMD2; VIP-21; VIP21,CAV3
P56545,CTBP2_HUMAN,CTBP2,C-terminal-binding protein 2; CtBP2,,1488,C-terminal binding protein 2,,,ribeye,C-terminal binding protein 2,,CTBP2
P56703,WNT3_HUMAN,WNT3; INT4,Proto-oncogene Wnt-3; Proto-oncogene Int-4 homolog,INT4,7473,Wnt family member 3,wingless-type MMTV integration site family; member 3,WNT-3 proto-oncogene protein,MGC131950; MGC138321; MGC138323,Wnt family member 3,INT4; TETAMS,WNT3
P56704,WNT3A_HUMAN,WNT3A,Protein Wnt-3a,,89780,Wnt family member 3A,wingless-type MMTV integration site family; member 3A,,,Wnt family member 3A,,WNT3A
P56705,WNT4_HUMAN,WNT4; UNQ426/PRO864,Protein Wnt-4,,54361,Wnt family member 4,wingless-type MMTV integration site family; member 4,,WNT-4,Wnt family member 4,SERKAL; WNT-4,WNT4
P56706,WNT7B_HUMAN,WNT7B,Protein Wnt-7b,,7477,Wnt family member 7B,wingless-type MMTV integration site family; member 7B,,,Wnt family member 7B,,WNT7B
P56817,BACE1_HUMAN,BACE1; BACE; KIAA1149,Beta-secretase 1; EC 3.4.23.46; Aspartyl protease 2; ASP2; Asp 2; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; Memapsin-2; Membrane-associated aspartic protease 2,BACE; KIAA1149,23621,beta-secretase 1,beta-site APP-cleaving enzyme; beta-site APP-cleaving enzyme 1,memapsin 2; aspartyl protease 2,Asp2,beta-secretase 1,ASP2; BACE; HSPC104,BACE1
P56945,BCAR1_HUMAN,BCAR1; CAS; CASS1; CRKAS,Breast cancer anti-estrogen resistance protein 1; CRK-associated substrate; Cas scaffolding protein family member 1; p130cas,CAS; CASS1; CRKAS,9564,BCAR1 scaffold protein; Cas family member,breast cancer anti-estrogen resistance 1; BCAR1; Cas family scaffolding protein; BCAR1; Cas family scaffold protein,Crk-associated substrate; Cas scaffolding protein family member 1,P130Cas; Crkas; CAS; CASS1,BCAR1 scaffold protein; Cas family member,CAS; CAS1; CASS1; CRKAS; P130Cas,BCAR1
P56962,STX17_HUMAN,STX17,Syntaxin-17,,55014,syntaxin 17,,,FLJ20651,syntaxin 17,,STX17
P57053,H2BFS_HUMAN,H2BC12L; H2BFS; H2BS1,Histone H2B type F-S; H2B-clustered histone 12 like; H2B.S histone 1; Histone H2B.s; H2B/s,H2BFS; H2BS1,102724334,H2B clustered histone 12 like,H2B histone family; member S; H2B histone family; member S (pseudogene); H2B histone family member S (pseudogene); H2B histone family member S; H2B.S histone 1,,,,,H2BC12L
P57059,SIK1_HUMAN,SIK1; SIK; SNF1LK,Serine/threonine-protein kinase SIK1; EC 2.7.11.1; Salt-inducible kinase 1; SIK-1; Serine/threonine-protein kinase SNF1-like kinase 1; Serine/threonine-protein kinase SNF1LK,SIK; SNF1LK,102724428,salt inducible kinase 1,SNF1-like kinase,myocardial SNF1-like kinase,msk,,SIK; SIK-1; SIK1; SIK1B; SNF1LK,SIK1
P57103,NAC3_HUMAN,SLC8A3; NCX3,Sodium/calcium exchanger 3; Na(+; 2+; Solute carrier family 8 member 3,NCX3,6547,solute carrier family 8 member A3,solute carrier family 8 (sodium/calcium exchanger); member 3,,NCX3,solute carrier family 8 member A3,NCX3,SLC8A3
P57682,KLF3_HUMAN,KLF3; BKLF,Krueppel-like factor 3; Basic krueppel-like factor; CACCC-box-binding protein BKLF; TEF-2,BKLF,51274,KLF transcription factor 3,Kruppel-like factor 3 (basic); Kruppel like factor 3,basic Kruppel-like factor,BKLF,KLF transcription factor 3,BKLF,KLF3
P57737,CORO7_HUMAN,CORO7,Coronin-7; Crn7; 70 kDa WD repeat tumor rejection antigen homolog,,79585,coronin 7,,,FLJ22021; POD1,coronin 7,0610011B16Rik; CRN7; POD1,CORO7
P58012,FOXL2_HUMAN,FOXL2,Forkhead box protein L2,,668,forkhead box L2,,,BPES1,forkhead box L2,BPES; BPES1; PFRK; PINTO; POF3,FOXL2
P58400,NRX1B_HUMAN,NRXN1,Neurexin-1-beta; Neurexin I-beta,,9378,neurexin 1,,,KIAA0578; Hs.22998,neurexin 1,Hs.22998; PTHSL2; SCZD17,NRXN1
P58753,TIRAP_HUMAN,TIRAP; MAL,Toll/interleukin-1 receptor domain-containing adapter protein; TIR domain-containing adapter protein; Adaptor protein Wyatt; MyD88 adapter-like protein; MyD88-2,MAL,114609,TIR domain containing adaptor protein,Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein,MyD88 adapter-like,Mal; wyatt,TIR domain containing adaptor protein,BACTS1; Mal; MyD88-2; wyatt,TIRAP
P58876,H2B1D_HUMAN,H2BC5; H2BFB; HIRIP2; HIST1H2BD,Histone H2B type 1-D; H2B-clustered histone 5; HIRA-interacting protein 2; Histone H2B.1 B; Histone H2B.b; H2B/b,H2BFB; HIRIP2; HIST1H2BD,3017,H2B clustered histone 5,H2B histone family; member B; histone 1; H2bd; histone cluster 1; H2bd; histone cluster 1 H2B family member d,,H2B/b,H2B clustered histone 5,H2B.1B; H2B/a; H2B/b; H2B/g; H2B/h; H2B/k; H2B/l; H2BFA; H2BFB; H2BFG; H2BFH; H2BFK; H2BFL; HIRIP2; HIST1H2BC; HIST1H2BD; HIST1H2BE; HIST1H2BF; HIST1H2BG; HIST1H2BI; dJ221C16.6,H2BC5
P59768,GBG2_HUMAN,GNG2,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2; I; S; O; G gamma-I,,54331,G protein subunit gamma 2,guanine nucleotide binding protein (G protein); gamma 2,,,G protein subunit gamma 2,HG3F1,GNG2
P60006,APC15_HUMAN,ANAPC15; C11orf51; HSPC020,Anaphase-promoting complex subunit 15; APC15,C11orf51,25906,anaphase promoting complex subunit 15,chromosome 11 open reading frame 51,,HSPC020; DKFZP564M082; APC15,anaphase promoting complex subunit 15,APC15; C11orf51; HSPC020,ANAPC15
P60484,PTEN_HUMAN,PTEN; MMAC1; TEP1,Phosphatidylinositol 3;4;5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN; EC 3.1.3.16; EC 3.1.3.48; EC 3.1.3.67; Inositol polyphosphate 3-phosphatase; EC 3.1.3.-; Mutated in multiple advanced cancers 1; Phosphatase and tensin homolog,MMAC1; TEP1,5728,phosphatase and tensin homolog,,mutated in multiple advanced cancers 1; Phosphatidylinositol 3;4;5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN,MMAC1; TEP1; PTEN1,phosphatase and tensin homolog,10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; PTENbeta; PTENgama; TEP1,PTEN
P60510,PP4C_HUMAN,PPP4C; PPP4; PPX,Serine/threonine-protein phosphatase 4 catalytic subunit; PP4C; Pp4; EC 3.1.3.16; Protein phosphatase X; PP-X,PPP4; PPX,5531,protein phosphatase 4 catalytic subunit,protein phosphatase 4 (formerly X); catalytic subunit; protein phosphatase 4; catalytic subunit,protein phosphatase X; catalytic subunit,PP4; PPX,protein phosphatase 4 catalytic subunit,PP-X; PP4; PP4C; PPH3; PPP4; PPX,PPP4C
P60520,GBRL2_HUMAN,GABARAPL2; FLC3A; GEF2,Gamma-aminobutyric acid receptor-associated protein-like 2; GABA(A; Ganglioside expression factor 2; GEF-2; General protein transport factor p16; Golgi-associated ATPase enhancer of 16 kDa; GATE-16; MAP1 light chain 3-related protein,FLC3A; GEF2,11345,GABA type A receptor associated protein like 2,GABA(A) receptor-associated protein like 2,,GEF2; ATG8; GATE16; GATE-16; ATG8C,GABA type A receptor associated protein like 2,ATG8; ATG8C; GATE-16; GATE16; GEF-2; GEF2,GABARAPL2
P60660,MYL6_HUMAN,MYL6,Myosin light polypeptide 6; 17 kDa myosin light chain; LC17; Myosin light chain 3; MLC-3; Myosin light chain alkali 3; Myosin light chain A3; Smooth muscle and nonmuscle myosin light chain alkali 6,,4637,myosin light chain 6,myosin; light polypeptide 6; alkali; smooth muscle and non-muscle; myosin; light chain 6; alkali; smooth muscle and non-muscle,,ESMLC; MLC3NM; MLC1SM,myosin light chain 6,ESMLC; LC17; LC17-GI; LC17-NM; LC17A; LC17B; MLC-3; MLC1SM; MLC3NM; MLC3SM,MYL6
P60709,ACTB_HUMAN,ACTB,Actin; cytoplasmic 1; EC 3.6.4.-; Beta-actin,,60,actin beta,,??-actin,,actin beta,BKRNS; BNS; BRWS1; CSMH; DDS1; PS1TP5BP1; THC8,ACTB
P60763,RAC3_HUMAN,RAC3,Ras-related C3 botulinum toxin substrate 3; EC 3.6.5.2; p21-Rac3,,5881,Rac family small GTPase 3,ras-related C3 botulinum toxin substrate 3 (rho family; small GTP binding protein Rac3),,,Rac family small GTPase 3,,RAC3
P60880,SNP25_HUMAN,SNAP25; SNAP,Synaptosomal-associated protein 25; SNAP-25; Super protein; SUP; Synaptosomal-associated 25 kDa protein,SNAP,6616,synaptosome associated protein 25,synaptosomal-associated protein; 25kDa,resistance to inhibitors of cholinesterase 4 homolog,SNAP-25; RIC-4; RIC4; SEC9; bA416N4.2; dJ1068F16.2,synaptosome associated protein 25,CMS18; RIC-4; RIC4; SEC9; SNAP; SNAP-25; SUP; bA416N4.2; dJ1068F16.2,SNAP25
P60891,PRPS1_HUMAN,PRPS1,Ribose-phosphate pyrophosphokinase 1; EC 2.7.6.1; PPRibP; Phosphoribosyl pyrophosphate synthase I; PRS-I,,5631,phosphoribosyl pyrophosphate synthetase 1,deafness; X-linked 2; perceptive; congenital,PRS I; ribose-phosphate diphosphokinase 1,CMTX5; DFNX1; PRS-I; PPRibP,phosphoribosyl pyrophosphate synthetase 1,ARTS; CMTX5; DFN2; DFNX1; PPRibP; PRS-I; PRSI,PRPS1
P60953,CDC42_HUMAN,CDC42,Cell division control protein 42 homolog; EC 3.6.5.2; G25K GTP-binding protein,,998,cell division cycle 42,cell division cycle 42 (GTP-binding protein; 25kD); cell division cycle 42 (GTP binding protein; 25kDa),GTP binding protein; 25kDa,G25K; CDC42Hs,cell division cycle 42,CDC42Hs; G25K; TKS,CDC42
P60981,DEST_HUMAN,DSTN; ACTDP; DSN,Destrin; Actin-depolymerizing factor; ADF,ACTDP; DSN,11034,destrin; actin depolymerizing factor,destrin (actin depolymerizing factor),,ADF; ACTDP,destrin; actin depolymerizing factor,ACTDP; ADF; HEL32; bA462D18.2,DSTN
P61020,RAB5B_HUMAN,RAB5B,Ras-related protein Rab-5B; EC 3.6.5.2,,5869,RAB5B; member RAS oncogene family,,,,RAB5B; member RAS oncogene family,,RAB5B
P61073,CXCR4_HUMAN,CXCR4,C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; FB22; Fusin; HM89; LCR1; Leukocyte-derived seven transmembrane domain receptor; LESTR; Lipopolysaccharide-associated protein 3; LAP-3; LPS-associated protein 3; NPYRL; Stromal cell-derived factor 1 receptor; SDF-1 receptor; CD antigen CD184,,7852,C-X-C motif chemokine receptor 4,chemokine (C-X-C motif); receptor 4 (fusin); chemokine (C-X-C motif) receptor 4,,LESTR; NPY3R; HM89; NPYY3R; D2S201E; fusin; HSY3RR; NPYR; CD184,C-X-C motif chemokine receptor 4,CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS; WHIMS1,CXCR4
P61160,ARP2_HUMAN,ACTR2; ARP2,Actin-related protein 2; Actin-like protein 2,ARP2,10097,actin related protein 2,ARP2 (actin-related protein 2; yeast) homolog; ARP2 actin-related protein 2 homolog (yeast); ARP2 actin related protein 2 homolog,,ARP2,actin related protein 2,ARP2,ACTR2
P61224,RAP1B_HUMAN,RAP1B; OK/SW-cl.11,Ras-related protein Rap-1b; EC 3.6.5.2; GTP-binding protein smg p21B,,5908,RAP1B; member of RAS oncogene family,,,K-REV; RAL1B; DKFZp586H0723,RAP1B; member of RAS oncogene family,K-REV; RAL1B; THC11,RAP1B
P61244,MAX_HUMAN,MAX; BHLHD4,Protein max; Class D basic helix-loop-helix protein 4; bHLHd4; Myc-associated factor X,BHLHD4,4149,MYC associated factor X,MAX protein,,bHLHd4; bHLHd5; bHLHd6; bHLHd7; bHLHd8,MYC associated factor X,PDMCS; bHLHd4,MAX
P61289,PSME3_HUMAN,PSME3,Proteasome activator complex subunit 3; 11S regulator complex subunit gamma; REG-gamma; Activator of multicatalytic protease subunit 3; Ki nuclear autoantigen; Proteasome activator 28 subunit gamma; PA28g; PA28gamma,,10197,proteasome activator subunit 3,proteasome (prosome; macropain) activator subunit 3 (PA28 gamma; Ki),,Ki; PA28-gamma; REG-GAMMA; PA28G,proteasome activator subunit 3,HEL-S-283; Ki; PA28-gamma; PA28G; PA28gamma; REG-GAMMA,PSME3
P61586,RHOA_HUMAN,RHOA; ARH12; ARHA; RHO12,Transforming protein RhoA; EC 3.6.5.2; Rho cDNA clone 12; h12,ARH12; ARHA; RHO12,387,ras homolog family member A,ras homolog gene family; member A,,Rho12; RHOH12,ras homolog family member A,ARH12; ARHA; EDFAOB; RHO12; RHOH12,RHOA
P61587,RND3_HUMAN,RND3; ARHE; RHO8; RHOE,Rho-related GTP-binding protein RhoE; Protein MemB; Rho family GTPase 3; Rho-related GTP-binding protein Rho8; Rnd3,ARHE; RHO8; RHOE,390,Rho family GTPase 3,ras homolog gene family; member E,,RhoE; Rho8,Rho family GTPase 3,ARHE; Rho8; RhoE; memB,RND3
P61812,TGFB2_HUMAN,TGFB2,Transforming growth factor beta-2 proprotein; Cetermin; Glioblastoma-derived T-cell suppressor factor; G-TSF; LAP; TGF-beta-2,,7042,transforming growth factor beta 2,transforming growth factor; beta 2,prepro-transforming growth factor beta-2,,transforming growth factor beta 2,G-TSF; LDS4; TGF-beta2,TGFB2
P61925,IPKA_HUMAN,PKIA; PRKACN1,cAMP-dependent protein kinase inhibitor alpha; PKI-alpha; cAMP-dependent protein kinase inhibitor; muscle/brain isoform,PRKACN1,5569,cAMP-dependent protein kinase inhibitor alpha,protein kinase (cAMP-dependent; catalytic) inhibitor alpha,,,cAMP-dependent protein kinase inhibitor alpha,PRKACN1,PKIA
P61952,GBG11_HUMAN,GNG11; GNGT11,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11; I; S; O,GNGT11,2791,G protein subunit gamma 11,guanine nucleotide binding protein (G protein); gamma 11,G protein gamma-11 subunit; guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-11 subunit,GNGT11,G protein subunit gamma 11,GNGT11; HG3H1,GNG11
P61978,HNRPK_HUMAN,HNRNPK; HNRPK,Heterogeneous nuclear ribonucleoprotein K; hnRNP K; Transformation up-regulated nuclear protein; TUNP,HNRPK,3190,heterogeneous nuclear ribonucleoprotein K,,transformation upregulated nuclear protein,CSBP; TUNP,heterogeneous nuclear ribonucleoprotein K,AUKS; CSBP; HNRPK; TUNP,HNRNPK
P61981,1433G_HUMAN,YWHAG,14-3-3 protein gamma; Protein kinase C inhibitor protein 1; KCIP-1,,7532,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; gamma polypeptide,14-3-3 gamma; protein phosphatase 1; regulatory subunit 170,PPP1R170; 14-3-3GAMMA; 14-3-3??,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma,14-3-3GAMMA; DEE56; EIEE56; PPP1R170,YWHAG
P62070,RRAS2_HUMAN,RRAS2; TC21,Ras-related protein R-Ras2; EC 3.6.5.-; Ras-like protein TC21; Teratocarcinoma oncogene,TC21,22800,RAS related 2,related RAS viral (r-ras) oncogene homolog 2,,TC21,RAS related 2,NS12; TC21,RRAS2
P62136,PP1A_HUMAN,PPP1CA; PPP1A,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit; PP-1A; EC 3.1.3.16,PPP1A,5499,protein phosphatase 1 catalytic subunit alpha,protein phosphatase 1; catalytic subunit; alpha isoform; protein phosphatase 1; catalytic subunit; alpha isozyme,,PP1A; PP-1A; PP1alpha,protein phosphatase 1 catalytic subunit alpha,PP-1A; PP1A; PP1alpha; PPP1A,PPP1CA
P62140,PP1B_HUMAN,PPP1CB,Serine/threonine-protein phosphatase PP1-beta catalytic subunit; PP-1B; PPP1CD; EC 3.1.3.16; EC 3.1.3.53,,5500,protein phosphatase 1 catalytic subunit beta,protein phosphatase 1; catalytic subunit; beta isoform; protein phosphatase 1; catalytic subunit; beta isozyme,myosin phosphatase,PP1B; PP-1B; PP1beta; PP1c; MP; PPP1beta,protein phosphatase 1 catalytic subunit beta,HEL-S-80p; MP; NSLH2; PP-1B; PP1B; PP1beta; PP1c; PPP1CD; PPP1beta,PPP1CB
P62195,PRS8_HUMAN,PSMC5; SUG1,26S proteasome regulatory subunit 8; 26S proteasome AAA-ATPase subunit RPT6; Proteasome 26S subunit ATPase 5; Proteasome subunit p45; Thyroid hormone receptor-interacting protein 1; TRIP1; p45/SUG,SUG1,5705,proteasome 26S subunit; ATPase 5,proteasome (prosome; macropain) 26S subunit; ATPase; 5,,SUG1; p45/SUG; TBP10; p45; S8; TRIP1; SUG-1; RPT6,proteasome 26S subunit; ATPase 5,RPT6; S8; SUG-1; SUG1; TBP10; TRIP1; p45; p45/SUG,PSMC5
P62258,1433E_HUMAN,YWHAE,14-3-3 protein epsilon; 14-3-3E,,7531,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; epsilon polypeptide,14-3-3 epsilon,FLJ45465,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,14-3-3E; HEL2; KCIP-1; MDCR; MDS,YWHAE
P62280,RS11_HUMAN,RPS11,Small ribosomal subunit protein uS17; 40S ribosomal protein S11,,6205,ribosomal protein S11,,40S ribosomal protein S11,S11; uS17,ribosomal protein S11,S11; uS17,RPS11
P62324,BTG1_HUMAN,BTG1,Protein BTG1; B-cell translocation gene 1 protein,,694,BTG anti-proliferation factor 1,B-cell translocation gene 1; anti-proliferative,,APRO2,BTG anti-proliferation factor 1,APRO2,BTG1
P62491,RB11A_HUMAN,RAB11A; RAB11,Ras-related protein Rab-11A; Rab-11; EC 3.6.5.2; YL8,RAB11,8766,RAB11A; member RAS oncogene family,,,YL8,RAB11A; member RAS oncogene family,YL8,RAB11A
P62714,PP2AB_HUMAN,PPP2CB,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform; PP2A-beta; EC 3.1.3.16,,5516,protein phosphatase 2 catalytic subunit beta,protein phosphatase 2 (formerly 2A); catalytic subunit; beta isoform; protein phosphatase 2; catalytic subunit; beta isozyme,protein phosphatase 2A catalytic subunit; beta isoform,PP2Abeta,protein phosphatase 2 catalytic subunit beta,PP2Abeta; PP2CB,PPP2CB
P62745,RHOB_HUMAN,RHOB; ARH6; ARHB,Rho-related GTP-binding protein RhoB; Rho cDNA clone 6; h6,ARH6; ARHB,388,ras homolog family member B,ras homolog gene family; member B,oncogene RHO H6,RHOH6; MST081,ras homolog family member B,ARH6; ARHB; MST081; MSTP081; RHOH6,RHOB
P62753,RS6_HUMAN,RPS6; OK/SW-cl.2,Small ribosomal subunit protein eS6; 40S ribosomal protein S6; Phosphoprotein NP33,,6194,ribosomal protein S6,,40S ribosomal protein S6; phosphoprotein NP33,S6; eS6,ribosomal protein S6,S6; eS6,RPS6
P62805,H4_HUMAN,H4C1; H4/A; H4FA; HIST1H4A; H4C2; H4/I; H4FI; HIST1H4B;; H4C3; H4/G; H4FG; HIST1H4C;; H4C4; H4/B; H4FB; HIST1H4D;; H4C5; H4/J; H4FJ; HIST1H4E;; H4C6; H4/C; H4FC; HIST1H4F;; H4C8; H4/H; H4FH; HIST1H4H;; H4C9; H4/M; H4FM; HIST1H4I;; H4C11; H4/E; H4FE; HIST1H4J;; H4C12; H4/D; H4FD; HIST1H4K;; H4C13; H4/K; H4FK; HIST1H4L;; H4C14; H4/N; H4F2; H4FN; HIST2H4; HIST2H4A;; H4C15; H4/O; H4FO; HIST2H4B;; H4C16; H4-16; HIST4H4,Histone H4,H4/A; H4FA; HIST1H4A;; H4/I; H4FI; HIST1H4B;; H4/G; H4FG; HIST1H4C;; H4/B; H4FB; HIST1H4D;; H4/J; H4FJ; HIST1H4E;; H4/C; H4FC; HIST1H4F;; H4/H; H4FH; HIST1H4H;; H4/M; H4FM; HIST1H4I;; H4/E; H4FE; HIST1H4J;; H4/D; H4FD; HIST1H4K;; H4/K; H4FK; HIST1H4L;; H4/N; H4F2; H4FN; HIST2H4; HIST2H4A;; H4/O; H4FO; HIST2H4B;; H4-16; HIST4H4,121504,H4 clustered histone 1,H4 histone family; member A; histone 1; H4a; histone cluster 1; H4a; histone cluster 1 H4 family member a,,,H4 histone 16,H4-16; H4/p; H4C1; H4C11; H4C12; H4C13; H4C14; H4C15; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; HIST4H4,H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16
P62807,H2B1C_HUMAN,H2BC4; H2BFL; HIST1H2BC;; H2BC6; H2BFH; HIST1H2BE;; H2BC7; H2BFG; HIST1H2BF;; H2BC8; H2BFA; HIST1H2BG;; H2BC10; H2BFK; HIST1H2BI,Histone H2B type 1-C/E/F/G/I; Histone H2B.1 A; Histone H2B.a; H2B/a; Histone H2B.g; H2B/g; Histone H2B.h; H2B/h; Histone H2B.k; H2B/k; Histone H2B.l; H2B/l,H2BFL; HIST1H2BC;; H2BFH; HIST1H2BE;; H2BFG; HIST1H2BF;; H2BFA; HIST1H2BG;; H2BFK; HIST1H2BI,3017,H2B clustered histone 4,H2B histone family; member L; histone 1; H2bc; histone cluster 1; H2bc; histone cluster 1 H2B family member c,,H2B/l; H2B.1,H2B clustered histone 5,H2B.1B; H2B/a; H2B/b; H2B/g; H2B/h; H2B/k; H2B/l; H2BFA; H2BFB; H2BFG; H2BFH; H2BFK; H2BFL; HIRIP2; HIST1H2BC; HIST1H2BD; HIST1H2BE; HIST1H2BF; HIST1H2BG; HIST1H2BI; dJ221C16.6,H2BC4; H2BC6; H2BC7; H2BC8; H2BC10
P62820,RAB1A_HUMAN,RAB1A; RAB1,Ras-related protein Rab-1A; EC 3.6.5.2; YPT1-related protein,RAB1,5861,RAB1A; member RAS oncogene family,,Rab GTPase YPT1 homolog (yeast),YPT1,RAB1A; member RAS oncogene family,RAB1; YPT1,RAB1A
P62826,RAN_HUMAN,RAN; ARA24; OK/SW-cl.81,GTP-binding nuclear protein Ran; EC 3.6.5.-; Androgen receptor-associated protein 24; GTPase Ran; Ras-like protein TC4; Ras-related nuclear protein,ARA24,5901,RAN; member RAS oncogene family,,,ARA24; TC4; Gsp1,RAN; member RAS oncogene family,ARA24; Gsp1; TC4,RAN
P62834,RAP1A_HUMAN,RAP1A; KREV1,Ras-related protein Rap-1A; EC 3.6.5.2; C21KG; G-22K; GTP-binding protein smg p21A; Ras-related protein Krev-1,KREV1,5906,RAP1A; member of RAS oncogene family,,,KREV-1; SMGP21,RAP1A; member of RAS oncogene family,C21KG; G-22K; KREV-1; KREV1; RAP1; SMGP21,RAP1A
P62841,RS15_HUMAN,RPS15; RIG,Small ribosomal subunit protein uS19; 40S ribosomal protein S15; RIG protein,RIG,6209,ribosomal protein S15,,40S ribosomal protein S15; homolog of rat insulinoma; insulinoma protein,RIG; MGC111130; S15; uS19,ribosomal protein S15,RIG; S15; uS19,RPS15
P62873,GBB1_HUMAN,GNB1,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1; I; S; T; Transducin beta chain 1,,2782,G protein subunit beta 1,guanine nucleotide binding protein (G protein); beta polypeptide 1,transducin beta chain 1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,,G protein subunit beta 1,HG2A; MDS; MRD42,GNB1
P62879,GBB2_HUMAN,GNB2,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2; I; S; T; G protein subunit beta-2; Transducin beta chain 2,,2783,G protein subunit beta 2,guanine nucleotide binding protein (G protein); beta polypeptide 2,G protein; beta-2 subunit; guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 2; signal-transducing guanine nucleotide-binding regulatory protein beta subunit; transducin beta chain 2,,G protein subunit beta 2,HG2C1; SSS4; SSS4; NEDHYDF,GNB2
P62913,RL11_HUMAN,RPL11,Large ribosomal subunit protein uL5; 60S ribosomal protein L11; CLL-associated antigen KW-12,,6135,ribosomal protein L11,,60S ribosomal protein L11,L11; uL5,ribosomal protein L11,DBA7; GIG34; L11; uL5,RPL11
P62917,RL8_HUMAN,RPL8,Large ribosomal subunit protein uL2; 60S ribosomal protein L8,,6132,ribosomal protein L8,,,L8; uL2,ribosomal protein L8,L8; uL2,RPL8
P62955,CCG7_HUMAN,CACNG7,Voltage-dependent calcium channel gamma-7 subunit; Neuronal voltage-gated calcium channel gamma-7 subunit; Transmembrane AMPAR regulatory protein gamma-7; TARP gamma-7,,59284,calcium voltage-gated channel auxiliary subunit gamma 7,calcium channel; voltage-dependent; gamma subunit 7,,,calcium voltage-gated channel auxiliary subunit gamma 7,,CACNG7
P62993,GRB2_HUMAN,GRB2; ASH,Growth factor receptor-bound protein 2; Adapter protein GRB2; Protein Ash; SH2/SH3 adapter GRB2,ASH,2885,growth factor receptor bound protein 2,growth factor receptor-bound protein 2,,NCKAP2,growth factor receptor bound protein 2,ASH; EGFRBP-GRB2; Grb3-3; MST084; MSTP084; NCKAP2,GRB2
P63000,RAC1_HUMAN,RAC1; TC25; MIG5,Ras-related C3 botulinum toxin substrate 1; EC 3.6.5.2; Cell migration-inducing gene 5 protein; Ras-like protein TC25; p21-Rac1,TC25,5879,Rac family small GTPase 1,ras-related C3 botulinum toxin substrate 1 (rho family; small GTP binding protein Rac1),,TC-25; p21-Rac1; Rac-1,Rac family small GTPase 1,MIG5; MRD48; Rac-1; TC-25; p21-Rac1,RAC1
P63010,AP2B1_HUMAN,AP2B1; ADTB2; CLAPB1,AP-2 complex subunit beta; AP105B; Adaptor protein complex AP-2 subunit beta; Adaptor-related protein complex 2 subunit beta; Beta-2-adaptin; Beta-adaptin; Clathrin assembly protein complex 2 beta large chain; Plasma membrane adaptor HA2/AP2 adaptin beta subunit,ADTB2; CLAPB1,163,adaptor related protein complex 2 subunit beta 1,adaptor related protein complex 2 subunit beta 1; adaptor related protein complex 2 beta 1 subunit,beta2-adaptin,,adaptor related protein complex 2 subunit beta 1,ADTB2; AP105B; AP2-BETA; CLAPB1,AP2B1
P63096,GNAI1_HUMAN,GNAI1,Guanine nucleotide-binding protein G(i) subunit alpha-1; i; EC 3.6.5.-; Adenylate cyclase-inhibiting G alpha protein,,2770,G protein subunit alpha i1,guanine nucleotide binding protein (G protein); alpha inhibiting activity polypeptide 1,Gi1 protein alpha subunit; Guanine nucleotide-binding protein G(i) subunit alpha-1,,G protein subunit alpha i1,Gi; HG1B; NEDHISB,GNAI1
P63098,CANB1_HUMAN,PPP3R1; CNA2; CNB,Calcineurin subunit B type 1; Protein phosphatase 2B regulatory subunit 1; Protein phosphatase 3 regulatory subunit B alpha isoform 1,CNA2; CNB,5534,protein phosphatase 3 regulatory subunit B; alpha,protein phosphatase 3 (formerly 2B); regulatory subunit B (19kD); alpha isoform (calcineurin B; type I); protein phosphatase 3 (formerly 2B); regulatory subunit B; 19kDa; alpha isoform (calcineurin B; type I); protein phosphatase 3 (formerly 2B); regulatory subunit B; alpha isoform; protein phosphatase 3; regulatory subunit B; alpha,calcineurin B; type I (19kDa); protein phosphatase 2B regulatory subunit B alpha,CALNB1; CNB; CNB1,protein phosphatase 3 regulatory subunit B; alpha,CALNB1; CNB; CNB1,PPP3R1
P63104,1433Z_HUMAN,YWHAZ,14-3-3 protein zeta/delta; Protein kinase C inhibitor protein 1; KCIP-1,,7534,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; delta polypeptide; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; zeta polypeptide,14-3-3 zeta; 14-3-3 delta,KCIP-1; 14-3-3-zeta,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD,YWHAZ
P63151,2ABA_HUMAN,PPP2R2A,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform; PP2A subunit B isoform B55-alpha; B55; PP2A subunit B isoform PR55-alpha; PP2A subunit B isoform R2-alpha; PP2A subunit B isoform alpha,,5520,protein phosphatase 2 regulatory subunit Balpha,protein phosphatase 2 (formerly 2A); regulatory subunit B (PR 52); alpha isoform,PP2A subunit B isoform alpha,PR52A; PR55A; B55A; PR55alpha; B55alpha,protein phosphatase 2 regulatory subunit Balpha,B55; B55A; B55ALPHA; PR52A; PR55A; PR55alpha,PPP2R2A
P63167,DYL1_HUMAN,DYNLL1; DLC1; DNCL1; DNCLC1; HDLC1,Dynein light chain 1; cytoplasmic; 8 kDa dynein light chain; DLC8; Dynein light chain LC8-type 1; Protein inhibitor of neuronal nitric oxide synthase; PIN,DLC1; DNCL1; DNCLC1; HDLC1,8655,dynein light chain LC8-type 1,dynein; cytoplasmic; light polypeptide 1,,hdlc1; DLC1; PIN; LC8; DLC8,dynein light chain LC8-type 1,DLC1; DLC8; DNCL1; DNCLC1; LC8; LC8a; PIN; hdlc1,DYNLL1
P63211,GBG1_HUMAN,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1; T; Transducin gamma chain,,2792,G protein subunit gamma transducin 1,guanine nucleotide binding protein (G protein); gamma transducing activity polypeptide 1,,GNG1,G protein subunit gamma transducin 1,GNG1; HG3G1,GNGT1
P63218,GBG5_HUMAN,GNG5; GNGT5,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5; I; S; O,GNGT5,2787,G protein subunit gamma 5,guanine nucleotide binding protein (G protein); gamma 5,,,G protein subunit gamma 5,,GNG5
P63244,RACK1_HUMAN,RACK1; GNB2L1; HLC7; PIG21,Small ribosomal subunit protein RACK1; Cell proliferation-inducing gene 21 protein; Guanine nucleotide-binding protein subunit beta-2-like 1; Guanine nucleotide-binding protein subunit beta-like protein 12.3; Human lung cancer oncogene 7 protein; HLC-7; Receptor for activated C kinase; Receptor of activated protein C kinase 1; Guanine nucleotide-binding protein subunit beta-2-like 1; N-terminally processed; Receptor of activated protein C kinase 1; N-terminally processed,GNB2L1,10399,receptor for activated C kinase 1,guanine nucleotide binding protein (G protein); beta polypeptide 2-like 1,,Gnb2-rs1; H12.3,receptor for activated C kinase 1,GNB2L1; Gnb2-rs1; H12.3; HLC-7; PIG21,RACK1
P63252,KCNJ2_HUMAN,KCNJ2; IRK1,Inward rectifier potassium channel 2; Cardiac inward rectifier potassium channel; Inward rectifier K(+; IRK-1; hIRK1; Potassium channel; inwardly rectifying subfamily J member 2,IRK1,3759,potassium inwardly rectifying channel subfamily J member 2,potassium inwardly-rectifying channel; subfamily J; member 2,,Kir2.1; IRK1; LQT7,potassium inwardly rectifying channel subfamily J member 2,ATFB9; HHBIRK1; HHIRK1; IRK1; KIR2.1; LQT7; SQT3,KCNJ2
P63261,ACTG_HUMAN,ACTG1; ACTG,Actin; cytoplasmic 2; EC 3.6.4.-; Gamma-actin,ACTG,71,actin gamma 1,deafness; autosomal dominant 20; deafness; autosomal dominant 26,,,actin gamma 1,ACT; ACTG; DFNA20; DFNA26; HEL-176,ACTG1
P63272,SPT4H_HUMAN,SUPT4H1; SPT4H; SUPT4H,Transcription elongation factor SPT4; hSPT4; DRB sensitivity-inducing factor 14 kDa subunit; DSIF p14; DRB sensitivity-inducing factor small subunit; DSIF small subunit,SPT4H; SUPT4H,6827,SPT4 homolog; DSIF elongation factor subunit,suppressor of Ty (S.cerevisiae) 4 homolog 1; suppressor of Ty 4 homolog 1 (S. cerevisiae),,SPT4H; Spt4; Supt4a,SPT4 homolog; DSIF elongation factor subunit,SPT4; SPT4H; SUPT4H; Supt4a,SUPT4H1
P63279,UBC9_HUMAN,UBE2I; UBC9; UBCE9,SUMO-conjugating enzyme UBC9; EC 2.3.2.-; RING-type E3 SUMO transferase UBC9; SUMO-protein ligase; Ubiquitin carrier protein 9; Ubiquitin carrier protein I; Ubiquitin-conjugating enzyme E2 I; Ubiquitin-protein ligase I; p18,UBC9; UBCE9,7329,ubiquitin conjugating enzyme E2 I,ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9); ubiquitin-conjugating enzyme E2I (UBC9 homolog; yeast); ubiquitin-conjugating enzyme E2I,,UBC9,ubiquitin conjugating enzyme E2 I,C358B7.1; P18; UBC9,UBE2I
P67775,PP2AA_HUMAN,PPP2CA,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform; PP2A-alpha; EC 3.1.3.16; Replication protein C; RP-C,,5515,protein phosphatase 2 catalytic subunit alpha,protein phosphatase 2 (formerly 2A); catalytic subunit; alpha isoform; protein phosphatase 2; catalytic subunit; alpha isozyme,protein phosphatase 2A catalytic subunit; alpha isoform,PP2Calpha; PP2AC,protein phosphatase 2 catalytic subunit alpha,HJS3; NEDLBA; PP2Ac; PP2CA; PP2Calpha; RP-C,PPP2CA
P67809,YBOX1_HUMAN,YBX1; NSEP1; YB1,Y-box-binding protein 1; YB-1; CCAAT-binding transcription factor I subunit A; CBF-A; DNA-binding protein B; DBPB; Enhancer factor I subunit A; EFI-A; Nuclease-sensitive element-binding protein 1; Y-box transcription factor,NSEP1; YB1,4904,Y-box binding protein 1,nuclease sensitive element binding protein 1,,YB-1; YB1; DBPB; NSEP-1; MDR-NF1; BP-8; CSDB; CSDA2,Y-box binding protein 1,BP-8; CBF-A; CSDA2; CSDB; DBPB; EFI-A; MDR-NF1; NSEP-1; NSEP1; YB-1; YB1,YBX1
P67870,CSK2B_HUMAN,CSNK2B; CK2N; G5A,Casein kinase II subunit beta; CK II beta; Phosvitin; Protein G5a,CK2N; G5A,1460,casein kinase 2 beta,casein kinase 2; beta polypeptide,,Ckb1; Ckb2,casein kinase 2 beta,CK2B; CK2N; CSK2B; Ckb1; Ckb2; G5A; POBINDS,CSNK2B
P68104,EF1A1_HUMAN,EEF1A1; EEF1A; EF1A; LENG7,Elongation factor 1-alpha 1; EF-1-alpha-1; EC 3.6.5.-; Elongation factor Tu; EF-Tu; Eukaryotic elongation factor 1 A-1; eEF1A-1; Leukocyte receptor cluster member 7,EEF1A; EF1A; LENG7,1915,eukaryotic translation elongation factor 1 alpha 1,leukocyte receptor cluster (LRC) member 7,Elongation factor 1-alpha 1,EE1A1; EF1A1; EF1alpha1,eukaryotic translation elongation factor 1 alpha 1,CCS-3; CCS3; EE1A1; EEF-1; EEF1A; EF-Tu; EF1A; EF1A1; EF1alpha1; GRAF-1EF; LENG7; PTI1; eEF1A-1,EEF1A1
P68363,TBA1B_HUMAN,TUBA1B,Tubulin alpha-1B chain; EC 3.6.5.-; Alpha-tubulin ubiquitous; Tubulin K-alpha-1; Tubulin alpha-ubiquitous chain,,10376,tubulin alpha 1b,,tubulin; alpha; ubiquitous,K-ALPHA-1,tubulin alpha 1b,K-ALPHA-1,TUBA1B
P68400,CSK21_HUMAN,CSNK2A1; CK2A1,Casein kinase II subunit alpha; CK II alpha; EC 2.7.11.1,CK2A1,1457,casein kinase 2 alpha 1,casein kinase 2; alpha 1 polypeptide,Casein kinase II subunit alpha,Cka1; Cka2,casein kinase 2 alpha 1,CK2A1; CKII; Cka1; Cka2; OCNDS,CSNK2A1
P68431,H31_HUMAN,H3C1; H3FA; HIST1H3A;; H3C2; H3FL; HIST1H3B;; H3C3; H3FC; HIST1H3C;; H3C4; H3FB; HIST1H3D;; H3C6; H3FD; HIST1H3E;; H3C7; H3FI; HIST1H3F;; H3C8; H3FH; HIST1H3G;; H3C10; H3FK; HIST1H3H;; H3C11; H3FF; HIST1H3I;; H3C12; H3FJ; HIST1H3J,Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l,H3FA; HIST1H3A;; H3FL; HIST1H3B;; H3FC; HIST1H3C;; H3FB; HIST1H3D;; H3FD; HIST1H3E;; H3FI; HIST1H3F;; H3FH; HIST1H3G;; H3FK; HIST1H3H;; H3FF; HIST1H3I;; H3FJ; HIST1H3J,8350,H3 clustered histone 1,H3 histone family; member A; histone 1; H3a; histone cluster 1; H3a; histone cluster 1 H3 family member a,,H3/A,H3 clustered histone 1,H3/A; H3C10; H3C11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3FA; HIST1H3A,H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12
P78317,RNF4_HUMAN,RNF4; SNURF; RES4-26,E3 ubiquitin-protein ligase RNF4; EC 2.3.2.27; RING finger protein 4; Small nuclear ring finger protein; Protein SNURF,SNURF,6047,ring finger protein 4,,,RES4-26; SNURF; SLX5,ring finger protein 4,RES4-26; SLX5; SNURF,RNF4
P78324,SHPS1_HUMAN,SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP,Tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; SHPS-1; Brain Ig-like molecule with tyrosine-based activation motifs; Bit; CD172 antigen-like family member A; Inhibitory receptor SHPS-1; Macrophage fusion receptor; MyD-1 antigen; Signal-regulatory protein alpha-1; Sirp-alpha-1; Signal-regulatory protein alpha-2; Sirp-alpha-2; Signal-regulatory protein alpha-3; Sirp-alpha-3; p84; CD antigen CD172a,BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP,140885,signal regulatory protein alpha,protein tyrosine phosphatase; non-receptor type substrate 1; signal-regulatory protein alpha,,SHPS1; SIRP; MYD-1; BIT; P84; SHPS-1; SIRPalpha; CD172a; SIRPalpha2; MFR; SIRP-ALPHA-1,signal regulatory protein alpha,BIT; CD172A; MFR; MYD-1; P84; PTPNS1; SHPS1; SIRP,SIRPA
P78344,IF4G2_HUMAN,EIF4G2; DAP5; OK/SW-cl.75,Eukaryotic translation initiation factor 4 gamma 2; eIF-4-gamma 2; eIF-4G 2; eIF4G 2; Death-associated protein 5; DAP-5; p97,DAP5,1982,eukaryotic translation initiation factor 4 gamma 2,eukaryotic translation initiation factor 4 gamma; 2,,DAP5; NAT1; p97,eukaryotic translation initiation factor 4 gamma 2,AAG1; DAP5; NAT1; P97,EIF4G2
P78347,GTF2I_HUMAN,GTF2I; BAP135; WBSCR6,General transcription factor II-I; GTFII-I; TFII-I; Bruton tyrosine kinase-associated protein 135; BAP-135; BTK-associated protein 135; SRF-Phox1-interacting protein; SPIN; Williams-Beuren syndrome chromosomal region 6 protein,BAP135; WBSCR6,2969,general transcription factor IIi,general transcription factor II; i,,TFII-I; BAP-135; SPIN; BTKAP1; DIWS; IB291,general transcription factor IIi,BAP135; BTKAP1; DIWS; GTFII-I; IB291; SPIN; TFII-I; WBS; WBSCR6,GTF2I
P78348,ASIC1_HUMAN,ASIC1; ACCN2; BNAC2,Acid-sensing ion channel 1; ASIC1; Amiloride-sensitive cation channel 2; neuronal; Brain sodium channel 2; BNaC2,ACCN2; BNAC2,41,acid sensing ion channel subunit 1,amiloride-sensitive cation channel 2; neuronal; acid-sensing (proton-gated) ion channel 1; acid sensing (proton gated) ion channel 1,,BNaC2; hBNaC2,acid sensing ion channel subunit 1,ACCN2; ASIC; BNaC2,ASIC1
P78352,DLG4_HUMAN,DLG4; PSD95,Disks large homolog 4; Postsynaptic density protein 95; PSD-95; Synapse-associated protein 90; SAP-90; SAP90,PSD95,1742,discs large MAGUK scaffold protein 4,discs; large homolog 4 (Drosophila); discs large homolog 4,,PSD-95; PSD95; SAP90; SAP-90,discs large MAGUK scaffold protein 4,MRD62; PSD95; SAP-90; SAP90,DLG4
P78356,PI42B_HUMAN,PIP4K2B; PIP5K2B,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta; EC 2.7.1.149; 1-phosphatidylinositol 5-phosphate 4-kinase 2-beta; Diphosphoinositide kinase 2-beta; Phosphatidylinositol 5-phosphate 4-kinase type II beta; PI(5; PIP4KII-beta; PtdIns(5,PIP5K2B,8396,phosphatidylinositol-5-phosphate 4-kinase type 2 beta,phosphatidylinositol-4-phosphate 5-kinase; type II; beta; phosphatidylinositol-5-phosphate 4-kinase; type II; beta,,PIP5KIIB; PIP5KIIbeta,phosphatidylinositol-5-phosphate 4-kinase type 2 beta,PI5P4KB; PIP5K2B; PIP5KIIB; PIP5KIIbeta; PIP5P4KB,PIP4K2B
P78362,SRPK2_HUMAN,SRPK2,SRSF protein kinase 2; EC 2.7.11.1; SFRS protein kinase 2; Serine/arginine-rich protein-specific kinase 2; SR-protein-specific kinase 2,,6733,SRSF protein kinase 2,SFRS protein kinase 2,SR protein kinase 2; serine/arginine-rich splicing factor kinase 2,SFRSK2,SRSF protein kinase 2,SFRSK2,SRPK2
P78368,KC1G2_HUMAN,CSNK1G2; CK1G2,Casein kinase I isoform gamma-2; CKI-gamma 2; EC 2.7.11.1,CK1G2,1455,casein kinase 1 gamma 2,casein kinase 1; gamma 2,,CK1g2,casein kinase 1 gamma 2,CK1g2,CSNK1G2
P78371,TCPB_HUMAN,CCT2; 99D8.1; CCTB,T-complex protein 1 subunit beta; TCP-1-beta; CCT-beta; Chaperonin containing T-complex polypeptide 1 subunit 2,99D8.1; CCTB,10576,chaperonin containing TCP1 subunit 2,chaperonin containing TCP1; subunit 2 (beta),,Cctb,chaperonin containing TCP1 subunit 2,99D8.1; CCT-beta; CCTB; HEL-S-100n; PRO1633; TCP-1-beta,CCT2
P78527,PRKDC_HUMAN,PRKDC; HYRC; HYRC1,DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; EC 2.7.11.1; DNPK1; Ser-473 kinase; S473K; p460,HYRC; HYRC1,5591,protein kinase; DNA-activated; catalytic subunit,protein kinase; DNA-activated; catalytic polypeptide,DNA-dependent protein kinase catalytic subunit,DNPK1; p350; DNAPK; XRCC7; DNA-PKcs; DNAPKc; DNA-PKC; p460,protein kinase; DNA-activated; catalytic subunit,DNA-PKC; DNA-PKcs; DNAPK; DNAPKc; DNPK1; HYRC; HYRC1; IMD26; S473K; XRCC7; p350,PRKDC
P78536,ADA17_HUMAN,ADAM17; CSVP; TACE,Disintegrin and metalloproteinase domain-containing protein 17; ADAM 17; EC 3.4.24.86; Snake venom-like protease; TNF-alpha convertase; TNF-alpha-converting enzyme; CD antigen CD156b,CSVP; TACE,6868,ADAM metallopeptidase domain 17,tumor necrosis factor; alpha; converting enzyme,cartilage snake venom-like protease; TNF-alpha convertase enzyme; a disintegrin and metalloproteinase 17,cSVP; CD156B,ADAM metallopeptidase domain 17,ADAM18; CD156B; CSVP; NISBD; NISBD1; TACE,ADAM17
P78543,BTG2_HUMAN,BTG2; PC3,Protein BTG2; BTG family member 2; NGF-inducible anti-proliferative protein PC3,PC3,7832,BTG anti-proliferation factor 2,BTG family; member 2; BTG family member 2,B-cell translocation gene 2; pheochromacytoma cell-3; NGF-inducible anti-proliferative protein PC3; nerve growth factor-inducible anti-proliferative,PC3; TIS21; MGC126063; MGC126064; APRO1,BTG anti-proliferation factor 2,APRO1; PC3; TIS21,BTG2
P78545,ELF3_HUMAN,ELF3; ERT; ESX; JEN,ETS-related transcription factor Elf-3; E74-like factor 3; Epithelial-restricted with serine box; Epithelium-restricted Ets protein ESX; Epithelium-specific Ets transcription factor 1; ESE-1,ERT; ESX; JEN,1999,E74 like ETS transcription factor 3,E74-like factor 3 (ets domain transcription factor; epithelial-specific ),,EPR-1; ESE-1; ERT,E74 like ETS transcription factor 3,EPR-1; ERT; ESE-1; ESX,ELF3
P78563,RED1_HUMAN,ADARB1; ADAR2; DRADA2; RED1,Double-stranded RNA-specific editase 1; EC 3.5.4.37; RNA-editing deaminase 1; RNA-editing enzyme 1; dsRNA adenosine deaminase,ADAR2; DRADA2; RED1,104,adenosine deaminase RNA specific B1,adenosine deaminase; RNA-specific; B1 (homolog of rat RED1),RED1 homolog (rat),ADAR2; DRADA2; ADAR2g; DRABA2; RED1; hRED1; ADAR2a-L1; ADAR2a-L2; ADAR2a-L3; ADAR2a; ADAR2b; ADAR2c; ADAR2d,adenosine deaminase RNA specific B1,ADAR2; DRABA2; DRADA2; NEDHYMS; RED1,ADARB1
P80192,M3K9_HUMAN,MAP3K9; MLK1; PRKE1,Mitogen-activated protein kinase kinase kinase 9; EC 2.7.11.25; Mixed lineage kinase 1,MLK1; PRKE1,4293,mitogen-activated protein kinase kinase kinase 9,,,PRKE1; MEKK9,mitogen-activated protein kinase kinase kinase 9,MEKK9; MLK1; PRKE1,MAP3K9
P81274,GPSM2_HUMAN,GPSM2; LGN,G-protein-signaling modulator 2; Mosaic protein LGN,LGN,29899,G protein signaling modulator 2,G-protein signalling modulator 2 (AGS3-like; C. elegans); deafness; autosomal recessive 82; G-protein signaling modulator 2,,LGN; Pins,G protein signaling modulator 2,CMCS; DFNB82; LGN; PINS,GPSM2
P83916,CBX1_HUMAN,CBX1; CBX,Chromobox protein homolog 1; HP1Hsbeta; Heterochromatin protein 1 homolog beta; HP1 beta; Heterochromatin protein p25; M31; Modifier 1 protein; p25beta,CBX,10951,chromobox 1,chromobox homolog 1 (Drosophila HP1 beta); chromobox homolog 1,HP1 beta homolog (Drosophila ),HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; Hp1beta,chromobox 1,CBX; HP1-BETA; HP1Hs-beta; HP1Hsbeta; Hp1beta; M31; MOD1; p25beta,CBX1
P84022,SMAD3_HUMAN,SMAD3; MADH3,Mothers against decapentaplegic homolog 3; MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3; JV15-2; SMAD family member 3; SMAD 3; Smad3; hSMAD3,MADH3,4088,SMAD family member 3,MAD; mothers against decapentaplegic homolog 3 (Drosophila); SMAD; mothers against DPP homolog 3 (Drosophila),,JV15-2; HsT17436,SMAD family member 3,HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3; hMAD-3; hSMAD3; mad3,SMAD3
P84098,RL19_HUMAN,RPL19,Large ribosomal subunit protein eL19; 60S ribosomal protein L19,,6143,ribosomal protein L19,,60S ribosomal protein L19; ribosomal protein L19; cytosolic; N-terminus truncated,FLJ27452; MGC71997; DKFZp779D216; L19; eL19,ribosomal protein L19,L19; eL19,RPL19
P84103,SRSF3_HUMAN,SRSF3; SFRS3; SRP20,Serine/arginine-rich splicing factor 3; Pre-mRNA-splicing factor SRP20; Splicing factor; arginine/serine-rich 3,SFRS3; SRP20,6428,serine and arginine rich splicing factor 3,splicing factor; arginine/serine-rich 3; serine/arginine-rich splicing factor 3,,SRp20,serine and arginine rich splicing factor 3,SFRS3; SRp20,SRSF3
P84243,H33_HUMAN,H3-3A; H3.3A; H3F3; H3F3A; PP781;; H3-3B; H3.3B; H3F3B,Histone H3.3,H3.3A; H3F3; H3F3A;; H3.3B; H3F3B,3020,H3.3 histone A,H3 histone; family 3A; H3 histone family member 3A,,H3.3A,H3.3 histone A,BRYLIB1; H3-3B; H3.3A; H3F3; H3F3A,H3-3A; H3-3B
P85298,RHG08_HUMAN,ARHGAP8,Rho GTPase-activating protein 8; Rho-type GTPase-activating protein 8,,23779,Rho GTPase activating protein 8,,,FLJ20185; BPGAP1,Rho GTPase activating protein 8,BPGAP1; PP610,ARHGAP8
P85299,PRR5_HUMAN,PRR5; PROTOR1; PP610,Proline-rich protein 5; Protein observed with Rictor-1; Protor-1,PROTOR1,55615,proline rich 5,proline rich 5 (renal),protein observed with Rictor-1,PP610; FLJ20185k; Protor-1.; PROTOR1,proline rich 5,FLJ20185k; PP610; PROTOR-1; PROTOR1,PRR5
P98077,SHC2_HUMAN,SHC2; SCK; SHCB,SHC-transforming protein 2; Protein Sck; SHC-transforming protein B; Src homology 2 domain-containing-transforming protein C2; SH2 domain protein C2,SCK; SHCB,25759,SHC adaptor protein 2,SHC (Src homology 2 domain containing) transforming protein 2,neuronal Shc adaptor homolog,SLI; SCK; SHCB,SHC adaptor protein 2,SCK; SHCB; SLI,SHC2
P98082,DAB2_HUMAN,DAB2; DOC2,Disabled homolog 2; Adaptor molecule disabled-2; Differentially expressed in ovarian carcinoma 2; DOC-2; Differentially-expressed protein 2,DOC2,1601,DAB adaptor protein 2,disabled (Drosophila) homolog 2 (mitogen-responsive phosphoprotein); disabled homolog 2; mitogen-responsive phosphoprotein (Drosophila); Dab; mitogen-responsive phosphoprotein; homolog 2 (Drosophila); DAB2; clathrin adaptor protein,,DOC-2,DAB adaptor protein 2,DOC-2; DOC2,DAB2
P98161,PKD1_HUMAN,PKD1,Polycystin-1; PC1; Autosomal dominant polycystic kidney disease 1 protein,,5310,polycystin 1; transient receptor potential channel interacting,polycystic kidney disease 1 (autosomal dominant),polycystin 1; transient receptor potential cation channel; subfamily P; member 1,PBP; Pc-1; TRPP1,polycystin 1; transient receptor potential channel interacting,PBP; PC1; Pc-1; TRPP1; eliosin,PKD1
P98170,XIAP_HUMAN,XIAP; API3; BIRC4; IAP3,E3 ubiquitin-protein ligase XIAP; EC 2.3.2.27; Baculoviral IAP repeat-containing protein 4; IAP-like protein; ILP; hILP; Inhibitor of apoptosis protein 3; IAP-3; hIAP-3; hIAP3; RING-type E3 ubiquitin transferase XIAP; X-linked inhibitor of apoptosis protein; X-linked IAP,API3; BIRC4; IAP3,331,X-linked inhibitor of apoptosis,baculoviral IAP repeat-containing 4; X-linked inhibitor of apoptosis; E3 ubiquitin protein ligase,IAP-like protein 1,hILP; ILP-1,X-linked inhibitor of apoptosis,API3; BIRC4; IAP-3; ILP1; MIHA; XLP2; hIAP-3; hIAP3,XIAP
P98175,RBM10_HUMAN,RBM10; DXS8237E; GPATC9; GPATCH9; KIAA0122,RNA-binding protein 10; G patch domain-containing protein 9; RNA-binding motif protein 10; RNA-binding protein S1-1; S1-1,DXS8237E; GPATC9; GPATCH9; KIAA0122,8241,RNA binding motif protein 10,,G-patch domain containing 9; zinc finger RANBP2-type containing 5,DXS8237E; KIAA0122; GPATC9; ZRANB5; GPATCH9; S1-1,RNA binding motif protein 10,DXS8237E; GPATC9; GPATCH9; MINAS-60; S1-1; TARPS; ZRANB5,RBM10
P98177,FOXO4_HUMAN,FOXO4; AFX; AFX1; MLLT7,Forkhead box protein O4; Fork head domain transcription factor AFX1,AFX; AFX1; MLLT7,4303,forkhead box O4,myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); translocated to; 7; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog; Drosophila); translocated to; 7,,AFX1,forkhead box O4,AFX; AFX1; MLLT7,FOXO4
P98179,RBM3_HUMAN,RBM3; RNPL,RNA-binding protein 3; RNA-binding motif protein 3; RNPL,RNPL,5935,RNA binding motif protein 3,,,IS1-RNPL,RNA binding motif protein 3,IS1-RNPL; RNPL,RBM3
Q00005,2ABB_HUMAN,PPP2R2B,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform; PP2A subunit B isoform B55-beta; PP2A subunit B isoform PR55-beta; PP2A subunit B isoform R2-beta; PP2A subunit B isoform beta,,5521,protein phosphatase 2 regulatory subunit Bbeta,spinocerebellar ataxia 12; protein phosphatase 2 (formerly 2A); regulatory subunit B (PR 52); beta isoform,PP2A subunit B isoform beta,PR55-BETA; PR52B; B55beta,protein phosphatase 2 regulatory subunit Bbeta,B55BETA; PP2AB55BETA; PP2ABBETA; PP2APR55B; PP2APR55BETA; PR2AB55BETA; PR2ABBETA; PR2APR55BETA; PR52B; PR55-BETA; PR55BETA; SCA12,PPP2R2B
Q00059,TFAM_HUMAN,TFAM; TCF6; TCF6L2,Transcription factor A; mitochondrial; mtTFA; Mitochondrial transcription factor 1; MtTF1; Transcription factor 6; TCF-6; Transcription factor 6-like 2,TCF6; TCF6L2,7019,transcription factor A; mitochondrial,,,,transcription factor A; mitochondrial,MTDPS15; MTTF1; MTTFA; TCF6; TCF6L1; TCF6L2; TCF6L3,TFAM
Q00341,VIGLN_HUMAN,HDLBP; HBP; VGL,Vigilin; High density lipoprotein-binding protein; HDL-binding protein,HBP; VGL,3069,high density lipoprotein binding protein,vigilin,,HBP,high density lipoprotein binding protein,HBP; PRO2900; VGL,HDLBP
Q00526,CDK3_HUMAN,CDK3; CDKN3,Cyclin-dependent kinase 3; EC 2.7.11.22; Cell division protein kinase 3,CDKN3,1018,cyclin dependent kinase 3,,,,cyclin dependent kinase 3,,CDK3
Q00534,CDK6_HUMAN,CDK6; CDKN6,Cyclin-dependent kinase 6; EC 2.7.11.22; Cell division protein kinase 6; Serine/threonine-protein kinase PLSTIRE,CDKN6,1021,cyclin dependent kinase 6,,,PLSTIRE,cyclin dependent kinase 6,MCPH12; PLSTIRE,CDK6
Q00535,CDK5_HUMAN,CDK5; CDKN5; PSSALRE,Cyclin-dependent kinase 5; EC 2.7.11.1; Cell division protein kinase 5; Cyclin-dependent-like kinase 5; Serine/threonine-protein kinase PSSALRE; Tau protein kinase II catalytic subunit; TPKII catalytic subunit,CDKN5; PSSALRE,1020,cyclin dependent kinase 5,,,PSSALRE,cyclin dependent kinase 5,LIS7; PSSALRE,CDK5
Q00536,CDK16_HUMAN,CDK16; PCTAIRE1; PCTK1,Cyclin-dependent kinase 16; EC 2.7.11.22; Cell division protein kinase 16; PCTAIRE-motif protein kinase 1; Serine/threonine-protein kinase PCTAIRE-1,PCTAIRE1; PCTK1,5127,cyclin dependent kinase 16,PCTAIRE protein kinase 1,serine/threonine-protein kinase,PCTAIRE; PCTAIRE1; PCTGAIRE; FLJ16665,cyclin dependent kinase 16,PCTAIRE; PCTAIRE1; PCTGAIRE; PCTK1,CDK16
Q00610,CLH1_HUMAN,CLTC; CLH17; CLTCL2; KIAA0034,Clathrin heavy chain 1; Clathrin heavy chain on chromosome 17; CLH-17,CLH17; CLTCL2; KIAA0034,1213,clathrin heavy chain,clathrin; heavy polypeptide (Hc); clathrin; heavy chain; clathrin; heavy polypeptide-like 2; clathrin; heavy chain (Hc),,Hc,clathrin heavy chain,CHC; CHC17; CLH-17; CLTCL2; Hc; MRD56,CLTC
Q00613,HSF1_HUMAN,HSF1; HSTF1,Heat shock factor protein 1; HSF 1; Heat shock transcription factor 1; HSTF 1,HSTF1,3297,heat shock transcription factor 1,,,HSTF1,heat shock transcription factor 1,HSTF1,HSF1
Q00653,NFKB2_HUMAN,NFKB2; LYT10,Nuclear factor NF-kappa-B p100 subunit; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10 protein; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt-10; Lyt10,LYT10,4791,nuclear factor kappa B subunit 2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),,LYT-10; p52; p105; NF-kB2; p49/p100,nuclear factor kappa B subunit 2,CVID10; H2TF1; LYT-10; LYT10; NF-kB2; p100; p49/p100; p52,NFKB2
Q00722,PLCB2_HUMAN,PLCB2,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-2; EC 3.1.4.11; Phosphoinositide phospholipase C-beta-2; Phospholipase C-beta-2; PLC-beta-2,,5330,phospholipase C beta 2,phospholipase C; beta 2,,FLJ38135,phospholipase C beta 2,PLC-beta-2,PLCB2
Q00839,HNRPU_HUMAN,HNRNPU; C1orf199; HNRPU; SAFA; U21.1,Heterogeneous nuclear ribonucleoprotein U; hnRNP U; GRIP120; Nuclear p120 ribonucleoprotein; Scaffold-attachment factor A; SAF-A; p120; pp120,C1orf199; HNRPU; SAFA; U21.1,3192,heterogeneous nuclear ribonucleoprotein U,HNRNPU antisense RNA 1; chromosome 1 open reading frame 199; non-protein coding RNA 201; HNRNPU antisense RNA 1 (non-protein coding); heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A),scaffold attachment factor A,SAF-A; FLJ37978; FLJ30202,heterogeneous nuclear ribonucleoprotein U,DEE54; EIEE54; GRIP120; HNRNPU-AS1; HNRPU; SAF-A; SAFA; U21.1; hnRNP U; pp120,HNRNPU
Q00987,MDM2_HUMAN,MDM2,E3 ubiquitin-protein ligase Mdm2; EC 2.3.2.27; Double minute 2 protein; Hdm2; Oncoprotein Mdm2; RING-type E3 ubiquitin transferase Mdm2; p53-binding protein Mdm2,,4193,MDM2 proto-oncogene,mouse double minute 2; human homolog of; p53-binding protein; Mdm2; transformed 3T3 cell double minute 2; p53 binding protein (mouse); Mdm2 p53 binding protein homolog (mouse); MDM2 proto-oncogene; E3 ubiquitin protein ligase,,HDM2; MGC5370,MDM2 proto-oncogene,ACTFS; HDMX; LSKB; hdm2,MDM2
Q01082,SPTB2_HUMAN,SPTBN1; SPTB2,Spectrin beta chain; non-erythrocytic 1; Beta-II spectrin; Fodrin beta chain; Spectrin; non-erythroid beta chain 1,SPTB2,6711,spectrin beta; non-erythrocytic 1,,Fodrin beta chain; Beta-II spectrin,,spectrin beta; non-erythrocytic 1,DDISBA; ELF; HEL102; SPTB2; betaSpII,SPTBN1
Q01094,E2F1_HUMAN,E2F1; RBBP3,Transcription factor E2F1; E2F-1; PBR3; Retinoblastoma-associated protein 1; RBAP-1; Retinoblastoma-binding protein 3; RBBP-3; pRB-binding protein E2F-1,RBBP3,1869,E2F transcription factor 1,retinoblastoma-binding protein 3 (E2F-like),,RBP3,E2F transcription factor 1,E2F-1; RBAP1; RBBP3; RBP3,E2F1
Q01105,SET_HUMAN,SET,Protein SET; HLA-DR-associated protein II; Inhibitor of granzyme A-activated DNase; IGAAD; PHAPII; Phosphatase 2A inhibitor I2PP2A; I-2PP2A; Template-activating factor I; TAF-I,,6418,SET nuclear proto-oncogene,SET translocation (myeloid leukemia-associated),protein phosphatase type 2A inhibitor; Template-Activating Factor-I; chromatin remodelling factor; HLA-DR-associated protein II; inhibitor of granzyme A-activated DNase,PHAPII; 2PP2A; IPP2A2; TAF-IBETA; IGAAD; TAF-I,SET nuclear proto-oncogene,2PP2A; I2PP2A; IGAAD; IPP2A2; MRD58; PHAPII; TAF-I; TAF-IBETA,SET
Q01118,SCN7A_HUMAN,SCN7A; SCN6A,Sodium channel protein type 7 subunit alpha; Atypical sodium channel Nav2.1; Nax channel; Sodium channel protein type VII subunit alpha,SCN6A,6332,sodium voltage-gated channel alpha subunit 7,sodium channel; voltage-gated; type VI; alpha; sodium channel; voltage-gated; type VII; alpha; sodium channel; voltage-gated; type VII; alpha subunit; sodium channel; voltage gated; type VII alpha subunit,,Nav2.1; Nav2.2; NaG,sodium voltage-gated channel alpha subunit 7,NaG; Nav2.1; Nav2.2; SCN6A,SCN7A
Q01130,SRSF2_HUMAN,SRSF2; SFRS2,Serine/arginine-rich splicing factor 2; Protein PR264; Splicing component; 35 kDa; Splicing factor SC35; SC-35; Splicing factor; arginine/serine-rich 2,SFRS2,6427,serine and arginine rich splicing factor 2,splicing factor; arginine/serine-rich 2; serine/arginine-rich splicing factor 2,SR splicing factor 2,SC-35; SC35; PR264; SFRS2A,serine and arginine rich splicing factor 2,PR264; SC-35; SC35; SFRS2; SFRS2A; SRp30b,SRSF2
Q01167,FOXK2_HUMAN,FOXK2; ILF; ILF1,Forkhead box protein K2; G/T-mismatch specific binding protein; nGTBP; Interleukin enhancer-binding factor 1,ILF; ILF1,3607,forkhead box K2,interleukin enhancer binding factor 1,,,forkhead box K2,ILF; ILF-1; ILF1; nGTBP,FOXK2
Q01196,RUNX1_HUMAN,RUNX1; AML1; CBFA2,Runt-related transcription factor 1; Acute myeloid leukemia 1 protein; Core-binding factor subunit alpha-2; CBF-alpha-2; Oncogene AML-1; Polyomavirus enhancer-binding protein 2 alpha B subunit; PEA2-alpha B; PEBP2-alpha B; SL3-3 enhancer factor 1 alpha B subunit; SL3/AKV core-binding factor alpha B subunit,AML1; CBFA2,861,RUNX family transcription factor 1,acute myeloid leukemia 1; runt-related transcription factor 1; runt related transcription factor 1,aml1 oncogene,PEBP2A2; AMLCR1,RUNX family transcription factor 1,AML1; AML1-EVI-1; AMLCR1; CBF2alpha; CBFA2; EVI-1; PEBP2aB; PEBP2alpha,RUNX1
Q01201,RELB_HUMAN,RELB,Transcription factor RelB; I-Rel,,5971,RELB proto-oncogene; NF-kB subunit,v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3),,REL-B,RELB proto-oncogene; NF-kB subunit,I-REL; IMD53; IREL; REL-B,RELB
Q01362,FCERB_HUMAN,MS4A2; APY; FCER1B; IGER,High affinity immunoglobulin epsilon receptor subunit beta; FcERI; Fc epsilon receptor I beta-chain; IgE Fc receptor subunit beta; Membrane-spanning 4-domains subfamily A member 2,APY; FCER1B; IGER,2206,membrane spanning 4-domains A2,IgE responsiveness (atopic); membrane-spanning 4-domains; subfamily A; member 2 (Fc fragment of IgE; high affinity I; receptor for; beta polypeptide); membrane-spanning 4-domains; subfamily A; member 2,Fc fragment of IgE; high affinity I; receptor for; beta polypeptide,,membrane spanning 4-domains A2,APY; ATOPY; FCER1B; FCERI; IGEL; IGER; IGHER,MS4A2
Q01449,MLRA_HUMAN,MYL7; MYL2A; MYLC2A,Myosin regulatory light chain 2; atrial isoform; MLC-2a; MLC2a; Myosin light chain 2a; Myosin regulatory light chain 7,MYL2A; MYLC2A,58498,myosin light chain 7,myosin; light polypeptide 7; regulatory; myosin; light chain 7; regulatory,,MYLC2A; MYL2A,myosin light chain 7,MYL2A; MYLC2A,MYL7
Q01534,TSPY1_HUMAN,TSPY1; TSPY,Testis-specific Y-encoded protein 1; Cancer/testis antigen 78; CT78,TSPY,100289087,testis specific protein Y-linked 1,testis specific protein; Y-linked,cancer/testis antigen 78,CT78,testis specific protein Y-linked 10,CT78; TSPY; TSPY1; TSPY3,TSPY1
Q01543,FLI1_HUMAN,FLI1,Friend leukemia integration 1 transcription factor; Proto-oncogene Fli-1; Transcription factor ERGB,,2313,Fli-1 proto-oncogene; ETS transcription factor,Friend leukemia virus integration 1,,SIC-1; EWSR2; FLI-1,Fli-1 proto-oncogene; ETS transcription factor,BDPLT21; EWSR2; FLI-1; SIC-1,FLI1
Q01581,HMCS1_HUMAN,HMGCS1; HMGCS,Hydroxymethylglutaryl-CoA synthase; cytoplasmic; HMG-CoA synthase; EC 2.3.3.10; 3-hydroxy-3-methylglutaryl coenzyme A synthase,HMGCS,3157,3-hydroxy-3-methylglutaryl-CoA synthase 1,3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble); 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble),3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase,,3-hydroxy-3-methylglutaryl-CoA synthase 1,HMGCS,HMGCS1
Q01628,IFM3_HUMAN,IFITM3,Interferon-induced transmembrane protein 3; Dispanin subfamily A member 2b; DSPA2b; Interferon-inducible protein 1-8U,,10410,interferon induced transmembrane protein 3,interferon induced transmembrane protein 3 (1-8U),dispanin subfamily A member 2b,1-8U; DSPA2b,interferon induced transmembrane protein 3,1-8U; DSPA2b; IP15,IFITM3
Q01668,CAC1D_HUMAN,CACNA1D; CACH3; CACN4; CACNL1A2; CCHL1A2,Voltage-dependent L-type calcium channel subunit alpha-1D; Calcium channel; L type; alpha-1 polypeptide; isoform 2; Voltage-gated calcium channel subunit alpha Cav1.3,CACH3; CACN4; CACNL1A2; CCHL1A2,776,calcium voltage-gated channel subunit alpha1 D,calcium channel; voltage-dependent; L type; alpha 1D subunit,,Cav1.3; CACH3; CACN4,calcium voltage-gated channel subunit alpha1 D,CACH3; CACN4; CACNL1A2; CCHL1A2; Cav1.3; PASNA; SANDD,CACNA1D
Q01814,AT2B2_HUMAN,ATP2B2; PMCA2,Plasma membrane calcium-transporting ATPase 2; PMCA2; EC 7.2.2.10; Plasma membrane calcium ATPase isoform 2; Plasma membrane calcium pump isoform 2,PMCA2,491,ATPase plasma membrane Ca2+ transporting 2,ATPase; Ca++ transporting; plasma membrane 2,plasma membrane Ca2+ pump 2; plasma membrane calcium-transporting ATPase 2,PMCA2,ATPase plasma membrane Ca2+ transporting 2,DFNA82; PMCA2; PMCA2a; PMCA2i,ATP2B2
Q01831,XPC_HUMAN,XPC; XPCC,DNA repair protein complementing XP-C cells; Xeroderma pigmentosum group C-complementing protein; p125,XPCC,7508,XPC complex subunit; DNA damage recognition and repair factor,xeroderma pigmentosum; complementation group C,xeroderma pigmentosum group C protein,XPCC; RAD4,XPC complex subunit; DNA damage recognition and repair factor,RAD4; XP3; XPCC; p125,XPC
Q01844,EWS_HUMAN,EWSR1; EWS,RNA-binding protein EWS; EWS oncogene; Ewing sarcoma breakpoint region 1 protein,EWS,2130,EWS RNA binding protein 1,Ewing sarcoma breakpoint region 1,,EWS,EWS RNA binding protein 1,EWS; EWS-FLI1; bK984G1.4,EWSR1
Q01860,PO5F1_HUMAN,POU5F1; OCT3; OCT4; OTF3,POU domain; class 5; transcription factor 1; Octamer-binding protein 3; Oct-3; Octamer-binding protein 4; Oct-4; Octamer-binding transcription factor 3; OTF-3,OCT3; OCT4; OTF3,5460,POU class 5 homeobox 1,POU domain class 5; transcription factor 1,,OCT3; Oct4; MGC22487; OCT-4; Oct3/4,POU class 5 homeobox 1,OCT3; OCT4; OCT4Borf1; OTF-3; OTF3; OTF4; Oct-3; Oct-4; Oct3/4,POU5F1
Q01892,SPIB_HUMAN,SPIB,Transcription factor Spi-B,,6689,Spi-B transcription factor,Spi-B transcription factor (Spi-1/PU.1 related),,SPI-B,Spi-B transcription factor,SPI-B,SPIB
Q01954,BNC1_HUMAN,BNC1; BNC,Zinc finger protein basonuclin-1,BNC,646,basonuclin zinc finger protein 1,basonuclin; basonuclin 1,,HsT19447; bn1; BSN1,basonuclin zinc finger protein 1,BNC; BSN1; HsT19447; POF16; bn1,BNC1
Q01959,SC6A3_HUMAN,SLC6A3; DAT1,Sodium-dependent dopamine transporter; DA transporter; DAT; Solute carrier family 6 member 3,DAT1,6531,solute carrier family 6 member 3,solute carrier family 6 (neurotransmitter transporter; dopamine); member 3; dopamine transporter 1; solute carrier family 6 (neurotransmitter transporter); member 3,dopamine transporter; Sodium-dependent dopamine transporter,DAT,solute carrier family 6 member 3,DAT; DAT1; PKDYS; PKDYS1,SLC6A3
Q01970,PLCB3_HUMAN,PLCB3,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-3; EC 3.1.4.11; Phosphoinositide phospholipase C-beta-3; Phospholipase C-beta-3; PLC-beta-3,,5331,phospholipase C beta 3,phospholipase C; beta 3 (phosphatidylinositol-specific),,,phospholipase C beta 3,SMDCD,PLCB3
Q02078,MEF2A_HUMAN,MEF2A; MEF2,Myocyte-specific enhancer factor 2A; Serum response factor-like protein 1,MEF2,4205,myocyte enhancer factor 2A,,,RSRFC4; RSRFC9,myocyte enhancer factor 2A,ADCAD1; RSRFC4; RSRFC9; mef2,MEF2A
Q02153,GCYB1_HUMAN,GUCY1B1; GUC1B3; GUCSB3; GUCY1B3,Guanylate cyclase soluble subunit beta-1; GCS-beta-1; EC 4.6.1.2; Guanylate cyclase soluble subunit beta-3; GCS-beta-3; Soluble guanylate cyclase small subunit,GUC1B3; GUCSB3; GUCY1B3,2983,guanylate cyclase 1 soluble subunit beta 1,guanylate cyclase 1; soluble; beta 3; guanylate cyclase 1 soluble subunit beta,,GC-SB3; GC-S-beta-1,guanylate cyclase 1 soluble subunit beta 1,GC-S-beta-1; GC-SB3; GUC1B3; GUCB3; GUCSB3; GUCY1B3,GUCY1B1
Q02156,KPCE_HUMAN,PRKCE; PKCE,Protein kinase C epsilon type; EC 2.7.11.13; nPKC-epsilon,PKCE,5581,protein kinase C epsilon,protein kinase C; epsilon,,,protein kinase C epsilon,PKCE; nPKC-epsilon,PRKCE
Q02224,CENPE_HUMAN,CENPE,Centromere-associated protein E; Centromere protein E; CENP-E; Kinesin-7; Kinesin-related protein CENPE,,1062,centromere protein E,centromere protein E (312kD); centromere protein E; 312kDa,protein phosphatase 1; regulatory subunit 61,KIF10; PPP1R61,centromere protein E,CENP-E; KIF10; MCPH13; PPP1R61,CENPE
Q02241,KIF23_HUMAN,KIF23; KNSL5; MKLP1,Kinesin-like protein KIF23; Kinesin-like protein 5; Mitotic kinesin-like protein 1,KNSL5; MKLP1,9493,kinesin family member 23,kinesin-like 5 (mitotic kinesin-like protein 1),,MKLP1; MKLP-1,kinesin family member 23,CDA3; CDAIII; CDAN3; CDAN3A; CHO1; KNSL5; MKLP-1; MKLP1,KIF23
Q02297,NRG1_HUMAN,NRG1; GGF; HGL; HRGA; NDF; SMDF,Pro-neuregulin-1; membrane-bound isoform; Pro-NRG1; Acetylcholine receptor-inducing activity; ARIA; Breast cancer cell differentiation factor p45; Glial growth factor; Heregulin; HRG; Neu differentiation factor; Sensory and motor neuron-derived factor,GGF; HGL; HRGA; NDF; SMDF,3084,neuregulin 1,NRG1 intronic transcript 2 (non-protein coding),,HRG; NDF; GGF,neuregulin 1,ARIA; GGF; GGF2; HGL; HRG; HRG1; HRGA; MST131; MSTP131; NDF; NRG1-IT2; SMDF,NRG1
Q02363,ID2_HUMAN,ID2; BHLHB26,DNA-binding protein inhibitor ID-2; Class B basic helix-loop-helix protein 26; bHLHb26; Inhibitor of DNA binding 2; Inhibitor of differentiation 2,BHLHB26,3398,inhibitor of DNA binding 2,inhibitor of differentiation 2; inhibitor of DNA binding 2; dominant negative helix-loop-helix protein,cell growth-inhibiting gene 8,GIG8; bHLHb26,inhibitor of DNA binding 2,GIG8; ID2A; ID2H; bHLHb26,ID2
Q02447,SP3_HUMAN,SP3,Transcription factor Sp3; SPR-2,,6670,Sp3 transcription factor,,,SPR-2,Sp3 transcription factor,SPR2,SP3
Q02535,ID3_HUMAN,ID3; 1R21; BHLHB25; HEIR1,DNA-binding protein inhibitor ID-3; Class B basic helix-loop-helix protein 25; bHLHb25; Helix-loop-helix protein HEIR-1; ID-like protein inhibitor HLH 1R21; Inhibitor of DNA binding 3; Inhibitor of differentiation 3,1R21; BHLHB25; HEIR1,3399,inhibitor of DNA binding 3,inhibitor of DNA binding 3; dominant negative helix-loop-helix protein,inhibitor of differentiation 3,HEIR-1; bHLHb25,inhibitor of DNA binding 3,HEIR-1; bHLHb25,ID3
Q02539,H11_HUMAN,H1-1; H1F1; HIST1H1A,Histone H1.1; Histone H1a,H1F1; HIST1H1A,3024,H1.1 linker histone; cluster member,H1 histone family; member 1; histone 1; H1a; histone cluster 1; H1a; histone cluster 1 H1 family member a,,H1.1; H1a,H1.1 linker histone; cluster member,H1.1; H1A; H1F1; HIST1; HIST1H1A,H1-1
Q02641,CACB1_HUMAN,CACNB1; CACNLB1,Voltage-dependent L-type calcium channel subunit beta-1; CAB1; Calcium channel voltage-dependent subunit beta 1,CACNLB1,782,calcium voltage-gated channel auxiliary subunit beta 1,calcium channel; voltage-dependent; beta 1 subunit,,,calcium voltage-gated channel auxiliary subunit beta 1,CAB1; CACNLB1; CCHLB1,CACNB1
Q02750,MP2K1_HUMAN,MAP2K1; MEK1; PRKMK1,Dual specificity mitogen-activated protein kinase kinase 1; MAP kinase kinase 1; MAPKK 1; MKK1; EC 2.7.12.2; ERK activator kinase 1; MAPK/ERK kinase 1; MEK 1,MEK1; PRKMK1,5604,mitogen-activated protein kinase kinase 1,,MAPK/ERK kinase 1; MAP kinase kinase 1; dual specificity mitogen-activated protein kinase kinase 1,MEK1; MAPKK1; MKK1,mitogen-activated protein kinase kinase 1,CFC3; MAPKK1; MEK1; MEL; MKK1; PRKMK1,MAP2K1
Q02763,TIE2_HUMAN,TEK; TIE2; VMCM; VMCM1,Angiopoietin-1 receptor; EC 2.7.10.1; Endothelial tyrosine kinase; Tunica interna endothelial cell kinase; Tyrosine kinase with Ig and EGF homology domains-2; Tyrosine-protein kinase receptor TEK; Tyrosine-protein kinase receptor TIE-2; hTIE2; p140 TEK; CD antigen CD202b,TIE2; VMCM; VMCM1,7010,TEK receptor tyrosine kinase,venous malformations; multiple cutaneous and mucosal; TEK tyrosine kinase; endothelial,angiopoietin-1 receptor,TIE2; TIE-2; VMCM1; CD202b,TEK receptor tyrosine kinase,CD202B; GLC3E; TIE-2; TIE2; VMCM; VMCM1,TEK
Q02779,M3K10_HUMAN,MAP3K10; MLK2; MST,Mitogen-activated protein kinase kinase kinase 10; EC 2.7.11.25; Mixed lineage kinase 2; Protein kinase MST,MLK2; MST,4294,mitogen-activated protein kinase kinase kinase 10,,MKN28 kinase; mixed lineage kinase 2; MKN28 derived nonreceptor_type serine/threonine kinase,MST; MEKK10,mitogen-activated protein kinase kinase kinase 10,MEKK10; MLK2; MST,MAP3K10
Q02790,FKBP4_HUMAN,FKBP4; FKBP52,Peptidyl-prolyl cis-trans isomerase FKBP4; PPIase FKBP4; EC 5.2.1.8; 51 kDa FK506-binding protein; FKBP51; 52 kDa FK506-binding protein; 52 kDa FKBP; FKBP-52; 59 kDa immunophilin; p59; FK506-binding protein 4; FKBP-4; FKBP59; HSP-binding immunophilin; HBI; Immunophilin FKBP52; Rotamase,FKBP52,2288,FKBP prolyl isomerase 4,FK506-binding protein 4 (59kD); FK506 binding protein 4; 59kDa; FK506 binding protein 4,,FKBP59; FKBP52,FKBP prolyl isomerase 4,FKBP51; FKBP52; FKBP59; HBI; Hsp56; PPIase; p52,FKBP4
Q02880,TOP2B_HUMAN,TOP2B,DNA topoisomerase 2-beta; EC 5.6.2.2; DNA topoisomerase II; beta isozyme,,7155,DNA topoisomerase II beta,topoisomerase (DNA) II beta 180kDa,,top2beta; TOPIIB,DNA topoisomerase II beta,BILU; TOPIIB; top2beta,TOP2B
Q02930,CREB5_HUMAN,CREB5; CREBPA,Cyclic AMP-responsive element-binding protein 5; CREB-5; cAMP-responsive element-binding protein 5; cAMP-response element-binding protein A; CRE-BPa,CREBPA,9586,cAMP responsive element binding protein 5,,cAMP response element binding protein CRE-Bpa,H_GS165L15.1; CRE-BPA,cAMP responsive element binding protein 5,CRE-BPA; CREB-5; CREBPA,CREB5
Q02952,AKA12_HUMAN,AKAP12; AKAP250,A-kinase anchor protein 12; AKAP-12; A-kinase anchor protein 250 kDa; AKAP 250; Gravin; Myasthenia gravis autoantigen,AKAP250,9590,A-kinase anchoring protein 12,A kinase (PRKA) anchor protein (gravin) 12; A kinase (PRKA) anchor protein 12,gravin; Src-Suppressed C Kinase Substrate,AKAP250; SSeCKS,A-kinase anchoring protein 12,AKAP250; SSeCKS,AKAP12
Q03014,HHEX_HUMAN,HHEX; HEX; PRH; PRHX,Hematopoietically-expressed homeobox protein HHEX; Homeobox protein HEX; Homeobox protein PRH; Proline-rich homeodomain protein,HEX; PRH; PRHX,3087,hematopoietically expressed homeobox,,,HEX; HOX11L-PEN,hematopoietically expressed homeobox,HEX; HMPH; HOX11L-PEN; PRH; PRHX,HHEX
Q03060,CREM_HUMAN,CREM,cAMP-responsive element modulator; Inducible cAMP early repressor; ICER,,1390,cAMP responsive element modulator,,,hCREM-2,cAMP responsive element modulator,CREM-2; ICER; hCREM-2,CREM
Q03111,ENL_HUMAN,MLLT1; ENL; LTG19; YEATS1,Protein ENL; YEATS domain-containing protein 1,ENL; LTG19; YEATS1,4298,MLLT1 super elongation complex subunit,myeloid/lymphoid or mixed-lineage leukemia; translocated to; 1,,ENL; LTG19; YEATS1,MLLT1 super elongation complex subunit,ENL; LTG19; YEATS1,MLLT1
Q03112,MECOM_HUMAN,MECOM; EVI1; MDS1; PRDM3,Histone-lysine N-methyltransferase MECOM; EC 2.1.1.367; Ecotropic virus integration site 1 protein homolog; EVI-1; MDS1 and EVI1 complex locus protein; Myelodysplasia syndrome 1 protein; Myelodysplasia syndrome-associated protein 1,EVI1; MDS1; PRDM3,2122,MDS1 and EVI1 complex locus,myelodysplasia syndrome 1; ecotropic viral integration site 1,PR domain 3,MDS1-EVI1; PRDM3; KMT8E,MDS1 and EVI1 complex locus,AML1-EVI-1; EVI1; KMT8E; MDS1; MDS1-EVI1; PRDM3; RUSAT2,MECOM
Q03135,CAV1_HUMAN,CAV1; CAV,Caveolin-1,CAV,857,caveolin 1,caveolin 1; caveolae protein; 22kD; caveolin 1; caveolae protein; 22kDa,,,caveolin 1,BSCL3; CGL3; LCCNS; MSTP085; PPH3; VIP21,CAV1
Q03164,KMT2A_HUMAN,KMT2A; ALL1; CXXC7; HRX; HTRX; MLL; MLL1; TRX1,Histone-lysine N-methyltransferase 2A; Lysine N-methyltransferase 2A; EC 2.1.1.364; ALL-1; CXXC-type zinc finger protein 7; Cysteine methyltransferase KMT2A; EC 2.1.1.-; Myeloid/lymphoid or mixed-lineage leukemia; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Trithorax-like protein; Zinc finger protein HRX; N-terminal cleavage product of 320 kDa; p320; C-terminal cleavage product of 180 kDa; p180,ALL1; CXXC7; HRX; HTRX; MLL; MLL1; TRX1,4297,lysine methyltransferase 2A,myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog; Drosophila); lysine (K)-specific methyltransferase 2A; Trithorax-like protein; CXXC-type zinc finger protein 7; Acute lymphocytic 1,Histone-lysine N-methyltransferase 2A,TRX1; HRX; ALL-1; HTRX1; CXXC7; MLL1A; MLL1; ALL1; HTRX,lysine methyltransferase 2A,ALL-1; ALL1; CXXC7; GAS7; HRX; HTRX; HTRX1; MLL; MLL1; MLL1A; TRX1; WDSTS,KMT2A
Q03167,TGBR3_HUMAN,TGFBR3,Transforming growth factor beta receptor type 3; TGF-beta receptor type 3; TGFR-3; Betaglycan; Transforming growth factor beta receptor III; TGF-beta receptor type III,,7049,transforming growth factor beta receptor 3,transforming growth factor; beta receptor III; transforming growth factor beta receptor III,betaglycan proteoglycan,betaglycan; BGCAN,transforming growth factor beta receptor 3,BGCAN; betaglycan,TGFBR3
Q03252,LMNB2_HUMAN,LMNB2; LMN2,Lamin-B2,LMN2,84823,lamin B2,,,,lamin B2,EPM9; LAMB2; LMN2; MCPH27,LMNB2
Q03393,PTPS_HUMAN,PTS,6-pyruvoyl tetrahydrobiopterin synthase; PTP synthase; PTPS; EC 4.2.3.12,,5805,6-pyruvoyltetrahydropterin synthase,,,PTPS,6-pyruvoyltetrahydropterin synthase,PTPS,PTS
Q03431,PTH1R_HUMAN,PTH1R; PTHR; PTHR1,Parathyroid hormone/parathyroid hormone-related peptide receptor; PTH/PTHrP type I receptor; PTH/PTHr receptor; Parathyroid hormone 1 receptor; PTH1 receptor,PTHR; PTHR1,5745,parathyroid hormone 1 receptor,parathyroid hormone receptor 1,,,parathyroid hormone 1 receptor,EKNS; PFE; PTHR; PTHR1,PTH1R
Q03468,ERCC6_HUMAN,ERCC6; CSB,DNA excision repair protein ERCC-6; EC 3.6.4.-; ATP-dependent helicase ERCC6; Cockayne syndrome protein CSB,CSB,2074,ERCC excision repair 6; chromatin remodeling factor,excision repair cross-complementing rodent repair deficiency; complementation group 6; excision repair cross-complementation group 6,Cockayne syndrome B protein,CSB; RAD26; ARMD5,ERCC excision repair 6; chromatin remodeling factor,ARMD5; CKN2; COFS; COFS1; CSB; CSB-PGBD3; POF11; RAD26; UVSS1,ERCC6
Q03721,KCNC4_HUMAN,KCNC4; C1orf30,Voltage-gated potassium channel KCNC4; KSHIIIC; Potassium voltage-gated channel subfamily C member 4; Voltage-gated potassium channel subunit Kv3.4,C1orf30,3749,potassium voltage-gated channel subfamily C member 4,chromosome 1 open reading frame 30; potassium voltage-gated channel; Shaw-related subfamily; member 4; potassium channel; voltage gated Shaw related subfamily C; member 4,,Kv3.4; HKSHIIIC,potassium voltage-gated channel subfamily C member 4,C1orf30; HKSHIIIC; KSHIIIC; KV3.4,KCNC4
Q04206,TF65_HUMAN,RELA; NFKB3,Transcription factor p65; Nuclear factor NF-kappa-B p65 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3,NFKB3,5970,RELA proto-oncogene; NF-kB subunit,nuclear factor of kappa light polypeptide gene enhancer in B-cells 3; v-rel avian reticuloendotheliosis viral oncogene homolog A,,p65,RELA proto-oncogene; NF-kB subunit,AIF3BL3; CMCU; NFKB3; p65,RELA
Q04323,UBXN1_HUMAN,UBXN1; SAKS1,UBX domain-containing protein 1; SAPK substrate protein 1; UBA/UBX 33.3 kDa protein,SAKS1,51035,UBX domain protein 1,,SAPK substrate protein 1,LOC51035; 2B28; UBXD10; SAKS1,UBX domain protein 1,2B28; SAKS1; UBXD10,UBXN1
Q04637,IF4G1_HUMAN,EIF4G1; EIF4F; EIF4G; EIF4GI,Eukaryotic translation initiation factor 4 gamma 1; eIF-4-gamma 1; eIF-4G 1; eIF-4G1; p220,EIF4F; EIF4G; EIF4GI,1981,eukaryotic translation initiation factor 4 gamma 1,eukaryotic translation initiation factor 4 gamma; 1,,p220; PARK18,eukaryotic translation initiation factor 4 gamma 1,EIF-4G1; EIF4F; EIF4G; EIF4GI; P220; PARK18,EIF4G1
Q04656,ATP7A_HUMAN,ATP7A; MC1; MNK,Copper-transporting ATPase 1; EC 7.2.2.8; Copper pump 1; Menkes disease-associated protein,MC1; MNK,538,ATPase copper transporting alpha,Menkes syndrome; ATPase; Cu++ transporting; alpha polypeptide,copper pump 1; copper-transporting ATPase 1,,ATPase copper transporting alpha,DSMAX; HMNX; MK; MNK; SMAX3,ATP7A
Q04724,TLE1_HUMAN,TLE1,Transducin-like enhancer protein 1; E(Sp1; Enhancer of split groucho-like protein 1; ESG1,,7088,TLE family member 1; transcriptional corepressor,transducin-like enhancer of split 1 (E(sp1) homolog; Drosophila); transducin like enhancer of split 1,enhancer of split groucho 1,ESG1; GRG1; ESG; TLE-1,TLE family member 1; transcriptional corepressor,ESG; ESG1; GRG1; TLE-1,TLE1
Q04759,KPCT_HUMAN,PRKCQ; PRKCT,Protein kinase C theta type; EC 2.7.11.13; nPKC-theta,PRKCT,5588,protein kinase C theta,protein kinase C; theta,,,protein kinase C theta,PRKCT; nPKC-theta,PRKCQ
Q04760,LGUL_HUMAN,GLO1,Lactoylglutathione lyase; EC 4.4.1.5; Aldoketomutase; Glyoxalase I; Glx I; Ketone-aldehyde mutase; Methylglyoxalase; S-D-lactoylglutathione methylglyoxal lyase,,2739,glyoxalase I,,lactoylglutathione lyase,GLOD1,glyoxalase I,GLOD1; GLYI; HEL-S-74,GLO1
Q04771,ACVR1_HUMAN,ACVR1; ACVRLK2,Activin receptor type-1; EC 2.7.11.30; Activin receptor type I; ACTR-I; Activin receptor-like kinase 2; ALK-2; Serine/threonine-protein kinase receptor R1; SKR1; TGF-B superfamily receptor type I; TSR-I,ACVRLK2,90,activin A receptor type 1,activin A receptor; type I,,SKR1; ALK2; ACVR1A,activin A receptor type 1,ACTRI; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI,ACVR1
Q04837,SSBP_HUMAN,SSBP1; SSBP,Single-stranded DNA-binding protein; mitochondrial; Mt-SSB; MtSSB; PWP1-interacting protein 17,SSBP,6742,single stranded DNA binding protein 1,single-stranded DNA-binding protein; single-stranded DNA binding protein 1; single-stranded DNA binding protein 1; mitochondrial,,SSBP; mtSSB,single stranded DNA binding protein 1,Mt-SSB; OPA13; SOSS-B1; SSBP; mtSSB,SSBP1
Q04864,REL_HUMAN,REL,Proto-oncogene c-Rel,,5966,REL proto-oncogene; NF-kB subunit,v-rel avian reticuloendotheliosis viral oncogene homolog,,I-Rel; c-Rel; HIVEN86A,REL proto-oncogene; NF-kB subunit,C-Rel; HIVEN86A; IMD92,REL
Q04912,RON_HUMAN,MST1R; PTK8; RON,Macrophage-stimulating protein receptor; MSP receptor; EC 2.7.10.1; CDw136; Protein-tyrosine kinase 8; p185-Ron; CD antigen CD136,PTK8; RON,4486,macrophage stimulating 1 receptor,PTK8 protein tyrosine kinase 8; S13 erythroblastosis (avian) oncogene homolog; S13 avian erythroblastosis oncogene homolog,c-met-related tyrosine kinase,CDw136; CD136,macrophage stimulating 1 receptor,CD136; CDw136; NPCA3; PTK8; RON; SEA; p185-Ron,MST1R
Q04917,1433F_HUMAN,YWHAH; YWHA1,14-3-3 protein eta; Protein AS1,YWHA1,7533,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein; eta polypeptide,14-3-3 eta,,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,YWHA1,YWHAH
Q05086,UBE3A_HUMAN,UBE3A; E6AP; EPVE6AP; HPVE6A,Ubiquitin-protein ligase E3A; EC 2.3.2.26; E6AP ubiquitin-protein ligase; HECT-type ubiquitin transferase E3A; Human papillomavirus E6-associated protein; Oncogenic protein-associated protein E6-AP; Renal carcinoma antigen NY-REN-54,E6AP; EPVE6AP; HPVE6A,7337,ubiquitin protein ligase E3A,human papilloma virus E6-associated protein,Angelman syndrome,AS; ANCR; E6-AP; FLJ26981,ubiquitin protein ligase E3A,ANCR; AS; E6-AP; EPVE6AP; HPVE6A; PIX1,UBE3A
Q05193,DYN1_HUMAN,DNM1; DNM,Dynamin-1; EC 3.6.5.5; Dynamin; Dynamin I,DNM,1759,dynamin 1,,,,dynamin 1,DEE31; DEE31A; DEE31B; DNM; EIEE31,DNM1
Q05195,MAD1_HUMAN,MXD1; MAD,Max dimerization protein 1; Max dimerizer 1; Protein MAD,MAD,4084,MAX dimerization protein 1,,,MAD1; bHLHc58,MAX dimerization protein 1,BHLHC58; MAD; MAD1,MXD1
Q05209,PTN12_HUMAN,PTPN12,Tyrosine-protein phosphatase non-receptor type 12; EC 3.1.3.48; PTP-PEST; Protein-tyrosine phosphatase G1; PTPG1,,5782,protein tyrosine phosphatase non-receptor type 12,,,PTPG1; PTP-PEST,protein tyrosine phosphatase non-receptor type 12,PTP-PEST; PTPG1,PTPN12
Q05329,DCE2_HUMAN,GAD2; GAD65,Glutamate decarboxylase 2; EC 4.1.1.15; 65 kDa glutamic acid decarboxylase; GAD-65; Glutamate decarboxylase 65 kDa isoform,GAD65,2572,glutamate decarboxylase 2,glutamate decarboxylase 2 (pancreatic islets and brain; 65kD); glutamate decarboxylase 2 (pancreatic islets and brain; 65kDa),,GAD65,glutamate decarboxylase 2,GAD65,GAD2
Q05397,FAK1_HUMAN,PTK2; FAK; FAK1,Focal adhesion kinase 1; FADK 1; EC 2.7.10.2; Focal adhesion kinase-related nonkinase; FRNK; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Protein-tyrosine kinase 2; p125FAK; pp125FAK,FAK; FAK1,5747,protein tyrosine kinase 2,PTK2 protein tyrosine kinase 2,protein phosphatase 1; regulatory subunit 71,FAK; FADK; FAK1; PPP1R71,protein tyrosine kinase 2,FADK; FADK 1; FAK; FAK1; FRNK; PPP1R71; p125FAK; pp125FAK,PTK2
Q05469,LIPS_HUMAN,LIPE,Hormone-sensitive lipase; HSL; EC 3.1.1.79; Monoacylglycerol lipase LIPE; EC 3.1.1.23; Retinyl ester hydrolase; REH,,3991,lipase E; hormone sensitive type,lipase; hormone-sensitive,,HSL,lipase E; hormone sensitive type,AOMS4; FPLD6; HSL; LHS; REH,LIPE
Q05513,KPCZ_HUMAN,PRKCZ; PKC2,Protein kinase C zeta type; EC 2.7.11.13; nPKC-zeta,PKC2,5590,protein kinase C zeta,protein kinase C; zeta,,PKC2,protein kinase C zeta,PKC-ZETA; PKC2,PRKCZ
Q05516,ZBT16_HUMAN,ZBTB16; PLZF; ZNF145,Zinc finger and BTB domain-containing protein 16; Promyelocytic leukemia zinc finger protein; Zinc finger protein 145; Zinc finger protein PLZF,PLZF; ZNF145,7704,zinc finger and BTB domain containing 16,zinc finger protein 145 (Kruppel-like; expressed in promyelocytic leukemia),promyelocytic leukaemia zinc finger,PLZF,zinc finger and BTB domain containing 16,PLZF; ZNF145,ZBTB16
Q05586,NMDZ1_HUMAN,GRIN1; NMDAR1,Glutamate receptor ionotropic; NMDA 1; GluN1; Glutamate NMDA receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; NMD-R1; hNR1,NMDAR1,2902,glutamate ionotropic receptor NMDA type subunit 1,N-methyl-D-aspartate receptor subunit NR1; glutamate receptor; ionotropic; N-methyl D-aspartate 1,,GluN1; NR1,glutamate ionotropic receptor NMDA type subunit 1,DEE101; GluN1; MRD8; NDHMSD; NDHMSR; NMD-R1; NMDA1; NMDAR1; NR1; hNR1,GRIN1
Q05639,EF1A2_HUMAN,EEF1A2; EEF1AL; STN,Elongation factor 1-alpha 2; EF-1-alpha-2; Eukaryotic elongation factor 1 A-2; eEF1A-2; Statin-S1,EEF1AL; STN,1917,eukaryotic translation elongation factor 1 alpha 2,statin-like; statin,,EEF1AL; HS1,eukaryotic translation elongation factor 1 alpha 2,DEE33; EEF1AL; EF-1-alpha-2; EF1A; EIEE33; HS1; MRD38; STN; STNL,EEF1A2
Q05655,KPCD_HUMAN,PRKCD; PKCD,Protein kinase C delta type; EC 2.7.11.13; Tyrosine-protein kinase PRKCD; EC 2.7.10.2; nPKC-delta; Sphingosine-dependent protein kinase-1; SDK1,PKCD,5580,protein kinase C delta,protein kinase C; delta,,,protein kinase C delta,ALPS3; CVID9; MAY1; PKCD; nPKC-delta,PRKCD
Q05682,CALD1_HUMAN,CALD1; CAD; CDM,Caldesmon; CDM,CAD; CDM,800,caldesmon 1,,,CDM; H-CAD; L-CAD; h-CD,caldesmon 1,CDM; H-CAD; HCAD; L-CAD; LCAD; NAG22; h-CD,CALD1
Q05923,DUSP2_HUMAN,DUSP2; PAC1,Dual specificity protein phosphatase 2; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase PAC-1,PAC1,1844,dual specificity phosphatase 2,,,PAC-1,dual specificity phosphatase 2,PAC-1; PAC1,DUSP2
Q05940,VMAT2_HUMAN,SLC18A2; SVMT; VMAT2,Synaptic vesicular amine transporter; Solute carrier family 18 member 2; Vesicular amine transporter 2; VAT2; Vesicular monoamine transporter 2,SVMT; VMAT2,6571,solute carrier family 18 member A2,solute carrier family 18 (vesicular monoamine transporter); member 2,Synaptic vesicular amine transporter,SVMT; SVAT; VAT2,solute carrier family 18 member A2,PKDYS2; SVAT; SVMT; VAT2; VMAT2,SLC18A2
Q06124,PTN11_HUMAN,PTPN11; PTP2C; SHPTP2,Tyrosine-protein phosphatase non-receptor type 11; EC 3.1.3.48; Protein-tyrosine phosphatase 1D; PTP-1D; Protein-tyrosine phosphatase 2C; PTP-2C; SH-PTP2; SHP-2; Shp2; SH-PTP3,PTP2C; SHPTP2,5781,protein tyrosine phosphatase non-receptor type 11,Noonan syndrome 1; protein tyrosine phosphatase; non-receptor type 11,SH2 domain-containing protein tyrosine phosphatase 2,BPTP3; SH-PTP2; SHP-2; PTP2C; SHP2,protein tyrosine phosphatase non-receptor type 11,BPTP3; CFC; JMML; METCDS; NS1; PTP-1D; PTP2C; SH-PTP2; SH-PTP3; SHP2,PTPN11
Q06187,BTK_HUMAN,BTK; AGMX1; ATK; BPK,Tyrosine-protein kinase BTK; EC 2.7.10.2; Agammaglobulinemia tyrosine kinase; ATK; B-cell progenitor kinase; BPK; Bruton tyrosine kinase,AGMX1; ATK; BPK,695,Bruton tyrosine kinase,Bruton agammaglobulinemia tyrosine kinase,Bruton's tyrosine kinase,ATK; XLA; PSCTK1,Bruton tyrosine kinase,AGMX1; AT; ATK; BPK; IGHD3; IMD1; PSCTK1; XLA,BTK
Q06190,P2R3A_HUMAN,PPP2R3A; PPP2R3,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha; PP2A subunit B isoform PR72/PR130; PP2A subunit B isoform R3 isoform; PP2A subunit B isoforms B''-PR72/PR130; PP2A subunit B isoforms B72/B130; Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B,PPP2R3,5523,protein phosphatase 2 regulatory subunit B''alpha,protein phosphatase 2 (formerly 2A); regulatory subunit B'' (PR 72); alpha isoform and (PR 130); beta isoform,PR130/B''alpha1 subunit; PR72/B''alpha2 subuit,PR130; PR72,protein phosphatase 2 regulatory subunit B''alpha,PPP2R3; PR130; PR72,PPP2R3A
Q06210,GFPT1_HUMAN,GFPT1; GFAT; GFPT,Glutamine--fructose-6-phosphate aminotransferase isomerizing 1; EC 2.6.1.16; D-fructose-6-phosphate amidotransferase 1; Glutamine:fructose-6-phosphate amidotransferase 1; GFAT 1; GFAT1; Hexosephosphate aminotransferase 1,GFAT; GFPT,2673,glutamine--fructose-6-phosphate transaminase 1,glutamine-fructose-6-phosphate transaminase 1,,GFAT; GFA; GFAT1,glutamine--fructose-6-phosphate transaminase 1,CMS12; CMSTA1; GFA; GFAT; GFAT 1; GFAT1; GFAT1m; GFPT; GFPT1L; MSLG,GFPT1
Q06265,EXOS9_HUMAN,EXOSC9; PMSCL1,Exosome complex component RRP45; Autoantigen PM/Scl 1; Exosome component 9; P75 polymyositis-scleroderma overlap syndrome-associated autoantigen; Polymyositis/scleroderma autoantigen 1; Polymyositis/scleroderma autoantigen 75 kDa; PM/Scl-75,PMSCL1,5393,exosome component 9,polymyositis/scleroderma autoantigen 1; 75kDa,polymyositis/scleroderma autoantigen 1 (75kD),PM/Scl-75; Rrp45p; RRP45; p5; p6,exosome component 9,PCH1D; PM/Scl-75; PMSCL1; RRP45; Rrp45p; p5; p6,EXOSC9
Q06330,SUH_HUMAN,RBPJ; IGKJRB; IGKJRB1; RBPJK; RBPSUH,Recombining binding protein suppressor of hairless; CBF-1; J kappa-recombination signal-binding protein; RBP-J kappa; RBP-J; RBP-JK; Renal carcinoma antigen NY-REN-30,IGKJRB; IGKJRB1; RBPJK; RBPSUH,3516,recombination signal binding protein for immunoglobulin kappa J region,recombining binding protein suppressor of hairless (Drosophila),suppressor of hairless homolog (Drosophila); CSL family DNA binding factor 1,SUH; IGKJRB; RBPJK; KBF2; RBP-J; CBF1,recombination signal binding protein for immunoglobulin kappa J region,AOS3; CBF-1; CBF1; IGKJRB; IGKJRB1; KBF2; RBP-J; RBP-J kappa; RBP-JK; RBPJK; RBPSUH; SUH; csl,RBPJ
Q06413,MEF2C_HUMAN,MEF2C,Myocyte-specific enhancer factor 2C; Myocyte enhancer factor 2C,,4208,myocyte enhancer factor 2C,,,,myocyte enhancer factor 2C,C5DELq14.3; DEL5q14.3; NEDHSIL,MEF2C
Q06418,TYRO3_HUMAN,TYRO3; BYK; DTK; RSE; SKY; TIF,Tyrosine-protein kinase receptor TYRO3; EC 2.7.10.1; Tyrosine-protein kinase BYK; Tyrosine-protein kinase DTK; Tyrosine-protein kinase RSE; Tyrosine-protein kinase SKY; Tyrosine-protein kinase TIF,BYK; DTK; RSE; SKY; TIF,7301,TYRO3 protein tyrosine kinase,,,Dtk; Brt; Tif; Sky; Etk-2; Rek,TYRO3 protein tyrosine kinase,BYK; Dtk; Etk-2; RSE; Rek; Sky; Tif,TYRO3
Q06432,CCG1_HUMAN,CACNG1; CACNLG,Voltage-dependent calcium channel gamma-1 subunit; Dihydropyridine-sensitive L-type; skeletal muscle calcium channel subunit gamma,CACNLG,786,calcium voltage-gated channel auxiliary subunit gamma 1,calcium channel; voltage-dependent; gamma subunit 1,,,calcium voltage-gated channel auxiliary subunit gamma 1,CACNLG,CACNG1
Q06481,APLP2_HUMAN,APLP2; APPL2,Amyloid beta precursor like protein 2; APPH; Amyloid beta (A4; Amyloid protein homolog; Amyloid-like protein 2; APLP-2; CDEI box-binding protein; CDEBP; Sperm membrane protein YWK-II,APPL2,334,amyloid beta precursor like protein 2,amyloid beta (A4) precursor-like protein 2,,APPH,amyloid beta precursor like protein 2,APLP-2; APPH; APPL2; CDEBP,APLP2
Q06609,RAD51_HUMAN,RAD51; RAD51A; RECA,DNA repair protein RAD51 homolog 1; HsRAD51; hRAD51; RAD51 homolog A,RAD51A; RECA,5888,RAD51 recombinase,RAD51 (S. cerevisiae) homolog (E coli RecA homolog); RAD51 homolog (RecA homolog; E. coli) (S. cerevisiae); RAD51 homolog (S. cerevisiae),BRCA1/BRCA2-containing complex; subunit 5,HsRad51; HsT16930; BRCC5; FANCR,RAD51 recombinase,BRCC5; FANCR; HRAD51; HsRad51; HsT16930; MRMV2; RAD51A; RECA,RAD51
Q06787,FMR1_HUMAN,FMR1,Fragile X messenger ribonucleoprotein 1; Fragile X messenger ribonucleoprotein; FMRP; Protein FMR-1,,2332,fragile X messenger ribonucleoprotein 1,premature ovarian failure 1; fragile X mental retardation 1; FMRP translational regulator 1,,FMRP; FRAXA; MGC87458,fragile X messenger ribonucleoprotein 1,FMRP; FRAXA; POF; POF1,FMR1
Q06830,PRDX1_HUMAN,PRDX1; PAGA; PAGB; TDPX2,Peroxiredoxin-1; EC 1.11.1.24; Natural killer cell-enhancing factor A; NKEF-A; Proliferation-associated gene protein; PAG; Thioredoxin peroxidase 2; Thioredoxin-dependent peroxide reductase 2; Thioredoxin-dependent peroxiredoxin 1,PAGA; PAGB; TDPX2,5052,peroxiredoxin 1,,,NKEFA,peroxiredoxin 1,MSP23; NKEF-A; NKEFA; PAG; PAGA; PAGB; PRX1; PRXI; TDPX2,PRDX1
Q07157,ZO1_HUMAN,TJP1; ZO1,Tight junction protein 1; Tight junction protein ZO-1; Zona occludens protein 1; Zonula occludens protein 1,ZO1,7082,tight junction protein 1,,zona occludens 1; tight junction protein ZO-1,ZO-1; MGC133289; DKFZp686M05161,tight junction protein 1,ZO-1,TJP1
Q07343,PDE4B_HUMAN,PDE4B; DPDE4,3';5'-cyclic-AMP phosphodiesterase 4B; EC 3.1.4.53; DPDE4; PDE32; cAMP-specific phosphodiesterase 4B,DPDE4,5142,phosphodiesterase 4B,phosphodiesterase 4B; cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E4); phosphodiesterase 4B; cAMP-specific (phosphodiesterase E4 dunce homolog; Drosophila); phosphodiesterase 4B; cAMP-specific,phosphodiesterase E4 dunce homolog (Drosophila); cAMP-specific 3';5'-cyclic phosphodiesterase 4B,,phosphodiesterase 4B,DPDE4; PDEIVB,PDE4B
Q07352,TISB_HUMAN,ZFP36L1; BERG36; BRF1; ERF1; RNF162B; TIS11B,mRNA decay activator protein ZFP36L1; Butyrate response factor 1; EGF-response factor 1; ERF-1; TPA-induced sequence 11b; Zinc finger protein 36; C3H1 type-like 1; ZFP36-like 1,BERG36; BRF1; ERF1; RNF162B; TIS11B,677,ZFP36 ring finger protein like 1,zinc finger protein; C3H type; 36-like 1; zinc finger protein 36; C3H type-like 1,,RNF162B; Berg36; ERF1; TIS11B; cMG1,ZFP36 ring finger protein like 1,BRF1; Berg36; ERF-1; ERF1; RNF162B; TIS11B; cMG1,ZFP36L1
Q07666,KHDR1_HUMAN,KHDRBS1; SAM68,KH domain-containing; RNA-binding; signal transduction-associated protein 1; GAP-associated tyrosine phosphoprotein p62; Src-associated in mitosis 68 kDa protein; Sam68; p21 Ras GTPase-activating protein-associated p62; p68,SAM68,10657,KH RNA binding domain containing; signal transduction associated 1,,GAP-associated tyrosine phosphoprotein p62; Src-associated in mitosis 68 kDa protein,Sam68; p62; FLJ34027,KH RNA binding domain containing; signal transduction associated 1,Sam68; p62; p68,KHDRBS1
Q07699,SCN1B_HUMAN,SCN1B,Sodium channel regulatory subunit beta-1,,6324,sodium voltage-gated channel beta subunit 1,sodium channel; voltage-gated; type I; beta polypeptide; sodium channel; voltage-gated; type I; beta; sodium channel; voltage-gated; type I; beta subunit; sodium channel; voltage gated; type I beta subunit,,,sodium voltage-gated channel beta subunit 1,ATFB13; BRGDA5; DEE52; EIEE52; GEFSP1,SCN1B
Q07812,BAX_HUMAN,BAX; BCL2L4,Apoptosis regulator BAX; Bcl-2-like protein 4; Bcl2-L-4,BCL2L4,581,BCL2 associated X; apoptosis regulator,BCL2-associated X protein; BCL2 associated X protein,,BCL2L4,BCL2 associated X; apoptosis regulator,BCL2L4,BAX
Q07817,B2CL1_HUMAN,BCL2L1; BCL2L; BCLX,Bcl-2-like protein 1; Bcl2-L-1; Apoptosis regulator Bcl-X,BCL2L; BCLX,598,BCL2 like 1,,protein phosphatase 1; regulatory subunit 52,BCLX; BCL2L; Bcl-X; bcl-xL; bcl-xS; PPP1R52,BCL2 like 1,BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52,BCL2L1
Q07820,MCL1_HUMAN,MCL1; BCL2L3,Induced myeloid leukemia cell differentiation protein Mcl-1; Bcl-2-like protein 3; Bcl2-L-3; Bcl-2-related protein EAT/mcl1; mcl1/EAT,BCL2L3,4170,MCL1 apoptosis regulator; BCL2 family member,myeloid cell leukemia sequence 1 (BCL2-related); myeloid cell leukemia 1; MCL1; BCL2 family apoptosis regulator,,BCL2L3; Mcl-1,MCL1 apoptosis regulator; BCL2 family member,BCL2L3; EAT; MCL1-ES; MCL1L; MCL1S; Mcl-1; TM; bcl2-L-3; mcl1/EAT,MCL1
Q07866,KLC1_HUMAN,KLC1; KLC; KNS2,Kinesin light chain 1; KLC 1,KLC; KNS2,3831,kinesin light chain 1,kinesin 2 60/70kDa; kinesin 2,,KNS2A; KLC; hKLC1S; hKLC1N; hKLC1P; hKLC1G; hKLC1R; hKLC1J; hKLC1B,kinesin light chain 1,KLC; KNS2; KNS2A,KLC1
Q07869,PPARA_HUMAN,PPARA; NR1C1; PPAR,Peroxisome proliferator-activated receptor alpha; PPAR-alpha; Nuclear receptor subfamily 1 group C member 1,NR1C1; PPAR,5465,peroxisome proliferator activated receptor alpha,peroxisome proliferative activated receptor; alpha; peroxisome proliferator-activated receptor alpha,,hPPAR; NR1C1,peroxisome proliferator activated receptor alpha,NR1C1; PPAR; PPAR-alpha; PPARalpha; hPPAR,PPARA
Q07889,SOS1_HUMAN,SOS1,Son of sevenless homolog 1; SOS-1,,6654,SOS Ras/Rac guanine nucleotide exchange factor 1,gingival fibromatosis; hereditary; 1; son of sevenless homolog 1 (Drosophila),,HGF; GF1,SOS Ras/Rac guanine nucleotide exchange factor 1,GF1; GGF1; GINGF; HGF; NS4; SOS-1,SOS1
Q07912,ACK1_HUMAN,TNK2; ACK1,Activated CDC42 kinase 1; ACK-1; EC 2.7.10.2; EC 2.7.11.1; Tyrosine kinase non-receptor protein 2,ACK1,10188,tyrosine kinase non receptor 2,tyrosine kinase; non-receptor; 2,activated Cdc42-associated kinase 1,p21cdc42Hs; ACK; ACK1,tyrosine kinase non receptor 2,ACK; ACK-1; ACK1; p21cdc42Hs,TNK2
Q07954,LRP1_HUMAN,LRP1; A2MR; APR,Prolow-density lipoprotein receptor-related protein 1; LRP-1; Alpha-2-macroglobulin receptor; A2MR; Apolipoprotein E receptor; APOER; CD antigen CD91; LRP-85; LRP-515; LRPICD,A2MR; APR,4035,LDL receptor related protein 1,alpha-2-macroglobulin receptor; low density lipoprotein receptor-related protein 1,transforming growth factor-&#946; receptor type V,LRP; CD91; LRP1A; APOER; IGFBP3R1; IGFBP-3R,LDL receptor related protein 1,A2MR; APOER; APR; CD91; DDH3; IGFBP-3R; IGFBP3R; IGFBP3R1; KPA; LRP; LRP1A; TGFBR5,LRP1
Q07955,SRSF1_HUMAN,SRSF1; ASF; SF2; SF2P33; SFRS1; OK/SW-cl.3,Serine/arginine-rich splicing factor 1; Alternative-splicing factor 1; ASF-1; Splicing factor; arginine/serine-rich 1; pre-mRNA-splicing factor SF2; P33 subunit,ASF; SF2; SF2P33; SFRS1,6426,serine and arginine rich splicing factor 1,splicing factor; arginine/serine-rich 1; serine/arginine-rich splicing factor 1,splicing factor 2; pre-mRNA-splicing factor SF2; P33 subunit; alternate splicing factor; SR splicing factor 1,ASF; SF2; SRp30a; SF2p33; MGC5228,serine and arginine rich splicing factor 1,ASF; NEDFBA; SF2; SF2p33; SFRS1; SRp30a,SRSF1
Q08050,FOXM1_HUMAN,FOXM1; FKHL16; HFH11; MPP2; WIN,Forkhead box protein M1; Forkhead-related protein FKHL16; Hepatocyte nuclear factor 3 forkhead homolog 11; HFH-11; HNF-3/fork-head homolog 11; M-phase phosphoprotein 2; MPM-2 reactive phosphoprotein 2; Transcription factor Trident; Winged-helix factor from INS-1 cells,FKHL16; HFH11; MPP2; WIN,2305,forkhead box M1,,M-phase phosphoprotein 2,HFH-11; trident; HNF-3; INS-1; MPP2; MPHOSPH2; TGT3,forkhead box M1,FKHL16; FOXM1A; FOXM1B; FOXM1C; HFH-11; HFH11; HNF-3; INS-1; MPHOSPH2; MPP-2; MPP2; PIG29; TRIDENT,FOXM1
Q08170,SRSF4_HUMAN,SRSF4; SFRS4; SRP75,Serine/arginine-rich splicing factor 4; Pre-mRNA-splicing factor SRP75; SRP001LB; Splicing factor; arginine/serine-rich 4,SFRS4; SRP75,6429,serine and arginine rich splicing factor 4,splicing factor; arginine/serine-rich 4; serine/arginine-rich splicing factor 4,SR splicing factor 4,SRP75,serine and arginine rich splicing factor 4,SFRS4; SRP75,SRSF4
Q08209,PP2BA_HUMAN,PPP3CA; CALNA; CNA,Protein phosphatase 3 catalytic subunit alpha; EC 3.1.3.16; CAM-PRP catalytic subunit; Calcineurin A alpha; Calmodulin-dependent calcineurin A subunit alpha isoform; CNA alpha; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,CALNA; CNA,5530,protein phosphatase 3 catalytic subunit alpha,protein phosphatase 3 (formerly 2B); catalytic subunit; alpha isoform (calcineurin A alpha); protein phosphatase 3 (formerly 2B); catalytic subunit; alpha isoform; protein phosphatase 3; catalytic subunit; alpha isozyme,calcineurin A alpha; protein phosphatase 2B; catalytic subunit; alpha isoform,CNA1; PPP2B,protein phosphatase 3 catalytic subunit alpha,ACCIID; CALN; CALNA; CALNA1; CCN1; CNA1; DEE91; IECEE; IECEE1; PPP2B,PPP3CA
Q08289,CACB2_HUMAN,CACNB2; CACNLB2; MYSB,Voltage-dependent L-type calcium channel subunit beta-2; CAB2; Calcium channel voltage-dependent subunit beta 2; Lambert-Eaton myasthenic syndrome antigen B; MYSB,CACNLB2; MYSB,783,calcium voltage-gated channel auxiliary subunit beta 2,calcium channel; voltage-dependent; beta 2 subunit,,,calcium voltage-gated channel auxiliary subunit beta 2,CAB2; CACNLB2; CAVB2; MYSB,CACNB2
Q08345,DDR1_HUMAN,DDR1; CAK; EDDR1; NEP; NTRK4; PTK3A; RTK6; TRKE,Epithelial discoidin domain-containing receptor 1; Epithelial discoidin domain receptor 1; EC 2.7.10.1; CD167 antigen-like family member A; Cell adhesion kinase; Discoidin receptor tyrosine kinase; HGK2; Mammary carcinoma kinase 10; MCK-10; Protein-tyrosine kinase 3A; Protein-tyrosine kinase RTK-6; TRK E; Tyrosine kinase DDR; Tyrosine-protein kinase CAK; CD antigen CD167a,CAK; EDDR1; NEP; NTRK4; PTK3A; RTK6; TRKE,780,discoidin domain receptor tyrosine kinase 1,discoidin domain receptor family; member 1,,RTK6; CD167,discoidin domain receptor tyrosine kinase 1,CAK; CD167; DDR; EDDR1; HGK2; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE,DDR1
Q08379,GOGA2_HUMAN,GOLGA2,Golgin subfamily A member 2; 130 kDa cis-Golgi matrix protein; GM130; GM130 autoantigen; Golgin-95,,2801,golgin A2,golgi autoantigen; golgin subfamily a; 2,Golgi matrix protein GM130; SY11 protein,GM130; golgin-95,golgin A2,DEDHMB; GM130,GOLGA2
Q08493,PDE4C_HUMAN,PDE4C; DPDE1,3';5'-cyclic-AMP phosphodiesterase 4C; EC 3.1.4.53; DPDE1; PDE21; cAMP-specific phosphodiesterase 4C,DPDE1,5143,phosphodiesterase 4C,phosphodiesterase 4C; cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E1); phosphodiesterase 4C; cAMP-specific,phosphodiesterase E1 dunce homolog (Drosophila),,phosphodiesterase 4C,DPDE1; PDE21,PDE4C
Q08495,DEMA_HUMAN,DMTN; DMT; EPB49,Dematin; Dematin actin-binding protein; Erythrocyte membrane protein band 4.9,DMT; EPB49,2039,dematin actin binding protein,erythrocyte membrane protein band 4.9 (dematin),,DMT,dematin actin binding protein,DMT; EPB49,DMTN
Q08499,PDE4D_HUMAN,PDE4D; DPDE3,3';5'-cyclic-AMP phosphodiesterase 4D; EC 3.1.4.53; DPDE3; PDE43; cAMP-specific phosphodiesterase 4D,DPDE3,5144,phosphodiesterase 4D,phosphodiesterase 4D; cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E3); phosphodiesterase 4D; cAMP-specific,phosphodiesterase E3 dunce homolog (Drosophila); cAMP-specific 3';5'-cyclic phosphodiesterase 4D,,phosphodiesterase 4D,ACRDYS2; DPDE3; HSPDE4D; PDE43; PDE4DN2; STRK1,PDE4D
Q08881,ITK_HUMAN,ITK; EMT; LYK,Tyrosine-protein kinase ITK/TSK; EC 2.7.10.2; Interleukin-2-inducible T-cell kinase; IL-2-inducible T-cell kinase; Kinase EMT; T-cell-specific kinase; Tyrosine-protein kinase Lyk,EMT; LYK,3702,IL2 inducible T cell kinase,IL2-inducible T-cell kinase; IL2 inducible T-cell kinase,,EMT; PSCTK2; LYK,IL2 inducible T cell kinase,EMT; LPFS1; LYK; PSCTK2,ITK
Q08945,SSRP1_HUMAN,SSRP1; FACT80,FACT complex subunit SSRP1; Chromatin-specific transcription elongation factor 80 kDa subunit; Facilitates chromatin transcription complex 80 kDa subunit; FACT 80 kDa subunit; FACTp80; Facilitates chromatin transcription complex subunit SSRP1; Recombination signal sequence recognition protein 1; Structure-specific recognition protein 1; hSSRP1; T160,FACT80,6749,structure specific recognition protein 1,,facilitates chromatin remodeling 80 kDa subunit,FACT80,structure specific recognition protein 1,FACT; FACT80; T160,SSRP1
Q08999,RBL2_HUMAN,RBL2; RB2,Retinoblastoma-like protein 2; 130 kDa retinoblastoma-associated protein; p130; Retinoblastoma-related protein 2; RBR-2; pRb2,RB2,5934,RB transcriptional corepressor like 2,retinoblastoma-like 2,,Rb2; p130,RB transcriptional corepressor like 2,BRUWAG; P130; Rb2,RBL2
Q08AD1,CAMP2_HUMAN,CAMSAP2; CAMSAP1L1; KIAA1078,Calmodulin-regulated spectrin-associated protein 2; Calmodulin-regulated spectrin-associated protein 1-like protein 1,CAMSAP1L1; KIAA1078,23271,calmodulin regulated spectrin associated protein family member 2,calmodulin regulated spectrin-associated protein 1-like 1; calmodulin regulated spectrin-associated protein family; member 2,,KIAA1078,calmodulin regulated spectrin associated protein family member 2,CAMSAP1L1,CAMSAP2
Q08J23,NSUN2_HUMAN,NSUN2; SAKI; TRM4,RNA cytosine C(5)-methyltransferase NSUN2; 5; EC 2.1.1.-; Myc-induced SUN domain-containing protein; Misu; NOL1/NOP2/Sun domain family member 2; Substrate of AIM1/Aurora kinase B; mRNA cytosine C(5; EC 2.1.1.-; tRNA cytosine C(5; EC 2.1.1.-; EC 2.1.1.203; tRNA methyltransferase 4 homolog; hTrm4,SAKI; TRM4,54888,NOP2/Sun RNA methyltransferase 2,NOL1/NOP2/Sun domain family; member 2; NOP2/Sun domain family; member 2; mental retardation; non-syndromic; autosomal recessive; 5,tRNA methyltransferase 4 homolog (S. cerevisiae); Myc-induced SUN-domain-containing protein; RNA cytosine C(5)-methyltransferase NSUN2,FLJ20303; TRM4; Misu; SAKI,NOP2/Sun RNA methyltransferase 2,MISU; MRT5; SAKI; TRM4,NSUN2
Q09013,DMPK_HUMAN,DMPK; DM1PK; MDPK,Myotonin-protein kinase; MT-PK; EC 2.7.11.1; DM-kinase; DMK; DM1 protein kinase; DMPK; Myotonic dystrophy protein kinase,DM1PK; MDPK,1760,DM1 protein kinase,dystrophia myotonica 1 (includes dystrophia myotonia protein kinase); dystrophia myotonica protein kinase,dystrophia myotonica 1; DM protein kinase; myotonin protein kinase A; myotonic dystrophy associated protein kinase; thymopoietin homolog; Myotonin-protein kinase,DMK; DM1PK; MDPK; MT-PK,DM1 protein kinase,DM; DM1; DM1PK; DMK; MDPK; MT-PK,DMPK
Q09161,NCBP1_HUMAN,NCBP1; CBP80; NCBP,Nuclear cap-binding protein subunit 1; 80 kDa nuclear cap-binding protein; CBP80; NCBP 80 kDa subunit,CBP80; NCBP,4686,nuclear cap binding protein subunit 1,nuclear cap binding protein subunit 1; 80kD; nuclear cap binding protein subunit 1; 80kDa,,CBP80; Sto1,nuclear cap binding protein subunit 1,CBP80; NCBP; Sto1,NCBP1
Q09470,KCNA1_HUMAN,KCNA1,Potassium voltage-gated channel subfamily A member 1; Voltage-gated K(+; Voltage-gated potassium channel HBK1; Voltage-gated potassium channel subunit Kv1.1,,3736,potassium voltage-gated channel subfamily A member 1,potassium voltage-gated channel; shaker-related subfamily; member 1 (episodic ataxia with myokymia),,Kv1.1; RBK1; HUK1; MBK1,potassium voltage-gated channel subfamily A member 1,AEMK; EA1; HBK1; HUK1; KV1.1; MBK1; MK1; RBK1,KCNA1
Q09472,EP300_HUMAN,EP300; P300,Histone acetyltransferase p300; p300 HAT; EC 2.3.1.48; E1A-associated protein p300; Histone butyryltransferase p300; EC 2.3.1.-; Histone crotonyltransferase p300; EC 2.3.1.-; Protein 2-hydroxyisobutyryltransferase p300; EC 2.3.1.-; Protein lactyltransferas p300; EC 2.3.1.-; Protein propionyltransferase p300; EC 2.3.1.-,P300,2033,E1A binding protein p300,,histone acetyltransferase p300,p300; KAT3B,E1A binding protein p300,KAT3B; MKHK2; RSTS2; p300,EP300
Q09666,AHNK_HUMAN,AHNAK; PM227,Neuroblast differentiation-associated protein AHNAK; Desmoyokin,PM227,79026,AHNAK nucleoprotein,AHNAK nucleoprotein (desmoyokin),desmoyokin,MGC5395; AHNAK1,AHNAK nucleoprotein,AHNAK1; AHNAKRS; PM227,AHNAK
Q0VD86,INCA1_HUMAN,INCA1; HSD45,Protein INCA1; Inhibitor of CDK interacting with cyclin A1,,388324,inhibitor of CDK; cyclin A1 interacting protein 1,,,,inhibitor of CDK; cyclin A1 interacting protein 1,HSD45,INCA1
Q12772,SRBP2_HUMAN,SREBF2; BHLHD2; SREBP2,Sterol regulatory element-binding protein 2; SREBP-2; Class D basic helix-loop-helix protein 2; bHLHd2; Sterol regulatory element-binding transcription factor 2; Transcription factor SREBF2,BHLHD2; SREBP2,6721,sterol regulatory element binding transcription factor 2,,Sterol regulatory element-binding protein 2,SREBP2; bHLHd2,sterol regulatory element binding transcription factor 2,SREBP-2; SREBP2; bHLHd2,SREBF2
Q12778,FOXO1_HUMAN,FOXO1; FKHR; FOXO1A,Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma,FKHR; FOXO1A,2308,forkhead box O1,forkhead homolog in rhabdomyosarcoma,,FKH1,forkhead box O1,FKH1; FKHR; FOXO1A,FOXO1
Q12789,TF3C1_HUMAN,GTF3C1,General transcription factor 3C polypeptide 1; TF3C-alpha; TFIIIC box B-binding subunit; Transcription factor IIIC 220 kDa subunit; TFIIIC 220 kDa subunit; TFIIIC220; Transcription factor IIIC subunit alpha,,2975,general transcription factor IIIC subunit 1,general transcription factor IIIC; polypeptide 1 (alpha subunit; 220kD ); general transcription factor IIIC; polypeptide 1; alpha 220kDa,,TFIIIC220,general transcription factor IIIC subunit 1,TFIIIC; TFIIIC220; TFIIICalpha,GTF3C1
Q12791,KCMA1_HUMAN,KCNMA1; KCNMA; SLO,Calcium-activated potassium channel subunit alpha-1; BK channel; BKCA alpha; Calcium-activated potassium channel; subfamily M subunit alpha-1; K(VCA; KCa1.1; Maxi K channel; MaxiK; Slo-alpha; Slo1; Slowpoke homolog; Slo homolog; hSlo,KCNMA; SLO,3778,potassium calcium-activated channel subfamily M alpha 1,potassium large conductance calcium-activated channel; subfamily M; alpha member 1; potassium channel; calcium activated large conductance subfamily M alpha; member 1,BK channel alpha subunit; maxiK channel; big potassium channel alpha subunit,KCa1.1; mSLO1,potassium calcium-activated channel subfamily M alpha 1,BKTM; CADEDS; IEG16; KCa1.1; LIWAS; MaxiK; PNKD3; SAKCA; SLO; SLO-ALPHA; SLO1; bA205K10.1; hSlo; mSLO1,KCNMA1
Q12798,CETN1_HUMAN,CETN1; CEN1; CETN,Centrin-1; Caltractin isoform 2,CEN1; CETN,1068,centrin 1,centrin; EF-hand protein; 1,,CEN1,centrin 1,CEN1; CETN,CETN1
Q12800,TFCP2_HUMAN,TFCP2; LSF; SEF,Alpha-globin transcription factor CP2; SAA3 enhancer factor; Transcription factor LSF,LSF; SEF,7024,transcription factor CP2,,,CP2; LSF; LBP-1C; TFCP2C,transcription factor CP2,LBP1C; LSF; LSF1D; SEF; TFCP2C,TFCP2
Q12802,AKP13_HUMAN,AKAP13; BRX; HT31; LBC,A-kinase anchor protein 13; AKAP-13; AKAP-Lbc; Breast cancer nuclear receptor-binding auxiliary protein; Guanine nucleotide exchange factor Lbc; Human thyroid-anchoring protein 31; Lymphoid blast crisis oncogene; LBC oncogene; Non-oncogenic Rho GTPase-specific GTP exchange factor; Protein kinase A-anchoring protein 13; PRKA13; p47,BRX; HT31; LBC,11214,A-kinase anchoring protein 13,lymphoid blast crisis oncogene; A kinase (PRKA) anchor protein 13,,Ht31; BRX; AKAP-Lbc; c-lbc; PROTO-LB; HA-3; ARHGEF13,A-kinase anchoring protein 13,AKAP-13; AKAP-Lbc; ARHGEF13; BRX; HA-3; Ht31; LBC; PRKA13; PROTO-LB; PROTO-LBC; c-lbc; p47,AKAP13
Q12809,KCNH2_HUMAN,KCNH2; ERG; ERG1; HERG,Voltage-gated inwardly rectifying potassium channel KCNH2; Eag homolog; Ether-a-go-go-related gene potassium channel 1; ERG-1; Eag-related protein 1; Ether-a-go-go-related protein 1; H-ERG; hERG-1; hERG1; Potassium voltage-gated channel subfamily H member 2; Voltage-gated potassium channel subunit Kv11.1,ERG; ERG1; HERG,3757,potassium voltage-gated channel subfamily H member 2,potassium voltage-gated channel; subfamily H (eag-related); member 2,human ether-a-go-go-related gene; long QT syndrome type 2,Kv11.1; HERG; erg1,potassium voltage-gated channel subfamily H member 2,ERG-1; ERG1; H-ERG; HERG; HERG1; Kv11.1; LQT2; SQT1,KCNH2
Q12834,CDC20_HUMAN,CDC20,Cell division cycle protein 20 homolog; p55CDC,,991,cell division cycle 20,CDC20 (cell division cycle 20; S. cerevisiae; homolog); CDC20 cell division cycle 20 homolog (S. cerevisiae); cell division cycle 20 homolog (S. cerevisiae),fizzy homolog (drosophila),p55CDC; CDC20A,cell division cycle 20,CDC20A; OOMD14; OZEMA14; bA276H19.3; p55CDC,CDC20
Q12840,KIF5A_HUMAN,KIF5A; NKHC1,Kinesin heavy chain isoform 5A; Kinesin heavy chain neuron-specific 1; Neuronal kinesin heavy chain; NKHC,NKHC1,3798,kinesin family member 5A,spastic paraplegia 10 (autosomal dominant),neuron-specific kinesin heavy chain,D12S1889; NKHC; MY050,kinesin family member 5A,ALS25; D12S1889; MY050; NEIMY; NKHC; SPG10,KIF5A
Q12851,M4K2_HUMAN,MAP4K2; GCK; RAB8IP,Mitogen-activated protein kinase kinase kinase kinase 2; EC 2.7.11.1; B lymphocyte serine/threonine-protein kinase; Germinal center kinase; GC kinase; MAPK/ERK kinase kinase kinase 2; MEK kinase kinase 2; MEKKK 2; Rab8-interacting protein,GCK; RAB8IP,5871,mitogen-activated protein kinase kinase kinase kinase 2,,,GCK; BL44,mitogen-activated protein kinase kinase kinase kinase 2,BL44; GCK; RAB8IP,MAP4K2
Q12852,M3K12_HUMAN,MAP3K12; ZPK,Mitogen-activated protein kinase kinase kinase 12; EC 2.7.11.25; Dual leucine zipper bearing kinase; DLK; Leucine-zipper protein kinase; ZPK; MAPK-upstream kinase; MUK; Mixed lineage kinase,ZPK,7786,mitogen-activated protein kinase kinase kinase 12,,dual leucine zipper kinase DLK,MUK; DLK; ZPKP1; MEKK12,mitogen-activated protein kinase kinase kinase 12,DLK; HP09298; MEKK12; MUK; ZPK; ZPKP1,MAP3K12
Q12866,MERTK_HUMAN,MERTK; MER,Tyrosine-protein kinase Mer; EC 2.7.10.1; Proto-oncogene c-Mer; Receptor tyrosine kinase MerTK,MER,10461,MER proto-oncogene; tyrosine kinase,c-mer proto-oncogene tyrosine kinase,,mer; RP38; c-Eyk; Tyro12,MER proto-oncogene; tyrosine kinase,MER; RP38; Tyro12; c-Eyk; c-mer,MERTK
Q12879,NMDE1_HUMAN,GRIN2A; NMDAR2A,Glutamate receptor ionotropic; NMDA 2A; GluN2A; Glutamate NMDA receptor subunit epsilon-1; N-methyl D-aspartate receptor subtype 2A; NMDAR2A; NR2A; hNR2A,NMDAR2A,2903,glutamate ionotropic receptor NMDA type subunit 2A,glutamate receptor; ionotropic; N-methyl D-aspartate 2A,,GluN2A; NR2A,glutamate ionotropic receptor NMDA type subunit 2A,EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A,GRIN2A
Q12888,TP53B_HUMAN,TP53BP1,TP53-binding protein 1; 53BP1; p53-binding protein 1; p53BP1,,7158,tumor protein p53 binding protein 1,tumor protein p53-binding protein; 1,,53BP1; p202; TDRD30,tumor protein p53 binding protein 1,53BP1; TDRD30; p202; p53BP1,TP53BP1
Q12904,AIMP1_HUMAN,AIMP1; EMAP2; SCYE1,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1; Multisynthase complex auxiliary component p43; EMAP-2; Endothelial monocyte-activating polypeptide II; EMAP-II; Small inducible cytokine subfamily E member 1,EMAP2; SCYE1,9255,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,small inducible cytokine subfamily E; member 1 (endothelial monocyte-activating),EMAP II; ARS-interacting multifunctional protein 1; multisynthetase complex auxiliary component p43,EMAPII; EMAP-2; p43,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,EMAP2; EMAPII; HLD3; SCYE1; p43,AIMP1
Q12906,ILF3_HUMAN,ILF3; DRBF; MPHOSPH4; NF90,Interleukin enhancer-binding factor 3; Double-stranded RNA-binding protein 76; DRBP76; M-phase phosphoprotein 4; MPP4; Nuclear factor associated with dsRNA; NFAR; Nuclear factor of activated T-cells 90 kDa; NF-AT-90; Translational control protein 80; TCP80,DRBF; MPHOSPH4; NF90,3609,interleukin enhancer binding factor 3,interleukin enhancer binding factor 3; 90kD; interleukin enhancer binding factor 3; 90kDa,M-phase phosphoprotein 4; nuclear factor of activated T-cells 90 kDa; nuclear factor of activated T-cells 110 kDa; translational control protein 80; double-stranded RNA-binding protein; 76 kD; M phase phosphoprotein 4; nuclear factor associated with DS RNA; dsRNA binding protein NFAR-2/MPP4,NF90; MPHOSPH4; MPP4; NFAR-1; NFAR110; NFAR-2; TCP110; NF110; DRBP76; NFAR90; NF110b; NF90a; NF90c; NF90ctv; MPP4110,interleukin enhancer binding factor 3,CBTF; DRBF; DRBP76; MMP4; MPHOSPH4; MPP4; MPP4110; NF-AT-90; NF110; NF110b; NF90; NF90a; NF90b; NF90c; NF90ctv; NFAR; NFAR-1; NFAR-2; NFAR110; NFAR2; NFAR90; TCP110; TCP80,ILF3
Q12913,PTPRJ_HUMAN,PTPRJ; DEP1,Receptor-type tyrosine-protein phosphatase eta; Protein-tyrosine phosphatase eta; R-PTP-eta; EC 3.1.3.48; Density-enhanced phosphatase 1; DEP-1; HPTP eta; Protein-tyrosine phosphatase receptor type J; R-PTP-J; CD antigen CD148,DEP1,5795,protein tyrosine phosphatase receptor type J,,,DEP1; HPTPeta; CD148,protein tyrosine phosphatase receptor type J,CD148; DEP1; HPTP eta; HPTPeta; R-PTP-ETA; R-PTP-J; SCC1; THC10,PTPRJ
Q12923,PTN13_HUMAN,PTPN13; PNP1; PTP1E; PTPL1,Tyrosine-protein phosphatase non-receptor type 13; EC 3.1.3.48; Fas-associated protein-tyrosine phosphatase 1; FAP-1; PTP-BAS; Protein-tyrosine phosphatase 1E; PTP-E1; hPTPE1; Protein-tyrosine phosphatase PTPL1,PNP1; PTP1E; PTPL1,5783,protein tyrosine phosphatase non-receptor type 13,protein tyrosine phosphatase; non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),APO-1/CD95 (Fas)-associated phosphatase,PTP1E; PTP-BAS; PTPL1; PTP-BL,protein tyrosine phosphatase non-receptor type 13,FAP-1; PNP1; PTP-BAS; PTP-BL; PTP1E; PTPL1; PTPLE; hPTP1E,PTPN13
Q12931,TRAP1_HUMAN,TRAP1; HSP75; HSPC5,Heat shock protein 75 kDa; mitochondrial; HSP 75; Heat shock protein family C member 5; TNFR-associated protein 1; Tumor necrosis factor type 1 receptor-associated protein; TRAP-1,HSP75; HSPC5,10131,TNF receptor associated protein 1,TNF receptor-associated protein 1,,HSP75; HSP90L,TNF receptor associated protein 1,HSP 75; HSP75; HSP90L; TRAP-1,TRAP1
Q12933,TRAF2_HUMAN,TRAF2; TRAP3,TNF receptor-associated factor 2; EC 2.3.2.27; E3 ubiquitin-protein ligase TRAF2; RING-type E3 ubiquitin transferase TRAF2; Tumor necrosis factor type 2 receptor-associated protein 3,TRAP3,7186,TNF receptor associated factor 2,,,TRAP3; RNF117,TNF receptor associated factor 2,MGC:45012; RNF117; TRAP; TRAP3,TRAF2
Q12948,FOXC1_HUMAN,FOXC1; FKHL7; FREAC3,Forkhead box protein C1; Forkhead-related protein FKHL7; Forkhead-related transcription factor 3; FREAC-3,FKHL7; FREAC3,2296,forkhead box C1,,,FREAC3; ARA; IGDA; IHG1,forkhead box C1,ARA; ASGD3; FKHL7; FREAC-3; FREAC3; IGDA; IHG1; IRID1; RIEG3,FOXC1
Q12959,DLG1_HUMAN,DLG1,Disks large homolog 1; Synapse-associated protein 97; SAP-97; SAP97; hDlg,,1739,discs large MAGUK scaffold protein 1,discs; large homolog 1 (Drosophila); discs large homolog 1; scribble cell polarity complex component,discs large homolog 1; presynaptic protein SAP97; synapse-associated protein 97,SAP97; SAP-97; hdlg; DLGH1; dJ1061C18.1.1,discs large MAGUK scaffold protein 1,DLGH1; SAP-97; SAP97; hdlg,DLG1
Q12968,NFAC3_HUMAN,NFATC3; NFAT4,Nuclear factor of activated T-cells; cytoplasmic 3; NF-ATc3; NFATc3; NFATx; T-cell transcription factor NFAT4; NF-AT4; NF-AT4c,NFAT4,4775,nuclear factor of activated T cells 3,nuclear factor of activated T-cells; cytoplasmic; calcineurin-dependent 3; nuclear factor of activated T-cells 3,,NFAT4; NFATX; n339260,nuclear factor of activated T cells 3,NF-AT4c; NFAT4; NFATX; n339260,NFATC3
Q12972,PP1R8_HUMAN,PPP1R8; ARD1; NIPP1,Nuclear inhibitor of protein phosphatase 1; NIPP-1; Protein phosphatase 1 regulatory inhibitor subunit 8; EC 3.1.4.-; ARD-1,ARD1; NIPP1,5511,protein phosphatase 1 regulatory subunit 8,protein phosphatase 1; regulatory (inhibitor) subunit 8; protein phosphatase 1; regulatory subunit 8,RNase E; nuclear subunit of PP-1; nuclear inhibitor of protein phosphatase-1; activator of RNA decay; protein phosphatase 1 regulatory subunit 8,ard-1; NIPP-1; PRO2047; ARD1; NIPP1,protein phosphatase 1 regulatory subunit 8,ARD-1; ARD1; NIPP-1; NIPP1; PRO2047,PPP1R8
Q12983,BNIP3_HUMAN,BNIP3; NIP3,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,NIP3,664,BCL2 interacting protein 3,BCL2/adenovirus E1B 19kDa interacting protein 3,nineteen kD interacting protein-3; Hypoxia-Activated BNIP3 Overlapping Non-coding RNA,Nip3; HABON,BCL2 interacting protein 3,HABON; NIP3,BNIP3
Q13002,GRIK2_HUMAN,GRIK2; GLUR6,Glutamate receptor ionotropic; kainate 2; GluK2; Excitatory amino acid receptor 4; EAA4; Glutamate receptor 6; GluR-6; GluR6,GLUR6,2898,glutamate ionotropic receptor kainate type subunit 2,glutamate receptor; ionotropic; kainate 2,excitatory amino acid receptor 4?,GluK2; MRT6; GluR-6; EAA4; GLUK6,glutamate ionotropic receptor kainate type subunit 2,EAA4; GLR6; GLUK6; GLUR6; GluK2; MRT6; NEDLAS,GRIK2
Q13009,TIAM1_HUMAN,TIAM1,Rho guanine nucleotide exchange factor TIAM1; T-lymphoma invasion and metastasis-inducing protein 1; TIAM-1,,7074,TIAM Rac1 associated GEF 1,T-cell lymphoma invasion and metastasis 1,,,TIAM Rac1 associated GEF 1,NEDLDS; TIAM-1,TIAM1
Q13017,RHG05_HUMAN,ARHGAP5; RHOGAP5,Rho GTPase-activating protein 5; Rho-type GTPase-activating protein 5; p190-B,RHOGAP5,394,Rho GTPase activating protein 5,growth factor independent 2,,RhoGAP5; p190-B; p190BRhoGAP,Rho GTPase activating protein 5,GFI2; RhoGAP5; p190-B; p190BRhoGAP,ARHGAP5
Q13042,CDC16_HUMAN,CDC16; ANAPC6,Cell division cycle protein 16 homolog; Anaphase-promoting complex subunit 6; APC6; CDC16 homolog; CDC16Hs; Cyclosome subunit 6,ANAPC6,8881,cell division cycle 16,CDC16 (cell division cycle 16; S. cerevisiae; homolog); CDC16 cell division cycle 16 homolog (S. cerevisiae); cell division cycle 16 homolog (S. cerevisiae),anaphase-promoting complex; subunit 6,APC6; ANAPC6; CUT9,cell division cycle 16,ANAPC6; APC6; CDC16Hs; CUT9,CDC16
Q13043,STK4_HUMAN,STK4; KRS2; MST1,Serine/threonine-protein kinase 4; EC 2.7.11.1; Mammalian STE20-like protein kinase 1; MST-1; STE20-like kinase MST1; Serine/threonine-protein kinase Krs-2; MST1/N; MST1/C,KRS2; MST1,6789,serine/threonine kinase 4,,mammalian sterile 20-like 1; yeast Ste20-like; kinase responsive to stress 2; hippo (Drosophila) homolog,MST1; KRS2; YSK3,serine/threonine kinase 4,KRS2; MST1; YSK3,STK4
Q13045,FLII_HUMAN,FLII; FLIL,Protein flightless-1 homolog,FLIL,2314,FLII actin remodeling protein,flightless I (Drosophila) homolog; flightless I homolog (Drosophila); flightless I actin binding protein,,FLI; FLIL; Fli1; MGC39265,FLII actin remodeling protein,CMD2J; FLI; FLIL; Fli1,FLII
Q13085,ACACA_HUMAN,ACACA; ACAC; ACC1; ACCA,Acetyl-CoA carboxylase 1; ACC1; EC 6.4.1.2; Acetyl-Coenzyme A carboxylase alpha; ACC-alpha,ACAC; ACC1; ACCA,31,acetyl-CoA carboxylase alpha,acetyl-Coenzyme A carboxylase alpha,acetyl-CoA carboxylase 1,ACC1; ACC-alpha; ACCA; ACCalpha; ACACalpha; Acac1; hACC1,acetyl-CoA carboxylase alpha,ACAC; ACACAD; ACACalpha; ACC; ACC1; ACCA; ACCalpha; Acac1; hACC1,ACACA
Q13094,LCP2_HUMAN,LCP2,Lymphocyte cytosolic protein 2; SH2 domain-containing leukocyte protein of 76 kDa; SLP-76 tyrosine phosphoprotein; SLP76,,3937,lymphocyte cytosolic protein 2,lymphocyte cytosolic protein 2 (SH2 domain-containing leukocyte protein of 76kD); lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa),76 kDa tyrosine phosphoprotein; SH2 domain-containing leukocyte protein of 76kD,SLP-76,lymphocyte cytosolic protein 2,IMD81; SLP-76; SLP76,LCP2
Q13098,CSN1_HUMAN,GPS1; COPS1; CSN1,COP9 signalosome complex subunit 1; SGN1; Signalosome subunit 1; G protein pathway suppressor 1; GPS-1; JAB1-containing signalosome subunit 1; Protein MFH,COPS1; CSN1,2873,G protein pathway suppressor 1,,COP9 signalosome subunit 1,COPS1; CSN1,G protein pathway suppressor 1,COPS1; CSN1; SGN1,GPS1
Q13107,UBP4_HUMAN,USP4; UNP; UNPH,Ubiquitin carboxyl-terminal hydrolase 4; EC 3.4.19.12; Deubiquitinating enzyme 4; Ubiquitin thioesterase 4; Ubiquitin-specific-processing protease 4; Ubiquitous nuclear protein homolog,UNP; UNPH,7375,ubiquitin specific peptidase 4,ubiquitin specific peptidase 4 (proto-oncogene),,Unph,ubiquitin specific peptidase 4,UNP; Unph,USP4
Q13114,TRAF3_HUMAN,TRAF3; CAP-1; CRAF1; TRAFAMN,TNF receptor-associated factor 3; EC 2.3.2.27; CD40 receptor-associated factor 1; CRAF1; CD40-binding protein; CD40BP; LMP1-associated protein 1; LAP1; RING-type E3 ubiquitin transferase TRAF3,CAP-1; CRAF1; TRAFAMN,7187,TNF receptor associated factor 3,,,CAP-1; CD40bp; CRAF1; LAP1; RNF118,TNF receptor associated factor 3,CAP-1; CAP1; CD40bp; CRAF1; IIAE5; IMD132A; IMD132B; LAP1; RNF118,TRAF3
Q13115,DUS4_HUMAN,DUSP4; MKP2; VH2,Dual specificity protein phosphatase 4; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase hVH2; Mitogen-activated protein kinase phosphatase 2; MAP kinase phosphatase 2; MKP-2,MKP2; VH2,1846,dual specificity phosphatase 4,,VH1 homologous phosphatase 2; MAP kinase phosphatase 2,HVH2; MKP-2; TYP,dual specificity phosphatase 4,HVH2; MKP-2; MKP2; TYP,DUSP4
Q13118,KLF10_HUMAN,KLF10; TIEG; TIEG1,Krueppel-like factor 10; EGR-alpha; Transforming growth factor-beta-inducible early growth response protein 1; TGFB-inducible early growth response protein 1; TIEG-1,TIEG; TIEG1,7071,KLF transcription factor 10,TGFB inducible early growth response; Kruppel like factor 10,early growth response alpha,EGRA; TIEG1,KLF transcription factor 10,EGR-alpha; EGRA; TIEG; TIEG1,KLF10
Q13127,REST_HUMAN,REST; NRSF; XBR,RE1-silencing transcription factor; Neural-restrictive silencer factor; X2 box repressor,NRSF; XBR,5978,RE1 silencing transcription factor,RE1-silencing transcription factor; deafness; autosomal dominant 27,neuron-restrictive silencer factor,NRSF; XBR,RE1 silencing transcription factor,DFNA27; GINGF5; HGF5; NRSF; WT6; XBR,REST
Q13131,AAPK1_HUMAN,PRKAA1; AMPK1,5'-AMP-activated protein kinase catalytic subunit alpha-1; AMPK subunit alpha-1; EC 2.7.11.1; Acetyl-CoA carboxylase kinase; ACACA kinase; Hydroxymethylglutaryl-CoA reductase kinase; HMGCR kinase; EC 2.7.11.31; Tau-protein kinase PRKAA1; EC 2.7.11.26,AMPK1,5562,protein kinase AMP-activated catalytic subunit alpha 1,protein kinase; AMP-activated; alpha 1 catalytic subunit,AMPK; alpha; 1,AMPKa1,protein kinase AMP-activated catalytic subunit alpha 1,AMPK; AMPK alpha 1; AMPKa1,PRKAA1
Q13133,NR1H3_HUMAN,NR1H3; LXRA,Oxysterols receptor LXR-alpha; Liver X receptor alpha; Nuclear receptor subfamily 1 group H member 3,LXRA,10062,nuclear receptor subfamily 1 group H member 3,nuclear receptor subfamily 1; group H; member 3,liver X receptor-alpha,LXR-a; RLD-1; LXRa,nuclear receptor subfamily 1 group H member 3,LXR-a; LXRA; RLD-1,NR1H3
Q13136,LIPA1_HUMAN,PPFIA1; LIP1,Liprin-alpha-1; LAR-interacting protein 1; LIP-1; Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1; PTPRF-interacting protein alpha-1,LIP1,8500,PTPRF interacting protein alpha 1,protein tyrosine phosphatase; receptor type; f polypeptide (PTPRF); interacting protein (liprin); alpha 1,Liprin-alpha1,LIP.1; LIPRIN,PTPRF interacting protein alpha 1,LIP.1; LIP1; LIPRIN,PPFIA1
Q13137,CACO2_HUMAN,CALCOCO2; NDP52,Calcium-binding and coiled-coil domain-containing protein 2; Antigen nuclear dot 52 kDa protein; Nuclear domain 10 protein NDP52; Nuclear domain 10 protein 52; Nuclear dot protein 52,NDP52,10241,calcium binding and coiled-coil domain 2,,,MGC17318; NDP52,calcium binding and coiled-coil domain 2,NDP52,CALCOCO2
Q13148,TADBP_HUMAN,TARDBP; TDP43,TAR DNA-binding protein 43; TDP-43,TDP43,23435,TAR DNA binding protein,,,TDP-43; ALS10,TAR DNA binding protein,ALS10; TDP-43,TARDBP
Q13151,ROA0_HUMAN,HNRNPA0; HNRPA0,Heterogeneous nuclear ribonucleoprotein A0; hnRNP A0,HNRPA0,10949,heterogeneous nuclear ribonucleoprotein A0,,,,heterogeneous nuclear ribonucleoprotein A0,HNRPA0,HNRNPA0
Q13153,PAK1_HUMAN,PAK1,Serine/threonine-protein kinase PAK 1; EC 2.7.11.1; Alpha-PAK; p21-activated kinase 1; PAK-1; p65-PAK,,5058,p21 (RAC1) activated kinase 1,p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related); p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog; yeast); p21 protein (Cdc42/Rac)-activated kinase 1,STE20 homolog; yeast,,p21 (RAC1) activated kinase 1,IDDMSSD; PAKalpha; alpha-PAK; p65-PAK,PAK1
Q13155,AIMP2_HUMAN,AIMP2; JTV1; PRO0992,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2; Multisynthase complex auxiliary component p38; Protein JTV-1,JTV1,7965,aminoacyl tRNA synthetase complex interacting multifunctional protein 2,,multisynthetase complex auxiliary component p38,p38; PRO0992; JTV-1; JTV1,aminoacyl tRNA synthetase complex interacting multifunctional protein 2,HLD17; JTV-1; JTV1; P38,AIMP2
Q13158,FADD_HUMAN,FADD; MORT1; GIG3,FAS-associated death domain protein; FAS-associating death domain-containing protein; Growth-inhibiting gene 3 protein; Mediator of receptor induced toxicity,MORT1,8772,Fas associated via death domain,Fas (TNFRSF6)-associated via death domain,Fas-associating protein with death domain; Fas-associating death domain-containing protein; mediator of receptor-induced toxicity; growth-inhibiting gene 3 protein,MORT1; GIG3,Fas associated via death domain,GIG3; IMD90; MORT1,FADD
Q13163,MP2K5_HUMAN,MAP2K5; MEK5; MKK5; PRKMK5,Dual specificity mitogen-activated protein kinase kinase 5; MAP kinase kinase 5; MAPKK 5; EC 2.7.12.2; MAPK/ERK kinase 5; MEK 5,MEK5; MKK5; PRKMK5,5607,mitogen-activated protein kinase kinase 5,,dual specificity mitogen-activated protein kinase kinase 5; MAPK/ERK kinase 5; MAP kinase kinase 5,MEK5; MAPKK5; HsT17454,mitogen-activated protein kinase kinase 5,HsT17454; MAPKK5; MEK5; PRKMK5,MAP2K5
Q13164,MK07_HUMAN,MAPK7; BMK1; ERK5; PRKM7,Mitogen-activated protein kinase 7; MAP kinase 7; MAPK 7; EC 2.7.11.24; Big MAP kinase 1; BMK-1; Extracellular signal-regulated kinase 5; ERK-5,BMK1; ERK5; PRKM7,5598,mitogen-activated protein kinase 7,,BMK1 kinase; extracellular-signal-regulated kinase 5,BMK1; ERK5,mitogen-activated protein kinase 7,BMK1; ERK4; ERK5; PRKM7,MAPK7
Q13177,PAK2_HUMAN,PAK2,Serine/threonine-protein kinase PAK 2; EC 2.7.11.1; Gamma-PAK; PAK65; S6/H4 kinase; p21-activated kinase 2; PAK-2; p58; p27; p34; C-t-PAK2,,5062,p21 (RAC1) activated kinase 2,p21 (CDKN1A)-activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2,S6/H4 kinase,PAK65; PAKgamma,p21 (RAC1) activated kinase 2,KNO2; PAK65; PAKgamma,PAK2
Q13185,CBX3_HUMAN,CBX3,Chromobox protein homolog 3; HECH; Heterochromatin protein 1 homolog gamma; HP1 gamma; Modifier 2 protein,,11335,chromobox 3,chromobox homolog 3 (Drosophila HP1 gamma); chromobox homolog 3,HP1 gamma homolog (Drosophila),HP1Hs-gamma; HP1gamma,chromobox 3,HECH; HP1-GAMMA; HP1Hs-gamma; HP1gamma,CBX3
Q13188,STK3_HUMAN,STK3; KRS1; MST2,Serine/threonine-protein kinase 3; EC 2.7.11.1; Mammalian STE20-like protein kinase 2; MST-2; STE20-like kinase MST2; Serine/threonine-protein kinase Krs-1; MST2/N; MST2/C,KRS1; MST2,6788,serine/threonine kinase 3,serine/threonine kinase 3 (Ste20; yeast homolog),hippo (Drosophila) homolog,MST2; KRS1,serine/threonine kinase 3,KRS1; MST2,STK3
Q13191,CBLB_HUMAN,CBLB; RNF56; Nbla00127,E3 ubiquitin-protein ligase CBL-B; EC 2.3.2.27; Casitas B-lineage lymphoma proto-oncogene b; RING finger protein 56; RING-type E3 ubiquitin transferase CBL-B; SH3-binding protein CBL-B; Signal transduction protein CBL-B,RNF56,868,Cbl proto-oncogene B,Cas-Br-M (murine) ectropic retroviral transforming sequence b; Cas-Br-M (murine) ecotropic retroviral transforming sequence b; Cbl proto-oncogene B; E3 ubiquitin protein ligase,,RNF56; Cbl-b,Cbl proto-oncogene B,ADMIO3; Cbl-b; Nbla00127; RNF56,CBLB
Q13202,DUS8_HUMAN,DUSP8; C11orf81; VH5,Dual specificity protein phosphatase 8; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase hVH-5,C11orf81; VH5,1850,dual specificity phosphatase 8,chromosome 11 open reading frame 81,serine/threonine specific protein phosphatase; H1 phosphatase; vaccinia virus homolog,HVH-5; HB5; FLJ42958,dual specificity phosphatase 8,C11orf81; HB5; HVH-5; HVH8,DUSP8
Q13224,NMDE2_HUMAN,GRIN2B; NMDAR2B,Glutamate receptor ionotropic; NMDA 2B; GluN2B; Glutamate NMDA receptor subunit epsilon-2; N-methyl D-aspartate receptor subtype 2B; NMDAR2B; NR2B; N-methyl-D-aspartate receptor subunit 3; NR3; hNR3,NMDAR2B,2904,glutamate ionotropic receptor NMDA type subunit 2B,glutamate receptor; ionotropic; N-methyl D-aspartate 2B,,GluN2B; NR2B,glutamate ionotropic receptor NMDA type subunit 2B,DEE27; EIEE27; GluN2B; MRD6; NMDAR2B; NR2B; NR3; hNR3,GRIN2B
Q13233,M3K1_HUMAN,MAP3K1; MAPKKK1; MEKK; MEKK1,Mitogen-activated protein kinase kinase kinase 1; EC 2.7.11.25; MAPK/ERK kinase kinase 1; MEK kinase 1; MEKK 1; EC 2.3.2.27,MAPKKK1; MEKK; MEKK1,4214,mitogen-activated protein kinase kinase kinase 1,MEKK1,,MEKK; MAPKKK1,mitogen-activated protein kinase kinase kinase 1,MAPKKK1; MEKK; MEKK 1; MEKK1; SRXY6,MAP3K1
Q13237,KGP2_HUMAN,PRKG2; PRKGR2,cGMP-dependent protein kinase 2; cGK 2; cGK2; EC 2.7.11.12; cGMP-dependent protein kinase II; cGKII,PRKGR2,5593,protein kinase cGMP-dependent 2,protein kinase; cGMP-dependent; type II,,cGKII; PRKGR2; PKG2,protein kinase cGMP-dependent 2,AMD4; PKG2; PRKGR2; SMDP; cGK2; cGKII,PRKG2
Q13242,SRSF9_HUMAN,SRSF9; SFRS9; SRP30C,Serine/arginine-rich splicing factor 9; Pre-mRNA-splicing factor SRp30C; Splicing factor; arginine/serine-rich 9,SFRS9; SRP30C,8683,serine and arginine rich splicing factor 9,splicing factor; arginine/serine-rich 9; serine/arginine-rich splicing factor 9,SR splicing factor 9,SRp30c,serine and arginine rich splicing factor 9,SFRS9; SRp30c,SRSF9
Q13243,SRSF5_HUMAN,SRSF5; HRS; SFRS5; SRP40,Serine/arginine-rich splicing factor 5; Delayed-early protein HRS; Pre-mRNA-splicing factor SRP40; Splicing factor; arginine/serine-rich 5,HRS; SFRS5; SRP40,6430,serine and arginine rich splicing factor 5,splicing factor; arginine/serine-rich 5; serine/arginine-rich splicing factor 5,SR splicing factor 5,SRP40; HRS,serine and arginine rich splicing factor 5,HRS; SFRS5; SRP40,SRSF5
Q13247,SRSF6_HUMAN,SRSF6; SFRS6; SRP55,Serine/arginine-rich splicing factor 6; Pre-mRNA-splicing factor SRP55; Splicing factor; arginine/serine-rich 6,SFRS6; SRP55,6431,serine and arginine rich splicing factor 6,splicing factor; arginine/serine-rich 6; serine/arginine-rich splicing factor 6,pre-mRNA splicing factor SRP55; SR splicing factor 6,SRP55; B52,serine and arginine rich splicing factor 6,B52; HEL-S-91; SFRS6; SRP55,SRSF6
Q13255,GRM1_HUMAN,GRM1; GPRC1A; MGLUR1,Metabotropic glutamate receptor 1; mGluR1,GPRC1A; MGLUR1,2911,glutamate metabotropic receptor 1,glutamate receptor; metabotropic 1,protein phosphatase 1; regulatory subunit 85,GPRC1A; mGlu1; MGLUR1; PPP1R85,glutamate metabotropic receptor 1,GPRC1A; MGLU1; MGLUR1; PPP1R85; SCA44; SCAR13,GRM1
Q13257,MD2L1_HUMAN,MAD2L1; MAD2,Mitotic spindle assembly checkpoint protein MAD2A; HsMAD2; Mitotic arrest deficient 2-like protein 1; MAD2-like protein 1,MAD2,4085,mitotic arrest deficient 2 like 1,MAD2 (mitotic arrest deficient; yeast; homolog)-like 1,,MAD2; HSMAD2,mitotic arrest deficient 2 like 1,HSMAD2; MAD2,MAD2L1
Q13263,TIF1B_HUMAN,TRIM28; KAP1; RNF96; TIF1B,Transcription intermediary factor 1-beta; TIF1-beta; E3 SUMO-protein ligase TRIM28; EC 2.3.2.27; KRAB-associated protein 1; KAP-1; KRAB-interacting protein 1; KRIP-1; Nuclear corepressor KAP-1; RING finger protein 96; RING-type E3 ubiquitin transferase TIF1-beta; Tripartite motif-containing protein 28,KAP1; RNF96; TIF1B,10155,tripartite motif containing 28,tripartite motif-containing 28,protein phosphatase 1; regulatory subunit 157; Transcription intermediary factor 1-beta; RING finger protein 96; KRAB-associated protein 1,TIF1B; KAP1; TF1B; RNF96; PPP1R157; KAP-1; TIF1-beta; TIF1beta,tripartite motif containing 28,KAP1; PPP1R157; RNF96; TF1B; TIF1B; TIF1beta,TRIM28
Q13283,G3BP1_HUMAN,G3BP1; G3BP,Ras GTPase-activating protein-binding protein 1; G3BP-1; EC 3.6.4.12; EC 3.6.4.13; ATP-dependent DNA helicase VIII; hDH VIII; GAP SH3 domain-binding protein 1,G3BP,10146,G3BP stress granule assembly factor 1,GTPase activating protein (SH3 domain) binding protein 1,Ras-GTPase-activating protein SH3-domain-binding protein; DNA helicase VIII,HDH-VIII; G3BP,G3BP stress granule assembly factor 1,G3BP; HDH-VIII,G3BP1
Q13285,STF1_HUMAN,NR5A1; AD4BP; FTZF1; SF1,Steroidogenic factor 1; SF-1; STF-1; hSF-1; Adrenal 4-binding protein; Fushi tarazu factor homolog 1; Nuclear receptor subfamily 5 group A member 1; Steroid hormone receptor Ad4BP,AD4BP; FTZF1; SF1,2516,nuclear receptor subfamily 5 group A member 1,nuclear receptor subfamily 5; group A; member 1,steroidogenic factor 1,FTZ1; SF-1; ELP; AD4BP; hSF-1; SF1,nuclear receptor subfamily 5 group A member 1,AD4BP; ELP; FTZ1; FTZF1; POF7; SF-1; SF1; SPGF8; SRXX4; SRXY3; hSF-1,NR5A1
Q13291,SLAF1_HUMAN,SLAMF1; SLAM,Signaling lymphocytic activation molecule; CDw150; IPO-3; SLAM family member 1; CD antigen CD150,SLAM,6504,signaling lymphocytic activation molecule family member 1,signaling lymphocytic activation molecule,,CD150; IPO-3; IPO3,signaling lymphocytic activation molecule family member 1,CD150; CDw150; SLAM,SLAMF1
Q13303,KCAB2_HUMAN,KCNAB2; KCNA2B; KCNK2,Voltage-gated potassium channel subunit beta-2; EC 1.1.1.-; K(+; Kv-beta-2; hKvbeta2,KCNA2B; KCNK2,8514,potassium voltage-gated channel subfamily A regulatory beta subunit 2,potassium voltage-gated channel; shaker-related subfamily; beta member 2; potassium channel; voltage gated subfamily A regulatory beta subunit 2,,AKR6A5; KCNA2B; HKvbeta2.1; HKvbeta2.2,potassium voltage-gated channel subfamily A regulatory beta subunit 2,AKR6A5; HKvbeta2; HKvbeta2.1; HKvbeta2.2; KCNA2B; KV-BETA-2,KCNAB2
Q13309,SKP2_HUMAN,SKP2; FBXL1,S-phase kinase-associated protein 2; Cyclin-A/CDK2-associated protein p45; F-box protein Skp2; F-box/LRR-repeat protein 1; p45skp2,FBXL1,6502,S-phase kinase associated protein 2,S-phase kinase-associated protein 2 (p45); S-phase kinase-associated protein 2; E3 ubiquitin protein ligase,,FBXL1; FBL1; p45,S-phase kinase associated protein 2,FBL1; FBXL1; FLB1; p45,SKP2
Q13315,ATM_HUMAN,ATM,Serine-protein kinase ATM; EC 2.7.11.1; Ataxia telangiectasia mutated; A-T mutated,,472,ATM serine/threonine kinase,ataxia telangiectasia mutated (includes complementation groups A; C and D); ataxia telangiectasia mutated,TEL1; telomere maintenance 1; homolog (S. cerevisiae),TEL1; TELO1,ATM serine/threonine kinase,AT1; ATA; ATC; ATD; ATDC; ATE; TEL1; TELO1,ATM
Q13322,GRB10_HUMAN,GRB10; GRBIR; KIAA0207,Growth factor receptor-bound protein 10; GRB10 adapter protein; Insulin receptor-binding protein Grb-IR,GRBIR; KIAA0207,2887,growth factor receptor bound protein 10,growth factor receptor-bound protein 10,,,growth factor receptor bound protein 10,GRB-IR; Grb-10; IRBP; MEG1; RSS,GRB10
Q13323,BIK_HUMAN,BIK; NBK,Bcl-2-interacting killer; Apoptosis inducer NBK; BIP1; BP4,NBK,638,BCL2 interacting killer,BCL2-interacting killer (apoptosis-inducing),natural born killer,NBK,BCL2 interacting killer,BIP1; BP4; NBK,BIK
Q13330,MTA1_HUMAN,MTA1,Metastasis-associated protein MTA1,,9112,metastasis associated 1,,,,metastasis associated 1,,MTA1
Q13332,PTPRS_HUMAN,PTPRS,Receptor-type tyrosine-protein phosphatase S; R-PTP-S; EC 3.1.3.48; Receptor-type tyrosine-protein phosphatase sigma; R-PTP-sigma,,5802,protein tyrosine phosphatase receptor type S,,,PTPsigma; PTP-sigma,protein tyrosine phosphatase receptor type S,PTP-sigma; PTPSIGMA; R-PTP-S; R-PTP-sigma,PTPRS
Q13352,CENPR_HUMAN,ITGB3BP; CENPR; NRIF3,Centromere protein R; CENP-R; Beta-3-endonexin; Integrin beta-3-binding protein; Nuclear receptor-interacting factor 3,CENPR; NRIF3,23421,integrin subunit beta 3 binding protein,integrin beta 3 binding protein (beta3-endonexin),centromere protein R; beta3-endonexin,NRIF3; HSU37139; TAP20; CENPR,integrin subunit beta 3 binding protein,CENP-R; CENPR; HSU37139; NRIF3; TAP20,ITGB3BP
Q13362,2A5G_HUMAN,PPP2R5C; KIAA0044,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform; PP2A B subunit isoform B'-gamma; PP2A B subunit isoform B56-gamma; PP2A B subunit isoform PR61-gamma; PP2A B subunit isoform R5-gamma; Renal carcinoma antigen NY-REN-29,KIAA0044,5527,protein phosphatase 2 regulatory subunit B'gamma,protein phosphatase 2; regulatory subunit B (B56); gamma isoform,,B56G; PR61G; B56gamma,protein phosphatase 2 regulatory subunit B'gamma,B56G; B56gamma; PR61G,PPP2R5C
Q13363,CTBP1_HUMAN,CTBP1; CTBP,C-terminal-binding protein 1; CtBP1; EC 1.1.1.-,CTBP,1487,C-terminal binding protein 1,,brefeldin A-ribosylated substrate,BARS,C-terminal binding protein 1,BARS; HADDTS,CTBP1
Q13370,PDE3B_HUMAN,PDE3B,cGMP-inhibited 3';5'-cyclic phosphodiesterase 3B; EC 3.1.4.17; CGIPDE1; CGIP1; Cyclic GMP-inhibited phosphodiesterase B; CGI-PDE B,,5140,phosphodiesterase 3B,phosphodiesterase 3B; cGMP-inhibited,,HcGIP1,phosphodiesterase 3B,HcGIP1; cGIPDE1,PDE3B
Q13371,PHLP_HUMAN,PDCL; PHLOP1; PhLP1,Phosducin-like protein; PHLP,PHLOP1; PhLP1,5082,phosducin like,,,PhLP; DKFZp564M1863,phosducin like,PhLP,PDCL
Q13393,PLD1_HUMAN,PLD1,Phospholipase D1; PLD 1; hPLD1; EC 3.1.4.4; Choline phosphatase 1; Phosphatidylcholine-hydrolyzing phospholipase D1,,5337,phospholipase D1,phospholipase D1; phosphatidylcholine-specific,choline phosphatase 1,,phospholipase D1,CVDD; CVDP1,PLD1
Q13415,ORC1_HUMAN,ORC1; ORC1L; PARC1,Origin recognition complex subunit 1; Replication control protein 1,ORC1L; PARC1,4998,origin recognition complex subunit 1,origin recognition complex; subunit 1 (yeast homolog)-like; origin recognition complex; subunit 1-like (yeast); origin recognition complex; subunit 1 homolog (S. cerevisiae); origin recognition complex; subunit 1,origin recognition complex; subunit 1; S. cerevisiae; homolog-like; origin recognition complex 1; replication control protein 1,HSORC1; PARC1,origin recognition complex subunit 1,HSORC1; ORC1L; PARC1,ORC1
Q13416,ORC2_HUMAN,ORC2; ORC2L,Origin recognition complex subunit 2,ORC2L,4999,origin recognition complex subunit 2,origin recognition complex; subunit 2 (yeast homolog)-like; origin recognition complex; subunit 2-like (yeast); origin recognition complex; subunit 2 homolog (yeast); origin recognition complex; subunit 2,,,origin recognition complex subunit 2,ORC2L,ORC2
Q13418,ILK_HUMAN,ILK; ILK1; ILK2,Scaffold protein ILK; ILK-1; ILK-2; Inactive integrin-linked kinase; p59ILK,ILK1; ILK2,3611,integrin linked kinase,integrin-linked kinase,,,integrin linked kinase,HEL-S-28; ILK-1; ILK-2; P59; p59ILK,ILK
Q13422,IKZF1_HUMAN,IKZF1; IK1; IKAROS; LYF1; ZNFN1A1,DNA-binding protein Ikaros; Ikaros family zinc finger protein 1; Lymphoid transcription factor LyF-1,IK1; IKAROS; LYF1; ZNFN1A1,10320,IKAROS family zinc finger 1,zinc finger protein; subfamily 1A; 1 (Ikaros); IKAROS family zinc finger 1 (Ikaros),protein phosphatase 1; regulatory subunit 92,hIk-1; LyF-1; Hs.54452; IKAROS; PPP1R92,IKAROS family zinc finger 1,CVID13; Hs.54452; IK1; IKAROS; LYF1; LyF-1; PPP1R92; PRO0758; ZNFN1A1,IKZF1
Q13426,XRCC4_HUMAN,XRCC4,DNA repair protein XRCC4; hXRCC4; X-ray repair cross-complementing protein 4; XRCC4/C,,7518,X-ray repair cross complementing 4,X-ray repair complementing defective repair in Chinese hamster cells 4,X-ray repair; complementing defective; repair in Chinese hamster; DNA repair protein XRCC4,hXRCC4,X-ray repair cross complementing 4,SSMED; hXRCC4,XRCC4
Q13428,TCOF_HUMAN,TCOF1,Treacle protein; Treacher Collins syndrome protein,,6949,treacle ribosome biogenesis factor 1,Treacher Collins-Franceschetti syndrome 1,,treacle; TCS,treacle ribosome biogenesis factor 1,MFD1; TCS; TCS1; treacle,TCOF1
Q13435,SF3B2_HUMAN,SF3B2; SAP145,Splicing factor 3B subunit 2; Pre-mRNA-splicing factor SF3b 145 kDa subunit; SF3b145; Spliceosome-associated protein 145; SAP 145,SAP145,10992,splicing factor 3b subunit 2,splicing factor 3b; subunit 2; 145kD; splicing factor 3b; subunit 2; 145kDa,,SAP145; SF3b1; Cus1; SF3b145,splicing factor 3b subunit 2,CFM; Cus1; HFM; SAP145; SF3B145; SF3b1; SF3b150,SF3B2
Q13439,GOGA4_HUMAN,GOLGA4,Golgin subfamily A member 4; 256 kDa golgin; Golgin-245; Protein 72.1; Trans-Golgi p230,,2803,golgin A4,golgi autoantigen; golgin subfamily a; 4,golgin 245,GOLG; GCP2; p230; golgin-240,golgin A4,CRPF46; GCP2; GOLG; MU-RMS-40.18; p230,GOLGA4
Q13444,ADA15_HUMAN,ADAM15; MDC15,Disintegrin and metalloproteinase domain-containing protein 15; ADAM 15; EC 3.4.24.-; Metalloprotease RGD disintegrin protein; Metalloproteinase-like; disintegrin-like; and cysteine-rich protein 15; MDC-15; Metargidin,MDC15,8751,ADAM metallopeptidase domain 15,a disintegrin and metalloproteinase domain 15 (metargidin),metargidin,MDC15,ADAM metallopeptidase domain 15,MDC15,ADAM15
Q13464,ROCK1_HUMAN,ROCK1,Rho-associated protein kinase 1; EC 2.7.11.1; Renal carcinoma antigen NY-REN-35; Rho-associated; coiled-coil-containing protein kinase 1; Rho-associated; coiled-coil-containing protein kinase I; ROCK-I; p160 ROCK-1; p160ROCK,,6093,Rho associated coiled-coil containing protein kinase 1,,,p160ROCK,Rho associated coiled-coil containing protein kinase 1,P160ROCK; ROCK-I,ROCK1
Q13467,FZD5_HUMAN,FZD5; C2orf31,Frizzled-5; Fz-5; hFz5; FzE5,C2orf31,7855,frizzled class receptor 5,frizzled (Drosophila) homolog 5; chromosome 2 open reading frame 31; frizzled homolog 5 (Drosophila); frizzled 5; seven transmembrane spanning receptor; frizzled family receptor 5,,HFZ5; DKFZP434E2135,frizzled class receptor 5,C2orf31; HFZ5; MCOPCB11,FZD5
Q13469,NFAC2_HUMAN,NFATC2; NFAT1; NFATP,Nuclear factor of activated T-cells; cytoplasmic 2; NF-ATc2; NFATc2; NFAT pre-existing subunit; NF-ATp; T-cell transcription factor NFAT1,NFAT1; NFATP,4773,nuclear factor of activated T cells 2,nuclear factor of activated T-cells; cytoplasmic; calcineurin-dependent 2; nuclear factor of activated T-cells 2,,NF-ATP; NFATp; NFAT1,nuclear factor of activated T cells 2,JCOSL; NFAT1; NFATP,NFATC2
Q13470,TNK1_HUMAN,TNK1,Non-receptor tyrosine-protein kinase TNK1; EC 2.7.10.2; CD38 negative kinase 1,,8711,tyrosine kinase non receptor 1,tyrosine kinase; non-receptor; 1,,KOS1,tyrosine kinase non receptor 1,KOS1,TNK1
Q13480,GAB1_HUMAN,GAB1,GRB2-associated-binding protein 1; GRB2-associated binder 1; Growth factor receptor bound protein 2-associated protein 1,,2549,GRB2 associated binding protein 1,deafness; autosomal recessive 26,,,GRB2 associated binding protein 1,DFNB26,GAB1
Q13485,SMAD4_HUMAN,SMAD4; DPC4; MADH4,Mothers against decapentaplegic homolog 4; MAD homolog 4; Mothers against DPP homolog 4; Deletion target in pancreatic carcinoma 4; SMAD family member 4; SMAD 4; Smad4; hSMAD4,DPC4; MADH4,4089,SMAD family member 4,MAD; mothers against decapentaplegic homolog 4 (Drosophila); SMAD; mothers against DPP homolog 4 (Drosophila),,DPC4,SMAD family member 4,DPC4; JIP; MADH4; MYHRS,SMAD4
Q13501,SQSTM_HUMAN,SQSTM1; ORCA; OSIL,Sequestosome-1; EBI3-associated protein of 60 kDa; EBIAP; p60; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa; Ubiquitin-binding protein p62; p62,ORCA; OSIL,8878,sequestosome 1,Paget disease of bone 3; oxidative stress induced like,autophagy receptor p62,p62; p60; p62B; A170,sequestosome 1,A170; DMRV; EBIAP; FTDALS3; NADGP; OSIL; PDB3; ZIP3; p60; p62; p62B,SQSTM1
Q13507,TRPC3_HUMAN,TRPC3; TRP3,Short transient receptor potential channel 3; TrpC3; Transient receptor protein 3; TRP-3; hTrp-3; hTrp3,TRP3,7222,transient receptor potential cation channel subfamily C member 3,transient receptor potential cation channel; subfamily C; member 3,,,transient receptor potential cation channel subfamily C member 3,SCA41; TRP3,TRPC3
Q13509,TBB3_HUMAN,TUBB3; TUBB4,Tubulin beta-3 chain; Tubulin beta-4 chain; Tubulin beta-III,TUBB4,10381,tubulin beta 3 class III,tubulin; beta 3; fibrosis of extraocular muscles; congenital; 3,class III beta-tubulin,beta-4; CFEOM3; CFEOM3A,tubulin beta 3 class III,CDCBM; CDCBM1; CFEOM3; CFEOM3A; FEOM3; TUBB4; beta-4,TUBB3
Q13522,PPR1A_HUMAN,PPP1R1A; IPP1,Protein phosphatase 1 regulatory subunit 1A; Protein phosphatase inhibitor 1; I-1; IPP-1,IPP1,5502,protein phosphatase 1 regulatory inhibitor subunit 1A,protein phosphatase 1; regulatory (inhibitor) subunit 1A,,,protein phosphatase 1 regulatory inhibitor subunit 1A,I1; IPP1,PPP1R1A
Q13523,PRP4K_HUMAN,PRP4K; KIAA0536; PRP4; PRP4B; PRP4H; PRPF4K,Serine/threonine-protein kinase PRP4 homolog; EC 2.7.11.1; PRP4 kinase; PRP4 pre-mRNA-processing factor 4 homolog,KIAA0536; PRP4; PRP4B; PRP4H; PRPF4K,8899,pre-mRNA processing factor kinase PRP4K,PRP4 pre-mRNA processing factor 4 homolog B (yeast); pre-mRNA processing factor 4B,,Prp4; PR4H; KIAA0536; Prp4B,pre-mRNA processing factor kinase PRP4K,PR4H; PRP4; PRP4H; PRPF4B; Prp4B; dJ1013A10.1,PRP4K
Q13526,PIN1_HUMAN,PIN1,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; EC 5.2.1.8; Peptidyl-prolyl cis-trans isomerase Pin1; PPIase Pin1; Rotamase Pin1,,5300,peptidylprolyl cis/trans isomerase; NIMA-interacting 1,protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1,protein interacting with never in mitosis A1; parvulin PIN1,dod,peptidylprolyl cis/trans isomerase; NIMA-interacting 1,DOD; UBL5,PIN1
Q13535,ATR_HUMAN,ATR; FRP1,Serine/threonine-protein kinase ATR; EC 2.7.11.1; Ataxia telangiectasia and Rad3-related protein; FRAP-related protein 1,FRP1,545,ATR serine/threonine kinase,ataxia telangiectasia and Rad3 related,MEC1; mitosis entry checkpoint 1; homolog (S. cerevisiae),FRP1; SCKL; SCKL1; MEC1,ATR serine/threonine kinase,FCTCS; FRP1; MEC1; SCKL; SCKL1,ATR
Q13541,4EBP1_HUMAN,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1; 4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein regulated by insulin 1; PHAS-I,,1978,eukaryotic translation initiation factor 4E binding protein 1,,phosphorylated heat- and acid-stable protein regulated by insulin 1,PHAS-I; 4E-BP1,eukaryotic translation initiation factor 4E binding protein 1,4E-BP1; 4EBP1; BP-1; PHAS-I,EIF4EBP1
Q13546,RIPK1_HUMAN,RIPK1; RIP; RIP1,Receptor-interacting serine/threonine-protein kinase 1; EC 2.7.11.1; Cell death protein RIP; Receptor-interacting protein 1; RIP-1,RIP; RIP1,8737,receptor interacting serine/threonine kinase 1,receptor (TNFRSF)-interacting serine-threonine kinase 1,receptor-interacting protein kinase 1,RIP; RIP1; RIP-1,receptor interacting serine/threonine kinase 1,AIEFL; IMD57; RIP; RIP-1; RIP1,RIPK1
Q13547,HDAC1_HUMAN,HDAC1; RPD3L1,Histone deacetylase 1; HD1; EC 3.5.1.98; Protein deacetylase HDAC1; EC 3.5.1.-; Protein deacylase HDAC1; EC 3.5.1.-,RPD3L1,3065,histone deacetylase 1,,,HD1; GON-10; KDAC1,histone deacetylase 1,GON-10; HD1; KDAC1; RPD3; RPD3L1,HDAC1
Q13554,KCC2B_HUMAN,CAMK2B; CAM2; CAMK2; CAMKB,Calcium/calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; EC 2.7.11.17,CAM2; CAMK2; CAMKB,816,calcium/calmodulin dependent protein kinase II beta,calcium/calmodulin-dependent protein kinase (CaM kinase) II beta,CaM-kinase II beta chain; calcium/calmodulin-dependent protein kinase type II beta chain; CaM kinase II beta subunit; proline rich calmodulin-dependent protein kinase,CAM2; CAMK2; CaMKII??,calcium/calmodulin dependent protein kinase II beta,CAM2; CAMK2; CAMKB; CaMKIIbeta; MRD54,CAMK2B
Q13555,KCC2G_HUMAN,CAMK2G; CAMK; CAMK-II; CAMKG,Calcium/calmodulin-dependent protein kinase type II subunit gamma; CaM kinase II subunit gamma; CaMK-II subunit gamma; EC 2.7.11.17,CAMK; CAMK-II; CAMKG,818,calcium/calmodulin dependent protein kinase II gamma,calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma,,,calcium/calmodulin dependent protein kinase II gamma,CAMK; CAMK-II; CAMKG; MRD59,CAMK2G
Q13557,KCC2D_HUMAN,CAMK2D; CAMKD,Calcium/calmodulin-dependent protein kinase type II subunit delta; CaM kinase II subunit delta; CaMK-II subunit delta; EC 2.7.11.17,CAMKD,817,calcium/calmodulin dependent protein kinase II delta,calcium/calmodulin-dependent protein kinase (CaM kinase) II delta,,,calcium/calmodulin dependent protein kinase II delta,CAMKD,CAMK2D
Q13563,PKD2_HUMAN,PKD2; TRPP1; TRPP2,Polycystin-2; PC2; Autosomal dominant polycystic kidney disease type II protein; Polycystic kidney disease 2 protein; Polycystwin; R48321; Transient receptor potential cation channel subfamily P member 2,TRPP1; TRPP2,5311,polycystin 2; transient receptor potential cation channel,polycystic kidney disease 2 (autosomal dominant),transient receptor potential cation channel; subfamily P; member 2,PKD4; PC2; Pc-2; TRPP2,polycystin 2; transient receptor potential cation channel,APKD2; PC2; PKD4; Pc-2; TRPP2,PKD2
Q13568,IRF5_HUMAN,IRF5,Interferon regulatory factor 5; IRF-5,,3663,interferon regulatory factor 5,,,IRF-5,interferon regulatory factor 5,SLEB10,IRF5
Q13573,SNW1_HUMAN,SNW1; SKIIP; SKIP,SNW domain-containing protein 1; Nuclear protein SkiP; Nuclear receptor coactivator NCoA-62; Ski-interacting protein,SKIIP; SKIP,22938,SNW domain containing 1,SKI interacting protein,,NCoA-62; SKIP; Prp45; PRPF45; Bx42; SKIP1; FUN20,SNW domain containing 1,Bx42; FUN20; NCOA-62; PRPF45; Prp45; SKIIP; SKIP; SKIP1,SNW1
Q13576,IQGA2_HUMAN,IQGAP2,Ras GTPase-activating-like protein IQGAP2,,10788,IQ motif containing GTPase activating protein 2,,,,IQ motif containing GTPase activating protein 2,,IQGAP2
Q13586,STIM1_HUMAN,STIM1; GOK,Stromal interaction molecule 1,GOK,6786,stromal interaction molecule 1,,,GOK; D11S4896E,stromal interaction molecule 1,D11S4896E; GOK; IMD10; STRMK; TAM; TAM1,STIM1
Q13614,MTMR2_HUMAN,MTMR2; KIAA1073,Phosphatidylinositol-3;5-bisphosphate 3-phosphatase MTMR2; EC 3.1.3.95; Myotubularin-related protein 2; Phosphatidylinositol-3-phosphate phosphatase,KIAA1073,8898,myotubularin related protein 2,,phosphatidylinositol-3-phosphatase; phosphoinositide-3-phosphatase,KIAA1073,myotubularin related protein 2,CMT4B; CMT4B1,MTMR2
Q13621,S12A1_HUMAN,SLC12A1; NKCC2,Solute carrier family 12 member 1; Bumetanide-sensitive sodium-(potassium; BSC1; Kidney-specific Na-K-Cl symporter; Na-K-2Cl cotransporter 2; NKCC2,NKCC2,6557,solute carrier family 12 member 1,solute carrier family 12 (sodium/potassium/chloride transporter); member 1,Na-K-2Cl cotransporter 2; bumetanide-sensitive cotransporter type 1; Kidney-specific Na-K-Cl symporter,NKCC2; CCC2; BSC1; BSC; BSC-1,solute carrier family 12 member 1,BSC; BSC-1; BSC1; CCC2; NKCC2,SLC12A1
Q13625,ASPP2_HUMAN,TP53BP2; ASPP2; BBP,Apoptosis-stimulating of p53 protein 2; Bcl2-binding protein; Bbp; Renal carcinoma antigen NY-REN-51; Tumor suppressor p53-binding protein 2; 53BP2; p53-binding protein 2; p53BP2,ASPP2; BBP,7159,tumor protein p53 binding protein 2,tumor protein p53-binding protein; 2,,PPP1R13A; ASPP2; 53BP2,tumor protein p53 binding protein 2,53BP2; ASPP2; BBP; P53BP2; PPP1R13A,TP53BP2
Q13627,DYR1A_HUMAN,DYRK1A; DYRK; MNB; MNBH,Dual specificity tyrosine-phosphorylation-regulated kinase 1A; EC 2.7.11.23; EC 2.7.12.1; Dual specificity YAK1-related kinase; HP86; Protein kinase minibrain homolog; MNBH; hMNB,DYRK; MNB; MNBH,1859,dual specificity tyrosine phosphorylation regulated kinase 1A,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,,,dual specificity tyrosine phosphorylation regulated kinase 1A,DYRK; DYRK1; HP86; MNB; MNBH; MRD7,DYRK1A
Q13642,FHL1_HUMAN,FHL1; SLIM1,Four and a half LIM domains protein 1; FHL-1; Skeletal muscle LIM-protein 1; SLIM; SLIM-1,SLIM1,2273,four and a half LIM domains 1,,Four-and-a-half LIM domains 1; LIM protein SLIMMER,SLIM1; KYO-T; bA535K18.1; FHL1B; XMPMA; FLH1A; MGC111107,four and a half LIM domains 1,FCMSU; FHL-1; FHL1A; FHL1B; FLH1A; KYOT; RBMX1A; RBMX1B; SLIM; SLIM-1; SLIM1; SLIMMER; XMPMA,FHL1
Q13651,I10R1_HUMAN,IL10RA; IL10R,Interleukin-10 receptor subunit alpha; IL-10 receptor subunit alpha; IL-10R subunit alpha; IL-10RA; CDw210a; Interleukin-10 receptor subunit 1; IL-10R subunit 1; IL-10R1; CD antigen CD210,IL10R,3587,interleukin 10 receptor subunit alpha,interleukin 10 receptor; alpha,,HIL-10R; CDW210A; CD210a; CD210,interleukin 10 receptor subunit alpha,CD210; CD210a; CDW210A; HIL-10R; IL-10R1; IL10R,IL10RA
Q13671,RIN1_HUMAN,RIN1,Ras and Rab interactor 1; Ras inhibitor JC99; Ras interaction/interference protein 1,,9610,Ras and Rab interactor 1,,,,Ras and Rab interactor 1,,RIN1
Q13698,CAC1S_HUMAN,CACNA1S; CACH1; CACN1; CACNL1A3,Voltage-dependent L-type calcium channel subunit alpha-1S; Calcium channel; L type; alpha-1 polypeptide; isoform 3; skeletal muscle; Voltage-gated calcium channel subunit alpha Cav1.1,CACH1; CACN1; CACNL1A3,779,calcium voltage-gated channel subunit alpha1 S,calcium channel; voltage-dependent; L type; alpha 1S subunit,,Cav1.1; hypoPP,calcium voltage-gated channel subunit alpha1 S,CACNL1A3; CCHL1A3; CMYO18; CMYP18; Cav1.1; DHPRM; HOKPP; HOKPP1; MHS5; TTPP1; hypoPP,CACNA1S
Q13733,AT1A4_HUMAN,ATP1A4; ATP1AL2,Sodium/potassium-transporting ATPase subunit alpha-4; Na(+; +; EC 7.2.2.13; Sodium pump subunit alpha-4,ATP1AL2,480,ATPase Na+/K+ transporting subunit alpha 4,ATPase; Na+/K+ transporting; alpha polypeptide-like 2; ATPase; Na+/K+ transporting; alpha 4 polypeptide,sodium/potassium-transporting ATPase subunit alpha-4; sodium pump subunit alpha-4; sodium-potassium ATPase catalytic subunit alpha-4,,ATPase Na+/K+ transporting subunit alpha 4,ATP1A1; ATP1AL2,ATP1A4
Q13761,RUNX3_HUMAN,RUNX3; AML2; CBFA3; PEBP2A3,Runt-related transcription factor 3; Acute myeloid leukemia 2 protein; Core-binding factor subunit alpha-3; CBF-alpha-3; Oncogene AML-2; Polyomavirus enhancer-binding protein 2 alpha C subunit; PEA2-alpha C; PEBP2-alpha C; SL3-3 enhancer factor 1 alpha C subunit; SL3/AKV core-binding factor alpha C subunit,AML2; CBFA3; PEBP2A3,864,RUNX family transcription factor 3,runt-related transcription factor 3; runt related transcription factor 3,,AML2; PEBP2A3,RUNX family transcription factor 3,AML2; CBFA3; PEBP2aC,RUNX3
Q13765,NACA_HUMAN,NACA; HSD48,Nascent polypeptide-associated complex subunit alpha; NAC-alpha; Alpha-NAC; allergen Hom s 2,,4666,nascent polypeptide associated complex subunit alpha,nascent-polypeptide-associated complex alpha polypeptide,,NACA1; Alpha-NAC,nascent polypeptide associated complex subunit alpha,HSD48; NAC-alpha; NACA1; skNAC,NACA
Q13769,THOC5_HUMAN,THOC5; C22orf19; KIAA0983,THO complex subunit 5; Functional spliceosome-associated protein 79; fSAP79; NF2/meningioma region protein pK1.3; Placental protein 39.2; PP39.2; hTREX90,C22orf19; KIAA0983,8563,THO complex subunit 5,chromosome 22 open reading frame 19; THO complex 5,functional spliceosome-associated protein 79,PK1.3; KIAA0983; Fmip; fSAP79,THO complex subunit 5,C22orf19; Fmip; PK1.3; fSAP79,THOC5
Q13794,APR_HUMAN,PMAIP1; NOXA,Phorbol-12-myristate-13-acetate-induced protein 1; PMA-induced protein 1; Immediate-early-response protein APR; Protein Noxa,NOXA,5366,phorbol-12-myristate-13-acetate-induced protein 1,,,APR; NOXA,phorbol-12-myristate-13-acetate-induced protein 1,APR; NOXA,PMAIP1
Q13813,SPTN1_HUMAN,SPTAN1; NEAS; SPTA2,Spectrin alpha chain; non-erythrocytic 1; Alpha-II spectrin; Fodrin alpha chain; Spectrin; non-erythroid alpha subunit,NEAS; SPTA2,6709,spectrin alpha; non-erythrocytic 1,,alpha-fodrin,,spectrin alpha; non-erythrocytic 1,DEE5; DEVEP; EIEE5; HMN11; HMND11; NEAS; SPG91; SPTA2,SPTAN1
Q13829,BACD2_HUMAN,TNFAIP1; BACURD2; EDP1,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2; hBACURD2; BTB/POZ domain-containing protein TNFAIP1; Protein B12; Tumor necrosis factor; alpha-induced protein 1; endothelial,BACURD2; EDP1,7126,TNF alpha induced protein 1,tumor necrosis factor; alpha-induced protein 1 (endothelial),,B61; B12; MGC2317; BTBD34,TNF alpha induced protein 1,B12; B61; BTBD34; EDP1; hBACURD2,TNFAIP1
Q13873,BMPR2_HUMAN,BMPR2; PPH1,Bone morphogenetic protein receptor type-2; BMP type-2 receptor; BMPR-2; EC 2.7.11.30; Bone morphogenetic protein receptor type II; BMP type II receptor; BMPR-II,PPH1,659,bone morphogenetic protein receptor type 2,primary pulmonary hypertension 1; bone morphogenetic protein receptor; type II (serine/threonine kinase); bone morphogenetic protein receptor type II,,BRK-3; T-ALK; BMPR3; BMPR-II,bone morphogenetic protein receptor type 2,BMPR-II; BMPR3; BMR2; BRK-3; POVD1; PPH1; T-ALK,BMPR2
Q13882,PTK6_HUMAN,PTK6; BRK,Protein-tyrosine kinase 6; EC 2.7.10.2; Breast tumor kinase; Tyrosine-protein kinase BRK,BRK,5753,protein tyrosine kinase 6,PTK6 protein tyrosine kinase 6,,BRK,protein tyrosine kinase 6,BRK,PTK6
Q13887,KLF5_HUMAN,KLF5; BTEB2; CKLF; IKLF,Krueppel-like factor 5; Basic transcription element-binding protein 2; BTE-binding protein 2; Colon krueppel-like factor; GC-box-binding protein 2; Intestinal-enriched krueppel-like factor; Transcription factor BTEB2,BTEB2; CKLF; IKLF,688,KLF transcription factor 5,Kruppel-like factor 5 (intestinal); Kruppel like factor 5,intestinal Kruppel-like factor,IKLF; CKLF,KLF transcription factor 5,BTEB2; CKLF; IKLF,KLF5
Q13905,RPGF1_HUMAN,RAPGEF1; GRF2,Rap guanine nucleotide exchange factor 1; CRK SH3-binding GNRP; Guanine nucleotide-releasing factor 2; Protein C3G,GRF2,2889,Rap guanine nucleotide exchange factor 1,guanine nucleotide-releasing factor 2 (specific for crk proto-oncogene); Rap guanine nucleotide exchange factor (GEF) 1,,C3G,Rap guanine nucleotide exchange factor 1,C3G; GRF2,RAPGEF1
Q13907,IDI1_HUMAN,IDI1,Isopentenyl-diphosphate Delta-isomerase 1; EC 5.3.3.2; Isopentenyl pyrophosphate isomerase 1; IPP isomerase 1; IPPI1,,3422,isopentenyl-diphosphate delta isomerase 1,isopentenyl-diphosphate delta isomerase,IPP isomerase,,isopentenyl-diphosphate delta isomerase 1,IPP1; IPPI1,IDI1
Q13936,CAC1C_HUMAN,CACNA1C; CACH2; CACN2; CACNL1A1; CCHL1A1,Voltage-dependent L-type calcium channel subunit alpha-1C; Calcium channel; L type; alpha-1 polypeptide; isoform 1; cardiac muscle; Voltage-gated calcium channel subunit alpha Cav1.2,CACH2; CACN2; CACNL1A1; CCHL1A1,775,calcium voltage-gated channel subunit alpha1 C,calcium channel; voltage-dependent; L type; alpha 1C subunit; CACNA1C intronic transcript 2; CACNA1C intronic transcript 2 (non-protein coding),,Cav1.2; CACH2; CACN2; TS; LQT8,calcium voltage-gated channel subunit alpha1 C,CACH2; CACN2; CACNA1C-IT2; CACNL1A1; CCHL1A1; CaV1.2; LQT8; NEDHLSS; TS; TS. LQT8,CACNA1C
Q13950,RUNX2_HUMAN,RUNX2; AML3; CBFA1; OSF2; PEBP2A,Runt-related transcription factor 2; Acute myeloid leukemia 3 protein; Core-binding factor subunit alpha-1; CBF-alpha-1; Oncogene AML-3; Osteoblast-specific transcription factor 2; OSF-2; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEA2-alpha A; PEBP2-alpha A; SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit,AML3; CBFA1; OSF2; PEBP2A,860,RUNX family transcription factor 2,runt-related transcription factor 2; runt related transcription factor 2,,AML3; PEBP2A1; PEBP2aA1,RUNX family transcription factor 2,AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA,RUNX2
Q13972,RGRF1_HUMAN,RASGRF1; CDC25; GNRP; GRF1,Ras-specific guanine nucleotide-releasing factor 1; Ras-GRF1; Guanine nucleotide-releasing protein; GNRP; Ras-specific nucleotide exchange factor CDC25,CDC25; GNRP; GRF1,5923,Ras protein specific guanine nucleotide releasing factor 1,,CDC25 like (S. cerevisiae),CDC25L; CDC25; GRF55; H-GRF55; GNRP; PP13187,Ras protein specific guanine nucleotide releasing factor 1,CDC25; CDC25L; GNRP; GRF1; GRF55; H-GRF55; PP13187; ras-GRF1,RASGRF1
Q13976,KGP1_HUMAN,PRKG1; PRKG1B; PRKGR1A; PRKGR1B,cGMP-dependent protein kinase 1; cGK 1; cGK1; EC 2.7.11.12; cGMP-dependent protein kinase I; cGKI,PRKG1B; PRKGR1A; PRKGR1B,5592,protein kinase cGMP-dependent 1,protein kinase; cGMP-dependent; type I,,PGK; PKG; PKG1,protein kinase cGMP-dependent 1,AAT8; PKG; PKG1; PRKG1B; PRKGR1B; cGK; cGK 1; cGK1; cGKI; cGKI-BETA; cGKI-alpha,PRKG1
Q14004,CDK13_HUMAN,CDK13; CDC2L; CDC2L5; CHED; KIAA1791,Cyclin-dependent kinase 13; EC 2.7.11.22; EC 2.7.11.23; CDC2-related protein kinase 5; Cell division cycle 2-like protein kinase 5; Cell division protein kinase 13; hCDK13; Cholinesterase-related cell division controller,CDC2L; CDC2L5; CHED; KIAA1791,8621,cyclin dependent kinase 13,cell division cycle 2-like 5 (cholinesterase-related cell division controller),cholinesterase-related cell division controller,CHED; CDC2L; KIAA1791,cyclin dependent kinase 13,CDC2L; CDC2L5; CHDFIDD; CHED; hCDK13,CDK13
Q14005,IL16_HUMAN,IL16,Pro-interleukin-16 Cleaved into: Interleukin-16; IL-16; Lymphocyte chemoattractant factor; LCF,,3603,interleukin 16,interleukin 16 (lymphocyte chemoattractant factor),prointerleukin 16; lymphocyte chemoattractant factor,LCF; IL-16; prIL-16; HsT19289; FLJ42735; FLJ16806,interleukin 16,LCF; NIL16; PRIL16; prIL-16,IL16
Q14012,KCC1A_HUMAN,CAMK1,Calcium/calmodulin-dependent protein kinase type 1; EC 2.7.11.17; CaM kinase I; CaM-KI; CaM kinase I alpha; CaMKI-alpha,,8536,calcium/calmodulin dependent protein kinase I,,,CaMKI; CaMKI-alpha,calcium/calmodulin dependent protein kinase I,CAMKI,CAMK1
Q14103,HNRPD_HUMAN,HNRNPD; AUF1; HNRPD,Heterogeneous nuclear ribonucleoprotein D0; hnRNP D0; AU-rich element RNA-binding protein 1,AUF1; HNRPD,3184,heterogeneous nuclear ribonucleoprotein D,heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA-binding protein 1; 37kD); AU-rich element RNA binding protein 1; 37kDa,AU-rich RNA-binding factor 1; Heterogeneous nuclear ribonucleoprotein D0,,heterogeneous nuclear ribonucleoprotein D,AUF1; AUF1A; HNRPD; P37; hnRNPD0,HNRNPD
Q14118,DAG1_HUMAN,DAG1,Dystroglycan 1; Dystroglycan; Dystrophin-associated glycoprotein 1; Alpha-DG; Beta-DG,,1605,dystroglycan 1,dystroglycan 1 (dystrophin-associated glycoprotein 1),alpha-dystroglycan; dystrophin-associated glycoprotein-1; beta-dystroglycan,A3a; 156DAG; AGRNR; DAG,dystroglycan 1,156DAG; A3a; AGRNR; DAG; LGMDR16; MDDGA9; MDDGC7; MDDGC9,DAG1
Q14134,TRI29_HUMAN,TRIM29; ATDC,Tripartite motif-containing protein 29; Ataxia telangiectasia group D-associated protein,ATDC,23650,tripartite motif containing 29,tripartite motif-containing 29,tripartite motif protein TRIM29; ataxia-telangiectasia group D-associated protein,ATDC; FLJ36085,tripartite motif containing 29,ATDC,TRIM29
Q14135,VGLL4_HUMAN,VGLL4; KIAA0121,Transcription cofactor vestigial-like protein 4; Vgl-4,KIAA0121,9686,vestigial like family member 4,vestigial like 4 (Drosophila); vestigial-like family member 4,,KIAA0121,vestigial like family member 4,VGL-4,VGLL4
Q14145,KEAP1_HUMAN,KEAP1; INRF2; KIAA0132; KLHL19,Kelch-like ECH-associated protein 1; Cytosolic inhibitor of Nrf2; INrf2; Kelch-like protein 19,INRF2; KIAA0132; KLHL19,9817,kelch like ECH associated protein 1,,kelch-like family member 19,KIAA0132; MGC10630; MGC1114; MGC20887; MGC4407; MGC9454; INrf2; KLHL19,kelch like ECH associated protein 1,INrf2; KLHL19,KEAP1
Q14155,ARHG7_HUMAN,ARHGEF7; COOL1; KIAA0142; P85SPR; PAK3BP; PIXB; Nbla10314,Rho guanine nucleotide exchange factor 7; Beta-Pix; COOL-1; PAK-interacting exchange factor beta; p85,COOL1; KIAA0142; P85SPR; PAK3BP; PIXB,8874,Rho guanine nucleotide exchange factor 7,Rho guanine nucleotide exchange factor (GEF) 7,SH3 domain-containing proline-rich protein; PAK-interacting exchange factor beta,KIAA0142; PIXB; DKFZp761K1021; Nbla10314; DKFZp686C12170; BETA-PIX; COOL1; P85SPR; P85; P85COOL1; P50BP; PAK3; P50,Rho guanine nucleotide exchange factor 7,BETA-PIX; COOL-1; COOL1; Nbla10314; P50; P50BP; P85; P85COOL1; P85SPR; PAK3; PIXB,ARHGEF7
Q14157,UBP2L_HUMAN,UBAP2L; KIAA0144; NICE4,Ubiquitin-associated protein 2-like; Protein NICE-4; RNA polymerase II degradation factor UBAP2L,KIAA0144; NICE4,9898,ubiquitin associated protein 2 like,ubiquitin associated protein 2-like,,NICE-4; KIAA0144,ubiquitin associated protein 2 like,NEDLBF; NICE-4; NICE4,UBAP2L
Q14160,SCRIB_HUMAN,SCRIB; CRIB1; KIAA0147; LAP4; SCRB1; VARTUL,Protein scribble homolog; Scribble; hScrib; Protein LAP4,CRIB1; KIAA0147; LAP4; SCRB1; VARTUL,23513,scribble planar cell polarity protein,scribbled homolog (Drosophila),,KIAA0147; SCRB1; Vartul,scribble planar cell polarity protein,CRIB1; SCRB1; SCRIB1; Vartul; oSCRIB,SCRIB
Q14161,GIT2_HUMAN,GIT2; KIAA0148,ARF GTPase-activating protein GIT2; ARF GAP GIT2; Cool-interacting tyrosine-phosphorylated protein 2; CAT-2; CAT2; G protein-coupled receptor kinase-interactor 2; GRK-interacting protein 2,KIAA0148,9815,GIT ArfGAP 2,G protein-coupled receptor kinase interactor 2; G protein-coupled receptor kinase interacting ArfGAP 2,Paxillin kinase linker,KIAA0148; PKL,GIT ArfGAP 2,CAT-2; CAT2; PKL,GIT2
Q14164,IKKE_HUMAN,IKBKE; IKKE; IKKI; KIAA0151,Inhibitor of nuclear factor kappa-B kinase subunit epsilon; I-kappa-B kinase epsilon; IKK-E; IKK-epsilon; IkBKE; EC 2.7.11.10; Inducible I kappa-B kinase; IKK-i,IKKE; IKKI; KIAA0151,9641,inhibitor of nuclear factor kappa B kinase subunit epsilon,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase epsilon,,IKKE; IKK-i; KIAA0151,inhibitor of nuclear factor kappa B kinase subunit epsilon,IKK-E; IKK-i; IKKE; IKKI,IKBKE
Q14186,TFDP1_HUMAN,TFDP1; DP1,Transcription factor Dp-1; DRTF1-polypeptide 1; DRTF1; E2F dimerization partner 1,DP1,7027,transcription factor Dp-1,,down-regulated in liver cancer stem cells,Dp-1; DRTF1; DP1; DILC,transcription factor Dp-1,DILC; DP1; DRTF1; Dp-1,TFDP1
Q14191,WRN_HUMAN,WRN; RECQ3; RECQL2,Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN; DNA helicase; RecQ-like type 3; RecQ protein-like 2; Werner syndrome protein; EC 3.1.-.-; EC 5.6.2.4; DNA 3'-5' helicase WRN,RECQ3; RECQL2,7486,WRN RecQ like helicase,Werner syndrome; Werner syndrome RecQ like helicase,,RECQL2; RECQ3,WRN RecQ like helicase,RECQ3; RECQL2; RECQL3,WRN
Q14194,DPYL1_HUMAN,CRMP1; DPYSL1; ULIP3,Dihydropyrimidinase-related protein 1; DRP-1; Collapsin response mediator protein 1; CRMP-1; Inactive dihydropyrimidinase; Unc-33-like phosphoprotein 3; ULIP-3,DPYSL1; ULIP3,1400,collapsin response mediator protein 1,,,DRP-1; DPYSL1,collapsin response mediator protein 1,CRMP-1; DPYSL1; DRP-1; DRP1; ULIP-3,CRMP1
Q14195,DPYL3_HUMAN,DPYSL3; CRMP4; DRP3; ULIP; ULIP1,Dihydropyrimidinase-related protein 3; DRP-3; Collapsin response mediator protein 4; CRMP-4; Unc-33-like phosphoprotein 1; ULIP-1,CRMP4; DRP3; ULIP; ULIP1,1809,dihydropyrimidinase like 3,dihydropyrimidinase-like 3,,DRP-3; ULIP; CRMP4,dihydropyrimidinase like 3,CRMP-4; CRMP4; DRP-3; DRP3; LCRMP; ULIP; ULIP-1,DPYSL3
Q14202,ZMYM3_HUMAN,ZMYM3; DXS6673E; KIAA0385; ZNF261,Zinc finger MYM-type protein 3; Zinc finger protein 261,DXS6673E; KIAA0385; ZNF261,9203,zinc finger MYM-type containing 3,zinc finger protein 261,zinc finger; myeloproliferative; and mental retardation-type 3,ZNF198L2; DXS6673E; KIAA0385; MYM,zinc finger MYM-type containing 3,DXS6673E; MYM; XFIM; XLID112; ZNF198L2; ZNF261,ZMYM3
Q14203,DCTN1_HUMAN,DCTN1,Dynactin subunit 1; 150 kDa dynein-associated polypeptide; DAP-150; DP-150; p135; p150-glued,,1639,dynactin subunit 1,dynactin 1 (p150; Glued (Drosophila) homolog),p150 glued homolog (Drosophila),,dynactin subunit 1,DAP-150; DP-150; HMND14; P135,DCTN1
Q14207,NPAT_HUMAN,NPAT; CAND3; E14,Protein NPAT; Nuclear protein of the ataxia telangiectasia mutated locus; Nuclear protein of the ATM locus; p220,CAND3; E14,4863,nuclear protein; coactivator of histone transcription,nuclear protein; ataxia-telangiectasia locus,,E14; p220,nuclear protein; coactivator of histone transcription,E14; E14/NPAT; p220,NPAT
Q14244,MAP7_HUMAN,MAP7,Ensconsin; Epithelial microtubule-associated protein of 115 kDa; E-MAP-115; Microtubule-associated protein 7; MAP-7,,9053,microtubule associated protein 7,,ensconsin,E-MAP-115,microtubule associated protein 7,E-MAP-115; EMAP115,MAP7
Q14247,SRC8_HUMAN,CTTN; EMS1,Src substrate cortactin; Amplaxin; Oncogene EMS1,EMS1,2017,cortactin,ems1 sequence (mammary tumor and squamous cell carcinoma-associated (p80/85 src substrate),,,cortactin,EMS1,CTTN
Q14254,FLOT2_HUMAN,FLOT2; ESA1; M17S1,Flotillin-2; Epidermal surface antigen; ESA; Membrane component chromosome 17 surface marker 1,ESA1; M17S1,2319,flotillin 2,,Flotillin 2 (epidermal surface antigen 1); membrane component; chromosome 17; surface marker 1 (35kD protein identified by monoclonal antibody ECS-1),ESA; ESA1; ECS-1; ECS1,flotillin 2,ECS-1; ECS1; ESA; ESA1; M17S1,FLOT2
Q14289,FAK2_HUMAN,PTK2B; FAK2; PYK2; RAFTK,Protein-tyrosine kinase 2-beta; EC 2.7.10.2; Calcium-dependent tyrosine kinase; CADTK; Calcium-regulated non-receptor proline-rich tyrosine kinase; Cell adhesion kinase beta; CAK-beta; CAKB; Focal adhesion kinase 2; FADK 2; Proline-rich tyrosine kinase 2; Related adhesion focal tyrosine kinase; RAFTK,FAK2; PYK2; RAFTK,2185,protein tyrosine kinase 2 beta,FAK2,,CAKB; PYK2; RAFTK; PTK; CADTK,protein tyrosine kinase 2 beta,CADTK; CAKB; FADK2; FAK2; PKB; PTK; PYK2; RAFTK,PTK2B
Q14315,FLNC_HUMAN,FLNC; ABPL; FLN2,Filamin-C; FLN-C; FLNc; ABP-280-like protein; ABP-L; Actin-binding-like protein; Filamin-2; Gamma-filamin,ABPL; FLN2,2318,filamin C,filamin C; gamma (actin binding protein 280); filamin C; gamma,actin binding protein 280; gamma filamin,ABP-280; ABPL,filamin C,ABP-280; ABP280A; ABPA; ABPL; ARVC15; CMH26; FLN2; MFM5; MPD4; RCM5,FLNC
Q14332,FZD2_HUMAN,FZD2,Frizzled-2; Fz-2; hFz2; FzE2,,2535,frizzled class receptor 2,frizzled (Drosophila) homolog 2; frizzled homolog 2 (Drosophila); frizzled 2; seven transmembrane spanning receptor; frizzled family receptor 2,,,frizzled class receptor 2,Fz2; OMOD2; fz-2; fzE2; hFz2,FZD2
Q14344,GNA13_HUMAN,GNA13,Guanine nucleotide-binding protein subunit alpha-13; G alpha-13; G-protein subunit alpha-13,,10672,G protein subunit alpha 13,guanine nucleotide binding protein (G protein); alpha 13,,G13; MGC46138,G protein subunit alpha 13,G13; HG1N,GNA13
Q14432,PDE3A_HUMAN,PDE3A,cGMP-inhibited 3';5'-cyclic phosphodiesterase 3A; EC 3.1.4.17; Cyclic GMP-inhibited phosphodiesterase A; CGI-PDE A; cGMP-inhibited cAMP phosphodiesterase; cGI-PDE,,5139,phosphodiesterase 3A,phosphodiesterase 3A; cGMP-inhibited,cGMP-inhibited 3';5'-cyclic phosphodiesterase A,CGI-PDE,phosphodiesterase 3A,CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB,PDE3A
Q14451,GRB7_HUMAN,GRB7,Growth factor receptor-bound protein 7; B47; Epidermal growth factor receptor GRB-7; GRB7 adapter protein,,2886,growth factor receptor bound protein 7,growth factor receptor-bound protein 7,,,growth factor receptor bound protein 7,,GRB7
Q14457,BECN1_HUMAN,BECN1; GT197,Beclin-1; Coiled-coil myosin-like BCL2-interacting protein; Protein GT197,GT197,8678,beclin 1,beclin 1 (coiled-coil; moesin-like BCL2 interacting protein); beclin 1; autophagy related,ATG6 autophagy related 6 homolog (S. cerevisiae),ATG6; VPS30,beclin 1,ATG6; VPS30; beclin1,BECN1
Q14493,SLBP_HUMAN,SLBP; HBP,Histone RNA hairpin-binding protein; Histone stem-loop-binding protein,HBP,7884,stem-loop histone mRNA binding protein,stem-loop (histone) binding protein; stem-loop binding protein,histone binding protein,HBP,stem-loop histone mRNA binding protein,HBP,SLBP
Q14494,NF2L1_HUMAN,NFE2L1; HBZ17; NRF1; TCF11,Endoplasmic reticulum membrane sensor NFE2L1; Locus control region-factor 1; LCR-F1; Nuclear factor erythroid 2-related factor 1; NF-E2-related factor 1; NFE2-related factor 1; Nuclear factor; erythroid derived 2; like 1; Protein NRF1; p120 form; Transcription factor 11; TCF-11; Protein NRF1; p110 form,HBZ17; NRF1; TCF11,4779,NFE2 like bZIP transcription factor 1,nuclear factor (erythroid-derived 2)-like 1; nuclear factor; erythroid 2-like 1; NF-E2-related factor 1; nuclear factor; erythroid 2 like 1,nuclear factor erythroid 2-related factor 1; locus control region-factor 1; transcription factor 11,NRF1; LCR-F1; FLJ00380; NRF-1,NFE2 like bZIP transcription factor 1,LCR-F1; NRF-1; NRF1; TCF11,NFE2L1
Q14498,RBM39_HUMAN,RBM39; HCC1; RNPC2,RNA-binding protein 39; CAPER alpha; CAPERalpha; Hepatocellular carcinoma protein 1; RNA-binding motif protein 39; RNA-binding region-containing protein 2; Splicing factor HCC1,HCC1; RNPC2,9584,RNA binding motif protein 39,RNA-binding region (RNP1; RRM) containing 2,coactivator of activating protein-1 and estrogen receptors; functional spliceosome-associated protein 59,CC1.3; HCC1; CAPER; fSAP59; CAPERalpha,RNA binding motif protein 39,CAPER; CAPERalpha; FSAP59; HCC1; RNPC2,RBM39
Q14511,CASL_HUMAN,NEDD9; CASL,Enhancer of filamentation 1; hEF1; CRK-associated substrate-related protein; CAS-L; CasL; Cas scaffolding protein family member 2; CASS2; Neural precursor cell expressed developmentally down-regulated protein 9; NEDD-9; Renal carcinoma antigen NY-REN-12; p105,CASL,4739,neural precursor cell expressed; developmentally down-regulated 9,,Cas scaffolding protein family member 2; Cas-like,HEF1; CAS-L; CASS2,neural precursor cell expressed; developmentally down-regulated 9,CAS-L; CAS2; CASL; CASS2; HEF1,NEDD9
Q14524,SCN5A_HUMAN,SCN5A,Sodium channel protein type 5 subunit alpha; Sodium channel protein cardiac muscle subunit alpha; Sodium channel protein type V subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.5; hH1,,6331,sodium voltage-gated channel alpha subunit 5,sodium channel; voltage-gated; type V; alpha (long QT syndrome 3); sodium channel; voltage-gated; type V; alpha subunit; sodium channel; voltage gated; type V alpha subunit,long QT syndrome 3,Nav1.5; LQT3; HB1; HBBD; PFHB1; IVF; HB2; HH1; SSS1; CDCD2; CMPD2; ICCD,sodium voltage-gated channel alpha subunit 5,CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1,SCN5A
Q14571,ITPR2_HUMAN,ITPR2,Inositol 1;4;5-trisphosphate-gated calcium channel ITPR2; IP3 receptor isoform 2; IP3R 2; InsP3R2; Inositol 1;4;5-trisphosphate receptor type 2; Type 2 inositol 1;4;5-trisphosphate receptor; Type 2 InsP3 receptor,,3709,inositol 1;4;5-trisphosphate receptor type 2,inositol 1;4;5-triphosphate receptor; type 2; inositol 1;4;5-trisphosphate receptor; type 2,cilia and flagella associated protein 48,IP3R2; CFAP48,inositol 1;4;5-trisphosphate receptor type 2,ANHD; CFAP48; INSP3R2; IP3R2,ITPR2
Q14573,ITPR3_HUMAN,ITPR3,Inositol 1;4;5-trisphosphate-gated calcium channel ITPR3; IP3 receptor isoform 3; IP3R-3; InsP3R3; Type 3 inositol 1;4;5-trisphosphate receptor; Type 3 InsP3 receptor,,3710,inositol 1;4;5-trisphosphate receptor type 3,inositol 1;4;5-triphosphate receptor; type 3; inositol 1;4;5-trisphosphate receptor; type 3,,IP3R3,inositol 1;4;5-trisphosphate receptor type 3,CMT1J; IP3R; IP3R-3; IP3R3,ITPR3
Q14643,ITPR1_HUMAN,ITPR1; INSP3R1,Inositol 1;4;5-trisphosphate-gated calcium channel ITPR1; IP3 receptor isoform 1; IP3R 1; InsP3R1; Inositol 1;4;5 trisphosphate receptor; Inositol 1;4;5-trisphosphate receptor type 1; Type 1 inositol 1;4;5-trisphosphate receptor; Type 1 InsP3 receptor,INSP3R1,3708,inositol 1;4;5-trisphosphate receptor type 1,spinocerebellar ataxia 15; spinocerebellar ataxia 16; spinocerebellar ataxia 29; inositol 1;4;5-trisphosphate receptor; type 1,protein phosphatase 1; regulatory subunit 94,Insp3r1; IP3R1; ACV; PPP1R94,inositol 1;4;5-trisphosphate receptor type 1,ACV; CLA4; INSP3R1; IP3R; IP3R1; PPP1R94; SCA15; SCA16; SCA29,ITPR1
Q14653,IRF3_HUMAN,IRF3,Interferon regulatory factor 3; IRF-3,,3661,interferon regulatory factor 3,,,,interferon regulatory factor 3,IIAE7,IRF3
Q14654,KCJ11_HUMAN,KCNJ11,ATP-sensitive inward rectifier potassium channel 11; IKATP; Inward rectifier K(+; Potassium channel; inwardly rectifying subfamily J member 11,,3767,potassium inwardly rectifying channel subfamily J member 11,potassium inwardly-rectifying channel; subfamily J; member 11,ATP-sensitive inward rectifier potassium channel 11; beta-cell inward rectifier,Kir6.2; BIR,potassium inwardly rectifying channel subfamily J member 11,BIR; HHF2; IKATP; KIR6.2; MODY13; PHHI; PNDM2; TNDM3,KCNJ11
Q14669,TRIPC_HUMAN,TRIP12; KIAA0045; ULF,E3 ubiquitin-protein ligase TRIP12; EC 2.3.2.26; E3 ubiquitin-protein ligase for Arf; ULF; HECT-type E3 ubiquitin transferase TRIP12; Thyroid receptor-interacting protein 12; TR-interacting protein 12; TRIP-12,KIAA0045; ULF,9320,thyroid hormone receptor interactor 12,,E3 ubiquitin-protein ligase for Arf,KIAA0045; ULF; TRIPC,thyroid hormone receptor interactor 12,MRD49; TRIP-12; TRIPC; ULF,TRIP12
Q14674,ESPL1_HUMAN,ESPL1; ESP1; KIAA0165,Separin; EC 3.4.22.49; Caspase-like protein ESPL1; Extra spindle poles-like 1 protein; Separase,ESP1; KIAA0165,9700,extra spindle pole bodies like 1; separase,extra spindle poles like 1 (S. cerevisiae); extra spindle pole bodies homolog 1 (S. cerevisiae),separin; separase; separin; cysteine protease,KIAA0165; ESP1; SEPA,extra spindle pole bodies like 1; separase,ESP1; SEPA,ESPL1
Q14676,MDC1_HUMAN,MDC1; KIAA0170; NFBD1,Mediator of DNA damage checkpoint protein 1; Nuclear factor with BRCT domains 1,KIAA0170; NFBD1,9656,mediator of DNA damage checkpoint 1,mediator of DNA-damage checkpoint 1,,NFBD1; KIAA0170; Em:AB023051.5,mediator of DNA damage checkpoint 1,NFBD1,MDC1
Q14680,MELK_HUMAN,MELK; KIAA0175,Maternal embryonic leucine zipper kinase; hMELK; EC 2.7.11.1; Protein kinase Eg3; pEg3 kinase; Protein kinase PK38; hPK38; Tyrosine-protein kinase MELK; EC 2.7.10.2,KIAA0175,9833,maternal embryonic leucine zipper kinase,,,KIAA0175,maternal embryonic leucine zipper kinase,HPK38,MELK
Q14683,SMC1A_HUMAN,SMC1A; DXS423E; KIAA0178; SB1.8; SMC1; SMC1L1,Structural maintenance of chromosomes protein 1A; SMC protein 1A; SMC-1-alpha; SMC-1A; Sb1.8,DXS423E; KIAA0178; SB1.8; SMC1; SMC1L1,8243,structural maintenance of chromosomes 1A,SMC1 (structural maintenance of chromosomes 1; yeast)-like 1; SMC1 structural maintenance of chromosomes 1-like 1 (yeast),,DXS423E; KIAA0178; SB1.8; Smcb,structural maintenance of chromosomes 1A,CDLS2; DEE85; DXS423E; EIEE85; SB1.8; SMC1; SMC1L1; SMC1alpha; SMCB,SMC1A
Q14686,NCOA6_HUMAN,NCOA6; AIB3; KIAA0181; RAP250; TRBP,Nuclear receptor coactivator 6; Activating signal cointegrator 2; ASC-2; Amplified in breast cancer protein 3; Cancer-amplified transcriptional coactivator ASC-2; Nuclear receptor coactivator RAP250; NRC RAP250; Nuclear receptor-activating protein; 250 kDa; Peroxisome proliferator-activated receptor-interacting protein; PPAR-interacting protein; PRIP; Thyroid hormone receptor-binding protein,AIB3; KIAA0181; RAP250; TRBP,23054,nuclear receptor coactivator 6,,nuclear receptor coactivator RAP250; activating signal cointegrator-2; peroxisome proliferator-activated receptor interacting protein,KIAA0181; RAP250; ASC2; AIB3; PRIP; TRBP; NRC,nuclear receptor coactivator 6,AIB3; ASC2; NRC; PRIP; RAP250; TRBP,NCOA6
Q14693,LPIN1_HUMAN,LPIN1; KIAA0188,Phosphatidate phosphatase LPIN1; EC 3.1.3.4; Lipin-1,KIAA0188,23175,lipin 1,,phosphatidate phosphatase LPIN1,KIAA0188,lipin 1,PAP1,LPIN1
Q14694,UBP10_HUMAN,USP10; KIAA0190,Ubiquitin carboxyl-terminal hydrolase 10; EC 3.4.19.12; Deubiquitinating enzyme 10; Ubiquitin thioesterase 10; Ubiquitin-specific-processing protease 10,KIAA0190,9100,ubiquitin specific peptidase 10,ubiquitin specific protease 10,,UBPO; KIAA0190,ubiquitin specific peptidase 10,UBPO,USP10
Q14721,KCNB1_HUMAN,KCNB1,Potassium voltage-gated channel subfamily B member 1; Delayed rectifier potassium channel 1; DRK1; h-DRK1; Voltage-gated potassium channel subunit Kv2.1,,3745,potassium voltage-gated channel subfamily B member 1,potassium voltage-gated channel; Shab-related subfamily; member 1,,Kv2.1,potassium voltage-gated channel subfamily B member 1,DEE26; DRK1; Kv2.1,KCNB1
Q14738,2A5D_HUMAN,PPP2R5D,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform; PP2A B subunit isoform B'-delta; PP2A B subunit isoform B56-delta; PP2A B subunit isoform PR61-delta; PP2A B subunit isoform R5-delta,,5528,protein phosphatase 2 regulatory subunit B'delta,protein phosphatase 2; regulatory subunit B (B56); delta isoform,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform,B56D; B56delta,protein phosphatase 2 regulatory subunit B'delta,B56D; B56delta; HJS1; MRD35,PPP2R5D
Q14739,LBR_HUMAN,LBR,Delta(14)-sterol reductase LBR; 14; Delta-14-SR; EC 1.3.1.70; 3-beta-hydroxysterol Delta (14; C-14 sterol reductase; C14SR; Integral nuclear envelope inner membrane protein; LMN2R; Lamin-B receptor; Sterol C14-reductase,,3930,lamin B receptor,,tudor domain containing 18,DHCR14B; TDRD18,lamin B receptor,C14SR; DHCR14B; LMN2R; PHA; PHASK; TDRD18,LBR
Q14765,STAT4_HUMAN,STAT4,Signal transducer and activator of transcription 4,,6775,signal transducer and activator of transcription 4,,,,signal transducer and activator of transcription 4,DPMC; SLEB11,STAT4
Q14790,CASP8_HUMAN,CASP8; MCH5,Caspase-8; CASP-8; EC 3.4.22.61; Apoptotic cysteine protease; Apoptotic protease Mch-5; CAP4; FADD-homologous ICE/ced-3-like protease; FADD-like ICE; FLICE; ICE-like apoptotic protease 5; MORT1-associated ced-3 homolog; MACH,MCH5,841,caspase 8,caspase 8; apoptosis-related cysteine protease; caspase 8; apoptosis-related cysteine peptidase,,MCH5; MACH; FLICE; Casp-8,caspase 8,ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5,CASP8
Q14807,KIF22_HUMAN,KIF22; KID; KNSL4,Kinesin-like protein KIF22; Kinesin-like DNA-binding protein; Kinesin-like protein 4,KID; KNSL4,3835,kinesin family member 22,kinesin-like 4,,Kid; OBP-1; OBP-2,kinesin family member 22,A-328A3.2; KID; KNSL4; OBP; OBP-1; OBP-2; SEMDJL2,KIF22
Q14814,MEF2D_HUMAN,MEF2D,Myocyte-specific enhancer factor 2D,,4209,myocyte enhancer factor 2D,,,,myocyte enhancer factor 2D,,MEF2D
Q14832,GRM3_HUMAN,GRM3; GPRC1C; MGLUR3,Metabotropic glutamate receptor 3; mGluR3,GPRC1C; MGLUR3,2913,glutamate metabotropic receptor 3,glutamate receptor; metabotropic 3,,GPRC1C; mGlu3; MGLUR3,glutamate metabotropic receptor 3,GLUR3; GPRC1C; MGLUR3; mGlu3,GRM3
Q14839,CHD4_HUMAN,CHD4,Chromodomain-helicase-DNA-binding protein 4; CHD-4; EC 3.6.4.12; ATP-dependent helicase CHD4; Mi-2 autoantigen 218 kDa protein; Mi2-beta,,1108,chromodomain helicase DNA binding protein 4,,,Mi-2b; Mi2-BETA,chromodomain helicase DNA binding protein 4,CHD-4; Mi-2b; Mi2-BETA; SIHIWES,CHD4
Q14847,LASP1_HUMAN,LASP1; MLN50,LIM and SH3 domain protein 1; LASP-1; Metastatic lymph node gene 50 protein; MLN 50,MLN50,3927,LIM and SH3 protein 1,,,MLN50; Lasp-1,LIM and SH3 protein 1,Lasp-1; MLN50,LASP1
Q14896,MYPC3_HUMAN,MYBPC3,Myosin-binding protein C; cardiac-type; Cardiac MyBP-C; C-protein; cardiac muscle isoform,,4607,myosin binding protein C3,myosin-binding protein C; cardiac,,FHC; cMyBP-C,myosin binding protein C3,CMD1MM; CMH4; FHC; LVNC10; MYBP-C; cMyBP-C,MYBPC3
Q14934,NFAC4_HUMAN,NFATC4; NFAT3,Nuclear factor of activated T-cells; cytoplasmic 4; NF-ATc4; NFATc4; T-cell transcription factor NFAT3; NF-AT3,NFAT3,4776,nuclear factor of activated T cells 4,nuclear factor of activated T-cells; cytoplasmic; calcineurin-dependent 4; nuclear factor of activated T-cells 4,,NFAT3,nuclear factor of activated T cells 4,NF-AT3; NF-ATC4; NFAT3,NFATC4
Q14940,SL9A5_HUMAN,SLC9A5; NHE5,Sodium/hydrogen exchanger 5; Na(+; +; NHE-5; Solute carrier family 9 member 5,NHE5,6553,solute carrier family 9 member A5,solute carrier family 9 (sodium/hydrogen exchanger); isoform 5; solute carrier family 9 (sodium/hydrogen exchanger); member 5; solute carrier family 9; subfamily A (NHE5; cation proton antiporter 5); member 5,,NHE5,solute carrier family 9 member A5,NHE5,SLC9A5
Q14957,NMDE3_HUMAN,GRIN2C; NMDAR2C,Glutamate receptor ionotropic; NMDA 2C; GluN2C; Glutamate NMDA receptor subunit epsilon-3; N-methyl D-aspartate receptor subtype 2C; NMDAR2C; NR2C,NMDAR2C,2905,glutamate ionotropic receptor NMDA type subunit 2C,glutamate receptor; ionotropic; N-methyl D-aspartate 2C,,GluN2C; NR2C,glutamate ionotropic receptor NMDA type subunit 2C,GluN2C; NMDAR2C; NR2C,GRIN2C
Q14966,ZN638_HUMAN,ZNF638; NP220; ZFML,Zinc finger protein 638; Cutaneous T-cell lymphoma-associated antigen se33-1; CTCL-associated antigen se33-1; Nuclear protein 220; Zinc finger matrin-like protein,NP220; ZFML,27332,zinc finger protein 638,zinc finger; matrin-like,,NP220; MGC26130; Zfp638,zinc finger protein 638,NP220; ZFML; Zfp638,ZNF638
Q14973,NTCP_HUMAN,SLC10A1; NTCP; GIG29,Hepatic sodium/bile acid cotransporter; Cell growth-inhibiting gene 29 protein; Na(+; Na(+; Sodium/taurocholate cotransporting polypeptide; NTCP; Solute carrier family 10 member 1; SLC10A1,NTCP,6554,solute carrier family 10 member 1,solute carrier family 10 (sodium/bile acid cotransporter); member 1,Na+/taurocholate cotransporting polypeptide,NTCP; NTCP1,solute carrier family 10 member 1,FHCA2; NTCP,SLC10A1
Q14978,NOLC1_HUMAN,NOLC1; KIAA0035; NS5ATP13,Nucleolar and coiled-body phosphoprotein 1; 140 kDa nucleolar phosphoprotein; Nopp140; Hepatitis C virus NS5A-transactivated protein 13; HCV NS5A-transactivated protein 13; Nucleolar 130 kDa protein; Nucleolar phosphoprotein p130,KIAA0035; NS5ATP13,9221,nucleolar and coiled-body phosphoprotein 1,,,P130; KIAA0035; NOPP140; NOPP130; Srp40,nucleolar and coiled-body phosphoprotein 1,NOPP130; NOPP140; NS5ATP13; P130; Srp40,NOLC1
Q14980,NUMA1_HUMAN,NUMA1; NMP22; NUMA,Nuclear mitotic apparatus protein 1; Nuclear matrix protein-22; NMP-22; Nuclear mitotic apparatus protein; NuMA protein; SP-H antigen,NMP22; NUMA,4926,nuclear mitotic apparatus protein 1,,,NUMA,nuclear mitotic apparatus protein 1,NMP-22; NUMA,NUMA1
Q14994,NR1I3_HUMAN,NR1I3; CAR,Nuclear receptor subfamily 1 group I member 3; Constitutive activator of retinoid response; Constitutive active response; Constitutive androstane receptor; CAR; Orphan nuclear receptor MB67,CAR,9970,nuclear receptor subfamily 1 group I member 3,nuclear receptor subfamily 1; group I; member 3,constitutive androstane receptor,MB67; CAR1; CAR,nuclear receptor subfamily 1 group I member 3,CAR; CAR1; MB67,NR1I3
Q14C86,GAPD1_HUMAN,GAPVD1; GAPEX5; KIAA1521; RAP6,GTPase-activating protein and VPS9 domain-containing protein 1; GAPex-5; Rab5-activating protein 6,GAPEX5; KIAA1521; RAP6,26130,GTPase activating protein and VPS9 domains 1,,,DKFZP434C212; KIAA1521,GTPase activating protein and VPS9 domains 1,GAPEX5; GAPex-5; RAP6,GAPVD1
Q14CB8,RHG19_HUMAN,ARHGAP19,Rho GTPase-activating protein 19; Rho-type GTPase-activating protein 19,,84986,Rho GTPase activating protein 19,,,FLJ00194; MGC14258,Rho GTPase activating protein 19,,ARHGAP19
Q14CS0,UBX2B_HUMAN,UBXN2B,UBX domain-containing protein 2B; NSFL1 cofactor p37; p97 cofactor p37,,137886,UBX domain protein 2B,,,p37,UBX domain protein 2B,p37,UBXN2B
Q15003,CND2_HUMAN,NCAPH; BRRN; BRRN1; CAPH; KIAA0074,Condensin complex subunit 2; Barren homolog protein 1; Chromosome-associated protein H; hCAP-H; Non-SMC condensin I complex subunit H; XCAP-H homolog,BRRN; BRRN1; CAPH; KIAA0074,23397,non-SMC condensin I complex subunit H,barren (Drosophila) homolog; barren homolog (Drosophila); barren homolog 1 (Drosophila); non-SMC condensin I complex; subunit H,,CAP-H; hCAP-H; NCAPH1,non-SMC condensin I complex subunit H,BRRN1; CAP-H; CAPH; MCPH23; NCAPH1,NCAPH
Q15019,SEPT2_HUMAN,SEPTIN2; DIFF6; KIAA0158; NEDD5; SEPT2,Septin-2; Neural precursor cell expressed developmentally down-regulated protein 5; NEDD-5,DIFF6; KIAA0158; NEDD5; SEPT2,4735,septin 2,neural precursor cell expressed; developmentally down-regulated 5,,KIAA0158; hNedd5; Pnutl3; Septin-2,septin 2,DIFF6; NEDD-5; NEDD5; Pnutl3; SEPT2; Septin-2; hNedd5,SEPTIN2
Q15022,SUZ12_HUMAN,SUZ12; CHET9; JJAZ1; KIAA0160,Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog,CHET9; JJAZ1; KIAA0160,23512,SUZ12 polycomb repressive complex 2 subunit,suppressor of zeste 12 homolog (Drosophila),,JJAZ1; KIAA0160; CHET9,SUZ12 polycomb repressive complex 2 subunit,CHET9; IMMAS; JJAZ1,SUZ12
Q15027,ACAP1_HUMAN,ACAP1; CENTB1; KIAA0050,Arf-GAP with coiled-coil; ANK repeat and PH domain-containing protein 1; Centaurin-beta-1; Cnt-b1,CENTB1; KIAA0050,9744,ArfGAP with coiled-coil; ankyrin repeat and PH domains 1,centaurin; beta 1,,KIAA0050,ArfGAP with coiled-coil; ankyrin repeat and PH domains 1,CENTB1,ACAP1
Q15036,SNX17_HUMAN,SNX17; KIAA0064,Sorting nexin-17,KIAA0064,9784,sorting nexin 17,,,KIAA0064,sorting nexin 17,,SNX17
Q15046,SYK_HUMAN,KARS1; KARS; KIAA0070,Lysine--tRNA ligase; EC 2.7.7.-; EC 6.1.1.6; Lysyl-tRNA synthetase; LysRS,KARS; KIAA0070,3735,lysyl-tRNA synthetase 1,deafness; autosomal recessive 89; lysyl-tRNA synthetase,lysine tRNA ligase,KARS2,lysyl-tRNA synthetase 1,CMTRIB; DEAPLE; DFNB89; KARS; KARS2; KRS; LEPID,KARS1
Q15047,SETB1_HUMAN,SETDB1; ESET; KIAA0067; KMT1E,Histone-lysine N-methyltransferase SETDB1; EC 2.1.1.366; ERG-associated protein with SET domain; ESET; Histone H3-K9 methyltransferase 4; H3-K9-HMTase 4; Lysine N-methyltransferase 1E; SET domain bifurcated 1,ESET; KIAA0067; KMT1E,9869,SET domain bifurcated histone lysine methyltransferase 1,SET domain; bifurcated 1; SET domain bifurcated 1,tudor domain containing 21,KG1T; KIAA0067; ESET; KMT1E; TDRD21,SET domain bifurcated histone lysine methyltransferase 1,ESET; H3-K9-HMTase4; KG1T; KMT1E; TDRD21,SETDB1
Q15052,ARHG6_HUMAN,ARHGEF6; COOL2; KIAA0006; PIXA,Rho guanine nucleotide exchange factor 6; Alpha-Pix; COOL-2; PAK-interacting exchange factor alpha; Rac/Cdc42 guanine nucleotide exchange factor 6,COOL2; KIAA0006; PIXA,9459,Rac/Cdc42 guanine nucleotide exchange factor 6,mental retardation; X-linked 46; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6,Rac/Cdc42 guanine exchange factor (GEF) 6; PAK-interacting exchange factor; alpha; rho guanine nucleotide exchange factor 6,alphaPIX; Cool-2; KIAA0006; alpha-PIX; Cool2; ??Pix,Rac/Cdc42 guanine nucleotide exchange factor 6,COOL2; Cool-2; MRX46; PIXA; alpha-PIX; alphaPIX,ARHGEF6
Q15054,DPOD3_HUMAN,POLD3; KIAA0039,DNA polymerase delta subunit 3; DNA polymerase delta subunit C; DNA polymerase delta subunit p66; DNA polymerase delta subunit p68,KIAA0039,10714,DNA polymerase delta 3; accessory subunit,polymerase (DNA-directed); delta 3; accessory subunit; polymerase (DNA) delta 3; accessory subunit,DNA polymerase delta subunit p66; Pol delta C subunit (p66); protein phosphatase 1; regulatory subunit 128,P66; KIAA0039; P68; PPP1R128,DNA polymerase delta 3; accessory subunit,IMD122; P66; P68; PPP1R128,POLD3
Q15058,KIF14_HUMAN,KIF14; KIAA0042,Kinesin-like protein KIF14,KIAA0042,9928,kinesin family member 14,,,KIAA0042,kinesin family member 14,MCPH20; MKS12,KIF14
Q15075,EEA1_HUMAN,EEA1; ZFYVE2,Early endosome antigen 1; Endosome-associated protein p162; Zinc finger FYVE domain-containing protein 2,ZFYVE2,8411,early endosome antigen 1,early endosome antigen 1; 162kD,,ZFYVE2,early endosome antigen 1,MST105; MSTP105; ZFYVE2,EEA1
Q15078,CD5R1_HUMAN,CDK5R1; CDK5R; NCK5A,Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit; p35; p25; Tau protein kinase II 23 kDa subunit; p23,CDK5R; NCK5A,8851,cyclin dependent kinase 5 regulatory subunit 1,cyclin-dependent kinase 5; regulatory subunit 1 (p35),,p35nck5a; Nck5a; p35,cyclin dependent kinase 5 regulatory subunit 1,CDK5P35; CDK5R; NCK5A; p23; p25; p35; p35nck5a,CDK5R1
Q15080,NCF4_HUMAN,NCF4; SH3PXD4,Neutrophil cytosol factor 4; NCF-4; Neutrophil NADPH oxidase factor 4; SH3 and PX domain-containing protein 4; p40-phox; p40phox,SH3PXD4,4689,neutrophil cytosolic factor 4,neutrophil cytosolic factor 4 (40kD); neutrophil cytosolic factor 4; 40kDa,neutrophil NADPH oxidase factor 4,p40phox; SH3PXD4,neutrophil cytosolic factor 4,CGD3; NCF; P40PHOX; SH3PXD4,NCF4
Q15084,PDIA6_HUMAN,PDIA6; ERP5; P5; TXNDC7,Protein disulfide-isomerase A6; EC 5.3.4.1; Endoplasmic reticulum protein 5; ER protein 5; ERp5; Protein disulfide isomerase P5; Thioredoxin domain-containing protein 7,ERP5; P5; TXNDC7,10130,protein disulfide isomerase family A member 6,thioredoxin domain containing 7 (protein disulfide isomerase); protein disulfide isomerase-associated 6; protein disulfide isomerase family A; member 6,protein disulfide isomerase-related protein,P5; ERp5,protein disulfide isomerase family A member 6,ERP5; P5; TXNDC7,PDIA6
Q15109,RAGE_HUMAN,AGER; RAGE,Advanced glycosylation end product-specific receptor; Receptor for advanced glycosylation end products,RAGE,177,advanced glycosylation end-product specific receptor,,receptor for advanced glycation end-products,RAGE; SCARJ1; sRAGE,advanced glycosylation end-product specific receptor,RAGE; SCARJ1; sRAGE,AGER
Q15116,PDCD1_HUMAN,PDCD1; PD1,Programmed cell death protein 1; Protein PD-1; hPD-1; CD antigen CD279,PD1,5133,programmed cell death 1,systemic lupus erythematosus susceptibility 2,,CD279; PD1; hSLE1; PD-1,programmed cell death 1,AIMTBS; CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1,PDCD1
Q15118,PDK1_HUMAN,PDK1; PDHK1,Pyruvate dehydrogenase; acetyl-transferring; EC 2.7.11.2; Pyruvate dehydrogenase kinase isoform 1; PDH kinase 1,PDHK1,5163,pyruvate dehydrogenase kinase 1,pyruvate dehydrogenase kinase; isoenzyme 1; pyruvate dehydrogenase kinase; isozyme 1,,,pyruvate dehydrogenase kinase 1,,PDK1
Q15119,PDK2_HUMAN,PDK2; PDHK2,Pyruvate dehydrogenase; acetyl-transferring; EC 2.7.11.2; Pyruvate dehydrogenase kinase isoform 2; PDH kinase 2; PDKII,PDHK2,5164,pyruvate dehydrogenase kinase 2,pyruvate dehydrogenase kinase; isoenzyme 2; pyruvate dehydrogenase kinase; isozyme 2,,PDHK2,pyruvate dehydrogenase kinase 2,PDHK2; PDKII,PDK2
Q15120,PDK3_HUMAN,PDK3; PDHK3,Pyruvate dehydrogenase; acetyl-transferring; EC 2.7.11.2; Pyruvate dehydrogenase kinase isoform 3,PDHK3,5165,pyruvate dehydrogenase kinase 3,pyruvate dehydrogenase kinase; isoenzyme 3; pyruvate dehydrogenase kinase; isozyme 3,,,pyruvate dehydrogenase kinase 3,CMTX6; GS1-358P8.4,PDK3
Q15121,PEA15_HUMAN,PEA15,Astrocytic phosphoprotein PEA-15; 15 kDa phosphoprotein enriched in astrocytes; Phosphoprotein enriched in diabetes; PED,,8682,proliferation and apoptosis adaptor protein 15,phosphoprotein enriched in astrocytes 15; proliferation and apoptosis adaptor 15,Phosphoprotein enriched in astrocytes; 15kD; homolog of mouse MAT-1 oncogene; Phosphoprotein enriched in diabetes,HMAT1; MAT1; PED; PEA-15; MAT1H; HUMMAT1H; PED-PEA15; PED/PEA15,proliferation and apoptosis adaptor protein 15,HMAT1; HUMMAT1H; MAT1; MAT1H; PEA-15; PED; PED-PEA15; PED/PEA15,PEA15
Q15131,CDK10_HUMAN,CDK10,Cyclin-dependent kinase 10; EC 2.7.11.22; Cell division protein kinase 10; Serine/threonine-protein kinase PISSLRE,,8558,cyclin dependent kinase 10,cyclin-dependent kinase (CDC2-like) 10,,PISSLRE,cyclin dependent kinase 10,ALSAS; PISSLRE,CDK10
Q15139,KPCD1_HUMAN,PRKD1; PKD; PKD1; PRKCM,Serine/threonine-protein kinase D1; EC 2.7.11.13; Protein kinase C mu type; Protein kinase D; nPKC-D1; nPKC-mu,PKD; PKD1; PRKCM,5587,protein kinase D1,protein kinase C; mu,,PKCM; PKD; PKC-mu,protein kinase D1,CHDED; PKC-MU; PKCM; PKD; PRKCM,PRKD1
Q15147,PLCB4_HUMAN,PLCB4,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-4; EC 3.1.4.11; Phosphoinositide phospholipase C-beta-4; Phospholipase C-beta-4; PLC-beta-4,,5332,phospholipase C beta 4,phospholipase C; beta 4,,,phospholipase C beta 4,ARCND2; ARCND2A; ARCND2B; PI-PLC,PLCB4
Q15149,PLEC_HUMAN,PLEC; PLEC1,Plectin; PCN; PLTN; Hemidesmosomal protein 1; HD1; Plectin-1,PLEC1,5339,plectin,plectin 1; intermediate filament binding protein; 500kD; epidermolysis bullosa simplex 1 (Ogna); plectin 1; intermediate filament binding protein 500kDa,,PCN; PLTN,plectin,EBS1; EBS5A; EBS5B; EBS5C; EBS5D; EBSMD; EBSND; EBSO; EBSOG; EBSPA; HD1; LGMD2Q; LGMDR17; PCN; PLEC1; PLEC1b; PLTN,PLEC
Q15154,PCM1_HUMAN,PCM1,Pericentriolar material 1 protein; PCM-1; hPCM-1,,5108,pericentriolar material 1,,,PTC4,pericentriolar material 1,PTC4; RET/PCM-1,PCM1
Q15172,2A5A_HUMAN,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform; PP2A B subunit isoform B'-alpha; PP2A B subunit isoform B56-alpha; PP2A B subunit isoform PR61-alpha; PR61alpha; PP2A B subunit isoform R5-alpha,,5525,protein phosphatase 2 regulatory subunit B'alpha,protein phosphatase 2; regulatory subunit B (B56); alpha isoform,,PR61A; B56A; B56alpha,protein phosphatase 2 regulatory subunit B'alpha,B56A; B56alpha; PR61A,PPP2R5A
Q15173,2A5B_HUMAN,PPP2R5B,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform; PP2A B subunit isoform B'-beta; PP2A B subunit isoform B56-beta; PP2A B subunit isoform PR61-beta; PP2A B subunit isoform R5-beta,,5526,protein phosphatase 2 regulatory subunit B'beta,protein phosphatase 2; regulatory subunit B (B56); beta isoform,PP2A; B subunit; B' beta isoform; PP2A; B subunit; B56 beta isoform; PP2A; B subunit; PR61 beta isoform; PP2A; B subunit; R5 beta isoform; serine/threonine protein phosphatase 2A; 56 kDa regulatory subunit; beta isoform,FLJ35411; B56B; PR61B; B56beta,protein phosphatase 2 regulatory subunit B'beta,B56B; B56beta; PR61B,PPP2R5B
Q15185,TEBP_HUMAN,PTGES3; P23; TEBP,Prostaglandin E synthase 3; EC 5.3.99.3; Cytosolic prostaglandin E2 synthase; cPGES; Hsp90 co-chaperone; Progesterone receptor complex p23; Telomerase-binding protein p23,P23; TEBP,10728,prostaglandin E synthase 3,prostaglandin E synthase 3 (cytosolic),,p23; TEBP; cPGES,prostaglandin E synthase 3,P23; TEBP; cPGES,PTGES3
Q15208,STK38_HUMAN,STK38; NDR1,Serine/threonine-protein kinase 38; EC 2.7.11.1; NDR1 protein kinase; Nuclear Dbf2-related kinase 1,NDR1,11329,serine/threonine kinase 38,,nuclear Dbf2-related 1,NDR; NDR1,serine/threonine kinase 38,NDR; NDR1,STK38
Q15233,NONO_HUMAN,NONO; NRB54,Non-POU domain-containing octamer-binding protein; NonO protein; 54 kDa nuclear RNA- and DNA-binding protein; p54(nrb; p54nrb; 55 kDa nuclear protein; NMT55; DNA-binding p52/p100 complex; 52 kDa subunit,NRB54,4841,non-POU domain containing octamer binding,non-POU-domain-containing; octamer-binding,Nuclear RNA-binding protein; 54-kD; non-Pou domain-containing octamer (ATGCAAAT) binding protein; protein phosphatase 1; regulatory subunit 114,NRB54; NMT55; P54NRB; P54; PPP1R114,non-POU domain containing octamer binding,MRXS34; NMT55; NRB54; P54; P54NRB; PPP1R114,NONO
Q15256,PTPRR_HUMAN,PTPRR; ECPTP; PTPRQ,Receptor-type tyrosine-protein phosphatase R; R-PTP-R; EC 3.1.3.48; Ch-1PTPase; NC-PTPCOM1; Protein-tyrosine phosphatase PCPTP1,ECPTP; PTPRQ,5801,protein tyrosine phosphatase receptor type R,,,PTPBR7; PTP-SL; EC-PTP; PCPTP1,protein tyrosine phosphatase receptor type R,EC-PTP; PCPTP1; PTP-SL; PTPBR7; PTPRQ,PTPRR
Q15257,PTPA_HUMAN,PTPA; PPP2R4,Serine/threonine-protein phosphatase 2A activator; EC 5.2.1.8; PP2A; subunit B'; PR53 isoform; Phosphotyrosyl phosphatase activator; PTPA; Serine/threonine-protein phosphatase 2A regulatory subunit 4; Serine/threonine-protein phosphatase 2A regulatory subunit B',PPP2R4,5524,protein phosphatase 2 phosphatase activator,protein phosphatase 2A; regulatory subunit B' (PR 53); protein phosphatase 2A activator; regulatory subunit 4; protein phosphatase 2 regulatory subunit 4,phosphotyrosyl phosphatase activator; PP2A phosphatase activator,PR53,protein phosphatase 2 phosphatase activator,PARK25; PP2A; PPP2R4; PR53,PTPA
Q15262,PTPRK_HUMAN,PTPRK; PTPK,Receptor-type tyrosine-protein phosphatase kappa; Protein-tyrosine phosphatase kappa; R-PTP-kappa; EC 3.1.3.48,PTPK,5796,protein tyrosine phosphatase receptor type K,,,R-PTP-kappa,protein tyrosine phosphatase receptor type K,R-PTP-kappa,PTPRK
Q15276,RABE1_HUMAN,RABEP1; RAB5EP; RABPT5; RABPT5A,Rab GTPase-binding effector protein 1; Rabaptin-4; Rabaptin-5; Rabaptin-5alpha; Renal carcinoma antigen NY-REN-17,RAB5EP; RABPT5; RABPT5A,9135,rabaptin; RAB GTPase binding effector protein 1,,,neurocrescin; RAB5EP; RABPT5; rabaptin-5,rabaptin; RAB GTPase binding effector protein 1,RAB5EP; RABPT5,RABEP1
Q15287,RNPS1_HUMAN,RNPS1; LDC2,RNA-binding protein with serine-rich domain 1; SR-related protein LDC2,LDC2,10921,RNA binding protein with serine rich domain 1,RNA-binding protein S1; serine-rich domain,,,RNA binding protein with serine rich domain 1,E5.1,RNPS1
Q15291,RBBP5_HUMAN,RBBP5; RBQ3,Retinoblastoma-binding protein 5; RBBP-5; Retinoblastoma-binding protein RBQ-3,RBQ3,5929,RB binding protein 5; histone lysine methyltransferase complex subunit,retinoblastoma-binding protein 5; retinoblastoma binding protein 5,SWD1; Set1c WD40 repeat protein; homolog (S. cerevisiae),RBQ3; SWD1,RB binding protein 5; histone lysine methyltransferase complex subunit,RBQ3; SWD1,RBBP5
Q15303,ERBB4_HUMAN,ERBB4; HER4,Receptor tyrosine-protein kinase erbB-4; EC 2.7.10.1; Proto-oncogene-like protein c-ErbB-4; Tyrosine kinase-type cell surface receptor HER4; p180erbB4; 4ICD; E4ICD; s80HER4,HER4,2066,erb-b2 receptor tyrosine kinase 4,v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4,human epidermal growth factor receptor 4,ALS19; HER4,erb-b2 receptor tyrosine kinase 4,ALS19; HER4; p180erbB4,ERBB4
Q15311,RBP1_HUMAN,RALBP1; RLIP; RLIP1; RLIP76,RalA-binding protein 1; RalBP1; 76 kDa Ral-interacting protein; Dinitrophenyl S-glutathione ATPase; DNP-SG ATPase; EC 7.6.2.2; EC 7.6.2.3; Ral-interacting protein 1,RLIP; RLIP1; RLIP76,10928,ralA binding protein 1,,,RLIP76; RIP1; RIP,ralA binding protein 1,RIP1; RLIP1; RLIP76,RALBP1
Q15334,L2GL1_HUMAN,LLGL1; DLG4; HUGL; HUGL1,Lethal(2) giant larvae protein homolog 1; 2; LLGL; DLG4; Hugl-1; Human homolog to the D-lgl gene protein,DLG4; HUGL; HUGL1,3996,LLGL scribble cell polarity complex component 1,lethal giant larvae homolog 1 (Drosophila); lethal giant larvae homolog 1; scribble cell polarity complex component,,Lgl1; Mgl1,LLGL scribble cell polarity complex component 1,DLG4; HUGL; HUGL-1; HUGL1; LLGL; Lgl1; Mgl1,LLGL1
Q15349,KS6A2_HUMAN,RPS6KA2; MAPKAPK1C; RSK3,Ribosomal protein S6 kinase alpha-2; S6K-alpha-2; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 2; p90-RSK 2; p90RSK2; MAP kinase-activated protein kinase 1c; MAPK-activated protein kinase 1c; MAPKAP kinase 1c; MAPKAPK-1c; Ribosomal S6 kinase 3; RSK-3; pp90RSK3,MAPKAPK1C; RSK3,6196,ribosomal protein S6 kinase A2,ribosomal protein S6 kinase; 90kD; polypeptide 2,,RSK3; HU-2,ribosomal protein S6 kinase A2,HU-2; MAPKAPK1C; RSK; RSK3; S6K-alpha; S6K-alpha2; p90-RSK3; p90RSK2; pp90RSK3,RPS6KA2
Q15365,PCBP1_HUMAN,PCBP1,Poly(rC)-binding protein 1; rC; Alpha-CP1; Heterogeneous nuclear ribonucleoprotein E1; hnRNP E1; Nucleic acid-binding protein SUB2.3,,5093,poly(rC) binding protein 1,poly(rC)-binding protein 1,heterogeneous nuclear ribonucleoprotein E1,HNRPE1; hnRNP-E1; HNRPX; hnRNP-X,poly(rC) binding protein 1,HEL-S-85; HNRPE1; HNRPX; hnRNP-E1; hnRNP-X,PCBP1
Q15382,RHEB_HUMAN,RHEB; RHEB2,GTP-binding protein Rheb; EC 3.6.5.-; Ras homolog enriched in brain,RHEB2,6009,Ras homolog; mTORC1 binding,Ras homolog enriched in brain 2; Ras homolog enriched in brain,,,Ras homolog; mTORC1 binding,RHEB2,RHEB
Q15398,DLGP5_HUMAN,DLGAP5; DLG7; KIAA0008,Disks large-associated protein 5; DAP-5; Discs large homolog 7; Disks large-associated protein DLG7; Hepatoma up-regulated protein; HURP,DLG7; KIAA0008,9787,DLG associated protein 5,discs; large homolog 7 (Drosophila); discs; large (Drosophila) homolog-associated protein 5; discs large homolog associated protein 5,,KIAA0008; DLG1; HURP,DLG associated protein 5,DLG7; HURP,DLGAP5
Q15417,CNN3_HUMAN,CNN3,Calponin-3; Calponin; acidic isoform,,1266,calponin 3,calponin 3; acidic,,,calponin 3,,CNN3
Q15418,KS6A1_HUMAN,RPS6KA1; MAPKAPK1A; RSK1,Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAPK-1a; Ribosomal S6 kinase 1; RSK-1,MAPKAPK1A; RSK1,6195,ribosomal protein S6 kinase A1,ribosomal protein S6 kinase; 90kD; polypeptide 1,,RSK1; HU-1; p90Rsk; MAPKAPK1,ribosomal protein S6 kinase A1,HU-1; MAPKAPK1; MAPKAPK1A; RSK; RSK1; p90Rsk,RPS6KA1
Q15435,PP1R7_HUMAN,PPP1R7; SDS22,Protein phosphatase 1 regulatory subunit 7; Protein phosphatase 1 regulatory subunit 22,SDS22,5510,protein phosphatase 1 regulatory subunit 7,protein phosphatase 1; regulatory (inhibitor) subunit 7; protein phosphatase 1; regulatory subunit 7,,sds22,protein phosphatase 1 regulatory subunit 7,SDS22,PPP1R7
Q15436,SC23A_HUMAN,SEC23A,Protein transport protein Sec23A; hSec23A; SEC23-related protein A,,10484,SEC23 homolog A; COPII coat complex component,Sec23 (S. cerevisiae) homolog A; Sec23 homolog A (S. cerevisiae); Sec23 homolog A; COPII coat complex component,,,SEC23 homolog A; COPII coat complex component,CLSD; hSec23A,SEC23A
Q15466,NR0B2_HUMAN,NR0B2; SHP,Nuclear receptor subfamily 0 group B member 2; Orphan nuclear receptor SHP; Small heterodimer partner,SHP,8431,nuclear receptor subfamily 0 group B member 2,nuclear receptor subfamily 0; group B; member 2,,SHP,nuclear receptor subfamily 0 group B member 2,SHP; SHP1,NR0B2
Q15468,STIL_HUMAN,STIL; SIL,SCL-interrupting locus protein; TAL-1-interrupting locus protein,SIL,6491,STIL centriolar assembly protein,TAL1 (SCL) interrupting locus; SCL/TAL1 interrupting locus,,MCPH7,STIL centriolar assembly protein,MCPH7; SIL,STIL
Q15545,TAF7_HUMAN,TAF7; TAF2F; TAFII55,Transcription initiation factor TFIID subunit 7; RNA polymerase II TBP-associated factor subunit F; Transcription initiation factor TFIID 55 kDa subunit; TAF(II; TAFII-55; TAFII55,TAF2F; TAFII55,6879,TATA-box binding protein associated factor 7,TATA box binding protein (TBP)-associated factor; RNA polymerase II; F; 55kD; TAF7 RNA polymerase II; TATA box binding protein (TBP)-associated factor; 55kDa,,TAFII55,TATA-box binding protein associated factor 7,TAF2F; TAFII55,TAF7
Q15554,TERF2_HUMAN,TERF2; TRBF2; TRF2,Telomeric repeat-binding factor 2; TTAGGG repeat-binding factor 2; Telomeric DNA-binding protein,TRBF2; TRF2,7014,telomeric repeat binding factor 2,,,TRF2,telomeric repeat binding factor 2,TRBF2; TRF2,TERF2
Q15555,MARE2_HUMAN,MAPRE2; RP1,Microtubule-associated protein RP/EB family member 2; APC-binding protein EB2; End-binding protein 2; EB2,RP1,10982,microtubule associated protein RP/EB family member 2,,APC-binding protein EB1,RP1; EB1; EB2,microtubule associated protein RP/EB family member 2,CSCSC2; EB1; EB2; RP1,MAPRE2
Q15596,NCOA2_HUMAN,NCOA2; BHLHE75; SRC2; TIF2,Nuclear receptor coactivator 2; NCoA-2; Class E basic helix-loop-helix protein 75; bHLHe75; Transcriptional intermediary factor 2; hTIF2,BHLHE75; SRC2; TIF2,10499,nuclear receptor coactivator 2,,glucocorticoid receptor interacting protein 1,TIF2; GRIP1; NCoA-2; KAT13C; bHLHe75,nuclear receptor coactivator 2,GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75,NCOA2
Q15599,NHRF2_HUMAN,NHERF2; SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2; +; +; NHERF-2; NHE3 kinase A regulatory protein E3KARP; SRY-interacting protein 1; SIP-1; Sodium-hydrogen exchanger regulatory factor 2; Solute carrier family 9 isoform A3 regulatory factor 2; Tyrosine kinase activator protein 1; TKA-1,SLC9A3R2,9351,NHERF family PDZ scaffold protein 2,solute carrier family 9 (sodium/hydrogen exchanger); isoform 3 regulatory factor 2; solute carrier family 9 (sodium/hydrogen exchanger); isoform 3 regulator 2; solute carrier family 9 (sodium/hydrogen exchanger); member 3 regulator 2; solute carrier family 9; subfamily A (NHE3; cation proton antiporter 3); member 3 regulator 2; SLC9A3 regulator 2,Na(+)/H(+) exchange regulatory cofactor 2; SRY-interacting protein 1; NHE3 kinase A regulatory protein; Tyrosine kinase activator protein 1,SIP-1; TKA-1; NHERF-2; E3KARP; OCTS2,NHERF family PDZ scaffold protein 2,E3KARP; NHE3RF2; NHERF-2; OCTS2; SIP-1; SIP1; SLC9A3R2; TKA-1,NHERF2
Q155Q3,DIXC1_HUMAN,DIXDC1; CCD1; KIAA1735,Dixin; Coiled-coil protein DIX1; Coiled-coil-DIX1; DIX domain-containing protein 1,CCD1; KIAA1735,85458,DIX domain containing 1,,,KIAA1735; Dixin,DIX domain containing 1,CCD1,DIXDC1
Q15633,TRBP2_HUMAN,TARBP2; TRBP,RISC-loading complex subunit TARBP2; TAR RNA-binding protein 2; Trans-activation-responsive RNA-binding protein,TRBP,6895,TARBP2 subunit of RISC loading complex,TAR (HIV-1) RNA binding protein 2; TARBP2; RISC loading complex RNA binding subunit,TAR RNA binding protein 2; TAR (HIV) RNA-binding protein 2; trans-activation responsive RNA-binding protein,Trbp,TARBP2 subunit of RISC loading complex,LOQS; TRBP; TRBP1; TRBP2,TARBP2
Q15637,SF01_HUMAN,SF1; ZFM1; ZNF162,Splicing factor 1; Mammalian branch point-binding protein; BBP; mBBP; Transcription factor ZFM1; Zinc finger gene in MEN1 locus; Zinc finger protein 162,ZFM1; ZNF162,7536,splicing factor 1,zinc finger protein 162,branch point-binding protein,ZFM1; ZCCHC25; BBP,splicing factor 1,BBP; D11S636; MBBP; ZCCHC25; ZFM1; ZNF162,SF1
Q15642,CIP4_HUMAN,TRIP10; CIP4; STOT; STP,Cdc42-interacting protein 4; Protein Felic; Salt tolerant protein; hSTP; Thyroid receptor-interacting protein 10; TR-interacting protein 10; TRIP-10,CIP4; STOT; STP,9322,thyroid hormone receptor interactor 10,salt tolerator,Cdc42-interacting protein,STP; HSTP; CIP4,thyroid hormone receptor interactor 10,CIP4; HSTP; STOT; STP; TRIP-10,TRIP10
Q15648,MED1_HUMAN,MED1; ARC205; CRSP1; CRSP200; DRIP205; DRIP230; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2,Mediator of RNA polymerase II transcription subunit 1; Activator-recruited cofactor 205 kDa component; ARC205; Mediator complex subunit 1; Peroxisome proliferator-activated receptor-binding protein; PBP; PPAR-binding protein; Thyroid hormone receptor-associated protein complex 220 kDa component; Trap220; Thyroid receptor-interacting protein 2; TR-interacting protein 2; TRIP-2; Vitamin D receptor-interacting protein complex component DRIP205; p53 regulatory protein RB18A,ARC205; CRSP1; CRSP200; DRIP205; DRIP230; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2,5469,mediator complex subunit 1,PPAR binding protein,,PBP; TRAP220; RB18A; DRIP230; CRSP200; CRSP1,mediator complex subunit 1,CRSP1; CRSP200; DRIP205; DRIP230; PBP; PPARBP; PPARGBP; RB18A; TRAP220; TRIP2,MED1
Q15653,IKBB_HUMAN,NFKBIB; IKBB; TRIP9,NF-kappa-B inhibitor beta; NF-kappa-BIB; I-kappa-B-beta; IkB-B; IkB-beta; IkappaBbeta; Thyroid receptor-interacting protein 9; TR-interacting protein 9; TRIP-9,IKBB; TRIP9,4793,NFKB inhibitor beta,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; beta,NF-kappa-B inhibitor beta,IKBB; TRIP9,NFKB inhibitor beta,IKBB; TRIP9,NFKBIB
Q15654,TRIP6_HUMAN,TRIP6; OIP1,Thyroid receptor-interacting protein 6; TR-interacting protein 6; TRIP-6; Opa-interacting protein 1; OIP-1; Zyxin-related protein 1; ZRP-1,OIP1,7205,thyroid hormone receptor interactor 6,,,ZRP-1; OIP1; MGC10556; MGC10558; MGC29959; MGC3837; MGC4423,thyroid hormone receptor interactor 6,OIP-1; OIP1; TRIP-6; TRIP6i2; ZRP-1,TRIP6
Q15672,TWST1_HUMAN,TWIST1; BHLHA38; TWIST,Twist-related protein 1; Class A basic helix-loop-helix protein 38; bHLHa38; H-twist,BHLHA38; TWIST,7291,twist family bHLH transcription factor 1,blepharophimosis; epicanthus inversus and ptosis 3; acrocephalosyndactyly 3; twist homolog 1 (Drosophila); twist basic helix-loop-helix transcription factor 1; craniosynostosis,Saethre-Chotzen syndrome,SCS; H-twist; BPES2; bHLHa38; CRS1,twist family bHLH transcription factor 1,ACS3; BPES2; BPES3; CRS; CRS1; CSO; SCS; SWCOS; TWIST; bHLHa38,TWIST1
Q15678,PTN14_HUMAN,PTPN14; PEZ; PTPD2,Tyrosine-protein phosphatase non-receptor type 14; EC 3.1.3.48; Protein-tyrosine phosphatase pez,PEZ; PTPD2,5784,protein tyrosine phosphatase non-receptor type 14,,,PEZ; PTPD2,protein tyrosine phosphatase non-receptor type 14,CATLPH; PEZ; PTP36; PTPD2,PTPN14
Q15691,MARE1_HUMAN,MAPRE1,Microtubule-associated protein RP/EB family member 1; APC-binding protein EB1; End-binding protein 1; EB1,,22919,microtubule associated protein RP/EB family member 1,,adenomatous polyposis coli-binding protein EB1,EB1,microtubule associated protein RP/EB family member 1,EB1,MAPRE1
Q15700,DLG2_HUMAN,DLG2,Disks large homolog 2; Channel-associated protein of synapse-110; Chapsyn-110; Postsynaptic density protein PSD-93,,1740,discs large MAGUK scaffold protein 2,discs; large homolog 2; chapsyn-110 (Drosophila); discs; large homolog 2 (Drosophila); discs large homolog 2,protein phosphatase 1; regulatory subunit 58,PSD-93; PSD93; chapsyn-110; PPP1R58,discs large MAGUK scaffold protein 2,PPP1R58; PSD-93; PSD93; chapsyn-110,DLG2
Q15717,ELAV1_HUMAN,ELAVL1; HUR,ELAV-like protein 1; Hu-antigen R; HuR,HUR,1994,ELAV like RNA binding protein 1,ELAV (embryonic lethal; abnormal vision; Drosophila)-like 1 (Hu antigen R),embryonic lethal; abnormal vision; drosophila; homolog-like 1; Hu antigen R; Human antigen R,HuR; Hua; MelG,ELAV like RNA binding protein 1,ELAV1; HUR; Hua; MelG,ELAVL1
Q15722,LT4R1_HUMAN,LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7,Leukotriene B4 receptor 1; LTB4-R 1; LTB4-R1; Chemoattractant receptor-like 1; G-protein coupled receptor 16; P2Y purinoceptor 7; P2Y7,BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7,1241,leukotriene B4 receptor,,,BLTR; P2Y7; LTB4R1,leukotriene B4 receptor,BLT1; BLTR; CMKRL1; GPR16; LTB4R1; LTBR1; P2RY7; P2Y7,LTB4R
Q15746,MYLK_HUMAN,MYLK; MLCK; MLCK1; MYLK1,Myosin light chain kinase; smooth muscle; MLCK; smMLCK; EC 2.7.11.18; Kinase-related protein; KRP; Telokin,MLCK; MLCK1; MYLK1,4638,myosin light chain kinase,myosin; light polypeptide kinase,smooth muscle myosin light chain kinase; kinase related protein,MLCK; smMLCK; MYLK1; MLCK1; KRP; Telokin; MLCK108; MLCK210; MYLK-L,myosin light chain kinase,AAT7; KRP; MLCK; MLCK1; MLCK108; MLCK210; MMIHS; MMIHS1; MSTP083; MYLK-L; MYLK1; smMLCK,MYLK
Q15750,TAB1_HUMAN,TAB1; MAP3K7IP1,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TGF-beta-activated kinase 1-binding protein 1; TAK1-binding protein 1,MAP3K7IP1,10454,TGF-beta activated kinase 1 (MAP3K7) binding protein 1,mitogen-activated protein kinase kinase kinase 7 interacting protein 1; TGF-beta activated kinase 1/MAP3K7 binding protein 1,TAK1-binding protein 1; mitogen-activated protein kinase kinase kinase 7 interacting protein 1,,TGF-beta activated kinase 1 (MAP3K7) binding protein 1,3'-Tab1; MAP3K7IP1,TAB1
Q15759,MK11_HUMAN,MAPK11; PRKM11; SAPK2; SAPK2B,Mitogen-activated protein kinase 11; MAP kinase 11; MAPK 11; EC 2.7.11.24; Mitogen-activated protein kinase p38 beta; MAP kinase p38 beta; p38b; Stress-activated protein kinase 2b; SAPK2b; p38-2,PRKM11; SAPK2; SAPK2B,5600,mitogen-activated protein kinase 11,,,p38-2; p38Beta; SAPK2,mitogen-activated protein kinase 11,P38B; P38BETA2; PRKM11; SAPK2; SAPK2B; p38-2; p38Beta,MAPK11
Q15762,CD226_HUMAN,CD226; DNAM1,CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD antigen CD226,DNAM1,10666,CD226 molecule,CD226 antigen,,DNAM-1; DNAM1; PTA1; TLiSA1,CD226 molecule,DNAM-1; DNAM1; PTA1; TLiSA1,CD226
Q15788,NCOA1_HUMAN,NCOA1; BHLHE74; SRC1,Nuclear receptor coactivator 1; NCoA-1; EC 2.3.1.48; Class E basic helix-loop-helix protein 74; bHLHe74; Protein Hin-2; RIP160; Renal carcinoma antigen NY-REN-52; Steroid receptor coactivator 1; SRC-1,BHLHE74; SRC1,8648,nuclear receptor coactivator 1,,,SRC1; F-SRC-1; NCoA-1; KAT13A; RIP160; bHLHe74,nuclear receptor coactivator 1,F-SRC-1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74,NCOA1
Q15796,SMAD2_HUMAN,SMAD2; MADH2; MADR2,Mothers against decapentaplegic homolog 2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; SMAD 2; Smad2; hSMAD2,MADH2; MADR2,4087,SMAD family member 2,MAD; mothers against decapentaplegic homolog 2 (Drosophila); SMAD; mothers against DPP homolog 2 (Drosophila),,MADR2; JV18-1,SMAD family member 2,CHTD8; JV18; JV18-1; LDS6; MADH2; MADR2; hMAD-2; hSMAD2,SMAD2
Q15797,SMAD1_HUMAN,SMAD1; BSP1; MADH1; MADR1,Mothers against decapentaplegic homolog 1; MAD homolog 1; Mothers against DPP homolog 1; JV4-1; Mad-related protein 1; SMAD family member 1; SMAD 1; Smad1; hSMAD1; Transforming growth factor-beta-signaling protein 1; BSP-1,BSP1; MADH1; MADR1,4086,SMAD family member 1,MAD; mothers against decapentaplegic homolog 1 (Drosophila); SMAD; mothers against DPP homolog 1 (Drosophila),,MADR1; JV4-1,SMAD family member 1,BSP-1; BSP1; JV4-1; JV41; MADH1; MADR1,SMAD1
Q15813,TBCE_HUMAN,TBCE,Tubulin-specific chaperone E; Tubulin-folding cofactor E,,6905,tubulin folding cofactor E,tubulin-specific chaperone e; Kenny-Caffey syndrome; hypoparathyroidism; growth and mental retardation; and dysmorphism,,KCS1; pac2,tubulin folding cofactor E,HRD; KCS; KCS1; PEAMO; pac2,TBCE
Q15831,STK11_HUMAN,STK11; LKB1; PJS,Serine/threonine-protein kinase STK11; EC 2.7.11.1; Liver kinase B1; LKB1; hLKB1; Renal carcinoma antigen NY-REN-19,LKB1; PJS,6794,serine/threonine kinase 11,serine/threonine kinase 11 (Peutz-Jeghers syndrome),polarization-related protein LKB1,PJS; LKB1,serine/threonine kinase 11,LKB1; PJS; hLKB1,STK11
Q15833,STXB2_HUMAN,STXBP2; UNC18B,Syntaxin-binding protein 2; Protein unc-18 homolog 2; Unc18-2; Protein unc-18 homolog B; Unc-18B,UNC18B,6813,syntaxin binding protein 2,,,UNC18B; Hunc18b; Unc18-2; MUNC18-2,syntaxin binding protein 2,FHL5; Hunc18b; MUNC18-2; UNC18-2; UNC18B; pp10122; unc-18B,STXBP2
Q15835,GRK1_HUMAN,GRK1; RHOK,Rhodopsin kinase GRK1; RK; EC 2.7.11.14; G protein-coupled receptor kinase 1,RHOK,6011,G protein-coupled receptor kinase 1,rhodopsin kinase,,GPRK1; RK,G protein-coupled receptor kinase 1,GPRK1; RHOK; RK,GRK1
Q15853,USF2_HUMAN,USF2; BHLHB12,Upstream stimulatory factor 2; Class B basic helix-loop-helix protein 12; bHLHb12; FOS-interacting protein; FIP; Major late transcription factor 2; Upstream transcription factor 2,BHLHB12,7392,upstream transcription factor 2; c-fos interacting,,,FIP; bHLHb12,upstream transcription factor 2; c-fos interacting,FIP; bHLHb12,USF2
Q15858,SCN9A_HUMAN,SCN9A; NENA,Sodium channel protein type 9 subunit alpha; Neuroendocrine sodium channel; hNE-Na; Peripheral sodium channel 1; PN1; Sodium channel protein type IX subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.7,NENA,6335,sodium voltage-gated channel alpha subunit 9,sodium channel; voltage-gated; type IX; alpha polypeptide; sodium channel; voltage-gated; type IX; alpha subunit; sodium channel; voltage gated; type IX alpha subunit,,Nav1.7; PN1; NE-NA; NENA; ETHA,sodium voltage-gated channel alpha subunit 9,ETHA; FEB3B; GEFSP7; HSAN2D; NE-NA; NENA; Nav1.7; PN1; SFNP,SCN9A
Q15910,EZH2_HUMAN,EZH2; KMT6,Histone-lysine N-methyltransferase EZH2; EC 2.1.1.356; ENX-1; Enhancer of zeste homolog 2; Lysine N-methyltransferase 6,KMT6,2146,enhancer of zeste 2 polycomb repressive complex 2 subunit,enhancer of zeste (Drosophila) homolog 2; enhancer of zeste homolog 2 (Drosophila),,EZH1; ENX-1; KMT6; KMT6A,enhancer of zeste 2 polycomb repressive complex 2 subunit,ENX-1; ENX1; EZH2b; KMT6; KMT6A; WVS; WVS2,EZH2
Q15942,ZYX_HUMAN,ZYX,Zyxin; Zyxin-2,,7791,zyxin,,,,zyxin,ESP-2; HED-2,ZYX
Q16082,HSPB2_HUMAN,HSPB2,Heat shock protein beta-2; HspB2; DMPK-binding protein; MKBP; Heat shock protein family B member 2,,3316,heat shock protein family B (small) member 2,heat shock 27kD protein 2; heat shock 27kDa protein 2,,Hs.78846; MKBP,heat shock protein family B (small) member 2,HSP27; Hs.78846; LOH11CR1K; MKBP,HSPB2
Q16143,SYUB_HUMAN,SNCB,Beta-synuclein,,6620,synuclein beta,,??-synuclein,,synuclein beta,,SNCB
Q16181,SEPT7_HUMAN,SEPTIN7; CDC10; SEPT7,Septin-7; CDC10 protein homolog,CDC10; SEPT7,989,septin 7,CDC10 cell division cycle 10 homolog (S. cerevisiae),,CDC3; SEPT7A; Septin-7,septin 7,CDC10; CDC3; NBLA02942; SEPT7; SEPT7A; Septin-7,SEPTIN7
Q16204,CCDC6_HUMAN,CCDC6; D10S170; TST1,Coiled-coil domain-containing protein 6; Papillary thyroid carcinoma-encoded protein; Protein H4,D10S170; TST1,8030,coiled-coil domain containing 6,DNA segment on chromosome 10 (unique) 170; transforming sequence; thyroid-1,DNA segment; single copy; probe pH4 (transforming sequence; thyroid-1; thyroid papillary carcinoma,PTC; TPC; H4; PTC1,coiled-coil domain containing 6,D10S170; H4; PTC; PTC1; TPC; TST1,CCDC6
Q16206,ENOX2_HUMAN,ENOX2; COVA1,Ecto-NOX disulfide-thiol exchanger 2; APK1 antigen; Cytosolic ovarian carcinoma antigen 1; Tumor-associated hydroquinone oxidase; tNOX; EC 1.-.-.-; EC 1.-.-.-,COVA1,10495,ecto-NOX disulfide-thiol exchanger 2,cytosolic ovarian carcinoma antigen 1,tumor-associated NADH oxidase; ecto-NADPH oxidase disulfide-thiol exchanger 2,APK1; tNOX,ecto-NOX disulfide-thiol exchanger 2,APK1; COVA1; tNOX,ENOX2
Q16236,NF2L2_HUMAN,NFE2L2; NRF2,Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; Nrf-2; Nuclear factor; erythroid derived 2; like 2,NRF2,4780,NFE2 like bZIP transcription factor 2,nuclear factor (erythroid-derived 2)-like 2; nuclear factor; erythroid 2-like 2; nuclear factor; erythroid 2 like 2,NF-E2-related factor 2,NRF2; NRF-2,NFE2 like bZIP transcription factor 2,HEBP1; IMDDHH; NRF2; Nrf-2,NFE2L2
Q16254,E2F4_HUMAN,E2F4,Transcription factor E2F4; E2F-4,,1874,E2F transcription factor 4,E2F transcription factor 4; p107/p130-binding,,E2F-4,E2F transcription factor 4,E2F-4,E2F4
Q16288,NTRK3_HUMAN,NTRK3; TRKC,NT-3 growth factor receptor; EC 2.7.10.1; GP145-TrkC; Trk-C; Neurotrophic tyrosine kinase receptor type 3; TrkC tyrosine kinase,TRKC,4916,neurotrophic receptor tyrosine kinase 3,neurotrophic tyrosine kinase; receptor; type 3,,TRKC,neurotrophic receptor tyrosine kinase 3,GP145-TrkC; TRKC; gp145(trkC),NTRK3
Q16512,PKN1_HUMAN,PKN1; PAK1; PKN; PRK1; PRKCL1,Serine/threonine-protein kinase N1; EC 2.7.11.13; Protease-activated kinase 1; PAK-1; Protein kinase C-like 1; Protein kinase C-like PKN; Protein kinase PKN-alpha; Protein-kinase C-related kinase 1; Serine-threonine protein kinase N,PAK1; PKN; PRK1; PRKCL1,5585,protein kinase N1,protein kinase C-like 1,,DBK; PRK1; PKN; MGC46204; PAK1,protein kinase N1,DBK; PAK-1; PAK1; PKN; PKN-ALPHA; PRK1; PRKCL1,PKN1
Q16513,PKN2_HUMAN,PKN2; PRK2; PRKCL2,Serine/threonine-protein kinase N2; EC 2.7.11.13; PKN gamma; Protein kinase C-like 2; Protein-kinase C-related kinase 2,PRK2; PRKCL2,5586,protein kinase N2,protein kinase C-like 2,cardiolipin-activated protein kinase Pak2,PRK2; Pak-2; STK7,protein kinase N2,PAK2; PRK2; PRKCL2; PRO2042; Pak-2; STK7,PKN2
Q16531,DDB1_HUMAN,DDB1; XAP1,DNA damage-binding protein 1; DDB p127 subunit; DNA damage-binding protein a; DDBa; Damage-specific DNA-binding protein 1; HBV X-associated protein 1; XAP-1; UV-damaged DNA-binding factor; UV-damaged DNA-binding protein 1; UV-DDB 1; XPE-binding factor; XPE-BF; Xeroderma pigmentosum group E-complementing protein; XPCe,XAP1,1642,damage specific DNA binding protein 1,damage-specific DNA binding protein 1 (127kD),,,damage specific DNA binding protein 1,DDBA; UV-DDB1; WHIKERS; XAP1; XPCE; XPE; XPE-BF,DDB1
Q16537,2A5E_HUMAN,PPP2R5E,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform; PP2A B subunit isoform B'-epsilon; PP2A B subunit isoform B56-epsilon; PP2A B subunit isoform PR61-epsilon; PP2A B subunit isoform R5-epsilon,,5529,protein phosphatase 2 regulatory subunit B'epsilon,protein phosphatase 2; regulatory subunit B (B56); epsilon isoform,,B56E; B56epsilon,protein phosphatase 2 regulatory subunit B'epsilon,B56E; B56epsilon,PPP2R5E
Q16539,MK14_HUMAN,MAPK14; CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A,Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; EC 2.7.11.24; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; MAP kinase p38 alpha; Stress-activated protein kinase 2a; SAPK2a,CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A,1432,mitogen-activated protein kinase 14,,p38 MAP kinase,PRKM14; p38; Mxi2; PRKM15,mitogen-activated protein kinase 14,CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA,MAPK14
Q16543,CDC37_HUMAN,CDC37; CDC37A,Hsp90 co-chaperone Cdc37; Hsp90 chaperone protein kinase-targeting subunit; p50Cdc37,CDC37A,11140,cell division cycle 37; HSP90 cochaperone,CDC37 (cell division cycle 37; S. cerevisiae; homolog); CDC37 cell division cycle 37 homolog (S. cerevisiae); cell division cycle 37 homolog (S. cerevisiae),CDC37 cell division cycle 37 homolog; Hsp90 co-chaperone Cdc37; CDC37 (cell division cycle 37; S. cerevisiae; homolog),P50CDC37,cell division cycle 37; HSP90 cochaperone,P50CDC37,CDC37
Q16555,DPYL2_HUMAN,DPYSL2; CRMP2; ULIP2,Dihydropyrimidinase-related protein 2; DRP-2; Collapsin response mediator protein 2; CRMP-2; N2A3; Unc-33-like phosphoprotein 2; ULIP-2,CRMP2; ULIP2,1808,dihydropyrimidinase like 2,dihydropyrimidinase-like 2,,DRP-2; DHPRP2; CRMP2; DRP2,dihydropyrimidinase like 2,CRMP-2; CRMP2; DHPRP2; DRP-2; DRP2; N2A3; ULIP-2; ULIP2,DPYSL2
Q16558,KCMB1_HUMAN,KCNMB1,Calcium-activated potassium channel subunit beta-1; BK channel subunit beta-1; BKbeta; BKbeta1; Hbeta1; Calcium-activated potassium channel; subfamily M subunit beta-1; Calcium-activated potassium channel subunit beta; Charybdotoxin receptor subunit beta-1; K(VCA; Maxi K channel subunit beta-1; Slo-beta-1; Slo-beta,,3779,potassium calcium-activated channel subfamily M regulatory beta subunit 1,potassium large conductance calcium-activated channel; subfamily M; beta member 1; potassium channel subfamily M regulatory beta subunit 1,BK channel beta subunit 1; MaxiK channel beta-subunit 1; big potassium channel beta subunit 1,hslo-beta,potassium calcium-activated channel subfamily M regulatory beta subunit 1,BKbeta1; K(VCA)beta; SLO-BETA; hbeta1; hslo-beta; k(VCA)beta-1; slo-beta-1,KCNMB1
Q16566,KCC4_HUMAN,CAMK4; CAMK; CAMK-GR; CAMKIV,Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; EC 2.7.11.17; CaM kinase-GR,CAMK; CAMK-GR; CAMKIV,814,calcium/calmodulin dependent protein kinase IV,,brain Ca++-calmodulin-dependent protein kinase type IV; calcium/calmodulin-dependent protein kinase type IV catalytic chain; CAM kinase IV; CAM kinase- GR,CaMK-GR; CaMKIV,calcium/calmodulin dependent protein kinase IV,CaMK IV; CaMK-GR; CaMKIV; caMK,CAMK4
Q16584,M3K11_HUMAN,MAP3K11; MLK3; PTK1; SPRK,Mitogen-activated protein kinase kinase kinase 11; EC 2.7.11.25; Mixed lineage kinase 3; Src-homology 3 domain-containing proline-rich kinase,MLK3; PTK1; SPRK,4296,mitogen-activated protein kinase kinase kinase 11,,,SPRK; MEKK11,mitogen-activated protein kinase kinase kinase 11,MEKK11; MLK-3; MLK3; PTK1; SPRK,MAP3K11
Q16595,FRDA_HUMAN,FXN; FRDA; X25,Frataxin; mitochondrial; EC 1.16.3.1; Friedreich ataxia protein; Fxn; i-FXN; 56-210; m56-FXN; 78-210; d-FXN; m78-FXN; Frataxin(81-210; m81-FXN,FRDA; X25,2395,frataxin,Friedreich ataxia,,FA; FARR; X25; CyaY,frataxin,CyaY; FA; FARR; FRDA; X25,FXN
Q16600,ZN239_HUMAN,ZNF239; HOK2; MOK2,Zinc finger protein 239; Zinc finger protein HOK-2; Zinc finger protein MOK-2,HOK2; MOK2,8187,zinc finger protein 239,,,MOK2; HOK-2,zinc finger protein 239,HOK-2; MOK2,ZNF239
Q16611,BAK_HUMAN,BAK1; BAK; BCL2L7; CDN1,Bcl-2 homologous antagonist/killer; Apoptosis regulator BAK; Bcl-2-like protein 7; Bcl2-L-7,BAK; BCL2L7; CDN1,578,BCL2 antagonist/killer 1,BCL2-antagonist/killer 1,,BCL2L7; BAK,BCL2 antagonist/killer 1,BAK; BAK-LIKE; BCL2L7; CDN1,BAK1
Q16612,NREP_HUMAN,NREP; C5orf13; P311,Neuronal regeneration-related protein; Neuronal protein 3.1; Protein p311,C5orf13; P311,9315,neuronal regeneration related protein,chromosome 5 open reading frame 13; neuronal regeneration related protein homolog (rat),neuronal protein 3.1,P311; D4S114; PRO1873; PTZ17; SEZ17,neuronal regeneration related protein,C5orf13; D4S114; P311; PRO1873; PTZ17; SEZ17,NREP
Q16620,NTRK2_HUMAN,NTRK2; TRKB,BDNF/NT-3 growth factors receptor; EC 2.7.10.1; GP145-TrkB; Trk-B; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine kinase; Tropomyosin-related kinase B,TRKB,4915,neurotrophic receptor tyrosine kinase 2,neurotrophic tyrosine kinase; receptor; type 2,BDNF/NT-3 growth factors receptor,TRKB,neurotrophic receptor tyrosine kinase 2,DEE58; EIEE58; GP145-TrkB; OBHD; TRKB; trk-B,NTRK2
Q16621,NFE2_HUMAN,NFE2,Transcription factor NF-E2 45 kDa subunit; Leucine zipper protein NF-E2; Nuclear factor; erythroid-derived 2 45 kDa subunit; p45 NF-E2,,4778,nuclear factor; erythroid 2,nuclear factor (erythroid-derived 2); 45kD; nuclear factor (erythroid-derived 2); 45kDa,,NF-E2,nuclear factor; erythroid 2,NF-E2; p45,NFE2
Q16623,STX1A_HUMAN,STX1A; STX1,Syntaxin-1A; Neuron-specific antigen HPC-1,STX1,6804,syntaxin 1A,syntaxin 1A (brain),,HPC-1; p35-1,syntaxin 1A,HPC-1; P35-1; STX1; SYN1A,STX1A
Q16625,OCLN_HUMAN,OCLN,Occludin,,100506658,occludin,,tight junction protein occludin TM4 minus; phosphatase 1; regulatory subunit 115,PPP1R115,occludin,BLCPMG; PPP1R115; PTORCH1,OCLN
Q16629,SRSF7_HUMAN,SRSF7; SFRS7,Serine/arginine-rich splicing factor 7; Splicing factor 9G8; Splicing factor; arginine/serine-rich 7,SFRS7,6432,serine and arginine rich splicing factor 7,splicing factor; arginine/serine-rich 7 (35kD); splicing factor; arginine/serine-rich 7; 35kDa; serine/arginine-rich splicing factor 7,SR splicing factor 7,9G8; ZCRB2; HSSG1; AAG3; RBM37; ZCCHC20,serine and arginine rich splicing factor 7,9G8; AAG3; SFRS7,SRSF7
Q16637,SMN_HUMAN,SMN1; SMN; SMNT;; SMN2; SMNC,Survival motor neuron protein; Component of gems 1; Gemin-1,SMN; SMNT;; SMNC,6606,survival of motor neuron 1; telomeric,spinal muscular atrophy (Werdnig-Hoffmann disease; Kugelberg-Welander disease),gemin-1; tudor domain containing 16A,BCD541; SMNT; SMA1; SMA2; SMA3; GEMIN1; TDRD16A,survival of motor neuron 1; telomeric,BCD541; GEMIN1; SMA; SMA1; SMA2; SMA3; SMA4; SMA@; SMN; SMNT; T-BCD541; TDRD16A,SMN1; SMN2
Q16643,DREB_HUMAN,DBN1; D0S117E,Drebrin; Developmentally-regulated brain protein,D0S117E,1627,drebrin 1,,,,drebrin 1,D0S117E,DBN1
Q16644,MAPK3_HUMAN,MAPKAPK3,MAP kinase-activated protein kinase 3; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAP-K3; MAPKAPK-3; MK-3; EC 2.7.11.1; Chromosome 3p kinase; 3pK,,7867,MAPK activated protein kinase 3,mitogen-activated protein kinase-activated protein kinase 3,,3pK; MAPKAP3; 3PK; MK-3; MK3,MAPK activated protein kinase 3,3PK; MAPKAP-K3; MAPKAP3; MAPKAPK-3; MDPT3; MK-3; MK3,MAPKAPK3
Q16654,PDK4_HUMAN,PDK4; PDHK4,Pyruvate dehydrogenase; acetyl-transferring; EC 2.7.11.2; Pyruvate dehydrogenase kinase isoform 4,PDHK4,5166,pyruvate dehydrogenase kinase 4,pyruvate dehydrogenase kinase; isoenzyme 4; pyruvate dehydrogenase kinase; isozyme 4,,,pyruvate dehydrogenase kinase 4,,PDK4
Q16658,FSCN1_HUMAN,FSCN1; FAN1; HSN; SNL,Fascin; 55 kDa actin-bundling protein; Singed-like protein; p55,FAN1; HSN; SNL,6624,fascin actin-bundling protein 1,singed (Drosophila)-like (sea urchin fascin homolog like); fascin homolog 1; actin-bundling protein (Strongylocentrotus purpuratus),Singed; drosophila; homolog-like; actin bundling protein,p55; FLJ38511,fascin actin-bundling protein 1,FAN1; HSN; SNL; p55,FSCN1
Q16659,MK06_HUMAN,MAPK6; ERK3; PRKM6,Mitogen-activated protein kinase 6; MAP kinase 6; MAPK 6; EC 2.7.11.24; Extracellular signal-regulated kinase 3; ERK-3; MAP kinase isoform p97; p97-MAPK,ERK3; PRKM6,5597,mitogen-activated protein kinase 6,,,ERK3; p97MAPK; HsT17250,mitogen-activated protein kinase 6,ERK3; HsT17250; PRKM6; p97MAPK,MAPK6
Q16665,HIF1A_HUMAN,HIF1A; BHLHE78; MOP1; PASD8,Hypoxia-inducible factor 1-alpha; HIF-1-alpha; HIF1-alpha; ARNT-interacting protein; Basic-helix-loop-helix-PAS protein MOP1; Class E basic helix-loop-helix protein 78; bHLHe78; Member of PAS protein 1; PAS domain-containing protein 8,BHLHE78; MOP1; PASD8,3091,hypoxia inducible factor 1 subunit alpha,hypoxia inducible factor 1; alpha subunit (basic helix-loop-helix transcription factor),PAS domain-containing protein 8; Class E basic helix-loop-helix protein 78; Member of PAS protein 1,MOP1; HIF-1alpha; PASD8; HIF1; bHLHe78,hypoxia inducible factor 1 subunit alpha,HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78,HIF1A
Q16666,IF16_HUMAN,IFI16; IFNGIP1,Gamma-interferon-inducible protein 16; Ifi-16; Interferon-inducible myeloid differentiation transcriptional activator,IFNGIP1,3428,interferon gamma inducible protein 16,,,IFNGIP1; PYHIN2,interferon gamma inducible protein 16,IFNGIP1; PYHIN2,IFI16
Q16667,CDKN3_HUMAN,CDKN3; CDI1; CIP2; KAP,Cyclin-dependent kinase inhibitor 3; EC 3.1.3.16; EC 3.1.3.48; CDK2-associated dual-specificity phosphatase; Cyclin-dependent kinase interactor 1; Cyclin-dependent kinase-interacting protein 2; Kinase-associated phosphatase,CDI1; CIP2; KAP,1033,cyclin dependent kinase inhibitor 3,,kinase associated phosphatase; cyclin-dependent kinase inhibitor; CDK2-associated dual specificity phosphatase,KAP; CDI1,cyclin dependent kinase inhibitor 3,CDI1; CIP2; KAP; KAP1,CDKN3
Q16690,DUS5_HUMAN,DUSP5; VH3,Dual specificity protein phosphatase 5; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase hVH3,VH3,1847,dual specificity phosphatase 5,,,HVH3,dual specificity phosphatase 5,DUSP; HVH3,DUSP5
Q16695,H31T_HUMAN,H3-4; H3FT; HIST3H3,Histone H3.1t; H3/t; H3t; H3/g; Histone H3.4,H3FT; HIST3H3,8290,H3.4 histone; cluster member,H3 histone family; member T; histone 3; H3; histone cluster 3; H3; histone cluster 3 H3; H3.4 histone,H3 clustered histone 16,H3t; H3/g; H3.4; H3C16,H3.4 histone; cluster member,H3.4; H3/g; H3C16; H3FT; H3t; HIST3H3,H3-4
Q16720,AT2B3_HUMAN,ATP2B3,Plasma membrane calcium-transporting ATPase 3; PMCA3; EC 7.2.2.10; Plasma membrane calcium ATPase isoform 3; Plasma membrane calcium pump isoform 3,,492,ATPase plasma membrane Ca2+ transporting 3,spinocerebellar ataxia; X-linked 1; cerebellar ataxia 2 (X-linked); ATPase; Ca++ transporting; plasma membrane 3,plasma membrane calcium-transporting ATPase 3; cilia and flagella associated protein 39,PMCA3; CFAP39,ATPase plasma membrane Ca2+ transporting 3,CFAP39; CLA2; OPCA; PMCA3; PMCA3a; SCAX1,ATP2B3
Q16763,UBE2S_HUMAN,UBE2S; E2EPF; OK/SW-cl.73,Ubiquitin-conjugating enzyme E2 S; EC 2.3.2.23; E2 ubiquitin-conjugating enzyme S; E2-EPF; Ubiquitin carrier protein S; Ubiquitin-conjugating enzyme E2-24 kDa; Ubiquitin-conjugating enzyme E2-EPF5; Ubiquitin-protein ligase S,E2EPF,27338,ubiquitin conjugating enzyme E2 S,ubiquitin-conjugating enzyme E2S,ubiquitin carrier protein; ubiquitin-conjugating enzyme E2-24 kD; ubiquitin-protein ligase,E2-EPF,ubiquitin conjugating enzyme E2 S,E2-EPF; E2EPF; EPF5,UBE2S
Q16778,H2B2E_HUMAN,H2BC21; H2BFQ; HIST2H2BE,Histone H2B type 2-E; H2B-clustered histone 21; Histone H2B-GL105; Histone H2B.q; H2B/q,H2BFQ; HIST2H2BE,8349,H2B clustered histone 21,H2B histone family; member Q; histone 2; H2be; histone cluster 2; H2be; histone cluster 2 H2B family member e,,H2B/q; H2B.1; H2BE; H2B-GL105,H2B clustered histone 21,GL105; H2B; H2B-GL105; H2B.1; H2BE; H2BFQ; H2BGL105; H2BQ; HIST2H2BE,H2BC21
Q16790,CAH9_HUMAN,CA9; G250; MN,Carbonic anhydrase 9; EC 4.2.1.1; Carbonate dehydratase IX; Carbonic anhydrase IX; CA-IX; CAIX; Membrane antigen MN; P54/58N; Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; pMW1,G250; MN,768,carbonic anhydrase 9,carbonic anhydrase IX,carbonic dehydratase; RCC-associated protein G250,MN; CAIX,carbonic anhydrase 9,CAIX; MN,CA9
Q16816,PHKG1_HUMAN,PHKG1; PHKG,Phosphorylase b kinase gamma catalytic chain; skeletal muscle/heart isoform; PHK-gamma-M; EC 2.7.11.19; Phosphorylase kinase subunit gamma-1; Serine/threonine-protein kinase PHKG1; EC 2.7.11.1; EC 2.7.11.26,PHKG,5260,phosphorylase kinase catalytic subunit gamma 1,phosphorylase kinase; gamma 1 (muscle),,,phosphorylase kinase catalytic subunit gamma 1,PHKG,PHKG1
Q16821,PPR3A_HUMAN,PPP1R3A; PP1G,Protein phosphatase 1 regulatory subunit 3A; Protein phosphatase 1 glycogen-associated regulatory subunit; Protein phosphatase type-1 glycogen targeting subunit; RG1,PP1G,5506,protein phosphatase 1 regulatory subunit 3A,protein phosphatase 1; regulatory (inhibitor) subunit 3A (glycogen and sarcoplasmic reticulum binding subunit; skeletal muscle); protein phosphatase 1; regulatory (inhibitor) subunit 3A; protein phosphatase 1; regulatory subunit 3A,glycogen-associated regulatory subunit of protein phosphatase-1; protein phosphatase 1 regulatory subunit GM,GM,protein phosphatase 1 regulatory subunit 3A,GM; PP1G; PPP1R3,PPP1R3A
Q16825,PTN21_HUMAN,PTPN21; PTPD1,Tyrosine-protein phosphatase non-receptor type 21; EC 3.1.3.48; Protein-tyrosine phosphatase D1,PTPD1,11099,protein tyrosine phosphatase non-receptor type 21,,,PTPD1; PTPRL10,protein tyrosine phosphatase non-receptor type 21,PTPD1; PTPRL10,PTPN21
Q16827,PTPRO_HUMAN,PTPRO; GLEPP1; PTPU2,Receptor-type tyrosine-protein phosphatase O; R-PTP-O; EC 3.1.3.48; Glomerular epithelial protein 1; Protein tyrosine phosphatase U2; PTP-U2; PTPase U2,GLEPP1; PTPU2,5800,protein tyrosine phosphatase receptor type O,,osteoclastic transmembrane protein-tyrosine phosphatase,PTPU2; GLEPP1; PTP-U2; PTP-oc; NPHS6,protein tyrosine phosphatase receptor type O,GLEPP1; NPHS6; PTP-OC; PTP-U2; PTPROT; PTPU2; R-PTP-O,PTPRO
Q16828,DUS6_HUMAN,DUSP6; MKP3; PYST1,Dual specificity protein phosphatase 6; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase PYST1; Mitogen-activated protein kinase phosphatase 3; MAP kinase phosphatase 3; MKP-3,MKP3; PYST1,1848,dual specificity phosphatase 6,,,MKP-3; PYST1,dual specificity phosphatase 6,HH19; MKP3; PYST1,DUSP6
Q16829,DUS7_HUMAN,DUSP7; PYST2,Dual specificity protein phosphatase 7; EC 3.1.3.16; EC 3.1.3.48; Dual specificity protein phosphatase PYST2,PYST2,1849,dual specificity phosphatase 7,,,MKP-X; PYST2,dual specificity phosphatase 7,MKPX; PYST2,DUSP7
Q16832,DDR2_HUMAN,DDR2; NTRKR3; TKT; TYRO10,Discoidin domain-containing receptor 2; Discoidin domain receptor 2; EC 2.7.10.1; CD167 antigen-like family member B; Discoidin domain-containing receptor tyrosine kinase 2; Neurotrophic tyrosine kinase; receptor-related 3; Receptor protein-tyrosine kinase TKT; Tyrosine-protein kinase TYRO10; CD antigen CD167b,NTRKR3; TKT; TYRO10,4921,discoidin domain receptor tyrosine kinase 2,discoidin domain receptor family; member 2,,TKT,discoidin domain receptor tyrosine kinase 2,MIG20a; NTRKR3; TKT; TYRO10; WRCN,DDR2
Q16873,LTC4S_HUMAN,LTC4S,Leukotriene C4 synthase; LTC4 synthase; EC 4.4.1.20; Glutathione S-transferase LTC4; EC 2.5.1.-; Leukotriene-C(4; Leukotriene-C4 synthase,,4056,leukotriene C4 synthase,,,MGC33147,leukotriene C4 synthase,,LTC4S
Q16875,F263_HUMAN,PFKFB3,6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 3; 6PF-2-K/Fru-2;6-P2ase 3; PFK/FBPase 3; 6PF-2-K/Fru-2;6-P2ase brain/placenta-type isozyme; Renal carcinoma antigen NY-REN-56; iPFK-2; EC 2.7.1.105; EC 3.1.3.46,,5209,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 3,,,,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 3,IPFK2; PFK2; iPFK-2,PFKFB3
Q16877,F264_HUMAN,PFKFB4,6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 4; 6PF-2-K/Fru-2;6-P2ase 4; PFK/FBPase 4; 6PF-2-K/Fru-2;6-P2ase testis-type isozyme; EC 2.7.1.105; EC 3.1.3.46,,5210,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 4,,,,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 4,,PFKFB4
Q16891,MIC60_HUMAN,IMMT; HMP; MIC60; MINOS2; PIG4; PIG52,MICOS complex subunit MIC60; Cell proliferation-inducing gene 4/52 protein; Mitochondrial inner membrane protein; Mitofilin; p87/89,HMP; MIC60; MINOS2,10989,inner membrane mitochondrial protein,inner membrane protein; mitochondrial (mitofilin),mitofilin; mitochondrial inner membrane organizing system 2; heart muscle protein; mitochondrial contact site and cristae organizing system subunit 60,P87; P89; HMP; MINOS2; Mic60; MICOS60,inner membrane mitochondrial protein,HMP; MICOS60; MINOS2; Mic60; P87; P87/89; P89; PIG4; PIG52,IMMT
Q17RY0,CPEB4_HUMAN,CPEB4; KIAA1673,Cytoplasmic polyadenylation element-binding protein 4; CPE-BP4; CPE-binding protein 4; hCPEB-4,KIAA1673,80315,cytoplasmic polyadenylation element binding protein 4,,,KIAA1673,cytoplasmic polyadenylation element binding protein 4,CPE-BP4; hCPEB-4,CPEB4
Q27J81,INF2_HUMAN,INF2; C14orf151; C14orf173,Inverted formin-2; HBEBP2-binding protein C,C14orf151; C14orf173,64423,inverted formin 2,chromosome 14 open reading frame 151; chromosome 14 open reading frame 173; inverted formin; FH2 and WH2 domain containing,,MGC13251,inverted formin 2,C14orf151; C14orf173; CMTDIE; FSGS5; pp9484,INF2
Q2M1Z3,RHG31_HUMAN,ARHGAP31; CDGAP; KIAA1204,Rho GTPase-activating protein 31; Cdc42 GTPase-activating protein,CDGAP; KIAA1204,57514,Rho GTPase activating protein 31,,,CDGAP,Rho GTPase activating protein 31,AOS; AOS1; CDGAP,ARHGAP31
Q2M2I8,AAK1_HUMAN,AAK1; KIAA1048,AP2-associated protein kinase 1; EC 2.7.11.1; Adaptor-associated kinase 1,KIAA1048,22848,AP2 associated kinase 1,,,KIAA1048; DKFZp686K16132,AP2 associated kinase 1,,AAK1
Q2M2Z5,KIZ_HUMAN,KIZ; C20orf19; NCRNA00153; PLK1S1; HT013,Centrosomal protein kizuna; Polo-like kinase 1 substrate 1,C20orf19; NCRNA00153; PLK1S1,55857,kizuna centrosomal protein,non-protein coding RNA 153; chromosome 20 open reading frame 19; polo-like kinase 1 substrate 1,,HT013,kizuna centrosomal protein,C20orf19; HT013; Kizuna; NCRNA00153; PLK1S1; RP69,KIZ
Q2NKX8,ERC6L_HUMAN,ERCC6L; PICH,DNA excision repair protein ERCC-6-like; EC 3.6.4.12; ATP-dependent helicase ERCC6-like; PLK1-interacting checkpoint helicase; Tumor antigen BJ-HCC-15,PICH,54821,ERCC excision repair 6 like; spindle assembly checkpoint helicase,excision repair cross-complementing rodent repair deficiency; complementation group 6-like; excision repair cross-complementation group 6 like,PLK1-interacting checkpoint helicase,FLJ20105; PICH; RAD26L,ERCC excision repair 6 like; spindle assembly checkpoint helicase,PICH; RAD26L,ERCC6L
Q2PPJ7,RGPA2_HUMAN,RALGAPA2; C20orf74; KIAA1272,Ral GTPase-activating protein subunit alpha-2; 250 kDa substrate of Akt; AS250; p220,C20orf74; KIAA1272,57186,Ral GTPase activating protein catalytic subunit alpha 2,chromosome 20 open reading frame 74,,dJ1049G11.4; AS250; KIAA1272; RapGAPalpha2,Ral GTPase activating protein catalytic subunit alpha 2,AS250; C20orf74; bA287B20.1; dJ1049G11; dJ1049G11.4; p220,RALGAPA2
Q2TAZ0,ATG2A_HUMAN,ATG2A; KIAA0404,Autophagy-related protein 2 homolog A,KIAA0404,23130,autophagy related 2A,ATG2 autophagy related 2 homolog A (S. cerevisiae),bridge-like lipid transfer protein family member 4A,KIAA0404; BLTP4A,autophagy related 2A,BLTP4A,ATG2A
Q32MK0,MYLK3_HUMAN,MYLK3; MLCK,Myosin light chain kinase 3; EC 2.7.11.18; Cardiac-MyBP-C-associated Ca/CaM kinase; Cardiac-MLCK,MLCK,91807,myosin light chain kinase 3,,MLC kinase,caMLCK; MLCK,myosin light chain kinase 3,MLCK; MLCK2; caMLCK,MYLK3
Q32P44,EMAL3_HUMAN,EML3,Echinoderm microtubule-associated protein-like 3; EMAP-3,,256364,EMAP like 3,echinoderm microtubule associated protein like 3,,FLJ35827; ELP95,EMAP like 3,ELP95; EMAP3; EMAP95,EML3
Q38SD2,LRRK1_HUMAN,LRRK1; KIAA1790,Leucine-rich repeat serine/threonine-protein kinase 1; EC 2.7.11.1,KIAA1790,79705,leucine rich repeat kinase 1,,,FLJ23119; KIAA1790; ROCO1; RIPK6,leucine rich repeat kinase 1,OSMD; RIPK6; Roco1,LRRK1
Q3KR16,PKHG6_HUMAN,PLEKHG6,Pleckstrin homology domain-containing family G member 6; PH domain-containing family G member 6; Myosin-interacting guanine nucleotide exchange factor; MyoGEF,,55200,pleckstrin homology and RhoGEF domain containing G6,pleckstrin homology domain containing; family G (with RhoGef domain) member 6,myosin II interacting GEF,FLJ10665; MYOGEF; ARHGEF46,pleckstrin homology and RhoGEF domain containing G6,ARHGEF46; MyoGEF,PLEKHG6
Q3MJ16,PA24E_HUMAN,PLA2G4E,Cytosolic phospholipase A2 epsilon; cPLA2-epsilon; EC 3.1.1.4; Calcium-dependent N-acyltransferase; Phospholipase A2 group IVE,,123745,phospholipase A2 group IVE,phospholipase A2; group IVE,,FLJ45651,phospholipase A2 group IVE,,PLA2G4E
Q3V6T2,GRDN_HUMAN,CCDC88A; APE; GRDN; KIAA1212,Girdin; Akt phosphorylation enhancer; APE; Coiled-coil domain-containing protein 88A; G alpha-interacting vesicle-associated protein; GIV; Girders of actin filament; Hook-related protein 1; HkRP1,APE; GRDN; KIAA1212,55704,coiled-coil domain containing 88A,KIAA1212,Galpha-interacting vesicle-associated protein; Akt-phosphorylation enhancer; girdin; girders of actin filaments,FLJ10392; APE; GIV; HkRP1; GRDN,coiled-coil domain containing 88A,APE; GIRDIN; GIV; GRDN; HkRP1; KIAA1212; PEHO; PEHOL,CCDC88A
Q49MG5,MAP9_HUMAN,MAP9; ASAP,Microtubule-associated protein 9; Aster-associated protein,ASAP,79884,microtubule associated protein 9,,aster-associated protein,ASAP; FLJ21159,microtubule associated protein 9,ASAP,MAP9
Q4G163,FBX43_HUMAN,FBXO43; EMI2,F-box only protein 43; Endogenous meiotic inhibitor 2,EMI2,286151,F-box protein 43,,,Fbx43,F-box protein 43,EMI2; ERP1; FBX43; OOMD12; OZEMA12; SPGF64,FBXO43
Q4VCS5,AMOT_HUMAN,AMOT; KIAA1071,Angiomotin,KIAA1071,154796,angiomotin,,,KIAA1071,angiomotin,,AMOT
Q53EL6,PDCD4_HUMAN,PDCD4; H731,Programmed cell death protein 4; Neoplastic transformation inhibitor protein; Nuclear antigen H731-like; Protein 197/15a,H731,27250,programmed cell death 4,programmed cell death 4 (neoplastic transformation inhibitor),nuclear antigen H731,H731,programmed cell death 4,H731,PDCD4
Q53ET0,CRTC2_HUMAN,CRTC2; TORC2,CREB-regulated transcription coactivator 2; Transducer of regulated cAMP response element-binding protein 2; TORC-2; Transducer of CREB protein 2,TORC2,200186,CREB regulated transcription coactivator 2,,,TORC2,CREB regulated transcription coactivator 2,TORC-2; TORC2,CRTC2
Q53EZ4,CEP55_HUMAN,CEP55; C10orf3; URCC6,Centrosomal protein of 55 kDa; Cep55; Up-regulated in colon cancer 6,C10orf3; URCC6,55165,centrosomal protein 55,chromosome 10 open reading frame 3; centrosomal protein 55kDa,cancer/testis antigen 111,FLJ10540; CT111,centrosomal protein 55,C10orf3; CT111; MARCH; URCC6,CEP55
Q53F19,NCBP3_HUMAN,NCBP3; C17orf85,Nuclear cap-binding protein subunit 3; Protein ELG,C17orf85,55421,nuclear cap binding subunit 3,chromosome 17 open reading frame 85,ELG protein,HSA277841; ELG,nuclear cap binding subunit 3,C17orf85; ELG; HSA277841,NCBP3
Q53GL7,PAR10_HUMAN,PARP10,Protein mono-ADP-ribosyltransferase PARP10; EC 2.4.2.-; ADP-ribosyltransferase diphtheria toxin-like 10; ARTD10; Poly ADP-ribose polymerase 10; PARP-10,,84875,poly(ADP-ribose) polymerase family member 10,,,FLJ14464; ARTD10,poly(ADP-ribose) polymerase family member 10,ARTD10,PARP10
Q53H47,SETMR_HUMAN,SETMAR,Histone-lysine N-methyltransferase SETMAR; SET domain and mariner transposase fusion protein; Metnase; EC 2.1.1.357; EC 3.1.-.-,,6419,SET domain and mariner transposase fusion gene,,,metnase,SET domain and mariner transposase fusion gene,METNASE; Mar1,SETMAR
Q53H80,AKIR2_HUMAN,AKIRIN2; C6orf166,Akirin-2,C6orf166,55122,akirin 2,chromosome 6 open reading frame 166,,FLJ10342; dJ486L4.2,akirin 2,C6orf166; FBI1; dJ486L4.2,AKIRIN2
Q53HL2,BOREA_HUMAN,CDCA8; PESCRG3,Borealin; Cell division cycle-associated protein 8; Dasra-B; hDasra-B; Pluripotent embryonic stem cell-related gene 3 protein,PESCRG3,55143,cell division cycle associated 8,,borealin,FLJ12042; MESRGP; BOR; DasraB,cell division cycle associated 8,BOR; BOREALIN; DasraB; MESRGP,CDCA8
Q5BJF6,ODFP2_HUMAN,ODF2,Outer dense fiber protein 2; Cenexin; Outer dense fiber of sperm tails protein 2,,4957,outer dense fiber of sperm tails 2,outer dense fibre of sperm tails 2,cancer/testis antigen 134; cenexin,ODF84; CT134,outer dense fiber of sperm tails 2,CT134; ODF2/1; ODF2/2; ODF84,ODF2
Q5FBB7,SGO1_HUMAN,SGO1; SGOL1,Shugoshin 1; Serologically defined breast cancer antigen NY-BR-85; Shugoshin-like 1,SGOL1,151648,shugoshin 1,shugoshin-like 1 (S. pombe),,NY-BR-85,shugoshin 1,CAID; NY-BR-85; SGO; SGOL1,SGO1
Q5JQC9,AKAP4_HUMAN,AKAP4; AKAP82,A-kinase anchor protein 4; AKAP-4; A-kinase anchor protein 82 kDa; AKAP 82; hAKAP82; Major sperm fibrous sheath protein; HI; Protein kinase A-anchoring protein 4; PRKA4,AKAP82,8852,A-kinase anchoring protein 4,A kinase (PRKA) anchor protein 4,A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A anchoring protein 4; cancer/testis antigen 99,p82; hAKAP82; AKAP82; Fsc1; HI; CT99,A-kinase anchoring protein 4,AKAP 82; AKAP-4; AKAP82; CT99; FSC1; HI; PRKA4; hAKAP82; p82,AKAP4
Q5JSZ5,PRC2B_HUMAN,PRRC2B; BAT2L; BAT2L1; KIAA0515,Protein PRRC2B; HLA-B-associated transcript 2-like 1; Proline-rich coiled-coil protein 2B,BAT2L; BAT2L1; KIAA0515,84726,proline rich coiled-coil 2B,KIAA0515; HLA-B associated transcript 2-like; HLA-B associated transcript 2-like 1; proline-rich coiled-coil 2B,,MGC10526; LQFBS-1,proline rich coiled-coil 2B,BAT2L; BAT2L1; KIAA0515; LQFBS-1,PRRC2B
Q5JTV8,TOIP1_HUMAN,TOR1AIP1; LAP1,Torsin-1A-interacting protein 1; Lamin-associated protein 1B; LAP1B,LAP1,26092,torsin 1A interacting protein 1,torsin A interacting protein 1,lamina associated polypeptide 1B,LAP1B; FLJ13142; LAP1; LAP1C,torsin 1A interacting protein 1,LAP1; LAP1B; LAP1C; LGMD2Y,TOR1AIP1
Q5JTZ9,SYAM_HUMAN,AARS2; AARSL; KIAA1270,Alanine--tRNA ligase; mitochondrial; EC 6.1.1.7; Alanyl-tRNA synthetase; AlaRS; Protein lactyltransferase AARS2; EC 6.-.-.-,AARSL; KIAA1270,57505,alanyl-tRNA synthetase 2; mitochondrial,alanyl-tRNA synthetase like; alanyl-tRNA synthetase 2; mitochondrial (putative),alanine tRNA ligase 2; mitochondrial,KIAA1270; bA444E17.1,alanyl-tRNA synthetase 2; mitochondrial,AARSL; COXPD8; LKENP; MT-ALARS; MTALARS,AARS2
Q5JVS0,HABP4_HUMAN,HABP4,Intracellular hyaluronan-binding protein 4; IHABP-4; IHABP4; Hyaluronan-binding protein 4; Ki-1/57 intracellular antigen,,22927,hyaluronan binding protein 4,,,IHABP4; SERBP1L,hyaluronan binding protein 4,IHABP-4; IHABP4; Ki-1/57; SERBP1L,HABP4
Q5JXC2,MIIP_HUMAN,MIIP; IIP45,Migration and invasion-inhibitory protein; IGFBP2-binding protein; Invasion-inhibitory protein 45; IIp45,IIP45,60672,migration and invasion inhibitory protein,,invasion inhibitory protein 45,FLJ12438; IIp45,migration and invasion inhibitory protein,IIP45,MIIP
Q5MIZ7,P4R3B_HUMAN,PPP4R3B; KIAA1387; PP4R3B; SMEK2,Serine/threonine-protein phosphatase 4 regulatory subunit 3B; SMEK homolog 2,KIAA1387; PP4R3B; SMEK2,57223,protein phosphatase 4 regulatory subunit 3B,SMEK homolog 2; suppressor of mek1 (Dictyostelium); protein phosphatase 4; regulatory subunit 3B,,PSY2; FLFL2; KIAA1387; FLJ31474,protein phosphatase 4 regulatory subunit 3B,FLFL2; PP4R3B; PSY2; SMEK2; smk1,PPP4R3B
Q5NUL3,FFAR4_HUMAN,FFAR4; GPR120; GPR129; O3FAR1; PGR4,Free fatty acid receptor 4; G-protein coupled receptor 120; G-protein coupled receptor 129; G-protein coupled receptor GT01; G-protein coupled receptor PGR4; Omega-3 fatty acid receptor 1,GPR120; GPR129; O3FAR1; PGR4,338557,free fatty acid receptor 4,G protein-coupled receptor 129; G protein-coupled receptor 120; omega-3 fatty acid receptor 1,,PGR4,free fatty acid receptor 4,BMIQ10; GPR120; GPR129; GT01; O3FAR1; OB10Q; PGR4,FFAR4
Q5QNW6,H2B2F_HUMAN,H2BC18; HIST2H2BF,Histone H2B type 2-F; H2B-clustered histone 18,HIST2H2BF,440689,H2B clustered histone 18,histone 2; H2bf; histone cluster 2; H2bf; histone cluster 2 H2B family member f,,,H2B clustered histone 18,HIST2H2BF,H2BC18
Q5S007,LRRK2_HUMAN,LRRK2; PARK8,Leucine-rich repeat serine/threonine-protein kinase 2; EC 2.7.11.1; EC 3.6.5.-; Dardarin,PARK8,120892,leucine rich repeat kinase 2,Parkinson disease (autosomal dominant) 8,dardarin,ROCO2; DKFZp434H2111; FLJ45829; RIPK7,leucine rich repeat kinase 2,AURA17; DARDARIN; PARK8; RIPK7; ROCO2,LRRK2
Q5SGD2,PPM1L_HUMAN,PPM1L; PP2CE,Protein phosphatase 1L; EC 3.1.3.16; Protein phosphatase 1-like; Protein phosphatase 2C isoform epsilon; PP2C-epsilon,PP2CE,151742,protein phosphatase; Mg2+/Mn2+ dependent 1L,protein phosphatase 1 (formerly 2C)-like; protein phosphatase; Mg2+/Mn2+ dependent; 1L,PP2Cepsilon; Protein phosphatase 2C epsilon isoform,PP2CE,protein phosphatase; Mg2+/Mn2+ dependent 1L,PP2C-epsilon; PP2CE; PPM1-LIKE,PPM1L
Q5SQI0,ATAT_HUMAN,ATAT1; C6orf134; MEC17; Nbla00487,Alpha-tubulin N-acetyltransferase 1; Alpha-TAT; Alpha-TAT1; TAT; EC 2.3.1.108; Acetyltransferase mec-17 homolog,C6orf134; MEC17,79969,alpha tubulin acetyltransferase 1,chromosome 6 open reading frame 134,alpha-tubulin N-acetyltransferase,FLJ13158; Em:AB023049.7; MEC17,alpha tubulin acetyltransferase 1,C6orf134; MEC17; Nbla00487; TAT; alpha-TAT; alpha-TAT1,ATAT1
Q5T447,HECD3_HUMAN,HECTD3,E3 ubiquitin-protein ligase HECTD3; EC 2.3.2.26; HECT domain-containing protein 3; HECT-type E3 ubiquitin transferase HECTD3,,79654,HECT domain E3 ubiquitin protein ligase 3,HECT domain containing E3 ubiquitin protein ligase 3,,FLJ21156,HECT domain E3 ubiquitin protein ligase 3,,HECTD3
Q5T4S7,UBR4_HUMAN,UBR4; KIAA0462; KIAA1307; RBAF600,E3 ubiquitin-protein ligase UBR4; EC 2.3.2.27; 600 kDa retinoblastoma protein-associated factor; p600; N-recognin-4; Retinoblastoma-associated factor of 600 kDa; RBAF600,KIAA0462; KIAA1307; RBAF600,23352,ubiquitin protein ligase E3 component n-recognin 4,zinc finger; UBR1 type 1,,KIAA1307; KIAA0462; RBAF600; p600,ubiquitin protein ligase E3 component n-recognin 4,RBAF600; ZUBR1; p600,UBR4
Q5T5U3,RHG21_HUMAN,ARHGAP21; ARHGAP10; KIAA1424,Rho GTPase-activating protein 21; Rho GTPase-activating protein 10; Rho-type GTPase-activating protein 21,ARHGAP10; KIAA1424,57584,Rho GTPase activating protein 21,,,KIAA1424; ARHGAP10,Rho GTPase activating protein 21,ARHGAP10,ARHGAP21
Q5T7P8,SYT6_HUMAN,SYT6,Synaptotagmin-6; Synaptotagmin VI; SytVI,,148281,synaptotagmin 6,synaptotagmin VI,,,synaptotagmin 6,sytVI,SYT6
Q5TB30,DEP1A_HUMAN,DEPDC1; DEPDC1A,DEP domain-containing protein 1A,DEPDC1A,55635,DEP domain containing 1,,,DEP.8; FLJ20354; SDP35; DEPDC1A,DEP domain containing 1,DEP.8; DEPDC1-V2; DEPDC1A; SDP35,DEPDC1
Q5TCX8,M3K21_HUMAN,MAP3K21; KIAA1804; MLK4,Mitogen-activated protein kinase kinase kinase 21; EC 2.7.11.25; Mitogen-activated protein kinase kinase kinase MLK4; Mixed lineage kinase 4,KIAA1804; MLK4,84451,mitogen-activated protein kinase kinase kinase 21,,mixed lineage kinase 4,KIAA1804; MLK4,mitogen-activated protein kinase kinase kinase 21,MLK4; dJ862P8.3,MAP3K21
Q5TCY1,TTBK1_HUMAN,TTBK1; BDTK; KIAA1855,Tau-tubulin kinase 1; EC 2.7.11.1; Brain-derived tau kinase,BDTK; KIAA1855,84630,tau tubulin kinase 1,,,KIAA1855,tau tubulin kinase 1,BDTK,TTBK1
Q5TKA1,LIN9_HUMAN,LIN9; BARA; TGS,Protein lin-9 homolog; HuLin-9; hLin-9; Beta subunit-associated regulator of apoptosis; TUDOR gene similar protein; Type I interferon receptor beta chain-associated protein; pRB-associated protein,BARA; TGS,286826,lin-9 DREAM MuvB core complex component,lin-9 homolog (C. elegans),TUDOR gene similar; rb related pathway actor,TGS,lin-9 DREAM MuvB core complex component,BARA; BARPsv; Lin-9; TGS; TGS1; TGS2,LIN9
Q5TZA2,CROCC_HUMAN,CROCC; KIAA0445,Rootletin; Ciliary rootlet coiled-coil protein,KIAA0445,9696,ciliary rootlet coiled-coil; rootletin,,rootletin; ciliary rootlet protein,rootletin; ROLT; CROCC1,ciliary rootlet coiled-coil; rootletin,CROCC1; ROLT; TAX1BP2,CROCC
Q5UE93,PI3R6_HUMAN,PIK3R6; C17orf38,Phosphoinositide 3-kinase regulatory subunit 6; Phosphoinositide 3-kinase gamma adapter protein of 87 kDa; p84 PI3K adapter protein; p84 PIKAP; p87 PI3K adapter protein; p87PIKAP,C17orf38,146850,phosphoinositide-3-kinase regulatory subunit 6,chromosome 17 open reading frame 38; phosphoinositide-3-kinase; regulatory subunit 6,,FLJ34500; HsT41028; p87PIKAP,phosphoinositide-3-kinase regulatory subunit 6,C17orf38; HsT41028; p84 PIKAP; p87(PIKAP); p87PIKAP,PIK3R6
Q5UIP0,RIF1_HUMAN,RIF1,Telomere-associated protein RIF1; Rap1-interacting factor 1 homolog,,55183,replication timing regulatory factor 1,RAP1 interacting factor homolog (yeast),,FLJ12870; FLJ10599,replication timing regulatory factor 1,,RIF1
Q5VT25,MRCKA_HUMAN,CDC42BPA; KIAA0451,Serine/threonine-protein kinase MRCK alpha; EC 2.7.11.1; CDC42-binding protein kinase alpha; DMPK-like alpha; Myotonic dystrophy kinase-related CDC42-binding kinase alpha; MRCK alpha; Myotonic dystrophy protein kinase-like alpha,KIAA0451,8476,CDC42 binding protein kinase alpha,CDC42-binding protein kinase alpha (DMPK-like),myotonic dystrophy kinase-related Cdc42-binding kinase,MRCKA; PK428; FLJ23347; KIAA0451; MRCKalpha,CDC42 binding protein kinase alpha,MRCK; MRCKA; MRCKalpha; PK428,CDC42BPA
Q5VTR2,BRE1A_HUMAN,RNF20; BRE1A,E3 ubiquitin-protein ligase BRE1A; BRE1-A; hBRE1; EC 2.3.2.27; RING finger protein 20; RING-type E3 ubiquitin transferase BRE1A,BRE1A,56254,ring finger protein 20,,BRE1 E3 ubiquitin ligase homolog (S. cerevisiae),FLJ20382; FLJ11189; KAIA2779; BRE1A; hBRE1; BRE1,ring finger protein 20,BRE1; BRE1A; hBRE1,RNF20
Q5VWQ8,DAB2P_HUMAN,DAB2IP; AF9Q34; AIP1; KIAA1743,Disabled homolog 2-interacting protein; DAB2 interaction protein; DAB2-interacting protein; ASK-interacting protein 1; AIP-1; DOC-2/DAB-2 interactive protein,AF9Q34; AIP1; KIAA1743,153090,DAB2 interacting protein,,nGAP-like protein; DOC-2/DAB2 interactive protein; ASK-interacting protein; ASK1-interacting protein 1,AF9Q34; DIP1/2; KIAA1743; AIP1,DAB2 interacting protein,AF9Q34; AIP-1; AIP1; DIP1/2,DAB2IP
Q5XUX0,FBX31_HUMAN,FBXO31; FBX14; FBX31; PP2386,F-box only protein 31,FBX14; FBX31,79791,F-box protein 31,F-box only protein 31,,FBX14; FBXO14; Fbx31; MGC15419,F-box protein 31,FBX14; FBXO14; Fbx31; MRT45; pp2386,FBXO31
Q641Q2,WAC2A_HUMAN,WASHC2A; FAM21A; FAM21B,WASH complex subunit 2A,FAM21A; FAM21B,387680,WASH complex subunit 2A,family with sequence similarity 21; member B; family with sequence similarity 21; member A; family with sequence similarity 21 member A,,bA56A21.1; bA98I6.1; FLJ10824,WASH complex subunit 2A,FAM21A; FAM21B; bA56A21.1; bA98I6.1,WASHC2A
Q676U5,A16L1_HUMAN,ATG16L1; APG16L; UNQ9393/PRO34307,Autophagy-related protein 16-1; APG16-like 1,APG16L,55054,autophagy related 16 like 1,APG16 autophagy 16-like (S. cerevisiae); ATG16 autophagy related 16-like (S. cerevisiae); ATG16 autophagy related 16-like 1 (S. cerevisiae),,WDR30; FLJ10035; ATG16A,autophagy related 16 like 1,APG16L; ATG16A; ATG16L; IBD10; WDR30,ATG16L1
Q684P5,RPGP2_HUMAN,RAP1GAP2; GARNL4; KIAA1039; RAP1GA2,Rap1 GTPase-activating protein 2; Rap1GAP2; GTPase-activating Rap/Ran-GAP domain-like protein 4,GARNL4; KIAA1039; RAP1GA2,23108,RAP1 GTPase activating protein 2,GTPase activating RANGAP domain-like 4; GTPase activating Rap/RanGAP domain-like 4,,KIAA1039,RAP1 GTPase activating protein 2,GARNL4; RAP1GA3,RAP1GAP2
Q68CJ9,CR3L3_HUMAN,CREB3L3; CREBH; HYST1481,Cyclic AMP-responsive element-binding protein 3-like protein 3; cAMP-responsive element-binding protein 3-like protein 3; Transcription factor CREB-H,CREBH,84699,cAMP responsive element binding protein 3 like 3,,cAMP-responsive element-binding protein; hepatic-specific,CREB-H; CREBH,cAMP responsive element binding protein 3 like 3,CREB-H; CREBH; HYST1481; HYTG2,CREB3L3
Q68CZ2,TENS3_HUMAN,TNS3; TEM6; TENS1; TPP,Tensin-3; EC 3.1.3.-; Tensin-like SH2 domain-containing protein 1; Tumor endothelial marker 6,TEM6; TENS1; TPP,64759,tensin 3,tensin-like SH2 domain-containing 1,tumor endothelial marker 6,TEM6; H_NH0549I23.2; FLJ13732,tensin 3,TEM6; TENS1,TNS3
Q68DD2,PA24F_HUMAN,PLA2G4F,Cytosolic phospholipase A2 zeta; cPLA2-zeta; EC 3.1.1.4; Phospholipase A2 group IVF,,255189,phospholipase A2 group IVF,phospholipase A2; group IVF,,PLA2G4F/Z,phospholipase A2 group IVF,PLA2G4FZ,PLA2G4F
Q68EM7,RHG17_HUMAN,ARHGAP17; RICH1; MSTP066; MSTP110,Rho GTPase-activating protein 17; Rho-type GTPase-activating protein 17; RhoGAP interacting with CIP4 homologs protein 1; RICH-1,RICH1,55114,Rho GTPase activating protein 17,,,RICH1; FLJ10308; NADRIN; FLJ13219; WBP15,Rho GTPase activating protein 17,MST066; MST110; MSTP038; MSTP066; MSTP110; NADRIN; PP367; PP4534; RICH-1; RICH1; WBP15,ARHGAP17
Q68J44,DUS29_HUMAN,DUSP29; DUPD1; DUSP27,Dual specificity phosphatase 29; Dual specificity phosphatase 27; Dual specificity phosphatase DUPD1; EC 3.1.3.16; EC 3.1.3.48,DUPD1; DUSP27,338599,dual specificity phosphatase 29,dual specificity phosphatase and pro isomerase domain containing 1,,DUSP27,dual specificity phosphatase 29,DUPD1; DUSP27; FMDSP,DUSP29
Q69YH5,CDCA2_HUMAN,CDCA2,Cell division cycle-associated protein 2; Recruits PP1 onto mitotic chromatin at anaphase protein; Repo-Man,,157313,cell division cycle associated 2,,protein phosphatase 1; regulatory subunit 81,Repo-Man; PPP1R81,cell division cycle associated 2,PPP1R81; Repo-Man,CDCA2
Q6DN03,H2B2C_HUMAN,H2BC20P; HIST2H2BC,Putative histone H2B type 2-C; H2B-clustered histone 20 pseudogene; Histone H2B.t; H2B/t,HIST2H2BC,,H2B clustered histone 20; pseudogene,histone 2; H2bc; histone cluster 2; H2bc; histone cluster 2; H2bc (pseudogene); histone cluster 2 H2B family member c (pseudogene),lncRNA essential for tumor cell proliferation via NPM1,H2B/t; LETN,,,H2BC20P
Q6DRA6,H2B2D_HUMAN,H2BC19P; HIST2H2BD,Putative histone H2B type 2-D; H2B-clustered histone 19 pseudogene,HIST2H2BD,,H2B clustered histone 19; pseudogene,histone 2; H2bd; H2B histone family; member O; histone cluster 2; H2bd (pseudogene); histone cluster 2 H2B family member d (pseudogene),,H2B/s; H2B/o,,,H2BC19P
Q6FI13,H2A2A_HUMAN,H2AC18; H2AFO; HIST2H2AA; HIST2H2AA3;; H2AC19; HIST2H2AA4,Histone H2A type 2-A; H2A-clustered histone 18; H2A-clustered histone 19; Histone H2A.2; Histone H2A/o,H2AFO; HIST2H2AA; HIST2H2AA3;; HIST2H2AA4,723790,H2A clustered histone 18,H2A histone family; member O; histone 2; H2aa; histone 2; H2aa3; histone cluster 2; H2aa3; histone cluster 2 H2A family member a3,,H2A.2; H2A/q,H2A clustered histone 19,H2A/R; H2AC18; HIST2H2AA4,H2AC18; H2AC19
Q6GYQ0,RGPA1_HUMAN,RALGAPA1; GARNL1; KIAA0884; TULIP1,Ral GTPase-activating protein subunit alpha-1; GAP-related-interacting partner to E12; GRIPE; GTPase-activating Rap/Ran-GAP domain-like 1; Tuberin-like protein 1; p240,GARNL1; KIAA0884; TULIP1,253959,Ral GTPase activating protein catalytic subunit alpha 1,GTPase activating RANGAP domain-like 1; GTPase activating Rap/RanGAP domain-like 1,tuberin-like protein 1; GAP-related interacting protein to E12,GRIPE; DKFZp667F074; KIAA0884; Tulip1; RalGAPalpha1,Ral GTPase activating protein catalytic subunit alpha 1,GARNL1; GRIPE; NEDHRIT; RalGAPalpha1; TULIP1; p240,RALGAPA1
Q6IBW4,CNDH2_HUMAN,NCAPH2; CAPH2,Condensin-2 complex subunit H2; Chromosome-associated protein H2; hCAP-H2; Kleisin-beta; Non-SMC condensin II complex subunit H2,CAPH2,29781,non-SMC condensin II complex subunit H2,non-SMC condensin II complex; subunit H2,kleisin beta; CAP-H2 subunit of the condensin II complex,384D8-2; hCAP-H2; CAP-H2,non-SMC condensin II complex subunit H2,CAPH2,NCAPH2
Q6IE81,JADE1_HUMAN,JADE1; KIAA1807; PHF17,Protein Jade-1; Jade family PHD finger protein 1; PHD finger protein 17,KIAA1807; PHF17,79960,jade family PHD finger 1,PHD finger protein 17,,JADE-1,jade family PHD finger 1,PHF17,JADE1
Q6IN85,P4R3A_HUMAN,PPP4R3A; KIAA2010; PP4R3A; SMEK1; MSTP033,Serine/threonine-protein phosphatase 4 regulatory subunit 3A; SMEK homolog 1,KIAA2010; PP4R3A; SMEK1,55671,protein phosphatase 4 regulatory subunit 3A,KIAA2010; SMEK homolog 1; suppressor of mek1 (Dictyostelium); protein phosphatase 4; regulatory subunit 3A,,FLJ20707; MSTP033; FLFL1; smk-1; smk1; PP4R3,protein phosphatase 4 regulatory subunit 3A,FLFL1; KIAA2010; MSTP033; PP4R3; PP4R3A; SMEK1; smk-1; smk1,PPP4R3A
Q6IQ55,TTBK2_HUMAN,TTBK2; KIAA0847,Tau-tubulin kinase 2; EC 2.7.11.1,KIAA0847,146057,tau tubulin kinase 2,spinocerebellar ataxia 11,,KIAA0847,tau tubulin kinase 2,SCA11; TTBK,TTBK2
Q6J4K2,NCLX_HUMAN,SLC8B1; NCKX6; NCLX; SLC24A6,Mitochondrial sodium/calcium exchanger protein; Na(+; +; 2+; Sodium/calcium exchanger protein; mitochondrial; Sodium/potassium/calcium exchanger 6; Solute carrier family 24 member 6; Solute carrier family 8 member B1,NCKX6; NCLX; SLC24A6,80024,solute carrier family 8 member B1,solute carrier family 24 (sodium/potassium/calcium exchanger); member 6; solute carrier family 24 (sodium/lithium/calcium exchanger); member 6; solute carrier family 8 (sodium/lithium/calcium exchanger); member B1,,FLJ22233; NCKX6; NCLX,solute carrier family 8 member B1,NCKX6; NCLX; SLC24A6,SLC8B1
Q6JBY9,CPZIP_HUMAN,RCSD1; CAPZIP,CapZ-interacting protein; Protein kinase substrate CapZIP; RCSD domain-containing protein 1,CAPZIP,92241,RCSD domain containing 1,,CapZ interacting protein,MK2S4; MGC21854; CapZIP,RCSD domain containing 1,CAPZIP; MK2S4,RCSD1
Q6NUN9,ZN746_HUMAN,ZNF746; PARIS,Zinc finger protein 746; Parkin-interacting substrate; PARIS,PARIS,155061,zinc finger protein 746,,parkin interacting substrate,FLJ31413; PARIS,zinc finger protein 746,PARIS,ZNF746
Q6NXT2,H3C_HUMAN,H3-5; H3F3C,Histone H3.3C; Histone H3.5,H3F3C,440093,H3.5 histone,H3 histone; family 3C; H3 histone family member 3C,,H3.5; H3.3C,H3.5 histone,H3.3C; H3.5; H3F3C,H3-5
Q6NZI2,CAVN1_HUMAN,CAVIN1; PTRF; FKSG13,Caveolae-associated protein 1; Cavin-1; Polymerase I and transcript release factor,PTRF,284119,caveolae associated protein 1,polymerase I and transcript release factor,congenital generalized lipodystrophy 4,cavin-1; CGL4,caveolae associated protein 1,CAVIN; CGL4; FKSG13; PTRF; cavin-1,CAVIN1
Q6P1J9,CDC73_HUMAN,CDC73; C1orf28; HRPT2,Parafibromin; Cell division cycle protein 73 homolog; Hyperparathyroidism 2 protein,C1orf28; HRPT2,79577,cell division cycle 73,chromosome 1 open reading frame 28; hyperparathyroidism 2 (with jaw tumor); cell division cycle 73; Paf1/RNA polymerase II complex component; homolog (S. cerevisiae); hyperparathyroidism 1; Familial isolated hyperparathyroidism,Paf1/RNA polymerase II complex component,parafibromin; FIHP,cell division cycle 73,C1orf28; FIHP; HPTJT; HRPT1; HRPT2; HYX,CDC73
Q6P1M3,L2GL2_HUMAN,LLGL2,LLGL scribble cell polarity complex component 2; HGL; Lethal(2,,3993,LLGL scribble cell polarity complex component 2,lethal giant larvae homolog 2 (Drosophila); lethal giant larvae homolog 2; scribble cell polarity complex component; LLGL2; scribble cell polarity complex component,,HGL; Hugl-2,LLGL scribble cell polarity complex component 2,HGL; Hugl-2; LGL2,LLGL2
Q6P1N0,C2D1A_HUMAN,CC2D1A; AKI1; LGD2,Coiled-coil and C2 domain-containing protein 1A; Akt kinase-interacting protein 1; Five prime repressor element under dual repression-binding protein 1; FRE under dual repression-binding protein 1; Freud-1; Putative NF-kappa-B-activating protein 023N,AKI1; LGD2,54862,coiled-coil and C2 domain containing 1A,,mental retardation; nonsyndromic; autosomal recessive; 3; Five prime repressor element under dual repression-binding protein 1; lethal (2) giant discs homolog 2; TBK1-associated protein in endolysosomes; Akt Kinase-Interacting Protein 1,FLJ20241; MRT3; Freud-1; Lgd2; TAPE; Aki-1,coiled-coil and C2 domain containing 1A,Aki-1; FREUD-1; Freud-1/Aki1; Lgd2; MRT3; TAPE,CC2D1A
Q6P2M8,KCC1B_HUMAN,PNCK,Calcium/calmodulin-dependent protein kinase type 1B; EC 2.7.11.17; CaM kinase I beta; CaM kinase IB; CaM-KI beta; CaMKI-beta; Pregnancy up-regulated non-ubiquitously-expressed CaM kinase,,139728,pregnancy up-regulated nonubiquitous CaM kinase,pregnancy upregulated non-ubiquitously expressed CaM kinase; pregnancy up-regulated non-ubiquitously expressed CaM kinase,,MGC45419; CaMK1b,pregnancy up-regulated nonubiquitous CaM kinase,BSTK3; CaMK1b,PNCK
Q6P597,KLC3_HUMAN,KLC3; KLC2; KLC2L,Kinesin light chain 3; KLC2-like; kinesin light chain 2,KLC2; KLC2L,147700,kinesin light chain 3,,,KLC2L; KNS2B; KLCt,kinesin light chain 3,KLC2; KLC2L; KLCt; KNS2B,KLC3
Q6P5Z2,PKN3_HUMAN,PKN3; PKNBETA,Serine/threonine-protein kinase N3; EC 2.7.11.13; Protein kinase PKN-beta; Protein-kinase C-related kinase 3,PKNBETA,29941,protein kinase N3,,,PKNbeta; UTDP4-1,protein kinase N3,UTDP4-1,PKN3
Q6PCD5,RFWD3_HUMAN,RFWD3; RNF201,E3 ubiquitin-protein ligase RFWD3; EC 2.3.2.27; RING finger and WD repeat domain-containing protein 3; RING finger protein 201,RNF201,55159,ring finger and WD repeat domain 3,,,FLJ10520; RNF201; FANCW,ring finger and WD repeat domain 3,FANCW; RNF201,RFWD3
Q6PD62,CTR9_HUMAN,CTR9; KIAA0155; SH2BP1,RNA polymerase-associated protein CTR9 homolog; SH2 domain-binding protein 1,KIAA0155; SH2BP1,9646,CTR9 homolog; Paf1/RNA polymerase II complex component,SH2 domain binding protein 1 (tetratricopeptide repeat containing); Ctr9; Paf1/RNA polymerase II complex component; homolog (S. cerevisiae),,KIAA0155; TSBP; p150TSP,CTR9 homolog; Paf1/RNA polymerase II complex component,SH2BP1; TSBP; p150; p150TSP,CTR9
Q6PGQ7,BORA_HUMAN,BORA; C13orf34,Protein aurora borealis; HsBora,C13orf34,79866,BORA aurora kinase A activator,chromosome 13 open reading frame 34; bora; aurora kinase A activator,,FLJ22624,BORA aurora kinase A activator,C13orf34,BORA
Q6PHR2,ULK3_HUMAN,ULK3,Serine/threonine-protein kinase ULK3; EC 2.7.11.1; Unc-51-like kinase 3,,25989,unc-51 like kinase 3,unc-51-like kinase 3 (C. elegans),,DKFZP434C131; FLJ90566,unc-51 like kinase 3,,ULK3
Q6PKG0,LARP1_HUMAN,LARP1; KIAA0731; LARP,La-related protein 1; La ribonucleoprotein domain family member 1,KIAA0731; LARP,23367,La ribonucleoprotein 1; translational regulator,La ribonucleoprotein domain family; member 1; La ribonucleoprotein domain family member 1,,LARP; KIAA0731; MGC19556; Lar1; Lhp1,La ribonucleoprotein 1; translational regulator,LARP; Lar1; Lhp1,LARP1
Q6R327,RICTR_HUMAN,RICTOR; KIAA1999,Rapamycin-insensitive companion of mTOR; AVO3 homolog; hAVO3,KIAA1999,253260,RPTOR independent companion of MTOR complex 2,RPTOR independent companion of MTOR; complex 2,rapamycin-insensitive companion of mTOR; pianissimo,MGC39830; AVO3; PIA; KIAA1999,RPTOR independent companion of MTOR complex 2,AVO3; PIA; hAVO3,RICTOR
Q6S5L8,SHC4_HUMAN,SHC4; SHCD; UNQ6438/PRO21364,SHC-transforming protein 4; Rai-like protein; RaLP; SHC-transforming protein D; hShcD; Src homology 2 domain-containing-transforming protein C4; SH2 domain protein C4,SHCD,399694,SHC adaptor protein 4,SHC (Src homology 2 domain containing) family; member 4,rai-like protein,RaLP; SHCD,SHC adaptor protein 4,RaLP; SHCD,SHC4
Q6SA08,TSSK4_HUMAN,TSSK4; C14orf20; STK22E; TSSK5,Testis-specific serine/threonine-protein kinase 4; TSK-4; TSSK-4; Testis-specific kinase 4; EC 2.7.11.1; Serine/threonine-protein kinase 22E,C14orf20; STK22E; TSSK5,283629,testis specific serine kinase 4,serine/threonine kinase 22E,chromosome 14 open reading frame 20,,testis specific serine kinase 4,C14orf20; STK22E; TSK-4; TSK4; TSSK5,TSSK4
Q6STE5,SMRD3_HUMAN,SMARCD3; BAF60C,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3; 60 kDa BRG-1/Brm-associated factor subunit C; BRG1-associated factor 60C; BAF60C,BAF60C,6604,SWI/SNF related BAF chromatin remodeling complex subunit D3,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily d; member 3,mammalian chromatin remodeling complex BRG1-associated factor 60C; Swp73-like protein; SWI/SNF complex 60 kDa subunit C; 60kDa BRG-1/Brm associated factor subunit c,BAF60C; Rsc6p; CRACD3,SWI/SNF related BAF chromatin remodeling complex subunit D3,BAF60C; CRACD3; Rsc6p,SMARCD3
Q6T4R5,NHS_HUMAN,NHS,Actin remodeling regulator NHS; Congenital cataracts and dental anomalies protein; Nance-Horan syndrome protein,,4810,NHS actin remodeling regulator,Nance-Horan syndrome (congenital cataracts and dental anomalies),,,NHS actin remodeling regulator,CTRCT40; CXN; SCML1,NHS
Q6TCH7,PAQR3_HUMAN,PAQR3,Progestin and adipoQ receptor family member 3; Progestin and adipoQ receptor family member III; Raf kinase trapping to Golgi; RKTG,,152559,progestin and adipoQ receptor family member 3,progestin and adipoQ receptor family member III,,,progestin and adipoQ receptor family member 3,RKTG,PAQR3
Q6U7Q0,ZN322_HUMAN,ZNF322; ZNF322A; ZNF388; ZNF489,Zinc finger protein 322; Zinc finger protein 322A; Zinc finger protein 388; Zinc finger protein 489,ZNF322A; ZNF388; ZNF489,79692,zinc finger protein 322,zinc finger protein 489; HLA complex group 12; zinc finger protein 322A,,bA457M11.3; bA457M11.2,zinc finger protein 322,HCG12; ZNF322A; ZNF388; ZNF489,ZNF322
Q6UB35,C1TM_HUMAN,MTHFD1L; FTHFSDC1,Monofunctional C1-tetrahydrofolate synthase; mitochondrial; EC 6.3.4.3; Formyltetrahydrofolate synthetase,FTHFSDC1,25902,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like,formyltetrahydrofolate synthetase domain containing 1,10-formyl-THF synthetase; mitochondrial C1-tetrahydrofolate synthase; monofunctional C1-tetrahydrofolate synthase; mitochondrial,DKFZP586G1517; FLJ21145,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like,FTHFSDC1; MTC1THFS; dJ292B18.2,MTHFD1L
Q6UB98,ANR12_HUMAN,ANKRD12; ANCO2; KIAA0874,Ankyrin repeat domain-containing protein 12; Ankyrin repeat-containing cofactor 2; GAC-1 protein,ANCO2; KIAA0874,23253,ankyrin repeat domain 12,,ankyrin repeats containing cofactor 2,KIAA0874; FLJ20053; GAC-1; ANCO-2,ankyrin repeat domain 12,ANCO-2; ANCO1; GAC-1; Nbla00144,ANKRD12
Q6UN15,FIP1_HUMAN,FIP1L1; FIP1; RHE,Pre-mRNA 3'-end-processing factor FIP1; hFip1; FIP1-like 1 protein; Factor interacting with PAP; Rearranged in hypereosinophilia,FIP1; RHE,81608,factor interacting with PAPOLA and CPSF1,FIP1 like 1 (S. cerevisiae); FIP1L1 cleavage and polyadenylation specific factor subunit,,DKFZp586K0717; FIP1; hFip1,factor interacting with PAPOLA and CPSF1,FIP1; Rhe; hFip1,FIP1L1
Q6UWZ7,ABRX1_HUMAN,ABRAXAS1; ABRA1; CCDC98; FAM175A; UNQ496/PRO1013,BRCA1-A complex subunit Abraxas 1; Coiled-coil domain-containing protein 98; Protein FAM175A,ABRA1; CCDC98; FAM175A,84142,abraxas 1; BRCA1 A complex subunit,coiled-coil domain containing 98; family with sequence similarity 175; member A; family with sequence similarity 175 member A; Abraxas 1; BRCA1 A complex subunit,Abraxas protein,FLJ13614; ABRA1; ABRAXAS,abraxas 1; BRCA1 A complex subunit,ABRA1; CCDC98; FAM175A,ABRAXAS1
Q6UXZ4,UNC5D_HUMAN,UNC5D; KIAA1777; UNC5H4; UNQ6012/PRO34692,Netrin receptor UNC5D; Protein unc-5 homolog 4; Protein unc-5 homolog D,KIAA1777; UNC5H4,137970,unc-5 netrin receptor D,unc-5 homolog D (C. elegans),Netrin receptor UNC5D; Protein unc-5 homolog 4; Protein unc-5 homolog D,KIAA1777; Unc5h4,unc-5 netrin receptor D,PRO34692; Unc5h4,UNC5D
Q6VAB6,KSR2_HUMAN,KSR2,Kinase suppressor of Ras 2; hKSR2; EC 2.7.11.1,,283455,kinase suppressor of ras 2,,,FLJ25965,kinase suppressor of ras 2,,KSR2
Q6VY07,PACS1_HUMAN,PACS1; KIAA1175,Phosphofurin acidic cluster sorting protein 1; PACS-1,KIAA1175,55690,phosphofurin acidic cluster sorting protein 1,,,FLJ10209; KIAA1175,phosphofurin acidic cluster sorting protein 1,MRD17; SHMS,PACS1
Q6WKZ4,RFIP1_HUMAN,RAB11FIP1; RCP,Rab11 family-interacting protein 1; Rab11-FIP1; Rab-coupling protein,RCP,80223,RAB11 family interacting protein 1,RAB11 family interacting protein 1 (class I),,RCP; FLJ22622; FLJ22524; Rab11-FIP1,RAB11 family interacting protein 1,NOEL1A; RCP; rab11-FIP1,RAB11FIP1
Q6Y7W6,GGYF2_HUMAN,GIGYF2; KIAA0642; PERQ2; TNRC15,GRB10-interacting GYF protein 2; PERQ amino acid-rich with GYF domain-containing protein 2; Trinucleotide repeat-containing gene 15 protein,KIAA0642; PERQ2; TNRC15,26058,GRB10 interacting GYF protein 2,PERQ amino acid rich; with GYF domain 2; PERQ amino acid rich; with GYF domain 3; trinucleotide repeat containing 15; Parkinson disease (autosomal recessive; early onset) 11,GYF domain containing 2,KIAA0642; GYF2,GRB10 interacting GYF protein 2,GYF2; PARK11; PERQ2; PERQ3; TNRC15,GIGYF2
Q6ZMG9,CERS6_HUMAN,CERS6; LASS6,Ceramide synthase 6; CerS6; LAG1 longevity assurance homolog 6; Sphingoid base N-palmitoyltransferase CERS6; EC 2.3.1.291,LASS6,253782,ceramide synthase 6,LAG1 longevity assurance homolog 6 (S. cerevisiae); LAG1 homolog; ceramide synthase 6,,,ceramide synthase 6,CERS5; LASS6,CERS6
Q6ZN44,UNC5A_HUMAN,UNC5A; KIAA1976; UNC5H1,Netrin receptor UNC5A; Protein unc-5 homolog 1; Protein unc-5 homolog A,KIAA1976; UNC5H1,90249,unc-5 netrin receptor A,unc5 (C.elegans homolog) a; unc-5 homolog A (C. elegans),,KIAA1976; UNC5H1,unc-5 netrin receptor A,UNC5H1,UNC5A
Q6ZSY5,PPR3F_HUMAN,PPP1R3F,Protein phosphatase 1 regulatory subunit 3F; R3F,,89801,protein phosphatase 1 regulatory subunit 3F,protein phosphatase 1; regulatory (inhibitor) subunit 3F; protein phosphatase 1; regulatory subunit 3F,,Hb2E,protein phosphatase 1 regulatory subunit 3F,HB2E; LL0XNC01-7P3.1; R3F,PPP1R3F
Q6ZUJ8,BCAP_HUMAN,PIK3AP1; BCAP,Phosphoinositide 3-kinase adapter protein 1; B-cell adapter for phosphoinositide 3-kinase; B-cell phosphoinositide 3-kinase adapter protein 1,BCAP,118788,phosphoinositide-3-kinase adaptor protein 1,,,BCAP; FLJ35564,phosphoinositide-3-kinase adaptor protein 1,BCAP,PIK3AP1
Q6ZVD8,PHLP2_HUMAN,PHLPP2; KIAA0931; PHLPPL,PH domain leucine-rich repeat-containing protein phosphatase 2; EC 3.1.3.16; PH domain leucine-rich repeat-containing protein phosphatase-like; PHLPP-like,KIAA0931; PHLPPL,23035,PH domain and leucine rich repeat protein phosphatase 2,PH domain and leucine rich repeat protein phosphatase-like,protein phosphatase; Mg2+/Mn2+ dependent 3B,KIAA0931; PPM3B,PH domain and leucine rich repeat protein phosphatase 2,PHLPPL; PPM3B,PHLPP2
Q70CQ2,UBP34_HUMAN,USP34; KIAA0570; KIAA0729,Ubiquitin carboxyl-terminal hydrolase 34; EC 3.4.19.12; Deubiquitinating enzyme 34; Ubiquitin thioesterase 34; Ubiquitin-specific-processing protease 34,KIAA0570; KIAA0729,9736,ubiquitin specific peptidase 34,ubiquitin specific protease 34,,KIAA0570; KIAA0729,ubiquitin specific peptidase 34,,USP34
Q70SY1,CR3L2_HUMAN,CREB3L2; BBF2H7,Cyclic AMP-responsive element-binding protein 3-like protein 2; cAMP-responsive element-binding protein 3-like protein 2; BBF2 human homolog on chromosome 7,BBF2H7,64764,cAMP responsive element binding protein 3 like 2,,BBF2 human homolog on chromosome 7,BBF2H7; TCAG_1951439,cAMP responsive element binding protein 3 like 2,BBF2H7,CREB3L2
Q70Z35,PREX2_HUMAN,PREX2; DEPDC2,Phosphatidylinositol 3;4;5-trisphosphate-dependent Rac exchanger 2 protein; P-Rex2; PtdIns(3;4;5; DEP domain-containing protein 2,DEPDC2,80243,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 2,DEP domain containing 2; phosphatidylinositol-3;4;5-trisphosphate-dependent Rac exchange factor 2,protein phosphatase 1; regulatory subunit 129,DEP.2; FLJ12987; P-REX2; PPP1R129,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 2,DEP.2; DEPDC2; P-REX2; PPP1R129,PREX2
Q712K3,UB2R2_HUMAN,UBE2R2; CDC34B; UBC3B,Ubiquitin-conjugating enzyme E2 R2; EC 2.3.2.23; E2 ubiquitin-conjugating enzyme R2; Ubiquitin carrier protein R2; Ubiquitin-conjugating enzyme E2-CDC34B; Ubiquitin-protein ligase R2,CDC34B; UBC3B,54926,ubiquitin conjugating enzyme E2 R2,ubiquitin-conjugating enzyme E2R 2,,UBC3B; CDC34B; FLJ20419; MGC10481,ubiquitin conjugating enzyme E2 R2,CDC34B; E2-CDC34B; UBC3B,UBE2R2
Q71DI3,H32_HUMAN,H3C15; HIST2H3A;; H3C14; H3F2; H3FM; HIST2H3C;; H3C13; HIST2H3D,Histone H3.2; H3-clustered histone 13; H3-clustered histone 14; H3-clustered histone 15; Histone H3/m; Histone H3/o,HIST2H3A;; H3F2; H3FM; HIST2H3C;; HIST2H3D,126961,H3 clustered histone 13,histone 2; H3d; histone cluster 2; H3d; histone cluster 2 H3 family member d,,,H3 clustered histone 14,H3; H3.2; H3/M; H3C13; H3C15; H3F2; H3FM; H3FN; HIST2H3C,H3C15; H3C14; H3C13
Q71F23,CENPU_HUMAN,CENPU; ICEN24; KLIP1; MLF1IP; PBIP1,Centromere protein U; CENP-U; Centromere protein of 50 kDa; CENP-50; Interphase centromere complex protein 24; KSHV latent nuclear antigen-interacting protein 1; MLF1-interacting protein; Polo-box-interacting protein 1,ICEN24; KLIP1; MLF1IP; PBIP1,79682,centromere protein U,MLF1 interacting protein,polo-box-interacting protein 1,CENP-U; KLIP1; CENP-50; PBIP1,centromere protein U,CENP50; CENPU50; KLIP1; MLF1IP; PBIP1,CENPU
Q71UM5,RS27L_HUMAN,RPS27L,Ribosomal protein eS27-like; 40S ribosomal protein S27-like; Small ribosomal subunit protein eS27-like,,51065,ribosomal protein S27 like,ribosomal protein S27-like,,,ribosomal protein S27 like,,RPS27L
Q76I76,SSH2_HUMAN,SSH2; KIAA1725; SSH2L,Protein phosphatase Slingshot homolog 2; EC 3.1.3.16; EC 3.1.3.48; SSH-like protein 2; SSH-2L; hSSH-2L,KIAA1725; SSH2L,85464,slingshot protein phosphatase 2,slingshot homolog 2 (Drosophila),,KIAA1725,slingshot protein phosphatase 2,SSH-2; SSH-2L,SSH2
Q76M96,CCD80_HUMAN,CCDC80; DRO1; URB; HBE245,Coiled-coil domain-containing protein 80; Down-regulated by oncogenes protein 1; Up-regulated in BRS-3 deficient mouse homolog,DRO1; URB,151887,coiled-coil domain containing 80,long intergenic non-protein coding RNA 1279,steroid sensitive gene 1,URB; SSG1; DRO1; CL2; TCONS_00006930,coiled-coil domain containing 80,CL2; DRO1; LINC01279; SSG1; URB; okuribin,CCDC80
Q7KZ85,SPT6H_HUMAN,SUPT6H; KIAA0162; SPT6H,Transcription elongation factor SPT6; hSPT6; Histone chaperone suppressor of Ty6; Tat-cotransactivator 2 protein; Tat-CT2 protein,KIAA0162; SPT6H,6830,SPT6 homolog; histone chaperone and transcription elongation factor,suppressor of Ty (S.cerevisiae) 6 homolog; suppressor of Ty 6 homolog (S. cerevisiae); SPT6 homolog; histone chaperone,,KIAA0162; SPT6H,SPT6 homolog; histone chaperone and transcription elongation factor,SPT6; SPT6H; emb-5,SUPT6H
Q7KZF4,SND1_HUMAN,SND1; TDRD11,Staphylococcal nuclease domain-containing protein 1; EC 3.1.31.1; 100 kDa coactivator; EBNA2 coactivator p100; Tudor domain-containing protein 11; p100 co-activator,TDRD11,27044,staphylococcal nuclease and tudor domain containing 1,,p100 EBNA2 co-activator; Tudor-SN,TDRD11; p100; TSN,staphylococcal nuclease and tudor domain containing 1,TDRD11; TSN; Tudor-SN; p100,SND1
Q7KZI7,MARK2_HUMAN,MARK2; EMK1,Serine/threonine-protein kinase MARK2; EC 2.7.11.1; EC 2.7.11.26; ELKL motif kinase 1; EMK-1; MAP/microtubule affinity-regulating kinase 2; PAR1 homolog; PAR1 homolog b; Par-1b; Par1b,EMK1,2011,microtubule affinity regulating kinase 2,ELKL motif kinase; MAP/microtubule affinity-regulating kinase 2,ELKL motif kinase 1; serine/threonine kinase; protein-serine/threonine kinase; Ser/Thr protein kinase PAR-1B,PAR-1; Par1b; PAR-1B,microtubule affinity regulating kinase 2,EMK-1; EMK1; PAR-1; Par-1b; Par1b,MARK2
Q7L0J3,SV2A_HUMAN,SV2A; KIAA0736; PSEC0174,Synaptic vesicle glycoprotein 2A,KIAA0736,9900,synaptic vesicle glycoprotein 2A,,solute carrier family 22 member B1,SV2; KIAA0736; SLC22B1,synaptic vesicle glycoprotein 2A,DEE113; SLC22B1; SV2,SV2A
Q7L0Q8,RHOU_HUMAN,RHOU; ARHU; CDC42L1; G28K; WRCH1; SB128,Rho-related GTP-binding protein RhoU; CDC42-like GTPase 1; GTP-binding protein-like 1; Rho GTPase-like protein ARHU; Ryu GTPase; Wnt-1 responsive Cdc42 homolog 1; WRCH-1,ARHU; CDC42L1; G28K; WRCH1,58480,ras homolog family member U,ras homolog gene family; member U,Ryu GTPase; Wnt-1 responsive Cdc42 homolog; 2310026M05Rik; GTP-binding protein like 1; CDC42-like GTPase; GTP-binding protein SB128; ras-like gene family member U,WRCH-1; DJ646B12.2; FLJ10616; WRCH1; CDC42L1; hG28K; fJ646B12.2,ras homolog family member U,ARHU; CDC42L1; G28K; WRCH1; hG28K,RHOU
Q7L2Z9,CENPQ_HUMAN,CENPQ; C6orf139,Centromere protein Q; CENP-Q,C6orf139,55166,centromere protein Q,chromosome 6 open reading frame 139,,FLJ10545; CENP-Q,centromere protein Q,C6orf139; CENP-Q,CENPQ
Q7L5N1,CSN6_HUMAN,COPS6; CSN6; HVIP,COP9 signalosome complex subunit 6; SGN6; Signalosome subunit 6; JAB1-containing signalosome subunit 6; MOV34 homolog; Vpr-interacting protein; hVIP,CSN6; HVIP,10980,COP9 signalosome subunit 6,COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis),COP9 subunit 6 (MOV34 homolog; 34 kD),MOV34-34KD; CSN6,COP9 signalosome subunit 6,CSN6; MOV34-34KD,COPS6
Q7L7L0,H2A3_HUMAN,H2AC25; H2AW; HIST3H2A,Histone H2A type 3; H2A-clustered histone 25,H2AW; HIST3H2A,92815,H2A clustered histone 25,histone 3; H2a; histone cluster 3; H2a; histone cluster 3 H2A; H2A.W histone,,MGC3165,H2A clustered histone 25,H2AW; HIST3H2A,H2AC25
Q7L7X3,TAOK1_HUMAN,TAOK1; KIAA1361; MAP3K16; MARKK,Serine/threonine-protein kinase TAO1; EC 2.7.11.1; Kinase from chicken homolog B; hKFC-B; MARK Kinase; MARKK; Prostate-derived sterile 20-like kinase 2; PSK-2; PSK2; Prostate-derived STE20-like kinase 2; Thousand and one amino acid protein kinase 1; TAOK1; hTAOK1,KIAA1361; MAP3K16; MARKK,57551,TAO kinase 1,,prostate-derived sterile 20-like kinase 2; MARK kinase; thousand and one amino acid protein kinase 1,KIAA1361; MARKK; PSK2; MAP3K16; FLJ14314; TAO1; hTAOK1; hKFC-B,TAO kinase 1,DDIB; KFC-B; MAP3K16; MARKK; PSK-2; PSK2; TAO1; hKFC-B; hTAOK1,TAOK1
Q7L804,RFIP2_HUMAN,RAB11FIP2; KIAA0941,Rab11 family-interacting protein 2; Rab11-FIP2; NRip11,KIAA0941,22841,RAB11 family interacting protein 2,RAB11 family interacting protein 2 (class I),,KIAA0941; nRip11; Rab11-FIP2,RAB11 family interacting protein 2,Rab11-FIP2; nRip11,RAB11FIP2
Q7L9L4,MOB1B_HUMAN,MOB1B; MOB4A; MOBKL1A,MOB kinase activator 1B; Mob1 homolog 1A; Mob1A; Mob1B; Mps one binder kinase activator-like 1A,MOB4A; MOBKL1A,92597,MOB kinase activator 1B,MOB1; Mps One Binder kinase activator-like 1A (yeast); MOB1 Mps One Binder homolog B (yeast),Mob4A protein,MOB4A,MOB kinase activator 1B,MATS2; MOB4A; MOBKL1A,MOB1B
Q7LBC6,KDM3B_HUMAN,KDM3B; C5orf7; JHDM2B; JMJD1B; KIAA1082,Lysine-specific demethylase 3B; EC 1.14.11.65; JmjC domain-containing histone demethylation protein 2B; Jumonji domain-containing protein 1B; Nuclear protein 5qNCA; histone H3-dimethyl-L-lysine(9,C5orf7; JHDM2B; JMJD1B; KIAA1082,51780,lysine demethylase 3B,chromosome 5 open reading frame 7; jumonji domain containing 1B; lysine (K)-specific demethylase 3B,,KIAA1082; NET22,lysine demethylase 3B,5qNCA; C5orf7; DIJOS; JMJD1B; NET22,KDM3B
Q7LDG7,GRP2_HUMAN,RASGRP2; CDC25L; MCG7,RAS guanyl-releasing protein 2; Calcium and DAG-regulated guanine nucleotide exchange factor I; CalDAG-GEFI; Cdc25-like protein; hCDC25L; F25B3.3 kinase-like protein,CDC25L; MCG7,10235,RAS guanyl releasing protein 2,RAS guanyl releasing protein 2 (calcium and DAG-regulated),calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I,CALDAG-GEFI,RAS guanyl releasing protein 2,CALDAG-GEFI; CDC25L,RASGRP2
Q7LG56,RIR2B_HUMAN,RRM2B; P53R2,Ribonucleoside-diphosphate reductase subunit M2 B; EC 1.17.4.1; TP53-inducible ribonucleotide reductase M2 B; p53-inducible ribonucleotide reductase small subunit 2-like protein; p53R2,P53R2,50484,ribonucleotide reductase regulatory TP53 inducible subunit M2B,ribonucleotide reductase M2 B (TP53 inducible),,p53R2,ribonucleotide reductase regulatory TP53 inducible subunit M2B,MTDPS8A; MTDPS8B; P53R2; RCDFRD,RRM2B
Q7RTN6,STRAA_HUMAN,STRADA; LYK5; STRAD,STE20-related kinase adapter protein alpha; STRAD alpha; STE20-related adapter protein; Serologically defined breast cancer antigen NY-BR-96,LYK5; STRAD,92335,STE20 related adaptor alpha,STE20-related kinase adaptor alpha,STE20-like pseudokinase,NY-BR-96; LYK5; Stlk; STRAD,STE20 related adaptor alpha,LYK5; NY-BR-96; PMSE; STRAD; STRAD alpha; Stlk,STRADA
Q7Z2E3,APTX_HUMAN,APTX; AXA1,Aprataxin; EC 3.6.1.71; EC 3.6.1.72; Forkhead-associated domain histidine triad-like protein; FHA-HIT,AXA1,54840,aprataxin,ataxia 1; early onset with hypoalbuminemia,,FLJ20157; AOA; AOA1; EAOH; EOAHA,aprataxin,AOA; AOA1; AXA1; EAOH; EOAHA; FHA-HIT,APTX
Q7Z2W7,TRPM8_HUMAN,TRPM8; LTRPC6; TRPP8,Transient receptor potential cation channel subfamily M member 8; Long transient receptor potential channel 6; LTrpC-6; LTrpC6; Transient receptor potential p8; Trp-p8,LTRPC6; TRPP8,79054,transient receptor potential cation channel subfamily M member 8,transient receptor potential cation channel; subfamily M; member 8,,,transient receptor potential cation channel subfamily M member 8,LTRPC6; LTrpC-6; TRPP8; trp-p8,TRPM8
Q7Z2Y5,NRK_HUMAN,NRK,Nik-related protein kinase; EC 2.7.11.1,,203447,Nik related kinase,,,DKFZp686A17109,Nik related kinase,NESK,NRK
Q7Z2Z1,TICRR_HUMAN,TICRR; C15orf42,Treslin; TopBP1-interacting checkpoint and replication regulator; TopBP1-interacting; replication-stimulating protein,C15orf42,90381,TOPBP1 interacting checkpoint and replication regulator,chromosome 15 open reading frame 42,TOPBP1-interacting replication-stimulating protein; SLD3 homolog (S. cerevisiae),MGC45866; FLJ41618; Treslin; SLD3,TOPBP1 interacting checkpoint and replication regulator,C15orf42; SLD3; Treslin,TICRR
Q7Z3C6,ATG9A_HUMAN,ATG9A; APG9L1,Autophagy-related protein 9A; APG9-like 1; mATG9,APG9L1,79065,autophagy related 9A,APG9 autophagy 9-like 1 (S. cerevisiae); ATG9 autophagy related 9 homolog A (S. cerevisiae),,FLJ22169,autophagy related 9A,APG9L1; MGD3208; mATG9,ATG9A
Q7Z3S7,CA2D4_HUMAN,CACNA2D4,Voltage-dependent calcium channel subunit alpha-2/delta-4; Voltage-gated calcium channel subunit alpha-2/delta-4,,93589,calcium voltage-gated channel auxiliary subunit alpha2delta 4,calcium channel; voltage-dependent; alpha 2/delta subunit 4,,alpha2delta-4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,RCD4,CACNA2D4
Q7Z589,EMSY_HUMAN,EMSY; C11orf30; GL002,BRCA2-interacting transcriptional repressor EMSY,C11orf30,56946,EMSY transcriptional repressor; BRCA2 interacting,chromosome 11 open reading frame 30; EMSY; BRCA2 interacting transcriptional repressor,,,EMSY transcriptional repressor; BRCA2 interacting,C11orf30; GL002,EMSY
Q7Z5H3,RHG22_HUMAN,ARHGAP22; RHOGAP2,Rho GTPase-activating protein 22; Rho-type GTPase-activating protein 22,RHOGAP2,58504,Rho GTPase activating protein 22,,,RhoGAP2,Rho GTPase activating protein 22,RhoGAP2; RhoGap22,ARHGAP22
Q7Z5Q1,CPEB2_HUMAN,CPEB2,Cytoplasmic polyadenylation element-binding protein 2; CPE-BP2; CPE-binding protein 2; hCPEB-2,,132864,cytoplasmic polyadenylation element binding protein 2,,,,cytoplasmic polyadenylation element binding protein 2,CPE-BP2; CPEB-2; hCPEB-2,CPEB2
Q7Z628,ARHG8_HUMAN,NET1; ARHGEF8,Neuroepithelial cell-transforming gene 1 protein; Proto-oncogene p65 Net1; Rho guanine nucleotide exchange factor 8,ARHGEF8,10276,neuroepithelial cell transforming 1,,,ARHGEF8; NET1A,neuroepithelial cell transforming 1,ARHGEF8; NET1A,NET1
Q7Z6J0,SH3R1_HUMAN,SH3RF1; KIAA1494; POSH; POSH1; RNF142; SH3MD2,E3 ubiquitin-protein ligase SH3RF1; EC 2.3.2.27; Plenty of SH3s; Protein POSH; RING finger protein 142; RING-type E3 ubiquitin transferase SH3RF1; SH3 domain-containing RING finger protein 1; SH3 multiple domains protein 2,KIAA1494; POSH; POSH1; RNF142; SH3MD2,57630,SH3 domain containing ring finger 1,SH3 multiple domains 2,plenty of SH3 domains,POSH; RNF142; KIAA1494,SH3 domain containing ring finger 1,POSH; RNF142; SH3MD2,SH3RF1
Q7Z6Z7,HUWE1_HUMAN,HUWE1; KIAA0312; KIAA1578; UREB1; HSPC272,E3 ubiquitin-protein ligase HUWE1; EC 2.3.2.26; ARF-binding protein 1; ARF-BP1; HECT; UBA and WWE domain-containing protein 1; HECT-type E3 ubiquitin transferase HUWE1; Homologous to E6AP carboxyl terminus homologous protein 9; HectH9; Large structure of UREB1; LASU1; Mcl-1 ubiquitin ligase E3; Mule; Upstream regulatory element-binding protein 1; URE-B1; URE-binding protein 1,KIAA0312; KIAA1578; UREB1,10075,HECT; UBA and WWE domain containing E3 ubiquitin protein ligase 1,HECT; UBA and WWE domain containing 1,,Ib772; KIAA0312; UREB1,HECT; UBA and WWE domain containing E3 ubiquitin protein ligase 1,ARF-BP1; HECTH9; HSPC272; Ib772; LASU1; MRXST; MULE; URE-B1; UREB1,HUWE1
Q86T82,UBP37_HUMAN,USP37; KIAA1594,Ubiquitin carboxyl-terminal hydrolase 37; EC 3.4.19.12; Deubiquitinating enzyme 37; Ubiquitin thioesterase 37; Ubiquitin-specific-processing protease 37,KIAA1594,57695,ubiquitin specific peptidase 37,ubiquitin specific protease 37,,KIAA1594,ubiquitin specific peptidase 37,,USP37
Q86TB9,PATL1_HUMAN,PATL1; OK/KNS-cl.5,Protein PAT1 homolog 1; PAT1-like protein 1; Protein PAT1 homolog b; Pat1b; hPat1b,,219988,PAT1 homolog 1; processing body mRNA decay factor,protein associated with topoisomerase II homolog 1 (yeast),,FLJ36874; Pat1b,PAT1 homolog 1; processing body mRNA decay factor,Pat1b; hPat1b,PATL1
Q86TI0,TBCD1_HUMAN,TBC1D1; KIAA1108,TBC1 domain family member 1,KIAA1108,23216,TBC1 domain family member 1,TBC1 (tre-2/USP6; BUB2; cdc16) domain family; member 1; TBC1 domain family; member 1,,TBC; TBC1; KIAA1108,TBC1 domain family member 1,TBC; TBC1,TBC1D1
Q86U86,PB1_HUMAN,PBRM1; BAF180; PB1,Protein polybromo-1; hPB1; BRG1-associated factor 180; BAF180; Polybromo-1D,BAF180; PB1,55193,polybromo 1,,,BAF180; PB1; SMARCH1,polybromo 1,BAF180; PB1; RCC; SMARCH1,PBRM1
Q86UC2,RSPH3_HUMAN,RSPH3; RSHL2; RSP3,Radial spoke head protein 3 homolog; A-kinase anchor protein RSPH3; Radial spoke head-like protein 2,RSHL2; RSP3,83861,radial spoke head 3,radial spokehead-like 2; radial spoke head 3 homolog (Chlamydomonas),,dJ111C20.1; RSP3,radial spoke head 3,CILD32; RSHL2; RSP3; dJ111C20.1,RSPH3
Q86UE8,TLK2_HUMAN,TLK2,Serine/threonine-protein kinase tousled-like 2; EC 2.7.11.1; HsHPK; PKU-alpha; Tousled-like kinase 2,,11011,tousled like kinase 2,tousled-like kinase 2,,PKU-ALPHA; MGC44450,tousled like kinase 2,HsHPK; MRD57; PKU-ALPHA,TLK2
Q86UR1,NOXA1_HUMAN,NOXA1; P51NOX,NADPH oxidase activator 1; NOX activator 1; Antigen NY-CO-31; NCF2-like protein; P67phox-like factor; p51-nox,P51NOX,10811,NADPH oxidase activator 1,serologically defined colon cancer antigen 31,,NY-CO-31; FLJ25475,NADPH oxidase activator 1,NY-CO-31; SDCCAG31; p51NOX,NOXA1
Q86V81,THOC4_HUMAN,ALYREF; ALY; BEF; THOC4,THO complex subunit 4; Tho4; Ally of AML-1 and LEF-1; Aly/REF export factor; Transcriptional coactivator Aly/REF; bZIP-enhancing factor BEF,ALY; BEF; THOC4,10189,Aly/REF export factor,THO complex 4,THO complex subunit 4,ALY; BEF; ALY/REF; REF,Aly/REF export factor,ALY; ALY/REF; BEF; REF; THOC4,ALYREF
Q86V86,PIM3_HUMAN,PIM3,Serine/threonine-protein kinase pim-3; EC 2.7.11.1,,415116,Pim-3 proto-oncogene; serine/threonine kinase,pim-3 oncogene,,,Pim-3 proto-oncogene; serine/threonine kinase,pim-3,PIM3
Q86VP1,TAXB1_HUMAN,TAX1BP1; T6BP; PRO0105,Tax1-binding protein 1; TRAF6-binding protein,T6BP,8887,Tax1 binding protein 1,Tax1 (human T-cell leukemia virus type I) binding protein 1,,TXBP151; CALCOCO3,Tax1 binding protein 1,CALCOCO3; T6BP; TXBP151,TAX1BP1
Q86VP3,PACS2_HUMAN,PACS2; KIAA0602; PACS1L,Phosphofurin acidic cluster sorting protein 2; PACS-2; PACS1-like protein,KIAA0602; PACS1L,23241,phosphofurin acidic cluster sorting protein 2,phosphofurin acidic cluster sorting protein 1-like,,KIAA0602,phosphofurin acidic cluster sorting protein 2,DEE66; EIEE66; PACS-2; PACS1L,PACS2
Q86W47,KCMB4_HUMAN,KCNMB4,Calcium-activated potassium channel subunit beta-4; BK channel subunit beta-4; BKbeta4; Hbeta4; Calcium-activated potassium channel; subfamily M subunit beta-4; Charybdotoxin receptor subunit beta-4; K(VCA; Maxi K channel subunit beta-4; Slo-beta-4,,27345,potassium calcium-activated channel subfamily M regulatory beta subunit 4,potassium large conductance calcium-activated channel; subfamily M; beta member 4; potassium channel subfamily M regulatory beta subunit 4,BK channel beta subunit 4; MaxiK channel beta-subunit 4; big potassium channel beta subunit 4,,potassium calcium-activated channel subfamily M regulatory beta subunit 4,,KCNMB4
Q86WB0,ZC3C1_HUMAN,ZC3HC1; NIPA; HSPC216,Zinc finger C3HC-type protein 1; Nuclear-interacting partner of ALK; hNIPA; Nuclear-interacting partner of anaplastic lymphoma kinase,NIPA,51530,zinc finger C3HC-type containing 1,,nuclear interaction partner of ALK,NIPA,zinc finger C3HC-type containing 1,HSPC216; NIPA,ZC3HC1
Q86WV1,SKAP1_HUMAN,SKAP1; SCAP1; SKAP55,Src kinase-associated phosphoprotein 1; Src family-associated phosphoprotein 1; Src kinase-associated phosphoprotein of 55 kDa; SKAP-55; pp55,SCAP1; SKAP55,8631,src kinase associated phosphoprotein 1,src family associated phosphoprotein 1,,SKAP55,src kinase associated phosphoprotein 1,HEL-S-81p; SCAP1; SKAP55,SKAP1
Q86WV6,STING_HUMAN,STING1; ERIS; MITA; STING; TMEM173,Stimulator of interferon genes protein; hSTING; Endoplasmic reticulum interferon stimulator; ERIS; Mediator of IRF3 activation; hMITA; Transmembrane protein 173,ERIS; MITA; STING; TMEM173,340061,stimulator of interferon response cGAMP interactor 1,transmembrane protein 173,stimulator of interferon genes; endoplasmic reticulum IFN stimulator,FLJ38577; NET23; ERIS; MPYS; STING; MITA,stimulator of interferon response cGAMP interactor 1,ERIS; MITA; MPYS; NET23; SAVI; STING; STING-beta; TMEM173; hMITA; hSTING,STING1
Q86X55,CARM1_HUMAN,CARM1; PRMT4,Histone-arginine methyltransferase CARM1; EC 2.1.1.319; Coactivator-associated arginine methyltransferase 1; Protein arginine N-methyltransferase 4,PRMT4,10498,coactivator associated arginine methyltransferase 1,,,PRMT4,coactivator associated arginine methyltransferase 1,PRMT4,CARM1
Q86XL3,ANKL2_HUMAN,ANKLE2; KIAA0692; LEM4,Ankyrin repeat and LEM domain-containing protein 2; LEM domain-containing protein 4,KIAA0692; LEM4,23141,ankyrin repeat and LEM domain containing 2,KIAA0692,LEM domain containing 7; LEM-domain protein 4,LEMD7; Lem4,ankyrin repeat and LEM domain containing 2,KIAA0692; LEMD7; Lem4; MCPH16,ANKLE2
Q86XP0,PA24D_HUMAN,PLA2G4D,Cytosolic phospholipase A2 delta; cPLA2-delta; EC 3.1.1.4; Phospholipase A2 group IVD,,283748,phospholipase A2 group IVD,phospholipase A2; group IVD (cytosolic),,cPLA2delta,phospholipase A2 group IVD,cPLA2delta,PLA2G4D
Q86XR7,TCAM2_HUMAN,TICAM2; TIRAP3; TIRP; TRAM,TIR domain-containing adapter molecule 2; TICAM-2; Putative NF-kappa-B-activating protein 502; TRIF-related adapter molecule; Toll-like receptor adaptor protein 3; Toll/interleukin-1 receptor domain-containing protein; MyD88-4,TIRAP3; TIRP; TRAM,100302736,TIR domain containing adaptor molecule 2,toll-like receptor adaptor molecule 2; toll like receptor adaptor molecule 2,Trif-related adapter molecule,TRAM; TICAM-2; TIRP,TMED7-TICAM2 readthrough,MyD88-4; TICAM-2; TICAM2; TIRAP3; TIRP; TRAM,TICAM2
Q86Y07,VRK2_HUMAN,VRK2,Serine/threonine-protein kinase VRK2; EC 2.7.11.1; Vaccinia-related kinase 2,,7444,VRK serine/threonine kinase 2,vaccinia related kinase 2,,,VRK serine/threonine kinase 2,,VRK2
Q86YS7,C2CD5_HUMAN,C2CD5; CDP138; KIAA0528,C2 domain-containing protein 5; C2 domain-containing phosphoprotein of 138 kDa,CDP138; KIAA0528,9847,C2 calcium dependent domain containing 5,KIAA0528,138 kDa C2 domain-containing phosphoprotein,CDP138,C2 calcium dependent domain containing 5,CDP138; KIAA0528,C2CD5
Q86YV6,MYLK4_HUMAN,MYLK4; SGK085,Myosin light chain kinase family member 4; EC 2.7.11.1; Sugen kinase 85; SgK085,SGK085,340156,myosin light chain kinase family member 4,myosin light chain kinase family; member 4,caMLCK like,SgK085,myosin light chain kinase family member 4,SgK085,MYLK4
Q86Z02,HIPK1_HUMAN,HIPK1; KIAA0630; MYAK; NBAK2,Homeodomain-interacting protein kinase 1; EC 2.7.11.1; Nuclear body-associated kinase 2,KIAA0630; MYAK; NBAK2,204851,homeodomain interacting protein kinase 1,,,KIAA0630; Myak; MGC26642; Nbak2; MGC33446; MGC33548,homeodomain interacting protein kinase 1,Myak; Nbak2,HIPK1
Q8IU85,KCC1D_HUMAN,CAMK1D; CAMKID,Calcium/calmodulin-dependent protein kinase type 1D; EC 2.7.11.17; CaM kinase I delta; CaM kinase ID; CaM-KI delta; CaMKI delta; CaMKID; CaMKI-like protein kinase; CKLiK,CAMKID,57118,calcium/calmodulin dependent protein kinase ID,calcium/calmodulin-dependent protein kinase ID,,CKLiK,calcium/calmodulin dependent protein kinase ID,CKLiK; CaM-K1; CaMKID,CAMK1D
Q8IUE6,H2A2B_HUMAN,H2AC21; HIST2H2AB,Histone H2A type 2-B; H2A-clustered histone 21,HIST2H2AB,317772,H2A clustered histone 21,histone 2; H2ab; histone cluster 2; H2ab; histone cluster 2 H2A family member b,,,H2A clustered histone 21,H2AB; HIST2H2AB,H2AC21
Q8IUQ4,SIAH1_HUMAN,SIAH1; HUMSIAH,E3 ubiquitin-protein ligase SIAH1; EC 2.3.2.27; RING-type E3 ubiquitin transferase SIAH1; Seven in absentia homolog 1; Siah-1; Siah-1a,HUMSIAH,6477,siah E3 ubiquitin protein ligase 1,seven in absentia homolog 1 (Drosophila),,hSIAH1,siah E3 ubiquitin protein ligase 1,BURHAS; SIAH1A,SIAH1
Q8IV61,GRP3_HUMAN,RASGRP3; GRP3; KIAA0846,Ras guanyl-releasing protein 3; Calcium and DAG-regulated guanine nucleotide exchange factor III; Guanine nucleotide exchange factor for Rap1,GRP3; KIAA0846,25780,RAS guanyl releasing protein 3,RAS guanyl releasing protein 3 (calcium and DAG-regulated),calcium- and diacylglycerol-regulated guanine nucleotide exchange factor III,KIAA0846; GRP3; CalDAG-GEFIII,RAS guanyl releasing protein 3,GRP3,RASGRP3
Q8IV63,VRK3_HUMAN,VRK3,Serine/threonine-protein kinase VRK3; EC 2.7.11.22; Vaccinia-related kinase 3,,51231,VRK serine/threonine kinase 3,vaccinia related kinase 3,,,VRK serine/threonine kinase 3,,VRK3
Q8IVH8,M4K3_HUMAN,MAP4K3; RAB8IPL1,Mitogen-activated protein kinase kinase kinase kinase 3; EC 2.7.11.1; Germinal center kinase-related protein kinase; GLK; MAPK/ERK kinase kinase kinase 3; MEK kinase kinase 3; MEKKK 3,RAB8IPL1,8491,mitogen-activated protein kinase kinase kinase kinase 3,,,GLK; MAPKKKK3,mitogen-activated protein kinase kinase kinase kinase 3,GLK; MAPKKKK3; MEKKK 3; MEKKK3; RAB8IPL1,MAP4K3
Q8IVM0,CCD50_HUMAN,CCDC50; C3orf6,Coiled-coil domain-containing protein 50; Protein Ymer,C3orf6,152137,coiled-coil domain containing 50,deafness; autosomal dominant 44,,Ymer,coiled-coil domain containing 50,C3orf6; DFNA44; YMER,CCDC50
Q8IVP5,FUND1_HUMAN,FUNDC1,FUN14 domain-containing protein 1,,139341,FUN14 domain containing 1,,,MGC51029,FUN14 domain containing 1,,FUNDC1
Q8IVT2,MISP_HUMAN,MISP; C19orf21,Mitotic interactor and substrate of PLK1; Mitotic spindle positioning protein,C19orf21,126353,mitotic spindle positioning,chromosome 19 open reading frame 21,mitotic interactor and substrate of Plk1,DKFZp686H18209; Caprice; MISP1,mitotic spindle positioning,C19orf21; MISP1,MISP
Q8IVT5,KSR1_HUMAN,KSR1; KSR,Kinase suppressor of Ras 1; EC 2.7.11.1,KSR,8844,kinase suppressor of ras 1,kinase suppressor of ras,,RSU2,kinase suppressor of ras 1,KSR; RSU2,KSR1
Q8IW19,APLF_HUMAN,APLF; C2orf13; PALF; XIP1,Aprataxin and PNK-like factor; EC 3.1.-.-; Apurinic-apyrimidinic endonuclease APLF; PNK and APTX-like FHA domain-containing protein; XRCC1-interacting protein 1,C2orf13; PALF; XIP1,200558,aprataxin and PNKP like factor,chromosome 2 open reading frame 13,XRCC1-interacting protein 1; zinc finger; CX5CX6HX5H motif containing 1,MGC47799; Xip1; ZCCHH1,aprataxin and PNKP like factor,APFL; C2orf13; PALF; Xip1; ZCCHH1,APLF
Q8IW41,MAPK5_HUMAN,MAPKAPK5; PRAK,MAP kinase-activated protein kinase 5; MAPK-activated protein kinase 5; MAPKAP kinase 5; MAPKAP-K5; MAPKAPK-5; MK-5; MK5; EC 2.7.11.1; p38-regulated/activated protein kinase; PRAK,PRAK,8550,MAPK activated protein kinase 5,mitogen-activated protein kinase-activated protein kinase 5,,PRAK; MK5,MAPK activated protein kinase 5,MAPKAP-K5; MK-5; MK5; NCFD; PRAK,MAPKAPK5
Q8IWB6,TEX14_HUMAN,TEX14; SGK307,Inactive serine/threonine-protein kinase TEX14; Protein kinase-like protein SgK307; Sugen kinase 307; Testis-expressed sequence 14; Testis-expressed sequence 14 protein,SGK307,56155,testis expressed 14; intercellular bridge forming factor,testis expressed sequence 14; testis expressed 14,cancer/testis antigen 113; Inactive serine/threonine-protein kinase TEX14,CT113; SgK307,testis expressed 14; intercellular bridge forming factor,CT113; SPGF23; SgK307,TEX14
Q8IWQ3,BRSK2_HUMAN,BRSK2; C11orf7; PEN11B; SADA; STK29; HUSSY-12,Serine/threonine-protein kinase BRSK2; EC 2.7.11.1; Brain-selective kinase 2; EC 2.7.11.26; Brain-specific serine/threonine-protein kinase 2; BR serine/threonine-protein kinase 2; Serine/threonine-protein kinase 29; Serine/threonine-protein kinase SAD-A,C11orf7; PEN11B; SADA; STK29,9024,BR serine/threonine kinase 2,chromsosome 11 open reading frame 7,serine/threonine kinase 29; brain selective kinase 2,PEN11B; SAD-A,BR serine/threonine kinase 2,C11orf7; PEN11B; SAD-A; SAD1; SADA; STK29,BRSK2
Q8IWT1,SCN4B_HUMAN,SCN4B,Sodium channel regulatory subunit beta-4,,6330,sodium voltage-gated channel beta subunit 4,sodium channel; voltage-gated; type IV; beta; sodium channel; voltage-gated; type IV; beta subunit; sodium channel; voltage gated; type IV beta subunit,,LQT10,sodium voltage-gated channel beta subunit 4,ATFB17; LQT10; Navbeta4,SCN4B
Q8IWU2,LMTK2_HUMAN,LMTK2; AATYK2; BREK; KIAA1079; KPI2; LMR2,Serine/threonine-protein kinase LMTK2; EC 2.7.11.1; Apoptosis-associated tyrosine kinase 2; Brain-enriched kinase; hBREK; CDK5/p35-regulated kinase; CPRK; Kinase/phosphatase/inhibitor 2; Lemur tyrosine kinase 2; Serine/threonine-protein kinase KPI-2,AATYK2; BREK; KIAA1079; KPI2; LMR2,22853,lemur tyrosine kinase 2,,protein phosphatase 1; regulatory subunit 100,KIAA1079; KPI2; KPI-2; cprk; LMR2; BREK; AATYK2; PPP1R100,lemur tyrosine kinase 2,AATYK2; BREK; KPI-2; KPI2; LMR2; PPP1R100; cprk; hBREK,LMTK2
Q8IWW6,RHG12_HUMAN,ARHGAP12,Rho GTPase-activating protein 12; Rho-type GTPase-activating protein 12,,94134,Rho GTPase activating protein 12,,,FLJ20737; FLJ10971; FLJ21785,Rho GTPase activating protein 12,,ARHGAP12
Q8IX01,SUGP2_HUMAN,SUGP2; KIAA0365; SFRS14,SURP and G-patch domain-containing protein 2; Arginine/serine-rich-splicing factor 14; Splicing factor; arginine/serine-rich 14,KIAA0365; SFRS14,10147,SURP and G-patch domain containing 2,splicing factor; arginine/serine-rich 14,,KIAA0365,SURP and G-patch domain containing 2,SFRS14; SRFS14,SUGP2
Q8IX03,KIBRA_HUMAN,WWC1; KIAA0869; KIBRA,Protein KIBRA; HBeAg-binding protein 3; Kidney and brain protein; KIBRA; WW domain-containing protein 1,KIAA0869; KIBRA,23286,WW and C2 domain containing 1,WW; C2 and coiled-coil domain containing 1,protein phosphatase 1; regulatory subunit 168,KIBRA; KIAA0869; PPP1R168,WW and C2 domain containing 1,HBEBP3; HBEBP36; KIBRA; MEMRYQTL; PPP1R168,WWC1
Q8IX90,SKA3_HUMAN,SKA3; C13orf3; RAMA1,Spindle and kinetochore-associated protein 3,C13orf3; RAMA1,221150,spindle and kinetochore associated complex subunit 3,chromosome 13 open reading frame 3,,MGC4832; RAMA1,spindle and kinetochore associated complex subunit 3,C13orf3; RAMA1,SKA3
Q8IXH7,NELFD_HUMAN,NELFCD; NELFD; TH1; TH1L; HSPC130,Negative elongation factor C/D; NELF-C/D; TH1-like protein,NELFD; TH1; TH1L,51497,negative elongation factor complex member C/D,TH1-like (Drosophila homolog); TH1-like (Drosophila),trihydrophobin 1,HSPC130; TH1; NELF-C; NELF-D,negative elongation factor complex member C/D,HSPC130; NELF-C; NELF-D; TH1; TH1L,NELFCD
Q8IXI2,MIRO1_HUMAN,RHOT1; ARHT1,Mitochondrial Rho GTPase 1; MIRO-1; hMiro-1; EC 3.6.5.-; Rac-GTP-binding protein-like protein; Ras homolog gene family member T1,ARHT1,55288,ras homolog family member T1,ras homolog gene family; member T1,mitochondrial Rho (MIRO) GTPase 1,MIRO-1; FLJ11040; MIRO1,ras homolog family member T1,ARHT1; MIRO-1; MIRO1,RHOT1
Q8IXJ6,SIR2_HUMAN,SIRT2; SIR2L; SIR2L2,NAD-dependent protein deacetylase sirtuin-2; EC 2.3.1.286; NAD-dependent protein defatty-acylase sirtuin-2; EC 2.3.1.-; Regulatory protein SIR2 homolog 2; SIR2-like protein 2,SIR2L; SIR2L2,22933,sirtuin 2,sirtuin (silent mating type information regulation 2; S.cerevisiae; homolog) 2; sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae),,,sirtuin 2,SIR2; SIR2L; SIR2L2,SIRT2
Q8IXL6,FA20C_HUMAN,FAM20C; DMP4,Extracellular serine/threonine protein kinase FAM20C; EC 2.7.11.1; Dentin matrix protein 4; DMP-4; Golgi casein kinase; Golgi-enriched fraction casein kinase; GEF-CK,DMP4,56975,FAM20C golgi associated secretory pathway kinase,family with sequence similarity 20; member C; FAM20C; golgi associated secretory pathway kinase,dentin matrix protein 4; golgi casein kinase,IMAGE:4942737; DKFZp547D065; DMP4; G-CK,FAM20C golgi associated secretory pathway kinase,DMP-4; DMP4; G-CK; GEF-CK; RNS,FAM20C
Q8IXM2,BAP18_HUMAN,BACC1; BAP18; C17orf49,BPTF-associated chromatin complex component 1; BPTF-associated protein of 18 kDa; Chromatin complexes subunit BAP18,BAP18; C17orf49,124944,BPTF associated chromatin complex component 1,chromosome 17 open reading frame 49,BPTF associated protein of 18 kDa; human embryo lung cellular protein interacting with SARS-CoV nsp-10,MGC49942; BAP18; HEPIS,BPTF associated chromatin complex component 1,BAP18; C17orf49; HEPIS,BACC1
Q8IXW5,RPAP2_HUMAN,RPAP2; C1orf82,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2; EC 3.1.3.16; RNA polymerase II-associated protein 2,C1orf82,79871,RNA polymerase II associated protein 2,chromosome 1 open reading frame 82,,FLJ13150; Rtr1,RNA polymerase II associated protein 2,C1orf82; Rtr1,RPAP2
Q8IY84,NIM1_HUMAN,NIM1K; NIM1,Serine/threonine-protein kinase NIM1; EC 2.7.11.1; NIM1 serine/threonine-protein kinase,NIM1,167359,NIM1 serine/threonine protein kinase,,,MGC42105; NIM1,NIM1 serine/threonine protein kinase,NIM1,NIM1K
Q8IY92,SLX4_HUMAN,SLX4; BTBD12; KIAA1784; KIAA1987,Structure-specific endonuclease subunit SLX4; BTB/POZ domain-containing protein 12,BTBD12; KIAA1784; KIAA1987,84464,SLX4 structure-specific endonuclease subunit,BTB (POZ) domain containing 12; SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae),Fanconi anemia; complementation group P,KIAA1784; KIAA1987; FANCP,SLX4 structure-specific endonuclease subunit,BTBD12; FANCP; MUS312,SLX4
Q8IYB3,SRRM1_HUMAN,SRRM1; SRM160,Serine/arginine repetitive matrix protein 1; SR-related nuclear matrix protein of 160 kDa; SRm160; Ser/Arg-related nuclear matrix protein,SRM160,10250,serine and arginine repetitive matrix 1,serine/arginine repetitive matrix 1,Ser/Arg-related nuclear matrix protein; plenty of prolines 101-like,SRM160; POP101; MGC39488,serine and arginine repetitive matrix 1,160-KD; POP101; SRM160,SRRM1
Q8IYJ3,SYTL1_HUMAN,SYTL1; SLP1; SB146,Synaptotagmin-like protein 1; Exophilin-7; Protein JFC1,SLP1,84958,synaptotagmin like 1,synaptotagmin-like 1,,SLP1; JFC1; FLJ14996; exophilin-7,synaptotagmin like 1,JFC1; SLP1,SYTL1
Q8IYM1,SEP12_HUMAN,SEPTIN12; SEPT12,Septin-12,SEPT12,124404,septin 12,,,FLJ25410,septin 12,SEPT12; SPGF10,SEPTIN12
Q8IYT8,ULK2_HUMAN,ULK2; KIAA0623,Serine/threonine-protein kinase ULK2; EC 2.7.11.1; Unc-51-like kinase 2,KIAA0623,9706,unc-51 like autophagy activating kinase 2,unc-51 (C. elegans)-like kinase 2; unc-51-like kinase 2 (C. elegans),,KIAA0623; Unc51.2; ATG1B,unc-51 like autophagy activating kinase 2,ATG1B; Unc51.2,ULK2
Q8IYU2,HACE1_HUMAN,HACE1; KIAA1320,E3 ubiquitin-protein ligase HACE1; EC 2.3.2.26; HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1; HECT-type E3 ubiquitin transferase HACE1,KIAA1320,57531,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,,,KIAA1320,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,SPPRS,HACE1
Q8IZD2,KMT2E_HUMAN,KMT2E; MLL5,Inactive histone-lysine N-methyltransferase 2E; Inactive lysine N-methyltransferase 2E; Myeloid/lymphoid or mixed-lineage leukemia protein 5,MLL5,55904,lysine methyltransferase 2E (inactive),myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog; Drosophila); lysine (K)-specific methyltransferase 2E; lysine methyltransferase 2E,,HDCMC04P; SETD5B,lysine methyltransferase 2E (inactive),HDCMC04P; MLL5; NKp44L; ODLURO; SETD5B,KMT2E
Q8IZJ1,UNC5B_HUMAN,UNC5B; P53RDL1; UNC5H2; UNQ1883/PRO4326,Netrin receptor UNC5B; Protein unc-5 homolog 2; Protein unc-5 homolog B; p53-regulated receptor for death and life protein 1; p53RDL1,P53RDL1; UNC5H2,219699,unc-5 netrin receptor B,unc5 (C.elegans homolog) b; unc-5 homolog B (C. elegans),,UNC5H2; p53RDL1,unc-5 netrin receptor B,UNC5H2; p53RDL1,UNC5B
Q8IZL8,PELP1_HUMAN,PELP1; HMX3; MNAR,Proline-; glutamic acid- and leucine-rich protein 1; Modulator of non-genomic activity of estrogen receptor; Transcription factor HMX3,HMX3; MNAR,27043,proline; glutamate and leucine rich protein 1,proline; glutamic acid and leucine rich protein 1,,MNAR,proline; glutamate and leucine rich protein 1,MNAR; P160,PELP1
Q8IZL9,CDK20_HUMAN,CDK20; CCRK; CDCH,Cyclin-dependent kinase 20; EC 2.7.11.22; CDK-activating kinase p42; CAK-kinase p42; Cell cycle-related kinase; Cell division protein kinase 20; Cyclin-dependent protein kinase H; Cyclin-kinase-activating kinase p42,CCRK; CDCH,23552,cyclin dependent kinase 20,cell cycle related kinase,,p42; PNQALRE,cyclin dependent kinase 20,CCRK; CDCH; P42; PNQALRE,CDK20
Q8IZP0,ABI1_HUMAN,ABI1; SSH3BP1,Abl interactor 1; Abelson interactor 1; Abi-1; Abl-binding protein 4; AblBP4; Eps8 SH3 domain-binding protein; Eps8-binding protein; Nap1-binding protein; Nap1BP; Spectrin SH3 domain-binding protein 1; e3B1,SSH3BP1,10006,abl interactor 1,spectrin SH3 domain binding protein 1; abl-interactor 1,,E3B1; ABI-1,abl interactor 1,ABI-1; ABLBP4; E3B1; NAP1BP; SSH3BP; SSH3BP1,ABI1
Q8IZS8,CA2D3_HUMAN,CACNA2D3,Voltage-dependent calcium channel subunit alpha-2/delta-3; Voltage-gated calcium channel subunit alpha-2/delta-3,,55799,calcium voltage-gated channel auxiliary subunit alpha2delta 3,calcium channel; voltage-dependent; alpha 2/delta subunit 3,Voltage-dependent calcium channel subunit alpha-2/delta-3,HSA272268; alpha2delta-3,calcium voltage-gated channel auxiliary subunit alpha2delta 3,HSA272268,CACNA2D3
Q8N0W4,NLGNX_HUMAN,NLGN4X; KIAA1260; NLGN4; UNQ365/PRO701,Neuroligin-4; X-linked; Neuroligin X; HNLX,KIAA1260; NLGN4,57502,neuroligin 4 X-linked,neuroligin 4,,KIAA1260; NLGN; HLNX,neuroligin 4 X-linked,ASPGX2; AUTSX2; HLNX; HNL4X; NLGN4,NLGN4X
Q8N122,RPTOR_HUMAN,RPTOR; KIAA1303; RAPTOR,Regulatory-associated protein of mTOR; Raptor; p150 target of rapamycin (TOR,KIAA1303; RAPTOR,57521,regulatory associated protein of MTOR complex 1,regulatory associated protein of MTOR; complex 1,regulatory associated protein of mTOR,KOG1; Mip1; KIAA1303; raptor,regulatory associated protein of MTOR complex 1,KOG1; Mip1,RPTOR
Q8N137,CNTRB_HUMAN,CNTROB; LIP8; PP1221,Centrobin; Centrosomal BRCA2-interacting protein; LYST-interacting protein 8,LIP8,116840,centrobin; centriole duplication and spindle assembly protein,centrobin; centrosomal BRCA2 interacting protein,centrobin,LIP8; PP1221,centrobin; centriole duplication and spindle assembly protein,LIP8; PP1221,CNTROB
Q8N163,CCAR2_HUMAN,CCAR2; DBC1; KIAA1967,Cell cycle and apoptosis regulator protein 2; Cell division cycle and apoptosis regulator protein 2; DBIRD complex subunit KIAA1967; Deleted in breast cancer gene 1 protein; DBC-1; DBC.1; NET35; p30 DBC,DBC1; KIAA1967,57805,cell cycle and apoptosis regulator 2,KIAA1967,deleted in breast cancer 1,DBC-1; DBC1; NET35,cell cycle and apoptosis regulator 2,DBC-1; DBC1; KIAA1967; NET35; p30 DBC; p30DBC,CCAR2
Q8N1K5,THMS1_HUMAN,THEMIS; C6orf190; C6orf207,Protein THEMIS; Thymocyte-expressed molecule involved in selection,C6orf190; C6orf207,387357,thymocyte selection associated,chromosome 6 open reading frame 207; chromosome 6 open reading frame 190; thymocyte selection pathway associated,thymocyte expressed molecule involved in selection,bA325O24.4; FLJ40584; bA325O24.3; THEMIS1,thymocyte selection associated,C6orf190; C6orf207; GASP; SPOT; THEMIS1; TSEPA,THEMIS
Q8N1W1,ARG28_HUMAN,ARHGEF28; KIAA1998; RGNEF,Rho guanine nucleotide exchange factor 28; 190 kDa guanine nucleotide exchange factor; p190-RhoGEF; p190RhoGEF; Rho guanine nucleotide exchange factor,KIAA1998; RGNEF,64283,Rho guanine nucleotide exchange factor 28,Rho guanine nucleotide exchange factor (GEF) 28,,RGNEF; p190RhoGEF; RIP2,Rho guanine nucleotide exchange factor 28,RGNEF; RIP2; p190RHOGEF,ARHGEF28
Q8N257,H2B3B_HUMAN,H2BC26; H2BU1; HIST3H2BB,Histone H2B type 3-B; H2B type 12; H2B-clustered histone 26; H2B.U histone 1,H2BU1; HIST3H2BB,128312,H2B clustered histone 26,histone 3; H2bb; histone cluster 3; H2bb; histone cluster 3 H2B family member b; H2B.U histone 1,,,H2B clustered histone 26,H2BU1; H2Bb; HIST3H2BB,H2BC26
Q8N264,RHG24_HUMAN,ARHGAP24; FILGAP,Rho GTPase-activating protein 24; Filamin-A-associated RhoGAP; FilGAP; RAC1- and CDC42-specific GTPase-activating protein of 72 kDa; RC-GAP72; Rho-type GTPase-activating protein 24; RhoGAP of 73 kDa; Sarcoma antigen NY-SAR-88; p73RhoGAP,FILGAP,83478,Rho GTPase activating protein 24,,,DKFZP564B1162; FLJ33877; FilGAP,Rho GTPase activating protein 24,FILGAP; RC-GAP72; RCGAP72; p73; p73RhoGAP,ARHGAP24
Q8N2W9,PIAS4_HUMAN,PIAS4; PIASG,E3 SUMO-protein ligase PIAS4; EC 2.3.2.27; PIASy; Protein inhibitor of activated STAT protein 4; Protein inhibitor of activated STAT protein gamma; PIAS-gamma,PIASG,51588,protein inhibitor of activated STAT 4,,zinc finger; MIZ-type containing 6,Piasg; PIASY; FLJ12419; ZMIZ6,protein inhibitor of activated STAT 4,PIAS-gamma; PIASY; Piasg; ZMIZ6,PIAS4
Q8N3F0,MTURN_HUMAN,MTURN; C7orf41,Maturin; Maturin neural progenitor differentiation regulator protein homolog; Protein Ells1,C7orf41,222166,maturin; neural progenitor differentiation regulator homolog,chromosome 7 open reading frame 41; maturin; neural progenitor differentiation regulator homolog (Xenopus),,FLJ25903; Ells1,maturin; neural progenitor differentiation regulator homolog,C7orf41; Ells1,MTURN
Q8N3J5,PPM1K_HUMAN,PPM1K; PP2CM,Protein phosphatase Mn(2+)-dependent 1K; 2+; EC 3.1.3.16; Branched-chain alpha-ketoacid dehydrogenase phosphatase; BCKDH; BDP; EC 3.1.3.52; PP2C domain-containing protein phosphatase 1K; PP2C-like mitochondrial protein; PP2C-type mitochondrial phosphoprotein phosphatase; PTMP; Protein phosphatase 2C family member; Protein phosphatase 2C isoform kappa; PP2C-kappa; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring,PP2CM,152926,protein phosphatase; Mg2+/Mn2+ dependent 1K,protein phosphatase 1K (PP2C domain containing); protein phosphatase; Mg2+/Mn2+ dependent; 1K,PP2C-type mitochondrial phosphoprotein phosphatase; protein phosphatase 2C kappa; branched-chain ??-ketoacid dehydrogenase phosphatase,DKFZp761G058; PP2Ckappa; hPTMP; PP2Cm; BDP,protein phosphatase; Mg2+/Mn2+ dependent 1K,BCKDH; BDP; MSUDMV; PP2Ckappa; PP2Cm; PTMP; UG0882E07,PPM1K
Q8N4C8,MINK1_HUMAN,MINK1; B55; MAP4K6; MINK; YSK2; ZC3,Misshapen-like kinase 1; EC 2.7.11.1; GCK family kinase MiNK; MAPK/ERK kinase kinase kinase 6; MEK kinase kinase 6; MEKKK 6; Misshapen/NIK-related kinase; Mitogen-activated protein kinase kinase kinase kinase 6,B55; MAP4K6; MINK; YSK2; ZC3,50488,misshapen like kinase 1,misshapen-like kinase 1 (zebrafish); misshapen-like kinase 1,misshapen/NIK-related kinase,B55; MINK; ZC3; MAP4K6; YSK2,misshapen like kinase 1,B55; MAP4K6; MEKKK 6; MINK; YSK2; ZC3,MINK1
Q8N4N8,KIF2B_HUMAN,KIF2B,Kinesin-like protein KIF2B,,84643,kinesin family member 2B,,,,kinesin family member 2B,,KIF2B
Q8N4X5,AF1L2_HUMAN,AFAP1L2; KIAA1914; XB130,Actin filament-associated protein 1-like 2; AFAP1-like protein 2,KIAA1914; XB130,84632,actin filament associated protein 1 like 2,KIAA1914; actin filament associated protein 1-like 2,,FLJ14564; Em:AC005383.4; XB130,actin filament associated protein 1 like 2,CTB-1144G6.4; KIAA1914; XB130,AFAP1L2
Q8N556,AFAP1_HUMAN,AFAP1; AFAP,Actin filament-associated protein 1; 110 kDa actin filament-associated protein; AFAP-110,AFAP,60312,actin filament associated protein 1,,,AFAP-110; AFAP,actin filament associated protein 1,AFAP; AFAP-110; AFAP110,AFAP1
Q8N5B7,CERS5_HUMAN,CERS5; LASS5,Ceramide synthase 5; CerS5; LAG1 longevity assurance homolog 5; Sphingoid base N-palmitoyltransferase CERS5; EC 2.3.1.291; Sphingosine N-acyltransferase CERS5; EC 2.3.1.24,LASS5,91012,ceramide synthase 5,LAG1 longevity assurance homolog 5 (S. cerevisiae); LAG1 homolog; ceramide synthase 5,,Trh4; MGC45411; FLJ25304,ceramide synthase 5,LASS5; Trh4,CERS5
Q8N5C8,TAB3_HUMAN,TAB3; MAP3K7IP3,TGF-beta-activated kinase 1 and MAP3K7-binding protein 3; Mitogen-activated protein kinase kinase kinase 7-interacting protein 3; NF-kappa-B-activating protein 1; TAK1-binding protein 3; TAB-3; TGF-beta-activated kinase 1-binding protein 3,MAP3K7IP3,257397,TGF-beta activated kinase 1 (MAP3K7) binding protein 3,mitogen-activated protein kinase kinase kinase 7 interacting protein 3; TGF-beta activated kinase 1/MAP3K7 binding protein 3; TGF-beta activated kinase 1 and MAP3K7 binding protein 3,TAK1 binding protein 3,,TGF-beta activated kinase 1 (MAP3K7) binding protein 3,MAP3K7IP3; NAP1,TAB3
Q8N5S9,KKCC1_HUMAN,CAMKK1; CAMKKA,Calcium/calmodulin-dependent protein kinase kinase 1; CaM-KK 1; CaM-kinase kinase 1; CaMKK 1; EC 2.7.11.17; CaM-kinase IV kinase; Calcium/calmodulin-dependent protein kinase kinase alpha; CaM-KK alpha; CaM-kinase kinase alpha; CaMKK alpha,CAMKKA,84254,calcium/calmodulin dependent protein kinase kinase 1,calcium/calmodulin-dependent protein kinase kinase 1; alpha,calcium/calmodulin-dependent protein kinase kinase alpha,DKFZp761M0423; CAMKKA; MGC34095,calcium/calmodulin dependent protein kinase kinase 1,CAMKKA,CAMKK1
Q8N680,ZBTB2_HUMAN,ZBTB2; KIAA1483; ZNF437,Zinc finger and BTB domain-containing protein 2,KIAA1483; ZNF437,57621,zinc finger and BTB domain containing 2,,,KIAA1483; ZNF437; bA351K16.2,zinc finger and BTB domain containing 2,ZNF437,ZBTB2
Q8N6F7,GCSAM_HUMAN,GCSAM; GAL; GCET2,Germinal center-associated signaling and motility protein; Germinal center B-cell-expressed transcript 2 protein; Germinal center-associated lymphoma protein; hGAL,GAL; GCET2,257144,germinal center associated signaling and motility,germinal center expressed transcript 2,human germinal center-associated lymphoma,MGC40441; HGAL,germinal center associated signaling and motility,GCAT2; GCET2; HGAL,GCSAM
Q8N6T7,SIR6_HUMAN,SIRT6; SIR2L6,NAD-dependent protein deacylase sirtuin-6; EC 2.3.1.-; NAD-dependent protein deacetylase sirtuin-6; EC 2.3.1.286; Protein mono-ADP-ribosyltransferase sirtuin-6; EC 2.4.2.-; Regulatory protein SIR2 homolog 6; hSIRT6; SIR2-like protein 6,SIR2L6,51548,sirtuin 6,sirtuin (silent mating type information regulation 2; S. cerevisiae; homolog) 6; sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae),,,sirtuin 6,SIR2L6; hSIRT6,SIRT6
Q8N726,ARF_HUMAN,CDKN2A; CDKN2; MLM,Tumor suppressor ARF; Alternative reading frame; ARF; Cyclin-dependent kinase inhibitor 2A; p14ARF,CDKN2; MLM,1029,cyclin dependent kinase inhibitor 2A,cyclin-dependent kinase inhibitor 2A (melanoma; p16; inhibits CDK4),CDKN2A/ARF Intron 2 lncRNA; multiple tumour suppressor 1; cyclin-dependent kinase 4 inhibitor A; p19 alternate open reading frame; p14 alternate open reading frame; inhibitor of cdk4 A,CDK4I; p16; INK4a; MTS1; CMM2; ARF; p19; p14; INK4; p16INK4a; p19Arf; p14ARF; P16-INK4A; CAI2,cyclin dependent kinase inhibitor 2A,ARF; CAI2; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16,CDKN2A
Q8N752,KC1AL_HUMAN,CSNK1A1L,Casein kinase I isoform alpha-like; CKI-alpha-like; EC 2.7.11.1; CK1,,122011,casein kinase 1 alpha 1 like,casein kinase 1; alpha 1-like,,MGC33182,casein kinase 1 alpha 1 like,CK1,CSNK1A1L
Q8N8S7,ENAH_HUMAN,ENAH; MENA,Protein enabled homolog,MENA,55740,ENAH actin regulator,enabled homolog (Drosophila),mammalian enabled,FLJ10773; NDPP1; MENA,ENAH actin regulator,ENA; MENA; NDPP1,ENAH
Q8N9N5,BANP_HUMAN,BANP; BEND1; SMAR1,Protein BANP; BEN domain-containing protein 1; Btg3-associated nuclear protein; Scaffold/matrix-associated region-1-binding protein,BEND1; SMAR1,54971,BTG3 associated nuclear protein,,BEN domain containing 1,SMARBP1; SMAR1; FLJ20538; DKFZp761H172; FLJ10177; BEND1,BTG3 associated nuclear protein,BEND1; SMAR1; SMARBP1,BANP
Q8NB16,MLKL_HUMAN,MLKL,Mixed lineage kinase domain-like protein; hMLKL,,197259,mixed lineage kinase domain like pseudokinase,mixed lineage kinase domain-like,,FLJ34389,mixed lineage kinase domain like pseudokinase,hMLKL,MLKL
Q8NBZ0,IN80E_HUMAN,INO80E; CCDC95,INO80 complex subunit E; Coiled-coil domain-containing protein 95,CCDC95,283899,INO80 complex subunit E,coiled-coil domain containing 95,,FLJ90652,INO80 complex subunit E,CCDC95,INO80E
Q8NCD3,HJURP_HUMAN,HJURP; FAKTS; FLEG1; URLC9,Holliday junction recognition protein; 14-3-3-associated AKT substrate; Fetal liver-expressing gene 1 protein; Up-regulated in lung cancer 9,FAKTS; FLEG1; URLC9,55355,Holliday junction recognition protein,,,DKFZp762E1312; URLC9; hFLEG1; FAKTS,Holliday junction recognition protein,FAKTS; URLC9; hFLEG1,HJURP
Q8NE35,CPEB3_HUMAN,CPEB3; KIAA0940,Cytoplasmic polyadenylation element-binding protein 3; CPE-BP3; CPE-binding protein 3; hCPEB-3,KIAA0940,22849,cytoplasmic polyadenylation element binding protein 3,,,KIAA0940,cytoplasmic polyadenylation element binding protein 3,,CPEB3
Q8NE63,HIPK4_HUMAN,HIPK4,Homeodomain-interacting protein kinase 4; EC 2.7.11.1,,147746,homeodomain interacting protein kinase 4,,,FLJ32818,homeodomain interacting protein kinase 4,,HIPK4
Q8NE71,ABCF1_HUMAN,ABCF1; ABC50,ATP-binding cassette sub-family F member 1; ATP-binding cassette 50; TNF-alpha-stimulated ABC protein,ABC50,23,ATP binding cassette subfamily F member 1,ATP-binding cassette; sub-family F (GCN20); member 1,,EST123147,ATP binding cassette subfamily F member 1,ABC27; ABC50,ABCF1
Q8NEB9,PK3C3_HUMAN,PIK3C3; VPS34,Phosphatidylinositol 3-kinase catalytic subunit type 3; PI3-kinase type 3; PI3K type 3; PtdIns-3-kinase type 3; EC 2.7.1.137; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide-3-kinase class 3; hVps34,VPS34,5289,phosphatidylinositol 3-kinase catalytic subunit type 3,phosphoinositide-3-kinase; class 3; phosphatidylinositol 3-kinase; catalytic subunit type 3,vacuolar protein sorting 34 homolog,Vps34; hVps34,phosphatidylinositol 3-kinase catalytic subunit type 3,VPS34; Vps34; hVps34,PIK3C3
Q8NEJ0,DUS18_HUMAN,DUSP18; LMWDSP20,Dual specificity protein phosphatase 18; EC 3.1.3.16; EC 3.1.3.48; Low molecular weight dual specificity phosphatase 20; LMW-DSP20,LMWDSP20,150290,dual specificity phosphatase 18,,,DUSP20,dual specificity phosphatase 18,DSP18; DUSP20; LMWDSP20,DUSP18
Q8NER1,TRPV1_HUMAN,TRPV1; VR1,Transient receptor potential cation channel subfamily V member 1; TrpV1; Capsaicin receptor; Osm-9-like TRP channel 1; OTRPC1; Vanilloid receptor 1,VR1,7442,transient receptor potential cation channel subfamily V member 1,vanilloid receptor subtype 1; transient receptor potential cation channel; subfamily V; member 1,,,transient receptor potential cation channel subfamily V member 1,VR1,TRPV1
Q8NER5,ACV1C_HUMAN,ACVR1C; ALK7,Activin receptor type-1C; EC 2.7.11.30; Activin receptor type IC; ACTR-IC; Activin receptor-like kinase 7; ALK-7,ALK7,130399,activin A receptor type 1C,activin A receptor; type IC,,ALK7; ACVRLK7,activin A receptor type 1C,ACVRLK7; ALK7,ACVR1C
Q8NET8,TRPV3_HUMAN,TRPV3,Transient receptor potential cation channel subfamily V member 3; TrpV3; Vanilloid receptor-like 3; VRL-3,,162514,transient receptor potential cation channel subfamily V member 3,transient receptor potential cation channel; subfamily V; member 3,,VRL3,transient receptor potential cation channel subfamily V member 3,FNEPPK2; OLMS; OLMS1; VRL3,TRPV3
Q8NEV1,CSK23_HUMAN,CSNK2A3; CSNK2A1P,Casein kinase II subunit alpha 3; CK II alpha 3; EC 2.7.11.1; Casein kinase II alpha 1 polypeptide pseudogene,CSNK2A1P,283106,casein kinase 2 alpha 3,casein kinase 2; alpha 1 polypeptide pseudogene; casein kinase 2; alpha 3 polypeptide,,,casein kinase 2 alpha 3,CSNK2A1P,CSNK2A3
Q8NEV4,MYO3A_HUMAN,MYO3A,Myosin-IIIa; EC 2.7.11.1,,53904,myosin IIIA,deafness; autosomal recessive 30,,,myosin IIIA,DFNA90; DFNB30,MYO3A
Q8NEY8,PPHLN_HUMAN,PPHLN1; HSPC206; HSPC232,Periphilin-1; CDC7 expression repressor; CR; Gastric cancer antigen Ga50,,51535,periphilin 1,,,,periphilin 1,CR; HSPC206; HSPC232,PPHLN1
Q8NF50,DOCK8_HUMAN,DOCK8,Dedicator of cytokinesis protein 8,,81704,dedicator of cytokinesis 8,,,FLJ00026; FLJ00152; ZIR8; FLJ00346,dedicator of cytokinesis 8,HEL-205; HIES2; MRD2; ZIR8,DOCK8
Q8NFA2,NOXO1_HUMAN,NOXO1; P41NOX; SH3PXD5,NADPH oxidase organizer 1; NADPH oxidase regulatory protein; Nox organizer 1; Nox-organizing protein 1; SH3 and PX domain-containing protein 5,P41NOX; SH3PXD5,124056,NADPH oxidase organizer 1,,,P41NOXA; P41NOXB; P41NOXC; SH3PXD5; SNX28,NADPH oxidase organizer 1,P41NOX; P41NOXA; P41NOXB; P41NOXC; SH3PXD5; SNX28,NOXO1
Q8NFH8,REPS2_HUMAN,REPS2; POB1,RalBP1-associated Eps domain-containing protein 2; Partner of RalBP1; RalBP1-interacting protein 2,POB1,9185,RALBP1 associated Eps domain containing 2,,,POB1,RALBP1 associated Eps domain containing 2,POB1,REPS2
Q8NFJ5,RAI3_HUMAN,GPRC5A; GPCR5A; RAI3; RAIG1,Retinoic acid-induced protein 3; G-protein coupled receptor family C group 5 member A; Phorbol ester induced gene 1; PEIG-1; Retinoic acid-induced gene 1 protein; RAIG-1,GPCR5A; RAI3; RAIG1,9052,G protein-coupled receptor class C group 5 member A,retinoic acid induced 3; G protein-coupled receptor; class C; group 5; member A,,RAIG1; TIG1; PEIG-1,G protein-coupled receptor class C group 5 member A,GPCR5A; PEIG-1; RAI3; RAIG1; TIG1,GPRC5A
Q8NG31,KNL1_HUMAN,KNL1; CASC5; KIAA1570,Outer kinetochore KNL1 complex subunit KNL1; ALL1-fused gene from chromosome 15q14 protein; AF15q14; Bub-linking kinetochore protein; Blinkin; Cancer susceptibility candidate gene 5 protein; Cancer/testis antigen 29; CT29; Kinetochore scaffold 1; Kinetochore-null protein 1; Protein CASC5; Protein D40/AF15q14,CASC5; KIAA1570,57082,kinetochore scaffold 1,microcephaly; primary autosomal recessive 4; cancer susceptibility candidate 5,cancer/testis antigen 29; kinetochore null 1 homolog (C. elegans); blinkin; bub-linking kinetochore protein; protein phosphatase 1; regulatory subunit 55,D40; AF15Q14; CT29; KIAA1570; hKNL-1; hSpc105; PPP1R55; Spc7,kinetochore scaffold 1,AF15Q14; CASC5; CT29; D40; MCPH4; PPP1R55; Spc7; hKNL-1; hSpc105,KNL1
Q8NG66,NEK11_HUMAN,NEK11,Serine/threonine-protein kinase Nek11; EC 2.7.11.1; Never in mitosis A-related kinase 11; NimA-related protein kinase 11,,79858,NIMA related kinase 11,NIMA (never in mitosis gene a)- related kinase 11,,FLJ23495,NIMA related kinase 11,,NEK11
Q8NG98,OR7D4_HUMAN,OR7D4; OR7D4P,Olfactory receptor 7D4; OR19-B; Odorant receptor family subfamily D member 4RT; Olfactory receptor OR19-7,OR7D4P,125958,olfactory receptor family 7 subfamily D member 4,olfactory receptor; family 7; subfamily D; member 4,,hg105; OR19-B,olfactory receptor family 7 subfamily D member 4,OR19-7; OR19-B; OR19B; OR7D4P; hg105,OR7D4
Q8NGI8,O5AN1_HUMAN,OR5AN1,Olfactory receptor 5AN1; Olfactory receptor OR11-244,,390195,olfactory receptor family 5 subfamily AN member 1,olfactory receptor; family 5; subfamily AN; member 1,,,olfactory receptor family 5 subfamily AN member 1,OR11-244,OR5AN1
Q8NHC4,O10J5_HUMAN,OR10J5,Olfactory receptor 10J5; Olfactory receptor OR1-28,,127385,olfactory receptor family 10 subfamily J member 5,olfactory receptor; family 10; subfamily J; member 5,,,olfactory receptor family 10 subfamily J member 5,MOR23; OLFR16; OR1-28,OR10J5
Q8NHG8,ZNRF2_HUMAN,ZNRF2; RNF202,E3 ubiquitin-protein ligase ZNRF2; EC 2.3.2.27; Protein Ells2; RING finger protein 202; RING-type E3 ubiquitin transferase ZNRF2; Zinc/RING finger protein 2,RNF202,223082,zinc and ring finger 2,zinc and ring finger 2; E3 ubiquitin protein ligase,,RNF202,zinc and ring finger 2,RNF202,ZNRF2
Q8NHV4,NEDD1_HUMAN,NEDD1,Protein NEDD1; Neural precursor cell expressed developmentally down-regulated protein 1; NEDD-1,,121441,NEDD1 gamma-tubulin ring complex targeting factor,neural precursor cell expressed; developmentally down-regulated 1,tubulin gamma complex associated protein 7,GCP-WD; TUBGCP7,NEDD1 gamma-tubulin ring complex targeting factor,GCP-WD; TUBGCP7,NEDD1
Q8NHW3,MAFA_HUMAN,MAFA,Transcription factor MafA; Pancreatic beta-cell-specific transcriptional activator; RIPE3b1 factor; V-maf musculoaponeurotic fibrosarcoma oncogene homolog A,,389692,MAF bZIP transcription factor A,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A,RIPE3b1 activator,RIPE3b1; hMafA,MAF bZIP transcription factor A,INSDM; RIPE3b1; hMafA,MAFA
Q8NHY2,COP1_HUMAN,COP1; RFWD2; RNF200,E3 ubiquitin-protein ligase COP1; EC 2.3.2.27; Constitutive photomorphogenesis protein 1 homolog; hCOP1; RING finger and WD repeat domain protein 2; RING finger protein 200; RING-type E3 ubiquitin transferase RFWD2,RFWD2; RNF200,64326,COP1 E3 ubiquitin ligase,ring finger and WD repeat domain 2,constitutive photomorphogenic protein 1 (Arabidopsis),FLJ10416; RNF200; FAP78; CFAP78,COP1 E3 ubiquitin ligase,CFAP78; FAP78; RFWD2; RNF200,COP1
Q8NHZ8,CDC26_HUMAN,CDC26; ANAPC12; C9orf17,Anaphase-promoting complex subunit CDC26; Anaphase-promoting complex subunit 12; APC12; Cell division cycle protein 26 homolog,ANAPC12; C9orf17,246184,cell division cycle 26,C9orf17,CDC26 subunit of anaphase promoting complex; anaphase promoting complex subunit 12,APC12; ANAPC12,cell division cycle 26,ANAPC12; APC12; C9orf17,CDC26
Q8TAE8,G45IP_HUMAN,GADD45GIP1; MRPL59; PLINP1; PRG6,Large ribosomal subunit protein mL64; 39S ribosomal protein L59; mitochondrial; MRP-L59; CKII beta-associating protein; CR6-interacting factor 1; CRIF1; Growth arrest and DNA damage-inducible proteins-interacting protein 1; Papillomavirus L2-interacting nuclear protein 1; PLINP; PLINP-1; p53-responsive gene 6 protein,MRPL59; PLINP1; PRG6,90480,GADD45G interacting protein 1,growth arrest and DNA-damage-inducible; gamma interacting protein 1,papillomavirus L2 interacting nuclear protein 1; CKII beta binding protein 2; CR6 interacting factor 1; p53-responsive gene 6,PLINP-1; MGC4667; MGC4758; CKBBP2; PRG6; Plinp1; CRIF1; CKbetaBP2; mL64,GADD45G interacting protein 1,CKBBP2; CKbetaBP2; CRIF1; MRP-L59; PLINP; PLINP-1; PRG6; Plinp1; mL64,GADD45GIP1
Q8TAP6,CEP76_HUMAN,CEP76; C18orf9,Centrosomal protein of 76 kDa; Cep76,C18orf9,79959,centrosomal protein 76,chromosome 18 open reading frame 9; centrosomal protein 76kDa,,HsT1705; FLJ12542,centrosomal protein 76,C18orf9; HsT1705,CEP76
Q8TAP9,MPLKI_HUMAN,MPLKIP; C7orf11; TTDN1,M-phase-specific PLK1-interacting protein; TTD non-photosensitive 1 protein,C7orf11; TTDN1,136647,M-phase specific PLK1 interacting protein,chromosome 7 open reading frame 11,,ORF20; TTDN1,M-phase specific PLK1 interacting protein,ABHS; C7orf11; ORF20; TTD4,MPLKIP
Q8TAQ2,SMRC2_HUMAN,SMARCC2; BAF170,SWI/SNF complex subunit SMARCC2; BRG1-associated factor 170; BAF170; SWI/SNF complex 170 kDa subunit; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2,BAF170,6601,SWI/SNF related BAF chromatin remodeling complex subunit C2,SWI/SNF related; matrix associated; actin dependent regulator of chromatin subfamily c member 2; SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily c; member 2,,BAF170; Rsc8; CRACC2,SWI/SNF related BAF chromatin remodeling complex subunit C2,BAF170; CRACC2; CSS8; Rsc8,SMARCC2
Q8TAS1,UHMK1_HUMAN,UHMK1; KIS; KIST,Serine/threonine-protein kinase Kist; EC 2.7.11.1; Kinase interacting with stathmin; PAM COOH-terminal interactor protein 2; P-CIP2; U2AF homology motif kinase 1,KIS; KIST,127933,U2AF homology motif kinase 1,U2AF homology motif (UHM) kinase 1,,KIS; Kist,U2AF homology motif kinase 1,KIS; KIST; P-CIP2,UHMK1
Q8TB45,DPTOR_HUMAN,DEPTOR; DEPDC6,DEP domain-containing mTOR-interacting protein; hDEPTOR; DEP domain-containing protein 6,DEPDC6,64798,DEP domain containing MTOR interacting protein,DEP domain containing 6,,DEP.6; FLJ12428,DEP domain containing MTOR interacting protein,DEP.6; DEPDC6; hDEPTOR,DEPTOR
Q8TBX8,PI42C_HUMAN,PIP4K2C; PIP5K2C,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma; EC 2.7.1.149; Phosphatidylinositol 5-phosphate 4-kinase type II gamma; PI(5; PIP4KII-gamma,PIP5K2C,79837,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,phosphatidylinositol-4-phosphate 5-kinase; type II; gamma; phosphatidylinositol-5-phosphate 4-kinase; type II; gamma,,FLJ22055,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,PIP5K2C,PIP4K2C
Q8TCG1,CIP2A_HUMAN,CIP2A; KIAA1524,Protein CIP2A; Cancerous inhibitor of PP2A; p90 autoantigen,KIAA1524,57650,cellular inhibitor of PP2A,KIAA1524; cell proliferation regulating inhibitor of protein phosphatase 2A,cancerous inhibitor of protein phosphatase 2A,,cellular inhibitor of PP2A,KIAA1524; NOCIVA; p90,CIP2A
Q8TCS8,PNPT1_HUMAN,PNPT1; PNPASE,Polyribonucleotide nucleotidyltransferase 1; mitochondrial; EC 2.7.7.8; 3'-5' RNA exonuclease OLD35; PNPase old-35; Polynucleotide phosphorylase 1; PNPase 1; Polynucleotide phosphorylase-like protein,PNPASE,87178,polyribonucleotide nucleotidyltransferase 1,deafness; autosomal recessive 70,polynucleotide phosphorylase; 3'-5' RNA exonuclease,PNPase; OLD35; old-35,polyribonucleotide nucleotidyltransferase 1,COXPD13; DFNB70; OLD35; PNPASE; SCA25; old-35,PNPT1
Q8TCU5,NMD3A_HUMAN,GRIN3A; KIAA1973,Glutamate receptor ionotropic; NMDA 3A; GluN3A; N-methyl-D-aspartate receptor subtype 3A; NMDAR3A; NR3A; NMDAR-L,KIAA1973,116443,glutamate ionotropic receptor NMDA type subunit 3A,glutamate receptor; ionotropic; N-methyl-D-aspartate 3A,,GluN3A,glutamate ionotropic receptor NMDA type subunit 3A,GluN3A; NMDAR-L; NMDAR3A; NR3A,GRIN3A
Q8TCU6,PREX1_HUMAN,PREX1; KIAA1415,Phosphatidylinositol 3;4;5-trisphosphate-dependent Rac exchanger 1 protein; P-Rex1; PtdIns(3;4;5,KIAA1415,57580,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 1,phosphatidylinositol-3;4;5-trisphosphate-dependent Rac exchange factor 1,PIP3 dependent Rac exchange factor 1,KIAA1415; P-REX1,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 1,P-REX1,PREX1
Q8TD08,MK15_HUMAN,MAPK15; ERK7; ERK8,Mitogen-activated protein kinase 15; MAP kinase 15; MAPK 15; EC 2.7.11.24; Extracellular signal-regulated kinase 7; ERK-7; Extracellular signal-regulated kinase 8; ERK-8,ERK7; ERK8,225689,mitogen-activated protein kinase 15,,extracellular signal regulated kinase 8,ERK8; ERK7,mitogen-activated protein kinase 15,ERK7; ERK8,MAPK15
Q8TD19,NEK9_HUMAN,NEK9; KIAA1995; NEK8; NERCC,Serine/threonine-protein kinase Nek9; EC 2.7.11.1; Nercc1 kinase; Never in mitosis A-related kinase 9; NimA-related protein kinase 9; NimA-related kinase 8; Nek8,KIAA1995; NEK8; NERCC,91754,NIMA related kinase 9,NIMA (never in mitosis gene a)- related kinase 9,,Nek8; NERCC; DKFZp434D0935; MGC16714; NERCC1,NIMA related kinase 9,APUG; LCCS10; NC; NERCC; NERCC1,NEK9
Q8TD43,TRPM4_HUMAN,TRPM4; LTRPC4,Transient receptor potential cation channel subfamily M member 4; hTRPM4; Calcium-activated non-selective cation channel 1; Long transient receptor potential channel 4; LTrpC-4; LTrpC4; Melastatin-4,LTRPC4,54795,transient receptor potential cation channel subfamily M member 4,transient receptor potential cation channel; subfamily M; member 4,,FLJ20041,transient receptor potential cation channel subfamily M member 4,EKVP6; LTrpC4; PFHB1B; TRPM4B; hTRPM4,TRPM4
Q8TDC3,BRSK1_HUMAN,BRSK1; KIAA1811; SAD1; SADB,Serine/threonine-protein kinase BRSK1; EC 2.7.11.1; Brain-selective kinase 1; EC 2.7.11.26; Brain-specific serine/threonine-protein kinase 1; BR serine/threonine-protein kinase 1; Serine/threonine-protein kinase SAD-B; Synapses of Amphids Defective homolog 1; SAD1 homolog; hSAD1,KIAA1811; SAD1; SADB,84446,BR serine/threonine kinase 1,,brain selective kinase 1,KIAA1811; SAD-B,BR serine/threonine kinase 1,SAD-B; hSAD1,BRSK1
Q8TDN4,CABL1_HUMAN,CABLES1; CABLES,CDK5 and ABL1 enzyme substrate 1; Interactor with CDK3 1; Ik3-1,CABLES,91768,Cdk5 and Abl enzyme substrate 1,,,HsT2563; FLJ35924,Cdk5 and Abl enzyme substrate 1,CABL1; CABLES; HsT2563; IK3-1,CABLES1
Q8TDQ0,HAVR2_HUMAN,HAVCR2; TIM3; TIMD3,Hepatitis A virus cellular receptor 2; HAVcr-2; T-cell immunoglobulin and mucin domain-containing protein 3; TIMD-3; T-cell immunoglobulin mucin receptor 3; TIM-3; T-cell membrane protein 3; CD antigen CD366,TIM3; TIMD3,84868,hepatitis A virus cellular receptor 2,,T-cell immunoglobulin mucin family member 3,Tim-3; TIM3; FLJ14428; TIMD3; CD366,hepatitis A virus cellular receptor 2,CD366; HAVcr-2; KIM-3; SPTCL; TIM3; TIMD-3; TIMD3; Tim-3,HAVCR2
Q8TDQ1,CLM1_HUMAN,CD300LF; CD300F; CLM1; IGSF13; IREM1; NKIR; UNQ3105/PRO10111,CMRF35-like molecule 1; CLM-1; CD300 antigen-like family member F; Immune receptor expressed on myeloid cells 1; IREM-1; Immunoglobulin superfamily member 13; IgSF13; NK inhibitory receptor; CD antigen CD300f,CD300F; CLM1; IGSF13; IREM1; NKIR,146722,CD300 molecule like family member f,CD300 antigen like family member F; CD300 molecule-like family member f,,IREM1; NKIR; IGSF13; CD300f; CLM1,CD300 molecule like family member f,CD300f; CLM-1; CLM1; IREM-1; IREM1; IgSF13; LMIR3; NKIR,CD300LF
Q8TDX7,NEK7_HUMAN,NEK7,Serine/threonine-protein kinase Nek7; EC 2.7.11.34; Never in mitosis A-related kinase 7; NimA-related protein kinase 7,,140609,NIMA related kinase 7,NIMA (never in mitosis gene a)-related kinase 7,,,NIMA related kinase 7,,NEK7
Q8TDY2,RBCC1_HUMAN,RB1CC1; KIAA0203; RBICC,RB1-inducible coiled-coil protein 1; FAK family kinase-interacting protein of 200 kDa; FIP200,KIAA0203; RBICC,9821,RB1 inducible coiled-coil 1,,200 kDa FAK family kinase-interacting protein; phosphatase 1; regulatory subunit 131,KIAA0203; Cc1; DRAGOU14; FIP200; ATG17; PPP1R131,RB1 inducible coiled-coil 1,ATG17; CC1; FIP200; PPP1R131,RB1CC1
Q8TDY4,ASAP3_HUMAN,ASAP3; DDEFL1; UPLC1,Arf-GAP with SH3 domain; ANK repeat and PH domain-containing protein 3; Development and differentiation-enhancing factor-like 1; Protein up-regulated in liver cancer 1,DDEFL1; UPLC1,55616,ArfGAP with SH3 domain; ankyrin repeat and PH domain 3,development and differentiation enhancing factor-like 1,centaurin; beta 6,FLJ20199; UPLC1; CENTB6,ArfGAP with SH3 domain; ankyrin repeat and PH domain 3,ACAP4; CENTB6; DDEFL1; UPLC1,ASAP3
Q8TE77,SSH3_HUMAN,SSH3; SSH3L,Protein phosphatase Slingshot homolog 3; EC 3.1.3.16; EC 3.1.3.48; SSH-like protein 3; SSH-3L; hSSH-3L,SSH3L,54961,slingshot protein phosphatase 3,slingshot homolog 3 (Drosophila),,FLJ20515; FLJ10928,slingshot protein phosphatase 3,SSH3L,SSH3
Q8TE85,GRHL3_HUMAN,GRHL3; SOM; TFCP2L4,Grainyhead-like protein 3 homolog; Sister of mammalian grainyhead; Transcription factor CP2-like 4,SOM; TFCP2L4,57822,grainyhead like transcription factor 3,transcription factor CP2-like 4; grainyhead-like 3 (Drosophila),sister-of-mammalian grainyhead,SOM,grainyhead like transcription factor 3,SOM; TFCP2L4; VWS2,GRHL3
Q8TEP8,CE192_HUMAN,CEP192; KIAA1569; PP8407,Centrosomal protein of 192 kDa; Cep192; Cep192/SPD-2,KIAA1569,55125,centrosomal protein 192,centrosomal protein 192kDa,protein phosphatase 1; regulatory subunit 62,KIAA1569; FLJ10352; PPP1R62,centrosomal protein 192,PPP1R62,CEP192
Q8TEV9,SMCR8_HUMAN,SMCR8,Guanine nucleotide exchange protein SMCR8; Smith-Magenis syndrome chromosomal region candidate gene 8 protein,,140775,SMCR8-C9orf72 complex subunit,Smith-Magenis syndrome chromosome region; candidate 8,,FLJ34716; DENND8A,SMCR8-C9orf72 complex subunit,DENND8A,SMCR8
Q8TEW0,PARD3_HUMAN,PARD3; PAR3; PAR3A,Partitioning defective 3 homolog; PAR-3; PARD-3; Atypical PKC isotype-specific-interacting protein; ASIP; CTCL tumor antigen se2-5; PAR3-alpha,PAR3; PAR3A,56288,par-3 family cell polarity regulator,par-3 (partitioning defective 3; C.elegans) homolog; par-3 partitioning defective 3 homolog (C. elegans),atypical PKC isotype-specific interacting protein; par-3 family cell polarity regulator alpha; protein phosphatase 1; regulatory subunit 118,PAR3; PARD3A; Bazooka; Baz; ASIP; PPP1R118,par-3 family cell polarity regulator,ASIP; Baz; PAR3; PAR3alpha; PARD-3; PARD3A; PPP1R118; SE2-5L16; SE2-5LT1; SE2-5T2,PARD3
Q8TEY5,CR3L4_HUMAN,CREB3L4; AIBZIP; CREB4; JAL,Cyclic AMP-responsive element-binding protein 3-like protein 4; cAMP-responsive element-binding protein 3-like protein 4; Androgen-induced basic leucine zipper protein; AIbZIP; Attaching to CRE-like 1; ATCE1; Cyclic AMP-responsive element-binding protein 4; CREB-4; cAMP-responsive element-binding protein 4; Transcript induced in spermiogenesis protein 40; Tisp40; hJAL,AIBZIP; CREB4; JAL,148327,cAMP responsive element binding protein 3 like 4,,Androgen-Induced bZIP; attaching to CRE-like 1; Cyclic AMP-responsive element-binding protein 4,AIbZIP; CREB4; CREB3; hJAL; ATCE1,cAMP responsive element binding protein 3 like 4,AIBZIP; ATCE1; CREB3; CREB4; JAL; hJAL,CREB3L4
Q8TF42,UBS3B_HUMAN,UBASH3B; KIAA1959; STS1,Ubiquitin-associated and SH3 domain-containing protein B; EC 3.1.3.48; Cbl-interacting protein p70; Suppressor of T-cell receptor signaling 1; STS-1; T-cell ubiquitin ligand 2; TULA-2; Tyrosine-protein phosphatase STS1/TULA2,KIAA1959; STS1,84959,ubiquitin associated and SH3 domain containing B,,SH3 domain-containing 70 kDa protein; suppressor of T-cell receptor signaling 1; nm23-phosphorylated unknown substrate; T-cell ubiquitin ligand 2,KIAA1959; STS-1; TULA2; TULA-2,ubiquitin associated and SH3 domain containing B,STS-1; STS1; TULA-2; TULA2; p70,UBASH3B
Q8TF76,HASP_HUMAN,HASPIN; GSG2,Serine/threonine-protein kinase haspin; EC 2.7.11.1; Germ cell-specific gene 2 protein; H-haspin; Haploid germ cell-specific nuclear protein kinase,GSG2,83903,histone H3 associated protein kinase,germ cell associated 2 (haspin),,,histone H3 associated protein kinase,GSG2,HASPIN
Q8WTQ7,GRK7_HUMAN,GRK7; GPRK7,Rhodopsin kinase GRK7; EC 2.7.11.14; G protein-coupled receptor kinase 7; G protein-coupled receptor kinase GRK7,GPRK7,131890,G protein-coupled receptor kinase 7,,,,G protein-coupled receptor kinase 7,GPRK7,GRK7
Q8WTR2,DUS19_HUMAN,DUSP19; DUSP17; LMWDSP3; SKRP1,Dual specificity protein phosphatase 19; EC 3.1.3.16; EC 3.1.3.48; Dual specificity phosphatase TS-DSP1; Low molecular weight dual specificity phosphatase 3; LMW-DSP3; Protein phosphatase SKRP1; Stress-activated protein kinase pathway-regulating phosphatase 1; SAPK pathway-regulating phosphatase 1,DUSP17; LMWDSP3; SKRP1,142679,dual specificity phosphatase 19,,,SKRP1; DUSP17,dual specificity phosphatase 19,DUSP17; LMWDSP3; SKRP1; TS-DSP1,DUSP19
Q8WUI4,HDAC7_HUMAN,HDAC7; HDAC7A,Histone deacetylase 7; HD7; EC 3.5.1.98; Histone deacetylase 7A; HD7a; Protein deacetylase HDAC7; EC 3.5.1.-,HDAC7A,51564,histone deacetylase 7,histone deacetylase 7A,,DKFZP586J0917,histone deacetylase 7,HD7; HD7A; HDAC7A,HDAC7
Q8WUM0,NU133_HUMAN,NUP133,Nuclear pore complex protein Nup133; 133 kDa nucleoporin; Nucleoporin Nup133,,55746,nucleoporin 133,nucleoporin 133kDa,,FLJ10814,nucleoporin 133,GAMOS8; NPHS18; hNUP133,NUP133
Q8WV24,PHLA1_HUMAN,PHLDA1; PHRIP; TDAG51,Pleckstrin homology-like domain family A member 1; Apoptosis-associated nuclear protein; Proline- and glutamine-rich protein; PQ-rich protein; PQR protein; Proline- and histidine-rich protein; T-cell death-associated gene 51 protein,PHRIP; TDAG51,22822,pleckstrin homology like domain family A member 1,pleckstrin homology-like domain; family A; member 1,T-cell death-associated gene 51; proline-histidine rich protein,TDAG51; DT1P1B11; PHRIP,pleckstrin homology like domain family A member 1,DT1P1B11; PHRIP; TDAG51,PHLDA1
Q8WV28,BLNK_HUMAN,BLNK; BASH; SLP65,B-cell linker protein; B-cell adapter containing a SH2 domain protein; B-cell adapter containing a Src homology 2 domain protein; Cytoplasmic adapter protein; Src homology 2 domain-containing leukocyte protein of 65 kDa; SLP-65,BASH; SLP65,29760,B cell linker,,B-cell adapter containing a SH2 domain protein; B-cell activation; Src homology SH2 domain-containing leukocyte protein of 65 kD; B cell adaptor containing SH2 domain,SLP65; Ly57; SLP-65; BLNK-s; BASH; bca,B cell linker,AGM4; BASH; BLNK-S; LY57; SLP-65; SLP65; bca,BLNK
Q8WVB6,CTF18_HUMAN,CHTF18; C16orf41; CTF18,Chromosome transmission fidelity protein 18 homolog; hCTF18; CHL12,C16orf41; CTF18,63922,chromosome transmission fidelity factor 18,chromosome 16 open reading frame 41; CTF18; chromosome transmission fidelity factor 18 homolog (S. cerevisiae),,CHL12; C321D2.4; Ctf18,chromosome transmission fidelity factor 18,C16orf41; C321D2.2; C321D2.3; C321D2.4; CHL12; Ctf18; RUVBL,CHTF18
Q8WVD3,RN138_HUMAN,RNF138; NARF; HSD-4; HSD4,E3 ubiquitin-protein ligase RNF138; EC 2.3.2.27; Nemo-like kinase-associated RING finger protein; NLK-associated RING finger protein; hNARF; RING finger protein 138; RING-type E3 ubiquitin transferase RNF138,NARF,51444,ring finger protein 138,ring finger protein 138; E3 ubiquitin protein ligase,nemo-like kinase associated ring finger protein,STRIN; NARF,ring finger protein 138,HSD-4; NARF; STRIN; hNARF,RNF138
Q8WVY7,UBCP1_HUMAN,UBLCP1,Ubiquitin-like domain-containing CTD phosphatase 1; EC 3.1.3.16; Nuclear proteasome inhibitor UBLCP1,,134510,ubiquitin like domain containing CTD phosphatase 1,ubiquitin-like domain containing CTD phosphatase 1,CTD phosphatase-like with ubiquitin domain 1,MGC10067; CPUB1,ubiquitin like domain containing CTD phosphatase 1,CPUB1,UBLCP1
Q8WWI1,LMO7_HUMAN,LMO7; FBX20; FBXO20; KIAA0858,LIM domain only protein 7; LMO-7; F-box only protein 20; LOMP,FBX20; FBXO20; KIAA0858,4008,LIM domain 7,LIM domain only 7,F-box only protein 20,FBX20; KIAA0858,LIM domain 7,FBX20; FBXO20; LMO7b; LOMP,LMO7
Q8WWK9,CKAP2_HUMAN,CKAP2; LB1; TMAP,Cytoskeleton-associated protein 2; CTCL tumor antigen se20-10; Tumor- and microtubule-associated protein,LB1; TMAP,26586,cytoskeleton associated protein 2,,tumor-associated microtubule-associated protein,LB1; FLJ10749; se20-10; TMAP,cytoskeleton associated protein 2,LB1; TMAP; se20-10,CKAP2
Q8WWM7,ATX2L_HUMAN,ATXN2L; A2D; A2LG; A2LP; A2RP,Ataxin-2-like protein; Ataxin-2 domain protein; Ataxin-2-related protein,A2D; A2LG; A2LP; A2RP,11273,ataxin 2 like,ataxin 2-like,,A2lp; A2D,ataxin 2 like,A2D; A2LG; A2LP; A2RP,ATXN2L
Q8WX92,NELFB_HUMAN,NELFB; COBRA1; KIAA1182,Negative elongation factor B; NELF-B; Cofactor of BRCA1,COBRA1; KIAA1182,25920,negative elongation factor complex member B,cofactor of BRCA1,,KIAA1182; NELF-B,negative elongation factor complex member B,COBRA1; NELF-B,NELFB
Q8WX93,PALLD_HUMAN,PALLD; KIAA0992; CGI-151,Palladin; SIH002; Sarcoma antigen NY-SAR-77,KIAA0992,23022,palladin; cytoskeletal associated protein,,,KIAA0992; SIH002; CGI-151,palladin; cytoskeletal associated protein,CGI-151; CGI151; MYN; PNCA1; SIH002,PALLD
Q8WXE1,ATRIP_HUMAN,ATRIP; AGS1,ATR-interacting protein; ATM and Rad3-related-interacting protein,AGS1,84126,ATR interacting protein,,,FLJ12343; MGC20625; MGC21482; MGC26740,ATR interacting protein,,ATRIP
Q8WXH5,SOCS4_HUMAN,SOCS4; SOCS7,Suppressor of cytokine signaling 4; SOCS-4; Suppressor of cytokine signaling 7; SOCS-7,SOCS7,122809,suppressor of cytokine signaling 4,suppressor of cytokine signaling 7,,,suppressor of cytokine signaling 4,SOCS7,SOCS4
Q8WXS5,CCG8_HUMAN,CACNG8; CACNG6,Voltage-dependent calcium channel gamma-8 subunit; Neuronal voltage-gated calcium channel gamma-8 subunit; Transmembrane AMPAR regulatory protein gamma-8; TARP gamma-8,CACNG6,59283,calcium voltage-gated channel auxiliary subunit gamma 8,calcium channel; voltage-dependent; gamma subunit 8,,,calcium voltage-gated channel auxiliary subunit gamma 8,,CACNG8
Q8WY54,PPM1E_HUMAN,PPM1E; CAMKN; KIAA1072; POPX1,Protein phosphatase 1E; EC 3.1.3.16; Ca(2+; CaMKP-N; CaMKP-nucleus; CaMKN; Partner of PIX 1; Partner of PIX-alpha; Partner of PIXA,CAMKN; KIAA1072; POPX1,22843,protein phosphatase; Mg2+/Mn2+ dependent 1E,protein phosphatase 1E (PP2C domain containing); protein phosphatase; Mg2+/Mn2+ dependent; 1E,partner of PIX 1; nuclear calmodulin-dependent protein kinase phosphatase,POPX1; KIAA1072; PP2CH; CaMKP-N,protein phosphatase; Mg2+/Mn2+ dependent 1E,CAMKPN; CaMKP-N; POPX1; PP2CH; caMKN,PPM1E
Q8WYH8,ING5_HUMAN,ING5,Inhibitor of growth protein 5; p28ING5,,84289,inhibitor of growth family member 5,,,FLJ23842; p28ING5,inhibitor of growth family member 5,p28ING5,ING5
Q8WYJ6,SEPT1_HUMAN,SEPTIN1; DIFF6; PNUTL3; SEPT1,Septin-1; LARP; Peanut-like protein 3; Serologically defined breast cancer antigen NY-BR-24,DIFF6; PNUTL3; SEPT1,1731,septin 1,,,PNUTL3; Septin-1,septin 1,DIFF6; LARP; PNUTL3; SEP1; SEPT1; Septin-1,SEPTIN1
Q8WYK2,JDP2_HUMAN,JDP2,Jun dimerization protein 2,,122953,Jun dimerization protein 2,,progesterone receptor co-activator,,Jun dimerization protein 2,JUNDM2,JDP2
Q8WYL5,SSH1_HUMAN,SSH1; KIAA1298; SSH1L,Protein phosphatase Slingshot homolog 1; EC 3.1.3.16; EC 3.1.3.48; SSH-like protein 1; SSH-1L; hSSH-1L,KIAA1298; SSH1L,54434,slingshot protein phosphatase 1,slingshot homolog 1 (Drosophila),,KIAA1298; SSH1L,slingshot protein phosphatase 1,SSH1L,SSH1
Q8WYQ5,DGCR8_HUMAN,DGCR8; C22orf12; DGCRK6; LP4941,Microprocessor complex subunit DGCR8; DiGeorge syndrome critical region 8,C22orf12; DGCRK6,54487,DGCR8 microprocessor complex subunit,chromosome 22 open reading frame 12; DiGeorge syndrome critical region gene 8; DGCR8; microprocessor complex subunit,,DGCRK6; Gy1; pasha,DGCR8 microprocessor complex subunit,C22orf12; DGCRK6; Gy1; pasha,DGCR8
Q8WYR1,PI3R5_HUMAN,PIK3R5,Phosphoinositide 3-kinase regulatory subunit 5; PI3-kinase regulatory subunit 5; PI3-kinase p101 subunit; Phosphatidylinositol 4;5-bisphosphate 3-kinase regulatory subunit; PtdIns-3-kinase regulatory subunit; Protein FOAP-2; PtdIns-3-kinase p101; p101-PI3K,,23533,phosphoinositide-3-kinase regulatory subunit 5,phosphoinositide-3-kinase; regulatory subunit 5,,P101-PI3K; p101,phosphoinositide-3-kinase regulatory subunit 5,F730038I15Rik; FOAP-2; P101-PI3K; p101,PIK3R5
Q8WZ42,TITIN_HUMAN,TTN,Titin; EC 2.7.11.1; Connectin; Rhabdomyosarcoma antigen MU-RMS-40.14,,7273,titin,cardiomyopathy; dilated 1G (autosomal dominant),,CMPD4; FLJ32040; TMD; CMH9; LGMD2J; MYLK5,titin,CMD1G; CMH9; CMPD4; CMYO5; CMYP5; EOMFC; HMERF; LGMD2J; LGMDR10; MYLK5; SALMY; TMD,TTN
Q92519,TRIB2_HUMAN,TRIB2; TRB2,Tribbles homolog 2; TRB-2,TRB2,28951,tribbles pseudokinase 2,tribbles homolog 2 (Drosophila),,TRB2; GS3955,tribbles pseudokinase 2,C5FW; GS3955; TRB2,TRIB2
Q92529,SHC3_HUMAN,SHC3; NSHC; SHCC,SHC-transforming protein 3; Neuronal Shc; N-Shc; Protein Rai; SHC-transforming protein C; Src homology 2 domain-containing-transforming protein C3; SH2 domain protein C3,NSHC; SHCC,53358,SHC adaptor protein 3,src homology 2 domain containing transforming protein C3; SHC (Src homology 2 domain containing) transforming protein 3,,N-Shc; NSHC; SHCC,SHC adaptor protein 3,N-Shc; NSHC; RAI; SHCC,SHC3
Q92538,GBF1_HUMAN,GBF1; KIAA0248,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1; BFA-resistant GEF 1,KIAA0248,8729,golgi brefeldin A resistant guanine nucleotide exchange factor 1,golgi-specific brefeldin A resistance factor 1,,KIAA0248; ARF1GEF,golgi brefeldin A resistant guanine nucleotide exchange factor 1,ARF1GEF; CMT2GG; CMTDI2; CMTDIA,GBF1
Q92539,LPIN2_HUMAN,LPIN2; KIAA0249,Phosphatidate phosphatase LPIN2; EC 3.1.3.4; Lipin-2,KIAA0249,9663,lipin 2,,Phosphatidate phosphatase LPIN2,KIAA0249,lipin 2,CRMO1; MJDS,LPIN2
Q92542,NICA_HUMAN,NCSTN; KIAA0253; UNQ1874/PRO4317,Nicastrin,KIAA0253,23385,nicastrin,,,KIAA0253; APH2,nicastrin,ATAG1874,NCSTN
Q92547,TOPB1_HUMAN,TOPBP1; KIAA0259,DNA topoisomerase 2-binding protein 1; DNA topoisomerase II-beta-binding protein 1; TopBP1; DNA topoisomerase II-binding protein 1,KIAA0259,11073,DNA topoisomerase II binding protein 1,topoisomerase (DNA) II binding protein 1,,KIAA0259; TOP2BP1; Dpb11,DNA topoisomerase II binding protein 1,Dpb11; TOP2BP1,TOPBP1
Q92556,ELMO1_HUMAN,ELMO1; KIAA0281,Engulfment and cell motility protein 1; Protein ced-12 homolog,KIAA0281,9844,engulfment and cell motility 1,engulfment and cell motility 1 (ced-12 homolog; C. elegans),,KIAA0281; CED12; ELMO-1; CED-12,engulfment and cell motility 1,CED-12; CED12; ELMO-1,ELMO1
Q92558,WASF1_HUMAN,WASF1; KIAA0269; SCAR1; WAVE1,Actin-binding protein WASF1; Protein WAVE-1; Verprolin homology domain-containing protein 1; Wiskott-Aldrich syndrome protein family member 1; WASP family protein member 1,KIAA0269; SCAR1; WAVE1,8936,WASP family member 1,WAS protein family; member 1; WAS protein family member 1,,WAVE1; SCAR1; KIAA0269; WAVE,WASP family member 1,NEDALVS; SCAR1; WAVE; WAVE1,WASF1
Q92569,P55G_HUMAN,PIK3R3,Phosphatidylinositol 3-kinase regulatory subunit gamma; PI3-kinase regulatory subunit gamma; PI3K regulatory subunit gamma; PtdIns-3-kinase regulatory subunit gamma; Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma; PI3-kinase subunit p55-gamma; PtdIns-3-kinase regulatory subunit p55-gamma; p55PIK,,8503,phosphoinositide-3-kinase regulatory subunit 3,phosphoinositide-3-kinase; regulatory subunit 3 (gamma),phosphoinositide-3-kinase regulatory subunit gamma,p55,phosphoinositide-3-kinase regulatory subunit 3,p55; p55-GAMMA; p55PIK,PIK3R3
Q92574,TSC1_HUMAN,TSC1; KIAA0243; TSC,Hamartin; Tuberous sclerosis 1 protein,KIAA0243; TSC,7248,TSC complex subunit 1,tuberous sclerosis 1,hamartin,KIAA0243; LAM; hamartin,TSC complex subunit 1,LAM; TSC,TSC1
Q92597,NDRG1_HUMAN,NDRG1; CAP43; DRG1; RTP,Protein NDRG1; Differentiation-related gene 1 protein; DRG-1; N-myc downstream-regulated gene 1 protein; Nickel-specific induction protein Cap43; Reducing agents and tunicamycin-responsive protein; RTP; Rit42,CAP43; DRG1; RTP,10397,N-myc downstream regulated 1,,,DRG1; RTP; TDD5; NDR1,N-myc downstream regulated 1,CAP43; CMT4D; DRG-1; DRG1; GC4; HMSNL; NDR1; NMSL; PROXY1; RIT42; RTP; TARG1; TDD5,NDRG1
Q92599,SEPT8_HUMAN,SEPTIN8; KIAA0202; SEPT8,Septin-8,KIAA0202; SEPT8,23176,septin 8,,,KIAA0202; SEP2; Septin-8,septin 8,SEP2; SEPT8; Septin-8,SEPTIN8
Q92630,DYRK2_HUMAN,DYRK2,Dual specificity tyrosine-phosphorylation-regulated kinase 2; EC 2.7.12.1,,8445,dual specificity tyrosine phosphorylation regulated kinase 2,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2; dual specificity tyrosine-(Y)-phosphorylation regulated kinase 2,,,dual specificity tyrosine phosphorylation regulated kinase 2,,DYRK2
Q92673,SORL_HUMAN,SORL1; C11orf32,Sortilin-related receptor; Low-density lipoprotein receptor relative with 11 ligand-binding repeats; LDLR relative with 11 ligand-binding repeats; LR11; SorLA-1; Sorting protein-related receptor containing LDLR class A repeats; SorLA,C11orf32,6653,sortilin related receptor 1,chromosome 11 open reading frame 32; sortilin-related receptor; L(DLR class) A repeats-containing,LDLR relative with 11 ligand-binding repeats,gp250; LR11; LRP9; SorLA; SorLA-1,sortilin related receptor 1,C11orf32; LR11; LRP9; SORLA; SorLA-1; gp250,SORL1
Q92681,RSCA1_HUMAN,RSC1A1,Regulatory solute carrier protein family 1 member 1; Transporter regulator RS1; hRS1,,6248,regulator of solute carriers 1,regulatory solute carrier protein; family 1; member 1,,RS1,regulator of solute carriers 1,RS1,RSC1A1
Q92688,AN32B_HUMAN,ANP32B; APRIL; PHAPI2,Acidic leucine-rich nuclear phosphoprotein 32 family member B; Acidic protein rich in leucines; Putative HLA-DR-associated protein I-2; PHAPI2; Silver-stainable protein SSP29,APRIL; PHAPI2,10541,acidic nuclear phosphoprotein 32 family member B,acidic (leucine-rich) nuclear phosphoprotein 32 family; member B,acidic protein rich in leucines,SSP29; PHAPI2; APRIL,acidic nuclear phosphoprotein 32 family member B,APRIL; PHAPI2; SSP29,ANP32B
Q92698,RAD54_HUMAN,RAD54L; RAD54A,DNA repair and recombination protein RAD54-like; EC 3.6.4.12; RAD54 homolog; hHR54; hRAD54,RAD54A,8438,RAD54 like,RAD54 (S.cerevisiae)-like; RAD54 like (S. cerevisiae),,hHR54; hRAD54; RAD54A,RAD54 like,HR54; RAD54A; hHR54; hRAD54,RAD54L
Q92729,PTPRU_HUMAN,PTPRU; FMI; PCP2; PTPRO,Receptor-type tyrosine-protein phosphatase U; R-PTP-U; EC 3.1.3.48; Pancreatic carcinoma phosphatase 2; PCP-2; Protein-tyrosine phosphatase J; PTP-J; hPTP-J; Protein-tyrosine phosphatase pi; PTP pi; Protein-tyrosine phosphatase receptor omicron; PTP-RO; Receptor-type protein-tyrosine phosphatase psi; R-PTP-psi,FMI; PCP2; PTPRO,10076,protein tyrosine phosphatase receptor type U,,pi R-PTP-Psi,PTPRO; hPTP-J; PCP-2; FMI; PTP,protein tyrosine phosphatase receptor type U,FMI; PCP-2; PTP; PTP-J; PTP-PI; PTP-RO; PTPPSI; PTPRO; PTPU2; R-PTP-PSI; R-PTP-U; hPTP-J,PTPRU
Q92731,ESR2_HUMAN,ESR2; ESTRB; NR3A2,Estrogen receptor beta; ER-beta; Nuclear receptor subfamily 3 group A member 2,ESTRB; NR3A2,2100,estrogen receptor 2,estrogen receptor 2 (ER beta),ER beta; estrogen receptor beta; oestrogen receptor beta; nuclear receptor subfamily 3 group A member 2,NR3A2; Erb; ER-beta,estrogen receptor 2,ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8,ESR2
Q92734,TFG_HUMAN,TFG,Protein TFG; TRK-fused gene protein,,10342,trafficking from ER to golgi regulator,TRK-fused gene,,TF6; FLJ36137; SPG57,trafficking from ER to golgi regulator,HMSNP; SPG57; TF6; TRKT3,TFG
Q92736,RYR2_HUMAN,RYR2,Ryanodine receptor 2; RYR-2; RyR2; hRYR-2; Cardiac muscle ryanodine receptor; Cardiac muscle ryanodine receptor-calcium release channel; Type 2 ryanodine receptor,,6262,ryanodine receptor 2,arrhythmogenic right ventricular dysplasia 2; ryanodine receptor 2 (cardiac),,ARVC2; VTSIP,ryanodine receptor 2,ARVC2; ARVD2; RYR-2; RyR; VACRDS; VTSIP,RYR2
Q92738,US6NL_HUMAN,USP6NL; KIAA0019,USP6 N-terminal-like protein; Related to the N-terminus of tre; RN-tre,KIAA0019,9712,USP6 N-terminal like,USP6NL intronic transcript 1 (non-protein coding),related to the N terminus of tre,RNTRE; KIAA0019; TRE2NL; RN-tre,USP6 N-terminal like,RNTRE; TRE2NL; USP6NL-IT1,USP6NL
Q92769,HDAC2_HUMAN,HDAC2,Histone deacetylase 2; HD2; EC 3.5.1.98; Protein deacylase HDAC2; EC 3.5.1.-,,3066,histone deacetylase 2,,,RPD3; YAF1; KDAC2,histone deacetylase 2,HD2; KDAC2; RPD3; YAF1,HDAC2
Q92772,CDKL2_HUMAN,CDKL2,Cyclin-dependent kinase-like 2; EC 2.7.11.22; Protein kinase p56 KKIAMRE; Serine/threonine-protein kinase KKIAMRE,,8999,cyclin dependent kinase like 2,cyclin-dependent kinase-like 2 (CDC2-related kinase),,P56; KKIAMRE,cyclin dependent kinase like 2,KKIAMRE; P56,CDKL2
Q92784,DPF3_HUMAN,DPF3; BAF45C; CERD4,Zinc finger protein DPF3; BRG1-associated factor 45C; BAF45C; Zinc finger protein cer-d4,BAF45C; CERD4,8110,double PHD fingers 3,D4; zinc and double PHD fingers; family 3,,cer-d4; Cerd4; FLJ14079; BAF45c; SMARCG3,double PHD fingers 3,BAF45C; CERD4; SMARCG3,DPF3
Q92785,REQU_HUMAN,DPF2; BAF45D; REQ; UBID4,Zinc finger protein ubi-d4; Apoptosis response zinc finger protein; BRG1-associated factor 45D; BAF45D; D4; zinc and double PHD fingers family 2; Protein requiem,BAF45D; REQ; UBID4,5977,double PHD fingers 2,requiem; apoptosis response zinc finger gene; D4; zinc and double PHD fingers family 2,,ubi-d4; BAF45d; SMARCG2,double PHD fingers 2,CSS7; REQ; SMARCG2; UBID4; ubi-d4,DPF2
Q92793,CBP_HUMAN,CREBBP; CBP,CREB-binding protein; Histone lysine acetyltransferase CREBBP; EC 2.3.1.48; Protein lactyltransferas CREBBP; EC 2.3.1.-; Protein-lysine acetyltransferase CREBBP; EC 2.3.1.-,CBP,1387,CREB binding protein,Rubinstein-Taybi syndrome,,RTS; CBP; KAT3A,CREB binding protein,CBP; KAT3A; MKHK1; RSTS; RSTS1,CREBBP
Q92794,KAT6A_HUMAN,KAT6A; MOZ; MYST3; RUNXBP2; ZNF220,Histone acetyltransferase KAT6A; EC 2.3.1.48; MOZ; YBF2/SAS3; SAS2 and TIP60 protein 3; MYST-3; Monocytic leukemia zinc finger protein; Runt-related transcription factor-binding protein 2; Zinc finger protein 220,MOZ; MYST3; RUNXBP2; ZNF220,7994,lysine acetyltransferase 6A,runt-related transcription factor binding protein 2; MYST histone acetyltransferase (monocytic leukemia) 3; K(lysine) acetyltransferase 6A,Monocytic leukemia zinc finger protein,MOZ; ZC2HC6A,lysine acetyltransferase 6A,ARTHS; MOZ; MRD32; MYST-3; MYST3; RUNXBP2; ZC2HC6A; ZNF220,KAT6A
Q92796,DLG3_HUMAN,DLG3; KIAA1232,Disks large homolog 3; Neuroendocrine-DLG; Synapse-associated protein 102; SAP-102; SAP102; XLMR,KIAA1232,1741,discs large MAGUK scaffold protein 3,discs; large homolog 3 (neuroendocrine-dlg; Drosophila); discs; large homolog 3 (Drosophila); discs large homolog 3,neuroendocrine-dlg; protein phosphatase 1; regulatory subunit 82; synapse associated protein 102,NE-Dlg; SAP102; SAP-102; NEDLG; KIAA1232; MRX90; PPP1R82,discs large MAGUK scaffold protein 3,MRX; MRX90; NEDLG; PPP1R82; SAP102; XLID90; XLMR,DLG3
Q92797,SYMPK_HUMAN,SYMPK; SPK,Symplekin,SPK,8189,symplekin scaffold protein,symplekin,,SYM; SPK; Pta1,symplekin scaffold protein,Pta1; SPK; SYM,SYMPK
Q92819,HYAS2_HUMAN,HAS2,Hyaluronan synthase 2; EC 2.4.1.212; Hyaluronate synthase 2; Hyaluronic acid synthase 2; HA synthase 2,,3037,hyaluronan synthase 2,,,,hyaluronan synthase 2,,HAS2
Q92837,FRAT1_HUMAN,FRAT1,Proto-oncogene FRAT1; Frequently rearranged in advanced T-cell lymphomas 1; FRAT-1,,10023,FRAT regulator of WNT signaling pathway 1,frequently rearranged in advanced T-cell lymphomas; frequently rearranged in advanced T-cell lymphomas 1; FRAT1; WNT signaling pathway regulator,,,FRAT regulator of WNT signaling pathway 1,,FRAT1
Q92845,KIFA3_HUMAN,KIFAP3; KIF3AP; SMAP,Kinesin-associated protein 3; KAP-3; KAP3; Smg GDS-associated protein,KIF3AP; SMAP,22920,kinesin associated protein 3,kinesin-associated protein 3,Smg GDS,SMAP; KAP3; FLA3; KAP-1,kinesin associated protein 3,FLA3; KAP-1; KAP-3; KAP3; SMAP; Smg-GDS; dJ190I16.1,KIFAP3
Q92878,RAD50_HUMAN,RAD50,DNA repair protein RAD50; hRAD50; EC 3.6.-.-,,10111,RAD50 double strand break repair protein,RAD50 (S. cerevisiae) homolog; RAD50 homolog (S. cerevisiae); RAD50 homolog; double strand break repair protein,,hRad50; RAD50-2,RAD50 double strand break repair protein,NBSLD; RAD502; hRad50,RAD50
Q92879,CELF1_HUMAN,CELF1; BRUNOL2; CUGBP; CUGBP1; NAB50,CUGBP Elav-like family member 1; CELF-1; 50 kDa nuclear polyadenylated RNA-binding protein; Bruno-like protein 2; CUG triplet repeat RNA-binding protein 1; CUG-BP1; CUG-BP- and ETR-3-like factor 1; Deadenylation factor CUG-BP; Embryo deadenylation element-binding protein homolog; EDEN-BP homolog; RNA-binding protein BRUNOL-2,BRUNOL2; CUGBP; CUGBP1; NAB50,10658,CUGBP Elav-like family member 1,CUG triplet repeat; RNA-binding protein 1; CUG triplet repeat; RNA binding protein 1; CUGBP; Elav-like family member 1,CUG RNA-binding protein; nuclear polyadenylated RNA-binding protein; 50-kD; bruno-like 2; embryo deadenylation element binding protein,CUG-BP; hNab50; BRUNOL2; NAB50; CUGBP; NAPOR; EDEN-BP,CUGBP Elav-like family member 1,BRUNOL2; CUG-BP; CUGBP; CUGBP1; EDEN-BP; NAB50; NAPOR; hNab50,CELF1
Q92882,OSTF1_HUMAN,OSTF1,Osteoclast-stimulating factor 1,,26578,osteoclast stimulating factor 1,,,SH3P2; OSF; bA235O14.1,osteoclast stimulating factor 1,OSF; SH3P2; bA235O14.1,OSTF1
Q92888,ARHG1_HUMAN,ARHGEF1,Rho guanine nucleotide exchange factor 1; 115 kDa guanine nucleotide exchange factor; p115-RhoGEF; p115RhoGEF; Sub1.5,,9138,Rho guanine nucleotide exchange factor 1,Rho guanine nucleotide exchange factor (GEF) 1,,P115-RHOGEF; SUB1.5; LBCL2,Rho guanine nucleotide exchange factor 1,GEF1; IMD62; LBCL2; LSC; P115-RHOGEF; SUB1.5,ARHGEF1
Q92900,RENT1_HUMAN,UPF1; KIAA0221; RENT1,Regulator of nonsense transcripts 1; EC 3.6.4.12; EC 3.6.4.13; ATP-dependent helicase RENT1; Nonsense mRNA reducing factor 1; NORF1; Up-frameshift suppressor 1 homolog; hUpf1,KIAA0221; RENT1,5976,UPF1 RNA helicase and ATPase,regulator of nonsense transcripts 1; UPF1 regulator of nonsense transcripts homolog (yeast); UPF1; RNA helicase and ATPase,UP Frameshift 1; smg-2 homolog; nonsense mediated mRNA decay factor (C. elegans),HUPF1; KIAA0221; NORF1; pNORF1; smg-2,UPF1 RNA helicase and ATPase,HUPF1; NORF1; RENT1; UTF; pNORF1; smg-2,UPF1
Q92903,CDS1_HUMAN,CDS1; CDS,Phosphatidate cytidylyltransferase 1; EC 2.7.7.41; CDP-DAG synthase 1; CDP-DG synthase 1; CDP-diacylglycerol synthase 1; CDS 1; CDP-diglyceride pyrophosphorylase 1; CDP-diglyceride synthase 1; CTP:phosphatidate cytidylyltransferase 1,CDS,1040,CDP-diacylglycerol synthase 1,,phosphatidate cytidylyltransferase,,CDP-diacylglycerol synthase 1,CDS 1,CDS1
Q92904,DAZL_HUMAN,DAZL; DAZH; DAZL1; DAZLA; SPGYLA,Deleted in azoospermia-like; DAZ homolog; DAZ-like autosomal; Deleted in azoospermia-like 1; SPGY-like-autosomal,DAZH; DAZL1; DAZLA; SPGYLA,1618,deleted in azoospermia like,deleted in azoospermia-like,,DAZH; SPGYLA; MGC26406; DAZL1,deleted in azoospermia like,DAZH; DAZL1; DAZLA; SPGYLA,DAZL
Q92908,GATA6_HUMAN,GATA6,Transcription factor GATA-6; GATA-binding factor 6,,2627,GATA binding protein 6,GATA-binding protein 6,,,GATA binding protein 6,,GATA6
Q92915,FGF14_HUMAN,FGF14; FHF4,Fibroblast growth factor 14; FGF-14; Fibroblast growth factor homologous factor 4; FHF-4,FHF4,2259,fibroblast growth factor 14,,,FHF4; SCA27,fibroblast growth factor 14,FGF-14; FHF-4; FHF4; NYS4; SCA27; SCA27A; SCA27B,FGF14
Q92917,GPKOW_HUMAN,GPKOW; GPATC5; GPATCH5; T54,G-patch domain and KOW motifs-containing protein; G-patch domain-containing protein 5; Protein MOS2 homolog; Protein T54,GPATC5; GPATCH5; T54,27238,G-patch domain and KOW motifs,,G patch domain containing 5,T54; GPATC5; GPATCH5; Spp2; Mos2,G-patch domain and KOW motifs,GPATC5; GPATCH5; Mos2; Spp2; T54,GPKOW
Q92918,M4K1_HUMAN,MAP4K1; HPK1,Mitogen-activated protein kinase kinase kinase kinase 1; EC 2.7.11.1; Hematopoietic progenitor kinase; MAPK/ERK kinase kinase kinase 1; MEK kinase kinase 1; MEKKK 1,HPK1,11184,mitogen-activated protein kinase kinase kinase kinase 1,,hematopoietic progenitor kinase 1,HPK1,mitogen-activated protein kinase kinase kinase kinase 1,HPK1,MAP4K1
Q92934,BAD_HUMAN,BAD; BBC6; BCL2L8,Bcl2-associated agonist of cell death; BAD; Bcl-2-binding component 6; Bcl-2-like protein 8; Bcl2-L-8; Bcl-xL/Bcl-2-associated death promoter; Bcl2 antagonist of cell death,BBC6; BCL2L8,572,BCL2 associated agonist of cell death,,,BCL2L8; BBC2,BCL2 associated agonist of cell death,BBC2; BCL2L8,BAD
Q92945,FUBP2_HUMAN,KHSRP; FUBP2,Far upstream element-binding protein 2; FUSE-binding protein 2; KH type-splicing regulatory protein; KSRP; p75,FUBP2,8570,KH-type splicing regulatory protein,,FUSE binding protein 2,KSRP; FBP2; FUBP2,KH-type splicing regulatory protein,FBP2; FUBP2; KSRP; p75,KHSRP
Q92952,KCNN1_HUMAN,KCNN1; SK,Small conductance calcium-activated potassium channel protein 1; SK1; SKCa 1; SKCa1; hSK1; KCa2.1,SK,3780,potassium calcium-activated channel subfamily N member 1,potassium intermediate/small conductance calcium-activated channel; subfamily N; member 1; potassium channel; calcium activated intermediate/small conductance subfamily N alpha; member 1,small conductance calcium-activated potassium channel 1,KCa2.1; hSK1,potassium calcium-activated channel subfamily N member 1,KCa2.1; SK1; SKCA1; hSK1,KCNN1
Q92974,ARHG2_HUMAN,ARHGEF2; KIAA0651; LFP40,Rho guanine nucleotide exchange factor 2; Guanine nucleotide exchange factor H1; GEF-H1; Microtubule-regulated Rho-GEF; Proliferating cell nucleolar antigen p40,KIAA0651; LFP40,9181,Rho/Rac guanine nucleotide exchange factor 2,rho/rac guanine nucleotide exchange factor (GEF) 2; Rho/Rac guanine nucleotide exchange factor (GEF) 2,,LFP40; GEF-H1; KIAA0651; P40; Lfc; GEFH1,Rho/Rac guanine nucleotide exchange factor 2,GEF; GEF-H1; GEFH1; LFP40; Lfc; NEDMHM; P40,ARHGEF2
Q92985,IRF7_HUMAN,IRF7,Interferon regulatory factor 7; IRF-7,,3665,interferon regulatory factor 7,,,,interferon regulatory factor 7,IMD39; IRF-7; IRF-7H; IRF7A; IRF7B; IRF7C; IRF7H,IRF7
Q92993,KAT5_HUMAN,KAT5; HTATIP; TIP60,Histone acetyltransferase KAT5; EC 2.3.1.48; 60 kDa Tat-interactive protein; Tip60; Histone acetyltransferase HTATIP; HIV-1 Tat interactive protein; Lysine acetyltransferase 5; Protein 2-hydroxyisobutyryltransferase KAT5; EC 2.3.1.-; Protein acetyltransferase KAT5; EC 2.3.1.-; Protein crotonyltransferase KAT5; EC 2.3.1.-; Protein lactyltransferase KAT5; EC 2.3.1.-; cPLA(2,HTATIP; TIP60,10524,lysine acetyltransferase 5,HIV-1 Tat interactive protein; 60kDa; K(lysine) acetyltransferase 5,Tat interacting protein; 60kDa; K-acetyltransferase 5,TIP60; PLIP; cPLA2; HTATIP1; ESA1; ZC2HC5,lysine acetyltransferase 5,ESA1; HTATIP; HTATIP1; NEDFASB; PLIP; TIP; TIP60; ZC2HC5; cPLA2,KAT5
Q92994,TF3B_HUMAN,BRF1; BRF; GTF3B; TAF3B2; TAF3C,Transcription factor IIIB 90 kDa subunit; TFIIIB90; hTFIIIB90; B-related factor 1; BRF-1; hBRF; TAF3B2; TATA box-binding protein-associated factor; RNA polymerase III; subunit 2,BRF; GTF3B; TAF3B2; TAF3C,2972,BRF1 general transcription factor IIIB subunit,BRF1 RNA polymerase III transcription initiation factor subunit; BRF1; RNA polymerase III transcription initiation factor 90 kDa subunit; TATA box binding protein (TBP)-associated factor; RNA polymerase III; GTF3B subunit 2; BRF1 homolog; subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae),,TFIIIB90; BRF; hBRF,BRF1 general transcription factor IIIB subunit,BRF; BRF-1; CFDS; GTF3B; HEL-S-76p; TAF3B2; TAF3C; TAFIII90; TF3B90; TFIIIB90; hBRF,BRF1
Q92997,DVL3_HUMAN,DVL3; KIAA0208,Segment polarity protein dishevelled homolog DVL-3; Dishevelled-3; DSH homolog 3,KIAA0208,1857,dishevelled segment polarity protein 3,dishevelled 3 (homologous to Drosophila dsh); dishevelled; dsh homolog 3 (Drosophila),,KIAA0208,dishevelled segment polarity protein 3,DRS3,DVL3
Q93009,UBP7_HUMAN,USP7; HAUSP,Ubiquitin carboxyl-terminal hydrolase 7; EC 3.4.19.12; Deubiquitinating enzyme 7; Herpesvirus-associated ubiquitin-specific protease; Ubiquitin thioesterase 7; Ubiquitin-specific-processing protease 7,HAUSP,7874,ubiquitin specific peptidase 7,ubiquitin specific peptidase 7 (herpes virus-associated),,,ubiquitin specific peptidase 7,C16DELp13.2; DEL16P13.2; HAFOUS; HAUSP; TEF1,USP7
Q93034,CUL5_HUMAN,CUL5; VACM1,Cullin-5; CUL-5; Vasopressin-activated calcium-mobilizing receptor 1; VACM-1,VACM1,8065,cullin 5,,,VACM-1,cullin 5,CUL-5; VACM-1; VACM1,CUL5
Q93045,STMN2_HUMAN,STMN2; SCG10; SCGN10,Stathmin-2; Superior cervical ganglion-10 protein; Protein SCG10,SCG10; SCGN10,11075,stathmin 2,stathmin-like 2,,SCG10,stathmin 2,SCG10; SCGN10,STMN2
Q93052,LPP_HUMAN,LPP,Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma,,4026,LIM domain containing preferred translocation partner in lipoma,LIM domain-containing preferred translocation partner in lipoma,lipoma preferred partner gene,,LIM domain containing preferred translocation partner in lipoma,,LPP
Q93077,H2A1C_HUMAN,H2AC6; H2AFL; HIST1H2AC,Histone H2A type 1-C; H2A-clustered histone 6; Histone H2A/l,H2AFL; HIST1H2AC,8334,H2A clustered histone 6,H2A histone family; member L; histone 1; H2ac; histone cluster 1; H2ac; histone cluster 1 H2A family member c,,,H2A clustered histone 6,H2A/l; H2AFL; HIST1H2AC; dJ221C16.4,H2AC6
Q93079,H2B1H_HUMAN,H2BC9; H2BFJ; HIST1H2BH,Histone H2B type 1-H; H2B-clustered histone 9; Histone H2B.j; H2B/j,H2BFJ; HIST1H2BH,8345,H2B clustered histone 9,H2B histone family; member J; histone 1; H2bh; histone cluster 1; H2bh; histone cluster 1 H2B family member h,,H2B/j,H2B clustered histone 9,H2B/j; H2BFJ; HIST1H2BH,H2BC9
Q93096,TP4A1_HUMAN,PTP4A1; PRL1; PTPCAAX1,Protein tyrosine phosphatase type IVA 1; EC 3.1.3.48; PTP(CAAXI; Protein-tyrosine phosphatase 4a1; Protein-tyrosine phosphatase of regenerating liver 1; PRL-1,PRL1; PTPCAAX1,7803,protein tyrosine phosphatase 4A1,protein tyrosine phosphatase type IVA; member 1,phosphatase of regenerating liver 1,PTPCAAX1; PRL-1; PRL1,protein tyrosine phosphatase 4A1,HH72; PRL-1; PRL1; PTP(CAAX1); PTPCAAX1,PTP4A1
Q93097,WNT2B_HUMAN,WNT2B; WNT13,Protein Wnt-2b; Protein Wnt-13,WNT13,7482,Wnt family member 2B,wingless-type MMTV integration site family; member 2B,XWNT2; Xenopus; homolog of; wingless-type MMTV integration site family; member 13,XWNT2,Wnt family member 2B,WNT13,WNT2B
Q93098,WNT8B_HUMAN,WNT8B,Protein Wnt-8b,,7479,Wnt family member 8B,wingless-type MMTV integration site family; member 8B,,,Wnt family member 8B,,WNT8B
Q93100,KPBB_HUMAN,PHKB,Phosphorylase b kinase regulatory subunit beta; Phosphorylase kinase subunit beta,,5257,phosphorylase kinase regulatory subunit beta,phosphorylase kinase; beta,,,phosphorylase kinase regulatory subunit beta,,PHKB
Q969H0,FBXW7_HUMAN,FBXW7; FBW7; FBX30; SEL10,F-box/WD repeat-containing protein 7; Archipelago homolog; hAgo; F-box and WD-40 domain-containing protein 7; F-box protein FBX30; SEL-10; hCdc4,FBW7; FBX30; SEL10,55294,F-box and WD repeat domain containing 7,F-box and WD-40 domain protein 7 (archipelago homolog; Drosophila); F-box and WD repeat domain containing 7; E3 ubiquitin protein ligase,archipelago homolog (Drosophila),AGO; FLJ11071; SEL-10; SEL10; FBW7; FBX30; CDC4; FBXW6,F-box and WD repeat domain containing 7,AGO; CDC4; DEDHIL; FBW6; FBW7; FBX30; FBXO30; FBXW6; SEL-10; SEL10; hAgo; hCdc4,FBXW7
Q969H4,CNKR1_HUMAN,CNKSR1; CNK1,Connector enhancer of kinase suppressor of ras 1; Connector enhancer of KSR 1; CNK homolog protein 1; CNK1; hCNK1; Connector enhancer of KSR-like,CNK1,10256,connector enhancer of kinase suppressor of Ras 1,,,CNK1; KSR; CNK,connector enhancer of kinase suppressor of Ras 1,CNK; CNK1,CNKSR1
Q969Q6,P2R3C_HUMAN,PPP2R3C; C14orf10; G5PR,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma; Protein phosphatase subunit G5PR; Rhabdomyosarcoma antigen MU-RMS-40.6A/6C,C14orf10; G5PR,55012,protein phosphatase 2 regulatory subunit B''gamma,chromosome 14 open reading frame 10; protein phosphatase 2 (formerly 2A); regulatory subunit B'',,FLJ20644; G4-1; G5PR,protein phosphatase 2 regulatory subunit B''gamma,C14orf10; G4-1; G5pr; GDRM; MEGD; SPGF36,PPP2R3C
Q969R5,LMBL2_HUMAN,L3MBTL2,Lethal(3)malignant brain tumor-like protein 2; 3; H-l(3; L(3,,83746,L3MBTL histone methyl-lysine binding protein 2,l(3)mbt-like 2 (Drosophila); L3MBTL2; polycomb repressive complex 1 subunit,,H-l(3)mbt-l; DKFZP761I141; dJ756G23.3,L3MBTL histone methyl-lysine binding protein 2,H-l(3)mbt-l; L3MBT,L3MBTL2
Q969S3,ZN622_HUMAN,ZNF622; ZPR9,Cytoplasmic 60S subunit biogenesis factor ZNF622; Zinc finger protein 622; Zinc finger-like protein 9,ZPR9,90441,zinc finger protein 622,,,MGC2485; MGC17552; ZPR9,zinc finger protein 622,ZPR9,ZNF622
Q969T9,WBP2_HUMAN,WBP2,WW domain-binding protein 2; WBP-2,,23558,WW domain binding protein 2,,,WBP-2; GRAMD6,WW domain binding protein 2,DFNB107; GRAMD6; WBP-2,WBP2
Q969U6,FBXW5_HUMAN,FBXW5; FBW5; PP3971,F-box/WD repeat-containing protein 5; F-box and WD-40 domain-containing protein 5,FBW5,54461,F-box and WD repeat domain containing 5,F-box and WD-40 domain protein 5,,DKFZP434B205; MGC20962; Fbw5,F-box and WD repeat domain containing 5,Fbw5,FBXW5
Q969V6,MRTFA_HUMAN,MRTFA; KIAA1438; MAL; MKL1,Myocardin-related transcription factor A; MRTF-A; MKL/myocardin-like protein 1; Megakaryoblastic leukemia 1 protein; Megakaryocytic acute leukemia protein,KIAA1438; MAL; MKL1,57591,myocardin related transcription factor A,megakaryoblastic leukemia (translocation) 1,megakaryocytic acute leukemia; basic; SAP and coiled-coil domain,KIAA1438; MAL; MRTF-A; BSAC; MKL,myocardin related transcription factor A,BSAC; MAL; MKL; MKL1; MRTF-A,MRTFA
Q96A32,MYL11_HUMAN,MYL11; HSRLC; MYLPF,Myosin regulatory light chain 11; Fast skeletal myosin light chain 2; MLC2B; Myosin light chain 11; Myosin regulatory light chain 2; skeletal muscle isoform,HSRLC; MYLPF,29895,myosin light chain 11,myosin light chain; phosphorylatable; fast skeletal muscle,myosin; light chain 11; regulatory; myosin regulatory light chain 2,MRLC2; HUMMLC2B,myosin light chain 11,DA1C; HUMMLC2B; MLC2B; MRLC2; MYLPF,MYL11
Q96A54,PAQR1_HUMAN,ADIPOR1; PAQR1; TESBP1A; CGI-45,Adiponectin receptor protein 1; Progestin and adipoQ receptor family member 1; Progestin and adipoQ receptor family member I,PAQR1; TESBP1A,51094,adiponectin receptor 1,,,PAQR1; ACDCR1,adiponectin receptor 1,ACDCR1; CGI-45; CGI45; PAQR1; TESBP1A,ADIPOR1
Q96AC1,FERM2_HUMAN,FERMT2; KIND2; MIG2; PLEKHC1,Fermitin family homolog 2; Kindlin-2; Mitogen-inducible gene 2 protein; MIG-2; Pleckstrin homology domain-containing family C member 1; PH domain-containing family C member 1,KIND2; MIG2; PLEKHC1,10979,FERM domain containing kindlin 2,pleckstrin homology domain containing; family C (with FERM domain) member 1; fermitin family homolog 2 (Drosophila); fermitin family member 2,kindlin-2; mitogen inducible gene-2,mig-2; KIND2; UNC112B,FERM domain containing kindlin 2,KIND2; MIG2; PLEKHC1; UNC112; UNC112B; mig-2,FERMT2
Q96AE4,FUBP1_HUMAN,FUBP1,Far upstream element-binding protein 1; FBP; FUSE-binding protein 1; DNA helicase V; hDH V,,8880,far upstream element binding protein 1,far upstream element (FUSE) binding protein 1,FUSE binding protein 1,FBP,far upstream element binding protein 1,FBP; FUBP; hDH V,FUBP1
Q96AP0,ACD_HUMAN,ACD; PIP1; PTOP; TINT1; TPP1,Adrenocortical dysplasia protein homolog; POT1 and TIN2-interacting protein,PIP1; PTOP; TINT1; TPP1,65057,ACD shelterin complex subunit and telomerase recruitment factor,adrenocortical dysplasia homolog (mouse),TIN2 interacting protein 1; POT1 and TIN2 organizing protein,Ptop; Pip1; Tpp1; Tint1,ACD shelterin complex subunit and telomerase recruitment factor,PIP1; PTOP; TINT1; TPP1,ACD
Q96AX2,RAB37_HUMAN,RAB37,Ras-related protein Rab-37,,326624,RAB37; member RAS oncogene family,,,,RAB37; member RAS oncogene family,,RAB37
Q96B36,AKTS1_HUMAN,AKT1S1; PRAS40,Proline-rich AKT1 substrate 1; 40 kDa proline-rich AKT substrate,PRAS40,84335,AKT1 substrate 1,AKT1 substrate 1 (proline-rich),proline-rich Akt substrate; 40 kDa,PRAS40; MGC2865; Lobe,AKT1 substrate 1,Lobe; PRAS40,AKT1S1
Q96BA8,CR3L1_HUMAN,CREB3L1; OASIS; PSEC0238,Cyclic AMP-responsive element-binding protein 3-like protein 1; cAMP-responsive element-binding protein 3-like protein 1; Old astrocyte specifically-induced substance; OASIS,OASIS,90993,cAMP responsive element binding protein 3 like 1,,BBF-2 homolog (drosophila); old astrocyte specifically induced substance,OASIS,cAMP responsive element binding protein 3 like 1,C16DELp11.2; DEL16p11.2; OASIS; OI16,CREB3L1
Q96BD6,SPSB1_HUMAN,SPSB1; SSB1,SPRY domain-containing SOCS box protein 1; SSB-1,SSB1,80176,splA/ryanodine receptor domain and SOCS box containing 1,,,SSB-1,splA/ryanodine receptor domain and SOCS box containing 1,SSB-1; SSB1,SPSB1
Q96BF3,TMIG2_HUMAN,TMIGD2; CD28H; IGPR1; UNQ3059/PRO9879,Transmembrane and immunoglobulin domain-containing protein 2; CD28 homolog; Immunoglobulin and proline-rich receptor 1; IGPR-1,CD28H; IGPR1,126259,transmembrane and immunoglobulin domain containing 2,,CD28 homologue; immunoglobulin-containing and proline-rich receptor-1,MGC23244; CD28H; IGPR-1,transmembrane and immunoglobulin domain containing 2,CD28H; IGPR-1; IGPR1,TMIGD2
Q96BK5,PINX1_HUMAN,PINX1; LPTL; LPTS,PIN2/TERF1-interacting telomerase inhibitor 1; Liver-related putative tumor suppressor; Pin2-interacting protein X1; Protein 67-11-3; TRF1-interacting protein 1,LPTL; LPTS,54984,PIN2 (TERF1) interacting telomerase inhibitor 1,PIN2/TERF1 interacting telomerase inhibitor 1,PIN2 interacting protein 1; liver-related putative tumor suppressor,LPTL; LPTS; FLJ20565; MGC8850; Gno1; Pxr1,PIN2 (TERF1) interacting telomerase inhibitor 1,Gno1; LPTL; LPTS; Pxr1,PINX1
Q96BR1,SGK3_HUMAN,SGK3; CISK; SGKL,Serine/threonine-protein kinase Sgk3; EC 2.7.11.1; Cytokine-independent survival kinase; Serum/glucocorticoid-regulated kinase 3; Serum/glucocorticoid-regulated kinase-like,CISK; SGKL,100533105,serum/glucocorticoid regulated kinase family member 3,serum/glucocorticoid regulated kinase-like; serum/glucocorticoid regulated kinase family; member 3,,,C8orf44-SGK3 readthrough,,SGK3
Q96BY7,ATG2B_HUMAN,ATG2B; C14orf103,Autophagy-related protein 2 homolog B,C14orf103,55102,autophagy related 2B,chromosome 14 open reading frame 103; ATG2 autophagy related 2 homolog B (S. cerevisiae),bridge-like lipid transfer protein family member 4B,FLJ10242; BLTP4B,autophagy related 2B,BLTP4B; C14orf103,ATG2B
Q96C36,P5CR2_HUMAN,PYCR2,Pyrroline-5-carboxylate reductase 2; P5C reductase 2; P5CR 2; EC 1.5.1.2,,29920,pyrroline-5-carboxylate reductase 2,pyrroline-5-carboxylate reductase family member 2,,P5CR2,pyrroline-5-carboxylate reductase 2,HLD10; P5CR2,PYCR2
Q96CF2,CHM4C_HUMAN,CHMP4C; SHAX3,Charged multivesicular body protein 4c; Chromatin-modifying protein 4c; CHMP4c; SNF7 homolog associated with Alix 3; SNF7-3; hSnf7-3; Vacuolar protein sorting-associated protein 32-3; Vps32-3; hVps32-3,SHAX3,92421,charged multivesicular body protein 4C,chromatin modifying protein 4C,Snf7 homologue associated with Alix 3,MGC22825; Shax3; VPS32C,charged multivesicular body protein 4C,SNF7-3; Shax3; VPS32C,CHMP4C
Q96CG3,TIFA_HUMAN,TIFA; T2BP,TRAF-interacting protein with FHA domain-containing protein A; Putative MAPK-activating protein PM14; Putative NF-kappa-B-activating protein 20; TRAF2-binding protein,T2BP,92610,TRAF interacting protein with forkhead associated domain,TRAF-interacting protein with forkhead-associated domain,TRAF2 binding protein; TRAF6 binding protein,MGC20791; T2BP; T6BP; TIFAA,TRAF interacting protein with forkhead associated domain,T2BP; T6BP; TIFAA,TIFA
Q96CV9,OPTN_HUMAN,OPTN; FIP2; GLC1E; HIP7; HYPL; NRP,Optineurin; E3-14.7K-interacting protein; FIP-2; Huntingtin yeast partner L; Huntingtin-interacting protein 7; HIP-7; Huntingtin-interacting protein L; NEMO-related protein; Optic neuropathy-inducing protein; Transcription factor IIIA-interacting protein; TFIIIA-IntP,FIP2; GLC1E; HIP7; HYPL; NRP,10133,optineurin,glaucoma 1; open angle; E (adult-onset),,FIP2; HYPL; FIP-2; TFIIIA-INTP; NRP; HIP7,optineurin,ALS12; FIP2; GLC1E; HIP7; HYPL; NRP; TFIIIA-INTP,OPTN
Q96CW1,AP2M1_HUMAN,AP2M1; CLAPM1; KIAA0109,AP-2 complex subunit mu; AP-2 mu chain; Adaptin-mu2; Adaptor protein complex AP-2 subunit mu; Adaptor-related protein complex 2 subunit mu; Clathrin assembly protein complex 2 mu medium chain; Clathrin coat assembly protein AP50; Clathrin coat-associated protein AP50; HA2 50 kDa subunit; Plasma membrane adaptor AP-2 50 kDa protein,CLAPM1; KIAA0109,1173,adaptor related protein complex 2 subunit mu 1,adaptor related protein complex 2 mu 1 subunit,clathrin-associated/assembly/adaptor protein; medium 1; plasma membrane adaptor AP-2 50kDA protein; clathrin coat adaptor protein AP50; clathrin adaptor complex AP2; mu subunit; HA2 50 kDA subunit; clathrin assembly protein complex 2 medium chain; AP-2 mu 2 chain,AP50; mu2,adaptor related protein complex 2 subunit mu 1,AP50; CLAPM1; MRD60; mu2,AP2M1
Q96D31,ORAI1_HUMAN,ORAI1; CRACM1; TMEM142A,Calcium release-activated calcium channel protein 1; Protein orai-1; Transmembrane protein 142A,CRACM1; TMEM142A,84876,ORAI calcium release-activated calcium modulator 1,transmembrane protein 142A,calcium release-activated calcium modulator 1,FLJ14466; CRACM1,ORAI calcium release-activated calcium modulator 1,CRACM1; IMD9; ORAT1; TAM2; TMEM142A,ORAI1
Q96D96,HVCN1_HUMAN,HVCN1; VSOP; UNQ578/PRO1140,Voltage-gated hydrogen channel 1; Hydrogen voltage-gated channel 1; HV1; Voltage sensor domain-only protein,VSOP,84329,hydrogen voltage gated channel 1,hydrogen voltage-gated channel 1,voltage sensor domain-only protein,MGC15619; Hv1; VSOP,hydrogen voltage gated channel 1,HV1; VSOP,HVCN1
Q96DE5,APC16_HUMAN,ANAPC16; C10orf104; CENP-27,Anaphase-promoting complex subunit 16; APC16; Cyclosome subunit 16,C10orf104; CENP-27,119504,anaphase promoting complex subunit 16,chromosome 10 open reading frame 104,centromere protein 27,bA570G20.3; FLJ33728; APC16; CENP-27,anaphase promoting complex subunit 16,APC16; C10orf104; CENP-27; MSAG; bA570G20.3,ANAPC16
Q96E09,PBIR1_HUMAN,PABIR1; C9orf42; FAM122A,PPP2R1A-PPP2R2A-interacting phosphatase regulator 1; PABIR family member 1,C9orf42; FAM122A,116224,PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1,chromosome 9 open reading frame 42; family with sequence similarity 122A,,MGC17347,PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1,C9orf42; FAM122A,PABIR1
Q96E14,RMI2_HUMAN,RMI2; C16orf75,RecQ-mediated genome instability protein 2; hRMI2; BLM-associated protein of 18 kDa; BLAP18,C16orf75,116028,RecQ mediated genome instability 2,chromosome 16 open reading frame 75; RMI2; RecQ mediated genome instability 2; homolog (S. cerevisiae),,MGC24665; BLAP18,RecQ mediated genome instability 2,BLAP18; C16orf75,RMI2
Q96EB6,SIR1_HUMAN,SIRT1; SIR2L1,NAD-dependent protein deacetylase sirtuin-1; hSIRT1; EC 2.3.1.286; NAD-dependent protein deacylase sirtuin-1; EC 2.3.1.-; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2; 75SirT1,SIR2L1,23411,sirtuin 1,sirtuin (silent mating type information regulation 2; S. cerevisiae; homolog) 1; sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae),,SIR2L1,sirtuin 1,SIR2; SIR2L1; SIR2alpha,SIRT1
Q96EP5,DAZP1_HUMAN,DAZAP1,DAZ-associated protein 1; Deleted in azoospermia-associated protein 1,,26528,DAZ associated protein 1,,deleted in azoospermia associated protein 1,MGC19907,DAZ associated protein 1,,DAZAP1
Q96EZ8,MCRS1_HUMAN,MCRS1; INO80Q; MSP58,Microspherule protein 1; 58 kDa microspherule protein; Cell cycle-regulated factor p78; INO80 complex subunit J; MCRS2,INO80Q; MSP58,10445,microspherule protein 1,,INO80 complex subunit Q,ICP22BP; MSP58; P78; MCRS2; INO80Q,microspherule protein 1,ICP22BP; INO80Q; MCRS2; MSP58; P78,MCRS1
Q96F46,I17RA_HUMAN,IL17RA; IL17R,Interleukin-17 receptor A; IL-17 receptor A; IL-17RA; CDw217; CD antigen CD217,IL17R,23765,interleukin 17 receptor A,interleukin 17 receptor,,hIL-17R; IL-17RA; CDw217; CD217,interleukin 17 receptor A,CANDF5; CD217; CDw217; IL-17RA; IL17R; IMD51; hIL-17R,IL17RA
Q96F86,EDC3_HUMAN,EDC3; LSM16; YJDC; YJEFN2; PP844,Enhancer of mRNA-decapping protein 3; LSM16 homolog; YjeF N-terminal domain-containing protein 2; YjeF_N2; hYjeF_N2; YjeF domain-containing protein 1,LSM16; YJDC; YJEFN2,80153,enhancer of mRNA decapping 3,yjeF domain containing (E.coli); enhancer of mRNA decapping 3 homolog (S. cerevisiae),LSM16 homolog (EDC3; S. cerevisiae),FLJ21128; hYjeF_N2-15q23; YJEFN2; LSM16,enhancer of mRNA decapping 3,LSM16; MRT50; YJDC; YJEFN2; hYjeF_N2-15q23,EDC3
Q96FA3,PELI1_HUMAN,PELI1; PRISM,E3 ubiquitin-protein ligase pellino homolog 1; Pellino-1; EC 2.3.2.27; Pellino-related intracellular-signaling molecule; RING-type E3 ubiquitin transferase pellino homolog 1,PRISM,57162,pellino E3 ubiquitin protein ligase 1,pellino (Drosophila) homolog 1; pellino homolog 1 (Drosophila),,,pellino E3 ubiquitin protein ligase 1,,PELI1
Q96FF9,CDCA5_HUMAN,CDCA5,Sororin; Cell division cycle-associated protein 5; p35,,113130,cell division cycle associated 5,,sororin,,cell division cycle associated 5,SORORIN,CDCA5
Q96FI4,NEIL1_HUMAN,NEIL1,Endonuclease 8-like 1; EC 3.2.2.-; EC 4.2.99.18; DNA glycosylase/AP lyase Neil1; DNA-(apurinic or apyrimidinic site; Endonuclease VIII-like 1; FPG1; Nei homolog 1; NEH1; Nei-like protein 1,,79661,nei like DNA glycosylase 1,nei endonuclease VIII-like 1 (E. coli),DNA endonuclease eight-like glycosylase 1,FLJ22402; hFPG1; NEI1; FPG1,nei like DNA glycosylase 1,FPG1; NEI1; hFPG1,NEIL1
Q96FW1,OTUB1_HUMAN,OTUB1; OTB1; OTU1; HSPC263,Ubiquitin thioesterase OTUB1; EC 3.4.19.12; Deubiquitinating enzyme OTUB1; OTU domain-containing ubiquitin aldehyde-binding protein 1; Otubain-1; hOTU1; Ubiquitin-specific-processing protease OTUB1,OTB1; OTU1,55611,OTU deubiquitinase; ubiquitin aldehyde binding 1,OTU domain; ubiquitin aldehyde binding 1,,FLJ20113; FLJ40710,OTU deubiquitinase; ubiquitin aldehyde binding 1,HSPC263; OTB1; OTU1,OTUB1
Q96GD0,PLPP_HUMAN,PDXP; CIN; PLP; PLPP,Chronophin; EC 3.1.3.16; EC 3.1.3.74; Pyridoxal phosphate phosphatase; PLP phosphatase,CIN; PLP; PLPP,57026,pyridoxal phosphatase,pyridoxal (pyridoxine; vitamin B6) phosphatase,chronophin,dJ37E16.5; FLJ32703; CIN,pyridoxal phosphatase,CIN; PLP; dJ37E16.5,PDXP
Q96GD4,AURKB_HUMAN,AURKB; AIK2; AIM1; AIRK2; ARK2; STK1; STK12; STK5,Aurora kinase B; EC 2.7.11.1; Aurora 1; Aurora- and IPL1-like midbody-associated protein 1; AIM-1; Aurora/IPL1-related kinase 2; ARK-2; Aurora-related kinase 2; STK-1; Serine/threonine-protein kinase 12; Serine/threonine-protein kinase 5; Serine/threonine-protein kinase aurora-B,AIK2; AIM1; AIRK2; ARK2; STK1; STK12; STK5,9212,aurora kinase B,serine/threonine kinase 12,aurora-B; aurora-1; protein phosphatase 1; regulatory subunit 48; aurora- and Ipl1-like midbody-associated protein 1 homolog (rat),Aik2; IPL1; AurB; AIM-1; ARK2; STK5; PPP1R48,aurora kinase B,AIK2; AIM-1; AIM1; ARK-2; ARK2; AurB; IPL1; PPP1R48; STK-1; STK12; STK5; aurkb-sv1; aurkb-sv2,AURKB
Q96GE6,CALL4_HUMAN,CALML4,Calmodulin-like protein 4; Serologically defined breast cancer antigen NY-BR-20,,91860,calmodulin like 4,calmodulin-like 4,,MGC4809; NY-BR-20,calmodulin like 4,NY-BR-20,CALML4
Q96GX5,GWL_HUMAN,MASTL; GW; GWL; THC2,Serine/threonine-protein kinase greatwall; GW; GWL; hGWL; EC 2.7.11.1; Microtubule-associated serine/threonine-protein kinase-like; MAST-L,GW; GWL; THC2,84930,microtubule associated serine/threonine kinase like,microtubule associated serine/threonine kinase-like,greatwall kinase homolog,FLJ14813; THC2; Gwl,microtubule associated serine/threonine kinase like,GREATWALL; GW; GWL; MAST-L; THC2,MASTL
Q96HP0,DOCK6_HUMAN,DOCK6; KIAA1395,Dedicator of cytokinesis protein 6,KIAA1395,57572,dedicator of cytokinesis 6,,,KIAA1395; ZIR1,dedicator of cytokinesis 6,AOS2; ZIR1,DOCK6
Q96HS1,PGAM5_HUMAN,PGAM5,Serine/threonine-protein phosphatase PGAM5; mitochondrial; EC 3.1.3.16; Bcl-XL-binding protein v68; Phosphoglycerate mutase family member 5,,192111,PGAM family member 5; mitochondrial serine/threonine protein phosphatase,phosphoglycerate mutase family member 5; PGAM family member 5; serine/threonine protein phosphatase; mitochondrial,Bcl-XL-binding protein v68,MGC5352; BXLBv68,PGAM family member 5; mitochondrial serine/threonine protein phosphatase,BXLBV68,PGAM5
Q96HZ4,HES6_HUMAN,HES6; BHLHB41,Transcription cofactor HES-6; C-HAIRY1; Class B basic helix-loop-helix protein 41; bHLHb41; Hairy and enhancer of split 6,BHLHB41,55502,hes family bHLH transcription factor 6,hairy and enhancer of split 6 (Drosophila),,bHLHb41,hes family bHLH transcription factor 6,C-HAIRY1; HES-6; bHLHb41; bHLHc23,HES6
Q96I25,SPF45_HUMAN,RBM17; SPF45,Splicing factor 45; 45 kDa-splicing factor; RNA-binding motif protein 17,SPF45,84991,RNA binding motif protein 17,,splicing factor 45kDa,SPF45; MGC14439,RNA binding motif protein 17,SPF45,RBM17
Q96IF1,AJUBA_HUMAN,AJUBA; JUB,LIM domain-containing protein ajuba,JUB,84962,ajuba LIM protein,jub; ajuba homolog (Xenopus laevis),,MGC15563,ajuba LIM protein,JUB,AJUBA
Q96II8,LRCH3_HUMAN,LRCH3,DISP complex protein LRCH3; Leucine-rich repeat and calponin homology domain-containing protein 3,,84859,leucine rich repeats and calponin homology domain containing 3,leucine-rich repeats and calponin homology (CH) domain containing 3,,MGC4126,leucine rich repeats and calponin homology domain containing 3,,LRCH3
Q96IZ0,PAWR_HUMAN,PAWR; PAR4,PRKC apoptosis WT1 regulator protein; Prostate apoptosis response 4 protein; Par-4,PAR4,5074,pro-apoptotic WT1 regulator,PRKC; apoptosis; WT1; regulator,prostate apoptosis response-4,par-4; PAR4,pro-apoptotic WT1 regulator,PAR4; Par-4,PAWR
Q96J02,ITCH_HUMAN,ITCH,E3 ubiquitin-protein ligase Itchy homolog; Itch; EC 2.3.2.26; Atrophin-1-interacting protein 4; AIP4; HECT-type E3 ubiquitin transferase Itchy homolog; NFE2-associated polypeptide 1; NAPP1,,83737,itchy E3 ubiquitin protein ligase,itchy (mouse homolog) E3 ubiquitin protein ligase; itchy E3 ubiquitin protein ligase homolog (mouse),,AIP4,itchy E3 ubiquitin protein ligase,ADMFD; AIF4; AIP4; NAPP1,ITCH
Q96J92,WNK4_HUMAN,WNK4; PRKWNK4,Serine/threonine-protein kinase WNK4; EC 2.7.11.1; Protein kinase lysine-deficient 4; Protein kinase with no lysine 4,PRKWNK4,65266,WNK lysine deficient protein kinase 4,protein kinase; lysine deficient 4,,,WNK lysine deficient protein kinase 4,PHA2B; PRKWNK4,WNK4
Q96JH7,VCIP1_HUMAN,VCPIP1; KIAA1850; VCIP135,Deubiquitinating protein VCPIP1; EC 3.4.19.12; Valosin-containing protein p97/p47 complex-interacting protein 1; Valosin-containing protein p97/p47 complex-interacting protein p135; VCP/p47 complex-interacting 135-kDa protein,KIAA1850; VCIP135,80124,valosin containing protein interacting protein 1,valosin containing protein (p97)/p47 complex interacting protein 1,,VCIP135; KIAA1850; FLJ23132; DUBA3,valosin containing protein interacting protein 1,DUBA3; VCIP135,VCPIP1
Q96JJ3,ELMO2_HUMAN,ELMO2; CED12A; KIAA1834,Engulfment and cell motility protein 2; Protein ced-12 homolog A; hCed-12A,CED12A; KIAA1834,63916,engulfment and cell motility 2,engulfment and cell motility 2 (ced-12 homolog; C. elegans),,CED12; ELMO-2; CED-12; KIAA1834; FLJ11656,engulfment and cell motility 2,CED-12; CED12; Ced-12A; ELMO-2; VMPI,ELMO2
Q96KB5,TOPK_HUMAN,PBK; TOPK,Lymphokine-activated killer T-cell-originated protein kinase; EC 2.7.12.2; Cancer/testis antigen 84; CT84; MAPKK-like protein kinase; Nori-3; PDZ-binding kinase; Spermatogenesis-related protein kinase; SPK; T-LAK cell-originated protein kinase,TOPK,55872,PDZ binding kinase,,T-LAK cell-originated protein kinase; cancer/testis antigen 84,TOPK; FLJ14385; Nori-3; SPK; CT84,PDZ binding kinase,CT84; HEL164; Nori-3; SPK; TOPK,PBK
Q96KG7,MEG10_HUMAN,MEGF10; KIAA1780,Multiple epidermal growth factor-like domains protein 10; Multiple EGF-like domains protein 10,KIAA1780,84466,multiple EGF like domains 10,multiple EGF-like-domains 10,,KIAA1780; SR-F3,multiple EGF like domains 10,CMYO10A; CMYO10B; CMYP10A; CMYP10B; EMARDD; SR-F3,MEGF10
Q96KK4,O10C1_HUMAN,OR10C1; OR10C2,Olfactory receptor 10C1; Hs6M1-17; Olfactory receptor 10C2,OR10C2,442194,olfactory receptor family 10 subfamily C member 1,olfactory receptor; family 10; subfamily C; member 2; olfactory receptor; family 10; subfamily C; member 1; olfactory receptor; family 10; subfamily C; member 1 (gene/pseudogene); olfactory receptor family 10 subfamily C member 1 (gene/pseudogene),,hs6M1-17; OR10C1P,olfactory receptor family 10 subfamily C member 1,OR10C1P; OR10C2; OR6-31; hs6M1-17,OR10C1
Q96KK5,H2A1H_HUMAN,H2AC12; HIST1H2AH; HIST1H2AI,Histone H2A type 1-H; H2A-clustered histone 12; Histone H2A/s,HIST1H2AH; HIST1H2AI,85235,H2A clustered histone 12,histone 1; H2ah; histone cluster 1; H2ah; histone cluster 1 H2A family member h,,H2AFALii; dJ86C11.1; H2A/S,H2A clustered histone 12,H2A/S; H2AFALii; H2AH; HIST1H2AH; dJ86C11.1,H2AC12
Q96KQ7,EHMT2_HUMAN,EHMT2; BAT8; C6orf30; G9A; KMT1C; NG36,Histone-lysine N-methyltransferase EHMT2; EC 2.1.1.-; EC 2.1.1.367; Euchromatic histone-lysine N-methyltransferase 2; HLA-B-associated transcript 8; Histone H3-K9 methyltransferase 3; H3-K9-HMTase 3; Lysine N-methyltransferase 1C; Protein G9a,BAT8; C6orf30; G9A; KMT1C; NG36,10919,euchromatic histone lysine methyltransferase 2,chromosome 6 open reading frame 30; HLA-B associated transcript 8,,G9A; Em:AF134726.3; NG36/G9a; KMT1C,euchromatic histone lysine methyltransferase 2,BAT8; C6orf30; G9A; GAT8; KMT1C; NG36,EHMT2
Q96KR7,PHAR3_HUMAN,PHACTR3; C20orf101; SCAPIN1,Phosphatase and actin regulator 3; Scaffold-associated PP1-inhibiting protein; Scapinin,C20orf101; SCAPIN1,116154,phosphatase and actin regulator 3,chromosome 20 open reading frame 101,protein phosphatase 1; regulatory subunit 123,PPP1R123,phosphatase and actin regulator 3,C20orf101; H17739; PPP1R123; SCAPIN1; SCAPININ,PHACTR3
Q96KS0,EGLN2_HUMAN,EGLN2; EIT6,Prolyl hydroxylase EGLN2; EC 1.14.11.-; Egl nine homolog 2; EC 1.14.11.29; Estrogen-induced tag 6; EIT-6; HPH-3; Hypoxia-inducible factor prolyl hydroxylase 1; HIF-PH1; HIF-prolyl hydroxylase 1; HPH-1; Prolyl hydroxylase domain-containing protein 1; PHD1,EIT6,112398,egl-9 family hypoxia inducible factor 2,egl nine homolog 2 (C. elegans),HIF prolyl hydroxylase 1,PHD1; HIFPH1,egl-9 family hypoxia inducible factor 2,EIT-6; EIT6; HIF-PH1; HIFPH1; HPH-1; HPH-3; PHD1,EGLN2
Q96L34,MARK4_HUMAN,MARK4; KIAA1860; MARKL1,MAP/microtubule affinity-regulating kinase 4; EC 2.7.11.1; MAP/microtubule affinity-regulating kinase-like 1,KIAA1860; MARKL1,57787,microtubule affinity regulating kinase 4,MAP/microtubule affinity-regulating kinase like 1; MAP/microtubule affinity-regulating kinase 4,,Nbla00650; FLJ90097; KIAA1860; PAR-1D,microtubule affinity regulating kinase 4,MARK4L; MARK4S; MARKL1; MARKL1L; PAR-1D,MARK4
Q96LC7,SIG10_HUMAN,SIGLEC10; SLG2; UNQ477/PRO940,Sialic acid-binding Ig-like lectin 10; Siglec-10; Siglec-like protein 2,SLG2,89790,sialic acid binding Ig like lectin 10,sialic acid binding Ig-like lectin 10,sialic acid binding Ig-like lectin 10 Ig-like lectin 7; siglec-like gene 2,SIGLEC-10; SLG2; PRO940; MGC126774,sialic acid binding Ig like lectin 10,PRO940; SIGLEC-10; SLG2,SIGLEC10
Q96LC9,BMF_HUMAN,BMF,Bcl-2-modifying factor,,90427,Bcl2 modifying factor,,,FLJ00065,Bcl2 modifying factor,,BMF
Q96LZ3,CANB2_HUMAN,PPP3R2; CBLP; PPP3RL,Calcineurin subunit B type 2; Calcineurin B-like protein; CBLP; Calcineurin BII; CNBII; PPP3R1-like; Protein phosphatase 2B regulatory subunit 2; Protein phosphatase 3 regulatory subunit B beta isoform,CBLP; PPP3RL,5535,protein phosphatase 3 regulatory subunit B; beta,protein phosphatase 3 (formerly 2B); regulatory subunit B (19kD); beta isoform (calcineurin B; type II); protein phosphatase 3 (formerly 2B); regulatory subunit B; 19kDa; beta isoform (calcineurin B; type II); protein phosphatase 3 (formerly 2B); regulatory subunit B; beta isoform; protein phosphatase 3; regulatory subunit B; beta,protein phosphatase 3; regulatory subunit B (calcineurin B)-like; calcineurin B; type II (19kDa); protein phosphatase 2B regulatory subunit 2,PPP3RL,protein phosphatase 3 regulatory subunit B; beta,PPP3RL,PPP3R2
Q96MI6,PPM1M_HUMAN,PPM1M; PPM1E,Protein phosphatase 1M; EC 3.1.3.16; Protein phosphatase 2C isoform eta; PP2C-eta; PP2CE,PPM1E,132160,protein phosphatase; Mg2+/Mn2+ dependent 1M,protein phosphatase 1M (PP2C domain containing); protein phosphatase; Mg2+/Mn2+ dependent; 1M,protein phosphatase 2C eta,PP2Ceta; FLJ32332,protein phosphatase; Mg2+/Mn2+ dependent 1M,PP2C-eta; PP2CE; PP2Ceta,PPM1M
Q96MS0,ROBO3_HUMAN,ROBO3,Roundabout homolog 3; Roundabout-like protein 3,,64221,roundabout guidance receptor 3,roundabout (axon guidance receptor; Drosophila) homolog 3; horizontal gaze palsy with progressive scoliosis; roundabout; axon guidance receptor; homolog 3 (Drosophila),,RBIG1; FLJ21044; HGPS,roundabout guidance receptor 3,HGPPS; HGPPS1; HGPS; RBIG1; RIG1,ROBO3
Q96N67,DOCK7_HUMAN,DOCK7; KIAA1771,Dedicator of cytokinesis protein 7,KIAA1771,85440,dedicator of cytokinesis 7,,,KIAA1771; ZIR2,dedicator of cytokinesis 7,DEE23; EIEE23; ZIR2,DOCK7
Q96NX5,KCC1G_HUMAN,CAMK1G; CLICK3; VWS1,Calcium/calmodulin-dependent protein kinase type 1G; EC 2.7.11.17; CaM kinase I gamma; CaM kinase IG; CaM-KI gamma; CaMKI gamma; CaMKIG; CaMK-like CREB kinase III; CLICK III,CLICK3; VWS1,57172,calcium/calmodulin dependent protein kinase IG,calcium/calmodulin-dependent protein kinase IG,,VWS1; CLICKIII; dJ272L16.1,calcium/calmodulin dependent protein kinase IG,CLICK3; CLICKIII; VWS1,CAMK1G
Q96NY9,MUS81_HUMAN,MUS81,Crossover junction endonuclease MUS81; EC 3.1.22.-,,80198,MUS81 structure-specific endonuclease subunit,MUS81 endonuclease homolog (yeast); MUS81 endonuclease homolog (S. cerevisiae),SLX3 structure-specific endonuclease subunit homolog (S. cerevisiae),FLJ44872; SLX3,MUS81 structure-specific endonuclease subunit,SLX3,MUS81
Q96P20,NLRP3_HUMAN,NLRP3; C1orf7; CIAS1; NALP3; PYPAF1,NACHT; LRR and PYD domains-containing protein 3; EC 3.6.4.-; Angiotensin/vasopressin receptor AII/AVP-like; Caterpiller protein 1.1; CLR1.1; Cold-induced autoinflammatory syndrome 1 protein; Cryopyrin; PYRIN-containing APAF1-like protein 1,C1orf7; CIAS1; NALP3; PYPAF1,114548,NLR family pyrin domain containing 3,cold autoinflammatory syndrome 1; deafness; autosomal dominant 34,Cryopyrin; nucleotide-binding oligomerization domain; leucine rich repeat and pyrin domain containing 3,AGTAVPRL; AII; AVP; FCAS; FCU; NALP3; PYPAF1; MWS; CLR1.1,NLR family pyrin domain containing 3,AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1,NLRP3
Q96P31,FCRL3_HUMAN,FCRL3; FCRH3; IFGP3; IRTA3; SPAP2,Fc receptor-like protein 3; FcR-like protein 3; FcRL3; Fc receptor homolog 3; FcRH3; IFGP family protein 3; hIFGP3; Immune receptor translocation-associated protein 3; MAIA; SH2 domain-containing phosphatase anchor protein 2; CD antigen CD307c,FCRH3; IFGP3; IRTA3; SPAP2,115352,Fc receptor like 3,Fc receptor-like 3,,FCRH3; IRTA3; IFGP3; SPAP2a; SPAP2; SPAP2b; SPAP2c; SPAP2d; SPAP2e; CD307c,Fc receptor like 3,CD307c; FCRH3; IFGP3; IRTA3; MAIA; SPAP2,FCRL3
Q96P48,ARAP1_HUMAN,ARAP1; CENTD2; KIAA0782,Arf-GAP with Rho-GAP domain; ANK repeat and PH domain-containing protein 1; Centaurin-delta-2; Cnt-d2,CENTD2; KIAA0782,116985,ArfGAP with RhoGAP domain; ankyrin repeat and PH domain 1,centaurin; delta 2,,,ArfGAP with RhoGAP domain; ankyrin repeat and PH domain 1,CENTD2; cnt-d2,ARAP1
Q96PE2,ARHGH_HUMAN,ARHGEF17; KIAA0337; TEM4,Rho guanine nucleotide exchange factor 17; 164 kDa Rho-specific guanine-nucleotide exchange factor; p164-RhoGEF; p164RhoGEF; Tumor endothelial marker 4,KIAA0337; TEM4,9828,Rho guanine nucleotide exchange factor 17,Rho guanine nucleotide exchange factor (GEF) 17,Rho-specific guanine-nucleotide exchange factor 164 kDa; tumor endothelial marker 4,TEM4; KIAA0337; p164-RhoGEF,Rho guanine nucleotide exchange factor 17,P164RHOGEF; RHOGEF17; TEM4; p164-RhoGEF,ARHGEF17
Q96PH1,NOX5_HUMAN,NOX5,NADPH oxidase 5; EC 1.6.3.-,,134826889,NADPH oxidase 5,NADPH oxidase; EF-hand calcium binding domain 5,,NOX5A; NOX5B,,,NOX5
Q96PK6,RBM14_HUMAN,RBM14; SIP,RNA-binding protein 14; Paraspeckle protein 2; PSP2; RNA-binding motif protein 14; RRM-containing coactivator activator/modulator; Synaptotagmin-interacting protein; SYT-interacting protein,SIP,100526737,RNA binding motif protein 14,,coactivator activator; SYT interacting protein,SIP; SYTIP1; COAA; DKFZp779J0927,RBM14-RBM4 readthrough,COAZ; PSP2; RBM14; SIP,RBM14
Q96PM5,ZN363_HUMAN,RCHY1; ARNIP; CHIMP; PIRH2; RNF199; ZNF363,RING finger and CHY zinc finger domain-containing protein 1; EC 2.3.2.27; Androgen receptor N-terminal-interacting protein; CH-rich-interacting match with PLAG1; E3 ubiquitin-protein ligase Pirh2; RING finger protein 199; RING-type E3 ubiquitin transferase RCHY1; Zinc finger protein 363; p53-induced RING-H2 protein; hPirh2,ARNIP; CHIMP; PIRH2; RNF199; ZNF363,25898,ring finger and CHY zinc finger domain containing 1,ZNF363,androgen-receptor N-terminal-interacting protein; p53-induced protein with a RING-H2 domain; zinc finger; CHY-type,CHIMP; DKFZp586C1620; PRO1996; RNF199; ARNIP; PIRH2; ZCHY,ring finger and CHY zinc finger domain containing 1,ARNIP; CHIMP; PIRH2; PRO1996; RNF199; ZCHY; ZNF363,RCHY1
Q96PU5,NED4L_HUMAN,NEDD4L; KIAA0439; NEDL3,E3 ubiquitin-protein ligase NEDD4-like; EC 2.3.2.26; EC 2.3.2.36; HECT-type E3 ubiquitin transferase NED4L; NEDD4.2; Nedd4-2,KIAA0439; NEDL3,23327,NEDD4 like E3 ubiquitin protein ligase,neural precursor cell expressed; developmentally down-regulated 4-like; neural precursor cell expressed; developmentally down-regulated 4-like; E3 ubiquitin protein ligase,,KIAA0439; RSP5; NEDD4-2,NEDD4 like E3 ubiquitin protein ligase,NEDD4-2; NEDD4.2; PVNH7; RSP5; hNEDD4-2,NEDD4L
Q96PX8,SLIK1_HUMAN,SLITRK1; KIAA1910; LRRC12; UNQ233/PRO266,SLIT and NTRK-like protein 1; Leucine-rich repeat-containing protein 12,KIAA1910; LRRC12,114798,SLIT and NTRK like family member 1,leucine rich repeat containing 12; SLIT and NTRK-like family; member 1,,KIAA1910,SLIT and NTRK like family member 1,LRRC12; TTM,SLITRK1
Q96PY5,FMNL2_HUMAN,FMNL2; FHOD2; KIAA1902,Formin-like protein 2; Formin homology 2 domain-containing protein 2,FHOD2; KIAA1902,114793,formin like 2,formin homology 2 domain containing 2; formin-like 2,,KIAA1902,formin like 2,FHOD2,FMNL2
Q96PY6,NEK1_HUMAN,NEK1; KIAA1901,Serine/threonine-protein kinase Nek1; EC 2.7.11.1; Never in mitosis A-related kinase 1; NimA-related protein kinase 1; Renal carcinoma antigen NY-REN-55,KIAA1901,4750,NIMA related kinase 1,NIMA (never in mitosis gene a)-related kinase 1,,NY-REN-55; KIAA1901,NIMA related kinase 1,ALS24; NY-REN-55; OFD2; SRPS2; SRPS2A; SRTD6,NEK1
Q96Q15,SMG1_HUMAN,SMG1; ATX; KIAA0421; LIP,Serine/threonine-protein kinase SMG1; SMG-1; hSMG-1; EC 2.7.11.1; Lambda/iota protein kinase C-interacting protein; Lambda-interacting protein; Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1,ATX; KIAA0421; LIP,23049,SMG1 nonsense mediated mRNA decay associated PI3K related kinase,smg-1 homolog; phosphatidylinositol 3-kinase-related kinase (C. elegans); SMG1 phosphatidylinositol 3-kinase-related kinase; SMG1; nonsense mediated mRNA decay associated PI3K related kinase,phosphatidylinositol 3-kinase-related kinase,LIP; KIAA0421; ATX,SMG1 nonsense mediated mRNA decay associated PI3K related kinase,61E3.4; ATX; LIP,SMG1
Q96Q27,ASB2_HUMAN,ASB2,Ankyrin repeat and SOCS box protein 2; ASB-2,,51676,ankyrin repeat and SOCS box containing 2,ankyrin repeat and SOCS box-containing 2,,ASB-2,ankyrin repeat and SOCS box containing 2,ASB-2,ASB2
Q96Q89,KI20B_HUMAN,KIF20B; KRMP1; MPHOSPH1,Kinesin-like protein KIF20B; Cancer/testis antigen 90; CT90; Kinesin family member 20B; Kinesin-related motor interacting with PIN1; M-phase phosphoprotein 1; MPP1,KRMP1; MPHOSPH1,9585,kinesin family member 20B,M-phase phosphoprotein 1,cancer/testis antigen 90,MPP1; KRMP1; CT90,kinesin family member 20B,CT90; KRMP1; MPHOSPH1; MPP-1; MPP1,KIF20B
Q96QB1,RHG07_HUMAN,DLC1; ARHGAP7; KIAA1723; STARD12,Rho GTPase-activating protein 7; Deleted in liver cancer 1 protein; DLC-1; HP protein; Rho-type GTPase-activating protein 7; START domain-containing protein 12; StARD12; StAR-related lipid transfer protein 12,ARHGAP7; KIAA1723; STARD12,10395,DLC1 Rho GTPase activating protein,deleted in liver cancer 1,StAR-related lipid transfer (START) domain containing 12,HP; ARHGAP7; STARD12; DLC-1; p122-RhoGAP,DLC1 Rho GTPase activating protein,ARHGAP7; HP; STARD12; p122-RhoGAP,DLC1
Q96QD9,UIF_HUMAN,FYTTD1; UIF,UAP56-interacting factor; Forty-two-three domain-containing protein 1; Protein 40-2-3,UIF,84248,forty-two-three domain containing 1,,UAP56-interacting factor,DKFZp761B1514; UIF,forty-two-three domain containing 1,UIF,FYTTD1
Q96QF0,RAB3I_HUMAN,RAB3IP; RABIN8,Rab-3A-interacting protein; Rab3A-interacting protein; Rabin-3; Rabin8; SSX2-interacting protein,RABIN8,117177,RAB3A interacting protein,,rabin3,RABIN3; FLJ22548; RABIN8,RAB3A interacting protein,RABIN3; RABIN8,RAB3IP
Q96QT4,TRPM7_HUMAN,TRPM7; CHAK1; LTRPC7,Transient receptor potential cation channel subfamily M member 7; EC 2.7.11.1; Channel-kinase 1; Long transient receptor potential channel 7; LTrpC-7; LTrpC7; M7CK,CHAK1; LTRPC7,54822,transient receptor potential cation channel subfamily M member 7,transient receptor potential cation channel; subfamily M; member 7,,CHAK1; LTRPC7; TRP-PLIK,transient receptor potential cation channel subfamily M member 7,ALSPDC; CHAK; CHAK1; LTRPC7; LTrpC-7; TRP-PLIK,TRPM7
Q96QV6,H2A1A_HUMAN,H2AC1; H2AFR; HIST1H2AA,Histone H2A type 1-A; H2A-clustered histone 1; Histone H2A/r,H2AFR; HIST1H2AA,221613,H2A clustered histone 1,H2A histone family; member R; histone 1; H2aa; histone cluster 1; H2aa; histone cluster 1 H2A family member a,,bA317E16.2; H2AFR,H2A clustered histone 1,H2AA; H2AFR; HIST1H2AA; HISTH2AA; TH2A; bA317E16.2,H2AC1
Q96R06,SPAG5_HUMAN,SPAG5,Sperm-associated antigen 5; Astrin; Deepest; Mitotic spindle-associated protein p126; MAP126,,10615,sperm associated antigen 5,,mitotic spindle coiled-coil related protein; astrin; mitotic spindle associated protein p126,DEEPEST; MAP126; hMAP126,sperm associated antigen 5,DEEPEST; MAP126; hMAP126,SPAG5
Q96RG2,PASK_HUMAN,PASK; KIAA0135,PAS domain-containing serine/threonine-protein kinase; PAS-kinase; PASKIN; hPASK; EC 2.7.11.1,KIAA0135,23178,PAS domain containing serine/threonine kinase,,,PASKIN; KIAA0135; STK37,PAS domain containing serine/threonine kinase,PASKIN; STK37,PASK
Q96RI1,NR1H4_HUMAN,NR1H4; BAR; FXR; HRR1; RIP14,Bile acid receptor; Farnesoid X-activated receptor; Farnesol receptor HRR-1; Nuclear receptor subfamily 1 group H member 4; Retinoid X receptor-interacting protein 14; RXR-interacting protein 14,BAR; FXR; HRR1; RIP14,9971,nuclear receptor subfamily 1 group H member 4,nuclear receptor subfamily 1; group H; member 4,farnesoid X receptor; bile acid receptor,FXR; RIP14; HRR1; HRR-1,nuclear receptor subfamily 1 group H member 4,BAR; FXR; HRR-1; HRR1; PFIC5; RIP14,NR1H4
Q96RK0,CIC_HUMAN,CIC; KIAA0306,Protein capicua homolog,KIAA0306,23152,capicua transcriptional repressor,capicua (Drosophila) homolog; capicua homolog (Drosophila),,KIAA0306,capicua transcriptional repressor,MRD45,CIC
Q96RL1,UIMC1_HUMAN,UIMC1; RAP80; RXRIP110,BRCA1-A complex subunit RAP80; Receptor-associated protein 80; Retinoid X receptor-interacting protein 110; Ubiquitin interaction motif-containing protein 1,RAP80; RXRIP110,51720,ubiquitin interaction motif containing 1,,receptor associated protein 80,RAP80,ubiquitin interaction motif containing 1,RAP80; X2HRIP110,UIMC1
Q96RR4,KKCC2_HUMAN,CAMKK2; CAMKKB; KIAA0787,Calcium/calmodulin-dependent protein kinase kinase 2; CaM-KK 2; CaM-kinase kinase 2; CaMKK 2; EC 2.7.11.17; Calcium/calmodulin-dependent protein kinase kinase beta; CaM-KK beta; CaM-kinase kinase beta; CaMKK beta,CAMKKB; KIAA0787,10645,calcium/calmodulin dependent protein kinase kinase 2,calcium/calmodulin-dependent protein kinase kinase 2; beta,calcium/calmodulin-dependent protein kinase kinase beta,CAMKK; KIAA0787; CAMKKB; MGC15254,calcium/calmodulin dependent protein kinase kinase 2,CAMKK; CAMKKB,CAMKK2
Q96RS0,TGS1_HUMAN,TGS1; HCA137; NCOA6IP; PIMT,Trimethylguanosine synthase; EC 2.1.1.-; CLL-associated antigen KW-2; Cap-specific guanine-N(2; Hepatocellular carcinoma-associated antigen 137; Nuclear receptor coactivator 6-interacting protein; PRIP-interacting protein with methyltransferase motif; PIMT; PIPMT,HCA137; NCOA6IP; PIMT,96764,trimethylguanosine synthase 1,nuclear receptor coactivator 6 interacting protein; trimethylguanosine synthase homolog (S. cerevisiae),,PIMT,trimethylguanosine synthase 1,NCOA6IP; PIMT; PIPMT,TGS1
Q96RU2,UBP28_HUMAN,USP28; KIAA1515,Ubiquitin carboxyl-terminal hydrolase 28; EC 3.4.19.12; Deubiquitinating enzyme 28; Ubiquitin thioesterase 28; Ubiquitin-specific-processing protease 28,KIAA1515,57646,ubiquitin specific peptidase 28,ubiquitin specific protease 28,,KIAA1515,ubiquitin specific peptidase 28,,USP28
Q96S44,PRPK_HUMAN,TP53RK; C20orf64; PRPK,EKC/KEOPS complex subunit TP53RK; EC 3.6.-.-; Atypical serine/threonine protein kinase TP53RK; Nori-2; TP53-regulating kinase; EC 2.7.11.1; p53-related protein kinase,C20orf64; PRPK,112858,TP53 regulating kinase,chromosome 20 open reading frame 64,p53-related protein kinase,dJ101A2.2; prpk; Nori-2p; BUD32; TPRKB,TP53 regulating kinase,BUD32; C20orf64; GAMOS4; Nori-2; Nori-2p; PRPK; TPRKB; dJ101A2,TP53RK
Q96S53,TESK2_HUMAN,TESK2,Dual specificity testis-specific protein kinase 2; EC 2.7.12.1; Testicular protein kinase 2,,10420,testis associated actin remodelling kinase 2,testis-specific kinase 2,,,testis associated actin remodelling kinase 2,,TESK2
Q96S59,RANB9_HUMAN,RANBP9; RANBPM,Ran-binding protein 9; RanBP9; BPM-L; BPM90; Ran-binding protein M; RanBPM; RanBP7,RANBPM,10048,RAN binding protein 9,,Ran Binding Protein in the Microtubule organizing center,RanBPM,RAN binding protein 9,BPM-L; BPM90; RANBPM; RanBP7,RANBP9
Q96S94,CCNL2_HUMAN,CCNL2; SB138,Cyclin-L2; Paneth cell-enhanced expression protein,,81669,cyclin L2,cyclin M,cyclin S,ania-6b; PCEE; SB138; HLA-ISO; CCNS,cyclin L2,ANIA-6B; CCNM; CCNS; HCLA-ISO; HLA-ISO; PCEE; SB138,CCNL2
Q96SB4,SRPK1_HUMAN,SRPK1,SRSF protein kinase 1; EC 2.7.11.1; SFRS protein kinase 1; Serine/arginine-rich protein-specific kinase 1; SR-protein-specific kinase 1,,6732,SRSF protein kinase 1,SFRS protein kinase 1,SR protein kinase 1; serine/arginine-rich splicing factor kinase 1,SFRSK1,SRSF protein kinase 1,SFRSK1,SRPK1
Q96SD1,DCR1C_HUMAN,DCLRE1C; ARTEMIS; ASCID; SCIDA; SNM1C,Protein artemis; EC 3.1.-.-; DNA cross-link repair 1C protein; Protein A-SCID; SNM1 homolog C; hSNM1C; SNM1-like protein,ARTEMIS; ASCID; SCIDA; SNM1C,64421,DNA cross-link repair 1C,severe combined immunodeficiency; type a (Athabascan); DNA cross-link repair 1C (PSO2 homolog; S. cerevisiae),PSO2 homolog (S. cerevisiae),ARTEMIS; FLJ11360; SNM1C; A-SCID,DNA cross-link repair 1C,A-SCID; DCLREC1C; RS-SCID; SCIDA; SNM1C,DCLRE1C
Q96SN8,CK5P2_HUMAN,CDK5RAP2; CEP215; KIAA1633,CDK5 regulatory subunit-associated protein 2; CDK5 activator-binding protein C48; Centrosome-associated protein 215,CEP215; KIAA1633,55755,CDK5 regulatory subunit associated protein 2,microcephaly; primary autosomal recessive 3,centrosomin,C48; FLJ10867; CEP215,CDK5 regulatory subunit associated protein 2,C48; Cep215; MCPH3,CDK5RAP2
Q96ST3,SIN3A_HUMAN,SIN3A,Paired amphipathic helix protein Sin3a; Histone deacetylase complex subunit Sin3a; Transcriptional corepressor Sin3a,,25942,SIN3 transcription regulator family member A,SIN3 homolog A; transcription regulator (yeast); SIN3 transcription regulator homolog A (yeast),,KIAA0700; DKFZP434K2235,SIN3 transcription regulator family member A,CHR15DELq24; DEL15Q24; WITKOS,SIN3A
Q96SU4,OSBL9_HUMAN,OSBPL9; ORP9; OSBP4,Oxysterol-binding protein-related protein 9; ORP-9; OSBP-related protein 9,ORP9; OSBP4,114883,oxysterol binding protein like 9,oxysterol binding protein-like 9,,,oxysterol binding protein like 9,ORP-9; ORP9,OSBPL9
Q96T23,RSF1_HUMAN,RSF1; HBXAP; XAP8,Remodeling and spacing factor 1; Rsf-1; HBV pX-associated protein 8; Hepatitis B virus X-associated protein; p325 subunit of RSF chromatin-remodeling complex,HBXAP; XAP8,51773,remodeling and spacing factor 1,hepatitis B virus x associated protein,,XAP8; RSF-1; p325,remodeling and spacing factor 1,HBXAP; RSF-1; XAP8; p325,RSF1
Q96T49,PP16B_HUMAN,PPP1R16B; ANKRD4; KIAA0823,Protein phosphatase 1 regulatory inhibitor subunit 16B; Ankyrin repeat domain-containing protein 4; CAAX box protein TIMAP; TGF-beta-inhibited membrane-associated protein; hTIMAP,ANKRD4; KIAA0823,26051,protein phosphatase 1 regulatory subunit 16B,protein phosphatase 1; regulatory (inhibitor) subunit 16B; protein phosphatase 1; regulatory subunit 16B,TGF-beta-inhibited membrane-associated protein; ankyrin repeat domain protein 4,KIAA0823; TIMAP; ANKRD4,protein phosphatase 1 regulatory subunit 16B,ANKRD4; TIMAP,PPP1R16B
Q96T51,RUFY1_HUMAN,RUFY1; RABIP4; ZFYVE12,RUN and FYVE domain-containing protein 1; FYVE-finger protein EIP1; La-binding protein 1; Rab4-interacting protein; Zinc finger FYVE domain-containing protein 12,RABIP4; ZFYVE12,80230,RUN and FYVE domain containing 1,,,FLJ22251; ZFYVE12; RABIP4,RUN and FYVE domain containing 1,RABIP4; ZFYVE12,RUFY1
Q96T58,MINT_HUMAN,SPEN; KIAA0929; MINT; SHARP,Msx2-interacting protein; SMART/HDAC1-associated repressor protein; SPEN homolog,KIAA0929; MINT; SHARP,23013,spen family transcriptional repressor,SPEN homolog; transcriptional regulator (Drosophila); spen homolog; transcriptional regulator (Drosophila),,KIAA0929; MINT; SHARP; RBM15C,spen family transcriptional repressor,HIAA0929; MINT; RATARS; RBM15C; SHARP,SPEN
Q96T60,PNKP_HUMAN,PNKP,Bifunctional polynucleotide phosphatase/kinase; DNA 5'-kinase/3'-phosphatase; Polynucleotide kinase-3'-phosphatase; EC 3.1.3.32; 2'(3'; EC 2.7.1.78,,11284,polynucleotide kinase 3'-phosphatase,,,PNK,polynucleotide kinase 3'-phosphatase,AOA4; CMT2B2; EIEE10; MCSZ; PNK,PNKP
Q96T88,UHRF1_HUMAN,UHRF1; ICBP90; NP95; RNF106,E3 ubiquitin-protein ligase UHRF1; EC 2.3.2.27; Inverted CCAAT box-binding protein of 90 kDa; Nuclear protein 95; Nuclear zinc finger protein Np95; HuNp95; hNp95; RING finger protein 106; RING-type E3 ubiquitin transferase UHRF1; Transcription factor ICBP90; Ubiquitin-like PHD and RING finger domain-containing protein 1; hUHRF1; Ubiquitin-like-containing PHD and RING finger domains protein 1,ICBP90; NP95; RNF106,29128,ubiquitin like with PHD and ring finger domains 1,,inverted CCAAT box binding protein 90,ICBP90; Np95; FLJ21925; RNF106; TDRD22,ubiquitin like with PHD and ring finger domains 1,ICBP90; Np95; RNF106; TDRD22; hNP95; hUHRF1; huNp95,UHRF1
Q96TA1,NIBA2_HUMAN,NIBAN2; C9orf88; FAM129B,Protein Niban 2; Meg-3; Melanoma invasion by ERK; MINERVA; Niban-like protein 1; Protein FAM129B,C9orf88; FAM129B,64855,niban apoptosis regulator 2,chromosome 9 open reading frame 88; family with sequence similarity 129 member B,melanoma invasion by ERK,DKFZP434H0820; FLJ13518; FLJ22151; FLJ22298; bA356B19.6; MINERVA,niban apoptosis regulator 2,C9orf88; FAM129B; MEG-3; MINERVA; OC58; bA356B19.6,NIBAN2
Q96TC7,RMD3_HUMAN,RMDN3; FAM82A2; FAM82C; PTPIP51; hucep-10; UNQ3122/PRO10274,Regulator of microtubule dynamics protein 3; RMD-3; hRMD-3; Cerebral protein 10; Protein FAM82A2; Protein FAM82C; Protein tyrosine phosphatase-interacting protein 51; TCPTP-interacting protein 51,FAM82A2; FAM82C; PTPIP51,55177,regulator of microtubule dynamics 3,family with sequence similarity 82; member A2,,FLJ10579; PTPIP51; RMD3,regulator of microtubule dynamics 3,FAM82A2; FAM82C; RMD-3; RMD3; ptpip51,RMDN3
Q99259,DCE1_HUMAN,GAD1; GAD; GAD67,Glutamate decarboxylase 1; EC 4.1.1.15; 67 kDa glutamic acid decarboxylase; GAD-67; Glutamate decarboxylase 67 kDa isoform,GAD; GAD67,2571,glutamate decarboxylase 1,glutamate decarboxylase 1 (brain; 67kD); glutamate decarboxylase 1 (brain; 67kDa),,,glutamate decarboxylase 1,CPSQ1; DEE89; GAD; SCP,GAD1
Q99418,CYH2_HUMAN,CYTH2; ARNO; PSCD2; PSCD2L,Cytohesin-2; ARF exchange factor; ARF nucleotide-binding site opener; Protein ARNO; PH; SEC7 and coiled-coil domain-containing protein 2,ARNO; PSCD2; PSCD2L,9266,cytohesin 2,pleckstrin homology; Sec7 and coiled/coil domains 2 (cytohesin-2); pleckstrin homology; Sec7 and coiled-coil domains 2,,CTS18.1; Sec7p-L; ARNO; Sec7p-like; cytohesin-2,cytohesin 2,ARNO; CTS18; CTS18.1; PSCD2; PSCD2L; SEC7L; Sec7p-L; Sec7p-like; cytohesin-2,CYTH2
Q99426,TBCB_HUMAN,TBCB; CG22; CKAP1,Tubulin-folding cofactor B; Cytoskeleton-associated protein 1; Cytoskeleton-associated protein CKAPI; Tubulin-specific chaperone B,CG22; CKAP1,1155,tubulin folding cofactor B,cytoskeleton-associated protein 1; cytoskeleton associated protein 1,,CG22; CKAPI,tubulin folding cofactor B,CG22; CKAP1; CKAPI,TBCB
Q99439,CNN2_HUMAN,CNN2,Calponin-2; Calponin H2; smooth muscle; Neutral calponin,,1265,calponin 2,,,,calponin 2,,CNN2
Q99459,CDC5L_HUMAN,CDC5L; KIAA0432; PCDC5RP,Cell division cycle 5-like protein; Cdc5-like protein; Pombe cdc5-related protein,KIAA0432; PCDC5RP,988,cell division cycle 5 like,CDC5 (cell division cycle 5; S. pombe; homolog)-like; CDC5 cell division cycle 5-like (S. pombe); cell division cycle 5-like,,PCDC5RP; hCDC5; CEF1; CDC5,cell division cycle 5 like,CDC5; CDC5-LIKE; CEF1; PCDC5RP; dJ319D22.1,CDC5L
Q99490,AGAP2_HUMAN,AGAP2; CENTG1; KIAA0167,Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 2; AGAP-2; Centaurin-gamma-1; Cnt-g1; GTP-binding and GTPase-activating protein 2; GGAP2; Phosphatidylinositol 3-kinase enhancer; PIKE,CENTG1; KIAA0167,116986,ArfGAP with GTPase domain; ankyrin repeat and PH domain 2,centaurin; gamma 1,,,ArfGAP with GTPase domain; ankyrin repeat and PH domain 2,CENTG1; GGAP2; PIKE,AGAP2
Q99502,EYA1_HUMAN,EYA1,Protein phosphatase EYA1; EC 3.1.3.16; EC 3.1.3.48; Eyes absent homolog 1,,2138,EYA transcriptional coactivator and phosphatase 1,eyes absent (Drosophila) homolog 1; eyes absent homolog 1 (Drosophila),,,EYA transcriptional coactivator and phosphatase 1,BOP; BOR; BOS1; OFC1; OTFCS,EYA1
Q99504,EYA3_HUMAN,EYA3,Protein phosphatase EYA3; EC 3.1.3.48; Eyes absent homolog 3,,2140,EYA transcriptional coactivator and phosphatase 3,eyes absent (Drosophila) homolog 3; eyes absent homolog 3 (Drosophila),,DKFZp686C132,EYA transcriptional coactivator and phosphatase 3,,EYA3
Q99538,LGMN_HUMAN,LGMN; PRSC1,Legumain; EC 3.4.22.34; Asparaginyl endopeptidase; AEP; Protease; cysteine 1,PRSC1,5641,legumain,protease; cysteine; 1 (legumain),,LGMN1,legumain,AEP; LGMN1; PRSC1,LGMN
Q99558,M3K14_HUMAN,MAP3K14; NIK,Mitogen-activated protein kinase kinase kinase 14; EC 2.7.11.25; NF-kappa-beta-inducing kinase; HsNIK; Serine/threonine-protein kinase NIK,NIK,9020,mitogen-activated protein kinase kinase kinase 14,,serine/threonine protein-kinase,NIK; HSNIK; FTDCR1B; HS,mitogen-activated protein kinase kinase kinase 14,FTDCR1B; HS; HSNIK; IMD112; NIK,MAP3K14
Q99590,SCAFB_HUMAN,SCAF11; CASP11; SFRS2IP; SIP1; SRSF2IP,Protein SCAF11; CTD-associated SR protein 11; Renal carcinoma antigen NY-REN-40; SC35-interacting protein 1; SR-related and CTD-associated factor 11; SRSF2-interacting protein; Serine/arginine-rich splicing factor 2-interacting protein; Splicing factor; arginine/serine-rich 2-interacting protein; Splicing regulatory protein 129; SRrp129,CASP11; SFRS2IP; SIP1; SRSF2IP,9169,SR-related CTD associated factor 11,splicing factor; arginine/serine-rich 2; interacting protein; serine/arginine-rich splicing factor 2; interacting protein,,SIP1; SRRP129; CASP11,SR-related CTD associated factor 11,CASP11; SFRS2IP; SIP1; SRRP129; SRSF2IP,SCAF11
Q99607,ELF4_HUMAN,ELF4; ELFR; MEF,ETS-related transcription factor Elf-4; E74-like factor 4; Myeloid Elf-1-like factor,ELFR; MEF,2000,E74 like ETS transcription factor 4,E74-like factor 4 (ets domain transcription factor),,MEF; ELFR,E74 like ETS transcription factor 4,AIFBL2; ELFR; MEF,ELF4
Q99623,PHB2_HUMAN,PHB2; BAP; REA,Prohibitin-2; B-cell receptor-associated protein BAP37; D-prohibitin; Repressor of estrogen receptor activity,BAP; REA,11331,prohibitin 2,,B cell receptor associated protein 37,REA; BCAP37; Bap37; p22,prohibitin 2,BAP; BCAP37; Bap37; PNAS-141; REA; hBAP; p22,PHB2
Q99626,CDX2_HUMAN,CDX2; CDX3,Homeobox protein CDX-2; CDX-3; Caudal-type homeobox protein 2,CDX3,1045,caudal type homeobox 2,caudal type homeo box transcription factor 2,,,caudal type homeobox 2,CDX-3; CDX2/AS; CDX3,CDX2
Q99638,RAD9A_HUMAN,RAD9A,Cell cycle checkpoint control protein RAD9A; hRAD9; EC 3.1.11.2; DNA repair exonuclease rad9 homolog A,,5883,RAD9 checkpoint clamp component A,RAD9 (S. pombe) homolog; RAD9 homolog A (S. pombe),,,RAD9 checkpoint clamp component A,RAD9,RAD9A
Q99640,PMYT1_HUMAN,PKMYT1; MYT1,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; EC 2.7.11.1; Myt1 kinase,MYT1,9088,protein kinase; membrane associated tyrosine/threonine 1,,membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; protein phosphatase 1; regulatory subunit 126,MYT1; PPP1R126,protein kinase; membrane associated tyrosine/threonine 1,MYT1; PPP1R126,PKMYT1
Q99661,KIF2C_HUMAN,KIF2C; KNSL6,Kinesin-like protein KIF2C; Kinesin-like protein 6; Mitotic centromere-associated kinesin; MCAK,KNSL6,11004,kinesin family member 2C,kinesin-like 6 (mitotic centromere-associated kinesin),,MCAK; CT139,kinesin family member 2C,CT139; KNSL6; MCAK,KIF2C
Q99683,M3K5_HUMAN,MAP3K5; ASK1; MAPKKK5; MEKK5,Mitogen-activated protein kinase kinase kinase 5; EC 2.7.11.25; Apoptosis signal-regulating kinase 1; ASK-1; MAPK/ERK kinase kinase 5; MEK kinase 5; MEKK 5,ASK1; MAPKKK5; MEKK5,4217,mitogen-activated protein kinase kinase kinase 5,,apoptosis signal regulating kinase 1,MAPKKK5; ASK1,mitogen-activated protein kinase kinase kinase 5,ASK1; MAPKKK5; MEKK5,MAP3K5
Q99689,FEZ1_HUMAN,FEZ1,Fasciculation and elongation protein zeta-1; Zygin I; Zygin-1,,9638,fasciculation and elongation protein zeta 1,,zygin I,UNC-76,fasciculation and elongation protein zeta 1,UNC-76,FEZ1
Q99704,DOK1_HUMAN,DOK1,Docking protein 1; Downstream of tyrosine kinase 1; p62(dok; pp62,,1796,docking protein 1,docking protein 1; 62kD (downstream of tyrosine kinase 1); docking protein 1; 62kDa (downstream of tyrosine kinase 1),downstream of tyrosine kinase 1,p62dok,docking protein 1,P62DOK; pp62,DOK1
Q99708,CTIP_HUMAN,RBBP8; CTIP,DNA endonuclease RBBP8; EC 3.1.-.-; CtBP-interacting protein; CtIP; Retinoblastoma-binding protein 8; RBBP-8; Retinoblastoma-interacting protein and myosin-like; RIM; Sporulation in the absence of SPO11 protein 2 homolog; SAE2,CTIP,5932,RB binding protein 8; endonuclease,retinoblastoma-binding protein 8; Seckel syndrome 2; retinoblastoma binding protein 8,CTBP-interacting protein,CtIP; RIM; COM1,RB binding protein 8; endonuclease,COM1; CTIP; JAWAD; JWDS; RIM; SAE2; SCKL2,RBBP8
Q99717,SMAD5_HUMAN,SMAD5; MADH5,Mothers against decapentaplegic homolog 5; MAD homolog 5; Mothers against DPP homolog 5; JV5-1; SMAD family member 5; SMAD 5; Smad5; hSmad5,MADH5,4090,SMAD family member 5,MAD; mothers against decapentaplegic homolog 5 (Drosophila); SMAD; mothers against DPP homolog 5 (Drosophila),,Dwfc; JV5-1,SMAD family member 5,DWFC; JV5-1; MADH5,SMAD5
Q99719,SEPT5_HUMAN,SEPTIN5; PNUTL1; SEPT5,Septin-5; Cell division control-related protein 1; CDCrel-1; Peanut-like protein 1,PNUTL1; SEPT5,5413,septin 5,peanut-like 1 (Drosophila),Cell division control-related protein 1,HCDCREL-1; H5; Septin-5; CDCREL-1,septin 5,CDCREL; CDCREL-1; CDCREL1; H5; HCDCREL-1; PNUTL1; SEPT5; Septin-5,SEPTIN5
Q99728,BARD1_HUMAN,BARD1,BRCA1-associated RING domain protein 1; BARD-1; EC 2.3.2.27; RING-type E3 ubiquitin transferase BARD1,,580,BRCA1 associated RING domain 1,,,,BRCA1 associated RING domain 1,,BARD1
Q99741,CDC6_HUMAN,CDC6; CDC18L,Cell division control protein 6 homolog; CDC6-related protein; Cdc18-related protein; HsCdc18; p62(cdc6; HsCDC6,CDC18L,990,cell division cycle 6,CDC6 (cell division cycle 6; S. cerevisiae) homolog; CDC6 cell division cycle 6 homolog (S. cerevisiae); cell division cycle 6 homolog (S. cerevisiae),,,cell division cycle 6,CDC18L; HsCDC18; HsCDC6; MGORS5,CDC6
Q99755,PI51A_HUMAN,PIP5K1A,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha; PIP5K1-alpha; PtdIns(4; EC 2.7.1.68; 68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha; Phosphatidylinositol 4-phosphate 5-kinase type I alpha; PIP5KIalpha,,8394,phosphatidylinositol-4-phosphate 5-kinase type 1 alpha,phosphatidylinositol-4-phosphate 5-kinase; type I; alpha,,,phosphatidylinositol-4-phosphate 5-kinase type 1 alpha,,PIP5K1A
Q99759,M3K3_HUMAN,MAP3K3; MAPKKK3; MEKK3,Mitogen-activated protein kinase kinase kinase 3; EC 2.7.11.25; MAPK/ERK kinase kinase 3; MEK kinase 3; MEKK 3,MAPKKK3; MEKK3,4215,mitogen-activated protein kinase kinase kinase 3,,MAPK/ERK kinase kinase 3,MAPKKK3,mitogen-activated protein kinase kinase kinase 3,CCM5; MAPKKK3; MEKK3,MAP3K3
Q99801,NKX31_HUMAN,NKX3-1; NKX3.1; NKX3A,Homeobox protein Nkx-3.1; Homeobox protein NK-3 homolog A,NKX3.1; NKX3A,4824,NK3 homeobox 1,NK homeobox (Drosophila); family 3; A; NK3 transcription factor related; locus 1 (Drosophila),,NKX3.1; BAPX2,NK3 homeobox 1,BAPX2; NKX3; NKX3.1; NKX3A,NKX3-1
Q99808,S29A1_HUMAN,SLC29A1; ENT1,Equilibrative nucleoside transporter 1; hENT1; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Equilibrative NBMPR-sensitive nucleoside transporter; es nucleoside transporter; Nucleoside transporter; es-type; Solute carrier family 29 member 1,ENT1,2030,solute carrier family 29 member 1 (Augustine blood group),solute carrier family 29 (equilibrative nucleoside transporter); member 1,,,solute carrier family 29 member 1 (Augustine blood group),AUG; ENT1; hENT1,SLC29A1
Q99814,EPAS1_HUMAN,EPAS1; BHLHE73; HIF2A; MOP2; PASD2,Endothelial PAS domain-containing protein 1; EPAS-1; Basic-helix-loop-helix-PAS protein MOP2; Class E basic helix-loop-helix protein 73; bHLHe73; HIF-1-alpha-like factor; HLF; Hypoxia-inducible factor 2-alpha; HIF-2-alpha; HIF2-alpha; Member of PAS protein 2; PAS domain-containing protein 2,BHLHE73; HIF2A; MOP2; PASD2,2034,endothelial PAS domain protein 1,,HIF-1 alpha-like factor,MOP2; PASD2; HIF2A; HLF; bHLHe73,endothelial PAS domain protein 1,ECYT4; HIF2A; HLF; MOP2; PASD2; bHLHe73,EPAS1
Q99828,CIB1_HUMAN,CIB1; CIB; KIP; PRKDCIP,Calcium and integrin-binding protein 1; CIB; Calcium- and integrin-binding protein; CIBP; Calmyrin; DNA-PKcs-interacting protein; Kinase-interacting protein; KIP; SNK-interacting protein 2-28; SIP2-28,CIB; KIP; PRKDCIP,10519,calcium and integrin binding 1,,calmyrin,SIP2-28; CIB; KIP,calcium and integrin binding 1,CIB; CIBP; EV3; KIP1; PRKDCIP; SIP2-28,CIB1
Q99835,SMO_HUMAN,SMO; SMOH,Protein smoothened; Protein Gx,SMOH,6608,smoothened; frizzled class receptor,smoothened (Drosophila) homolog; smoothened homolog (Drosophila); smoothened; seven transmembrane spanning receptor; smoothened; frizzled family receptor,frizzled family member 11,FZD11,smoothened; frizzled class receptor,CRJS; FZD11; Gx; PHLS; SMOH,SMO
Q99848,EBP2_HUMAN,EBNA1BP2; EBP2,Probable rRNA-processing protein EBP2; EBNA1-binding protein 2; Nucleolar protein p40,EBP2,10969,EBNA1 binding protein 2,EBNA1-binding protein 2,,NOBP; EBP2; P40,EBNA1 binding protein 2,EBP2; NOBP; P40,EBNA1BP2
Q99877,H2B1N_HUMAN,H2BC15; H2BFD; HIST1H2BN,Histone H2B type 1-N; Histone H2B.d; H2B/d,H2BFD; HIST1H2BN,8341,H2B clustered histone 15,H2B histone family; member D; histone 1; H2bn; histone cluster 1; H2bn; histone cluster 1 H2B family member n,,H2B/d,H2B clustered histone 15,H2B/d; H2BFD; HIST1H2BN,H2BC15
Q99878,H2A1J_HUMAN,H2AC14; H2AFE; HIST1H2AJ,Histone H2A type 1-J; Histone H2A/e,H2AFE; HIST1H2AJ,8331,H2A clustered histone 14,H2A histone family; member E; histone 1; H2aj; histone cluster 1; H2aj; histone cluster 1 H2A family member j,,H2A/E,H2A clustered histone 14,H2A/E; H2AFE; HIST1H2AJ; dJ160A22.4,H2AC14
Q99879,H2B1M_HUMAN,H2BC14; H2BFE; HIST1H2BM,Histone H2B type 1-M; Histone H2B.e; H2B/e,H2BFE; HIST1H2BM,8342,H2B clustered histone 14,H2B histone family; member E; histone 1; H2bm; histone cluster 1; H2bm; histone cluster 1 H2B family member m,,H2B/e; dJ160A22.3,H2B clustered histone 14,H2B/e; H2BFE; HIST1H2BM; dJ160A22.3,H2BC14
Q99880,H2B1L_HUMAN,H2BC13; H2BFC; HIST1H2BL,Histone H2B type 1-L; Histone H2B.c; H2B/c,H2BFC; HIST1H2BL,8340,H2B clustered histone 13,H2B histone family; member C; histone 1; H2bl; histone cluster 1; H2bl; histone cluster 1 H2B family member l,,H2B/c; dJ97D16.4,H2B clustered histone 13,H2B/c; H2BFC; HIST1H2BL; dJ97D16.4,H2BC13
Q99941,ATF6B_HUMAN,ATF6B; CREBL1; G13,Cyclic AMP-dependent transcription factor ATF-6 beta; cAMP-dependent transcription factor ATF-6 beta; Activating transcription factor 6 beta; ATF6-beta; Protein G13; cAMP response element-binding protein-related protein; Creb-rp; cAMP-responsive element-binding protein-like 1,CREBL1; G13,1388,activating transcription factor 6 beta,cAMP responsive element binding protein-like 1,Cyclic AMP-dependent transcription factor ATF-6 beta,G13; ATF6beta,activating transcription factor 6 beta,ATF6beta; CREB-RP; CREBL1; G13,ATF6B
Q99952,PTN18_HUMAN,PTPN18; BDP1,Tyrosine-protein phosphatase non-receptor type 18; EC 3.1.3.48; Brain-derived phosphatase,BDP1,26469,protein tyrosine phosphatase non-receptor type 18,protein tyrosine phosphatase; non-receptor type 18 (brain-derived),brain derived phosphatase,BDP1,protein tyrosine phosphatase non-receptor type 18,BDP1; PTP-HSCF,PTPN18
Q99956,DUS9_HUMAN,DUSP9; MKP4,Dual specificity protein phosphatase 9; EC 3.1.3.16; EC 3.1.3.48; Mitogen-activated protein kinase phosphatase 4; MAP kinase phosphatase 4; MKP-4,MKP4,1852,dual specificity phosphatase 9,,map kinase phosphatase 4,MKP-4; MKP4,dual specificity phosphatase 9,MKP-4; MKP4,DUSP9
Q99958,FOXC2_HUMAN,FOXC2; FKHL14; MFH1,Forkhead box protein C2; Forkhead-related protein FKHL14; Mesenchyme fork head protein 1; MFH-1 protein; Transcription factor FKH-14,FKHL14; MFH1,2303,forkhead box C2,forkhead box C2 (MFH-1; mesenchyme forkhead 1),mesenchyme forkhead 1,MFH-1,forkhead box C2,FKHL14; LD; MFH-1; MFH1,FOXC2
Q99961,SH3G1_HUMAN,SH3GL1; CNSA1; SH3D2B,Endophilin-A2; EEN fusion partner of MLL; Endophilin-2; Extra eleven-nineteen leukemia fusion gene protein; EEN; SH3 domain protein 2B; SH3 domain-containing GRB2-like protein 1,CNSA1; SH3D2B,6455,SH3 domain containing GRB2 like 1; endophilin A2,SH3-domain GRB2-like 1; SH3 domain containing GRB2 like 1,extra 11-19 leukemia fusion; fusion partner of MLL; SH3-containing Grb-2-like 1 protein; SH3-containing protein EEN; SH3 domain GRB2-like 1; endophilin A2,SH3P8; SH3D2B; CNSA1; EEN; MGC111371,SH3 domain containing GRB2 like 1; endophilin A2,CNSA1; EEN; SH3D2B; SH3P8,SH3GL1
Q99962,SH3G2_HUMAN,SH3GL2; CNSA2; SH3D2A,Endophilin-A1; EEN-B1; Endophilin-1; SH3 domain protein 2A; SH3 domain-containing GRB2-like protein 2,CNSA2; SH3D2A,6456,SH3 domain containing GRB2 like 2; endophilin A1,SH3 domain containing GRB2 like 2,endophilin-A1,SH3P4; SH3D2A; CNSA2; EEN-B1,SH3 domain containing GRB2 like 2; endophilin A1,CNSA2; EEN-B1; SH3D2A; SH3P4,SH3GL2
Q99986,VRK1_HUMAN,VRK1,Serine/threonine-protein kinase VRK1; EC 2.7.11.1; Vaccinia-related kinase 1,,7443,VRK serine/threonine kinase 1,vaccinia related kinase 1,,,VRK serine/threonine kinase 1,HMNR10; PCH1; PCH1A,VRK1
Q9BPX3,CND3_HUMAN,NCAPG; CAPG; NYMEL3,Condensin complex subunit 3; Chromosome-associated protein G; Condensin subunit CAP-G; hCAP-G; Melanoma antigen NY-MEL-3; Non-SMC condensin I complex subunit G; XCAP-G homolog,CAPG; NYMEL3,64151,non-SMC condensin I complex subunit G,non-SMC condensin I complex; subunit G,chromosome condensation protein G,FLJ12450; hCAP-G; CAP-G; YCG1,non-SMC condensin I complex subunit G,CAPG; CHCG; NY-MEL-3; YCG1,NCAPG
Q9BPZ7,SIN1_HUMAN,MAPKAP1; MIP1; SIN1,Target of rapamycin complex 2 subunit MAPKAP1; TORC2 subunit MAPKAP1; Mitogen-activated protein kinase 2-associated protein 1; Stress-activated map kinase-interacting protein 1; SAPK-interacting protein 1; mSIN1,MIP1; SIN1,79109,MAPK associated protein 1,mitogen-activated protein kinase associated protein 1,stress-activated protein kinase-interacting 1,MGC2745; SIN1; MIP1,MAPK associated protein 1,JC310; MIP1; SIN1; SIN1b; SIN1g,MAPKAP1
Q9BQ15,SOSB1_HUMAN,NABP2; OBFC2B; SSB1; LP3587,SOSS complex subunit B1; Nucleic acid-binding protein 2; Oligonucleotide/oligosaccharide-binding fold-containing protein 2B; Sensor of single-strand DNA complex subunit B1; Sensor of ssDNA subunit B1; SOSS-B1; Single-stranded DNA-binding protein 1; hSSB1,OBFC2B; SSB1,79035,nucleic acid binding protein 2,oligonucleotide/oligosaccharide-binding fold containing 2B,single strand DNA-binding protein 1; sensor of single-strand DNA complex subunit B1,MGC2731; SSB1; hSSB1; SOSS-B1,nucleic acid binding protein 2,OBFC2B; SOSS-B1; SSB1; hSSB1,NABP2
Q9BQA1,MEP50_HUMAN,WDR77; MEP50; WD45; HKMT1069; Nbla10071,Methylosome protein WDR77; Androgen receptor cofactor p44; Methylosome protein 50; MEP-50; WD repeat-containing protein 77; p44/Mep50,MEP50; WD45,79084,WD repeat domain 77,,methylosome protein 50,MEP50; p44,WD repeat domain 77,HKMT1069; MEP-50; MEP50; Nbla10071; p44; p44/Mep50,WDR77
Q9BQE3,TBA1C_HUMAN,TUBA1C; TUBA6,Tubulin alpha-1C chain; EC 3.6.5.-; Alpha-tubulin 6; Tubulin alpha-6 chain,TUBA6,84790,tubulin alpha 1c,tubulin; alpha 6,,MGC14580; MGC10851; bcm948,tubulin alpha 1c,TUBA6; bcm948,TUBA1C
Q9BQG0,MBB1A_HUMAN,MYBBP1A; P160,Myb-binding protein 1A,P160,10514,MYB binding protein 1a,MYB binding protein (P160) 1a,p53-activated protein-2,P160; PAP2; FLJ37886; Pol5,MYB binding protein 1a,P160; PAP2; Pol5,MYBBP1A
Q9BQI3,E2AK1_HUMAN,EIF2AK1; HRI; KIAA1369; PRO1362,Eukaryotic translation initiation factor 2-alpha kinase 1; EC 2.7.11.1; Heme-controlled repressor; HCR; Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase; Heme-regulated inhibitor; hHRI; Hemin-sensitive initiation factor 2-alpha kinase,HRI; KIAA1369,27102,eukaryotic translation initiation factor 2 alpha kinase 1,,heme regulated initiation factor 2 alpha kinase; Heme-regulated inhibitor; hemin-controlled repressor,HRI; KIAA1369; hHRI; HCR,eukaryotic translation initiation factor 2 alpha kinase 1,HCR; HRI; LEMSPAD; hHRI,EIF2AK1
Q9BQK8,LPIN3_HUMAN,LPIN3; LIPN3L,Phosphatidate phosphatase LPIN3; EC 3.1.3.4; Lipin-3; Lipin-3-like,LIPN3L,64900,lipin 3,lipin 3-like,Phosphatidate phosphatase LPIN3,SMP2,lipin 3,LIPN3L; SMP2; dJ620E11.2,LPIN3
Q9BQQ3,GORS1_HUMAN,GORASP1; GOLPH5; GRASP65,Golgi reassembly-stacking protein 1; Golgi peripheral membrane protein p65; Golgi phosphoprotein 5; GOLPH5; Golgi reassembly-stacking protein of 65 kDa; GRASP65,GOLPH5; GRASP65,64689,golgi reassembly stacking protein 1,golgi phosphoprotein 5; golgi reassembly stacking protein 1; 65kDa,,GRASP65; P65; FLJ23443,golgi reassembly stacking protein 1,GOLPH5; GRASP65; P65,GORASP1
Q9BR01,ST4A1_HUMAN,SULT4A1; SULTX3,Sulfotransferase 4A1; ST4A1; EC 2.8.2.-; Brain sulfotransferase-like protein; hBR-STL; hBR-STL-1; Nervous system sulfotransferase; NST,SULTX3,25830,sulfotransferase family 4A member 1,sulfotransferase family 4A; member 1,,SULTX3; hBR-STL-1,sulfotransferase family 4A member 1,BR-STL-1; BRSTL1; DJ388M5.3; NST; SULTX3; hBR-STL-1,SULT4A1
Q9BR39,JPH2_HUMAN,JPH2; JP2,Junctophilin-2; JP-2; Junctophilin type 2; JP2NT,JP2,57158,junctophilin 2,,junctophilin2,JP-2; JP2,junctophilin 2,CMD2E; CMH17; JP-2; JP2,JPH2
Q9BR76,COR1B_HUMAN,CORO1B,Coronin-1B; Coronin-2,,57175,coronin 1B,coronin; actin-binding protein; 1B,,coronin-2,coronin 1B,CORONIN-2,CORO1B
Q9BRD0,BUD13_HUMAN,BUD13,BUD13 homolog,,84811,BUD13 homolog,BUD13 homolog (yeast); BUD13 homolog (S. cerevisiae),functional spliceosome-associated protein 71,MGC13125; fSAP71; Cwc26,BUD13 homolog,ACHPS; Cwc26; fSAP71,BUD13
Q9BRL6,SRSF8_HUMAN,SRSF8; SFRS2B; SRP46,Serine/arginine-rich splicing factor 8; Pre-mRNA-splicing factor SRP46; Splicing factor SRp46; Splicing factor; arginine/serine-rich 2B,SFRS2B; SRP46,10929,serine and arginine rich splicing factor 8,splicing factor; arginine/serine-rich 2B; serine/arginine-rich splicing factor 8,SR splicing factor 8,SRP46,serine and arginine rich splicing factor 8,DSM-1; SFRS2B; SRP46,SRSF8
Q9BRQ0,PYGO2_HUMAN,PYGO2; PP7910,Pygopus homolog 2,,90780,pygopus family PHD finger 2,pygopus homolog 2 (Drosophila),,,pygopus family PHD finger 2,1190004M21Rik,PYGO2
Q9BRS2,RIOK1_HUMAN,RIOK1; RIO1,Serine/threonine-protein kinase RIO1; EC 2.7.11.1; EC 3.6.3.-; RIO kinase 1,RIO1,83732,RIO kinase 1,RIO kinase 1 (yeast),,AD034; FLJ30006; bA288G3.1; RRP10,RIO kinase 1,AD034; RIO1; RRP10; bA288G3.1,RIOK1
Q9BRS8,LARP6_HUMAN,LARP6,La-related protein 6; Acheron; Achn; La ribonucleoprotein domain family member 6,,55323,La ribonucleoprotein 6; translational regulator,La ribonucleoprotein domain family; member 6; La ribonucleoprotein domain family member 6,,acheron; FLJ11196,La ribonucleoprotein 6; translational regulator,ACHN,LARP6
Q9BRV8,SIKE1_HUMAN,SIKE1; SIKE,Suppressor of IKBKE 1; Suppressor of IKK-epsilon,SIKE,80143,suppressor of IKBKE 1,,suppressor of IKK epsilon,FLJ21168; SIKE,suppressor of IKBKE 1,SIKE,SIKE1
Q9BS18,APC13_HUMAN,ANAPC13,Anaphase-promoting complex subunit 13; APC13; Cyclosome subunit 13,,25847,anaphase promoting complex subunit 13,,,SWM1; APC13; DKFZP566D193,anaphase promoting complex subunit 13,APC13; SWM1,ANAPC13
Q9BSB4,ATGA1_HUMAN,ATG101; C12orf44; PP894,Autophagy-related protein 101,C12orf44,60673,autophagy related 101,chromosome 12 open reading frame 44,,FLJ11773,autophagy related 101,C12orf44,ATG101
Q9BSI4,TINF2_HUMAN,TINF2; TIN2,TERF1-interacting nuclear factor 2; TRF1-interacting nuclear protein 2,TIN2,26277,TERF1 interacting nuclear factor 2,TERF1 (TRF1)-interacting nuclear factor 2,,TIN2,TERF1 interacting nuclear factor 2,DKCA3; TIN2,TINF2
Q9BSJ6,PIMRE_HUMAN,PIMREG; CATS; FAM64A; RCS1,Protein PIMREG; CALM-interactor expressed in thymus and spleen; PICALM-interacting mitotic regulator; Regulator of chromosome segregation protein 1,CATS; FAM64A; RCS1,54478,PICALM interacting mitotic regulator,family with sequence similarity 64; member A; family with sequence similarity 64 member A,CALM interacting protein expressed in thymus and spleen; Regulator of chromosome segregation protein 1,FLJ10156; FLJ10491; CATS; RCS1,PICALM interacting mitotic regulator,CATS; FAM64A; RCS1,PIMREG
Q9BSQ5,CCM2_HUMAN,CCM2; C7orf22; PP10187,Cerebral cavernous malformations 2 protein; Malcavernin,C7orf22,83605,CCM2 scaffold protein,chromosome 7 open reading frame 22; cerebral cavernous malformation 2; CCM2 scaffolding protein,malcavernin; osmosensing scaffold for MEKK3,MGC4607; OSM,CCM2 scaffold protein,C7orf22; OSM; PP10187,CCM2
Q9BST9,RTKN_HUMAN,RTKN; RTKN1,Rhotekin,RTKN1,6242,rhotekin,,,B5; RTKN-1,rhotekin,RTKN-1,RTKN
Q9BTD8,RBM42_HUMAN,RBM42,RNA-binding protein 42; RNA-binding motif protein 42,,79171,RNA binding motif protein 42,,,MGC10433,RNA binding motif protein 42,,RBM42
Q9BTL3,RAMAC_HUMAN,RAMAC; C15orf18; FAM103A1; RAMMET,RNA guanine-N7 methyltransferase activating subunit; Protein FAM103A1; RNA guanine-7 methyltransferase activating subunit; RNMT-activating mRNA cap methyltransferase subunit; RNMT-activating mini protein; RAM,C15orf18; FAM103A1; RAMMET,83640,RNA guanine-7 methyltransferase activating subunit,family with sequence similarity 103 member A1; RNMT activating mRNA cap methyltransferase subunit,RNMT-activating mini protein,HsT19360; C15orf18; MGC2560; RAM,RNA guanine-7 methyltransferase activating subunit,C15orf18; FAM103A1; HsT19360; RAM; RAMMET,RAMAC
Q9BU19,ZN692_HUMAN,ZNF692; AREBP; ZFP692,Zinc finger protein 692; AICAR responsive element binding protein,AREBP; ZFP692,55657,zinc finger protein 692,,AICAR responsive element binding protein,FLJ20531; Zfp692; AREBP,zinc finger protein 692,AREBP; Zfp692,ZNF692
Q9BUB5,MKNK1_HUMAN,MKNK1; MNK1,MAP kinase-interacting serine/threonine-protein kinase 1; EC 2.7.11.1; MAP kinase signal-integrating kinase 1; MAPK signal-integrating kinase 1; Mnk1,MNK1,8569,MAPK interacting serine/threonine kinase 1,MAP kinase interacting serine/threonine kinase 1,,MNK1,MAPK interacting serine/threonine kinase 1,MNK1,MKNK1
Q9BUL8,PDC10_HUMAN,PDCD10; CCM3; TFAR15,Programmed cell death protein 10; Cerebral cavernous malformations 3 protein; TF-1 cell apoptosis-related protein 15,CCM3; TFAR15,11235,programmed cell death 10,cerebral cavernous malformations 3,,TFAR15,programmed cell death 10,CCM3; TFAR15,PDCD10
Q9BUR4,TCAB1_HUMAN,WRAP53; TCAB1; WDR79,Telomerase Cajal body protein 1; WD repeat-containing protein 79; WD40 repeat-containing protein antisense to TP53 gene; WRAP53beta,TCAB1; WDR79,55135,WD repeat containing antisense to TP53,WD repeat domain 79; WD repeat containing; antisense to TP53,telomerase cajal body protein 1; WD-encoding RNA antisense to p53,FLJ10385; TCAB1,WD repeat containing antisense to TP53,DKCB3; TCAB1; WDR79,WRAP53
Q9BUZ4,TRAF4_HUMAN,TRAF4; CART1; MLN62; RNF83,TNF receptor-associated factor 4; EC 2.3.2.27; Cysteine-rich domain associated with RING and Traf domains protein 1; Metastatic lymph node gene 62 protein; MLN 62; RING finger protein 83,CART1; MLN62; RNF83,9618,TNF receptor associated factor 4,,,CART1; MLN62; RNF83,TNF receptor associated factor 4,CART1; MLN62; RNF83,TRAF4
Q9BV47,DUS26_HUMAN,DUSP26; DUSP24; LDP4; MKP8; NATA1; SKRP3,Dual specificity protein phosphatase 26; EC 3.1.3.16; EC 3.1.3.48; Dual specificity phosphatase SKRP3; Low-molecular-mass dual-specificity phosphatase 4; DSP-4; LDP-4; Mitogen-activated protein kinase phosphatase 8; MAP kinase phosphatase 8; MKP-8; Novel amplified gene in thyroid anaplastic cancer,DUSP24; LDP4; MKP8; NATA1; SKRP3,78986,dual specificity phosphatase 26,dual specificity phosphatase 26 (putative),neuroendocrine-associated phosphatase,MGC1136; DUSP24; NEAP,dual specificity phosphatase 26,DSP-4; DUSP24; LDP-4; LDP4; MKP-8; MKP8; NATA1; NEAP; SKRP3,DUSP26
Q9BV73,CP250_HUMAN,CEP250; CEP2; CNAP1,Centrosome-associated protein CEP250; 250 kDa centrosomal protein; Cep250; Centrosomal Nek2-associated protein 1; C-Nap1; Centrosomal protein 2,CEP2; CNAP1,11190,centrosomal protein 250,centrosomal protein 2; centrosomal protein 250kDa,,C-NAP1,centrosomal protein 250,C-NAP1; CEP2; CNAP1; CRDHL2,CEP250
Q9BVI0,PHF20_HUMAN,PHF20; C20orf104; GLEA2; HCA58; NZF; TZP,PHD finger protein 20; Glioma-expressed antigen 2; Hepatocellular carcinoma-associated antigen 58; Novel zinc finger protein; Transcription factor TZP,C20orf104; GLEA2; HCA58; NZF; TZP,51230,PHD finger protein 20,chromosome 20 open reading frame 104,tudor domain containing 20A,dJ1121G12.1; TDRD20A,PHD finger protein 20,C20orf104; GLEA2; HCA58; NZF; TDRD20A; TZP,PHF20
Q9BVJ7,DUS23_HUMAN,DUSP23; LDP3; VHZ,Dual specificity protein phosphatase 23; EC 3.1.3.16; EC 3.1.3.48; Low molecular mass dual specificity phosphatase 3; LDP-3; VH1-like phosphatase Z,LDP3; VHZ,54935,dual specificity phosphatase 23,,,FLJ20442; DUSP25,dual specificity phosphatase 23,DUSP25; LDP-3; LDP3; MOSP; VHZ,DUSP23
Q9BVS4,RIOK2_HUMAN,RIOK2; RIO2,Serine/threonine-protein kinase RIO2; EC 2.7.11.1; RIO kinase 2,RIO2,55781,RIO kinase 2,RIO kinase 2 (yeast),,FLJ11159,RIO kinase 2,RIO2,RIOK2
Q9BW19,KIFC1_HUMAN,KIFC1; HSET; KNSL2,Kinesin-like protein KIFC1; Kinesin-like protein 2; Kinesin-related protein HSET,HSET; KNSL2,3833,kinesin family member C1,kinesin-like 2,,HSET,kinesin family member C1,HSET; KNSL2,KIFC1
Q9BW61,DDA1_HUMAN,DDA1; C19orf58; PCIA1,DET1- and DDB1-associated protein 1; Placenta cross-immune reaction antigen 1; PCIA-1,C19orf58; PCIA1,79016,DET1 and DDB1 associated 1,chromosome 19 open reading frame 58,,PCIA1; MGC2594,DET1 and DDB1 associated 1,C19orf58; PCIA1,DDA1
Q9BWF3,RBM4_HUMAN,RBM4; RBM4A,RNA-binding protein 4; Lark homolog; hLark; RNA-binding motif protein 4; RNA-binding motif protein 4a,RBM4A,5936,RNA binding motif protein 4,,,LARK; RBM4A; ZCRB3A; ZCCHC21,RNA binding motif protein 4,LARK; RBM4A; ZCCHC21; ZCRB3A,RBM4
Q9BWT1,CDCA7_HUMAN,CDCA7; JPO1,Cell division cycle-associated protein 7; Protein JPO1,JPO1,83879,cell division cycle associated 7,,,FLJ14736; JPO1,cell division cycle associated 7,ICF3; JPO1,CDCA7
Q9BWT7,CAR10_HUMAN,CARD10; CARMA3,Caspase recruitment domain-containing protein 10; CARD-containing MAGUK protein 3; Carma 3,CARMA3,29775,caspase recruitment domain family member 10,caspase recruitment domain family; member 10,,CARMA3; BIMP1,caspase recruitment domain family member 10,BIMP1; CARMA3; IMD89,CARD10
Q9BWU1,CDK19_HUMAN,CDK19; CDC2L6; CDK11; KIAA1028,Cyclin-dependent kinase 19; EC 2.7.11.22; CDC2-related protein kinase 6; Cell division cycle 2-like protein kinase 6; Cell division protein kinase 19; Cyclin-dependent kinase 11; Death-preventing kinase,CDC2L6; CDK11; KIAA1028,23097,cyclin dependent kinase 19,cyclin-dependent kinase (CDC2-like) 11; cell division cycle 2-like 6 (CDK8-like),,KIAA1028; bA346C16.3,cyclin dependent kinase 19,CDC2L6; CDK11; DEE87; EIEE87; bA346C16.3,CDK19
Q9BWW4,SSBP3_HUMAN,SSBP3; SSDP; SSDP1,Single-stranded DNA-binding protein 3; Sequence-specific single-stranded-DNA-binding protein,SSDP; SSDP1,23648,single stranded DNA binding protein 3,single-stranded DNA-binding protein 3,,CSDP; SSDP; FLJ10355; SSDP1,single stranded DNA binding protein 3,CSDP; SSDP; SSDP1,SSBP3
Q9BX66,SRBS1_HUMAN,SORBS1; KIAA0894; KIAA1296; SH3D5,Sorbin and SH3 domain-containing protein 1; Ponsin; SH3 domain protein 5; SH3P12; c-Cbl-associated protein; CAP,KIAA0894; KIAA1296; SH3D5,10580,sorbin and SH3 domain containing 1,SH3-domain protein 5 (ponsin),c-Cbl-associated protein,FLJ12406; CAP; sh3p12; ponsin; KIAA1296,sorbin and SH3 domain containing 1,CAP; FLAF2; R85FL; SH3D5; SH3P12; SORB1,SORBS1
Q9BX84,TRPM6_HUMAN,TRPM6; CHAK2,Transient receptor potential cation channel subfamily M member 6; EC 2.7.11.1; Channel kinase 2; Melastatin-related TRP cation channel 6,CHAK2,140803,transient receptor potential cation channel subfamily M member 6,hypomagnesemia; secondary hypocalcemia; transient receptor potential cation channel; subfamily M; member 6,,CHAK2; FLJ22628,transient receptor potential cation channel subfamily M member 6,CHAK2; HMGX; HOMG; HOMG1; HSH,TRPM6
Q9BXB4,OSB11_HUMAN,OSBPL11; ORP11; OSBP12,Oxysterol-binding protein-related protein 11; ORP-11; OSBP-related protein 11,ORP11; OSBP12,114885,oxysterol binding protein like 11,oxysterol binding protein-like 11,,ORP-11; ORP11; FLJ13012; FLJ13164,oxysterol binding protein like 11,ORP-11; ORP11; OSBP12; TCCCIA00292,OSBPL11
Q9BXH1,BBC3_HUMAN,BBC3; PUMA,Bcl-2-binding component 3; isoforms 1/2; JFY-1; p53 up-regulated modulator of apoptosis,PUMA,27113,BCL2 binding component 3,,p53-upregulated modulator of apoptosis,JFY1; PUMA,BCL2 binding component 3,JFY-1; JFY1; PUMA,BBC3
Q9BXL6,CAR14_HUMAN,CARD14; CARMA2,Caspase recruitment domain-containing protein 14; CARD-containing MAGUK protein 2; Carma 2,CARMA2,79092,caspase recruitment domain family member 14,psoriasis susceptibility 2; caspase recruitment domain family; member 14,,CARMA2; BIMP2,caspase recruitment domain family member 14,BIMP2; CARMA2; PRP; PSORS2; PSS1,CARD14
Q9BXL7,CAR11_HUMAN,CARD11; CARMA1,Caspase recruitment domain-containing protein 11; CARD-containing MAGUK protein 1; Carma 1,CARMA1,84433,caspase recruitment domain family member 11,caspase recruitment domain family; member 11,card-maguk protein 1; bcl10-interacting maguk protein 3,CARMA1; BIMP3,caspase recruitment domain family member 11,BENTA; BIMP3; CARMA1; IMD11; IMD11A; PPBL,CARD11
Q9BXM7,PINK1_HUMAN,PINK1,Serine/threonine-protein kinase PINK1; mitochondrial; EC 2.7.11.1; BRPK; PTEN-induced putative kinase protein 1,,65018,PTEN induced kinase 1,Parkinson disease (autosomal recessive) 6; PTEN induced putative kinase 1,,BRPK,PTEN induced kinase 1,BRPK; PARK6,PINK1
Q9BXP5,SRRT_HUMAN,SRRT; ARS2; ASR2,Serrate RNA effector molecule homolog; Arsenite-resistance protein 2,ARS2; ASR2,51593,serrate; RNA effector molecule,serrate RNA effector molecule homolog (Arabidopsis),arsenite resistance protein,Asr2; serrate; ARS2,serrate; RNA effector molecule,ARS2; ASR2; serrate,SRRT
Q9BXR0,TGT_HUMAN,QTRT1; TGT; TGUT,Queuine tRNA-ribosyltransferase catalytic subunit 1; EC 2.4.2.64; Guanine insertion enzyme; tRNA-guanine transglycosylase,TGT; TGUT,81890,queuine tRNA-ribosyltransferase catalytic subunit 1,queuine tRNA-ribosyltransferase 1,tRNA-guanine transglycosylase,TGT,queuine tRNA-ribosyltransferase catalytic subunit 1,FP3235; TGT; TGUT,QTRT1
Q9BXS5,AP1M1_HUMAN,AP1M1; CLTNM,AP-1 complex subunit mu-1; AP-mu chain family member mu1A; Adaptor protein complex AP-1 subunit mu-1; Adaptor-related protein complex 1 subunit mu-1; Clathrin assembly protein complex 1 mu-1 medium chain 1; Clathrin coat assembly protein AP47; Clathrin coat-associated protein AP47; Golgi adaptor HA1/AP1 adaptin mu-1 subunit; Mu-adaptin 1; Mu1A-adaptin,CLTNM,8907,adaptor related protein complex 1 subunit mu 1,adaptor-related protein complex 1; mu 1 subunit; adaptor related protein complex 1 mu 1 subunit,,AP47; CLAPM2; mu1A,adaptor related protein complex 1 subunit mu 1,AP47; CLAPM2; CLTNM; MU-1A; mu1A,AP1M1
Q9BXS6,NUSAP_HUMAN,NUSAP1; ANKT; BM-037; PRO0310,Nucleolar and spindle-associated protein 1; NuSAP,ANKT,51203,nucleolar and spindle associated protein 1,,,FLJ13421; LNP; ANKT; SAPL; BM037; PRO0310p1; Q0310,nucleolar and spindle associated protein 1,ANKT; BM037; LNP; NUSAP; PRO0310p1; Q0310; SAPL,NUSAP1
Q9BXW4,MLP3C_HUMAN,MAP1LC3C,Microtubule-associated protein 1 light chain 3 gamma; Autophagy-related protein LC3 C; Autophagy-related ubiquitin-like modifier LC3 C; MAP1 light chain 3-like protein 3; Microtubule-associated proteins 1A/1B light chain 3C; MAP1A/MAP1B LC3 C; MAP1A/MAP1B light chain 3 C,,440738,microtubule associated protein 1 light chain 3 gamma,,,ATG8J,microtubule associated protein 1 light chain 3 gamma,ATG8J; LC3C,MAP1LC3C
Q9BXW9,FACD2_HUMAN,FANCD2; FACD,Fanconi anemia group D2 protein; Protein FACD2,FACD,2177,FA complementation group D2,Fanconi anemia complementation group D2,,FAD; FA-D2,FA complementation group D2,FA-D2; FA4; FACD; FAD; FAD2; FANCD,FANCD2
Q9BY11,PACN1_HUMAN,PACSIN1; KIAA1379,Protein kinase C and casein kinase substrate in neurons protein 1; Syndapin-1,KIAA1379,29993,protein kinase C and casein kinase substrate in neurons 1,,syndapin I,SDPI,protein kinase C and casein kinase substrate in neurons 1,SDPI,PACSIN1
Q9BY41,HDAC8_HUMAN,HDAC8; HDACL1; CDA07,Histone deacetylase 8; HD8; EC 3.5.1.98; Protein deacetylase HDAC8; EC 3.5.1.-; Protein decrotonylase HDAC8; EC 3.5.1.-,HDACL1,55869,histone deacetylase 8,histone deacetylase-like 1; Wilson-Turner X-linked mental retardation syndrome,,RPD3; KDAC8,histone deacetylase 8,CDA07; CDLS5; HD8; HDACL1; KDAC8; MRXS6; RPD3; WTS,HDAC8
Q9BY77,PDIP3_HUMAN,POLDIP3; KIAA1649; PDIP46,Polymerase delta-interacting protein 3; 46 kDa DNA polymerase delta interaction protein; p46; S6K1 Aly/REF-like target; SKAR,KIAA1649; PDIP46,84271,DNA polymerase delta interacting protein 3,polymerase (DNA-directed); delta interacting protein 3,S6K1 Aly/REF-like target,PDIP46; KIAA1649; SKAR; PDIP3,DNA polymerase delta interacting protein 3,PDIP3; PDIP46; SKAR,POLDIP3
Q9BY84,DUS16_HUMAN,DUSP16; KIAA1700; MKP7,Dual specificity protein phosphatase 16; EC 3.1.3.16; EC 3.1.3.48; Mitogen-activated protein kinase phosphatase 7; MAP kinase phosphatase 7; MKP-7,KIAA1700; MKP7,80824,dual specificity phosphatase 16,,MAPK phosphatase-7,MKP-7; KIAA1700; MKP7,dual specificity phosphatase 16,MKP-7; MKP7,DUSP16
Q9BYE7,PCGF6_HUMAN,PCGF6; MBLR; RNF134,Polycomb group RING finger protein 6; Mel18 and Bmi1-like RING finger; RING finger protein 134,MBLR; RNF134,84108,polycomb group ring finger 6,ring finger protein 134,,MBLR,polycomb group ring finger 6,MBLR; RNF134,PCGF6
Q9BYG3,MK67I_HUMAN,NIFK; MKI67IP; NOPP34,MKI67 FHA domain-interacting nucleolar phosphoprotein; Nucleolar phosphoprotein Nopp34; Nucleolar protein interacting with the FHA domain of pKI-67; hNIFK,MKI67IP; NOPP34,84365,nucleolar protein interacting with the FHA domain of MKI67,MKI67 (FHA domain) interacting nucleolar phosphoprotein,nucleolar protein interacting with the FHA domain of pKi-67,Nopp34; hNIFK,nucleolar protein interacting with the FHA domain of MKI67,MKI67IP; Nopp34,NIFK
Q9BYP7,WNK3_HUMAN,WNK3; KIAA1566; PRKWNK3,Serine/threonine-protein kinase WNK3; EC 2.7.11.1; Protein kinase lysine-deficient 3; Protein kinase with no lysine 3,KIAA1566; PRKWNK3,65267,WNK lysine deficient protein kinase 3,protein kinase; lysine deficient 3,,,WNK lysine deficient protein kinase 3,MRXS2; PRKWNK3; PRS,WNK3
Q9BYV9,BACH2_HUMAN,BACH2,Transcription regulator protein BACH2; BTB and CNC homolog 2,,60468,BTB domain and CNC homolog 2,BTB and CNC homology 1; basic leucine zipper transcription factor 2,,BTBD25,BTB domain and CNC homolog 2,BTBD25; IMD60,BACH2
Q9BYX4,IFIH1_HUMAN,IFIH1; MDA5; RH116,Interferon-induced helicase C domain-containing protein 1; EC 3.6.4.13; Clinically amyopathic dermatomyositis autoantigen 140 kDa; CADM-140 autoantigen; Helicase with 2 CARD domains; Helicard; Interferon-induced with helicase C domain protein 1; Melanoma differentiation-associated protein 5; MDA-5; Murabutide down-regulated protein; RIG-I-like receptor 2; RLR-2; RNA helicase-DEAD box protein 116,MDA5; RH116,64135,interferon induced with helicase C domain 1,,helicard; melanoma differentiation-associated gene 5,MDA-5; Hlcd; MDA5; IDDM19,interferon induced with helicase C domain 1,AGS7; Hlcd; IDDM19; IMD95; MDA-5; MDA5; RLR-2; SGMRT1,IFIH1
Q9BZB8,CPEB1_HUMAN,CPEB1; CPEB,Cytoplasmic polyadenylation element-binding protein 1; CPE-BP1; CPE-binding protein 1; h-CPEB; hCPEB-1,CPEB,64506,cytoplasmic polyadenylation element binding protein 1,,,FLJ13203; CPEB,cytoplasmic polyadenylation element binding protein 1,CPE-BP1; CPEB; CPEB-1; h-CPEB; hCPEB-1,CPEB1
Q9BZG1,RAB34_HUMAN,RAB34; RAB39; RAH,Ras-related protein Rab-34; Ras-related protein Rab-39; Ras-related protein Rah,RAB39; RAH,83871,RAB34; member RAS oncogene family,,nine-amino acid residue-repeats,RAB39; RAH; NARR,RAB34; member RAS oncogene family,NARR; OFD20; RAB39; RAH,RAB34
Q9BZG2,PPAT_HUMAN,ACP4; ACPT,Testicular acid phosphatase; EC 3.1.3.2; Acid phosphatase 4,ACPT,93650,acid phosphatase 4,acid phosphatase; testicular,testicular acid phosphatase,,acid phosphatase 4,ACPT; AI1J,ACP4
Q9BZK7,TBL1R_HUMAN,TBL1XR1; IRA1; TBLR1,F-box-like/WD repeat-containing protein TBL1XR1; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1-related protein 1; Transducin beta-like 1X-related protein 1,IRA1; TBLR1,79718,TBL1X/Y related 1,transducin (beta)-like 1X-linked receptor 1; transducin beta like 1 X-linked receptor 1; TBL1X receptor 1,F-box-like/WD repeat-containing protein TBL1XR1; TBL1-related protein,IRA1; FLJ12894; TBLR1; C21; DC42,TBL1X/Y related 1,C21; DC42; IRA1; MRD41; TBLR1,TBL1XR1
Q9BZL4,PP12C_HUMAN,PPP1R12C; LENG3; MBS85,Protein phosphatase 1 regulatory subunit 12C; Protein phosphatase 1 myosin-binding subunit of 85 kDa; Protein phosphatase 1 myosin-binding subunit p85,LENG3; MBS85,54776,protein phosphatase 1 regulatory subunit 12C,leukocyte receptor cluster (LRC) member 3; protein phosphatase 1; regulatory (inhibitor) subunit 12C; protein phosphatase 1; regulatory subunit 12C,myosin-binding subunit 85,DKFZP434D0412; p84; MBS85; p85; AAVS1,protein phosphatase 1 regulatory subunit 12C,AAVS1; LENG3; MBS85; p84; p85,PPP1R12C
Q9BZL6,KPCD2_HUMAN,PRKD2; PKD2; HSPC187,Serine/threonine-protein kinase D2; EC 2.7.11.13; nPKC-D2,PKD2,25865,protein kinase D2,,,PKD2; HSPC187; DKFZP586E0820,protein kinase D2,HSPC187; PKD2; nPKC-D2,PRKD2
Q9BZQ8,NIBA1_HUMAN,NIBAN1; C1orf24; FAM129A; NIBAN; GIG39,Protein Niban 1; Cell growth-inhibiting gene 39 protein; Protein FAM129A,C1orf24; FAM129A; NIBAN,116496,niban apoptosis regulator 1,chromosome 1 open reading frame 24; family with sequence similarity 129 member A,cell growth inhibiting protein 39,NIBAN; GIG39,niban apoptosis regulator 1,C1orf24; FAM129A; GIG39; NIBAN,NIBAN1
Q9BZS1,FOXP3_HUMAN,FOXP3; IPEX; JM2,Forkhead box protein P3; Scurfin,IPEX,50943,forkhead box P3,immune dysregulation; polyendocrinopathy; enteropathy; X-linked,,JM2; XPID; AIID; PIDX; DIETER; SCURFIN,forkhead box P3,AIID; DIETER; IPEX; JM2; PIDX; XPID,FOXP3
Q9BZW8,CD244_HUMAN,CD244; 2B4,Natural killer cell receptor 2B4; NK cell activation-inducing ligand; NAIL; NK cell type I receptor protein 2B4; NKR2B4; h2B4; SLAM family member 4; SLAMF4; Signaling lymphocytic activation molecule 4; CD antigen CD244,2B4,51744,CD244 molecule,natural killer cell receptor 2B4; CD244 natural killer cell receptor 2B4; CD244 molecule; natural killer cell receptor 2B4,,2B4; NAIL; NKR2B4; Nmrk; SLAMF4,CD244 molecule,2B4; NAIL; NKR2B4; Nmrk; SLAMF4,CD244
Q9C026,TRIM9_HUMAN,TRIM9; KIAA0282; RNF91,E3 ubiquitin-protein ligase TRIM9; EC 2.3.2.27; RING finger protein 91; RING-type E3 ubiquitin transferase TRIM9; Tripartite motif-containing protein 9,KIAA0282; RNF91,114088,tripartite motif containing 9,tripartite motif-containing 9,SNAP-25-interacting RING finger protein,SPRING; RNF91,tripartite motif containing 9,RNF91; SPRING,TRIM9
Q9C0C2,TB182_HUMAN,TNKS1BP1; KIAA1741; TAB182,182 kDa tankyrase-1-binding protein,KIAA1741; TAB182,85456,tankyrase 1 binding protein 1,tankyrase 1 binding protein 1; 182kDa,,TAB182; KIAA1741; FLJ45975; CNOT12,tankyrase 1 binding protein 1,CNOT12; TAB182,TNKS1BP1
Q9C0C7,AMRA1_HUMAN,AMBRA1; DCAF3; KIAA1736,Activating molecule in BECN1-regulated autophagy protein 1; DDB1- and CUL4-associated factor 3,DCAF3; KIAA1736,55626,autophagy and beclin 1 regulator 1,autophagy/beclin-1 regulator 1,WD repeat domain 94; DDB1 and CUL4 associated factor 3,FLJ20294; KIAA1736; WDR94; DCAF3,autophagy and beclin 1 regulator 1,DCAF3; WDR94,AMBRA1
Q9C0C9,UBE2O_HUMAN,UBE2O; KIAA1734,(E3-independent) E2 ubiquitin-conjugating enzyme; E3-independent; EC 2.3.2.24; E2/E3 hybrid ubiquitin-protein ligase UBE2O; Ubiquitin carrier protein O; Ubiquitin-conjugating enzyme E2 O; Ubiquitin-conjugating enzyme E2 of 230 kDa; Ubiquitin-conjugating enzyme E2-230K; Ubiquitin-protein ligase O,KIAA1734,63893,ubiquitin conjugating enzyme E2 O,ubiquitin-conjugating enzyme E2O,,E2-230K,ubiquitin conjugating enzyme E2 O,E2-230K,UBE2O
Q9C0D5,TANC1_HUMAN,TANC1; KIAA1728,Protein TANC1; Tetratricopeptide repeat; ankyrin repeat and coiled-coil domain-containing protein 1,KIAA1728,85461,tetratricopeptide repeat; ankyrin repeat and coiled-coil containing 1,,rolling pebbles homolog B (Drosophila),KIAA1728; ROLSB,tetratricopeptide repeat; ankyrin repeat and coiled-coil containing 1,ROLSB; TANC,TANC1
Q9C0H9,SRCN1_HUMAN,SRCIN1; KIAA1684; P140; SNIP,SRC kinase signaling inhibitor 1; SNAP-25-interacting protein; SNIP; p130Cas-associated protein; p140Cap,KIAA1684; P140; SNIP,80725,SRC kinase signaling inhibitor 1,,p130Cas-associated protein; SNAP-25-interacting protein,SNIP; p140Cap; KIAA1684,SRC kinase signaling inhibitor 1,P140; SNIP,SRCIN1
Q9C0K0,BC11B_HUMAN,BCL11B; CTIP2; RIT1,B-cell lymphoma/leukemia 11B; BCL-11B; B-cell CLL/lymphoma 11B; COUP-TF-interacting protein 2; Radiation-induced tumor suppressor gene 1 protein; hRit1,CTIP2; RIT1,64919,BCL11 transcription factor B,B-cell CLL/lymphoma 11B (zinc finger protein); B cell CLL/lymphoma 11B; BCL11B; BAF complex component; BAF chromatin remodeling complex subunit BCL11B,,CTIP-2; CTIP2; hRIT1-alpha; SMARCM2,BCL11 transcription factor B,ATL1; ATL1-alpha; ATL1-beta; ATL1-delta; ATL1-gamma; CTIP-2; CTIP2; IDDFSTA; IMD49; RIT1; SMARCM2; ZNF856B; hRIT1-alpha,BCL11B
Q9GZM8,NDEL1_HUMAN,NDEL1; EOPA; MITAP1; NUDEL,Nuclear distribution protein nudE-like 1; Protein Nudel; Mitosin-associated protein 1,EOPA; MITAP1; NUDEL,81565,nudE neurodevelopment protein 1 like 1,nudE nuclear distribution gene E homolog (A. nidulans)-like 1; nudE nuclear distribution E homolog (A. nidulans)-like 1,,NUDEL; MITAP1; NDE1L1; NDE2,nudE neurodevelopment protein 1 like 1,EOPA; MITAP1; NDE1L1; NDE2; NUDEL,NDEL1
Q9GZQ8,MLP3B_HUMAN,MAP1LC3B; MAP1ALC3,Microtubule-associated protein 1 light chain 3 beta; Autophagy-related protein LC3 B; Autophagy-related ubiquitin-like modifier LC3 B; MAP1 light chain 3-like protein 2; Microtubule-associated proteins 1A/1B light chain 3B; MAP1A/MAP1B LC3 B; MAP1A/MAP1B light chain 3 B,MAP1ALC3,81631,microtubule associated protein 1 light chain 3 beta,,,ATG8F,microtubule associated protein 1 light chain 3 beta,ATG8F; LC3B; MAP1A/1BLC3; MAP1LC3B-a,MAP1LC3B
Q9GZR7,DDX24_HUMAN,DDX24,ATP-dependent RNA helicase DDX24; EC 3.6.4.13; DEAD box protein 24,,57062,DEAD-box helicase 24,DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 24; DEAD (Asp-Glu-Ala-Asp) box polypeptide 24; DEAD (Asp-Glu-Ala-Asp) box helicase 24,,,DEAD-box helicase 24,,DDX24
Q9GZT5,WN10A_HUMAN,WNT10A,Protein Wnt-10a,,80326,Wnt family member 10A,wingless-type MMTV integration site family; member 10A,,,Wnt family member 10A,ECTD16; OODD; SSPS; STHAG4,WNT10A
Q9GZU1,MCLN1_HUMAN,MCOLN1; ML4; TRPML1; MSTP080,Mucolipin-1; ML1; MG-2; Mucolipidin; Transient receptor potential channel mucolipin 1; TRPML1,ML4; TRPML1,57192,mucolipin TRP cation channel 1,mucolipin 1,mucolipidosis type IV; transient receptor potential cation channel mucolipin subfamily member 1; transient receptor potential mucolipin 1,TRPML1; ML4; MLIV; MST080; MSTP080; TRPM-L1,mucolipin TRP cation channel 1,LECD; MG-2; ML1; ML4; MLIV; MST080; MSTP080; TRP-ML1; TRPM-L1; TRPML1,MCOLN1
Q9GZU7,CTDS1_HUMAN,CTDSP1; NIF3; NLIIF; SCP1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1; EC 3.1.3.16; Nuclear LIM interactor-interacting factor 3; NLI-IF; NLI-interacting factor 3; Small C-terminal domain phosphatase 1; SCP1; Small CTD phosphatase 1,NIF3; NLIIF; SCP1,58190,CTD small phosphatase 1,CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) small phosphatase 1,nuclear LIM interactor-interacting factor; small CTD phosphatase 1,NLIIF; SCP1,CTD small phosphatase 1,NIF3; NLI-IF; NLIIF; SCP1,CTDSP1
Q9GZV1,ANKR2_HUMAN,ANKRD2; ARPP,Ankyrin repeat domain-containing protein 2; Skeletal muscle ankyrin repeat protein; hArpp,ARPP,26287,ankyrin repeat domain 2,ankyrin repeat domain 2 (stretch responsive muscle),,ARPP,ankyrin repeat domain 2,ARPP,ANKRD2
Q9GZV5,WWTR1_HUMAN,WWTR1; TAZ,WW domain-containing transcription regulator protein 1; Transcriptional coactivator with PDZ-binding motif,TAZ,25937,WW domain containing transcription regulator 1,,transcriptional coactivator with PDZ-binding motif,TAZ; DKFZp586I1419,WW domain containing transcription regulator 1,TAZ,WWTR1
Q9GZV9,FGF23_HUMAN,FGF23; HYPF; UNQ3027/PRO9828,Fibroblast growth factor 23; FGF-23; Phosphatonin; Tumor-derived hypophosphatemia-inducing factor,HYPF,8074,fibroblast growth factor 23,,,,fibroblast growth factor 23,ADHR; FGFN; HFTC2; HPDR2; HYPF; PHPTC,FGF23
Q9GZX7,AICDA_HUMAN,AICDA; AID,Single-stranded DNA cytosine deaminase; EC 3.5.4.38; Activation-induced cytidine deaminase; AID; Cytidine aminohydrolase,AID,57379,activation induced cytidine deaminase,activation-induced cytidine deaminase,,HIGM2; CDA2; ARP2; AID,activation induced cytidine deaminase,AID; ARP2; CDA2; HEL-S-284; HIGM2,AICDA
Q9GZY6,NTAL_HUMAN,LAT2; LAB; NTAL; WBS15; WBSCR15; WBSCR5; HSPC046,Linker for activation of T-cells family member 2; Linker for activation of B-cells; Membrane-associated adapter molecule; Non-T-cell activation linker; Williams-Beuren syndrome chromosomal region 15 protein; Williams-Beuren syndrome chromosomal region 5 protein,LAB; NTAL; WBS15; WBSCR15; WBSCR5,7462,linker for activation of T cells family member 2,Williams-Beuren syndrome chromosome region 5; linker for activation of T cells family; member 2; linker for activation of T-cells family member 2,linker for activation of B cells; non-T cell activation linker; linker for activation of T cells; transmembrane adaptor 2,WSCR5; HSPC046; LAB; NTAL,linker for activation of T cells family member 2,HSPC046; LAB; NTAL; WBSCR15; WBSCR5; WSCR5,LAT2
Q9H063,MAF1_HUMAN,MAF1,Repressor of RNA polymerase III transcription MAF1 homolog,,84232,MAF1 homolog; negative regulator of RNA polymerase III,MAF1 homolog (S. cerevisiae),,DKFZp586G1123,MAF1 homolog; negative regulator of RNA polymerase III,,MAF1
Q9H093,NUAK2_HUMAN,NUAK2; OMPHK2; SNARK,NUAK family SNF1-like kinase 2; EC 2.7.11.1; Omphalocele kinase 2; SNF1/AMP kinase-related kinase; SNARK,OMPHK2; SNARK,81788,NUAK family kinase 2,NUAK family; SNF1-like kinase; 2,SNF1/AMP activated protein kinase,SNARK; FLJ90349,NUAK family kinase 2,ANPH2; SNARK,NUAK2
Q9H0B6,KLC2_HUMAN,KLC2,Kinesin light chain 2; KLC 2,,64837,kinesin light chain 2,,,FLJ12387,kinesin light chain 2,,KLC2
Q9H0D6,XRN2_HUMAN,XRN2,5'-3' exoribonuclease 2; EC 3.1.13.-; DHM1-like protein; DHP protein,,22803,5'-3' exoribonuclease 2,,,,5'-3' exoribonuclease 2,,XRN2
Q9H0H5,RGAP1_HUMAN,RACGAP1; KIAA1478; MGCRACGAP,Rac GTPase-activating protein 1; Male germ cell RacGap; MgcRacGAP; Protein CYK4 homolog; CYK4; HsCYK-4,KIAA1478; MGCRACGAP,29127,Rac GTPase activating protein 1,,,MgcRacGAP; CYK4,Rac GTPase activating protein 1,CDAN3B; CYK4; HsCYK-4; ID-GAP; MgcRacGAP; RCGAP1,RACGAP1
Q9H0K1,SIK2_HUMAN,SIK2; KIAA0781; QIK; SNF1LK2,Serine/threonine-protein kinase SIK2; EC 2.7.11.1; Qin-induced kinase; Salt-inducible kinase 2; SIK-2; Serine/threonine-protein kinase SNF1-like kinase 2,KIAA0781; QIK; SNF1LK2,23235,salt inducible kinase 2,SNF1-like kinase 2,Qin-induced kinase,KIAA0781; QIK; DKFZp434K1115; LOH11CR1I,salt inducible kinase 2,LOH11CR1I; QIK; SIK-2; SNF1LK2,SIK2
Q9H0R8,GBRL1_HUMAN,GABARAPL1; GEC1,Gamma-aminobutyric acid receptor-associated protein-like 1; Early estrogen-regulated protein; GABA(A; Glandular epithelial cell protein 1; GEC-1,GEC1,23710,GABA type A receptor associated protein like 1,GABA(A) receptor-associated protein like 1,,gec1; APG8L; ATG8L; ATG8B,GABA type A receptor associated protein like 1,APG8-LIKE; APG8L; ATG8; ATG8B; ATG8L; GEC1,GABARAPL1
Q9H0Z9,RBM38_HUMAN,RBM38; RNPC1; SEB4,RNA-binding protein 38; CLL-associated antigen KW-5; HSRNASEB; RNA-binding motif protein 38; RNA-binding region-containing protein 1; ssDNA-binding protein SEB4,RNPC1; SEB4,55544,RNA binding motif protein 38,RNA-binding region (RNP1; RRM) containing 1,,HSRNASEB; SEB4D; seb4B; dJ800J21.2,RNA binding motif protein 38,HSRNASEB; RNPC1; SEB4B; SEB4D; dJ800J21.2,RBM38
Q9H1A4,APC1_HUMAN,ANAPC1; TSG24,Anaphase-promoting complex subunit 1; APC1; Cyclosome subunit 1; Mitotic checkpoint regulator; Testis-specific gene 24 protein,TSG24,64682,anaphase promoting complex subunit 1,,,MCPR; TSG24; APC1,anaphase promoting complex subunit 1,APC1; MCPR; TSG24,ANAPC1
Q9H1D0,TRPV6_HUMAN,TRPV6; ECAC2,Transient receptor potential cation channel subfamily V member 6; TrpV6; CaT-like; CaT-L; Calcium transport protein 1; CaT1; Epithelial calcium channel 2; ECaC2,ECAC2,55503,transient receptor potential cation channel subfamily V member 6,epithelial calcium channel 2; transient receptor potential cation channel; subfamily V; member 6,,CaT1,transient receptor potential cation channel subfamily V member 6,ABP/ZF; CAT1; CATL; ECAC2; HRPTTN; HSA277909; LP6728; ZFAB,TRPV6
Q9H1E3,NUCKS_HUMAN,NUCKS1; NUCKS; JC7,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1; P1,NUCKS,64710,nuclear casein kinase and cyclin dependent kinase substrate 1,,,NUCKS,nuclear casein kinase and cyclin dependent kinase substrate 1,JC7; NUCKS,NUCKS1
Q9H1J5,WNT8A_HUMAN,WNT8A; WNT8D,Protein Wnt-8a; Protein Wnt-8d,WNT8D,7478,Wnt family member 8A,wingless-type MMTV integration site family; member 8A,,WNT8D,Wnt family member 8A,WNT8D,WNT8A
Q9H1J7,WNT5B_HUMAN,WNT5B,Protein Wnt-5b,,81029,Wnt family member 5B,wingless-type MMTV integration site family; member 5B,,,Wnt family member 5B,,WNT5B
Q9H1K0,RBNS5_HUMAN,RBSN; ZFYVE20,Rabenosyn-5; 110 kDa protein; FYVE finger-containing Rab5 effector protein rabenosyn-5; RAB effector RBSN; Zinc finger FYVE domain-containing protein 20,ZFYVE20,64145,rabenosyn; RAB effector,zinc finger; FYVE domain containing 20,Rabenosyn-5,,rabenosyn; RAB effector,KAREVS; MFANDO; Rabenosyn-5; ZFYVE20,RBSN
Q9H1K1,ISCU_HUMAN,ISCU; NIFUN,Iron-sulfur cluster assembly enzyme ISCU; NifU-like N-terminal domain-containing protein; NifU-like protein,NIFUN,23479,iron-sulfur cluster assembly enzyme,NifU-like N-terminal domain containing; IscU iron-sulfur cluster scaffold homolog (E. coli); iron-sulfur cluster scaffold homolog (E. coli),,ISU2; hnifU,iron-sulfur cluster assembly enzyme,2310020H20Rik; HML; ISU2; NIFU; NIFUN; hnifU,ISCU
Q9H1R3,MYLK2_HUMAN,MYLK2,Myosin light chain kinase 2; skeletal/cardiac muscle; MLCK2; EC 2.7.11.18,,85366,myosin light chain kinase 2,myosin light chain kinase 2; skeletal muscle,skeletal muscle myosin light chain kinase,skMLCK; KMLC; MLCK2,myosin light chain kinase 2,KMLC; MLCK; MLCK2; skMLCK,MYLK2
Q9H204,MED28_HUMAN,MED28; EG1; FKSG20,Mediator of RNA polymerase II transcription subunit 28; Endothelial-derived protein 1; Mediator complex subunit 28; Merlin and Grb2-interacting cytoskeletal protein; Magicin; Tumor angiogenesis marker EG-1,EG1,80306,mediator complex subunit 28,mediator of RNA polymerase II transcription; subunit 28 homolog (S. cerevisiae),,EG1; DKFZP434N185; magicin,mediator complex subunit 28,1500003D12Rik; EG1; magicin,MED28
Q9H211,CDT1_HUMAN,CDT1,DNA replication factor Cdt1; Double parked homolog; DUP,,81620,chromatin licensing and DNA replication factor 1,,,DUP; RIS2,chromatin licensing and DNA replication factor 1,DUP; RIS2,CDT1
Q9H255,O51E2_HUMAN,OR51E2; PSGR,Olfactory receptor 51E2; HPRAJ; Olfactory receptor OR11-16; Prostate-specific G-protein coupled receptor,PSGR,81285,olfactory receptor family 51 subfamily E member 2,olfactory receptor; family 51; subfamily E; member 2,,PSGR,olfactory receptor family 51 subfamily E member 2,HPRAJ; OR51E3P; OR52A2; PSGR,OR51E2
Q9H257,CARD9_HUMAN,CARD9,Caspase recruitment domain-containing protein 9; hCARD9,,64170,caspase recruitment domain family member 9,caspase recruitment domain family; member 9,,,caspase recruitment domain family member 9,CANDF2; IMD103; hCARD9,CARD9
Q9H2B2,SYT4_HUMAN,SYT4; KIAA1342,Synaptotagmin-4; Synaptotagmin IV; SytIV,KIAA1342,6860,synaptotagmin 4,synaptotagmin IV,,KIAA1342; HsT1192,synaptotagmin 4,HsT1192,SYT4
Q9H2D6,TARA_HUMAN,TRIOBP; KIAA1662; TARA; HRIHFB2122,TRIO and F-actin-binding protein; Protein Tara; TRF1-associated protein of 68 kDa; Trio-associated repeat on actin,KIAA1662; TARA,11078,TRIO and F-actin binding protein,,,HRIHFB2122; KIAA1662; Tara; TAP68,TRIO and F-actin binding protein,DFNB28; HRIHFB2122; TAP68; TARA; dJ37E16.4,TRIOBP
Q9H2G2,SLK_HUMAN,SLK; KIAA0204; STK2,STE20-like serine/threonine-protein kinase; STE20-like kinase; hSLK; EC 2.7.11.1; CTCL tumor antigen se20-9; STE20-related serine/threonine-protein kinase; STE20-related kinase; Serine/threonine-protein kinase 2,KIAA0204; STK2,9748,STE20 like kinase,SNF1 (sucrose nonfermenting; yeast; homolog)-like kinase; SNF1 sucrose nonfermenting like kinase (yeast); STE20-like kinase (yeast); STE20-like kinase,,STK2; se20-9; KIAA0204,STE20 like kinase,LOSK; STK2; bA16H23.1; se20-9,SLK
Q9H2G4,TSYL2_HUMAN,TSPYL2; CDA1; DENTT; TSPX; HRIHFB2216,Testis-specific Y-encoded-like protein 2; TSPY-like protein 2; Cell division autoantigen 1; Cutaneous T-cell lymphoma-associated antigen se20-4; CTCL-associated antigen se20-4; Differentially-expressed nucleolar TGF-beta1 target protein; Nuclear protein of 79 kDa; NP79,CDA1; DENTT; TSPX,64061,TSPY like 2,,,SE20-4; HRIHFB2216; CTCL; DENTT; CDA1; CINAP; TSPX,TSPY like 2,CDA1; CINAP; CTCL; DENTT; HRIHFB2216; NP79; SE204; TSPX,TSPYL2
Q9H2K8,TAOK3_HUMAN,TAOK3; DPK; JIK; KDS; MAP3K18,Serine/threonine-protein kinase TAO3; EC 2.7.11.1; Cutaneous T-cell lymphoma-associated antigen HD-CL-09; CTCL-associated antigen HD-CL-09; Dendritic cell-derived protein kinase; JNK/SAPK-inhibitory kinase; Jun kinase-inhibitory kinase; Kinase from chicken homolog A; hKFC-A; Thousand and one amino acid protein 3,DPK; JIK; KDS; MAP3K18,51347,TAO kinase 3,,,JIK; DPK; MAP3K18,TAO kinase 3,DPK; JIK; MAP3K18; hKFC-A,TAOK3
Q9H2S1,KCNN2_HUMAN,KCNN2,Small conductance calcium-activated potassium channel protein 2; SK2; SKCa 2; SKCa2; KCa2.2,,3781,potassium calcium-activated channel subfamily N member 2,potassium intermediate/small conductance calcium-activated channel; subfamily N; member 2; potassium channel; calcium activated intermediate/small conductance subfamily N alpha; member 2,small conductance calcium-activated potassium channel 2,KCa2.2; hSK2,potassium calcium-activated channel subfamily N member 2,DYT34; KCa2.2; NEDMAB; SK2; SKCA2; SKCa 2; hSK2,KCNN2
Q9H2X6,HIPK2_HUMAN,HIPK2,Homeodomain-interacting protein kinase 2; hHIPk2; EC 2.7.11.1,,28996,homeodomain interacting protein kinase 2,homeodomain-interacting protein kinase 2,,,homeodomain interacting protein kinase 2,PRO0593,HIPK2
Q9H2X9,S12A5_HUMAN,SLC12A5; KCC2; KIAA1176,Solute carrier family 12 member 5; Electroneutral potassium-chloride cotransporter 2; K-Cl cotransporter 2; hKCC2; Neuronal K-Cl cotransporter,KCC2; KIAA1176,57468,solute carrier family 12 member 5,solute carrier family 12 (potassium/chloride transporter); member 5,K-Cl cotransporter 2,KIAA1176; KCC2; hKCC2,solute carrier family 12 member 5,DEE34; EIEE34; EIG14; KCC2; hKCC2,SLC12A5
Q9H329,E41LB_HUMAN,EPB41L4B; EHM2; LULU2,Band 4.1-like protein 4B; Erythrocyte membrane protein band 4.1-like 4B; FERM-containing protein CG1; Protein EHM2,EHM2; LULU2,54566,erythrocyte membrane protein band 4.1 like 4B,,,EHM2; LULU2,erythrocyte membrane protein band 4.1 like 4B,CG1; EHM2; LULU2,EPB41L4B
Q9H3D4,P63_HUMAN,TP63; KET; P63; P73H; P73L; TP73L,Tumor protein 63; p63; Chronic ulcerative stomatitis protein; CUSP; Keratinocyte transcription factor KET; Transformation-related protein 63; TP63; Tumor protein p73-like; p73L; p40; p51,KET; P63; P73H; P73L; TP73L,8626,tumor protein p63,tumor protein p73-like; tumor protein p53-like; tumor protein p53-competing protein,,p51; SHFM4; EEC3; p63; p73L; OFC8; KET; p73H; NBP; p53CP; p40,tumor protein p63,AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L,TP63
Q9H3M7,TXNIP_HUMAN,TXNIP; VDUP1,Thioredoxin-interacting protein; Thioredoxin-binding protein 2; Vitamin D3 up-regulated protein 1,VDUP1,10628,thioredoxin interacting protein,,upregulated by 1;25-dihydroxyvitamin D-3; thioredoxin binding protein 2,VDUP1; EST01027; HHCPA78; THIF; ARRDC6,thioredoxin interacting protein,ARRDC6; EST01027; HHCPA78; THIF; VDUP1,TXNIP
Q9H3P2,NELFA_HUMAN,NELFA; WHSC2; P/OKcl.15,Negative elongation factor A; NELF-A; Wolf-Hirschhorn syndrome candidate 2 protein,WHSC2,7469,negative elongation factor complex member A,Wolf-Hirschhorn syndrome candidate 2,,NELF-A,negative elongation factor complex member A,NELF-A; P/OKcl.15; WHSC2,NELFA
Q9H3S7,PTN23_HUMAN,PTPN23; KIAA1471,Tyrosine-protein phosphatase non-receptor type 23; EC 3.1.3.48; His domain-containing protein tyrosine phosphatase; HD-PTP; Protein tyrosine phosphatase TD14; PTP-TD14,KIAA1471,25930,protein tyrosine phosphatase non-receptor type 23,,,DKFZP564F0923; KIAA1471; HD-PTP,protein tyrosine phosphatase non-receptor type 23,HD-PTP; HDPTP; NEDBASS; PTP-TD14,PTPN23
Q9H3Y6,SRMS_HUMAN,SRMS; C20orf148,Tyrosine-protein kinase Srms; EC 2.7.10.2,C20orf148,6725,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,chromosome 20 open reading frame 148,,SRM; dJ697K14.1; PTK70,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,C20orf148; PTK70; SRM; dJ697K14.1,SRMS
Q9H3Z4,DNJC5_HUMAN,DNAJC5; CLN4,DnaJ homolog subfamily C member 5; Ceroid-lipofuscinosis neuronal protein 4; Cysteine string protein; CSP,CLN4,80331,DnaJ heat shock protein family (Hsp40) member C5,ceroid-lipofuscinosis; neuronal 4 (Kufs disease); DnaJ (Hsp40) homolog; subfamily C; member 5,,FLJ00118; FLJ13070; DNAJC5A,DnaJ heat shock protein family (Hsp40) member C5,CLN4; CLN4B; CSP; DNAJC5A; NCL; mir-941-2; mir-941-3; mir-941-4; mir-941-5,DNAJC5
Q9H410,DSN1_HUMAN,DSN1; C20orf172; MIS13,Kinetochore-associated protein DSN1 homolog,C20orf172; MIS13,79980,DSN1 component of MIS12 kinetochore complex,chromosome 20 open reading frame 172; DSN1; MIND kinetochore complex component; homolog (S. cerevisiae); DSN1 homolog; MIS12 kinetochore complex component,kinetochore null 3 homolog (C. elegans),dJ469A13.2; MIS13; KNL3; hKNL-3,DSN1 component of MIS12 kinetochore complex,C20orf172; KNL3; MIS13; dJ469A13.2; hKNL-3,DSN1
Q9H422,HIPK3_HUMAN,HIPK3; DYRK6; FIST3; PKY,Homeodomain-interacting protein kinase 3; EC 2.7.11.1; Androgen receptor-interacting nuclear protein kinase; ANPK; Fas-interacting serine/threonine-protein kinase; FIST; Homolog of protein kinase YAK1,DYRK6; FIST3; PKY,10114,homeodomain interacting protein kinase 3,homeodomain-interacting protein kinase 3,,PKY; DYRK6; YAK1; FIST3,homeodomain interacting protein kinase 3,DYRK6; FIST3; PKY; YAK1,HIPK3
Q9H461,FZD8_HUMAN,FZD8,Frizzled-8; Fz-8; hFz8,,8325,frizzled class receptor 8,frizzled (Drosophila) homolog 8; frizzled homolog 8 (Drosophila); frizzled 8; seven transmembrane spanning receptor; frizzled family receptor 8,Frizzled-8,FZ-8,frizzled class receptor 8,FZ-8; hFZ8,FZD8
Q9H467,CUED2_HUMAN,CUEDC2; C10orf66; HOYS6,CUE domain-containing protein 2,C10orf66,79004,CUE domain containing 2,chromosome 10 open reading frame 66,,MGC2491,CUE domain containing 2,C10orf66; bA18I14.5,CUEDC2
Q9H492,MLP3A_HUMAN,MAP1LC3A,Microtubule-associated protein 1 light chain 3 alpha; Autophagy-related protein LC3 A; Autophagy-related ubiquitin-like modifier LC3 A; MAP1 light chain 3-like protein 1; Microtubule-associated proteins 1A/1B light chain 3A; MAP1A/MAP1B LC3 A; MAP1A/MAP1B light chain 3 A,,84557,microtubule associated protein 1 light chain 3 alpha,,,MAP1BLC3; MAP1ALC3; LC3; LC3A; ATG8E,microtubule associated protein 1 light chain 3 alpha,ATG8E; LC3; LC3A; MAP1ALC3; MAP1BLC3,MAP1LC3A
Q9H4A3,WNK1_HUMAN,WNK1; HSN2; KDP; KIAA0344; PRKWNK1,Serine/threonine-protein kinase WNK1; EC 2.7.11.1; Erythrocyte 65 kDa protein; p65; Kinase deficient protein; Protein kinase lysine-deficient 1; Protein kinase with no lysine 1; hWNK1,HSN2; KDP; KIAA0344; PRKWNK1,65125,WNK lysine deficient protein kinase 1,protein kinase; lysine deficient 1; hereditary sensory neuropathy; type II,protein phosphatase 1; regulatory subunit 167,HSAN2; PPP1R167,WNK lysine deficient protein kinase 1,HSAN2; HSN2; KDP; PPP1R167; PRKWNK1; PSK; p65,WNK1
Q9H4A6,GOLP3_HUMAN,GOLPH3; GPP34,Golgi phosphoprotein 3; Coat protein GPP34; Mitochondrial DNA absence factor; MIDAS,GPP34,64083,golgi phosphoprotein 3,golgi phosphoprotein 3 (coat-protein),golgi peripheral membrane protein 1; 34 kDa; golgi protein; coat-protein; golgi-associated protein,GPP34; GOPP1; MIDAS; Vps74,golgi phosphoprotein 3,GOPP1; GPP34; MIDAS; Vps74,GOLPH3
Q9H4B4,PLK3_HUMAN,PLK3; CNK; FNK; PRK,Serine/threonine-protein kinase PLK3; EC 2.7.11.21; Cytokine-inducible serine/threonine-protein kinase; FGF-inducible kinase; Polo-like kinase 3; PLK-3; Proliferation-related kinase,CNK; FNK; PRK,1263,polo like kinase 3,cytokine-inducible kinase; polo-like kinase 3 (Drosophila); polo-like kinase 3,,FNK; PRK,polo like kinase 3,CNK; FNK; PLK-3; PRK,PLK3
Q9H4B6,SAV1_HUMAN,SAV1; WW45,Protein salvador homolog 1; 45 kDa WW domain protein; hWW45,WW45,60485,salvador family WW domain containing protein 1,salvador homolog 1 (Drosophila),WW domain-containing adaptor 45,WW45; WWP4; salvador,salvador family WW domain containing protein 1,SAV; WW45; WWP4,SAV1
Q9H4E7,DEFI6_HUMAN,DEF6; IBP,Differentially expressed in FDCP 6 homolog; DEF-6; IRF4-binding protein,IBP,50619,DEF6 guanine nucleotide exchange factor,differentially expressed in FDCP (mouse homolog) 6; differentially expressed in FDCP 6 homolog (mouse),SWAP-70-like adaptor protein of T cells,IBP; SLAT; SWAP70L,DEF6 guanine nucleotide exchange factor,IBP; IMD87; SLAT; SWAP70L,DEF6
Q9H4P4,RNF41_HUMAN,RNF41; FLRF; NRDP1; SBBI03,E3 ubiquitin-protein ligase NRDP1; EC 2.3.2.27; RING finger protein 41; RING-type E3 ubiquitin transferase NRDP1,FLRF; NRDP1,10193,ring finger protein 41,ring finger protein 41; E3 ubiquitin protein ligase,,SBBI03; NRDP1,ring finger protein 41,FLRF; NRDP1; SBBI03,RNF41
Q9H4X1,RGCC_HUMAN,RGCC; C13orf15; RGC32,Regulator of cell cycle RGCC; Response gene to complement 32 protein; RGC-32,C13orf15; RGC32,28984,regulator of cell cycle,chromosome 13 open reading frame 15,response gene to complement 32,bA157L14.2; RGC-32; RGC32,regulator of cell cycle,C13orf15; RGC-32; RGC32; bA157L14.2,RGCC
Q9H5H4,ZN768_HUMAN,ZNF768,Zinc finger protein 768,,79724,zinc finger protein 768,,,FLJ23436,zinc finger protein 768,,ZNF768
Q9H5V8,CDCP1_HUMAN,CDCP1; TRASK; UNQ2486/PRO5773,CUB domain-containing protein 1; Membrane glycoprotein gp140; Subtractive immunization M plus HEp3-associated 135 kDa protein; SIMA135; Transmembrane and associated with src kinases; CD antigen CD318,TRASK,64866,CUB domain containing protein 1,,,CD318; SIMA135,CUB domain containing protein 1,CD318; SIMA135; TRASK,CDCP1
Q9H6E5,STPAP_HUMAN,TUT1; RBM21,Speckle targeted PIP5K1A-regulated poly(A) polymerase; A; Star-PAP; EC 2.7.7.19; RNA-binding motif protein 21; RNA-binding protein 21; U6 snRNA-specific terminal uridylyltransferase 1; U6-TUTase; EC 2.7.7.52,RBM21,64852,terminal uridylyl transferase 1; U6 snRNA-specific,RNA binding motif protein 21,RNA uridylyltransferase; U6 TUTase; TUTase 6,FLJ22347; FLJ22267; FLJ21850; PAPD2; TUTase; TENT1,terminal uridylyl transferase 1; U6 snRNA-specific,PAPD2; RBM21; STARPAP; TENT1; TUTase; URLC6,TUT1
Q9H6K1,ILRUN_HUMAN,ILRUN; C6orf106,Protein ILRUN; Inflammation and lipid regulator with UBA-like and NBR1-like domains protein,C6orf106,64771,inflammation and lipid regulator with UBA-like and NBR1-like domains,chromosome 6 open reading frame 106,,FLJ22195; dJ391O22.4,inflammation and lipid regulator with UBA-like and NBR1-like domains,C6orf106; FP852; dJ391O22.4,ILRUN
Q9H6Z4,RANB3_HUMAN,RANBP3,Ran-binding protein 3; RanBP3,,8498,RAN binding protein 3,,,,RAN binding protein 3,,RANBP3
Q9H788,SH24A_HUMAN,SH2D4A; PPP1R38; SH2A,SH2 domain-containing protein 4A; Protein SH(2; Protein phosphatase 1 regulatory subunit 38,PPP1R38; SH2A,63898,SH2 domain containing 4A,,protein phosphatase 1; regulatory subunit 38,FLJ20967; SH2A; PPP1R38,SH2 domain containing 4A,PPP1R38; SH2A,SH2D4A
Q9H792,PEAK1_HUMAN,PEAK1; KIAA2002,Inactive tyrosine-protein kinase PEAK1; Pseudopodium-enriched atypical kinase 1; Sugen kinase 269; Tyrosine-protein kinase SgK269,KIAA2002,79834,pseudopodium enriched atypical kinase 1,,,KIAA2002; sgk269,pseudopodium enriched atypical kinase 1,SGK269,PEAK1
Q9H7P9,PKHG2_HUMAN,PLEKHG2,Pleckstrin homology domain-containing family G member 2; PH domain-containing family G member 2,,64857,pleckstrin homology and RhoGEF domain containing G2,pleckstrin homology domain containing; family G (with RhoGef domain) member 2,,CLG; FLJ00018; ARHGEF42,pleckstrin homology and RhoGEF domain containing G2,ARHGEF42; CLG; CTB-60E11.4; LDAMD,PLEKHG2
Q9H8M2,BRD9_HUMAN,BRD9; UNQ3040/PRO9856,Bromodomain-containing protein 9; Rhabdomyosarcoma antigen MU-RMS-40.8,,65980,bromodomain containing 9,,,FLJ13441; SMARCI2,bromodomain containing 9,LAVS3040; PRO9856; SMARCI2,BRD9
Q9H8N7,ZN395_HUMAN,ZNF395; HDBP2; PBF,Zinc finger protein 395; HD-regulating factor 2; HDRF-2; Huntington disease gene regulatory region-binding protein 2; HD gene regulatory region-binding protein 2; HDBP-2; Papillomavirus regulatory factor 1; PRF-1; Papillomavirus-binding factor,HDBP2; PBF,55893,zinc finger protein 395,,,PRF-1; HDBP2; PBF; DKFZp434K1210,zinc finger protein 395,HDBP-2; HDBP2; HDRF-2; PBF; PRF-1; PRF1; Si-1-8-14,ZNF395
Q9H8S9,MOB1A_HUMAN,MOB1A; C2orf6; MOB4B; MOBK1B; MOBKL1B,MOB kinase activator 1A; Mob1 alpha; Mob1A; Mob1 homolog 1B; Mps one binder kinase activator-like 1B,C2orf6; MOB4B; MOBK1B; MOBKL1B,55233,MOB kinase activator 1A,chromosome 2 open reading frame 6; MOB1; Mps One Binder kinase activator-like 1B (yeast); MOB1 Mps One Binder homolog A (yeast),,FLJ10788; MOB1; FLJ11595; Mob4B; Mats1,MOB kinase activator 1A,C2orf6; MABKL1B; MATS1; MOB1; MOBK1B; MOBKL1B; Mob4B,MOB1A
Q9H8V3,ECT2_HUMAN,ECT2,Protein ECT2; Epithelial cell-transforming sequence 2 oncogene,,1894,epithelial cell transforming 2,epithelial cell transforming sequence 2 oncogene,,ARHGEF31,epithelial cell transforming 2,ARHGEF31,ECT2
Q9H8Y8,GORS2_HUMAN,GORASP2; GOLPH6,Golgi reassembly-stacking protein 2; GRS2; Golgi phosphoprotein 6; GOLPH6; Golgi reassembly-stacking protein of 55 kDa; GRASP55; p59,GOLPH6,26003,golgi reassembly stacking protein 2,golgi reassembly stacking protein 2; 55 kDa; golgi reassembly stacking protein 2; 55kDa,,GRASP55; GRS2; GOLPH6,golgi reassembly stacking protein 2,GOLPH6; GRASP55; GRS2; p59,GORASP2
Q9H910,JUPI2_HUMAN,JPT2; C16orf34; HN1L; L11,Jupiter microtubule associated homolog 2; Hematological and neurological expressed 1-like protein; HN1-like protein,C16orf34; HN1L,90861,Jupiter microtubule associated homolog 2,chromosome 16 open reading frame 34; hematological and neurological expressed 1-like; hematological and neurological expressed 1 like,,FLJ13092; L11; KIAA1426,Jupiter microtubule associated homolog 2,C16orf34; HN1L; L11,JPT2
Q9H9Q4,NHEJ1_HUMAN,NHEJ1; XLF,Non-homologous end-joining factor 1; Protein cernunnos; XRCC4-like factor,XLF,79840,non-homologous end joining factor 1,nonhomologous end-joining factor 1,XRCC4-like factor,Cernunnos; XLF; FLJ12610,non-homologous end joining factor 1,IMD124; MCOPCB13; XLF,NHEJ1
Q9H9S0,NANOG_HUMAN,NANOG,Homeobox protein NANOG; Homeobox transcription factor Nanog; hNanog,,79923,Nanog homeobox,,,FLJ12581; FLJ40451,Nanog homeobox,,NANOG
Q9HA82,CERS4_HUMAN,CERS4; LASS4,Ceramide synthase 4; CerS4; EC 2.3.1.-; LAG1 longevity assurance homolog 4; Sphingosine N-acyltransferase CERS4; EC 2.3.1.24,LASS4,79603,ceramide synthase 4,LAG1 longevity assurance homolog 4 (S. cerevisiae); LAG1 homolog; ceramide synthase 4,,FLJ12089; Trh1,ceramide synthase 4,LASS4; Trh1,CERS4
Q9HAN9,NMNA1_HUMAN,NMNAT1; NMNAT,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1; NMN/NaMN adenylyltransferase 1; EC 2.7.7.1; EC 2.7.7.18; Nicotinamide-nucleotide adenylyltransferase 1; NMN adenylyltransferase 1; Nicotinate-nucleotide adenylyltransferase 1; NaMN adenylyltransferase 1,NMNAT,64802,nicotinamide nucleotide adenylyltransferase 1,nicotinamide nucleotide adenylyltransferase; Leber congenital amaurosis 9; Leber's congenital amaurosis 9,nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,NMNAT; PNAT1,nicotinamide nucleotide adenylyltransferase 1,LCA9; NMNAT; PNAT1; SHILCA,NMNAT1
Q9HAP2,MLXIP_HUMAN,MLXIP; BHLHE36; KIAA0867; MIR; MONDOA,MLX-interacting protein; Class E basic helix-loop-helix protein 36; bHLHe36; Transcriptional activator MondoA,BHLHE36; KIAA0867; MIR; MONDOA,22877,MLX interacting protein,,,MONDOA; KIAA0867; MIR; bHLHe36,MLX interacting protein,MIR; MONDOA; bHLHe36,MLXIP
Q9HAT8,PELI2_HUMAN,PELI2,E3 ubiquitin-protein ligase pellino homolog 2; Pellino-2; EC 2.3.2.27; RING-type E3 ubiquitin transferase pellino homolog 2,,57161,pellino E3 ubiquitin protein ligase family member 2,pellino (Drosophila) homolog 2; pellino homolog 2 (Drosophila),,,pellino E3 ubiquitin protein ligase family member 2,,PELI2
Q9HAV0,GBB4_HUMAN,GNB4,Guanine nucleotide-binding protein subunit beta-4; Transducin beta chain 4,,59345,G protein subunit beta 4,guanine nucleotide binding protein (G protein); beta polypeptide 4,transducin beta chain 4; Guanine nucleotide-binding protein subunit beta-4,,G protein subunit beta 4,CMTD1F; HG2B,GNB4
Q9HAW4,CLSPN_HUMAN,CLSPN,Claspin; hClaspin,,63967,claspin,claspin homolog (Xenopus laevis),,,claspin,,CLSPN
Q9HAW7,UD17_HUMAN,UGT1A7; GNT1; UGT1,UDP-glucuronosyltransferase 1A7; UGT1A7; EC 2.4.1.17; UDP-glucuronosyltransferase 1-7; UDPGT 1-7; UGT1*7; UGT1-07; UGT1.7; UDP-glucuronosyltransferase 1-G; UGT-1G; UGT1G,GNT1; UGT1,54577,UDP glucuronosyltransferase family 1 member A7,UDP glycosyltransferase 1 family; polypeptide A7,,UGT1G,UDP glucuronosyltransferase family 1 member A7,GNT1; UDPGT; UDPGT 1-7; UGT-1A; UGT-1G; UGT1; UGT1-01; UGT1-07; UGT1.1; UGT1.7; UGT1A; UGT1A1; UGT1G; hUG-BR1,UGT1A7
Q9HAZ1,CLK4_HUMAN,CLK4,Dual specificity protein kinase CLK4; EC 2.7.12.1; CDC-like kinase 4,,57396,CDC like kinase 4,CDC-like kinase 4,,,CDC like kinase 4,,CLK4
Q9HB96,FANCE_HUMAN,FANCE; FACE,Fanconi anemia group E protein; Protein FACE,FACE,2178,FA complementation group E,Fanconi anemia complementation group E,,FAE,FA complementation group E,FACE; FAE,FANCE
Q9HBA0,TRPV4_HUMAN,TRPV4; VRL2; VROAC,Transient receptor potential cation channel subfamily V member 4; TrpV4; Osm-9-like TRP channel 4; OTRPC4; Transient receptor potential protein 12; TRP12; Vanilloid receptor-like channel 2; Vanilloid receptor-like protein 2; VRL-2; Vanilloid receptor-related osmotically-activated channel; VR-OAC,VRL2; VROAC,59341,transient receptor potential cation channel subfamily V member 4,transient receptor potential cation channel; subfamily V; member 4,osmosensitive transient receptor potential channel 4,OTRPC4; TRP12; VROAC; VRL-2; VR-OAC; CMT2C,transient receptor potential cation channel subfamily V member 4,BCYM3; CMT2C; HMSN2C; OTRPC4; SMAL; SPSMA; SSQTL1; TRP12; VRL2; VROAC,TRPV4
Q9HBH9,MKNK2_HUMAN,MKNK2; GPRK7; MNK2,MAP kinase-interacting serine/threonine-protein kinase 2; EC 2.7.11.1; MAP kinase signal-integrating kinase 2; MAPK signal-integrating kinase 2; Mnk2,GPRK7; MNK2,2872,MAPK interacting serine/threonine kinase 2,G protein-coupled receptor kinase 7; MAP kinase interacting serine/threonine kinase 2,Putative map kinase interacting kinase,MNK2,MAPK interacting serine/threonine kinase 2,GPRK7; MNK2,MKNK2
Q9HBY8,SGK2_HUMAN,SGK2,Serine/threonine-protein kinase Sgk2; EC 2.7.11.1; Serum/glucocorticoid-regulated kinase 2,,10110,serum/glucocorticoid regulated kinase 2,serum/glucocorticoid regulated kinase 2; SGK2; serine/threonine kinase 2,,,serum/glucocorticoid regulated kinase 2,H-SGK2; dJ138B7.2,SGK2
Q9HC16,ABC3G_HUMAN,APOBEC3G; MDS019,DNA dC->dU-editing enzyme APOBEC-3G; EC 3.5.4.38; APOBEC-related cytidine deaminase; APOBEC-related protein; ARCD; APOBEC-related protein 9; ARP-9; CEM-15; CEM15; Deoxycytidine deaminase; A3G,,60489,apolipoprotein B mRNA editing enzyme catalytic subunit 3G,apolipoprotein B mRNA editing enzyme; catalytic polypeptide-like 3G,DNA dC->dU-editing enzyme APOBEC-3G,CEM15; MDS019; dJ494G10.1; FLJ12740; bK150C2.7,apolipoprotein B mRNA editing enzyme catalytic subunit 3G,A3G; ARCD; ARP-9; ARP9; CEM-15; CEM15; MDS019; bK150C2.7; dJ494G10.1,APOBEC3G
Q9HC62,SENP2_HUMAN,SENP2; KIAA1331,Sentrin-specific protease 2; EC 3.4.22.-; Axam2; SMT3-specific isopeptidase 2; Smt3ip2; Sentrin/SUMO-specific protease SENP2,KIAA1331,59343,SUMO specific peptidase 2,SUMO1/sentrin/SMT3 specific protease 2; SUMO1/sentrin/SMT3 specific peptidase 2; sentrin (SUMO1) specific peptidase 2,,SMT3IP2; KIAA1331; DKFZp762A2316; AXAM2,SUMO specific peptidase 2,AXAM2; SMT3IP2,SENP2
Q9HC77,CPAP_HUMAN,CPAP; CENPJ; LAP; LIP1,Centrosomal P4.1-associated protein; Centromere protein J; CENP-J; Centrosome assembly and centriole elongation protein; LAG-3-associated protein; LYST-interacting protein 1,CENPJ; LAP; LIP1,55835,centrosome assembly and centriole elongation protein,centromere protein J; microcephaly; primary autosomal recessive 6,centrosomal P4.1-associated protein; Seckel syndrome 4; Spindle assembly abnormal 4; LAG-3-associated protein,LAP; LIP1; BM032; SASS4; SCKL4; Sas-4,centrosome assembly and centriole elongation protein,BM032; CENP-J; CENPJ; LAP; LIP1; MCPH6; SASS4; SCKL4; Sas-4,CPAP
Q9HC98,NEK6_HUMAN,NEK6,Serine/threonine-protein kinase Nek6; EC 2.7.11.34; Never in mitosis A-related kinase 6; NimA-related protein kinase 6; Protein kinase SID6-1512,,10783,NIMA related kinase 6,NIMA (never in mitosis gene a)-related kinase 6,putative serine-threonine protein kinase,SID6-1512,NIMA related kinase 6,SID6-1512,NEK6
Q9HCH0,NCK5L_HUMAN,NCKAP5L; CEP169; KIAA1602; FP1193,Nck-associated protein 5-like; NCKAP5-like; Centrosomal protein of 169 kDa; Cep169,CEP169; KIAA1602,57701,NCK associated protein 5 like,KIAA1602,,,NCK associated protein 5 like,Cep169; FP1193; KIAA1602,NCKAP5L
Q9HCJ2,LRC4C_HUMAN,LRRC4C; KIAA1580; NGL1; UNQ292/PRO331,Leucine-rich repeat-containing protein 4C; Netrin-G1 ligand; NGL-1,KIAA1580; NGL1,57689,leucine rich repeat containing 4C,,netrin-G ligand-1,KIAA1580; NGL-1,leucine rich repeat containing 4C,NGL-1; NGL1,LRRC4C
Q9HCK4,ROBO2_HUMAN,ROBO2; KIAA1568,Roundabout homolog 2,KIAA1568,6092,roundabout guidance receptor 2,roundabout (axon guidance receptor; Drosophila) homolog 2; roundabout; axon guidance receptor; homolog 2 (Drosophila),,KIAA1568,roundabout guidance receptor 2,SAX3,ROBO2
Q9HCM2,PLXA4_HUMAN,PLXNA4; KIAA1550; PLXNA4A; PLXNA4B; UNQ2820/PRO34003,Plexin-A4,KIAA1550; PLXNA4A; PLXNA4B,91584,plexin A4,plexin A4; A; plexin A4; B,,KIAA1550; DKFZp434G0625PRO34003; FAYV2820,plexin A4,FAYV2820; PLEXA4; PLXNA4A; PLXNA4B; PRO34003,PLXNA4
Q9HCP0,KC1G1_HUMAN,CSNK1G1,Casein kinase I isoform gamma-1; CKI-gamma 1; EC 2.7.11.1,,53944,casein kinase 1 gamma 1,casein kinase 1; gamma 1,,CK1gamma1,casein kinase 1 gamma 1,CK1gamma1,CSNK1G1
Q9HCR9,PDE11_HUMAN,PDE11A,Dual 3';5'-cyclic-AMP and -GMP phosphodiesterase 11A; EC 3.1.4.35; EC 3.1.4.53; cAMP and cGMP phosphodiesterase 11A,,50940,phosphodiesterase 11A,,Dual 3';5'-cyclic-AMP and -GMP phosphodiesterase 11A,,phosphodiesterase 11A,PPNAD2,PDE11A
Q9HCS4,TF7L1_HUMAN,TCF7L1; TCF3,Transcription factor 7-like 1; HMG box transcription factor 3; TCF-3,TCF3,83439,transcription factor 7 like 1,transcription factor 7-like 1 (T-cell specific; HMG-box),,,transcription factor 7 like 1,TCF-3; TCF3,TCF7L1
Q9HCU9,BRMS1_HUMAN,BRMS1,Breast cancer metastasis-suppressor 1,,25855,BRMS1 transcriptional repressor and anoikis regulator,breast cancer metastasis suppressor 1,,DKFZP564A063,BRMS1 transcriptional repressor and anoikis regulator,,BRMS1
Q9HCX4,TRPC7_HUMAN,TRPC7; TRP7,Short transient receptor potential channel 7; TrpC7; Transient receptor protein 7; TRP-7; hTRP7,TRP7,57113,transient receptor potential cation channel subfamily C member 7,transient receptor potential cation channel; subfamily C; member 7,,,transient receptor potential cation channel subfamily C member 7,TRP7,TRPC7
Q9HD43,PTPRH_HUMAN,PTPRH; SAP1,Receptor-type tyrosine-protein phosphatase H; R-PTP-H; EC 3.1.3.48; Stomach cancer-associated protein tyrosine phosphatase 1; SAP-1; Transmembrane-type protein-tyrosine phosphatase type H,SAP1,5794,protein tyrosine phosphatase receptor type H,,,SAP-1,protein tyrosine phosphatase receptor type H,R-PTP-H; SAP1,PTPRH
Q9NP31,SH22A_HUMAN,SH2D2A; SCAP; TSAD; VRAP,SH2 domain-containing protein 2A; SH2 domain-containing adapter protein; T cell-specific adapter protein; TSAd; VEGF receptor-associated protein,SCAP; TSAD; VRAP,9047,SH2 domain containing 2A,SH2 domain protein 2A,T lymphocyte specific adaptor protein; T cell specific adapter protein TSAd; T cell specific adpater protein TSAd,TSAd; F2771,SH2 domain containing 2A,F2771; SCAP; TSAD; VRAP,SH2D2A
Q9NP62,GCM1_HUMAN,GCM1; GCMA,Chorion-specific transcription factor GCMa; hGCMa; GCM motif protein 1; Glial cells missing homolog 1,GCMA,8521,glial cells missing transcription factor 1,glial cells missing (Drosophila) homolog a; glial cells missing homolog 1 (Drosophila),,hGCMa,glial cells missing transcription factor 1,GCMA; hGCMa,GCM1
Q9NP71,MLXPL_HUMAN,MLXIPL; BHLHD14; MIO; WBSCR14,Carbohydrate-responsive element-binding protein; ChREBP; Class D basic helix-loop-helix protein 14; bHLHd14; MLX interactor; MLX-interacting protein-like; WS basic-helix-loop-helix leucine zipper protein; WS-bHLH; Williams-Beuren syndrome chromosomal region 14 protein,BHLHD14; MIO; WBSCR14,51085,MLX interacting protein like,Williams Beuren syndrome chromosome region 14; MLX interacting protein-like,carbohydrate response element binding protein,WS-bHLH; MIO; CHREBP; MONDOB; bHLHd14,MLX interacting protein like,CHREBP; MIO; MLX; MONDOB; WBSCR14; WS-bHLH; bHLHd14,MLXIPL
Q9NP77,SSU72_HUMAN,SSU72; HSPC182; PNAS-120,RNA polymerase II subunit A C-terminal domain phosphatase SSU72; CTD phosphatase SSU72; EC 3.1.3.16,,29101,SSU72 homolog; RNA polymerase II CTD phosphatase,Ssu72 RNA polymerase II CTD phosphatase homolog (yeast); SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),,HSPC182,SSU72 homolog; RNA polymerase II CTD phosphatase,HSPC182; PNAS-120,SSU72
Q9NP80,PLPL8_HUMAN,PNPLA8; IPLA22; IPLA2G; BM-043,Calcium-independent phospholipase A2-gamma; EC 3.1.1.-; EC 3.1.1.5; Intracellular membrane-associated calcium-independent phospholipase A2 gamma; iPLA2-gamma; PNPLA-gamma; Patatin-like phospholipase domain-containing protein 8; iPLA2-2,IPLA22; IPLA2G,50640,patatin like domain 8; phospholipase A2,patatin like phospholipase domain containing 8; patatin-like phospholipase domain containing 8,calcium-independent phospholipase A2-gamma,IPLA2G; IPLA2-2; iPLA2gamma,patatin like domain 8; phospholipase A2,IPLA2-2; IPLA2G; MMLA; PNPLA-gamma; iPLA2gamma,PNPLA8
Q9NP87,DPOLM_HUMAN,POLM; polmu,DNA-directed DNA/RNA polymerase mu; Pol Mu; EC 2.7.7.7; Terminal transferase,polmu,27434,DNA polymerase mu,polymerase (DNA directed); mu; polymerase (DNA) mu,Pol iota,Tdt-N,DNA polymerase mu,Pol Mu; Tdt-N,POLM
Q9NP97,DLRB1_HUMAN,DYNLRB1; BITH; DNCL2A; DNLC2A; ROBLD1; HSPC162,Dynein light chain roadblock-type 1; Bithoraxoid-like protein; BLP; Dynein light chain 2A; cytoplasmic; Dynein-associated protein Km23; Roadblock domain-containing protein 1,BITH; DNCL2A; DNLC2A; ROBLD1,83658,dynein light chain roadblock-type 1,dynein; cytoplasmic; light polypeptide 2A,roadblock domain containing 1,DNLC2A; ROBLD1,dynein light chain roadblock-type 1,BITH; BLP; DNCL2A; DNLC2A; ROBLD1,DYNLRB1
Q9NPA1,KCMB3_HUMAN,KCNMB3; KCNMB2; KCNMBL,Calcium-activated potassium channel subunit beta-3; BK channel subunit beta-3; BKbeta3; Hbeta3; Calcium-activated potassium channel; subfamily M subunit beta-3; Charybdotoxin receptor subunit beta-3; K(VCA; Maxi K channel subunit beta-3; Slo-beta-3,KCNMB2; KCNMBL,27094,potassium calcium-activated channel subfamily M regulatory beta subunit 3,potassium large conductance calcium-activated channel; subfamily M beta member 3; potassium channel subfamily M regulatory beta subunit 3,BK channel beta subunit 3; MaxiK channel beta-subunit 3; big potassium channel beta subunit 3,,potassium calcium-activated channel subfamily M regulatory beta subunit 3,BKBETA3; HBETA3; K(VCA)BETA-3; KCNMB2; KCNMBL; SLO-BETA-3; SLOBETA3,KCNMB3
Q9NPB6,PAR6A_HUMAN,PARD6A; PAR6A,Partitioning defective 6 homolog alpha; PAR-6; PAR-6 alpha; PAR-6A; PAR6C; Tax interaction protein 40; TIP-40,PAR6A,50855,par-6 family cell polarity regulator alpha,par-6 (partitioning defective 6; C.elegans) homolog alpha; par-6 partitioning defective 6 homolog alpha (C. elegans),,PAR-6; PAR-6A; TAX40; PAR6alpha; TIP-40,par-6 family cell polarity regulator alpha,PAR-6A; PAR6; PAR6C; PAR6alpha; TAX40; TIP-40,PARD6A
Q9NPC1,LT4R2_HUMAN,LTB4R2; BLT2R; BLTR2,Leukotriene B4 receptor 2; LTB4-R 2; LTB4-R2; LTB4 receptor JULF2; Leukotriene B4 receptor BLT2; Seven transmembrane receptor BLTR2,BLT2R; BLTR2,56413,leukotriene B4 receptor 2,,,BLTR2; BLT2; JULF2; NOP9,leukotriene B4 receptor 2,BLT2; BLTR2; JULF2; KPG_004; LTB4-R 2; LTB4-R2; NOP9,LTB4R2
Q9NPC2,KCNK9_HUMAN,KCNK9; TASK3,Potassium channel subfamily K member 9; Acid-sensitive potassium channel protein TASK-3; TWIK-related acid-sensitive K(+; Two pore potassium channel KT3.2; Two pore K(+,TASK3,51305,potassium two pore domain channel subfamily K member 9,potassium channel; subfamily K; member 9; potassium channel; two pore domain subfamily K; member 9,TWIK-related acid-sensitive K+ 3,K2p9.1; TASK3; TASK-3,potassium two pore domain channel subfamily K member 9,BIBARS; K2p9.1; KT3.2; TASK-3; TASK3; TASK32,KCNK9
Q9NPG1,FZD3_HUMAN,FZD3,Frizzled-3; Fz-3; hFz3,,7976,frizzled class receptor 3,frizzled (Drosophila) homolog 3; frizzled homolog 3 (Drosophila); frizzled 3; seven transmembrane spanning receptor; frizzled family receptor 3,Frizzled-3,Fz-3,frizzled class receptor 3,Fz-3,FZD3
Q9NPH5,NOX4_HUMAN,NOX4; RENOX,NADPH oxidase 4; EC 1.6.3.1; Kidney oxidase-1; KOX-1; Kidney superoxide-producing NADPH oxidase; Renal NAD(P,RENOX,50507,NADPH oxidase 4,,,KOX-1; KOX,NADPH oxidase 4,KOX; KOX-1; RENOX,NOX4
Q9NPI6,DCP1A_HUMAN,DCP1A; SMIF,mRNA-decapping enzyme 1A; EC 3.6.1.62; Smad4-interacting transcriptional co-activator; Transcription factor SMIF,SMIF,55802,decapping mRNA 1A,DCP1 decapping enzyme homolog A (S. cerevisiae),,HSA275986; SMIF; SMAD4IP1,decapping mRNA 1A,HSA275986; Nbla00360; SMAD4IP1; SMIF,DCP1A
Q9NPP4,NLRC4_HUMAN,NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215,NLR family CARD domain-containing protein 4; CARD; LRR; and NACHT-containing protein; CED-4-like protein Clan; Caspase recruitment domain-containing protein 12; Ice protease-activating factor; Ipaf,CARD12; CLAN; CLAN1; IPAF,58484,NLR family CARD domain containing 4,caspase recruitment domain family; member 12,nucleotide-binding oligomerization domain; leucine rich repeat and CARD domain containing 4; NOD-like receptor C4,CLAN1; ipaf; CLANA; CLANB; CLANC; CLAND; CLR2.1; CLAN,NLR family CARD domain containing 4,AIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; FCAS4; IPAF,NLRC4
Q9NPY3,C1QR1_HUMAN,CD93; C1QR1; MXRA4,Complement component C1q receptor; C1q/MBL/SPA receptor; C1qR; C1qR(p; C1qRp; CDw93; Complement component 1 q subcomponent receptor 1; Matrix-remodeling-associated protein 4; CD antigen CD93,C1QR1; MXRA4,22918,CD93 molecule,matrix-remodelling associated 4; complement component 1; q subcomponent; receptor 1; CD93 antigen,,C1qRP; C1qR(P); dJ737E23.1; CDw93; ECSM3,CD93 molecule,C1QR1; C1qR(P); C1qRP; CDw93; ECSM3; MXRA4; dJ737E23.1,CD93
Q9NQ66,PLCB1_HUMAN,PLCB1; KIAA0581,1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-1; EC 3.1.4.11; PLC-154; Phosphoinositide phospholipase C-beta-1; Phospholipase C-I; PLC-I; Phospholipase C-beta-1; PLC-beta-1,KIAA0581,23236,phospholipase C beta 1,phospholipase C; beta 1 (phosphoinositide-specific),phosphoinositide phospholipase C,KIAA0581; PLC-I; PLC154,phospholipase C beta 1,DEE12; EIEE12; PI-PLC; PLC-154; PLC-I; PLC-beta-1; PLC154; PLCB1A; PLCB1B,PLCB1
Q9NQA5,TRPV5_HUMAN,TRPV5; ECAC1,Transient receptor potential cation channel subfamily V member 5; TrpV5; Calcium transport protein 2; CaT2; Epithelial calcium channel 1; ECaC; ECaC1; Osm-9-like TRP channel 3; OTRPC3,ECAC1,56302,transient receptor potential cation channel subfamily V member 5,epithelial calcium channel 1; transient receptor potential cation channel; subfamily V; member 5,,CaT2,transient receptor potential cation channel subfamily V member 5,CAT2; ECAC1; OTRPC3,TRPV5
Q9NQB0,TF7L2_HUMAN,TCF7L2; TCF4,Transcription factor 7-like 2; HMG box transcription factor 4; T-cell-specific transcription factor 4; T-cell factor 4; TCF-4; hTCF-4,TCF4,6934,transcription factor 7 like 2,transcription factor 7-like 2 (T-cell specific; HMG-box),,TCF-4,transcription factor 7 like 2,TCF-4; TCF4,TCF7L2
Q9NQC3,RTN4_HUMAN,RTN4; KIAA0886; NOGO; My043; SP1507,Reticulon-4; Foocen; Neurite outgrowth inhibitor; Nogo protein; Neuroendocrine-specific protein; NSP; Neuroendocrine-specific protein C homolog; RTN-x; Reticulon-5,KIAA0886; NOGO,57142,reticulon 4,,,NSP-CL; KIAA0886; NOGO; ASY,reticulon 4,ASY; NI220/250; NOGO; NSP; NSP-CL; Nbla00271; Nbla10545; RTN-X; RTN4-A; RTN4-B1; RTN4-B2; RTN4-C,RTN4
Q9NQC7,CYLD_HUMAN,CYLD; CYLD1; KIAA0849; HSPC057,Ubiquitin carboxyl-terminal hydrolase CYLD; EC 3.4.19.12; Deubiquitinating enzyme CYLD; Ubiquitin thioesterase CYLD; Ubiquitin-specific-processing protease CYLD,CYLD1; KIAA0849,1540,CYLD lysine 63 deubiquitinase,cylindromatosis (turban tumor syndrome),ubiquitin specific peptidase like 2,KIAA0849; USPL2,CYLD lysine 63 deubiquitinase,BRSS; CDMT; CYLD1; CYLDI; EAC; FTDALS8; MFT; MFT1; SBS; TEM; USPL2,CYLD
Q9NQG5,RPR1B_HUMAN,RPRD1B; C20orf77; CREPT,Regulation of nuclear pre-mRNA domain-containing protein 1B; Cell cycle-related and expression-elevated protein in tumor,C20orf77; CREPT,58490,regulation of nuclear pre-mRNA domain containing 1B,chromosome 20 open reading frame 77,cell-cycle related and expression-elevated protein in tumor; Ku70-binding protein 5-Hera,dJ1057B20.2; DKFZp434P0735; CREPT; FLJ44520; NET60; Kub5-Hera; K-H,regulation of nuclear pre-mRNA domain containing 1B,C20orf77; CREPT; K-H; Kub5-Hera; NET60; dJ1057B20.2,RPRD1B
Q9NQR1,KMT5A_HUMAN,KMT5A; PRSET7; SET07; SET8; SETD8,N-lysine methyltransferase KMT5A; EC 2.1.1.-; H4-K20-HMTase KMT5A; Histone-lysine N-methyltransferase KMT5A; EC 2.1.1.361; Lysine N-methyltransferase 5A; Lysine-specific methylase 5A; PR/SET domain-containing protein 07; PR-Set7; PR/SET07; SET domain-containing protein 8,PRSET7; SET07; SET8; SETD8,387893,lysine methyltransferase 5A,SET domain containing (lysine methyltransferase) 8; lysine (K)-specific methyltransferase 5A,,SET8; SET07; PR-Set7,lysine methyltransferase 5A,PR-Set7; PR/SET07; SET07; SET8; SETD8,KMT5A
Q9NQS7,INCE_HUMAN,INCENP,Inner centromere protein,,3619,inner centromere protein,inner centromere protein antigens (135kD; 155kD); inner centromere protein antigens 135/155kDa,,FLJ31633,inner centromere protein,,INCENP
Q9NQT8,KI13B_HUMAN,KIF13B; GAKIN; KIAA0639,Kinesin-like protein KIF13B; Kinesin-like protein GAKIN,GAKIN; KIAA0639,23303,kinesin family member 13B,,guanylate kinase associated kinesin,GAKIN; KIAA0639,kinesin family member 13B,GAKIN,KIF13B
Q9NQU5,PAK6_HUMAN,PAK6; PAK5,Serine/threonine-protein kinase PAK 6; EC 2.7.11.1; PAK-5; p21-activated kinase 6; PAK-6,PAK5,106821730,p21 (RAC1) activated kinase 6,p21(CDKN1A)-activated kinase 6; p21 protein (Cdc42/Rac)-activated kinase 6,,PAK5,BUB1B-PAK6 readthrough,PAK-5; PAK-6; PAK5; PAK6,PAK6
Q9NQZ2,SAS10_HUMAN,UTP3; CRLZ1; SAS10,Something about silencing protein 10; Charged amino acid-rich leucine zipper 1; CRL1; Disrupter of silencing SAS10; UTP3 homolog,CRLZ1; SAS10,57050,UTP3 small subunit processome component,UTP3; small subunit (SSU) processome component; homolog (S. cerevisiae),disrupter of silencing 10,FLJ23256; DKFZp761F222; SAS10; CRLZ1,UTP3 small subunit processome component,CRL1; CRLZ1; SAS10,UTP3
Q9NR19,ACSA_HUMAN,ACSS2; ACAS2,Acetyl-coenzyme A synthetase; cytoplasmic; EC 6.2.1.1; Acetate--CoA ligase; Acetyl-CoA synthetase; ACS; AceCS; Acetyl-CoA synthetase 1; AceCS1; Acyl-CoA synthetase short-chain family member 2; Acyl-activating enzyme; Propionate--CoA ligase; EC 6.2.1.17,ACAS2,55902,acyl-CoA synthetase short chain family member 2,acetyl-Coenzyme A synthetase 2 (ADP forming),,ACS; ACSA; AceCS; dJ1161H23.1,acyl-CoA synthetase short chain family member 2,ACAS2; ACECS; ACS; ACSA; AceCS1; dJ1161H23.1,ACSS2
Q9NR28,DBLOH_HUMAN,DIABLO; SMAC,Diablo IAP-binding mitochondrial protein; Diablo homolog; mitochondrial; Direct IAP-binding protein with low pI; Second mitochondria-derived activator of caspases; SMAC,SMAC,56616,diablo IAP-binding mitochondrial protein,diablo; IAP-binding mitochondrial protein,second mitochondria-derived activator of caspase,SMAC; DIABLO-S; FLJ25049; FLJ10537; DFNA64,diablo IAP-binding mitochondrial protein,DFNA64; SMAC,DIABLO
Q9NR80,ARHG4_HUMAN,ARHGEF4; KIAA1112,Rho guanine nucleotide exchange factor 4; APC-stimulated guanine nucleotide exchange factor 1; Asef; Asef1,KIAA1112,50649,Rho guanine nucleotide exchange factor 4,Rho guanine nucleotide exchange factor (GEF) 4,APC-stimulated guanine nucleotide exchange factor; APC-stimulated guanine nucleotide exchange factor 1,STM6; KIAA1112; ASEF; ASEF1,Rho guanine nucleotide exchange factor 4,ASEF; ASEF1; GEF4; SMIM39; STM6,ARHGEF4
Q9NRA0,SPHK2_HUMAN,SPHK2; SK2,Sphingosine kinase 2; SK 2; SPK 2; EC 2.7.1.91,SK2,56848,sphingosine kinase 2,,,,sphingosine kinase 2,SK 2; SK-2; SPK 2; SPK-2,SPHK2
Q9NRA8,4ET_HUMAN,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter; 4E-T; eIF4E transporter; Eukaryotic translation initiation factor 4E nuclear import factor 1,,56478,eukaryotic translation initiation factor 4E nuclear import factor 1,,4E-transporter,4E-T; FLJ21601; Clast4; 2610509L04Rik,eukaryotic translation initiation factor 4E nuclear import factor 1,4E-T; Clast4,EIF4ENIF1
Q9NRD5,PICK1_HUMAN,PICK1; PRKCABP,PRKCA-binding protein; Protein interacting with C kinase 1; Protein kinase C-alpha-binding protein,PRKCABP,9463,protein interacting with PRKCA 1,protein kinase C; alpha binding protein; protein interacting with PRKCA,,dJ1039K5; MGC15204,protein interacting with PRKCA 1,PICK; PRKCABP,PICK1
Q9NRD9,DUOX1_HUMAN,DUOX1; DUOX; LNOX1; THOX1,Dual oxidase 1; EC 1.11.1.-; EC 1.6.3.1; Large NOX 1; Long NOX 1; NADPH thyroid oxidase 1; Thyroid oxidase 1,DUOX; LNOX1; THOX1,53905,dual oxidase 1,,NADPH thyroid oxidase 1; flavoprotein NADPH oxidase; nicotinamide adenine dinucleotide phosphate oxidase,NOXEF1; THOX1; LNOX1,dual oxidase 1,LNOX1; NOXEF1; THOX1,DUOX1
Q9NRF2,SH2B1_HUMAN,SH2B1; KIAA1299; SH2B,SH2B adapter protein 1; Pro-rich; PH and SH2 domain-containing signaling mediator; PSM; SH2 domain-containing protein 1B,KIAA1299; SH2B,25970,SH2B adaptor protein 1,,SH2-B homolog,FLJ30542; SH2B,SH2B adaptor protein 1,PSM; SH2B,SH2B1
Q9NRF8,PYRG2_HUMAN,CTPS2,CTP synthase 2; EC 6.3.4.2; CTP synthetase 2; UTP--ammonia ligase 2,,56474,CTP synthase 2,CTP synthase II,,GATD5B,CTP synthase 2,GATD5B,CTPS2
Q9NRH2,SNRK_HUMAN,SNRK; KIAA0096; SNFRK,SNF-related serine/threonine-protein kinase; EC 2.7.11.1; SNF1-related kinase,KIAA0096; SNFRK,54861,SNF related kinase,,,FLJ20224; HSNFRK; KIAA0096,SNF related kinase,HSNFRK,SNRK
Q9NRH3,TBG2_HUMAN,TUBG2,Tubulin gamma-2 chain; Gamma-2-tubulin,,27175,tubulin gamma 2,tubulin; gamma 2,,,tubulin gamma 2,,TUBG2
Q9NRL2,BAZ1A_HUMAN,BAZ1A; ACF1; WCRF180; HSPC317,Bromodomain adjacent to zinc finger domain protein 1A; ATP-dependent chromatin-remodeling protein; ATP-utilizing chromatin assembly and remodeling factor 1; hACF1; CHRAC subunit ACF1; Williams syndrome transcription factor-related chromatin-remodeling factor 180; WCRF180; hWALp1,ACF1; WCRF180,11177,bromodomain adjacent to zinc finger domain 1A,,,hACF1; ACF1; WALp1; WCRF180,bromodomain adjacent to zinc finger domain 1A,ACF1; WALp1; WCRF180; hACF1,BAZ1A
Q9NRM7,LATS2_HUMAN,LATS2; KPM,Serine/threonine-protein kinase LATS2; EC 2.7.11.1; Kinase phosphorylated during mitosis protein; Large tumor suppressor homolog 2; Serine/threonine-protein kinase kpm; Warts-like kinase,KPM,26524,large tumor suppressor kinase 2,LATS (large tumor suppressor; Drosophila) homolog 2; LATS; large tumor suppressor; homolog 2 (Drosophila),,,large tumor suppressor kinase 2,KPM,LATS2
Q9NRR4,RNC_HUMAN,DROSHA; RN3; RNASE3L; RNASEN,Ribonuclease 3; EC 3.1.26.3; Protein Drosha; Ribonuclease III; RNase III; p241,RN3; RNASE3L; RNASEN,29102,drosha ribonuclease III,ribonuclease type III; nuclear; drosha; ribonuclease type III,drosha; ribonuclease type III; drosha; double-stranded RNA-specific endoribonuclease,RNASE3L; Etohi2; HSA242976; RN3,drosha ribonuclease III,ETOHI2; HSA242976; RANSE3L; RN3; RNASE3L; RNASEN,DROSHA
Q9NRW4,DUS22_HUMAN,DUSP22; JSP1; LMWDSP2; MKPX,Dual specificity protein phosphatase 22; EC 3.1.3.16; EC 3.1.3.48; JNK pathway associated phosphatase; JKAP; JNK-stimulatory phosphatase-1; JSP-1; Low molecular weight dual specificity phosphatase 2; LMW-DSP2; Mitogen-activated protein kinase phosphatase x; MAP kinase phosphatase x; MKP-x,JSP1; LMWDSP2; MKPX,56940,dual specificity phosphatase 22,,,MKPX; JSP1; JKAP; VHX,dual specificity phosphatase 22,JKAP; JSP-1; JSP1; LMW-DSP2; LMWDSP2; MKP-x; MKPX; VHX,DUSP22
Q9NRX4,PHP14_HUMAN,PHPT1; PHP14; CGI-202; HSPC141,14 kDa phosphohistidine phosphatase; EC 3.9.1.3; Phosphohistidine phosphatase 1; PHPT1; Protein histidine phosphatase; PHP; Protein janus-A homolog,PHP14,29085,phosphohistidine phosphatase 1,,phosphohistidine phosphatase 14kDa; sex-regulated protein janus-a,PHP14; HSPC141; CGI-202; DKFZp564M173; bA216L13.10,phosphohistidine phosphatase 1,CGI-202; HEL-S-132P; HSPC141; PHP; PHP14,PHPT1
Q9NRY4,RHG35_HUMAN,ARHGAP35; GRF1; GRLF1; KIAA1722; P190A; p190ARHOGAP,Rho GTPase-activating protein 35; Glucocorticoid receptor DNA-binding factor 1; Glucocorticoid receptor repression factor 1; GRF-1; Rho GAP p190A; p190-A,GRF1; GRLF1; KIAA1722; P190A; p190ARHOGAP,2909,Rho GTPase activating protein 35,glucocorticoid receptor DNA binding factor 1,,GRF-1; p190ARhoGAP; P190A; KIAA1722; p190RhoGAP,Rho GTPase activating protein 35,GRF-1; GRLF1; P190-A; P190A; p190ARhoGAP; p190RhoGAP,ARHGAP35
Q9NRY6,PLS3_HUMAN,PLSCR3,Phospholipid scramblase 3; PL scramblase 3; Ca(2+,,57048,phospholipid scramblase 3,,,,phospholipid scramblase 3,,PLSCR3
Q9NS23,RASF1_HUMAN,RASSF1; RDA32,Ras association domain-containing protein 1,RDA32,11186,Ras association domain family member 1,Ras association (RalGDS/AF-6) domain family member 1,,NORE2A; REH3P21; RDA32; 123F2,Ras association domain family member 1,123F2; NORE2A; RASSF1A; RDA32; REH3P21,RASSF1
Q9NS56,TOPRS_HUMAN,TOPORS; LUN; TP53BPL,E3 ubiquitin-protein ligase Topors; EC 2.3.2.27; RING-type E3 ubiquitin transferase Topors; SUMO1-protein E3 ligase Topors; Topoisomerase I-binding RING finger protein; Topoisomerase I-binding arginine/serine-rich protein; Tumor suppressor p53-binding protein 3; p53-binding protein 3; p53BP3,LUN; TP53BPL,10210,TOP1 binding arginine/serine rich protein; E3 ubiquitin ligase,retinitis pigmentosa 31 (autosomal dominant); TOP1 binding arginine/serine rich protein,,TP53BPL; LUN,TOP1 binding arginine/serine rich protein; E3 ubiquitin ligase,LUN; P53BP3; RP31; TP53BPL,TOPORS
Q9NS91,RAD18_HUMAN,RAD18; RNF73,E3 ubiquitin-protein ligase RAD18; EC 2.3.2.27; Postreplication repair protein RAD18; hHR18; hRAD18; RING finger protein 73; RING-type E3 ubiquitin transferase RAD18,RNF73,56852,RAD18 E3 ubiquitin protein ligase,RAD18 homolog (S. cerevisiae),,RNF73,RAD18 E3 ubiquitin protein ligase,RNF73,RAD18
Q9NSK0,KLC4_HUMAN,KLC4; KNSL8,Kinesin light chain 4; KLC 4; Kinesin-like protein 8,KNSL8,89953,kinesin light chain 4,kinesin-like 8,,bA387M24.3,kinesin light chain 4,KNSL8; bA387M24.3,KLC4
Q9NSV4,DIAP3_HUMAN,DIAPH3; DIAP3,Protein diaphanous homolog 3; Diaphanous-related formin-3; DRF3; MDia2,DIAP3,81624,diaphanous related formin 3,diaphanous (Drosophila; homolog) 3; auditory neuropathy; autosomal dominant 1; diaphanous homolog 3 (Drosophila),,DRF3; FLJ34705; AN; NSDAN,diaphanous related formin 3,AN; AUNA1; DIA2; DRF3; NSDAN; diap3; mDia2,DIAPH3
Q9NTG7,SIR3_HUMAN,SIRT3; SIR2L3,NAD-dependent protein deacetylase sirtuin-3; mitochondrial; hSIRT3; EC 2.3.1.286; NAD-dependent protein delactylase sirtuin-3; EC 2.3.1.-; Regulatory protein SIR2 homolog 3; SIR2-like protein 3,SIR2L3,23410,sirtuin 3,sirtuin (silent mating type information regulation 2; S.cerevisiae; homolog) 3; sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae),,SIR2L3,sirtuin 3,SIR2L3,SIRT3
Q9NTI5,PDS5B_HUMAN,PDS5B; APRIN; AS3; KIAA0979,Sister chromatid cohesion protein PDS5 homolog B; Androgen-induced proliferation inhibitor; Androgen-induced prostate proliferative shutoff-associated protein AS3,APRIN; AS3; KIAA0979,23047,PDS5 cohesin associated factor B,androgen-induced proliferation inhibitor; PDS5; regulator of cohesion maintenance; homolog B (S. cerevisiae),,AS3; KIAA0979; FLJ23236; CG008,PDS5 cohesin associated factor B,APRIN; AS3; CG008,PDS5B
Q9NUU7,DD19A_HUMAN,DDX19A; DDX19L,ATP-dependent RNA helicase DDX19A; EC 3.6.4.13; DDX19-like protein; DEAD box protein 19A,DDX19L,55308,DEAD-box helicase 19A,DEAD (Asp-Glu-Ala-As) box polypeptide 19-like; DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A,,FLJ11126,DEAD-box helicase 19A,DDX19-DDX19L; DDX19L,DDX19A
Q9NUW8,TYDP1_HUMAN,TDP1,Tyrosyl-DNA phosphodiesterase 1; Tyr-DNA phosphodiesterase 1; EC 3.1.4.-,,55775,tyrosyl-DNA phosphodiesterase 1,,,FLJ11090; SCAN1,tyrosyl-DNA phosphodiesterase 1,,TDP1
Q9NV92,NFIP2_HUMAN,NDFIP2; KIAA1165; N4WBP5A,NEDD4 family-interacting protein 2; NEDD4 WW domain-binding protein 5A; Putative MAPK-activating protein PM04/PM05/PM06/PM07; Putative NF-kappa-B-activating protein 413,KIAA1165; N4WBP5A,54602,Nedd4 family interacting protein 2,,,KIAA1165; N4wbp5a,Nedd4 family interacting protein 2,N4WBP5A,NDFIP2
Q9NVI1,FANCI_HUMAN,FANCI; KIAA1794,Fanconi anemia group I protein; Protein FACI,KIAA1794,55215,FA complementation group I,KIAA1794; Fanconi anemia complementation group I,,FLJ10719,FA complementation group I,KIAA1794,FANCI
Q9NVP2,ASF1B_HUMAN,ASF1B,Histone chaperone ASF1B; Anti-silencing function protein 1 homolog B; hAsf1; hAsf1b; CCG1-interacting factor A-II; CIA-II; hCIA-II,,55723,anti-silencing function 1B histone chaperone,ASF1 anti-silencing function 1 homolog B (S. cerevisiae),,FLJ10604,anti-silencing function 1B histone chaperone,CIA-II,ASF1B
Q9NWH9,SLTM_HUMAN,SLTM; MET,SAFB-like transcription modulator; Modulator of estrogen-induced transcription,MET,79811,SAFB like transcription modulator,,,Met; FLJ13213,SAFB like transcription modulator,Met,SLTM
Q9NWQ8,PHAG1_HUMAN,PAG1; CBP; PAG,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1; Csk-binding protein; Transmembrane adapter protein PAG; Transmembrane phosphoprotein Cbp,CBP; PAG,55824,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,phosphoprotein associated with glycosphingolipid microdomains 1,Csk-binding protein; transmembrane adaptor protein PAG,PAG; CBP,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,CBP; PAG,PAG1
Q9NWV8,BABA1_HUMAN,BABAM1; C19orf62; MERIT40; NBA1; HSPC142,BRISC and BRCA1-A complex member 1; Mediator of RAP80 interactions and targeting subunit of 40 kDa; New component of the BRCA1-A complex,C19orf62; MERIT40; NBA1,29086,BRISC and BRCA1 A complex member 1,chromosome 19 open reading frame 62,Mediator of Rap80 Interactions and Targeting 40 kD; new component of the BRCA1 A complex,FLJ20571; HSPC142; NBA1; MERIT40,BRISC and BRCA1 A complex member 1,C19orf62; HSPC142; MERIT40; NBA1,BABAM1
Q9NWZ3,IRAK4_HUMAN,IRAK4,Interleukin-1 receptor-associated kinase 4; IRAK-4; EC 2.7.11.1; Renal carcinoma antigen NY-REN-64,,51135,interleukin 1 receptor associated kinase 4,,,NY-REN-64,interleukin 1 receptor associated kinase 4,IMD67; IPD1; IRAK-4; NY-REN-64; REN64,IRAK4
Q9NX63,MIC19_HUMAN,CHCHD3; MIC19; MINOS3,MICOS complex subunit MIC19; Coiled-coil-helix-coiled-coil-helix domain-containing protein 3,MIC19; MINOS3,54927,coiled-coil-helix-coiled-coil-helix domain containing 3,,mitochondrial inner membrane organizing system 3; protein phosphatase 1; regulatory subunit 22; mitochondrial contact site and cristae organizing system subunit 19,FLJ20420; MINOS3; PPP1R22; Mic19; MICOS19,coiled-coil-helix-coiled-coil-helix domain containing 3,MICOS19; MINOS3; Mic19; PPP1R22,CHCHD3
Q9NXE8,CWC25_HUMAN,CWC25; CCDC49,Pre-mRNA-splicing factor CWC25 homolog; Coiled-coil domain-containing protein 49; Spliceosome-associated protein homolog CWC25,CCDC49,54883,CWC25 spliceosome associated protein homolog,coiled-coil domain containing 49; CWC25 spliceosome-associated protein homolog (S. cerevisiae),,FLJ20291,CWC25 spliceosome associated protein homolog,CCDC49,CWC25
Q9NXR1,NDE1_HUMAN,NDE1; NUDE,Nuclear distribution protein nudE homolog 1; NudE,NUDE,54820,nudE neurodevelopment protein 1,nudE nuclear distribution gene E homolog 1 (A. nidulans); nudE nuclear distribution E homolog 1 (A. nidulans),,nudE; FLJ20101; NDE,nudE neurodevelopment protein 1,HOM-TES-87; LIS4; MHAC; NDE; NUDE; NUDE1,NDE1
Q9NY47,CA2D2_HUMAN,CACNA2D2; KIAA0558,Voltage-dependent calcium channel subunit alpha-2/delta-2; Voltage-gated calcium channel subunit alpha-2/delta-2,KIAA0558,9254,calcium voltage-gated channel auxiliary subunit alpha2delta 2,calcium channel; voltage-dependent; alpha 2/delta subunit 2,gene 26,KIAA0558; alpha2delta-2,calcium voltage-gated channel auxiliary subunit alpha2delta 2,CACNA2D; CASVDD,CACNA2D2
Q9NY61,AATF_HUMAN,AATF; CHE1; DED; HSPC277,Protein AATF; Apoptosis-antagonizing transcription factor; Rb-binding protein Che-1,CHE1; DED,26574,apoptosis antagonizing transcription factor,,,DED; CHE-1; CHE1; BFR2,apoptosis antagonizing transcription factor,BFR2; CHE-1; CHE1; DED,AATF
Q9NYA1,SPHK1_HUMAN,SPHK1; SK1; SPHK; SPK,Sphingosine kinase 1; SK 1; SPK 1; EC 2.7.1.91; Acetyltransferase SPHK1; EC 2.3.1.-,SK1; SPHK; SPK,8877,sphingosine kinase 1,,,SPHK,sphingosine kinase 1,SPHK,SPHK1
Q9NYA4,MTMR4_HUMAN,MTMR4; KIAA0647; ZFYVE11,Phosphatidylinositol-3;5-bisphosphate 3-phosphatase MTMR4; EC 3.1.3.95; FYVE domain-containing dual specificity protein phosphatase 2; FYVE-DSP2; Myotubularin-related protein 4; Phosphatidylinositol-3;5-bisphosphate 3-phosphatase; Zinc finger FYVE domain-containing protein 11,KIAA0647; ZFYVE11,9110,myotubularin related protein 4,,,KIAA0647; ZFYVE11,myotubularin related protein 4,FYVE-DSP2; ZFYVE11,MTMR4
Q9NYB0,TE2IP_HUMAN,TERF2IP; DRIP5; RAP1; PP8000,Telomeric repeat-binding factor 2-interacting protein 1; TERF2-interacting telomeric protein 1; TRF2-interacting telomeric protein 1; Dopamine receptor-interacting protein 5; Repressor/activator protein 1 homolog; RAP1 homolog; hRap1,DRIP5; RAP1,54386,TERF2 interacting protein,telomeric repeat binding factor 2; interacting protein,,RAP1,TERF2 interacting protein,DRIP5; RAP1,TERF2IP
Q9NYF0,DACT1_HUMAN,DACT1; DPR1; HNG3,Dapper homolog 1; hDPR1; Dapper antagonist of catenin 1; Hepatocellular carcinoma novel gene 3 protein,DPR1; HNG3,51339,dishevelled binding antagonist of beta catenin 1,dapper homolog 1; antagonist of beta-catenin (xenopus); dapper; antagonist of beta-catenin; homolog 1 (Xenopus laevis),,DAPPER1; THYEX3; HDPR1; DAPPER; FRODO,dishevelled binding antagonist of beta catenin 1,DAPPER; DAPPER1; DPR1; FRODO; HDPR1; TBS2; THYEX3,DACT1
Q9NYF8,BCLF1_HUMAN,BCLAF1; BTF; KIAA0164,Bcl-2-associated transcription factor 1; Btf; BCLAF1 and THRAP3 family member 1,BTF; KIAA0164,9774,BCL2 associated transcription factor 1,BCL2-associated transcription factor 1,BCLAF1 and THRAP3 family member 1,KIAA0164; BTF,BCL2 associated transcription factor 1,BTF; bK211L9.1,BCLAF1
Q9NYG5,APC11_HUMAN,ANAPC11; HSPC214,Anaphase-promoting complex subunit 11; APC11; Cyclosome subunit 11; Hepatocellular carcinoma-associated RING finger protein,,51529,anaphase promoting complex subunit 11,anaphase promoting complex subunit 11 (yeast APC11 homolog),,HSPC214; APC11; Apc11p; MGC882,anaphase promoting complex subunit 11,APC11; Apc11p; HSPC214,ANAPC11
Q9NYL2,M3K20_HUMAN,MAP3K20; MLK7; MLTK; ZAK; HCCS4,Mitogen-activated protein kinase kinase kinase 20; EC 2.7.11.25; Human cervical cancer suppressor gene 4 protein; HCCS-4; Leucine zipper- and sterile alpha motif-containing kinase; MLK-like mitogen-activated protein triple kinase; Mitogen-activated protein kinase kinase kinase MLT; Mixed lineage kinase 7; Mixed lineage kinase-related kinase; MLK-related kinase; MRK; Sterile alpha motif- and leucine zipper-containing kinase AZK,MLK7; MLTK; ZAK,51776,mitogen-activated protein kinase kinase kinase 20,,ZAK1 homolog; leucine zipper and sterile-alpha motif kinase (Dictyostelium); mixed lineage kinase 7,MLTKalpha; MLTKbeta; ZAK; MLTK; MLK7; MRK,mitogen-activated protein kinase kinase kinase 20,AZK; CNM6; MLK7; MLT; MLTK; MLTKalpha; MLTKbeta; MRK; SFMMP; ZAK; mlklak; pk,MAP3K20
Q9NYP9,MS18A_HUMAN,MIS18A; C21orf45; C21orf46; FASP1,Protein Mis18-alpha; FAPP1-associated protein 1,C21orf45; C21orf46; FASP1,54069,MIS18 kinetochore protein A,chromosome 21 open reading frame 46; chromosome 21 open reading frame 45; MIS18 kinetochore protein homolog A (S. pombe),,B28; FASP1; hMis18alpha,MIS18 kinetochore protein A,B28; C21orf45; C21orf46; FASP1; MIS18alpha; hMis18alpha,MIS18A
Q9NYV4,CDK12_HUMAN,CDK12; CRK7; CRKRS; KIAA0904,Cyclin-dependent kinase 12; EC 2.7.11.22; EC 2.7.11.23; Cdc2-related kinase; arginine/serine-rich; CrkRS; Cell division cycle 2-related protein kinase 7; CDC2-related protein kinase 7; Cell division protein kinase 12; hCDK12,CRK7; CRKRS; KIAA0904,51755,cyclin dependent kinase 12,Cdc2-related kinase; arginine/serine-rich,CDC2 related protein kinase 7,CRK7; CRKR; KIAA0904,cyclin dependent kinase 12,CRK7; CRKR; CRKRS,CDK12
Q9NYV6,RRN3_HUMAN,RRN3; TIFIA,RNA polymerase I-specific transcription initiation factor RRN3; Transcription initiation factor IA; TIF-IA,TIFIA,54700,RRN3 homolog; RNA polymerase I transcription factor,RRN3 RNA polymerase I transcription factor homolog (yeast); RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae),transcription initiation factor IA,DKFZp566E104; TIF-IA,RRN3 homolog; RNA polymerase I transcription factor,A-270G1.2; TIFIA,RRN3
Q9NYY3,PLK2_HUMAN,PLK2; SNK,Serine/threonine-protein kinase PLK2; EC 2.7.11.21; Polo-like kinase 2; PLK-2; hPlk2; Serine/threonine-protein kinase SNK; hSNK; Serum-inducible kinase,SNK,10769,polo like kinase 2,polo-like kinase 2 (Drosophila); polo-like kinase 2,serum-inducible kinase,SNK,polo like kinase 2,SNK; hPlk2; hSNK,PLK2
Q9NYZ3,GTSE1_HUMAN,GTSE1,G2 and S phase-expressed protein 1; GTSE-1; Protein B99 homolog,,51512,G2 and S-phase expressed 1,G-2 and S-phase expressed 1,,GTSE-1; B99; Lnc_bc060912,G2 and S-phase expressed 1,B99,GTSE1
Q9NZ72,STMN3_HUMAN,STMN3; SCLIP,Stathmin-3; SCG10-like protein,SCLIP,50861,stathmin 3,stathmin-like 3,,SCLIP,stathmin 3,SCLIP,STMN3
Q9NZA1,CLIC5_HUMAN,CLIC5,Chloride intracellular channel protein 5; Glutaredoxin-like oxidoreductase CLIC5; EC 1.8.-.-,,53405,chloride intracellular channel 5,,,DFNB102,chloride intracellular channel 5,DFNB102; DFNB103; MST130; MSTP130,CLIC5
Q9NZC7,WWOX_HUMAN,WWOX; FOR; SDR41C1; WOX1,WW domain-containing oxidoreductase; EC 1.1.1.-; Fragile site FRA16D oxidoreductase; Short chain dehydrogenase/reductase family 41C member 1,FOR; SDR41C1; WOX1,51741,WW domain containing oxidoreductase,WW domain-containing oxidoreductase,short chain dehydrogenase/reductase family 41C; member 1,FOR; WOX1; SDR41C1,WW domain containing oxidoreductase,D16S432E; DEE28; EIEE28; FOR; FRA16D; HHCMA56; PRO0128; SCAR12; SDR41C1; WOX1,WWOX
Q9NZC9,SMAL1_HUMAN,SMARCAL1; HARP,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1; EC 3.6.4.-; HepA-related protein; hHARP; Sucrose nonfermenting protein 2-like 1,HARP,50485,SNF2 related chromatin remodeling annealing helicase 1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a like 1,HepA-related protein; ATP-driven annealing helicase,HHARP; HARP,SNF2 related chromatin remodeling annealing helicase 1,HARP; HHARP,SMARCAL1
Q9NZJ0,DTL_HUMAN,DTL; CDT2; CDW1; DCAF2; L2DTL; RAMP,Denticleless protein homolog; DDB1- and CUL4-associated factor 2; Lethal(2; Retinoic acid-regulated nuclear matrix-associated protein,CDT2; CDW1; DCAF2; L2DTL; RAMP,51514,denticleless E3 ubiquitin protein ligase homolog,denticleless homolog (Drosophila); denticleless E3 ubiquitin protein ligase homolog (Drosophila),RA regulated nuclear matrix associated protein; DDB1 and CUL4 associated factor 2,RAMP; L2DTL; DCAF2; CDT2,denticleless E3 ubiquitin protein ligase homolog,CDT2; DCAF2; L2DTL; RAMP,DTL
Q9NZJ5,E2AK3_HUMAN,EIF2AK3; PEK; PERK,Eukaryotic translation initiation factor 2-alpha kinase 3; EC 2.7.11.1; PRKR-like endoplasmic reticulum kinase; Pancreatic eIF2-alpha kinase; HsPEK; Protein tyrosine kinase EIF2AK3; EC 2.7.10.2,PEK; PERK,9451,eukaryotic translation initiation factor 2 alpha kinase 3,,PRKR-like endoplasmic reticulum kinase; pancreatic eIF-2alpha kinase; PKR-like ER kinase,PEK; PERK,eukaryotic translation initiation factor 2 alpha kinase 3,PEK; PERK; WRS,EIF2AK3
Q9NZM5,NOP53_HUMAN,NOP53; GLT; GLTSCR2; PICT1,Ribosome biogenesis protein NOP53; Glioma tumor suppressor candidate region gene 2 protein; Protein interacting with carboxyl terminus 1; PICT-1; p60,GLT; GLTSCR2; PICT1,29997,NOP53 ribosome biogenesis factor,glioma tumor suppressor candidate region gene 2,,PICT-1; PICT1,NOP53 ribosome biogenesis factor,GLTSCR2; PICT-1; PICT1,NOP53
Q9NZN5,ARHGC_HUMAN,ARHGEF12; KIAA0382; LARG,Rho guanine nucleotide exchange factor 12; Leukemia-associated RhoGEF,KIAA0382; LARG,23365,Rho guanine nucleotide exchange factor 12,Rho guanine nucleotide exchange factor (GEF) 12,,KIAA0382; LARG,Rho guanine nucleotide exchange factor 12,LARG; PRO2792,ARHGEF12
Q9NZN8,CNOT2_HUMAN,CNOT2; CDC36; NOT2; HSPC131; MSTP046,CCR4-NOT transcription complex subunit 2; CCR4-associated factor 2,CDC36; NOT2,4848,CCR4-NOT transcription complex subunit 2,CCR4-NOT transcription complex; subunit 2,CC chemokine receptor 4-negative regulator of transcription 2,CDC36; NOT2H,CCR4-NOT transcription complex subunit 2,CDC36; HSPC131; IDNADFS; NOT2; NOT2H,CNOT2
Q9NZQ3,SPN90_HUMAN,NCKIPSD; AF3P21; SPIN90,NCK-interacting protein with SH3 domain; 54 kDa VacA-interacting protein; 54 kDa vimentin-interacting protein; VIP54; 90 kDa SH3 protein interacting with Nck; AF3p21; Dia-interacting protein 1; DIP-1; Diaphanous protein-interacting protein; SH3 adapter protein SPIN90; WASP-interacting SH3-domain protein; WISH; Wiskott-Aldrich syndrome protein-interacting protein,AF3P21; SPIN90,51517,NCK interacting protein with SH3 domain,,dia interacting protein; diaphanous protein interacting protein; SH3 protein interacting with Nck; 90 kDa,AF3P21; SPIN90; ORF1; WISH; WASLBP; DIP1,NCK interacting protein with SH3 domain,AF3P21; DIP; DIP1; ORF1; SPIN90; VIP54; WASLBP; WISH,NCKIPSD
Q9NZT1,CALL5_HUMAN,CALML5; CLSP,Calmodulin-like protein 5; Calmodulin-like skin protein,CLSP,51806,calmodulin like 5,calmodulin-like 5,calmodulin-like skin protein,CLSP,calmodulin like 5,CLSP,CALML5
Q9NZV8,KCND2_HUMAN,KCND2; KIAA1044,A-type voltage-gated potassium channel KCND2; Potassium voltage-gated channel subfamily D member 2; Voltage-gated potassium channel subunit Kv4.2,KIAA1044,3751,potassium voltage-gated channel subfamily D member 2,potassium voltage-gated channel; Shal-related subfamily; member 2,,Kv4.2; RK5; KIAA1044,potassium voltage-gated channel subfamily D member 2,KV4.2; RK5,KCND2
Q9P0J1,PDP1_HUMAN,PDP1; PDP; PPM2C,Pyruvate dehydrogenase acetyl-transferring-phosphatase 1; mitochondrial; PDP 1; EC 3.1.3.43; Protein phosphatase 2C; Pyruvate dehydrogenase phosphatase catalytic subunit 1; PDPC 1,PDP; PPM2C,54704,pyruvate dehydrogenase phosphatase catalytic subunit 1,protein phosphatase 2C; magnesium-dependent; catalytic subunit,protein phosphatase; Mg2+/Mn2+ dependent 2A,PDP; PDH; PPM2A,pyruvate dehydrogenase phosphatase catalytic subunit 1,PDH; PDP; PDPC; PDPC 1; PPM2A; PPM2C,PDP1
Q9P0L2,MARK1_HUMAN,MARK1; KIAA1477; MARK,Serine/threonine-protein kinase MARK1; EC 2.7.11.1; EC 2.7.11.26; MAP/microtubule affinity-regulating kinase 1; PAR1 homolog c; Par-1c; Par1c,KIAA1477; MARK,4139,microtubule affinity regulating kinase 1,MAP/microtubule affinity-regulating kinase 1,,MARK; PAR-1C,microtubule affinity regulating kinase 1,MARK; Par-1c; Par1c,MARK1
Q9P0L9,PK2L1_HUMAN,PKD2L1; PKD2L; PKDL; TRPP3,Polycystin-2-like protein 1; Polycystin-2L1; Polycystic kidney disease 2-like 1 protein; Polycystin-2 homolog; Polycystin-L; Polycystin-L1,PKD2L; PKDL; TRPP3,9033,polycystin 2 like 1; transient receptor potential cation channel,polycystic kidney disease 2-like 1,transient receptor potential cation channel; subfamily P; member 3; polycystin-L,PCL; TRPP3,polycystin 2 like 1; transient receptor potential cation channel,PCL; PKD2L; PKDL; TRPP3,PKD2L1
Q9P1W9,PIM2_HUMAN,PIM2,Serine/threonine-protein kinase pim-2; EC 2.7.11.1; Pim-2h,,11040,Pim-2 proto-oncogene; serine/threonine kinase,pim-2 oncogene,,,Pim-2 proto-oncogene; serine/threonine kinase,,PIM2
Q9P1Z0,ZBTB4_HUMAN,ZBTB4; KIAA1538,Zinc finger and BTB domain-containing protein 4; KAISO-like zinc finger protein 1; KAISO-L1,KIAA1538,57659,zinc finger and BTB domain containing 4,,,KIAA1538; KAISO-L1; ZNF903,zinc finger and BTB domain containing 4,KAISO-L1; ZNF903,ZBTB4
Q9P219,DAPLE_HUMAN,CCDC88C; DAPLE; KIAA1509,Protein Daple; Coiled-coil domain-containing protein 88C; Dvl-associating protein with a high frequency of leucine residues; hDaple; Hook-related protein 2; HkRP2,DAPLE; KIAA1509,440193,coiled-coil domain containing 88C,KIAA1509,Dvl-associating protein with a high frequency of leucine residues; spinocerebellar ataxia 40,DAPLE; HkRP2; SCA40,coiled-coil domain containing 88C,DAPLE; HKRP2; HYC1; KIAA1509; SCA40,CCDC88C
Q9P270,SLAI2_HUMAN,SLAIN2; KIAA1458,SLAIN motif-containing protein 2,KIAA1458,57606,SLAIN motif family member 2,KIAA1458,,FLJ21611,SLAIN motif family member 2,KIAA1458,SLAIN2
Q9P286,PAK5_HUMAN,PAK5; KIAA1264; PAK7,Serine/threonine-protein kinase PAK 5; EC 2.7.11.1; p21-activated kinase 5; PAK-5; p21-activated kinase 7; PAK-7,KIAA1264; PAK7,57144,p21 (RAC1) activated kinase 5,p21(CDKN1A)-activated kinase 7; p21 protein (Cdc42/Rac)-activated kinase 7; p21 (RAC1) activated kinase 7,,KIAA1264,p21 (RAC1) activated kinase 5,PAK7,PAK5
Q9P289,STK26_HUMAN,STK26; MASK; MST4,Serine/threonine-protein kinase 26; EC 2.7.11.1; MST3 and SOK1-related kinase; Mammalian STE20-like protein kinase 4; MST-4; STE20-like kinase MST4; Serine/threonine-protein kinase MASK,MASK; MST4,51765,serine/threonine kinase 26,,STE20-like kinase 4,MST4; MASK,serine/threonine kinase 26,MASK; MST4,STK26
Q9P2B4,CT2NL_HUMAN,CTTNBP2NL; KIAA1433,CTTNBP2 N-terminal-like protein,KIAA1433,55917,CTTNBP2 N-terminal like,,,DKFZp547A023,CTTNBP2 N-terminal like,,CTTNBP2NL
Q9P2D0,IBTK_HUMAN,IBTK; BTKI; KIAA1417,Inhibitor of Bruton tyrosine kinase; IBtk,BTKI; KIAA1417,25998,inhibitor of Bruton tyrosine kinase,Bruton agammaglobulinemia tyrosine kinase inhibitor; inhibitor of Bruton agammaglobulinemia tyrosine kinase,,DKFZP564B116; BTBD26,inhibitor of Bruton tyrosine kinase,BTBD26; BTKI,IBTK
Q9P2D1,CHD7_HUMAN,CHD7; KIAA1416,Chromodomain-helicase-DNA-binding protein 7; CHD-7; EC 3.6.4.12; ATP-dependent helicase CHD7,KIAA1416,55636,chromodomain helicase DNA binding protein 7,CHARGE association,,KIAA1416; FLJ20357; FLJ20361,chromodomain helicase DNA binding protein 7,CRG; HH5; IS3; KAL5,CHD7
Q9P2K8,E2AK4_HUMAN,EIF2AK4; GCN2; KIAA1338,eIF-2-alpha kinase GCN2; EC 2.7.11.1; Eukaryotic translation initiation factor 2-alpha kinase 4; GCN2-like protein,GCN2; KIAA1338,440275,eukaryotic translation initiation factor 2 alpha kinase 4,,eIF-2-alpha kinase,GCN2; KIAA1338,eukaryotic translation initiation factor 2 alpha kinase 4,GCN2; PVOD2,EIF2AK4
Q9P2M7,CING_HUMAN,CGN; KIAA1319,Cingulin,KIAA1319,57530,cingulin,,,KIAA1319,cingulin,,CGN
Q9P2W3,GBG13_HUMAN,GNG13,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13; I; S; O,,51764,G protein subunit gamma 13,guanine nucleotide binding protein (G protein); gamma 13,G gamma subunit; clone:h2-35,h2-35; G(gamma)13,G protein subunit gamma 13,G(gamma)13; HG3J; h2-35,GNG13
Q9P2Y5,UVRAG_HUMAN,UVRAG,UV radiation resistance-associated gene protein; p63,,7405,UV radiation resistance associated,UV radiation resistance associated gene,beclin 1 binding protein,VPS38,UV radiation resistance associated,DHTX; VPS38; p63,UVRAG
Q9UBB4,ATX10_HUMAN,ATXN10; SCA10,Ataxin-10; Brain protein E46 homolog; Spinocerebellar ataxia type 10 protein,SCA10,25814,ataxin 10,spinocerebellar ataxia 10,,E46L; FLJ37990; ATX10,ataxin 10,ATX10; E46L; HUMEEP; SCA10,ATXN10
Q9UBE8,NLK_HUMAN,NLK; LAK1,Serine/threonine-protein kinase NLK; EC 2.7.11.24; Nemo-like kinase; Protein LAK1,LAK1,51701,nemo like kinase,nemo-like kinase,,,nemo like kinase,,NLK
Q9UBF6,RBX2_HUMAN,RNF7; RBX2; ROC2; SAG,RING-box protein 2; Rbx2; EC 2.3.2.27; EC 2.3.2.32; CKII beta-binding protein 1; CKBBP1; RING finger protein 7; Regulator of cullins 2; Sensitive to apoptosis gene protein,RBX2; ROC2; SAG,9616,ring finger protein 7,,sensitive to apoptosis zinc RING finger protein SAG; regulator of cullins 2; RING-box protein 2,SAG; ROC2; CKBBP1; RBX2,ring finger protein 7,CKBBP1; ROC2; SAG; rbx2,RNF7
Q9UBF8,PI4KB_HUMAN,PI4KB; PIK4CB,Phosphatidylinositol 4-kinase beta; PI4K-beta; PI4Kbeta; PtdIns 4-kinase beta; EC 2.7.1.67; NPIK; PI4K92; PI4KIII,PIK4CB,5298,phosphatidylinositol 4-kinase beta,phosphatidylinositol 4-kinase; catalytic; beta,,PI4K-BETA; pi4K92,phosphatidylinositol 4-kinase beta,DFNA87; NPIK; PI4K-BETA; PI4K92; PI4KBETA; PI4KIII; PI4KIIIBETA; PIK4CB,PI4KB
Q9UBI6,GBG12_HUMAN,GNG12,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12; I; S; O,,55970,G protein subunit gamma 12,guanine nucleotide binding protein (G protein); gamma 12,,,G protein subunit gamma 12,HG3A,GNG12
Q9UBK2,PRGC1_HUMAN,PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1,Peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PGC-1-alpha; PPAR-gamma coactivator 1-alpha; PPARGC-1-alpha; Ligand effect modulator 6,LEM6; PGC1; PGC1A; PPARGC1,10891,PPARG coactivator 1 alpha,peroxisome proliferative activated receptor; gamma; coactivator 1; peroxisome proliferative activated receptor; gamma; coactivator 1; alpha; peroxisome proliferator-activated receptor gamma; coactivator 1 alpha,PPARgamma coactivator 1alpha,PGC1; PGC1A; PGC-1alpha; PPARAGCI??,PPARG coactivator 1 alpha,LEM6; PGC-1(alpha); PGC-1alpha; PGC-1v; PGC1; PGC1A; PPARGC1,PPARGC1A
Q9UBN1,CCG4_HUMAN,CACNG4,Voltage-dependent calcium channel gamma-4 subunit; Neuronal voltage-gated calcium channel gamma-4 subunit; Transmembrane AMPAR regulatory protein gamma-4; TARP gamma-4,,27092,calcium voltage-gated channel auxiliary subunit gamma 4,calcium channel; voltage-dependent; gamma subunit 4,,MGC11138; MGC24983,calcium voltage-gated channel auxiliary subunit gamma 4,,CACNG4
Q9UBN4,TRPC4_HUMAN,TRPC4,Short transient receptor potential channel 4; TrpC4; Trp-related protein 4; hTrp-4; hTrp4,,7223,transient receptor potential cation channel subfamily C member 4,transient receptor potential cation channel; subfamily C; member 4,,HTRP4; TRP4,transient receptor potential cation channel subfamily C member 4,HTRP-4; HTRP4; TRP4,TRPC4
Q9UBN7,HDAC6_HUMAN,HDAC6; KIAA0901; JM21,Histone deacetylase 6; HD6; EC 3.5.1.98; Protein deacetylase HDAC6; EC 3.5.1.-; Tubulin-lysine deacetylase HDAC6; EC 3.5.1.-,KIAA0901,10013,histone deacetylase 6,,protein phosphatase 1; regulatory subunit 90; alpha-tubulin deacetylase HDAC6,KIAA0901; JM21; HD6; FLJ16239; PPP1R90; KDAC6,histone deacetylase 6,CPBHM; HD6; JM21; KDAC6; PPP1R90,HDAC6
Q9UBP6,TRMB_HUMAN,METTL1; C12orf1,tRNA; guanine-N(7; EC 2.1.1.33; Methyltransferase-like protein 1; mRNA (guanine-N(7; EC 2.1.1.-; miRNA (guanine-N(7; EC 2.1.1.-; tRNA (guanine(46; 7; tRNA(m7G46,C12orf1,4234,methyltransferase 1; tRNA methylguanosine,methyltransferase like 1,,TRM8; TRMT8,methyltransferase 1; tRNA methylguanosine,C12orf1; TRM8; TRMT8; YDL201w,METTL1
Q9UBS0,KS6B2_HUMAN,RPS6KB2; STK14B,Ribosomal protein S6 kinase beta-2; S6K-beta-2; S6K2; EC 2.7.11.1; 70 kDa ribosomal protein S6 kinase 2; P70S6K2; p70-S6K 2; S6 kinase-related kinase; SRK; Serine/threonine-protein kinase 14B; p70 ribosomal S6 kinase beta; S6K-beta; p70 S6 kinase beta; p70 S6K-beta; p70 S6KB; p70-beta,STK14B,6199,ribosomal protein S6 kinase B2,ribosomal protein S6 kinase; 70kD; polypeptide 2,,p70S6Kb; P70-BETA; STK14B; KLS; S6KB; S6Kbeta; S6K??,ribosomal protein S6 kinase B2,KLS; P70-beta; P70-beta-1; P70-beta-2; S6K-beta2; S6K2; S6KB; S6KI(2); S6Kbeta; SRK; STK14B; p70(S6K)-beta; p70S6Kb,RPS6KB2
Q9UBU3,GHRL_HUMAN,GHRL; MTLRP; UNQ524/PRO1066,Appetite-regulating hormone; Growth hormone secretagogue; Growth hormone-releasing peptide; Motilin-related peptide; Protein M46; Ghrelin,MTLRP,51738,ghrelin and obestatin prepropeptide,ghrelin; growth hormone secretagogue receptor ligand; ghrelin/obestatin prepropeptide,prepro-appetite regulatory hormone,MTLRP; ghrelin; obestatin,ghrelin and obestatin prepropeptide,MTLRP,GHRL
Q9UBU7,DBF4A_HUMAN,DBF4; ASK; DBF4A; ZDBF1,Protein DBF4 homolog A; Activator of S phase kinase; Chiffon homolog A; DBF4-type zinc finger-containing protein 1,ASK; DBF4A; ZDBF1,10926,DBF4-CDC7 kinase regulatory subunit,DBF4 homolog (S. cerevisiae); DBF4 zinc finger,activator of S phase kinase; chiffon homolog (Drosophila); zinc finger; DBF-type containing 1; DBF4 zinc finger A; regulatory subunit of DDK,ASK; chif; ZDBF1; DBF4A,DBF4-CDC7 kinase regulatory subunit,ASK; CHIF; DBF4A; ZDBF1,DBF4
Q9UBV4,WNT16_HUMAN,WNT16,Protein Wnt-16,,51384,Wnt family member 16,wingless-type MMTV integration site family; member 16,,,Wnt family member 16,,WNT16
Q9UBW7,ZMYM2_HUMAN,ZMYM2; FIM; RAMP; ZNF198,Zinc finger MYM-type protein 2; Fused in myeloproliferative disorders protein; Rearranged in atypical myeloproliferative disorder protein; Zinc finger protein 198,FIM; RAMP; ZNF198,7750,zinc finger MYM-type containing 2,zinc finger protein 198,,RAMP; FIM; MYM,zinc finger MYM-type containing 2,FIM; MYM; NECRC; RAMP; SCLL; ZNF198,ZMYM2
Q9UD71,PPR1B_HUMAN,PPP1R1B; DARPP32,Protein phosphatase 1 regulatory subunit 1B; DARPP-32; Dopamine- and cAMP-regulated neuronal phosphoprotein,DARPP32,84152,protein phosphatase 1 regulatory inhibitor subunit 1B,protein phosphatase 1; regulatory (inhibitor) subunit 1B,dopamine and cAMP regulated phosphoprotein,DARPP-32; FLJ20940,protein phosphatase 1 regulatory inhibitor subunit 1B,DARPP-32; DARPP32,PPP1R1B
Q9UEE5,ST17A_HUMAN,STK17A; DRAK1,Serine/threonine-protein kinase 17A; EC 2.7.11.1; DAP kinase-related apoptosis-inducing protein kinase 1,DRAK1,9263,serine/threonine kinase 17a,serine/threonine kinase 17a (apoptosis-inducing),death-associated protein kinase-related 1,DRAK1,serine/threonine kinase 17a,DRAK1,STK17A
Q9UER7,DAXX_HUMAN,DAXX; BING2; DAP6,Death domain-associated protein 6; Daxx; hDaxx; ETS1-associated protein 1; EAP1; Fas death domain-associated protein,BING2; DAP6,1616,death domain associated protein,death-associated protein 6,,DAP6,death domain associated protein,BING2; DAP6; EAP1; SMIM40,DAXX
Q9UEW8,STK39_HUMAN,STK39; PASK; SPAK,STE20/SPS1-related proline-alanine-rich protein kinase; Ste-20-related kinase; EC 2.7.11.1; DCHT; Serine/threonine-protein kinase 39,PASK; SPAK,27347,serine/threonine kinase 39,serine threonine kinase 39,STE20/SPS1 homolog (yeast),DCHT; SPAK,serine/threonine kinase 39,DCHT; PASK; SPAK,STK39
Q9UEY8,ADDG_HUMAN,ADD3; ADDL,Gamma-adducin; Adducin-like protein 70,ADDL,120,adducin 3,adducin 3 (gamma),gamma-adducin,,adducin 3,ADDL; CPSQ3,ADD3
Q9UFW8,CGBP1_HUMAN,CGGBP1; CGGBP,CGG triplet repeat-binding protein 1; CGG-binding protein 1; 20 kDa CGG-binding protein; p20-CGGBP DNA-binding protein,CGGBP,8545,CGG triplet repeat binding protein 1,,p20-CGG binding protein,p20-CGGBP; CGGBP,CGG triplet repeat binding protein 1,CGGBP; p20-CGGBP,CGGBP1
Q9UGI0,ZRAN1_HUMAN,ZRANB1; TRABID,Ubiquitin thioesterase ZRANB1; EC 3.4.19.12; TRAF-binding domain-containing protein; hTrabid; Zinc finger Ran-binding domain-containing protein 1,TRABID,54764,zinc finger RANBP2-type containing 1,zinc finger; RAN-binding domain containing 1,,TRABID,zinc finger RANBP2-type containing 1,TRABID,ZRANB1
Q9UGI9,AAKG3_HUMAN,PRKAG3; AMPKG3,5'-AMP-activated protein kinase subunit gamma-3; AMPK gamma3; AMPK subunit gamma-3,AMPKG3,53632,protein kinase AMP-activated non-catalytic subunit gamma 3,protein kinase; AMP-activated; gamma 3 non-catalytic subunit,,,protein kinase AMP-activated non-catalytic subunit gamma 3,AMPKG3; SMGMQTL,PRKAG3
Q9UGJ0,AAKG2_HUMAN,PRKAG2,5'-AMP-activated protein kinase subunit gamma-2; AMPK gamma2; AMPK subunit gamma-2; H91620p,,51422,protein kinase AMP-activated non-catalytic subunit gamma 2,protein kinase; AMP-activated; gamma 2 non-catalytic subunit,AMPK gamma2,AAKG; AAKG2; H91620p; WPWS; CMH6,protein kinase AMP-activated non-catalytic subunit gamma 2,AAKG; AAKG2; CMH6; H91620p; WPWS,PRKAG2
Q9UGK3,STAP2_HUMAN,STAP2; BKS,Signal-transducing adaptor protein 2; STAP-2; Breast tumor kinase substrate; BRK substrate,BKS,55620,signal transducing adaptor family member 2,,,STAP-2; BKS,signal transducing adaptor family member 2,BKS,STAP2
Q9UGP5,DPOLL_HUMAN,POLL,DNA polymerase lambda; Pol Lambda; EC 2.7.7.7; EC 4.2.99.-; DNA polymerase beta-2; Pol beta2; DNA polymerase kappa,,27343,DNA polymerase lambda,polymerase (DNA directed); lambda; polymerase (DNA) lambda,,,DNA polymerase lambda,BETAN; POLKAPPA,POLL
Q9UH65,SWP70_HUMAN,SWAP70; KIAA0640; HSPC321,Switch-associated protein 70; SWAP-70,KIAA0640,23075,switching B cell complex subunit SWAP70,SWAP switching B-cell complex 70kDa subunit; SWAP switching B-cell complex subunit 70,switch-associated protein 70,KIAA0640; SWAP-70,switching B cell complex subunit SWAP70,HSPC321; SWAP-70,SWAP70
Q9UH77,KLHL3_HUMAN,KLHL3; KIAA1129,Kelch-like protein 3,KIAA1129,26249,kelch like family member 3,kelch (Drosophila)-like 3; kelch-like 3 (Drosophila),,KIAA1129,kelch like family member 3,PHA2D,KLHL3
Q9UH92,MLX_HUMAN,MLX; BHLHD13; TCFL4,Max-like protein X; Class D basic helix-loop-helix protein 13; bHLHd13; Max-like bHLHZip protein; Protein BigMax; Transcription factor-like protein 4,BHLHD13; TCFL4,6945,MAX dimerization protein MLX,transcription factor-like 4; MAX-like protein X,,MAD7; MXD7; bHLHd13,MAX dimerization protein MLX,MAD7; MXD7; TCFL4; TF4; bHLHd13,MLX
Q9UH99,SUN2_HUMAN,SUN2; FRIGG; KIAA0668; RAB5IP; UNC84B,SUN domain-containing protein 2; Protein unc-84 homolog B; Rab5-interacting protein; Rab5IP; Sad1/unc-84 protein-like 2,FRIGG; KIAA0668; RAB5IP; UNC84B,25777,Sad1 and UNC84 domain containing 2,unc-84 homolog B (C. elegans),,,Sad1 and UNC84 domain containing 2,UNC84B; rab5IP,SUN2
Q9UHB6,LIMA1_HUMAN,LIMA1; EPLIN; SREBP3; PP624,LIM domain and actin-binding protein 1; Epithelial protein lost in neoplasm,EPLIN; SREBP3,51474,LIM domain and actin binding 1,,epithelial protein lost in neoplasm beta,EPLIN,LIM domain and actin binding 1,EPLIN; LDLCQ8; SREBP3,LIMA1
Q9UHD2,TBK1_HUMAN,TBK1; NAK,Serine/threonine-protein kinase TBK1; EC 2.7.11.1; NF-kappa-B-activating kinase; T2K; TANK-binding kinase 1,NAK,29110,TANK binding kinase 1,TANK-binding kinase 1,,NAK,TANK binding kinase 1,AIARV; FTDALS4; IIAE8; NAK; T2K,TBK1
Q9UHD8,SEPT9_HUMAN,SEPTIN9; KIAA0991; MSF; SEPT9,Septin-9; MLL septin-like fusion protein MSF-A; MLL septin-like fusion protein; Ovarian/Breast septin; Ov/Br septin; Septin D1,KIAA0991; MSF; SEPT9,10801,septin 9,MLL septin-like fusion,Ov/Br septin; peanut-like 4 (Drosophila),MSF1; KIAA0991; PNUTL4; AF17q25; SeptD1,septin 9,AF17q25; MSF; MSF1; NAPB; PNUTL4; SEPT9; SINT1; SeptD1,SEPTIN9
Q9UHH9,IP6K2_HUMAN,IP6K2; IHPK2; TCCCIA00113,Inositol hexakisphosphate kinase 2; InsP6 kinase 2; InsP6K2; EC 2.7.4.-; P(i; PiUS,IHPK2,51447,inositol hexakisphosphate kinase 2,inositol hexaphosphate kinase 2,,,inositol hexakisphosphate kinase 2,IHPK2; InsP6K2; PIUS,IP6K2
Q9UHI6,DDX20_HUMAN,DDX20; DP103; GEMIN3,Probable ATP-dependent RNA helicase DDX20; EC 3.6.1.15; EC 3.6.4.13; Component of gems 3; DEAD box protein 20; DEAD box protein DP 103; Gemin-3,DP103; GEMIN3,11218,DEAD-box helicase 20,DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 20; 103kD; DEAD (Asp-Glu-Ala-Asp) box polypeptide 20,Probable ATP-dependent RNA helicase DDX20,DP103; GEMIN3,DEAD-box helicase 20,DP103; GEMIN3,DDX20
Q9UHL9,GT2D1_HUMAN,GTF2IRD1; CREAM1; GTF3; MUSTRD1; RBAP2; WBSCR11; WBSCR12,General transcription factor II-I repeat domain-containing protein 1; GTF2I repeat domain-containing protein 1; General transcription factor III; MusTRD1/BEN; Muscle TFII-I repeat domain-containing protein 1; Slow-muscle-fiber enhancer-binding protein; USE B1-binding protein; Williams-Beuren syndrome chromosomal region 11 protein; Williams-Beuren syndrome chromosomal region 12 protein,CREAM1; GTF3; MUSTRD1; RBAP2; WBSCR11; WBSCR12,9569,GTF2I repeat domain containing 1,GTF2I repeat domain-containing 1,binding factor for early enhancer,MusTRD1; RBAP2; GTF3; WBSCR12; BEN; Cream1,GTF2I repeat domain containing 1,BEN; CREAM1; GTF3; MUSTRD1; RBAP2; WBS; WBSCR11; WBSCR12; hMusTRD1alpha1,GTF2IRD1
Q9UHP3,UBP25_HUMAN,USP25; USP21,Ubiquitin carboxyl-terminal hydrolase 25; EC 3.4.19.12; Deubiquitinating enzyme 25; USP on chromosome 21; Ubiquitin thioesterase 25; Ubiquitin-specific-processing protease 25,USP21,29761,ubiquitin specific peptidase 25,ubiquitin specific protease 25,,USP21,ubiquitin specific peptidase 25,EIG19; USP21,USP25
Q9UHR4,BI2L1_HUMAN,BAIAP2L1; IRTKS,BAR/IMD domain-containing adapter protein 2-like 1; Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1; BAI1-associated protein 2-like protein 1; Insulin receptor tyrosine kinase substrate,IRTKS,55971,BAR/IMD domain containing adaptor protein 2 like 1,BAI1 associated protein 2 like 1,insulin receptor tyrosine kinase substrate,IRTKS,BAR/IMD domain containing adaptor protein 2 like 1,IRTKS,BAIAP2L1
Q9UHW9,S12A6_HUMAN,SLC12A6; KCC3,Solute carrier family 12 member 6; Electroneutral potassium-chloride cotransporter 3; K-Cl cotransporter 3,KCC3,9990,solute carrier family 12 member 6,agenesis of corpus callosum and peripheral neuropathy (Andermann syndrome); solute carrier family 12 (potassium/chloride transporter); member 6,K-Cl cotransporter 3,KCC3A; KCC3B,solute carrier family 12 member 6,ACCPN; CMT2II; KCC3; KCC3A; KCC3B,SLC12A6
Q9UI95,MD2L2_HUMAN,MAD2L2; MAD2B; REV7,Mitotic spindle assembly checkpoint protein MAD2B; Mitotic arrest deficient 2-like protein 2; MAD2-like protein 2; REV7 homolog; hREV7,MAD2B; REV7,10459,mitotic arrest deficient 2 like 2,MAD2 (mitotic arrest deficient; yeast; homolog)-like 2,mitotic arrest deficient homolog-like 2; polymerase (DNA-directed); zeta 2; accessory subunit,MAD2B; REV7; POLZ2; FANCV,mitotic arrest deficient 2 like 2,FANCV; MAD2B; POLZ2; REV7,MAD2L2
Q9UIF9,BAZ2A_HUMAN,BAZ2A; KIAA0314; TIP5,Bromodomain adjacent to zinc finger domain protein 2A; Transcription termination factor I-interacting protein 5; TTF-I-interacting protein 5; Tip5; hWALp3,KIAA0314; TIP5,11176,bromodomain adjacent to zinc finger domain 2A,,TTF-I interacting peptide 5,KIAA0314; TIP5; WALp3,bromodomain adjacent to zinc finger domain 2A,TIP5; WALp3,BAZ2A
Q9UIG0,BAZ1B_HUMAN,BAZ1B; WBSC10; WBSCR10; WBSCR9; WSTF,Tyrosine-protein kinase BAZ1B; EC 2.7.10.2; Bromodomain adjacent to zinc finger domain protein 1B; Williams syndrome transcription factor; Williams-Beuren syndrome chromosomal region 10 protein; Williams-Beuren syndrome chromosomal region 9 protein; hWALp2,WBSC10; WBSCR10; WBSCR9; WSTF,9031,bromodomain adjacent to zinc finger domain 1B,,Williams-Beuren syndrome chromosome region 9; Williams-Beuren syndrome chromosome region 10; transcription factor WSTF,WSTF,bromodomain adjacent to zinc finger domain 1B,WBSCR10; WBSCR9; WSTF,BAZ1B
Q9UII2,ATIF1_HUMAN,ATP5IF1; ATPI; ATPIF1,ATPase inhibitor; mitochondrial; ATP synthase F1 subunit epsilon; Inhibitor of F(1; o; IF(1; IF1,ATPI; ATPIF1,93974,ATP synthase inhibitory factor subunit 1,ATPase inhibitory factor 1,ATPase inhibitor protein; ATP synthase inhibitor protein,ATPI; IP; ATPIP; MGC1167; MGC8898,ATP synthase inhibitory factor subunit 1,ATPI; ATPIF1; ATPIP; IP,ATP5IF1
Q9UII6,DS13B_HUMAN,DUSP13B; DUSP13; SKRP4; TMDP,Dual specificity protein phosphatase 13B; EC 3.1.3.16; EC 3.1.3.48; Dual specificity phosphatase SKRP4; Testis- and skeletal-muscle-specific DSP,DUSP13; SKRP4; TMDP,51207,dual specificity phosphatase 13B,dual specificity phosphatase 13,Testis- and skeletal muscle-specific DUSP,TMDP; SKRP4,dual specificity phosphatase 13B,DUSP13; MDSP; SKRP4; TMDP,DUSP13B
Q9UIK4,DAPK2_HUMAN,DAPK2,Death-associated protein kinase 2; DAP kinase 2; EC 2.7.11.1; DAP-kinase-related protein 1; DRP-1,,23604,death associated protein kinase 2,,,DRP-1; MGC119312,death associated protein kinase 2,DRP-1; DRP1,DAPK2
Q9UIW2,PLXA1_HUMAN,PLXNA1; NOV; PLXN1,Plexin-A1; Semaphorin receptor NOV,NOV; PLXN1,5361,plexin A1,,,NOV,plexin A1,DWOPNED; NOV; NOVP; PLEXIN-A1; PLXN1,PLXNA1
Q9UJ70,NAGK_HUMAN,NAGK,N-acetyl-D-glucosamine kinase; N-acetylglucosamine kinase; EC 2.7.1.59; GlcNAc kinase; Muramyl dipeptide kinase; EC 2.7.1.-; N-acetyl-D-mannosamine kinase; EC 2.7.1.60,,55577,N-acetylglucosamine kinase,,,GNK,N-acetylglucosamine kinase,GNK; HSA242910,NAGK
Q9UJM3,ERRFI_HUMAN,ERRFI1; MIG6,ERBB receptor feedback inhibitor 1; Mitogen-inducible gene 6 protein; MIG-6,MIG6,54206,ERBB receptor feedback inhibitor 1,,,MIG-6; GENE-33; RALT,ERBB receptor feedback inhibitor 1,GENE-33; MIG-6; MIG6; RALT,ERRFI1
Q9UJU2,LEF1_HUMAN,LEF1,Lymphoid enhancer-binding factor 1; LEF-1; T cell-specific transcription factor 1-alpha; TCF1-alpha,,51176,lymphoid enhancer binding factor 1,lymphoid enhancer-binding factor 1,,TCF1ALPHA; TCF10; TCF7L3,lymphoid enhancer binding factor 1,LEF-1; TCF10; TCF1ALPHA; TCF7L3,LEF1
Q9UJU6,DBNL_HUMAN,DBNL; CMAP; SH3P7; PP5423,Drebrin-like protein; Cervical SH3P7; Cervical mucin-associated protein; Drebrin-F; HPK1-interacting protein of 55 kDa; HIP-55; SH3 domain-containing protein 7,CMAP; SH3P7,28988,drebrin like,drebrin-like,actin-binding protein 1; HPK1-interacting protein of 55 kDa,SH3P7; HIP-55; ABP1,drebrin like,ABP1; HIP-55; HIP55; SH3P7,DBNL
Q9UJV9,DDX41_HUMAN,DDX41; ABS,Probable ATP-dependent RNA helicase DDX41; EC 3.6.4.13; DEAD box protein 41; DEAD box protein abstrakt homolog,ABS,51428,DEAD-box helicase 41,DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,Abstrakt,ABS; MGC8828,DEAD-box helicase 41,ABS; MPLPF,DDX41
Q9UJX2,CDC23_HUMAN,CDC23; ANAPC8,Cell division cycle protein 23 homolog; Anaphase-promoting complex subunit 8; APC8; Cyclosome subunit 8,ANAPC8,8697,cell division cycle 23,CDC23 (cell division cycle 23; yeast; homolog); cell division cycle 23 homolog (S. cerevisiae),anaphase promoting complex subunit 8,APC8; ANAPC8; CUT23,cell division cycle 23,ANAPC8; APC8; CUT23,CDC23
Q9UJX3,APC7_HUMAN,ANAPC7; APC7,Anaphase-promoting complex subunit 7; APC7; Cyclosome subunit 7,APC7,,anaphase promoting complex subunit 7,,,APC7,,,ANAPC7
Q9UJX4,APC5_HUMAN,ANAPC5; APC5,Anaphase-promoting complex subunit 5; APC5; Cyclosome subunit 5,APC5,51433,anaphase promoting complex subunit 5,,,APC5,anaphase promoting complex subunit 5,APC5,ANAPC5
Q9UJX5,APC4_HUMAN,ANAPC4; APC4,Anaphase-promoting complex subunit 4; APC4; Cyclosome subunit 4,APC4,29945,anaphase promoting complex subunit 4,,,APC4,anaphase promoting complex subunit 4,APC4,ANAPC4
Q9UJX6,ANC2_HUMAN,ANAPC2; APC2; KIAA1406,Anaphase-promoting complex subunit 2; APC2; Cyclosome subunit 2,APC2; KIAA1406,29882,anaphase promoting complex subunit 2,,,APC2; KIAA1406,anaphase promoting complex subunit 2,APC2,ANAPC2
Q9UJY1,HSPB8_HUMAN,HSPB8; CRYAC; E2IG1; HSP22; PP1629,Heat shock protein beta-8; HspB8; Alpha-crystallin C chain; E2-induced gene 1 protein; Heat shock protein family B member 8; Protein kinase H11; Small stress protein-like protein HSP22,CRYAC; E2IG1; HSP22,26353,heat shock protein family B (small) member 8,heat shock 27kDa protein 8; heat shock 22kDa protein 8,,H11; E2IG1; HSP22; CMT2L,heat shock protein family B (small) member 8,CMT2L; DHMN2; E2IG1; H11; HMN2; HMN2A; HMND2; HSP22; HSPB8-N1; HSPB8-N2; MFM13,HSPB8
Q9UJY5,GGA1_HUMAN,GGA1,ADP-ribosylation factor-binding protein GGA1; Gamma-adaptin-related protein 1; Golgi-localized; gamma ear-containing; ARF-binding protein 1,,26088,golgi associated; gamma adaptin ear containing; ARF binding protein 1,,,,golgi associated; gamma adaptin ear containing; ARF binding protein 1,,GGA1
Q9UK17,KCND3_HUMAN,KCND3,A-type voltage-gated potassium channel KCND3; Potassium voltage-gated channel subfamily D member 3; Voltage-gated potassium channel subunit Kv4.3,,3752,potassium voltage-gated channel subfamily D member 3,spinocerebellar ataxia 22; spinocerebellar ataxia 19; potassium voltage-gated channel; Shal-related subfamily; member 3,,Kv4.3; KSHIVB,potassium voltage-gated channel subfamily D member 3,BRGDA9; KCND3L; KCND3S; KSHIVB; KV4.3; SCA19; SCA22,KCND3
Q9UK32,KS6A6_HUMAN,RPS6KA6; RSK4,Ribosomal protein S6 kinase alpha-6; S6K-alpha-6; EC 2.7.11.1; 90 kDa ribosomal protein S6 kinase 6; p90-RSK 6; p90RSK6; Ribosomal S6 kinase 4; RSK-4; pp90RSK4,RSK4,27330,ribosomal protein S6 kinase A6,ribosomal protein S6 kinase; 90kD; polypeptide 6,,RSK4,ribosomal protein S6 kinase A6,PP90RSK4; RSK-4; RSK4; S6K-alpha-6; p90RSK6,RPS6KA6
Q9UK53,ING1_HUMAN,ING1,Inhibitor of growth protein 1,,3621,inhibitor of growth family member 1,,inhibitor of growth 1; tumor suppressor ING1; growth inhibitor ING1; growth inhibitory protein ING1,p33ING1; p33ING1b; p24ING1c; p33; p47; p47ING1a,inhibitor of growth family member 1,p24ING1c; p33; p33ING1; p33ING1b; p47; p47ING1a,ING1
Q9UK80,UBP21_HUMAN,USP21; USP23; PP1490,Ubiquitin carboxyl-terminal hydrolase 21; EC 3.4.19.12; Deubiquitinating enzyme 21; Ubiquitin thioesterase 21; Ubiquitin-specific-processing protease 21,USP23,27005,ubiquitin specific peptidase 21,ubiquitin specific protease 21,,USP16,ubiquitin specific peptidase 21,USP16; USP23,USP21
Q9UKA4,AKA11_HUMAN,AKAP11; AKAP220; KIAA0629,A-kinase anchor protein 11; AKAP-11; A-kinase anchor protein 220 kDa; AKAP 220; hAKAP220; Protein kinase A-anchoring protein 11; PRKA11,AKAP220; KIAA0629,11215,A-kinase anchoring protein 11,A kinase (PRKA) anchor protein 11,AKAP 220; A-kinase anchoring protein; 220kDa; protein kinase A anchoring protein 11; protein phosphatase 1; regulatory subunit 44,KIAA0629; AKAP220; PRKA11; FLJ11304; DKFZp781I12161; PPP1R44,A-kinase anchoring protein 11,AKAP-11; AKAP220; PPP1R44; PRKA11,AKAP11
Q9UKE5,TNIK_HUMAN,TNIK; KIAA0551,TRAF2 and NCK-interacting protein kinase; EC 2.7.11.1,KIAA0551,23043,TRAF2 and NCK interacting kinase,,,KIAA0551,TRAF2 and NCK interacting kinase,MRT54,TNIK
Q9UKG1,DP13A_HUMAN,APPL1; APPL; DIP13A; KIAA1428,DCC-interacting protein 13-alpha; Dip13-alpha; Adapter protein containing PH domain; PTB domain and leucine zipper motif 1,APPL; DIP13A; KIAA1428,26060,adaptor protein; phosphotyrosine interacting with PH domain and leucine zipper 1,adaptor protein; phosphotyrosine interaction; PH domain and leucine zipper containing 1,DCC-interacting protein 13-alpha,APPL,adaptor protein; phosphotyrosine interacting with PH domain and leucine zipper 1,APPL; DIP13alpha; MODY14,APPL1
Q9UKI8,TLK1_HUMAN,TLK1; KIAA0137,Serine/threonine-protein kinase tousled-like 1; EC 2.7.11.1; PKU-beta; Tousled-like kinase 1,KIAA0137,9874,tousled like kinase 1,tousled-like kinase 1,,KIAA0137; PKU-BETA,tousled like kinase 1,PKU-beta,TLK1
Q9UKM9,RALY_HUMAN,RALY; HNRPCL2; P542,RNA-binding protein Raly; Autoantigen p542; Heterogeneous nuclear ribonucleoprotein C-like 2; hnRNP core protein C-like 2; hnRNP associated with lethal yellow protein homolog,HNRPCL2; P542,22913,RALY heterogeneous nuclear ribonucleoprotein,RNA-binding protein (autoantigenic; hnRNP-associated with lethal yellow); RNA binding protein; autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)),,P542; HNRPCL2,RALY heterogeneous nuclear ribonucleoprotein,HNRPCL2; P542,RALY
Q9UKT4,FBX5_HUMAN,FBXO5; EMI1; FBX5,F-box only protein 5; Early mitotic inhibitor 1,EMI1; FBX5,26271,F-box protein 5,F-box only protein 5,early fission inhibitory protein 1,FBX5; Fbxo31; EMI1,F-box protein 5,EMI1; FBX5; Fbxo31,FBXO5
Q9UKT5,FBX4_HUMAN,FBXO4; FBX4,F-box only protein 4,FBX4,26272,F-box protein 4,F-box only protein 4,,FBX4,F-box protein 4,FBX4,FBXO4
Q9UKV0,HDAC9_HUMAN,HDAC9; HDAC7; HDAC7B; HDRP; KIAA0744; MITR,Histone deacetylase 9; HD9; EC 3.5.1.98; Histone deacetylase 7B; HD7; HD7b; Histone deacetylase-related protein; MEF2-interacting transcription repressor MITR,HDAC7; HDAC7B; HDRP; KIAA0744; MITR,9734,histone deacetylase 9,,,KIAA0744; HDAC; MITR; HD7; HDAC7B,histone deacetylase 9,ARCND4; HD7; HD7b; HD9; HDAC; HDAC7; HDAC7B; HDAC9B; HDAC9FL; HDRP; MITR,HDAC9
Q9UKV3,ACINU_HUMAN,ACIN1; ACINUS; KIAA0670,Apoptotic chromatin condensation inducer in the nucleus; Acinus,ACINUS; KIAA0670,22985,apoptotic chromatin condensation inducer 1,apoptotic chromatin condensation inducer in the nucleus,functional spliceosome-associated protein 152,KIAA0670; fSAP152,apoptotic chromatin condensation inducer 1,ACINUS; ACN; fSAP152,ACIN1
Q9UKV5,AMFR_HUMAN,AMFR; RNF45,E3 ubiquitin-protein ligase AMFR; EC 2.3.2.36; Autocrine motility factor receptor; AMF receptor; RING finger protein 45; gp78,RNF45,267,autocrine motility factor receptor,,,RNF45; gp78,autocrine motility factor receptor,GP78; RNF45; SPG89,AMFR
Q9UKV8,AGO2_HUMAN,AGO2; EIF2C2,Protein argonaute-2; Argonaute2; hAgo2; EC 3.1.26.n2; Argonaute RISC catalytic component 2; Eukaryotic translation initiation factor 2C 2; eIF-2C 2; eIF2C 2; PAZ Piwi domain protein; PPD; Protein slicer,EIF2C2,27161,argonaute RISC catalytic component 2,eukaryotic translation initiation factor 2C; 2; cancer susceptibility candidate 7 (non-protein coding),argonaute 2,hAGO2; Q10; LINC00980,argonaute RISC catalytic component 2,CASC7; EIF2C2; LESKRES; LINC00980; PPD; Q10,AGO2
Q9UKW4,VAV3_HUMAN,VAV3,Guanine nucleotide exchange factor VAV3; VAV-3,,10451,vav guanine nucleotide exchange factor 3,vav 3 oncogene; vav 3 guanine nucleotide exchange factor,,,vav guanine nucleotide exchange factor 3,,VAV3
Q9UKX2,MYH2_HUMAN,MYH2; MYHSA2,Myosin-2; Myosin heavy chain 2; Myosin heavy chain 2a; MyHC-2a; Myosin heavy chain IIa; MyHC-IIa; Myosin heavy chain; skeletal muscle; adult 2,MYHSA2,4620,myosin heavy chain 2,myosin; heavy polypeptide 2; skeletal muscle; adult; inclusion body myopathy 3; autosomal dominant,,MYH2A; MYHSA2; MyHC-IIa; MYHas8; MyHC-2A,myosin heavy chain 2,CMYO6; CMYP6; IBM3; MYH2A; MYHSA2; MYHas8; MYPOP; MyHC-2A; MyHC-IIa,MYH2
Q9UKX7,NUP50_HUMAN,NUP50; NPAP60L; PRO1146,Nuclear pore complex protein Nup50; 50 kDa nucleoporin; Nuclear pore-associated protein 60 kDa-like; Nucleoporin Nup50,NPAP60L,10762,nucleoporin 50,nucleoporin 50kDa,,,nucleoporin 50,NPAP60; NPAP60L,NUP50
Q9UKY1,ZHX1_HUMAN,ZHX1,Zinc fingers and homeoboxes protein 1,,11244,zinc fingers and homeoboxes 1,zinc-fingers and homeoboxes 1,,,zinc fingers and homeoboxes 1,,ZHX1
Q9UL17,TBX21_HUMAN,TBX21; TBET; TBLYM,T-box transcription factor TBX21; T-box protein 21; T-cell-specific T-box transcription factor T-bet; Transcription factor TBLYM,TBET; TBLYM,30009,T-box transcription factor 21,T-box 21,T-box transcription factor expressed in T cells,TBLYM; T-bet,T-box transcription factor 21,IMD88; T-PET; T-bet; TBET; TBLYM,TBX21
Q9UL54,TAOK2_HUMAN,TAOK2; KIAA0881; MAP3K17; PSK; PSK1; UNQ2971/PRO7431,Serine/threonine-protein kinase TAO2; EC 2.7.11.1; Kinase from chicken homolog C; hKFC-C; Prostate-derived sterile 20-like kinase 1; PSK-1; PSK1; Prostate-derived STE20-like kinase 1; Thousand and one amino acid protein kinase 2,KIAA0881; MAP3K17; PSK; PSK1,9344,TAO kinase 2,,Serine/threonine-protein kinase TAO2; Thousand and one amino acid protein kinase 2; Kinase from chicken homolog C; Prostate-derived sterile 20-like kinase 1,TAO1; KIAA0881; PSK; PSK1; TAO2; MAP3K17; hKFC-C; PSK-1; PSK1-BETA; Tao2beta,TAO kinase 2,MAP3K17; PSK; PSK1; PSK1-BETA; TAO1; TAO2; Tao2beta,TAOK2
Q9ULC4,MCTS1_HUMAN,MCTS1; MCT1,Malignant T-cell-amplified sequence 1; MCT-1; Multiple copies T-cell malignancies,MCT1,28985,MCTS1 re-initiation and release factor,malignant T-cell amplified sequence 1; MCTS1; re-initiation and release factor,multiple copies in T-cell lymphoma-1,MCT-1,MCTS1 re-initiation and release factor,IMD118; MCT-1; MCT1,MCTS1
Q9ULH0,KDIS_HUMAN,KIDINS220; ARMS; KIAA1250,Kinase D-interacting substrate of 220 kDa; Ankyrin repeat-rich membrane-spanning protein,ARMS; KIAA1250,57498,kinase D interacting substrate 220,kinase D-interacting substrate 220kDa,ankyrin repeat-rich membrane-spanning protein,ARMS,kinase D interacting substrate 220,ARMS; SINO; VENARG,KIDINS220
Q9ULJ8,NEB1_HUMAN,PPP1R9A; KIAA1222,Neurabin-1; Neurabin-I; Neural tissue-specific F-actin-binding protein I; Protein phosphatase 1 regulatory subunit 9A,KIAA1222,55607,protein phosphatase 1 regulatory subunit 9A,protein phosphatase 1; regulatory (inhibitor) subunit 9A; protein phosphatase 1; regulatory subunit 9A,,Neurabin-I; KIAA1222; FLJ20068,protein phosphatase 1 regulatory subunit 9A,NRB1; NRBI; Neurabin-I,PPP1R9A
Q9ULR3,PPM1H_HUMAN,PPM1H; ARHCL1; KIAA1157; URCC2,Protein phosphatase 1H; EC 3.1.3.16,ARHCL1; KIAA1157; URCC2,57460,protein phosphatase; Mg2+/Mn2+ dependent 1H,ras homolog gene family; member C like 1; protein phosphatase 1H (PP2C domain containing); protein phosphatase; Mg2+/Mn2+ dependent; 1H,neurite extension-related protein phosphatase related to PP2C,KIAA1157; FLJ13253; NERPP-2C,protein phosphatase; Mg2+/Mn2+ dependent 1H,ARHCL1; NERPP-2C; URCC2,PPM1H
Q9ULV1,FZD4_HUMAN,FZD4,Frizzled-4; Fz-4; hFz4; FzE4; CD antigen CD344,,8322,frizzled class receptor 4,frizzled (Drosophila) homolog 4; exudative vitreoretinopathy 1; frizzled homolog 4 (Drosophila); frizzled 4; seven transmembrane spanning receptor; frizzled family receptor 4,,CD344,frizzled class receptor 4,CD344; EVR1; FEVR; FZD4S; Fz-4; Fz4; FzE4; GPCR; hFz4,FZD4
Q9ULV4,COR1C_HUMAN,CORO1C; CRN2; CRNN4,Coronin-1C; Coronin-3; hCRNN4,CRN2; CRNN4,23603,coronin 1C,coronin; actin-binding protein; 1C,,coronin-3; HCRNN4,coronin 1C,HCRNN4,CORO1C
Q9ULV5,HSF4_HUMAN,HSF4,Heat shock factor protein 4; HSF 4; hHSF4; Heat shock transcription factor 4; HSTF 4,,3299,heat shock transcription factor 4,cataract; Marner,,,heat shock transcription factor 4,CTM; CTRCT5,HSF4
Q9ULV8,CBLC_HUMAN,CBLC; CBL3; RNF57,E3 ubiquitin-protein ligase CBL-C; EC 2.3.2.27; RING finger protein 57; RING-type E3 ubiquitin transferase CBL-C; SH3-binding protein CBL-3; SH3-binding protein CBL-C; Signal transduction protein CBL-C,CBL3; RNF57,23624,Cbl proto-oncogene C,Cas-Br-M (murine) ectropic retroviral transforming sequence c; Cas-Br-M (murine) ecotropic retroviral transforming sequence c; Cbl proto-oncogene C; E3 ubiquitin protein ligase,,CBL-3; CBL-SL; RNF57,Cbl proto-oncogene C,CBL-3; CBL-SL; RNF57,CBLC
Q9ULW0,TPX2_HUMAN,TPX2; C20orf1; C20orf2; DIL2; HCA519,Targeting protein for Xklp2; Differentially expressed in cancerous and non-cancerous lung cells 2; DIL-2; Hepatocellular carcinoma-associated antigen 519; Hepatocellular carcinoma-associated antigen 90; Protein fls353; Restricted expression proliferation-associated protein 100; p100,C20orf1; C20orf2; DIL2; HCA519,22974,TPX2 microtubule nucleation factor,chromosome 20 open reading frame 1; TPX2; microtubule-associated; homolog (Xenopus laevis); TPX2; microtubule-associated,Targeting protein for Xklp2; differentially expressed in cancerous and noncancerous lung cells 2; hepatocellular carcinoma-associated antigen 519,p100; DIL-2; HCA519; FLS353,TPX2 microtubule nucleation factor,C20orf1; C20orf2; DIL-2; DIL2; FLS353; GD:C20orf1; HCA519; HCTP4; REPP86; p100,TPX2
Q9ULW2,FZD10_HUMAN,FZD10,Frizzled-10; Fz-10; hFz10; FzE7; CD antigen CD350,,11211,frizzled class receptor 10,frizzled (Drosophila) homolog 10; frizzled homolog 10 (Drosophila); frizzled 10; seven transmembrane spanning receptor; frizzled family receptor 10,Frizzled-10,CD350,frizzled class receptor 10,CD350; FZ-10; Fz10; FzE7; hFz10,FZD10
Q9ULX3,NOB1_HUMAN,NOB1; ART4; NOB1P; PSMD8BP1; MSTP158,RNA-binding protein NOB1; EC 3.1.-.-; Phosphorylation regulatory protein HP-10; Protein ART-4,ART4; NOB1P; PSMD8BP1,28987,NIN1 (RPN12) binding protein 1 homolog,PSMD8 binding protein 1; NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); NIN1/PSMD8 binding protein 1 homolog,nin one binding protein,NOB1P; ART-4; MST158,NIN1 (RPN12) binding protein 1 homolog,ART-4; MST158; MSTP158; NOB1P; PSMD8BP1,NOB1
Q9UM11,FZR1_HUMAN,FZR1; CDH1; FYR; FZR; KIAA1242,Fizzy-related protein homolog; Fzr; CDC20-like protein 1; Cdh1/Hct1 homolog; hCDH1,CDH1; FYR; FZR; KIAA1242,51343,fizzy and cell division cycle 20 related 1,fizzy/cell division cycle 20 related 1 (Drosophila); fizzy/cell division cycle 20 related 1,CDC20 homolog 1,HCDH1; CDH1; HCDH; FZR; FZR2; KIAA1242; CDC20C,fizzy and cell division cycle 20 related 1,CDC20C; CDH1; DEE109; FZR; FZR2; HCDH; HCDH1,FZR1
Q9UM13,APC10_HUMAN,ANAPC10; APC10,Anaphase-promoting complex subunit 10; APC10; Cyclosome subunit 10,APC10,10393,anaphase promoting complex subunit 10,,,APC10; DOC1; DKFZP564L0562,anaphase promoting complex subunit 10,APC10; DOC1,ANAPC10
Q9UM54,MYO6_HUMAN,MYO6; KIAA0389,Unconventional myosin-VI; Unconventional myosin-6,KIAA0389,4646,myosin VI,deafness; autosomal recessive 37,,KIAA0389,myosin VI,DFNA22; DFNB37,MYO6
Q9UM73,ALK_HUMAN,ALK,ALK tyrosine kinase receptor; EC 2.7.10.1; Anaplastic lymphoma kinase; CD antigen CD246,,238,ALK receptor tyrosine kinase,anaplastic lymphoma kinase (Ki-1); anaplastic lymphoma receptor tyrosine kinase,,CD246; ALK1,ALK receptor tyrosine kinase,ALK1; CD246; NBLST3,ALK
Q9UMD9,COHA1_HUMAN,COL17A1; BP180; BPAG2,Collagen alpha-1(XVII) chain; XVII; 180 kDa bullous pemphigoid antigen 2; Bullous pemphigoid antigen 2; 120 kDa linear IgA dermatosis antigen; Linear IgA disease antigen 1; LAD-1; 97 kDa linear IgA bullous dermatosis antigen; 97 kDa LAD antigen; 97-LAD; Linear IgA bullous disease antigen of 97 kDa; LABD97,BP180; BPAG2,1308,collagen type XVII alpha 1 chain,collagen; type XVII; alpha 1,,BP180,collagen type XVII alpha 1 chain,BA16H23.2; BP180; BPA-2; BPAG2; ERED; JEB4; LAD-1,COL17A1
Q9UMR2,DD19B_HUMAN,DDX19B; DBP5; DDX19; TDBP,ATP-dependent RNA helicase DDX19B; EC 3.6.4.13; DEAD box RNA helicase DEAD5; DEAD box protein 19B,DBP5; DDX19; TDBP,11269,DEAD-box helicase 19B,DEAD (Asp-Glu-Ala-As) box polypeptide 19; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 19 (Dbp5; yeast; homolog); DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B,dead box protein 5 homolog (S. cerevisiae),DBP5,DEAD-box helicase 19B,DBP5; DDX19; RNAh,DDX19B
Q9UMS0,NFU1_HUMAN,NFU1; HIRIP5; CGI-33,NFU1 iron-sulfur cluster scaffold homolog; mitochondrial; HIRA-interacting protein 5,HIRIP5,27247,NFU1 iron-sulfur cluster scaffold,HIRA interacting protein 5; NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae),,CGI-33; NifU; NIFUC,NFU1 iron-sulfur cluster scaffold,CGI-33; HIRIP; HIRIP5; MMDFS; MMDS1; NIFUC; Nfu; NifU; SPG93,NFU1
Q9UMX1,SUFU_HUMAN,SUFU; UNQ650/PRO1280,Suppressor of fused homolog; SUFUH,,51684,SUFU negative regulator of hedgehog signaling,suppressor of fused homolog (Drosophila),,SUFUH; SUFUXL; PRO1280,SUFU negative regulator of hedgehog signaling,BCNS2; JBTS32; PRO1280; SUFUH; SUFUXL,SUFU
Q9UN19,DAPP1_HUMAN,DAPP1; BAM32; HSPC066,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide; hDAPP1; B lymphocyte adapter protein Bam32; B-cell adapter molecule of 32 kDa,BAM32,27071,dual adaptor of phosphotyrosine and 3-phosphoinositides 1,,,BAM32,dual adaptor of phosphotyrosine and 3-phosphoinositides 1,BAM32,DAPP1
Q9UN36,NDRG2_HUMAN,NDRG2; KIAA1248; SYLD,Protein NDRG2; N-myc downstream-regulated gene 2 protein; Protein Syld709613,KIAA1248; SYLD,57447,NDRG family member 2,,,KIAA1248; SYLD,NDRG family member 2,SYLD,NDRG2
Q9UN42,AT1B4_HUMAN,ATP1B4,Protein ATP1B4; X;K-ATPase subunit beta-m; X/potassium-transporting ATPase subunit beta-m,,23439,ATPase Na+/K+ transporting family member beta 4,ATPase; (Na+)/K+ transporting; beta 4 polypeptide; ATPase; Na+/K+ transporting; beta 4 polypeptide,Na;K-ATPase beta m-subunit; BetaM,,ATPase Na+/K+ transporting family member beta 4,,ATP1B4
Q9UNH5,CC14A_HUMAN,CDC14A,Dual specificity protein phosphatase CDC14A; EC 3.1.3.16; EC 3.1.3.48; CDC14 cell division cycle 14 homolog A,,8556,cell division cycle 14A,CDC10 (cell division cycle 10; S. cerevisiae; homolog); CDC14 cell division cycle 14 homolog A (S. cerevisiae); deafness; autosomal recessive 32,,Cdc14A1; Cdc14A2; cdc14; DFNB105,cell division cycle 14A,DFNB105; DFNB32; DFNB35; cdc14; hCDC14,CDC14A
Q9UNI6,DUS12_HUMAN,DUSP12,Dual specificity protein phosphatase 12; EC 3.1.3.16; EC 3.1.3.48; Dual specificity tyrosine phosphatase YVH1,,11266,dual specificity phosphatase 12,,serine/threonine specific protein phosphatase; YVH1 protein-tyrosine phosphatase (S. cerevisiae) ortholog,YVH1; DUSP1,dual specificity phosphatase 12,DUSP1; YVH1,DUSP12
Q9UNN5,FAF1_HUMAN,FAF1; UBXD12; UBXN3A; CGI-03,FAS-associated factor 1; hFAF1; UBX domain-containing protein 12; UBX domain-containing protein 3A,UBXD12; UBXN3A,11124,Fas associated factor 1,Fas (TNFRSF6) associated factor 1,TNFRSF6-associated factor 1; UBX domain protein 3A,CGI-03; hFAF1; HFAF1s; UBXD12; UBXN3A,Fas associated factor 1,CGI-03; HFAF1s; UBXD12; UBXN3A; hFAF1,FAF1
Q9UNQ0,ABCG2_HUMAN,ABCG2; ABCP; BCRP; BCRP1; MXR,Broad substrate specificity ATP-binding cassette transporter ABCG2; EC 7.6.2.2; ATP-binding cassette sub-family G member 2; Breast cancer resistance protein; CDw338; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; Urate exporter; CD antigen CD338,ABCP; BCRP; BCRP1; MXR,9429,ATP binding cassette subfamily G member 2 (JR blood group),ATP-binding cassette; sub-family G (WHITE); member 2; ATP-binding cassette; sub-family G (WHITE); member 2 (Junior blood group); ATP binding cassette subfamily G member 2 (Junior blood group),,EST157481; MXR; BCRP; ABCP; CD338,ATP binding cassette subfamily G member 2 (JR blood group),ABC15; ABCP; BCRP; BCRP1; BMDP; CD338; CDw338; CDw388; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; UAQTL1,ABCG2
Q9UNZ2,NSF1C_HUMAN,NSFL1C; UBXN2C,NSFL1 cofactor p47; UBX domain-containing protein 2C; p97 cofactor p47,UBXN2C,55968,NSFL1 cofactor,NSFL1 (p97) cofactor (p47),SHP1 homolog (S. cerevisiae); UBX domain protein 2C,dJ776F14.1; p47; UBXD10; UBX1; UBXN2C,NSFL1 cofactor,P47; UBX1; UBXD10; UBXN2C; dJ776F14.1,NSFL1C
Q9UP38,FZD1_HUMAN,FZD1,Frizzled-1; Fz-1; hFz1; FzE1,,8321,frizzled class receptor 1,frizzled (Drosophila) homolog 1; frizzled homolog 1 (Drosophila); frizzled 1; seven transmembrane spanning receptor; frizzled family receptor 1,Wnt receptor; frizzled; Drosophila; homolog of; 1; Frizzled-1,DKFZp564G072; Hfz1,frizzled class receptor 1,,FZD1
Q9UP65,PA24C_HUMAN,PLA2G4C,Cytosolic phospholipase A2 gamma; cPLA2-gamma; EC 3.1.1.4; Cytosolic lysophospholipase; EC 3.1.1.5; Cytosolic lysophospholipid O-acyltransferase; EC 2.3.1.-; Phospholipase A2 group IVC,,8605,phospholipase A2 group IVC,phospholipase A2; group IVC (cytosolic; calcium-independent),,cPLA2-gamma,phospholipase A2 group IVC,CPLA2-gamma,PLA2G4C
Q9UP95,S12A4_HUMAN,SLC12A4; KCC1,Solute carrier family 12 member 4; Electroneutral potassium-chloride cotransporter 1; Erythroid K-Cl cotransporter 1; hKCC1,KCC1,6560,solute carrier family 12 member 4,solute carrier family 12 (potassium/chloride transporter); member 4,,KCC1,solute carrier family 12 member 4,CTC-479C5.17; KCC1; hKCC1,SLC12A4
Q9UPN3,MACF1_HUMAN,MACF1; ABP620; ACF7; KIAA0465; KIAA0754; KIAA1251,Microtubule-actin cross-linking factor 1; isoforms 1/2/3/4/5; 620 kDa actin-binding protein; ABP620; Actin cross-linking family protein 7; Macrophin-1; Trabeculin-alpha,ABP620; ACF7; KIAA0465; KIAA0754; KIAA1251,23499,microtubule actin crosslinking factor 1,KIAA0754,actin cross-linking factor; 620 kDa actin binding protein; macrophin 1; trabeculin-alpha; actin cross-linking family protein 7; postulated migration inhibitory factor,KIAA0465; ACF7; ABP620; KIAA1251; MACF; FLJ45612; FLJ46776; Lnc-PMIF,microtubule actin crosslinking factor 1,ABP620; ACF7; KIAA0754; LIS9; Lnc-PMIF; MACF; OFC4,MACF1
Q9UPN4,CP131_HUMAN,CEP131; AZI1; KIAA1118,Centrosomal protein of 131 kDa; 5-azacytidine-induced protein 1; Pre-acrosome localization protein 1,AZI1; KIAA1118,22994,centrosomal protein 131,5-azacytidine induced 1; centrosomal protein 131kDa,,AZ1; KIAA1118,centrosomal protein 131,AZ1; AZI1; ZA1,CEP131
Q9UPP1,PHF8_HUMAN,PHF8; KIAA1111; ZNF422,Histone lysine demethylase PHF8; EC 1.14.11.27; EC 1.14.11.65; PHD finger protein 8; histone H3-dimethyl-L-lysine(36; histone H3-dimethyl-L-lysine(9,KIAA1111; ZNF422,23133,PHD finger protein 8,,jumonji C domain-containing histone demethylase 1F; histone lysine demethylase PHF8; lysine demethylase 7B; zinc finger protein 422,ZNF422; KIAA1111; JHDM1F; KDM7B,PHD finger protein 8,JHDM1F; KDM7B; MRXSSD; ZNF422,PHF8
Q9UPR5,NAC2_HUMAN,SLC8A2; KIAA1087; NCX2,Sodium/calcium exchanger 2; Na(+; 2+; Solute carrier family 8 member 2,KIAA1087; NCX2,6543,solute carrier family 8 member A2,solute carrier family 8 (sodium/calcium exchanger); member 2,,NCX2; KIAA1087,solute carrier family 8 member A2,NCX2,SLC8A2
Q9UPT5,EXOC7_HUMAN,EXOC7; EXO70; KIAA1067,Exocyst complex component 7; Exocyst complex component Exo70,EXO70; KIAA1067,23265,exocyst complex component 7,,,EXO70; KIAA1067; YJL085W; Exo70p; BLOM4,exocyst complex component 7,2-5-3p; BLOM4; EX070; EXO70; EXOC1; Exo70p; NEDSEBA; YJL085W,EXOC7
Q9UPT6,JIP3_HUMAN,MAPK8IP3; JIP3; KIAA1066,C-Jun-amino-terminal kinase-interacting protein 3; JIP-3; JNK-interacting protein 3; JNK MAP kinase scaffold protein 3; Mitogen-activated protein kinase 8-interacting protein 3,JIP3; KIAA1066,23162,mitogen-activated protein kinase 8 interacting protein 3,,homolog of Drosophila Sunday driver 2,KIAA1066; JSAP1; JIP3; syd,mitogen-activated protein kinase 8 interacting protein 3,JIP-3; JIP3; JSAP1; NEDBA; SYD2; syd,MAPK8IP3
Q9UPT8,ZC3H4_HUMAN,ZC3H4; C19orf7; KIAA1064,Zinc finger CCCH domain-containing protein 4,C19orf7; KIAA1064,23211,zinc finger CCCH-type containing 4,chromosome 19 open reading frame 7,,KIAA1064,zinc finger CCCH-type containing 4,C19orf7,ZC3H4
Q9UPU5,UBP24_HUMAN,USP24; KIAA1057,Ubiquitin carboxyl-terminal hydrolase 24; EC 3.4.19.12; Deubiquitinating enzyme 24; Ubiquitin thioesterase 24; Ubiquitin-specific-processing protease 24,KIAA1057,23358,ubiquitin specific peptidase 24,ubiquitin specific protease 24,,KIAA1057,ubiquitin specific peptidase 24,,USP24
Q9UPV0,CE164_HUMAN,CEP164; KIAA1052; NPHP15,Centrosomal protein of 164 kDa; Cep164,KIAA1052; NPHP15,22897,centrosomal protein 164,centrosomal protein 164kDa,,KIAA1052; NPHP15,centrosomal protein 164,NPHP15,CEP164
Q9UPY5,XCT_HUMAN,SLC7A11,Cystine/glutamate transporter; Amino acid transport system xc-; Calcium channel blocker resistance protein CCBR1; Solute carrier family 7 member 11; xCT,,23657,solute carrier family 7 member 11,solute carrier family 7 (anionic amino acid transporter light chain; xc- system); member 11,,xCT,solute carrier family 7 member 11,CCBR1; xCT,SLC7A11
Q9UPY6,WASF3_HUMAN,WASF3; KIAA0900; SCAR3; WAVE3,Actin-binding protein WASF3; Protein WAVE-3; Verprolin homology domain-containing protein 3; Wiskott-Aldrich syndrome protein family member 3; WASP family protein member 3,KIAA0900; SCAR3; WAVE3,10810,WASP family member 3,WAS protein family; member 3; WAS protein family member 3,,WAVE3; SCAR3; KIAA0900,WASP family member 3,Brush-1; SCAR3; WAVE3,WASF3
Q9UPY8,MARE3_HUMAN,MAPRE3,Microtubule-associated protein RP/EB family member 3; EB1 protein family member 3; EBF3; End-binding protein 3; EB3; RP3,,22924,microtubule associated protein RP/EB family member 3,,,RP3; EB3,microtubule associated protein RP/EB family member 3,EB3; EBF3; EBF3-S; RP3,MAPRE3
Q9UPZ9,CILK1_HUMAN,CILK1; ICK; KIAA0936,Serine/threonine-protein kinase ICK; EC 2.7.11.1; Ciliogenesis associated kinase 1; Intestinal cell kinase; hICK; Laryngeal cancer kinase 2; LCK2; MAK-related kinase; MRK,ICK; KIAA0936,22858,ciliogenesis associated kinase 1,intestinal cell (MAK-like) kinase; intestinal cell kinase,serine/threonine-protein kinase ICK; MAK-related kinase,MRK; LCK2; KIAA0936; MGC46090,ciliogenesis associated kinase 1,ECO; EJM10; ICK; LCK2; MRK; hICK,CILK1
Q9UQ13,SHOC2_HUMAN,SHOC2; KIAA0862,Leucine-rich repeat protein SHOC-2; Protein soc-2 homolog; Protein sur-8 homolog,KIAA0862,8036,SHOC2 leucine rich repeat scaffold protein,soc-2 (suppressor of clear; C.elegans) homolog; soc-2 suppressor of clear homolog (C. elegans); SHOC2 leucine-rich repeat scaffold protein; SHOC2; leucine rich repeat scaffold protein,,KIAA0862; SOC2; SUR-8; SOC-2; SUR8,SHOC2 leucine rich repeat scaffold protein,NSLH1; SIAA0862; SOC2; SUR8,SHOC2
Q9UQ35,SRRM2_HUMAN,SRRM2; KIAA0324; SRL300; SRM300; HSPC075,Serine/arginine repetitive matrix protein 2; 300 kDa nuclear matrix antigen; Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa; SR-related nuclear matrix protein of 300 kDa; Ser/Arg-related nuclear matrix protein of 300 kDa; Splicing coactivator subunit SRm300; Tax-responsive enhancer element-binding protein 803; TaxREB803,KIAA0324; SRL300; SRM300,23524,serine/arginine repetitive matrix 2,,,SRm300; SRL300; KIAA0324; Cwc21,serine/arginine repetitive matrix 2,300-KD; CWF21; Cwc21; HSPC075; MRD72; SRL300; SRm300,SRRM2
Q9UQ80,PA2G4_HUMAN,PA2G4; EBP1,Proliferation-associated protein 2G4; Cell cycle protein p38-2G4 homolog; hG4-1; ErbB3-binding protein 1,EBP1,5036,proliferation-associated 2G4,proliferation-associated 2G4; 38kD; proliferation-associated 2G4; 38kDa,ErbB-3 receptor binding protein; IRES-specific cellular transacting factor 45,EBP1; ITAF45,proliferation-associated 2G4,EBP1; HG4-1; ITAF45; p38-2G4,PA2G4
Q9UQ84,EXO1_HUMAN,EXO1; EXOI; HEX1,Exonuclease 1; hExo1; EC 3.1.-.-; Exonuclease I; hExoI,EXOI; HEX1,9156,exonuclease 1,,rad2 nuclease family member; homolog of S. cerevisiae exonuclease 1,HEX1; hExoI,exonuclease 1,HEX1; hExoI,EXO1
Q9UQB8,BAIP2_HUMAN,BAIAP2,BAR/IMD domain-containing adapter protein 2; Brain-specific angiogenesis inhibitor 1-associated protein 2; BAI-associated protein 2; BAI1-associated protein 2; Protein BAP2; Fas ligand-associated factor 3; FLAF3; Insulin receptor substrate p53/p58; IRS-58; IRSp53/58; Insulin receptor substrate protein of 53 kDa; IRSp53; Insulin receptor substrate p53,,10458,BAR/IMD domain containing adaptor protein 2,BAI1 associated protein 2,insulin receptor substrate of 53 kDa; WASP and MIM like,BAP2; IRSp53; WAML,BAR/IMD domain containing adaptor protein 2,BAP2; FLAF3; IRSP53; WAML,BAIAP2
Q9UQB9,AURKC_HUMAN,AURKC; AIE2; AIK3; AIRK3; ARK3; STK13,Aurora kinase C; EC 2.7.11.1; Aurora 3; Aurora/IPL1-related kinase 3; ARK-3; Aurora-related kinase 3; Aurora/IPL1/Eg2 protein 2; Serine/threonine-protein kinase 13; Serine/threonine-protein kinase aurora-C,AIE2; AIK3; AIRK3; ARK3; STK13,6795,aurora kinase C,serine/threonine kinase 13 (aurora/IPL1-like),,AurC; ARK3,aurora kinase C,AIE2; AIK3; ARK3; AurC; HEL-S-90; SPGF5; STK13; aurora-C,AURKC
Q9UQC2,GAB2_HUMAN,GAB2; KIAA0571,GRB2-associated-binding protein 2; GRB2-associated binder 2; Growth factor receptor bound protein 2-associated protein 2; pp100,KIAA0571,9846,GRB2 associated binding protein 2,,Grb2-associated binder 2,KIAA0571,GRB2 associated binding protein 2,,GAB2
Q9UQE7,SMC3_HUMAN,SMC3; BAM; BMH; CSPG6; SMC3L1,Structural maintenance of chromosomes protein 3; SMC protein 3; SMC-3; Basement membrane-associated chondroitin proteoglycan; Bamacan; Chondroitin sulfate proteoglycan 6; Chromosome-associated polypeptide; hCAP,BAM; BMH; CSPG6; SMC3L1,9126,structural maintenance of chromosomes 3,chondroitin sulfate proteoglycan 6 (bamacan),bamacan proteoglycan,HCAP; BAM; SMC3L1; bamacan,structural maintenance of chromosomes 3,BAM; BMH; CDLS3; CSPG6; HCAP; SMC3L1,SMC3
Q9UQF2,JIP1_HUMAN,MAPK8IP1; IB1; JIP1; PRKM8IP,C-Jun-amino-terminal kinase-interacting protein 1; JIP-1; JNK-interacting protein 1; Islet-brain 1; IB-1; JNK MAP kinase scaffold protein 1; Mitogen-activated protein kinase 8-interacting protein 1,IB1; JIP1; PRKM8IP,9479,mitogen-activated protein kinase 8 interacting protein 1,,,IB1; JIP-1; JIP1,mitogen-activated protein kinase 8 interacting protein 1,IB1; JIP-1; JIP1; PRKM8IP,MAPK8IP1
Q9UQK1,PPR3C_HUMAN,PPP1R3C; PPP1R5,Protein phosphatase 1 regulatory subunit 3C; Protein phosphatase 1 regulatory subunit 5; PP1 subunit R5; Protein targeting to glycogen; PTG,PPP1R5,5507,protein phosphatase 1 regulatory subunit 3C,protein phosphatase 1; regulatory (inhibitor) subunit 3C; protein phosphatase 1; regulatory subunit 3C,Phosphatase 1; regulatory inhibitor subunit 5; protein targeting to glycogen,PTG,protein phosphatase 1 regulatory subunit 3C,PPP1R5; PTG,PPP1R3C
Q9UQL6,HDAC5_HUMAN,HDAC5; KIAA0600,Histone deacetylase 5; HD5; EC 3.5.1.98; Antigen NY-CO-9,KIAA0600,10014,histone deacetylase 5,,,KIAA0600; NY-CO-9; FLJ90614,histone deacetylase 5,HD5; NY-CO-9,HDAC5
Q9UQM7,KCC2A_HUMAN,CAMK2A; CAMKA; KIAA0968,Calcium/calmodulin-dependent protein kinase type II subunit alpha; CaM kinase II subunit alpha; CaMK-II subunit alpha; EC 2.7.11.17,CAMKA; KIAA0968,815,calcium/calmodulin dependent protein kinase II alpha,calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha,CaM-kinase II alpha chain; calcium/calmodulin-dependent protein kinase II alpha-B subunit; CaM kinase II alpha subunit; CaMK-II alpha subunit; calcium/calmodulin-dependent protein kinase type II alpha chain,KIAA0968; CaMKIINalpha; CaMKII??,calcium/calmodulin dependent protein kinase II alpha,CAMKA; CaMKIINalpha; CaMKIIalpha; MRD53; MRT63,CAMK2A
Q9UQQ2,SH2B3_HUMAN,SH2B3; LNK,SH2B adapter protein 3; Lymphocyte adapter protein; Lymphocyte-specific adapter protein Lnk; Signal transduction protein Lnk,LNK,10019,SH2B adaptor protein 3,,lymphocyte adaptor protein,LNK; IDDM20,SH2B adaptor protein 3,IDDM20; LNK,SH2B3
Q9UQR0,SCML2_HUMAN,SCML2,Sex comb on midleg-like protein 2,,10389,Scm polycomb group protein like 2,sex comb on midleg (Drosophila)-like 2; sex comb on midleg like 2 (Drosophila),,,Scm polycomb group protein like 2,,SCML2
Q9UQR1,ZN148_HUMAN,ZNF148; ZBP89,Zinc finger protein 148; Transcription factor ZBP-89; Zinc finger DNA-binding protein 89,ZBP89,7707,zinc finger protein 148,zinc finger protein 148 (pHZ-52),,BERF-1; ZBP-89; BFCOL1; HT-BETA; ZFP148; pHZ-52,zinc finger protein 148,BERF-1; BFCOL1; GDACCF; HT-BETA; ZBP-89; ZFP148; pHZ-52,ZNF148
Q9Y210,TRPC6_HUMAN,TRPC6; TRP6,Short transient receptor potential channel 6; TrpC6; Transient receptor protein 6; TRP-6,TRP6,7225,transient receptor potential cation channel subfamily C member 6,focal segmental glomerulosclerosis 2; transient receptor potential cation channel; subfamily C; member 6,,TRP6,transient receptor potential cation channel subfamily C member 6,FSGS2; TRP6,TRPC6
Q9Y233,PDE10_HUMAN,PDE10A,cAMP and cAMP-inhibited cGMP 3';5'-cyclic phosphodiesterase 10A; EC 3.1.4.17,,10846,phosphodiesterase 10A,,cAMP and cAMP-inhibited cGMP 3';5'-cyclic phosphodiesterase 10A,,phosphodiesterase 10A,ADSD2; HSPDE10A; IOLOD; LINC00473; PDE10A19,PDE10A
Q9Y237,PIN4_HUMAN,PIN4,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4; EC 5.2.1.8; Parvulin-14; Par14; hPar14; Parvulin-17; Par17; hPar17; Peptidyl-prolyl cis-trans isomerase Pin4; PPIase Pin4; Peptidyl-prolyl cis/trans isomerase EPVH; hEPVH; Rotamase Pin4,,5303,peptidylprolyl cis/trans isomerase; NIMA-interacting 4,protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting; 4 (parvulin); peptidylprolyl cis/trans isomerase NIMA-interacting; 4,parvulin,PAR14; PAR17; EPVH,peptidylprolyl cis/trans isomerase; NIMA-interacting 4,EPVH; PAR14; PAR17; hEPVH; hPar14; hPar17,PIN4
Q9Y243,AKT3_HUMAN,AKT3; PKBG,RAC-gamma serine/threonine-protein kinase; EC 2.7.11.1; Protein kinase Akt-3; Protein kinase B gamma; PKB gamma; RAC-PK-gamma; STK-2,PKBG,10000,AKT serine/threonine kinase 3,v-akt murine thymoma viral oncogene homolog 3,protein kinase B; gamma,PKBG; RAC-gamma; PRKBG,AKT serine/threonine kinase 3,MPPH; MPPH2; PKB-GAMMA; PKBG; PRKBG; RAC-PK-gamma; RAC-gamma; STK-2,AKT3
Q9Y248,PSF2_HUMAN,GINS2; PSF2; CGI-122; DC5; HSPC037,DNA replication complex GINS protein PSF2; GINS complex subunit 2,PSF2,51659,GINS complex subunit 2,GINS complex subunit 2 (Psf2 homolog),,PSF2; Pfs2,GINS complex subunit 2,HSPC037; PSF2; Pfs2,GINS2
Q9Y253,POLH_HUMAN,POLH; RAD30; RAD30A; XPV,DNA polymerase eta; EC 2.7.7.7; RAD30 homolog A; Xeroderma pigmentosum variant type protein,RAD30; RAD30A; XPV,5429,DNA polymerase eta,polymerase (DNA directed); eta; polymerase (DNA) eta,,RAD30A; XP-V,DNA polymerase eta,RAD30; RAD30A; XP-V; XPV,POLH
Q9Y259,CHKB_HUMAN,CHKB; CHETK; CHKL,Choline/ethanolamine kinase; Choline kinase beta; CK; CKB; EC 2.7.1.32; Choline kinase-like protein; Ethanolamine kinase; EK; EC 2.7.1.82; Ethanolamine kinase beta; EKB; choline/ethanolamine kinase beta; CKEKB,CHETK; CHKL,1120,choline kinase beta,choline kinase-like,,CHETK,choline kinase beta,CHETK; CHKL; CK; CKB; CKEKB; EK; EKB; MDCMC,CHKB
Q9Y261,FOXA2_HUMAN,FOXA2; HNF3B; TCF3B,Hepatocyte nuclear factor 3-beta; HNF-3-beta; HNF-3B; Forkhead box protein A2; Transcription factor 3B; TCF-3B,HNF3B; TCF3B,3170,forkhead box A2,hepatocyte nuclear factor 3; beta,,,forkhead box A2,HNF-3-beta; HNF3B; TCF3B,FOXA2
Q9Y265,RUVB1_HUMAN,RUVBL1; INO80H; NMP238; TIP49; TIP49A,RuvB-like 1; EC 3.6.4.12; 49 kDa TATA box-binding protein-interacting protein; 49 kDa TBP-interacting protein; 54 kDa erythrocyte cytosolic protein; ECP-54; INO80 complex subunit H; Nuclear matrix protein 238; NMP 238; Pontin 52; TIP49a; TIP60-associated protein 54-alpha; TAP54-alpha,INO80H; NMP238; TIP49; TIP49A,8607,RuvB like AAA ATPase 1,RuvB (E coli homolog)-like 1; RuvB-like 1 (E. coli); RuvB-like AAA ATPase; RuvB-like AAA ATPase 1,pontin; INO80 complex subunit H,TIP49; NMP238; RVB1; TIP49a; Pontin52; ECP54; TIH1; Rvb1; INO80H,RuvB like AAA ATPase 1,ECP-54; ECP54; INO80H; NMP 238; NMP238; PONTIN; Pontin52; RVB1; TIH1; TIP49; TIP49A,RUVBL1
Q9Y266,NUDC_HUMAN,NUDC,Nuclear migration protein nudC; Nuclear distribution protein C homolog,,10726,nuclear distribution C; dynein complex regulator,nuclear distribution gene C homolog (A. nidulans); nuclear distribution C homolog (A. nidulans); nudC nuclear distribution protein,,,nuclear distribution C; dynein complex regulator,HNUDC; MNUDC; NPD011,NUDC
Q9Y281,COF2_HUMAN,CFL2,Cofilin-2; Cofilin; muscle isoform,,1073,cofilin 2,cofilin 2 (muscle),nemaline myopathy type 7,NEM7,cofilin 2,NEM7,CFL2
Q9Y283,INVS_HUMAN,INVS; INV; NPHP2,Inversin; Inversion of embryo turning homolog; Nephrocystin-2,INV; NPHP2,27130,inversin,nephronophthisis 2 (infantile),nephrocystin 2,,inversin,INV; NPH2; NPHP2,INVS
Q9Y285,SYFA_HUMAN,FARSA; FARS; FARSL; FARSLA,Phenylalanine--tRNA ligase alpha subunit; EC 6.1.1.20; CML33; Phenylalanyl-tRNA synthetase alpha subunit; PheRS,FARS; FARSL; FARSLA,2193,phenylalanyl-tRNA synthetase subunit alpha,phenylalanine-tRNA synthetase-like; phenylalanyl-tRNA synthetase-like; alpha subunit,phenylalanine tRNA ligase 1; alpha; cytoplasmic,CML33,phenylalanyl-tRNA synthetase subunit alpha,CML33; FARSL; FARSLA; FRSA; PheHA; RILDBC2,FARSA
Q9Y294,ASF1A_HUMAN,ASF1A; CGI-98; HSPC146,Histone chaperone ASF1A; Anti-silencing function protein 1 homolog A; hAsf1; hAsf1a; CCG1-interacting factor A; CIA; hCIA,,25842,anti-silencing function 1A histone chaperone,ASF1 anti-silencing function 1 homolog A (S. cerevisiae),,DKFZP547E2110; CIA,anti-silencing function 1A histone chaperone,CGI-98; CIA; HSPC146,ASF1A
Q9Y295,DRG1_HUMAN,DRG1; NEDD3,Developmentally-regulated GTP-binding protein 1; DRG-1; Neural precursor cell expressed developmentally down-regulated protein 3; NEDD-3; Translation factor GTPase DRG1; TRAFAC GTPase DRG1; EC 3.6.5.-,NEDD3,4733,developmentally regulated GTP binding protein 1,developmentally regulated GTP-binding protein 1,,,developmentally regulated GTP binding protein 1,NEDD3; TANALS,DRG1
Q9Y2H1,ST38L_HUMAN,STK38L; KIAA0965; NDR2,Serine/threonine-protein kinase 38-like; EC 2.7.11.1; NDR2 protein kinase; Nuclear Dbf2-related kinase 2,KIAA0965; NDR2,23012,serine/threonine kinase 38 like,,nuclear Dbf2-related 2,KIAA0965; NDR2,serine/threonine kinase 38 like,NDR2,STK38L
Q9Y2I6,NINL_HUMAN,NINL; KIAA0980; NLP,Ninein-like protein,KIAA0980; NLP,22981,ninein like,,ninein-like protein,KIAA0980; NLP,ninein like,NLP,NINL
Q9Y2I7,FYV1_HUMAN,PIKFYVE; KIAA0981; PIP5K3,1-phosphatidylinositol 3-phosphate 5-kinase; Phosphatidylinositol 3-phosphate 5-kinase; EC 2.7.1.150; FYVE finger-containing phosphoinositide kinase; PIKfyve; Phosphatidylinositol 3-phosphate 5-kinase type III; PIPkin-III; Type III PIP kinase; Serine-protein kinase PIKFYVE; EC 2.7.11.1,KIAA0981; PIP5K3,200576,phosphoinositide kinase; FYVE-type zinc finger containing,phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase; type III; phosphoinositide kinase; FYVE finger containing,zinc finger; FYVE domain containing 29,MGC40423; KIAA0981; PIP5K; p235; ZFYVE29; FAB1,phosphoinositide kinase; FYVE-type zinc finger containing,CFD; FAB1; HEL37; PIP5K; PIP5K3; ZFYVE29,PIKFYVE
Q9Y2J4,AMOL2_HUMAN,AMOTL2; KIAA0989,Angiomotin-like protein 2; Leman coiled-coil protein; LCCP,KIAA0989,51421,angiomotin like 2,,Leman coiled-coil protein; angiomotin-like protein 2,LCCP,angiomotin like 2,LCCP,AMOTL2
Q9Y2K2,SIK3_HUMAN,SIK3; KIAA0999; QSK; L19,Serine/threonine-protein kinase SIK3; EC 2.7.11.1; Salt-inducible kinase 3; SIK-3; Serine/threonine-protein kinase QSK,KIAA0999; QSK,23387,SIK family kinase 3,,salt-inducible kinase 3,FLJ12240; L19; KIAA0999; QSK,SIK family kinase 3,L19; QSK; SEMDK; SIK-3,SIK3
Q9Y2K6,UBP20_HUMAN,USP20; KIAA1003; LSFR3A; VDU2,Ubiquitin carboxyl-terminal hydrolase 20; EC 3.4.19.12; Deubiquitinating enzyme 20; Ubiquitin thioesterase 20; Ubiquitin-specific-processing protease 20; VHL-interacting deubiquitinating enzyme 2; hVDU2,KIAA1003; LSFR3A; VDU2,10868,ubiquitin specific peptidase 20,ubiquitin specific protease 20,,KIAA1003,ubiquitin specific peptidase 20,LSFR3A; VDU2; hVDU2,USP20
Q9Y2K7,KDM2A_HUMAN,KDM2A; CXXC8; FBL11; FBL7; FBXL11; JHDM1A; KIAA1004,Lysine-specific demethylase 2A; EC 1.14.11.27; CXXC-type zinc finger protein 8; F-box and leucine-rich repeat protein 11; F-box protein FBL7; F-box protein Lilina; F-box/LRR-repeat protein 11; JmjC domain-containing histone demethylation protein 1A; Histone-H3-lysine-36 demethylase 1A,CXXC8; FBL11; FBL7; FBXL11; JHDM1A; KIAA1004,22992,lysine demethylase 2A,F-box and leucine-rich repeat protein 11; lysine (K)-specific demethylase 2A,F-box protein FBL11; jumonji C domain-containing histone demethylase 1A,KIAA1004; FBL11; LILINA; DKFZP434M1735; FBL7; FLJ00115; CXXC8; JHDM1A,lysine demethylase 2A,CXXC8; FBL11; FBL7; FBXL11; JHDM1A; LILINA,KDM2A
Q9Y2R2,PTN22_HUMAN,PTPN22; PTPN8,Tyrosine-protein phosphatase non-receptor type 22; EC 3.1.3.48; Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP; Lymphoid phosphatase; LyP; PEST-domain phosphatase; PEP,PTPN8,26191,protein tyrosine phosphatase non-receptor type 22,protein tyrosine phosphatase; non-receptor type 8; protein tyrosine phosphatase; non-receptor type 22 (lymphoid),,Lyp; Lyp1; Lyp2,protein tyrosine phosphatase non-receptor type 22,LYP; LYP1; LYP2; PEP; PTPN22.5; PTPN22.6; PTPN8,PTPN22
Q9Y2R4,DDX52_HUMAN,DDX52; ROK1; HUSSY-19,Probable ATP-dependent RNA helicase DDX52; EC 3.6.4.13; ATP-dependent RNA helicase ROK1-like; DEAD box protein 52,ROK1,11056,DExD-box helicase 52,DEAD (Asp-Glu-Ala-Asp) box polypeptide 52; DEAD-box helicase 52,,ROK1,DExD-box helicase 52,HUSSY19; ROK1,DDX52
Q9Y2T1,AXIN2_HUMAN,AXIN2,Axin-2; Axin-like protein; Axil; Axis inhibition protein 2; Conductin,,8313,axin 2,,conductin; axil,MGC126582; DKFZp781B0869,axin 2,AXIL; ODCRCS,AXIN2
Q9Y2T7,YBOX2_HUMAN,YBX2; CSDA3; MSY2,Y-box-binding protein 2; Contrin; DNA-binding protein C; Dbpc; Germ cell-specific Y-box-binding protein; MSY2 homolog,CSDA3; MSY2,51087,Y-box binding protein 2,,,MSY2; CSDA3; Contrin,Y-box binding protein 2,CONTRIN; CSDA3; DBPC; MSY2,YBX2
Q9Y2U5,M3K2_HUMAN,MAP3K2; MAPKKK2; MEKK2,Mitogen-activated protein kinase kinase kinase 2; EC 2.7.11.25; MAPK/ERK kinase kinase 2; MEK kinase 2; MEKK 2,MAPKKK2; MEKK2,10746,mitogen-activated protein kinase kinase kinase 2,,MAP/ERK kinase kinase 2,MEKK2B,mitogen-activated protein kinase kinase kinase 2,MEKK2; MEKK2B,MAP3K2
Q9Y2V2,CHSP1_HUMAN,CARHSP1,Calcium-regulated heat-stable protein 1; Calcium-regulated heat-stable protein of 24 kDa; CRHSP-24,,23589,calcium regulated heat stable protein 1,calcium regulated heat stable protein 1 (24kD); calcium regulated heat stable protein 1; 24kDa,,CRHSP-24; CSDC1,calcium regulated heat stable protein 1,CRHSP-24; CRHSP24; CSDC1,CARHSP1
Q9Y2W1,TR150_HUMAN,THRAP3; BCLAF2; TRAP150,Thyroid hormone receptor-associated protein 3; BCLAF1 and THRAP3 family member 2; Thyroid hormone receptor-associated protein complex 150 kDa component; Trap150,BCLAF2; TRAP150,9967,thyroid hormone receptor associated protein 3,,TR-associated protein; 150-kDa; BCLAF1 and THRAP3 family member 2,TRAP150; BCLAF2,thyroid hormone receptor associated protein 3,BCLAF2; TRAP150,THRAP3
Q9Y2W7,CSEN_HUMAN,KCNIP3; CSEN; DREAM; KCHIP3,Calsenilin; A-type potassium channel modulatory protein 3; DRE-antagonist modulator; DREAM; Kv channel-interacting protein 3; KChIP3,CSEN; DREAM; KCHIP3,30818,potassium voltage-gated channel interacting protein 3,calsenilin; presenilin-binding protein; EF hand transcription factor; Kv channel interacting protein 3; calsenilin,calsenilin; DRE-antagonist modulator,DREAM; KCHIP3,potassium voltage-gated channel interacting protein 3,CSEN; DREAM; KCHIP3,KCNIP3
Q9Y2X7,GIT1_HUMAN,GIT1,ARF GTPase-activating protein GIT1; ARF GAP GIT1; Cool-associated and tyrosine-phosphorylated protein 1; CAT-1; CAT1; G protein-coupled receptor kinase-interactor 1; GRK-interacting protein 1; p95-APP1,,28964,GIT ArfGAP 1,G protein-coupled receptor kinase interactor 1; G protein-coupled receptor kinase interacting ArfGAP 1,,,GIT ArfGAP 1,p95-APP1,GIT1
Q9Y2X9,ZN281_HUMAN,ZNF281; GZP1; ZBP99,Zinc finger protein 281; GC-box-binding zinc finger protein 1; Transcription factor ZBP-99; Zinc finger DNA-binding protein 99,GZP1; ZBP99,23528,zinc finger protein 281,,,ZBP-99,zinc finger protein 281,GZP1; ZBP-99; ZBP99; ZNP-99,ZNF281
Q9Y2Z0,SGT1_HUMAN,SUGT1,Protein SGT1 homolog; Protein 40-6-3; Sgt1; Suppressor of G2 allele of SKP1 homolog,,10910,SGT1 homolog; MIS12 kinetochore complex assembly cochaperone,SGT1; suppressor of G2 allele of SKP1 (S. cerevisiae),,SGT1,SGT1 homolog; MIS12 kinetochore complex assembly cochaperone,SGT1,SUGT1
Q9Y365,STA10_HUMAN,STARD10; SDCCAG28; CGI-52,START domain-containing protein 10; StARD10; Antigen NY-CO-28; PCTP-like protein; PCTP-L; Serologically defined colon cancer antigen 28; StAR-related lipid transfer protein 10,SDCCAG28,10809,StAR related lipid transfer domain containing 10,serologically defined colon cancer antigen 28; START domain containing 10,,NY-CO-28; CGI-52; PCTP2,StAR related lipid transfer domain containing 10,CGI-52; NY-CO-28; PCTP2; SDCCAG28,STARD10
Q9Y371,SHLB1_HUMAN,SH3GLB1; KIAA0491; CGI-61,Endophilin-B1; Bax-interacting factor 1; Bif-1; SH3 domain-containing GRB2-like protein B1,KIAA0491,51100,SH3 domain containing GRB2 like; endophilin B1,SH3-domain; GRB2-like; endophilin B1,protein phosphatase 1; regulatory subunit 70,CGI-61; KIAA0491; Bif-1; PPP1R70,SH3 domain containing GRB2 like; endophilin B1,Bif-1; CGI-61; PPP1R70; dJ612B15.2,SH3GLB1
Q9Y3C5,RNF11_HUMAN,RNF11; CGI-123,RING finger protein 11,,26994,ring finger protein 11,,,CGI-123; Sid1669p; MGC51169,ring finger protein 11,CGI-123; SID1669,RNF11
Q9Y3E5,PTH2_HUMAN,PTRH2; BIT1; PTH2; CGI-147,Peptidyl-tRNA hydrolase 2; mitochondrial; PTH 2; EC 3.1.1.29; Bcl-2 inhibitor of transcription 1,BIT1; PTH2,51651,peptidyl-tRNA hydrolase 2,,Bcl-2 inhibitor of transcription; cilia and flagella associated protein 37,BIT1; CGI-147; PTH2; CFAP37,peptidyl-tRNA hydrolase 2,BIT1; CFAP37; CGI-147; IMNEPD; PTH; PTH 2; PTH2,PTRH2
Q9Y3F4,STRAP_HUMAN,STRAP; MAWD; UNRIP,Serine-threonine kinase receptor-associated protein; MAP activator with WD repeats; UNR-interacting protein; WD-40 repeat protein PT-WD,MAWD; UNRIP,11171,serine/threonine kinase receptor associated protein,,Unr-interacting protein; mitogen-activated protein kinase activator with WD repeats; MAPK activator with WD repeats,UNRIP; pt-wd; MAWD,serine/threonine kinase receptor associated protein,MAWD; PT-WD; UNRIP,STRAP
Q9Y3M2,CBY1_HUMAN,CBY1; ARB1; C22orf2; CBY; PGEA1; HRIHFB2025,Protein chibby homolog 1; ARPP-binding protein; Cytosolic leucine-rich protein; PIGEA-14; PKD2 interactor; Golgi and endoplasmic reticulum-associated 1,ARB1; C22orf2; CBY; PGEA1,25776,chibby 1; beta catenin antagonist,chromosome 22 open reading frame 2; PKD2 interactor; golgi and endoplasmic reticulum associated 1; chibby homolog 1 (Drosophila); chibby family member 1; beta catenin antagonist,chibby CTNNB1-mediated transcription inhibitor,PIGEA14; PIGEA-14; Chibby; Cby; Chibby1,chibby 1; beta catenin antagonist,C22orf2; CBY; Chibby1; HS508I15A; PGEA1; PIGEA-14; PIGEA14; arb1,CBY1
Q9Y3Q4,HCN4_HUMAN,HCN4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,,10021,hyperpolarization activated cyclic nucleotide gated potassium channel 4,hyperpolarization activated cyclic nucleotide-gated potassium channel 4,,,hyperpolarization activated cyclic nucleotide gated potassium channel 4,BRGDA8; EIG18; SSS2,HCN4
Q9Y3S1,WNK2_HUMAN,WNK2; KIAA1760; PRKWNK2; SDCCAG43; P/OKcl.13,Serine/threonine-protein kinase WNK2; EC 2.7.11.1; Antigen NY-CO-43; Protein kinase lysine-deficient 2; Protein kinase with no lysine 2; Serologically defined colon cancer antigen 43,KIAA1760; PRKWNK2; SDCCAG43,65268,WNK lysine deficient protein kinase 2,serologically defined colon cancer antigen 43,,NY-CO-43; KIAA1760,WNK lysine deficient protein kinase 2,NY-CO-43; P/OKcl.13; PRKWNK2; SDCCAG43,WNK2
Q9Y3Y2,CHTOP_HUMAN,CHTOP; C1orf77; FOP; HT031; PP7704,Chromatin target of PRMT1 protein; Friend of PRMT1 protein; Small arginine- and glycine-rich protein; SRAG,C1orf77; FOP,26097,chromatin target of PRMT1,chromosome 1 open reading frame 77,small protein rich in arginine and glycine; Friend of Prmt1,DKFZP547E1010; SRAG; FOP,chromatin target of PRMT1,C10orf77; C1orf77; FL-SRAG; FOP; SRAG; SRAG-3; SRAG-5; pp7704,CHTOP
Q9Y3Z3,SAMH1_HUMAN,SAMHD1; MOP5,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1; dNTPase; EC 3.1.5.-; Dendritic cell-derived IFNG-induced protein; DCIP; Monocyte protein 5; MOP-5; SAM domain and HD domain-containing protein 1; hSAMHD1,MOP5,25939,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,SAM domain and HD domain 1,HD domain containing 1; monocyte protein 5; Aicardi-Goutieres syndrome 5,SBBI88; Mg11; HDDC1; MOP-5; AGS5,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,CHBL2; DCIP; HDDC1; MOP-5; SBBI88; hSAMHD1,SAMHD1
Q9Y463,DYR1B_HUMAN,DYRK1B; MIRK,Dual specificity tyrosine-phosphorylation-regulated kinase 1B; EC 2.7.12.1; Minibrain-related kinase; Mirk protein kinase,MIRK,9149,dual specificity tyrosine phosphorylation regulated kinase 1B,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B; dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1B,minibrain-related kinase,MIRK,dual specificity tyrosine phosphorylation regulated kinase 1B,AOMS3; MIRK,DYRK1B
Q9Y478,AAKB1_HUMAN,PRKAB1; AMPK,5'-AMP-activated protein kinase subunit beta-1; AMPK subunit beta-1; AMPKb,AMPK,5564,protein kinase AMP-activated non-catalytic subunit beta 1,protein kinase; AMP-activated; beta 1 non-catalytic subunit,AMPK beta 1,,protein kinase AMP-activated non-catalytic subunit beta 1,AMPK; HAMPKb,PRKAB1
Q9Y490,TLN1_HUMAN,TLN1; KIAA1027; TLN,Talin-1,KIAA1027; TLN,7094,talin 1,,,ILWEQ,talin 1,ILWEQ; TLN; talin-1,TLN1
Q9Y496,KIF3A_HUMAN,KIF3A; KIF3,Kinesin-like protein KIF3A; Microtubule plus end-directed kinesin motor 3A,KIF3,11127,kinesin family member 3A,,kinesin family protein 3A,FLA10; KLP-20,kinesin family member 3A,FLA10; KLP-20,KIF3A
Q9Y4C1,KDM3A_HUMAN,KDM3A; JHDM2A; JMJD1; JMJD1A; KIAA0742; TSGA,Lysine-specific demethylase 3A; EC 1.14.11.65; JmjC domain-containing histone demethylation protein 2A; Jumonji domain-containing protein 1A; histone H3-dimethyl-L-lysine(9,JHDM2A; JMJD1; JMJD1A; KIAA0742; TSGA,55818,lysine demethylase 3A,jumonji domain containing 1; jumonji domain containing 1A; lysine (K)-specific demethylase 3A,jumonji C domain-containing histone demethylase 2A,TSGA; KIAA0742; JHMD2A,lysine demethylase 3A,JHDM2A; JHMD2A; JMJD1; JMJD1A; TSGA,KDM3A
Q9Y4D2,DGLA_HUMAN,DAGLA; C11orf11; KIAA0659; NSDDR,Diacylglycerol lipase-alpha; DAGL-alpha; DGL-alpha; EC 3.1.1.116; Neural stem cell-derived dendrite regulator; Sn1-specific diacylglycerol lipase alpha,C11orf11; KIAA0659; NSDDR,747,diacylglycerol lipase alpha,chromosome 11 open reading frame 11; diacylglycerol lipase; alpha,neural stem cell-derived dendrite regulator,KIAA0659; NSDDR; DAGLALPHA,diacylglycerol lipase alpha,C11orf11; DAGL(ALPHA); DAGLALPHA; NOC2; NSDDR,DAGLA
Q9Y4E8,UBP15_HUMAN,USP15; KIAA0529,Ubiquitin carboxyl-terminal hydrolase 15; EC 3.4.19.12; Deubiquitinating enzyme 15; Ubiquitin thioesterase 15; Ubiquitin-specific-processing protease 15; Unph-2; Unph4,KIAA0529,9958,ubiquitin specific peptidase 15,ubiquitin specific protease 15,,KIAA0529; UNPH4,ubiquitin specific peptidase 15,UNPH-2; UNPH4,USP15
Q9Y4G8,RPGF2_HUMAN,RAPGEF2; KIAA0313; NRAPGEP; PDZGEF1,Rap guanine nucleotide exchange factor 2; Cyclic nucleotide ras GEF; CNrasGEF; Neural RAP guanine nucleotide exchange protein; nRap GEP; PDZ domain-containing guanine nucleotide exchange factor 1; PDZ-GEF1; RA-GEF-1; Ras/Rap1-associating GEF-1,KIAA0313; NRAPGEP; PDZGEF1,9693,Rap guanine nucleotide exchange factor 2,PDZ domain containing guanine nucleotide exchange factor (GEF) 1; Rap guanine nucleotide exchange factor (GEF) 2,Rap GEP,PDZ-GEF1; RA-GEF; DKFZP586O1422; KIAA0313,Rap guanine nucleotide exchange factor 2,CNrasGEF; NRAPGEP; PDZ-GEF1; PDZGEF1; RA-GEF; RA-GEF-1; RAGEF; Rap-GEP; nRap GEP,RAPGEF2
Q9Y4H2,IRS2_HUMAN,IRS2,Insulin receptor substrate 2; IRS-2,,8660,insulin receptor substrate 2,,,,insulin receptor substrate 2,IRS-2,IRS2
Q9Y4K3,TRAF6_HUMAN,TRAF6; RNF85,TNF receptor-associated factor 6; EC 2.3.2.27; E3 ubiquitin-protein ligase TRAF6; Interleukin-1 signal transducer; RING finger protein 85; RING-type E3 ubiquitin transferase TRAF6,RNF85,7189,TNF receptor associated factor 6,TNF receptor-associated factor 6; E3 ubiquitin protein ligase,RING finger protein 85,RNF85,TNF receptor associated factor 6,MGC:3310; RNF85,TRAF6
Q9Y4K4,M4K5_HUMAN,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5; EC 2.7.11.1; Kinase homologous to SPS1/STE20; KHS; MAPK/ERK kinase kinase kinase 5; MEK kinase kinase 5; MEKKK 5,,11183,mitogen-activated protein kinase kinase kinase kinase 5,,germinal center kinase-related,KHS1; GCKR; KHS,mitogen-activated protein kinase kinase kinase kinase 5,GCKR; KHS; KHS1; MAPKKKK5,MAP4K5
Q9Y4P1,ATG4B_HUMAN,ATG4B; APG4B; AUTL1; KIAA0943,Cysteine protease ATG4B; EC 3.4.22.-; AUT-like 1 cysteine endopeptidase; Autophagy-related cysteine endopeptidase 1; Autophagin-1; Autophagy-related protein 4 homolog B; HsAPG4B; hAPG4B,APG4B; AUTL1; KIAA0943,23192,autophagy related 4B cysteine peptidase,APG4 autophagy 4 homolog B (S. cerevisiae); ATG4 autophagy related 4 homolog B (S. cerevisiae); autophagy related 4B; cysteine peptidase,,Apg4B; KIAA0943; DKFZp586D1822; AUTL1,autophagy related 4B cysteine peptidase,APG4B; AUTL1; HsAPG4B,ATG4B
Q9Y4R8,TELO2_HUMAN,TELO2; KIAA0683,Telomere length regulation protein TEL2 homolog; Protein clk-2 homolog; hCLK2,KIAA0683,9894,telomere maintenance 2,TEL2; telomere maintenance 2; homolog (S. cerevisiae),,KIAA0683; hCLK2; TEL2,telomere maintenance 2,CLK2; TEL2; YHFS,TELO2
Q9Y520,PRC2C_HUMAN,PRRC2C; BAT2D1; BAT2L2; KIAA1096; XTP2,Protein PRRC2C; BAT2 domain-containing protein 1; HBV X-transactivated gene 2 protein; HBV XAg-transactivated protein 2; HLA-B-associated transcript 2-like 2; Proline-rich and coiled-coil-containing protein 2C,BAT2D1; BAT2L2; KIAA1096; XTP2,23215,proline rich coiled-coil 2C,BAT2 domain containing 1; HLA-B associated transcript 2-like 2; proline-rich coiled-coil 2C,,KIAA1096; XTP2,proline rich coiled-coil 2C,BAT2-iso; BAT2D1; BAT2L2; XTP2,PRRC2C
Q9Y570,PPME1_HUMAN,PPME1; PME1; PP2593; PRO0750,Protein phosphatase methylesterase 1; PME-1; EC 3.1.1.89,PME1,51400,protein phosphatase methylesterase 1,,,PME-1; ABDH19,protein phosphatase methylesterase 1,ABDH19; PME-1,PPME1
Q9Y572,RIPK3_HUMAN,RIPK3; RIP3,Receptor-interacting serine/threonine-protein kinase 3; EC 2.7.11.1; RIP-like protein kinase 3; Receptor-interacting protein 3; RIP-3,RIP3,11035,receptor interacting serine/threonine kinase 3,receptor-interacting serine-threonine kinase 3,,RIP3,receptor interacting serine/threonine kinase 3,RIP3,RIPK3
Q9Y5B0,CTDP1_HUMAN,CTDP1; FCP1,RNA polymerase II subunit A C-terminal domain phosphatase; EC 3.1.3.16; TFIIF-associating CTD phosphatase,FCP1,9150,CTD phosphatase subunit 1,CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) phosphatase; subunit 1,,FCP1,CTD phosphatase subunit 1,CCFDN; FCP1,CTDP1
Q9Y5B9,SP16H_HUMAN,SUPT16H; FACT140; FACTP140,FACT complex subunit SPT16; Chromatin-specific transcription elongation factor 140 kDa subunit; FACT 140 kDa subunit; FACTp140; Facilitates chromatin transcription complex subunit SPT16; hSPT16,FACT140; FACTP140,11198,SPT16 homolog; facilitates chromatin remodeling subunit,suppressor of Ty (S.cerevisiae) 16 homolog; suppressor of Ty 16 homolog (S. cerevisiae),facilitates chromatin remodeling 140 kDa subunit,FACT; FACTP140; SPT16/CDC68; FLJ14010; FLJ10857; CDC68,SPT16 homolog; facilitates chromatin remodeling subunit,CDC68; FACTP140; NEDDFAC; SPT16; SPT16/CDC68,SUPT16H
Q9Y5K3,PCY1B_HUMAN,PCYT1B; CCTB,Choline-phosphate cytidylyltransferase B; EC 2.7.7.15; CCT-beta; CTP:phosphocholine cytidylyltransferase B; CCT B; CT B; Phosphorylcholine transferase B,CCTB,9468,phosphate cytidylyltransferase 1B; choline,phosphate cytidylyltransferase 1; choline; beta isoform; phosphate cytidylyltransferase 1; choline; beta,CTP:phosphocholine cytidylyltransferase-beta; choline-phosphate cytidylyltransferase beta; phosphorylcholine transferase beta,CCT-beta; CTB; CCTbeta,phosphate cytidylyltransferase 1B; choline,CCTB; CTB,PCYT1B
Q9Y5N6,ORC6_HUMAN,ORC6; ORC6L,Origin recognition complex subunit 6,ORC6L,23594,origin recognition complex subunit 6,origin recognition complex; subunit 6 homolog-like (yeast); origin recognition complex; subunit 6 like (yeast); origin recognition complex; subunit 6,,,origin recognition complex subunit 6,ORC6L,ORC6
Q9Y5P4,CERT_HUMAN,CERT1; CERT; COL4A3BP; STARD11,Ceramide transfer protein; hCERT; Collagen type IV alpha-3-binding protein; Goodpasture antigen-binding protein; GPBP; START domain-containing protein 11; StARD11; StAR-related lipid transfer protein 11,CERT; COL4A3BP; STARD11,10087,ceramide transporter 1,collagen; type IV; alpha 3 (Goodpasture antigen) binding protein; collagen type IV alpha 3 binding protein,ceramide transporter; StAR-related lipid transfer (START) domain containing 11,GPBP; STARD11; CERT,ceramide transporter 1,CERT; CERTL; COL4A3BP; GPBP; MRD34; NEDHSF; STARD11,CERT1
Q9Y5P8,P2R3B_HUMAN,PPP2R3B; PPP2R3L,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta; PP2A subunit B isoform PR48; Protein phosphatase 2A 48 kDa regulatory subunit,PPP2R3L,28227,protein phosphatase 2 regulatory subunit B''beta,protein phosphatase 2 (formerly 2A); regulatory subunit B''; beta,,PPP2R3LY; PR48; PR70,protein phosphatase 2 regulatory subunit B''beta,NYREN8; PPP2R3L; PPP2R3LY; PR48; PR70,PPP2R3B
Q9Y5S2,MRCKB_HUMAN,CDC42BPB; KIAA1124,Serine/threonine-protein kinase MRCK beta; EC 2.7.11.1; CDC42-binding protein kinase beta; CDC42BP-beta; DMPK-like beta; Myotonic dystrophy kinase-related CDC42-binding kinase beta; MRCK beta; Myotonic dystrophy protein kinase-like beta,KIAA1124,9578,CDC42 binding protein kinase beta,CDC42-binding protein kinase beta (DMPK-like),,MRCKB; KIAA1124,CDC42 binding protein kinase beta,CHOCNS; MRCKB,CDC42BPB
Q9Y5S9,RBM8A_HUMAN,RBM8A; RBM8; HSPC114; MDS014,RNA-binding protein 8A; Binder of OVCA1-1; BOV-1; RNA-binding motif protein 8A; RNA-binding protein Y14; Ribonucleoprotein RBM8A,RBM8,9939,RNA binding motif protein 8A,,binder of OVCA1; exon junction complex core component Y14,ZNRP; BOV-1A; BOV-1B; BOV-1C; Y14,RNA binding motif protein 8A,BOV-1A; BOV-1B; BOV-1C; C1DELq21.1; DEL1q21.1; MDS014; RBM8; RBM8B; TAR; Y14; ZNRP; ZRNP1,RBM8A
Q9Y5T5,UBP16_HUMAN,USP16; MSTP039,Ubiquitin carboxyl-terminal hydrolase 16; EC 3.4.19.12; Deubiquitinating enzyme 16; Ubiquitin thioesterase 16; Ubiquitin-processing protease UBP-M; Ubiquitin-specific-processing protease 16,,10600,ubiquitin specific peptidase 16,ubiquitin specific protease 16,,Ubp-M,ubiquitin specific peptidase 16,UBP-M; UBPM,USP16
Q9Y5X2,SNX8_HUMAN,SNX8,Sorting nexin-8,,29886,sorting nexin 8,,,Mvp1,sorting nexin 8,Mvp1,SNX8
Q9Y613,FHOD1_HUMAN,FHOD1; FHOS; FHOS1,FH1/FH2 domain-containing protein 1; Formin homolog overexpressed in spleen 1; FHOS; Formin homology 2 domain-containing protein 1,FHOS; FHOS1,29109,formin homology 2 domain containing 1,,,FHOS,formin homology 2 domain containing 1,FHOS,FHOD1
Q9Y618,NCOR2_HUMAN,NCOR2; CTG26,Nuclear receptor corepressor 2; N-CoR2; CTG repeat protein 26; SMAP270; Silencing mediator of retinoic acid and thyroid hormone receptor; SMRT; T3 receptor-associating factor; TRAC; Thyroid-; retinoic-acid-receptor-associated corepressor,CTG26,9612,nuclear receptor corepressor 2,nuclear receptor co-repressor 2,silencing mediator of retinoic acid and thyroid hormone receptor; CTG repeat protein 26; thyroid-; retinoic-acid-receptor-associated corepressor,SMRT; SMRTE; TRAC-1; CTG26; TNRC14,nuclear receptor corepressor 2,CTG26; N-CoR2; SMAP270; SMRT; SMRTE; SMRTE-tau; TNRC14; TRAC; TRAC-1; TRAC1,NCOR2
Q9Y624,JAM1_HUMAN,F11R; JAM1; JCAM; UNQ264/PRO301,Junctional adhesion molecule A; JAM-A; Junctional adhesion molecule 1; JAM-1; Platelet F11 receptor; Platelet adhesion molecule 1; PAM-1; CD antigen CD321,JAM1; JCAM,50848,F11 receptor,junctional adhesion molecule 1,,PAM-1; JCAM; JAM-1; JAM-A; JAMA; CD321,F11 receptor,CD321; JAM; JAM1; JAMA; JCAM; KAT; PAM-1,F11R
Q9Y666,S12A7_HUMAN,SLC12A7; KCC4,Solute carrier family 12 member 7; Electroneutral potassium-chloride cotransporter 4; K-Cl cotransporter 4,KCC4,10723,solute carrier family 12 member 7,solute carrier family 12 (potassium/chloride transporter); member 7,,KCC4; DKFZP434F076,solute carrier family 12 member 7,KCC4,SLC12A7
Q9Y676,RT18B_HUMAN,MRPS18B; C6orf14; HSPC183; PTD017,Small ribosomal subunit protein mS40; 28S ribosomal protein S18-2; mitochondrial; MRP-S18-2; 28S ribosomal protein S18b; mitochondrial; MRP-S18-b; Mrps18-b; S18mt-b; Small ribosomal subunit protein bS18b,C6orf14,28973,mitochondrial ribosomal protein S18B,,,MRPS18-2; PTD017; C6orf14; HSPC183; mS40,mitochondrial ribosomal protein S18B,C6orf14; HSPC183; HumanS18a; MRP-S18-2; MRPS18-2; PTD017; S18amt; mS40,MRPS18B
Q9Y691,KCMB2_HUMAN,KCNMB2,Calcium-activated potassium channel subunit beta-2; BK channel subunit beta-2; BKbeta2; Hbeta2; Calcium-activated potassium channel; subfamily M subunit beta-2; Charybdotoxin receptor subunit beta-2; Hbeta3; K(VCA; Maxi K channel subunit beta-2; Slo-beta-2,,10242,potassium calcium-activated channel subfamily M regulatory beta subunit 2,potassium large conductance calcium-activated channel; subfamily M; beta member 2; potassium channel subfamily M regulatory beta subunit 2,BK channel beta subunit 2; MaxiK channel beta-subunit 2; big potassium channel beta subunit 2,,potassium calcium-activated channel subfamily M regulatory beta subunit 2,,KCNMB2
Q9Y698,CCG2_HUMAN,CACNG2,Voltage-dependent calcium channel gamma-2 subunit; Neuronal voltage-gated calcium channel gamma-2 subunit; Transmembrane AMPAR regulatory protein gamma-2; TARP gamma-2,,10369,calcium voltage-gated channel auxiliary subunit gamma 2,calcium channel; voltage-dependent; gamma subunit 2,,stargazin; MGC138502; MGC138504,calcium voltage-gated channel auxiliary subunit gamma 2,MRD10,CACNG2
Q9Y6A5,TACC3_HUMAN,TACC3; ERIC1,Transforming acidic coiled-coil-containing protein 3; ERIC-1,ERIC1,10460,transforming acidic coiled-coil containing protein 3,transforming; acidic coiled-coil containing protein 3,,ERIC1; ERIC-1; maskin; Tacc4,transforming acidic coiled-coil containing protein 3,ERIC-1; ERIC1; Tacc4; maskin,TACC3
Q9Y6D6,BIG1_HUMAN,ARFGEF1; ARFGEP1; BIG1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1; Brefeldin A-inhibited GEP 1; ADP-ribosylation factor guanine nucleotide-exchange factor 1; p200 ARF guanine nucleotide exchange factor; p200 ARF-GEP1,ARFGEP1; BIG1,10565,ARF guanine nucleotide exchange factor 1,ADP ribosylation factor guanine nucleotide exchange factor 1; ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited),Brefeldin A-inhibited guanine nucleotide-exchange protein 1,DKFZP434L057; BIG1; ARFGEP1; p200,ARF guanine nucleotide exchange factor 1,ARFGEP1; BIG1; DEDISB; P200,ARFGEF1
Q9Y6D9,MD1L1_HUMAN,MAD1L1; MAD1; TXBP181,Mitotic spindle assembly checkpoint protein MAD1; Mitotic arrest deficient 1-like protein 1; MAD1-like protein 1; Mitotic checkpoint MAD1 protein homolog; HsMAD1; hMAD1; Tax-binding protein 181,MAD1; TXBP181,8379,mitotic arrest deficient 1 like 1,MAD1 (mitotic arrest deficient; yeast; homolog)-like 1; MAD1 mitotic arrest deficient-like 1 (yeast); MAD1 mitotic arrest deficient like 1,,HsMAD1; TXBP181; MAD1; PIG9; TP53I9,mitotic arrest deficient 1 like 1,MAD1; MVA7; PIG9; TP53I9; TXBP181,MAD1L1
Q9Y6E0,STK24_HUMAN,STK24; MST3; STK3,Serine/threonine-protein kinase 24; EC 2.7.11.1; Mammalian STE20-like protein kinase 3; MST-3; STE20-like kinase MST3; Mammalian STE20-like protein kinase 3 N-terminal; MST3/N; Mammalian STE20-like protein kinase 3 C-terminal; MST3/C,MST3; STK3,8428,serine/threonine kinase 24,serine/threonine kinase 24 (Ste20; yeast homolog),STE20-like kinase 3; sterile 20-like kinase 3,MST-3; MST3; MST3B; STK3; STE20,serine/threonine kinase 24,HEL-S-95; MST3; MST3B; STE20; STK3,STK24
Q9Y6F6,IRAG1_HUMAN,IRAG1; IRAG; JAW1L; MRVI1,Inositol 1;4;5-triphosphate receptor associated 1; Inositol 1;4;5-trisphosphate receptor-associated cGMP kinase substrate; JAW1-related protein MRVI1; Protein MRVI1,IRAG; JAW1L; MRVI1,10335,inositol 1;4;5-triphosphate receptor associated 1,murine retrovirus integration site 1 homolog,inositol 1;4;5-triphosphate-associated cGMP kinase substrate; IP3R-associated cGMP kinase substrate,JAW1L; IRAG,inositol 1;4;5-triphosphate receptor associated 1,IRAG; JAW1L; MRVI1,IRAG1
Q9Y6F9,WNT6_HUMAN,WNT6,Protein Wnt-6,,7475,Wnt family member 6,wingless-type MMTV integration site family; member 6,,,Wnt family member 6,,WNT6
Q9Y6H1,CHCH2_HUMAN,CHCHD2; C7orf17; AAG10,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2; Aging-associated gene 10 protein; HCV NS2 trans-regulated protein; NS2TP,C7orf17,51142,coiled-coil-helix-coiled-coil-helix domain containing 2,chromosome 7 open reading frame 17,MIX17 homolog B; mitochondrial nuclear retrograde regulator 1,MIX17B; MNRR1,coiled-coil-helix-coiled-coil-helix domain containing 2,C7orf17; MIX17B; MNRR1; NS2TP; PARK22,CHCHD2
Q9Y6H5,SNCAP_HUMAN,SNCAIP,Synphilin-1; Sph1; Alpha-synuclein-interacting protein,,9627,synuclein alpha interacting protein,,synphilin,SYPH1,synuclein alpha interacting protein,SYPH1; Sph1,SNCAIP
Q9Y6H6,KCNE3_HUMAN,KCNE3,Potassium voltage-gated channel subfamily E member 3; MinK-related peptide 2; MiRP2; Minimum potassium ion channel-related peptide 2; Potassium channel subunit beta MiRP2,,10008,potassium voltage-gated channel subfamily E regulatory subunit 3,potassium voltage-gated channel; Isk-related family; member 3; potassium channel; voltage gated subfamily E regulatory beta subunit 3,,MiRP2; HOKPP,potassium voltage-gated channel subfamily E regulatory subunit 3,BRGDA6; HOKPP; HYPP; MiRP2,KCNE3
Q9Y6I3,EPN1_HUMAN,EPN1,Epsin-1; EH domain-binding mitotic phosphoprotein; EPS-15-interacting protein 1,,29924,epsin 1,,,,epsin 1,,EPN1
Q9Y6J0,CABIN_HUMAN,CABIN1; KIAA0330,Calcineurin-binding protein cabin-1; Calcineurin inhibitor; CAIN,KIAA0330,23523,calcineurin binding protein 1,,,KIAA0330; PPP3IN,calcineurin binding protein 1,CAIN; KB-318B8.7; PPP3IN,CABIN1
Q9Y6K9,NEMO_HUMAN,IKBKG; FIP3; NEMO,NF-kappa-B essential modulator; NEMO; FIP-3; IkB kinase-associated protein 1; IKKAP1; Inhibitor of nuclear factor kappa-B kinase subunit gamma; I-kappa-B kinase subunit gamma; IKK-gamma; IKKG; IkB kinase subunit gamma; NF-kappa-B essential modifier,FIP3; NEMO,8517,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,incontinentia pigmenti; inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase gamma; inhibitor of nuclear factor kappa B kinase subunit gamma,NF-kappa-B essential modulator; IkB kinase-associated protein 1; I-kappa-B kinase subunit gamma; IkB kinase subunit gamma; 14.7K (adenovirus E3 protein) interacting protein 3,IKK-gamma; NEMO; Fip3p; FIP-3; FIP3; ZC2HC9; IKKAP1; IKKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,AMCBX1; EDAID1; FIP-3; FIP3; Fip3p; IKK-gamma; IKKAP1; IKKG; IMD33; IP; IP1; IP2; IPD2; NEMO; SAIDX; ZC2HC9,IKBKG
Q9Y6M4,KC1G3_HUMAN,CSNK1G3,Casein kinase I isoform gamma-3; CKI-gamma 3; EC 2.7.11.1,,1456,casein kinase 1 gamma 3,casein kinase 1; gamma 3,,,casein kinase 1 gamma 3,CKI-gamma 3; CSNK1G3L,CSNK1G3
Q9Y6N7,ROBO1_HUMAN,ROBO1; DUTT1,Roundabout homolog 1; Deleted in U twenty twenty; H-Robo-1,DUTT1,6091,roundabout guidance receptor 1,roundabout (axon guidance receptor; Drosophila) homolog 1; roundabout; axon guidance receptor; homolog 1 (Drosophila),,DUTT1; FLJ21882; SAX3,roundabout guidance receptor 1,CPHD8; DUTT1; NORS; NYS8; SAX3,ROBO1
Q9Y6Q6,TNR11_HUMAN,TNFRSF11A; RANK,Tumor necrosis factor receptor superfamily member 11A; Osteoclast differentiation factor receptor; ODFR; Receptor activator of NF-KB; CD antigen CD265,RANK,8792,TNF receptor superfamily member 11a,tumor necrosis factor receptor superfamily; member 11a; activator of NFKB; Paget disease of bone 2; loss of heterozygosity; 18; chromosomal region 1; tumor necrosis factor receptor superfamily; member 11a; NFKB activator,osteoclast differentiation factor receptor; receptor activator of nuclear factor kappa B; familial expansile osteolysis; TRANCE receptor,RANK; CD265; FEO; ODFR; TRANCE-R,TNF receptor superfamily member 11a,CD265; FEO; LOH18CR1; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TRANCE-R; TRANCER,TNFRSF11A
Q9Y6Q9,NCOA3_HUMAN,NCOA3; AIB1; BHLHE42; RAC3; TRAM1,Nuclear receptor coactivator 3; NCoA-3; EC 2.3.1.48; ACTR; Amplified in breast cancer 1 protein; AIB-1; CBP-interacting protein; pCIP; Class E basic helix-loop-helix protein 42; bHLHe42; Receptor-associated coactivator 3; RAC-3; Steroid receptor coactivator protein 3; SRC-3; Thyroid hormone receptor activator molecule 1; TRAM-1,AIB1; BHLHE42; RAC3; TRAM1,8202,nuclear receptor coactivator 3,,receptor-associated coactivator 3; thyroid hormone receptor activator molecule 1,RAC3; AIB1; ACTR; p/CIP; TRAM-1; CAGH16; TNRC16; KAT13B; bHLHe42; SRC-3; SRC3,nuclear receptor coactivator 3,ACTR; AIB-1; AIB1; CAGH16; CTG26; KAT13B; RAC3; SRC-3; SRC3; TNRC14; TNRC16; TRAM-1; bHLHe42; pCIP,NCOA3
Q9Y6R1,S4A4_HUMAN,SLC4A4; NBC; NBC1; NBCE1,Electrogenic sodium bicarbonate cotransporter 1; Sodium bicarbonate cotransporter; Na(+; -; Solute carrier family 4 member 4; kNBC1,NBC; NBC1; NBCE1,8671,solute carrier family 4 member 4,solute carrier family 4; sodium bicarbonate cotransporter; member 4; solute carrier family 4 (sodium bicarbonate cotransporter); member 4,Electrogenic sodium bicarbonate cotransporter 1; kidney type Na+/HCO3- cotransporter; pancreatic sodium bicarbonate cotransporter,NBC1; HNBC1; NBC2; pNBC; hhNMC; kNBC1; KNBC; NBCe1,solute carrier family 4 member 4,HNBC1; KNBC; NBC1; NBC2; NBCe1; NBCe1-A; PRTAO; SLC4A5; hhNMC; kNBC1; pNBC,SLC4A4
Q9Y6R4,M3K4_HUMAN,MAP3K4; KIAA0213; MAPKKK4; MEKK4; MTK1,Mitogen-activated protein kinase kinase kinase 4; EC 2.7.11.25; MAP three kinase 1; MAPK/ERK kinase kinase 4; MEK kinase 4; MEKK 4,KIAA0213; MAPKKK4; MEKK4; MTK1,4216,mitogen-activated protein kinase kinase kinase 4,,,MTK1; MAPKKK4; KIAA0213,mitogen-activated protein kinase kinase kinase 4,MAPKKK4; MEKK 4; MEKK4; MTK1; PRO0412,MAP3K4
Q9Y6W5,WASF2_HUMAN,WASF2; WAVE2,Actin-binding protein WASF2; Protein WAVE-2; Verprolin homology domain-containing protein 2; Wiskott-Aldrich syndrome protein family member 2; WASP family protein member 2,WAVE2,10163,WASP family member 2,WAS protein family; member 2; WAS protein family member 2,,WAVE2; SCAR2,WASP family member 2,IMD2; SCAR2; WASF4; WAVE2; dJ393P12.2,WASF2
Q9Y6W6,DUS10_HUMAN,DUSP10; MKP5,Dual specificity protein phosphatase 10; EC 3.1.3.16; EC 3.1.3.48; Mitogen-activated protein kinase phosphatase 5; MAP kinase phosphatase 5; MKP-5,MKP5,11221,dual specificity phosphatase 10,,,MKP-5; MKP5,dual specificity phosphatase 10,MKP-5; MKP5,DUSP10
Q9Y6X9,MORC2_HUMAN,MORC2; KIAA0852; ZCWCC1,ATPase MORC2; EC 3.6.1.-; MORC family CW-type zinc finger protein 2; Zinc finger CW-type coiled-coil domain protein 1,KIAA0852; ZCWCC1,22880,MORC family CW-type zinc finger 2,zinc finger; CW-type with coiled-coil domain 1; zinc finger; CW type with coiled-coil domain 1,,ZCW3; KIAA0852; AC004542.C22.1,MORC family CW-type zinc finger 2,CMT2Z; DIGFAN; ZCW3; ZCWCC1,MORC2
Q9Y6Y9,LY96_HUMAN,LY96; ESOP1; MD2,Lymphocyte antigen 96; Ly-96; ESOP-1; Protein MD-2,ESOP1; MD2,23643,lymphocyte antigen 96,,,MD-2,lymphocyte antigen 96,ESOP-1; MD-2; MD2; ly-96,LY96
A2RUS2,DEND3_HUMAN,DENND3; KIAA0870,DENN domain-containing protein 3,KIAA0870,22898,DENN domain containing 3,DENN/MADD domain containing 3,,KIAA0870,DENN domain containing 3,,DENND3
A4D2G3,O2A25_HUMAN,OR2A25; OR2A25P; OR2A27,Olfactory receptor 2A25; Olfactory receptor 2A27,OR2A25P; OR2A27,392138,olfactory receptor family 2 subfamily A member 25,olfactory receptor; family 2; subfamily A; member 25,,,olfactory receptor family 2 subfamily A member 25,OR2A24P; OR2A25P; OR2A27,OR2A25
A6NCE7,MP3B2_HUMAN,MAP1LC3B2,Microtubule-associated protein 1 light chain 3 beta 2; Microtubule-associated proteins 1A/1B light chain 3 beta 2; Microtubule-associated proteins 1A/1B light chain 3B-like; MAP1A/MAP1B LC3 B-like; MAP1A/MAP1B light chain 3 B-like,,643246,microtubule associated protein 1 light chain 3 beta 2,,,ATG8G,microtubule associated protein 1 light chain 3 beta 2,ATG8G,MAP1LC3B2
A6ND48,O14I1_HUMAN,OR14I1; OR5BU1; OR5BU1P,Olfactory receptor 14I1; Olfactory receptor 5BU1,OR5BU1; OR5BU1P,401994,olfactory receptor family 14 subfamily I member 1,olfactory receptor; family 5; subfamily BU; member 1; olfactory receptor; family 14; subfamily I; member 1,,,olfactory receptor family 14 subfamily I member 1,OR5BU1; OR5BU1P,OR14I1
A6NH00,OR2T8_HUMAN,OR2T8; OR2T8P,Olfactory receptor 2T8,OR2T8P,343172,olfactory receptor family 2 subfamily T member 8,olfactory receptor; family 2; subfamily T; member 8,,,olfactory receptor family 2 subfamily T member 8,OR2T8P,OR2T8
A6NMY6,AXA2L_HUMAN,ANXA2P2; ANX2L2; ANX2P2; LPC2B,Putative annexin A2-like protein; Annexin A2 pseudogene 2; Lipocortin II pseudogene,ANX2L2; ANX2P2; LPC2B,,annexin A2 pseudogene 2,,,,,,ANXA2P2
A6NND4,O2AT4_HUMAN,OR2AT4,Olfactory receptor 2AT4; Olfactory receptor OR11-265,,341152,olfactory receptor family 2 subfamily AT member 4,olfactory receptor; family 2; subfamily AT; member 4,,,olfactory receptor family 2 subfamily AT member 4,OR11-265,OR2AT4
E9PAV3,NACAM_HUMAN,NACA,Nascent polypeptide-associated complex subunit alpha; muscle-specific form; Alpha-NAC; muscle-specific form; skNAC,,,nascent polypeptide associated complex subunit alpha,nascent-polypeptide-associated complex alpha polypeptide,,NACA1; Alpha-NAC,,,NACA
O60262,GBG7_HUMAN,GNG7; GNGT7,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7; I; S; O,GNGT7,2788,G protein subunit gamma 7,guanine nucleotide binding protein (G protein); gamma 7,,FLJ00058,G protein subunit gamma 7,HG3B,GNG7
O60412,OR7C2_HUMAN,OR7C2; OR7C3,Olfactory receptor 7C2; Olfactory receptor 19-18; OR19-18; Olfactory receptor 7C3; Olfactory receptor OR19-22,OR7C3,26658,olfactory receptor family 7 subfamily C member 2,olfactory receptor; family 7; subfamily C; member 2; olfactory receptor family 7 subfamily C member 2 (gene/pseudogene),,OR19-18,olfactory receptor family 7 subfamily C member 2,CIT-HSP-87M17; OR19-18; OR7C3,OR7C2
O76001,OR2J3_HUMAN,OR2J3,Olfactory receptor 2J3; Hs6M1-3; Olfactory receptor OR6-16; OR6-6; Olfactory receptor 6-6,,442186,olfactory receptor family 2 subfamily J member 3,olfactory receptor; family 2; subfamily J; member 3,,OR6-6,olfactory receptor family 2 subfamily J member 3,6M1-3; C3HEXS; HS6M1-3; OR6-16; OR6-6; OR6.3.6; ORL671,OR2J3
O76002,OR2J2_HUMAN,OR2J2,Olfactory receptor 2J2; Hs6M1-6; Olfactory receptor 6-8; OR6-8; Olfactory receptor OR6-19,,26707,olfactory receptor family 2 subfamily J member 2,olfactory receptor; family 2; subfamily J; member 2,,OR6-8; hs6M1-6; dJ80I19.4,olfactory receptor family 2 subfamily J member 2,OR6-19; OR6-8; OR6.3.8; ORL684; dJ80I19.4; hs6M1-6,OR2J2
O76099,OR7C1_HUMAN,OR7C1; OR7C4,Olfactory receptor 7C1; Olfactory receptor 7C4; Olfactory receptor OR19-16; Olfactory receptor TPCR86,OR7C4,26664,olfactory receptor family 7 subfamily C member 1,olfactory receptor; family 7; subfamily C; member 1,,OR19-5,olfactory receptor family 7 subfamily C member 1,CIT-HSP-146E8; HSTPCR86P; OR19-5; OR7C4; TPCR86,OR7C1
O95007,OR6B1_HUMAN,OR6B1,Olfactory receptor 6B1; Olfactory receptor 7-3; OR7-3; Olfactory receptor OR7-9,,135946,olfactory receptor family 6 subfamily B member 1,olfactory receptor; family 6; subfamily B; member 1,,OR7-3,olfactory receptor family 6 subfamily B member 1,OR7-3; OR7-9,OR6B1
O95222,OR6A2_HUMAN,OR6A2; OR6A1; OR6A2P,Olfactory receptor 6A2; Olfactory receptor 11-55; OR11-55; Olfactory receptor 6A1; Olfactory receptor OR11-83; hP2 olfactory receptor,OR6A1; OR6A2P,8590,olfactory receptor family 6 subfamily A member 2,olfactory receptor; family 6; subfamily A; member 2,,OR11-55,olfactory receptor family 6 subfamily A member 2,I7; OR11-55; OR6A1; OR6A2P,OR6A2
O95371,OR2C1_HUMAN,OR2C1; OR2C2P,Olfactory receptor 2C1; OLFmf3; Olfactory receptor 2C2; Olfactory receptor OR16-1; Olfactory receptor OR16-2,OR2C2P,4993,olfactory receptor family 2 subfamily C member 1,olfactory receptor; family 2; subfamily C; member 1,,OLFmf3,olfactory receptor family 2 subfamily C member 1,OLFmf3; OR2C2P,OR2C1
O95625,ZBT11_HUMAN,ZBTB11,Zinc finger and BTB domain-containing protein 11,,27107,zinc finger and BTB domain containing 11,,,ZNF-U69274; ZNF913,zinc finger and BTB domain containing 11,MRT69; ZNF-U69274; ZNF913,ZBTB11
O95685,PPR3D_HUMAN,PPP1R3D; PPP1R6,Protein phosphatase 1 regulatory subunit 3D; Protein phosphatase 1 regulatory subunit 6; PP1 subunit R6; Protein phosphatase 1-binding subunit R6,PPP1R6,5509,protein phosphatase 1 regulatory subunit 3D,protein phosphatase 1; regulatory (inhibitor) subunit 3D; protein phosphatase 1; regulatory subunit 3D,,,protein phosphatase 1 regulatory subunit 3D,PPP1R6,PPP1R3D
O95918,OR2H2_HUMAN,OR2H2; FAT11; OLFR2; OR2H3,Olfactory receptor 2H2; Hs6M1-12; Olfactory receptor 2H3; Olfactory receptor-like protein FAT11,FAT11; OLFR2; OR2H3,7932,olfactory receptor family 2 subfamily H member 2,olfactory receptor; family 2; subfamily H; member 2,,hs6M1-12,olfactory receptor family 2 subfamily H member 2,FAT11; OLFR2; OLFR42B; OR2H3; dJ271M21.2; hs6M1-12,OR2H2
P0C617,O5AL1_HUMAN,OR5AL1; OR5AL1P,Olfactory receptor 5AL1; Olfactory receptor OR11-184,OR5AL1P,79482,olfactory receptor family 5 subfamily AL member 1 (gene/pseudogene),olfactory receptor; family 5; subfamily AL; member 1 pseudogene; olfactory receptor; family 5; subfamily AL; member 1 (gene/pseudogene),,,olfactory receptor family 5 subfamily AL member 1 (gene/pseudogene),OR5AL1P,OR5AL1
P0C645,OR4E1_HUMAN,OR4E1; OR4E1P,Olfactory receptor 4E1; Olfactory receptor OR14-43,OR4E1P,26687,olfactory receptor family 4 subfamily E member 1,olfactory receptor; family 4; subfamily E; member 1 pseudogene; olfactory receptor; family 4; subfamily E; member 1 (gene/pseudogene); olfactory receptor family 4 subfamily E member 1 (gene/pseudogene),,,olfactory receptor family 4 subfamily E member 1,OR4E1P,OR4E1
P30953,OR1E1_HUMAN,OR1E1; OR1E5; OR1E6; OR1E9P,Olfactory receptor 1E1; Olfactory receptor 13-66; OR13-66; Olfactory receptor 17-2/17-32; OR17-2; OR17-32; Olfactory receptor 1E5; Olfactory receptor 1E6; Olfactory receptor 5-85; OR5-85; Olfactory receptor OR17-18; Olfactory receptor-like protein HGMP07I,OR1E5; OR1E6; OR1E9P,8387,olfactory receptor family 1 subfamily E member 1,olfactory receptor; family 1; subfamily E; member 1,,OR17-2; HGM071; OR17-32; OR13-66,olfactory receptor family 1 subfamily E member 1,HGM071; OR13-66; OR17-2; OR17-32; OR1E5; OR1E6; OR1E8P; OR1E9P; OST547,OR1E1
P30954,O10J1_HUMAN,OR10J1,Olfactory receptor 10J1; Olfactory receptor OR1-26; Olfactory receptor-like protein HGMP07J,,26476,olfactory receptor family 10 subfamily J member 1,olfactory receptor; family 10; subfamily J; member 1,,HGMP07J; HSHGMP07J,olfactory receptor family 10 subfamily J member 1,HGMP07J; HSHGMP07J,OR10J1
P32314,FOXN2_HUMAN,FOXN2; HTLF,Forkhead box protein N2; Human T-cell leukemia virus enhancer factor,HTLF,3344,forkhead box N2,human T-cell leukemia virus enhancer factor,,,forkhead box N2,HTLF,FOXN2
P47887,OR1E2_HUMAN,OR1E2; OR1E4,Olfactory receptor 1E2; Olfactory receptor 17-93/17-135/17-136; OR17-135; OR17-136; OR17-93; Olfactory receptor 1E4,OR1E4,8388,olfactory receptor family 1 subfamily E member 2,olfactory receptor; family 1; subfamily E; member 2,,OR17-93; OR17-135,olfactory receptor family 1 subfamily E member 2,OR17-135; OR17-136; OR17-93; OR1E4; OR1E7; OST529,OR1E2
P47888,OR3A3_HUMAN,OR3A3; OR3A6; OR3A7; OR3A8P,Olfactory receptor 3A3; Olfactory receptor 17-201; OR17-201; Olfactory receptor 3A6; Olfactory receptor 3A7; Olfactory receptor 3A8; Olfactory receptor OR17-22,OR3A6; OR3A7; OR3A8P,8392,olfactory receptor family 3 subfamily A member 3,olfactory receptor; family 3; subfamily A; member 3,,OR17-201; OR17-137; OR17-16,olfactory receptor family 3 subfamily A member 3,OR17-137; OR17-16; OR17-201; OR3A6; OR3A7; OR3A8P,OR3A3
P47893,OR3A2_HUMAN,OR3A2; OLFRA04,Olfactory receptor 3A2; Olfactory receptor 17-228; OR17-228; Olfactory receptor OR17-14,OLFRA04,4995,olfactory receptor family 3 subfamily A member 2,olfactory receptor; family 3; subfamily A; member 2,,OLFRA04; OR228; OR17-228,olfactory receptor family 3 subfamily A member 2,OLFRA04; OR17-14; OR17-228; OR228,OR3A2
P58173,OR2B6_HUMAN,OR2B6; OR2B1; OR2B1P; OR2B5; OR2B6P,Olfactory receptor 2B6; Hs6M1-32; Olfactory receptor 2B1; Olfactory receptor 2B5; Olfactory receptor 5-40; OR5-40; Olfactory receptor 6-31; OR6-31; Olfactory receptor OR6-4,OR2B1; OR2B1P; OR2B5; OR2B6P,26212,olfactory receptor family 2 subfamily B member 6,olfactory receptor; family 2; subfamily B; member 6,,OR6-31; dJ408B20.2; OR5-40; OR5-41,olfactory receptor family 2 subfamily B member 6,OR2B1; OR2B1P; OR2B5; OR2B6P; OR5-40; OR5-41; OR6-31; dJ408B20.2,OR2B6
P58182,O12D2_HUMAN,OR12D2,Olfactory receptor 12D2; Hs6M1-20; Olfactory receptor OR6-28,,26529,olfactory receptor family 12 subfamily D member 2,olfactory receptor; family 12; subfamily D; member 2; olfactory receptor; family 12; subfamily D; member 2 (gene/pseudogene); olfactory receptor family 12 subfamily D member 2 (gene/pseudogene),,hs6M1-20,olfactory receptor family 12 subfamily D member 2,DJ994E9.8; HS6M1-20,OR12D2
P60983,GMFB_HUMAN,GMFB,Glia maturation factor beta; GMF-beta,,2764,glia maturation factor beta,,,GMF,glia maturation factor beta,GMF,GMFB
P63215,GBG3_HUMAN,GNG3; GNGT3,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3; I; S; O,GNGT3,2785,G protein subunit gamma 3,guanine nucleotide binding protein (G protein); gamma 3,guanine nucleotide-binding protein gamma-3 subunit; NBP gamma-3,,G protein subunit gamma 3,HG3D,GNG3
P82970,HMGN5_HUMAN,HMGN5; NSBP1,High mobility group nucleosome-binding domain-containing protein 5; Nucleosome-binding protein 1,NSBP1,79366,high mobility group nucleosome binding domain 5,nucleosomal binding protein 1; high-mobility group nucleosome binding domain 5,,,high mobility group nucleosome binding domain 5,NBP-45; NSBP1,HMGN5
Q01995,TAGL_HUMAN,TAGLN; SM22; WS3-10,Transgelin; 22 kDa actin-binding protein; Protein WS3-10; Smooth muscle protein 22-alpha; SM22-alpha,SM22; WS3-10,6876,transgelin,,SM22-alpha,SM22; WS3-10; TAGLN1; SMCC; DKFZp686P11128; TGLN,transgelin,SM22; SM22-alpha; SMCC; TAGLN1; TGLN; WS3-10,TAGLN
Q02045,MYL5_HUMAN,MYL5,Myosin light chain 5; Myosin regulatory light chain 5; Superfast myosin regulatory light chain 2; MYLC2; MyLC-2,,4636,myosin light chain 5,myosin; light polypeptide 5; regulatory; myosin; light chain 5; regulatory,,,myosin light chain 5,MYLC2,MYL5
Q05D32,CTSL2_HUMAN,CTDSPL2; HSPC058; HSPC129,CTD small phosphatase-like protein 2; CTDSP-like 2; EC 3.1.3.-,,51496,CTD small phosphatase like 2,CTD (carboxy-terminal domain; RNA polymerase II; polypeptide A) small phosphatase like 2,,HSPC129; FLJ10523,CTD small phosphatase like 2,HSPC058; HSPC129; SCP4,CTDSPL2
Q13606,OR5I1_HUMAN,OR5I1; OLF1,Olfactory receptor 5I1; Olfactory receptor OR11-159; Olfactory receptor-like protein OLF1,OLF1,10798,olfactory receptor family 5 subfamily I member 1,olfactory receptor; family 5; subfamily I; member 1,,HSOlf1; OLF1,olfactory receptor family 5 subfamily I member 1,HSOlf1; OLF1,OR5I1
Q13607,OR2F1_HUMAN,OR2F1; OLF3; OR2F3; OR2F3P; OR2F4; OR2F5,Olfactory receptor 2F1; Olfactory receptor 2F3; Olfactory receptor 2F4; Olfactory receptor 2F5; Olfactory receptor-like protein OLF3,OLF3; OR2F3; OR2F3P; OR2F4; OR2F5,26211,olfactory receptor family 2 subfamily F member 1,olfactory receptor; family 2; subfamily F; member 1; olfactory receptor; family 2; subfamily F; member 1 (gene/pseudogene); olfactory receptor family 2 subfamily F member 1 (gene/pseudogene),,OLF3; OR7-140; OR7-139; OR14-60,olfactory receptor family 2 subfamily F member 1,7M1-2; OLF3; OR14-60; OR2F3; OR2F3P; OR2F4; OR2F5; OR7-139; OR7-140,OR2F1
Q15612,OR1Q1_HUMAN,OR1Q1; OR1Q2; OR1Q3,Olfactory receptor 1Q1; OST226; Olfactory receptor 1Q2; Olfactory receptor 1Q3; Olfactory receptor 9-A; OR9-A; Olfactory receptor OR9-25; Olfactory receptor TPCR106,OR1Q2; OR1Q3,158131,olfactory receptor family 1 subfamily Q member 1,olfactory receptor; family 1; subfamily Q; member 1,,OST226; OR9-A; HSTPCR106; OST226OR9-A; TPCR106,olfactory receptor family 1 subfamily Q member 1,HSTPCR106; OR1Q2; OR1Q3; OR9-25; OR9-A; OST226; OST226OR9-A; TPCR106,OR1Q1
Q15617,OR8G1_HUMAN,OR8G1; OR8G1P,Olfactory receptor 8G1; Olfactory receptor OR11-281; Olfactory receptor TPCR25,OR8G1P,26494,olfactory receptor family 8 subfamily G member 1,olfactory receptor; family 8; subfamily G; member 1 pseudogene; olfactory receptor; family 8; subfamily G; member 1 (gene/pseudogene); olfactory receptor family 8 subfamily G member 1 (gene/pseudogene),,TPCR25; HSTPCR25,olfactory receptor family 8 subfamily G member 1,HSTPCR25; OR8G1P; TPCR25,OR8G1
Q15620,OR8B8_HUMAN,OR8B8,Olfactory receptor 8B8; Olfactory receptor TPCR85; Olfactory-like receptor JCG8,,26493,olfactory receptor family 8 subfamily B member 8,olfactory receptor; family 8; subfamily B; member 8,,TPCR85,olfactory receptor family 8 subfamily B member 8,TPCR85,OR8B8
Q2NL82,TSR1_HUMAN,TSR1; KIAA1401,Pre-rRNA-processing protein TSR1 homolog,KIAA1401,55720,TSR1 ribosome maturation factor,TSR1; 20S rRNA accumulation; homolog (yeast); TSR1; ribosome maturation factor,,FLJ10534,TSR1 ribosome maturation factor,,TSR1
Q5JTH9,RRP12_HUMAN,RRP12; KIAA0690,RRP12-like protein,KIAA0690,23223,ribosomal RNA processing 12 homolog,KIAA0690; ribosomal RNA processing 12 homolog (S. cerevisiae),,,ribosomal RNA processing 12 homolog,KIAA0690,RRP12
Q5T8P6,RBM26_HUMAN,RBM26; C13orf10; PRO1777,RNA-binding protein 26; CTCL tumor antigen se70-2; RNA-binding motif protein 26,C13orf10,64062,RNA binding motif protein 26,chromosome 13 open reading frame 10,acidic rich RS domain containing 2; protein phosphatase 1; regulatory 132,PRO1777; SE70-2; FLJ20957; ZC3H17; ARRS2; PPP1R132,RNA binding motif protein 26,ARRS2; C13orf10; PPP1R132; PRO1777; SE70-2; ZC3H17,RBM26
Q66LE6,2ABD_HUMAN,PPP2R2D; KIAA1541,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform; PP2A subunit B isoform B55-delta; PP2A subunit B isoform PR55-delta; PP2A subunit B isoform R2-delta; PP2A subunit B isoform delta,KIAA1541,55844,protein phosphatase 2 regulatory subunit Bdelta,protein phosphatase 2; regulatory subunit B; delta isoform,PP2A subunit B isoform delta,MDS026; B55delta; B55D,protein phosphatase 2 regulatory subunit Bdelta,B55D; B55delta; MDS026,PPP2R2D
Q6IFH4,OR6B2_HUMAN,OR6B2; OR6B2P,Olfactory receptor 6B2; Olfactory receptor OR2-1,OR6B2P,389090,olfactory receptor family 6 subfamily B member 2,olfactory receptor; family 6; subfamily B; member 2 pseudogene; olfactory receptor; family 6; subfamily B; member 2,,,olfactory receptor family 6 subfamily B member 2,OR2-1; OR6B2P,OR6B2
Q7Z3T1,OR2W3_HUMAN,OR2W3; OR2W3P; OR2W8P,Olfactory receptor 2W3; Olfactory receptor 2W8; Olfactory receptor OR1-49,OR2W3P; OR2W8P,343171,olfactory receptor family 2 subfamily W member 3,olfactory receptor; family 2; subfamily W; member 3,,OST718,olfactory receptor family 2 subfamily W member 3,OR2W3P; OR2W8P; OST718,OR2W3
Q86X10,RLGPB_HUMAN,RALGAPB; KIAA1219,Ral GTPase-activating protein subunit beta; p170,KIAA1219,57148,Ral GTPase activating protein non-catalytic subunit beta,KIAA1219,,DKFZp781M2411; RalGAPbeta,Ral GTPase activating protein non-catalytic subunit beta,KIAA1219; RalGAPbeta,RALGAPB
Q86XI6,PPR3B_HUMAN,PPP1R3B; PPP1R4,Protein phosphatase 1 regulatory subunit 3B; Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL; Protein phosphatase 1 regulatory subunit 4; PP1 subunit R4; Protein phosphatase 1 subunit GL; PTG,PPP1R4,79660,protein phosphatase 1 regulatory subunit 3B,protein phosphatase 1; regulatory (inhibitor) subunit 3B; protein phosphatase 1; regulatory subunit 3B,PP1 subunit R4; hepatic glycogen-targeting subunit; G(L),GL; FLJ14005; PPP1R4,protein phosphatase 1 regulatory subunit 3B,GL; PPP1R4; PTG,PPP1R3B
Q8IY67,RAVR1_HUMAN,RAVER1; KIAA1978,Ribonucleoprotein PTB-binding 1; Protein raver-1,KIAA1978,125950,ribonucleoprotein; PTB binding 1,ribonucleoprotein; PTB-binding 1,,KIAA1978,ribonucleoprotein; PTB binding 1,,RAVER1
Q8N628,OR2C3_HUMAN,OR2C3; OR2C4; OR2C5P,Olfactory receptor 2C3; Olfactory receptor 2C4; Olfactory receptor 2C5; Olfactory receptor OR1-30,OR2C4; OR2C5P,81472,olfactory receptor family 2 subfamily C member 3,olfactory receptor; family 2; subfamily C; member 4; olfactory receptor; family 2; subfamily C; member 3,,OST742,olfactory receptor family 2 subfamily C member 3,OR2C4; OR2C5P; OST742,OR2C3
Q8NGA0,OR7G1_HUMAN,OR7G1; OR7G1P,Olfactory receptor 7G1; Olfactory receptor 19-15; OR19-15; Olfactory receptor OR19-8,OR7G1P,125962,olfactory receptor family 7 subfamily G member 1,olfactory receptor; family 7; subfamily G; member 1,,OR19-15,olfactory receptor family 7 subfamily G member 1,OR19-15; OR19-8; OR7G1P,OR7G1
Q8NGC8,O11H7_HUMAN,OR11H7; OR11H7P,Olfactory receptor 11H7; Olfactory receptor OR14-32,OR11H7P,390441,olfactory receptor family 11 subfamily H member 7 (gene/pseudogene),olfactory receptor; family 11; subfamily H; member 7 pseudogene; olfactory receptor; family 11; subfamily H; member 7 (gene/pseudogene),,,olfactory receptor family 11 subfamily H member 7 (gene/pseudogene),OR11H7P,OR11H7
Q8NGD0,OR4M1_HUMAN,OR4M1,Olfactory receptor 4M1; Olfactory receptor OR14-7,,441670,olfactory receptor family 4 subfamily M member 1,olfactory receptor; family 4; subfamily M; member 1,,,olfactory receptor family 4 subfamily M member 1,OLFR734; OR14-7,OR4M1
Q8NGE3,O10P1_HUMAN,OR10P1; OR10P1P; OR10P2P; OR10P3P,Olfactory receptor 10P1; Olfactory receptor 10P2; Olfactory receptor 10P3; Olfactory receptor OR12-7,OR10P1P; OR10P2P; OR10P3P,121130,olfactory receptor family 10 subfamily P member 1,olfactory receptor; family 10; subfamily P; member 1,,OST701,olfactory receptor family 10 subfamily P member 1,OR10P1P; OR10P2P; OR10P3P; OR12-7; OST701,OR10P1
Q8NGG2,OR5T2_HUMAN,OR5T2,Olfactory receptor 5T2; Olfactory receptor OR11-177,,219464,olfactory receptor family 5 subfamily T member 2,olfactory receptor; family 5; subfamily T; member 2,,,olfactory receptor family 5 subfamily T member 2,OR11-177,OR5T2
Q8NGH7,O52L1_HUMAN,OR52L1,Olfactory receptor 52L1; Olfactory receptor OR11-50,,338751,olfactory receptor family 52 subfamily L member 1,olfactory receptor; family 52; subfamily L; member 1; olfactory receptor family 52 subfamily L member 1 (gene/pseudogene),,,olfactory receptor family 52 subfamily L member 1,OR11-50,OR52L1
Q8NGI2,O52N4_HUMAN,OR52N4,Olfactory receptor 52N4; Olfactory receptor OR11-64,,390072,olfactory receptor family 52 subfamily N member 4,olfactory receptor; family 52; subfamily N; member 4; olfactory receptor; family 52; subfamily N; member 4 (gene/pseudogene); olfactory receptor family 52 subfamily N member 4 (gene/pseudogene),,,olfactory receptor family 52 subfamily N member 4,OR11-64,OR52N4
Q8NGK2,O52B4_HUMAN,OR52B4,Olfactory receptor 52B4; Olfactory receptor OR11-3,,143496,olfactory receptor family 52 subfamily B member 4,olfactory receptor; family 52; subfamily B; member 4 (gene/pseudogene); olfactory receptor family 52 subfamily B member 4 (gene/pseudogene),,,olfactory receptor family 52 subfamily B member 4,OR11-3,OR52B4
Q8NGM9,OR8D4_HUMAN,OR8D4,Olfactory receptor 8D4; Olfactory receptor OR11-275,,338662,olfactory receptor family 8 subfamily D member 4,olfactory receptor; family 8; subfamily D; member 4,,,olfactory receptor family 8 subfamily D member 4,OR11-275,OR8D4
Q8NGN3,O10G4_HUMAN,OR10G4,Olfactory receptor 10G4; Olfactory receptor OR11-278,,390264,olfactory receptor family 10 subfamily G member 4,olfactory receptor; family 10; subfamily G; member 4,,,olfactory receptor family 10 subfamily G member 4,OR11-278,OR10G4
Q8NGQ1,OR9G4_HUMAN,OR9G4,Olfactory receptor 9G4; Olfactory receptor OR11-216,,283189,olfactory receptor family 9 subfamily G member 4,olfactory receptor; family 9; subfamily G; member 4,,,olfactory receptor family 9 subfamily G member 4,OR11-216,OR9G4
Q8NGR2,OR1L6_HUMAN,OR1L6; OR1L7,Olfactory receptor 1L6; Olfactory receptor 1L7; Olfactory receptor OR9-30,OR1L7,392390,olfactory receptor family 1 subfamily L member 6,olfactory receptor; family 1; subfamily L; member 6,,,olfactory receptor family 1 subfamily L member 6,HG16; OR1K1; OR1L7; OR9-30,OR1L6
Q8NGR6,OR1B1_HUMAN,OR1B1,Olfactory receptor 1B1; Olfactory receptor 9-B; OR9-B; Olfactory receptor OR9-26,,347169,olfactory receptor family 1 subfamily B member 1,olfactory receptor; family 1; subfamily B; member 1 (gene/pseudogene); olfactory receptor family 1 subfamily B member 1 (gene/pseudogene),,OR9-B,olfactory receptor family 1 subfamily B member 1,OR9-26; OR9-B,OR1B1
Q8NGS2,OR1J2_HUMAN,OR1J2; OR1J3; OR1J5,Olfactory receptor 1J2; HSA5; HTPCRX15; OST044; Olfactory receptor 1J3; Olfactory receptor 1J5; Olfactory receptor OR9-19,OR1J3; OR1J5,26740,olfactory receptor family 1 subfamily J member 2,olfactory receptor; family 1; subfamily J; member 2,,OST044,olfactory receptor family 1 subfamily J member 2,HG152; HSA5; OR1J3; OR1J5; OR9-19; OST044,OR1J2
Q8NGS8,O13C5_HUMAN,OR13C5,Olfactory receptor 13C5; Olfactory receptor OR9-11,,138799,olfactory receptor family 13 subfamily C member 5,olfactory receptor; family 13; subfamily C; member 5,,,olfactory receptor family 13 subfamily C member 5,OR9-11,OR13C5
Q8NGT0,O13C9_HUMAN,OR13C9,Olfactory receptor 13C9; Olfactory receptor OR9-13,,286362,olfactory receptor family 13 subfamily C member 9,olfactory receptor; family 13; subfamily C; member 9,,,olfactory receptor family 13 subfamily C member 9,OR37L; OR9-13,OR13C9
Q8NGV6,OR5H6_HUMAN,OR5H6,Olfactory receptor 5H6; Olfactory receptor OR3-11,,79295,olfactory receptor family 5 subfamily H member 6,olfactory receptor; family 5; subfamily H; member 6; olfactory receptor; family 5; subfamily H; member 6 (gene/pseudogene); olfactory receptor family 5 subfamily H member 6 (gene/pseudogene),,,olfactory receptor family 5 subfamily H member 6,OR3-11,OR5H6
Q8NGW1,OR6B3_HUMAN,OR6B3; OR6B3P,Olfactory receptor 6B3; Olfactory receptor OR2-2,OR6B3P,150681,olfactory receptor family 6 subfamily B member 3,olfactory receptor; family 6; subfamily B; member 3 pseudogene; olfactory receptor; family 6; subfamily B; member 3,,OR6B3Q,olfactory receptor family 6 subfamily B member 3,OR6B3P; OR6B3Q,OR6B3
Q8NGW6,OR6K6_HUMAN,OR6K6,Olfactory receptor 6K6; Olfactory receptor OR1-21,,128371,olfactory receptor family 6 subfamily K member 6,olfactory receptor; family 6; subfamily K; member 6,,,olfactory receptor family 6 subfamily K member 6,OR1-21,OR6K6
Q8NGX3,O10T2_HUMAN,OR10T2,Olfactory receptor 10T2; Olfactory receptor OR1-3,,128360,olfactory receptor family 10 subfamily T member 2,olfactory receptor; family 10; subfamily T; member 2,,,olfactory receptor family 10 subfamily T member 2,OR1-3,OR10T2
Q8NGY0,O10X1_HUMAN,OR10X1; OR10X1P,Olfactory receptor 10X1; Olfactory receptor OR1-14,OR10X1P,128367,olfactory receptor family 10 subfamily X member 1,olfactory receptor; family 10; subfamily X; member 1; olfactory receptor; family 10; subfamily X; member 1 (gene/pseudogene); olfactory receptor family 10 subfamily X member 1 (gene/pseudogene),,,olfactory receptor family 10 subfamily X member 1,OR1-13; OR1-14; OR10X1P,OR10X1
Q8NGY3,OR6K3_HUMAN,OR6K3,Olfactory receptor 6K3; Olfactory receptor OR1-18,,391114,olfactory receptor family 6 subfamily K member 3,olfactory receptor; family 6; subfamily K; member 3,,,olfactory receptor family 6 subfamily K member 3,OR1-18,OR6K3
Q8NH10,OR8U1_HUMAN,OR8U1,Olfactory receptor 8U1,,219417,olfactory receptor family 8 subfamily U member 1,olfactory receptor; family 8; subfamily U; member 1,,,olfactory receptor family 8 subfamily U member 1,,OR8U1
Q8NH19,O10AG_HUMAN,OR10AG1,Olfactory receptor 10AG1; Olfactory receptor OR11-160,,282770,olfactory receptor family 10 subfamily AG member 1,olfactory receptor; family 10; subfamily AG; member 1,,,olfactory receptor family 10 subfamily AG member 1,OR11-160,OR10AG1
Q8NH43,OR4L1_HUMAN,OR4L1; OR4L2P,Olfactory receptor 4L1; Olfactory receptor 4L2; Olfactory receptor OR14-28,OR4L2P,122742,olfactory receptor family 4 subfamily L member 1,olfactory receptor; family 4; subfamily L; member 1; olfactory receptor family 4 subfamily L member 1 (gene/pseudogene),,,olfactory receptor family 4 subfamily L member 1,OR14-28; OR4L2P,OR4L1
Q8NH48,OR5B3_HUMAN,OR5B3; OR5B13,Olfactory receptor 5B3; Olfactory receptor 5B13; Olfactory receptor OR11-239,OR5B13,441608,olfactory receptor family 5 subfamily B member 3,olfactory receptor; family 5; subfamily B; member 3,,OST129,olfactory receptor family 5 subfamily B member 3,OR11-239; OR5B13; OST129,OR5B3
Q8NH59,O51Q1_HUMAN,OR51Q1,Olfactory receptor 51Q1,,390061,olfactory receptor family 51 subfamily Q member 1,olfactory receptor; family 51; subfamily Q; member 1; olfactory receptor; family 51; subfamily Q; member 1 (gene/pseudogene); olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene),,,olfactory receptor family 51 subfamily Q member 1,,OR51Q1
Q8NH69,OR5W2_HUMAN,OR5W2; OR5W2P; OR5W3P,Olfactory receptor 5W2; Olfactory receptor 5W3; Olfactory receptor OR11-155,OR5W2P; OR5W3P,390148,olfactory receptor family 5 subfamily W member 2,olfactory receptor; family 5; subfamily W; member 2,,,olfactory receptor family 5 subfamily W member 2,OR5W2P; OR5W3P,OR5W2
Q8NH85,OR5R1_HUMAN,OR8U3; OR5R1; OR5R1P,Olfactory receptor 8U3; Olfactory receptor 5R1; Olfactory receptor OR11-185,OR5R1; OR5R1P,219479,olfactory receptor family 8 subfamily U member 3,olfactory receptor; family 5; subfamily R; member 1 (gene/pseudogene); olfactory receptor family 5 subfamily R member 1 (gene/pseudogene); olfactory receptor family 5 subfamily R member 1,,,olfactory receptor family 8 subfamily U member 3,OR11-185; OR5R1; OR5R1P,OR8U3
Q8NH87,OR9G1_HUMAN,OR9G1; OR9G5,Olfactory receptor 9G1; Olfactory receptor 9G5; Olfactory receptor OR11-114,OR9G5,390174,olfactory receptor family 9 subfamily G member 1,olfactory receptor; family 9; subfamily G; member 1,,,olfactory receptor family 9 subfamily G member 1,OR9G5,OR9G1
Q8NH92,OR1S1_HUMAN,OR1S1,Olfactory receptor 1S1; Olfactory receptor OR11-232,,219959,olfactory receptor family 1 subfamily S member 1,olfactory receptor; family 1; subfamily S; member 1 (gene/pseudogene); olfactory receptor family 1 subfamily S member 1 (gene/pseudogene),,OST034,olfactory receptor family 1 subfamily S member 1,OR11-232; OST034,OR1S1
Q8NH94,OR1L1_HUMAN,OR1L1; OR1L2,Olfactory receptor 1L1; Olfactory receptor 1L2; Olfactory receptor 9-C; OR9-C; Olfactory receptor OR9-27,OR1L2,26737,olfactory receptor family 1 subfamily L member 1,olfactory receptor; family 1; subfamily L; member 1,,OR9-C,olfactory receptor family 1 subfamily L member 1,HG23; OR1L2; OR9-27; OR9-C,OR1L1
Q8NHC8,OR2T6_HUMAN,OR2T6; OR2T6P; OR2T9,Olfactory receptor 2T6; OST703; Olfactory receptor 2T9,OR2T6P; OR2T9,254879,olfactory receptor family 2 subfamily T member 6,olfactory receptor; family 2; subfamily T; member 6,,OST703,olfactory receptor family 2 subfamily T member 6,OR2T6P; OR2T9; OST703,OR2T6
Q8TAE6,PP14C_HUMAN,PPP1R14C; KEPI,Protein phosphatase 1 regulatory subunit 14C; Kinase-enhanced PP1 inhibitor; PKC-potentiated PP1 inhibitory protein; Serologically defined breast cancer antigen NY-BR-81,KEPI,81706,protein phosphatase 1 regulatory inhibitor subunit 14C,protein phosphatase 1; regulatory (inhibitor) subunit 14C,kinase C-enhanced PP1 inhibitor,CPI17-like; NY-BR-81; KEPI,protein phosphatase 1 regulatory inhibitor subunit 14C,CPI17-like; KEPI; NY-BR-81,PPP1R14C
Q8TAQ5,ZN420_HUMAN,ZNF420,Zinc finger protein 420,,147923,zinc finger protein 420,,,FLJ32191,zinc finger protein 420,APAK,ZNF420
Q8TCB6,O51E1_HUMAN,OR51E1; GPR164; OR51E1P; OR52A3P; POGR; PSGR2,Olfactory receptor 51E1; D-GPCR; G-protein coupled receptor 164; Olfactory receptor 52A3; Prostate-overexpressed G protein-coupled receptor; Prostate-specific G protein-coupled receptor 2,GPR164; OR51E1P; OR52A3P; POGR; PSGR2,143503,olfactory receptor family 51 subfamily E member 1,olfactory receptor; family 51; subfamily E; member 1 pseudogene; olfactory receptor; family 51; subfamily E; member 1,,GPR136,olfactory receptor family 51 subfamily E member 1,D-GPCR; DGPCR; GPR136; GPR164; OR51E1P; OR52A3P; POGR; PSGR2,OR51E1
Q8WZ84,OR8D1_HUMAN,OR8D1; OR8D3,Olfactory receptor 8D1; OST004; Olfactory receptor 8D3; Olfactory receptor OR11-301; Olfactory receptor-like protein JCG9,OR8D3,283159,olfactory receptor family 8 subfamily D member 1,olfactory receptor; family 8; subfamily D; member 1,,OST004,olfactory receptor family 8 subfamily D member 1,JCG9; OR8D3; OST004; PDJ9J14,OR8D1
Q8WZ94,OR5P3_HUMAN,OR5P3,Olfactory receptor 5P3; Olfactory receptor OR11-94; Olfactory receptor-like protein JCG1,,120066,olfactory receptor family 5 subfamily P member 3,olfactory receptor; family 5; subfamily P; member 3,,JCG1,olfactory receptor family 5 subfamily P member 3,JCG1,OR5P3
Q96A00,PP14A_HUMAN,PPP1R14A; CPI17; PPP1INL,Protein phosphatase 1 regulatory subunit 14A; 17 kDa PKC-potentiated inhibitory protein of PP1; Protein kinase C-potentiated inhibitor protein of 17 kDa; CPI-17,CPI17; PPP1INL,94274,protein phosphatase 1 regulatory inhibitor subunit 14A,protein phosphatase 1; regulatory (inhibitor) subunit 14A,17-kDa PKC-potentiated inhibitory protein of PP1; PKC-potentiated inhibitory protein of PP1; 17-KDa protein,CPI-17,protein phosphatase 1 regulatory inhibitor subunit 14A,CPI-17; CPI17; PPP1INL,PPP1R14A
Q96C19,EFHD2_HUMAN,EFHD2; SWS1,EF-hand domain-containing protein D2; Swiprosin-1,SWS1,79180,EF-hand domain family member D2,EF hand domain containing 2,swiprosin-1,MGC4342,EF-hand domain family member D2,SWS1,EFHD2
Q96CX2,KCD12_HUMAN,KCTD12; C13orf2; KIAA1778; PFET1,BTB/POZ domain-containing protein KCTD12; Pfetin; Predominantly fetal expressed T1 domain,C13orf2; KIAA1778; PFET1,115207,potassium channel tetramerization domain containing 12,chromosome 13 open reading frame 2; potassium channel tetramerisation domain containing 12,predominantly fetal expressed T1 domain,KIAA1778; PFET1,potassium channel tetramerization domain containing 12,C13orf2; PFET1; PFETIN,KCTD12
Q96R48,OR2A5_HUMAN,OR2A5; OR2A26; OR2A8,Olfactory receptor 2A5; Olfactory receptor 2A26; Olfactory receptor 2A8; Olfactory receptor 7-138/7-141; OR7-138; OR7-141,OR2A26; OR2A8,393046,olfactory receptor family 2 subfamily A member 5,olfactory receptor; family 2; subfamily A; member 5,,OR7-138; OR7-141,olfactory receptor family 2 subfamily A member 5,OR2A11P; OR2A26; OR2A8; OR7-138; OR7-141,OR2A5
Q96RA2,OR7D2_HUMAN,OR7D2,Olfactory receptor 7D2; HTPCRH03; Olfactory receptor 19-4; OR19-4; Olfactory receptor OR19-10,,162998,olfactory receptor family 7 subfamily D member 2,olfactory receptor; family 7; subfamily D; member 2,,OR19-4; HTPCRH03; FLJ38149,olfactory receptor family 7 subfamily D member 2,HTPCRH03; OR19-10; OR19-4,OR7D2
Q99666,RGPD5_HUMAN,RGPD5; RANBP2L1; RGP5; RGP7; RGPD7;; RGPD6; RANBP2L2; RGP6,RANBP2-like and GRIP domain-containing protein 5/6; Ran-binding protein 2-like 1/2; RanBP2-like 1/2; RanBP2L1; RanBP2L2; Sperm membrane protein BS-63,RANBP2L1; RGP5; RGP7; RGPD7;; RANBP2L2; RGP6,729540,RANBP2 like and GRIP domain containing 5,,,RGP5; BS-63; DKFZp686I1842,RANBP2 like and GRIP domain containing 6,RGP6; RGPD7; RanBP2L1; RanBP2L2,RGPD5; RGPD6
Q9BUG6,ZSA5A_HUMAN,ZSCAN5A; ZNF495; ZSCAN5,Zinc finger and SCAN domain-containing protein 5A; Zinc finger protein 495,ZNF495; ZSCAN5,79149,zinc finger and SCAN domain containing 5A,zinc finger protein 495; zinc finger and SCAN domain containing 5,,MGC4161,zinc finger and SCAN domain containing 5A,ZNF495; ZSCAN5,ZSCAN5A
Q9BXT2,CCG6_HUMAN,CACNG6,Voltage-dependent calcium channel gamma-6 subunit; Neuronal voltage-gated calcium channel gamma-6 subunit,,59285,calcium voltage-gated channel auxiliary subunit gamma 6,calcium channel; voltage-dependent; gamma subunit 6,,,calcium voltage-gated channel auxiliary subunit gamma 6,,CACNG6
Q9GZK4,OR2H1_HUMAN,OR2H1; OR2H6; OR2H8,Olfactory receptor 2H1; Hs6M1-16; OLFR42A-9004.14/9026.2; Olfactory receptor 2H6; Olfactory receptor 2H8; Olfactory receptor 6-2; OR6-2; Olfactory receptor OR6-32,OR2H6; OR2H8,26716,olfactory receptor family 2 subfamily H member 1,olfactory receptor; family 2; subfamily H; member 8; olfactory receptor; family 2; subfamily H; member 1,,OR6-2,olfactory receptor family 2 subfamily H member 1,6M1-16; HS6M1-16; OLFR42A-9004-14; OLFR42A-9004.14/9026.2; OR2H6; OR2H8; OR6-2; dJ994E9.4,OR2H1
Q9GZK6,OR2J1_HUMAN,OR2J1; OR2J1P,Olfactory receptor 2J1; Hs6M1-4; Olfactory receptor 6-5; OR6-5,OR2J1P,442185,olfactory receptor family 2 subfamily J member 1,olfactory receptor; family 2; subfamily J; member 1 pseudogene; olfactory receptor; family 2; subfamily J; member 1; olfactory receptor; family 2; subfamily J; member 1 (gene/pseudogene); olfactory receptor family 2 subfamily J member 1 (gene/pseudogene),,OR6-5; hs6M1-4; dJ80I19.2,olfactory receptor family 2 subfamily J member 1,6M1-4P; OR2J1P; OR6-15; OR6-5; dJ80I19.2; hs6M1-4,OR2J1
Q9GZM6,OR8D2_HUMAN,OR8D2,Olfactory receptor 8D2; Olfactory receptor OR11-303; Olfactory receptor-like protein JCG2,,283160,olfactory receptor family 8 subfamily D member 2,olfactory receptor; family 8; subfamily D; member 2 (gene/pseudogene); olfactory receptor family 8 subfamily D member 2 (gene/pseudogene),,,olfactory receptor family 8 subfamily D member 2,JCG2,OR8D2
Q9H205,O2AG1_HUMAN,OR2AG1; OR2AG3,Olfactory receptor 2AG1; HT3; Olfactory receptor 2AG3; Olfactory receptor OR11-79,OR2AG3,144125,olfactory receptor family 2 subfamily AG member 1,olfactory receptor; family 2; subfamily AG; member 1 (gene/pseudogene); olfactory receptor family 2 subfamily AG member 1 (gene/pseudogene),,,olfactory receptor family 2 subfamily AG member 1,OR11-79; OR2AG3,OR2AG1
Q9H207,O10A5_HUMAN,OR10A5; OR10A1,Olfactory receptor 10A5; HP3; Olfactory receptor 10A1; Olfactory receptor 11-403; OR11-403; Olfactory receptor-like protein JCG6,OR10A1,144124,olfactory receptor family 10 subfamily A member 5,olfactory receptor; family 10; subfamily A; member 5,,OR11-403; JCG6,olfactory receptor family 10 subfamily A member 5,JCG6; OR10A1; OR11-403,OR10A5
Q9H208,O10A2_HUMAN,OR10A2; OR10A2P,Olfactory receptor 10A2; HP4; Olfactory receptor OR11-86,OR10A2P,341276,olfactory receptor family 10 subfamily A member 2,olfactory receptor; family 10; subfamily A; member 2,,OST363,olfactory receptor family 10 subfamily A member 2,OR10A2P; OR11-82; OR11-86; OST363,OR10A2
Q9H209,O10A4_HUMAN,OR10A4; OR10A4P,Olfactory receptor 10A4; HP2; Olfactory receptor-like protein JCG5,OR10A4P,283297,olfactory receptor family 10 subfamily A member 4,olfactory receptor; family 10; subfamily A; member 4 pseudogene; olfactory receptor; family 10; subfamily A; member 4,,,olfactory receptor family 10 subfamily A member 4,JCG5; OR10A4P,OR10A4
Q9H210,OR2D2_HUMAN,OR2D2; OR2D1,Olfactory receptor 2D2; HB2; Olfactory receptor 11-610; OR11-610; Olfactory receptor 2D1; Olfactory receptor OR11-88,OR2D1,120776,olfactory receptor family 2 subfamily D member 2,olfactory receptor; family 2; subfamily D; member 2,,OR11-610; hg27,olfactory receptor family 2 subfamily D member 2,OR11-610; OR2D1; hg27,OR2D2
Q9H339,O51B5_HUMAN,OR51B5,Olfactory receptor 51B5; Odorant receptor HOR5'beta5; Olfactory receptor OR11-37,,282763,olfactory receptor family 51 subfamily B member 5,olfactory receptor; family 51; subfamily B; member 5,,,olfactory receptor family 51 subfamily B member 5,HOR5'Beta5; OR11-37,OR51B5
Q9H340,O51B6_HUMAN,OR51B6,Olfactory receptor 51B6; Odorant receptor HOR5'beta6,,390058,olfactory receptor family 51 subfamily B member 6,olfactory receptor; family 51; subfamily B; member 6,,,olfactory receptor family 51 subfamily B member 6,HOR5'Beta6,OR51B6
Q9H341,O51M1_HUMAN,OR51M1,Olfactory receptor 51M1; Odorant receptor HOR5'beta7; Olfactory receptor OR11-40,,390059,olfactory receptor family 51 subfamily M member 1,olfactory receptor; family 51; subfamily M; member 1,,,olfactory receptor family 51 subfamily M member 1,HOR5'Beta7; OR11-40,OR51M1
Q9H6F5,CCD86_HUMAN,CCDC86; CYCLON,Coiled-coil domain-containing protein 86; Cytokine-induced protein with coiled-coil domain,CYCLON,79080,coiled-coil domain containing 86,,cytokine-induced protein with coiled-coil domain,MGC2574; cyclon; Cgr1,coiled-coil domain containing 86,Cgr1,CCDC86
Q9HB09,B2L12_HUMAN,BCL2L12; BPR,Bcl-2-like protein 12; Bcl2-L-12; Bcl-2-related proline-rich protein,BPR,83596,BCL2 like 12,BCL2-like 12 (proline rich),,,BCL2 like 12,,BCL2L12
Q9NQN1,OR2S1_HUMAN,OR2S2,Olfactory receptor 2S2; Olfactory receptor OR9-3,,56656,olfactory receptor family 2 subfamily S member 2,olfactory receptor; family 2; subfamily S; member 2 (gene/pseudogene); olfactory receptor family 2 subfamily S member 2 (gene/pseudogene),,,olfactory receptor family 2 subfamily S member 2,OR37A; OST715,OR2S2
Q9NQS1,AVEN_HUMAN,AVEN,Cell death regulator Aven,,57099,apoptosis and caspase activation inhibitor,,cell death regulator aven; programmed cell death 12,PDCD12,apoptosis and caspase activation inhibitor,PDCD12,AVEN
Q9NS28,RGS18_HUMAN,RGS18; RGS13,Regulator of G-protein signaling 18; RGS18,RGS13,64407,regulator of G protein signaling 18,regulator of G-protein signalling 18; regulator of G-protein signaling 18,,RGS13,regulator of G protein signaling 18,RGS13,RGS18
Q9NZH5,PTTG2_HUMAN,PTTG2,Securin-2; Pituitary tumor-transforming gene 2 protein,,10744,pituitary tumor-transforming 2,,,,pituitary tumor-transforming 2,,PTTG2
Q9NZT2,OGFR_HUMAN,OGFR,Opioid growth factor receptor; OGFr; Protein 7-60; Zeta-type opioid receptor,,11054,opioid growth factor receptor,,,Jul-60,opioid growth factor receptor,,OGFR
Q9P2J9,PDP2_HUMAN,PDP2; KIAA1348,Pyruvate dehydrogenase acetyl-transferring-phosphatase 2; mitochondrial; PDP 2; EC 3.1.3.43; Pyruvate dehydrogenase phosphatase catalytic subunit 2; PDPC 2,KIAA1348,57546,pyruvate dehydrogenase phosphatase catalytic subunit 2,,protein phosphatase 2C; magnesium-dependent; catalytic subunit 2; protein phosphatase; Mg2+/Mn2+ dependent 2B; pyruvate dehydrogenase (acetyl-transferring)-phosphatase,KIAA1348; PPM2C2; PPM2B,pyruvate dehydrogenase phosphatase catalytic subunit 2,PDPC 2; PPM2B; PPM2C2,PDP2
Q9UF02,CCG5_HUMAN,CACNG5,Voltage-dependent calcium channel gamma-5 subunit; Neuronal voltage-gated calcium channel gamma-5 subunit; Transmembrane AMPAR regulatory protein gamma-5; TARP gamma-5,,27091,calcium voltage-gated channel auxiliary subunit gamma 5,calcium channel; voltage-dependent; gamma subunit 5,,,calcium voltage-gated channel auxiliary subunit gamma 5,,CACNG5
Q9UK08,GBG8_HUMAN,GNG8; GNG9; GNGT9,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8; I; S; O; Gamma-9,GNG9; GNGT9,94235,G protein subunit gamma 8,guanine nucleotide binding protein (G protein); gamma 8,,,G protein subunit gamma 8,HG3E,GNG8
Q9UKD2,MRT4_HUMAN,MRTO4; C1orf33; MRT4,mRNA turnover protein 4 homolog; Ribosome assembly factor MRTO4,C1orf33; MRT4,51154,MRT4 homolog; ribosome maturation factor,chromosome 1 open reading frame 33; MRT4; mRNA turnover 4; homolog (S. cerevisiae); mRNA turnover 4 homolog (S. cerevisiae),,dJ657E11.4; MRT4,MRT4 homolog; ribosome maturation factor,C1orf33; MRT4; dJ657E11.4,MRTO4
Q9UKL2,O52A1_HUMAN,OR52A1,Olfactory receptor 52A1; HPFH1OR; Odorant receptor HOR3'beta4; Olfactory receptor OR11-319,,23538,olfactory receptor family 52 subfamily A member 1,olfactory receptor; family 52; subfamily A; member 1,,HPFH1OR,olfactory receptor family 52 subfamily A member 1,HPFH1OR,OR52A1
Q9UKL4,CXD2_HUMAN,GJD2; GJA9,Gap junction delta-2 protein; Connexin-36; Cx36; Gap junction alpha-9 protein,GJA9,57369,gap junction protein delta 2,gap junction protein; alpha 9; 36kDa; gap junction protein; delta 2; 36kDa,connexin 36,CX36,gap junction protein delta 2,CX36; GJA9,GJD2
Q9Y2T4,2ABG_HUMAN,PPP2R2C,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform; IMYPNO1; PP2A subunit B isoform B55-gamma; PP2A subunit B isoform PR55-gamma; PP2A subunit B isoform R2-gamma; PP2A subunit B isoform gamma,,5522,protein phosphatase 2 regulatory subunit Bgamma,protein phosphatase 2 (formerly 2A); regulatory subunit B (PR 52); gamma isoform,PP2A subunit B isoform gamma,PR52; IMYPNO; MGC33570; PR55G; B55gamma,protein phosphatase 2 regulatory subunit Bgamma,B55-GAMMA; B55gamma; IMYPNO; IMYPNO1; PR52; PR55G,PPP2R2C
Q9Y4F5,C170B_HUMAN,CEP170B; FAM68C; KIAA0284,Centrosomal protein of 170 kDa protein B; Centrosomal protein 170B; Cep170B,FAM68C; KIAA0284,283638,centrosomal protein 170B,KIAA0284,Cep170-related,FAM68C; Cep170R,centrosomal protein 170B,CEP170R; FAM68C; KIAA0284,CEP170B
Q9Y585,OR1A2_HUMAN,OR1A2,Olfactory receptor 1A2; Olfactory receptor 17-6; OR17-6; Olfactory receptor OR17-10,,26189,olfactory receptor family 1 subfamily A member 2,olfactory receptor; family 1; subfamily A; member 2,,OR17-6,olfactory receptor family 1 subfamily A member 2,OR17-6,OR1A2
Q9Y5P1,O51B2_HUMAN,OR51B2; OR51B1P,Olfactory receptor 51B2; Odorant receptor HOR5'beta3; Olfactory receptor 51B1,OR51B1P,79345,olfactory receptor family 51 subfamily B member 2,olfactory receptor; family 51; subfamily B; member 2 (gene/pseudogene); olfactory receptor family 51 subfamily B member 2 (gene/pseudogene),,,olfactory receptor family 51 subfamily B member 2,HOR5'Beta3; OR51B1P,OR51B2
A3KFT3,OR2M5_HUMAN,OR2M5; OR2M5P,Olfactory receptor 2M5,OR2M5P,127059,olfactory receptor family 2 subfamily M member 5,olfactory receptor; family 2; subfamily M; member 5,,,olfactory receptor family 2 subfamily M member 5,OR2M5P,OR2M5
A6NCV1,O6C74_HUMAN,OR6C74,Olfactory receptor 6C74,,254783,olfactory receptor family 6 subfamily C member 74,olfactory receptor; family 6; subfamily C; member 74,,,olfactory receptor family 6 subfamily C member 74,,OR6C74
A6NDH6,O5H15_HUMAN,OR5H15,Olfactory receptor 5H15,,403274,olfactory receptor family 5 subfamily H member 15,olfactory receptor; family 5; subfamily H; member 15,,,olfactory receptor family 5 subfamily H member 15,,OR5H15
A6NDL8,O6C68_HUMAN,OR6C68,Olfactory receptor 6C68,,403284,olfactory receptor family 6 subfamily C member 68,olfactory receptor; family 6; subfamily C; member 68,,,olfactory receptor family 6 subfamily C member 68,,OR6C68
A6NET4,OR5K3_HUMAN,OR5K3,Olfactory receptor 5K3,,403277,olfactory receptor family 5 subfamily K member 3,olfactory receptor; family 5; subfamily K; member 3,,,olfactory receptor family 5 subfamily K member 3,,OR5K3
A6NF89,OR6C6_HUMAN,OR6C6,Olfactory receptor 6C6,,283365,olfactory receptor family 6 subfamily C member 6,olfactory receptor; family 6; subfamily C; member 6,,,olfactory receptor family 6 subfamily C member 6,,OR6C6
A6NHA9,O4C46_HUMAN,OR4C46,Olfactory receptor 4C46,,119749,olfactory receptor family 4 subfamily C member 46,olfactory receptor; family 4; subfamily C; member 46,,,olfactory receptor family 4 subfamily C member 46,,OR4C46
A6NHG9,O5H14_HUMAN,OR5H14,Olfactory receptor 5H14,,403273,olfactory receptor family 5 subfamily H member 14,olfactory receptor; family 5; subfamily H; member 14,,,olfactory receptor family 5 subfamily H member 14,,OR5H14
A6NIJ9,O6C70_HUMAN,OR6C70,Olfactory receptor 6C70,,390327,olfactory receptor family 6 subfamily C member 70,olfactory receptor; family 6; subfamily C; member 70,,,olfactory receptor family 6 subfamily C member 70,,OR6C70
A6NJZ3,O6C65_HUMAN,OR6C65,Olfactory receptor 6C65,,403282,olfactory receptor family 6 subfamily C member 65,olfactory receptor; family 6; subfamily C; member 65,,,olfactory receptor family 6 subfamily C member 65,,OR6C65
A6NKK0,OR5H1_HUMAN,OR5H1,Olfactory receptor 5H1; HTPCRX14,,26341,olfactory receptor family 5 subfamily H member 1,olfactory receptor; family 5; subfamily H; member 1,,HTPCRX14; HSHTPCRX14,olfactory receptor family 5 subfamily H member 1,HSHTPCRX14; HTPCRX14,OR5H1
A6NKT7,RGPD3_HUMAN,RGPD3; RGP3,RanBP2-like and GRIP domain-containing protein 3,RGP3,653489,RANBP2 like and GRIP domain containing 3,,,RGP3,RANBP2 like and GRIP domain containing 3,RGP3,RGPD3
A6NL08,O6C75_HUMAN,OR6C75,Olfactory receptor 6C75,,390323,olfactory receptor family 6 subfamily C member 75,olfactory receptor; family 6; subfamily C; member 75,,,olfactory receptor family 6 subfamily C member 75,,OR6C75
A6NL26,O5B21_HUMAN,OR5B21,Olfactory receptor 5B21,,219968,olfactory receptor family 5 subfamily B member 21,olfactory receptor; family 5; subfamily B; member 21,,,olfactory receptor family 5 subfamily B member 21,,OR5B21
A6NM03,O2AG2_HUMAN,OR2AG2; OR2AG2P,Olfactory receptor 2AG2,OR2AG2P,338755,olfactory receptor family 2 subfamily AG member 2,olfactory receptor; family 2; subfamily AG; member 2,,,olfactory receptor family 2 subfamily AG member 2,OR11-76; OR2AG2P,OR2AG2
A6NM76,O6C76_HUMAN,OR6C76,Olfactory receptor 6C76,,390326,olfactory receptor family 6 subfamily C member 76,olfactory receptor; family 6; subfamily C; member 76,,,olfactory receptor family 6 subfamily C member 76,,OR6C76
A6NMS3,OR5K4_HUMAN,OR5K4,Olfactory receptor 5K4,,403278,olfactory receptor family 5 subfamily K member 4,olfactory receptor; family 5; subfamily K; member 4,,,olfactory receptor family 5 subfamily K member 4,,OR5K4
A6NMX2,I4E1B_HUMAN,EIF4E1B,Eukaryotic translation initiation factor 4E type 1B,,253314,eukaryotic translation initiation factor 4E family member 1B,,,FLJ36951,eukaryotic translation initiation factor 4E family member 1B,,EIF4E1B
A6NMZ5,O4C45_HUMAN,OR4C45,Olfactory receptor 4C45,,403257,olfactory receptor family 4 subfamily C member 45 (gene/pseudogene),olfactory receptor; family 4; subfamily C; member 45,,,olfactory receptor family 4 subfamily C member 45 (gene/pseudogene),,OR4C45
B2RN74,O11HC_HUMAN,OR11H12,Olfactory receptor 11H12,,440153,olfactory receptor family 11 subfamily H member 12,olfactory receptor; family 11; subfamily H; member 12,,,olfactory receptor family 11 subfamily H member 12,,OR11H12
O14581,OR7AH_HUMAN,OR7A17,Olfactory receptor 7A17,,26333,olfactory receptor family 7 subfamily A member 17,olfactory receptor; family 7; subfamily A; member 17,,HTPCRX19,olfactory receptor family 7 subfamily A member 17,BC85395_4; HTPCRX19,OR7A17
O14715,RGPD8_HUMAN,RGPD8; RANBP2ALPHA; RANBP2L1; RANBP2L3,RANBP2-like and GRIP domain-containing protein 8; Ran-binding protein 2-like 3; RanBP2-like 3; RanBP2L3,RANBP2ALPHA; RANBP2L1; RANBP2L3,727851,RANBP2 like and GRIP domain containing 8,RAN binding protein 2-like 1,,RanBP2alpha,RANBP2 like and GRIP domain containing 8,RANBP2L1; RGP8; RanBP2alpha,RGPD8
O14921,RGS13_HUMAN,RGS13,Regulator of G-protein signaling 13; RGS13,,6003,regulator of G protein signaling 13,regulator of G-protein signalling 13; regulator of G-protein signaling 13,,,regulator of G protein signaling 13,,RGS13
O43869,OR2T1_HUMAN,OR2T1,Olfactory receptor 2T1; Olfactory receptor 1-25; OR1-25; Olfactory receptor OR1-61,,26696,olfactory receptor family 2 subfamily T member 1,olfactory receptor; family 2; subfamily T; member 1,,OR1-25,olfactory receptor family 2 subfamily T member 1,OR1-25,OR2T1
O60403,O10H2_HUMAN,OR10H2,Olfactory receptor 10H2; Olfactory receptor OR19-23,,26538,olfactory receptor family 10 subfamily H member 2,olfactory receptor; family 10; subfamily H; member 2,,,olfactory receptor family 10 subfamily H member 2,,OR10H2
O60404,O10H3_HUMAN,OR10H3,Olfactory receptor 10H3; Olfactory receptor OR19-24,,26532,olfactory receptor family 10 subfamily H member 3,olfactory receptor; family 10; subfamily H; member 3,,,olfactory receptor family 10 subfamily H member 3,,OR10H3
O60431,OR1I1_HUMAN,OR1I1,Olfactory receptor 1I1; Olfactory receptor 19-20; OR19-20,,126370,olfactory receptor family 1 subfamily I member 1,olfactory receptor; family 1; subfamily I; member 1,,OR1I1P; OR19-20; OR1I1Q,olfactory receptor family 1 subfamily I member 1,OR19-20; OR1I1P; OR1I1Q,OR1I1
O76000,OR2B3_HUMAN,OR2B3; OR2B3P,Putative olfactory receptor 2B3; Hs6M1-1; Olfactory receptor OR6-14; OR6-4; Olfactory receptor 6-4,OR2B3P,442184,olfactory receptor family 2 subfamily B member 3,olfactory receptor; family 2; subfamily B; member 3 pseudogene; olfactory receptor; family 2; subfamily B; member 3,,OR6-4,olfactory receptor family 2 subfamily B member 3,6M1-1; OR2B3P; OR6-14; OR6-4,OR2B3
O76100,OR7AA_HUMAN,OR7A10,Olfactory receptor 7A10; OST027; Olfactory receptor OR19-18,,390892,olfactory receptor family 7 subfamily A member 10,olfactory receptor; family 7; subfamily A; member 10,,,olfactory receptor family 7 subfamily A member 10,BC85395_3; OR19-18,OR7A10
O95006,OR2F2_HUMAN,OR2F2,Olfactory receptor 2F2; Olfactory receptor 7-1; OR7-1; Olfactory receptor OR7-6,,135948,olfactory receptor family 2 subfamily F member 2,olfactory receptor; family 2; subfamily F; member 2,,OR7-1,olfactory receptor family 2 subfamily F member 2,OR7-1,OR2F2
O95013,O4F21_HUMAN,OR4F21; OR4F21P,Olfactory receptor 4F21,OR4F21P,441308,olfactory receptor family 4 subfamily F member 21,olfactory receptor; family 4; subfamily F; member 21,,,olfactory receptor family 4 subfamily F member 21,OR4F21P,OR4F21
O95221,OR5F1_HUMAN,OR5F1,Olfactory receptor 5F1; Olfactory receptor 11-10; OR11-10; Olfactory receptor OR11-167,,338674,olfactory receptor family 5 subfamily F member 1,olfactory receptor; family 5; subfamily F; member 1,,OR11-10,olfactory receptor family 5 subfamily F member 1,OR11-10,OR5F1
P0C7N5,OR8U9_HUMAN,OR8U9,Olfactory receptor 8U9,,504190,olfactory receptor family 8 subfamily U member 9,olfactory receptor; family 8; subfamily U; member 9,,,olfactory receptor family 8 subfamily U member 9,,OR8U9
P0C7T3,O56A5_HUMAN,OR56A5; OR56A5P,Olfactory receptor 56A5,OR56A5P,390084,olfactory receptor family 56 subfamily A member 5,olfactory receptor; family 56; subfamily A; member 5,,,olfactory receptor family 56 subfamily A member 5,OR56A5P,OR56A5
P0DN82,O12D1_HUMAN,OR12D1; OR12D1P,Olfactory receptor 12D1,OR12D1P,26530,olfactory receptor family 12 subfamily D member 1 (gene/pseudogene),olfactory receptor; family 12; subfamily D; member 1; olfactory receptor; family 12; subfamily D; member 1 pseudogene; olfactory receptor; family 12; subfamily D; member 1 (gene/pseudogene),,hs6M1-19,olfactory receptor family 12 subfamily D member 1 (gene/pseudogene),OR12D1P; hs6M1-19,OR12D1
P47881,OR3A1_HUMAN,OR3A1; OLFRA03,Olfactory receptor 3A1; Olfactory receptor 17-40; OR17-40; Olfactory receptor OR17-15,OLFRA03,4994,olfactory receptor family 3 subfamily A member 1,olfactory receptor; family 3; subfamily A; member 1; olfactory receptor family 3 subfamily A member 1 (gene/pseudogene),,OLFRA03; OR40; OR17-40,olfactory receptor family 3 subfamily A member 1,OLFRA03; OR17-40; OR17-82; OR40,OR3A1
P47890,OR1G1_HUMAN,OR1G1; OR1G2,Olfactory receptor 1G1; Olfactory receptor 17-209; OR17-209; Olfactory receptor 1G2; Olfactory receptor OR17-8,OR1G2,8390,olfactory receptor family 1 subfamily G member 1,olfactory receptor; family 1; subfamily G; member 1,,OR17-209,olfactory receptor family 1 subfamily G member 1,OR17-130; OR17-209; OR1G2,OR1G1
P52943,CRIP2_HUMAN,CRIP2; CRP2,Cysteine-rich protein 2; CRP-2; Protein ESP1,CRP2,1397,cysteine rich protein 2,,,CRP2; ESP1,cysteine rich protein 2,CRIP; CRP2; ESP1,CRIP2
P58170,OR1D5_HUMAN,OR1D5,Olfactory receptor 1D5; Olfactory receptor 17-31; OR17-31,,8386,olfactory receptor family 1 subfamily D member 5,olfactory receptor; family 1; subfamily D; member 5,,OR17-31,olfactory receptor family 1 subfamily D member 5,C17orf2; OR17-2; OR17-30; OR17-31; OR1D4,OR1D5
P58180,OR4D2_HUMAN,OR4D2,Olfactory receptor 4D2; B-lymphocyte membrane protein BC2009; Olfactory receptor OR17-24,,124538,olfactory receptor family 4 subfamily D member 2,olfactory receptor; family 4; subfamily D; member 2,,,olfactory receptor family 4 subfamily D member 2,BC2009; OR17-24,OR4D2
P58181,O10A3_HUMAN,OR10A3,Olfactory receptor 10A3; HTPCRX12; Olfactory receptor OR11-97,,26496,olfactory receptor family 10 subfamily A member 3,olfactory receptor; family 10; subfamily A; member 3,,HTPCRX12; HSHTPCRX12,olfactory receptor family 10 subfamily A member 3,HSHTPCRX12; HTPCRX12,OR10A3
Q15615,OR4D1_HUMAN,OR4D1; OR4D3,Olfactory receptor 4D1; Olfactory receptor 4D3; Olfactory receptor TPCR16,OR4D3,26689,olfactory receptor family 4 subfamily D member 1,olfactory receptor; family 4; subfamily D; member 1,,TPCR16,olfactory receptor family 4 subfamily D member 1,OR17-23; OR4D3; OR4D4P; TPCR16,OR4D1
Q15619,OR1C1_HUMAN,OR1C1,Olfactory receptor 1C1; Olfactory receptor OR1-42; Olfactory receptor TPCR27,,26188,olfactory receptor family 1 subfamily C member 1,olfactory receptor; family 1; subfamily C; member 1,,TPCR27; HSTPCR27,olfactory receptor family 1 subfamily C member 1,HSTPCR27; OR1-42; OR1.5.10; ORL211; TPCR27,OR1C1
Q15622,OR7A5_HUMAN,OR7A5,Olfactory receptor 7A5; Olfactory receptor OR19-17; Olfactory receptor TPCR92,,26659,olfactory receptor family 7 subfamily A member 5,olfactory receptor; family 7; subfamily A; member 5 pseudogene; olfactory receptor; family 7; subfamily A; member 5,,HTPCR2,olfactory receptor family 7 subfamily A member 5,HTPCR2,OR7A5
Q16559,TAL2_HUMAN,TAL2; BHLHA19,T-cell acute lymphocytic leukemia protein 2; TAL-2; Class A basic helix-loop-helix protein 19; bHLHa19,BHLHA19,6887,TAL bHLH transcription factor 2,T-cell acute lymphocytic leukemia 2,,bHLHa19,TAL bHLH transcription factor 2,,TAL2
Q52LA3,LIN52_HUMAN,LIN52; C14orf46,Protein lin-52 homolog,C14orf46,91750,lin-52 DREAM MuvB core complex component,chromosome 14 open reading frame 46; lin-52 homolog (C. elegans),,,lin-52 DREAM MuvB core complex component,C14orf46; c14_5549,LIN52
Q53SF7,COBL1_HUMAN,COBLL1; KIAA0977,Cordon-bleu protein-like 1,KIAA0977,22837,cordon-bleu WH2 repeat protein like 1,COBL-like 1; cordon-bleu WH2 repeat protein-like 1,,KIAA0977,cordon-bleu WH2 repeat protein like 1,COBLR1,COBLL1
Q5JQS5,OR2BB_HUMAN,OR2B11,Olfactory receptor 2B11,,127623,olfactory receptor family 2 subfamily B member 11,olfactory receptor; family 2; subfamily B; member 11,,,olfactory receptor family 2 subfamily B member 11,,OR2B11
Q5TZ20,OR2G6_HUMAN,OR2G6,Olfactory receptor 2G6,,391211,olfactory receptor family 2 subfamily G member 6,olfactory receptor; family 2; subfamily G; member 6,,,olfactory receptor family 2 subfamily G member 6,,OR2G6
Q6IEU7,OR5MA_HUMAN,OR5M10,Olfactory receptor 5M10; Olfactory receptor OR11-207,,390167,olfactory receptor family 5 subfamily M member 10,olfactory receptor; family 5; subfamily M; member 10,,,olfactory receptor family 5 subfamily M member 10,OR11-207,OR5M10
Q6IEV9,OR4CB_HUMAN,OR4C11; OR4C11P,Olfactory receptor 4C11; Olfactory receptor OR11-136,OR4C11P,219429,olfactory receptor family 4 subfamily C member 11,olfactory receptor; family 4; subfamily C; member 11,,,olfactory receptor family 4 subfamily C member 11,OR11-136; OR4C11P,OR4C11
Q6IEY1,OR4F3_HUMAN,OR4F3;; OR4F16;; OR4F29,Olfactory receptor 4F3/4F16/4F29; Olfactory receptor OR1-1,;; ;,26683,olfactory receptor family 4 subfamily F member 3,olfactory receptor; family 4; subfamily F; member 3,,,olfactory receptor family 4 subfamily F member 3,,OR4F3; OR4F16; OR4F29
Q6IEZ7,OR2T5_HUMAN,OR2T5,Olfactory receptor 2T5; Olfactory receptor OR1-62,,401993,olfactory receptor family 2 subfamily T member 5,olfactory receptor; family 2; subfamily T; member 5,,,olfactory receptor family 2 subfamily T member 5,OR1-62; OR2T29,OR2T5
Q6IF00,OR2T2_HUMAN,OR2T2; OR2T2P,Olfactory receptor 2T2; Olfactory receptor OR1-43,OR2T2P,401992,olfactory receptor family 2 subfamily T member 2,olfactory receptor; family 2; subfamily T; member 2 pseudogene; olfactory receptor; family 2; subfamily T; member 2,,,olfactory receptor family 2 subfamily T member 2,OR1-43; OR2T2P,OR2T2
Q6IF42,OR2A2_HUMAN,OR2A2; OR2A17P; OR2A2P,Olfactory receptor 2A2; Olfactory receptor 2A17; Olfactory receptor OR7-11,OR2A17P; OR2A2P,442361,olfactory receptor family 2 subfamily A member 2,olfactory receptor; family 2; subfamily A; member 2,,OST008,olfactory receptor family 2 subfamily A member 2,OR2A17P; OR2A2P; OR7-11; OST008,OR2A2
Q6IF63,O52W1_HUMAN,OR52W1; OR52W1P,Olfactory receptor 52W1; Olfactory receptor OR11-71,OR52W1P,120787,olfactory receptor family 52 subfamily W member 1,olfactory receptor; family 52; subfamily W; member 1,,,olfactory receptor family 52 subfamily W member 1,OR11-71; OR52W1P,OR52W1
Q6IF82,O4A47_HUMAN,OR4A47,Olfactory receptor 4A47; Olfactory receptor OR11-113,,403253,olfactory receptor family 4 subfamily A member 47,olfactory receptor; family 4; subfamily A; member 47,,,olfactory receptor family 4 subfamily A member 47,OR11-113,OR4A47
Q6IF99,O10K2_HUMAN,OR10K2,Olfactory receptor 10K2; Olfactory receptor OR1-4,,391107,olfactory receptor family 10 subfamily K member 2,olfactory receptor; family 10; subfamily K; member 2,,,olfactory receptor family 10 subfamily K member 2,OR1-4,OR10K2
Q6IFG1,O52E8_HUMAN,OR52E8,Olfactory receptor 52E8; Olfactory receptor OR11-54,,390079,olfactory receptor family 52 subfamily E member 8,olfactory receptor; family 52; subfamily E; member 8 pseudogene; olfactory receptor; family 52; subfamily E; member 8,,,olfactory receptor family 52 subfamily E member 8,OR11-54,OR52E8
Q6IFN5,O7E24_HUMAN,OR7E24; OR7E24P,Olfactory receptor 7E24; Olfactory receptor OR19-14,OR7E24P,26648,olfactory receptor family 7 subfamily E member 24,olfactory receptor; family 7; subfamily E; member 24 pseudogene; olfactory receptor; family 7; subfamily E; member 24,,OR19-8; HSHT2; OR7E24Q,olfactory receptor family 7 subfamily E member 24,HSHT2; OR19-8; OR7E24P; OR7E24Q,OR7E24
Q7Z3J3,RGPD4_HUMAN,RGPD4; RGP4,RanBP2-like and GRIP domain-containing protein 4,RGP4,285190,RANBP2 like and GRIP domain containing 4,,,RGP4; DKFZp686P0288,RANBP2 like and GRIP domain containing 4,RGP4,RGPD4
Q86V87,FHI2B_HUMAN,FHIP2B; FAM160B2; RAI16; FP13191,FHF complex subunit HOOK-interacting protein 2B; FHIP2B; Retinoic acid-induced protein 16,FAM160B2; RAI16,64760,FHF complex subunit HOOK interacting protein 2B,retinoic acid induced 16; family with sequence similarity 160 member B2,,FLJ21801,FHF complex subunit HOOK interacting protein 2B,FAI16; FAM160B2; RAI16; RAM160B2,FHIP2B
Q86WR7,PRSR2_HUMAN,PROSER2; C10orf47,Proline and serine-rich protein 2,C10orf47,254427,proline and serine rich 2,chromosome 10 open reading frame 47; proline and serine-rich protein 2,,MGC35403,proline and serine rich 2,C10orf47,PROSER2
Q8IXE1,OR4N5_HUMAN,OR4N5,Olfactory receptor 4N5; Olfactory receptor OR14-33,,390437,olfactory receptor family 4 subfamily N member 5,olfactory receptor; family 4; subfamily N; member 5,,,olfactory receptor family 4 subfamily N member 5,,OR4N5
Q8N0Y3,OR4N4_HUMAN,OR4N4,Olfactory receptor 4N4; Olfactory receptor OR15-1; Olfactory receptor OR15-5,,283694,olfactory receptor family 4 subfamily N member 4,olfactory receptor; family 4; subfamily N; member 4,,,olfactory receptor family 4 subfamily N member 4,OR15-1; OR15-5,OR4N4
Q8N0Y5,OR8I2_HUMAN,OR8I2,Olfactory receptor 8I2; Olfactory receptor OR11-170,,120586,olfactory receptor family 8 subfamily I member 2,olfactory receptor; family 8; subfamily I; member 2,,,olfactory receptor family 8 subfamily I member 2,OR11-170,OR8I2
Q8N127,O5AS1_HUMAN,OR5AS1,Olfactory receptor 5AS1; Olfactory receptor OR11-168,,219447,olfactory receptor family 5 subfamily AS member 1,olfactory receptor; family 5; subfamily AS; member 1,,,olfactory receptor family 5 subfamily AS member 1,OR11-168,OR5AS1
Q8N146,OR8H3_HUMAN,OR8H3,Olfactory receptor 8H3; Olfactory receptor OR11-172,,390152,olfactory receptor family 8 subfamily H member 3,olfactory receptor; family 8; subfamily H; member 3,,,olfactory receptor family 8 subfamily H member 3,OR11-172,OR8H3
Q8N148,OR6V1_HUMAN,OR6V1,Olfactory receptor 6V1; Olfactory receptor OR7-3,,346517,olfactory receptor family 6 subfamily V member 1,olfactory receptor; family 6; subfamily V; member 1,,GPR138,olfactory receptor family 6 subfamily V member 1,GPR138,OR6V1
Q8N162,OR8H2_HUMAN,OR8H2,Olfactory receptor 8H2; Olfactory receptor OR11-171,,390151,olfactory receptor family 8 subfamily H member 2,olfactory receptor; family 8; subfamily H; member 2,,,olfactory receptor family 8 subfamily H member 2,OR11-171,OR8H2
Q8N349,OR2LD_HUMAN,OR2L13; OR2L14,Olfactory receptor 2L13; Olfactory receptor 2L14,OR2L14,284521,olfactory receptor family 2 subfamily L member 13,olfactory receptor; family 2; subfamily L; member 13,,,olfactory receptor family 2 subfamily L member 13,OR2L14,OR2L13
Q8N4S0,CCD82_HUMAN,CCDC82; HT025,Coiled-coil domain-containing protein 82,,79780,coiled-coil domain containing 82,,,FLJ23518,coiled-coil domain containing 82,HSPC048,CCDC82
Q8NEM2,SHCBP_HUMAN,SHCBP1,SHC SH2 domain-binding protein 1,,79801,SHC binding and spindle associated 1,SHC SH2-domain binding protein 1,Protein expressed in Activated Lymphocytes,FLJ22009; PAL,SHC binding and spindle associated 1,PAL,SHCBP1
Q8NG75,OR5T1_HUMAN,OR5T1; OR5T1P,Olfactory receptor 5T1; Olfactory receptor OR11-179,OR5T1P,390155,olfactory receptor family 5 subfamily T member 1,olfactory receptor; family 5; subfamily T; member 1,,,olfactory receptor family 5 subfamily T member 1,OR11-179; OR5T1P,OR5T1
Q8NG76,O2T33_HUMAN,OR2T33,Olfactory receptor 2T33; Olfactory receptor OR1-56,,391195,olfactory receptor family 2 subfamily T member 33,olfactory receptor; family 2; subfamily T; member 33,,,olfactory receptor family 2 subfamily T member 33,OR1-56; OR2T32,OR2T33
Q8NG77,O2T12_HUMAN,OR2T12,Olfactory receptor 2T12; Olfactory receptor OR1-57,,127064,olfactory receptor family 2 subfamily T member 12,olfactory receptor; family 2; subfamily T; member 12,,,olfactory receptor family 2 subfamily T member 12,OR1-57,OR2T12
Q8NG78,OR8G5_HUMAN,OR8G5; OR8G5P; OR8G6,Olfactory receptor 8G5; Olfactory receptor 8G6; Olfactory receptor OR11-298,OR8G5P; OR8G6,219865,olfactory receptor family 8 subfamily G member 5,olfactory receptor; family 8; subfamily G; member 5,,,olfactory receptor family 8 subfamily G member 5,OR11-298; OR8G5P; OR8G6,OR8G5
Q8NG80,OR2L5_HUMAN,OR2L5; OR2L11,Olfactory receptor 2L5; Olfactory receptor 2L11; Olfactory receptor OR1-53,OR2L11,81466,olfactory receptor family 2 subfamily L member 5,olfactory receptor; family 2; subfamily L; member 5,,,olfactory receptor family 2 subfamily L member 5,OR2L11; OR2L5P,OR2L5
Q8NG81,OR2M7_HUMAN,OR2M7,Olfactory receptor 2M7; Olfactory receptor OR1-58,,391196,olfactory receptor family 2 subfamily M member 7,olfactory receptor; family 2; subfamily M; member 7,,,olfactory receptor family 2 subfamily M member 7,OR1-58,OR2M7
Q8NG83,OR2M3_HUMAN,OR2M3; OR2M3P; OR2M6,Olfactory receptor 2M3; Olfactory receptor 2M6; Olfactory receptor OR1-54,OR2M3P; OR2M6,127062,olfactory receptor family 2 subfamily M member 3,olfactory receptor; family 2; subfamily M; member 3,,OST003,olfactory receptor family 2 subfamily M member 3,OR1-54; OR2M3P; OR2M6; OST003,OR2M3
Q8NG84,O2AK2_HUMAN,OR2AK2; OR2AK1P,Olfactory receptor 2AK2; Olfactory receptor 2AK1; Olfactory receptor OR1-47,OR2AK1P,391191,olfactory receptor family 2 subfamily AK member 2,olfactory receptor; family 2; subfamily AK; member 2,,,olfactory receptor family 2 subfamily AK member 2,OR1-47; OR2AK1P,OR2AK2
Q8NG85,OR2L3_HUMAN,OR2L3,Olfactory receptor 2L3,,391192,olfactory receptor family 2 subfamily L member 3,olfactory receptor; family 2; subfamily L; member 3,,,olfactory receptor family 2 subfamily L member 3,,OR2L3
Q8NG92,O13H1_HUMAN,OR13H1,Olfactory receptor 13H1; Olfactory receptor ORX-1,,347468,olfactory receptor family 13 subfamily H member 1,olfactory receptor; family 13; subfamily H; member 1,,,olfactory receptor family 13 subfamily H member 1,ORX1,OR13H1
Q8NG94,O11H1_HUMAN,OR11H1,Olfactory receptor 11H1; Olfactory receptor OR22-1,,81061,olfactory receptor family 11 subfamily H member 1,olfactory receptor; family 11; subfamily H; member 1,,OR22-1,olfactory receptor family 11 subfamily H member 1,OR11H12; OR22-1,OR11H1
Q8NG95,OR7G3_HUMAN,OR7G3,Olfactory receptor 7G3; OST085; Olfactory receptor OR19-9,,390883,olfactory receptor family 7 subfamily G member 3,olfactory receptor; family 7; subfamily G; member 3,,OST085,olfactory receptor family 7 subfamily G member 3,OST085,OR7G3
Q8NG97,OR2Z1_HUMAN,OR2Z1; OR2Z2,Olfactory receptor 2Z1; Olfactory receptor 2Z2; Olfactory receptor OR19-4,OR2Z2,284383,olfactory receptor family 2 subfamily Z member 1,olfactory receptor; family 2; subfamily Z; member 2; olfactory receptor; family 2; subfamily Z; member 1,,,olfactory receptor family 2 subfamily Z member 1,OR19-4; OR2Z2,OR2Z1
Q8NG99,OR7G2_HUMAN,OR7G2,Olfactory receptor 7G2; OST260; Olfactory receptor 19-13; OR19-13; Olfactory receptor OR19-6,,390882,olfactory receptor family 7 subfamily G member 2,olfactory receptor; family 7; subfamily G; member 2,,OST260,olfactory receptor family 7 subfamily G member 2,OR19-6; OST260,OR7G2
Q8NGA1,OR1M1_HUMAN,OR1M1,Olfactory receptor 1M1; Olfactory receptor 19-6; OR19-6; Olfactory receptor OR19-5,,125963,olfactory receptor family 1 subfamily M member 1,olfactory receptor; family 1; subfamily M; member 1,,OR19-6,olfactory receptor family 1 subfamily M member 1,OR19-5; OR19-6,OR1M1
Q8NGA5,O10H4_HUMAN,OR10H4,Olfactory receptor 10H4; Olfactory receptor OR19-28,,126541,olfactory receptor family 10 subfamily H member 4,olfactory receptor; family 10; subfamily H; member 4,,,olfactory receptor family 10 subfamily H member 4,OR19-28,OR10H4
Q8NGA6,O10H5_HUMAN,OR10H5,Olfactory receptor 10H5; Olfactory receptor OR19-25; Olfactory receptor OR19-26,,284433,olfactory receptor family 10 subfamily H member 5,olfactory receptor; family 10; subfamily H; member 5,,,olfactory receptor family 10 subfamily H member 5,OR19-25; OR19-26,OR10H5
Q8NGA8,O4F17_HUMAN,OR4F17; OR4F11P; OR4F18; OR4F19,Olfactory receptor 4F17; Olfactory receptor 4F11; Olfactory receptor 4F18; Olfactory receptor 4F19,OR4F11P; OR4F18; OR4F19,81099,olfactory receptor family 4 subfamily F member 17,olfactory receptor; family 4; subfamily F; member 17,,,olfactory receptor family 4 subfamily F member 17,OR4F11P; OR4F18; OR4F19; OR4F5,OR4F17
Q8NGB2,OR4C5_HUMAN,OR4C5,Olfactory receptor 4C5; Olfactory receptor OR11-99,,79346,olfactory receptor family 4 subfamily C member 5,olfactory receptor; family 4; subfamily C; member 5 pseudogene; olfactory receptor; family 4; subfamily C; member 5; olfactory receptor; family 4; subfamily C; member 5 (gene/pseudogene); olfactory receptor family 4 subfamily C member 5 (gene/pseudogene),,OR4C5Q,olfactory receptor family 4 subfamily C member 5,OR4C5P; OR4C5Q,OR4C5
Q8NGB4,OR4S1_HUMAN,OR4S1,Olfactory receptor 4S1; Olfactory receptor OR11-100,,256148,olfactory receptor family 4 subfamily S member 1,olfactory receptor; family 4; subfamily S; member 1,,,olfactory receptor family 4 subfamily S member 1,OR11-100,OR4S1
Q8NGB6,OR4M2_HUMAN,OR4M2,Olfactory receptor 4M2; Olfactory receptor OR15-3,,390538,olfactory receptor family 4 subfamily M member 2,olfactory receptor; family 4; subfamily M; member 2,,,olfactory receptor family 4 subfamily M member 2,OR15-3,OR4M2
Q8NGB8,O4F15_HUMAN,OR4F15,Olfactory receptor 4F15; Olfactory receptor OR15-14,,390649,olfactory receptor family 4 subfamily F member 15,olfactory receptor; family 4; subfamily F; member 15,,,olfactory receptor family 4 subfamily F member 15,,OR4F15
Q8NGB9,OR4F6_HUMAN,OR4F6; OR4F12,Olfactory receptor 4F6; Olfactory receptor 4F12; Olfactory receptor OR15-15,OR4F12,390648,olfactory receptor family 4 subfamily F member 6,olfactory receptor; family 4; subfamily F; member 12; olfactory receptor; family 4; subfamily F; member 6,,,olfactory receptor family 4 subfamily F member 6,OR15-15; OR4F12,OR4F6
Q8NGC0,O5AU1_HUMAN,OR5AU1,Olfactory receptor 5AU1; Olfactory receptor OR14-38,,390445,olfactory receptor family 5 subfamily AU member 1,olfactory receptor; family 5; subfamily AU; member 1,,,olfactory receptor family 5 subfamily AU member 1,OR14-38,OR5AU1
Q8NGC1,O11G2_HUMAN,OR11G2,Olfactory receptor 11G2; Olfactory receptor OR14-34,,390439,olfactory receptor family 11 subfamily G member 2,olfactory receptor; family 11; subfamily G; member 2,,,olfactory receptor family 11 subfamily G member 2,OR14-34,OR11G2
Q8NGC3,O10G2_HUMAN,OR10G2,Olfactory receptor 10G2,,26534,olfactory receptor family 10 subfamily G member 2,olfactory receptor; family 10; subfamily G; member 2,,,olfactory receptor family 10 subfamily G member 2,OR14-41,OR10G2
Q8NGC4,O10G3_HUMAN,OR10G3,Olfactory receptor 10G3; Olfactory receptor OR14-40,,26533,olfactory receptor family 10 subfamily G member 3,olfactory receptor; family 10; subfamily G; member 3,,,olfactory receptor family 10 subfamily G member 3,OR14-40,OR10G3
Q8NGC5,OR6J1_HUMAN,OR6J1; OR6J2,Olfactory receptor 6J1; Olfactory receptor 6J2,OR6J2,79549,olfactory receptor family 6 subfamily J member 1,olfactory receptor; family 6; subfamily J; member 1; olfactory receptor; family 6; subfamily J; member 1 (gene/pseudogene); olfactory receptor family 6 subfamily J member 1 (gene/pseudogene),,,olfactory receptor family 6 subfamily J member 1,OR6J1P; OR6J2,OR6J1
Q8NGC7,O11H6_HUMAN,OR11H6,Olfactory receptor 11H6; Olfactory receptor OR14-35,,122748,olfactory receptor family 11 subfamily H member 6,olfactory receptor; family 11; subfamily H; member 6,,,olfactory receptor family 11 subfamily H member 6,,OR11H6
Q8NGC9,O11H4_HUMAN,OR11H4,Olfactory receptor 11H4; Olfactory receptor OR14-36,,390442,olfactory receptor family 11 subfamily H member 4,olfactory receptor; family 11; subfamily H; member 4,,,olfactory receptor family 11 subfamily H member 4,OR14-36,OR11H4
Q8NGD1,OR4N2_HUMAN,OR4N2,Olfactory receptor 4N2; Olfactory receptor OR14-13; Olfactory receptor OR14-8,,390429,olfactory receptor family 4 subfamily N member 2,olfactory receptor; family 4; subfamily N; member 2,,,olfactory receptor family 4 subfamily N member 2,OR14-13; OR14-8,OR4N2
Q8NGD2,OR4K2_HUMAN,OR4K2,Olfactory receptor 4K2; Olfactory receptor OR14-15,,390431,olfactory receptor family 4 subfamily K member 2,olfactory receptor; family 4; subfamily K; member 2,,,olfactory receptor family 4 subfamily K member 2,OR14-15,OR4K2
Q8NGD3,OR4K5_HUMAN,OR4K5,Olfactory receptor 4K5; Olfactory receptor OR14-16,,79317,olfactory receptor family 4 subfamily K member 5,olfactory receptor; family 4; subfamily K; member 5,,,olfactory receptor family 4 subfamily K member 5,OR14-16,OR4K5
Q8NGD4,OR4K1_HUMAN,OR4K1,Olfactory receptor 4K1; Olfactory receptor OR14-19,,79544,olfactory receptor family 4 subfamily K member 1,olfactory receptor; family 4; subfamily K; member 1,,,olfactory receptor family 4 subfamily K member 1,OR14-19,OR4K1
Q8NGD5,OR4KE_HUMAN,OR4K14,Olfactory receptor 4K14; Olfactory receptor OR14-22,,122740,olfactory receptor family 4 subfamily K member 14,olfactory receptor; family 4; subfamily K; member 14,,,olfactory receptor family 4 subfamily K member 14,OR14-18; OR14-22,OR4K14
Q8NGE0,O10AD_HUMAN,OR10AD1; OR10AD1P,Olfactory receptor 10AD1; Olfactory receptor OR12-1,OR10AD1P,121275,olfactory receptor family 10 subfamily AD member 1,olfactory receptor; family 10; subfamily AD; member 1 pseudogene; olfactory receptor; family 10; subfamily AD; member 1,,,olfactory receptor family 10 subfamily AD member 1,OR10AD1P; OR12-1,OR10AD1
Q8NGE1,OR6C4_HUMAN,OR6C4,Olfactory receptor 6C4; Olfactory receptor OR12-10,,341418,olfactory receptor family 6 subfamily C member 4,olfactory receptor; family 6; subfamily C; member 4,,,olfactory receptor family 6 subfamily C member 4,OR12-10,OR6C4
Q8NGE2,O2AP1_HUMAN,OR2AP1; OR2AP1P,Olfactory receptor 2AP1; Olfactory receptor OR12-9,OR2AP1P,121129,olfactory receptor family 2 subfamily AP member 1,olfactory receptor; family 2; subfamily AP; member 1 pseudogene; olfactory receptor; family 2; subfamily AP; member 1,,,olfactory receptor family 2 subfamily AP member 1,OR2AP1P,OR2AP1
Q8NGE5,O10A7_HUMAN,OR10A7,Olfactory receptor 10A7; Olfactory receptor OR12-6,,121364,olfactory receptor family 10 subfamily A member 7,olfactory receptor; family 10; subfamily A; member 7,,,olfactory receptor family 10 subfamily A member 7,OR12-6,OR10A7
Q8NGE7,OR9K2_HUMAN,OR9K2,Olfactory receptor 9K2; Olfactory receptor OR12-2,,441639,olfactory receptor family 9 subfamily K member 2,olfactory receptor; family 9; subfamily K; member 2,,,olfactory receptor family 9 subfamily K member 2,OR12-2,OR9K2
Q8NGE8,OR4D9_HUMAN,OR4D9,Olfactory receptor 4D9; Olfactory receptor OR11-253,,390199,olfactory receptor family 4 subfamily D member 9,olfactory receptor; family 4; subfamily D; member 9 pseudogene; olfactory receptor; family 4; subfamily D; member 9,,,olfactory receptor family 4 subfamily D member 9,OR11-253,OR4D9
Q8NGE9,OR9Q2_HUMAN,OR9Q2; OR9Q2P,Olfactory receptor 9Q2,OR9Q2P,219957,olfactory receptor family 9 subfamily Q member 2,olfactory receptor; family 9; subfamily Q; member 2,,,olfactory receptor family 9 subfamily Q member 2,OR9Q2P,OR9Q2
Q8NGF0,O52B6_HUMAN,OR52B6,Olfactory receptor 52B6; Olfactory receptor OR11-47,,340980,olfactory receptor family 52 subfamily B member 6,olfactory receptor; family 52; subfamily B; member 6,,,olfactory receptor family 52 subfamily B member 6,OR11-47,OR52B6
Q8NGF1,O52R1_HUMAN,OR52R1,Olfactory receptor 52R1; Olfactory receptor OR11-22,,119695,olfactory receptor family 52 subfamily R member 1,olfactory receptor; family 52; subfamily R; member 1 (gene/pseudogene); olfactory receptor family 52 subfamily R member 1 (gene/pseudogene),,,olfactory receptor family 52 subfamily R member 1,OR11-22,OR52R1
Q8NGF3,O51D1_HUMAN,OR51D1,Olfactory receptor 51D1; Olfactory receptor OR11-14,,390038,olfactory receptor family 51 subfamily D member 1,olfactory receptor; family 51; subfamily D; member 1,,OR51D1Q,olfactory receptor family 51 subfamily D member 1,OR11-14; OR51D1Q,OR51D1
Q8NGF4,O5AP2_HUMAN,OR5AP2,Olfactory receptor 5AP2,,338675,olfactory receptor family 5 subfamily AP member 2,olfactory receptor; family 5; subfamily AP; member 2,,,olfactory receptor family 5 subfamily AP member 2,OR9J1,OR5AP2
Q8NGF6,O10W1_HUMAN,OR10W1; OR10W1P; UNQ6469/PRO34070,Olfactory receptor 10W1; Olfactory receptor OR11-236,OR10W1P,81341,olfactory receptor family 10 subfamily W member 1,olfactory receptor; family 10; subfamily W; member 1 pseudogene; olfactory receptor; family 10; subfamily W; member 1,,,olfactory receptor family 10 subfamily W member 1,OR10W1P; OR10W1Q; OR11-236; UNQ6469,OR10W1
Q8NGF7,OR5BH_HUMAN,OR5B17; OR5B20P,Olfactory receptor 5B17; Olfactory receptor 5B20; Olfactory receptor OR11-237,OR5B20P,219965,olfactory receptor family 5 subfamily B member 17,olfactory receptor; family 5; subfamily B; member 17,,,olfactory receptor family 5 subfamily B member 17,OR11-237; OR5B20P,OR5B17
Q8NGF8,OR4B1_HUMAN,OR4B1,Olfactory receptor 4B1; OST208; Olfactory receptor OR11-106,,119765,olfactory receptor family 4 subfamily B member 1,olfactory receptor; family 4; subfamily B; member 1,,OST208,olfactory receptor family 4 subfamily B member 1,OR11-106; OST208,OR4B1
Q8NGF9,OR4X2_HUMAN,OR4X2,Olfactory receptor 4X2; Olfactory receptor OR11-105,,119764,olfactory receptor family 4 subfamily X member 2,olfactory receptor; family 4; subfamily X; member 2 (gene/pseudogene); olfactory receptor family 4 subfamily X member 2 (gene/pseudogene),,,olfactory receptor family 4 subfamily X member 2,OR11-105,OR4X2
Q8NGG0,OR8J3_HUMAN,OR8J3,Olfactory receptor 8J3; Olfactory receptor OR11-173,,81168,olfactory receptor family 8 subfamily J member 3,olfactory receptor; family 8; subfamily J; member 3,,,olfactory receptor family 8 subfamily J member 3,OR11-173,OR8J3
Q8NGG3,OR5T3_HUMAN,OR5T3,Olfactory receptor 5T3; Olfactory receptor OR11-178,,390154,olfactory receptor family 5 subfamily T member 3,olfactory receptor; family 5; subfamily T; member 3,,OR5T3Q,olfactory receptor family 5 subfamily T member 3,OR11-178; OR5T3Q,OR5T3
Q8NGG4,OR8H1_HUMAN,OR8H1,Olfactory receptor 8H1; Olfactory receptor OR11-180,,219469,olfactory receptor family 8 subfamily H member 1,olfactory receptor; family 8; subfamily H; member 1,,,olfactory receptor family 8 subfamily H member 1,OR11-180,OR8H1
Q8NGG5,OR8K1_HUMAN,OR8K1,Olfactory receptor 8K1; Olfactory receptor OR11-182,,390157,olfactory receptor family 8 subfamily K member 1,olfactory receptor; family 8; subfamily K; member 1,,,olfactory receptor family 8 subfamily K member 1,OR11-182; OR8N1P,OR8K1
Q8NGG6,OR8BC_HUMAN,OR8B12,Olfactory receptor 8B12; Olfactory receptor OR11-317,,219858,olfactory receptor family 8 subfamily B member 12,olfactory receptor; family 8; subfamily B; member 12,,,olfactory receptor family 8 subfamily B member 12,OR11-317,OR8B12
Q8NGG7,OR8A1_HUMAN,OR8A1,Olfactory receptor 8A1; OST025; Olfactory receptor OR11-318,,390275,olfactory receptor family 8 subfamily A member 1,olfactory receptor; family 8; subfamily A; member 1,,OST025,olfactory receptor family 8 subfamily A member 1,OR11-318; OST025,OR8A1
Q8NGG8,OR8B3_HUMAN,OR8B3,Olfactory receptor 8B3; Olfactory receptor OR11-311,,390271,olfactory receptor family 8 subfamily B member 3,olfactory receptor; family 8; subfamily B; member 3,,,olfactory receptor family 8 subfamily B member 3,OR11-311,OR8B3
Q8NGH3,OR2D3_HUMAN,OR2D3,Olfactory receptor 2D3; Olfactory receptor OR11-89,,120775,olfactory receptor family 2 subfamily D member 3,olfactory receptor; family 2; subfamily D; member 3,,,olfactory receptor family 2 subfamily D member 3,OR11-89,OR2D3
Q8NGH5,O56A1_HUMAN,OR56A1,Olfactory receptor 56A1; Olfactory receptor OR11-75,,120796,olfactory receptor family 56 subfamily A member 1,olfactory receptor; family 56; subfamily A; member 1,,,olfactory receptor family 56 subfamily A member 1,OR11-75,OR56A1
Q8NGH8,O56A4_HUMAN,OR56A4,Olfactory receptor 56A4; Olfactory receptor OR11-49,,120793,olfactory receptor family 56 subfamily A member 4,olfactory receptor; family 56; subfamily A; member 4,,,olfactory receptor family 56 subfamily A member 4,OR11-49,OR56A4
Q8NGH9,O52E4_HUMAN,OR52E4,Olfactory receptor 52E4; Olfactory receptor OR11-55,,390081,olfactory receptor family 52 subfamily E member 4,olfactory receptor; family 52; subfamily E; member 4,,,olfactory receptor family 52 subfamily E member 4,OR11-55,OR52E4
Q8NGI0,O52N2_HUMAN,OR52N2,Olfactory receptor 52N2; Olfactory receptor OR11-57,,390077,olfactory receptor family 52 subfamily N member 2,olfactory receptor; family 52; subfamily N; member 2,,,olfactory receptor family 52 subfamily N member 2,OR11-57,OR52N2
Q8NGI3,O56B1_HUMAN,OR56B1; OR56B1P,Olfactory receptor 56B1; Olfactory receptor OR11-65,OR56B1P,387748,olfactory receptor family 56 subfamily B member 1,olfactory receptor; family 56; subfamily B; member 1,,,olfactory receptor family 56 subfamily B member 1,OR11-65; OR56B1P,OR56B1
Q8NGI4,OR4DB_HUMAN,OR4D11; OR4D11P,Olfactory receptor 4D11,OR4D11P,219986,olfactory receptor family 4 subfamily D member 11,olfactory receptor; family 4; subfamily D; member 11,,,olfactory receptor family 4 subfamily D member 11,OR4D11P,OR4D11
Q8NGI6,OR4DA_HUMAN,OR4D10; OR4D10P,Olfactory receptor 4D10; Olfactory receptor OR11-251,OR4D10P,390197,olfactory receptor family 4 subfamily D member 10,olfactory receptor; family 4; subfamily D; member 10,,OST711,olfactory receptor family 4 subfamily D member 10,OR11-251; OR4D10P; OST711,OR4D10
Q8NGI7,O10V1_HUMAN,OR10V1,Olfactory receptor 10V1; Olfactory receptor OR11-256,,390201,olfactory receptor family 10 subfamily V member 1,olfactory receptor; family 10; subfamily V; member 1,,,olfactory receptor family 10 subfamily V member 1,OR11-256,OR10V1
Q8NGI9,OR5A2_HUMAN,OR5A2,Olfactory receptor 5A2; Olfactory receptor OR11-248,,219981,olfactory receptor family 5 subfamily A member 2,olfactory receptor; family 5; subfamily A; member 2,,,olfactory receptor family 5 subfamily A member 2,,OR5A2
Q8NGJ0,OR5A1_HUMAN,OR5A1; OR5A1P,Olfactory receptor 5A1; OST181; Olfactory receptor OR11-249,OR5A1P,219982,olfactory receptor family 5 subfamily A member 1,olfactory receptor; family 5; subfamily A; member 1,,OST181,olfactory receptor family 5 subfamily A member 1,OR11-249; OR5A1P; OST181,OR5A1
Q8NGJ1,OR4D6_HUMAN,OR4D6,Olfactory receptor 4D6; Olfactory receptor OR11-250,,219983,olfactory receptor family 4 subfamily D member 6,olfactory receptor; family 4; subfamily D; member 6,,,olfactory receptor family 4 subfamily D member 6,OR11-250,OR4D6
Q8NGJ2,O52H1_HUMAN,OR52H1,Olfactory receptor 52H1; Olfactory receptor OR11-45,,390067,olfactory receptor family 52 subfamily H member 1,olfactory receptor; family 52; subfamily H; member 1; olfactory receptor family 52 subfamily H member 1 (gene/pseudogene),,,olfactory receptor family 52 subfamily H member 1,OR11-41; OR11-45,OR52H1
Q8NGJ3,O52E1_HUMAN,OR52E1; OR52E1P,Olfactory receptor 52E1,OR52E1P,79296,olfactory receptor family 52 subfamily E member 1 (gene/pseudogene),olfactory receptor; family 52; subfamily E; member 1 pseudogene; olfactory receptor; family 52; subfamily E; member 1 gene/pseudogene; olfactory receptor; family 52; subfamily E; member 1 (gene/pseudogene),,,olfactory receptor family 52 subfamily E member 1 (gene/pseudogene),OR52E1P,OR52E1
Q8NGJ4,O52E2_HUMAN,OR52E2,Olfactory receptor 52E2,,119678,olfactory receptor family 52 subfamily E member 2,olfactory receptor; family 52; subfamily E; member 2,,,olfactory receptor family 52 subfamily E member 2,,OR52E2
Q8NGJ5,O51L1_HUMAN,OR51L1,Olfactory receptor 51L1; Olfactory receptor OR11-31,,119682,olfactory receptor family 51 subfamily L member 1,olfactory receptor; family 51; subfamily L; member 1,,,olfactory receptor family 51 subfamily L member 1,OR11-31,OR51L1
Q8NGJ6,O51A4_HUMAN,OR51A4,Olfactory receptor 51A4,,401666,olfactory receptor family 51 subfamily A member 4,olfactory receptor; family 51; subfamily A; member 4,,,olfactory receptor family 51 subfamily A member 4,,OR51A4
Q8NGJ7,O51A2_HUMAN,OR51A2,Olfactory receptor 51A2,,401667,olfactory receptor family 51 subfamily A member 2,olfactory receptor; family 51; subfamily A; member 2,,,olfactory receptor family 51 subfamily A member 2,,OR51A2
Q8NGJ8,O51S1_HUMAN,OR51S1,Olfactory receptor 51S1; Olfactory receptor OR11-24,,119692,olfactory receptor family 51 subfamily S member 1,olfactory receptor; family 51; subfamily S; member 1,,,olfactory receptor family 51 subfamily S member 1,OR11-24,OR51S1
Q8NGJ9,O51T1_HUMAN,OR51T1,Olfactory receptor 51T1; Olfactory receptor OR11-26,,401665,olfactory receptor family 51 subfamily T member 1,olfactory receptor; family 51; subfamily T; member 1,,,olfactory receptor family 51 subfamily T member 1,OR11-26,OR51T1
Q8NGK0,O51G2_HUMAN,OR51G2,Olfactory receptor 51G2; Olfactory receptor OR11-28,,81282,olfactory receptor family 51 subfamily G member 2,olfactory receptor; family 51; subfamily G; member 2,,,olfactory receptor family 51 subfamily G member 2,OR11-28,OR51G2
Q8NGK1,O51G1_HUMAN,OR51G1; OR51G3P,Olfactory receptor 51G1; Olfactory receptor 51G3; Olfactory receptor OR11-29,OR51G3P,79324,olfactory receptor family 51 subfamily G member 1,olfactory receptor; family 51; subfamily G; member 1 (gene/pseudogene); olfactory receptor family 51 subfamily G member 1 (gene/pseudogene),,,olfactory receptor family 51 subfamily G member 1,OR11-29; OR51G3P,OR51G1
Q8NGK3,O52K2_HUMAN,OR52K2,Olfactory receptor 52K2; Olfactory receptor OR11-7,,119774,olfactory receptor family 52 subfamily K member 2,olfactory receptor; family 52; subfamily K; member 2,,,olfactory receptor family 52 subfamily K member 2,OR11-7,OR52K2
Q8NGK4,O52K1_HUMAN,OR52K1,Olfactory receptor 52K1; Olfactory receptor OR11-8,,390036,olfactory receptor family 52 subfamily K member 1,olfactory receptor; family 52; subfamily K; member 1,,,olfactory receptor family 52 subfamily K member 1,OR11-8,OR52K1
Q8NGK5,O52M1_HUMAN,OR52M1; OR52M1P,Olfactory receptor 52M1; Olfactory receptor OR11-11,OR52M1P,119772,olfactory receptor family 52 subfamily M member 1,olfactory receptor; family 52; subfamily M; member 1 pseudogene; olfactory receptor; family 52; subfamily M; member 1,,,olfactory receptor family 52 subfamily M member 1,OR11-11; OR52M1P; OR52M3P,OR52M1
Q8NGK6,O52I1_HUMAN,OR52I1,Olfactory receptor 52I1; Olfactory receptor OR11-13,,390037,olfactory receptor family 52 subfamily I member 1,olfactory receptor; family 52; subfamily I; member 1,,,olfactory receptor family 52 subfamily I member 1,OR11-13,OR52I1
Q8NGK9,OR5DG_HUMAN,OR5D16,Olfactory receptor 5D16; Olfactory receptor OR11-154,,390144,olfactory receptor family 5 subfamily D member 16,olfactory receptor; family 5; subfamily D; member 16,,,olfactory receptor family 5 subfamily D member 16,OR11-154,OR5D16
Q8NGL0,OR5L2_HUMAN,OR5L2,Olfactory receptor 5L2; HTPCRX16; Olfactory receptor OR11-153,,26338,olfactory receptor family 5 subfamily L member 2,olfactory receptor; family 5; subfamily L; member 2,,HTPCRX16; HSHTPCRX16,olfactory receptor family 5 subfamily L member 2,HSHTPCRX16; HTPCRX16; OR11-153,OR5L2
Q8NGL1,OR5DI_HUMAN,OR5D18,Olfactory receptor 5D18; Olfactory receptor OR11-143; Olfactory receptor OR11-152,,219438,olfactory receptor family 5 subfamily D member 18,olfactory receptor; family 5; subfamily D; member 18,,,olfactory receptor family 5 subfamily D member 18,OR11-143,OR5D18
Q8NGL2,OR5L1_HUMAN,OR5L1,Olfactory receptor 5L1; OST262; Olfactory receptor OR11-151,,219437,olfactory receptor family 5 subfamily L member 1,olfactory receptor; family 5; subfamily L; member 1 (gene/pseudogene); olfactory receptor family 5 subfamily L member 1 (gene/pseudogene),,OST262,olfactory receptor family 5 subfamily L member 1,OR11-151; OST262,OR5L1
Q8NGL3,OR5DE_HUMAN,OR5D14,Olfactory receptor 5D14; Olfactory receptor OR11-141; Olfactory receptor OR11-150,,219436,olfactory receptor family 5 subfamily D member 14,olfactory receptor; family 5; subfamily D; member 14,,,olfactory receptor family 5 subfamily D member 14,OR11-141; OR11-150,OR5D14
Q8NGL4,OR5DD_HUMAN,OR5D13,Olfactory receptor 5D13; Olfactory receptor OR11-142; Olfactory receptor OR11-148,,390142,olfactory receptor family 5 subfamily D member 13,olfactory receptor; family 5; subfamily D; member 13 (gene/pseudogene); olfactory receptor family 5 subfamily D member 13 (gene/pseudogene),,,olfactory receptor family 5 subfamily D member 13,,OR5D13
Q8NGL6,O4A15_HUMAN,OR4A15,Olfactory receptor 4A15; Olfactory receptor OR11-118,,81328,olfactory receptor family 4 subfamily A member 15,olfactory receptor; family 4; subfamily A; member 15,,,olfactory receptor family 4 subfamily A member 15,OR11-118,OR4A15
Q8NGL7,OR4P4_HUMAN,OR4P4; OR4P3P,Olfactory receptor 4P4; Olfactory receptor 4P3,OR4P3P,81300,olfactory receptor family 4 subfamily P member 4,olfactory receptor; family 4; subfamily P; member 4,,,olfactory receptor family 4 subfamily P member 4,OR4P3P,OR4P4
Q8NGL9,OR4CG_HUMAN,OR4C16,Olfactory receptor 4C16; Olfactory receptor OR11-135,,219428,olfactory receptor family 4 subfamily C member 16,olfactory receptor; family 4; subfamily C; member 16; olfactory receptor; family 4; subfamily C; member 16 (gene/pseudogene); olfactory receptor family 4 subfamily C member 16 (gene/pseudogene),,,olfactory receptor family 4 subfamily C member 16,OR11-135,OR4C16
Q8NGM1,OR4CF_HUMAN,OR4C15,Olfactory receptor 4C15; Olfactory receptor OR11-127; Olfactory receptor OR11-134,,81309,olfactory receptor family 4 subfamily C member 15,olfactory receptor; family 4; subfamily C; member 15,,,olfactory receptor family 4 subfamily C member 15,OR11-127; OR11-134,OR4C15
Q8NGM8,OR6M1_HUMAN,OR6M1,Olfactory receptor 6M1; Olfactory receptor OR11-271,,390261,olfactory receptor family 6 subfamily M member 1,olfactory receptor; family 6; subfamily M; member 1,,,olfactory receptor family 6 subfamily M member 1,OR11-271,OR6M1
Q8NGN0,OR4D5_HUMAN,OR4D5,Olfactory receptor 4D5; Olfactory receptor OR11-276,,219875,olfactory receptor family 4 subfamily D member 5,olfactory receptor; family 4; subfamily D; member 5,,,olfactory receptor family 4 subfamily D member 5,OR11-276,OR4D5
Q8NGN1,OR6T1_HUMAN,OR6T1,Olfactory receptor 6T1; Olfactory receptor OR11-277,,219874,olfactory receptor family 6 subfamily T member 1,olfactory receptor; family 6; subfamily T; member 1,,,olfactory receptor family 6 subfamily T member 1,OR11-277,OR6T1
Q8NGN2,O10S1_HUMAN,OR10S1,Olfactory receptor 10S1; Olfactory receptor OR11-279,,219873,olfactory receptor family 10 subfamily S member 1,olfactory receptor; family 10; subfamily S; member 1,,,olfactory receptor family 10 subfamily S member 1,OR11-279,OR10S1
Q8NGN4,O10G9_HUMAN,OR10G9; OR10G10P,Olfactory receptor 10G9; Olfactory receptor 10G10,OR10G10P,219870,olfactory receptor family 10 subfamily G member 9,olfactory receptor; family 10; subfamily G; member 9,,,olfactory receptor family 10 subfamily G member 9,OR10G10P,OR10G9
Q8NGN5,O10G8_HUMAN,OR10G8,Olfactory receptor 10G8; Olfactory receptor OR11-282,,219869,olfactory receptor family 10 subfamily G member 8,olfactory receptor; family 10; subfamily G; member 8,,,olfactory receptor family 10 subfamily G member 8,OR11-274; OR11-282,OR10G8
Q8NGN6,O10G7_HUMAN,OR10G7,Olfactory receptor 10G7; Olfactory receptor OR11-283,,390265,olfactory receptor family 10 subfamily G member 7,olfactory receptor; family 10; subfamily G; member 7,,,olfactory receptor family 10 subfamily G member 7,OR11-283,OR10G7
Q8NGP0,OR4CD_HUMAN,OR4C13,Olfactory receptor 4C13; Olfactory receptor OR11-260,,283092,olfactory receptor family 4 subfamily C member 13,olfactory receptor; family 4; subfamily C; member 13,,,olfactory receptor family 4 subfamily C member 13,,OR4C13
Q8NGP2,OR8J1_HUMAN,OR8J1,Olfactory receptor 8J1; Olfactory receptor OR11-183,,219477,olfactory receptor family 8 subfamily J member 1,olfactory receptor; family 8; subfamily J; member 1,,,olfactory receptor family 8 subfamily J member 1,OR11-183,OR8J1
Q8NGP3,OR5M9_HUMAN,OR5M9,Olfactory receptor 5M9; Olfactory receptor OR11-190,,390162,olfactory receptor family 5 subfamily M member 9,olfactory receptor; family 5; subfamily M; member 9,,,olfactory receptor family 5 subfamily M member 9,OR11-190,OR5M9
Q8NGP4,OR5M3_HUMAN,OR5M3,Olfactory receptor 5M3; Olfactory receptor OR11-191,,219482,olfactory receptor family 5 subfamily M member 3,olfactory receptor; family 5; subfamily M; member 3,,,olfactory receptor family 5 subfamily M member 3,OR11-191,OR5M3
Q8NGP6,OR5M8_HUMAN,OR5M8,Olfactory receptor 5M8; Olfactory receptor OR11-194,,219484,olfactory receptor family 5 subfamily M member 8,olfactory receptor; family 5; subfamily M; member 8,,,olfactory receptor family 5 subfamily M member 8,OR11-194,OR5M8
Q8NGP8,OR5M1_HUMAN,OR5M1,Olfactory receptor 5M1; OST050; Olfactory receptor OR11-208,,390168,olfactory receptor family 5 subfamily M member 1,olfactory receptor; family 5; subfamily M; member 1,,OST050,olfactory receptor family 5 subfamily M member 1,OR11-208; OST050,OR5M1
Q8NGP9,O5AR1_HUMAN,OR5AR1,Olfactory receptor 5AR1; Olfactory receptor OR11-209,,219493,olfactory receptor family 5 subfamily AR member 1,olfactory receptor; family 5; subfamily AR; member 1; olfactory receptor; family 5; subfamily AR; member 1 (gene/pseudogene); olfactory receptor family 5 subfamily AR member 1 (gene/pseudogene),,,olfactory receptor family 5 subfamily AR member 1,OR11-209,OR5AR1
Q8NGQ2,OR6Q1_HUMAN,OR6Q1,Olfactory receptor 6Q1; Olfactory receptor OR11-226,,219952,olfactory receptor family 6 subfamily Q member 1,olfactory receptor; family 6; subfamily Q; member 1 (gene/pseudogene); olfactory receptor family 6 subfamily Q member 1 (gene/pseudogene),,,olfactory receptor family 6 subfamily Q member 1,OR11-226,OR6Q1
Q8NGQ3,OR1S2_HUMAN,OR1S2,Olfactory receptor 1S2; Olfactory receptor OR11-231,,219958,olfactory receptor family 1 subfamily S member 2,olfactory receptor; family 1; subfamily S; member 2,,,olfactory receptor family 1 subfamily S member 2,OR11-231,OR1S2
Q8NGQ4,O10Q1_HUMAN,OR10Q1,Olfactory receptor 10Q1; Olfactory receptor OR11-233,,219960,olfactory receptor family 10 subfamily Q member 1,olfactory receptor; family 10; subfamily Q; member 1,,,olfactory receptor family 10 subfamily Q member 1,OR11-233,OR10Q1
Q8NGQ5,OR9Q1_HUMAN,OR9Q1,Olfactory receptor 9Q1,,219956,olfactory receptor family 9 subfamily Q member 1,olfactory receptor; family 9; subfamily Q; member 1,,,olfactory receptor family 9 subfamily Q member 1,,OR9Q1
Q8NGQ6,OR9I1_HUMAN,OR9I1,Olfactory receptor 9I1; Olfactory receptor OR11-228,,219954,olfactory receptor family 9 subfamily I member 1,olfactory receptor; family 9; subfamily I; member 1,,,olfactory receptor family 9 subfamily I member 1,OR11-228,OR9I1
Q8NGR1,O13A1_HUMAN,OR13A1,Olfactory receptor 13A1; Olfactory receptor OR10-3,,79290,olfactory receptor family 13 subfamily A member 1,olfactory receptor; family 13; subfamily A; member 1,,,olfactory receptor family 13 subfamily A member 1,,OR13A1
Q8NGR3,OR1K1_HUMAN,OR1K1,Olfactory receptor 1K1,,392392,olfactory receptor family 1 subfamily K member 1,olfactory receptor; family 1; subfamily K; member 1,,hg99; MNAB,olfactory receptor family 1 subfamily K member 1,hg99,OR1K1
Q8NGR4,OR5C1_HUMAN,OR5C1; OR5C2P,Olfactory receptor 5C1; Olfactory receptor 5C2; Olfactory receptor 9-F; OR9-F,OR5C2P,392391,olfactory receptor family 5 subfamily C member 1,olfactory receptor; family 5; subfamily C; member 1,,OR9-F; hRPK-465_F_21,olfactory receptor family 5 subfamily C member 1,OR5C2P; OR9-31; OR9-F,OR5C1
Q8NGR5,OR1L4_HUMAN,OR1L4; OR1L5,Olfactory receptor 1L4; OST046; Olfactory receptor 1L5; Olfactory receptor 9-E; OR9-E; Olfactory receptor OR9-29,OR1L5,254973,olfactory receptor family 1 subfamily L member 4,olfactory receptor; family 1; subfamily L; member 4,,OR9-E,olfactory receptor family 1 subfamily L member 4,OR1L5; OR9-29; OR9-E; OST046,OR1L4
Q8NGR8,OR1L8_HUMAN,OR1L8,Olfactory receptor 1L8; Olfactory receptor OR9-24,,138881,olfactory receptor family 1 subfamily L member 8,olfactory receptor; family 1; subfamily L; member 8,,,olfactory receptor family 1 subfamily L member 8,OR9-24,OR1L8
Q8NGR9,OR1N2_HUMAN,OR1N2,Olfactory receptor 1N2; Olfactory receptor OR9-23,,138882,olfactory receptor family 1 subfamily N member 2,olfactory receptor; family 1; subfamily N; member 2,,,olfactory receptor family 1 subfamily N member 2,OR9-23,OR1N2
Q8NGS0,OR1N1_HUMAN,OR1N1; OR1N3,Olfactory receptor 1N1; Olfactory receptor 1-26; OR1-26; Olfactory receptor 1N3; Olfactory receptor OR9-22,OR1N3,138883,olfactory receptor family 1 subfamily N member 1,olfactory receptor; family 1; subfamily N; member 1,,OR1-26,olfactory receptor family 1 subfamily N member 1,OR1-26; OR1N3; OR9-22,OR1N1
Q8NGS1,OR1J4_HUMAN,OR1J4,Olfactory receptor 1J4; HTPCRX01; Olfactory receptor OR9-21,,26219,olfactory receptor family 1 subfamily J member 4,olfactory receptor; family 1; subfamily J; member 4,,HTPCRX01; HSHTPCRX01,olfactory receptor family 1 subfamily J member 4,HSHTPCRX01; HTPCRX01; OR9-21,OR1J4
Q8NGS3,OR1J1_HUMAN,OR1J1,Olfactory receptor 1J1; Olfactory receptor OR9-18,,347168,olfactory receptor family 1 subfamily J member 1,olfactory receptor; family 1; subfamily J; member 1,,hg32,olfactory receptor family 1 subfamily J member 1,OR9-18; hg32,OR1J1
Q8NGS4,O13F1_HUMAN,OR13F1,Olfactory receptor 13F1; Olfactory receptor OR9-6,,138805,olfactory receptor family 13 subfamily F member 1,olfactory receptor; family 13; subfamily F; member 1,,,olfactory receptor family 13 subfamily F member 1,OR9-6,OR13F1
Q8NGS5,O13C4_HUMAN,OR13C4,Olfactory receptor 13C4; Olfactory receptor OR9-7,,138804,olfactory receptor family 13 subfamily C member 4,olfactory receptor; family 13; subfamily C; member 4,,,olfactory receptor family 13 subfamily C member 4,HSHTPCRX17; HTPCRX17; OR2K1; OR37F; OR9-7,OR13C4
Q8NGS6,O13C3_HUMAN,OR13C3,Olfactory receptor 13C3; Olfactory receptor OR9-8,,138803,olfactory receptor family 13 subfamily C member 3,olfactory receptor; family 13; subfamily C; member 3,,,olfactory receptor family 13 subfamily C member 3,OR37G; OR9-8,OR13C3
Q8NGS7,O13C8_HUMAN,OR13C8,Olfactory receptor 13C8,,138802,olfactory receptor family 13 subfamily C member 8,olfactory receptor; family 13; subfamily C; member 8,,,olfactory receptor family 13 subfamily C member 8,OR37H; OR9-10,OR13C8
Q8NGS9,O13C2_HUMAN,OR13C2,Olfactory receptor 13C2; Olfactory receptor OR9-12,,392376,olfactory receptor family 13 subfamily C member 2,olfactory receptor; family 13; subfamily C; member 2,,,olfactory receptor family 13 subfamily C member 2,OR37K,OR13C2
Q8NGT1,OR2K2_HUMAN,OR2K2; OR2AR1P,Olfactory receptor 2K2; HTPCRH06; Olfactory receptor OR9-17,OR2AR1P,26248,olfactory receptor family 2 subfamily K member 2,olfactory receptor; family 2; subfamily K; member 2,,HTPCRH06; HSHTPCRH06,olfactory receptor family 2 subfamily K member 2,HSHTPCRH06; HTPCRH06; OR2AN1P; OR2AR1P,OR2K2
Q8NGT2,O13J1_HUMAN,OR13J1,Olfactory receptor 13J1; Olfactory receptor OR9-2,,392309,olfactory receptor family 13 subfamily J member 1,olfactory receptor; family 13; subfamily J; member 1,,,olfactory receptor family 13 subfamily J member 1,OR9-2,OR13J1
Q8NGT5,OR9A2_HUMAN,OR9A2,Olfactory receptor 9A2; Olfactory receptor OR7-2,,135924,olfactory receptor family 9 subfamily A member 2,olfactory receptor; family 9; subfamily A; member 2,,,olfactory receptor family 9 subfamily A member 2,,OR9A2
Q8NGT7,O2A12_HUMAN,OR2A12; OR2A12P,Olfactory receptor 2A12; Olfactory receptor OR7-10,OR2A12P,346525,olfactory receptor family 2 subfamily A member 12,olfactory receptor; family 2; subfamily A; member 12 pseudogene; olfactory receptor; family 2; subfamily A; member 12,,,olfactory receptor family 2 subfamily A member 12,OR2A12P; OR2A16P,OR2A12
Q8NGT9,OR2A1_HUMAN,OR2A1;; OR2A42,Olfactory receptor 2A1/2A42; Olfactory receptor OR7-16; Olfactory receptor OR7-19,;,346528,olfactory receptor family 2 subfamily A member 1,olfactory receptor; family 2; subfamily A; member 1,,,olfactory receptor family 2 subfamily A member 1,,OR2A1; OR2A42
Q8NGU2,OR9A4_HUMAN,OR9A4,Olfactory receptor 9A4; Olfactory receptor OR7-1,,130075,olfactory receptor family 9 subfamily A member 4,olfactory receptor; family 9; subfamily A; member 4,,,olfactory receptor family 9 subfamily A member 4,,OR9A4
Q8NGV0,OR2Y1_HUMAN,OR2Y1,Olfactory receptor 2Y1; Olfactory receptor OR5-2,,134083,olfactory receptor family 2 subfamily Y member 1,olfactory receptor; family 2; subfamily Y; member 1,,,olfactory receptor family 2 subfamily Y member 1,OR5-2,OR2Y1
Q8NGV5,O13D1_HUMAN,OR13D1,Olfactory receptor 13D1; Olfactory receptor OR9-15,,286365,olfactory receptor family 13 subfamily D member 1,olfactory receptor; family 13; subfamily D; member 1,,,olfactory receptor family 13 subfamily D member 1,OR9-15,OR13D1
Q8NGV7,OR5H2_HUMAN,OR5H2,Olfactory receptor 5H2; Olfactory receptor OR3-10,,79310,olfactory receptor family 5 subfamily H member 2,olfactory receptor; family 5; subfamily H; member 2,,,olfactory receptor family 5 subfamily H member 2,OR3-10,OR5H2
Q8NGX0,O11L1_HUMAN,OR11L1,Olfactory receptor 11L1,,391189,olfactory receptor family 11 subfamily L member 1,olfactory receptor; family 11; subfamily L; member 1,,,olfactory receptor family 11 subfamily L member 1,,OR11L1
Q8NGX1,O2T34_HUMAN,OR2T34,Olfactory receptor 2T34; Olfactory receptor OR1-63,,127068,olfactory receptor family 2 subfamily T member 34,olfactory receptor; family 2; subfamily T; member 34,,,olfactory receptor family 2 subfamily T member 34,,OR2T34
Q8NGX2,O2T35_HUMAN,OR2T35,Olfactory receptor 2T35; Olfactory receptor OR1-66,,403244,olfactory receptor family 2 subfamily T member 35 (gene/pseudogene),olfactory receptor family 2 subfamily T member 35; olfactory receptor; family 2; subfamily T; member 35,,,olfactory receptor family 2 subfamily T member 35 (gene/pseudogene),,OR2T35
Q8NGX5,O10K1_HUMAN,OR10K1,Olfactory receptor 10K1; Olfactory receptor OR1-6,,391109,olfactory receptor family 10 subfamily K member 1,olfactory receptor; family 10; subfamily K; member 1,,,olfactory receptor family 10 subfamily K member 1,OR1-6,OR10K1
Q8NGX6,O10R2_HUMAN,OR10R2,Olfactory receptor 10R2; Olfactory receptor OR1-8,,343406,olfactory receptor family 10 subfamily R member 2,olfactory receptor; family 10; subfamily R; member 2,,OR10R2Q,olfactory receptor family 10 subfamily R member 2,OR1-8; OR10R2Q,OR10R2
Q8NGX8,OR6Y1_HUMAN,OR6Y1; OR6Y2,Olfactory receptor 6Y1; Olfactory receptor 6Y2; Olfactory receptor OR1-11,OR6Y2,391112,olfactory receptor family 6 subfamily Y member 1,olfactory receptor; family 6; subfamily Y; member 1,,,olfactory receptor family 6 subfamily Y member 1,OR1-11; OR6Y2,OR6Y1
Q8NGX9,OR6P1_HUMAN,OR6P1,Olfactory receptor 6P1; Olfactory receptor OR1-12,,128366,olfactory receptor family 6 subfamily P member 1,olfactory receptor; family 6; subfamily P; member 1,,,olfactory receptor family 6 subfamily P member 1,,OR6P1
Q8NGY1,O10Z1_HUMAN,OR10Z1,Olfactory receptor 10Z1; Olfactory receptor OR1-15,,128368,olfactory receptor family 10 subfamily Z member 1,olfactory receptor; family 10; subfamily Z; member 1,,,olfactory receptor family 10 subfamily Z member 1,OR1-15,OR10Z1
Q8NGY2,OR6K2_HUMAN,OR6K2,Olfactory receptor 6K2; Olfactory receptor OR1-17,,81448,olfactory receptor family 6 subfamily K member 2,olfactory receptor; family 6; subfamily K; member 2,,,olfactory receptor family 6 subfamily K member 2,OR1-17,OR6K2
Q8NGY5,OR6N1_HUMAN,OR6N1,Olfactory receptor 6N1,,128372,olfactory receptor family 6 subfamily N member 1,olfactory receptor; family 6; subfamily N; member 1,,,olfactory receptor family 6 subfamily N member 1,OR1-22,OR6N1
Q8NGY6,OR6N2_HUMAN,OR6N2,Olfactory receptor 6N2; Olfactory receptor OR1-23,,81442,olfactory receptor family 6 subfamily N member 2,olfactory receptor; family 6; subfamily N; member 2,,,olfactory receptor family 6 subfamily N member 2,OR1-23,OR6N2
Q8NGY9,OR2L8_HUMAN,OR2L8,Olfactory receptor 2L8; Olfactory receptor OR1-46,,391190,olfactory receptor family 2 subfamily L member 8,olfactory receptor; family 2; subfamily L; member 8; olfactory receptor; family 2; subfamily L; member 8 (gene/pseudogene); olfactory receptor family 2 subfamily L member 8 (gene/pseudogene),,,olfactory receptor family 2 subfamily L member 8,,OR2L8
Q8NGZ3,O13G1_HUMAN,OR13G1,Olfactory receptor 13G1; Olfactory receptor OR1-37,,441933,olfactory receptor family 13 subfamily G member 1,olfactory receptor; family 13; subfamily G; member 1,,,olfactory receptor family 13 subfamily G member 1,OR1-37,OR13G1
Q8NGZ4,OR2G3_HUMAN,OR2G3,Olfactory receptor 2G3; Olfactory receptor OR1-33,,81469,olfactory receptor family 2 subfamily G member 3,olfactory receptor; family 2; subfamily G; member 3,,,olfactory receptor family 2 subfamily G member 3,OR1-33,OR2G3
Q8NGZ5,OR2G2_HUMAN,OR2G2,Olfactory receptor 2G2; Olfactory receptor OR1-32,,81470,olfactory receptor family 2 subfamily G member 2,olfactory receptor; family 2; subfamily G; member 2 pseudogene; olfactory receptor; family 2; subfamily G; member 2,,,olfactory receptor family 2 subfamily G member 2,OR1-32,OR2G2
Q8NGZ6,OR6F1_HUMAN,OR6F1,Olfactory receptor 6F1; Olfactory receptor OR1-38,,343169,olfactory receptor family 6 subfamily F member 1,olfactory receptor; family 6; subfamily F; member 1,,OST731,olfactory receptor family 6 subfamily F member 1,OR1-34; OR1-38; OST731,OR6F1
Q8NGZ9,O2T10_HUMAN,OR2T10,Olfactory receptor 2T10; Olfactory receptor OR1-64,,127069,olfactory receptor family 2 subfamily T member 10,olfactory receptor; family 2; subfamily T; member 10,,,olfactory receptor family 2 subfamily T member 10,OR1-64,OR2T10
Q8NH00,OR2T4_HUMAN,OR2T4,Olfactory receptor 2T4; Olfactory receptor OR1-60,,127074,olfactory receptor family 2 subfamily T member 4,olfactory receptor; family 2; subfamily T; member 4,,OR2T4Q,olfactory receptor family 2 subfamily T member 4,OR1-60; OR2T4Q,OR2T4
Q8NH01,O2T11_HUMAN,OR2T11,Olfactory receptor 2T11; Olfactory receptor OR1-65,,127077,olfactory receptor family 2 subfamily T member 11,olfactory receptor; family 2; subfamily T; member 11; olfactory receptor; family 2; subfamily T; member 11 (gene/pseudogene); olfactory receptor family 2 subfamily T member 11 (gene/pseudogene),,OR2T11Q,olfactory receptor family 2 subfamily T member 11,OR2T11Q,OR2T11
Q8NH02,O2T29_HUMAN,OR2T29,Olfactory receptor 2T29,,343563,olfactory receptor family 2 subfamily T member 29,olfactory receptor; family 2; subfamily T; member 29,,,olfactory receptor family 2 subfamily T member 29,,OR2T29
Q8NH03,OR2T3_HUMAN,OR2T3,Olfactory receptor 2T3,,343173,olfactory receptor family 2 subfamily T member 3,olfactory receptor; family 2; subfamily T; member 3,,,olfactory receptor family 2 subfamily T member 3,,OR2T3
Q8NH04,O2T27_HUMAN,OR2T27,Olfactory receptor 2T27; Olfactory receptor OR1-67,,403239,olfactory receptor family 2 subfamily T member 27,olfactory receptor; family 2; subfamily T; member 27,,,olfactory receptor family 2 subfamily T member 27,,OR2T27
Q8NH05,OR4Q3_HUMAN,OR4Q3; C14orf13; OR4Q4,Olfactory receptor 4Q3; Olfactory receptor 4Q4; Olfactory receptor OR14-3,C14orf13; OR4Q4,441669,olfactory receptor family 4 subfamily Q member 3,olfactory receptor; family 4; subfamily Q; member 3,,C14orf13,olfactory receptor family 4 subfamily Q member 3,C14orf13; HSA6; OR14-3; OR4Q4; c14_5008,OR4Q3
Q8NH07,O11H2_HUMAN,OR11H2; C14orf15; OR11H2P,Olfactory receptor 11H2; Olfactory receptor OR14-1,C14orf15; OR11H2P,79334,olfactory receptor family 11 subfamily H member 2,olfactory receptor; family 11; subfamily H; member 8 pseudogene; olfactory receptor; family 11; subfamily H; member 2,,,olfactory receptor family 11 subfamily H member 2,C14orf15; OR11H13; OR11H2P; OR11H8P,OR11H2
Q8NH16,OR2L2_HUMAN,OR2L2; OR2L12; OR2L4P,Olfactory receptor 2L2; HTPCRH07; Olfactory receptor 2L12; Olfactory receptor 2L4,OR2L12; OR2L4P,26246,olfactory receptor family 2 subfamily L member 2,olfactory receptor; family 2; subfamily L; member 2,,HTPCRH07; HSHTPCRH07,olfactory receptor family 2 subfamily L member 2,HSHTPCRH07; HTPCRH07; OR1-48; OR2L12; OR2L4P,OR2L2
Q8NH18,OR5J2_HUMAN,OR5J2,Olfactory receptor 5J2; Olfactory receptor OR11-266,,282775,olfactory receptor family 5 subfamily J member 2,olfactory receptor; family 5; subfamily J; member 2,,,olfactory receptor family 5 subfamily J member 2,OR11-266,OR5J2
Q8NH37,OR4C3_HUMAN,OR4C3,Olfactory receptor 4C3; Olfactory receptor OR11-98,,256144,olfactory receptor family 4 subfamily C member 3,olfactory receptor; family 4; subfamily C; member 3,,,olfactory receptor family 4 subfamily C member 3,OR11-98,OR4C3
Q8NH40,OR6S1_HUMAN,OR6S1,Olfactory receptor 6S1; Olfactory receptor OR14-37,,341799,olfactory receptor family 6 subfamily S member 1,olfactory receptor; family 6; subfamily S; member 1,,OR6S1Q,olfactory receptor family 6 subfamily S member 1,OR14-37; OR6S1Q,OR6S1
Q8NH41,OR4KF_HUMAN,OR4K15,Olfactory receptor 4K15; Olfactory receptor OR14-20,,81127,olfactory receptor family 4 subfamily K member 15,olfactory receptor; family 4; subfamily K; member 15,,OR4K15Q,olfactory receptor family 4 subfamily K member 15,OR14-20; OR4K15Q,OR4K15
Q8NH42,OR4KD_HUMAN,OR4K13,Olfactory receptor 4K13; Olfactory receptor OR14-27,,390433,olfactory receptor family 4 subfamily K member 13,olfactory receptor; family 4; subfamily K; member 13,,,olfactory receptor family 4 subfamily K member 13,OR14-27,OR4K13
Q8NH49,OR4X1_HUMAN,OR4X1,Olfactory receptor 4X1; Olfactory receptor OR11-104,,390113,olfactory receptor family 4 subfamily X member 1,olfactory receptor; family 4; subfamily X; member 1; olfactory receptor; family 4; subfamily X; member 1 (gene/pseudogene); olfactory receptor family 4 subfamily X member 1 (gene/pseudogene),,,olfactory receptor family 4 subfamily X member 1,OR11-104,OR4X1
Q8NH50,OR8K5_HUMAN,OR8K5,Olfactory receptor 8K5; Olfactory receptor OR11-174,,219453,olfactory receptor family 8 subfamily K member 5,olfactory receptor; family 8; subfamily K; member 5,,,olfactory receptor family 8 subfamily K member 5,OR11-174,OR8K5
Q8NH51,OR8K3_HUMAN,OR8K3,Olfactory receptor 8K3; Olfactory receptor OR11-181,,219473,olfactory receptor family 8 subfamily K member 3 (gene/pseudogene),olfactory receptor; family 8; subfamily K; member 3 (gene/pseudogene),,,olfactory receptor family 8 subfamily K member 3 (gene/pseudogene),OR11-181,OR8K3
Q8NH53,O52N1_HUMAN,OR52N1,Olfactory receptor 52N1; Olfactory receptor OR11-61,,79473,olfactory receptor family 52 subfamily N member 1,olfactory receptor; family 52; subfamily N; member 1,,,olfactory receptor family 52 subfamily N member 1,OR11-61,OR52N1
Q8NH54,O56A3_HUMAN,OR56A3; OR56A3P; OR56A6,Olfactory receptor 56A3; Olfactory receptor 56A6,OR56A3P; OR56A6,390083,olfactory receptor family 56 subfamily A member 3,olfactory receptor; family 56; subfamily A; member 3,,,olfactory receptor family 56 subfamily A member 3,OR56A2P; OR56A3P; OR56A6,OR56A3
Q8NH56,O52N5_HUMAN,OR52N5,Olfactory receptor 52N5; Olfactory receptor OR11-62,,390075,olfactory receptor family 52 subfamily N member 5,olfactory receptor; family 52; subfamily N; member 5,,OR52N5Q,olfactory receptor family 52 subfamily N member 5,OR11-62; OR52N5Q,OR52N5
Q8NH60,O52J3_HUMAN,OR52J3,Olfactory receptor 52J3; Olfactory receptor OR11-32,,119679,olfactory receptor family 52 subfamily J member 3,olfactory receptor; family 52; subfamily J; member 3,,,olfactory receptor family 52 subfamily J member 3,OR11-32,OR52J3
Q8NH61,O51F2_HUMAN,OR51F2,Olfactory receptor 51F2; Olfactory receptor OR11-23,,119694,olfactory receptor family 51 subfamily F member 2,olfactory receptor; family 51; subfamily F; member 2,,,olfactory receptor family 51 subfamily F member 2,OR11-23,OR51F2
Q8NH64,O51A7_HUMAN,OR51A7,Olfactory receptor 51A7; Olfactory receptor OR11-27,,119687,olfactory receptor family 51 subfamily A member 7,olfactory receptor; family 51; subfamily A; member 7,,,olfactory receptor family 51 subfamily A member 7,OR11-27,OR51A7
Q8NH67,O52I2_HUMAN,OR52I2,Olfactory receptor 52I2; Olfactory receptor OR11-12,,143502,olfactory receptor family 52 subfamily I member 2,olfactory receptor; family 52; subfamily I; member 2,,,olfactory receptor family 52 subfamily I member 2,OR11-12; OR52I1,OR52I2
Q8NH70,O4A16_HUMAN,OR4A16,Olfactory receptor 4A16; Olfactory receptor OR11-117,,81327,olfactory receptor family 4 subfamily A member 16,olfactory receptor; family 4; subfamily A; member 16,,OR4A16Q,olfactory receptor family 4 subfamily A member 16,OR11-117; OR4A16Q,OR4A16
Q8NH72,OR4C6_HUMAN,OR4C6,Olfactory receptor 4C6; Olfactory receptor OR11-138,,219432,olfactory receptor family 4 subfamily C member 6,olfactory receptor; family 4; subfamily C; member 6,,,olfactory receptor family 4 subfamily C member 6,OR11-138,OR4C6
Q8NH73,OR4S2_HUMAN,OR4S2; OR4S2P,Olfactory receptor 4S2; Olfactory receptor OR11-137,OR4S2P,219431,olfactory receptor family 4 subfamily S member 2,olfactory receptor; family 4; subfamily S; member 2 pseudogene; olfactory receptor; family 4; subfamily S; member 2,,OST725,olfactory receptor family 4 subfamily S member 2,OR11-137; OR4S2P; OST725,OR4S2
Q8NH74,O10A6_HUMAN,OR10A6,Olfactory receptor 10A6; Olfactory receptor OR11-96,,390093,olfactory receptor family 10 subfamily A member 6 (gene/pseudogene),olfactory receptor; family 10; subfamily A; member 6 (gene/pseudogene),,,olfactory receptor family 10 subfamily A member 6 (gene/pseudogene),OR11-96,OR10A6
Q8NH76,O56B4_HUMAN,OR56B4,Olfactory receptor 56B4; Olfactory receptor OR11-67,,196335,olfactory receptor family 56 subfamily B member 4,olfactory receptor; family 56; subfamily B; member 4,,,olfactory receptor family 56 subfamily B member 4,OR11-67,OR56B4
Q8NH79,OR6X1_HUMAN,OR6X1,Olfactory receptor 6X1; Olfactory receptor OR11-270,,390260,olfactory receptor family 6 subfamily X member 1,olfactory receptor; family 6; subfamily X; member 1,,,olfactory receptor family 6 subfamily X member 1,OR11-270,OR6X1
Q8NH83,OR4A5_HUMAN,OR4A5,Olfactory receptor 4A5; Olfactory receptor OR11-111,,81318,olfactory receptor family 4 subfamily A member 5,olfactory receptor; family 4; subfamily A; member 5,,,olfactory receptor family 4 subfamily A member 5,OR11-111,OR4A5
Q8NH90,O5AK2_HUMAN,OR5AK2,Olfactory receptor 5AK2,,390181,olfactory receptor family 5 subfamily AK member 2,olfactory receptor; family 5; subfamily AK; member 2,,,olfactory receptor family 5 subfamily AK member 2,,OR5AK2
Q8NH93,OR1L3_HUMAN,OR1L3,Olfactory receptor 1L3; Olfactory receptor 9-D; OR9-D; Olfactory receptor OR9-28,,26735,olfactory receptor family 1 subfamily L member 3,olfactory receptor; family 1; subfamily L; member 3,,OR9-D,olfactory receptor family 1 subfamily L member 3,OR9-28; OR9-D,OR1L3
Q8NHA4,O2AE1_HUMAN,OR2AE1; OR2AE2,Olfactory receptor 2AE1; Olfactory receptor 2AE2,OR2AE2,81392,olfactory receptor family 2 subfamily AE member 1,olfactory receptor; family 2; subfamily AE; member 2; olfactory receptor; family 2; subfamily AE; member 1,,,olfactory receptor family 2 subfamily AE member 1,OR2AE2,OR2AE1
Q8NHB1,OR2V1_HUMAN,OR2V1,Olfactory receptor 2V1,,26693,olfactory receptor family 2 subfamily V member 1,olfactory receptor; family 2; subfamily V; member 1,,OST265,olfactory receptor family 2 subfamily V member 1,OR2V1P; OST265,OR2V1
Q8NHB7,OR5K1_HUMAN,OR5K1,Olfactory receptor 5K1; HTPCRX10; Olfactory receptor OR3-8,,26339,olfactory receptor family 5 subfamily K member 1,olfactory receptor; family 5; subfamily K; member 1,,HTPCRX10; HSHTPCRX10,olfactory receptor family 5 subfamily K member 1,HSHTPCRX10; HTPCRX10; OR3-8,OR5K1
Q8NHB8,OR5K2_HUMAN,OR5K2,Olfactory receptor 5K2; Olfactory receptor OR3-9,,402135,olfactory receptor family 5 subfamily K member 2,olfactory receptor; family 5; subfamily K; member 2,,,olfactory receptor family 5 subfamily K member 2,OR3-9,OR5K2
Q8NHC5,O14AG_HUMAN,OR14A16; OR5AT1,Olfactory receptor 14A16; Olfactory receptor 5AT1; Olfactory receptor OR1-45,OR5AT1,284532,olfactory receptor family 14 subfamily A member 16,olfactory receptor; family 5; subfamily AT; member 1; olfactory receptor; family 14; subfamily A; member 16,,,olfactory receptor family 14 subfamily A member 16,OR5AT1,OR14A16
Q8NHC7,O14CZ_HUMAN,OR14C36; OR5BF1,Olfactory receptor 14C36; Olfactory receptor 5BF1; Olfactory receptor OR1-59,OR5BF1,127066,olfactory receptor family 14 subfamily C member 36,olfactory receptor; family 5; subfamily BF; member 1; olfactory receptor; family 14; subfamily C; member 36,,,olfactory receptor family 14 subfamily C member 36,OR5BF1,OR14C36
Q8TD86,CALL6_HUMAN,CALML6; CAGLP; CALGP,Calmodulin-like protein 6; Calglandulin-like protein,CAGLP; CALGP,163688,calmodulin like 6,calmodulin-like 6,,CAGLP,calmodulin like 6,CAGLP,CALML6
Q8WVI7,PPR1C_HUMAN,PPP1R1C,Protein phosphatase 1 regulatory subunit 1C; Inhibitor-5 of protein phosphatase 1; IPP5,,151242,protein phosphatase 1 regulatory inhibitor subunit 1C,protein phosphatase 1; regulatory (inhibitor) subunit 1C,,Inhibitor-1-like,protein phosphatase 1 regulatory inhibitor subunit 1C,IPP5,PPP1R1C
Q8WZ92,OR5P2_HUMAN,OR5P2,Olfactory receptor 5P2; Olfactory receptor-like protein JCG3,,120065,olfactory receptor family 5 subfamily P member 2,olfactory receptor; family 5; subfamily P; member 2,,JCG3,olfactory receptor family 5 subfamily P member 2,JCG3; JCG4,OR5P2
Q96C90,PP14B_HUMAN,PPP1R14B; PLCB3N; PNG,Protein phosphatase 1 regulatory subunit 14B; Phospholipase C-beta-3 neighbouring gene protein,PLCB3N; PNG,26472,protein phosphatase 1 regulatory inhibitor subunit 14B,protein phosphatase 1; regulatory (inhibitor) subunit 14B,,SOM172; PNG; PHI-1,protein phosphatase 1 regulatory inhibitor subunit 14B,PHI-1; PLCB3N; PNG; SOM172,PPP1R14B
Q96E39,RMXL1_HUMAN,RBMXL1,RNA binding motif protein; X-linked-like-1; Heterogeneous nuclear ribonucleoprotein G-like 1,,494115,RBMX like 1,RNA binding motif protein; X-linked like 1,kynurenine aminotransferase III,KAT3,RBMX like 1,RBM1,RBMXL1
Q96R08,OR5BC_HUMAN,OR5B12; OR5B12P; OR5B16,Olfactory receptor 5B12; Olfactory receptor 5B16; Olfactory receptor OR11-241,OR5B12P; OR5B16,390191,olfactory receptor family 5 subfamily B member 12,olfactory receptor; family 5; subfamily B; member 12,,OST743,olfactory receptor family 5 subfamily B member 12,OR11-241; OR5B12P; OR5B16; OST743,OR5B12
Q96R09,OR5B2_HUMAN,OR5B2,Olfactory receptor 5B2; OST073; Olfactory receptor OR11-240,,390190,olfactory receptor family 5 subfamily B member 2,olfactory receptor; family 5; subfamily B; member 2,,OST073,olfactory receptor family 5 subfamily B member 2,OR11-240; OST073,OR5B2
Q96R27,OR2M4_HUMAN,OR2M4,Olfactory receptor 2M4; HTPCRX18; OST710; Olfactory receptor OR1-55; Olfactory receptor TPCR100,,26245,olfactory receptor family 2 subfamily M member 4,olfactory receptor; family 2; subfamily M; member 4,,HTPCRX18; TPCR100; HSHTPCRX18; OST710,olfactory receptor family 2 subfamily M member 4,HSHTPCRX18; HTPCRX18; OR1-55; OST710; TPCR100,OR2M4
Q96R28,OR2M2_HUMAN,OR2M2,Olfactory receptor 2M2; OST423,,391194,olfactory receptor family 2 subfamily M member 2,olfactory receptor; family 2; subfamily M; member 2,,OST423; OR2M2Q,olfactory receptor family 2 subfamily M member 2,OR2M2Q; OST423,OR2M2
Q96R30,OR2V2_HUMAN,OR2V2; OR2V3,Olfactory receptor 2V2; Olfactory receptor 2V3; Olfactory receptor OR5-3,OR2V3,285659,olfactory receptor family 2 subfamily V member 2,olfactory receptor; family 2; subfamily V; member 2,,OST713,olfactory receptor family 2 subfamily V member 2,OR2V3; OST713,OR2V2
Q96R45,OR2A7_HUMAN,OR2A7,Olfactory receptor 2A7; Olfactory receptor OR7-18,,401427,olfactory receptor family 2 subfamily A member 7,olfactory receptor; family 2; subfamily A; member 7,,HSDJ0798C17,olfactory receptor family 2 subfamily A member 7,HSDJ0798C17; OR2A21,OR2A7
Q96R47,O2A14_HUMAN,OR2A14; OR2A14P; OR2A6,Olfactory receptor 2A14; OST182; Olfactory receptor 2A6; Olfactory receptor OR7-12,OR2A14P; OR2A6,135941,olfactory receptor family 2 subfamily A member 14,olfactory receptor; family 2; subfamily A; member 14,,OST182,olfactory receptor family 2 subfamily A member 14,OR2A14P; OR2A6; OST182,OR2A14
Q96R67,OR4CC_HUMAN,OR4C12,Olfactory receptor 4C12; Olfactory receptor OR11-259,,283093,olfactory receptor family 4 subfamily C member 12,olfactory receptor; family 4; subfamily C; member 12,,,olfactory receptor family 4 subfamily C member 12,OR11-259,OR4C12
Q96RB7,OR5MB_HUMAN,OR5M11,Olfactory receptor 5M11,,219487,olfactory receptor family 5 subfamily M member 11,olfactory receptor; family 5; subfamily M; member 11,,OR11-199,olfactory receptor family 5 subfamily M member 11,OR11-199,OR5M11
Q96RC9,OR8B4_HUMAN,OR8B4; OR8B4P,Olfactory receptor 8B4; Olfactory receptor OR11-315,OR8B4P,283162,olfactory receptor family 8 subfamily B member 4,olfactory receptor; family 8; subfamily B; member 4 (gene/pseudogene); olfactory receptor family 8 subfamily B member 4 (gene/pseudogene),,,olfactory receptor family 8 subfamily B member 4,OR11-315; OR8B4P,OR8B4
Q96RD0,OR8B2_HUMAN,OR8B2,Olfactory receptor 8B2; Olfactory receptor OR11-309,,26595,olfactory receptor family 8 subfamily B member 2,olfactory receptor; family 8; subfamily B; member 2,,,olfactory receptor family 8 subfamily B member 2,OR11-309; OR11-310,OR8B2
Q96RD1,OR6C1_HUMAN,OR6C1,Olfactory receptor 6C1; OST267,,390321,olfactory receptor family 6 subfamily C member 1,olfactory receptor; family 6; subfamily C; member 1,,OST267,olfactory receptor family 6 subfamily C member 1,OST267,OR6C1
Q96RD2,O52B2_HUMAN,OR52B2,Olfactory receptor 52B2; Olfactory receptor OR11-70,,255725,olfactory receptor family 52 subfamily B member 2,olfactory receptor; family 52; subfamily B; member 2,,,olfactory receptor family 52 subfamily B member 2,OR11-70,OR52B2
Q96RD3,O52E6_HUMAN,OR52E6,Olfactory receptor 52E6; Olfactory receptor OR11-58,,390078,olfactory receptor family 52 subfamily E member 6,olfactory receptor; family 52; subfamily E; member 6,,,olfactory receptor family 52 subfamily E member 6,OR11-58,OR52E6
Q9BUA6,MYL10_HUMAN,MYL10; MYLC2PL; PLRLC,Myosin regulatory light chain 10; Myosin light chain 2; lymphocyte-specific; Precursor lymphocyte-specific regulatory light chain,MYLC2PL; PLRLC,93408,myosin light chain 10,myosin; light chain 10; regulatory,,MGC3479; MYLC2PL; PLRLC,myosin light chain 10,MYLC2PL; PLRLC,MYL10
Q9GZK3,OR2B2_HUMAN,OR2B2; OR2B9,Olfactory receptor 2B2; Hs6M1-10; Olfactory receptor 2B9; Olfactory receptor 6-1; OR6-1,OR2B9,81697,olfactory receptor family 2 subfamily B member 2,olfactory receptor; family 2; subfamily B; member 9; olfactory receptor; family 2; subfamily B; member 2,,hs6M1-10; OR6-1; OR2B2Q,olfactory receptor family 2 subfamily B member 2,OR2B2Q; OR2B9; OR6-1; dJ193B12.4; hs6M1-10,OR2B2
Q9GZK7,O11A1_HUMAN,OR11A1; OR11A2,Olfactory receptor 11A1; Hs6M1-18; Olfactory receptor 11A2; Olfactory receptor OR6-30,OR11A2,26531,olfactory receptor family 11 subfamily A member 1,olfactory receptor; family 11; subfamily A; member 2; olfactory receptor; family 11; subfamily A; member 1,,hs6M1-18,olfactory receptor family 11 subfamily A member 1,6M1-18; OR11A2; dJ994E9.6; hs6M1-18,OR11A1
Q9H2C5,O52A5_HUMAN,OR52A5,Olfactory receptor 52A5; Odorant receptor HOR3'beta5; Olfactory receptor OR11-33,,390054,olfactory receptor family 52 subfamily A member 5,olfactory receptor; family 52; subfamily A; member 5,,,olfactory receptor family 52 subfamily A member 5,OR11-33,OR52A5
Q9H2C8,O51V1_HUMAN,OR51V1; OR51A12,Olfactory receptor 51V1; Odorant receptor HOR3'beta1; Olfactory receptor 51A12; Olfactory receptor OR11-36,OR51A12,283111,olfactory receptor family 51 subfamily V member 1,olfactory receptor; family 51; subfamily V; member 1,,,olfactory receptor family 51 subfamily V member 1,OR11-36; OR51A12,OR51V1
Q9H343,O51I1_HUMAN,OR51I1,Olfactory receptor 51I1; Odorant receptor HOR5'beta11; Olfactory receptor OR11-39,,390063,olfactory receptor family 51 subfamily I member 1,olfactory receptor; family 51; subfamily I; member 1,,,olfactory receptor family 51 subfamily I member 1,,OR51I1
Q9H344,O51I2_HUMAN,OR51I2,Olfactory receptor 51I2; Odorant receptor HOR5'beta12; Olfactory receptor OR11-38,,390064,olfactory receptor family 51 subfamily I member 2,olfactory receptor; family 51; subfamily I; member 2,,,olfactory receptor family 51 subfamily I member 2,OR11-38,OR51I2
Q9H346,O52D1_HUMAN,OR52D1,Olfactory receptor 52D1; Odorant receptor HOR5'beta14; Olfactory receptor OR11-43,,390066,olfactory receptor family 52 subfamily D member 1,olfactory receptor; family 52; subfamily D; member 1; olfactory receptor family 52 subfamily D member 1 (gene/pseudogene),,,olfactory receptor family 52 subfamily D member 1,OR11-43,OR52D1
Q9H425,CA198_HUMAN,C1orf198,Uncharacterized protein C1orf198,,84886,chromosome 1 open reading frame 198,,,FLJ14525; MGC10710; FLJ16283; DKFZp667D152; FLJ38847,chromosome 1 open reading frame 198,,C1orf198
Q9H7J1,PPR3E_HUMAN,PPP1R3E,Protein phosphatase 1 regulatory subunit 3E,,90673,protein phosphatase 1 regulatory subunit 3E,protein phosphatase 1; regulatory (inhibitor) subunit 3E; protein phosphatase 1; regulatory subunit 3E,,FLJ00089,protein phosphatase 1 regulatory subunit 3E,,PPP1R3E
Q9H8G2,CAAP1_HUMAN,CAAP1; C9orf82; CAAP,Caspase activity and apoptosis inhibitor 1; Conserved anti-apoptotic protein; CAAP,C9orf82; CAAP,79886,caspase activity and apoptosis inhibitor 1,chromosome 9 open reading frame 82,conserved anti-apoptotic protein,FLJ13657; CAAP,caspase activity and apoptosis inhibitor 1,C9orf82; CAAP,CAAP1
Q9NZP0,OR6C3_HUMAN,OR6C3,Olfactory receptor 6C3; HSA8,,254786,olfactory receptor family 6 subfamily C member 3,olfactory receptor; family 6; subfamily C; member 3,,OST709,olfactory receptor family 6 subfamily C member 3,OST709,OR6C3
Q9NZP2,OR6C2_HUMAN,OR6C2,Olfactory receptor 6C2; HSA3,,341416,olfactory receptor family 6 subfamily C member 2,olfactory receptor; family 6; subfamily C; member 2,,OR6C67,olfactory receptor family 6 subfamily C member 2,OR6C67,OR6C2
Q9NZP5,O5AC2_HUMAN,OR5AC2,Olfactory receptor 5AC2; HSA1,,81050,olfactory receptor family 5 subfamily AC member 2,olfactory receptor; family 5; subfamily AC; member 2,,HSA1,olfactory receptor family 5 subfamily AC member 2,HSA1,OR5AC2
Q9P1Q5,OR1A1_HUMAN,OR1A1,Olfactory receptor 1A1; Olfactory receptor 17-7; OR17-7; Olfactory receptor OR17-11,,8383,olfactory receptor family 1 subfamily A member 1,olfactory receptor; family 1; subfamily A; member 1; olfactory receptor family 1 subfamily A member 1 (gene/pseudogene),,OR17-7,olfactory receptor family 1 subfamily A member 1,OR17-7,OR1A1
Q9P227,RHG23_HUMAN,ARHGAP23; KIAA1501,Rho GTPase-activating protein 23; Rho-type GTPase-activating protein 23,KIAA1501,57636,Rho GTPase activating protein 23,,,KIAA1501,Rho GTPase activating protein 23,,ARHGAP23
Q9UGF5,O14J1_HUMAN,OR14J1; OR5U1,Olfactory receptor 14J1; Hs6M1-28; Olfactory receptor 5U1; Olfactory receptor OR6-25,OR5U1,442191,olfactory receptor family 14 subfamily J member 1,olfactory receptor; family 5; subfamily U; member 1; olfactory receptor; family 14; subfamily J; member 1,,hs6M1-28,olfactory receptor family 14 subfamily J member 1,OR5U1; OR6-25; bA150A6.4; hs6M1-28,OR14J1
Q9UGF6,OR5V1_HUMAN,OR5V1,Olfactory receptor 5V1; Hs6M1-21; Olfactory receptor OR6-26,,81696,olfactory receptor family 5 subfamily V member 1,olfactory receptor; family 5; subfamily V; member 1,,hs6M1-21,olfactory receptor family 5 subfamily V member 1,6M1-21; hs6M1-21,OR5V1
Q9UGF7,O12D3_HUMAN,OR12D3,Olfactory receptor 12D3; Hs6M1-27; Olfactory receptor OR6-27,,81797,olfactory receptor family 12 subfamily D member 3,olfactory receptor; family 12; subfamily D; member 3,,hs6M1-27,olfactory receptor family 12 subfamily D member 3,hs6M1-27,OR12D3
Q9Y3N9,OR2W1_HUMAN,OR2W1,Olfactory receptor 2W1; Hs6M1-15; Olfactory receptor OR6-13,,26692,olfactory receptor family 2 subfamily W member 1,olfactory receptor; family 2; subfamily W; member 1,,hs6M1-15,olfactory receptor family 2 subfamily W member 1,hs6M1-15,OR2W1
Q9Y4A9,O10H1_HUMAN,OR10H1,Olfactory receptor 10H1; Olfactory receptor OR19-27,,26539,olfactory receptor family 10 subfamily H member 1,olfactory receptor; family 10; subfamily H; member 1,,,olfactory receptor family 10 subfamily H member 1,,OR10H1
Q9Y534,CSDC2_HUMAN,CSDC2; PIPPIN,Cold shock domain-containing protein C2; RNA-binding protein PIPPin,PIPPIN,27254,cold shock domain containing C2,cold shock domain containing C2; RNA binding,,PIPPin,cold shock domain containing C2,PIPPIN; dJ347H13.2,CSDC2
Q9Y5P0,O51B4_HUMAN,OR51B4,Olfactory receptor 51B4; Odorant receptor HOR5'beta1,,79339,olfactory receptor family 51 subfamily B member 4,olfactory receptor; family 51; subfamily B; member 4,,,olfactory receptor family 51 subfamily B member 4,HOR5'Beta1,OR51B4
Q8NH21,OR4F5_HUMAN,OR4F5,Olfactory receptor 4F5,,79501,olfactory receptor family 4 subfamily F member 5,olfactory receptor; family 4; subfamily F; member 5,,,olfactory receptor family 4 subfamily F member 5,,OR4F5
A0A024R1X5,A0A024R1X5_HUMAN,BECN1; hCG_16958,Beclin-1,,,,,,,,,BECN1
A0A024R324,A0A024R324_HUMAN,RHOA; hCG_20136,"Epididymis secretory sperm binding protein; Ras homolog gene family, member A, isoform CRA_a",,,,,,,,,RHOA
A0A090N7W4,A0A090N7W4_HUMAN,CDK5; hCG_18690; tcag7.772,Cell division protein kinase 5,,,,,,,,,CDK5
A0A0S2Z3C5,A0A0S2Z3C5_HUMAN,BCL2L1,Bcl-2-like protein 1; Apoptosis regulator Bcl-X,,,,,,,,,BCL2L1
A0A0S2Z3Q4,A0A0S2Z3Q4_HUMAN,CRK,Adapter molecule crk,,,,,,,,,CRK
A0A0S2Z3W6,A0A0S2Z3W6_HUMAN,ATP1A2,Sodium/potassium-transporting ATPase subunit alpha,,,,,,,,,ATP1A2
A0A0S2Z4C6,A0A0S2Z4C6_HUMAN,PPP3CA,Serine/threonine-protein phosphatase; EC 3.1.3.16,,,,,,,,,PPP3CA
A0A0S2Z4D1,A0A0S2Z4D1_HUMAN,STK11,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,STK11
A0A0S2Z4Z8,A0A0S2Z4Z8_HUMAN,RIPK2,Receptor-interacting serine-threonine kinase 2 isoform 1,,,,,,,,,RIPK2
A0A2P9DU05,A0A2P9DU05_HUMAN,ROCK2,Rho-associated protein kinase; EC 2.7.11.1,,,,,,,,,ROCK2
A0A2X0SFG1,A0A2X0SFG1_HUMAN,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha,,,,,,,,,PIK3R1
A0A384MDW3,A0A384MDW3_HUMAN,,Ribosomal protein S6 kinase; EC 2.7.11.1,,,,,,,,,
A0A384MR07,A0A384MR07_HUMAN,,Serine/threonine-protein kinase 3; EC 2.7.11.1,,,,,,,,,
A0A384N611,A0A384N611_HUMAN,,Protein Wnt,,,,,,,,,
A0A654IBU3,A0A654IBU3_HUMAN,CXNK2,Gap junction protein,,,,,,,,,CXNK2
A3QNQ0,A3QNQ0_HUMAN,TGFBR2; hCG_1997782,TGF-beta receptor type-2; TGFR-2; EC 2.7.11.30; TGF-beta type II receptor; Transforming growth factor-beta receptor type II,,,,,,,,,TGFBR2
A4QPA9,A4QPA9_HUMAN,MAP2K1; hCG_24510,Dual specificity mitogen-activated protein kinase kinase 1; EC 2.7.12.2; ERK activator kinase 1; MAPK/ERK kinase 1,,,,,,,,,MAP2K1
A8K3M3,A8K3M3_HUMAN,PTPN1; hCG_37134,Tyrosine-protein phosphatase non-receptor type; EC 3.1.3.48,,,,,,,,,PTPN1
A8K602,A8K602_HUMAN,,Mitogen-activated protein kinase kinase kinase kinase; EC 2.7.11.1,,,,,,,,,
A8K8W7,A8K8W7_HUMAN,,Hormone-sensitive lipase; EC 3.1.1.23; EC 3.1.1.79; Monoacylglycerol lipase LIPE; Retinyl ester hydrolase,,,,,,,,,
B0LPE5,B0LPE5_HUMAN,AKT1; hCG_96740,RAC-alpha serine/threonine-protein kinase; EC 2.7.11.1; RAC-PK-alpha,,,,,,,,,AKT1
B4E359,B4E359_HUMAN,,Interleukin-1 receptor-associated kinase 4; EC 2.7.11.1,,,,,,,,,
D0VY79,D0VY79_HUMAN,HIF1A; hCG_21199,Hypoxia-inducible factor 1-alpha,,,,,,,,,HIF1A
D3DPA4,D3DPA4_HUMAN,ACVR1; hCG_1811747,Serine/threonine-protein kinase receptor; EC 2.7.11.30,,,,,,,,,ACVR1
F1D8S4,F1D8S4_HUMAN,NR1C1,Peroxisome proliferator-activated receptor alpha; Nuclear receptor subfamily 1 group C member 1,,,,,,,,,NR1C1
F2YGG7,F2YGG7_HUMAN,,Receptor protein-tyrosine kinase; EC 2.7.10.1,,,,,,,,,
F6KD01,F6KD01_HUMAN,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN; EC 3.1.3.16; EC 3.1.3.48; EC 3.1.3.67; Phosphatase and tensin homolog",,,,,,,,,PTEN
G4XH65,G4XH65_HUMAN,ESR1,Estrogen receptor; ER; ER-alpha; Estradiol receptor; Nuclear receptor subfamily 3 group A member 1,,,,,,,,,ESR1
K7PPA8,K7PPA8_HUMAN,TP53,Cellular tumor antigen p53,,,,,,,,,TP53
L7RRS6,L7RRS6_HUMAN,RAF1,RAF proto-oncogene serine/threonine-protein kinase; EC 2.7.11.1; Proto-oncogene c-RAF; Raf-1,,,,,,,,,RAF1
L7RT18,L7RT18_HUMAN,CRK,Adapter molecule crk,,,,,,,,,CRK
L7RTI5,L7RTI5_HUMAN,PRKCE,Protein kinase C epsilon type; EC 2.7.11.13; nPKC-epsilon,,,,,,,,,PRKCE
L7RXH5,L7RXH5_HUMAN,MAPK3,Mitogen-activated protein kinase; EC 2.7.11.24,,,,,,,,,MAPK3
Q1HBJ4,Q1HBJ4_HUMAN,MAPK1; hCG_32557,Mitogen-activated protein kinase; EC 2.7.11.24,,,,,,,,,MAPK1
Q2TNI1,Q2TNI1_HUMAN,CAV1; hCG_39088; tcag7.24,Caveolin,,,,,,,,,CAV1
Q504U8,Q504U8_HUMAN,EGFR,Receptor protein-tyrosine kinase; EC 2.7.10.1,,,,,,,,,EGFR
Q53XR6,Q53XR6_HUMAN,SMAD2; hCG_22544,Mothers against decapentaplegic homolog; MAD homolog; Mothers against DPP homolog; SMAD family member,,,,,,,,,SMAD2
Q53YD1,Q53YD1_HUMAN,DDIT3; hCG_39661,DNA damage-inducible transcript 3 protein; DDIT-3; C/EBP zeta; C/EBP-homologous protein; C/EBP-homologous protein 10; CCAAT/enhancer-binding protein homologous protein; Growth arrest and DNA-damage-inducible protein GADD153,,,,,,,,,DDIT3
Q547U9,Q547U9_HUMAN,NR2A; GRIN2A; hCG_14641,Glutamate receptor,GRIN2A,,,,,,,,NR2A
Q548C2,Q548C2_HUMAN,NTRK2,Tyrosine-protein kinase receptor; EC 2.7.10.1,,,,,,,,,NTRK2
Q5T7S2,Q5T7S2_HUMAN,TGFBR1; hCG_30154,TGF-beta receptor type-1; EC 2.7.11.30; Transforming growth factor-beta receptor type I,,,,,,,,,TGFBR1
Q69FE3,Q69FE3_HUMAN,IRAK4; hCG_39494,Interleukin-1 receptor-associated kinase 4; EC 2.7.11.1,,,,,,,,,IRAK4
Q6FG41,Q6FG41_HUMAN,FOS; hCG_22355,Protein c-Fos; Cellular oncogene fos,,,,,,,,,FOS
Q6I9V6,Q6I9V6_HUMAN,CDKN1B; hCG_27692,Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; p27Kip1,,,,,,,,,CDKN1B
Q86WV8,Q86WV8_HUMAN,TSC1,TSC complex subunit 1; Tuberous sclerosis 1,,,,,,,,,TSC1
V9HW29,V9HW29_HUMAN,HEL-S-61,Kinesin-like protein,,,,,,,,,HEL-S-61
V9HWC9,V9HWC9_HUMAN,HEL-S-44,Superoxide dismutase [Cu-Zn]; EC 1.15.1.1,,,,,,,,,HEL-S-44
W0S0X4,W0S0X4_HUMAN,Pe1Fe3,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,Pe1Fe3
X5DNK3,X5DNK3_HUMAN,ERBB2,Receptor tyrosine-protein kinase erbB-2; EC 2.7.10.1; Proto-oncogene c-ErbB-2; p185erbB2,,,,,,,,,ERBB2
X5DNX5,X5DNX5_HUMAN,PDE4B,Phosphodiesterase; EC 3.1.4.-,,,,,,,,,PDE4B
A0A024R178,A0A024R178_HUMAN,ARAF; hCG_29140,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,ARAF
A0A0S2Z392,A0A0S2Z392_HUMAN,ADRBK1,G protein-coupled receptor kinase; EC 2.7.11.-,,,,,,,,,ADRBK1
A0A140VJS0,A0A140VJS0_HUMAN,,Serine/threonine-protein phosphatase; EC 3.1.3.16,,,,,,,,,
A0A8D9PH81,A0A8D9PH81_HUMAN,GRIN2C,Glutamate receptor,,,,,,,,,GRIN2C
A0N0Q0,A0N0Q0_HUMAN,CCR7; hCG_1643840,"Chemokine; C-C motif; cDNA FLJ45911 fis, clone PEBLM2005615, highly similar to C-C chemokine receptor type 7",,,,,,,,,CCR7
A0PJF8,A0PJF8_HUMAN,RPS6KA4,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,RPS6KA4
A2A3R6,A2A3R6_HUMAN,RPS6; hCG_1741512,40S ribosomal protein S6,,,,,,,,,RPS6
A8K3Y2,A8K3Y2_HUMAN,MAP2K6; hCG_28772,mitogen-activated protein kinase kinase; EC 2.7.12.2,,,,,,,,,MAP2K6
A8K5M4,A8K5M4_HUMAN,,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,
A8YXX4,A8YXX4_HUMAN,PIG59; GLUL; hCG_24393,Glutamine synthetase; EC 6.3.1.2,GLUL,,,,,,,,PIG59
B0AZM9,B0AZM9_HUMAN,,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,
B2R4P9,B2R4P9_HUMAN,H3F3B; H3F3A; hCG_1984517; hCG_1989319,Histone H3,H3F3A,,,,,,,,H3F3B
B3KUN1,B3KUN1_HUMAN,PPP2CA; hCG_16586,Serine/threonine-protein phosphatase; EC 3.1.3.16,,,,,,,,,PPP2CA
B3VK56,B3VK56_HUMAN,NOS1; hCG_40354,Nitric oxide synthase; EC 1.14.13.39,,,,,,,,,NOS1
B4DJ51,B4DJ51_HUMAN,HEL-S-72; CALM1; CALM3; hCG_20313; hCG_21749,"Calmodulin 1; Phosphorylase kinase, delta; Calmodulin 3 (Phosphorylase kinase, delta; Epididymis secretory protein Li 72; cDNA FLJ61744, highly similar to Calmodulin",CALM1; CALM3,,,,,,,,HEL-S-72
B4DXN7,B4DXN7_HUMAN,,TGF-beta receptor type-1; EC 2.7.11.30; Transforming growth factor-beta receptor type I,,,,,,,,,
L7RSM7,L7RSM7_HUMAN,PRKCA,Protein kinase C; EC 2.7.11.13,,,,,,,,,PRKCA
L8B082,L8B082_HUMAN,TYR; hCG_19690,Tyrosinase; EC 1.14.18.1; Monophenol monooxygenase,,,,,,,,,TYR
Q14DU5,Q14DU5_HUMAN,ROCK2,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,ROCK2
Q499G7,Q499G7_HUMAN,MAPK1,Mitogen-activated protein kinase; EC 2.7.11.24,,,,,,,,,MAPK1
Q53PC4,Q53PC4_HUMAN,IL8RB; hCG_16291,C-X-C chemokine receptor type 2; High affinity interleukin-8 receptor B,,,,,,,,,IL8RB
Q53X57,Q53X57_HUMAN,CAV2; hCG_39087; tcag7.25,Caveolin,,,,,,,,,CAV2
Q53X93,Q53X93_HUMAN,CREB1; hCG_15208,"CREB1 protein; cAMP responsive element binding protein 1; cDNA, FLJ96224, Homo sapiens cAMP responsive element binding protein 1 (CREB1",,,,,,,,,CREB1
Q53XC0,Q53XC0_HUMAN,EIF2S1; hCG_21909,Eukaryotic translation initiation factor 2 subunit 1; Eukaryotic translation initiation factor 2 subunit alpha,,,,,,,,,EIF2S1
Q546S1,Q546S1_HUMAN,EGR1; hCG_18777,Early growth response protein,,,,,,,,,EGR1
Q59F04,Q59F04_HUMAN,,receptor protein-tyrosine kinase; EC 2.7.10.1,,,,,,,,,
Q5R352,Q5R352_HUMAN,PLN; hCG_20805,Phospholamban; PLB,,,,,,,,,PLN
Q5U045,Q5U045_HUMAN,CSNK1E; hCG_2014051,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,CSNK1E
Q658W2,Q658W2_HUMAN,DKFZp666O0110,Focal adhesion kinase 1; EC 2.7.10.2; Protein-tyrosine kinase 2; pp125FAK,,,,,,,,,DKFZp666O0110
Q68DB7,Q68DB7_HUMAN,DKFZp781O1323; DKFZp781C1895; SMAD5; hCG_41402,Mothers against decapentaplegic homolog; MAD homolog; Mothers against DPP homolog; SMAD family member,DKFZp781C1895; SMAD5,,,,,,,,DKFZp781O1323
Q6FI00,Q6FI00_HUMAN,CCND1; hCG_2016647,"CCND1 protein; Cyclin D1 (PRAD1: parathyroid adenomatosis 1; Cyclin D1, isoform CRA_c",,,,,,,,,CCND1
Q6FI27,Q6FI27_HUMAN,GSK3B; hCG_1818062,Glycogen synthase kinase-3 beta; EC 2.7.11.26,,,,,,,,,GSK3B
Q7Z6C1,Q7Z6C1_HUMAN,EP300,histone acetyltransferase; EC 2.3.1.48,,,,,,,,,EP300
Q8N619,Q8N619_HUMAN,CDK5R1,Cyclin-dependent kinase 5 activator,,,,,,,,,CDK5R1
V9HW04,V9HW04_HUMAN,HEL-S-80p,Serine/threonine-protein phosphatase; EC 3.1.3.16,,,,,,,,,HEL-S-80p
V9HWB4,V9HWB4_HUMAN,HEL-S-89n,78 kDa glucose-regulated protein; Binding-immunoglobulin protein; Heat shock protein 70 family protein 5; Heat shock protein family A member 5; Immunoglobulin heavy chain-binding protein,,,,,,,,,HEL-S-89n
V9HWF0,V9HWF0_HUMAN,HEL-S-28,Scaffold protein ILK; ILK-1; ILK-2; Inactive integrin-linked kinase; p59ILK,,,,,,,,,HEL-S-28
X5D2R1,X5D2R1_HUMAN,NTRK3; hCG_26627,Tyrosine-protein kinase receptor; EC 2.7.10.1,,,,,,,,,NTRK3
X5D9D2,X5D9D2_HUMAN,TSC1,Tuberous sclerosis 1 isoform A,,,,,,,,,TSC1
A0A024R0V4,A0A024R0V4_HUMAN,VASP,Vasodilator-stimulated phosphoprotein isoform 1,,,,,,,,,VASP
A0A024R240,A0A024R240_HUMAN,,Guanine nucleotide-binding protein subunit alpha,,,,,,,,,
A0A024R625,A0A024R625_HUMAN,PPP4C; hCG_1770706,Serine/threonine-protein phosphatase; EC 3.1.3.16,,,,,,,,,PPP4C
A0A0S2Z4Y3,A0A0S2Z4Y3_HUMAN,NCK1,NCK adaptor protein 1 isoform 1,,,,,,,,,NCK1
A0A0S2Z595,A0A0S2Z595_HUMAN,FOSL1,FOS-like antigen 1 isoform 1,,,,,,,,,FOSL1
A0A140VJM3,A0A140VJM3_HUMAN,PRKG2; hCG_25079,cGMP-dependent protein kinase; EC 2.7.11.12,,,,,,,,,PRKG2
A0A140VJR0,A0A140VJR0_HUMAN,PDE4D; hCG_1811507,Phosphodiesterase; EC 3.1.4.-,,,,,,,,,PDE4D
A0A1U9X785,A0A1U9X785_HUMAN,,AGER,,,,,,,,,
A0A1U9X830,A0A1U9X830_HUMAN,,Negative elongation factor E,,,,,,,,,
A0A286YF97,A0A286YF97_HUMAN,MAPK10,Stress-activated protein kinase JNK; EC 2.7.11.24,,,,,,,,,MAPK10
A0A384MDX3,A0A384MDX3_HUMAN,,Protein Wnt,,,,,,,,,
A0A8D9PHB2,A0A8D9PHB2_HUMAN,GRIN2B; hCG_1811072,Glutamate receptor,,,,,,,,,GRIN2B
A1L4K2,A1L4K2_HUMAN,MAPK8; hCG_23734,Stress-activated protein kinase JNK; EC 2.7.11.24,,,,,,,,,MAPK8
A3KLL5,A3KLL5_HUMAN,ATP1B1; hCG_37798,Sodium/potassium-transporting ATPase subunit beta,,,,,,,,,ATP1B1
A8KAH9,A8KAH9_HUMAN,RAP1A; hCG_1818872,small monomeric GTPase; EC 3.6.5.2,,,,,,,,,RAP1A
B0YJ88,B0YJ88_HUMAN,RDX; hCG_39182,"Radixin; cDNA, FLJ93349, Homo sapiens radixin (RDX",,,,,,,,,RDX
B2R5T5,B2R5T5_HUMAN,PRKAR1A; hCG_28462,cAMP-dependent protein kinase type I-alpha regulatory subunit,,,,,,,,,PRKAR1A
B2RAH2,B2RAH2_HUMAN,,Sodium/hydrogen exchanger,,,,,,,,,
B2RDI5,B2RDI5_HUMAN,,Calpain-1 catalytic subunit; EC 3.4.22.52; Calcium-activated neutral proteinase 1; Calpain mu-type; Calpain-1 large subunit; Micromolar-calpain,,,,,,,,,
B3KVQ9,B3KVQ9_HUMAN,PPP1R1B; hCG_30016,Protein phosphatase 1 regulatory subunit 1B; DARPP-32; Dopamine- and cAMP-regulated neuronal phosphoprotein,,,,,,,,,PPP1R1B
B4DG68,B4DG68_HUMAN,,Nitric oxide synthase; EC 1.14.13.39,,,,,,,,,
B4DU40,B4DU40_HUMAN,,Dual specificity protein phosphatase; EC 3.1.3.16; EC 3.1.3.48,,,,,,,,,
B4DYR6,B4DYR6_HUMAN,,Dynamin-1-like protein; EC 3.6.5.5,,,,,,,,,
B5BNW5,B5BNW5_HUMAN,KCNMB2,"Calcium-activated potassium channel subunit beta; BKbeta; BK channel subunit beta; Calcium-activated potassium channel, subfamily M subunit beta; Charybdotoxin receptor subunit beta; K(VCA; Maxi K channel subunit beta; Slo-beta",,,,,,,,,KCNMB2
C7S316,C7S316_HUMAN,KCNE1,Potassium voltage-gated channel subfamily E member 1,,,,,,,,,KCNE1
H9KVD2,H9KVD2_HUMAN,SCN5A,Sodium channel protein,,,,,,,,,SCN5A
L7RSM2,L7RSM2_HUMAN,MAPK14; hCG_1818055,Mitogen-activated protein kinase 14; EC 2.7.11.24; Mitogen-activated protein kinase p38 alpha,,,,,,,,,MAPK14
O15398,O15398_HUMAN,NMDAR2C,Glutamate receptor,,,,,,,,,NMDAR2C
O43849,O43849_HUMAN,PDE4C,Phosphodiesterase; EC 3.1.4.-,,,,,,,,,PDE4C
Q17R51,Q17R51_HUMAN,GRIA3,Glutamate receptor,,,,,,,,,GRIA3
Q1KLZ0,Q1KLZ0_HUMAN,PS1TP5BP1; hCG_15971,"HCG15971, isoform CRA_a; PS1TP5-binding protein 1",,,,,,,,,PS1TP5BP1
Q1WWK6,Q1WWK6_HUMAN,GRIA4,Glutamate receptor,,,,,,,,,GRIA4
Q32MM7,Q32MM7_HUMAN,PDE4C,Phosphodiesterase; EC 3.1.4.-,,,,,,,,,PDE4C
Q4JHT5,Q4JHT5_HUMAN,SOCS1; hCG_14617,Suppressor of cytokine signaling 1,,,,,,,,,SOCS1
Q53GA5,Q53GA5_HUMAN,,Cellular tumor antigen p53; Tumor suppressor p53,,,,,,,,,
Q53Y01,Q53Y01_HUMAN,GNG11; hCG_19197; tcag7.247,Guanine nucleotide-binding protein subunit gamma,,,,,,,,,GNG11
Q53ZR5,Q53ZR5_HUMAN,SPHK1; hCG_30901,Sphingosine kinase 1; cDNA FLJ78254,,,,,,,,,SPHK1
Q549N0,Q549N0_HUMAN,CFL2; hCG_21174,"Cofilin 2; Muscle; Cofilin 2 (Muscle; Cofilin isoform; cDNA, FLJ94864, Homo sapiens cofilin 2 (muscle; CFL2",,,,,,,,,CFL2
Q59EF6,Q59EF6_HUMAN,,Calpain-2 catalytic subunit; EC 3.4.22.53; Calcium-activated neutral proteinase 2; Calpain M-type; Calpain-2 large subunit; Millimolar-calpain,,,,,,,,,
Q59EH3,Q59EH3_HUMAN,,Low molecular weight phosphotyrosine protein phosphatase; LMW-PTP; LMW-PTPase; EC 3.1.3.2; EC 3.1.3.48; Low molecular weight cytosolic acid phosphatase,,,,,,,,,
Q59FK4,Q59FK4_HUMAN,,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,
Q59GM6,Q59GM6_HUMAN,,Focal adhesion kinase 1; EC 2.7.10.2; Protein-tyrosine kinase 2; pp125FAK,,,,,,,,,
Q59GU3,Q59GU3_HUMAN,,Voltage-dependent L-type calcium channel subunit alpha,,,,,,,,,
Q5F0I5,Q5F0I5_HUMAN,GRIN3B,Glutamate receptor,,,,,,,,,GRIN3B
Q5JY90,Q5JY90_HUMAN,BTK; hCG_20400,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,BTK
Q5U079,Q5U079_HUMAN,JUNB; hCG_172481,Transcription factor JunB; Transcription factor AP-1 subunit JunB,,,,,,,,,JUNB
Q6FGX2,Q6FGX2_HUMAN,TNNI3,"Troponin I, cardiac muscle; Cardiac troponin I",,,,,,,,,TNNI3
Q6FHJ6,Q6FHJ6_HUMAN,KCNE1,Potassium voltage-gated channel subfamily E member 1,,,,,,,,,KCNE1
Q6FI23,Q6FI23_HUMAN,MAP2K3,mitogen-activated protein kinase kinase; EC 2.7.12.2,,,,,,,,,MAP2K3
Q6FI39,Q6FI39_HUMAN,SOCS3; hCG_1776363,Suppressor of cytokine signaling 3,,,,,,,,,SOCS3
Q6IAW1,Q6IAW1_HUMAN,GABARAP; hCG_1987397,"Epididymis secretory sperm binding protein; GABA(A; GABARAP protein; HCG1987397, isoform CRA_b",,,,,,,,,GABARAP
Q6IBV1,Q6IBV1_HUMAN,BNIP3L; hCG_17158,BCL2/adenovirus E1B 19kDa interacting protein 3-like; BNIP3L protein,,,,,,,,,BNIP3L
Q6P9C2,Q6P9C2_HUMAN,DUSP9,Dual specificity protein phosphatase; EC 3.1.3.16; EC 3.1.3.48,,,,,,,,,DUSP9
Q7LCB3,Q7LCB3_HUMAN,NR3A2; ESR2; hCG_21449,Estrogen receptor beta; Nuclear receptor subfamily 3 group A member 2,ESR2,,,,,,,,NR3A2
Q86V29,Q86V29_HUMAN,WEE1,Wee1-like protein kinase; EC 2.7.10.2,,,,,,,,,WEE1
V9HW43,V9HW43_HUMAN,HEL-S-102,Heat shock protein beta-1; Heat shock 27 kDa protein,,,,,,,,,HEL-S-102
V9HWB8,V9HWB8_HUMAN,HEL-S-30,Pyruvate kinase; EC 2.7.1.40,,,,,,,,,HEL-S-30
X5D945,X5D945_HUMAN,HRAS,Harvey rat sarcoma viral oncoprotein isoform A,,,,,,,,,HRAS
A0A024R2I8,A0A024R2I8_HUMAN,NR1A2,Thyroid hormone nuclear receptor beta variant 1,,,,,,,,,NR1A2
A0A024R2W3,A0A024R2W3_HUMAN,PRKAR2A; hCG_1779456,cAMP-dependent protein kinase type II-alpha regulatory subunit,,,,,,,,,PRKAR2A
A0A024RCH9,A0A024RCH9_HUMAN,OR11A1,Olfactory receptor,,,,,,,,,OR11A1
A0A024RCM6,A0A024RCM6_HUMAN,OR2H1,Olfactory receptor,,,,,,,,,OR2H1
A0A024RD04,A0A024RD04_HUMAN,MAPK13,Mitogen-activated protein kinase 13; EC 2.7.11.24,,,,,,,,,MAPK13
A0A090N8Q6,A0A090N8Q6_HUMAN,PRKAG2; hCG_2043270; tcag7.766,"Protein kinase, AMP-activated, gamma 2 non-catalytic subunit",,,,,,,,,PRKAG2
A0A0B4J1S0,A0A0B4J1S0_HUMAN,OR1L1,Olfactory receptor,,,,,,,,,OR1L1
A0A0C4DFP3,A0A0C4DFP3_HUMAN,OR2K2; hCG_1790497,Olfactory receptor,,,,,,,,,OR2K2
A0A0C4DFU5,A0A0C4DFU5_HUMAN,OR6K3,Olfactory receptor,,,,,,,,,OR6K3
A0A0C4DFX5,A0A0C4DFX5_HUMAN,OR51T1,Olfactory receptor,,,,,,,,,OR51T1
A0A0C4DFX9,A0A0C4DFX9_HUMAN,NELFA,Negative elongation factor complex member A,,,,,,,,,NELFA
A0A0S2Z3Y8,A0A0S2Z3Y8_HUMAN,LCK,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,LCK
A0A0S2Z4M6,A0A0S2Z4M6_HUMAN,NCK2,NCK adaptor protein 2 isoform 1,,,,,,,,,NCK2
A0A126GV57,A0A126GV57_HUMAN,OR6N2,Olfactory receptor,,,,,,,,,OR6N2
A0A126GV63,A0A126GV63_HUMAN,OR10Z1,Olfactory receptor,,,,,,,,,OR10Z1
A0A126GV67,A0A126GV67_HUMAN,OR2M3,Olfactory receptor,,,,,,,,,OR2M3
A0A126GV68,A0A126GV68_HUMAN,OR6F1,Olfactory receptor,,,,,,,,,OR6F1
A0A126GV70,A0A126GV70_HUMAN,OR10J5,OR10J5,,,,,,,,,OR10J5
A0A126GV72,A0A126GV72_HUMAN,OR6P1; hCG_2044698,Olfactory receptor,,,,,,,,,OR6P1
A0A126GV73,A0A126GV73_HUMAN,OR2M4; hCG_1643372,Olfactory receptor,,,,,,,,,OR2M4
A0A126GV74,A0A126GV74_HUMAN,OR10T2; hCG_2040323,Olfactory receptor,,,,,,,,,OR10T2
A0A126GV76,A0A126GV76_HUMAN,OR2B3,Olfactory receptor,,,,,,,,,OR2B3
A0A126GV79,A0A126GV79_HUMAN,OR2T10,Olfactory receptor,,,,,,,,,OR2T10
A0A126GV80,A0A126GV80_HUMAN,OR10C1,Olfactory receptor,,,,,,,,,OR10C1
A0A126GV92,A0A126GV92_HUMAN,OR4F16,Olfactory receptor,,,,,,,,,OR4F16
A0A126GV94,A0A126GV94_HUMAN,OR1C1,Olfactory receptor,,,,,,,,,OR1C1
A0A126GV96,A0A126GV96_HUMAN,OR4F6,Olfactory receptor,,,,,,,,,OR4F6
A0A126GV98,A0A126GV98_HUMAN,OR2F1,Olfactory receptor,,,,,,,,,OR2F1
A0A126GV99,A0A126GV99_HUMAN,OR5V1,Olfactory receptor,,,,,,,,,OR5V1
A0A126GVA1,A0A126GVA1_HUMAN,OR2W1,Olfactory receptor,,,,,,,,,OR2W1
A0A126GVB0,A0A126GVB0_HUMAN,OR2A14,Olfactory receptor,,,,,,,,,OR2A14
A0A126GVB1,A0A126GVB1_HUMAN,OR9A4,Olfactory receptor,,,,,,,,,OR9A4
A0A126GVB4,A0A126GVB4_HUMAN,OR5K2,Olfactory receptor,,,,,,,,,OR5K2
A0A126GVB8,A0A126GVB8_HUMAN,OR9G9; OR9G1,Olfactory receptor,OR9G1,,,,,,,,OR9G9
A0A126GVC5,A0A126GVC5_HUMAN,OR1L8,Olfactory receptor,,,,,,,,,OR1L8
A0A126GVC7,A0A126GVC7_HUMAN,OR13C8; hCG_1799737,Olfactory receptor,,,,,,,,,OR13C8
A0A126GVC8,A0A126GVC8_HUMAN,OR7A10,Olfactory receptor,,,,,,,,,OR7A10
A0A126GVC9,A0A126GVC9_HUMAN,OR13C4; hCG_1804868,Olfactory receptor,,,,,,,,,OR13C4
A0A126GVD1,A0A126GVD1_HUMAN,OR1L3,Olfactory receptor,,,,,,,,,OR1L3
A0A126GVD4,A0A126GVD4_HUMAN,OR5AS1; hCG_2044294,Olfactory receptor,,,,,,,,,OR5AS1
A0A126GVD5,A0A126GVD5_HUMAN,OR5A2,Olfactory receptor,,,,,,,,,OR5A2
A0A126GVD8,A0A126GVD8_HUMAN,OR13A1,Olfactory receptor,,,,,,,,,OR13A1
A0A126GVE3,A0A126GVE3_HUMAN,OR8J3; hCG_41019,Olfactory receptor,,,,,,,,,OR8J3
A0A126GVE5,A0A126GVE5_HUMAN,OR5I1; hCG_1730362,Olfactory receptor,,,,,,,,,OR5I1
A0A126GVE6,A0A126GVE6_HUMAN,OR5P3,Olfactory receptor,,,,,,,,,OR5P3
A0A126GVE9,A0A126GVE9_HUMAN,OR51I2; hCG_2043328,Olfactory receptor,,,,,,,,,OR51I2
A0A126GVF2,A0A126GVF2_HUMAN,OR52K1; hCG_1992239,Olfactory receptor,,,,,,,,,OR52K1
A0A126GVF5,A0A126GVF5_HUMAN,OR51G1; hCG_2041338,Olfactory receptor,,,,,,,,,OR51G1
A0A126GVF8,A0A126GVF8_HUMAN,OR51E1,Olfactory receptor,,,,,,,,,OR51E1
A0A126GVG1,A0A126GVG1_HUMAN,OR4S2; hCG_2044351,Olfactory receptor,,,,,,,,,OR4S2
A0A126GVG6,A0A126GVG6_HUMAN,OR8D1,Olfactory receptor,,,,,,,,,OR8D1
A0A126GVG9,A0A126GVG9_HUMAN,OR52D1,Olfactory receptor,,,,,,,,,OR52D1
A0A126GVH0,A0A126GVH0_HUMAN,OR52E8,Olfactory receptor,,,,,,,,,OR52E8
A0A126GVH3,A0A126GVH3_HUMAN,OR5B3; hCG_2044361,Olfactory receptor,,,,,,,,,OR5B3
A0A126GVJ1,A0A126GVJ1_HUMAN,OR4D10,Olfactory receptor,,,,,,,,,OR4D10
A0A126GVJ4,A0A126GVJ4_HUMAN,OR9I1,Olfactory receptor,,,,,,,,,OR9I1
A0A126GVJ7,A0A126GVJ7_HUMAN,OR5P2; hCG_1784551,Olfactory receptor,,,,,,,,,OR5P2
A0A126GVJ8,A0A126GVJ8_HUMAN,OR51L1,Olfactory receptor,,,,,,,,,OR51L1
A0A126GVK0,A0A126GVK0_HUMAN,OR51E2,Olfactory receptor,,,,,,,,,OR51E2
A0A126GVK2,A0A126GVK2_HUMAN,OR6M1,Olfactory receptor,,,,,,,,,OR6M1
A0A126GVK5,A0A126GVK5_HUMAN,OR52E6,Olfactory receptor,,,,,,,,,OR52E6
A0A126GVK8,A0A126GVK8_HUMAN,OR52K2,Olfactory receptor,,,,,,,,,OR52K2
A0A126GVL0,A0A126GVL0_HUMAN,OR5L1; hCG_2040388,Olfactory receptor,,,,,,,,,OR5L1
A0A126GVL6,A0A126GVL6_HUMAN,OR5T1,Olfactory receptor,,,,,,,,,OR5T1
A0A126GVL8,A0A126GVL8_HUMAN,OR5B17,Olfactory receptor,,,,,,,,,OR5B17
A0A126GVL9,A0A126GVL9_HUMAN,OR5M11,Olfactory receptor,,,,,,,,,OR5M11
A0A126GVM0,A0A126GVM0_HUMAN,OR6X1,Olfactory receptor,,,,,,,,,OR6X1
A0A126GVM2,A0A126GVM2_HUMAN,OR51D1; hCG_2040513,Olfactory receptor,,,,,,,,,OR51D1
A0A126GVM8,A0A126GVM8_HUMAN,OR10AG1,Olfactory receptor,,,,,,,,,OR10AG1
A0A126GVN0,A0A126GVN0_HUMAN,OR4C6,Olfactory receptor,,,,,,,,,OR4C6
A0A126GVN2,A0A126GVN2_HUMAN,OR4N4,Olfactory receptor,,,,,,,,,OR4N4
A0A126GVN4,A0A126GVN4_HUMAN,OR4N5; hCG_2044309,Olfactory receptor,,,,,,,,,OR4N5
A0A126GVN5,A0A126GVN5_HUMAN,OR4K5; hCG_2044251,Olfactory receptor,,,,,,,,,OR4K5
A0A126GVN6,A0A126GVN6_HUMAN,OR4C11; hCG_2040350,Olfactory receptor,,,,,,,,,OR4C11
A0A126GVN8,A0A126GVN8_HUMAN,OR10A6,Olfactory receptor,,,,,,,,,OR10A6
A0A126GVP1,A0A126GVP1_HUMAN,OR3A1,Olfactory receptor,,,,,,,,,OR3A1
A0A126GVP2,A0A126GVP2_HUMAN,OR4K14,Olfactory receptor,,,,,,,,,OR4K14
A0A126GVP4,A0A126GVP4_HUMAN,OR11H6; hCG_2044308,Olfactory receptor,,,,,,,,,OR11H6
A0A126GVP5,A0A126GVP5_HUMAN,OR4K2,Olfactory receptor,,,,,,,,,OR4K2
A0A126GVP6,A0A126GVP6_HUMAN,OR6Q1; hCG_1645623,Olfactory receptor,,,,,,,,,OR6Q1
A0A126GVP8,A0A126GVP8_HUMAN,OR4D9; hCG_2044273,Olfactory receptor,,,,,,,,,OR4D9
A0A126GVP9,A0A126GVP9_HUMAN,OR5AN1; hCG_2044276,Olfactory receptor,,,,,,,,,OR5AN1
A0A126GVQ4,A0A126GVQ4_HUMAN,OR8B2,Olfactory receptor,,,,,,,,,OR8B2
A0A126GVR1,A0A126GVR1_HUMAN,OR7D4,Olfactory receptor,,,,,,,,,OR7D4
A0A126GVR3,A0A126GVR3_HUMAN,OR10A7; hCG_2014374,Olfactory receptor,,,,,,,,,OR10A7
A0A126GVR4,A0A126GVR4_HUMAN,OR7G3,Olfactory receptor,,,,,,,,,OR7G3
A0A126GVR5,A0A126GVR5_HUMAN,OR7A17; hCG_1779708,Olfactory receptor,,,,,,,,,OR7A17
A0A126GVR6,A0A126GVR6_HUMAN,OR4C3,Olfactory receptor,,,,,,,,,OR4C3
A0A126GVR8,A0A126GVR8_HUMAN,OR4E2; hCG_1647028,Olfactory receptor,,,,,,,,,OR4E2
A0A126GVS2,A0A126GVS2_HUMAN,OR4K13; hCG_1800595,Olfactory receptor,,,,,,,,,OR4K13
A0A126GVS5,A0A126GVS5_HUMAN,OR2AP1; hCG_1648196,Olfactory receptor,,,,,,,,,OR2AP1
A0A126GVS6,A0A126GVS6_HUMAN,OR7G1,Olfactory receptor,,,,,,,,,OR7G1
A0A126GVT2,A0A126GVT2_HUMAN,OR4N2; hCG_2044375,Olfactory receptor,,,,,,,,,OR4N2
A0A126GVT8,A0A126GVT8_HUMAN,OR2Z1,Olfactory receptor,,,,,,,,,OR2Z1
A0A126GVU1,A0A126GVU1_HUMAN,OR4S1; hCG_1807712,Olfactory receptor,,,,,,,,,OR4S1
A0A126GVV4,A0A126GVV4_HUMAN,OR1D2; hCG_2039669,Olfactory receptor,,,,,,,,,OR1D2
A0A126GVV5,A0A126GVV5_HUMAN,OR2A25,Olfactory receptor,,,,,,,,,OR2A25
A0A126GVW5,A0A126GVW5_HUMAN,OR2T3,Olfactory receptor,,,,,,,,,OR2T3
A0A126GVW6,A0A126GVW6_HUMAN,OR8H1,Olfactory receptor,,,,,,,,,OR8H1
A0A126GVW7,A0A126GVW7_HUMAN,OR5AU1,Olfactory receptor,,,,,,,,,OR5AU1
A0A126GVX0,A0A126GVX0_HUMAN,OR2G3,Olfactory receptor,,,,,,,,,OR2G3
A0A126GVX6,A0A126GVX6_HUMAN,OR8G1; hCG_2032663,Olfactory receptor,,,,,,,,,OR8G1
A0A126GVY3,A0A126GVY3_HUMAN,OR2T1,Olfactory receptor,,,,,,,,,OR2T1
A0A126GVY5,A0A126GVY5_HUMAN,OR2B11,Olfactory receptor,,,,,,,,,OR2B11
A0A126GVY9,A0A126GVY9_HUMAN,OR13C3,Olfactory receptor,,,,,,,,,OR13C3
A0A126GVZ1,A0A126GVZ1_HUMAN,OR2M7; N,Olfactory receptor,,,,,,,,,OR2M7 N
A0A126GVZ2,A0A126GVZ2_HUMAN,OR10A3,Olfactory receptor,,,,,,,,,OR10A3
A0A126GVZ4,A0A126GVZ4_HUMAN,OR4K17,Olfactory receptor,,,,,,,,,OR4K17
A0A126GVZ6,A0A126GVZ6_HUMAN,OR8K1; hCG_2044295,Olfactory receptor,,,,,,,,,OR8K1
A0A126GW01,A0A126GW01_HUMAN,OR9K2,Olfactory receptor,,,,,,,,,OR9K2
A0A126GW05,A0A126GW05_HUMAN,OR6C2,Olfactory receptor,,,,,,,,,OR6C2
A0A126GW06,A0A126GW06_HUMAN,OR1J4,Olfactory receptor,,,,,,,,,OR1J4
A0A126GW10,A0A126GW10_HUMAN,OR14J1,Olfactory receptor,,,,,,,,,OR14J1
A0A126GW13,A0A126GW13_HUMAN,OR6C74,Olfactory receptor,,,,,,,,,OR6C74
A0A126GW15,A0A126GW15_HUMAN,OR6C6,Olfactory receptor,,,,,,,,,OR6C6
A0A126GW18,A0A126GW18_HUMAN,OR1J2,Olfactory receptor,,,,,,,,,OR1J2
A0A126GW19,A0A126GW19_HUMAN,OR11H4,Olfactory receptor,,,,,,,,,OR11H4
A0A126GW31,A0A126GW31_HUMAN,OR1N1,Olfactory receptor,,,,,,,,,OR1N1
A0A126GW32,A0A126GW32_HUMAN,OR4Q3,Olfactory receptor,,,,,,,,,OR4Q3
A0A126GW34,A0A126GW34_HUMAN,OR2L2; hCG_2041355,Olfactory receptor,,,,,,,,,OR2L2
A0A126GW41,A0A126GW41_HUMAN,OR4F15,Olfactory receptor,,,,,,,,,OR4F15
A0A126GW42,A0A126GW42_HUMAN,OR5C1,Olfactory receptor,,,,,,,,,OR5C1
A0A126GW43,A0A126GW43_HUMAN,OR7G2; hCG_1794757,Olfactory receptor,,,,,,,,,OR7G2
A0A126GW44,A0A126GW44_HUMAN,OR6C3; hCG_2044321,Olfactory receptor,,,,,,,,,OR6C3
A0A126GW45,A0A126GW45_HUMAN,OR2A2,Olfactory receptor,,,,,,,,,OR2A2
A0A126GW49,A0A126GW49_HUMAN,OR2A5,Olfactory receptor,,,,,,,,,OR2A5
A0A126GW53,A0A126GW53_HUMAN,OR2G6,Olfactory receptor,,,,,,,,,OR2G6
A0A126GW60,A0A126GW60_HUMAN,OR7A5,Olfactory receptor,,,,,,,,,OR7A5
A0A126GW65,A0A126GW65_HUMAN,OR4C3,Olfactory receptor,,,,,,,,,OR4C3
A0A126GW71,A0A126GW71_HUMAN,OR6C65,Olfactory receptor,,,,,,,,,OR6C65
A0A126GW73,A0A126GW73_HUMAN,OR8B8,Olfactory receptor,,,,,,,,,OR8B8
A0A126GW79,A0A126GW79_HUMAN,OR5H1,Olfactory receptor,,,,,,,,,OR5H1
A0A126GW81,A0A126GW81_HUMAN,OR1E2; hCG_1775671,Olfactory receptor,,,,,,,,,OR1E2
A0A126GW85,A0A126GW85_HUMAN,OR9Q2; hCG_2044355,Olfactory receptor,,,,,,,,,OR9Q2
A0A126GW86,A0A126GW86_HUMAN,OR5H6; hCG_2044421,Olfactory receptor,,,,,,,,,OR5H6
A0A126GW87,A0A126GW87_HUMAN,OR4A16; hCG_2044396,Olfactory receptor,,,,,,,,,OR4A16
A0A126GW91,A0A126GW91_HUMAN,OR6A2; hCG_1643359,Olfactory receptor,,,,,,,,,OR6A2
A0A126GW92,A0A126GW92_HUMAN,OR6C75,Olfactory receptor,,,,,,,,,OR6C75
A0A126GW96,A0A126GW96_HUMAN,OR2L13; hCG_1725377,Olfactory receptor,,,,,,,,,OR2L13
A0A126GWA4,A0A126GWA4_HUMAN,OR10X1,Olfactory receptor,,,,,,,,,OR10X1
A0A126GWB1,A0A126GWB1_HUMAN,OR2AT4,Olfactory receptor,,,,,,,,,OR2AT4
A0A126GWC1,A0A126GWC1_HUMAN,OR5K1,Olfactory receptor,,,,,,,,,OR5K1
A0A126GWC3,A0A126GWC3_HUMAN,OR4M1,Olfactory receptor,,,,,,,,,OR4M1
A0A126GWD0,A0A126GWD0_HUMAN,OR2B2,Olfactory receptor,,,,,,,,,OR2B2
A0A126GWD2,A0A126GWD2_HUMAN,OR52A5; hCG_1647754,Olfactory receptor,,,,,,,,,OR52A5
A0A126GWD5,A0A126GWD5_HUMAN,OR51A2,Olfactory receptor,,,,,,,,,OR51A2
A0A126GWD6,A0A126GWD6_HUMAN,OR5M8,Olfactory receptor,,,,,,,,,OR5M8
A0A126GWE7,A0A126GWE7_HUMAN,OR51I1,Olfactory receptor,,,,,,,,,OR51I1
A0A126GWI7,A0A126GWI7_HUMAN,OR2M2; hCG_1747589,Olfactory receptor,,,,,,,,,OR2M2
A0A126GWJ2,A0A126GWJ2_HUMAN,OR4A5; hCG_2044384,Olfactory receptor,,,,,,,,,OR4A5
A0A126GWK8,A0A126GWK8_HUMAN,OR52I2; hCG_2040529,Olfactory receptor,,,,,,,,,OR52I2
A0A126GWK9,A0A126GWK9_HUMAN,OR2T1; hCG_1724362,Olfactory receptor,,,,,,,,,OR2T1
A0A126GWN0,A0A126GWN0_HUMAN,OR4F17,Olfactory receptor,,,,,,,,,OR4F17
A0A126GWP9,A0A126GWP9_HUMAN,OR1J1,Olfactory receptor,,,,,,,,,OR1J1
A0A126GWQ4,A0A126GWQ4_HUMAN,OR6V1,Olfactory receptor,,,,,,,,,OR6V1
A0A126GWQ9,A0A126GWQ9_HUMAN,OR10J1,Olfactory receptor,,,,,,,,,OR10J1
A0A126GWR0,A0A126GWR0_HUMAN,OR10A5,Olfactory receptor,,,,,,,,,OR10A5
A0A126GWR7,A0A126GWR7_HUMAN,OR13C2,Olfactory receptor,,,,,,,,,OR13C2
A0A126GWR8,A0A126GWR8_HUMAN,OR2L5; hCG_2044366,Olfactory receptor,,,,,,,,,OR2L5
A0A126GWS4,A0A126GWS4_HUMAN,OR2J2,Olfactory receptor,,,,,,,,,OR2J2
A0A126GWS7,A0A126GWS7_HUMAN,OR8B12,Olfactory receptor,,,,,,,,,OR8B12
A0A126GWS8,A0A126GWS8_HUMAN,OR11G2,Olfactory receptor,,,,,,,,,OR11G2
A0A126GWT2,A0A126GWT2_HUMAN,OR2J3,Olfactory receptor,,,,,,,,,OR2J3
A0A126GWU6,A0A126GWU6_HUMAN,OR7C1,Olfactory receptor,,,,,,,,,OR7C1
A0A140VJL1,A0A140VJL1_HUMAN,HIPK4; hCG_20798,"Homeodomain interacting protein kinase 4, isoform CRA_b; Testicular tissue protein Li 87",,,,,,,,,HIPK4
A0A140VJQ8,A0A140VJQ8_HUMAN,PXN; hCG_27772,Paxillin,,,,,,,,,PXN
A0A140VK14,A0A140VK14_HUMAN,,"Glutamate dehydrogenase 2, mitochondrial; EC 1.4.1.3",,,,,,,,,
A0A1U9X844,A0A1U9X844_HUMAN,,Olfactory receptor,,,,,,,,,
A0A1X9RU27,A0A1X9RU27_HUMAN,FOXO6,Forkhead box O6; Forkhead box protein O6,,,,,,,,,FOXO6
A0A2C9F2M4,A0A2C9F2M4_HUMAN,OR4C15,Olfactory receptor,,,,,,,,,OR4C15
A0A2K8FKV1,A0A2K8FKV1_HUMAN,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase; EC 2.7.1.153",,,,,,,,,PIK3CD
A0A2K8FR47,A0A2K8FR47_HUMAN,WNT10A,Protein Wnt,,,,,,,,,WNT10A
A0A2X0SFL3,A0A2X0SFL3_HUMAN,RASGRF2,RASGRF2,,,,,,,,,RASGRF2
A0A384MDR8,A0A384MDR8_HUMAN,,Pyruvate dehydrogenase E1 component subunit beta; EC 1.2.4.1,,,,,,,,,
A0A384N5W4,A0A384N5W4_HUMAN,STAT5A; hCG_16573,Signal transducer and activator of transcription,,,,,,,,,STAT5A
A0A384NKY7,A0A384NKY7_HUMAN,WNT8B; hCG_24657,Protein Wnt,,,,,,,,,WNT8B
A0AAG2T390,A0AAG2T390_HUMAN,OR8U8,Olfactory receptor,,,,,,,,,OR8U8
A0AAG2TFE4,A0AAG2TFE4_HUMAN,EEF2K; hCG_17932,Eukaryotic elongation factor 2 kinase; EC 2.7.11.20,,,,,,,,,EEF2K
A0AAG2UY17,A0AAG2UY17_HUMAN,OR4Q2,Olfactory receptor,,,,,,,,,OR4Q2
A0AAU7BN28,A0AAU7BN28_HUMAN,RPS6KA6,Ribosomal protein S6 kinase; EC 2.7.11.1,,,,,,,,,RPS6KA6
A0N0N3,A0N0N3_HUMAN,CXCR6; hCG_15326,C-X-C chemokine receptor type 6; G-protein coupled receptor bonzo,,,,,,,,,CXCR6
A0N0Q1,A0N0Q1_HUMAN,CCR4; hCG_1776165,"Chemokine; C-C motif; cDNA FLJ75821, highly similar to Homo sapiens chemokine (C-C motif; CCR4",,,,,,,,,CCR4
A0N0R2,A0N0R2_HUMAN,BLR1; hCG_37947,"Burkitt lymphoma receptor 1, GTP binding protein; Chemokine (C-X-C motif; C-x-c chemokine receptor type 5",,,,,,,,,BLR1
A0PJJ7,A0PJJ7_HUMAN,NOS1,nitric-oxide synthase; NADPH; EC 1.14.13.39,,,,,,,,,NOS1
A4D2J9,A4D2J9_HUMAN,CAMK2B; tcag7.799,calcium/calmodulin-dependent protein kinase; EC 2.7.11.17,,,,,,,,,CAMK2B
A4D2P1,A4D2P1_HUMAN,RAC1; hCG_14926; tcag7.839,"Ras-related C3 botulinum toxin substrate 1; Rho family, small GTP binding protein Rac1; Ras-related C3 botulinum toxin substrate 1 isoform Rac1; cDNA FLJ30431 fis, clone BRACE2008968, highly similar to Ras-related C3 botulinum toxin substrate 1; cDNA FLJ75553, highly similar to Homo sapiens ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1; RAC1",,,,,,,,,RAC1
A5PKZ7,A5PKZ7_HUMAN,PLA2G4F,Phospholipase A2; EC 3.1.1.4,,,,,,,,,PLA2G4F
A6H8K3,A6H8K3_HUMAN,ITPR3,"Inositol 1,4,5-trisphosphate receptor",,,,,,,,,ITPR3
A6NLW9,A6NLW9_HUMAN,OR51F1,Olfactory receptor,,,,,,,,,OR51F1
A7E2E5,A7E2E5_HUMAN,PDE3B,Phosphodiesterase; EC 3.1.4.-,,,,,,,,,PDE3B
A8K161,A8K161_HUMAN,CAMK2A; hCG_38614,calcium/calmodulin-dependent protein kinase; EC 2.7.11.17,,,,,,,,,CAMK2A
A8K379,A8K379_HUMAN,,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,
A8K385,A8K385_HUMAN,,Netrin receptor UNC5,,,,,,,,,
A8K3T2,A8K3T2_HUMAN,,Occludin,,,,,,,,,
A8K3Z6,A8K3Z6_HUMAN,ANAPC13; hCG_1646826,Anaphase-promoting complex subunit 13; Cyclosome subunit 13,,,,,,,,,ANAPC13
A8K647,A8K647_HUMAN,,"cDNA FLJ77143, highly similar to Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein; chemokine (C-X-C motif; BLR1",,,,,,,,,
A8K6I5,A8K6I5_HUMAN,,Signal transducer and activator of transcription,,,,,,,,,
A8K7B7,A8K7B7_HUMAN,PPP2R1A; hCG_19686,"Protein phosphatase 2; Formerly 2A; PR 65; Testicular secretory protein Li 1; cDNA, FLJ96799, Homo sapiens protein phosphatase 2 (formerly 2A; PR 65; PPP2R1A",,,,,,,,,PPP2R1A
A8K9G9,A8K9G9_HUMAN,,"phosphatidylinositol-4,5-bisphosphate 3-kinase; EC 2.7.1.153",,,,,,,,,
A8KAH7,A8KAH7_HUMAN,,cAMP-dependent protein kinase type II-alpha regulatory subunit,,,,,,,,,
B0YJ93,B0YJ93_HUMAN,SCN4B; hCG_1646677,"Sodium channel beta-4 subunit; Sodium channel, voltage-gated, type IV, beta, isoform CRA_b; cDNA, FLJ95353, Homo sapiens sodium channel, voltage-gated, type IV, beta (SCN4B",,,,,,,,,SCN4B
B1APZ0,B1APZ0_HUMAN,GNG4; hCG_23460,Guanine nucleotide-binding protein subunit gamma,,,,,,,,,GNG4
B2R6F3,B2R6F3_HUMAN,SFRS3; hCG_14802,"Epididymis secretory sperm binding protein; Splicing factor arginine/serine-rich 3; Splicing factor, arginine/serine-rich 3, isoform CRA_d; cDNA, FLJ92926, Homo sapiens splicing factor, arginine/serine-rich 3 (SFRS3",,,,,,,,,SFRS3
B2RA75,B2RA75_HUMAN,,"cDNA, FLJ94739, highly similar to Homo sapiens cAMP responsive element binding protein 3-like 1; CREB3L1",,,,,,,,,
B2RAH5,B2RAH5_HUMAN,,Protein phosphatase 1 regulatory subunit,,,,,,,,,
B2RB89,B2RB89_HUMAN,PRKACB; hCG_23660,cAMP-dependent protein kinase; EC 2.7.11.11,,,,,,,,,PRKACB
B2RNI9,B2RNI9_HUMAN,OR51M1,Olfactory receptor,,,,,,,,,OR51M1
B3KNA8,B3KNA8_HUMAN,,mRNA decay activator protein ZFP36; Zinc finger protein 36,,,,,,,,,
B3KP24,B3KP24_HUMAN,,"cDNA FLJ31012 fis, clone HLUNG2000217, highly similar to Guanine nucleotide-binding protein G(i), alpha-2 subunit; i",,,,,,,,,
B3KP89,B3KP89_HUMAN,,Guanine nucleotide-binding protein G(o) subunit alpha; o,,,,,,,,,
B3KQV3,B3KQV3_HUMAN,,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma; EC 2.7.1.149; Phosphatidylinositol 5-phosphate 4-kinase type II gamma,,,,,,,,,
B3KRV2,B3KRV2_HUMAN,,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,
B3KS38,B3KS38_HUMAN,CDC25B; hCG_39252,M-phase inducer phosphatase; EC 3.1.3.48,,,,,,,,,CDC25B
B3KY45,B3KY45_HUMAN,,PRKR-like endoplasmic reticulum kinase,,,,,,,,,
B4DFV1,B4DFV1_HUMAN,,protein kinase C; EC 2.7.11.13,,,,,,,,,
B4DT73,B4DT73_HUMAN,,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,
B4E2K6,B4E2K6_HUMAN,,"cDNA FLJ60405, highly similar to Rho guanine nucleotide exchange factor 12",,,,,,,,,
B4E322,B4E322_HUMAN,,choline-phosphate cytidylyltransferase; EC 2.7.7.15,,,,,,,,,
B5B2S1,B5B2S1_HUMAN,NFATC3; hCG_28103,"Nuclear factor of activated T-cells c3 isoform IB-deltaXa; Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3, isoform CRA_b",,,,,,,,,NFATC3
B6ZGS9,B6ZGS9_HUMAN,NR1H4; hCG_20893,"Farnesoid X receptor; Nuclear receptor subfamily 1, group H, member 4, isoform CRA_a",,,,,,,,,NR1H4
C5H3H2,C5H3H2_HUMAN,C10orf104; hCG_1789694,Anaphase-promoting complex subunit 16; Cyclosome subunit 16,,,,,,,,,C10orf104
D2XT27,D2XT27_HUMAN,OR12D3; hCG_25624,Olfactory receptor,,,,,,,,,OR12D3
D9ZGG3,D9ZGG3_HUMAN,WNT9A,Protein Wnt,,,,,,,,,WNT9A
E9KL48,E9KL48_HUMAN,GLUD1; hCG_1993805,"Glutamate dehydrogenase 1, mitochondrial; EC 1.4.1.3",,,,,,,,,GLUD1
F1T0G5,F1T0G5_HUMAN,GNB3; hCG_25935,Guanine nucleotide binding protein; G protein; Guanine nucleotide-binding protein G(I; S; T,,,,,,,,,GNB3
G8XRH5,G8XRH5_HUMAN,OPRM1,Mu-type opioid receptor,,,,,,,,,OPRM1
H0UI80,H0UI80_HUMAN,NELFCD; TH1L; hCG_28547,Negative elongation factor complex member C/D; TH1-like (Drosophila,TH1L,,,,,,,,NELFCD
I1SRC5,I1SRC5_HUMAN,,UBE2L3/KRAS fusion protein,,,,,,,,,
L7RT34,L7RT34_HUMAN,PIK3R5,Phosphoinositide 3-kinase regulatory subunit 5,,,,,,,,,PIK3R5
N0E4C7,N0E4C7_HUMAN,CSNK2B,Casein kinase II subunit beta; CK II beta,,,,,,,,,CSNK2B
Q05CQ2,Q05CQ2_HUMAN,,Olfactory receptor,,,,,,,,,
Q05D26,Q05D26_HUMAN,BLK,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,BLK
Q0IJ49,Q0IJ49_HUMAN,PKMYT1,non-specific serine/threonine protein kinase; EC 2.7.11.1,,,,,,,,,PKMYT1
Q17R91,Q17R91_HUMAN,DIAPH2,DIAPH2 protein,,,,,,,,,DIAPH2
Q2YD84,Q2YD84_HUMAN,CXCR5,Chemokine; C-X-C motif,,,,,,,,,CXCR5
Q38L21,Q38L21_HUMAN,CCR5; hCG_15321,C-C chemokine receptor type 5,,,,,,,,,CCR5
Q4LE43,Q4LE43_HUMAN,PLCG1; variant; protein,Phosphoinositide phospholipase C; EC 3.1.4.11,,,,,,,,,PLCG1 variant protein
Q4LE51,Q4LE51_HUMAN,PIK3CA; variant; protein,"phosphatidylinositol-4,5-bisphosphate 3-kinase; EC 2.7.1.153",,,,,,,,,PIK3CA variant protein
Q53ES0,Q53ES0_HUMAN,,Sodium/potassium-transporting ATPase subunit alpha,,,,,,,,,
Q53FN0,Q53FN0_HUMAN,,"Serine/arginine-rich splicing factor 2; Splicing component, 35 kDa; Splicing factor SC35; Splicing factor, arginine/serine-rich 2",,,,,,,,,
Q53RG0,Q53RG0_HUMAN,tmp_locus_9; EIF4E2; hCG_33450,"Eukaryotic translation initiation factor 4E member 2, isoform CRA_c; cDNA FLJ12456 fis, clone NT2RM1000661, highly similar to Eukaryotic translation initiation factor 4E type 3",EIF4E2,,,,,,,,tmp_locus_9
Q53XM7,Q53XM7_HUMAN,VAPB; hCG_26693,"VAMP; Vesicle-associated membrane protein; cDNA FLJ13179 fis, clone NT2RP3003918, highly similar to Vesicle-associated membrane protein-associated protein B/C",,,,,,,,,VAPB
Q53ZR1,Q53ZR1_HUMAN,SLC12A2; hCG_27034,Bumetanide-sensitive Na-K-Cl cotransporter; Solute carrier family 12 (Sodium/potassium/chloride transporters,,,,,,,,,SLC12A2
Q59E85,Q59E85_HUMAN,,Caveolin,,,,,,,,,
Q59F77,Q59F77_HUMAN,,Phosphoinositide phospholipase C; EC 3.1.4.11,,,,,,,,,
Q59F91,Q59F91_HUMAN,,protein-tyrosine-phosphatase; EC 3.1.3.48,,,,,,,,,
Q59GD8,Q59GD8_HUMAN,,"Calcium channel, voltage-dependent, L type, alpha 1D subunit variant",,,,,,,,,
Q59GL5,Q59GL5_HUMAN,,Glutamate receptor,,,,,,,,,
Q59GY7,Q59GY7_HUMAN,,Signal transducer and activator of transcription,,,,,,,,,
Q5H9R6,Q5H9R6_HUMAN,DKFZp686J1568; hCG_1790822,Full-length cDNA clone CS0DD006YF02 of Neuroblastoma of Homo sapiens; human; HCG1790822,,,,,,,,,DKFZp686J1568
Q5U003,Q5U003_HUMAN,CCR1; hCG_15324,Chemokine; C-C motif,,,,,,,,,CCR1
Q5VWE5,Q5VWE5_HUMAN,NTRK2; hCG_1985371,"Neurotrophic tyrosine kinase, receptor, type 2, isoform CRA_a; cDNA FLJ76753, highly similar to Homo sapiens neurotrophic tyrosine kinase, receptor, type 2 (NTRK2",,,,,,,,,NTRK2
Q60FE5,Q60FE5_HUMAN,FLNA,Filamin A,,,,,,,,,FLNA
Q658J6,Q658J6_HUMAN,DKFZp762B153; MAP1LC3B; hCG_32374,"Microtubule-associated protein 1 light chain 3 beta, isoform CRA_c; cDNA FLJ77661, highly similar to Homo sapiens microtubule-associated protein 1 light chain 3 beta(MAP1LC3B",MAP1LC3B,,,,,,,,DKFZp762B153
Q6AZW6,Q6AZW6_HUMAN,ATF6B,Activating transcription factor 6 beta,,,,,,,,,ATF6B
Q6MZW8,Q6MZW8_HUMAN,DKFZp686G14213,M-phase inducer phosphatase; EC 3.1.3.48,,,,,,,,,DKFZp686G14213
Q6NSL8,Q6NSL8_HUMAN,FZD10,Frizzled homolog 10; Drosophila,,,,,,,,,FZD10
Q6NUK7,Q6NUK7_HUMAN,LYN,Tyrosine-protein kinase; EC 2.7.10.2,,,,,,,,,LYN
Q6NVI1,Q6NVI1_HUMAN,MARCKS,Myristoylated alanine-rich C-kinase substrate,,,,,,,,,MARCKS
Q6NVY4,Q6NVY4_HUMAN,BNIP3,BNIP3 protein,,,,,,,,,BNIP3
Q6P164,Q6P164_HUMAN,KIF5B,Kinesin-like protein,,,,,,,,,KIF5B
Q6PKD3,Q6PKD3_HUMAN,RDX,RDX protein,,,,,,,,,RDX
Q7LC14,Q7LC14_HUMAN,NFKBIE,"NFKB inhibitor epsilon; NFKBIE protein; cDNA FLJ61640, highly similar to NF-kappa-B inhibitor epsilon",,,,,,,,,NFKBIE
Q7LDD5,Q7LDD5_HUMAN,CAMK2A; hCG_38614,calcium/calmodulin-dependent protein kinase; EC 2.7.11.17,,,,,,,,,CAMK2A
Q86TL3,Q86TL3_HUMAN,PTPN5,protein-tyrosine-phosphatase; EC 3.1.3.48,,,,,,,,,PTPN5
Q86UZ8,Q86UZ8_HUMAN,FZD2,Frizzled-2,,,,,,,,,FZD2
Q8IW76,Q8IW76_HUMAN,EIF2AK2,eIF2AK2 protein,,,,,,,,,EIF2AK2
Q8IWE0,Q8IWE0_HUMAN,CAMK2A,calcium/calmodulin-dependent protein kinase; EC 2.7.11.17,,,,,,,,,CAMK2A
Q8N2E5,Q8N2E5_HUMAN,,Protein Wnt,,,,,,,,,
Q8N381,Q8N381_HUMAN,PIK3R3,"Phosphoinositide-3-kinase, regulatory subunit 3; Gamma",,,,,,,,,PIK3R3
Q8N433,Q8N433_HUMAN,,G protein-coupled receptor kinase; EC 2.7.11.-,,,,,,,,,
Q8N6I9,Q8N6I9_HUMAN,GNAO1,Guanine nucleotide-binding protein G(o) subunit alpha; o,,,,,,,,,GNAO1
Q8TAX8,Q8TAX8_HUMAN,MAX,Protein max; Myc-associated factor X,,,,,,,,,MAX
Q96FC3,Q96FC3_HUMAN,TPX2,TPX2 protein,,,,,,,,,TPX2
R9QE65,R9QE65_HUMAN,STAT2; hCG_24995,Signal transducer and activator of transcription,,,,,,,,,STAT2
V9HWC0,V9HWC0_HUMAN,HEL70; MSN; hCG_18939,"Epididymis luminal protein 70; Moesin, isoform CRA_a",MSN,,,,,,,,HEL70
W8DTH1,W8DTH1_HUMAN,TRPM8,Transient receptor melastatin 8,,,,,,,,,TRPM8
A0A0C4DFP2,A0A0C4DFP2_HUMAN,OR1L6,Olfactory receptor family 1 subfamily L member 6,,,,,,,,,OR1L6
A0A126GV58,A0A126GV58_HUMAN,OR6K2,OR6K2,,,,,,,,,OR6K2
A0A126GV64,A0A126GV64_HUMAN,OR10K1,OR10K1,,,,,,,,,OR10K1
A0A126GV65,A0A126GV65_HUMAN,OR10K2; hCG_2044642,"OR10K2; Olfactory receptor, family 10, subfamily K, member 2",,,,,,,,,OR10K2
A0A126GV87,A0A126GV87_HUMAN,OR12D2,OR12D2,,,,,,,,,OR12D2
A0A126GVB5,A0A126GVB5_HUMAN,OR56A1,OR56A1,,,,,,,,,OR56A1
A0A126GVB9,A0A126GVB9_HUMAN,OR1K1,OR1K1,,,,,,,,,OR1K1
A0A126GVD0,A0A126GVD0_HUMAN,OR2AG1,OR2AG1,,,,,,,,,OR2AG1
A0A126GVD9,A0A126GVD9_HUMAN,OR4D5,OR4D5,,,,,,,,,OR4D5
A0A126GVG3,A0A126GVG3_HUMAN,OR8D2,OR8D2,,,,,,,,,OR8D2
A0A126GVH4,A0A126GVH4_HUMAN,OR1A2,OR1A2,,,,,,,,,OR1A2
A0A126GVH6,A0A126GVH6_HUMAN,OR4B1; hCG_2040367,"OR4B1; Olfactory receptor, family 4, subfamily B, member 1",,,,,,,,,OR4B1
A0A126GVK6,A0A126GVK6_HUMAN,OR5M9; hCG_2044259,"OR5M9; Olfactory receptor, family 5, subfamily M, member 9",,,,,,,,,OR5M9
A0A126GVK9,A0A126GVK9_HUMAN,OR52N5,OR52N5,,,,,,,,,OR52N5
A0A126GVL5,A0A126GVL5_HUMAN,OR4X2,OR4X2,,,,,,,,,OR4X2
A0A126GVM6,A0A126GVM6_HUMAN,OR5AR1; hCG_2016323,"OR5AR1; Olfactory receptor, family 5, subfamily AR, member 1",,,,,,,,,OR5AR1
A0A126GVN9,A0A126GVN9_HUMAN,OR2D2,OR2D2,,,,,,,,,OR2D2
A0A126GVP0,A0A126GVP0_HUMAN,OR5J2; hCG_2044299,"OR5J2; Olfactory receptor, family 5, subfamily J, member 2",,,,,,,,,OR5J2
A0A126GVQ3,A0A126GVQ3_HUMAN,OR3A2,OR3A2,,,,,,,,,OR3A2
A0A126GVQ6,A0A126GVQ6_HUMAN,OR1D5,OR1D5,,,,,,,,,OR1D5
A0A126GVQ9,A0A126GVQ9_HUMAN,OR4D11; hCG_2044272,"OR4D11; Olfactory receptor, family 4, subfamily D, member 11",,,,,,,,,OR4D11
A0A126GVU5,A0A126GVU5_HUMAN,OR10H1,OR10H1,,,,,,,,,OR10H1
A0A126GVV2,A0A126GVV2_HUMAN,OR10H4,OR10H4,,,,,,,,,OR10H4
A0A126GVW2,A0A126GVW2_HUMAN,OR2A4,OR2A4,,,,,,,,,OR2A4
A0A126GVX3,A0A126GVX3_HUMAN,OR10G8,OR10G8,,,,,,,,,OR10G8
A0A126GVX5,A0A126GVX5_HUMAN,OR8G5,OR8G5,,,,,,,,,OR8G5
A0A126GW16,A0A126GW16_HUMAN,OR6C76,OR6C76,,,,,,,,,OR6C76
A0A126GW20,A0A126GW20_HUMAN,OR5AK2,OR5AK2,,,,,,,,,OR5AK2
A0A126GW57,A0A126GW57_HUMAN,OR1G1; hCG_1645105,"OR1G1; Olfactory receptor, family 1, subfamily G, member 1",,,,,,,,,OR1G1
A0A126GW70,A0A126GW70_HUMAN,OR13H1; hCG_1783466,"OR13H1; Olfactory receptor, family 13, subfamily H, member 1",,,,,,,,,OR13H1
A0A126GW82,A0A126GW82_HUMAN,OR52B4,OR52B4,,,,,,,,,OR52B4
A0A126GW93,A0A126GW93_HUMAN,OR10H3,OR10H3,,,,,,,,,OR10H3
A0A126GW95,A0A126GW95_HUMAN,OR8G5,OR8G5; Olfactory receptor family 8 subfamily G member 5,,,,,,,,,OR8G5
A0A126GWA2,A0A126GWA2_HUMAN,OR1A1,OR1A1,,,,,,,,,OR1A1
A0A126GWB2,A0A126GWB2_HUMAN,OR51B2,OR51B2,,,,,,,,,OR51B2
A0A126GWB3,A0A126GWB3_HUMAN,OR3A3,OR3A3; Olfactory receptor family 3 subfamily A member 3,,,,,,,,,OR3A3
A0A126GWC6,A0A126GWC6_HUMAN,OR2AG2,OR2AG2,,,,,,,,,OR2AG2
A0A126GWD8,A0A126GWD8_HUMAN,OR2A7,OR2A7,,,,,,,,,OR2A7
A0A126GWE3,A0A126GWE3_HUMAN,OR10G3; hCG_2041507,"OR10G3; Olfactory receptor, family 10, subfamily G, member 3",,,,,,,,,OR10G3
A0A126GWE9,A0A126GWE9_HUMAN,OR10H5,OR10H5,,,,,,,,,OR10H5
A0A126GWF3,A0A126GWF3_HUMAN,OR10G7,OR10G7,,,,,,,,,OR10G7
A0A126GWF9,A0A126GWF9_HUMAN,OR11H1,OR11H1; Olfactory receptor family 11 subfamily H member 1,,,,,,,,,OR11H1
A0A126GWJ7,A0A126GWJ7_HUMAN,OR10H2; hCG_2039409,"OR10H2; Olfactory receptor, family 10, subfamily H, member 2",,,,,,,,,OR10H2
A0A126GWK0,A0A126GWK0_HUMAN,OR4D2; hCG_1686010,"OR4D2; Olfactory receptor, family 4, subfamily D, member 2",,,,,,,,,OR4D2
A0A126GWL6,A0A126GWL6_HUMAN,OR56A3,OR56A3,,,,,,,,,OR56A3
A0A126GWN3,A0A126GWN3_HUMAN,OR51S1,OR51S1,,,,,,,,,OR51S1
A0A126GWP3,A0A126GWP3_HUMAN,OR56A5,OR56A5,,,,,,,,,OR56A5
A0A126GWQ5,A0A126GWQ5_HUMAN,OR56A4,OR56A4,,,,,,,,,OR56A4
A0A126GWQ6,A0A126GWQ6_HUMAN,OR52H1,OR52H1; Olfactory receptor family 52 subfamily H member 1,,,,,,,,,OR52H1
A0A126GWS5,A0A126GWS5_HUMAN,OR10G4,OR10G4,,,,,,,,,OR10G4
A0A140VJJ8,A0A140VJJ8_HUMAN,,Testicular tissue protein Li 72,,,,,,,,,
A0A140VJT0,A0A140VJT0_HUMAN,,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B,,,,,,,,,
A0A2C9F2M6,A0A2C9F2M6_HUMAN,OR56A4,Olfactory receptor family 56 subfamily A member 4,,,,,,,,,OR56A4
A0A384NY64,A0A384NY64_HUMAN,,Epididymis secretory sperm binding protein,,,,,,,,,
A0A3B3ISU3,A0A3B3ISU3_HUMAN,FCGR3B,Fc gamma receptor IIIb,,,,,,,,,FCGR3B
A0A5K1VW61,A0A5K1VW61_HUMAN,CPEB2,Cytoplasmic polyadenylation element binding protein 2,,,,,,,,,CPEB2
A0PJJ0,A0PJJ0_HUMAN,LLGL2,LLGL2 protein,,,,,,,,,LLGL2
A4D177,A4D177_HUMAN,CBX3; CCDC32; hCG_1745364; hCG_1999239; tcag7.173,"Chromobox homolog 3; HP1 gamma homolog, Drosophila; Coiled-coil domain containing 32, isoform CRA_c",CCDC32,,,,,,,,CBX3
A8K0S6,A8K0S6_HUMAN,,cDNA FLJ76735,,,,,,,,,
A8K270,A8K270_HUMAN,,"cDNA FLJ77032, highly similar to Homo sapiens Ras protein-specific guanine nucleotide-releasing factor 1; RASGRF1",,,,,,,,,
A8K383,A8K383_HUMAN,,"cDNA FLJ75428, highly similar to Homo sapiens activating transcription factor 6; ATF6",,,,,,,,,
A8K9W7,A8K9W7_HUMAN,,"cDNA FLJ77440, highly similar to Homo sapiens general transcription factor II, i; GTF2I",,,,,,,,,
A8KAH6,A8KAH6_HUMAN,HSPB2-C11orf52; HSPB2; hCG_39461,"Heat shock 27kDa protein 2, isoform CRA_a; Heat-shock protein beta-2; Protein HSPB2-C11orf52; cDNA FLJ77220, highly similar to Homo sapiens heat shock 27kDa protein 2 (HSPB2",HSPB2,,,,,,,,HSPB2-C11orf52
B2R8B5,B2R8B5_HUMAN,,"cDNA, FLJ93820, highly similar to Homo sapiens vav 1 oncogene; VAV1",,,,,,,,,
B3KMM5,B3KMM5_HUMAN,,"cDNA FLJ11491 fis, clone HEMBA1001921, highly similar to Mitogen-activated protein kinase kinase kinase kinase 3",,,,,,,,,
B3KNJ3,B3KNJ3_HUMAN,,"cDNA FLJ14684 fis, clone NT2RP2004933, highly similar to Death-associated protein kinase 3",,,,,,,,,
B3KNV5,B3KNV5_HUMAN,,"cDNA FLJ30542 fis, clone BRAWH2001378, highly similar to Rattus norvegicus SH2-B PH domain containing signaling mediator 1; Sh2bpsm1",,,,,,,,,
B3KQ75,B3KQ75_HUMAN,,"cDNA FLJ33018 fis, clone THYMU1000459, highly similar to Homo sapiens transcription factor 7; T-cell specific, HMG-box; TCF7",,,,,,,,,
B3KQX9,B3KQX9_HUMAN,,Protein Wnt,,,,,,,,,
B3KRK9,B3KRK9_HUMAN,,"cDNA FLJ34500 fis, clone HLUNG2005479, highly similar to Phosphoinositide 3-kinase regulatory subunit 6",,,,,,,,,
B3KS07,B3KS07_HUMAN,,"cDNA FLJ35217 fis, clone PROST2000284, highly similar to MAP kinase-interactingserine/threonine-protein kinase 2",,,,,,,,,
B3KXC1,B3KXC1_HUMAN,CPEB3; hCG_20317,"Cytoplasmic polyadenylation element binding protein 3, isoform CRA_b; cDNA FLJ45117 fis, clone BRAWH3035403, highly similar to Mus musculus cytoplasmic polyadenylation element binding protein 3 (Cpeb3",,,,,,,,,CPEB3
B3KY43,B3KY43_HUMAN,,"cDNA FLJ46798 fis, clone TRACH3031660, highly similar to cAMP-dependent protein kinase type II-beta regulatory subunit",,,,,,,,,
B3KY55,B3KY55_HUMAN,,"cDNA FLJ46894 fis, clone UTERU3019708, highly similar to Regulator of nonsense transcripts 1",,,,,,,,,
B4DLN5,B4DLN5_HUMAN,SH2B1,"SH2B adaptor protein 1; cDNA FLJ59336, highly similar to Homo sapiens SH2-B homolog (SH2B",,,,,,,,,SH2B1
B4DNX3,B4DNX3_HUMAN,,"cDNA FLJ56412, highly similar to Advanced glycosylation end product-specific receptor",,,,,,,,,
B4DW78,B4DW78_HUMAN,,"cDNA FLJ59231, highly similar to C-ets-1 protein",,,,,,,,,
B4DZ33,B4DZ33_HUMAN,,"cDNA FLJ57817, highly similar to Homeodomain-interacting protein kinase 1",,,,,,,,,
B7Z1Q3,B7Z1Q3_HUMAN,,cDNA FLJ53544,,,,,,,,,
B9A6J6,B9A6J6_HUMAN,TBC1D1,"TBC1 domain family, member 1",,,,,,,,,TBC1D1
G1UI20,G1UI20_HUMAN,PTPRF,Receptor-type tyrosine-protein phosphatase F,,,,,,,,,PTPRF
K7PML8,K7PML8_HUMAN,CDKN2A,Cyclin-dependent kinase inhibitor 2A,,,,,,,,,CDKN2A
L7RSL8,L7RSL8_HUMAN,KRAS,V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,,,,,,,,,KRAS
P78453,P78453_HUMAN,c-fgr,Tyrosine kinase,,,,,,,,,c-fgr
Q1PSW9,Q1PSW9_HUMAN,GLI2,GLI family zinc finger 2; GLI2 transcription factor,,,,,,,,,GLI2
Q3B891,Q3B891_HUMAN,BRCA1,BRCA1 DNA repair associated; BRCA1 protein,,,,,,,,,BRCA1
Q499G6,Q499G6_HUMAN,GTF2I,"General transcription factor II, i",,,,,,,,,GTF2I
Q49AK4,Q49AK4_HUMAN,DCC,DCC protein,,,,,,,,,DCC
Q502V0,Q502V0_HUMAN,XCR1,Chemokine; C motif,,,,,,,,,XCR1
Q53H37,Q53H37_HUMAN,,Calmodulin-like skin protein variant,,,,,,,,,
Q53HG7,Q53HG7_HUMAN,,Cortactin isoform a variant,,,,,,,,,
Q59EG9,Q59EG9_HUMAN,,"Transforming growth factor, beta 2 variant",,,,,,,,,
Q59ES2,Q59ES2_HUMAN,,"Inositol 1,4,5-trisphosphate receptor type 3 variant",,,,,,,,,
Q59FV5,Q59FV5_HUMAN,,GLI-Kruppel family member GLI2 isoform beta variant,,,,,,,,,
Q59G17,Q59G17_HUMAN,,N-methyl-D-aspartate receptor subunit 2D variant,,,,,,,,,
Q59GB8,Q59GB8_HUMAN,,Kinesin heavy chain isoform 5C variant,,,,,,,,,
Q59GC2,Q59GC2_HUMAN,,Erythrocyte membrane protein band 4.1 like 4B variant,,,,,,,,,
Q59H48,Q59H48_HUMAN,,Lymphocyte adaptor protein variant,,,,,,,,,
Q59H94,Q59H94_HUMAN,,Gamma filamin variant,,,,,,,,,
Q59HC2,Q59HC2_HUMAN,,"Glutamate receptor, metabotropic 1 variant",,,,,,,,,
Q5H9Q5,Q5H9Q5_HUMAN,DKFZp781N0293,Uncharacterized protein DKFZp781N0293,,,,,,,,,DKFZp781N0293
Q5U091,Q5U091_HUMAN,NRAS; hCG_38454,Neuroblastoma RAS viral; V-ras,,,,,,,,,NRAS
Q5V9X9,Q5V9X9_HUMAN,CACNA1C,"Voltage-gated L-type calcium channel Cav1.2 alpha 1 subunit, splice variant 9*",,,,,,,,,CACNA1C
Q5W9H1,Q5W9H1_HUMAN,KIAA0142,KIAA0142 splice variant 1,,,,,,,,,KIAA0142
Q659G9,Q659G9_HUMAN,DKFZp586H0919,Uncharacterized protein DKFZp586H0919,,,,,,,,,DKFZp586H0919
Q689E2,Q689E2_HUMAN,XCR1,Chemokine C motif receptor 1; X-C motif chemokine receptor 1,,,,,,,,,XCR1
Q68D39,Q68D39_HUMAN,DKFZp686J04131,Uncharacterized protein DKFZp686J04131,,,,,,,,,DKFZp686J04131
Q68D60,Q68D60_HUMAN,DKFZp686N2325,Uncharacterized protein DKFZp686N2325,,,,,,,,,DKFZp686N2325
Q68DX5,Q68DX5_HUMAN,DKFZp781H1715,Uncharacterized protein DKFZp781H1715,,,,,,,,,DKFZp781H1715
Q6DKI0,Q6DKI0_HUMAN,raptor,Raptor protein,,,,,,,,,raptor
Q6FGP0,Q6FGP0_HUMAN,MRAS; hCG_17104,"MRAS protein; Muscle RAS oncogene homolog, isoform CRA_a; cDNA FLJ42964 fis, clone BRSTN2013741, highly similar to Ras-related protein M-Ras",,,,,,,,,MRAS
Q6FHM2,Q6FHM2_HUMAN,GNB2; hCG_20449,"Epididymis secretory sperm binding protein; GNB2 protein; Guanine nucleotide binding protein (G protein; cDNA FLJ77321, highly similar to Homo sapiens guanine nucleotide binding protein (G protein; GNB2",,,,,,,,,GNB2
Q6IB42,Q6IB42_HUMAN,MYL2; hCG_40212,"MYL2 protein; Myosin, light polypeptide 2, regulatory, cardiac, slow, isoform CRA_a; cDNA, FLJ92288, highly similar to Homo sapiens myosin, light polypeptide 2, regulatory, cardiac, slow (MYL2",,,,,,,,,MYL2
Q6MZJ2,Q6MZJ2_HUMAN,DKFZp686N19168,Uncharacterized protein DKFZp686N19168,,,,,,,,,DKFZp686N19168
Q6MZU1,Q6MZU1_HUMAN,DKFZp686A1195,Uncharacterized protein DKFZp686A1195,,,,,,,,,DKFZp686A1195
Q6NXF2,Q6NXF2_HUMAN,FLNA,FLNA protein,,,,,,,,,FLNA
Q6P669,Q6P669_HUMAN,JAK1,JAK1 protein,,,,,,,,,JAK1
Q6PJJ8,Q6PJJ8_HUMAN,TBC1D1,TBC1D1 protein,,,,,,,,,TBC1D1
Q7KYT6,Q7KYT6_HUMAN,STM7,Type I phosphatidylinositol-4-phosphate 5-kinase beta; EC 2.7.1.68,,,,,,,,,STM7
Q7Z727,Q7Z727_HUMAN,PRKCA,PRKCA protein,,,,,,,,,PRKCA
Q86T74,Q86T74_HUMAN,DKFZp451O0517,Uncharacterized protein DKFZp451O0517,,,,,,,,,DKFZp451O0517
Q86X09,Q86X09_HUMAN,PPP1R3D,Protein phosphatase 1 regulatory subunit,,,,,,,,,PPP1R3D
Q86YV3,Q86YV3_HUMAN,FLJ00308,FLJ00308 protein,,,,,,,,,FLJ00308
Q8IXL1,Q8IXL1_HUMAN,,"ELK4, ETS-domain protein; SRF accessory protein 1",,,,,,,,,
Q8N4Q3,Q8N4Q3_HUMAN,,Similar to Rac/Cdc42 guanine nucleotide exchange factor; GEF,,,,,,,,,
Q8N6W1,Q8N6W1_HUMAN,SMEK1,SMEK1 protein,,,,,,,,,SMEK1
Q8NC59,Q8NC59_HUMAN,,"cDNA FLJ32620 fis, clone STOMA2000386, highly similar to TBC1 domain family member 1; cDNA FLJ90473 fis, clone NT2RP3002571, highly similar to TBC1 domain family member 1",,,,,,,,,
Q8NEB1,Q8NEB1_HUMAN,,Similar to mitogen-activated protein kinase kinase kinase 9,,,,,,,,,
Q8TDP5,Q8TDP5_HUMAN,CCR3,C-C motif chemokine receptor 3; CC chemokine receptor 3,,,,,,,,,CCR3
Q8TES3,Q8TES3_HUMAN,FLJ00120,FLJ00120 protein,,,,,,,,,FLJ00120
Q8WVM9,Q8WVM9_HUMAN,,Uncharacterized protein,,,,,,,,,
Q96AI9,Q96AI9_HUMAN,,"Similar to potassium voltage-gated channel, KQT-like subfamily, member 1",,,,,,,,,
Q96D37,Q96D37_HUMAN,VAV1,VAV1 protein; Vav guanine nucleotide exchange factor 1,,,,,,,,,VAV1
Q96F31,Q96F31_HUMAN,NFKBIE,NFKBIE protein,,,,,,,,,NFKBIE
Q9H5M2,Q9H5M2_HUMAN,FOSL2; FLJ23306; hCG_1990537,"Alternative protein FOSL2; FOS-like antigen 2, isoform CRA_a; cDNA: FLJ23306 fis, clone HEP11541",FLJ23306,,,,,,,,FOSL2
Q9HA84,Q9HA84_HUMAN,,"cDNA FLJ12080 fis, clone HEMBB1002477, highly similar to Human Grb2-associated binder-1 mRNA",,,,,,,,,
Q9NPR5,Q9NPR5_HUMAN,,"PTPRJ, protein tyrosine phosphatase receptor J, eta",,,,,,,,,
Q9NSG9,Q9NSG9_HUMAN,DKFZp761N1814,Uncharacterized protein DKFZp761N1814,,,,,,,,,DKFZp761N1814
Q9P084,Q9P084_HUMAN,,HSPC298,,,,,,,,,
Q9P0T0,Q9P0T0_HUMAN,,HSPC193,,,,,,,,,
Q9P1M2,Q9P1M2_HUMAN,,PRO0412,,,,,,,,,
V9H0H7,V9H0H7_HUMAN,,HSPC022,,,,,,,,,
V9HWI5,V9HWI5_HUMAN,HEL-S-15,Epididymis secretory protein Li 15,,,,,,,,,HEL-S-15
X5DR09,X5DR09_HUMAN,GTF2I,General transcription factor IIi isoform A,,,,,,,,,GTF2I
